PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	de Coul, ELMO; Schreuder, I; Conti, S; van Sighem, A; Xiridou, M; Van Veen, MG; Heijne, JCM				de Coul, Eline L. M. Op; Schreuder, Imke; Conti, Stefano; van Sighem, Ard; Xiridou, Maria; Van Veen, Maaike G.; Heijne, Janneke C. M.			Changing Patterns of Undiagnosed HIV Infection in the Netherlands: Who Benefits Most from Intensified HIV Test and Treat Policies?	PLOS ONE			English	Article							MULTIPARAMETER EVIDENCE SYNTHESIS; PARTNER NOTIFICATION; DRUG-USERS; TRANSMISSION; VIRUS; PREVALENCE; EPIDEMIC; UNAWARE; DECLINE; AWARE	Objectives To estimate HIV prevalence, the number of people living with HIV/AIDS (PLWHA) and the undiagnosed proportion in the Netherlands for 2012, and to compare these with published 2007 estimates. Design Synthesis of all available data sources. Methods Multi-Parameter Evidence Synthesis (MPES) was used to obtain estimates in mutually exclusive key populations at higher risk in three geographical regions (Amsterdam, Rotterdam, rest of the Netherlands). Data sources included HIV prevalence surveys, diagnoses at STI clinics, and registered cases in HIV care. Group specific estimates were reported as Bayesian posterior medians and 95% credible intervals (CrI). Results The 2012 model estimated 24,350 PLWHA (95% CrI 20,420-31,280) aged 15-70 years; 2,906 (+14%) more than in 2007. The estimated population HIV prevalence was 0.20% (95% CrI 0.17-0.26%). The overall proportion of undiagnosed HIV was lower in 2012 (34%, 95% CrI 22-49%) compared to 2007 (40%, 95% CrI 25-55%). After MSM, migrants from sub-Saharan Africa and the Caribbean formed the largest groups of PLWHA, but proportions of undiagnosed HIV remained high in these groups, 48% and 44% respectively. Amsterdam had lowest proportions undiagnosed for most key populations at higher risk, including MSM and migrants. Conclusions In 2012, the number of PLWHA was higher compared to 2007, while the proportion of undiagnosed HIV was lower, especially among MSM. Higher HIV testing rates, earlier treatment, and an improved life expectancy may explain these differences. HIV interventions need to be expanded in all key populations at higher risk, with special focus on migrants and key populationsliving outside of Amsterdam.	[de Coul, Eline L. M. Op; Schreuder, Imke; Xiridou, Maria; Heijne, Janneke C. M.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Schreuder, Imke] Erasmus MC, Dept ViroSci, Rotterdam, Netherlands; [Conti, Stefano] Publ Hlth England, Stat Modelling & Econ Dept, London, England; [van Sighem, Ard] Stichting HIV Monitoring, Amsterdam, Netherlands; [Van Veen, Maaike G.] Amsterdam Hlth Serv, STI Clin Dept, Cluster Infect Dis, Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC; Public Health England	Heijne, JCM (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	janneke.heijne@rivm.nl			Netherlands Ministry of Health, Welfare and Sport; Gilead Sciences; ViiV Healthcare; Bristol-Myers Squibb	Netherlands Ministry of Health, Welfare and Sport; Gilead Sciences(Gilead Sciences); ViiV Healthcare; Bristol-Myers Squibb(Bristol-Myers Squibb)	Stichting HIV Monitoring is supported by a grant of the Netherlands Ministry of Health, Welfare and Sport. Ard van Sighem has received travel grants and honoraria to his institution from Gilead Sciences, ViiV Healthcare, and Bristol-Myers Squibb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades AE, 2006, J R STAT SOC A STAT, V169, P5, DOI 10.1111/j.1467-985X.2005.00377.x; [Anonymous], 2012, GLOB REP UNAIDS REP; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Centers for Disease Control and Prevention, 2012, HIV SURVEILLANCE R S, V17; Conti S, 2011, ANN APPL STAT, V5, P2359, DOI 10.1214/11-AOAS488; de Vos AS, 2013, ADDICTION, V108, P1070, DOI 10.1111/add.12125; Dukers-Muijrers NHTM, 2009, SEX TRANSM INFECT, V85, P226, DOI 10.1136/sti.2008.033191; Dutch Association of HIV-treating physicians, START TREATM; EMCDDA, 2013, EUR DRUG REP TRENDS; Gotz HM, 2014, SEX TRANSM INFECT, V90, P195, DOI 10.1136/sextrans-2013-051254; Guy RJ, 2008, SEX HEALTH, V5, P91, DOI 10.1071/SH07070; Haasnoot A, 2012, EPIDEMIOL INFECT, V140, P951, DOI 10.1017/S0950268811001336; Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f; Heijman RLJ, 2009, SEX TRANSM INFECT, V85, P249, DOI 10.1136/sti.2008.033258; Heijnen A, 2013, SEKSHAG EXPERTGROUP; Hospers HJ, 2006, SCHORER MONITOR 2006; Lange JMA, 2013, CLIN INFECT DIS, V57, P1048, DOI 10.1093/cid/cit425; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Op de Coul ELM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-185; Op de Coul ELM, 2014, 8 NETH C HIV PATH EP; Presanis AM, 2010, AIDS, V24, P2849, DOI 10.1097/QAD.0b013e32834021ed; Sanquin, SANQ ANN REP 2012; SOA AIDS Nederland, 2013, STRAT AANP SOAS HIV; Soetens LC, 2013, SEXUALLY TRANSMITTED; Van Aar F, 2014, SEXUALLY TRANSMITTED; van Aar F, 2014, 8 NETH C HIV PATH EP; van Aar F, 2015, INT J STD AIDS, V26, P565, DOI 10.1177/0956462414547398; van Aar F, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-114; van Beek P, 2013, PROGRAMMA BERICHT EX; van den Berg CHSB, 2007, EUR J EPIDEMIOL, V22, P183, DOI 10.1007/s10654-006-9089-7; van empelen P, 2011, SCHORER MONITOR 2011; van Sighem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044819; van Veen MG, 2011, AIDS, V25, P229, DOI 10.1097/QAD.0b013e32834171bc; van-Sighem A, 2013, MONITORING REPORT 20; Walker N, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010207; Zuilhof W, 2009, SEKSOA MAGAZINE	40	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133232	10.1371/journal.pone.0133232	http://dx.doi.org/10.1371/journal.pone.0133232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185998	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700113
J	Sued, O; Ambrosioni, J; Nicolas, D; Manzardo, C; Aguero, F; Claramonte, X; Plana, M; Tuset, M; Pumarola, T; Gallart, T; Gatell, JM; Miro, JM				Sued, Omar; Ambrosioni, Juan; Nicolas, David; Manzardo, Christian; Agueero, Fernando; Claramonte, Xavier; Plana, Montserrat; Tuset, Montserrat; Pumarola, Tomas; Gallart, Teresa; Gatell, Jose Mara; Maria Miro, Jose			Structured Treatment Interruptions and Low Doses of IL-2 in Patients with Primary HIV Infection. Inflammatory, Virological and Immunological Outcomes	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INTERLEUKIN-2 THERAPY; IMMUNE-RESPONSES; REPLICATION; IMPACT; AIDS; DISCONTINUATION; RESTORATION; SUBSETS; TRIAL	Background Interventions during primary HIV infection (PHI) can modify the clinical course during the chronic phase. The long-term effect of structured treatment interruptions (STI) followed by low doses of interleukin-2 (IL-2) in treated PHI patients is unknown. Methods Twelve PHI patients with viral load (VL) <20 copies/mL, CD4 cells >500 cells/mm3, and CD4/CD8 ratio >1, on antiretroviral therapy (ART) initiated within the first 90 days of infection and continued for at least 12 months were included. They underwent four STI and were then allocated (week 0 of the study) to ART alone or ART plus low doses of IL-2. ART was stopped once VL <20 copies/mL ('final stop'). Primary endpoints were VL< 3000 copies/mL and CD4 cells >500 cells/mm3 at 48 weeks; secondary endpoints were immune activation, inflammatory markers until 48 weeks and the time before resuming ART (CD4 <350 cells/mm3 or AIDS) after 'final stop', compared between groups. Results Ten out of 12 patients were males, median age was 35 years and the main risk was men-who-have-sex-with-men. Only one out of 12 patients (in the STI group) maintained VL< 3000 copies/mL and CD4 cells >500 cells/mm3 without ART at 48 weeks. All other virological and immunological parameters were comparable between groups at week 0, 'final stop' and week 48. However, the proportion of CD8-CD38+ cells, tumor necrosis factor and srIL-2 were higher in the IL-2 group at 'final stop' and week 24. All these differences vanished during follow-up. At 5 years after the final stop 3 out of 6 patients in the IL-2 group and 6 out of 6 patients in the STI group have resumed ART (P = 0.19). Conclusions STI and IL-2 failed to achieve virological control after ART interruption. STI were not deleterious in long-term follow-up, an important issue for eradication and functional cure trials.	[Sued, Omar; Ambrosioni, Juan; Nicolas, David; Manzardo, Christian; Agueero, Fernando; Claramonte, Xavier; Plana, Montserrat; Pumarola, Tomas; Gallart, Teresa; Gatell, Jose Mara; Maria Miro, Jose] Univ Barcelona, Hosp Clin, IDIBAPS, Infect Dis Serv, Barcelona, Spain; [Tuset, Montserrat] Univ Barcelona, Hosp Clin, IDIBAPS, Serv Pharm, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Miro, JM (corresponding author), Univ Barcelona, Hosp Clin, IDIBAPS, Infect Dis Serv, Barcelona, Spain.	jmmiro@ub.edu	Sued, Omar/GRJ-3964-2022; Pumarola, Tomàs/AAB-5532-2019; Gatell, Jose M/ABC-3607-2020; Suñe, Tomàs Pumarola/F-7583-2017; Plana, Montserrat/AAA-5124-2020	Pumarola, Tomàs/0000-0002-5171-7461; Suñe, Tomàs Pumarola/0000-0002-5171-7461; Tuset, Montse/0000-0002-9153-6956; Nicolas, David/0000-0002-1968-5287	Spanish Foundation for AIDS Research and Prevention (FIPSE), Madrid (Spain) [00/3128]; "Fondo de Investigaciones Sanitarias" (FIS) grant from the "Instituto de Salud Carlos III", Madrid, Spain [04/0363]; post-residency Scholarship Ajuts a la Recerca 'Josep Font', Hospital Clinic, Barcelona, Spain; "Instituto de Salud Carlos III", Madrid (Spain); "Ministerio de Economia and Competitividad", Madrid (Spain)	Spanish Foundation for AIDS Research and Prevention (FIPSE), Madrid (Spain); "Fondo de Investigaciones Sanitarias" (FIS) grant from the "Instituto de Salud Carlos III", Madrid, Spain; post-residency Scholarship Ajuts a la Recerca 'Josep Font', Hospital Clinic, Barcelona, Spain; "Instituto de Salud Carlos III", Madrid (Spain)(Instituto de Salud Carlos III); "Ministerio de Economia and Competitividad", Madrid (Spain)	This project was supported in part by grants from the Spanish Foundation for AIDS Research and Prevention (FIPSE), Grant 00/3128, Madrid (Spain) awarded to JM and by the "Fondo de Investigaciones Sanitarias" (FIS) grant 04/0363 from the "Instituto de Salud Carlos III", Madrid, Spain awarded to JM. Interlekin-2 (Macrolin (R)) was provided free-of-charge by Chiron, Madrid, Spain. JA developed this work in the frame of a 'Juan de la Cierva 2012' post-doctoral program, Ministerio de Competitividad, Spain. DN developed this work in the frame of a a post-residency Scholarship Ajuts a la Recerca 'Josep Font' 2014, Hospital Clinic, Barcelona, Spain, FA held a Rio Hortega Research Grant from the "Instituto de Salud Carlos III" and the "Ministerio de Economia and Competitividad", Madrid (Spain) whilst this work was being developed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Allen TM, 2002, TRENDS IMMUNOL, V23, P456, DOI 10.1016/S1471-4906(02)02297-4; Alos L, 2005, MODERN PATHOL, V18, P127, DOI 10.1038/modpathol.3800267; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Ambrosioni J, 2012, AIDS, V26, P2079, DOI 10.1097/QAD.0b013e32835805b6; Ambrosioni J, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-28; Autran B, 2000, SCIENCE, V290, P946, DOI 10.1126/science.290.5493.946; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cutrell J, 2013, CURR HIV-AIDS REP, V10, P207, DOI 10.1007/s11904-013-0166-8; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fagard C, 2003, ARCH INTERN MED, V163, P1220, DOI 10.1001/archinte.163.10.1220; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Gandhi RT, 2002, CURR OPIN IMMUNOL, V14, P487, DOI 10.1016/S0952-7915(02)00359-X; Goujard C, 2012, ANTIVIR THER, V17, P1001, DOI 10.3851/IMP2273; Goujard C, 2012, AIDS, V26, P1895, DOI 10.1097/QAD.0b013e32835844d9; Grijsen ML, 2012, HIV MED, V13, P630, DOI 10.1111/j.1468-1293.2012.01020.x; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; Hocqueloux L, 2013, J ANTIMICROB CHEMOTH; Hocqueloux L, 2010, AIDS, V24, P1598, DOI 10.1097/QAD.0b013e32833b61ba; Jacobson EL, 1996, P NATL ACAD SCI USA, V93, P10405, DOI 10.1073/pnas.93.19.10405; Jacobson EL, 1997, NEW ENGL J MED, V336, P1260, DOI 10.1056/NEJM199704243361716; Jacobson JM, 2006, J INFECT DIS, V194, P623, DOI 10.1086/506364; Kaufmann DE, 2004, PLOS MED, V1, P137, DOI 10.1371/journal.pmed.0010036; Kaufmann GR, 2000, AIDS, V14, P2643, DOI 10.1097/00002030-200012010-00003; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Lisziewicz J, 1999, NEW ENGL J MED, V340, P1683, DOI 10.1056/NEJM199905273402114; Lori F, 2000, SCIENCE, V290, P1591, DOI 10.1126/science.290.5496.1591; Ortiz GM, 1999, J CLIN INVEST, V104, pR13, DOI 10.1172/JCI7371; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; Papasavvas E, 2004, PLOS MED, V1, P218, DOI 10.1371/journal.pmed.0010064; Plana M, 1998, LANCET, V352, P1194, DOI 10.1016/S0140-6736(05)60532-6; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Schockmel GA, 1998, AIDS, V12, P1726; Shasha D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00162; Smith KA, 2001, AIDS, V15, pS28, DOI 10.1097/00002030-200102002-00006; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Yerly S, 2000, AIDS, V14, P2805, DOI 10.1097/00002030-200012220-00001; Zaunders JJ, 1999, J INFECT DIS, V180, P320, DOI 10.1086/314880; Zaunders J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00095	42	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131651	10.1371/journal.pone.0131651	http://dx.doi.org/10.1371/journal.pone.0131651			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186440	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700020
J	Zhao, L; Liu, S; Wang, Y; Zhang, QY; Zhao, WJ; Wang, ZJ; Yin, M				Zhao, Lu; Liu, Sha; Wang, Yin; Zhang, Qiaoyan; Zhao, Wenjuan; Wang, Zejian; Yin, Ming			Effects of Curculigoside on Memory Impairment and Bone Loss via Anti-Oxidative Character in APP/PS1 Mutated Transgenic Mice	PLOS ONE			English	Article							NF-KAPPA-B; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; AMYLOID-BETA; POSTMENOPAUSAL OSTEOPOROSIS; LIPID-PEROXIDATION; NITRIC-OXIDE; DIFFERENTIATION; ORCHIOIDES; OSTEOBLASTS	Alzheimer's disease (AD) and osteoporosis are two closely related multifactorial progressively degenerative diseases that predominantly affect aged people. These two diseases share many common risk factors, including old age, being female, smoking, excessive drinking, low estrogen, and vitamin D3 levels. Additionally, oxidative damage and the dysfunction of the antioxidant system play important roles in the pathogenesis of osteoporosis and AD. A beta not only leads to impaired memory but also plays a crucial role in the demineralization process of bone tissues of older people and women with menopause. Curculigoside can promote calcium deposition and increase the levels of ALP and Runx2 in osteoblasts under oxidative stress via anti-oxidative character. Therefore, we investigated the effects of CUR on the spatial learning and memory by the Morris water maze and brain immunohistochemistry, and bone microstructure and material properties of femurs by micro-computed tomography and mechanical testing in APP/PS1 mutated transgenic mice. Oral administration of CUR can significantly enhance learning performance and ameliorate bone loss in APP/PS1 mutated transgenic mice, and the mechanism may be related to its antioxidant effect. Based on these results, CUR has real potential as a new natural resource for developing medicines or dietary supplements for the prevention and treatment of the two closely linked multifactorial progressive degenerative disorders, AD and osteoporosis.	[Zhao, Lu; Zhao, Wenjuan; Wang, Zejian; Yin, Ming] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; [Wang, Yin] PLA 455 Hosp, Shanghai, Peoples R China; [Liu, Sha] Chengdu Med Coll, Sch Pharm, Dept Pharmacol, Chengdu, Sichuan, Peoples R China; [Zhang, Qiaoyan] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chengdu Medical College; Naval Medical University	Wang, ZJ (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China.	wangzejian@sjtu.edu.cn; myin@sjtu.edu.cn			National Natural Science Foundation of China [81274152]; natural science foundation of Shanghai science and Technology Commission, China [13ZR1449600]; scientific research fund of Shanghai City Health Planning Commission, China [2013299]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); natural science foundation of Shanghai science and Technology Commission, China; scientific research fund of Shanghai City Health Planning Commission, China	This study was supported by the grants from the National Natural Science Foundation of China (Grant No. 81274152), the natural science foundation of Shanghai science and Technology Commission, China (Grant No. 13ZR1449600), and the scientific research fund of Shanghai City Health Planning Commission, China (Grant No. 2013299).	Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Bai XC, 2004, BIOCHEM BIOPH RES CO, V314, P197, DOI 10.1016/j.bbrc.2003.12.073; Belkacemi A, 2012, FREE RADICAL BIO MED, V52, P593, DOI 10.1016/j.freeradbiomed.2011.11.020; Tung BT, 2015, EXP GERONTOL, V64, P1, DOI 10.1016/j.exger.2015.02.004; CALABRESE V, 2014, EXPT PHARM DRUG DISC, V5, P120; Cao Q, 2014, BIOMATERIALS, V35, P8273, DOI 10.1016/j.biomaterials.2014.06.020; Chen G, 2015, BIOL PHARM B; Garnero P, 1996, J BONE MINER RES, V11, P337, DOI 10.1002/jbmr.5650110307; Garnero P, 2014, BONE, V66, P46, DOI 10.1016/j.bone.2014.05.016; Gouras GK, 2014, NEUROTHERAPEUTICS, P1; Jagger CJ, 2005, ENDOCRINOLOGY, V146, P113, DOI 10.1210/en.2004-1058; Jia P, 2012, J ORTHOP RES, V30, P1843, DOI 10.1002/jor.22133; Jiao L, 2009, PHYTOMEDICINE, V16, P874, DOI 10.1016/j.phymed.2009.01.005; Kang Z, 2014, NEUROSCIENCE, V267, P232, DOI 10.1016/j.neuroscience.2014.02.050; Lakshmi V, 2003, J ETHNOPHARMACOL, V89, P181, DOI 10.1016/S0378-8741(03)00160-0; Lalonde R, 2012, REV NEUROSCIENCE, V23, P363, DOI 10.1515/revneuro-2012-0041; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li SF, 2014, BONE, V61, P164, DOI 10.1016/j.bone.2014.01.010; Lin TW, 2015, NEUROBIOL LEARN MEM, V118, P189, DOI 10.1016/j.nlm.2014.12.005; Liraz O, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-16; Liu Lei, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P1419, DOI 10.3736/jcim20121214; Liu MM, 2014, STEM CELLS DEV, V23, P146, DOI 10.1089/scd.2013.0261; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Melville KM, 2014, J BONE MINER RES, V29, P370, DOI 10.1002/jbmr.2082; Mlakar SJ, 2012, MENOPAUSE, V19, P368, DOI 10.1097/gme.0b013e31822d5b10; Morley JE, 2014, BIOCHEM PHARMACOL, V88, P479, DOI 10.1016/j.bcp.2013.12.018; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Ozgocmen S, 2007, ARCH MED RES, V38, P196, DOI 10.1016/j.arcmed.2006.09.010; Ozgocmen S, 2007, MOL CELL BIOCHEM, V295, P45, DOI 10.1007/s11010-006-9270-z; PECK WA, 1993, AM J MED, V94, P646; Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002; Sato Y, 2004, J NEUROL SCI, V223, P107, DOI 10.1016/j.jns.2004.03.033; Shen GS, 2014, CALCIFIED TISSUE INT, V94, P632, DOI 10.1007/s00223-014-9845-8; Steeve KT, 2004, CYTOKINE GROWTH F R, V15, P49, DOI 10.1016/j.cytogfr.2003.10.005; Tian Z, 2012, FOOD CHEM TOXICOL, V50, P4010, DOI 10.1016/j.fct.2012.08.006; Toth P., 2015, AGING CELL; Wang Y, 2012, ACTA BIOCH BIOPH SIN, V44, P431, DOI 10.1093/abbs/gms014; Wang YK, 2010, J ETHNOPHARMACOL, V132, P233, DOI 10.1016/j.jep.2010.08.008; [吴琼 WU Qiong], 2007, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V24, P6; Wu XY, 2012, MOLECULES, V17, P10108, DOI 10.3390/molecules170910108; Xia WF, 2013, J BONE MINER RES, V28, P2122, DOI 10.1002/jbmr.1954; Zhao Y, 2013, OXIDATIVE STRESS AND, V2013	42	17	24	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133289	10.1371/journal.pone.0133289	http://dx.doi.org/10.1371/journal.pone.0133289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186010	Green Submitted, gold, Green Published			2022-12-27	WOS:000358198700121
J	Lopper, ME; Boone, J; Morrow, C				Lopper, Matthew E.; Boone, Jacob; Morrow, Christopher			Deinococcus radiodurans PriA is a Pseudohelicase	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; STALLED REPLICATION FORKS; PHI X174-TYPE PRIMOSOME; ESCHERICHIA-COLI K-12; FACTOR-Y; PROTEIN; HELICASE; BINDING; RESTART; REPAIR	Reactivation of repaired DNA replication forks in bacteria is catalyzed by PriA helicase. This broadly-conserved bacterial enzyme can remodel the structure of DNA at a repaired DNA replication fork by unwinding small portions of duplex DNA to prepare the fork for replisome reloading. While PriA's helicase activity is not strictly required for cell viability in E. coli, the sequence motifs that confer helicase activity upon PriA are well-conserved among sequenced bacterial priA genes, suggesting that PriA's duplex DNA unwinding activity confers a selective advantage upon cells. However, these helicase sequence motifs are not well-conserved among priA genes from the Deinococcus-Thermus phylum. Here, we show that PriA from a highly radiation-resistant member of that phylum, Deinococcus radiodurans, lacks the ability to hydrolyze ATP and unwind duplex DNA, thus qualifying D. radiodurans PriA as a pseudohelicase. Despite the lack of helicase activity, D. radiodurans PriA has retained the DNA binding activity expected of a typical PriA helicase, and we present evidence for a physical interaction between D. radiodurans PriA and its cognate replicative helicase, DnaB. This suggests that PriA has retained a role in replisome reloading onto repaired DNA replication forks in D. radiodurans despite its lack of helicase activity.	[Lopper, Matthew E.; Boone, Jacob; Morrow, Christopher] Univ Dayton, Dept Chem, Dayton, OH 45469 USA	University of Dayton	Lopper, ME (corresponding author), Univ Dayton, Dept Chem, Dayton, OH 45469 USA.	mlopper1@udayton.edu		Morrow, Christopher/0000-0002-9208-2511	University of Dayton Honors Program	University of Dayton Honors Program	JB and CM were supported by the University of Dayton Honors Program.	BROSH RM, 1995, J BACTERIOL, V177, P5612, DOI 10.1128/jb.177.19.5612-5621.1995; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Feng C, 2011, BMC MICROBIOL, V11, DOI [10.1186/1471-2180-11-189, 10.1186/1471-2229-11-136]; Galletto R, 2004, BIOCHEMISTRY-US, V43, P11002, DOI 10.1021/bi049378q; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Jezewska MJ, 2000, J BIOL CHEM, V275, P27865; Jezewska MJ, 2000, BIOCHEMISTRY-US, V39, P10454, DOI 10.1021/bi001113y; Kogoma T, 1996, J BACTERIOL, V178, P1258, DOI 10.1128/jb.178.5.1258-1264.1996; LEE MS, 1987, P NATL ACAD SCI USA, V84, P8345, DOI 10.1073/pnas.84.23.8345; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Liu J, 1996, J BIOL CHEM, V271, P15656, DOI 10.1074/jbc.271.26.15656; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Ng JY, 1996, J BIOL CHEM, V271, P15642, DOI 10.1074/jbc.271.26.15642; NURSE P, 1990, P NATL ACAD SCI USA, V87, P4615, DOI 10.1073/pnas.87.12.4615; Pace C N, 1986, Methods Enzymol, V131, P266; Sandler SJ, 2000, GENETICS, V155, P487; Sandler SJ, 1996, GENETICS, V143, P5; SCHEKMAN R, 1975, J BIOL CHEM, V250, P5859; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WICKNER S, 1974, P NATL ACAD SCI USA, V71, P4120, DOI 10.1073/pnas.71.10.4120; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P3342, DOI 10.1073/pnas.72.9.3342; ZAVITZ KH, 1992, J BIOL CHEM, V267, P6933	28	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133419	10.1371/journal.pone.0133419	http://dx.doi.org/10.1371/journal.pone.0133419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182205	gold, Green Submitted, Green Published			2022-12-27	WOS:000358198200064
J	Moreno-Garcia, M; Vargas, V; Ramirez-Bello, I; Hernandez-Martinez, G; Lanz-Mendoza, H				Moreno-Garcia, Miguel; Vargas, Valeria; Ramirez-Bello, Inci; Hernandez-Martinez, Guadalupe; Lanz-Mendoza, Humberto			Bacterial Exposure at the Larval Stage Induced Sexual Immune Dimorphism and Priming in Adult Aedes aegypti Mosquitoes	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; YELLOW-FEVER MOSQUITO; ESCHERICHIA-COLI; NITRIC-OXIDE; TRADE-OFFS; ANTIBACTERIAL DEFENSE; BATEMANS PRINCIPLE; INFECTION; SYSTEM; INSECT	Gender differences in the immune response of insects are driven by natural selection for females and sexual selection for males. These natural forces entail a multitude of extrinsic and intrinsic factors involved in a genotype-environment interaction that results in sex-biased expression of the genes shared by males and females. However, little is known about how an infection at a particular ontogenetic stage may influence later stages, or how it may impact sexual immune dimorphism. Using Aedes aegypti mosquitoes, the aim of the present study was to analyze the effect of a bacterial exposure at the larval stage on adult immunity in males and females. The parameters measured were phenoloxidase activity, nitric oxide production, antimicrobial activity, and the antimicrobial peptide transcript response. As a measure of the immune response success, the persistence of injected bacteria was also evaluated. The results show that males, as well as females, were able to enhance survival in the adult stage as a result of being exposed at the larval stage, which indicates a priming effect. Moreover, there was a differential gender immune response, evidenced by higher PO activity in males as well as higher NO production and greater antimicrobial activity in females. The greater bacterial persistence in females suggests a gender-specific strategy for protection after a previous experience with an elicitor. Hence, this study provides a primary characterization of the complex and gender-specific immune response of male and female adults against a bacterial challenge in mosquitoes primed at an early ontogenetic stage.	[Moreno-Garcia, Miguel; Vargas, Valeria; Ramirez-Bello, Inci; Hernandez-Martinez, Guadalupe; Lanz-Mendoza, Humberto] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca 62100, Morelos, Mexico; [Vargas, Valeria] Univ Nacl Autonoma Mexico, Ciencias Biol, Mexico City 04510, DF, Mexico	Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico	Moreno-Garcia, M (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	miguelmoga2000@yahoo.com.mx; humberto@insp.mx	Lanz-Mendoza, Humberto/GLV-1737-2022	MORENO-GARCIA, MIGUEL/0000-0001-6733-9007; Vargas, Valeria/0000-0003-3657-2708	Programa Nacional de Posgrado de Calidad, SEP-CONACYT [290662 INSP]; Fondo Sectorial de Investigacion para la Educacion SEP-CONACYT [Proyect: 183027]; Posgrado en Ciencias Biologicas (CONACYT) [269766]; Comision Coordinadora de Institutos Nacionales de Salud y Hospitales de Alta Especialidad, Secretaria de Salud, Mexico (Programas de Becas de Inicio a la Investigacion grant)	Programa Nacional de Posgrado de Calidad, SEP-CONACYT; Fondo Sectorial de Investigacion para la Educacion SEP-CONACYT; Posgrado en Ciencias Biologicas (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Comision Coordinadora de Institutos Nacionales de Salud y Hospitales de Alta Especialidad, Secretaria de Salud, Mexico (Programas de Becas de Inicio a la Investigacion grant)	MM-G received a posdoctoral fellowship (Programa Nacional de Posgrado de Calidad, SEP-CONACYT; 290662 INSP) and Fondo Sectorial de Investigacion para la Educacion SEP-CONACYT (Proyect: 183027). VV received Posgrado en Ciencias Biologicas (CONACYT MsC grant No. 269766. IR-B received Comision Coordinadora de Institutos Nacionales de Salud y Hospitales de Alta Especialidad, Secretaria de Salud, Mexico (Programas de Becas de Inicio a la Investigacion grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2004, ANIM BEHAV, V68, P1443, DOI 10.1016/j.anbehav.2004.05.005; Adamo SA, 2001, ANIM BEHAV, V62, P417, DOI 10.1006/anbe.2001.1786; Altincicek B, 2011, DEV COMP IMMUNOL, V35, P1089, DOI 10.1016/j.dci.2011.03.017; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bartholomay LC, 2007, INSECT MOL BIOL, V16, P761, DOI 10.1111/j.1365-2583.2007.00773.x; Bartholomay LC, 2004, INSECT MOL BIOL, V13, P125, DOI 10.1111/j.0962-1075.2004.00467.x; BOMAN HG, 1972, NATURE, V237, P232, DOI 10.1038/237232a0; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Castillo J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002274; Choi YJ, 2012, INSECT BIOCHEM MOLEC, V42, P729, DOI 10.1016/j.ibmb.2012.06.005; Clements AN., 1992, BIOL MOSQUITOES DEV; Coggins SA, 2012, DEV COMP IMMUNOL, V37, P390, DOI 10.1016/j.dci.2012.01.005; Contreras-Garduno J, 2014, MICROBES INFECT, V16, P261, DOI 10.1016/j.micinf.2013.11.010; Contreras-Garduno J, 2015, DEV COMP IMMUNOL, V52, P172, DOI 10.1016/j.dci.2015.05.004; Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; Dada N, 2013, ACTA TROP, V126, P177, DOI 10.1016/j.actatropica.2013.02.023; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Dubovskiy IM, 2008, J INVERTEBR PATHOL, V98, P360, DOI 10.1016/j.jip.2008.03.011; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; Eleftherianos I, 2006, INSECT BIOCHEM MOLEC, V36, P517, DOI 10.1016/j.ibmb.2006.04.001; Fellowes MDE, 1998, P ROY SOC B-BIOL SCI, V265, P1553, DOI 10.1098/rspb.1998.0471; Ferguson HM, 2005, TRENDS ECOL EVOL, V20, P202, DOI 10.1016/j.tree.2005.02.003; Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Hernandez-Martinez S, 2002, J MED ENTOMOL, V39, P61, DOI 10.1603/0022-2585-39.1.61; Hillyer JF, 2004, MICROBES INFECT, V6, P448, DOI 10.1016/j.micinf.2004.01.005; Hillyer JF, 2005, CELL MICROBIOL, V7, P39, DOI 10.1111/j.1462-5822.2004.00430.x; Hillyer JF, 2010, DEV COMP IMMUNOL, V34, P141, DOI 10.1016/j.dci.2009.08.014; Jacot A, 2005, P ROY SOC B-BIOL SCI, V272, P63, DOI 10.1098/rspb.2004.2919; King JG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-55; Lazzaro BP, 2001, GENETICS, V159, P659; LECLAIRE M, 1994, OECOLOGIA, V100, P379, DOI 10.1007/BF00317858; Lowenberger C, 1999, J BIOL CHEM, V274, P20092, DOI 10.1074/jbc.274.29.20092; Lowenberger C, 2001, INSECT BIOCHEM MOLEC, V31, P219, DOI 10.1016/S0965-1748(00)00141-7; Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252; McKean KA, 2005, EVOLUTION, V59, P1510; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moreno-Garcia M, 2013, B ENTOMOL RES, V103, P127, DOI 10.1017/S000748531200048X; Moreno-Garcia M, 2010, J MED ENTOMOL, V47, P111, DOI 10.1603/ME08267; Moret Y, 2006, P R SOC B, V273, P1399, DOI 10.1098/rspb.2006.3465; Muller U, 1997, PROG NEUROBIOL, V51, P363, DOI 10.1016/S0301-0082(96)00067-6; Natori Shunji, 1998, P245; Ottaviani E, 2015, ISJ-INVERT SURVIV J, V12, P1; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Ponlawat A, 2009, AM J TROP MED HYG, V80, P395, DOI 10.4269/ajtmh.2009.80.395; Ramirez JL, 2014, J INNATE IMMUN, V6, P119, DOI 10.1159/000353765; Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561; Ramos-Castaneda J, 2008, INTERVIROLOGY, V51, P335, DOI 10.1159/000175639; Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548; Rantala MJ, 2006, J EVOLUTION BIOL, V19, P834, DOI 10.1111/j.1420-9101.2005.01048.x; Rice WR, 2001, J EVOLUTION BIOL, V14, P685, DOI 10.1046/j.1420-9101.2001.00319.x; Rivero A, 2006, TRENDS PARASITOL, V22, P219, DOI 10.1016/j.pt.2006.02.014; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Rolff J, 2002, P ROY SOC B-BIOL SCI, V269, P867, DOI 10.1098/rspb.2002.1959; Rolff J, 2004, P ROY SOC B-BIOL SCI, V271, P2157, DOI 10.1098/rspb.2004.2859; Sadd B, 2006, J EVOLUTION BIOL, V19, P321, DOI 10.1111/j.1420-9101.2005.01062.x; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schulenburg H, 2009, PHILOS T R SOC B, V364, P3, DOI 10.1098/rstb.2008.0249; Schwartz A, 2004, J EVOLUTION BIOL, V17, P834, DOI 10.1111/j.1420-9101.2004.00720.x; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Srygley RB, 2012, J INSECT PHYSIOL, V58, P342, DOI 10.1016/j.jinsphys.2011.12.005; Tate AT, 2012, OIKOS, V121, P1083, DOI 10.1111/j.1600-0706.2011.19725.x; Thomas AM, 2010, ECOL ENTOMOL, V35, P200, DOI 10.1111/j.1365-2311.2009.01169.x; Tidbury HJ, 2011, P ROY SOC B-BIOL SCI, V278, P871, DOI 10.1098/rspb.2010.1517; Voordouw MJ, 2008, OIKOS, V117, P1269, DOI 10.1111/j.0030-1299.2008.16741.x; WALKER ED, 1991, ECOLOGY, V72, P1529, DOI 10.2307/1940953; Wang JJ, 2013, DEV COMP IMMUNOL, V40, P142, DOI 10.1016/j.dci.2013.02.003; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]	73	34	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133240	10.1371/journal.pone.0133240	http://dx.doi.org/10.1371/journal.pone.0133240			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181517	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198200060
J	Ratliff, EP; Mauntz, RE; Kotzebue, RW; Gonzalez, A; Achal, M; Barekat, A; Finley, KA; Sparhawk, JM; Robinson, JE; Herr, DR; Harris, GL; Joiner, WJ; Finley, KD				Ratliff, Eric P.; Mauntz, Ruth E.; Kotzebue, Roxanne W.; Gonzalez, Arysa; Achal, Madhulika; Barekat, Ayeh; Finley, Kaelyn A.; Sparhawk, Jonathan M.; Robinson, James E.; Herr, Deron R.; Harris, Greg L.; Joiner, William J.; Finley, Kim D.			Aging and Autophagic Function Influences the Progressive Decline of Adult Drosophila Behaviors	PLOS ONE			English	Article							BINDING-PROTEIN GENES; CIRCADIAN-RHYTHMS; SLEEP; MELANOGASTER; SYSTEM; MEMORY; MODEL; NEURODEGENERATION; DISSATISFACTION; HEALTHSPAN	Multiple neurological disorders are characterized by the abnormal accumulation of protein aggregates and the progressive impairment of complex behaviors. Our Drosophila studies demonstrate that middle-aged wild-type flies (WT, similar to 4-weeks) exhibit a marked accumulation of neural aggregates that is commensurate with the decline of the autophagy pathway. However, enhancing autophagy via neuronal over-expression of Atg8a (Atg8a-OE) reduces the age-dependent accumulation of aggregates. Here we assess basal locomotor activity profiles for single- and group-housed male and female WT flies and observed that only modest behavioral changes occurred by 4-weeks of age, with the noted exception of group-housed male flies. Male flies in same-sex social groups exhibit a progressive increase in nighttime activity. Infrared videos show aged group-housed males (4-weeks) are engaged in extensive bouts of courtship during periods of darkness, which is partly repressed during lighted conditions. Together, these nighttime courtship behaviors were nearly absent in young WT flies and aged Atg8a-OE flies. Previous studies have indicated a regulatory role for olfaction in male courtship partner choice. Coincidently, the mRNA expression profiles of several olfactory genes decline with age in WT flies; however, they are maintained in age-matched Atg8a-OE flies. Together, these results suggest that middle-aged male flies develop impairments in olfaction, which could contribute to the dysregulation of courtship behaviors during dark time periods. Combined, our results demonstrate that as Drosophila age, they develop early behavior defects that are coordinate with protein aggregate accumulation in the nervous system. In addition, the nighttime activity behavior is preserved when neuronal autophagy is maintained (Atg8a-OE flies). Thus, environmental or genetic factors that modify autophagic capacity could have a positive impact on neuronal aging and complex behaviors.	[Ratliff, Eric P.; Mauntz, Ruth E.; Kotzebue, Roxanne W.; Gonzalez, Arysa; Achal, Madhulika; Barekat, Ayeh; Finley, Kaelyn A.; Sparhawk, Jonathan M.; Finley, Kim D.] San Diego State Univ, Donald P Shiley BioSci Ctr, San Diego, CA 92182 USA; [Ratliff, Eric P.; Mauntz, Ruth E.; Kotzebue, Roxanne W.; Gonzalez, Arysa; Finley, Kaelyn A.; Herr, Deron R.; Harris, Greg L.; Finley, Kim D.] Express Drug Designs LLC, San Diego, CA USA; [Ratliff, Eric P.; Kotzebue, Roxanne W.; Gonzalez, Arysa; Achal, Madhulika; Barekat, Ayeh; Sparhawk, Jonathan M.; Herr, Deron R.; Harris, Greg L.; Finley, Kim D.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Robinson, James E.; Joiner, William J.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Robinson, James E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Herr, Deron R.] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore	California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California San Diego; National University of Singapore	Finley, KD (corresponding author), San Diego State Univ, Donald P Shiley BioSci Ctr, San Diego, CA 92182 USA.	kfinley@mail.sdsu.edu	Herr, Deron/AAB-7380-2020	Herr, Deron/0000-0001-5755-0896; Mauntz, Ruth/0000-0003-0376-3313	National Institutes of Health/National Institute of Aging [R44AG033427, R01AG039628]; National Science Foundation [DGE-1144086]; University of California San Diego Graduate Cellular and Molecular Pharmacology [T32 GM007752]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R44AG033427, R01AG039628] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science Foundation(National Science Foundation (NSF)); University of California San Diego Graduate Cellular and Molecular Pharmacology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health/National Institute of Aging (http://www.nia.nih.gov): R44AG033427 and R01AG039628; the National Science Foundation (https://www.nsfgrfp.org): DGE-1144086; University of California San Diego Graduate Cellular and Molecular Pharmacology (http://biomedsci.ucsd.edu/): T32 GM007752. Expression Drug Designs, LLC provided support in the form of salaries for co-authors (Kim Finley, Eric Ratliff, Ruth Mauntz, Arysa Gonzalez, Kaelyn Finley, Deron Herr, and Greg Harris) but did not have any additional role in the study design, data collection and analysis or in the decision to publish or prepare the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agrawal S, 2014, J EXP BIOL, V217, P2796, DOI 10.1242/jeb.105817; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Andretic R, 2008, P NATL ACAD SCI USA, V105, P20392, DOI 10.1073/pnas.0806776105; Arya GH, 2010, GENETICS, V186, P1475, DOI 10.1534/genetics.110.123166; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Beaver LM, 2004, CURR BIOL, V14, P1492, DOI 10.1016/j.cub.2004.08.022; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Chen AY, 2014, GENES BRAIN BEHAV, V13, P812, DOI 10.1111/gbb.12172; Chen AY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097758; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Cumming RC, 2008, METHOD ENZYMOL, V451, P639, DOI 10.1016/S0076-6879(08)03235-7; de Castro IP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.394; Dean T, 2011, J NEUROSCI, V31, P11387, DOI 10.1523/JNEUROSCI.0502-11.2011; Diaper DC, 2013, HUM MOL GENET, V22, P3883, DOI 10.1093/hmg/ddt243; Diaper DC, 2013, HUM MOL GENET, V22, P1539, DOI 10.1093/hmg/ddt005; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Fedina TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049799; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Finley KD, 2003, J NEUROSCI, V23, P1254, DOI 10.1523/JNEUROSCI.23-04-01254.2003; Finley KD, 1997, P NATL ACAD SCI USA, V94, P913, DOI 10.1073/pnas.94.3.913; Finley KD, 1998, NEURON, V21, P1363, DOI 10.1016/S0896-6273(00)80655-8; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Giebultowicz J, 2010, CURR BIOL, V20, pR608, DOI 10.1016/j.cub.2010.05.052; Gilestro GF, 2012, NAT PROTOC, V7, P995, DOI 10.1038/nprot.2012.041; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harada E, 2008, GENES GENET SYST, V83, P257, DOI 10.1266/ggs.83.257; Heinrichsen ET, 2014, MOL METAB, V3, P42, DOI 10.1016/j.molmet.2013.10.003; Joiner MA, 2000, LEARN MEMORY, V7, P32, DOI 10.1101/lm.7.1.32; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Joiner WJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003605; Juhasz G, 2008, AUTOPHAGY, V4, P357, DOI 10.4161/auto.5572; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Krishnan N, 2009, AGING-US, V1, P937, DOI 10.18632/aging.100103; Kuo TH, 2012, J EXP BIOL, V215, P814, DOI 10.1242/jeb.064980; Lindmo K, 2008, AUTOPHAGY, V4, P500, DOI 10.4161/auto.5829; Lindmo K, 2006, EXP CELL RES, V312, P2018, DOI 10.1016/j.yexcr.2006.03.002; Linford NJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002668; Liu HJ, 2005, P NATL ACAD SCI USA, V102, P10522, DOI 10.1073/pnas.0500945102; Liu WJ, 2008, BIOCHEM BIOPH RES CO, V372, P798, DOI 10.1016/j.bbrc.2008.05.119; Marcora MS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-5; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Piazza N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005886; Rakshit K, 2013, EXP GERONTOL, V48, P1260, DOI 10.1016/j.exger.2013.07.013; Rakshit K, 2013, AGING CELL, V12, P752, DOI 10.1111/acel.12100; Rakshit K, 2012, CHRONOBIOL INT, V29, P5, DOI 10.3109/07420528.2011.635237; Reggiori Fulvio, 2012, Int J Cell Biol, V2012, P219625, DOI 10.1155/2012/219625; Rogers I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040569; Rusten TE, 2008, CELL CYCLE, V7, P1166, DOI 10.4161/cc.7.9.5784; Seelaar H, 2010, J NEUROL, V257, P747, DOI 10.1007/s00415-009-5404-z; Sehgal A, 2007, Cold Spring Harb Symp Quant Biol, V72, P557, DOI 10.1101/sqb.2007.72.018; Simon AF, 2006, MECH AGEING DEV, V127, P647, DOI 10.1016/j.mad.2006.02.006; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Simonsen A, 2007, GENETICS, V176, P1283, DOI 10.1534/genetics.106.065011; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Tamura T, 2003, NEURON, V40, P1003, DOI 10.1016/S0896-6273(03)00732-3; Tsai HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034784; van Alphen B, 2013, J NEUROSCI, V33, P6917, DOI 10.1523/JNEUROSCI.0061-13.2013; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; Vieira FG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r235; Vosshall LB, 2005, NEURON, V45, P179, DOI 10.1016/j.neuron.2005.01.001; White KE, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00205; Wu MN, 2008, SLEEP, V31, P465, DOI 10.1093/sleep/31.4.465; Wu MN, 2010, NAT NEUROSCI, V13, P69, DOI 10.1038/nn.2454; Yamazaki D, 2007, NAT NEUROSCI, V10, P478, DOI 10.1038/nn1863; Yang DS, 2014, BRAIN, V137, P3300, DOI 10.1093/brain/awu278; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Ziegler AB, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00072	72	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132768	10.1371/journal.pone.0132768	http://dx.doi.org/10.1371/journal.pone.0132768			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182057	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198200033
J	Hammes, HP; Welp, R; Kempe, HP; Wagner, C; Siegel, E; Holl, RW				Hammes, Hans-Peter; Welp, Reinhard; Kempe, Hans-Peter; Wagner, Christian; Siegel, Erhard; Holl, Reinhard W.		DPV Initiative-German BMBF Compete	Risk Factors for Retinopathy and DME in Type 2 Diabetes-Results from the German/Austrian DPV Database	PLOS ONE			English	Article							MACULAR EDEMA; PREVALENCE; OBESITY; COMPLICATIONS; NEPHROPATHY; MECHANISMS	To assess the prevalence and risk factors for early and severe diabetic retinopathy and macular edema in a large cohort of patients with type 2 diabetes Retinopathy grading (any retinopathy, severe retinopathy, diabetic macular edema) and risk factors of 64784 were prospectively recorded between January 2000 and March 2013 and analyzed by Kaplan-Meier analysis and logistic regression. Retinopathy was present in 20.12% of subjects, maculopathy was found in 0.77%. HbA1c > 8%, microalbuminuria, hypertension, BMI > 35 kg/m(2) and male sex were significantly associated with any retinopathy, while HbA1c and micro-and macroalbuminuria were the strongest risk predictors for severe retinopathy. Presence of macroalbuminuria increased the risk for DME by 177%. Retinopathy remains a significant clinical problem in patients with type 2 diabetes. Metabolic control and blood pressure are relevant factors amenable to treatment. Concomitant kidney disease identifies high risk patients and should be emphasized in interdisciplinary communication.	[Hammes, Hans-Peter] Heidelberg Univ, Univ Med Ctr, Dept Med 5, Mannheim, Germany; [Welp, Reinhard] Knappschafts Krankenhaus, Dept Internal Med, Bottrop, Germany; [Kempe, Hans-Peter] Ctr Diabet & Nutr Ludwigshafen, Ludwigshafen, Germany; [Wagner, Christian] Specialized Diabet Practice, Saaldorf, Germany; [Siegel, Erhard] St Josefs Hosp, Dept Internal Med, Heidelberg, Germany; [Holl, Reinhard W.] Univ Med Ctr, Inst Epidemiol & Med Biometry, Ulm, Germany	Ruprecht Karls University Heidelberg; Ulm University	Hammes, HP (corresponding author), Heidelberg Univ, Univ Med Ctr, Dept Med 5, Mannheim, Germany.	hp.hammes@umm.de	Hammes, Hans-Peter/S-3719-2019	Holl, Reinhard/0000-0003-1395-4842	Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) - Federal Ministry of Education and Research [FKZ 01GI1106]; European Foundation for the Study of Diabetes (EFSD); European Foundation for the Study of Diabetes [AZ Macrov 2014_2] Funding Source: researchfish	Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) - Federal Ministry of Education and Research; European Foundation for the Study of Diabetes (EFSD); European Foundation for the Study of Diabetes	This work was supported by the Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) funded by the Federal Ministry of Education and Research (FKZ 01GI1106). Additional funds were provided by the European Foundation for the Study of Diabetes (EFSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Awa WL, 2013, PEDIATR DIABETES, V14, P562, DOI 10.1111/pedi.12043; Bottazzo GF, 2005, DIABETOLOGIA, V48, P703, DOI 10.1007/s00125-005-1691-9; Chang SA, 2012, DIABETES METAB J, V36, P399, DOI 10.4093/dmj.2012.36.6.399; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Dirani M, 2011, INVEST OPHTH VIS SCI, V52, P4416, DOI 10.1167/iovs.11-7208; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gangaputra S, 2013, RETINA-J RET VIT DIS, V33, P1393, DOI 10.1097/IAE.0b013e318286c952; Hammes HP, 2011, DIABETOLOGIA, V54, P1977, DOI 10.1007/s00125-011-2198-1; Hammes HP, 2004, DIAGNOSTIK THERAPIE; Hermann Julia M, 2014, PLoS One, V9, pe91137, DOI 10.1371/journal.pone.0091137; Hesse L, 2001, OPHTHALMOLOGE, V98, P1065, DOI 10.1007/s003470170026; Klein R, 1997, ARCH INTERN MED, V157, P650, DOI 10.1001/archinte.157.6.650; Klein R, 2010, DIABETES, V59, P1853, DOI 10.2337/db09-1904; Klein R, 2006, CONTEMP DIAB, P473; Knudsen LL, 2007, BRIT J OPHTHALMOL, V91, P1593, DOI 10.1136/bjo.2006.111872; Knudsen ST, 2002, DIABETES CARE, V25, P2328, DOI 10.2337/diacare.25.12.2328; Lammert A, 2012, OBESITY, V20, P2262, DOI 10.1038/oby.2012.122; Levitsky LL, 2013, DIABETES CARE, V36, P1772, DOI 10.2337/dc12-2387; de Faria JBL, 2011, HYPERTENS RES, V34, P413, DOI 10.1038/hr.2010.263; Martin-Merino E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100283; Mendel TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065691; Pfister F, 2013, PFLUG ARCH EUR J PHY, V465, P789, DOI 10.1007/s00424-013-1272-6; Schwab KO, 2006, DIABETES CARE, V29, P218, DOI 10.2337/diacare.29.02.06.dc05-0724; Silva PS, 2012, TELEMED E-HEALTH, V18, P492, DOI 10.1089/tmj.2011.0232; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; van Leiden HA, 2002, DIABETES CARE, V25, P1320, DOI 10.2337/diacare.25.8.1320; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	29	69	69	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132492	10.1371/journal.pone.0132492	http://dx.doi.org/10.1371/journal.pone.0132492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177037	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600117
J	Sieni, E; Barba, C; Mortilla, M; Savelli, S; Grisotto, L; Di Giacomo, G; Romano, K; Fonda, C; Biggeri, A; Guerrini, R; Arico, M				Sieni, Elena; Barba, Carmen; Mortilla, Marzia; Savelli, Sara; Grisotto, Laura; Di Giacomo, Gianpiero; Romano, Katiuscia; Fonda, Claudio; Biggeri, Annibale; Guerrini, Renzo; Arico, Maurizio			Early Diagnosis and Monitoring of Neurodegenerative Langerhans Cell Histiocytosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PERMANENT CONSEQUENCES; DISEASE; CHILDREN; EXPERIENCE; CHILDHOOD; SEQUELAE; SOCIETY; PATTERN; BLOOD	Background Neurodegenerative Langerhans Cell Histiocytosis (ND-LCH) is a rare, unpredictable consequence that may devastate the quality of life of patients cured from LCH. We prospectively applied a multidisciplinary diagnostic work-up to early identify and follow-up patients with ND-LCH, with the ultimate goal of better determining the appropriate time for starting therapy. Methods We studied 27 children and young adults with either ND-LCH verified by structural magnetic resonance imaging (MRI) (group 1) or specific risk factors for (diabetes insipidus, craniofacial bone lesions), but no evidence of, neurodegenerative MRI changes (group 2). All patients underwent clinical, neurophysiological and MRI studies. Results Seventeen patients had MRI alterations typical for ND-LCH. Nine showed neurological impairment but only three were symptomatic; 11 had abnormal somatosensory evoked potentials (SEPs), and five had abnormal brainstem auditory evoked potentials (BAEPs). MR spectroscopy (MRS) showed reduced cerebellar NAA/Cr ratio in nine patients. SEPs showed sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for predicting ND-LCH of 70.6% (95% CI, 44.0%-89.7%), 100% (69.2%-100%), 100% (73.5%-100%), and 66.7%(38.4%-88.2%), respectively. Repeated investigations in group 1 revealed increasingly abnormal EP parameters, or neurological examination, or both, in nine of fifteen patients while MRI remained unchanged in all but one patient. Conclusion A targeted MRI study should be performed in all patients with risk factors for ND-LCH for early identification of demyelination. The combined use of SEPs and careful neurological evaluation may represent a valuable, low-cost, well-tolerated and easily available methodology to monitor patients from pre-symptomatic to symptomatic stages. We suggest a multidisciplinary protocol including clinical, MRS, and neurophysiological investigations to identify a population target for future therapeutic trials.	[Sieni, Elena; Arico, Maurizio] Meyer Childrens Univ Hosp, Pediat Hematol Oncol, Florence, Italy; [Barba, Carmen; Di Giacomo, Gianpiero; Romano, Katiuscia; Guerrini, Renzo] Meyer Childrens Univ Hosp, Pediat Neurol, Florence, Italy; [Mortilla, Marzia; Savelli, Sara; Fonda, Claudio] Meyer Childrens Univ Hosp, Pediat Radiol, Florence, Italy; [Savelli, Sara] Bambino Gesu Pediat Hosp, IRCCS, Dept Diagnost Imaging, Rome, Italy; [Grisotto, Laura; Biggeri, Annibale] Univ Florence, Dept Stat Informat & Applicat G Parenti, Florence, Italy; [Biggeri, Annibale] ISPO Canc Prevent & Res Inst, Biostat Unit, Florence, Italy; [Arico, Maurizio] Azienda Sanit Prov 7, Direz Gen, Ragusa, Italy	University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; IRCCS Bambino Gesu; University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Sieni, E (corresponding author), Meyer Childrens Univ Hosp, Pediat Hematol Oncol, Florence, Italy.	e.sieni@meyer.it	Savelli, Sara/AAA-6103-2020; Sieni, Elena/J-8729-2018; Barba, Carmen/AAB-7162-2022; barba, carmen/K-4942-2016; Arico, Maurizio/S-3039-2019; Mortilla, Marzia/AAV-5525-2020	Sieni, Elena/0000-0002-6192-9812; barba, carmen/0000-0001-5445-5842; Arico, Maurizio/0000-0002-1908-6671; Guerrini, Renzo/0000-0002-7272-7079	Ministero della Salute [RF-TOS-2008-1219488]; Associazione Italiana Ricerca Istiocitosi (AIRI); Associazione Ciemmeesse-Girotondo per il Meyer O.N.L.U.S	Ministero della Salute(Ministry of Health, Italy); Associazione Italiana Ricerca Istiocitosi (AIRI); Associazione Ciemmeesse-Girotondo per il Meyer O.N.L.U.S	This work was supported by the Ministero della Salute (RF-TOS-2008-1219488), Associazione Italiana Ricerca Istiocitosi (AIRI), and Associazione Ciemmeesse-Girotondo per il Meyer O.N.L.U.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arico M, 1998, HEMATOL ONCOL CLIN N, V12, P247, DOI 10.1016/S0889-8588(05)70508-6; Arico M, 1999, BRIT J HAEMATOL, V107, P883, DOI 10.1046/j.1365-2141.1999.01777.x; Badalian-Very G, 2013, ANNU REV PATHOL-MECH, V8, P1, DOI 10.1146/annurev-pathol-020712-163959; Barthez MA, 2000, J CHILD NEUROL, V15, P150, DOI 10.1177/088307380001500302; Bernstrand C, 2005, ACTA PAEDIATR, V94, P1073, DOI 10.1080/08035250510028263; Chaudhary V, 2013, JPN J RADIOL, V31, P786, DOI 10.1007/s11604-013-0254-0; Delprat C, 2014, BLOOD, V124, P867, DOI 10.1182/blood-2014-02-556407; Euskirchen P, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000078; Gadner H, 2001, J PEDIATR-US, V138, P728, DOI 10.1067/mpd.2001.111331; Gadner H, 2008, BLOOD, V111, P2556, DOI 10.1182/blood-2007-08-106211; Gadner H, 2013, BLOOD, V121, P5006, DOI 10.1182/blood-2012-09-455774; Grois N, 2006, PEDIATR BLOOD CANCER, V46, P228, DOI 10.1002/pbc.20425; Grois N, 2005, BRAIN, V128, P829, DOI 10.1093/brain/awh403; Grois NG, 1998, HEMATOL ONCOL CLIN N, V12, P287, DOI 10.1016/S0889-8588(05)70511-6; Guyot-Goubin A, 2008, PEDIATR BLOOD CANCER, V51, P71, DOI 10.1002/pbc.21498; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Haupt R, 2004, PEDIATR BLOOD CANCER, V42, P438, DOI 10.1002/pbc.20021; Horibe K, 2013, INT J HEMATOL, V98, P74, DOI 10.1007/s12185-013-1364-2; Kolodziejak A, 2000, J PHYSIOL PHARMACOL, V51, P41; Laurencikas E, 2011, PEDIATR BLOOD CANCER, V56, P250, DOI 10.1002/pbc.22791; Le Guennec L, 2014, J NEUROL, V261, P1537, DOI 10.1007/s00415-014-7375-y; Lee EK, 1998, J CLIN NEUROPHYSIOL, V15, P227, DOI 10.1097/00004691-199805000-00006; Mittheisz E, 2007, PEDIATR BLOOD CANCER, V48, P50, DOI 10.1002/pbc.20760; Munoz A, 2008, AJNR Am J Neuroradiol, V29, pe15, DOI 10.3174/ajnr.A0911; Murakami I, 2014, HUM PATHOL, V45, P119, DOI 10.1016/j.humpath.2013.05.028; Nanduri VR, 2003, J CLIN ONCOL, V21, P2961, DOI 10.1200/JCO.2003.05.048; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Prayer D, 2004, AM J NEURORADIOL, V25, P880; Prosch H, 2007, AM J NEURORADIOL, V28, P1022, DOI 10.3174/ajnr.A0509; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Steiner M, 2005, J CHILD NEUROL, V20, P253, DOI 10.1177/08830738050200031501; van't Hooft I, 2008, PEDIATR BLOOD CANCER, V51, P669, DOI 10.1002/pbc.21656; Whitsett SF, 1999, MED PEDIATR ONCOL, V33, P486, DOI 10.1002/(SICI)1096-911X(199911)33:5<486::AID-MPO9>3.3.CO;2-A; Willis B, 1996, J CLIN ONCOL, V14, P2073, DOI 10.1200/JCO.1996.14.7.2073; Wnorowski M, 2008, J PEDIATR-US, V153, P127, DOI 10.1016/j.jpeds.2007.12.042	35	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131635	10.1371/journal.pone.0131635	http://dx.doi.org/10.1371/journal.pone.0131635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176859	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600055
J	Zhang, HJ; Jiang, XJ; Lu, LP; Xiao, WF				Zhang, Hangjun; Jiang, Xiaojun; Lu, Liping; Xiao, Wenfeng			Biodegradation of polychlorinated biphenyls (PCBs) by the novel identified cyanobacterium Anabaena PD-1	PLOS ONE			English	Article							CONTAMINATED SOIL; RISK-ASSESSMENT; CHLOROPHYLL-A; DEGRADATION; PHYTOPLANKTON; AROCLOR-1242; RESPONSES; MICROORGANISMS; METABOLISM; SEDIMENTS	Polychlorinated biphenyls (PCBs), a class of hazardous pollutants, are difficult to dissipate in the natural environment. In this study, a cyanobacterial strain Anabaena PD-1 showed good resistance against PCB congeners. Compared to a control group, chlorophyll a content decreased 3.7% and 11.7% when Anabaena PD-1 was exposed to 2 and 5 mg/L PCBs for 7 d. This cyanobacterial strain was capable of decomposing PCB congeners which was conclusively proved by determination of chloride ion concentrations in chlorine-free medium. After 7 d, the chloride ion concentrations in PCB-treated groups (1, 2, 5 mg/L) were 3.55, 3.05, and 2.25 mg/L, respectively. The genetic information of strain PD-1 was obtained through 16S rRNA sequencing analysis. The GenBank accession number of 16S rRNA of Anabaena PD-1 was KF201693.1. Phylogenetic tree analysis clearly indicated that Anabaena PD-1 belonged to the genus Anabaena. The degradation half-life of Aroclor 1254 by Anabaena PD-1 was 11.36 d; the total degradation rate for Aroclor 1254 was 84.4% after 25 d. Less chlorinated PCB congeners were more likely to be degraded by Anabaena PD-1 in comparison with highly chlorinated congeners. Meta- and para-chlorines in trichlorodiphenyls and tetrachlorobiphenyls were more susceptible to dechlorination than ortho-chlorines during the PCB-degradation process by Anabaena PD-1. Furthermore, Anabaena PD-1 can decompose dioxin-like PCBs. The percent biodegradation of 12 dioxin-like PCBs by strain PD-1 ranged from 37.4% to 68.4% after 25 days. Results above demonstrate that Anabaena PD-1 is a PCB-degrader with great potential for the in situ bioremediation of PCB-contaminated paddy soils.	[Zhang, Hangjun; Jiang, Xiaojun; Lu, Liping; Xiao, Wenfeng] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou 310036, Zhejiang, Peoples R China; [Zhang, Hangjun] Hangzhou Normal Univ, Key Lab Hangzhou City Ecosyst Protect & Restorat, Hangzhou 310036, Zhejiang, Peoples R China	Hangzhou Normal University; Hangzhou Normal University	Zhang, HJ (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Xuelin Rd 16, Hangzhou 310036, Zhejiang, Peoples R China.	zhanghangjun@gmail.com		zhang, hangjun/0000-0002-3281-6093	Natural Science Foundation of China [21077030]; Program for Excellent Young Teachers in Hangzhou Normal University [JTAS 2011-01-012]; Program for '131' talents in Hangzhou City; Undergraduates innovation ability promotion project in Hangzhou Normal University [CX2013078]; Chinese Scholarship Council [201208330300]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Excellent Young Teachers in Hangzhou Normal University; Program for '131' talents in Hangzhou City; Undergraduates innovation ability promotion project in Hangzhou Normal University; Chinese Scholarship Council(China Scholarship Council)	This work was financially supported by the Natural Science Foundation of China (21077030), the Program for Excellent Young Teachers in Hangzhou Normal University (JTAS 2011-01-012), the Program for '131' talents in Hangzhou City, the Undergraduates innovation ability promotion project in Hangzhou Normal University (CX2013078) and the Grant of Chinese Scholarship Council (No: 201208330300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebusoye SA, 2008, CHEMOSPHERE, V73, P126, DOI 10.1016/j.chemosphere.2008.04.055; An Qiong, 2006, Huanjing Kexue, V27, P528; Baek SY, 2008, ENVIRON SCI TECHNOL, V42, P7336, DOI 10.1021/es801019k; BEDARD DL, 1987, APPL ENVIRON MICROB, V53, P1094, DOI 10.1128/AEM.53.5.1094-1102.1987; BEDARD DL, 1986, APPL ENVIRON MICROB, V51, P761, DOI 10.1128/AEM.51.4.761-768.1986; Borja J, 2005, PROCESS BIOCHEM, V40, P1999, DOI 10.1016/j.procbio.2004.08.006; Boyle Alfred W., 1992, Biodegradation, V3, P285, DOI 10.1007/BF00129089; Camara B, 2004, ENVIRON MICROBIOL, V6, P842, DOI 10.1111/j.1462-2920.2004.00630.x; Chavez FP, 2006, BIOTECHNOL ADV, V24, P309, DOI 10.1016/j.biotechadv.2005.11.007; Chen Yuwei, 2006, Hupo Kexue, V18, P550; Cogliano VJ, 1998, ENVIRON HEALTH PERSP, V106, P317, DOI 10.2307/3434037; Cvancarova M, 2012, CHEMOSPHERE, V88, P1317, DOI 10.1016/j.chemosphere.2012.03.107; Dalla Valle M, 2005, ENVIRON POLLUT, V134, P153, DOI 10.1016/j.envpol.2004.07.011; Dobbins DC, 1995, BIODEGRADATION POLLU, P1; Fischer LJ, 1998, TOXICOL SCI, V41, P49; Furukawa K, 2008, J BIOSCI BIOENG, V105, P433, DOI 10.1263/jbb.105.433; Furukawa Kensuke, 1994, P33; Galban-Malagon CJ, 2013, ENVIRON SCI TECHNOL, V47, P5578, DOI 10.1021/es400030q; Ge J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071521; Giesy JP, 1998, CRIT REV TOXICOL, V28, P511, DOI 10.1080/10408449891344263; Gilbert ES, 1997, APPL ENVIRON MICROB, V63, P1933, DOI 10.1128/AEM.63.5.1933-1938.1997; HARKNESS MR, 1993, SCIENCE, V259, P503, DOI 10.1126/science.8424172; Hatamian-Zarmi A, 2009, INT BIODETER BIODEGR, V63, P788, DOI 10.1016/j.ibiod.2009.06.009; Hong CY, 2013, J ENVIRON SCI HEAL A, V48, P1280, DOI 10.1080/10934529.2013.777242; IWASAKI I, 1952, B CHEM SOC JPN, V25, P226, DOI 10.1246/bcsj.25.226; Iwasaki T, 2007, BIOSCI BIOTECH BIOCH, V71, P993, DOI 10.1271/bbb.60663; JESPERSEN AM, 1987, ARCH HYDROBIOL, V109, P445; Kim IS, 2001, FEMS MICROBIOL LETT, V200, P17, DOI 10.1016/S0378-1097(01)00195-1; KOHLER HPE, 1988, APPL ENVIRON MICROB, V54, P1940, DOI 10.1128/AEM.54.8.1940-1945.1988; Lee SE, 2003, J AGR FOOD CHEM, V51, P1336, DOI 10.1021/jf0257289; Meijer SN, 2003, ENVIRON SCI TECHNOL, V37, P667, DOI 10.1021/es025809l; Mezzetta S, 2011, CHEMOSPHERE, V82, P1293, DOI 10.1016/j.chemosphere.2010.12.028; Moeckel C, 2008, ENVIRON SCI TECHNOL, V42, P8374, DOI 10.1021/es801703k; Narasimhan K, 2003, PLANT PHYSIOL, V132, P146, DOI 10.1104/pp.102.016295; Nie Xiang-ping, 2002, Acta Scientiarum Naturalium Universitatis Sunyatseni, V41, P68; Nollet H, 2003, CHEMOSPHERE, V53, P655, DOI 10.1016/S0045-6535(03)00517-4; Papazi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061682; Papazi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049037; Parnell JJ, 2006, APPL ENVIRON MICROB, V72, P6607, DOI 10.1128/AEM.01129-06; Pieper DH, 2008, J MOL MICROB BIOTECH, V15, P121, DOI 10.1159/000121325; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; RISEBROUGH RW, 1968, NATURE, V220, P1098, DOI 10.1038/2201098a0; Rodrigues JLM, 2006, APPL ENVIRON MICROB, V72, P2476, DOI 10.1128/AEM.72.4.2476-2482.2006; SAFE S, 1993, ENVIRON HEALTH PERSP, V100, P259, DOI 10.2307/3431532; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shen CF, 2008, ENVIRON SCI TECHNOL, V42, P49, DOI 10.1021/es071162z; Simon T, 2007, REGUL TOXICOL PHARM, V48, P148, DOI 10.1016/j.yrtph.2007.03.005; Singer AC, 2000, APPL MICROBIOL BIOT, V54, P838, DOI 10.1007/s002530000472; Singh DP, 2011, ENVIRON SCI POLLUT R, V18, P1351, DOI 10.1007/s11356-011-0472-x; Tigini V, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-5; Tsuji N, 2003, BIOTECHNOL LETT, V25, P241, DOI 10.1023/A:1022333406348; Villacieros M, 2005, APPL ENVIRON MICROB, V71, P2687, DOI 10.1128/AEM.71.5.2687-2694.2005; Wang S, 2014, CHEMOSPHERE, V95, P200, DOI 10.1016/j.chemosphere.2013.08.066; Wiegel J, 2000, FEMS MICROBIOL ECOL, V32, P1, DOI 10.1111/j.1574-6941.2000.tb00693.x; YADAV JS, 1995, APPL ENVIRON MICROB, V61, P2560, DOI 10.1128/AEM.61.7.2560-2565.1995; Zabelina ON, 2010, J ANAL CHEM+, V65, P1098, DOI 10.1134/S106193481011002X; Zhang HJ, 2012, J APPL PHYCOL, V24, P221, DOI 10.1007/s10811-011-9670-7; Zhao GF, 2009, SCI TOTAL ENVIRON, V407, P2565, DOI 10.1016/j.scitotenv.2008.11.062	59	15	18	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131450	10.1371/journal.pone.0131450	http://dx.doi.org/10.1371/journal.pone.0131450			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177203	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600044
J	Chao, CH; Su, YF; Chan, HM; Huang, SL; Lin, CL; Kwan, AL; Lou, YT; Chen, CW				Chao, Chia-Hung; Su, Yu-Feng; Chan, Hon-Man; Huang, Shiuh-Lin; Lin, Chih-Lung; Kwan, Aij-Lie; Lou, Yun-Ting; Chen, Chao-Wen			Osteoporosis Self-Assessment Tool for Asians Can Predict Neurologic Prognosis in Patients with Isolated Moderate Traumatic Brain Injury	PLOS ONE			English	Article							BONE-MINERAL DENSITY; PLACEBO-CONTROLLED TRIAL; VITAMIN-D HORMONE; POSTMENOPAUSAL WOMEN; INCREASED RISK; MULTIPLE TRAUMA; IDENTIFY WOMEN; HEAD-INJURY; MRC CRASH; VALIDATION	Objectives Osteoporosis Self-Assessment Tool for Asians (OSTA) has been proved to be a simple and effective tool for recognizing osteoporosis risk. Our previous study has demonstrated that the preoperative OSTA index was a good prognostic predictor for stage II and III colon cancer patients after surgery. We aim to evaluate the value of OSTA index in prognostication of isolated traumatic brain injury with moderate severity (GCS 9-13). Methods We retrospectively reviewed all patients visiting Kaohsiung Medical University Hospital emergency department due to isolated moderate traumatic brain injury from Jan. 2010 to Dec. 2012. Background data (including the OSTA index), clinical presentations, management and outcomes (ICU admission days, total admission days, complications, Glasgow outcome score (GOS) at discharge, mortality) of the patients were recorded for further analysis. Our major outcome was good neurologic recovery defined as GOS of 5. Pearson chisquare test and the Mann-Whitney U test were used to compare demographic features. Multiple logistic regression was used to identify independent risk factors. Results 107 isolated moderate TBI patients were studied. 40 patients (37.4%) showed good recovery and 10 (9.3%) died at discharge. The univariate analysis revealed that younger age, higher OSTA index, lower ISS, lower AIS-H, and avoidance to neurosurgery were associated with better neurologic outcome for all moderate TBI patients. Multivariate analysis revealed that lower ISS, higher OSTA, and the avoidance of neurosurgery were independent risk factors predicting good neurologic recovery. Conclusion Higher ISS, lower OSTA index and exposure to neurosurgery were the independent risk factors for poorer recovery from isolated moderate TBI. In addition to labeling the cohort harboring osteoporotic risk, OSTA index could predict neurologic prognosis in patients with isolated moderate traumatic brain injury.	[Chao, Chia-Hung; Su, Yu-Feng; Huang, Shiuh-Lin; Lin, Chih-Lung; Kwan, Aij-Lie] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Neurosurg, Dept Surg, Kaohsiung, Taiwan; [Chao, Chia-Hung] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Chan, Hon-Man; Huang, Shiuh-Lin; Lin, Chih-Lung; Kwan, Aij-Lie] Kaohsiung Med Univ, Dept Surg, Coll Med, Fac Med, Kaohsiung, Taiwan; [Lou, Yun-Ting] I Shou Univ, E DA Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Chen, Chao-Wen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Traumatol, Kaohsiung, Taiwan; [Chen, Chao-Wen] Kaohsiung Med Univ, Dept Emergency Med, Coll Med, Fac Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; E-Da Hospital; I Shou University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Chen, CW (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Traumatol, Kaohsiung, Taiwan.	cwchen@kmu.edu.tw		Su, Yu-feng/0000-0003-0355-3981; Chen, Chao Wen/0000-0002-8405-342X	Ministry of Science and Technology of Taiwan [MOST 102-2314-B-037-045, 103-2627-M-037 -005]; Kaohsiung Medical University [KMU-0M- 17]; National Sun Yat-sen University [NSYSUKMU103-P022]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University; National Sun Yat-sen University	CWC received the grant from Ministry of Science and Technology of Taiwan (MOST 102-2314-B-037-045 and 103-2627-M-037 -005; http://www.most.gov.tw/), Kaohsiung Medical University (KMU-0M- 17; http://www.kmuh.org.tw/) as well as National Sun Yat-sen University (NSYSUKMU103-P022; www.nsysu.edu.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari GA, 2012, ACTA CHIR ORTHOP TR, V79, P535; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Blake GM, 2010, SEMIN NUCL MED, V40, P62, DOI 10.1053/j.semnuclmed.2009.08.001; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Cekic M, 2010, NEUROTHERAPEUTICS, V7, P81, DOI 10.1016/j.nurt.2009.10.017; Chabas JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065034; Chaiyakunapruk N, 2006, J AM PHARM ASSOC, V46, P391, DOI 10.1331/154434506777069624; Chawda MN, 2004, INJURY, V35, P347, DOI 10.1016/S0020-1383(03)00140-2; Chen CW, 2013, J SURG RES, V181, P242, DOI 10.1016/j.jss.2012.06.062; Dimai HP, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-12; Edwards P, 2005, LANCET, V365, P1957; Fransiska Y, 2012, J ORTHOP SURG-HONG K, V20, P205, DOI 10.1177/230949901202000214; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Geater Sarayut, 2004, Journal of the Medical Association of Thailand, V87, P1286; Hang NP, 2004, J FORMOS MED ASSOC, V103, P130; Imai Yuuki, 2013, Clin Calcium, V23, P1621, DOI CliCa131116211626; JENNETT B, 1975, LANCET, V1, P480; Koh LKH, 2001, OSTEOPOROSIS INT, V12, P699, DOI 10.1007/s001980170070; Lane NE, 2006, AM J OBSTET GYNECOL, V194, pS3, DOI 10.1016/j.ajog.2005.08.047; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Li-Yu JT, 2005, OSTEOPOROSIS INT, V16, P1789, DOI 10.1007/s00198-005-1929-x; Liu Min-yan, 2011, Zhonghua Yi Xue Za Zhi, V91, P2112; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Norouzi V, 2013, ARCH TRAUMA RES, V2, P30, DOI [10.5812/atr.9411, 10.5812/atr.940]; Park HM, 2003, J CLIN DENSITOM, V6, P247, DOI 10.1385/JCD:6:3:247; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Reid IR, 2014, LANCET, V383, P146, DOI 10.1016/S0140-6736(13)61647-5; Richy F, 2004, QJM-INT J MED, V97, P39, DOI 10.1093/qjmed/hch002; Rubin KH, 2013, J BONE MINER RES, V28, P1701, DOI 10.1002/jbmr.1956; Rud B, 2007, OSTEOPOROSIS INT, V18, P1177, DOI 10.1007/s00198-006-0319-3; Rud B, 2009, OSTEOPOROSIS INT, V20, P599, DOI 10.1007/s00198-008-0713-0; Sanders S, 2013, SOUTH MED J, V106, P698, DOI 10.1097/SMJ.0b013e3182a0df8b; Simpkins JW, 2010, BBA-GEN SUBJECTS, V1800, P1113, DOI 10.1016/j.bbagen.2009.11.013; Stein DG, 2011, PM&R, V3, pS100, DOI 10.1016/j.pmrj.2011.03.010; Thomas T, 2013, PRESSE MED, V42, P1351, DOI 10.1016/j.lpm.2013.07.008; Wehren LE, 2004, J INTERN MED, V256, P375, DOI 10.1111/j.1365-2796.2004.01397.x; Wolf R L, 2000, Curr Rheumatol Rep, V2, P74, DOI 10.1007/s11926-996-0072-9; Yang Y, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-271	39	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132685	10.1371/journal.pone.0132685	http://dx.doi.org/10.1371/journal.pone.0132685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186582	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700054
J	Guez, J; Saar-Ashkenazy, R; Mualem, L; Efrati, M; Keha, E				Guez, Jonathan; Saar-Ashkenazy, Rotem; Mualem, Liran; Efrati, Matan; Keha, Eldad			Negative Emotional Arousal Impairs Associative Memory Performance for Emotionally Neutral Content in Healthy Participants	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ELDERLY SUBJECTS; CONSOLIDATION; RECOLLECTION; ENHANCEMENT; FAMILIARITY; RESPONSES; PICTURES	The effect of emotional arousal on memory presents a complex pattern with previous studies reporting conflicting results of both improved and reduced memory performance following arousal manipulations. In this study we further tested the effect of negative emotional arousal (NEA) on individual-item recognition and associative recognition of neutral stimuli in healthy participants, and hypothesized that NEA will particularly impair associative memory performance. The current study consists of two experiments; in both, participants studied a list of word-pairs and were then tested for items (items recognition test), and for associations (associative recognition test). In the first experiment, the arousal manipulation was induced by flashing emotionally-negative or neutral pictures between study-pairs while in the second experiment arousal was induced by presenting emotionally-negative or neutral pictures between lists. The results of the two experiments converged and supported an associative memory deficit observed under NEA conditions. We suggest that NEA is associated with an altered ability to bind one stimulus to another as a result of impaired recollection, resulting in poorer associative memory performance. The current study findings may contribute to the understanding of the mechanism underlying memory impairments reported in disorders associated with traumatic stress.	[Guez, Jonathan] Beer Sheva Mental Hlth Ctr, Beer Sheva, Israel; [Guez, Jonathan; Mualem, Liran; Efrati, Matan; Keha, Eldad] Achva Acad Coll, Dept Psychol, Beer Tuvia, Israel; [Saar-Ashkenazy, Rotem] Ben Gurion Univ Negev, Dept Cognit Neurosci, IL-84105 Beer Sheva, Israel; [Saar-Ashkenazy, Rotem] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Saar-Ashkenazy, Rotem] Ashkelon Acad Coll, Dept Psychol, Ashqelon, Israel; [Saar-Ashkenazy, Rotem] Ashkelon Acad Coll, Sch Social Work, Ashqelon, Israel; [Keha, Eldad] Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel	Ben Gurion University; Ben Gurion University; Tel Aviv University	Guez, J (corresponding author), Beer Sheva Mental Hlth Ctr, Beer Sheva, Israel.	jonjon@bgu.ac.il	Guez, Jonathan/M-1620-2019	Guez, Jonathan/0000-0002-4964-7206				American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bob P, 2008, MED SCI MONITOR, V14, pCR499; Bremner JD, 2000, PSYCHOL SCI, V11, P333, DOI 10.1111/1467-9280.00266; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Brewin CR, 2011, ANNU REV CLIN PSYCHO, V7, P203, DOI 10.1146/annurev-clinpsy-032210-104544; Danckwerts A, 2003, NEUROPSYCHOL REV, V13, P221, DOI 10.1023/B:NERV.0000009485.76839.b7; Diamond David M., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/60803; Doerksen S, 2001, EMOTION, V1, P5, DOI 10.1037/1528-3542.1.1.5; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehlers A, 2010, INT J PSYCHOPHYSIOL, V78, P27, DOI 10.1016/j.ijpsycho.2010.04.009; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Golier JA, 2002, AM J PSYCHIAT, V159, P1682, DOI 10.1176/appi.ajp.159.10.1682; Greve A, 2011, NEUROPSYCHOLOGIA, V49, P2746, DOI 10.1016/j.neuropsychologia.2011.06.002; Guez J, 2013, PSYCHIAT RES, V209, P479, DOI 10.1016/j.psychres.2012.12.013; Guez J, 2011, J TRAUMA STRESS, V24, P260, DOI 10.1002/jts.20635; Isaac CL, 2006, CLIN PSYCHOL REV, V26, P939, DOI 10.1016/j.cpr.2005.12.004; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kensinger EA, 2003, MEM COGNITION, V31, P1169, DOI 10.3758/BF03195800; Kudielka BM, 1998, J CLIN ENDOCR METAB, V83, P1756, DOI 10.1210/jc.83.5.1756; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lang PJ, 1999, A4 U FLOR CTR RES PS, DOI DOI 10.1016/J.BIOPSYCH.2010.04.020; Mather M, 2008, J MEM LANG, V58, P449, DOI 10.1016/j.jml.2007.01.004; Mather M, 2009, AM J PSYCHOL, V122, P349; Mather M, 2009, EMOT REV, V1, P118, DOI 10.1177/1754073908100435; MCEWEN BS, 1968, NATURE, V220, P911, DOI 10.1038/220911a0; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nashiro K, 2011, AM J PSYCHOL, V124, P301, DOI 10.5406/amerjpsyc.124.3.0301; Nashiro K, 2011, EXP AGING RES, V37, P108, DOI 10.1080/0361073X.2011.536746; O'Keane V, 2005, BIOL PSYCHIAT, V58, P963, DOI 10.1016/j.biopsych.2005.04.049; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; ROSNOW RL, 1995, PSYCHOL SCI, V6, P3, DOI 10.1111/j.1467-9280.1995.tb00297.x; Rubinstein O, 2005, WORD ASS NORMS DISCR; Saar-Ashkenazy R, 2014, J TRAUMA STRESS, V27, P18, DOI 10.1002/jts.21887; Samuelson Kristin W, 2011, Dialogues Clin Neurosci, V13, P346; Savic Miroslav M., 2005, Neural Plasticity, V12, P289, DOI 10.1155/NP.2005.289; Schwarze U, 2012, J NEUROSCI, V32, P1481, DOI 10.1523/JNEUROSCI.4497-11.2012; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; Suendermann O, 2010, PSYCHOSOM MED, V72, P301, DOI 10.1097/PSY.0b013e3181d07db8; Wolf OT, 1998, PSYCHONEUROENDOCRINO, V23, P617; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005; Zoellner LA, 2000, J ABNORM PSYCHOL, V109, P517, DOI 10.1037//0021-843X.109.3.517	45	4	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132405	10.1371/journal.pone.0132405	http://dx.doi.org/10.1371/journal.pone.0132405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186001	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700041
J	Husslik, F; Hanschmann, KM; Kramer, A; von Loetzen, CS; Schweimer, K; Bellinghausen, I; Treudler, R; Simon, JC; Vogel, L; Volker, E; Randow, S; Reuter, A; Rosch, P; Vieths, S; Holzhauser, T; Schiller, D				Husslik, Felix; Hanschmann, Kay-Martin; Kraemer, Ariane; von Loetzen, Christian Seutter; Schweimer, Kristian; Bellinghausen, Iris; Treudler, Regina; Simon, Jan C.; Vogel, Lothar; Voelker, Elke; Randow, Stefanie; Reuter, Andreas; Roesch, Paul; Vieths, Stefan; Holzhauser, Thomas; Schiller, Dirk			Folded or Not? Tracking Bet v 1 Conformation in Recombinant Allergen Preparations	PLOS ONE			English	Article							BIRCH POLLEN ALLERGEN; HIGH-LEVEL EXPRESSION; IMMUNE-RESPONSES; CIRCULAR-DICHROISM; CROSS-REACTIVITY; CELL RESPONSES; APPLE ALLERGEN; POTENTIAL USE; IGE BINDING; IN-VITRO	Background Recombinant Bet v 1a (rBet v 1a) has been used in allergy research for more than three decades, including clinical application of so-called hypoallergens. Quantitative IgE binding to rBet v 1a depends on its native protein conformation, which might be compromised upon heterologous expression, purification, or mutational engineering of rBet v 1a. Objective To correlate experimental/theoretical comparisons of IgE binding of defined molar ratios of folded/misfolded recombinant Bet v 1a variants and to determine accuracy and precision of immuno-and physicochemical assays routinely used to assess the quality of recombinant allergen preparations. Methods rBet v 1a and its misfolded variant rBet v 1a(S112P/R145P) were heterologously expressed and purified from Escherichia coli. Structural integrities and oligomerisation of the recombinant allergens were evaluated by H-1-nuclear magnetic resonance (H-1-NMR), circular dichroism (CD) spectroscopy, and dynamic light scattering (DLS). IgE binding of defined combinations of rBet v 1a and rBet v 1a(S112P/R145P) was assessed using immunoblotting (IB), enzyme-linked immunosorbent assay (ELISA) and mediator release (MR) of humanized rat basophilic leukemia cells sensitized with serum IgE of subjects allergic to birch pollen. Experimental and theoretically expected results of the analyses were compared. Results H-1-NMR spectra of rBet v 1a and rBet v 1a(S112P/R145P) demonstrate a native and highly disordered protein conformations, respectively. The CD spectra suggested typical alpha-helical and beta-sheet secondary structure content of rBet v 1a and random coil for rBet v 1a(S112P/R145P). The hydrodynamic radii (R-H) of 2.49 +/- 0.39 nm (rBet v 1a) and 3.1 +/- 0.56 nm (rBet v 1a(S112P/R145P)) showed monomeric dispersion of both allergens in solution. Serum IgE of birch pollen allergic subjects bound to 0.1% rBet v 1a in the presence of 99.9% of non-IgE binding rBet v 1aS112P/R145P. Immunoblot analysis overestimated, whereas ELISA and mediator release assay underestimated the actual quantity of IgE-reactive rBet v 1a in mixtures of rBet v 1a/rBet v 1aS112P/R145P with a molar ratio of rBet v 1a <= 10%. Conclusion Valid conclusions on quantitative IgE binding of recombinant Bet v 1a preparations depend on the accuracy and precision of physico-and immunochemical assays with which natively folded allergen is detected.	[Husslik, Felix; Kraemer, Ariane; Vogel, Lothar; Voelker, Elke; Randow, Stefanie; Reuter, Andreas; Vieths, Stefan; Holzhauser, Thomas; Schiller, Dirk] Paul Ehrlich Inst, Div Allergol, Langen, Hesse, Germany; [Hanschmann, Kay-Martin] Paul Ehrlich Inst, Biostat Sect, Div EU Cooperat Microbiol, Langen, Hesse, Germany; [von Loetzen, Christian Seutter; Schweimer, Kristian; Roesch, Paul] Univ Bayreuth, Dept Biopolymers, Bayreuth, Bavaria, Germany; [Bellinghausen, Iris] Univ Med Ctr, Dept Dermatol, Mainz, Rhineland Palat, Germany; [Treudler, Regina; Simon, Jan C.] Univ Leipzig, Dept Dermatol Venerol & Allergol, Leipzig, Saxony, Germany	Paul Ehrlich Institute; Paul Ehrlich Institute; University of Bayreuth; Johannes Gutenberg University of Mainz; Leipzig University	Schiller, D (corresponding author), Paul Ehrlich Inst, Div Allergol, Langen, Hesse, Germany.	Dirk.Schiller@pei.de	Holzhauser, Thomas/ABD-5038-2020	Schweimer, Kristian/0000-0002-3837-8442; Reuter, Andreas/0000-0002-6082-9000; Holzhauser, Thomas/0000-0002-7818-7261				Albrecht M, 2008, MOL NUTR FOOD RES, V52, pS186, DOI 10.1002/mnfr.200700424; Berkner H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111691; Bohle B, 2004, J IMMUNOL, V172, P6642, DOI 10.4049/jimmunol.172.11.6642; BRAUN D, 1994, J AM CHEM SOC, V116, P8466, DOI 10.1021/ja00098a005; Ciprandi G, 2012, J Biol Regul Homeost Agents, V26, pS113; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; Daniel C, 2006, ALLERGY, V61, P812, DOI 10.1111/j.1398-9995.2006.01071.x; De Amici M, 2003, ANN ALLERG ASTHMA IM, V91, P490, DOI 10.1016/S1081-1206(10)61519-0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ferreira F, 1998, FASEB J, V12, P231, DOI 10.1096/fasebj.12.2.231; Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599; Fiebig Helmut, 2009, Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess, V96, P71; Gafvelin G, 2005, INT ARCH ALLERGY IMM, V138, P59, DOI 10.1159/000087358; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gepp B, 2014, J ALLERGY CLIN IMMUN, V134, P188, DOI 10.1016/j.jaci.2013.12.1073; GodnicCvar J, 1997, J ALLERGY CLIN IMMUN, V99, P354, DOI 10.1016/S0091-6749(97)70053-8; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Gronlund H, 2010, HUM VACCINES, V6, P970, DOI 10.4161/hv.6.12.13348; Hecker J, 2012, ALLERGY, V67, P1530, DOI 10.1111/all.12045; Himly M, 2009, ALLERGY, V64, P1038, DOI 10.1111/j.1398-9995.2009.01957.x; HoffmannSommergruber K, 1997, PROTEIN EXPRES PURIF, V9, P33, DOI 10.1006/prep.1996.0671; Holm J, 2004, J IMMUNOL, V173, P5258, DOI 10.4049/jimmunol.173.8.5258; Holm J, 2011, J BIOL CHEM, V286, P17569, DOI 10.1074/jbc.M110.194878; HOLZWARTH G, 1965, J AM CHEM SOC, V87, P218, DOI 10.1021/ja01080a015; Jahn-Schmid B, 2005, J ALLERGY CLIN IMMUN, V116, P213, DOI 10.1016/j.jaci.2005.04.019; Kahlert H, 2008, INT ARCH ALLERGY IMM, V145, P193, DOI 10.1159/000109288; Kitzmuller C, 2012, ALLERGY, V67, P1375, DOI 10.1111/all.12016; Klinglmayr E, 2009, ALLERGY, V64, P647, DOI 10.1111/j.1398-9995.2008.01844.x; Kofler S, 2014, J BIOL CHEM, V289, P540, DOI 10.1074/jbc.M113.518795; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mahler V, 2004, CLIN EXP ALLERGY, V34, P115, DOI 10.1111/j.1365-2222.2004.01857.x; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466; Meyer W, 2013, ALLERGY, V68, P724, DOI 10.1111/all.12148; Pichler U, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/832404; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pree I, 2007, J IMMUNOL, V179, P5309, DOI 10.4049/jimmunol.179.8.5309; Purohit A, 2008, CLIN EXP ALLERGY, V38, P1514, DOI 10.1111/j.1365-2222.2008.03042.x; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Seutter von Loetzen C, 2014, BIOCHEM J, V457, P379, DOI 10.1042/BJ20130413; Siebeneicher S, 2014, ALLERGY, V69, P328, DOI 10.1111/all.12326; Smole U, 2010, IMMUNOBIOLOGY, V215, P903, DOI 10.1016/j.imbio.2009.11.003; Son DY, 1999, EUR J NUTR, V38, P201, DOI 10.1007/s003940050063; Tresch S, 2003, CLIN EXP ALLERGY, V33, P1153, DOI 10.1046/j.1365-2222.2003.01717.x; van Hage-Hamsten M, 2002, CLIN EXP ALLERGY, V32, P1448, DOI 10.1046/j.1365-2745.2002.01495.x; VENYAMINOV SY, 1993, ANAL BIOCHEM, V214, P17, DOI 10.1006/abio.1993.1450; Vieths S, 2012, Pharmeur Bio Sci Notes, V2012, P118; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; Wallner M, 2011, J ALLERGY CLIN IMMUN, V127, P1571, DOI 10.1016/j.jaci.2011.01.064; Wiedermann U, 1999, J ALLERGY CLIN IMMUN, V103, P1202, DOI 10.1016/S0091-6749(99)70200-9; WILLIAMSON MP, 1990, BIOPOLYMERS, V29, P1428; Winkler B, 2002, CLIN EXP ALLERGY, V32, P30, DOI 10.1046/j.0022-0477.2001.01214.x; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q	55	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132956	10.1371/journal.pone.0132956	http://dx.doi.org/10.1371/journal.pone.0132956			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186356	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700075
J	Ren, XN; Yang, ZY; Shao, B; Yin, SA; Yang, XG				Ren, Xiangnan; Yang, Zhenyu; Shao, Bing; Yin, Shi-an; Yang, Xiaoguang			B-Vitamin Levels in Human Milk among Different Lactation Stages and Areas in China	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; BREAST-MILK; RIBOFLAVIN SUPPLEMENTATION; JAPANESE WOMEN; FOLIC-ACID; THIAMIN; PREGNANCY; PRETERM; MOTHERS; TERM	To determine the contents of B-vitamins in human milk in China, we analyzed 1778 human milk samples from the sample bank of the National High Technique R & D Program (863 Projects) which was a cross-sectional survey and covered 6419 human milk samples from healthy lactating mothers who were at different stages of lactation (0-330 days postpartum) in 11 provinces of China. The contents of free forms of six B-vitamins in these human milk samples were analyzed by using UPLC-MS/MS. The median concentrations of free form of 6 B-vitamins in colostrums, transitional milk, 15-180 d mature milk and 181-330 d mature milk were respectively as follows: thiamin 5.0 mu g/L, 6.7 mu g/L, 21.1 mu g/L and 40.7 mu g/L; riboflavin 29.3 mu g/L, 40.6 mu g/L, 33.6 mu g/L and 29.6 mu g/L; niacin 470.7 mu g/L, 661.3 mu g/L, 687.0 mu g/L and 571.3 mu g/L; vitamin B-6 4.6 mu g/L, 16.1 mu g/L, 62.7 mu g/L and 80.7 mu g/L; flavin adenine dinucleotide (FAD) 808.7 mu g/L, 1162.8 mu g/L, 1023.9 mu g/L and 1057.2 mu g/L; pantothenic acid 1770.9 mu g/L, 2626.8 mu g/L, 2213.0 mu g/L and 1895.5 mu g/L. The contents of 6 B-vitamins varied significantly among the different lactation stages and different areas (coastal area vs inland area, rural area vs urban area). The present study indicated that the concentrations of B-vitamins in colostrum were generally much lower than those in transitional milk and mature milk. Further studies are warranted for their roles and significance on B-vitamins in colostrum in nutrition and metabolism of neonates.	[Ren, Xiangnan; Yang, Zhenyu; Yin, Shi-an; Yang, Xiaoguang] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing 100050, Peoples R China; [Shao, Bing] Beijing Res Ctr Prevent Med, Beijing Key Lab Diagnost & Traceabil Technol Food, Beijing 100013, Peoples R China	Chinese Center for Disease Control & Prevention	Yin, SA (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, 29 Nan Wei Rd, Beijing 100050, Peoples R China.	shianyin@126.com; xgyangcdc@vip.sina.com	shao, bing/L-8793-2019		National High Technology Research and Development Program of China (863 Program) [2010AA023004]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (863 Program) (No. 2010AA023004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes JM, 2011, POSTGRAD MED, V123, P70, DOI 10.3810/pgm.2011.03.2265; Blum JW, 1997, J NUTR, V127, P2024, DOI 10.1093/jn/127.10.2024; Bohm V, 1997, Z ERNAHRUNGSWISS, V36, P214, DOI 10.1007/BF01623366; Bowman BA, 1998, PRESENT KNOWLEDGE NU; Boylan LM, 2002, J AM DIET ASSOC, V102, P1433, DOI 10.1016/S0002-8223(02)90317-2; Boylan S, 2011, PUBLIC HEALTH NUTR, V14, P678, DOI 10.1017/S1368980010002570; Chinese Nutrition Society, 2013, CHIN DIET REF INT; Draper CE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-398; Dror DK, 2012, PAEDIATR PERINAT EP, V26, P55, DOI 10.1111/j.1365-3016.2012.01277.x; Elmadfa I, 2012, INT J VITAM NUTR RES, V82, P342, DOI 10.1024/0300-9831/a000129; FORD JE, 1983, ARCH DIS CHILD, V58, P367, DOI 10.1136/adc.58.5.367; Goedhart Annemiek C., 1994, Nutrition Research Reviews, V7, P1, DOI 10.1079/NRR19940004; Halvin K, 2013, ANAL BIOANAL CHEM, V405, P1213, DOI 10.1007/s00216-012-6538-x; HAMAKER B, 1985, AM J CLIN NUTR, V42, P650, DOI 10.1093/ajcn/42.4.650; Hampel D, 2012, J CHROMATOGR B, V903, P7, DOI 10.1016/j.jchromb.2012.06.024; KARRA MV, 1986, AM J CLIN NUTR, V43, P495, DOI 10.1093/ajcn/43.4.495; Liu HH, 2014, CHINESE J FOOD NUTR, V20, P77; Liu Huihui, 2014, Wei Sheng Yan Jiu, V43, P409; Liu XF, 2007, CHINESE J MODERN PRE, V34, P3321; Ma WJ, 2002, DESCRIPTION GUANGDON; MCCULLOUGH AL, 1990, AM J CLIN NUTR, V51, P1067, DOI 10.1093/ajcn/51.6.1067; McGready R, 2001, AM J CLIN NUTR, V74, P808; NAIL PA, 1980, AM J CLIN NUTR, V33, P198, DOI 10.1093/ajcn/33.2.198; Oguz SS, 2011, J PEDIATR ENDOCR MET, V24, P843, DOI 10.1515/JPEM.2011.318; Ornoy A, 2013, PEDIATR RES, V73, P111, DOI 10.1038/pr.2012.140; Ortega RM, 2004, BRIT J NUTR, V92, P129, DOI 10.1079/BJN20041153; Powers HJ, 2003, AM J CLIN NUTR, V77, P1352; RONNHOLM KA, 1986, AM J CLIN NUTR, V43, P1; ROUGHEAD ZK, 1990, AM J CLIN NUTR, V52, P854, DOI 10.1093/ajcn/52.5.854; Sakurai T, 2005, J NUTR SCI VITAMINOL, V51, P239, DOI 10.3177/jnsv.51.239; Shi YD, 2011, FOOD CHEM, V127, P1193, DOI 10.1016/j.foodchem.2011.01.123; SNEED SM, 1981, AM J CLIN NUTR, V34, P1338, DOI 10.1093/ajcn/34.7.1338; SONG WO, 1984, AM J CLIN NUTR, V40, P317, DOI 10.1093/ajcn/40.2.317; Stamm RA, 2013, NUTRIENTS, V5, P3920, DOI 10.3390/nu5103920; Stelmach W, 2005, PUBLIC HEALTH, V119, P498, DOI 10.1016/j.puhe.2004.09.006; Stuetz W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036280; Stuetz W, 2012, EUR J NUTR, V51, P425, DOI 10.1007/s00394-011-0226-z; THOMAS MR, 1980, AM J CLIN NUTR, V33, P2151, DOI 10.1093/ajcn/33.10.2151; UDIPI SA, 1985, AM J CLIN NUTR, V42, P522, DOI 10.1093/ajcn/42.3.522; Wang DK, 1986, CHINESE J ACTA NUTR, P81; Wang LD, 2002, DESCRIPTION CHINESE, P19; Yagi T, 2013, J NUTR SCI VITAMINOL, V59, P9, DOI 10.3177/jnsv.59.9; Yang YX., 2009, CHINA FOOD COMPOSITI; Yin T, 1989, Ying Yang Xue Bao, V11, P233; Zhai FengYing, 2005, Acta Nutrimenta Sinica, V27, P181; Zhai FY, 2002, DESCRIPTION CHINESE; Zhang L, 2014, VARIATIONS CHEM COMP, P55; Zhao XH, 2011, CORRELATION ANAL LAC, P317	48	11	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133285	10.1371/journal.pone.0133285	http://dx.doi.org/10.1371/journal.pone.0133285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186707	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700120
J	Roberts, SG; Winters, J; Chen, K				Roberts, Sean G.; Winters, James; Chen, Keith			Future Tense and Economic Decisions: Controlling for Cultural Evolution	PLOS ONE			English	Article							VERB ASPECT; WHORFIAN HYPOTHESIS; MANTEL TEST; LANGUAGE; COLOR; PSEUDOREPLICATION; REPRESENTATION; DIVERSITY; EXPANSION; ENGLISH	A previous study by Chen demonstrates a correlation between languages that grammatically mark future events and their speakers' propensity to save, even after controlling for numerous economic and demographic factors. The implication is that languages which grammatically distinguish the present and the future may bias their speakers to distinguish them psychologically, leading to less future-oriented decision making. However, Chen's original analysis assumed languages are independent. This neglects the fact that languages are related, causing correlations to appear stronger than is warranted (Galton's problem). In this paper, we test the robustness of Chen's correlations to corrections for the geographic and historical relatedness of languages. While the question seems simple, the answer is complex. In general, the statistical correlation between the two variables is weaker when controlling for relatedness. When applying the strictest tests for relatedness, and when data is not aggregated across individuals, the correlation is not significant. However, the correlation did remain reasonably robust under a number of tests. We argue that any claims of synchronic patterns between cultural variables should be tested for spurious correlations, with the kinds of approaches used in this paper. However, experiments or case-studies would be more fruitful avenues for future research on this specific topic, rather than further large-scale cross-cultural correlational studies.	[Roberts, Sean G.] Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Netherlands; [Winters, James] Univ Edinburgh, Language Evolut & Computat Res Unit, Edinburgh, Midlothian, Scotland; [Chen, Keith] Univ Calif Los Angeles, Anderson Sch Management, Los Angeles, CA USA	Max Planck Society; University of Edinburgh; University of California System; University of California Los Angeles	Roberts, SG (corresponding author), Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Netherlands.	sean.roberts@mpi.nl	Winters, James/S-2005-2019	Roberts, Sean/0000-0001-5990-9161	"Interactional Foundations of Language" project within the Language and Cognition Department at the Max Planck Institute for Psycholinguistics; AHRC [AH/K503010/1]	"Interactional Foundations of Language" project within the Language and Cognition Department at the Max Planck Institute for Psycholinguistics; AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	SR is supported by the "Interactional Foundations of Language" project within the Language and Cognition Department at the Max Planck Institute for Psycholinguistics. JW is supported by AHRC grant AH/K503010/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasopoulos P, 2013, COGNITIVE SCI, V37, P286, DOI 10.1111/cogs.12006; Athanasopoulos P, 2009, BILING-LANG COGN, V12, P83, DOI 10.1017/S136672890800388X; Atkinson QD., 2011, LINGUIST TYPOL, V15, P321, DOI [DOI 10.1515/LITY.2011.022, 10.1515/lity.2011.022]; Atkinson QD, 2011, SCIENCE, V332, P346, DOI 10.1126/science.1199295; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bentz C, 2013, LANG DYN CHANG, V3, P1, DOI 10.1163/22105832-13030105; Bergen B, 2010, BRAIN LANG, V112, P150, DOI 10.1016/j.bandl.2009.07.002; Bergen Benjamin., 2012, LOUDER WORDS NEW SCI; Bibiko HJ., 2009, PROGRAM FOR CREATING; Bickel B., 2014, CAMBRIDGE HDB LINGUI, P101, DOI DOI 10.1017/CBO9781139342872.006; Bickel B., 2010, CAMBRIDGE ENCY LANGU, P77; Bickel Balthasar., 2013, LANGUAGE TYPOLOGY HI, P415; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Borcard D, 2012, ECOLOGY, V93, P1473; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; Burridge K., 1995, HISTORICAL LINGUISTI; Candidi M, 2010, EUR J NEUROSCI, V32, P677, DOI 10.1111/j.1460-9568.2010.07305.x; Carreiras M, 1997, MEM COGNITION, V25, P438, DOI 10.3758/BF03201120; Casasanto D, 2008, LANG LEARN, V58, P63, DOI 10.1111/j.1467-9922.2008.00462.x; Chang YC, 2013, ROCK CENTER FOR CORP; Chen MK, 2013, AM ECON REV, V103, P690, DOI 10.1257/aer.103.2.690; Comrie B, 1984, AUSTRALIAN JOURNAL O, V4, P131; Croft William., 2011, LINGUIST TYPOL, V15, P433, DOI [DOI 10.1515/LITY.2011.029, 10.1515/lity.2011.029]; Cysouw M., 2011, SPACE IN LANGUAGE AN; Cysouw M, 2007, STUF-LANG TYPOL UNIV, V60, P95; Cysouw Michael., 2011, LINGUIST TYPOL, V15, P415, DOI [10.1515/lity.2011.028, DOI 10.1515/LITY.2011.028]; Dahl O, 2013, STUCK IN THE FUTUREL; Dahl ?sten., 2000, TENSE ASPECT LANGUAG, P309, DOI [10.1515/9783110197099.2.309, DOI 10.1515/9783110197099.2.309]; Davies IRL, 1997, BRIT J PSYCHOL, V88, P493, DOI 10.1111/j.2044-8295.1997.tb02653.x; Dediu D, 2007, P NATL ACAD SCI USA, V104, P10944, DOI 10.1073/pnas.0610848104; Dediu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055009; Dorie V., 2011, BLME BAYESIAN LINEAR; DRYER MS, 1989, STUD LANG, V13, P257, DOI 10.1075/sl.13.2.03dry; Dryer MS, 2009, LINGUIST TYPOL, V13, P121, DOI [10.1515/LITY.2009.007, DOI 10.1515/LITY.2009.007]; Dryer MS, 2013, POSITION OF NEGATIVE; Dunn M, 2011, NATURE, V473, P79, DOI 10.1038/nature09923; Ember CR, 2007, AM ANTHROPOL, V109, P180, DOI 10.1525/AA.2007.109.1.180; Engle RF, 1984, HANDBOOK OF ECONOMET, V2, P796; Everett C., 2015, P NAT AC SCI; Everett C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065275; Fausey CM, 2011, POLIT PSYCHOL, V32, P563, DOI 10.1111/j.1467-9221.2010.00802.x; FISHMAN JA, 1982, LANG SOC, V11, P1, DOI 10.1017/S0047404500009015; Flecken M, 2013, PROCEEDINGS OF THE 3, P2614; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Fuhrman O, 2011, COGNITIVE SCI, V35, P1305, DOI 10.1111/j.1551-6709.2011.01193.x; Gay V, 2013, BEHL WORKING PAPER S; Goraus K, 2014, UNIVERSITY OF WARSAW; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Greenberg JH., 1978, UNIVERSALS HUMAN LAN, P61; Grossman E., 2013, DIVERSITY LINGUISTIC; Gumperz JJ, 1996, RETHINKING LINGUISTI, V17; Harmon L, 2009, GEIGER ANALYSIS OF E; Harmon LJ, 2010, EVOLUTION, V64, P2173, DOI 10.1111/j.1558-5646.2010.00973.x; Haspelmath M, 2008, WORLD ATLAS OF LANGU; Heffner RA, 1996, ECOLOGY, V77, P2558, DOI 10.2307/2265754; Huette S, 2013, FRONTIERS IN PSYCHOL, V5; HUNT E, 1991, PSYCHOL REV, V98, P377, DOI 10.1037/0033-295X.98.3.377; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Iggesen OA, 2013, NUMBER OF CASES; Jaeger T.F., 2011, LINGUIST TYPOL, V15, P281, DOI [10.1515/lity.2011.021, DOI 10.1515/LITY.2011.021, DOI 10.1075/LA.227.04SZM]; Kandler A, 2012, ADVANCES IN COMPLEX, V15, P177; Karapandza R, 2011, SOCIAL SCIENCE RESEA; Kay P, 2003, P NATL ACAD SCI USA, V100, P9085, DOI 10.1073/pnas.1532837100; La Porta R, 2008, J ECON LIT, V46, P285, DOI 10.1257/jel.46.2.285; Labov W., 2001, PRINCIPLES OF LINGUI, V2, P29; Ladd DR, 2015, ANNU REV LINGUIST, V1, P221, DOI 10.1146/annurev-linguist-030514-124819; Lai VT, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00142; Lee P, 1996, THE WHORF THEORY COM, V81; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Lenneberg EH, 1953, COGNITION IN ETHNOLI, P463; Liberman P, 2012, CULTURAL DIFFUSION A; Lupyan Gary, 2010, PLoS One, V5, pe8559, DOI 10.1371/journal.pone.0008559; Madden CJ, 2009, Q J EXP PSYCHOL, V62, P1294, DOI 10.1080/17470210802696088; Madden CJ, 2003, MEM COGNITION, V31, P663, DOI 10.3758/BF03196106; Maddison WP, 2015, SYST BIOL, V64, P127, DOI 10.1093/sysbio/syu070; Magliano JP, 2000, DISCOURSE PROCESS, V29, P83, DOI 10.1207/S15326950dp2902_1; Majid A, 2013, FRONTIERS IN PSYCHOL, V4; Malotki E, 1983, HOPI TIME A LINGUIST, V20; Maslova Elena, 2000, LINGUIST TYPOL, V4, P307, DOI DOI 10.1515/LITY.2000.4.3.307; Matlock T, 2012, STUD LANG, V36, P699, DOI 10.1075/sl.36.3.09mat; Mavisakalyan A., 2011, ANU WORKING PAPERS I, V2011, P563; Messerli FH, 2012, NEW ENGL J MED, V367, P1562, DOI 10.1056/NEJMon1211064; Moscatelli A, 2012, J VISION, V12, DOI 10.1167/12.11.26; Nichols J, 2013, THE AUTOTYP GENEALOG; Nordhoff S, 2013, GLOTTOLOG 2 2; Nunn CL, 2006, CROSS-CULT RES, V40, P177, DOI 10.1177/1069397105283401; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Orme D., 2013, CAPER COMPARATIVE AN; Osten Dahl, 2000, STUD LANG, P309; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Ponelis FA, 1993, THE DEVELOPMENT OF A; Pullum GK, 2012, WHORFIAN ECONOMIST; R Core Team, 2021, R LANGUAGE ENV STAT; Rama T., 2011, PROGRAM FOR CALCULAT; Richardson DC, 2003, COGNITIVE SCI, V27, P767, DOI 10.1016/S0364-0213(03)00064-8; Roberson D, 2005, COGNITIVE PSYCHOL, V50, P378, DOI 10.1016/j.cogpsych.2004.10.001; Roberts S., 2012, PSYCHOL LANGUAGE COM, V16, P89, DOI DOI 10.2478/V10057-012-0008-6; Roberts S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070902; Santacreu-Vasut E, 2014, JOURNAL OF INTERNATI, V47, P1; Santacreu-Vasut E, 2013, APPL ECON LETT, V20, P495, DOI 10.1080/13504851.2012.714062; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Slobin DI, 2011, PROCEEDINGS OF THE A, V13; Taleb N. N, 2012, ANTIFRAGILE THINGS G; Trudgill P., 2011, SOCIOLINGUISTIC TYPO; TVERSKY A, 1971, PSYCHOL BULL, V76, P105, DOI 10.1037/h0031322; Uriel W, 1953, LANGUAGES IN CONTACT, P1; Verkerk A, 2014, THE EVOLUTIONARY DYN; Whorf BL, 1950, INT J AM LINGUIST, V16, P67, DOI 10.1086/464066; Whorf BL, 2012, LANGUAGE THOUGHT AND; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; World Values Survey Association, 2009, WORLD VALUES SURVEY; Zwaan RA, 2002, PSYCHOL SCI, V13, P168, DOI 10.1111/1467-9280.00430	116	34	34	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132145	10.1371/journal.pone.0132145	http://dx.doi.org/10.1371/journal.pone.0132145			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CN1RV	26186527	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700029
J	Tan, KW; Graf, BA; Mitra, SR; Stephen, ID				Tan, Kok Wei; Graf, Brigitte A.; Mitra, Soma R.; Stephen, Ian D.			Daily Consumption of a Fruit and Vegetable Smoothie Alters Facial Skin Color	PLOS ONE			English	Article							BETA-CAROTENE; FRUCTOSE; SUPPLEMENTATION; PIGMENTS; PLUMAGE; HEALTH	Consumption of dietary carotenoids or carotenoid supplements can alter the color (yellowness) of human skin through increased carotenoid deposition in the skin. As fruit and vegetables are the main dietary sources of carotenoids, skin yellowness may be a function of regular fruit and vegetable consumption. However, most previous studies have used tablets or capsules to supplement carotenoid intake, and less is known of the impact of increased fruit and vegetable consumption on skin color. Here, we examined skin color changes in an Asian population (Malaysian Chinese ethnicity) over a six week dietary intervention with a carotenoid-rich fruit smoothie. Eighty one university students (34 males, 47 females; mean age 20.48) were assigned randomly to consuming either a fruit smoothie (intervention group) or mineral water (control group) daily for six weeks. Participants' skin yellowness (CIELab b*), redness (a*) and luminance (L*) were measured at baseline, twice during the intervention period and at a two-week follow-up, using a handheld reflectance spectrophotometer. Results showed a large increment in skin yellowness (p<0.001) and slight increment in skin redness (p<0.001) after 4 weeks of intervention for participants in the intervention group. Skin yellowness and skin redness remained elevated at the two week follow up measurement. In conclusion, intervention with a carotenoid-rich fruit smoothie is associated with increased skin redness and yellowness in an Asian population. Changes in the reflectance spectrum of the skin suggest that this color change was caused by carotenoid deposition in the skin.	[Tan, Kok Wei; Stephen, Ian D.] Univ Nottingham, Fac Sci, Sch Psychol, Semenyih, Selangor, Malaysia; [Graf, Brigitte A.; Mitra, Soma R.] Univ Nottingham, Fac Sci, Sch Biosci, Semenyih, Selangor, Malaysia; [Graf, Brigitte A.] Manchester Metropolitan Univ, Hollings Fac, Dept Food & Tourism Management, Food Nutr & Hospitality Grp, Manchester M15 6BH, Lancs, England; [Stephen, Ian D.] Macquarie Univ, Fac Human Sci, Dept Psychol, N Ryde, NSW, Australia; [Stephen, Ian D.] Macquarie Univ, ARC Ctr Excellence Cognit & Disorders, N Ryde, NSW, Australia	University of Nottingham Malaysia; University of Nottingham Malaysia; Manchester Metropolitan University; Macquarie University; Macquarie University	Stephen, ID (corresponding author), Univ Nottingham, Fac Sci, Sch Psychol, Malaysia Campus, Semenyih, Selangor, Malaysia.	ian.stephen@mq.edu.au	Stephen, Ian/ABA-6218-2021	Stephen, Ian/0000-0001-9714-8295	Crops for the Future Research Centre (CFFRC) at University of Nottingham Malaysia Campus	Crops for the Future Research Centre (CFFRC) at University of Nottingham Malaysia Campus	This work was supported by an informal grant from the Crops for the Future Research Centre (CFFRC) at University of Nottingham Malaysia Campus. CFFRC had no role in the design, analysis or writing of this article.	Alaluf S, 2002, J NUTR, V132, P399, DOI 10.1093/jn/132.3.399; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Britton G., 1995, SPECTROSCOPY-US, V1B, P13; Brown MJ, 2004, AM J CLIN NUTR, V80, P396, DOI 10.1093/ajcn/80.2.396; Chung SJ, 2006, J HUM NUTR DIET, V19, P287, DOI 10.1111/j.1365-277X.2006.00704.x; Coetzee V, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.2.025004; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fleshman MK, 2011, J AGR FOOD CHEM, V59, P4448, DOI 10.1021/jf200416a; Heinrich U, 2003, J NUTR, V133, P98, DOI 10.1093/jn/133.1.98; Hughes DA, 1999, P NUTR SOC, V58, P713, DOI 10.1017/S0029665199000932; Inouye CY, 2001, AUK, V118, P900, DOI 10.1642/0004-8038(2001)118[0900:CPIMHF]2.0.CO;2; Jahns L, 2014, AM J CLIN NUTR, V100, P930, DOI 10.3945/ajcn.114.086900; Jaswir I, 2011, J MED PLANTS RES, V5, P7119, DOI 10.5897/JMPRx11.011; Jones BC, 2004, PERCEPTION, V33, P569, DOI 10.1068/p3463; Kopckel W, 2008, PHOTOCHEM PHOTOBIOL, V84, P284, DOI 10.1111/j.1751-1097.2007.00253.x; Loy S L, 2011, Malays J Nutr, V17, P1; Martinkauppi B, 2002, FACE COLOR VARYING I; McGraw KJ, 2004, J AVIAN BIOL, V35, P543, DOI 10.1111/j.0908-8857.2004.03345.x; Miller E S, 1937, Plant Physiol, V12, P667, DOI 10.1104/pp.12.3.667; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Palozza P, 1998, NUTR REV, V56, P257, DOI 10.1111/j.1753-4887.1998.tb01762.x; Palozza P, 2003, MOL ASPECTS MED, V24, P353, DOI 10.1016/S0098-2997(03)00031-1; Phebe D., 2009, International Food Research Journal, V16, P233; Prahl S., 1998, TABULATED MOLAR EXTI; Saks L, 2003, OECOLOGIA, V134, P301, DOI 10.1007/s00442-002-1125-z; Sarna T, 1988, PIGMENTARY SYSTEM PH, P333; Schwartz JL, 1996, J NUTR, V126, pS1221, DOI 10.1093/jn/126.suppl_4.1221S; Sievenpiper JL, 2012, ANN INTERN MED, V156, P291, DOI 10.7326/0003-4819-156-4-201202210-00007; Sopian K., 1992, Renewable Energy, V2, P319, DOI 10.1016/0960-1481(92)90044-4; Stahl W, 1998, J NUTR, V128, P903, DOI 10.1093/jn/128.5.903; Stanhope KL, 2011, J CLIN ENDOCR METAB, V96, pE1596, DOI 10.1210/jc.2011-1251; Stephen ID, 2011, EVOL HUM BEHAV, V32, P216, DOI 10.1016/j.evolhumbehav.2010.09.003; Tappy L, 2012, CURR OPIN CLIN NUTR, V15, P357, DOI 10.1097/MCO.0b013e328354727e; Whitehead RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032988; Whitehead RD, 2012, AM J PUBLIC HEALTH, V102, P207, DOI 10.2105/AJPH.2011.300405	37	31	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133445	10.1371/journal.pone.0133445	http://dx.doi.org/10.1371/journal.pone.0133445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186449	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000358198700140
J	Wang, C; Zhang, J; Deng, WJ; Gong, WY; Liu, X; Ye, ZC; Peng, H; Lou, TQ				Wang, Cheng; Zhang, Jun; Deng, Wenjie; Gong, Wenyu; Liu, Xun; Ye, Zengchun; Peng, Hui; Lou, Tanqi			Nighttime Systolic Blood-Pressure Load Is Correlated with Target-Organ Damage Independent of Ambulatory Blood-Pressure Level in Patients with Non-Diabetic Chronic Kidney Disease	PLOS ONE			English	Article							VENTRICULAR MASS INDEX; DIABETIC-NEPHROPATHY; PRACTICE GUIDELINES; HYPERTENSION; CHILDREN; STRATIFICATION; VARIABILITY; HYPERTROPHY; RISK	Background The impacts of blood pressure (BP) load on target-organ damage in patients with chronic kidney disease (CKD) are largely unclear. We examined whether BP load is correlated with target-organ damage (TOD) in Chinese CKD patients independent of BP level. Methods We recruited 1219 CKD patients admitted to our hospital division in this cross-sectional study. The TOD were measured by estimated glomerular filtration rate (eGFR), proteinuria, left ventricular mass index (LVMI) and carotid intima-media thickness (cIMT) in this study. Univariate and multivariate linear analyses were used to evaluate the relationship between systolic blood pressure (SBP) load, diastolic blood pressure (DBP) load and these renal, cardiovascular parameters. Results In multivariable-adjusted models, BP load and ambulatory BP levels both independently correlated with LVMI, eGFR and proteinuria in all groups of CKD patients (p<0.05), 24-h SBP correlated with cIMT only in non-diabetic CKD patients without hypertension (p<0.05), while nighttime SBP load was associated with cIMT only in non-diabetic CKD patients (p<0.05). Furthermore, nighttime SBP load additionally increased coefficient of determination (R-2) and correlated with LVMI, proteinuria in non-diabetic CKD patients without hypertension (R-2 = 0.034, P<0.001 and R-2 = 0.012, P = 0.006 respectively) and LVMI, cIMT, eGFR in non-diabetic CKD patients with hypertension (R-2>0.008, P<0.05) in multivariable-adjusted model which already including the 24-h BP. BP load did not refine this correlation based on the 24-h BP level in diabetic CKD patients. Conclusion Night-time SBP load was correlated with TOD in patients with non-diabetic chronic kidney disease independent of BP level.	[Wang, Cheng; Zhang, Jun; Deng, Wenjie; Gong, Wenyu; Liu, Xun; Ye, Zengchun; Peng, Hui; Lou, Tanqi] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Med, Div Nephrol, Guangzhou 510630, Guangdong, Peoples R China	Sun Yat Sen University	Lou, TQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Med, Div Nephrol, Guangzhou 510630, Guangdong, Peoples R China.	lou.tq@163.com	wang, cheng/A-4225-2017		National Natural Science Foundation of China [81300595]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (No.81300595). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakris GL, 2009, J CLIN HYPERTENS GRE, P11144; Bidani AK, 2012, AM J MED, V125, P1057, DOI 10.1016/j.amjmed.2012.04.008; Bidani AK, 2009, HYPERTENSION, V54, P393, DOI 10.1161/HYPERTENSIONAHA.109.133777; Bliziotis IA, 2012, J HYPERTENS, V30, P1289, DOI 10.1097/HJH.0b013e3283531eaf; Bostanci BK, 2012, PEDIATR NEPHROL, V27, P1929, DOI 10.1007/s00467-012-2187-8; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Drawz PE, 2010, RENAL FAILURE, V32, P1036, DOI 10.3109/0886022X.2010.510615; Fabbian F, 2013, CHRONOBIOL INT, V30, P17, DOI 10.3109/07420528.2012.715872; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Li JH, 2013, CLIN NEPHROL, V79, P199, DOI 10.5414/CN107401; Li Y, 2014, HYPERTENSION, V63, P925, DOI 10.1161/HYPERTENSIONAHA.113.02780; Liu M, 2013, J HYPERTENS, V31, P1812, DOI 10.1097/HJH.0b013e3283624f9b; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; Ptinopoulou AG, 2013, HYPERTENS RES, V36, P91, DOI 10.1038/hr.2012.157; Sarnak MJ, 2003, CIRCULATION; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sharma AP, 2013, PEDIATR NEPHROL, V28, P1275, DOI 10.1007/s00467-013-2468-x; Sorof JM, 2002, HYPERTENSION, V39, P903, DOI 10.1161/01.HYP.0000013266.40320.3B; Tamura K, 2008, CLIN EXP HYPERTENS, V30, P33, DOI 10.1080/10641960701813890; Tatasciore A, 2007, HYPERTENSION, V50, P325, DOI 10.1161/HYPERTENSIONAHA.107.090084; The Department of Disease Control Ministry of Health China the Chinese Diabetes Society, 2004, CHIN J PREV CONTROL, P12283; Urbina E, 2008, HYPERTENSION, V52, P433, DOI 10.1161/HYPERTENSIONAHA.108.190329; van der Meer IM, 2010, J RENAL CARE, V36, P34, DOI 10.1111/j.1755-6686.2010.00165.x; Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055419; WHITE WB, 1991, J HYPERTENS, V9, pS39; ZACHARIAH PK, 1991, JAMA-J AM MED ASSOC, V265, P1414, DOI 10.1001/jama.265.11.1414; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	29	17	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131546	10.1371/journal.pone.0131546	http://dx.doi.org/10.1371/journal.pone.0131546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186336	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700019
J	Chavoshi, SH; De Baets, B; Neutens, T; De Tre, G; Van de Weghe, N				Chavoshi, Seyed Hossein; De Baets, Bernard; Neutens, Tijs; De Tre, Guy; Van de Weghe, Nico			Exploring Dance Movement Data Using Sequence Alignment Methods	PLOS ONE			English	Article							QUALITATIVE TRAJECTORY CALCULUS; REPRESENTING MOVING-OBJECTS; ACTIVITY PATTERNS; SIMILARITY; BLUETOOTH; INFORMATION; DIAGRAMS; SEARCH; SPACE; TIME	Despite the abundance of research on knowledge discovery from moving object databases, only a limited number of studies have examined the interaction between moving point objects in space over time. This paper describes a novel approach for measuring similarity in the interaction between moving objects. The proposed approach consists of three steps. First, we transform movement data into sequences of successive qualitative relations based on the Qualitative Trajectory Calculus (QTC). Second, sequence alignment methods are applied to measure the similarity between movement sequences. Finally, movement sequences are grouped based on similarity by means of an agglomerative hierarchical clustering method. The applicability of this approach is tested using movement data from samba and tango dancers.	[Chavoshi, Seyed Hossein; Neutens, Tijs; Van de Weghe, Nico] Univ Ghent, Dept Geog, B-9000 Ghent, Belgium; [De Baets, Bernard] Univ Ghent, KERMIT, Dept Math Modelling Stat & Bioinformat, B-9000 Ghent, Belgium; [De Tre, Guy] Univ Ghent, Dept Telecommun & Informat Proc, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Chavoshi, SH (corresponding author), Univ Ghent, Dept Geog, B-9000 Ghent, Belgium.	seyedhossein.chavoshi@ugent.be	Van de Weghe, Nico/B-7680-2011; De Tre, Guy/C-6374-2014; Neutens, Tijs/A-8623-2015; Van de Weghe, Nico/N-4214-2019; De Baets, Bernard/E-8877-2010	Van de Weghe, Nico/0000-0002-5327-4000; Van de Weghe, Nico/0000-0002-5327-4000; De Baets, Bernard/0000-0002-3876-620X; De Tre, Guy/0000-0002-1283-1915	Special Research Fund of Ghent University (BOF)	Special Research Fund of Ghent University (BOF)(Ghent University)	The authors would like to thank the Special Research Fund of Ghent University (BOF) for supporting the research.	ABBOTT A, 1995, ANNU REV SOCIOL, V21, P93, DOI 10.1146/annurev.so.21.080195.000521; ALLEN JF, 1983, COMMUN ACM, V26, P832, DOI 10.1145/182.358434; [Anonymous], P 31 INT C VER LARG; Bogaert P, 2007, LECT NOTES ARTIF INT, V4387, P20; Brodie M., 2008, SPORTS TECHNOL, V1, P17, DOI [10.1080/19346182.2008.9648447, DOI 10.1080/19346182.2008.9648447, DOI 10.1002/JST.6]; Buchin K., 2009, P 17 ACM SIGSPATIAL, P296, DOI [10.1145/1653771.1653813, DOI 10.1145/1653771.1653813]; Chavoshi SH, 2014, APPL GEOGR, V47, P111, DOI 10.1016/j.apgeog.2013.12.007; Chen L., 2005, P 2005 ACM SIGMOD IN, P491, DOI DOI 10.1145/1066157.1066213; Colombo G, 2013, COMPUT AIDED DESIGN, V10, P671; DeCesare NJ, 2005, WILDLIFE SOC B, V33, P935, DOI 10.2193/0091-7648(2005)33[935:EOFCOG]2.0.CO;2; Delafontaine M., 2012, QUALITATIVE TRAJECTO, P147; Delafontaine M, 2012, APPL GEOGR, V34, P659, DOI 10.1016/j.apgeog.2012.04.003; Delafontaine M, 2011, INFORM SCIENCES, V181, P1573, DOI 10.1016/j.ins.2010.12.021; Delafontaine M, 2011, EXPERT SYST APPL, V38, P5187, DOI 10.1016/j.eswa.2010.10.042; Dodge S, 2011, THESIS U ZURICH ZURI, P160; Dodge S, 2012, INT J GEOGR INF SCI, V26, P1563, DOI 10.1080/13658816.2011.630003; Fabrikant SI, 2008, CARTOGR J, V45, P201, DOI 10.1179/000870408X311396; Faloutsos C, 1998, COMPRESSION AND COMPLEXITY OF SEQUENCES 1997 - PROCEEDINGS, P2, DOI 10.1109/SEQUEN.1997.666899; Frank AU, 1996, INT J GEOGR INF SYST, V10, P269, DOI 10.1080/026937996138043; FREKSA C, 1992, LECT NOTES COMPUT SC, V639, P162; Frentzos E, ICDE 2007 IEEE 23 IN, P816; Gagliardo A, 2007, J EXP BIOL, V210, P1132, DOI 10.1242/jeb.003244; Galton A, 2001, FUND INFORM, V46, P55; Gau RJ, 2004, WILDLIFE SOC B, V32, P693, DOI 10.2193/0091-7648(2004)032[0693:UFPOTG]2.0.CO;2; Giannotti, 2008, MOBILITY DATA MINING, DOI 10.1007/978-3-540-75177-9; Guerra-Salcedo CM, 2005, WMSCI 2005: 9th World Multi-Conference on Systemics, Cybernetics and Informatics, Vol 3, P146; Hornsby K, 2002, ANN MATH ARTIF INTEL, V36, P177, DOI 10.1023/A:1015812206586; Hvidberg M, 2006, EPIDEMIOLOGY, V17, pS38, DOI 10.1097/00001648-200611001-00059; Joh CH, 2002, TRANSPORT RES B-METH, V36, P385, DOI 10.1016/S0191-2615(01)00009-1; Laube P, 2005, INT J GEOGR INF SCI, V19, P639, DOI 10.1080/13658810500105572; Lin B, 2005, P 13 ANN ACM INT WOR, P21; Michael K, 2006, INT SYMP TECHNOL SOC, P97; Miller HJ, 2009, CH CRC DATA MIN KNOW, P1; Mirabella O, 4 INT C HUM SYST INT, P52; Morrison DA., 2010, SYST BIOL, V59, P363; Mount DW, 2007, CSH PROTOCOLS, V2007; Muller M., 2007, INFORM RETRIEVAL MUS, DOI [10.1007/978-3-540- 74048-3_4, DOI 10.1007/978-3-540-74048-3]; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ong R, 2011, LECT NOTES ARTIF INT, V6913, P650, DOI 10.1007/978-3-642-23808-6_49; Orellana D, 2012, TOURISM MANAGE, V33, P672, DOI 10.1016/j.tourman.2011.07.010; Pan XS, 2007, AI SOC, V22, P113, DOI 10.1007/s00146-007-0126-1; Pelekis N, 2007, INT WORKSHOP TEMPORA, P129; Randell D. A., 1992, Principles of Knowledge Representation and Reasoning: Proceedings of the Third International Conference (KR '92), P165; Rosenberg MS, 2009, SEQUENCE ALIGNMENT: METHODS, MODELS, CONCEPTS, AND STRATEGIES, P1; Shoval N, 2007, ANN ASSOC AM GEOGR, V97, P282, DOI 10.1111/j.1467-8306.2007.00536.x; Shoval N, 2007, ANN TOURISM RES, V34, P141, DOI 10.1016/j.annals.2006.07.007; Sinha G., 2005, J GEOGRAPHICAL SYSTE, V7, P115, DOI DOI 10.1007/S10109-005-0153-8; Van de Weghe N, 2005, LECT NOTES COMPUT SC, V3770, P228, DOI 10.1007/11568346_25; Van de Weghe N, 2005, LECT NOTES COMPUT SC, V3762, P1087; Van de Weghe N, 2004, INT GEOSCI REMOTE SE, P4157; Van de Weghe N, 2005, EXPERT SYST APPL, V29, P977, DOI 10.1016/j.eswa.2005.06.022; Van de Weghe N, P WORKSH BEH MON INT, P91; Van de Weghe N, 2004, THESIS GHENT U BELG, P268; Van de Weghe N, 2006, CONTROL CYBERN, V35, P97; van Kreveld M., 2007, P 15 ANN ACM INT S A, P1, DOI [10.1145/1341012.1341068, DOI 10.1145/1341012.1341068]; Van Shaick J, 2008, URBANISM TRACK APPL; Versichele M, 2012, SENSORS-BASEL, V12, P14196, DOI 10.3390/s121014196; Versichele M, 2012, APPL GEOGR, V32, P208, DOI 10.1016/j.apgeog.2011.05.011; Vlachos M, 2002, PROC INT CONF DATA, P673, DOI 10.1109/ICDE.2002.994784; Wang LA, 2003, PATTERN RECOGN, V36, P585, DOI 10.1016/S0031-3203(02)00100-0; Wilson C, 2006, ENVIRON PLANN A, V38, P187, DOI 10.1068/a3722; Wilson C, 2001, TRANSPORT RES REC, P55; Wilson C, 2008, TRANSPORTATION, V35, P485, DOI 10.1007/s11116-008-9162-z; Yanagisawa Y, 2003, LECT NOTES COMPUT SC, V2574, P63; Yuan YH, 2014, INT J GEOGR INF SCI, V28, P496, DOI 10.1080/13658816.2013.854369	65	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132452	10.1371/journal.pone.0132452	http://dx.doi.org/10.1371/journal.pone.0132452			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181435	Green Submitted, gold, Green Published			2022-12-27	WOS:000358198200019
J	Hashimoto, A; Tanaka, M; Takeda, S; Ito, H; Nagano, K				Hashimoto, Ayako; Tanaka, Michinori; Takeda, Satoshi; Ito, Hideki; Nagano, Keisuke			Cilostazol Induces PGI(2) Production via Activation of the Downstream Epac-1/Rap1 Signaling Cascade to Increase Intracellular Calcium by PLC epsilon and to Activate p44/42 MAPK in Human Aortic Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROSTACYCLIN; ADENOSINE; KINASE; PHOSPHORYLATION; COMBINATION; PROTECTION; MECHANISM; RELEASE; AGENT	Background Cilostazol, a selective phosphodiesterase 3 (PDE3) inhibitor, is known as an anti-platelet drug and acts directly on platelets. Cilostazol has been shown to exhibit vascular protection in ischemic diseases. Although vascular endothelium-derived prostaglandin I-2 (PGI(2)) plays an important role in vascular protection, it is unknown whether cilostazol directly stimulates PGI(2) synthesis in endothelial cells. Here, we elucidate the mechanism of cilostazol-induced PGI(2) stimulation in endothelial cells. Methods and Results Human aortic endothelial cells (HAECs) were stimulated with cilostazol and PGI(2) accumulation in the culture media was measured. Cilostazol increased PGI(2) synthesis via the arachidonic acid pathway. Cilostazol-induced intracellular calcium also promoted PGI(2) synthesis via the inositol 1,4,5-trisphosphate receptor. Using RNAi, silencing of PDE3B abolished the induction effect of cilostazol on PGI(2) synthesis and intracellular cAMP accumulation. Inhibition of the exchange protein, which was directly activated by cyclic AMP 1 (Epac-1) and its downstream signal the Ras-like small GTPase (Rap-1), abolished cilostazol-induced PGI(2) synthesis, but this did not take place via protein kinase A (PKA). Inhibition of downstream signaling, such as mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase (PI3K) gamma, and phospholipase C (PLC) epsilon, suppressed cilostazol-induced PGI(2) synthesis. Conclusions The PDE3/Epac-1/Rap-1 signaling pathway plays an important role in cilostazol-induced PGI(2) synthesis. Namely, stimulation of HAECs with cilostazol induces intracellular calcium elevation via the Rap-1/PLC epsilon/IP3 pathway, along with MAPK activation via direct activation by Epac-1/Rap-1 and indirect activation by Epac-1/Rap-1/PI3K gamma, resulting in synergistically induced PGI(2) synthesis.	[Hashimoto, Ayako; Ito, Hideki; Nagano, Keisuke] Otsuka Pharmaceut Co Ltd, Inst New Drug Discovery 1, Tokushima, Tokushima 77101, Japan; [Tanaka, Michinori] Otsuka Pharmaceut Co Ltd, Med Chem Res Inst, Tokushima, Tokushima 77101, Japan; [Takeda, Satoshi] Otsuka Pharmaceut Co Ltd, Qs Res Inst, Tokushima, Tokushima 77101, Japan	Otsuka Pharmaceutical; Otsuka Pharmaceutical; Otsuka Pharmaceutical	Hashimoto, A (corresponding author), Otsuka Pharmaceut Co Ltd, Inst New Drug Discovery 1, Tokushima, Tokushima 77101, Japan.	Hashimoto.Ayako@ostuka.jp			Otsuka Pharmaceutical Co., Ltd.	Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical)	This study is financially supported by Otsuka Pharmaceutical Co., Ltd. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Blanco FJ, 1999, J RHEUMATOL, V26, P1366; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; BROTHERTON AFA, 1982, THROMB RES, V28, P637, DOI 10.1016/0049-3848(82)90155-4; Cone J, 1999, J CARDIOVASC PHARM, V34, P497, DOI 10.1097/00005344-199910000-00004; Funk CD, 2007, J CARDIOVASC PHARM, V50, P470, DOI 10.1097/FJC.0b013e318157f72d; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Hashimoto A, 2006, ATHEROSCLEROSIS, V189, P350, DOI 10.1016/j.atherosclerosis.2006.01.022; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; IGAWA T, 1990, THROMB RES, V57, P617, DOI 10.1016/0049-3848(90)90079-R; Kambayashi J, 2003, CURR PHARM DESIGN, V9, P2289, DOI 10.2174/1381612033453910; Khazaei M, 2008, Pathophysiology, V15, P49, DOI 10.1016/j.pathophys.2008.02.002; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Manickavasagam S, 2007, CARDIOVASC DRUG THER, V21, P321, DOI 10.1007/s10557-007-6036-0; Mayati A, 2012, J BIOL CHEM, V287, P4041, DOI 10.1074/jbc.M111.319970; Mitchell JA, 2008, EXP PHYSIOL, V93, P141, DOI 10.1113/expphysiol.2007.038588; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; Oyama N, 2011, STROKE, V42, P2571, DOI 10.1161/STROKEAHA.110.609834; Packer M., 1998, FOOD DRUG ADM CARD R, P1; PARSONS WJ, 1988, MOL PHARMACOL, V33, P441; Porto I, 2012, CURR VASC PHARMACOL, V10, P468, DOI 10.2174/157016112800812854; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; Ray CJ, 2006, J PHYSIOL-LONDON, V570, P85, DOI 10.1113/jphysiol.2005.099390; Ray CJ, 2002, J PHYSIOL-LONDON, V544, P195, DOI 10.1113/jphysiol.2002.023440; Sheu JJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-164; Sudano I, 2006, J CARDIOVASC PHARM, V47, pS136, DOI 10.1097/00005344-200606001-00008; Sudo T, 2000, BIOCHEM PHARMACOL, V59, P347, DOI 10.1016/S0006-2952(99)00346-9; WHITE DG, 1989, BRIT J PHARMACOL, V97, P683, DOI 10.1111/j.1476-5381.1989.tb12004.x; Wilson LS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217026; Zhang QH, 2012, BIOCHEM BIOPH RES CO, V420, P17, DOI 10.1016/j.bbrc.2012.02.103	30	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132835	10.1371/journal.pone.0132835	http://dx.doi.org/10.1371/journal.pone.0132835			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181635	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198200040
J	Rostoker, G; Griuncelli, M; Loridon, C; Magna, T; Machado, G; Drahi, G; Dahan, H; Janklewicz, P; Cohen, Y				Rostoker, Guy; Griuncelli, Mireille; Loridon, Christelle; Magna, Theophile; Machado, Gabrielle; Drahi, Gilles; Dahan, Herve; Janklewicz, Philippe; Cohen, Yves			Reassessment of Iron Biomarkers for Prediction of Dialysis Iron Overload: An MRI Study	PLOS ONE			English	Article							BONE-MARROW IRON; CHRONIC KIDNEY-DISEASE; SERUM FERRITIN LEVELS; HEMODIALYSIS-PATIENTS; ANEMIA MANAGEMENT; RENAL-FAILURE; DEFICIENCY; STORES; DIAGNOSIS; EFFICACY	Background and Objectives Iron overload among hemodialysis patients was previously considered rare but is now an increasingly recognized clinical situation. We analyzed correlations between iron biomarkers and the liver iron concentration (LIC) measured by magnetic resonance imaging (MRI), and examined their diagnostic accuracy for iron overload. Design, Setting, Participants and Measurements We performed a prospective cross-sectional study from 31 January 2005 to 31 August 2013 in the dialysis centre of a French community-based private hospital. A cohort of 212 hemodialysis patients free of overt inflammation or malnutrition, were treated for anemia with parenteral iron-sucrose and an erythropoesis-stimulating agent, in keeping with current clinical guidelines. Blinded measurements of hepatic iron stores were performed by T1 and T2* contrast MRI, and relationships were analysed using Spearman's coefficient, logistic regression and receiver-operator characteristic (ROC) curves. Results Among the biological markers, only serum ferritin showed a strong correlation with LIC (rho= 0.52, 95% CI: 0.41-0.61, p< 0.0001, Spearman test). In logistic analysis, only serum ferritin correctly classified the overall cohort into patients with normal liver iron stores (LIC <= 50 mu mol/g) and those with elevated liver iron stores (LIC > 50 mu mol/g) (odds ratio 1.007; 95% CI: 1.004-1.010). Serum ferritin was the iron biomarker with the best discriminatory capacity in ROC curves analysis (area under the curve (AUC) = 0.767; 95% CI: 0.698-0.835). The optimal serum ferritin cutoffs were 160 mu g/L for LIC > 50 mu mol/g (mild iron overload) and 290 mu g/L for LIC > 200 mu mol/g (severe iron overload). Conclusions For clinical purposes, serum ferritin correctly reflects liver iron stores, as assessed by MRI, in hemodialysis patients without overt inflammation or malnutrition. These results strongly suggest that current ferritin target values should be lowered to avoid iron overload.	[Rostoker, Guy; Griuncelli, Mireille; Loridon, Christelle; Magna, Theophile] Hop Prive Claude Galien, Div Nephrol & Dialysis, Ramsay Gen Sante, Quincy Sous Senart, France; [Machado, Gabrielle] Hop Prive Claude Galien, Dept Biochem, Ramsay Gen Sante, Quincy Sous Senart, France; [Drahi, Gilles; Dahan, Herve; Janklewicz, Philippe; Cohen, Yves] Hop Prive Claude Galien, Div Radiol, Ramsay Gen Sante, Quincy Sous Senart, France		Rostoker, G (corresponding author), Hop Prive Claude Galien, Div Nephrol & Dialysis, Ramsay Gen Sante, Quincy Sous Senart, France.	rostotom@orange.fr	Rostoker, Guy/K-1432-2019	Rostoker, Guy/0000-0002-4383-3825	Association Quincy Recherche Clinique et Therapeutique (QRCT)	Association Quincy Recherche Clinique et Therapeutique (QRCT)	The authors received a grant from the non-for-profit Association Quincy Recherche Clinique et Therapeutique (QRCT).	ALI M, 1982, LANCET, V1, P652; ANASTASSIADES EG, 1993, NEPHROL DIAL TRANSPL, V8, P846; [Anonymous], 2014, KDIGO CONTR C IR MAN; Bailie GR, 2015, KIDNEY INT, V87, P162, DOI 10.1038/ki.2014.275; Barton JC., 2010, HDB IRON OVERLOAD DI; BELL JD, 1980, KIDNEY INT, V17, P237, DOI 10.1038/ki.1980.27; Bohning D, 2008, STAT METHODS MED RES, V17, P543, DOI 10.1177/0962280207081867; BRITTENHAM GM, 1994, NEW ENGL J MED, V331, P567, DOI 10.1056/NEJM199409013310902; Canavese C, 2004, KIDNEY INT, V65, P1091, DOI 10.1111/j.1523-1755.2004.00480.x; CECCHIN E, 1990, KIDNEY INT, V37, P943, DOI 10.1038/ki.1990.69; Fernandez-Rodriguez AM, 1999, AM J KIDNEY DIS, V34, P508, DOI 10.1016/S0272-6386(99)70079-X; Ferrari P, 2011, CLIN J AM SOC NEPHRO, V6, P77, DOI 10.2215/CJN.04190510; Fishbane S, 2014, NEPHROL DIAL TRANSPL, V29, P255, DOI 10.1093/ndt/gft269; Gandon Y, 2004, LANCET, V363, P357, DOI 10.1016/S0140-6736(04)15436-6; Ghoti H, 2012, EUR J HAEMATOL, V89, P87, DOI 10.1111/j.1600-0609.2012.01783.x; GOKAL R, 1979, Q J MED, V48, P393; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Harmatz P, 2000, BLOOD, V96, P76, DOI 10.1182/blood.V96.1.76.013k22_76_79; Herbert V, 1997, STEM CELLS, V15, P291, DOI 10.1002/stem.150291; HUSSEIN S, 1975, BRIT MED J, V1, P546, DOI 10.1136/bmj.1.5957.546; Kalantar-Zadeh K, 2006, CLIN J AM SOC NEPHRO, V1, pS9, DOI 10.2215/CJN.01390406; KALANTARZADEH K, 1995, AM J KIDNEY DIS, V26, P292, DOI 10.1016/0272-6386(95)90649-5; KDOQI, 2006, Am J Kidney Dis, V47, pS16; Kohgo Y, 2008, INT J HEMATOL, V88, P7, DOI 10.1007/s12185-008-0120-5; Kuo KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050295; Kuragano T, 2014, KIDNEY INT, V86, P845, DOI 10.1038/ki.2014.114; Locatelli F, 2013, NEPHROL DIAL TRANSPL, V28, P1346, DOI 10.1093/ndt/gft033; Locatelli F, 2009, NEPHROL DIAL TRANSPL, V24, P348, DOI 10.1093/ndt/gfn653; MILMAN N, 1980, ACTA MED SCAND, V207, P201; MIRAHMADI KS, 1977, JAMA-J AM MED ASSOC, V238, P601, DOI 10.1001/jama.238.7.601; Motulsky H., 2014, INTUITIVE BIOSTATIST, P203; Rostoker G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115096; Rostoker G, 2012, AM J MED, V125, P991, DOI 10.1016/j.amjmed.2012.01.015; Sheskin D. J., 2007, HDB PARAMETRIC NONPA; Skikne BS, 2008, AM J HEMATOL, V83, P872, DOI 10.1002/ajh.21279; VANWYCK DB, 1989, SEMIN NEPHROL, V9, P21; Vaziri ND, 2013, AM J KIDNEY DIS, V61, P992, DOI 10.1053/j.ajkd.2012.10.027; Vaziri ND, 2012, AM J MED, V125, P951, DOI 10.1016/j.amjmed.2012.02.009	38	32	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132006	10.1371/journal.pone.0132006	http://dx.doi.org/10.1371/journal.pone.0132006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182077	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198200013
J	Fernandez, V; Buffetaut, E; Suteethorn, V; Rage, JC; Tafforeau, P; Kundrat, M				Fernandez, Vincent; Buffetaut, Eric; Suteethorn, Varavudh; Rage, Jean-Claude; Tafforeau, Paul; Kundrat, Martin			Evidence of Egg Diversity in Squamate Evolution from Cretaceous Anguimorph Embryos	PLOS ONE			English	Article							RED-BED SEQUENCES; SPHENODON-PUNCTATUS; REPTILIA SQUAMATA; FOSSIL RECORD; DINOSAUR EGGS; KHORAT GROUP; SE ASIA; SHELLS; THAILAND; LIZARDS	Lizards are remarkable amongst amniotes, for they display a unique mosaic of reproduction modes ranging from egg-laying to live-bearing. Within this patchwork, geckoes are believed to represent the only group to ever have produced fully calcified rigid-shelled eggs, contrasting with the ubiquitous parchment shelled-eggs observed in other lineages. However, this hypothesis relies only on observations of modern taxa and fossilised gecko-like eggshells which have never been found in association with any embryonic or parental remains. We report here the first attested fossil eggs of lizards from the Early Cretaceous of Thailand, combining hard eggshells with exquisitely preserved embryos of anguimoph (e.g. Komodo dragons, mosasaurs). These fossils shed light on an apparently rare reproduction strategy of squamates, demonstrate that the evolution of rigid-shelled eggs are not an exclusive specialization of geckoes, and suggest a high plasticity in the reproductive organs mineralizing eggshells.	[Fernandez, Vincent; Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Fernandez, Vincent] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [Buffetaut, Eric] Ecole Normale Super, Geol Lab, CNRS, UMR Unite Mixte Rech 8538, F-75231 Paris, France; [Suteethorn, Varavudh] Mahasarakham Univ, Palaeontol Res & Educ Ctr, Kantharawichai Dist 44150, Maha Sarakham P, Thailand; [Rage, Jean-Claude] UPMC Paris6, CNRS, Univ Paris 04, Museum Natl Hist Nat,MNHN CR2P, F-75005 Paris, France; [Kundrat, Martin] Uppsala Univ, Dept Organismal Biol, Evolutionary Biol Ctr, Subdept Dev & Evolut, S-75236 Uppsala, Sweden; [Kundrat, Martin] Acad Sci Czech Republ, Inst Physiol, Dept Biomath, CR-14220 Prague, Czech Republic	European Synchrotron Radiation Facility (ESRF); University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Mahasarakham University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Uppsala University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Fernandez, V (corresponding author), European Synchrotron Radiat Facil, 71 Rue Martyrs, F-38043 Grenoble, France.	vinfernand@gmail.com; martin.kundrat@ebc.uu.se	Kundrát, Martin/F-4959-2017	Kundrát, Martin/0000-0001-9361-2273; Fernandez, Vincent/0000-0002-8315-1458; Tafforeau, Paul/0000-0002-5962-1683	European Synchrotron Radiation Facility (ESRF, France); ECLIPSE 2 programme of the Centre National de la Recherche Scientifique (CNRS, France); CNRS-Thailand Research Fund joint project; Biodiversity Research and Training Program (BRT, Thailand); Department of Mineral Resources (Bangkok, Thailand); Linnaeus Framework Grant "The Genomics of Phenotypic Diversity in Natural Populations" (the Swedish Research Council); Czech Science Foundation [P302/12/1207]	European Synchrotron Radiation Facility (ESRF, France); ECLIPSE 2 programme of the Centre National de la Recherche Scientifique (CNRS, France); CNRS-Thailand Research Fund joint project; Biodiversity Research and Training Program (BRT, Thailand); Department of Mineral Resources (Bangkok, Thailand); Linnaeus Framework Grant "The Genomics of Phenotypic Diversity in Natural Populations" (the Swedish Research Council); Czech Science Foundation(Grant Agency of the Czech Republic)	This project was funded by the European Synchrotron Radiation Facility (ESRF, France), the ECLIPSE 2 programme of the Centre National de la Recherche Scientifique (CNRS, France), the CNRS-Thailand Research Fund joint project, the Biodiversity Research and Training Program (BRT, Thailand), the Department of Mineral Resources (Bangkok, Thailand), the Linnaeus Framework Grant "The Genomics of Phenotypic Diversity in Natural Populations" (the Swedish Research Council), and the Czech Science Foundation (P302/12/1207).	[Anonymous], 1984, PALAEONTOL POLONICA; Bhullar BAS, 2012, J EXP ZOOL PART B, V318B, P521, DOI 10.1002/jez.b.22456; Blackburn DG, 1998, J EXP ZOOL, V282, P560; Buffetaut E, 2005, NATURWISSENSCHAFTEN, V92, P477, DOI 10.1007/s00114-005-0022-9; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Carpenter K., 1999, EGGS NESTS BABY DINO; Conrad JL, 2008, B AM MUS NAT HIST, P1, DOI 10.1206/310.1; Conrad JL, 2011, CLADISTICS, V27, P230, DOI 10.1111/j.1096-0031.2010.00330.x; Deeming DC, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140311; DEEMING DC, 1988, HERPETOL J, V1, P230; Estes R., 1988, P119; Evans SE, 2003, BIOL REV, V78, P513, DOI 10.1017/S1464793103006134; Evans SE, 2006, CRETACEOUS RES, V27, P673, DOI 10.1016/j.cretres.2006.03.004; Fernandez V, 2012, MICROSC MICROANAL, V18, P179, DOI 10.1017/S1431927611012426; Fernandez V, 2009, GEOL SOC SPEC PUBL, V315, P285, DOI 10.1144/SP315.20; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Grellet-Tinner G, 2006, PALAEOGEOGR PALAEOCL, V232, P294, DOI 10.1016/j.palaeo.2005.10.029; Grigorescu D, 1994, DINOSAUR EGGS BABIES, P85; Grigorescu D, 2010, PALAEOGEOGR PALAEOCL, V293, P360, DOI 10.1016/j.palaeo.2010.03.031; Hirsch K., 1989, Historical Biology, V3, P61; HIRSCH K F, 1987, Annals of Carnegie Museum, V56, P223; Hirsch KF, 1996, J VERTEBR PALEONTOL, V16, P752, DOI 10.1080/02724634.1996.10011363; HORNER JR, 1988, NATURE, V332, P256, DOI 10.1038/332256a0; Horner JR, 1996, NATURE, V383, P103, DOI 10.1038/383103b0; Horner JR, 1997, J VERTEBR PALEONTOL, V17, P431, DOI 10.1080/02724634.1997.10010987; KOHRING R, 1991, PALAEONTOLOGY, V34, P237; MACHATSCHKI F, 1936, FORTSCHRITTE MINERAL, V0020; McDOWELL SAMUEL BOOKER, 1954, BULL AMER MUS NAT HIST, V105, P1; NORELL MA, 1994, SCIENCE, V266, P779, DOI 10.1126/science.266.5186.779; PACKARD GC, 1977, BIOL REV, V52, P71, DOI 10.1111/j.1469-185X.1977.tb01346.x; PACKARD MJ, 1991, CAN J ZOOL, V69, P303, DOI 10.1139/z91-049; PACKARD MJ, 1982, J MORPHOL, V174, P197, DOI 10.1002/jmor.1051740208; PACKARD MJ, 1988, J MORPHOL, V197, P147, DOI 10.1002/jmor.1051970203; PACKARD MJ, 1982, ZOOL J LINN SOC-LOND, V75, P297, DOI 10.1111/j.1096-3642.1982.tb01950.x; PACKARD MJ, 1982, HERPETOLOGICA, V38, P136; PACKARD MJ, 1989, CAN J ZOOL, V67, P746, DOI 10.1139/z89-106; Pilati T, 1998, ACTA CRYSTALLOGR B, V54, P515, DOI 10.1107/S0108768197018181; PREGILL G K, 1986, Transactions of the San Diego Society of Natural History, V21, P167; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Racey A, 2009, GEOL SOC SPEC PUBL, V315, P41, DOI 10.1144/SP315.5; Racey A, 2009, GEOL SOC SPEC PUBL, V315, P69, DOI 10.1144/SP315.6; Rage JC, 2010, GEOBIOS-LYON, V43, P253, DOI 10.1016/j.geobios.2009.08.002; Rieppel O., 1992, FIELDIANA, V68, P1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shukla UK, 2008, CRETACEOUS RES, V29, P674, DOI 10.1016/j.cretres.2008.02.003; Tumpeesuwan Sakboworn, 2010, Tropical Natural History, V10, P93; Varricchio DJ, 2011, HIST BIOL, V23, P91, DOI 10.1080/08912963.2010.500379; Weitkamp T, 2011, J SYNCHROTRON RADIAT, V18, P617, DOI 10.1107/S0909049511002895	48	21	23	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0128610	10.1371/journal.pone.0128610	http://dx.doi.org/10.1371/journal.pone.0128610			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176757	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600009
J	Gaetano, LC; Abdala, F				Gaetano, Leandro C.; Abdala, Fernando			The Stapes of Gomphodont Cynodonts: Insights into the Middle Ear Structure of Non-Mammaliaform Cynodonts	PLOS ONE			English	Article							SOUTH-AFRICA; EVOLUTION; ORIGIN; PHYLOGENY; SKULL	The stapes is known in several non-mammaliaform cynodonts, although it has only been cursorily studied. Here we thoroughly analyze the stapedial anatomy of several basal cynodonts in a phylogenetic framework. Our study shows that the stapedial anatomy is more variable than previously thought. The morphological variation of the stapes led to the recognition of 11 phylogenetic characters that were included in a total evidence data matrix centered in the analysis of gomphodont cynodonts. Stapes morphology does not provide evidence to suggest a direct connection between the stapes and a postquadrate tympanic membrane (if present) and the hypothesis of a dorsal process as the site of attachment of a small ligament or the stapedial muscle is supported. The re-evaluation of the theories concerning the position of the tympanic membrane in non-mammaliaform cynodonts allowed us to conclude that the hypothetical postquadrate tympanic membrane associated with the squamosal sulcus is at best relictual and most likely non-functional (not connected with the stapes). The sound waves were most likely transmitted to the stapes from a postdentary tympanic membrane through the quadrate. Our analysis results in a better understanding of the auditory system in basal cynodonts and its evolution, highlighting the variability of the stapedial anatomy.	[Gaetano, Leandro C.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ciencias Geol, Inst Estudios Andinos Don Pablo Groeber, Buenos Aires, DF, Argentina; [Gaetano, Leandro C.; Abdala, Fernando] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Abdala, Fernando] NRF DST Ctr Excellence Palaeosci, Johannesburg, South Africa	University of Buenos Aires; University of Witwatersrand	Gaetano, LC (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ciencias Geol, Inst Estudios Andinos Don Pablo Groeber, Buenos Aires, DF, Argentina.	lcgaetano@gl.fcen.uba.ar	Abdala, Fernando/I-8054-2019		Agencia Nacional de Promocion Cientifica y Tecnologica (Proyecto de Investigacion Cientifica y Tecnologica) [2013-2701]; National Research Foundation of South Africa; South Africa (Department of Science and Technology); National Research Foundation Research Incentive; Universidad de Buenos Aires Ciencia y Tecnica [X 133, 00728 2011-2014]; Proyecto de Investigacion Cientifica y Tecnologica [07-373]; Proyecto de Investigacion Plurianual Consejo Nacional de Investigaciones Cientificas y Tecnicas [0209/10]	Agencia Nacional de Promocion Cientifica y Tecnologica (Proyecto de Investigacion Cientifica y Tecnologica); National Research Foundation of South Africa(National Research Foundation - South Africa); South Africa (Department of Science and Technology); National Research Foundation Research Incentive; Universidad de Buenos Aires Ciencia y Tecnica; Proyecto de Investigacion Cientifica y Tecnologica; Proyecto de Investigacion Plurianual Consejo Nacional de Investigaciones Cientificas y Tecnicas	This research was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (Proyecto de Investigacion Cientifica y Tecnologica-2013-2701 to LCG) and the National Research Foundation of South Africa (to FA). Travel funds were provided by the Bi-National Cooperation Project between South Africa (Department of Science and Technology to B. Rubidge) and Argentina (Ministerio de Ciencia, Tecnica e Innovacion Productiva to C. Marsicano) and by the National Research Foundation Research Incentive to FA. Field exploration was supported by Universidad de Buenos Aires Ciencia y Tecnica X 133, Universidad de Buenos Aires Ciencia y Tecnica 00728 2011-2014, Proyecto de Investigacion Cientifica y Tecnologica 07-373, and Proyecto de Investigacion Plurianual Consejo Nacional de Investigaciones Cientificas y Tecnicas 0209/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala F, 2006, ZOOL J LINN SOC-LOND, V147, P383, DOI 10.1111/j.1096-3642.2006.00224.x; Abdala F, 2002, J VERTEBR PALEONTOL, V22, P313, DOI 10.1671/0272-4634(2002)022[0313:ANSOTT]2.0.CO;2; Abdala F, 2000, J VERTEBR PALEONTOL, V20, P501, DOI 10.1671/0272-4634(2000)020[0501:GCOTCA]2.0.CO;2; Abdala F, 2010, PALAEOGEOGR PALAEOCL, V286, P202, DOI 10.1016/j.palaeo.2010.01.011; Abdala F, 2009, J VERTEBR PALEONTOL, V29, P837, DOI 10.1671/039.029.0303; Allin E.F., 1986, P283; ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; ALLIN EF, 1975, J MORPHOL, V147, P403, DOI 10.1002/jmor.1051470404; Anthwal N, 2013, J ANAT, V222, P147, DOI 10.1111/j.1469-7580.2012.01526.x; BARGHUSEN HERBERT R., 1968, POSTILLA [YALE PEABODY MUS], V116, P1; BARGHUSEN HR, 1970, SCIENCE, V168, P573, DOI 10.1126/science.168.3931.573; BONAPARTE JF, 1966, ACTA GEOLOGICA LILLO, V8, P5; Broom R, 1912, P ZOOL SOC LOND, V1912, P419; Clack JA, 2004, SPR HDB AUD, V22, P128; Crompton A.W., 1972, P231; CROMPTON A. W., 1963, PROC ZOOL SOC LONDON, V140, P697; Estes R., 1961, Bulletin of the Museum of Comparative Zoology, V125, P165; Faurie S., 1974, Annals S Afr Mus, V65, P337; Flynn JJ, 2000, J VERTEBR PALEONTOL, V20, P422, DOI 10.1671/0272-4634(2000)020[0422:NTSEFT]2.0.CO;2; FOURIE S, 1968, South African Journal of Science, V64, P255; Gaetano LC, 2014, 4 INT PAL C, P526; Gao KQ, 2010, AM MUS NOVIT, P1, DOI 10.1206/649.1; Gaupp E., 1913, ARCH ANATOMIE ENTWIC, P1; Goloboff P.A., 2003, TREE ANAL USING NEW; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goodrich ES., 1930, STUDIES STRUCTURE DE, DOI [DOI 10.5962/BHL.TITLE.82144, 10.5962/bhl.title.82144]; HOPSON JA, 1966, AM ZOOL, V6, P437; Hopson James A., 2005, Palaeontologia Africana, V41, P53; HOTTON N, 1959, EVOLUTION, V13, P99; Jenkins F. A. Jr., 1970, Breviora, V352, P1; Kammerer CF, 2008, J VERTEBR PALEONTOL, V28, P445, DOI 10.1671/0272-4634(2008)28[445:NMOMBC]2.0.CO;2; Kemp TS, 2007, J VERTEBR PALEONTOL, V27, P431, DOI 10.1671/0272-4634(2007)27[431:ATFOTP]2.0.CO;2; KEMP TS, 1979, PHILOS T ROY SOC B, V285, P73, DOI 10.1098/rstb.1979.0001; KEMP TS, 2005, ORIGIN EVOLUTION MAM; KERMACK K A, 1983, Acta Palaeontologica Polonica, V28, P147; Kermack K.A., 1982, Geobios Memoire Special (Lyon), P151; KERMACK KA, 1981, ZOOL J LINN SOC-LOND, V71, P1, DOI 10.1111/j.1096-3642.1981.tb01127.x; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; KlaauW C.J., 1923, Z ANATOMIE ENTWICKLU, V69, P32; Lillegraven J.A., 1991, Contributions to Geology University of Wyoming, V28, P39; Liu J, 2014, VERTEBR PALEOBIOL PA, P255, DOI 10.1007/978-94-007-6841-3_15; Liu J, 2010, J MAMM EVOL, V17, P151, DOI 10.1007/s10914-010-9136-8; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; MAIER W, 1990, NETH J ZOOL, V40, P55, DOI 10.1163/156854289X00183; Melo T, J VERT PALE IN PRESS; Meng J, 2011, NATURE, V472, P181, DOI 10.1038/nature09921; Novacek M.J., 1986, Contributions to Geology Special Paper, P35; PARRINGTON F. R., 1955, PROC ZOOL SOC LONDON, V125, P1; PARRINGTON FR, 1979, BIOL REV, V54, P369, DOI 10.1111/j.1469-185X.1979.tb00842.x; PARRINGTON FR, 1974, J NAT HIST, V8, P421, DOI 10.1080/00222937400770351; PARRINGTON FR, 1946, P ZOOL SOC LOND, V116, P181; Presley R., 1984, S ZOOL SOC LOND, V52, P127; Reichert C., 1837, ARCH ANATOMIE PHYSL, V1837, P120; Romer A, 1956, OSTEOLOGY REPTILES; Romer A. S., 1970, Breviora, VNo. 344, P1; Romer A.S., 1972, Breviora, VNo. 396, P1; ROMER ALFRED SHERWOOD, 1967, BREV MUS COMP ZOOL [HARVARD], V264, P1; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Schumacher, 1972, MORPHOLOGY MAXILLOMA, P26; SHUTE CCD, 1956, J ANAT, V90, P261; Takechi M, 2010, J EXP ZOOL PART B, V314B, P417, DOI 10.1002/jez.b.21347; TUMARKIN A, 1948, J Laryngol Otol, V62, P687, DOI 10.1017/S002221510000952X; WATSON DMS, 1953, EVOLUTION, V7, P159, DOI 10.1111/j.1558-5646.1953.tb00074.x; Westoll TS, 1943, PROC R SOC SER B-BIO, V131, P393, DOI 10.1098/rspb.1943.0014; WESTOLL TS, 1945, NATURE, V155, P114, DOI 10.1038/155114a0; Westoll TS, 1944, NATURE, V154, P770, DOI 10.1038/154770b0; WIBLE JR, 1993, MAMMAL PHYLOGENY, P45; Williams PL, 1989, GRAYS ANATOMY; YOUNG CC, 1947, P ZOOL SOC LOND, V117, P537	69	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131174	10.1371/journal.pone.0131174	http://dx.doi.org/10.1371/journal.pone.0131174			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176619	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600037
J	Altamiranda, EG; Manrique, JM; Perez, SE; Rios, GL; Odeon, AC; Leunda, MR; Jones, LR; Verna, A				Gonzalez Altamiranda, Erika; Manrique, Julieta M.; Perez, Sandra E.; Rios, Glenda L.; Odeon, Anselmo C.; Leunda, Maria R.; Jones, Leandro R.; Verna, Andrea			Molecular Characterization of the First Bovine Herpesvirus 4 (BoHV-4) Strains Isolated from In Vitro Bovine Embryos production in Argentina	PLOS ONE			English	Article							POSTPARTUM METRITIS; TYPE-4; INFECTION; VIRUS; BOVINE-HERPESVIRUS-4; ENDOMETRITIS; DISEASE; CATTLE; HERD	Bovine herpesvirus 4 (BoHV-4) is increasingly considered as responsible for various problems of the reproductive tract. The virus infects mainly blood mononuclear cells and displays specific tropism for vascular endothelia, reproductive and fetal tissues. Epidemiological studies suggest its impact on reproductive performance, and its presence in various sites in the reproductive tract highlights its potential transmission in transfer-stage embryos. This work describes the biological and genetic characterization of BoHV-4 strains isolated from an in vitro bovine embryo production system. BoHV-4 strains were isolated in 2011 and 2013 from granulosa cells and bovine oocytes from ovary batches collected at a local abattoir, used as "starting material" for in vitro production of bovine embryos. Compatible BoHV-4-CPE was observed in the co-culture of granulosa cells and oocytes with MDBK cells. The identity of the isolates was confirmed by PCR assays targeting three ORFs of the viral genome. The phylogenetic analyses of the strains suggest that they were evolutionary unlinked. Therefore it is possible that BoHV-4 ovary infections occurred regularly along the evolution of the virus, at least in Argentina, which can have implications in the systems of in vitro embryo production. Thus, although BoHV-4 does not appear to be a frequent risk factor for in vitro embryo production, data are still limited. This study reveals the potential of BoHV-4 transmission via embryo transfer. Moreover, the high variability among the BoHV-4 strains isolated from aborted cows in Argentina highlights the importance of further research on the role of this virus as an agent with the potential to cause reproductive disease in cattle. The genetic characterization of the isolated strains provides data to better understand the pathogenesis of BoHV-4 infections. Furthermore, it will lead to fundamental insights into the molecular aspects of the virus and the means by which these strains circulate in the herds.	[Gonzalez Altamiranda, Erika; Odeon, Anselmo C.; Leunda, Maria R.; Verna, Andrea] Inst Nacl Tecnol Agr, Virol Lab, Dept Anim Prod, Buenos Aires, DF, Argentina; [Manrique, Julieta M.; Jones, Leandro R.] Univ Nacl Patagonia San Juan Bosco, Lab Virol & Genet Mol, Fac Ciencias Nat Sede Trelew, Comodoro Rivadavia, Chubut, Argentina; [Perez, Sandra E.] Univ Nacl Ctr Prov Buenos Aires, Fac Ciencias Vet, Buenos Aires, DF, Argentina; [Rios, Glenda L.] Inst Nacl Tecnol Agr, Lab Prod Embriones, Dept Anim Prod, Buenos Aires, DF, Argentina; [Gonzalez Altamiranda, Erika; Manrique, Julieta M.; Perez, Sandra E.; Jones, Leandro R.; Verna, Andrea] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Universidad Nacional de la Patagonia San Juan Bosco; Comision Nacional de Energia Atomica (CNEA); Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Verna, A (corresponding author), Inst Nacl Tecnol Agr, Virol Lab, Dept Anim Prod, Buenos Aires, DF, Argentina.	verna.andrea@inta.gob.ar	perez, sandra elizabeth/S-9336-2019	Jones, Leandro/0000-0002-5877-4194	Instituto Nacional de Tecnologia Agropecuaria [PNSA1115053, PNSA1115052]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2011-0312]	Instituto Nacional de Tecnologia Agropecuaria; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	Support was provided by Instituto Nacional de Tecnologia Agropecuaria: Project PNSA1115053 and PNSA1115052; Agencia Nacional de Promocion Cientifica y Tecnologica: Project PICT 2011-0312. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTHA A, 1966, ACTA VET ACAD SCI H, V16, P357; BIELANSKI A, 1993, THERIOGENOLOGY, V40, P531, DOI 10.1016/0093-691X(93)90406-U; Bilge Dagalp S, 2007, REV MED VET-TOULOUSE, V158, P201; Brenner MPC, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-53; BUBLOT M, 1992, VIROLOGY, V190, P654, DOI 10.1016/0042-6822(92)90903-3; Chastant-Maillard S, 2013, TRANSBOUNDARY EMRGIN, P1; Czaplicki G, 1998, PREV VET MED, V33, P235, DOI 10.1016/S0167-5877(97)00036-6; Deim Z, 2007, CAN J VET RES, V71, P226; Deim Z, 2006, MICROB PATHOGENESIS, V41, P144, DOI 10.1016/j.micpath.2006.03.006; Donofrio G, 2003, VET RES COMMUN, V27, P415, DOI 10.1023/A:1024889606158; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Egyed L, 1996, J CLIN MICROBIOL, V34, P1091, DOI 10.1128/JCM.34.5.1091-1095.1996; Egyed L, 2011, MICROB PATHOGENESIS, V50, P322, DOI 10.1016/j.micpath.2010.10.006; FABIAN K, 2008, VET J, V177, P289, DOI DOI 10.1016/j.tvjl.2007.04.010; Felsenstein J., 2004, INFERRING PHYLOGENIE; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frazier K, 2001, J VET DIAGN INVEST, V13, P502, DOI 10.1177/104063870101300608; Gillet L, 2004, J VIROL, V78, P2336, DOI 10.1128/JVI.78.5.2336-2347.2004; Gur S, 2010, ANIM SCI J, V81, P304, DOI 10.1111/j.1740-0929.2010.00743.x; HENRY BE, 1986, AM J VET RES, V47, P2242; Kalman D, 2004, MICROB PATHOGENESIS, V37, P125, DOI 10.1016/j.micpath.2004.06.011; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Lete C, 2012, J VIROL, V86, P11567, DOI 10.1128/JVI.00456-12; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; Monge A, 2006, RES VET SCI, V80, P120, DOI 10.1016/j.rvsc.2005.04.001; Moran P E, 2013, Open Vet J, V3, P126; NAEEM K, 1989, AM J VET RES, V50, P1931; Nikolin VM, 2007, NEW MICROBIOL, V30, P53; Nylander JAA, 2004, PROGRAM DISTRIBUTED; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Shin YC, 2010, VIROLOGY, V400, P175, DOI 10.1016/j.virol.2010.01.030; Silva-Frade C, 2010, THERIOGENOLOGY, V74, P1296, DOI 10.1016/j.theriogenology.2010.06.001; STRINGFELLOW DA, 1990, THERIOGENOLOGY, V34, P427, DOI 10.1016/0093-691X(90)90755-I; THIRY E, 1992, VET MICROBIOL, V33, P79, DOI 10.1016/0378-1135(92)90037-T; Verna A., 2008, REV ARGENT MICROBIOL, V40, P130; Verna AE, 2012, VET MICROBIOL, V160, P1, DOI 10.1016/j.vetmic.2012.04.039; WELLEMANS G, 1986, ANN RECH VET, V17, P89; Wellenberg GJ, 2001, J VIROL METHODS, V97, P101, DOI 10.1016/S0166-0934(01)00341-X	40	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132212	10.1371/journal.pone.0132212	http://dx.doi.org/10.1371/journal.pone.0132212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177382	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600091
J	Gordon, SP; Tseng, E; Salamov, A; Zhang, JW; Meng, XD; Zhao, ZY; Kang, DW; Underwood, J; Grigoriev, IV; Figueroa, M; Schilling, JS; Chen, F; Wang, Z				Gordon, Sean P.; Tseng, Elizabeth; Salamov, Asaf; Zhang, Jiwei; Meng, Xiandong; Zhao, Zhiying; Kang, Dongwan; Underwood, Jason; Grigoriev, Igor V.; Figueroa, Melania; Schilling, Jonathan S.; Chen, Feng; Wang, Zhong			Widespread Polycistronic Transcripts in Fungi Revealed by Single-Molecule mRNA Sequencing	PLOS ONE			English	Article							POLY(A) SIGNALS; HUMAN GENOME; SEQ; EXPRESSION; GENES; INTERFERENCE; MECHANISMS; COMPLEXITY; GENERATION; PLATFORM	Genes in prokaryotic genomes are often arranged into clusters and co-transcribed into polycistronic RNAs. Isolated examples of polycistronic RNAs were also reported in some higher eukaryotes but their presence was generally considered rare. Here we developed a long-read sequencing strategy to identify polycistronic transcripts in several mushroom forming fungal species including Plicaturopsis crispa, Phanerochaete chrysosporium, Trametes versicolor, and Gloeophyllum trabeum. We found genome-wide prevalence of polycistronic transcription in these Agaricomycetes, involving up to 8% of the transcribed genes. Unlike polycistronic mRNAs in prokaryotes, these co-transcribed genes are also independently transcribed. We show that polycistronic transcription may interfere with expression of the downstream tandem gene. Further comparative genomic analysis indicates that polycistronic transcription is conserved among a wide range of mushroom forming fungi. In summary, our study revealed, for the first time, the genome prevalence of polycistronic transcription in a phylogenetic range of higher fungi. Furthermore, we systematically show that our long-read sequencing approach and combined bioinformatics pipeline is a generic powerful tool for precise characterization of complex transcriptomes that enables identification of mRNA isoforms not recovered via short-read assembly.	[Gordon, Sean P.; Salamov, Asaf; Meng, Xiandong; Zhao, Zhiying; Kang, Dongwan; Grigoriev, Igor V.; Chen, Feng; Wang, Zhong] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Tseng, Elizabeth; Underwood, Jason] Pacific Biosci, Menlo Pk, CA USA; [Zhang, Jiwei; Schilling, Jonathan S.] Univ Minnesota, Dept Bioprod & Biosyst Engn, St Paul, MN 55108 USA; [Figueroa, Melania] Univ Minnesota, Dept Plant Pathol, St Paul, MN USA; [Wang, Zhong] Univ Calif, Sch Nat Sci, Merced, CA USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Merced	Wang, Z (corresponding author), Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA.	zhongwang@lbl.gov	Figueroa, Melania/R-7696-2017; Figueroa, Melania/AAI-8692-2021	Figueroa, Melania/0000-0003-2636-661X; Figueroa, Melania/0000-0003-2636-661X; Grigoriev, Igor/0000-0002-3136-8903; Zhao, zhiying/0000-0001-7524-397X	Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Pacific Biosciences	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Pacific Biosciences	The work was conducted by the U.S. Department of Energy Joint Genome Institute and supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. Pacific Biosciences provided support in the form of salaries for authors ET and JU, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Au KF, 2013, P NATL ACAD SCI USA, V110, pE4821, DOI 10.1073/pnas.1320101110; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Grutzmann K, 2014, DNA RES, V21, P27, DOI 10.1093/dnares/dst038; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hainer SJ, 2011, GENE DEV, V25, P29, DOI 10.1101/gad.1975011; Horns F, 2012, GENOME BIOL EVOL, V4, P240, DOI 10.1093/gbe/evs005; Kim KE, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.45; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; McGary KL, 2013, P NATL ACAD SCI USA, V110, P11481, DOI 10.1073/pnas.1304461110; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munk C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r48; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Palmer AC, 2009, MOL CELL, V34, P545, DOI 10.1016/j.molcel.2009.04.018; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; Pelechano V, 2013, NATURE, V497, P127, DOI 10.1038/nature12121; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Shen YJ, 2008, GENETICS, V179, P167, DOI 10.1534/genetics.108.088971; Tanaka M, 2011, DNA RES, V18, P189, DOI 10.1093/dnares/dsr011; Thomas S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094650; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Treutlein B, 2014, P NATL ACAD SCI USA, V111, pE1291, DOI 10.1073/pnas.1403244111; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	43	195	203	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132628	10.1371/journal.pone.0132628	http://dx.doi.org/10.1371/journal.pone.0132628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177194	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600134
J	Jing, YL; Guan, DX; Wu, JB; Wang, AZ; Jin, CJ; Yuan, FH				Jing, Yanli; Guan, Dexin; Wu, Jiabing; Wang, Anzhi; Jin, Changjie; Yuan, Fenghui			An Experimental Comparison of Two Methods on Photosynthesis Driving Soil Respiration: Girdling and Defoliation	PLOS ONE			English	Article							HETEROTROPHIC RESPIRATION; RHIZOSPHERE RESPIRATION; ROOT EXUDATION; SPRUCE FOREST; CO2 EFFLUX; CARBON; ALLOCATION; VEGETATION; TEMPERATURE; RESPONSES	Previous studies with different experimental methods have demonstrated that photosynthesis significantly influences soil respiration (R-S). To compare the experimental results of different methods, R-S after girdling and defoliation was measured in five-year-old seedlings of Fraxinus mandshurica from June to September. Girdling and defoliation significantly reduced R-S by 33% and 25% within 4 days, and 40% and 32% within the entire treatment period, respectively. The differential response of R-S to girdling and defoliation was a result of the over-compensation for R-S after girdling and redistribution of stored carbon after defoliation. No significant effect on RS was observed between girdling and defoliation treatment, while the soluble sugar content in fine roots was higher in defoliation than in girdling treatment, indicating that defoliation had less compensation effect for R-S after interrupting photosynthates supply. We confirm the close coupling of R-S with photosynthesis and recommend defoliation for further studies to estimate the effect of photosynthesis on R-S.	[Jing, Yanli; Guan, Dexin; Wu, Jiabing; Wang, Anzhi; Jin, Changjie; Yuan, Fenghui] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Jing, Yanli] Shenyang Agr Univ, Shenyang 110161, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Shenyang Agricultural University	Guan, DX (corresponding author), Room 72 Wenhua Rd, Shenyang, Liaoning Provin, Peoples R China.	dxguan@iae.ac.cn	Guan, Dexin/I-4184-2018; Yuan, Fenghui/W-3609-2019; Yuan, Fenghui/M-7424-2013	Guan, Dexin/0000-0002-2183-3779; Yuan, Fenghui/0000-0003-1004-873X; Yuan, Fenghui/0000-0003-1004-873X	National Science Foundation of China [41375119]; State Key Laboratory of Forest and Soil Ecology [LFSE2013-11]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Forest and Soil Ecology	This study was financially supported by the National Science Foundation of China (No. 41375119), and the State Key Laboratory of Forest and Soil Ecology (Grant No. LFSE2013-11). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CP, 2005, EUR J FOREST RES, V124, P155, DOI 10.1007/s10342-005-0072-8; Bahn M, 2009, NEW PHYTOL, V182, P451, DOI 10.1111/j.1469-8137.2008.02755.x; BhupinderpalSingh, 2003, PLANT CELL ENVIRON, V26, P1287, DOI 10.1046/j.1365-3040.2003.01053.x; Binkley D, 2006, OECOLOGIA, V148, P447, DOI 10.1007/s00442-006-0383-6; Chen DM, 2010, PLANT SOIL, V326, P123, DOI 10.1007/s11104-009-9986-0; Crawford MC, 2000, PLANT SOIL, V227, P67, DOI 10.1023/A:1026599229920; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Frey B, 2006, FOREST ECOL MANAG, V225, P271, DOI 10.1016/j.foreco.2006.01.003; Fu SL, 2004, PLANT SOIL, V263, P345, DOI 10.1023/B:PLSO.0000047745.30929.32; Guitian R, 2000, PLANT SOIL, V220, P271, DOI 10.1023/A:1004787710886; Hamilton EW, 2008, SOIL BIOL BIOCHEM, V40, P2865, DOI 10.1016/j.soilbio.2008.08.007; Han GX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091182; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Hogberg P, 2009, FOREST ECOL MANAG, V257, P1764, DOI 10.1016/j.foreco.2009.01.036; Huang N, 2012, AGR FOREST METEOROL, V160, P80, DOI 10.1016/j.agrformet.2012.03.005; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Jetton RM, 2014, J INSECT SCI, V14, DOI 10.1673/031.014.107; Krause K, 2013, AGR FOREST METEOROL, V181, P61, DOI 10.1016/j.agrformet.2013.07.007; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Levy-Varon JH, 2012, OECOLOGIA, V169, P211, DOI 10.1007/s00442-011-2182-y; Li Jun-Nan, 2014, Chinese Journal of Plant Ecology, V38, P1082, DOI 10.3724/SP.J.1258.2014.00102; Mawdsley JL, 1997, BIOL FERT SOILS, V24, P52, DOI 10.1007/s003740050207; Mei Li, 2009, Yingyong Shengtai Xuebao, V20, P1791; Nakane K, 1996, ECOL RES, V11, P111, DOI 10.1007/BF02347678; Olsson P, 2005, GLOBAL CHANGE BIOL, V11, P1745, DOI 10.1111/j.1365-2486.2005.001033.x; Paterson E, 2005, PLANT CELL ENVIRON, V28, P1525, DOI 10.1111/j.1365-3040.2005.01389.x; Paterson E, 2003, PLANT SOIL, V250, P293, DOI 10.1023/A:1022819219947; Piper FI, 2014, J ECOL, V102, P1101, DOI 10.1111/1365-2745.12284; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Ravch E, 2006, HORTSCIENCE, V41, P1007; Savage K, 2013, GLOBAL CHANGE BIOL, V19, P1151, DOI 10.1111/gcb.12108; Shi TT, 2008, HYDROL PROCESS, V22, P3431, DOI 10.1002/hyp.6922; Snyder KA, 2007, FOREST ECOL MANAG, V246, P222, DOI 10.1016/j.foreco.2007.04.032; Subke JA, 2003, SOIL BIOL BIOCHEM, V35, P1467, DOI 10.1016/S0038-0717(03)00241-4; Subke JA, 2011, J ECOL, V99, P186, DOI 10.1111/j.1365-2745.2010.01740.x; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00978.x; Vargas-Ortiz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067879; Wan SQ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001971; Xu XK, 2007, SOIL SCI PLANT NUTR, V53, P430, DOI 10.1111/j.1747-0765.2007.00146.x; Yan LM, 2011, GLOBAL CHANGE BIOL, V17, P1990, DOI 10.1111/j.1365-2486.2010.02365.x; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; Zeller B, 2008, SOIL BIOL BIOCHEM, V40, P1155, DOI 10.1016/j.soilbio.2007.12.009; [张弥 Zhang Mi], 2005, [生态学杂志, Chinese Journal of Ecology], V24, P1007	44	4	4	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132649	10.1371/journal.pone.0132649	http://dx.doi.org/10.1371/journal.pone.0132649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177498	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600138
J	Lammert, AC; Narayanan, SS				Lammert, Adam C.; Narayanan, Shrikanth S.			On Short-Time Estimation of Vocal Tract Length from Formant Frequencies	PLOS ONE			English	Article							SPEAKER NORMALIZATION; BODY-SIZE; SPEECH; ACOUSTICS; VOWELS; ROARS	Vocal tract length is highly variable across speakers and determines many aspects of the acoustic speech signal, making it an essential parameter to consider for explaining behavioral variability. A method for accurate estimation of vocal tract length from formant frequencies would afford normalization of interspeaker variability and facilitate acoustic comparisons across speakers. A framework for considering estimation methods is developed from the basic principles of vocal tract acoustics, and an estimation method is proposed that follows naturally from this framework. The proposed method is evaluated using acoustic characteristics of simulated vocal tracts ranging from 14 to 19 cm in length, as well as real-time magnetic resonance imaging data with synchronous audio from five speakers whose vocal tracts range from 14.5 to 18.0 cm in length. Evaluations show improvements in accuracy over previously proposed methods, with 0.631 and 1.277 cm root mean square error on simulated and human speech data, respectively. Empirical results show that the effectiveness of the proposed method is based on emphasizing higher formant frequencies, which seem less affected by speech articulation. Theoretical predictions of formant sensitivity reinforce this empirical finding. Moreover, theoretical insights are explained regarding the reason for differences in formant sensitivity.	[Lammert, Adam C.] Swarthmore Coll, Dept Comp Sci, Swarthmore, PA 19081 USA; [Narayanan, Shrikanth S.] Univ So Calif, Signal Anal & Interpretat Lab, Los Angeles, CA USA	Swarthmore College; University of Southern California	Lammert, AC (corresponding author), Swarthmore Coll, Dept Comp Sci, Swarthmore, PA 19081 USA.	alammer1@swarthmore.edu	Narayanan, Shrikanth S/D-5676-2012		National Institutes of Health [DC007124]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC009975, R01DC007124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health, grant DC007124 (SSN received funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boersma Paul, 2002, GLOT INT, V5, P341; Bresch E, 2008, IEEE SIGNAL PROC MAG, V25, P123, DOI 10.1109/MSP.2008.918034; Bresch E, 2006, J ACOUST SOC AM, V120, P1791, DOI 10.1121/1.2335423; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chiba T, 1941, VOWEL ITS NATURE STR; Claes T, 1998, IEEE T SPEECH AUDI P, V6, P549, DOI 10.1109/89.725321; de Boer B., 2007, ACLC WORKING PAPERS, V2, P61; Echternach M, 2011, J VOICE, V25, P670, DOI 10.1016/j.jvoice.2010.09.008; Eide E, 1996, INT CONF ACOUST SPEE, P346, DOI 10.1109/ICASSP.1996.541103; Fant G., 1960, ACOUSTIC THEORY SPEE; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Gouvea E. B., 1997, 5 EUR C SPEECH COMM, P1139; Harris TR, 2006, ETHOLOGY, V112, P911, DOI 10.1111/j.1439-0310.2006.01247.x; Iskarous K, 2010, J PHONETICS, V38, P375, DOI 10.1016/j.wocn.2010.03.002; Kay S, 1988, MODERN SPECTRAL ESTI; Kelly J., 1962, P 4 INT C AC, P1; Kim YC, 2011, MAGN RESON MED, V65, P1365, DOI 10.1002/mrm.22714; KIRLIN RL, 1978, IEEE T ACOUST SPEECH, V26, P571, DOI 10.1109/TASSP.1978.1163151; Lee L, 1998, IEEE T SPEECH AUDI P, V6, P49, DOI 10.1109/89.650310; Lee L, 1996, INT CONF ACOUST SPEE, P353, DOI 10.1109/ICASSP.1996.541105; Lee S, 1999, J ACOUST SOC AM, V105, P1455, DOI 10.1121/1.426686; MERMELSTEIN P, 1967, J ACOUST SOC AM, V41, P1283, DOI 10.1121/1.1910470; MRAYATI M, 1988, SPEECH COMMUN, V7, P257, DOI 10.1016/0167-6393(88)90073-8; Narayanan S, 2004, J ACOUST SOC AM, V115, P1771, DOI 10.1121/1.1652588; Necioglu BF, 2000, INT CONF ACOUST SPEE, P1319, DOI 10.1109/ICASSP.2000.861821; Paige A, 1970, IEEE T AUDIO ELECTRO, P18; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Pitz M., 2001, EUROSPEECH, P721; Preparata F, 1990, COMPUTATIONAL GEOMET, P185; Rabiner L, 1978, DIGITAL PROCESSING S; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Rendall D, 2005, J ACOUST SOC AM, V117, P944, DOI 10.1121/1.1848011; Riede T, 1999, J EXP BIOL, V202, P2859; Santos GM, 2004, P ANN INT IEEE EMBS, V26, P1048; SCHROEDER MR, 1967, J ACOUST SOC AM, V41, P1002, DOI 10.1121/1.1910429; Stevens K, 1998, ACOUSTIC PHONETICS; STEVENS KN, 1989, J PHONETICS, V17, P3, DOI 10.1016/S0095-4470(19)31520-7; Story BH, 2006, J ACOUST SOC AM, V119, P715, DOI 10.1121/1.2151802; Story BH, 1996, J ACOUST SOC AM, V100, P537, DOI 10.1121/1.415960; Takemoto H, 2006, J ACOUST SOC AM, V119, P1037, DOI 10.1121/1.2151823; Turner RE, 2009, J ACOUST SOC AM, V125, P2374, DOI 10.1121/1.3079772; Vorperian HK, 2005, J ACOUST SOC AM, V117, P338, DOI 10.1121/1.1835958; Vorperian HK, 2009, J ACOUST SOC AM, V125, P1666, DOI 10.1121/1.3075589; WAKITA H, 1977, IEEE T ACOUST SPEECH, V25, P183, DOI 10.1109/TASSP.1977.1162929; Wegmann S, 1996, INT CONF ACOUST SPEE, P339, DOI 10.1109/ICASSP.1996.541101; WOOD S, 1979, J PHONETICS, V7, P25, DOI 10.1016/S0095-4470(19)31031-9	47	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132193	10.1371/journal.pone.0132193	http://dx.doi.org/10.1371/journal.pone.0132193			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177102	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600088
J	Lu, Y; Wang, AH; Shi, P; Zhang, H; Li, ZS				Lu, Yang; Wang, AiHua; Shi, Peng; Zhang, Hui; Li, ZeSheng			Quantum Chemical Study on the Antioxidation Mechanism of Piceatannol and Isorhapontigenin toward Hydroxyl and Hydroperoxyl Radicals	PLOS ONE			English	Article							INDUCED PEROXIDATION; OXIDATIVE STRESS; RESVERATROL; ANALOGS; STILBENE; APOPTOSIS; ENERGIES; DESIGN; WINE; ROS	A systematic study of the antioxidation mechanisms behind hydroxyl (center dot OH) and hydroperoxyl (center dot OOH) radical scavenging activity of piceatannol (PIC) and isorhapontigenin (ISO) was carried out using density functional theory (DFT) method. Two reaction mechanisms, abstraction (ABS) and radical adduct formation (RAF), were discussed. A total of 24 reaction pathways of scavenging center dot OH and center dot OOH with PIC and ISO were investigated in the gas phase and solution. The thermodynamic and kinetic properties of all pathways were calculated. Based on these results, we evaluated the antioxidant activity of every active site of PIC and ISO and compared the abilities of PIC and ISO to scavenge radicals. According to our results, PIC and ISO may act as effective center dot OH and center dot OOH scavengers in organism. A4-hydroxyl group is a very important active site for PIC and ISO to scavenge radicals. The introducing of -OH or -OCH3 group to the ortho-position of A4-hydroxyl group would increase its antioxidant activity. Meanwhile, the conformational effect was researched, the results suggest that the presence and pattern of intramolecular hydrogen bond (IHB) are considerable in determining the antioxidant activity of PIC and ISO.	[Lu, Yang; Wang, AiHua; Shi, Peng] Harbin Univ Sci & Technol, Coll Mat Sci & Engn, Harbin 150080, Peoples R China; [Zhang, Hui] Harbin Univ Sci & Technol, Coll Chem & Environm Engn, Harbin 150080, Peoples R China; [Li, ZeSheng] Beijing Inst Technol, Minist Educ, Key Lab Cluster Sci, Beijing 100081, Peoples R China; [Li, ZeSheng] Beijing Inst Technol, Sch Chem, Beijing 100081, Peoples R China	Harbin University of Science & Technology; Harbin University of Science & Technology; Beijing Institute of Technology; Beijing Institute of Technology	Zhang, H (corresponding author), Harbin Univ Sci & Technol, Coll Chem & Environm Engn, Harbin 150080, Peoples R China.	hust_zhanghui11@hotmail.com			National Basic Research Program of China [2012CB723308]; National Natural Science Foundation of China [51337002, 50977019]; Doctoral Foundation by the Ministry of Education of China [20112303110005]; Science Foundation for Distinguished Young Scholar of Heilongjiang Province [JC201206]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Foundation by the Ministry of Education of China; Science Foundation for Distinguished Young Scholar of Heilongjiang Province(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work is supported by the National Basic Research Program of China (2012CB723308), the National Natural Science Foundation of China (51337002 and 50977019), the Doctoral Foundation by the Ministry of Education of China (20112303110005), and the Science Foundation for Distinguished Young Scholar of Heilongjiang Province (JC201206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardura D, 2005, J PHYS CHEM B, V109, P23618, DOI 10.1021/jp0540499; Bastianetto S, 2009, CNS NEUROSCI THER, V15, P76, DOI 10.1111/j.1755-5949.2008.00074.x; Bavaresco L, 2002, VITIS, V41, P133; Cai YJ, 2003, BBA-MOL BASIS DIS, V1637, P31, DOI 10.1016/S0925-4439(02)00174-6; Cordova-Gomez M, 2013, RSC ADV, V3, P20209, DOI 10.1039/c3ra42923g; Djoko B, 2007, J AGR FOOD CHEM, V55, P2376, DOI 10.1021/jf062741a; Docherty JJ, 1999, ANTIVIR RES, V43, P145, DOI 10.1016/S0166-3542(99)00042-X; ESTERBAUER H, 1990, MUTAT RES, V238, P223, DOI 10.1016/0165-1110(90)90014-3; Fang JG, 2002, CHEM-EUR J, V8, P4191, DOI 10.1002/1521-3765(20020916)8:18<4191::AID-CHEM4191>3.0.CO;2-S; Fang YN, 2002, PHYTOMEDICINE, V9, P734, DOI 10.1078/094471102321621359; FERRIGNI NR, 1984, J NAT PROD, V47, P347, DOI 10.1021/np50032a019; Frisch G. W., 2013, GAUSSIAN 09; Galano A, 2010, J PHYS CHEM B, V114, P6625, DOI 10.1021/jp912001c; Hagen TM, 2003, ANTIOXID REDOX SIGN, V5, P503, DOI 10.1089/152308603770310149; HAMMOND GS, 1955, J AM CHEM SOC, V77, P334, DOI 10.1021/ja01607a027; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Fernandez-Marin MI, 2012, FOOD CHEM, V135, P1353, DOI 10.1016/j.foodchem.2012.05.086; Iuga C, 2011, J PHYS CHEM B, V115, P12234, DOI 10.1021/jp206347u; Jancinvoa V, 2013, OXIDATIVE MED CELLUL, P1; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; KIMURA Y, 1985, BIOCHIM BIOPHYS ACTA, V834, P275; King RE, 2006, COMPR REV FOOD SCI F, V5, P65, DOI 10.1111/j.1541-4337.2006.00001.x; Ku KL, 2005, J AGR FOOD CHEM, V53, P3877, DOI 10.1021/jf050242o; Lee SK, 1998, COMB CHEM HIGH T SCR, V1, P35; Leopoldini M, 2011, FOOD CHEM, V125, P288, DOI 10.1016/j.foodchem.2010.08.012; Liu YL, 2004, BIOCHEM PHARMACOL, V67, P777, DOI 10.1016/j.bcp.2003.09.025; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; MARNETT LJ, 1987, CARCINOGENESIS, V8, P1365, DOI 10.1093/carcin/8.10.1365; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mikulski D, 2012, J MOL MODEL, V18, P3255, DOI 10.1007/s00894-011-1342-7; Okuno Y, 1997, CHEM-EUR J, V3, P212, DOI 10.1002/chem.19970030208; Pastor N, 2000, J MOL BIOL, V304, P55, DOI 10.1006/jmbi.2000.4173; Perez-Gonzalez A, 2012, J MEX CHEM SOC, V56, P241; Potter GA, 2002, BRIT J CANCER, V86, P774, DOI 10.1038/sj.bjc.6600197; PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657, DOI 10.1146/annurev.ph.48.030186.003301; Ricks AB, 2010, J AM CHEM SOC, V132, P15427, DOI 10.1021/ja107420a; Rimando AM, 2004, J AGR FOOD CHEM, V52, P4713, DOI 10.1021/jf040095e; Rossi M, 2008, J AGR FOOD CHEM, V56, P10557, DOI 10.1021/jf801923j; Shang YJ, 2010, FOOD CHEM, V119, P1435, DOI 10.1016/j.foodchem.2009.09.024; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Stivala LA, 2001, J BIOL CHEM, V276, P22586, DOI 10.1074/jbc.M101846200; Stojanovic S, 2001, ARCH BIOCHEM BIOPHYS, V391, P79, DOI 10.1006/abbi.2001.2388; Surh YJ, 1999, CANCER LETT, V140, P1, DOI 10.1016/S0304-3835(99)00039-7; Wang MF, 1998, J AGR FOOD CHEM, V46, P4869, DOI 10.1021/jf980614b; Wang QL, 2001, JPN J PHARMACOL, V87, P61, DOI 10.1254/jjp.87.61; Zavala-Oseguera C, 2009, J PHYS CHEM A, V113, P13913, DOI 10.1021/jp906144d; Zhang HY, 2003, CHEM-EUR J, V9, P502, DOI 10.1002/chem.200390052; Zhao Y, 2006, J CHEM THEORY COMPUT, V2, P364, DOI 10.1021/ct0502763	49	19	19	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133259	10.1371/journal.pone.0133259	http://dx.doi.org/10.1371/journal.pone.0133259			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176778	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600234
J	McGill, LA; Scott, AD; Ferreira, PF; Nielles-Vallespin, S; Ismail, T; Kilner, PJ; Gatehouse, PD; de Silva, R; Prasad, SK; Giannakidis, A; Firmin, DN; Pennell, DJ				McGill, Laura-Ann; Scott, Andrew D.; Ferreira, Pedro F.; Nielles-Vallespin, Sonia; Ismail, Tevfik; Kilner, Philip J.; Gatehouse, Peter D.; de Silva, Ranil; Prasad, Sanjay K.; Giannakidis, Archontis; Firmin, David N.; Pennell, Dudley J.			Heterogeneity of Fractional Anisotropy and Mean Diffusivity Measurements by In Vivo Diffusion Tensor Imaging in Normal Human Hearts	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; MUSCLE CELL DISORGANIZATION; CARDIAC FIBER ARCHITECTURE; CANINE LEFT-VENTRICLE; HYPERTROPHIC CARDIOMYOPATHY; LAMINAR STRUCTURE; MYOCARDIAL MICROSTRUCTURE; HISTOLOGICAL VALIDATION; QUANTITATIVE-ANALYSIS; WATER DIFFUSION	Background Cardiac diffusion tensor imaging (cDTI) by cardiovascular magnetic resonance has the potential to assess microstructural changes through measures of fractional anisotropy (FA) and mean diffusivity (MD). However, normal variation in regional and transmural FA and MD is not well described. Methods Twenty normal subjects were scanned using an optimised cDTI sequence at 3T in systole. FA and MD were quantified in 3 transmural layers and 4 regional myocardial walls. Results FA was higher in the mesocardium (0.46 +/- 0.04) than the endocardium (0.40 +/- 0.04, p <= 0.001) and epicardium (0.39 +/- 0.04, p <= 0.001). On regional analysis, the FA in the septum was greater than the lateral wall (0.44 +/- 0.03 vs 0.40 +/- 0.05 p = 0.04). There was a transmural gradient in MD increasing towards the endocardium (epicardium 0.87 +/- 0.07 vs endocardium 0.91 +/- 0.08x10(-3) mm(2)/s, p = 0.04). With the lateral wall (0.87 +/- 0.08x10(-3) mm(2)/s) as the reference, the MD was higher in the anterior wall (0.92 +/- 0.08x10(-3) mm(2)/s, p = 0.016) and septum (0.92 +/- 0.07x10(-3) mm(2)/s, p = 0.028). Transmurally the signal to noise ratio (SNR) was greatest in the mesocardium (14.5 +/- 2.5 vs endocardium 13.1 +/- 2.2, p<0.001; vs epicardium 12.0 +/- 2.4, p<0.001) and regionally in the septum (16.0 +/- 3.4 vs lateral wall 11.5 +/- 1.5, p<0.001). Transmural analysis suggested a relative reduction in the rate of change in helical angle (HA) within the mesocardium. Conclusions In vivo FA and MD measurements in normal human heart are heterogeneous, varying significantly transmurally and regionally. Contributors to this heterogeneity are many, complex and interactive, but include SNR, variations in cardiac microstructure, partial volume effects and strain. These data indicate that the potential clinical use of FA and MD would require measurement standardisation by myocardial region and layer, unless pathological changes substantially exceed the normal variation identified.	[McGill, Laura-Ann; Scott, Andrew D.; Ferreira, Pedro F.; Nielles-Vallespin, Sonia; Ismail, Tevfik; Kilner, Philip J.; Gatehouse, Peter D.; de Silva, Ranil; Prasad, Sanjay K.; Giannakidis, Archontis; Firmin, David N.; Pennell, Dudley J.] Royal Brompton Hosp, NIHR Cardiovasc Biomed Res Unit, London SW3 6NP, England; [McGill, Laura-Ann; Scott, Andrew D.; Ferreira, Pedro F.; Ismail, Tevfik; Kilner, Philip J.; Gatehouse, Peter D.; de Silva, Ranil; Prasad, Sanjay K.; Giannakidis, Archontis; Firmin, David N.; Pennell, Dudley J.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	Royal Brompton Hospital; Imperial College London	Firmin, DN (corresponding author), Royal Brompton Hosp, NIHR Cardiovasc Biomed Res Unit, Sydney St, London SW3 6NP, England.	d.firmin@imperial.ac.uk	Ismail, Tevfik F/AAG-3303-2020	Ismail, Tevfik F/0000-0002-1691-7599; Gatehouse, Peter/0000-0002-0260-4719; Scott, Andrew/0000-0001-7656-3123; Giannakidis, Archontis/0000-0001-7403-923X; Pennell, Dudley/0000-0001-5523-1314; Ferreira, Pedro/0000-0002-0436-3496	National Institute for Health Research (NIHR) Cardiovascular Biomedical Research Unit based at Royal Brompton & Harefield Trust, Imperial College London; National Institute for Health Research [NF-SI-0508-10081] Funding Source: researchfish	National Institute for Health Research (NIHR) Cardiovascular Biomedical Research Unit based at Royal Brompton & Harefield Trust, Imperial College London; National Institute for Health Research(National Institute for Health Research (NIHR))	The research was funded by the National Institute for Health Research (NIHR) Cardiovascular Biomedical Research Unit based at Royal Brompton & Harefield Trust, Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli S, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0077-x; [Anonymous], DIFFUSION WEIGHTED M; Arts T, 2001, AM J PHYSIOL-HEART C, V280, pH2222, DOI 10.1152/ajpheart.2001.280.5.H2222; Axel L, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0089-6; Bammer R, 2009, MAGN RESON IMAGING C, V17, P175, DOI 10.1016/j.mric.2009.01.011; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Benson AP, 2011, INTERFACE FOCUS, V1, P101, DOI 10.1098/rsfs.2010.0005; BULKLEY BH, 1977, CIRCULATION, V56, P292, DOI 10.1161/01.CIR.56.2.292; Callot V, 2003, MAGN RESON MED, V50, P531, DOI 10.1002/mrm.10568; Delattre BMA, 2012, INVEST RADIOL, V47, P662, DOI 10.1097/RLI.0b013e31826ef901; Dou JG, 2003, MAGNET RESON MED, V50, P107, DOI 10.1002/mrm.10482; Dou JG, 2002, MAGNET RESON MED, V48, P105, DOI 10.1002/mrm.10188; EDELMAN RR, 1994, MAGNET RESON MED, V32, P423, DOI 10.1002/mrm.1910320320; Ferreira PF, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0087-8; Gilbert SH, 2012, AM J PHYSIOL-HEART C, V302, pH287, DOI 10.1152/ajpheart.00824.2011; GREENBAUM RA, 1981, BRIT HEART J, V45, P248; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Healy LJ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-74; Helm PA, 2005, MAGN RESON MED, V54, P850, DOI 10.1002/mrm.20622; Holmes AA, 2000, MAGNET RESON MED, V44, P157, DOI 10.1002/1522-2594(200007)44:1<157::AID-MRM22>3.0.CO;2-F; Hooks DA, 2007, CIRC RES, V101, pE103, DOI 10.1161/CIRCRESAHA.107.161075; Hsu EW, 1998, AM J PHYSIOL-HEART C, V274, pH1627, DOI 10.1152/ajpheart.1998.274.5.H1627; Jiang Y, 2007, AM J PHYSIOL-HEART C, V293, pH2377, DOI 10.1152/ajpheart.00337.2007; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Kingsley PB, 2006, CONCEPT MAGN RESON A, V28A, P155, DOI 10.1002/cmr.a.20050; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571, DOI 10.1152/ajpheart.1995.269.2.H571; LEGRICE IJ, 1995, CIRC RES, V77, P182, DOI 10.1161/01.RES.77.1.182; Lombaert H, 2012, IEEE T MED IMAGING, V31, P1436, DOI 10.1109/TMI.2012.2192743; MARON BJ, 1979, CIRCULATION, V59, P689, DOI 10.1161/01.CIR.59.4.689; MARON BJ, 1981, CIRCULATION, V63, P882, DOI 10.1161/01.CIR.63.4.882; McGill LA, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-86; MOSELEY ME, 1990, RADIOLOGY, V176, P439, DOI 10.1148/radiology.176.2.2367658; Nguyen C, 2014, MAGN RESON MED, V72, P1257, DOI 10.1002/mrm.25038; Nielles-Vallespin S, 2013, MAGN RESON MED, V70, P454, DOI 10.1002/mrm.24488; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; RADEMAKERS FE, 1994, CIRCULATION, V89, P1174, DOI 10.1161/01.CIR.89.3.1174; Reeder SB, 2005, MAGNET RESON MED, V54, P748, DOI 10.1002/mrm.20636; REESE TG, 1995, MAGNET RESON MED, V34, P786, DOI 10.1002/mrm.1910340603; Reese TG, 1996, J MAGN RESON SER B, V112, P253, DOI 10.1006/jmrb.1996.0139; Scollan DF, 1998, AM J PHYSIOL-HEART C, V275, pH2308, DOI 10.1152/ajpheart.1998.275.6.H2308; Scott AD, 2015, MAGN RESON MED, V74, P420, DOI 10.1002/mrm.25418; Stoeck CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107159; STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339; Toussaint N, 2013, MED IMAGE ANAL, V17, P1243, DOI 10.1016/j.media.2013.02.008; Tseng WI, 1999, MAGNET RESON MED, V42, P393, DOI 10.1002/(SICI)1522-2594(199908)42:2<393::AID-MRM22>3.0.CO;2-F; Tseng WYI, 2006, J MAGN RESON IMAGING, V23, P1, DOI 10.1002/jmri.20473; Tseng WYI, 2003, J MAGN RESON IMAGING, V17, P31, DOI 10.1002/jmri.10223; Tunnicliffe EM, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-31; WALDMAN LK, 1988, CIRC RES, V63, P550, DOI 10.1161/01.RES.63.3.550; Wu EX, 2007, MAGN RESON MED, V58, P687, DOI 10.1002/mrm.21350; Wu MT, 2006, CIRCULATION, V114, P1036, DOI 10.1161/CIRCULATIONAHA.105.545863	54	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132360	10.1371/journal.pone.0132360	http://dx.doi.org/10.1371/journal.pone.0132360			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177211	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000358197600104
J	Wang, H; Ji, FX; Liang, HB; Gu, HL; Ning, ZY; Liu, RC; Zhang, GH				Wang, Heng; Ji, Fangxiao; Liang, Huanbin; Gu, Honglang; Ning, Zhangyong; Liu, Rongchang; Zhang, Guihong			A Proline-Rich Domain in the Genotype 4 Hepatitis E Virus ORF3 C-Terminus Is Crucial for Downstream (VDLP108)-D-105 Immunoactivity	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; PROTECTIVE EFFICACY; PROTEIN; INFECTION; SWINE; CHINA; IMMUNOGENICITY; ANTIBODIES; RELEASE; HUMANS	The hepatitis E virus (HEV) is responsible for serious viral hepatitis worldwide. Animals are considered a reservoir of HEV, particularly pigs. While HEV infection in pigs and dogs is always asymptomatic, the virus causes high death rates in patients with pre-existing chronic liver disease and pregnant women in developing countries. HEV open reading frame 2 (ORF2) has been used as a diagnostic target to detect specific antibodies against HEV in serum samples. Recent research has additionally supported the potential utility of the ORF3 protein as a target in serum anti-HEV detection. However, the epitope distribution of ORF3 protein remains ambiguous. In the current study, we showed that continuous amino acid motif, VDLP, at the C-terminus of genotype 4 HEV ORF3 is a core sequence of the ORF3 protein epitope. Moreover, cooperative interaction with upstream elements is essential for its immunoactivity. Three proline residues (P99, P102 and P103) in the upstream proline-rich domain exerted significant effects on the immunocompetence of VDLP. ELISA results revealed that SAPPLPPVVDLP and SAPPLPPVVDLPQLGL peptides containing the identified VDLP epitope display weaker reactions with anti-HEV serum than the commercial ELISA kit. Our collective findings provide valuable information on the epitope distribution characteristics of HEV ORF3 and improve our understanding of the influence of the proline-rich domain on the immunoactivity of downstream amino acids in the C-terminal region.	[Wang, Heng; Ji, Fangxiao; Ning, Zhangyong; Zhang, Guihong] South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China; [Wang, Heng; Ning, Zhangyong; Liu, Rongchang] Key Lab Comprehens Prevent & Control Severe Clin, Guangzhou 510642, Guangdong, Peoples R China; [Ji, Fangxiao; Liang, Huanbin; Gu, Honglang; Zhang, Guihong] MOA Key Lab Anim Vaccine Dev, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University	Zhang, GH (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China.	guihongzh@scau.edu.cn			Ph.D. Programs Foundation of Ministry of Education of China [20104404110009, 20114404120010]; Department of Education of Guangdong province [2012LYM 0031]; Industry technology system of modern agriculture construction fund [CARS-36]	Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Department of Education of Guangdong province(National Natural Science Foundation of Guangdong Province); Industry technology system of modern agriculture construction fund	This work was supported by the Ph.D. Programs Foundation of Ministry of Education of China (No. 20104404110009 and No. 20114404120010), the Grant from the Department of Education of Guangdong province (No. 2012LYM 0031), and the Industry technology system of modern agriculture construction fund (No. CARS-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SK, 2011, J HEPATOL, V54, P9, DOI 10.1016/j.jhep.2010.08.008; Chandra V, 2008, J BIOSCIENCES, V33, P451, DOI 10.1007/s12038-008-0064-1; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Deshmukh TM, 2007, VACCINE, V25, P4350, DOI 10.1016/j.vaccine.2007.03.040; Guu TSY, 2009, P NATL ACAD SCI USA, V106, P12992, DOI 10.1073/pnas.0904848106; Izopet J, 2012, EMERG INFECT DIS, V18, P1274, DOI 10.3201/eid1808.120057; Kamili S, 2004, J INFECT DIS, V189, P258, DOI 10.1086/380801; Kenney SP, 2012, J VIROL, V86, P5637, DOI 10.1128/JVI.06711-11; KOONIN EV, 1992, P NATL ACAD SCI USA, V89, P8259, DOI 10.1073/pnas.89.17.8259; Korkaya H, 2001, J BIOL CHEM, V276, P42389, DOI 10.1074/jbc.M101546200; Lack JB, 2012, EMERG INFECT DIS, V18, P1268, DOI 10.3201/eid1808.120070; Lesinski GB, 2001, J MICROBIOL METH, V47, P135, DOI 10.1016/S0167-7012(01)00290-1; Li G, 2010, LETT APPL MICROBIOL, V51, P499, DOI 10.1111/j.1472-765X.2010.02919.x; Li WG, 2009, VET MICROBIOL, V133, P75, DOI 10.1016/j.vetmic.2008.06.026; Li XJ, 2008, J MED VIROL, V80, P1391, DOI 10.1002/jmv.21246; Liang HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088106; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Matsuda H, 2003, J INFECT DIS, V188, P944, DOI 10.1086/378074; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Moin SM, 2009, CELL MICROBIOL, V11, P1409, DOI 10.1111/j.1462-5822.2009.01340.x; Nagashima S, 2011, J GEN VIROL, V92, P269, DOI 10.1099/vir.0.025791-0; Nan YC, 2014, J VIROL, V88, P11924, DOI 10.1128/JVI.01935-14; Ratra R, 2008, BIOCHEMISTRY-US, V47, P1957, DOI 10.1021/bi7016552; Ren XF, 2010, J CLIN MICROBIOL, V48, P1875, DOI 10.1128/JCM.01707-09; Sarangi AN, 2011, INDIAN J MED RES, V133, P548; Takahashi H, 2012, ARCH VIROL, V157, P235, DOI 10.1007/s00705-011-1153-2; Turner J, 2010, J MED VIROL, V82, P1899, DOI 10.1002/jmv.21905; Xing L, 2011, J VIROL, V85, P1117, DOI 10.1128/JVI.00657-10; Yamada K, 2009, J GEN VIROL, V90, P1880, DOI 10.1099/vir.0.010561-0; Yamashita T, 2009, P NATL ACAD SCI USA, V106, P12986, DOI 10.1073/pnas.0903699106; Zhang MD, 2001, VACCINE, V20, P853, DOI 10.1016/S0264-410X(01)00399-1; Zhang W, 2008, ZOONOSES PUBLIC HLTH, V55, P291, DOI 10.1111/j.1863-2378.2008.01136.x; Zhao K, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-186; Zhou YH, 2004, VACCINE, V22, P2578, DOI 10.1016/j.vaccine.2003.12.017; Zhu YM, 2011, J CLIN VIROL, V52, P155, DOI 10.1016/j.jcv.2011.06.023	35	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133282	10.1371/journal.pone.0133282	http://dx.doi.org/10.1371/journal.pone.0133282			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177202	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600239
J	Wu, Y; Chen, P; Jing, YY; Wang, C; Men, YL; Zhan, W; Wang, Q; Gan, ZX; Huang, J; Xie, K; Mi, JS; Yu, CH; Yu, XQ; Chen, PC; Chang, JF; Cai, FF; Chen, S				Wu, You; Chen, Ping; Jing, Yuanya; Wang, Chen; Men, Yu-Long; Zhan, Wang; Wang, Qiang; Gan, Zhixue; Huang, Jin; Xie, Kun; Mi, Jiangsheng; Yu, Chenghua; Yu, Xiuqing; Chen, Pei-Chao; Chang, Jian-Feng; Cai, Fengfeng; Chen, Su			Microarray Analysis Reveals Potential Biological Functions of Histone H2B Monoubiquitination	PLOS ONE			English	Article							STEM-CELL DIFFERENTIATION; HOMOLOGOUS RECOMBINATION; H3K4 METHYLATION; CHROMATIN; UBIQUITINATION; YEAST; BRE1; DNA; MONOUBIQUITYLATION; TRIMETHYLATION	Histone H2B monoubiquitination is a key histone modification that has significant effects on chromatin higher-order structure and gene transcription. Multiple biological processes have been suggested to be tightly related to the dynamics of H2B monoubiquitination. However, a comprehensive understanding of biological roles of H2B monoubiquitination is still poorly understood. In the present study, we developed an efficient tool to disrupt endogenous H2B monoubiquitination levels by using an H2BK120R mutant construct expressed in human cells. Genome-wide microarray analysis of these cells revealed a potential global view of biological functions of H2B monoubiquitination. Bioinformatics analysis of our data demonstrated that while H2B monoubiquitination expectedly affected a number of previously reported biological pathways, we also uncovered the influence of this histone modification on many novel biological processes. Therefore, our work provided valuable information for understanding the role of H2B monoubiquitination and indicated potential directions for its further studies.	[Wu, You; Chen, Ping; Jing, Yuanya; Wang, Chen; Men, Yu-Long; Zhan, Wang; Gan, Zhixue; Huang, Jin; Xie, Kun; Chang, Jian-Feng; Cai, Fengfeng; Chen, Su] Tongji Univ, Yangpu Hosp, Dept Breast Surg, Res Ctr Translat Med,East Hosp,Sch Life Sci & Tec, Shanghai 200092, Peoples R China; [Mi, Jiangsheng; Yu, Chenghua; Yu, Xiuqing; Chen, Su] Peoples Hosp Zunhua, Dept Sci & Educ, Tangshan 064200, Hebei, Peoples R China; [Wang, Qiang] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Nephrol & Rheumatol, Shanghai 200092, Peoples R China; [Chen, Pei-Chao] Wenzhou Univ, Coll Life & Environm Sci, Wenzhou 325035, Zhejiang, Peoples R China	Tongji University; Tongji University; Wenzhou University	Cai, FF (corresponding author), Tongji Univ, Yangpu Hosp, Dept Breast Surg, Res Ctr Translat Med,East Hosp,Sch Life Sci & Tec, Shanghai 200092, Peoples R China.	fengfengcai@gmail.com; chensu@tongji.edu.cn	Men, Yulong/AFP-4952-2022	Men, Yulong/0000-0002-3954-7922; Chen, Peichao/0000-0001-9587-7080	National Basic Research Program of China (973 Program) [2015CB964800]; National Natural Science Foundation of China [31201051]; Shanghai Municipal Natural Science Foundation [12ZR1433100, 12ZR1433000]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation	This work was supported by the National Basic Research Program of China (973 Program, Grant No. 2015CB964800), the National Natural Science Foundation of China (Grant No. 31201051), and the Shanghai Municipal Natural Science Foundation (Grant No. 12ZR1433100, 12ZR1433000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; ARENTS G, 1993, P NATL ACAD SCI USA, V90, P10489, DOI 10.1073/pnas.90.22.10489; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; Chen P, 2010, PROTEIN CELL, V1, P967, DOI 10.1007/s13238-010-0130-y; Chen S, 2015, MOL CELL BIOL, V35, P406, DOI 10.1128/MCB.01044-14; Chen S, 2012, CELL RES, V22, P1402, DOI 10.1038/cr.2012.114; Chernikova SB, 2012, CANCER RES, V72, P2111, DOI 10.1158/0008-5472.CAN-11-2209; Daniel JA, 2005, CELL CYCLE, V4, P919, DOI 10.4161/cc.4.7.1824; Fonseca GJ, 2012, CELL HOST MICROBE, V11, P597, DOI 10.1016/j.chom.2012.05.005; Fonseca GJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003411; Fuchs G, 2012, MOL CELL, V46, P662, DOI 10.1016/j.molcel.2012.05.023; Herz HM, 2014, SCIENCE, V345, P1065, DOI 10.1126/science.1255104; Karpiuk O, 2012, MOL CELL, V46, P705, DOI 10.1016/j.molcel.2012.05.022; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Prenzel T, 2011, CANCER RES, V71, P5739, DOI 10.1158/0008-5472.CAN-11-1896; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Vethantham V, 2012, MOL CELL BIOL, V32, P1044, DOI 10.1128/MCB.06026-11; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X	34	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133444	10.1371/journal.pone.0133444	http://dx.doi.org/10.1371/journal.pone.0133444			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177367	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600256
J	Xu, XL; Zheng, WH; Zhu, SM; Zhao, A; Mao, WM				Xu, Xiao-Ling; Zheng, Wei-Hui; Zhu, Shuang-Mei; Zhao, An; Mao, Wei-Min			The Prognostic Impact of Lymph Node Involvement in Large Scale Operable Node-Positive Esophageal Squamous Cell Carcinoma Patients: A 10-Year Experience	PLOS ONE			English	Article							AMERICAN JOINT COMMITTEE; 7TH EDITION; INTERNATIONAL UNION; TNM CLASSIFICATION; CANCER; SURVIVAL; METASTASES; NUMBER	Background Lymph node (LN)-related factors including the number of LN regions involved, the LN ratio (LNR), and the number of metastatic LNs are strong prognostic indicators for esophageal squamous cell carcinoma (ESCC) patients. Accurately staging LN involvement may improve the stratification of patients and guide the management of patients. Methods A total of 688 potentially resectable patients who had regional LN metastases were enrolled in this retrospective study. Results ESCC involving a single region was associated with better outcomes than that involving multiple regions (P < 0.001 for both PFS and OS). An increased number of metastatic LNs was significantly associated with reduced PFS and OS based on univariate analysis (P < 0.001). PFS and OS were significantly higher in patients with a lower cancer-involved LNR, with 5year OS rates of 9.7% and 31.4% for patients with a lower and higher cancer-involved LNR, respectively. Based on multivariate analysis, patients with N1 LN involvement experienced longer survival than patients with N2 LN involvement (HR: 1.37; 95% CI: 1.12-1.68) or N3 LN involvement (HR: 1.96; 95% CI: 1.52-2.53). Higher LNR resulted in longer OS than lower LNR based on multivariate analysis (HR: 1.45; 95% CI: 1.15-1.84; P = 0.002). Conclusions Our study has shown that not only the number of metastatic LNs but also the number of involved LN regions predicts outcomes after definitive surgery among Chinese patients with N-positive ESCC. LNR might serve as a powerful indicator that should be included in TNM staging for EC patients.	[Xu, Xiao-Ling] Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China; [Xu, Xiao-Ling; Zheng, Wei-Hui; Zhao, An; Mao, Wei-Min] Zhejiang Canc Hosp, Zhejiang Canc Res Inst, Key Lab Diag & Treatment Technol Thorac Canc, Hangzhou, Zhejiang, Peoples R China; [Zhu, Shuang-Mei] Wenzhou Med Univ, Affiliated Hosp 6, Lishui Peoples Hosp, Dept Radio Chemotherapy Oncol, Wenzhou, Zhejiang, Peoples R China; [Mao, Wei-Min] Zhejiang Canc Hosp, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China	Zhejiang Cancer Hospital; Zhejiang Cancer Hospital; Wenzhou Medical University; Zhejiang Cancer Hospital	Mao, WM (corresponding author), Zhejiang Canc Hosp, Zhejiang Canc Res Inst, Key Lab Diag & Treatment Technol Thorac Canc, Hangzhou, Zhejiang, Peoples R China.	maowm1418@163.com	ZHAO, AN/O-1547-2014	ZHAO, An/0000-0002-2716-9733	Province Important Technology and Science Program (Special Feature of Major Province Scientific and Technological Program [2011C13039-1]	Province Important Technology and Science Program (Special Feature of Major Province Scientific and Technological Program	This work was supported by the Province Important Technology and Science Program (Special Feature of Major Province Scientific and Technological Program 2011), No. 2011C13039-1.	Ajani JA, 2015, J NATL COMPR CANC NE, V13, P194, DOI 10.6004/jnccn.2015.0028; Chen JQ, 2012, INT J RADIAT ONCOL, V82, P475, DOI 10.1016/j.ijrobp.2010.08.037; Chen XL, 2014, J KOREAN MED SCI, V29, P217, DOI 10.3346/jkms.2014.29.2.217; He ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073446; Hofstetter W, 2007, ANN THORAC SURG, V84, P365, DOI 10.1016/j.athoracsur.2007.01.067; Hsu PK, 2010, ANN THORAC SURG, V89, P1024, DOI 10.1016/j.athoracsur.2010.01.017; Hsu WH, 2009, J GASTROINTEST SURG, V13, P1913, DOI 10.1007/s11605-009-0982-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kelty CJ, 2010, J THORAC ONCOL, V5, P1467, DOI 10.1097/JTO.0b013e3181e8f6b1; LERUT TE, 1994, WORLD J SURG, V18, P379, DOI 10.1007/BF00316818; Li H, 2011, DIS ESOPHAGUS, V24, P108, DOI 10.1111/j.1442-2050.2010.01108.x; Liu YP, 2010, EJSO-EUR J SURG ONC, V36, P155, DOI 10.1016/j.ejso.2009.09.005; Reeh M, 2012, ANN THORAC SURG, V93, P890, DOI 10.1016/j.athoracsur.2011.11.035; Rice TW, 2009, DIS ESOPHAGUS, V22, P1, DOI 10.1111/j.1442-2050.2008.00901.x; Rice TW, 2010, CANCER-AM CANCER SOC, V116, P3763, DOI 10.1002/cncr.25146; Siewert JR, 2001, ANN SURG, V234, P360, DOI 10.1097/00000658-200109000-00010; Sobin LHGM., 2010, INT UNION CANC TNM C; Takeno S, 2012, EXP THER MED, V4, P1087, DOI 10.3892/etm.2012.705; Talsma K, 2012, ANN SURG ONCOL, V19, P2142, DOI 10.1245/s10434-012-2218-5; Wang J, 2014, WORLD J GASTROENTERO, V20, P18397, DOI 10.3748/wjg.v20.i48.18397; Wang NN, 2015, TUMOR BIOL, V36, P2335, DOI 10.1007/s13277-014-2840-x; Waterman TA, 2004, ANN THORAC SURG, V78, P1161, DOI 10.1016/j.athoracsur.2004.04.045; Xu QR, 2011, WORLD J SURG, V35, P1303, DOI 10.1007/s00268-011-1015-9; Yamasaki M, 2014, ANN SURG ONCOL, V21, P2850, DOI 10.1245/s10434-014-3696-4	24	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133076	10.1371/journal.pone.0133076	http://dx.doi.org/10.1371/journal.pone.0133076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177369	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600211
J	Maruyama, K; Akiyama, M; Kokame, K; Sekiya, A; Morishita, E; Miyata, T				Maruyama, Keiko; Akiyama, Masashi; Kokame, Koichi; Sekiya, Akiko; Morishita, Eriko; Miyata, Toshiyuki			ELISA-Based Detection System for Protein S K196E Mutation, a Genetic Risk Factor for Venous Thromboembolism	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; JAPANESE PATIENTS; C ANTICOAGULANT; COAGULATION; SUBSTITUTION; INFLAMMATION; DEFICIENCY; DOMAIN; GLU	Protein S (PS) acts as a cofactor for activated protein C in the plasma anticoagulant system. PS Lys196-to-Glu (K196E) mutation is a genetic risk factor for venous thromboembolism in Japanese individuals. Because of the substantial overlap in PS anticoagulant activity between KK (wild-type) and KE (heterozygous) genotypes, it is difficult to identify PS K196E carriers by measuring PS activity. Here, we generated monoclonal antibodies specific to the PS K196E mutant and developed a simple and reliable method for the identification of PS K196E carriers. We immunized mice with a keyhole limpet hemocyanin-conjugated synthetic peptide with Glu196. The hybridoma cells were screened for the binding ability of the produced antibodies to recombinant mutant EGF-like domains of PS (Ile117-Glu283). We obtained three hybridoma cell lines producing PS K196E mutation-specific antibodies. We established a sandwich enzyme-linked immunosorbent assay (ELISA) system in which the PS K196E mutation-specific monoclonal antibody was used as a detection antibody. We measured human plasma samples by using this system and successfully discriminated 11 individuals with the KE genotype from 122 individuals with the KK genotype. The ELISA system using the PS K196E mutation-specific antibody is a useful tool for the rapid identification of PS K196E carriers, who are at a higher risk for venous thromboembolism.	[Maruyama, Keiko; Akiyama, Masashi; Kokame, Koichi; Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka, Japan; [Sekiya, Akiko; Morishita, Eriko] Kanazawa Univ, Grad Sch Med Sci, Dept Clin Lab Sci, Kanazawa, Ishikawa, Japan	National Cerebral & Cardiovascular Center - Japan; Kanazawa University	Miyata, T (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka, Japan.	miyata@ncvc.go.jp		Kokame, Koichi/0000-0002-9654-6299; Akiyama, Masashi/0000-0001-5863-9315; Maruyama, Keiko/0000-0003-4183-0345	Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants-in-aid from the Ministry of Health, Labour and Welfare of Japan, the Japan Society for the Promotion of Science, and the Takeda Science Foundation.	Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Burstyn-Cohen T, 2009, J CLIN INVEST, V119, P2942, DOI 10.1172/JCI39325; Dahlback B, 2007, THROMB HAEMOSTASIS, V98, P90, DOI 10.1160/TH07-04-0269; De Frutos PG, 2007, THROMB HAEMOSTASIS, V98, P543, DOI 10.1160/TH07-03-0199; FUJIMURA H, 1995, THROMB HAEMOSTASIS, V74, P1381; Griffin JH, 2012, INT J HEMATOL, V95, P333, DOI 10.1007/s12185-012-1059-0; Hackeng TM, 2009, ARTERIOSCL THROM VAS, V29, P2015, DOI 10.1161/ATVBAHA.108.177436; HAYASHI T, 1994, BLOOD, V83, P683, DOI 10.1182/blood.V83.3.683.bloodjournal833683; Ikejiri M, 2010, INT J HEMATOL, V92, P302, DOI 10.1007/s12185-010-0671-0; Kimura R, 2006, J THROMB HAEMOST, V4, P2010, DOI 10.1111/j.1538-7836.2006.02071.x; Kimura R, 2006, BLOOD, V107, P1737, DOI 10.1182/blood-2005-09-3892; Kinoshita S, 2005, CLIN BIOCHEM, V38, P908, DOI 10.1016/j.clinbiochem.2005.05.006; Kujovich JL, 2011, GENET MED, V13, P1, DOI 10.1097/GIM.0b013e3181faa0f2; Liu WY, 2013, THROMB RES, V132, P314, DOI 10.1016/j.thromres.2013.05.008; Miyata T, 2012, J THROMB HAEMOST, V10, P319, DOI 10.1111/j.1538-7836.2011.04578.x; Miyata T, 1998, BLOOD COAGUL FIBRIN, V9, P451, DOI 10.1097/00001721-199807000-00011; Miyata T, 2009, THROMB RES, V124, P14, DOI 10.1016/j.thromres.2008.08.020; Sakaguchi N, 2005, J IMMUNOL, V174, P4485, DOI 10.4049/jimmunol.174.8.4485; Saller F, 2009, BLOOD, V114, P2307, DOI 10.1182/blood-2009-03-209031; Suleiman L, 2013, CRIT REV ONCOL HEMAT, V88, P637, DOI 10.1016/j.critrevonc.2013.07.004; Toda S, 2014, BLOOD, V123, P3963, DOI 10.1182/blood-2014-01-547976; Tsuda T, 2012, BLOOD COAGUL FIBRIN, V23, P56, DOI 10.1097/MBC.0b013e32834ddefd; Valentin MA, 2011, J PHARMACEUT BIOMED, V55, P869, DOI 10.1016/j.jpba.2011.03.033; van der Meer JHM, 2014, BLOOD, V123, P2460, DOI 10.1182/blood-2013-09-528752; YAMAZAKI T, 1993, THROMB RES, V70, P395, DOI 10.1016/0049-3848(93)90081-X; Yin T, 2014, J THROMB THROMBOLYS, V37, P56, DOI 10.1007/s11239-013-1005-x	28	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133196	10.1371/journal.pone.0133196	http://dx.doi.org/10.1371/journal.pone.0133196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186226	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700106
J	Kowalski, T; Grabowski, S; Deorowicz, S				Kowalski, Tomasz; Grabowski, Szymon; Deorowicz, Sebastian			Indexing Arbitrary-Length k-Mers in Sequencing Reads	PLOS ONE			English	Article							ALIGNMENT; VERSATILE; GENOMES; MEMORY; ERRORS	We propose a lightweight data structure for indexing and querying collections of NGS reads data in main memory. The data structure supports the interface proposed in the pioneering work by Philippe et al. for counting and locating k-mers in sequencing reads. Our solution, PgSA (pseudogenome suffix array), based on finding overlapping reads, is competitive to the existing algorithms in the space use, query times, or both. The main applications of our index include variant calling, error correction and analysis of reads from RNA-seq experiments.	[Kowalski, Tomasz; Grabowski, Szymon] Lodz Univ Technol, Inst Appl Comp Sci, PL-90924 Lodz, Poland; [Deorowicz, Sebastian] Silesian Tech Univ, Inst Informat, PL-44100 Gliwice, Poland	Lodz University of Technology; Silesian University of Technology	Deorowicz, S (corresponding author), Silesian Tech Univ, Inst Informat, Akad 16, PL-44100 Gliwice, Poland.	sebastian.deorowicz@polsl.pl	Kowalski, Tomasz M/V-1500-2017; Grabowski, Szymon/AAJ-2398-2021; Deorowicz, Sebastian/F-8386-2014	Kowalski, Tomasz M/0000-0003-0953-3762; Grabowski, Szymon/0000-0003-1714-1224; Deorowicz, Sebastian/0000-0002-9496-733X	Polish National Science Centre [DEC-2012/05/B/ST6/03148]; GeCONiI-Upper Silesian Center for Computational Science and Engineering [POIG.02.03.01-24-099/13]	Polish National Science Centre; GeCONiI-Upper Silesian Center for Computational Science and Engineering	This work was supported by The Polish National Science Centre under the project DEC-2012/05/B/ST6/03148. The infrastructure was supported by POIG.02.03.01-24-099/13 grant "GeCONiI-Upper Silesian Center for Computational Science and Engineering." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames SK, 2013, BIOINFORMATICS, V29, P2253, DOI 10.1093/bioinformatics/btt389; Bazinet AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-92; Bingmann T., 2013, P ALENEX, P88; Danek A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109384; Deorowicz S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-160; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; Grabowski S, 2014, SAMPLING SUFFIX ARRA; Grabowski S, 2015, BIOINFORMATICS, V31, P1389, DOI 10.1093/bioinformatics/btu844; Grossi R, 2003, SIAM PROC S, P841; Gusfield D., 1997, ALGORITHMS STRINGS T; Hayden EC, 2014, NATURE NEWS; Heo Y, 2014, BIOINFORMATICS, V30, P1354, DOI 10.1093/bioinformatics/btu030; Ilie L, 2013, BIOINFORMATICS, V29, P2490, DOI 10.1093/bioinformatics/btt407; Karkkainen J., 1996, Computing and Combinatorics. Second Annual International Conference. COCOON '96. Proceedings, P219; Kelly DR, 2010, GENOME BIOL, V11; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maier D, 1997, NOTE COMPLEXITY SUPE, P233; MANBER U, 1993, SIAM J COMPUT, V22, P935, DOI 10.1137/0222058; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Molnar M, 2014, BRIEFINGS BIOINFORMA; National Human Genome Research Institute, 2015, DNA SEQ COSTS; Philippe N, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r30; Philippe N, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-242; Rizk G, 2013, BIOINFORMATICS, V29, P652, DOI 10.1093/bioinformatics/btt020; Salmela L, 2010, BIOINFORMATICS, V26, P1284, DOI 10.1093/bioinformatics/btq151; Salzberg SL, 2014, HUM MUTAT, V35, P283, DOI 10.1002/humu.22503; Schroder J, 2009, BIOINFORMATICS, V25, P2157, DOI 10.1093/bioinformatics/btp379; Schulz MH, 2014, BIOINFORMATICS, V30, pI356, DOI 10.1093/bioinformatics/btu440; U S Department of Veteran Affairs, 2015, MILL VET PROGR; Valimaki Niko, 2013, Bioinformatics Research and Applications. 9th International Symposium, ISBRA 2013. Proceedings, P237, DOI 10.1007/978-3-642-38036-5_24; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	34	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133198	10.1371/journal.pone.0133198	http://dx.doi.org/10.1371/journal.pone.0133198			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182400	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198200055
J	Meireles, DD; Schripsema, J; Arnholdt, ACV; Dagnino, D				Meireles, Diogo de Abreu; Schripsema, Jan; Veto Arnholdt, Andrea Cristina; Dagnino, Denise			Persistence of Only a Minute Viable Population in Chlorotic Microcystis aeruginosa PCC 7806 Cultures Obtained by Nutrient Limitation	PLOS ONE			English	Article							STARVATION-INDUCED CHLOROSIS; CYANOBACTERIUM; ACCLIMATION; PCC-7806; DYNAMICS; BACTERIA; CYCLE; FLOW	Cultures from the cyanobacterial strain Microcystis aeruginosa PCC 7806 submitted to nutrient limitation become chlorotic. When returned to nutrient rich conditions these cultures regain their green colour. The aim of this study was to verify whether the cells in these cultures could be considered resting stages allowing the survival of periods of nutrient starvation as has been reported for Synechococcus PCC 7942. The experiments with Microcystis were carried out in parallel with Synechococcus cultures to rule out the possibility that any results obtained with Microcystis were due to our particular experimental conditions. The results of the experiments with Synechococcus PCC 7942 cultures were comparable to the reported in the literature. For Microcystis PCC 7806 a different response was observed. Analysis of chlorotic Microcystis cultures by flow cytometry showed that the phenotype of the cells in the population was not homogenous: the amount of nucleic acids was about the same in all cells but only around one percent of the population emitted red autofluorescence indicating the presence of chlorophyll. Monitoring of the reversion of chlorosis by flow cytometry showed that the re-greening was most likely the result of the division of the small population of red autofluorescent cells originally present in the chlorotic cultures. This assumption was confirmed by analysing the integrity of the DNA and the membrane permeability of the cells of chlorotic cultures. Most of the DNA of these cultures was degraded and only the autofluorescent population of the chlorotic cultures showed membrane integrity. Thus, contrary to what has been reported for other cyanobacterial genera, most of the cells in chlorotic Microcystis cultures are not resting stages but dead. It is interesting to note that the red autofluorescent cells of green and chlorotic cultures obtained in double strength ASM-1 medium differ with respect to metabolism: levels of emission of red autofluorescence are higher in the cells of green cultures and the ability to convert fluorescein diacetate of these cells are heterogeneous when compared to the autofluorescent cells of chlorotic cultures. Thus, the small population of the red autofluorescent cells of chlorotic cultures are in a differentiated metabolic state that allow them to persist in conditions in which most of the population loses viability; persistent cells can be detected in chlorotic cultures maintained for more than a year.	[Meireles, Diogo de Abreu; Dagnino, Denise] Univ Estadual Norte Fluminense, Lab Biotecnol, Campos Dos Goytacazes, RJ, Brazil; [Schripsema, Jan; Dagnino, Denise] Univ Estadual Norte Fluminense, Lab Ciencias Quim, Grp Metabol, Campos Dos Goytacazes, RJ, Brazil; [Veto Arnholdt, Andrea Cristina] Univ Estadual Norte Fluminense, Lab Biol Reconhecer, Campos Dos Goytacazes, RJ, Brazil	Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense	Dagnino, D (corresponding author), Univ Estadual Norte Fluminense, Lab Biotecnol, Campos Dos Goytacazes, RJ, Brazil.	dagnino@uenf.br	Schripsema, Jan/A-6395-2008; Meireles, Diogo/C-4427-2014; de Abreu Meireles, Diogo/AAP-7591-2020	Schripsema, Jan/0000-0002-5362-4074; Meireles, Diogo/0000-0002-8451-2083; de Abreu Meireles, Diogo/0000-0002-8451-2083; Arnholdt, Andrea Cristina Veto/0000-0003-3620-573X	Conselho Nacional de Pesquisa (CNPq); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ)	Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The authors thank the Conselho Nacional de Pesquisa (CNPq) and the Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MM, 1969, ARCH MIKROBIOL, V69, P114, DOI 10.1007/BF00409755; BOSTROM B, 1989, AQUAT SCI, V51, P153, DOI 10.1007/BF00879300; Brunberg AK, 2002, J PLANKTON RES, V24, P1247, DOI 10.1093/plankt/24.11.1247; Carmichael WW, 2001, HUM ECOL RISK ASSESS, V7, P1393, DOI 10.1080/20018091095087; Castenholz RW, 2001, BERGEYS MANUAL SYSTE, P473, DOI DOI 10.1007/978-0-387-21609-6_27; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Dagnino D, 2006, ENVIRON MICROBIOL, V8, P30, DOI 10.1111/j.1462-2920.2005.00866.x; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Gorbushina AA, 2007, ENVIRON MICROBIOL, V9, P1613, DOI 10.1111/j.1462-2920.2007.01301.x; Gorham P.R., 1964, INT VER THEOR ANGEW, V15, P1964, DOI [DOI 10.1080/03680770.1962.11895606, 10.1080/03680770.1962.11895606]; Gorl M, 1998, MICROBIOL-SGM, V144, P2449, DOI 10.1099/00221287-144-9-2449; Ionescu D, 2010, FEMS MICROBIOL ECOL, V72, P103, DOI 10.1111/j.1574-6941.2010.00835.x; Joux F, 2000, MICROBES INFECT, V2, P1523, DOI 10.1016/S1286-4579(00)01307-1; Kadouri D, 2005, CRIT REV MICROBIOL, V31, P55, DOI 10.1080/10408410590899228; Kaprelyants AS, 1996, APPL ENVIRON MICROB, V62, P1311, DOI 10.1128/AEM.62.4.1311-1316.1996; Kell DB, 1998, ANTON LEEUW INT J G, V73, P169, DOI 10.1023/A:1000664013047; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Moezelaar R, 1997, EUR J PHYCOL, V32, P373, DOI 10.1080/09670269710001737309; Moser S, 2009, EUR J ORG CHEM, V2009, P21, DOI 10.1002/ejoc.200800804; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Potts M, 2005, INTEGR COMP BIOL, V45, P800, DOI 10.1093/icb/45.5.800; REYNOLDS CS, 1981, PHILOS T ROY SOC B, V293, P419, DOI 10.1098/rstb.1981.0081; Saha SK, 2003, FEMS MICROBIOL ECOL, V45, P263, DOI 10.1016/S0168-6496(03)00162-4; Salomon E, 2013, BBA-BIOENERGETICS, V1827, P340, DOI 10.1016/j.bbabio.2012.11.010; Satoh K, 2002, PLANT CELL PHYSIOL, V43, P170, DOI 10.1093/pcp/pcf020; Sauer J, 2001, PLANT PHYSIOL, V126, P233, DOI 10.1104/pp.126.1.233; Schwarz R, 2005, MICROBIOL-SGM, V151, P2503, DOI 10.1099/mic.0.27883-0; STEVENS SE, 1981, ARCH MICROBIOL, V130, P204, DOI 10.1007/BF00459520; Tonk L, 2009, HARMFUL ALGAE, V8, P219, DOI 10.1016/j.hal.2008.05.005; Veldhuis MJW, 2001, EUR J PHYCOL, V36, P167, DOI 10.1080/09670260110001735318; Verspagen JMH, 2005, FRESHWATER BIOL, V50, P854, DOI 10.1111/j.1365-2427.2005.01368.x; Yoshida T, 2009, J GEN APPL MICROBIOL, V55, P135, DOI 10.2323/jgam.55.135	33	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133075	10.1371/journal.pone.0133075	http://dx.doi.org/10.1371/journal.pone.0133075			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181753	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198200051
J	Patel, RR; Barbosa, C; Xiao, YC; Cummins, TR				Patel, Reesha R.; Barbosa, Cindy; Xiao, Yucheng; Cummins, Theodore R.			Human Nav1.6 Channels Generate Larger Resurgent Currents than Human Nav1.1 Channels, but the Nav beta 4 Peptide Does Not Protect Either Isoform from Use-Dependent Reduction	PLOS ONE			English	Article							CEREBELLAR PURKINJE NEURONS; AXON INITIAL SEGMENT; MESENCEPHALIC TRIGEMINAL NEURONS; SUBTHRESHOLD SODIUM CURRENTS; ACTION-POTENTIAL INITIATION; MYELINATED NERVE-FIBERS; SLOW INACTIVATION; NA+ CHANNELS; INCOMPLETE INACTIVATION; FUNCTIONAL-ANALYSIS	Voltage-gated sodium channels are responsible for the initiation and propagation of action potentials (APs). Two brain isoforms, Nav1.1 and Nav1.6, have very distinct cellular and subcellular expression. Specifically, Nav1.1 is predominantly expressed in the soma and proximal axon initial segment of fast-spiking GABAergic neurons, while Nav1.6 is found at the distal axon initial segment and nodes of Ranvier of both fast-spiking GABAergic and excitatory neurons. Interestingly, an auxiliary voltage-gated sodium channel subunit, Nav beta 4, is also enriched in the axon initial segment of fast-spiking GABAergic neurons. The C-terminal tail of Nav beta 4 is thought to mediate resurgent sodium current, an atypical current that occurs immediately following the action potential and is predicted to enhance excitability. To better understand the contribution of Nav1.1, Nav1.6 and Nav beta 4 to high frequency firing, we compared the properties of these two channel isoforms in the presence and absence of a peptide corresponding to part of the C-terminal tail of Nav beta 4. We used whole-cell patch clamp recordings to examine the biophysical properties of these two channel isoforms in HEK293T cells and found several differences between human Nav1.1 and Nav1.6 currents. Nav1.1 channels exhibited slower closed-state inactivation but faster open-state inactivation than Nav1.6 channels. We also observed a greater propensity of Nav1.6 to generate resurgent currents, most likely due to its slower kinetics of open-state inactivation, compared to Nav1.1. These two isoforms also showed differential responses to slow and fast AP waveforms, which were altered by the Nav beta 4 peptide. Although the Nav beta 4 peptide substantially increased the rate of recovery from apparent inactivation, Nav beta 4 peptide did not protect either channel isoform from undergoing use-dependent reduction with 10 Hz step-pulse stimulation or trains of slow or fast AP waveforms. Overall, these two channels have distinct biophysical properties that may differentially contribute to regulating neuronal excitability.	[Patel, Reesha R.; Cummins, Theodore R.] Indiana Univ Sch Med, Program Med Neurosci, Indianapolis, IN 46202 USA; [Patel, Reesha R.; Xiao, Yucheng; Cummins, Theodore R.] Indiana Univ Sch Med, Paul & Carole Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Barbosa, Cindy; Xiao, Yucheng; Cummins, Theodore R.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Cummins, TR (corresponding author), Indiana Univ Sch Med, Program Med Neurosci, Indianapolis, IN 46202 USA.	trcummin@iu.edu			National Institutes of Health [NS053422]; Dravet Syndrome Foundation; Paul and Carole Stark Medical Neuroscience Graduate Student Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS090837, R56NS053422, R01NS053422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dravet Syndrome Foundation; Paul and Carole Stark Medical Neuroscience Graduate Student Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research was supported by a National Institutes of Health grant (NS053422) and a grant from the Dravet Syndrome Foundation to T.R.C. R.R. P. was partially supported by a Paul and Carole Stark Medical Neuroscience Graduate Student Fellowship.	Akemann W, 2006, J NEUROSCI, V26, P4602, DOI 10.1523/JNEUROSCI.5204-05.2006; Aman TK, 2007, BIOPHYS J, V92, P1938, DOI 10.1529/biophysj.106.093500; Aman TK, 2009, J NEUROSCI, V29, P2027, DOI 10.1523/JNEUROSCI.4531-08.2009; Bant JS, 2010, P NATL ACAD SCI USA, V107, P12357, DOI 10.1073/pnas.1005633107; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; BELLUZZI O, 1986, J PHYSIOL-LONDON, V380, P275, DOI 10.1113/jphysiol.1986.sp016285; Buffington SA, 2013, J NEUROSCI, V33, P6191, DOI 10.1523/JNEUROSCI.4051-12.2013; Burbidge SA, 2002, MOL BRAIN RES, V103, P80, DOI 10.1016/S0169-328X(02)00188-2; Carter BC, 2011, J NEUROPHYSIOL, V105, P860, DOI 10.1152/jn.01056.2010; Carter BC, 2009, NEURON, V64, P898, DOI 10.1016/j.neuron.2009.12.011; Castelli L, 2007, J PHYSIOL-LONDON, V582, P1179, DOI 10.1113/jphysiol.2007.135350; Castelli L, 2007, BRAIN RES, V1163, P44, DOI 10.1016/j.brainres.2007.05.065; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cummins TR, 2005, FEBS LETT, V579, P2166, DOI 10.1016/j.febslet.2005.03.009; Do MTH, 2003, NEURON, V39, P109, DOI 10.1016/S0896-6273(03)00360-X; Do MTH, 2004, J NEUROPHYSIOL, V92, P726, DOI 10.1152/jn.00186.2004; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Ellerkmann RK, 2001, J PHYSIOL-LONDON, V532, P385, DOI 10.1111/j.1469-7793.2001.0385f.x; Enomoto A, 2006, J NEUROSCI, V26, P3412, DOI 10.1523/JNEUROSCI.5274-05.2006; Enomoto A, 2007, J NEUROPHYSIOL, V98, P710, DOI 10.1152/jn.00292.2007; Fleidervish IA, 1996, J NEUROPHYSIOL, V76, P2125, DOI 10.1152/jn.1996.76.3.2125; Fry M, 2006, EUR J NEUROSCI, V24, P2557, DOI 10.1111/j.1460-9568.2006.05139.x; Gittis AH, 2010, J NEUROPHYSIOL, V104, P1625, DOI 10.1152/jn.00378.2010; Grieco TM, 2005, NEURON, V45, P233, DOI 10.1016/j.neuron.2004.12.035; Grieco TM, 2004, J NEUROSCI, V24, P35, DOI 10.1523/JNEUROSCI.3807-03.2004; He BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085188; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hu H, 2014, NAT NEUROSCI, V17, P686, DOI 10.1038/nn.3678; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Khaliq ZM, 2003, J NEUROSCI, V23, P4899, DOI 10.1523/jneurosci.23-12-04899.2003; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Magistretti J, 2006, J PHYSIOL-LONDON, V573, P83, DOI 10.1113/jphysiol.2006.106682; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Miyazaki H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6525; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Pospischil M, 2008, BIOL CYBERN, V99, P427, DOI 10.1007/s00422-008-0263-8; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raman IM, 2001, BIOPHYS J, V80, P729, DOI 10.1016/S0006-3495(01)76052-3; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; SCHWARZ JR, 1987, PFLUG ARCH EUR J PHY, V409, P569, DOI 10.1007/BF00584655; SCHWARZ JR, 1986, PFLUG ARCH EUR J PHY, V406, P397, DOI 10.1007/BF00590943; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Theile JW, 2011, J PHYSIOL-LONDON, V589, P597, DOI 10.1113/jphysiol.2010.200915; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Venkatesan K, 2014, J NEUROSCI, V34, P16126, DOI 10.1523/JNEUROSCI.1271-14.2014; Wang GK, 2006, J GEN PHYSIOL, V127, P277, DOI 10.1085/jgp.200509399; Yan HD, 2014, ELIFE, V3, DOI 10.7554/eLife.04193; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754	53	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133485	10.1371/journal.pone.0133485	http://dx.doi.org/10.1371/journal.pone.0133485			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182346	Green Published, gold			2022-12-27	WOS:000358198200065
J	Wagner, B; Melzer, H; Freymuller, G; Stumvoll, S; Rendi-Wagner, P; Paulke-Korinek, M; Repa, A; Mooi, FR; Kollaritsch, H; Mittermayer, H; Kessler, HH; Stanek, G; Steinborn, R; Duchene, M; Wiedermann, U				Wagner, Birgit; Melzer, Helen; Freymueller, Georg; Stumvoll, Sabine; Rendi-Wagner, Pamela; Paulke-Korinek, Maria; Repa, Andreas; Mooi, Frits R.; Kollaritsch, Herwig; Mittermayer, Helmut; Kessler, Harald H.; Stanek, Gerold; Steinborn, Ralf; Duchene, Michael; Wiedermann, Ursula			Genetic Variation of Bordetella pertussis in Austria	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; VIRULENCE FACTORS; ANTIGENIC DIVERGENCE; VACCINATION COVERAGE; COMPARATIVE GENOMICS; MITOCHONDRIAL-DNA; TEMPORAL TRENDS; TOXIN; PERTACTIN; POLYMORPHISM	In Austria, vaccination coverage against Bordetella pertussis infections during infancy is estimated at around 90%. Within the last years, however, the number of pertussis cases has increased steadily, not only in children but also in adolescents and adults, indicating both insufficient herd immunity and vaccine coverage. Waning immunity in the host and/or adaptation of the bacterium to the immunised hosts could contribute to the observed reemergence of pertussis. In this study we therefore addressed the genetic variability in B. pertussis strains from several Austrian cities. Between the years 2002 and 2008, 110 samples were collected from Vienna (n = 32), Linz (n = 63) and Graz (n = 15) by nasopharyngeal swabs. DNA was extracted from the swabs, and bacterial sequence polymorphisms were examined by MLVA (multiple-locus variable number of tandem repeat analysis) (n = 77), by PCR amplification and conventional Sanger sequencing of the polymorphic regions of the prn (pertactin) gene (n = 110), and by amplification refractory mutation system quantitative PCR (ARMS-qPCR) (n = 110) to directly address polymorphisms in the genes encoding two pertussis toxin subunits (ptxA and ptxB), a fimbrial adhesin (fimD), tracheal colonisation factor (tcfA), and the virulence sensor protein (bvgS). Finally, the ptxP promoter region was screened by ARMS-qPCR for the presence of the ptxP3 allele, which has been associated with elevated production of pertussis toxin. The MLVA analysis revealed the highest level of polymorphisms with an absence of MLVA Type 29, which is found outside Austria. Only Prn subtypes Prn1/7, Prn2 and Prn3 were found with a predominance of the non-vaccine type Prn2. The analysis of the ptxA, ptxB, fimD, tcfA and bvgS polymorphisms showed a genotype mixed between the vaccine strain Tohama I and a clinical isolate from 2006 (L517). The major part of the samples (93%) displayed the ptxP3 allele. The consequences for the vaccination strategy are discussed.	[Wagner, Birgit; Melzer, Helen; Rendi-Wagner, Pamela; Paulke-Korinek, Maria; Kollaritsch, Herwig; Duchene, Michael; Wiedermann, Ursula] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Melzer, Helen] Astellas Pharma, Vienna, Austria; [Freymueller, Georg; Steinborn, Ralf] Univ Vet Med, Genom Core Facil, VetCore, Vienna, Austria; [Stumvoll, Sabine; Mittermayer, Helmut] Elisabethinen Hosp, Dept Hyg Microbiol & Trop Med, Linz, Austria; [Stumvoll, Sabine; Mittermayer, Helmut] Anal BioLab, Linz, Austria; [Rendi-Wagner, Pamela; Paulke-Korinek, Maria] Fed Minist Hlth, Vienna, Austria; [Repa, Andreas] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Mooi, Frits R.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Kessler, Harald H.] Med Univ Graz, Dept Hyg Microbiol & Environm Med, Graz, Austria; [Stanek, Gerold] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Hyg & Appl Immunol, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; Ordensklinikum Linz Elisabethinen; Medical University of Vienna; Netherlands National Institute for Public Health & the Environment; Medical University of Graz; Medical University of Vienna	Duchene, M (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	michael.duchene@meduniwien.ac.at	Duchêne, Michael/G-6659-2019	Duchêne, Michael/0000-0003-1232-3600; Wiedermann, Ursula/0000-0002-1302-3223	VARPER from the Austrian endowment "Stiftung zur Forderung der Bekampfung der Tuberkulose und anderer Lungenerkrankungen"; Jubilaumsfonds der Osterreichischen Nationalbank [12226]	VARPER from the Austrian endowment "Stiftung zur Forderung der Bekampfung der Tuberkulose und anderer Lungenerkrankungen"; Jubilaumsfonds der Osterreichischen Nationalbank	This study was supported by a grant entitled VARPER from the Austrian endowment "Stiftung zur Forderung der Bekampfung der Tuberkulose und anderer Lungenerkrankungen", and by Grant 12226 from the "Jubilaumsfonds der Osterreichischen Nationalbank". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bart MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01074-14; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Borisova O, 2007, CLIN VACCINE IMMUNOL, V14, P234, DOI 10.1128/CVI.00294-06; Bottero D, 2007, CLIN VACCINE IMMUNOL, V14, P1490, DOI 10.1128/CVI.00177-07; Byrne S, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-53; Caro V, 2007, VACCINE, V25, P4335, DOI 10.1016/j.vaccine.2006.08.024; Cassiday P, 2000, J INFECT DIS, V182, P1402, DOI 10.1086/315881; Celentano LP, 2005, PEDIATR INFECT DIS J, V24, P761, DOI 10.1097/01.inf.0000177282.53500.77; Crowcroft NS, 2002, BMJ-BRIT MED J, V324, P1537, DOI 10.1136/bmj.324.7353.1537; de Gouw D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084523; ECDC (European Centre for Disease Prevention and Control), 2014, ANN EP REP VACC PREV, P21; Elomaa A, 2007, VACCINE, V25, P918, DOI 10.1016/j.vaccine.2006.09.012; Fry NK, 2001, INFECT IMMUN, V69, P5520, DOI 10.1128/IAI.69.9.5520-5528.2001; Gzyl A, 2004, VACCINE, V22, P2122, DOI 10.1016/j.vaccine.2003.12.006; Halperin SA, 2007, NEW ENGL J MED, V356, P110, DOI 10.1056/NEJMp068288; He Q, 2012, EUROSURVEILLANCE, V9, P17; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; Hegerle N, 2012, CLIN MICROBIOL INFEC, V18, pE340, DOI 10.1111/j.1469-0691.2012.03925.x; Heikkinen E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000904; King AJ, 2008, BMC GENOMICS, V9, P1, DOI 10.1186/1471-2164-9-311; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; Kodama A, 2004, J CLIN MICROBIOL, V42, P5453, DOI 10.1128/JCM.42.12.5453-5457.2004; Litt DJ, 2009, J CLIN MICROBIOL, V47, P680, DOI 10.1128/JCM.01838-08; Maharjan RP, 2008, RES MICROBIOL, V159, P602, DOI 10.1016/j.resmic.2008.08.004; Miyaji Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077165; Mooi FR, 1998, INFECT IMMUN, V66, P670, DOI 10.1128/IAI.66.2.670-675.1998; Mooi FR, 2000, EUR J CLIN MICROBIOL, V19, P174, DOI 10.1007/s100960050455; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; NEI M, 1981, GENETICS, V97, P145; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Paulke-Korinek M, 2011, VACCINE, V29, P5130, DOI 10.1016/j.vaccine.2011.05.046; Rendi-Wagner P, 2007, PEDIATR INFECT DIS J, V26, P806, DOI 10.1097/INF.0b013e318124a9dd; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Steinborn R, 1998, FEBS LETT, V426, P352, DOI 10.1016/S0014-5793(98)00350-0; Steinborn R, 2000, NAT GENET, V25, P255, DOI 10.1038/77000; Stibitz S, 1997, J BACTERIOL, V179, P5820, DOI 10.1128/jb.179.18.5820-5826.1997; Tartof SY, 2013, PEDIATRICS, V131, pE1047, DOI 10.1542/peds.2012-1928; Thierry-Carstensen B, 2013, VACCINE, V31, P5178, DOI 10.1016/j.vaccine.2013.08.034; van Amersfoorth SCM, 2005, J CLIN MICROBIOL, V43, P2837, DOI 10.1128/JCM.43.6.2837-2843.2005; van der Maas NAT, 2013, VACCINE, V31, P4541, DOI 10.1016/j.vaccine.2013.07.060; van Gent M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046407; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020340; van Loo IHM, 1999, J INFECT DIS, V179, P915, DOI 10.1086/314690; WHO, 2010, WEEKLY EPIDEMIOLOGIC; Zhang LJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001478.pub5	48	15	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132623	10.1371/journal.pone.0132623	http://dx.doi.org/10.1371/journal.pone.0132623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182210	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198200024
J	Yu, SG; Chu, WW; Zhang, LF; Han, HM; Zhao, RX; Wu, W; Zhu, JN; Dodson, MV; Wei, W; Liu, HL; Chen, J				Yu, ShiGang; Chu, WeiWei; Zhang, LiFan; Han, HouMing; Zhao, RongXue; Wu, Wei; Zhu, JiangNing; Dodson, Michael V.; Wei, Wei; Liu, HongLin; Chen, Jie			Identification of Laying-Related SNP Markers in Geese Using RAD Sequencing	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; CELL-CELL COMMUNICATION; NEXT-GENERATION; DE-NOVO; DISCOVERY; EXPRESSION; GENE; PROLACTIN; PROTEIN	Laying performance is an important economical trait of goose production. As laying performance is of low heritability, it is of significance to develop a marker-assisted selection (MAS) strategy for this trait. Definition of sequence variation related to the target trait is a prerequisite of quantitating MAS, but little is presently known about the goose genome, which greatly hinders the identification of genetic markers for the laying traits of geese. Recently developed restriction site-associated DNA (RAD) sequencing is a possible approach for discerning large-scale single nucleotide polymorphism (SNP) and reducing the complexity of a genome without having reference genomic information available. In the present study, we developed a pooled RAD sequencing strategy for detecting geese laying-related SNP. Two DNA pools were constructed, each consisting of equal amounts of genomic DNA from 10 individuals with either high estimated breeding value (HEBV) or low estimated breeding value (LEBV). A total of 139,013 SNP were obtained from 42,291,356 sequences, of which 18,771,943 were for LEBV and 23,519,413 were for HEBV cohorts. Fifty-five SNP which had different allelic frequencies in the two DNA pools were further validated by individual-based AS-PCR genotyping in the LEBV and HEBV cohorts. Ten out of 55 SNP exhibited distinct allele distributions in these two cohorts. These 10 SNP were further genotyped in a goose population of 492 geese to verify the association with egg numbers. The result showed that 8 of 10 SNP were associated with egg numbers. Additionally, liner regression analysis revealed that SNP Record-111407, 106975 and 112359 were involved in a multiplegene network affecting laying performance. We used IPCR to extend the unknown regions flanking the candidate RAD tags. The obtained sequences were subjected to BLAST to retrieve the orthologous genes in either ducks or chickens. Five novel genes were cloned for geese which harbored the candidate laying-related SNP, including membrane associated guanylate kinase (MAGI-1), KIAA1462, Rho GTPase activating protein 21 (ARHGAP21), acyl-CoA synthetase family member 2 (ACSF2), astrotactin 2 (ASTN2). Collectively, our data suggests that 8 SNP and 5 genes might be promising candidate markers or targets for marker-assisted selection of egg numbers in geese.	[Yu, ShiGang; Chu, WeiWei; Zhang, LiFan; Wei, Wei; Liu, HongLin; Chen, Jie] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Han, HouMing; Zhao, RongXue; Wu, Wei; Zhu, JiangNing] Jiangsu Lihua Anim Husb CO LTD, Changzhou, Peoples R China; [Dodson, Michael V.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	Nanjing Agricultural University; Washington State University	Chen, J (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	jiechen@njau.edu.cn	liu, honglin/HDN-0409-2022; YU, Shigang/HGA-1248-2022	liu, honglin/0000-0002-1254-3163; YU, Shigang/0000-0003-3378-8255; , Lifan/0000-0002-8166-9173	Jiangsu Lihua Animal Husbandry CO. LTD Research Fund; Jiangsu Agriculture Science and Technology Innovation Fund (JASTIF) [CX(14)2071]; Fundamental Research Funds for Central Universities [KYZ201414]	Jiangsu Lihua Animal Husbandry CO. LTD Research Fund; Jiangsu Agriculture Science and Technology Innovation Fund (JASTIF); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Jiangsu Lihua Animal Husbandry CO. LTD Research Fund to J. Chen. This work was also funded by Jiangsu Agriculture Science and Technology Innovation Fund (JASTIF, CX(14)2071) and the Fundamental Research Funds for the Central Universities (No. KYZ201414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Jiangsu Lihua Animal Husbandry CO. LTD provided the individual samples and egg performance data.	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Akashi M, 2011, BIOCHEM BIOPH RES CO, V413, P224, DOI 10.1016/j.bbrc.2011.08.073; Akiyama T, 2006, P NATL ACAD SCI USA, V103, P7339, DOI 10.1073/pnas.0510946103; Amish SJ, 2012, MOL ECOL RESOUR, V12, P653, DOI 10.1111/j.1755-0998.2012.03157.x; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barcellos KSA, 2013, J BIOL CHEM, V288, P2179, DOI 10.1074/jbc.M112.432716; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Bus A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-281; Carmichael SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077832; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chaurasia G, 2007, NUCLEIC ACIDS RES, V35, pD590, DOI 10.1093/nar/gkl817; Chen J, 2012, MOL BIOL REP, V39, P475, DOI 10.1007/s11033-011-0761-y; Chen LW, 2013, INT J GYNECOL PATHOL, V32, P156, DOI 10.1097/PGP.0b013e31825a0353; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Ding ST, 2007, POULTRY SCI, V86, P1206, DOI 10.1093/ps/86.6.1206; Eppig John J., 1997, Human Reproduction (Oxford), V12, P127; Erdmann J, 2010, EUROPEAN HEART JOURN; Everett MV, 2011, MOL ECOL RESOUR, V11, P93, DOI 10.1111/j.1755-0998.2010.02969.x; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Garner C, 2011, GENET EPIDEMIOL, V35, P261, DOI 10.1002/gepi.20574; Gautier M, 2013, MOL ECOL, V22, P3766, DOI 10.1111/mec.12360; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; [郭军 Guo Jun], 2011, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V42, P1477; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hayashi K, 2006, THEOR APPL GENET, V113, P251, DOI 10.1007/s00122-006-0290-6; Hou R, 2013, SCI CHINA LIFE SCI, V56, P104, DOI 10.1007/s11427-013-4441-0; Houston RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-244; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jiang RS, 2009, S AFR J ANIM SCI, V39, P83; Jiang ZH, 2009, INT J BIOL SCI, V5, P528; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Kang B, 2014, MOLECULAR BIOLOGY RE, P1; Kapun M, 2014, MOL ECOL, V23, P1813, DOI 10.1111/mec.12594; Khongmanee A, 2013, PROTEOMICS, V13, P3157, DOI 10.1002/pmic.201300219; Kranjec C, 2014, J VIROL, V88, P7155, DOI 10.1128/JVI.03247-13; Lancaster OM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001179; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Liu J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-34; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Menetrey J, 2007, EMBO J, V26, P1953, DOI 10.1038/sj.emboj.7601634; Montavon C, 2012, GYNECOL ONCOL, V124, P582, DOI 10.1016/j.ygyno.2011.11.026; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Murdock DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082194; Ogden R, 2013, MOL ECOL, V22, P3112, DOI 10.1111/mec.12234; Paraguassu-Braga FH, 2003, CELL DEATH DIFFER, V10, P1101, DOI 10.1038/sj.cdd.4401279; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pegadaraju V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-556; Pujolar JM, 2013, MOL ECOL RESOUR, V13, P706, DOI 10.1111/1755-0998.12117; Rowe HC, 2011, MOL ECOL, V20, P3499, DOI 10.1111/j.1365-294X.2011.05197.x; Ru hua W, 2009, ANIMAL HUSBANDRY AND, V2; Senn H, 2013, MOL ECOL, V22, P3141, DOI 10.1111/mec.12242; STEIN LS, 1991, CANCER RES, V51, P696; Stickney HL, 2002, GENOME RES, V12, P1929, DOI 10.1101/gr.777302; Suzuki F, 2013, TOHOKU J EXP MED, V231, P193, DOI 10.1620/tjem.231.193; Turner TL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001336; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4; Wang LQ, 2012, GYNECOL ENDOCRINOL, V28, P665, DOI 10.3109/09513590.2012.650768; Willing EM, 2011, BIOINFORMATICS, V27, P2187, DOI 10.1093/bioinformatics/btr346; Wilson MR, 2000, EXP CELL RES, V254, P257, DOI 10.1006/excr.1999.4771; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010; Xu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055496; Yang ZH, 1999, J MOL EVOL, V48, P274, DOI 10.1007/PL00006470; You FM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-59; Zhang X, 2013, FOLIA BIOL, V61, P1; Zhang X, 2013, FOLIA BIOL-KRAKOW, V61, P59, DOI 10.3409/fb61_1-2.59; Zhao X, 2011, CHINA POULTRY, V16; Zhu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041901	73	20	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0131572	10.1371/journal.pone.0131572	http://dx.doi.org/10.1371/journal.pone.0131572			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181055	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198200006
J	Drever, MC; Gyug, LW; Nielsen, J; Stuart-Smith, AK; Ohanjanian, IP; Martin, K				Drever, Mark C.; Gyug, Les W.; Nielsen, Jennifer; Stuart-Smith, A. Kari; Ohanjanian, I. Penny; Martin, Kathy			Using Field Data and GIS-Derived Variables to Model Occurrence of Williamson's Sapsucker Nesting Habitat at Multiple Spatial Scales	PLOS ONE			English	Article							BRITISH-COLUMBIA; INTERIOR; FORESTS; TREES	Williamson's sapsucker (Sphyrapicus thyroideus) is a migratory woodpecker that breeds in mixed coniferous forests in western North America. In Canada, the range of this woodpecker is restricted to three small populations in southern British Columbia, precipitating a national listing as 'Endangered' in 2005, and the need to characterize critical habitat for its survival and recovery. We compared habitat attributes between Williamson's sapsucker nest territories and random points without nests or detections of this sapsucker as part of a resource selection analysis to identify the habitat features that best explain the probability of nest occurrence in two separate geographic regions in British Columbia. We compared the relative explanatory power of generalized linear models based on field-derived and Geographic Information System (GIS) data within both a 225 m and 800 m radius of a nest or random point. The model based on field-derived variables explained the most variation in nest occurrence in the Okanagan-East Kootenay Region, whereas nest occurrence was best explained by GIS information at the 800 m scale in the Western Region. Probability of nest occurrence was strongly tied to densities of potential nest trees, which included open forests with very large (diameter at breast height, DBH, >= 57.5 cm) western larch (Larix occidentalis) trees in the Okanagan-East Kootenay Region, and very large ponderosa pine (Pinus ponderosa) and large (DBH 17.5-57.5 cm) trembling aspen (Populus tremuloides) trees in the Western Region. Our results have the potential to guide identification and protection of critical habitat as required by the Species at Risk Act in Canada, and to better manage Williamson's sapsucker habitat overall in North America. In particular, management should focus on the maintenance and recruitment of very large western larch and ponderosa pine trees.	[Drever, Mark C.; Martin, Kathy] Environm Canada, Canadian Wildlife Serv, Delta, BC, Canada; [Drever, Mark C.; Nielsen, Jennifer; Martin, Kathy] Univ British Columbia, Dept Forest & Conservat Sci, Ctr Appl Conservat Res, Vancouver, BC V5Z 1M9, Canada; [Gyug, Les W.] Okanagan Wildlife Consulting, West Kelowna, BC, Canada; [Stuart-Smith, A. Kari] Canadian Forest Prod Ltd, Cranbrook, BC, Canada	Environment & Climate Change Canada; Canadian Wildlife Service; University of British Columbia	Drever, MC (corresponding author), Environm Canada, Canadian Wildlife Serv, Delta, BC, Canada.	mark.drever@ec.gc.ca; j.nielsen@alumni.ubc.ca		Drever, Mark/0000-0001-5303-9230	Environment Canada; Natural Sciences and Engineering Research Council of Canada; Canadian Wildlife Service; B.C. Ministry of Environment; Forest Investment Account (B.C. Ministry of Forests); B.C. Timber Sales; Weyerhaeuser Ltd.; Interfor; Canadian Forest Products Ltd.; Tolko Industries Ltd	Environment Canada(CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Wildlife Service; B.C. Ministry of Environment; Forest Investment Account (B.C. Ministry of Forests); B.C. Timber Sales; Weyerhaeuser Ltd.; Interfor; Canadian Forest Products Ltd.(Natural Resources CanadaCanadian Forest Service); Tolko Industries Ltd	This research was funded by Environment Canada (support to MCD) and The Natural Sciences and Engineering Research Council of Canada (to JN). Funding was provided for various phases of the field project to LWG by Canadian Wildlife Service, B.C. Ministry of Environment, Forest Investment Account (B.C. Ministry of Forests), B.C. Timber Sales, Weyerhaeuser Ltd., Pope and Talbot Ltd. (now Interfor), Tembec Industries Ltd. (now Canadian Forest Products Ltd.), and Tolko Industries Ltd. The funders had a limited role in discussions of study design, and data collection, but no role in the analysis, decision to publish, or preparation of the manuscript, and does not alter our adherence to PLOS ONE policies on sharing data and materials.	ARNO SF, 1997, INTRP495 USDA FOR SE; Birds and Burns Network, 2005, INSTR VEG MEAS NESTS; British Columbia. Ministry of Forests, 2003, SILV SYST HDB BRIT C; British Columbia Ministry of Forests and Range, 2009, VEG RES INV; BULL EL, 1986, PNWRN444 USDA FOR SE; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Committee on the Status of Endangered Wildlife in Canada, 2005, SPHYR THYR, p[vii, 45]; CONWAY CJ, 1993, J WILDLIFE MANAGE, V57, P322, DOI 10.2307/3809429; CROCKETT AB, 1975, CONDOR, V77, P365, DOI 10.2307/1366254; Crockett AB., 1975, THESIS U COLORADO; Drever MC, 2008, BIOL CONSERV, V141, P624, DOI 10.1016/j.biocon.2007.12.004; Environment Canada, 2014, SPEC RISK ACT REC ST; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fiedler C.E., 2004, ECOL RESTOR, V22, P133; Gyug LW, 2009, CAN J FOREST RES, V39, P2319, DOI 10.1139/X09-138; Gyug Les W., 2014, British Columbia Birds, V24, P9; Gyug LW, 2014, CAN J FOREST RES, V44, P628, DOI 10.1139/cjfr-2013-0380; Gyug Les W., 2009, British Columbia Birds, V19, P6; Gyug LW, 2012, BIRDS N AM ONLINE, P285; Gyug LW, 2007, BRIT COLUMBIA BIRDS, V16, P15; Hall FC, 1976, P 15 ANN TALL TIMB F, P155; Husch B., 1972, FOREST MENSURATION; Klenner W, 2008, FOREST ECOL MANAG, V256, P1711, DOI 10.1016/j.foreco.2008.02.047; Manly B.F.J., 2002, RESOURCE SELECTION A; MARSHALL PL, 2000, TR003 BRIT COL FOR S; Martin K, 2004, CONDOR, V106, P5, DOI 10.1650/7482; McClelland B. R., 1977, THESIS U MONTANA; McClelland BR, 1999, WILDLIFE SOC B, V27, P846; MCCLELLAND BR, 1979, J FOREST, V77, P480; Nielsen-Pincus Nicole, 2007, Northwestern Naturalist, V88, P135, DOI 10.1898/1051-1733(2007)88[135:ROCBTC]2.0.CO;2; Seidel KW, 1986, PNWRN455 USDA FOR SE; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sousa PJ, 1983, FWSOBS821047 US DEP; Thomas J.W., 1979, U S Department of Agriculture Agriculture Handbook, P60; Venables WN., 2002, MODERN APPL STAT S 4	35	3	3	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130849	10.1371/journal.pone.0130849	http://dx.doi.org/10.1371/journal.pone.0130849			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177286	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600030
J	Fogolari, F; Corazza, A; Fortuna, S; Soler, MA; VanSchouwen, B; Brancolini, G; Corni, S; Melacini, G; Esposito, G				Fogolari, Federico; Corazza, Alessandra; Fortuna, Sara; Soler, Miguel Angel; VanSchouwen, Bryan; Brancolini, Giorgia; Corni, Stefano; Melacini, Giuseppe; Esposito, Gennaro			Distance-Based Configurational Entropy of Proteins from Molecular Dynamics Simulations	PLOS ONE			English	Article							CONFORMATIONAL ENTROPY; FORCE-FIELD; THERMODYNAMIC PROPERTIES; STATISTICAL-MECHANICS; BINDING AFFINITIES; CHAIN CONFORMATION; INTERNAL-ROTATION; LIQUID WATER; CYCLIC-AMP; RECOGNITION	Estimation of configurational entropy from molecular dynamics trajectories is a difficult task which is often performed using quasi-harmonic or histogram analysis. An entirely different approach, proposed recently, estimates local density distribution around each conformational sample by measuring the distance from its nearest neighbors. In this work we show this theoretically well grounded the method can be easily applied to estimate the entropy from conformational sampling. We consider a set of systems that are representative of important biomolecular processes. In particular: i. reference entropies for amino acids in unfolded proteins are obtained from a database of residues not participating in secondary structure elements; ii. the conformational entropy of folding of beta 2-microglobulin is computed from molecular dynamics simulations using reference entropies for the unfolded state; iii. backbone conformational entropy is computed from molecular dynamics simulations of four different states of the EPAC protein and compared with order parameters (often used as a measure of entropy); iv. the conformational and rototranslational entropy of binding is computed from simulations of 20 tripeptides bound to the peptide binding protein OppA and of beta 2-microglobulin bound to a citrate coated gold surface. This work shows the potential of the method in the most representative biological processes involving proteins, and provides a valuable alternative, principally in the shown cases, where other approaches are problematic.	[Fogolari, Federico; Corazza, Alessandra; Fortuna, Sara; Soler, Miguel Angel; Esposito, Gennaro] Univ Udine, Dipartimento Sci Med & Biol, I-33100 Udine, Italy; [Fogolari, Federico; Corazza, Alessandra; Esposito, Gennaro] Ist Nazl Biostrutture & Biosistemi, I-00136 Rome, Italy; [VanSchouwen, Bryan; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada; [Brancolini, Giorgia; Corni, Stefano] CNR, Ctr S3, Inst Nanosci, I-41125 Modena, Italy	University of Udine; McMaster University; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR)	Fogolari, F (corresponding author), Univ Udine, Dipartimento Sci Med & Biol, Piazzale Kolbe 4, I-33100 Udine, Italy.	federico.fogolari@uniud.it	Corazza, Alessandra/AGB-1457-2022; SOLER, MIGUEL/J-2389-2013; Brancolini, Giorgia/AAY-3318-2020; Fortuna, Sara/G-2356-2014	Corazza, Alessandra/0000-0003-2272-1928; SOLER, MIGUEL/0000-0002-5780-9949; Brancolini, Giorgia/0000-0002-1083-9198; Fortuna, Sara/0000-0002-8059-6064; Fogolari, Federico/0000-0001-9862-250X; Corni, Stefano/0000-0001-6707-108X	Oak Ridge National Laboratory by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy [CNMS2013-064]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Ministero dell'Istruzione, dell'Universita' e della Ricerca [PRIN 2012A7LMS3 001]	Oak Ridge National Laboratory by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Ministero dell'Istruzione, dell'Universita' e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was partly supported by Ministero dell'Istruzione, dell'Universita' e della Ricerca (PRIN 2012A7LMS3 001). Oak Ridge National Laboratory by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy is acknowledged for the supercomputing project CNMS2013-064. Facilities of the National Energy Research Scientific Computing Center (NERSC), which is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231, are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Andricioaei I, 2001, J CHEM PHYS, V115, P6289, DOI 10.1063/1.1401821; Berrera M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-8; Brancolini G, 2015, ACS NANO, V9, P2600, DOI 10.1021/nn506161j; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Darian E, 2005, J COMPUT CHEM, V26, P651, DOI 10.1002/jcc.20198; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DOIG AJ, 1995, PROTEIN SCI, V4, P2247, DOI 10.1002/pro.5560041101; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fenley AT, 2014, J PHYS CHEM B, V118, P6447, DOI 10.1021/jp411588b; FINKELSTEIN AV, 1989, PROTEIN ENG, V3, P1, DOI 10.1093/protein/3.1.1; Fogolari F, 2011, PROTEINS, V79, P986, DOI 10.1002/prot.22940; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; GO N, 1976, MACROMOLECULES, V9, P535, DOI 10.1021/ma60052a001; GUYER CA, 1986, J BACTERIOL, V168, P775, DOI 10.1128/jb.168.2.775-779.1986; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; Hnizdo V, 2003, J COMPUT CHEM, V24, P1172, DOI 10.1002/jcc.10289; Hnizdo V, 2008, J COMPUT CHEM, V29, P1605, DOI 10.1002/jcc.20919; Hnizdo V, 2007, J COMPUT CHEM, V28, P655, DOI 10.1002/jcc.20589; Hnizdo V, 2010, ENTROPY-SWITZ, V12, P578, DOI 10.3390/e12030578; Huggins DJ, 2014, J COMPUT CHEM, V35, P377, DOI 10.1002/jcc.23504; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huynh DQ, 2009, J MATH IMAGING VIS, V35, P155, DOI 10.1007/s10851-009-0161-2; Iori F, 2009, J COMPUT CHEM, V30, P1465, DOI 10.1002/jcc.21165; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; KARPLUS M, 1987, BIOPHYS J, V52, P1083, DOI 10.1016/S0006-3495(87)83303-9; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; Killian BJ, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2746329; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KOEHL P, 1994, J MOL BIOL, V239, P249, DOI 10.1006/jmbi.1994.1366; Kokh DB, 2010, J CHEM THEORY COMPUT, V6, P1753, DOI 10.1021/ct100086j; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LEVITT M, 1976, J MOL BIOL, V104, P59, DOI 10.1016/0022-2836(76)90004-8; LEVY RM, 1984, MACROMOLECULES, V17, P1370, DOI 10.1021/ma00137a013; Li ZG, 1996, PROTEIN SCI, V5, P2647, DOI 10.1002/pro.5560051228; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; MCGREGOR MJ, 1987, J MOL BIOL, V198, P295, DOI 10.1016/0022-2836(87)90314-7; McQuarrie D.A., 2000, STATISTICAL MECHANIC; MILES RE, 1965, BIOMETRIKA, V52, P636, DOI 10.2307/2333716; Minh DDL, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2794754; Minh DDL, 2005, BIOPHYS J, V89, pL25, DOI 10.1529/biophysj.105.069336; Misra N, 2010, ENTROPY-SWITZ, V12, P1125, DOI 10.3390/e12051125; Mukherjee A, 2011, J PHYS CHEM LETT, V2, P3021, DOI 10.1021/jz2013566; Nguyen CN, 2014, J CHEM THEORY COMPUT, V10, P2769, DOI 10.1021/ct401110x; Nguyen CN, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4733951; Numata J, 2007, GENOME INFORM SER, V18, P192; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Polyansky AA, 2012, METHODS MOL BIOL, V819, P327, DOI 10.1007/978-1-61779-465-0_21; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; R Core Team, 2018, R LANG ENV STAT COMP; Rennella E, 2012, BBA-PROTEINS PROTEOM, V1824, P842, DOI 10.1016/j.bbapap.2012.04.002; Rennella E, 2012, J AM CHEM SOC, V134, P4457, DOI 10.1021/ja209004q; Roux B, 1999, BIOPHYS CHEM, V78, P1, DOI 10.1016/S0301-4622(98)00226-9; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; SCHLITTER J, 1993, CHEM PHYS LETT, V215, P617, DOI 10.1016/0009-2614(93)89366-P; Singh H., 2003, American Journal of Mathematical and Management Sciences, V23, P301; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; TIDOR B, 1993, PROTEINS, V15, P71, DOI 10.1002/prot.340150109; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van der Spoel D., 2010, GROMACS USER MANUAL; VanSchouwen B, 2011, J BIOL CHEM, V286, P42655, DOI 10.1074/jbc.M111.277723; Verdone G, 2002, PROTEIN SCI, V11, P487, DOI 10.1110/ps.29002; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang L, 2009, J CHEM THEORY COMPUT, V5, P1462, DOI 10.1021/ct900078k; Wang T, 2002, J MED CHEM, V45, P4828, DOI 10.1021/jm020900l; Wereszczynski J, 2012, Q REV BIOPHYS, V45, P1, DOI 10.1017/S0033583511000096; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhou HX, 2009, CHEM REV, V109, P4092, DOI 10.1021/cr800551w	81	25	25	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132356	10.1371/journal.pone.0132356	http://dx.doi.org/10.1371/journal.pone.0132356			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177039	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600102
J	Hamasaki, H; Kawashima, Y; Tamada, Y; Furuta, M; Katsuyama, H; Sako, A; Yanai, H				Hamasaki, Hidetaka; Kawashima, Yu; Tamada, Yoshiki; Furuta, Masashi; Katsuyama, Hisayuki; Sako, Akahito; Yanai, Hidekatsu			Associations of Low-Intensity Resistance Training with Body Composition and Lipid Profile in Obese Patients with Type 2 Diabetes	PLOS ONE			English	Article							LIPOPROTEIN(A) LEVELS; SARCOPENIC OBESITY; INSULIN-RESISTANCE; PHYSICAL-EXERCISE; OLDER-ADULTS; MUSCLE; METABOLISM; STRENGTH; MEN	Resistance training to increase muscle mass and functional capacity is an integral part of diet and exercise programs for the management of obesity and type 2 diabetes. Low-intensity resistance training with slow movement and tonic force generation (LST) may be a practical and safe regimen for elderly obese individuals but the health benefits are uncertain. This study investigated the effects of LST on body composition and metabolic parameters in obese patients with type 2 diabetes. Twenty-six obese patients with type 2 diabetes engaged in LST training during hospitalization and were advised to maintain this regimen for 12 weeks after discharge. We compared lipid profile, arterial stiffness, and body composition before and after LST training. After 12 weeks of LST training, the ratio of lower extremity muscle mass to body weight increased significantly (0.176 +/- 0.028 to 0.184 +/- 0.023, mean +/- SD), while body fat mass and body fat percentage decreased significantly (36.2 +/- 10.9 kg to 34.3 +/- 9.4 kg and 41.2 +/- 8.6% to 40.1 +/- 7.7%, respectively). Moreover, high-density lipoprotein cholesterol was significantly increased (42.2 +/- 14 mg/dl to 46.3 +/- 12.4 mg/dl) and both free fatty acids and lipoprotein(a) were decreased (665.2 +/- 212.1 mu Eq/l to 525.4 +/- 231.3 mu Eq/l and 15.4 +/- 18 mg/dl to 13.8 +/- 18 mg/dl, respectively). No significant change was observed in arterial stiffness. Although this study was a non-controlled investigation and some confounding factors including dietary intake, medication and compliance with training might affect the study result, a brief (12-week) LST training program may be a safe and effective strategy for the management of obesity and type 2 diabetes.	[Hamasaki, Hidetaka; Kawashima, Yu; Katsuyama, Hisayuki; Sako, Akahito; Yanai, Hidekatsu] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Internal Med, Chiba, Japan; [Hamasaki, Hidetaka] Jichi Med Univ, Grad Sch, Community Healthcare Studies, Gen Internal Med, Shimotsuke, Tochigi, Japan; [Tamada, Yoshiki] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Rehabil, Chiba, Japan; [Furuta, Masashi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Nutr, Chiba, Japan	National Center for Global Health & Medicine - Japan; Jichi Medical University; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Hamasaki, H (corresponding author), Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Internal Med, Chiba, Japan.	hhamasaki78@gmail.com	Hamasaki, Hidetaka/H-2928-2016; Yanai, Hidekatsu/AFN-9517-2022	Hamasaki, Hidetaka/0000-0002-0124-597X; Sako, Akahito/0000-0002-2555-1293	National Center for Global Health and Medicine [26A-201]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This study was supported in part by a Grant-in-Aid for Research from the National Center for Global Health and Medicine (26A-201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Anderson LJ, 2012, NUTR RES, V32, P479, DOI 10.1016/j.nutres.2012.05.009; AUSTIN A, 1993, DIABETES CARE, V16, P421, DOI 10.2337/diacare.16.2.421; Braith RW, 2006, CIRCULATION, V113, P2642, DOI 10.1161/CIRCULATIONAHA.105.584060; Castaneda C, 2002, DIABETES CARE, V25, P2335, DOI 10.2337/diacare.25.12.2335; Coyle D, 2012, INT J TECHNOL ASSESS, V28, P228, DOI 10.1017/S0266462312000256; Durstine JL, 1996, MED SCI SPORT EXER, V28, P1277, DOI 10.1097/00005768-199610000-00011; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4; HELLSTEN G, 1989, ATHEROSCLEROSIS, V75, P93, DOI 10.1016/0021-9150(89)90211-6; Hills AP, 2010, OBES REV, V11, P740, DOI 10.1111/j.1467-789X.2009.00692.x; Hubinger L, 1997, MED SCI SPORT EXER, V29, P436, DOI 10.1097/00005768-199704000-00003; Hubinger L, 1996, MED SCI SPORT EXER, V28, P757, DOI 10.1097/00005768-199606000-00015; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Hurley BF, 2011, SPORTS MED, V41, P289, DOI 10.2165/11585920-000000000-00000; Jensen MD, 2003, ACTA PHYSIOL SCAND, V178, P385, DOI 10.1046/j.1365-201X.2003.01167.x; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Mavros Y, 2013, DIABETES CARE, V36, P2372, DOI 10.2337/dc12-2196; Misra A, 2008, DIABETES CARE, V31, P1282, DOI 10.2337/dc07-2316; Miyachi M, 2013, BRIT J SPORT MED, V47, P393, DOI 10.1136/bjsports-2012-090488; MULS E, 1993, INT J OBESITY, V17, P711; Phillips SM, 1996, J APPL PHYSIOL, V81, P2182, DOI 10.1152/jappl.1996.81.5.2182; PONJEE GAE, 1995, ANN CLIN BIOCHEM, V32, P181, DOI 10.1177/000456329503200208; Prado CMM, 2012, CLIN NUTR, V31, P583, DOI 10.1016/j.clnu.2012.06.010; Rigla M, 2000, METABOLISM, V49, P640, DOI 10.1016/S0026-0495(00)80041-4; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; Strasser B, 2010, SPORTS MED, V40, P397, DOI 10.2165/11531380-000000000-00000; Subramanian S, 2012, BBA-MOL CELL BIOL L, V1821, P819, DOI 10.1016/j.bbalip.2011.10.003; Tanimoto M, 2006, J APPL PHYSIOL, V100, P1150, DOI 10.1152/japplphysiol.00741.2005; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; Tuttle Lori J, 2012, J Aging Res, V2012, P172957, DOI 10.1155/2012/172957; Yagi S, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-27; Zamboni M, 2008, NUTR METAB CARDIOVAS, V18, P388, DOI 10.1016/j.numecd.2007.10.002	38	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132959	10.1371/journal.pone.0132959	http://dx.doi.org/10.1371/journal.pone.0132959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176700	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600188
J	Han, SY; You, BH; Kim, YC; Chin, YW; Choi, YH				Han, Seung Yon; You, Byoung Hoon; Kim, Yu Chul; Chin, Young-Won; Choi, Young Hee			Dose-Independent ADME Properties and Tentative Identification of Metabolites of alpha-Mangostin from Garcinia mangostana in Mice by Automated Microsampling and UPLC-MS/MS Methods	PLOS ONE			English	Article							TISSUE DISTRIBUTION; KAEMPFERIA-PARVIFLORA; GAMMA-MANGOSTINS; FRUIT EXTRACT; XANTHONES; PHARMACOKINETICS; BIOTRANSFORMATION; ISOLIQUIRITIGENIN; CONSTITUENTS; ABSORPTION	The information about a marker compound's pharmacokinetics in herbal products including the characteristics of absorption, distribution, metabolism, excretion (ADME) is closely related to the efficacy/toxicity. Also dose range and administration route are critical factors to determine the ADME profiles. Since the supply of a sufficient amount of a marker compound in in vivo study is still difficult, pharmacokinetic investigations which overcome the limit of blood collection in mice are desirable. Thus, we have attempted to investigate concurrently the ADME and proposed metabolite identification of alpha-mangostin, a major constituent of mangosteen, Garcinia mangostana L, in mice with a wide dose range using an in vitro as well as in vivo automated micro-sampling system together. alpha-mangostin showed dose-proportional pharmacokinetics at intravenous doses of 5-20 mg/kg and oral doses of 10-100 mg/kg. The gastrointestinal absorption of a-mangostin was poor and the distribution of alpha-mangostin was relatively high in the liver, intestine, kidney, fat, and lung. alpha-mangostin was extensively metabolized in the liver and intestine. With regards to the formation of metabolites, the glucuronidated, bis-glucuronidated, dehydrogenated, hydrogenated, oxidized, and methylated alpha-mangostins were tentatively identified. We suggest that these dose-independent pharmacokinetic characteristics of alpha-mangostin in mice provide an important basis for preclinical applications of alpha-mangostin as well as mangosteen. In addition, these experimental methods can be applied to evaluate the pharmacokinetics of natural products in mice.	[Han, Seung Yon; You, Byoung Hoon; Chin, Young-Won; Choi, Young Hee] Dongguk Univ Seoul, Coll Pharm, Goyang 410820, Gyeonggi Do, South Korea; [Han, Seung Yon; You, Byoung Hoon; Chin, Young-Won; Choi, Young Hee] Dongguk Univ Seoul, PLUS R FIND Team BK21, Goyang 410820, Gyeonggi Do, South Korea; [Kim, Yu Chul] C&C Res Labs, Discovery Res Ctr, Suwon 440746, Gyeonggi Do, South Korea	Dongguk University; Dongguk University	Choi, YH (corresponding author), Dongguk Univ Seoul, Coll Pharm, 32 Dongguk Lo, Goyang 410820, Gyeonggi Do, South Korea.	choiyh@dongguk.edu		Choi, Young Hee/0000-0002-9360-6436; Leggas, Markos/0000-0003-4314-4533; Chin, Young-Won/0000-0001-6964-1779	National Research Foundation of Korea (NRF) - government of Korea [S-2014-004424]; GRRC program of Gyeonggi province [GRRC-DONGGUK2015-B01, GRRC-DONGGUK2015-B03]	National Research Foundation of Korea (NRF) - government of Korea; GRRC program of Gyeonggi province	This work was supported by the National Research Foundation of Korea (NRF) funded by the government of Korea (S-2014-004424, Y. H. Choi) and GRRC program of Gyeonggi province [Development of new health supplements/therapeutics for neurodegenerative diseases (GRRC-DONGGUK2015-B01) and Development of functional food to alleviating metabolic syndromes and circulatory disorders (GRRC-DONGGUK2015-B03)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An GH, 2012, AAPS J, V14, P352, DOI 10.1208/s12248-012-9344-7; Arunrattiyakorn P, 2014, J MOL CATAL B-ENZYM, V102, P174, DOI 10.1016/j.molcatb.2014.02.010; Bumrungpert A, 2009, MOL NUTR FOOD RES, V53, pS54, DOI 10.1002/mnfr.200800260; Chae HS, 2012, FOOD CHEM, V134, P397, DOI 10.1016/j.foodchem.2012.02.075; Chin YW, 2008, MINI-REV ORG CHEM, V5, P355, DOI 10.2174/157019308786242223; Chiou WL, 1998, PHARMACEUT RES, V15, P1792, DOI 10.1023/A:1011981317451; Chitchumroonchokchai C, 2013, MOL NUTR FOOD RES, V57, P203, DOI 10.1002/mnfr.201200539; Chitchumroonchokchai C, 2012, J NUTR, V142, P675, DOI 10.3945/jn.111.156992; Choi YH, 2015, PLANTA MED IN PRESS; Choi YH, 2014, FOOD CHEM TOXICOL, V66, P140, DOI 10.1016/j.fct.2014.01.028; Cui JH, 2010, PHARMACOL BIOCHEM BE, V95, P166, DOI 10.1016/j.pbb.2009.12.021; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; DeSmet PAGM, 1997, CLIN PHARMACOKINET, V32, P427, DOI 10.2165/00003088-199732060-00001; Fang HY, 2012, FOOD CHEM TOXICOL, V50, P4042, DOI 10.1016/j.fct.2012.08.037; Foti RS, 2009, DRUG METAB DISPOS, V37, P1848, DOI 10.1124/dmd.109.028043; Gibaldi M., 1982, PHARMACOKINEICS; Guo J, 2008, DRUG METAB DISPOS, V36, P2104, DOI 10.1124/dmd.108.021857; Han SY, 2013, CHROMATOGRAPHIA, V76, P643, DOI 10.1007/s10337-013-2437-3; Han SY, 2013, BIOMED CHROMATOGR, V27, P741, DOI 10.1002/bmc.2854; Holcapek M, 2008, ANAL BIOANAL CHEM, V391, P59, DOI 10.1007/s00216-008-1962-7; Jamali F, 1999, BRIT J CLIN PHARMACO, V47, P391, DOI 10.1046/j.1365-2125.1999.00902.x; Jia W, 2015, DRUG METAB DISPOS; Lee YB, 2010, J FOOD SCI, V75, pH13, DOI 10.1111/j.1750-3841.2009.01407.x; Li L, 2013, PLANTA MED, V79, P646, DOI 10.1055/s-0032-1328543; Li L, 2011, MOL NUTR FOOD RES, V55, pS67, DOI 10.1002/mnfr.201000511; Li LH, 2013, EUR J CANCER, V49, P1752, DOI 10.1016/j.ejca.2012.12.013; Malaney P, 2014, CANCER LETT, V344, P1, DOI 10.1016/j.canlet.2013.10.010; Medhi B, 2009, PHARMACOLOGY, V84, P323, DOI 10.1159/000252658; Mekjaruskul C, 2012, DRUG METAB DISPOS, V40, P2342, DOI 10.1124/dmd.112.047142; Mitruka B M, 1987, CLIN BIOCH HEMATOLOG; Moridani MY, 2002, TOXICOL LETT, V133, P141, DOI 10.1016/S0378-4274(02)00105-4; Peerapattana J, 2013, J NAT MED-TOKYO, V67, P452, DOI 10.1007/s11418-012-0698-z; Peternel L, 2010, J PHARMACOL TOX MET, V61, P20, DOI 10.1016/j.vascn.2009.07.004; Petiwala SM, 2014, NUTR RES, V34, P336, DOI 10.1016/j.nutres.2014.03.002; Quan GH, 2010, PHYTOTHER RES, V24, P1575, DOI 10.1002/ptr.3177; Ramaiya A, 2012, CURR DRUG TARGETS, V13, P1698, DOI 10.2174/138945012804545524; Ritchie MR, 2007, P NUTR SOC, V66, P479, DOI 10.1017/S0029665107005794; Sanchez-Perez Y, 2010, CHEM-BIOL INTERACT, V188, P144, DOI 10.1016/j.cbi.2010.06.014; Shargel L., 2005, APPL BIOPHARMACEUTIC; Singh SS, 2006, CURR DRUG METAB, V7, P165, DOI 10.2174/138920006775541552; Skalli S, 2007, THER DRUG MONIT, V29, P679, DOI 10.1097/FTD.0b013e31815c17f6; Sutthanut K, 2007, J CHROMATOGR A, V1143, P227, DOI 10.1016/j.chroma.2007.01.033; Tanaka C, 2000, DRUG METAB DISPOS, V28, P582; Viana AFSC, 2013, J ETHNOPHARMACOL, V150, P316, DOI 10.1016/j.jep.2013.08.047; Yodhnu S, 2009, J CHROMATOGR SCI, V47, P185, DOI 10.1093/chromsci/47.3.185; Yokozawa T, 2000, RENAL FAILURE, V22, P115, DOI 10.1081/JDI-100100858	46	16	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131587	10.1371/journal.pone.0131587	http://dx.doi.org/10.1371/journal.pone.0131587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176540	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600051
J	Hoots, BE; Finlayson, TJ; Wejnert, C; Paz-Bailey, G				Hoots, Brooke E.; Finlayson, Teresa J.; Wejnert, Cyprian; Paz-Bailey, Gabriela		NHBS Study Grp	Early Linkage to HIV Care and Antiretroviral Treatment among Men Who Have Sex with Men-20 Cities, United States, 2008 and 2011	PLOS ONE			English	Article							WHITE MEN; DISPARITIES; RISK; PREVENTION; INFECTION; THERAPY; SURVEILLANCE; TRANSMISSION; ADHERENCE; BEHAVIORS	Early linkage to care and antiretroviral (ARV) treatment are associated with reduced HIV transmission. Male-to-male sexual contact represents the largest HIV transmission category in the United States; men who have sex with men (MSM) are an important focus of care and treatment efforts. With the release of the National HIV/AIDS Strategy and expanded HIV treatment guidelines, increases in early linkage to care and ARV treatment are expected. We examined differences in prevalence of early linkage to care and ARV treatment among HIV-positive MSM between 2008 and 2011. Data are from the National HIV Behavioral Surveillance System, which monitors behaviors among populations at high risk of HIV infection in 20 U.S. cities with high AIDS burden. MSM were recruited through venue-based, time-space sampling. Prevalence ratios comparing 2011 to 2008 were estimated using linear mixed models. Early linkage was defined as an HIV clinic visit within 3 months of diagnosis. ARV treatment was defined as use at interview. Prevalence of early linkage to care was 79% (187/236) in 2008 and 83% (241/291) in 2011. In multivariable analysis, prevalence of early linkage did not differ significantly between years overall (P = 0.44). Prevalence of ARV treatment was 69% (790/1,142) in 2008 and 79% (1,049/1,336) in 2001. In multivariable analysis, ARV treatment increased overall (P = 0.0003) and among most sub-groups. Black MSM were less likely than white MSM to report ARV treatment (P = 0.01). While early linkage to care did not increase significantly between 2008 and 2011, ARV treatment increased among most sub-groups. Progress is being made in getting MSM on HIV treatment, but more efforts are needed to decrease disparities in ARV coverage.	[Hoots, Brooke E.; Finlayson, Teresa J.; Wejnert, Cyprian; Paz-Bailey, Gabriela] Ctr Dis Control & Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Hoots, BE (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA 30329 USA.	vie2@cdc.gov		Al-Tayyib, Alia/0000-0002-5909-6719; Raymond, Henry/0000-0001-8621-2749				[Anonymous], 2010, NAT HIV AIDS STRAT U; [Anonymous], C RETR OPP INF MAR 3; [Anonymous], ASSESSING IMPACT AFF; [Anonymous], GUID US ANT AG HIV 1; [Anonymous], DIAGN HIV INF US DEP; Beer L, 2014, AIDS, V28, P105, DOI 10.1097/QAD.0000000000000021; Centers for Disease Control and Prevention, 2012, EST HIV INC US 2007; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P121; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Finlayson Teresa J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V38, P96, DOI 10.1097/00126334-200501010-00017; Golin CE, 2002, J GEN INTERN MED, V17, P756, DOI 10.1046/j.1525-1497.2002.11214.x; Halkitis P, 2008, AIDS PATIENT CARE ST, V22, P323, DOI 10.1089/apc.2007.0122; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Karon JM, 2012, J URBAN HEALTH, V89, P565, DOI 10.1007/s11524-012-9676-8; King WD, 2008, J EPIDEMIOL COMMUN H, V62, P798, DOI 10.1136/jech.2005.045567; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; MOORE RD, 1994, NEW ENGL J MED, V330, P763, DOI 10.1056/NEJM199403173301107; Oster AM, 2011, AIDS, V25, P1103, DOI 10.1097/QAD.0b013e3283471efa; Snider JT, 2014, HEALTH AFFAIR, V33, P386, DOI 10.1377/hlthaff.2013.1453; Wejnert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076878	24	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132962	10.1371/journal.pone.0132962	http://dx.doi.org/10.1371/journal.pone.0132962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176856	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600190
J	Lamb, J; Forfang, K; Hohmann-Marriott, M				Lamb, Jacob; Forfang, Kristin; Hohmann-Marriott, Martin			A Practical Solution for 77 K Fluorescence Measurements Based on LED Excitation and CCD Array Detector	PLOS ONE			English	Article							EMISSION-SPECTRA; ABSORBING FORM; PHOTOSYSTEM-I; PCC 6803; CHLOROPHYLL; FLUOROMETER; CONSTRUCTION; DESIGN; MUTANT; VIVO	The fluorescence emission spectrum of photosynthetic microorganisms at liquid nitrogen temperature (77 K) provides important insights into the organization of the photosynthetic machinery of bacteria and eukaryotes, which cannot be observed at room temperature. Conventionally, to obtain such spectra, a large and costly table-top fluorometer is required. Recently portable, reliable, and largely maintenance-free instruments have become available that can be utilized to accomplish a wide variety of spectroscopy-based measurements in photosynthesis research. In this report, we show how to build such an instrument in order to record 77K fluorescence spectra. This instrument consists of a low power monochromatic light-emitting diode (LED), and a portable CCD array based spectrometer. The optical components are coupled together using a fiber optic cable, and a custom made housing that also supports a dewar flask. We demonstrate that this instrument facilitates the reliable determination of chlorophyll fluorescence emission spectra for the cyanobacterium Synechocystis sp. PCC 6803, and the green alga Chlamydomonas reinhardtii.	[Hohmann-Marriott, Martin] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway; Norwegian Univ Sci & Technol, PhotoSynLab, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Hohmann-Marriott, M (corresponding author), Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway.	martin.hohmann-marriott@ntnu.no	Lamb, Jacob J./AAQ-4270-2020	Lamb, Jacob J./0000-0002-1019-6655	Norwegian University of Science and Technology, Trondheim, Norway	Norwegian University of Science and Technology, Trondheim, Norway	Funding was provided through the PhD position awarded to JJL by the Norwegian University of Science and Technology, Trondheim, Norway. The funder had no role in study design, data collection and analysis, discussion to publish, or preparation of the manuscript.	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Asundi AK, 1999, P SOC PHOTO-OPT INS, V3897, P204, DOI 10.1117/12.369310; Balsam J, 2012, ANALYST, V137, P5011, DOI 10.1039/c2an35729a; Balsam J, 2011, LAB CHIP, V11, P941, DOI [10.1039/c0lc00431f, 10.1039/c01c00431f]; Bina D, 2006, PHOTOSYNTH RES, V88, P351, DOI 10.1007/s1120-006-9071-y; BRODY SS, 1958, SCIENCE, V128, P839, DOI 10.1126/science.128.3328.838; BUTLER WL, 1961, ARCH BIOCHEM BIOPHYS, V93, P413, DOI 10.1016/0003-9861(61)90287-9; DAS M, 1967, BIOCHIM BIOPHYS ACTA, V143, P570, DOI 10.1016/0005-2728(67)90062-X; Eaton-Rye JJ, 2011, METHODS MOL BIOL, V684, P295, DOI [10.1007/978.1.60761.925.3_22, 10.1007/978-1-60761-925-3_22]; FLASCHKA H, 1973, MICROCHEM J, V18, P152, DOI 10.1016/0026-265X(73)90097-0; GASANOV R, 1979, Z PFLANZENPHYSIOL, V95, P149, DOI 10.1016/S0044-328X(79)80079-3; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Lamb JJ, 2013, CURR MICROBIOL, V67, P123, DOI 10.1007/s00284-013-0340-7; Lamb JJ, 2012, PHOTOSYNTH RES, V114, P59, DOI 10.1007/s11120-012-9777-y; Lee DS, 2005, SENSOR ACTUAT B-CHEM, V107, P872, DOI 10.1016/j.snb.2004.12.042; MULLET JE, 1980, PLANT PHYSIOL, V65, P814, DOI 10.1104/pp.65.5.814; MURATA N, 1966, BIOCHIM BIOPHYS ACTA, V126, P234, DOI 10.1016/0926-6585(66)90059-8; NAKATANI HY, 1984, BIOCHIM BIOPHYS ACTA, V765, P347, DOI 10.1016/0005-2728(84)90175-0; NILSSON F, 1992, ARCH BIOCHEM BIOPHYS, V295, P340, DOI 10.1016/0003-9861(92)90526-3; Rasooly R, 2015, BIOSENS BIOELECTRON, V68, P705, DOI 10.1016/j.bios.2015.01.065; RIJGERSBERG CP, 1979, BIOCHIM BIOPHYS ACTA, V545, P473, DOI 10.1016/0005-2728(79)90156-7; SATOH K, 1980, FEBS LETT, V110, P53, DOI 10.1016/0014-5793(80)80021-4; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Schreiber U, 2012, PHOTOSYNTH RES, V113, P127, DOI 10.1007/s11120-012-9758-1; SHEN GZ, 1994, J BIOL CHEM, V269, P13904; Stadnichuk IN, 2013, J PHOTOCH PHOTOBIO B, V125, P137, DOI 10.1016/j.jphotobiol.2013.05.014; SZABO K, 1992, RADIAT ENVIRON BIOPH, V31, P153, DOI 10.1007/BF01211213	27	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132258	10.1371/journal.pone.0132258	http://dx.doi.org/10.1371/journal.pone.0132258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177548	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600094
J	Navarro, F; Lieberman, J				Navarro, Francisco; Lieberman, Judy			miR-34 and p53: New Insights into a Complex Functional Relationship	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR NETWORK; LARGE GENE LISTS; DOWN-REGULATION; NEGATIVE REGULATOR; POSITIVE FEEDBACK; IN-VIVO; MICRORNAS; APOPTOSIS; ACTIVATION	miR-34, a tumor suppressor miRNA family transcriptionally activated by p53, is considered a critical mediator of p53 function. However, knockout of the mouse miR-34 family has little or no effect on the p53 response. The relative contribution of different miR-34 family members to p53 function or how much p53 relies on miR-34 in human cells is unclear. Here we show that miR-34a has a complex effect on the p53 response in human cells. In HCT116 cells miR-34a overexpression enhances p53 transcriptional activity, but the closely related family members, miR-34b and miR-34c, even when over-expressed, have little effect. Both TP53 itself and MDM4, a strong p53 transactivation inhibitor, are direct targets of miR-34a. The genes regulated by miR-34a also include four other post-translational inhibitors of p53. miR-34a overexpression leads to variable effects on p53 levels in p53-sufficient human cancer cell lines. In HCT116, miR-34a overexpression increases p53 protein levels and stability. About a quarter of all mRNAs that participate in the human p53 network bind to biotinylated miR-34a, suggesting that many are direct miR-34a targets. However, only about a fifth of the mRNAs that bind to miR-34a also bind to miR-34b or miR-34c. Two human cell lines knocked out for miR-34a have unimpaired p53-mediated responses to genotoxic stress, like mouse cells. The complex positive and negative effects of miR-34 on the p53 network suggest that rather than simply promoting the p53 response, miR-34a might act at a systems level to stabilize the robustness of the p53 response to genotoxic stress.	[Navarro, Francisco; Lieberman, Judy] Boston Childrens Hosp, Cellular & Mol Med Program, Boston, MA 02115 USA; [Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Navarro, F (corresponding author), Boston Childrens Hosp, Cellular & Mol Med Program, Boston, MA 02115 USA.	francisco.navarro.lop@gmail.com; judy.lieberman@childrens.harvard.edu	Lieberman, Judy/A-2717-2015		NIH [NIH-P50-NS40828, NIH-P30-HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Microarray experiments were supported by NIH grants NIH-P50-NS40828 and NIH-P30-HD18655. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi S, 1996, CANCER RES, V56, P3087; Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen QR, 2011, J PROTEOME RES, V10, P479, DOI 10.1021/pr1006697; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Comazzetto S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004597; Concepcion CP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002797; Ebner OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092166; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Finch RA, 2002, CANCER RES, V62, P3221; Freeman JA, 2013, BRIEF FUNCT GENOMICS, V12, P46, DOI 10.1093/bfgp/els058; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; Hahn S, 2013, EMBO J; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Javeri A, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0413-7; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kaller M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010462; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim NH, 2013, CELL CYCLE, V12, P1578, DOI 10.4161/cc.24739; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Krzeszinski JY, 2014, NATURE, V512, P431, DOI 10.1038/nature13375; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lize M, 2011, CELL CYCLE, V10, P2874, DOI 10.4161/cc.10.17.17181; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mandke P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042034; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; MIYASHITA T, 1995, CELL, V80, P293; Navarro F, 2009, BLOOD, V114, P2181, DOI 10.1182/blood-2009-02-205062; Okada N, 2014, GENE DEV, V28, P438, DOI 10.1101/gad.233585.113; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Piovan C, 2012, MOL ONCOL, V6, P458, DOI 10.1016/j.molonc.2012.03.003; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Song R, 2014, NATURE, V510, P115, DOI 10.1038/nature13413; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Sullivan KD, 2012, BBA-REV CANCER, V1825, P229, DOI 10.1016/j.bbcan.2012.01.004; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang P, 2007, P NATL ACAD SCI USA, V104, P4054, DOI 10.1073/pnas.0700020104; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Xiao JN, 2011, EMBO J, V30, P5021, DOI 10.1038/emboj.2011.463; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang J, 2013, ONCOGENE, V32, P61, DOI 10.1038/onc.2012.28; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	65	114	118	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132767	10.1371/journal.pone.0132767	http://dx.doi.org/10.1371/journal.pone.0132767			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177460	gold, Green Published			2022-12-27	WOS:000358197600152
J	Cuijpers, LS; Zaal, FTJM; De Poel, HJ				Cuijpers, Laura S.; Zaal, Frank T. J. M.; de Poel, Harjo J.			Rowing Crew Coordination Dynamics at Increasing Stroke Rates	PLOS ONE			English	Article							PHASE-ENTRAINMENT DYNAMICS; RELATIVE PHASE; FLUCTUATIONS; TRANSITIONS; MOVEMENTS; FREQUENCY; VELOCITY; ROCKING; ROWERS; FORCE	In rowing, perfect synchronisation is important for optimal performance of a crew. Remarkably, a recent study on ergometers demonstrated that antiphase crew coordination might be mechanically more efficient by reducing the power lost to within-cycle velocity fluctuations of the boat. However, coupled oscillator dynamics predict the stability of the coordination to decrease with increasing stroke rate, which in case of antiphase may eventually yield breakdowns to in-phase. Therefore, this study examined the effects of increasing stroke rate on in-and antiphase crew coordination in rowing dyads. Eleven experienced dyads rowed on two mechanically coupled ergometers on slides, which allowed the ergometer system to move back and forth as one 'boat'. The dyads performed a ramp trial in both in- and antiphase pattern, in which stroke rates gradually increased from 30 strokes per minute (spm) to as fast as possible in steps of 2 spm. Kinematics of rowers, handles and ergometers were captured. Two dyads showed a breakdown of antiphase into in-phase coordination at the first stroke rate of the ramp trial. The other nine dyads reached between 34-42 spm in antiphase but achieved higher rates in in-phase. As expected, the coordinative accuracy in antiphase was worse than in in-phase crew coordination, while, somewhat surprisingly, the coordinative variability did not differ between the patterns. Whereas crew coordination did not substantially deteriorate with increasing stroke rate, stroke rate did affect the velocity fluctuations of the ergometers: fluctuations were clearly larger in the in-phase pattern than in the antiphase pattern, and this difference significantly increased with stroke rate. Together, these results suggest that although antiphase rowing is less stable (i.e., less resistant to perturbation), potential on-water benefits of antiphase over in-phase rowing may actually increase with stroke rate.	[Cuijpers, Laura S.; Zaal, Frank T. J. M.; de Poel, Harjo J.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	University of Groningen	Cuijpers, LS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	l.s.cuijpers@gmail.com	Zaal, Frank TJM/A-5578-2008; Cuijpers, Laura/AAT-1338-2020	Zaal, Frank TJM/0000-0003-2697-3612; Cuijpers, Laura/0000-0001-9330-4721; de Poel, Harjo/0000-0001-8812-5390				AMAZEEN PG, 1995, BIOL CYBERN, V72, P511, DOI 10.1007/BF00199893; Baldissera F, 2008, EXP BRAIN RES, V190, P289, DOI 10.1007/s00221-008-1470-1; Bennett M, 2002, P ROY SOC A-MATH PHY, V458, P563, DOI 10.1098/rspa.2001.0888; Bosga J, 2010, MOTOR CONTROL, V14, P440, DOI 10.1123/mcj.14.4.440; Brearley M.N., 1998, MATH GAZ, V82, P389; Colloud F, 2006, J SPORT SCI, V24, P479, DOI 10.1080/02640410500189256; de Brouwer AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054996; de Poel HJ, 2007, ACTA PSYCHOL, V124, P209, DOI 10.1016/j.actpsy.2006.03.003; de Poel HJ, 2009, J EXP PSYCHOL HUMAN, V35, P762, DOI 10.1037/a0013549; De Poel HJ, 2016, INTERPERSONAL COORDI; Elliott Bruce, 2002, Sports Biomech, V1, P123, DOI 10.1080/14763140208522791; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Harrison SJ, 2010, J MOT BEH, V41, P519; Hill H, 2002, J SPORT SCI, V20, P101, DOI 10.1080/026404102317200819; Hill H, 2009, SCAND J MED SCI SPOR, V19, P585, DOI 10.1111/j.1600-0838.2008.00819.x; Hofmijster MJ, 2007, J SPORT SCI, V25, P403, DOI 10.1080/02640410600718046; Holsgaard-Larsen A, 2010, INT J SPORTS MED, V31, P870, DOI 10.1055/s-0030-1265148; INGHAM AG, 1974, J EXP SOC PSYCHOL, V10, P371, DOI 10.1016/0022-1031(74)90033-X; Keller PE, 2008, EMERG COMMUN-STUD NE, V10, P205; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; Kelso S., 1995, DYNAMIC PATTERNS SEL; King A, 2011, BRIT J SOCIOL, V62, P565, DOI 10.1111/j.1468-4446.2011.01381.x; Lagarde J, 2013, FRONT NEUROROBOTICS, V7, DOI [10.3389/fnbot.2013.0001, 10.3389/fnbot.2013.00018]; LAMB DH, 1989, AM J SPORT MED, V17, P367, DOI 10.1177/036354658901700310; LUTKENHONER B, 1991, ACTA OTO-LARYNGOL, P52; Marsh KL, 2009, TOP COGN SCI, V1, P320, DOI 10.1111/j.1756-8765.2009.01022.x; MARTIN TP, 1980, MED SCI SPORT EXER, V12, P250; Meerhoff LA, 2014, NEUROSCI LETT, V582, P12, DOI 10.1016/j.neulet.2014.08.022; Meerhoff LA, 2014, HUM MOVEMENT SCI, V35, P66, DOI 10.1016/j.humov.2014.04.003; Miles LK, 2010, EUR J SOC PSYCHOL, V40, P52, DOI 10.1002/ejsp.721; Millar SK, 2013, NONLIN DYNAM PSYCHOL, V17, P425; O'Brien C., 2011, ROWING FASTER, P173; Oullier O, 2008, SOC NEUROSCI, V3, P178, DOI 10.1080/17470910701563392; Pantaleone J, 2002, AM J PHYS, V70, P992, DOI 10.1119/1.1501118; Reed K, 2006, PSYCHOL SCI, V17, P365, DOI 10.1111/j.1467-9280.2006.01712.x; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Schmidt RC, 2011, HUM MOVEMENT SCI, V30, P834, DOI 10.1016/j.humov.2010.05.014; Schmidt RC, 1998, J EXP PSYCHOL HUMAN, V24, P884, DOI 10.1037/0096-1523.24.3.884; SCHMIDT RC, 1994, BIOL CYBERN, V70, P369, DOI 10.1007/BF00200334; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; SCHOLZ JP, 1987, PHYS LETT A, V123, P390, DOI 10.1016/0375-9601(87)90038-7; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Sofianidis G, 2014, ACTA PSYCHOL, V150, P106, DOI 10.1016/j.actpsy.2014.05.002; Temprado JJ, 2004, ACTA PSYCHOL, V115, P1, DOI 10.1016/j.actpsy.2003.09.002; van der Wel RPRD, 2011, J EXP PSYCHOL HUMAN, V37, P1420, DOI 10.1037/a0022337; van Ulzen NR, 2010, NEUROSCI LETT, V474, P79, DOI 10.1016/j.neulet.2010.03.008; Varlet M, 2013, PRESENCE-TELEOP VIRT, V22, P202, DOI 10.1162/PRES_a_00151; Varlet M, 2011, J BIOMECH, V44, P1200, DOI 10.1016/j.jbiomech.2011.02.001; Wing Alan M., 1995, Journal of Sports Sciences, V13, P187, DOI 10.1080/02640419508732227; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403	52	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133527	10.1371/journal.pone.0133527	http://dx.doi.org/10.1371/journal.pone.0133527			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185987	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700153
J	Dong, YJ; Wu, NQ; Li, FJ; Huang, LP; Wen, WW				Dong, Yajie; Wu, Naiqin; Li, Fengjiang; Huang, Linpei; Wen, Wenwen			Time-Transgressive Nature of the Magnetic Susceptibility Record across the Chinese Loess Plateau at the Pleistocene/Holocene Transition	PLOS ONE			English	Article							NORTHERN CHINA; MONSOON PRECIPITATION; CLIMATE CHANGES; DUST ACCUMULATION; HOLOCENE OPTIMUM; MODERN SOILS; DAIHAI LAKE; EAST-ASIA; PALEOSOL; DEPOSITS	The loess stratigraphic boundary at the Pleistocene/Holocene transition defined by the magnetic susceptibility (MS) has previously been assumed to be synchronous with the Marine Isotope Stage (MIS) 2/1 boundary, and approximately time-synchronous at different sections across the Chinese Loess Plateau (CLP). However, although this assumption has been used as a basis for proxy-age model of Chinese loess deposits, it has rarely been tested by using absolute dating methods. In this study, we applied a single-aliquot regenerative-dose (SAR) protocol to the 45-63 mu m quartz grain-size fraction to derive luminescence ages for the last glacial and Holocene sections of three loess sections on a transect from southeast to northwest across the CLP. Based on the 33 closely spaced optically stimulated luminescence (OSL) samples from the three sections, OSL chronologies were established using a polynomial curve fit at each section. Based on the OSL chronology, the timing of the Pleistocene/Holocene boundary, as defined by rapid changes in MS values, is dated at similar to 10.5 ka, 8.5 ka and 7.5 ka in the Yaoxian section, Jingchuan and Huanxian sections respectively. These results are clearly inconsistent with the MIS 2/1 boundary age of 12.05 ka, and therefore we conclude that the automatic correlation of the Pleistocene/Holocene transition, as inferred from the MS record, with the MIS 2/1 boundary is incorrect. The results clearly demonstrate that the marked changes in MS along the southeast to northwest transect are time-transgressive among the different sites, with the timing of significant paleosol development as indicated by the MS record being delayed by 3-4 ka in the northwest compared to the southeast. Our results suggest that this asynchronous paleosol development during the last deglacial was caused by the delayed arrival of the summer monsoon in the northwest CLP compared to the southeast.	[Dong, Yajie; Wu, Naiqin; Li, Fengjiang; Huang, Linpei; Wen, Wenwen] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China; [Dong, Yajie] Univ Chinese Acad Sci, Beijing, Peoples R China; [Huang, Linpei; Wen, Wenwen] Yunnan Normal Univ, Coll Tourism & Geog, Key Lab Plateau Lake Ecol & Global Change, Kunming, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Yunnan Normal University	Dong, YJ (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China.	dongyajie@mail.iggcas.ac.cn; nqwu@mail.iggcas.ac.cn		Dong, Yajie/0000-0003-3913-2812	Strategic Priority Research Program: Climate Change, Carbon Budget and Relevant Issues [XDA05120203]; National Natural Science Foundation of China [41272205, 41430103, 41372186]	Strategic Priority Research Program: Climate Change, Carbon Budget and Relevant Issues(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the Strategic Priority Research Program: Climate Change, Carbon Budget and Relevant Issues (XDA05120203), the National Natural Science Foundation of China (Projects 41272205, 41430103, and 41372186). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken M.J., 1998, INTRO OPTICAL DATING; AN ZH, 1991, QUATERNARY RES, V36, P29, DOI 10.1016/0033-5894(91)90015-W; An ZS, 2000, QUATERNARY SCI REV, V19, P743, DOI 10.1016/S0277-3791(99)00031-1; Balsam WL, 2011, QUATERNARY SCI REV, V30, P2732, DOI 10.1016/j.quascirev.2011.06.002; Buylaert JP, 2008, QUAT GEOCHRONOL, V3, P99, DOI 10.1016/j.quageo.2007.05.003; Derbyshire E, 1995, QUATERNARY SCI REV, V14, P681, DOI 10.1016/0277-3791(95)00077-1; DING Z, 1994, QUATERNARY SCI REV, V13, P39, DOI 10.1016/S0277-3791(99)00017-7; DING ZL, 1995, QUATERNARY RES, V44, P149, DOI 10.1006/qres.1995.1059; Ding ZL, 2005, EARTH PLANET SC LETT, V237, P45, DOI 10.1016/j.epsl.2005.06.036; DING ZL, 1993, CATENA, V20, P73, DOI 10.1016/0341-8162(93)90030-S; DING ZL, 1990, CHINESE SCI BULL, V34, P1494; Grimm EC, 1992, CLIM DYNAM, V6, P179, DOI 10.1007/BF00193530; Guo ZT, 2000, GEOPHYS RES LETT, V27, P1751, DOI 10.1029/1999GL008419; Han JM, 1996, STUD GEOPHYS GEOD, V40, P262, DOI 10.1007/BF02300742; Hao QZ, 2012, NATURE, V490, P393, DOI 10.1038/nature11493; Hao QZ, 1978, J GEOPHYS RES SOLID, P110; He Y, 2004, QUATERNARY RES, V61, P52, DOI 10.1016/j.yqres.2003.08.004; HELLER F, 1982, NATURE, V300, P431, DOI 10.1038/300431a0; HELLER F, 1984, GEOPHYS J ROY ASTR S, V77, P125, DOI 10.1111/j.1365-246X.1984.tb01928.x; Huang CC, 2003, EARTH SURF PROC LAND, V28, P1259, DOI 10.1002/esp.512; JACOBSON GL, 1986, ECOLOGY, V67, P958, DOI 10.2307/1939818; Jia YF, 2008, J GEOGR SCI, V18, P425, DOI 10.1007/s11442-008-0425-6; Kang SG, 2013, BOREAS, V42, P815, DOI 10.1111/bor.12005; Kang SG, 2011, QUAT GEOCHRONOL, V6, P480, DOI 10.1016/j.quageo.2011.04.004; KUKLA G, 1989, PALAEOGEOGR PALAEOCL, V72, P203, DOI 10.1016/0031-0182(89)90143-0; KUKLA G, 1988, GEOLOGY, V16, P811, DOI 10.1130/0091-7613(1988)016<0811:PCICDB>2.3.CO;2; KUKLA G, 1987, QUATERNARY SCI REV, V6, P191, DOI 10.1016/0277-3791(87)90004-7; Kutzbach J. E., 1993, P24; Lai ZP, 2006, HOLOCENE, V16, P893, DOI 10.1191/0959683606hol980rr; Lai ZP, 2007, PALAEOGEOGR PALAEOCL, V248, P431, DOI 10.1016/j.palaeo.2006.12.013; Li Q, 2014, GLOBAL PLANET CHANGE, V121, P101, DOI 10.1016/j.gloplacha.2014.07.009; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Liu JQ, 2000, GEOLOGOS, V5, P165; Liu QS, 2004, GEOPHYS J INT, V156, P267, DOI 10.1111/j.1365-246X.2003.02148.x; Liu T.S., 1992, QUAT SCI, V1, P12; Liu TS, 1998, ANNU REV EARTH PL SC, V26, P111, DOI 10.1146/annurev.earth.26.1.111; Liu TS, 1997, QUATERNARY ENV; Liu TS., 1985, LOESS ENV; Lotter AF, 1992, CLIM DYNAM, V6, P233, DOI 10.1007/BF00193536; Lu HY, 2007, QUATERNARY SCI REV, V26, P759, DOI 10.1016/j.quascirev.2006.10.006; Lu HY, 2006, CHINESE SCI BULL, V51, P2253, DOI 10.1007/s11434-006-2097-x; Lu HY, 2013, GEOLOGY, V41, P1023, DOI 10.1130/G34488.1; Lu HY, 2005, GEOPHYS RES LETT, P32; Lu YC, 2007, QUATERNARY RES, V67, P152, DOI 10.1016/j.yqres.2006.08.003; Maher BA, 1995, QUATERNARY RES, V44, P383, DOI 10.1006/qres.1995.1083; Mason JA, 2009, GEOLOGY, V37, P947, DOI 10.1130/G30240A.1; Mix AC, 1986, PALEOCEANOGRAPHY, V1, P43, DOI 10.1029/PA001i001p00043; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; Muschitiello F, 2015, QUATERNARY SCI REV, V109, P49, DOI 10.1016/j.quascirev.2014.11.015; Peterse F, 2014, QUATERNARY SCI REV, V83, P76, DOI 10.1016/j.quascirev.2013.11.001; Peterse F, 2011, EARTH PLANET SC LETT, V301, P256, DOI 10.1016/j.epsl.2010.11.010; PISIAS NG, 1984, MAR GEOL, V56, P119, DOI 10.1016/0025-3227(84)90009-4; PORTER SC, 1995, NATURE, V375, P305, DOI 10.1038/375305a0; Prell WL, 1986, PALEOCEANOGRAPHY, V1, P137, DOI 10.1029/PA001i002p00137; Prescott JR, 1997, RADIAT MEAS, V27, P893, DOI 10.1016/S1350-4487(97)00204-7; Qin JT, 2009, RADIAT MEAS, V44, P417, DOI 10.1016/j.radmeas.2009.06.008; [覃金堂 Qin Jintang], 2007, [第四纪研究, Quaternary Sciences], V27, P546; Roberts HM, 2008, BOREAS, V37, P483, DOI 10.1111/j.1502-3885.2008.00057.x; Roberts HM, 2004, RADIAT MEAS, V38, P241, DOI 10.1016/j.radmeas.2003.10.001; Ruddiman WF, 2001, EARTHS CLIMATE FUTUR; RUTTER N, 1991, QUATERNARY SCI REV, V10, P1, DOI 10.1016/0277-3791(91)90028-S; Song Y, 2014, QUATERN INT, V334, P119, DOI 10.1016/j.quaint.2013.12.010; Stevens T, 2008, GEOLOGY, V36, P415, DOI 10.1130/G24524A.1; Stevens T, 2007, EARTH-SCI REV, V80, P111, DOI 10.1016/j.earscirev.2006.09.001; Stevens T, 2006, GEOLOGY, V34, P849, DOI 10.1130/G22472.1; Timar A, 2010, QUAT GEOCHRONOL, V5, P143, DOI 10.1016/j.quageo.2009.03.003; Vriend M, 2011, QUATERN INT, V240, P167, DOI 10.1016/j.quaint.2010.11.009; Walker M, 2009, J QUATERNARY SCI, V24, P3, DOI 10.1002/jqs.1227; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wen RL, 2010, QUATERNARY RES, V73, P293, DOI 10.1016/j.yqres.2009.10.006; Wu NQ, 2002, BOREAS, V31, P20, DOI 10.1080/03009480210648; Xiao JL, 2004, QUATERNARY SCI REV, V23, P1669, DOI 10.1016/j.quascirev.2004.01.005; Xiao J, 2008, J PALEOLIMNOL, V40, P519, DOI 10.1007/s10933-007-9179-x; Xiao JL, 2006, HOLOCENE, V16, P551, DOI 10.1191/0959683606hl950rp; Yang SL, 2008, EARTH PLANET SC LETT, V274, P499, DOI 10.1016/j.epsl.2008.08.001; Zhai DY, 2011, QUATERNARY RES, V75, P512, DOI 10.1016/j.yqres.2011.02.008; Zhang J., 1992, CLIMATE CHINA; Zhang YZ, 2015, BOREAS, V44, P127, DOI 10.1111/bor.12095; Zhao H, 2007, HOLOCENE, V17, P1015, DOI 10.1177/0959683607080530; ZHOU LP, 1990, NATURE, V346, P737, DOI 10.1038/346737a0; Zhou WJ, 2007, RADIOCARBON, V49, P865, DOI 10.1017/S0033822200042739	81	14	16	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133541	10.1371/journal.pone.0133541	http://dx.doi.org/10.1371/journal.pone.0133541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186443	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700156
J	Stokes, J; Panagioti, M; Alam, R; Checkland, K; Cheraghi-Sohi, S; Bower, P				Stokes, Jonathan; Panagioti, Maria; Alam, Rahul; Checkland, Kath; Cheraghi-Sohi, Sudeh; Bower, Peter			Effectiveness of Case Management for 'At Risk' Patients in Primary Care: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							OUTPATIENT GERIATRIC EVALUATION; RANDOMIZED CONTROLLED-TRIAL; OBSTRUCTIVE PULMONARY-DISEASE; MULTIDISCIPLINARY TEAM CARE; NURSE CASE-MANAGEMENT; FRAIL ELDERLY-PEOPLE; GUIDED CARE; HEALTH-CARE; OLDER-PEOPLE; COMPLEX-PATIENTS	Background An ageing population with multimorbidity is putting pressure on health systems. A popular method of managing this pressure is identification of patients in primary care 'at-risk' of hospitalisation, and delivering case management to improve outcomes and avoid admissions. However, the effectiveness of this model has not been subjected to rigorous quantitative synthesis. Methods and Findings We carried out a systematic review and meta-analysis of the effectiveness of case management for 'at-risk' patients in primary care. Six bibliographic databases were searched using terms for 'case management', 'primary care', and a methodology filter (Cochrane EPOC group). Effectiveness compared to usual care was measured across a number of relevant outcomes: Health - self-assessed health status, mortality; Cost - total cost of care, healthcare utilisation (primary and non-specialist care and secondary care separately), and; Satisfaction - patient satisfaction. We conducted secondary subgroup analyses to assess whether effectiveness was moderated by the particular model of case management, context, and study design. A total of 15,327 titles and abstracts were screened, 36 unique studies were included. Meta-analyses showed no significant differences in total cost, mortality, utilisation of primary or secondary care. A very small significant effect favouring case management was found for self-reported health status in the short-term (0.07, 95% CI 0.00 to 0.14). A small significant effect favouring case management was found for patient satisfaction in the short- (0.26, 0.16 to 0.36) and long-term (0.35, 0.04 to 0.66). Secondary subgroup analyses suggested the effectiveness of case management may be increased when delivered by a multidisciplinary team, when a social worker was involved, and when delivered in a setting rated as low in initial 'strength' of primary care. Conclusions This was the first meta-analytic review which examined the effects of case management on a wide range of outcomes and considered also the effects of key moderators. Current results do not support case management as an effective model, especially concerning reduction of secondary care use or total costs. We consider reasons for lack of effect and highlight key research questions for the future.	[Stokes, Jonathan; Alam, Rahul; Cheraghi-Sohi, Sudeh; Bower, Peter] Univ Manchester, Manchester Acad Hlth Sci Ctr, NIHR Greater Manchester Primary Care Patient Safe, Manchester, Lancs, England; [Panagioti, Maria; Checkland, Kath] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Primary Care, NIHR Sch Primary Care Res, Manchester, Lancs, England	University of Manchester; University of Manchester	Stokes, J (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, NIHR Greater Manchester Primary Care Patient Safe, Manchester, Lancs, England.	jonathan.stokes-3@postgrad.manchester.ac.uk	Stokes, Jonathan/GYR-0813-2022; Bower, Peter/A-1508-2011; Checkland, Kath/G-8442-2014	Bower, Peter/0000-0001-9558-3349; Checkland, Kath/0000-0002-9961-5317; Panagioti, Maria/0000-0002-7153-5745; Stokes, Jonathan/0000-0002-3266-1474	National Institute for Health Research Greater Manchester Primary Care Patient Safety Translational Research Centre (NIHR GM PSTRC)	National Institute for Health Research Greater Manchester Primary Care Patient Safety Translational Research Centre (NIHR GM PSTRC)	This work was funded by the National Institute for Health Research Greater Manchester Primary Care Patient Safety Translational Research Centre (NIHR GM PSTRC). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderwick H., 2014, POPULATION HLTH SYST; Alkema GE, 2007, HEALTH SERV RES, V42, P1632, DOI 10.1111/j.1475-6773.2006.00668.x; Altman DG, 1996, BRIT MED J, V313, P1200, DOI 10.1136/bmj.313.7066.1200; Anglemyer A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000034.pub2; [Anonymous], 2013, CLOS NHS FUND GAP GE; Atun R, 2013, LANCET, V382, P65, DOI 10.1016/S0140-6736(13)61051-X; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bate P., 2014, PERSPECTIVES CONTEXT; Beland F, 2006, J GERONTOL A-BIOL, V61, P367, DOI 10.1093/gerona/61.4.367; Beland F, 2006, CAN J AGING, V25, P25, DOI 10.1353/cja.2006.0019; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bernabei R, 1998, BMJ-BRIT MED J, V316, P1348, DOI 10.1136/bmj.316.7141.1348; Bird S, 2010, AUST J PRIM HEALTH, V16, P326, DOI 10.1071/PY10007; BMA, 2014, GEN PRACT CONTR CHAN; Borrill CS, 2000, EFFECTIVENESS HLTH C; Boult C, 2001, J AM GERIATR SOC, V49, P351, DOI 10.1046/j.1532-5415.2001.49076.x; Boult C, 2008, J GERONTOL A-BIOL, V63, P321, DOI 10.1093/gerona/63.3.321; Boult C, 2013, J GEN INTERN MED, V28, P612, DOI 10.1007/s11606-012-2287-y; Boult C, 2011, ARCH INTERN MED, V171, P460, DOI 10.1001/archinternmed.2010.540; Boyd CM, 2008, J GEN INTERN MED, V23, P536, DOI 10.1007/s11606-008-0529-9; Boyd CM, 2010, J GEN INTERN MED, V25, P235, DOI 10.1007/s11606-009-1192-5; Boyd M L, 1996, Nurs Manage, V27, P31; BURNS R, 1995, ARCH INTERN MED, V155, P1313; Burns R, 2000, J AM GERIATR SOC, V48, P8, DOI 10.1111/j.1532-5415.2000.tb03021.x; Case Management Society of America, 2007, DEF CAS MAN 2007; Challis D, 2010, SELF CARE CASE MANAG; Coburn KD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001265; Cochrane Collaboration, 2012, LMIC FILT NORW SAT C; Cohen J.E., 1988, STAT POWER ANAL BEHA; Counsell SR, 2007, JAMA-J AM MED ASSOC, V298, P2623, DOI 10.1001/jama.298.22.2623; Counsell SR, 2009, J AM GERIATR SOC, V57, P1420, DOI 10.1111/j.1532-5415.2009.02383.x; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Dalby DM, 2000, CAN MED ASSOC J, V162, P497; de Stampa M, 2014, ARCH GERONTOL GERIAT, V58, P350, DOI 10.1016/j.archger.2014.01.005; Department of Health Social Services and Public Safety, 2005, CAS MAN POS PAP; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dorr DA, 2008, J AM GERIATR SOC, V56, P2195, DOI 10.1111/j.1532-5415.2008.02005.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eklund K, 2009, HEALTH SOC CARE COMM, V17, P447, DOI 10.1111/j.1365-2524.2009.00844.x; Engelhardt JB, 2006, RES SOCIAL WORK PRAC, V16, P20, DOI 10.1177/1049731505276047; Engelhardt JB, 1996, J AM GERIATR SOC, V44, P847, DOI 10.1111/j.1532-5415.1996.tb03747.x; Enguidanos Susan M, 2006, Home Health Care Serv Q, V25, P13, DOI 10.1300/J027v25n01_02; EPOC. EPOC, 2014, SUGG RISK BIAS CRIT, P2; Fan VS, 2012, ANN INTERN MED, V156, P673, DOI 10.7326/0003-4819-156-10-201205150-00003; Ferguson JA, 1998, J GEN INTERN MED, V13, P123, DOI 10.1046/j.1525-1497.1998.00029.x; FITZGERALD JF, 1994, ARCH INTERN MED, V154, P1721, DOI 10.1001/archinte.154.15.1721; Fordyce M, 1997, J Am Board Fam Pract, V10, P398; Fried TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112593; Fry J, 1994, PRIMARY HLTH CARE IN; Gagnon AJ, 1999, J AM GERIATR SOC, V47, P1118; Gebreselassie SG, 2011, J HEALTH POPUL NUTR, V29, P134; Gelman A, 2012, J RES EDUC EFF, V5, P189, DOI 10.1080/19345747.2011.618213; Georghiou T, 2011, PREDICTIVE RISK HLTH; Goodwin N., 2013, COORDINATED CARE PEO; Gr?ne O., 2001, INT J INTEGR CARE, V1, pe21, DOI DOI 10.5334/IJIC.28; Grant CC, 1997, NEW ZEAL MED J, V110, P35; Gravelle H, 2007, BMJ-BRIT MED J, V334, P31, DOI 10.1136/bmj.39020.413310.55; Gray D, 2010, CAN FAM PHYSICIAN, V56, pE20; Ham C, 2013, MAKING INTEGRATED CA; Harbord RM, 2009, STATA J, V9, P197, DOI 10.1177/1536867X0900900202; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Hickam DH, 2013, OUTPATIENT CASE MANA; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hogg W, 2009, CAN FAM PHYSICIAN, V55, pE76; HOLM S, 1979, SCAND J STAT, V6, P65; Huntley AL, 2013, FAM PRACT, V30, P266, DOI 10.1093/fampra/cms081; Hutt R, 2004, CASE MANAGING LONG T; Islam MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083783; Kodner Dennis L, 2002, Int J Integr Care, V2, pe12; Kontopantelis E, 2009, J STAT SOFTWARE, V30; Kruse RL, 2010, JCOM, V17, P209; Latour CHM, 2007, J PSYCHOSOM RES, V62, P385, DOI 10.1016/j.jpsychores.2006.10.015; Leff B, 2009, AM J MANAG CARE, V15, P555; Leung ACT, 2004, J APPL GERONTOL, V23, P70, DOI 10.1177/0733464804263088; Levine S, 2012, AM J MANAG CARE, V18, pE269; Lewis G, 2011, CHOOSING PREDICTIVE; Lipsey MW, 2001, PRACTICAL META ANAL, DOI DOI 10.1016/J.AUTNEU.2007.06.087; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Maciejewski ML, 2014, MED CARE, V52, pS23, DOI 10.1097/MLR.0000000000000060; Macinko J, 2003, HEALTH SERV RES, V38, P831, DOI 10.1111/1475-6773.00149; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Marshall M, 2004, OECD HLTH TECHNICAL, V1; Martin I R, 2004, Chron Respir Dis, V1, P191, DOI 10.1191/1479972304cd047oa; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; Metzelthin SF, 2013, EFFECTIVENESS INTERD; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morishita L, 1998, GERONTOLOGIST, V38, P303, DOI 10.1093/geront/38.3.303; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Newcomer R, 2004, EVAL HEALTH PROF, V27, P323, DOI 10.1177/0163278704270011; Nolte E, 2008, CARING FOR PEOPLE WI; Oeseburg B, 2009, NURS RES, V58, P201, DOI 10.1097/NNR.0b013e3181a30941; Ovid SP, 2014, EXPERT SEARCHES PRIM; Panagioti M, 2015, PLOS ONE UNPUB; Ploeg J, 2010, EFFECT PREVENTIVE PR; Powers BW, 2015, JAMA-J AM MED ASSOC, V313, P795, DOI 10.1001/jama.2014.18171; Rodenas F, 2008, EUR J AGEING, V5, P57, DOI 10.1007/s10433-008-0073-9; Roland M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6017; Ross S., 2011, CASE MANAGEMENT WHAT; Rubenstein LZ, 2007, J AM GERIATR SOC, V55, P166, DOI 10.1111/j.1532-5415.2007.01044.x; Sandars J, 2003, FAM PRACT, V20, P231, DOI 10.1093/fampra/cmg301; Schraeder C, 2001, J GERONTOL A-BIOL, V56, pM106, DOI 10.1093/gerona/56.2.M106; Schraeder C, 2008, J CLIN NURS, V17, P407, DOI 10.1111/j.1365-2702.2008.02578.x; Shannon GR, 2006, J AM GERIATR SOC, V54, P1102, DOI 10.1111/j.1532-5415.2006.00799.x; Shi L, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/432892; Sledge William H, 2006, Dis Manag, V9, P328, DOI 10.1089/dis.2006.9.328; Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205; Starfield B, 2002, HEALTH POLICY, V60, P201, DOI 10.1016/S0168-8510(01)00208-1; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; StataCorp, 2013, STATA STAT SOFTW REL; Sterne JAC, 2004, STATA J, V4, P127, DOI 10.1177/1536867X0400400204; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stuck AE, 2000, ARCH INTERN MED, V160, P977, DOI 10.1001/archinte.160.7.977; Sylvia ML, 2008, DIS MANAGE, V11, P29, DOI 10.1089/dis.2008.111723; Toseland RW, 1997, GERONTOLOGIST, V37, P324, DOI 10.1093/geront/37.3.324; Toseland RW, 1996, MED CARE, V34, P624, DOI 10.1097/00005650-199606000-00011; Valentijn Pim P, 2013, Int J Integr Care, V13, pe010; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van Hout HPJ, 2010, J GERONTOL A-BIOL, V65, P734, DOI 10.1093/gerona/glq037; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569; You EC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-395	122	97	101	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132340	10.1371/journal.pone.0132340	http://dx.doi.org/10.1371/journal.pone.0132340			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186598	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700038
J	Wilson, D; Goggin, K; Williams, K; Gerkovich, MM; Gqaleni, N; Syce, J; Bartman, P; Johnson, Q; Folk, WR				Wilson, Douglas; Goggin, Kathy; Williams, Karen; Gerkovich, Mary M.; Gqaleni, Nceba; Syce, James; Bartman, Patricia; Johnson, Quinton; Folk, William R.			Consumption of Sutherlandia frutescens by HIV-Seropositive South African Adults: An Adaptive Double-Blind Randomized Placebo Controlled Trial	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ALTERNATIVE MEDICINE; HERBAL MEDICINES; COMPLEMENTARY; OUTCOMES; DURBAN	Background Sutherlandia frutescens (L.) R. Br. is widely used as an over the counter complementary medicine and in traditional medications by HIV seropositive adults living in South Africa; however the plant's safety has not been objectively studied. An adaptive two-stage randomized double-blind placebo controlled study was used to evaluate the safety of consuming dried S. frutescens by HIV seropositive adults with CD4 T-lymphocyte count of >350 cells/mu L. Methods In Stage 1 56 participants were randomized to S. frutescens 400, 800 or 1,200 mg twice daily or matching placebo for 24 weeks. In Stage 2 77 additional participants were randomized to either 1,200 mg S. frutescens or placebo. In the final analysis data from Stage 1 and Stage 2 were combined such that 107 participants were analysed (54 in the S. frutescens 1,200 mg arm and 53 in the placebo arm). Results S. frutescens did not change HIV viral load, and CD4 T-lymphocyte count was similar in the two arms at 24 weeks; however, mean and total burden of infection (BOI; defined as days of infection-related events in each participant) was greater in the S. frutescens arm: mean (SD) 5.0 (5.5) vs. 9.0 (12.7) days (p = 0.045), attributed to two tuberculosis cases in subjects taking isoniazid preventive therapy (IPT). Conclusion A possible interaction between S. frutescens and IPT needs further evaluation, and may presage antagonistic interactions with other herbs having similar biochemical (antioxidant) properties. No other safety issues relating to consumption of S. frutescens in this cohort were identified.	[Wilson, Douglas] Univ KwaZulu Natal, Edendale Hosp, Dept Internal Med, Durban, South Africa; [Goggin, Kathy] Univ Missouri, Childrens Mercy Hosp & Clin, Hlth Serv & Outcomes Res, Kansas City, MO 64110 USA; [Goggin, Kathy] Univ Missouri, Sch Med, Kansas City, MO 64110 USA; [Goggin, Kathy] Univ Missouri, Sch Pharm, Kansas City, MO 64110 USA; [Williams, Karen; Gerkovich, Mary M.] Univ Missouri, Sch Med, Biomed & Hlth Informat, Kansas City, MO 64110 USA; [Gqaleni, Nceba] Durban Univ Technol, AIK Innovat Pty Ltd, Durban, South Africa; [Syce, James] Univ Western Cape, Sch Pharm, Cape Town, South Africa; [Bartman, Patricia] Edendale Hosp, Dept Internal Med Res Unit, Pietermaritzburg, South Africa; [Johnson, Quinton] Nelson Mandela Metropolitan Univ, George, South Africa; [Folk, William R.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Kwazulu Natal; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Durban University of Technology; University of the Western Cape; Nelson Mandela University; University of Missouri System; University of Missouri Columbia	Folk, WR (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	FolkW@missouri.edu	Gqaleni, Nceba/A-3609-2014	Gqaleni, Nceba/0000-0003-1946-3120; Folk, William/0000-0003-2216-3233	National Center for Complementary and Alternative Medicines [U19 AT003264]; Fogarty International Center, National Institutes of Health; AIK Innovations (Pty) Ltd; Office of Dietary Supplements; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [U19AT003264] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicines; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); AIK Innovations (Pty) Ltd; Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	The study funded by Grant U19 AT003264 (PI Folk) from the National Center for Complementary and Alternative Medicines, the Office of Dietary Supplements and the Fogarty International Center, National Institutes of Health. (http://nccam.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AIK Innovations (Pty) Ltd provided support in the form of salaries for author NG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of NG are articulated in the 'author contributions' section.	Assembly of Heads of State and Government, 2001, 37 ORD SESS 5 ORD SE; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Brown Dan L., 2001, Journal of Nutritional Immunology, V5, P17; Department of Health Republic of South Africa, 2010 NAT ANT SENT HI; Department of Health Republic of South Africa, S AFR ANT TREATM GUI; Fernandes AC, 2004, J ETHNOPHARMACOL, V95, P1, DOI 10.1016/j.jep.2004.05.024; Goggin Kathy, 2010, Alternation (Durb), V17, P273; Jiang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089748; Johnson Quinton, 2007, PLoS Clin Trials, V2, pe16, DOI 10.1371/journal.pctr.0020016; Katerere DR, 2005, PHYTOTHER RES, V19, P779, DOI 10.1002/ptr.1719; Katz IT, 2011, AIDS, V25, P2177, DOI 10.1097/QAD.0b013e32834b6464; Leserman J, 2003, BIOL PSYCHIAT, V54, P295, DOI 10.1016/S0006-3223(03)00323-8; Littlewood RA, 2008, AIDS CARE, V20, P1002, DOI 10.1080/09540120701767216; MacKenzie J, 2009, PHYTOTHER RES, V23, P1609, DOI 10.1002/ptr.2830; Medicines Control Council Department of Health Republic of South Africa, 2013, COMPL MED QUAL SAF E; Mills E, 2005, AIDS, V19, P95, DOI 10.1097/00002030-200501030-00013; Mills E, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-19; Minocha M, 2011, INT J PHARMACEUT, V413, P44, DOI 10.1016/j.ijpharm.2011.04.051; National Center for Complementary and Alternative Medicine, 2013, NCCAM POL NAT PROD I; National Institutes of Health, DIV AIDS TABL GRAD S; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Peltzer K, 2009, LANCET, V374, P956, DOI 10.1016/S0140-6736(09)61261-7; Peltzer K, 2009, AFR J TRADIT COMPLEM, V6, P175; Peltzer K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-255; Prevoo D, 2008, J ETHNOPHARMACOL, V118, P118, DOI 10.1016/j.jep.2008.03.019; Seier JV, 2002, FINAL REPORT; SIMON R, 1985, CANCER TREAT REP, V69, P1375; South African National AIDS Council, NAT STRAT PLAN HIV A; Statistics South Africa, MID POP EST 2013; Steinberg SM, 2002, STAT MED, V21, P1711, DOI 10.1002/sim.1150; Timmins GS, 2006, MOL MICROBIOL, V62, P1220, DOI 10.1111/j.1365-2958.2006.05467.x; Tobwala S, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-271; van Wyk BE, 2008, J ETHNOPHARMACOL, V119, P620, DOI 10.1016/j.jep.2008.08.003; WHO, 2011, PROGR REP DEC TRAD M; Wu AW, 1997, QUAL LIFE RES, V6, P481, DOI 10.1023/A:1018451930750	36	16	16	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0128522	10.1371/journal.pone.0128522	http://dx.doi.org/10.1371/journal.pone.0128522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186450	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700004
J	Bendas, A; Rothe, U; Kiess, W; Kapellen, TM; Stange, T; Manuwald, U; Salzsieder, E; Holl, RW; Schoffer, O; Stahl-Pehe, A; Giani, G; Ehehalt, S; Neu, A; Rosenbauer, J				Bendas, Alexander; Rothe, Ulrike; Kiess, Wieland; Kapellen, Thomas Michael; Stange, Thoralf; Manuwald, Ulf; Salzsieder, Eckhard; Holl, Reinhard Walter; Schoffer, Olaf; Stahl-Pehe, Anna; Giani, Guido; Ehehalt, Stefan; Neu, Andreas; Rosenbauer, Joachim			Trends in Incidence Rates during 1999-2008 and Prevalence in 2008 of Childhood Type 1 Diabetes Mellitus in GERMANY - Model-Based National Estimates	PLOS ONE			English	Article							TIME TRENDS; CHILDREN; AGE; PATHOGENESIS; POPULATION; REGISTRY; OBESITY	Aims To estimate the national incidence rate and trend of type 1 diabetes (T1DM) in Germany from 1999 to 2008 and the national prevalence in 2008 in the age group 0-14 years. Methods Data were taken from a nationwide registry for incident cases of T1DM in the ages 0-4 years and 3 regional registries (North-Rhine-Westphalia, Baden-Wuerttemberg and Saxony) for incident cases of T1DM in the ages 0-14 years covering 41% of the child population in Germany. The degree of ascertainment was >= 97% in all registries. Incident and prevalent cases were grouped by region, sex, age (0-4, 5-9, 10-14 years), and, for incident data, additionally by two 5-year periods (1999-2003, 2004-2008). Poisson regression models were fitted to the data to derive national estimates of incidence rate trends and prevalence in the age groups 5-9, 10-14 and 0-14 years. We used direct age-standardization. Results The estimated national incidence rate in 0-14-year-olds increased significantly by 18.1% (95% CI: 11.6-25.0%, p<0.001) from 1999-2003 to 2004-2008, independent of sex, corresponding to an average annual increase of 3.4% (95%-CI: 2.2-4.6%). The overall incidence rate was estimated at 22.9 per 100,000 person-years and we identified a within-country west-east-gradient previously unknown. The national prevalence in the ages 0-14 years on 31/12/2008 was estimated to be 148.1 per 100,000 persons. Conclusions The national incidence rate of childhood T1DM in Germany is higher than in many other countries around the world. Importantly, the estimated trend of the incidence rate confirms the international data of a global increase of T1DM incidences.	[Bendas, Alexander] Univ Hosp, Dept Otorhinolaryngol, Dresden, Germany; [Rothe, Ulrike; Manuwald, Ulf] Tech Univ Dresden, Fac Med Carl Gustav Carus, Hlth Sci Publ Hlth, Dresden, Germany; [Kiess, Wieland; Kapellen, Thomas Michael] Univ Leipzig, Hosp Children & Adolescents, Ctr Pediat Res, Dept Women & Child Hlth, D-04109 Leipzig, Germany; [Stange, Thoralf] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Med Informat & Biometry, Dresden, Germany; [Salzsieder, Eckhard] Inst Diabet Gerhardt Katsch Karlsburg, Karlsburg, Germany; [Holl, Reinhard Walter] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Schoffer, Olaf] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dept Tumorepidemiol, Dresden, Germany; [Stahl-Pehe, Anna; Giani, Guido; Rosenbauer, Joachim] Univ Dusseldorf, Leibniz Inst Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Ehehalt, Stefan] Publ Hlth Dept Stuttgart, Dept Pediat, Stuttgart, Germany; [Ehehalt, Stefan] Publ Hlth Dept Stuttgart, Dept Dent Hlth Care, Stuttgart, Germany; [Ehehalt, Stefan] Publ Hlth Dept Stuttgart, Dept Hlth Promot & Social Serv, Stuttgart, Germany; [Neu, Andreas] Univ Childrens Hosp Tubingen, Tubingen, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Leipzig University; Technische Universitat Dresden; Ulm University; Technische Universitat Dresden; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL	Rothe, U (corresponding author), Tech Univ Dresden, Fac Med Carl Gustav Carus, Hlth Sci Publ Hlth, Dresden, Germany.	ulrike.rothe@tu-dresden.de	Schoffer, Olaf/R-1841-2016	Schoffer, Olaf/0000-0001-6922-7148; Holl, Reinhard/0000-0003-1395-4842; Stahl-Pehe, Anna/0000-0002-5281-6023; Prof. Rothe, Ulrike/0000-0001-9779-7260	German Diabetes Association (DDG); Open Access Publication Funds of the TU Dresden	German Diabetes Association (DDG); Open Access Publication Funds of the TU Dresden	This work was supported by the German Diabetes Association (DDG) in 2010 and the Open Access Publication Funds of the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berhan Y, 2011, DIABETES, V60, P577, DOI 10.2337/db10-0813; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bluher S, 2011, INT J PEDIATR OBES, V6, pE199, DOI 10.3109/17477166.2010.526305; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Breslow NE, 1980, STATISTICAL METHODS, V32, P49; Bruno G, 2010, DIABETES, V59, P2281, DOI 10.2337/db10-0151; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Dahlquist G, 2006, DIABETOLOGIA, V49, P20, DOI 10.1007/s00125-005-0076-4; Ehehalt S, 2012, PEDIATR DIABETES, V13, P15, DOI 10.1111/j.1399-5448.2011.00799.x; Ehehalt S, 2010, DIABETES CARE, V33, P338, DOI 10.2337/dc09-1503; Ehehalt S, 2009, EUR J PEDIATR, V168, P613, DOI 10.1007/s00431-008-0808-9; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Galler A, 2010, HORM RES PAEDIAT, V74, P285, DOI 10.1159/000303141; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; Heinzl H, 2003, COMPUT STAT DATA AN, V44, P253, DOI 10.1016/S0167-9473(03)00062-8; International Diabbetes Federation, 2013, DIABETES ATLAS; Junghans C, 2013, EPIDEMIOLGIE DIABETE; Knip M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007690; McCullagh P, 1989, MONOGRAPHS STAT APPL, V37, P1, DOI DOI 10.1007/978-1-4899-3242-6; MICHAELIS D, 1993, DIABETES METAB, V19, P110; Moss A, 2012, EUR J PEDIATR, V171, P289, DOI 10.1007/s00431-011-1531-5; Patterson CC, 2007, DIABETOLOGIA, V50, P2439, DOI 10.1007/s00125-007-0824-8; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Rosenbauer J, 1999, DIABETOLOGIA, V42, P1055, DOI 10.1007/s001250051270; Rosenbauer J, 2002, J PEDIATR ENDOCR MET, V15, P1497; Rosenbauer J, 2002, DIABETOLOGIA, V45, P457; Rosenbauer J, 2012, DIABETES CARE, V35, P80, DOI 10.2337/dc11-0993; Solresz G, 2009, IDF DIABETES ATLAS, P1	29	59	62	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132716	10.1371/journal.pone.0132716	http://dx.doi.org/10.1371/journal.pone.0132716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181330	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198200027
J	Hui, BB; Ryder, N; Su, JY; Ward, J; Chen, MY; Donovan, B; Fairley, CK; Guy, RJ; Lahra, MM; Law, MG; Whiley, DM; Regan, DG				Hui, Ben B.; Ryder, Nathan; Su, Jiunn-Yih; Ward, James; Chen, Marcus Y.; Donovan, Basil; Fairley, Christopher K.; Guy, Rebecca J.; Lahra, Monica M.; Law, Mathew G.; Whiley, David M.; Regan, David G.			Exploring the Benefits of Molecular Testing for Gonorrhoea Antibiotic Resistance Surveillance in Remote Settings	PLOS ONE			English	Article							NEISSERIA-GONORRHOEAE; ANTIMICROBIAL RESISTANCE; PHARYNGEAL GONORRHEA; ACQUIRING GONORRHEA; 500 MG; AUSTRALIA; INFECTION; CEFTRIAXONE; PREVALENCE; RISK	Background Surveillance for gonorrhoea antimicrobial resistance (AMR) is compromised by a move away from culture-based testing in favour of more convenient nucleic acid amplification test (NAAT) tests. We assessed the potential benefit of a molecular resistance test in terms of the timeliness of detection of gonorrhoea AMR. Methods and Findings An individual-based mathematical model was developed to describe the transmission of gonorrhoea in a remote Indigenous population in Australia. We estimated the impact of the molecular test on the time delay between first importation and the first confirmation that the prevalence of gonorrhoea AMR (resistance proportion) has breached the WHO-recommended 5% threshold (when a change in antibiotic should occur). In the remote setting evaluated in this study, the model predicts that when culture is the only available means of testing for AMR, the breach will only be detected when the actual prevalence of AMR in the population has already reached 8 - 18%, with an associated delay of similar to 43 - 69 months between first importation and detection. With the addition of a molecular resistance test, the number of samples for which AMR can be determined increases facilitating earlier detection at a lower resistance proportion. For the best case scenario, where AMR can be determined for all diagnostic samples, the alert would be triggered at least 8 months earlier than using culture alone and the resistance proportion will have only slightly exceeded the 5% notification threshold. Conclusions Molecular tests have the potential to provide more timely warning of the emergence of gonorrhoea AMR. This in turn will facilitate earlier treatment switching and more targeted treatment, which has the potential to reduce the population impact of gonorrhoea AMR.	[Hui, Ben B.; Donovan, Basil; Guy, Rebecca J.; Law, Mathew G.; Regan, David G.] UNSW Australia, Kirby Inst, Sydney, NSW, Australia; [Ryder, Nathan; Su, Jiunn-Yih] Ctr Dis Control, Dept Hlth, Sexual Hlth & Blood Borne Virus Unit, Darwin, NT, Australia; [Ward, James] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Chen, Marcus Y.; Fairley, Christopher K.] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Chen, Marcus Y.; Fairley, Christopher K.] Alfred Hlth, Melbourne Sexual Hlth Ctr, Carlton, Vic, Australia; [Chen, Marcus Y.; Fairley, Christopher K.] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Donovan, Basil] Sydney Hosp, Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [Lahra, Monica M.] Prince Wales Hosp, WHO Collaborating Ctr STD, Dept Microbiol, South Eastern Area Lab Serv, Sydney, NSW, Australia; [Whiley, David M.] Queensland Childrens Hlth Serv, Queensland Paediat Infect Dis Lab, Brisbane, Qld, Australia; [Whiley, David M.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld 4072, Australia	University of New South Wales Sydney; Kirby Institute; South Australian Health & Medical Research Institute (SAHMRI); Monash University; University of Melbourne; University of Queensland	Hui, BB (corresponding author), UNSW Australia, Kirby Inst, Sydney, NSW, Australia.	bhui@kirby.unsw.edu.au	Shoushtari, Masoud/AAQ-7317-2020; Whiley, David M/E-8955-2011; Donovan, Basil J/K-1246-2012; Lahra, Monica/AAQ-6548-2020; Ward, James/ABD-1439-2020	Whiley, David M/0000-0001-5969-3161; Donovan, Basil J/0000-0001-8851-4126; Ward, James/0000-0002-2892-4542; Hui, Ben/0000-0002-6567-5821; Regan, David/0000-0002-2893-0969; Law, Matthew/0000-0002-3540-8837; Christopher, Fairley/0000-0001-9081-1664; Guy, Rebecca/0000-0002-2929-4634	National Health and Medical Research Council [APP1025517]; Australian Government Department of Health and Ageing	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	This work was supported by National Health and Medical Research Council Project Grants (APP1025517). The Kirby Institute is funded by the Australian Government Department of Health and Ageing and is affiliated with the Faculty of Medicine, University of New South Wales. The views expressed in this publication do not necessarily represent the position of the Australian Government.	[Australian Bureau of Statistics Australian Bureau of Statistics], 2011, EST AB TORR STRAIT I; Australian Bureau of Statistics, 2009, EXP EST PROJ AB TORR; Australian Government Department of Health, AUSTR GON SURV PROGR; Biddle N, 2009, J POPUL RES, V26, P305, DOI 10.1007/s12546-010-9026-1; BRUNHAM RC, 1991, P ROY SOC B-BIOL SCI, V246, P173, DOI 10.1098/rspb.1991.0141; Bryant J, 2011, SEX HEALTH, V8, P378, DOI 10.1071/SH10138; Chan CH, 2012, SEX TRANSM INFECT, V88, P200, DOI 10.1136/sextrans-2011-050049; Fagan PS, 2014, COMMUNICABLE DIS INT, V37; Garnett GP, 1999, PHILOS T R SOC B, V354, P787, DOI 10.1098/rstb.1999.0431; Goire N, 2014, NAT REV MICROBIOL, V12, P223, DOI 10.1038/nrmicro3217; Goire N, 2011, J CLIN MICROBIOL, V49, P513, DOI 10.1128/JCM.02024-10; Guy R, 2011, AUSTR SEX HLTH C 26, P139; Guy R, 2012, SEX HEALTH, V9, P205, DOI 10.1071/SH11074; HOLMES KK, 1970, AM J EPIDEMIOL, V91, P170, DOI 10.1093/oxfordjournals.aje.a121125; Hui BB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-188; Johnson LF, 2010, SEX TRANSM INFECT, V86, P169, DOI 10.1136/sti.2009.037341; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lahra MM, 2013, COMMUN DIS INTELL, V37, pE233; Lahra MM, 2013, SEX TRANSM INFECT, V89, P19, DOI 10.1136/sextrans-2012-050906; Lynn F, 2005, J CLIN MICROBIOL, V43, P368, DOI 10.1128/JCM.43.1.368-375.2005; McDonagh P, 2009, SEX HEALTH, V6, P241, DOI 10.1071/SH09025; Northern Territory Department of Health, 2013, SEX HLTH BLOOD BORN; Pinksky P, 1990, MATH BIOSCI, V98, P103; PLATT R, 1983, JAMA-J AM MED ASSOC, V250, P3205, DOI 10.1001/jama.250.23.3205; POTTERAT JJ, 1987, SEX TRANSM DIS, V14, P107, DOI 10.1097/00007435-198704000-00010; Read PJ, 2013, SEX HEALTH, V10, P460, DOI 10.1071/SH13077; Rissel CE, 2003, AUST NZ J PUBL HEAL, V27, P124, DOI 10.1111/j.1467-842X.2003.tb00799.x; Senior K, 2014, CULT HEALTH SEX, V16, P453, DOI 10.1080/13691058.2014.888096; Speers DJ, 2014, J ANTIMICROB CHEMOTH, V69, P1243, DOI 10.1093/jac/dkt501; Spicknall IH, 2013, AM J EPIDEMIOL, V178, P508, DOI 10.1093/aje/kwt017; Su J-Y, 2009, NO TERRITORY DIS CON, P11; Tabrizi S, 2012, 13 IUSTI WORLD C MEL, P72; Tapsall JW, 2008, J ANTIMICROB CHEMOTH, V61, P150, DOI 10.1093/jac/dkm434; Tapsall J, 2009, J MED MICROBIOL, V58, P683, DOI 10.1099/jmm.0.007641-0; The Kirby Institute, 2013, BLOODB VIR SEX TRANS; Thompson SC, 2008, AUSTR NZ HLTH POLICY, V5; Trembizki E, 2014, J MED MICROBIOL, V63, P45, DOI 10.1099/jmm.0.065094-0; World Health Organization, 2012, GLOB ACT PLAN CONTR; Chen M, 2013, J ANTIMICROB CHEMOTH, V68, P1445, DOI 10.1093/jac/dkt017	40	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133202	10.1371/journal.pone.0133202	http://dx.doi.org/10.1371/journal.pone.0133202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181042	Green Published, gold			2022-12-27	WOS:000358198200056
J	Lareau-Trudel, E; Le Troter, A; Ghattas, B; Pouget, J; Attarian, S; Bendahan, D; Salort-Campana, E				Lareau-Trudel, Emilie; Le Troter, Arnaud; Ghattas, Badih; Pouget, Jean; Attarian, Shahram; Bendahan, David; Salort-Campana, Emmanuelle			Muscle Quantitative MR Imaging and Clustering Analysis in Patients with Facioscapulohumeral Muscular Dystrophy Type 1	PLOS ONE			English	Article							ADIPOSE-TISSUE; SKELETAL-MUSCLE; MOLECULAR DIAGNOSIS; DNA REARRANGEMENTS; FAT INFILTRATION; INVOLVEMENT; QUANTIFICATION; SEGMENTATION; SEPARATION; PHENOTYPE	Background Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is the third most common inherited muscular dystrophy. Considering the highly variable clinical expression and the slow disease progression, sensitive outcome measures would be of interest. Methods and Findings Using muscle MRI, we assessed muscular fatty infiltration in the lower limbs of 35 FSHD1 patients and 22 healthy volunteers by two methods: a quantitative imaging (qMRI) combined with a dedicated automated segmentation method performed on both thighs and a standard T1-weighted four-point visual scale (visual score) on thighs and legs. Each patient had a clinical evaluation including manual muscular testing, Clinical Severity Score (CSS) scale and MFM scale. The intramuscular fat fraction measured using qMRI in the thighs was significantly higher in patients (21.9 +/- 20.4%) than in volunteers (3.6 +/- 2.8%) (p<0.001). In patients, the intramuscular fat fraction was significantly correlated with the muscular fatty infiltration in the thighs evaluated by the mean visual score (p<0.001). However, we observed a ceiling effect of the visual score for patients with a severe fatty infiltration clearly indicating the larger accuracy of the qMRI approach. Mean intramuscular fat fraction was significantly correlated with CSS scale (p <= 0.01) and was inversely correlated with MMT score, MFM subscore D1 (p <= 0.01) further illustrating the sensitivity of the qMRI approach. Overall, a clustering analysis disclosed three different imaging patterns of muscle involvement for the thighs and the legs which could be related to different stages of the disease and put forth muscles which could be of interest for a subtle investigation of the disease progression and/ or the efficiency of any therapeutic strategy. Conclusion The qMRI provides a sensitive measurement of fat fraction which should also be of high interest to assess disease progression and any therapeutic strategy in FSHD1 patients.	[Lareau-Trudel, Emilie; Pouget, Jean; Attarian, Shahram; Salort-Campana, Emmanuelle] Univ Aix Marseille, CHU Timone, Ctr Reference Malad Neuromusculaires & SLA, Marseille, France; [Le Troter, Arnaud; Bendahan, David] Aix Marseille Univ, Ctr Resonance Magnet Biol & Med, UMR CNRS 7339, Marseille, France; [Ghattas, Badih] Aix Marseille Univ, Inst Math Marseille, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Salort-Campana, E (corresponding author), Univ Aix Marseille, CHU Timone, Ctr Reference Malad Neuromusculaires & SLA, Marseille, France.	emmanuelle.salort-campana@ap-hm.fr	Attarian, Shahram/AAE-6214-2021; Bendahan, David/AAU-1420-2020	le troter, arnaud/0000-0002-7897-9672				Alabousi A, 2011, J MAGN RESON IMAGING, V34, P474, DOI 10.1002/jmri.22603; Berard C, 2005, NEUROMUSCULAR DISORD, V15, P463, DOI 10.1016/j.nmd.2005.03.004; Fischmann A, 2013, J NEUROL, V260, P969, DOI 10.1007/s00415-012-6733-x; Friedman SD, 2014, MUSCLE NERVE, V49, P257, DOI 10.1002/mus.23911; Gloor M, 2011, J MAGN RESON IMAGING, V33, P203, DOI 10.1002/jmri.22431; Janssen BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085416; Kan HE, 2009, NEUROMUSCULAR DISORD, V19, P357, DOI 10.1016/j.nmd.2009.02.009; Karampinos DC, 2012, J MAGN RESON IMAGING, V35, P899, DOI 10.1002/jmri.23512; Kullberg J, 2010, J MAGN RESON IMAGING, V32, P204, DOI 10.1002/jmri.22193; LAMMINEN AE, 1990, BRIT J RADIOL, V63, P946, DOI 10.1259/0007-1285-63-756-946; Layec G, 2009, MAGN RESON MED, V62, P840, DOI 10.1002/mrm.22085; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJFL, 2004, AM J HUM GENET, V75, P1124, DOI 10.1086/426035; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Mattei JP, 2006, MAGN RESON MATER PHY, V19, P275, DOI 10.1007/s10334-006-0051-1; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Mercuri Eugenio, 2002, Eur J Paediatr Neurol, V6, P305; Mercuri E, 2011, NEUROMUSCULAR DISORD, V21, P16, DOI 10.1016/j.nmd.2010.09.003; Mostacciuolo ML, 2009, CLIN GENET, V75, P550, DOI 10.1111/j.1399-0004.2009.01158.x; Olsen DB, 2006, J NEUROL, V253, P1437, DOI 10.1007/s00415-006-0230-z; PADBERG GW, 1995, MUSCLE NERVE, pS81, DOI 10.1002/mus.880181315; PERSONIUS KE, 1994, PHYS THER, V74, P253, DOI 10.1093/ptj/74.3.253; Positano V, 2009, J MAGN RESON IMAGING, V29, P677, DOI 10.1002/jmri.21699; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Scionti I, 2012, AM J HUM GENET, V90, P628, DOI 10.1016/j.ajhg.2012.02.019; Sookhoo S, 2007, CLIN RADIOL, V62, P160, DOI 10.1016/j.crad.2006.08.012; Statland JM, 2013, NEUROMUSCULAR DISORD, V23, P306, DOI 10.1016/j.nmd.2013.01.008; Tasca G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100292; Tasca G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038779; Valentinitsch A, 2013, J MAGN RESON IMAGING, V37, P917, DOI 10.1002/jmri.23884; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Wang CH, 2012, NEUROMUSCULAR DISORD, V22, P331, DOI 10.1016/j.nmd.2011.10.018; WIJMENGA C, 1993, NEUROMUSCULAR DISORD, V3, P487, DOI 10.1016/0960-8966(93)90102-P; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Willis TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070993; Wokke BH, 2013, J MAGN RESON IMAGING, V38, P619, DOI 10.1002/jmri.23998	36	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132717	10.1371/journal.pone.0132717	http://dx.doi.org/10.1371/journal.pone.0132717			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181385	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198200028
J	Badawi, D; Saleh, S; Natafgi, N; Mourad, Y; Behbehani, K				Badawi, Dalia; Saleh, Shadi; Natafgi, Nabil; Mourad, Yara; Behbehani, Kazem			Quality of Type II Diabetes Care in Primary Health Care Centers in Kuwait: Employment of a Diabetes Quality Indicator Set (DQIS)	PLOS ONE			English	Article							GLYCEMIC CONTROL; OF-CARE; MANAGEMENT; IMPLEMENTATION; DECLARATION; IMPROVEMENT; COUNTRIES	Diabetes Mellitus is one of the major public health challenges, affecting more than 347 million adults worldwide. The impact of diabetes necessitates assessing the quality of care received by people with diabetes, especially in countries with a significant diabetes burden such as Kuwait. This paper aimed at piloting an approach for measuring Type II diabetes care performance through the use of a diabetes quality indicator set (DQIS) in primary health care. The DQIS for Kuwait was adapted from that developed by the National Diabetes Quality Improvement Alliance and the International Diabetes Federation. Five key care domains/measures were employed: (1) Blood glucose level measurement, (2) Cholesterol level measurement, (3) Blood pressure measurement, (4) Kidney function testing and (5) Smoking status check. The sample included the four major primary health care centers with the highest case load in Kuwait City, 4,241 patients in 2012 and 3,211 in 2010. Findings revealed the applicability and utility of employing performance indicators for diabetes care in Kuwait. Furthermore, findings revealed that many of the primary health care centers have achieved noteworthy improvement in diabetes care between 2010 and 2012, with the exception of smoking status check. The DQIS can help policymakers identify performance gaps and investigate key system roadblocks related to diabetes care in Kuwait.	[Badawi, Dalia; Behbehani, Kazem] Dasman Diabet Inst, Kuwait, Kuwait; [Saleh, Shadi; Mourad, Yara] Amer Univ Beirut, Dept Hlth Management & Policy, Fac Hlth Sci, Beirut, Lebanon; [Natafgi, Nabil] Univ Iowa, Coll Publ Hlth, Dept Hlth Management & Policy, Iowa City, IA USA	American University of Beirut; University of Iowa	Saleh, S (corresponding author), Amer Univ Beirut, Dept Hlth Management & Policy, Fac Hlth Sci, Beirut, Lebanon.	ss117@aub.edu.lb		Natafgi, Nabil/0000-0003-4979-0317				Agency for Healthcare Research and Quality (AHRQ), 2008, APP G IND DIAB QUAL; Akbar D H, 2001, East Mediterr Health J, V7, P671; Al-Adsani A, 2008, MED PRIN PRACT, V17, P14, DOI 10.1159/000109584; Al-Baho A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043895; Al-Sultan F., 2005, KUWAIT MED J, V37, P98; Alhyas L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022186; [Anonymous], 2015, DIAB FACT SHEET; Beaton SJ, 2004, DIABETES CARE, V27, P694, DOI 10.2337/diacare.27.3.694; Cagliero E, 1999, DIABETES CARE, V22, P1785, DOI 10.2337/diacare.22.11.1785; Campbell SM, 2003, BRIT MED J, V326, P816, DOI 10.1136/bmj.326.7393.816; Diabetes UK, 2012, STAT NAT 2012 ENGL; Eledrisi M, 2007, DIABETES RES CLIN PR, V78, P145, DOI 10.1016/j.diabres.2007.02.017; Ezenwaka CE, 2001, CLIN EXP MED, V1, P91, DOI 10.1007/s10238-001-8018-z; Fleming BB, 2001, DIABETES CARE, V24, P1815, DOI 10.2337/diacare.24.10.1815; Giuffrida A, 1999, BRIT MED J, V319, P94, DOI 10.1136/bmj.319.7202.94; Gudbjornsdottir S, 2003, DIABETES CARE, V26, P1270, DOI 10.2337/diacare.26.4.1270; International Diabetes Federation, 2013, IDF DIAB ATL; International Diabetes Federation (IDF), 2012, GLOB GUID TYP 2 DIAB; IOM, 2000, ERR IS HUMAN BUILDIN; Khattab M, 2010, J DIABETES COMPLICAT, V24, P84, DOI 10.1016/j.jdiacomp.2008.12.008; Mainz J, 2003, INT J QUAL HEALTH C, V15, pI5, DOI 10.1093/intqhc/mzg084; National Committee for Quality Assurance, 2010, STAT HLTH CAR QUAL; National Institutes of Health (NIH) National Heart Lung and Blood Institute (NHLBI), 2011, COR HEART DIS RISK F; O'Connor PJ, 2011, DIABETES CARE, V34, P1651, DOI 10.2337/dc11-0735; PIWERNETZ K, 1993, DIABETIC MED, V10, P371, DOI 10.1111/j.1464-5491.1993.tb00083.x; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Schoen C, 2009, HEALTH AFFAIR, V28, pW1171, DOI 10.1377/hlthaff.28.6.w1171; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Si DM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-169; Toh MPHS, 2007, ANN ACAD MED SINGAP, V36, P980; World Heart Federation, 2013, DIABETES	32	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132883	10.1371/journal.pone.0132883	http://dx.doi.org/10.1371/journal.pone.0132883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176691	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600173
J	Czarniecka, A; Kowal, M; Rusinek, D; Krajewska, J; Jarzab, M; Stobiecka, E; Chmielik, E; Zembala-Nozynska, E; Poltorak, S; Sacher, A; Maciejewski, A; Zebracka-Gala, J; Lange, D; Oczko-Wojciechowska, M; Handkiewicz-Junak, D; Jarzab, B				Czarniecka, Agnieszka; Kowal, Monika; Rusinek, Dagmara; Krajewska, Jolanta; Jarzab, Michal; Stobiecka, Ewa; Chmielik, Ewa; Zembala-Nozynska, Ewa; Poltorak, Stanislaw; Sacher, Aleksander; Maciejewski, Adam; Zebracka-Gala, Jadwiga; Lange, Dariusz; Oczko-Wojciechowska, Malgorzata; Handkiewicz-Junak, Daria; Jarzab, Barbara			The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAF(V600E) Mutation Status and Other Prognostic Factors	PLOS ONE			English	Article							BRAF V600E MUTATION; NEEDLE-ASPIRATION BIOPSY; TERT PROMOTER MUTATIONS; LYMPH-NODE METASTASIS; CLINICOPATHOLOGICAL FEATURES; PREOPERATIVE RISK; CLINICAL-PRACTICE; KOREAN PATIENTS; FOLLOW-UP; CARCINOMA	Introduction The risk of over-treatment in low-advanced PTC stages has prompted clinicians to search for new reliable prognostic factors. The presence of BRAF mutation, the most frequent molecular event in PTC, seems to be a good candidate. However, there is still lack of randomised trials and its significance has been proved by retrospective analyses, involving a large group of patients. The question arises whether this factor is useful in smaller populations, characterised for specialised centres. Thus, the aim of the study was to evaluate the use of BRAF mutation as a potential predictive marker in PTC patients. Material 233 PTC subjects treated between 2004-2006, were retrospectively analysed. Stage pT1 was diagnosed in 64.8% patients and lymph node metastases in 30.9%. Median follow-up was 7.5 years. BRAF(V600E) mutation was assessed postoperatively in all cases. Results BRAF(V600E) mutation was found in 54.5%. It was more frequent in patients > 45 years (p=0.0001), and associated with larger tumour size (p=0.004). Patients with tumours <= 10 mm were over-represented among BRAF negative population (p=0.03). No association between BRAF mutation and other clinicopathological factors was observed. BRAF status was associated neither with relapse nor with disease-free survival (DFS) (p=0.76). Nodal status, extrathyroidal invasion and tumour size significantly influenced DFS. Conclusion The risk of PTC recurrence is mainly related to the presence of lymph node metastases and extrathyroidal invasion, whereas no impact of BRAF(V600E) mutation has been demonstrated.	[Czarniecka, Agnieszka; Poltorak, Stanislaw; Sacher, Aleksander; Maciejewski, Adam] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Oncol & Reconstruct Surg Clin, Gliwice Branch, Gliwice, Poland; [Kowal, Monika; Rusinek, Dagmara; Krajewska, Jolanta; Zebracka-Gala, Jadwiga; Oczko-Wojciechowska, Malgorzata; Handkiewicz-Junak, Daria; Jarzab, Barbara] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Gliwice Branch, Dept Nucl Med & Endocrine Oncol, Gliwice, Poland; [Jarzab, Michal] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Gliwice Branch, Dept Radiotherapy & Chemotherapy 3, Gliwice, Poland; [Stobiecka, Ewa; Chmielik, Ewa; Zembala-Nozynska, Ewa; Lange, Dariusz] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Gliwice Branch, Dept Tumor Pathol, Gliwice, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Czarniecka, A (corresponding author), Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Oncol & Reconstruct Surg Clin, Gliwice Branch, Gliwice, Poland.	Agnieszka.Czarniecka@io.gliwice.pl	Barbara, Jarzab/I-4654-2019; Maciejewski, Adam/GOH-0319-2022; Jarząb, Michał/G-4319-2012; Oczko-Wojciechowska, Malgorzata/P-2272-2018; Krajewska, Jolanta/AAW-9781-2020; Jarząb, Barbara/AAI-7942-2020; Czarniecka, Agnieszka/I-5137-2014	Maciejewski, Adam/0000-0002-4098-5233; Jarząb, Michał/0000-0002-2642-9724; Oczko-Wojciechowska, Malgorzata/0000-0002-8989-0075; Jarząb, Barbara/0000-0001-9811-9584; Rusinek, Dagmara/0000-0003-4115-3751; Handkiewicz-Junak, Daria/0000-0003-0802-2880; Czarniecka, Agnieszka/0000-0003-1249-7205; Krajewska, Jolanta/0000-0003-0479-4998; Chmielik, Ewa/0000-0001-8316-0541; Zembala-Nozynska, Ewa/0000-0002-6045-2995; Lange, Dariusz/0000-0001-7088-5439	Polish National Science Center [NN 403 194340]	Polish National Science Center	The study was partially funded by Polish National Science Center grant NN 403 194340 to A. C. The study was also conducted as an internal research project in MSC Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn D, 2012, AURIS NASUS LARYNX, V39, P198, DOI 10.1016/j.anl.2011.07.011; Alzahrani AS, 2013, ENDOCR-RELAT CANCER, V20, P13, DOI 10.1530/ERC-12-0309; Aschebrook-Kilfoy B, 2013, CANCER EPIDEM BIOMAR, V22, P1252, DOI 10.1158/1055-9965.EPI-13-0242; Barbaro D, 2014, ENDOCRINE, V45, P462, DOI 10.1007/s12020-013-0029-5; Bernstein J, 2013, THYROID, V23, P1525, DOI 10.1089/thy.2013.0154; Carling T, 2012, THYROID, V22, P237, DOI 10.1089/thy.2011.0317; Chakraborty A, 2012, ENDOCR PATHOL, V23, P83, DOI 10.1007/s12022-011-9184-5; Cho BY, 2013, THYROID, V23, P797, DOI 10.1089/thy.2012.0329; Choi SY, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-291; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Czarniecka A, ENDOKRYNOL POL, V61, P462; Czarniecka A, 2014, EUR THYROID J, V3, P104; Danilovic DLS, 2014, EUR J ENDOCRINOL, V170, P619, DOI 10.1530/EJE-13-0944; Didkowska J, 2013, CANC POLAND 2011; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P3943, DOI 10.1210/jc.2008-0607; Elisei R, 2012, J CLIN ENDOCR METAB, V97, P4390, DOI 10.1210/jc.2012-1775; Handkiewicz-Junak D, 2010, MOL CELL ENDOCRINOL, V322, P8, DOI 10.1016/j.mce.2010.01.007; Howell GM, 2013, ANN SURG ONCOL, V20, P47, DOI 10.1245/s10434-012-2611-0; Howell GM, 2011, ANN SURG ONCOL, V18, P3566, DOI 10.1245/s10434-011-1781-5; Huang YB, 2013, EUR J ENDOCRINOL, V168, P675, DOI 10.1530/EJE-12-1029; Ito Y, 2009, ENDOCR J, V56, P89, DOI 10.1507/endocrj.K08E-208; Jarzab B, 2010, ENDOKRYNOL POL, V61, P518; Joo JY, 2012, J CLIN ENDOCR METAB, V97, P3996, DOI 10.1210/jc.2012-2444; Kebebew E, 2007, ANN SURG, V246, P466, DOI 10.1097/SLA.0b013e318148563d; Kim J, 2006, ANN SURG, V244, P799, DOI 10.1097/01.sla.0000224751.80858.13; Kim SJ, 2012, WORLD J SURG, V36, P310, DOI 10.1007/s00268-011-1383-1; Kim TY, 2006, CLIN ENDOCRINOL, V65, P364, DOI 10.1111/j.1365-2265.2006.02605.x; KIM TH, 2012, CANCER-AM CANCER SOC, V118, P1764, DOI DOI 10.1002/cncr.26500; Kim TY, 2005, CLIN ENDOCRINOL, V63, P588, DOI 10.1111/j.1365-2265.2005.02389.x; Kurtulmus N, 2012, ENDOCRINE, V42, P404, DOI 10.1007/s12020-012-9651-x; Lee JH, 2007, CANCER-AM CANCER SOC, V110, P38, DOI 10.1002/cncr.22754; Li C, 2013, J CLIN ENDOCR METAB, V98, P3702, DOI 10.1210/jc.2013-1584; Li C, 2012, J CLIN ENDOCR METAB, V97, P4559, DOI 10.1210/jc.2012-2104; Liu XL, 2014, J CLIN ENDOCR METAB, V99, pE1130, DOI 10.1210/jc.2013-4048; Matosin N, 2014, DIS MODEL MECH, V7, P171, DOI 10.1242/dmm.015123; Mond M, 2014, INTERN MED J, V44, P727, DOI 10.1111/imj.12476; Nam JK, 2012, AM J SURG, V203, P436, DOI 10.1016/j.amjsurg.2011.02.013; Niederer-Wust SM, 2015, SURGERY, V157, P119, DOI 10.1016/j.surg.2014.07.015; Pacini F, 2012, ANN ONCOL, V23, P110, DOI 10.1093/annonc/mds230; Pelizzo MR, 2014, BIOMED PHARMACOTHER, V68, P413, DOI 10.1016/j.biopha.2014.03.008; Puxeddu E, 2014, ENDOCRINE, V45, P341, DOI 10.1007/s12020-013-0139-0; Randolph GW, 2012, THYROID, V22, P1144, DOI 10.1089/thy.2012.0043; Russo M, 2014, THYROID, V24, P1267, DOI 10.1089/thy.2013.0675; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Sun Y, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/128735; Virk RK, 2013, MODERN PATHOL, V26, P62, DOI 10.1038/modpathol.2012.152; Walczyk A, 2014, CLIN ENDOCRINOL, V80, P899, DOI 10.1111/cen.12386; Watkinson JC, 2004, NUCL MED COMMUN, V25, P897, DOI 10.1097/00006231-200409000-00006; Xing M, 2014, CLIN ONCOL, DOI [10.1200/JCO.2014.55.5094, DOI 10.1200/JCO.2014.55.5094]; Xing MZ, 2015, J CLIN ONCOL, V33, P42, DOI 10.1200/JCO.2014.56.8253; Xing MZ, 2014, J CLIN ONCOL, V32, P2718, DOI 10.1200/JCO.2014.55.5094; Xing MZ, 2013, LANCET, V381, P1058, DOI 10.1016/S0140-6736(13)60109-9; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Xing MZ, 2010, MOL CELL ENDOCRINOL, V321, P86, DOI 10.1016/j.mce.2009.10.012; Xing MZ, 2009, J CLIN ONCOL, V27, P2977, DOI 10.1200/JCO.2008.20.1426; Xing MZ, 2009, ANN SURG ONCOL, V16, P801, DOI 10.1245/s10434-008-0298-z; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987	58	30	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132821	10.1371/journal.pone.0132821	http://dx.doi.org/10.1371/journal.pone.0132821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177218	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600164
J	Geipel, J; Hadjichristidis, C; Surian, L				Geipel, Janet; Hadjichristidis, Constantinos; Surian, Luca			The Foreign Language Effect on Moral Judgment: The Role of Emotions and Norms	PLOS ONE			English	Article							TROLLEY; DILEMMAS	We investigated whether and why the use of a foreign language influences moral judgment. We studied the trolley and footbridge dilemmas, which propose an action that involves killing one individual to save five. In line with prior work, the use of a foreign language increased the endorsement of such consequentialist actions for the footbridge dilemma, but not for the trolley dilemma. But contrary to recent theorizing, this effect was not driven by an attenuation of emotions. An attenuation of emotions was found in both dilemmas, and it did not mediate the foreign language effect on moral judgment. An examination of additional scenarios revealed that foreign language influenced moral judgment when the proposed action involved a social or moral norm violation. We propose that foreign language influences moral judgment by reducing access to normative knowledge.	[Geipel, Janet; Surian, Luca] Univ Trento, Dept Psychol & Cognit Sci, Trento, Italy; [Hadjichristidis, Constantinos] Univ Trento, Dept Management & Econ, Trento, Italy; [Hadjichristidis, Constantinos] Univ Leeds, Leeds Business Sch, Res Ctr Decis Making, Leeds, W Yorkshire, England	University of Trento; University of Trento; Leeds Beckett University; University of Leeds	Geipel, J (corresponding author), Univ Trento, Dept Psychol & Cognit Sci, Trento, Italy.	janet.geipel@unitn.it	Surian, Luca/Q-2947-2019; Geipel, Janet/ABF-7836-2020	Geipel, Janet/0000-0003-1957-6213	Ministry for Education, University and Research (Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR) [2009LNJ2AP_001]	Ministry for Education, University and Research (Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR)	This work was supported by PRIN no. 2009LNJ2AP_001, Ministry for Education, University and Research (Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR), LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenius H, 2012, J COGN CULT, V12, P195, DOI 10.1163/15685373-12342073; Bloom P, 2011, YALE REV, V99, P26, DOI 10.1111/j.1467-9736.2011.00701.x; BOND MH, 1986, J SOC PSYCHOL, V126, P179; Caldwell-Harris CL, 2011, INT J BILINGUAL, V15, P329, DOI 10.1177/1367006910379262; Caldwell-Harris CL, 2009, INT J PSYCHOPHYSIOL, V71, P193, DOI 10.1016/j.ijpsycho.2008.09.006; Christensen Julia F, 2014, Front Psychol, V5, P607, DOI 10.3389/fpsyg.2014.00607; Cipolletti H, 2016, PHILOS PSYCHOL, V29, P23, DOI 10.1080/09515089.2014.993063; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa P, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0089254, 10.1371/journal.pone.0094842]; Council of Europe, 2001, COMM EUR FRAM REF LA; Cumming G., 2012, UNDERSTANDING NEW ST; Cushman F, 2006, PSYCHOL SCI, V17, P1082, DOI 10.1111/j.1467-9280.2006.01834.x; Cushman F, 2013, PERS SOC PSYCHOL REV, V17, P273, DOI 10.1177/1088868313495594; Dewaele JM, 2010, SOCIOLING STUD, V4, P595, DOI 10.1558/sols.v4i3.595; Dwyer S, 2009, MIND LANG, V24, P274, DOI 10.1111/j.1468-0017.2009.01363.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Foot P, 1978, VIRTUES VICES OTHER; Gawinkowska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081225; Geipel J, 2015, J EXP SOC PSYCHOL, V59, P8, DOI 10.1016/j.jesp.2015.02.001; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene Joshua., 2013, MORAL TRIBES EMOTION; Greene JD, 2008, COGNITION, V107, P1144, DOI 10.1016/j.cognition.2007.11.004; Greene JD, 2014, ETHICS, V124, P695, DOI 10.1086/675875; Greene JD, 2009, COGNITION, V111, P364, DOI 10.1016/j.cognition.2009.02.001; Hadjichristidis C, 2015, J EXP PSYCHOL-APPL, V21, P117, DOI 10.1037/xap0000044; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Hare RM, 1981, MORAL THINKING ITS L; Harris CatherineL., 2006, BILINGUAL MINDS EMOT, V56, P257; Harris CL, 2003, APPL PSYCHOLINGUIST, V24, P561, DOI 10.1017/S0142716403000286; Huebner B, 2009, TRENDS COGN SCI, V13, P1, DOI 10.1016/j.tics.2008.09.006; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kogut T, 2005, J BEHAV DECIS MAKING, V18, P157, DOI 10.1002/bdm.492; Kvaran T, 2013, PROG BRAIN RES, V202, P187, DOI 10.1016/B978-0-444-62604-2.00011-3; Lotto L, 2014, J BEHAV DECIS MAKING, V27, P57, DOI 10.1002/bdm.1782; Lucas BJ, 2014, J EXP SOC PSYCHOL, V53, P1, DOI 10.1016/j.jesp.2014.01.011; Marian V, 2000, J EXP PSYCHOL GEN, V129, P361, DOI 10.1037//0096-3445.129.3.361; Mendez MF, 2005, COGN BEHAV NEUROL, V18, P193, DOI 10.1097/01.wnn.0000191292.17964.bb; Mikhail J, 2007, TRENDS COGN SCI, V11, P143, DOI 10.1016/j.tics.2006.12.007; Moore AB, 2011, JUDGM DECIS MAK, V6, P186; Nakamura K, 2013, THINK REASONING, V19, P178, DOI 10.1080/13546783.2013.768551; Nichols S, 2013, ANN M INT ASS COMP P; Pavlenko A, 2012, INT J PSYCHOL, V47, P405, DOI 10.1080/00207594.2012.743665; Paxton JM, 2012, COGNITIVE SCI, V36, P163, DOI 10.1111/j.1551-6709.2011.01210.x; Pellizzoni S, 2010, DEVELOPMENTAL SCI, V13, P265, DOI 10.1111/j.1467-7687.2009.00851.x; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rottman J, 2015, MORAL BRAIN: A MULTIDISCIPLINARY PERSPECTIVE, P123; Sabanz, 2013, P 35 ANN C COGN SCI; Schrauf RW, 2000, MEM COGNITION, V28, P616, DOI 10.3758/BF03201251; Starcke K, 2011, PSYCHONEUROENDOCRINO, V36, P210, DOI 10.1016/j.psyneuen.2010.07.010; Sunstein CR, 2005, BEHAV BRAIN SCI, V28, P531, DOI 10.1017/S0140525X05000099; THOMSON JJ, 1985, YALE LAW J, V94, P1395, DOI 10.2307/796133; Young L, 2007, BRIT MED BULL, V84, P69, DOI 10.1093/bmb/ldm031	53	73	75	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131529	10.1371/journal.pone.0131529	http://dx.doi.org/10.1371/journal.pone.0131529			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177508	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600048
J	Hou, SK; Chiu, YH; Tsai, YF; Tai, LC; Hou, PC; How, CK; Yang, CC; Kao, WF				Hou, Sen-Kuang; Chiu, Yu-Hui; Tsai, Yi-Fang; Tai, Ling-Chen; Hou, Peter C.; How, Chorng-Kuang; Yang, Chen-Chang; Kao, Wei-Fong			Clinical Impact of Speed Variability to Identify Ultramarathon Runners at Risk for Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; ULTRA-MARATHON RACE; EXERTIONAL RHABDOMYOLYSIS; ENDURANCE PERFORMANCE; CONSTANT PACE; EXERCISE; HYPONATREMIA; RESPONSES	Background Ultramarathon is a high endurance exercise associated with a wide range of exercise-related problems, such as acute kidney injury (AKI). Early recognition of individuals at risk of AKI during ultramarathon event is critical for implementing preventative strategies. Objectives To investigate the impact of speed variability to identify the exercise-related acute kidney injury anticipatively in ultramarathon event. Methods This is a prospective, observational study using data from a 100 km ultramarathon in Taipei, Taiwan. The distance of entire ultramarathon race was divided into 10 splits. The mean and variability of speed, which was determined by the coefficient of variation (CV) in each 10 km-split (25 laps of 400 m oval track) were calculated for enrolled runners. Baseline characteristics and biochemical data were collected completely 1 week before, immediately post-race, and one day after race. The main outcome was the development of AKI, defined as Stage II or III according to the Acute Kidney Injury Network (AKIN) criteria. Multivariate analysis was performed to determine the independent association between variables and AKI development. Results 26 ultramarathon runners were analyzed in the study. The overall incidence of AKI (in all Stages) was 84.6%(22 in 26 runners). Among these 22 runners, 18 runners were determined as Stage I, 4 runners (15.4%) were determined as Stage II, and none was in Stage III. The covariates of BMI (25.22 +/- 2.02 vs. 22.55 +/- 1.96, p = 0.02), uric acid (6.88 +/- 1.47 vs. 5.62 +/- 0.86, p = 0.024), and CV of speed in specific 10-km splits (from secondary 10 km-split (10th - 20th km-split) to 60th - 70th km-split) were significantly different between runners with or without AKI (Stage II) in univariate analysis and showed discrimination ability in ROC curve. In the following multivariate analysis, only CV of speed in 40th - 50th km-split continued to show a significant association to the development of AKI (Stage II) (p = 0.032). Conclusions The development of exercise-related AKI was not infrequent in the ultramarathon runners. Because not all runners can routinely receive laboratory studies after race, variability of running speed (CV of speed) may offer a timely and efficient tool to identify AKI early during the competition, and used as a surrogate screening tool, at-risk runners can be identified and enrolled into prevention trials, such as adequate fluid management and avoidance of further NSAID use.	[Hou, Sen-Kuang; Kao, Wei-Fong] Taipei Med Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Hou, Sen-Kuang; Chiu, Yu-Hui; Yang, Chen-Chang; Kao, Wei-Fong] Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, Taipei 112, Taiwan; [Hou, Sen-Kuang; Hou, Peter C.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Chiu, Yu-Hui] Mackay Mem Hosp, Dept Emergency Med, Taipei, Taiwan; [Tsai, Yi-Fang; Tai, Ling-Chen] Taipei Vet Gen Hosp, Dept Gen Surg, Taipei, Taiwan; [Tsai, Yi-Fang; How, Chorng-Kuang] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Hou, Peter C.] Harvard Univ, Sch Med, Boston, MA USA; [How, Chorng-Kuang] Taipei Vet Gen Hosp, Dept Emergency Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; National Yang Ming Chiao Tung University; Harvard University; Brigham & Women's Hospital; Mackay Memorial Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Harvard University; Harvard Medical School; Taipei Veterans General Hospital	Kao, WF (corresponding author), Taipei Med Univ Hosp, Dept Emergency Med, Taipei, Taiwan.	wfkao100a@hotmail.com.tw			Taipei Veterans General Hospital, Taiwan [V100C-202]	Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital)	This study was supported by a grant from Taipei Veterans General Hospital, Taiwan (Grant V100C-202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond CSD, 2005, NEW ENGL J MED, V352, P1550, DOI 10.1056/NEJMoa043901; Asplund CA, 2011, BRIT J SPORT MED, V45, P1157, DOI 10.1136/bjsports-2011-090378; Billat VL, 2001, MED SCI SPORT EXER, V33, P2082, DOI 10.1097/00005768-200112000-00017; BOSCH AN, 1993, J APPL PHYSIOL, V74, P1921, DOI 10.1152/jappl.1993.74.4.1921; Bosch X, 2009, NEW ENGL J MED, V361, P62, DOI 10.1056/NEJMra0801327; Casa Douglas J, 2005, Curr Sports Med Rep, V4, P309; Cheuvront Samuel N, 2003, Curr Sports Med Rep, V2, P202, DOI 10.1249/00149619-200308000-00006; Clarkson PM, 2007, SPORTS MED, V37, P361, DOI 10.2165/00007256-200737040-00022; Cottin F, 2002, EUR J APPL PHYSIOL, V87, P17, DOI 10.1007/s00421-002-0582-8; Del Coso J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057602; Fortes MB, 2013, MED SCI SPORT EXER, V45, P1915, DOI 10.1249/MSS.0b013e318294b0f8; Garcin M, 2008, INT J SPORTS MED, V29, P453, DOI 10.1055/s-2007-989237; Goulet EDB, 2012, NUTR REV, V70, pS132, DOI 10.1111/j.1753-4887.2012.00530.x; Hoffman MD, 2014, INT J SPORT PHYSIOL, V9, P1054, DOI 10.1123/ijspp.2013-0556; Hoffman MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083867; Hoffman MD, 2013, J SPORT SCI, V31, P20, DOI 10.1080/02640414.2012.720705; Hoffman MD, 2010, INT J HIST SPORT, V27, P1877, DOI 10.1080/09523367.2010.494385; Junglee NA, 2013, AM J PHYSIOL-RENAL, V305, pF813, DOI 10.1152/ajprenal.00091.2013; KARLSSON J, 1971, J APPL PHYSIOL, V31, P203, DOI 10.1152/jappl.1971.31.2.203; Kenney W Larry, 2002, Curr Sports Med Rep, V1, P125; Kipps C, 2011, BRIT J SPORT MED, V45, P14, DOI 10.1136/bjsm.2009.059535; Lambert MI, 2004, J SPORT SCI MED, V3, P167; Lipman GS, 2014, RES SPORTS MED, V22, P185, DOI 10.1080/15438627.2014.881824; McCullough PA, 2011, NEPHROLOGY, V16, P194, DOI 10.1111/j.1440-1797.2010.01354.x; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mohseni M, 2011, SPORTS HEALTH, V3, P145, DOI 10.1177/1941738111400561; Patel DR, 2009, PHYSICIAN SPORTSMED, V37, P71, DOI 10.3810/psm.2009.04.1685; Pedoe DST, 2007, SPORTS MED, V37, P448, DOI 10.2165/00007256-200737040-00046; Ritz P, 2008, CLIN NUTR, V27, P740, DOI 10.1016/j.clnu.2008.07.010; Roberts WO, 2007, SPORTS MED, V37, P440, DOI 10.2165/00007256-200737040-00044; SANDERS LR, 1995, J AM SOC NEPHROL, V5, P2020; Santos-Lozano A, 2014, INT J SPORTS MED, V35, P933, DOI 10.1055/s-0034-1367048; SEEDAT YK, 1990, RENAL FAILURE, V11, P209; Waskiewicz Z, 2012, EUR J APPL PHYSIOL, V112, P1679, DOI 10.1007/s00421-011-2135-5	34	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133146	10.1371/journal.pone.0133146	http://dx.doi.org/10.1371/journal.pone.0133146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176768	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600219
J	Kucerova-Levisohn, M; Knirr, S; Mejia, RI; Ortiz, BD				Kucerova-Levisohn, Martina; Knirr, Stefan; Mejia, Rosa I.; Ortiz, Benjamin D.			The 3 '-J alpha Region of the TCR alpha Locus Bears Gene Regulatory Activity in Thymic and Peripheral T Cells	PLOS ONE			English	Article							HEAVY-CHAIN-LOCUS; V(D)J RECOMBINATION; SOMATIC HYPERMUTATION; ENHANCER ELEMENTS; IN-VITRO; C-ALPHA; E-MU; RECEPTOR; BETA; EXPRESSION	Much progress has been made in understanding the important cis-mediated controls on mouse TCR alpha gene function, including identification of the E alpha enhancer and TCR alpha locus control region (LCR). Nevertheless, previous data have suggested that other cis-regulatory elements may reside in the locus outside of the E alpha/LCR. Based on prior findings, we hypothesized the existence of gene regulatory elements in a 3.9-kb region 5' of the C alpha exons. Using DNase hypersensitivity assays and TCR alpha BAC reporter transgenes in mice, we detected gene regulatory activity within this 3.9-kb region. This region is active in both thymic and peripheral T cells, and selectively affects upstream, but not downstream, gene expression. Together, these data indicate the existence of a novel cis-acting regulatory complex that contributes to TCR alpha transgene expression in vivo. The active chromatin sites we discovered within this region would remain in the locus after TCR alpha gene rearrangement, and thus may contribute to endogenous TCR alpha gene activity, particularly in peripheral T cells, where the E alpha element has been found to be inactive.	[Kucerova-Levisohn, Martina; Knirr, Stefan; Mejia, Rosa I.; Ortiz, Benjamin D.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Kucerova-Levisohn, Martina; Ortiz, Benjamin D.] CUNY, Grad Ctr, Doctoral Program Biol, New York, NY USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System	Ortiz, BD (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	Ortiz@genectr.hunter.cuny.edu			National Institutes of Health (NIH) [SC1-GM095402]; Alliance/Merck Ciencia Scholarship; Hunter College Undergraduate Research Initiative Fellowship; Research Centers in Minority Institutions grant from the National Institute on Minority Health and Health Disparities of NIH [G12 MD007599]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM095402] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007599] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance/Merck Ciencia Scholarship; Hunter College Undergraduate Research Initiative Fellowship; Research Centers in Minority Institutions grant from the National Institute on Minority Health and Health Disparities of NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health (NIH) grant SC1-GM095402 (to BDO). RIM was supported by an Alliance/Merck Ciencia Scholarship and a Hunter College Undergraduate Research Initiative Fellowship. The biomedical research infrastructure at Hunter College is supported in part by Research Centers in Minority Institutions grant G12 MD007599 from the National Institute on Minority Health and Health Disparities of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birshtein BK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00163; Deindl E, 2001, BIOTECHNIQUES, V31, P1250, DOI 10.2144/01316bm04; del Blanco B, 2015, P NATL ACAD SCI USA, V112, pE1744, DOI 10.1073/pnas.1406551112; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gomos-Klein J, 2007, J IMMUNOL, V179, P1088, DOI 10.4049/jimmunol.179.2.1088; Harrow F, 2005, J IMMUNOL, V175, P6659, DOI 10.4049/jimmunol.175.10.6659; Harrow F, 2004, J BIOL CHEM, V279, P17842, DOI 10.1074/jbc.M401258200; HO IC, 1989, P NATL ACAD SCI USA, V86, P6714, DOI 10.1073/pnas.86.17.6714; Inlay MA, 2006, J IMMUNOL, V177, P1146, DOI 10.4049/jimmunol.177.2.1146; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Knirr S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015527; KOOP BF, 1992, GENOMICS, V13, P1209, DOI 10.1016/0888-7543(92)90039-U; Kovalovsky D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008675; Krangel MS, 2004, IMMUNOL REV, V200, P224, DOI 10.1111/j.0105-2896.2004.00155.x; Lahiji A, 2014, J IMMUNOL METHODS, V407, P135, DOI 10.1016/j.jim.2014.03.012; Lahiji A, 2013, J IMMUNOL, V191, P472, DOI 10.4049/jimmunol.1300521; Li FB, 2010, J IMMUNOL, V185, P6049, DOI 10.4049/jimmunol.0902992; Li FB, 2009, J EXP MED, V206, P153, DOI 10.1084/jem.20081202; LURIA S, 1987, EMBO J, V6, P3307, DOI 10.1002/j.1460-2075.1987.tb02650.x; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Ortiz BD, 1999, MOL CELL BIOL, V19, P1901; Ortiz BD, 1997, EMBO J, V16, P5037, DOI 10.1093/emboj/16.16.5037; Ortiz BD, 2001, J IMMUNOL, V167, P3836, DOI 10.4049/jimmunol.167.7.3836; Peng C, 2013, J IMMUNOL, V191, P4399, DOI 10.4049/jimmunol.1301858; Santoso B, 2000, J BIOL CHEM, V275, P1952, DOI 10.1074/jbc.275.3.1952; Schlissel MS, 2004, IMMUNOL REV, V200, P215, DOI 10.1111/j.0105-2896.2004.00157.x; Shih HY, 2011, IMMUNOL RES, V49, P192, DOI 10.1007/s12026-010-8181-y; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; WINOTO A, 1989, EMBO J, V8, P729, DOI 10.1002/j.1460-2075.1989.tb03432.x; Xiong N, 2002, IMMUNITY, V16, P453, DOI 10.1016/S1074-7613(02)00285-6	31	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132856	10.1371/journal.pone.0132856	http://dx.doi.org/10.1371/journal.pone.0132856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177549	gold, Green Published			2022-12-27	WOS:000358197600169
J	Lu, N; Sun, HX; Yu, JJ; Wang, XJ; Liu, DM; Zhao, L; Sun, LH; Zhao, HY; Tao, B; Liu, JM				Lu, Nan; Sun, Hanxiao; Yu, JingJia; Wang, Xiaojing; Liu, Dongmei; Zhao, Lin; Sun, Lihao; Zhao, Hongyan; Tao, Bei; Liu, Jianmin			Glucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetes	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GLP-1 RECEPTOR; IN-VITRO; OSTEOBLAST FORMATION; DIFFERENTIATION; MARROW; PROGENITORS; EXENDIN-4; MICE; RESORPTION	Recently, a number of studies have demonstrated the potential beneficial role for novel antidiabetic GLP-1 receptor agonists (GLP-1RAs) in the skeleton metabolism in diabetic rodents and patients. In this study, we evaluated the impacts of the synthetic GLP-1RA Liraglutide on bone mass and quality in osteoporotic rats induced by ovariectomy (OVX) but without diabetes, as well as its effect on the adipogenic and osteoblastogenic differentiation of bone marrow stromal cells (BMSCs). Three months after sham surgery or bilateral OVX, eighteen 5-month old female Wistar rats were randomly divided into three groups to receive the following treatments for 2 months: (1) Sham + normal saline; (2) OVX + normal saline; and (3) OVX + Liraglutide (0.6 mg/day). As revealed by micro-CT analysis, Liraglutide improved trabecular volume, thickness and number, increased BMD, and reduced trabecular spacing in the femurs in OVX rats; similar results were observed in the lumbar vertebrae of OVX rats treated with Liraglutide. Following in vitro treatment of rat and human BMSCs with 10 nM Liraglutide, there was a significant increase in the mRNA expression of osteoblast-specific transcriptional factor Runx2 and the osteoblast markers alkaline phosphatase (ALP) and collagen alpha 1 (Col-1), but a significant decrease in peroxisome proliferator-activated receptor gamma (PPAR gamma). In conclusion, our results indicate that the anti-diabetic drug Liraglutide can exert a bone protective effect even in non-diabetic osteoporotic OVX rats. This protective effect is likely attributable to the impact of Liraglutide on the lineage fate determination of BMSCs.	[Lu, Nan; Sun, Hanxiao; Yu, JingJia; Wang, Xiaojing; Liu, Dongmei; Zhao, Lin; Sun, Lihao; Zhao, Hongyan; Tao, Bei; Liu, Jianmin] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Rui Jin Hosp,Sch Med,Dept Endocrine & Metab Dis, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University	Tao, B (corresponding author), Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Rui Jin Hosp,Sch Med,Dept Endocrine & Metab Dis, Shanghai 200025, Peoples R China.	catherine-tao@163.com; liujianmin@medmail.com.cn			National Nature Science Foundation of China [81370977, 81370018, 81170804]; Shanghai Municipal Health Bureau Project [2012-235]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health Bureau Project	This work was supported by: National Nature Science Foundation of China No. 81370977 (JML); National Nature Science Foundation of China No. 81370018 (BT); National Nature Science Foundation of China No. 81170804 (HYZ); Shanghai Municipal Health Bureau Project 2012-235 (JML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2012, BONE, V50, P540, DOI 10.1016/j.bone.2011.06.030; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Aoyama E, 2014, INT J MOL MED, V34, P475, DOI 10.3892/ijmm.2014.1787; Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Bollag RJ, 2000, ENDOCRINOLOGY, V141, P1228, DOI 10.1210/en.141.3.1228; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Dicembrini I, 2012, EXP DIABETES RES, DOI 10.1155/2012/519784; Dienelt A, 2011, STEM CELLS DEV, V20, P465, DOI 10.1089/scd.2010.0205; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Ellenbroek JH, 2013, DIABETOLOGIA, V56, P1980, DOI 10.1007/s00125-013-2957-2; Garber AJ, 2012, EXPERT OPIN INV DRUG, V21, P45, DOI 10.1517/13543784.2012.638282; Giuliani N, 2005, BLOOD, V106, P2472, DOI 10.1182/blood-2004-12-4986; Holscher C, 2012, CNS DRUGS, V26, P871, DOI 10.2165/11635890-000000000-00000; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kazakos K, 2011, DIABETES RES CLIN PR, V93, pS32, DOI 10.1016/S0168-8227(11)70011-0; Knudsen LB, 2010, ENDOCRINOLOGY, V151, P1473, DOI 10.1210/en.2009-1272; Ko CH, 2011, J AGR FOOD CHEM, V59, P9870, DOI 10.1021/jf202015t; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Larsen PJ, 2001, DIABETES, V50, P2530, DOI 10.2337/diabetes.50.11.2530; Ma X, 2013, J BONE MINER RES, V28, P1641, DOI 10.1002/jbmr.1898; Mabilleau G, 2013, J ENDOCRINOL, V219, P59, DOI 10.1530/JOE-13-0146; Mieczkowska A, 2015, OSTEOPOROSIS INT, V26, P209, DOI 10.1007/s00198-014-2845-8; Nauck MA, 2011, AM J MED, V124, pS19, DOI 10.1016/j.amjmed.2010.11.002; Nomiyama T, 2014, DIABETES, V63, P3891, DOI 10.2337/db13-1169; Nuche-Berenguer B, 2011, J ENDOCRINOL, V209, P203, DOI 10.1530/JOE-11-0015; Nuche-Berenguer B, 2010, J CELL PHYSIOL, V225, P585, DOI 10.1002/jcp.22243; Nuche-Berenguer B, 2010, REGUL PEPTIDES, V159, P61, DOI 10.1016/j.regpep.2009.06.010; Nuche-Berenguer B, 2009, CALCIFIED TISSUE INT, V84, P453, DOI 10.1007/s00223-009-9220-3; Pacheco-Pantoja Elda L., 2011, BMC Physiology, V11, P12, DOI 10.1186/1472-6793-11-12; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; Papazafiropoulou A, 2014, CURR DIABETES REV, V10, P43, DOI 10.2174/1573399810666140217114848; Sanz C, 2010, AM J PHYSIOL-ENDOC M, V298, pE634, DOI 10.1152/ajpendo.00460.2009; Schwartz AV, 2012, DIABETES CARE, V35, P1525, DOI 10.2337/dc11-2184; Molinuevo MS, 2010, J BONE MINER RES, V25, P211, DOI 10.1359/jbmr.090732; Su B, 2015, ENDOCRINE, V48, P107, DOI 10.1007/s12020-014-0361-4; Taipaleenmaki H, 2011, EXP CELL RES, V317, P745, DOI 10.1016/j.yexcr.2010.12.015; Tang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066263; Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052; Wittrant Y, 2008, BONE, V42, P1122, DOI 10.1016/j.bone.2008.02.006; Wu JY, 2011, J CLIN INVEST, V121, P3492, DOI 10.1172/JCI46406; Yamada C, 2008, ENDOCRINOLOGY, V149, P574, DOI 10.1210/en.2007-1292	42	56	70	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132744	10.1371/journal.pone.0132744	http://dx.doi.org/10.1371/journal.pone.0132744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177280	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600150
J	Nowak, DM; Gajecka, M				Nowak, Dorota M.; Gajecka, Marzena			Nonrandom Distribution of miRNAs Genes and Single Nucleotide Variants in Keratoconus Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORNEAL ALDEHYDE DEHYDROGENASE; AUTOSOMAL-DOMINANT KERATOCONUS; VSX1 GENE; OXIDATIVE STRESS; CANDIDATE GENE; SEQUENCE VARIANTS; GROWTH-FACTOR; MUTATION; PROMOTER	Despite numerous studies, the causes of both development and progression of keratoconus remain elusive. Previous studies of this disorder focused mainly on one or two genetic factors only. However, in the analysis of such complex diseases all potential factors should be taken into consideration. The purpose of this study was a comprehensive analysis of known keratoconus loci to uncover genetic factors involved in this disease causation in the general population, which could be omitted in the original studies. In this investigation genomic data available in various databases and experimental own data were assessed. The lists of single nucleotide variants and miRNA genes localized in reported keratoconus loci were obtained from Ensembl and miRBase, respectively. The potential impact of nonsynonymous amino acid substitutions on protein structure and function was assessed with PolyPhen-2 and SIFT. For selected protein genes the ranking was made to choose those most promising for keratoconus development. Ranking results were based on topological features in the protein-protein interaction network. High specificity for the populations in which the causative sequence variants have been identified was found. In addition, the possibility of links between previously analyzed keratoconus loci was confirmed including miRNA-gene interactions. Identified number of genes associated with oxidative stress and inflammatory agents corroborated the hypothesis of their effect on the disease etiology. Distribution of the numerous sequences variants within both exons and mature miRNA which forces you to search for a broader look at the determinants of keratoconus. Our findings highlight the complexity of the keratoconus genetics.	[Nowak, Dorota M.; Gajecka, Marzena] Poznan Univ Med Sci, Dept Genet & Pharmaceut Microbiol, Poznan, Poland; [Nowak, Dorota M.; Gajecka, Marzena] Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland	Poznan University of Medical Sciences; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences	Gajecka, M (corresponding author), Poznan Univ Med Sci, Dept Genet & Pharmaceut Microbiol, Poznan, Poland.	gamar@man.poznan.pl	Gajecka, Marzena/V-9706-2019	Gajecka, Marzena/0000-0001-7468-2604; Nowak-Malczewska, Dorota/0000-0002-3836-979X	Polish Ministry of Science and Higher Education [N N402 097837, N N402 591740]; National Science Centre in Poland [2011/03/N/NZ5/01470, 2012/05/E/NZ5/02127]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre in Poland(National Science Centre, Poland)	This work was supported by the Polish Ministry of Science and Higher Education, grants no. N N402 097837 (DMN) and N N402 591740 (MG DMN) and National Science Centre in Poland, grants no. 2011/03/N/NZ5/01470 (DMN) and 2012/05/E/NZ5/02127 (MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEDINIA M, 1990, EXP EYE RES, V51, P419, DOI 10.1016/0014-4835(90)90154-M; Abu-Amero KK, 2014, MOL VIS, V20, P1203; Agrawal Vinay B, 2011, J Ophthalmic Vis Res, V6, P87; Al-Muammar AM, 2015, OPHTHALMIC GENET, V36, P373, DOI 10.3109/13816810.2014.889173; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arnal E, 2011, INVEST OPHTH VIS SCI, V52, P8592, DOI 10.1167/iovs.11-7732; Atilano SR, 2005, INVEST OPHTH VIS SCI, V46, P1256, DOI 10.1167/iovs.04-1395; Bisceglia L, 2005, INVEST OPHTH VIS SCI, V46, P39, DOI 10.1167/iovs.04-0533; Brancati F, 2004, J MED GENET, V41, P188, DOI 10.1136/jmg.2003.012872; Brown KA, 2008, J CELL BIOCHEM, V105, P596, DOI 10.1002/jcb.21860; Buddi R, 2002, J HISTOCHEM CYTOCHEM, V50, P341, DOI 10.1177/002215540205000306; Burdon KP, 2008, HUM GENET, V124, P379, DOI 10.1007/s00439-008-0555-z; Burdon KP, 2011, INVEST OPHTH VIS SCI, V52, P8514, DOI 10.1167/iovs.11-8261; Bykhovskaya Y, 2012, INVEST OPHTH VIS SCI, V53, P4152, DOI 10.1167/iovs.11-9268; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Chwa M, 2008, INVEST OPHTH VIS SCI, V49, P4361, DOI 10.1167/iovs.08-1969; Chwa M, 2006, INVEST OPHTH VIS SCI, V47, P1902, DOI 10.1167/iovs.05-0828; Czugala M, 2012, EUR J HUM GENET, V20, P389, DOI 10.1038/ejhg.2011.203; Engler C, 2011, AM J OPHTHALMOL, V151, P752, DOI 10.1016/j.ajo.2010.11.008; Eran P, 2008, OPHTHALMIC GENET, V29, P53, DOI 10.1080/13816810802008242; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Funnell C, 2006, CORNEA, V25, P1224, DOI 10.1097/01.ico.0000240092.20849.e3; Gajecka M, 2009, INVEST OPHTH VIS SCI, V50, P1531, DOI 10.1167/iovs.08-2173; Gao XY, 2013, INVEST OPHTH VIS SCI, V54, P2435, DOI 10.1167/iovs.13-11692; GASSET AR, 1978, AM J OPHTHALMOL, V85, P339, DOI 10.1016/S0002-9394(14)77725-6; GONDHOWIARDJO TD, 1993, CORNEA, V12, P146, DOI 10.1097/00003226-199303000-00010; GONDHOWIARDJO TD, 1993, CORNEA, V12, P310, DOI 10.1097/00003226-199307000-00006; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Guan T, 2012, GENE, V503, P137, DOI 10.1016/j.gene.2012.04.061; HARRISON RJ, 1989, BRIT J OPHTHALMOL, V73, P816, DOI 10.1136/bjo.73.10.816; Heon E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/hmg/11.9.1029; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; HOPPENREIJS VPT, 1993, INVEST OPHTH VIS SCI, V34, P637; Hughes AE, 2011, AM J HUM GENET, V89, P628, DOI 10.1016/j.ajhg.2011.09.014; Jacq PL, 1997, J FR OPHTALMOL, V20, P97; Jung K, 2011, J ALLERGY CLIN IMMUN, V127, P420, DOI 10.1016/j.jaci.2010.10.043; Karamichos D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04608; Karolak JA, 2011, MOL VIS, V17, P827; Kenney M. Cristina, 2000, CLAO Journal, V26, P10; Kim SH, 2008, MOL VIS, V14, P2109; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lee S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1015; Li X, 2013, INVEST OPHTH VIS SCI, V54, P2696, DOI 10.1167/iovs.13-11601; Li XH, 2012, HUM MOL GENET, V21, P421, DOI 10.1093/hmg/ddr460; Liskova P, 2007, MOL VIS, V13, P1887; Lu Y, 2013, NAT GENET, V45, P155, DOI 10.1038/ng.2506; Maltseva I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069642; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mikami T, 2013, MOL VIS, V19, P845; Mok JW, 2008, J HUM GENET, V53, P842, DOI 10.1007/s10038-008-0319-6; Mukhopadhyay A, 2006, INVEST OPHTH VIS SCI, V47, P3565, DOI 10.1167/iovs.06-0141; Nowak DM, 2013, INVEST OPHTH VIS SCI, V54, P2207, DOI 10.1167/iovs.13-11592; Nowak DM, 2011, MIDDLE EAST AFR J OP, V18, P2, DOI 10.4103/0974-9233.75876; Paliwal P, 2011, MOL VIS, V17, P481; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; RAHI A, 1977, BRIT J OPHTHALMOL, V61, P761, DOI 10.1136/bjo.61.12.761; Roy S, 2007, P NATL ACAD SCI USA, V104, P14472, DOI 10.1073/pnas.0706793104; Ryan D, 2006, MOL VIS, V12, P1175; Sabarinathan R, 2013, HUM MUTAT, V34, P546, DOI 10.1002/humu.22273; Saee-Rad S, 2011, MOL VIS, V17, P3128; Sahebjada S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084067; Stabuc-Silih M, 2010, CORNEA, V29, P172, DOI 10.1097/ICO.0b013e3181aebf7a; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Szczesniak MW, 2011, MOL BIOL EVOL, V28, P33, DOI 10.1093/molbev/msq260; Tang YMG, 2008, CORNEA, V27, P189, DOI 10.1097/ICO.0b013e31815a50e7; Tremblay F, 2009, J BIOL CHEM, V284, P8136, DOI 10.1074/jbc.M809535200; Udar N, 2006, INVEST OPHTH VIS SCI, V47, P3345, DOI 10.1167/iovs.05-1500; WACHTMEISTER L, 1982, ACTA OPHTHALMOL, V60, P113; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7	71	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132143	10.1371/journal.pone.0132143	http://dx.doi.org/10.1371/journal.pone.0132143			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176855	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600085
J	Park, HJ; Choi, YJ; Kim, JW; Chun, HS; Im, I; Yoon, S; Han, YM; Song, CW; Kim, H				Park, Han-Jin; Choi, Young-Jun; Kim, Ji Woo; Chun, Hang-Suk; Im, Ilkyun; Yoon, Seokjoo; Han, Yong-Mahn; Song, Chang-Woo; Kim, Hyemin			Differences in the Epigenetic Regulation of Cytochrome P450 Genes between Human Embryonic Stem Cell-Derived Hepatocytes and Primary Hepatocytes	PLOS ONE			English	Article							DNA METHYLATION; HUMAN LIVER; HUMAN CYP1A1; HUMAN LUNG; EXPRESSION; MECHANISMS; QUANTIFICATION; CYP2E1; DIFFERENTIATION; PLACENTA	Human pluripotent stem cell-derived hepatocytes have the potential to provide in vitro model systems for drug discovery and hepatotoxicity testing. However, these cells are currently unsuitable for drug toxicity and efficacy testing because of their limited expression of genes encoding drug-metabolizing enzymes, especially cytochrome P450 (CYP) enzymes. Transcript levels of major CYP genes were much lower in human embryonic stem cellderived hepatocytes (hESC-Hep) than in human primary hepatocytes (hPH). To verify the mechanism underlying this reduced expression of CYP genes, including CYP1A1, CYP1A2, CYP1B1, CYP2D6, and CYP2E1, we investigated their epigenetic regulation in terms of DNA methylation and histone modifications in hESC-Hep and hPH. CpG islands of CYP genes were hypermethylated in hESC-Hep, whereas they had an open chromatin structure, as represented by hypomethylation of CpG sites and permissive histone modifications, in hPH. Inhibition of DNA methyltransferases (DNMTs) during hepatic maturation induced demethylation of the CpG sites of CYP1A1 and CYP1A2, leading to the up-regulation of their transcription. Combinatorial inhibition of DNMTs and histone deacetylases (HDACs) increased the transcript levels of CYP1A1, CYP1A2, CYP1B1, and CYP2D6. Our findings suggest that limited expression of CYP genes in hESC-Hep is modulated by epigenetic regulatory factors such as DNMTs and HDACs.	[Park, Han-Jin; Im, Ilkyun; Han, Yong-Mahn] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Park, Han-Jin; Im, Ilkyun; Han, Yong-Mahn] Korea Adv Inst Sci & Technol, Ctr Stem Cell Differentiat, Taejon 305701, South Korea; [Park, Han-Jin; Choi, Young-Jun; Kim, Ji Woo; Chun, Hang-Suk; Yoon, Seokjoo; Kim, Hyemin] Korea Inst Toxicol, Dept Predict Toxicol, Taejon 305343, South Korea; [Song, Chang-Woo] Korea Inst Toxicol, Dept Inhalat Res, Jeollabuk Do 580185, South Korea; [Choi, Young-Jun; Yoon, Seokjoo; Song, Chang-Woo] Univ Sci & Technol, Sch Engn, Human & Environm Toxicol, Taejon 303333, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT); Korea Institute of Toxicology	Kim, H (corresponding author), Korea Inst Toxicol, Dept Predict Toxicol, Taejon 305343, South Korea.	hyeminkim@kitox.re.kr	Han, Yong-Mahn/C-1652-2011		Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning (MSIP), Republic of Korea [NRF-2012M3A9C7050138]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning (MSIP), Republic of Korea	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP), Republic of Korea (No. NRF-2012M3A9C7050138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Baxter M, 2014, J HEPATOL; Beedanagari SR, 2010, MOL PHARMACOL, V78, P608, DOI 10.1124/mol.110.064899; Berger DR, 2014, HEPATOLOGY; Bieche I, 2007, PHARMACOGENET GENOM, V17, P731, DOI 10.1097/FPC.0b013e32810f2e58; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bonder MJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-860; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chang TKH, 2003, TOXICOL SCI, V71, P11, DOI 10.1093/toxsci/71.1.11; Czekaj P, 2005, ARCH TOXICOL, V79, P13, DOI 10.1007/s00204-004-0607-7; Ghotbi R, 2009, PHARMACOGENOMICS J, V9, P208, DOI 10.1038/tpj.2009.4; Gieseck RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086372; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Guguen-Guillouzo C, 2010, TOXICOLOGY, V270, P3, DOI 10.1016/j.tox.2009.09.019; Hagarman JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053880; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153; Hart SN, 2009, DRUG METAB DISPOS, V37, P116, DOI 10.1124/dmd.108.023812; Hasler J A, 1999, Mol Aspects Med, V20, P12; Hirota T, 2008, CURR DRUG METAB, V9, P34; Holmgren G, 2014, DRUG METAB DISPOS, V42, P1401, DOI 10.1124/dmd.114.059154; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; JONES SM, 1992, BIOCHEM PHARMACOL, V43, P1876, DOI 10.1016/0006-2952(92)90726-Y; Jorge-Nebert LF, 2010, HUM MUTAT, V31, P27, DOI 10.1002/humu.21132; Kacevska M, 2011, CLIN PHARMACOL THER, V89, P902, DOI 10.1038/clpt.2011.21; Kacevska M, 2012, BIOCHIMIE, V94, P2338, DOI 10.1016/j.biochi.2012.07.013; Kawakami H, 2011, J PHARM SCI-US, V100, P341, DOI 10.1002/jps.22255; Kia R, 2013, BRIT J CLIN PHARMACO, V75, P885, DOI 10.1111/j.1365-2125.2012.04360.x; Kondo Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104010; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Lee JS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-33; Lee JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024381; Lee JE, 2010, CELL TRANSPLANT, V19, P1383, DOI 10.3727/096368910X513991; Nakajima M, 2003, TOXICOL LETT, V144, P247, DOI 10.1016/S0378-4274(03)00216-9; Rich KJ, 1997, MICROSC RES TECHNIQ, V39, P424, DOI 10.1002/(SICI)1097-0029(19971201)39:5<424::AID-JEMT5>3.0.CO;2-G; Rowlands JC, 1997, CRIT REV TOXICOL, V27, P109, DOI 10.3109/10408449709021615; Scott CW, 2013, TOXICOL LETT, V219, P49, DOI 10.1016/j.toxlet.2013.02.020; Sjogren AKM, 2014, ARCH TOXICOL, V88, P1427, DOI 10.1007/s00204-014-1265-z; Stiborova M, 2005, CANCER LETT, V220, P145, DOI 10.1016/j.canlet.2004.07.036; Szkolnicka D, 2013, ANNU REV PHARMACOL, V53, P147, DOI 10.1146/annurev-pharmtox-011112-140306; Takayama K, 2014, P NATL ACAD SCI USA, V111, P16772, DOI 10.1073/pnas.1413481111; Takayama K, 2013, BIOMATERIALS, V34, P1781, DOI 10.1016/j.biomaterials.2012.11.029; Tekpli X, 2012, INT J CANCER, V131, P1509, DOI 10.1002/ijc.27421; TRELUYER JM, 1991, EUR J BIOCHEM, V202, P583, DOI 10.1111/j.1432-1033.1991.tb16411.x; Tsuchiya Y, 2003, J BIOCHEM, V133, P583, DOI 10.1093/jb/mvg075; Ueda R, 2006, MOL PHARMACOL, V69, P1924, DOI 10.1124/mol.105.021220; Vieira I, 1996, EUR J BIOCHEM, V238, P476, DOI 10.1111/j.1432-1033.1996.0476z.x; Vieira I, 1998, PHARMACOL TOXICOL, V83, P183, DOI 10.1111/j.1600-0773.1998.tb01466.x; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weng MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102035; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zhong XB, 2013, DRUG METAB DISPOS, V41, P1721, DOI 10.1124/dmd.113.053942	53	41	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132992	10.1371/journal.pone.0132992	http://dx.doi.org/10.1371/journal.pone.0132992			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177506	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600198
J	Park, SH; Park, S; Kim, DY; Pyo, A; Kimura, RH; Sathirachinda, A; Choy, HE; Min, JJ; Gambhir, SS; Hong, Y				Park, Seung-Hwan; Park, Sukho; Kim, Dong-Yeon; Pyo, Ayoung; Kimura, Richard H.; Sathirachinda, Ataya; Choy, Hyon E.; Min, Jung-Joon; Gambhir, Sanjiv Sam; Hong, Yeongjin			Isolation and Characterization of a Monobody with a Fibronectin Domain III Scaffold That Specifically Binds EphA2	PLOS ONE			English	Article							YEAST SURFACE DISPLAY; CANCER-CELLS; HIGH-AFFINITY; IN-VIVO; TYROSINE KINASE; RECEPTOR; ANTIBODY; PEPTIDE; INVASION; DELIVERY	Monobodies are binding scaffold proteins originating from a human fibronectin domain III (Fn3) scaffold that can be easily engineered with specificity and affinity. Human EphA2 (hEphA2) is an early detection marker protein for various tumors including lung, breast, and colon cancer. In this study, we isolated two hEphA2-specific monobodies (E1 and E10) by screening a yeast surface display library. They showed the same amino acid sequence except in the DE loop and had high affinity (similar to 2 nM Kd) against hEphA2. E1 bound only hEphA2 and mEphA2, although it bound hEphA2 with an affinity 2-fold higher than that of mEphA2. However, E10 also bound the mEphA6 and mEphA8 homologs as well as hEphA2 and mEphA2. Thus, E1 but not E10 was highly specific for hEphA2. E1 specifically bound human cells and xenograft tumor tissues expressing hEphA on the cell surface. In vivo optical imaging showed strong targeting of Cy5.5-labeled E1 to mouse tumor tissue induced by PC3 cells, a human prostate cancer cell line that expresses a high level of hEphA2. In conclusion, the highly specific monobody E1 is useful as a hEphA2 probe candidate for in vivo diagnosis and therapy.	[Park, Seung-Hwan; Kim, Dong-Yeon; Pyo, Ayoung; Min, Jung-Joon] Chonnam Natl Univ, Sch Med, Dept Nucl Med, Gwangju, South Korea; [Park, Sukho; Choy, Hyon E.; Hong, Yeongjin] Chonnam Natl Univ, Sch Med, Dept Microbiol, Gwangju, South Korea; [Kimura, Richard H.; Sathirachinda, Ataya; Gambhir, Sanjiv Sam] Stanford Univ, Dept Radiol, Mol Imaging Program Stanford, BioX Program, Palo Alto, CA 94304 USA	Chonnam National University; Chonnam National University; Stanford University	Hong, Y (corresponding author), Chonnam Natl Univ, Sch Med, Dept Microbiol, 5,Hak 1 Dong, Gwangju, South Korea.	yjhong@chonnam.ac.kr		Park, Seung-Hwan/0000-0003-4613-4680	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A6A3A04057492]; Chonnam National University Hwasun Hospital Institute for Biomedical Science [HCRI14006-1]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Chonnam National University Hwasun Hospital Institute for Biomedical Science	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2014R1A6A3A04057492). Y. H was supported by a grant (HCRI14006-1) from Chonnam National University Hwasun Hospital Institute for Biomedical Science.	Blackburn WH, 2009, BIOCONJUGATE CHEM, V20, P960, DOI 10.1021/bc800547c; Bloom L, 2009, DRUG DISCOV TODAY, V14, P949, DOI 10.1016/j.drudis.2009.06.007; Bruckheimer EM, 2009, NEOPLASIA, V11, P509, DOI 10.1593/neo.81578; Cai WB, 2007, EUR J NUCL MED MOL I, V34, P2024, DOI 10.1007/s00259-007-0503-5; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Cheng N, 2002, MOL CANCER RES, V1, P2; Coffman KT, 2003, CANCER RES, V63, P7907; Dickerson EB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-10; DICKINSON CD, 1994, J MOL BIOL, V236, P1079, DOI 10.1016/0022-2836(94)90013-2; Faoro L, 2010, J BIOL CHEM, V285, P18575, DOI 10.1074/jbc.M109.075085; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gobin AM, 2008, INT J NANOMED, V3, P351; Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051; Hackel BJ, 2012, RADIOLOGY, V263, P179, DOI 10.1148/radiol.12111504; Hackel BJ, 2010, J MOL BIOL, V401, P84, DOI 10.1016/j.jmb.2010.06.004; Hackel BJ, 2010, PROTEIN ENG DES SEL, V23, P211, DOI 10.1093/protein/gzp083; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Hammond SA, 2007, CANCER RES, V67, P3927, DOI 10.1158/0008-5472.CAN-06-2760; Herath NI, 2010, INT J CANCER, V126, P2003, DOI 10.1002/ijc.25147; Jackson D, 2008, CANCER RES, V68, P9367, DOI 10.1158/0008-5472.CAN-08-1933; Jiang SN, 2013, MOL THER, V21, P1985, DOI 10.1038/mt.2013.183; Johansson Staffan, 1997, Frontiers in Bioscience (online), V2, pD126; Kinch MS, 2003, CLIN EXP METASTAS, V20, P59, DOI 10.1023/A:1022546620495; Koolpe M, 2002, J BIOL CHEM, V277, P46974, DOI 10.1074/jbc.M208495200; Landen CN, 2006, J NATL CANCER I, V98, P1558, DOI 10.1093/jnci/djj414; Lee JW, 2009, JNCI-J NATL CANCER I, V101, P1193, DOI 10.1093/jnci/djp231; Lipovsek D, 2011, PROTEIN ENG DES SEL, V24, P3, DOI 10.1093/protein/gzq097; Lipovsek D, 2007, J MOL BIOL, V368, P1024, DOI 10.1016/j.jmb.2007.02.029; Liu Y, 2014, NUCL MED BIOL, V41, P450, DOI 10.1016/j.nucmedbio.2014.03.020; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; Mitra S, 2010, BIOCHEMISTRY-US, V49, P6687, DOI 10.1021/bi1006223; Mosch B, 2010, J ONCOL, V2010, DOI 10.1155/2010/135285; Noblitt LW, 2004, CANCER GENE THER, V11, P757, DOI 10.1038/sj.cgt.7700761; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Parri M, 2009, CANCER RES, V69, P2072, DOI 10.1158/0008-5472.CAN-08-1845; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Ponsel D, 2011, MOLECULES, V16, P3675, DOI 10.3390/molecules16053675; Scarberry KE, 2008, J AM CHEM SOC, V130, P10258, DOI 10.1021/ja801969b; Scarberry KE, 2010, NANOMED-NANOTECHNOL, V6, P399, DOI 10.1016/j.nano.2009.11.003; Taddei ML, 2009, AM J PATHOL, V174, P1492, DOI 10.2353/ajpath.2009.080473; Thomas SM, 2004, CANCER TREAT REV, V30, P255, DOI 10.1016/j.ctrv.2003.10.003; Wesa AK, 2008, J IMMUNOL, V181, P7721, DOI 10.4049/jimmunol.181.11.7721; Wykosky J, 2007, MOL CANCER THER, V6, P3208, DOI 10.1158/1535-7163.MCT-07-0200	45	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132976	10.1371/journal.pone.0132976	http://dx.doi.org/10.1371/journal.pone.0132976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177208	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600194
J	Pham, CQ; Bremen, P; Shen, WD; Yang, SM; Middlebrooks, JC; Zeng, FG; Mc Laughlin, M				Pham, Carol Q.; Bremen, Peter; Shen, Weidong; Yang, Shi-Ming; Middlebrooks, John C.; Zeng, Fan-Gang; Mc Laughlin, Myles			Central Auditory Processing of Temporal and Spectral-Variance Cues in Cochlear Implant Listeners	PLOS ONE			English	Article							SPATIAL TUNING CURVES; INFORMATIONAL MASKING; MULTICOMPONENT MASKERS; FREQUENCY-SELECTIVITY; STREAM SEGREGATION; SPEECH RECOGNITION; USERS; NERVE; NOISE; RESOLUTION	Cochlear implant (CI) listeners have difficulty understanding speech in complex listening environments. This deficit is thought to be largely due to peripheral encoding problems arising from current spread, which results in wide peripheral filters. In normal hearing (NH) listeners, central processing contributes to segregation of speech from competing sounds. We tested the hypothesis that basic central processing abilities are retained in post-lingually deaf CI listeners, but processing is hampered by degraded input from the periphery. In eight CI listeners, we measured auditory nerve compound action potentials to characterize peripheral filters. Then, we measured psychophysical detection thresholds in the presence of multi-electrode maskers placed either inside (peripheral masking) or outside (central masking) the peripheral filter. This was intended to distinguish peripheral from central contributions to signal detection. Introduction of temporal asynchrony between the signal and masker improved signal detection in both peripheral and central masking conditions for all CI listeners. Randomly varying components of the masker created spectral-variance cues, which seemed to benefit only two out of eight CI listeners. Contrastingly, the spectral-variance cues improved signal detection in all five NH listeners who listened to our CI simulation. Together these results indicate that widened peripheral filters significantly hamper central processing of spectral-variance cues but not of temporal cues in post-lingually deaf CI listeners. As indicated by two CI listeners in our study, however, post-lingually deaf CI listeners may retain some central processing abilities similar to NH listeners.	[Pham, Carol Q.; Bremen, Peter; Middlebrooks, John C.; Zeng, Fan-Gang; Mc Laughlin, Myles] Univ Calif Irvine, Ctr Hearing Res, Irvine, CA 92697 USA; [Pham, Carol Q.; Zeng, Fan-Gang] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Bremen, Peter; Middlebrooks, John C.; Zeng, Fan-Gang; Mc Laughlin, Myles] Univ Calif Irvine, Dept Otolaryngol Head & Neck Surg, Irvine, CA USA; [Shen, Weidong; Yang, Shi-Ming] Chinese PLA Genera Hosp, Inst Otolaryngol, Beijing, Peoples R China; [Middlebrooks, John C.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Middlebrooks, John C.; Zeng, Fan-Gang] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Middlebrooks, John C.; Zeng, Fan-Gang] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Pham, CQ (corresponding author), Univ Calif Irvine, Ctr Hearing Res, Irvine, CA 92697 USA.	carol.pham@uci.edu	Mc Laughlin, Myles/G-3497-2015	Mc Laughlin, Myles/0000-0001-8574-1841; Bremen, Peter/0000-0003-1709-6224; Pham, Carol/0000-0002-3968-0600	National Institutes of Health [RO1-DC000420, RO1-DC008858, P30-DC008369, T32-DC010775, UL1 TR000153]; European Union; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000153, TL1TR001415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000420, P30DC008369, T32DC010775, R01DC008858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors express gratitude toward all of the listeners for their dedication to the study. The authors would also like to thank Dr. Thomas Lu for technical assistance and Dr. Ginger Stickney for facilitating subject recruitment. This work was supported by grants from the National Institutes of Health: RO1-DC000420, RO1-DC008858, P30-DC008369, T32-DC010775, UL1 TR000153, and by a European Union FP7 Marie Curie Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas PJ, 1999, EAR HEARING, V20, P45, DOI 10.1097/00003446-199902000-00005; Abbas PJ, 2004, COCHLEAR IMPLANTS AU, P187; Bernstein JGW, 2006, J ACOUST SOC AM, V120, P3929, DOI 10.1121/1.2372452; Bizley JK, 2013, NAT REV NEUROSCI, V14, P693, DOI 10.1038/nrn3565; Bregman A.S., 1990, AUDITORY SCENE ANAL; Bremen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059815; BROWN CJ, 1990, J ACOUST SOC AM, V88, P1385, DOI 10.1121/1.399716; Chatterjee M, 2006, HEARING RES, V222, P100, DOI 10.1016/j.heares.2006.09.001; Choi I, 2014, HEARING RES, V314, P10, DOI 10.1016/j.heares.2014.04.008; Dorman MF, 1998, J ACOUST SOC AM, V104, P3583, DOI 10.1121/1.423940; Durlach NI, 2003, J ACOUST SOC AM, V113, P2984, DOI 10.1121/1.1570435; Evans AJ, 2009, J BIOMED MATER RES A, V91A, P241, DOI 10.1002/jbm.a.32228; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Fu QJ, 2005, JARO-J ASSOC RES OTO, V6, P19, DOI 10.1007/s10162-004-5024-3; HARTMANN R, 1984, HEARING RES, V13, P47, DOI 10.1016/0378-5955(84)90094-7; Hartmann R., 1990, COCHLEAR IMPLANTS MO, P135; Hong RS, 2009, J ACOUST SOC AM, V126, P291, DOI 10.1121/1.3140592; Javel E., 1990, COCHLEAR IMPLANTS MO, P247, DOI [10.1007/978-1-4612-3256-8_17, DOI 10.1007/978-1-4612-3256-8_17]; Joris PX, 2011, P NATL ACAD SCI USA, V108, P17516, DOI 10.1073/pnas.1105867108; KIDD G, 1995, J ACOUST SOC AM, V97, P3782, DOI 10.1121/1.413107; KIDD G, 1994, J ACOUST SOC AM, V95, P3475, DOI 10.1121/1.410023; Kidd Gerald Jr., 2008, V29, P143; Kral A, 1998, HEARING RES, V121, P11, DOI 10.1016/S0378-5955(98)00061-6; Kral A, 2012, TRENDS NEUROSCI, V35, P111, DOI 10.1016/j.tins.2011.09.004; Lai WK, 2000, AUDIOL NEURO-OTOL, V5, P333, DOI 10.1159/000013899; Leake PA, 2011, J COMP NEUROL, V519, P1526, DOI 10.1002/cne.22582; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Loizou PC, 2000, EAR HEARING, V21, P25, DOI 10.1097/00003446-200002000-00006; Middlebrooks JC, 2007, JARO-J ASSOC RES OTO, V8, P258, DOI 10.1007/s10162-007-0070-2; MOORE B C J, 1985, British Journal of Audiology, V19, P189; NEFF DL, 1988, J ACOUST SOC AM, V83, P1833, DOI 10.1121/1.396518; NEFF DL, 1987, PERCEPT PSYCHOPHYS, V41, P409, DOI 10.3758/BF03203033; NEFF DL, 1993, J ACOUST SOC AM, V94, P3112, DOI 10.1121/1.407217; Nelson DA, 1996, J ACOUST SOC AM, V100, P2393, DOI 10.1121/1.417949; Nelson DA, 2008, J ACOUST SOC AM, V123, P1522, DOI 10.1121/1.2836786; Nelson DA, 2011, J ACOUST SOC AM, V129, P3916, DOI 10.1121/1.3583503; Nourski KV, 2013, JARO-J ASSOC RES OTO, V14, P435, DOI 10.1007/s10162-013-0382-3; Shera CA, 2002, P NATL ACAD SCI USA, V99, P3318, DOI 10.1073/pnas.032675099; Stickney GS, 2004, J ACOUST SOC AM, V116, P1081, DOI 10.1121/1.1772399; Stickney GS, 2004, INT CONGR SER, V1273, P23, DOI 10.1016/j.ics.2004.09.017; Unoki M, 2006, J ACOUST SOC AM, V120, P1474, DOI 10.1121/1.2228539; VANDENHONERT C, 1984, HEARING RES, V14, P225, DOI 10.1016/0378-5955(84)90052-2; VANDENHONERT C, 1987, HEARING RES, V29, P207, DOI 10.1016/0378-5955(87)90168-7; Won JH, 2007, JARO-J ASSOC RES OTO, V8, P384, DOI 10.1007/s10162-007-0085-8; WYGONSKI J, 2002, HEI NUCL RES INTERFA	45	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132423	10.1371/journal.pone.0132423	http://dx.doi.org/10.1371/journal.pone.0132423			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176553	Green Published, gold			2022-12-27	WOS:000358197600111
J	Riordan, DP; Varma, S; West, RB; Brown, PO				Riordan, Daniel P.; Varma, Sushama; West, Robert B.; Brown, Patrick O.			Automated Analysis and Classification of Histological Tissue Features by Multi-Dimensional Microscopic Molecular Profiling	PLOS ONE			English	Article							CELL; CYTOMETRY; PLATFORM; TOOL	Characterization of the molecular attributes and spatial arrangements of cells and features within complex human tissues provides a critical basis for understanding processes involved in development and disease. Moreover, the ability to automate steps in the analysis and interpretation of histological images that currently require manual inspection by pathologists could revolutionize medical diagnostics. Toward this end, we developed a new imaging approach called multidimensional microscopic molecular profiling (MMMP) that can measure several independent molecular properties in situ at subcellular resolution for the same tissue specimen. MMMP involves repeated cycles of antibody or histochemical staining, imaging, and signal removal, which ultimately can generate information analogous to a multidimensional flow cytometry analysis on intact tissue sections. We performed a MMMP analysis on a tissue microarray containing a diverse set of 102 human tissues using a panel of 15 informative antibody and 5 histochemical stains plus DAPI. Large-scale unsupervised analysis of MMMP data, and visualization of the resulting classifications, identified molecular profiles that were associated with functional tissue features. We then directly annotated H&E images from this MMMP series such that canonical histological features of interest (e.g. blood vessels, epithelium, red blood cells) were individually labeled. By integrating image annotation data, we identified molecular signatures that were associated with specific histological annotations and we developed statistical models for automatically classifying these features. The classification accuracy for automated histology labeling was objectively evaluated using a cross-validation strategy, and significant accuracy (with a median per-pixel rate of 77% per feature from 15 annotated samples) for de novo feature prediction was obtained. These results suggest that high-dimensional profiling may advance the development of computer-based systems for automatically parsing relevant histological and cellular features from molecular imaging data of arbitrary human tissue samples, and can provide a framework and resource to spur the optimization of these technologies.	[Riordan, Daniel P.; Brown, Patrick O.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Riordan, Daniel P.; Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Varma, Sushama; West, Robert B.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Riordan, DP (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	driordan@stanford.edu		West, Robert/0000-0002-8330-8283	National Heart, Lung, and Blood Institute (NHLBI) Progenitor Cell Biology Consortium Grant [U01HL099995]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099995] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI) Progenitor Cell Biology Consortium Grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute (NHLBI) U01HL099995 Progenitor Cell Biology Consortium Grant (POB, DPR, SV, RBW) and by the Howard Hughes Medical Institute (POB and DPR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; Autissier P, 2010, CYTOM PART A, V77A, P410, DOI 10.1002/cyto.a.20859; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Ferte C, 2010, NAT REV CLIN ONCOL, V7, P367, DOI 10.1038/nrclinonc.2010.84; Friedenberger M, 2007, NAT PROTOC, V2, P2285, DOI 10.1038/nprot.2007.320; Gerdes MJ, 2013, P NATL ACAD SCI USA, V110, P11982, DOI 10.1073/pnas.1300136110; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Kolling J, 2012, BIOINFORMATICS, V28, P1143, DOI 10.1093/bioinformatics/bts104; Kovacheva VN, 2014, BIOINFORMATICS, V30, P420, DOI 10.1093/bioinformatics/btt676; Lassmann S, 2012, HISTOL HISTOPATHOL, V27, P289, DOI 10.14670/HH-27.289; Marinelli RJ, 2008, NUCLEIC ACIDS RES, V36, pD871, DOI 10.1093/nar/gkm861; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; Tsurui H, 2000, J HISTOCHEM CYTOCHEM, V48, P653, DOI 10.1177/002215540004800509; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; West RB, 2006, HISTOPATHOLOGY, V48, P22, DOI 10.1111/j.1365-2559.2005.02286.x; Zrazhevskiy P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2635	25	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0128975	10.1371/journal.pone.0128975	http://dx.doi.org/10.1371/journal.pone.0128975			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176839	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600010
J	Sehgal, D; Vikram, P; Sansaloni, CP; Ortiz, C; St Pierre, C; Payne, T; Ellis, M; Amri, A; Petroli, CD; Wenzl, P; Singh, S				Sehgal, Deepmala; Vikram, Prashant; Paola Sansaloni, Carolina; Ortiz, Cynthia; St Pierre, Carolina; Payne, Thomas; Ellis, Marc; Amri, Ahmed; Daniel Petroli, Cesar; Wenzl, Peter; Singh, Sukhwinder			Exploring and Mobilizing the Gene Bank Biodiversity for Wheat Improvement	PLOS ONE			English	Article							BREAD WHEAT; HEXAPLOID WHEAT; MOLECULAR DIVERSITY; TEMPORAL TRENDS; GERMPLASM; BARLEY; POLYMORPHISM; RESOURCES; LANDRACES; CULTIVARS	Identifying and mobilizing useful genetic variation from germplasm banks to breeding programs is an important strategy for sustaining crop genetic improvement. The molecular diversity of 1,423 spring bread wheat accessions representing major global production environments was investigated using high quality genotyping-by-sequencing (GBS) loci, and gene-based markers for various adaptive and quality traits. Mean diversity index (DI) estimates revealed synthetic hexaploids to be genetically more diverse (DI = 0.284) than elites (DI = 0.267) and landraces (DI = 0.245). GBS markers discovered thousands of new SNP variations in the landraces which were well known to be adapted to drought (1273 novel GBS SNPs) and heat (4473 novel GBS SNPs) stress environments. This may open new avenues for pre-breeding by enriching the elite germplasm with novel alleles for drought and heat tolerance. Furthermore, new allelic variation for vernalization and glutenin genes was also identified from 47 landraces originating from Iraq, Iran, India, Afghanistan, Pakistan, Uzbekistan and Turkmenistan. The information generated in the study has been utilized to select 200 diverse gene bank accessions to harness their potential in pre-breeding and for allele mining of candidate genes for drought and heat stress tolerance, thus channeling novel variation into breeding pipelines. This research is part of CIMMYT's ongoing 'Seeds of Discovery' project visioning towards the development of high yielding wheat varieties that address future challenges from climate change.	[Sehgal, Deepmala; Vikram, Prashant; Paola Sansaloni, Carolina; Ortiz, Cynthia; St Pierre, Carolina; Payne, Thomas; Ellis, Marc; Daniel Petroli, Cesar; Singh, Sukhwinder] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco 56130, Edo De Mexico, Mexico; [Amri, Ahmed] Int Ctr Agr Res Dry Areas, Beirut 11082010, Lebanon; [Wenzl, Peter] Global Crop Div Trust, DivSeek, D-53113 Bonn, Germany	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA)	Singh, S (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Km 45 Carretera Mexico Veracruz, Texcoco 56130, Edo De Mexico, Mexico.	suk.singh@cgiar.org		Vikram, Prashant/0000-0002-3740-6608; Saint Pierre, Carolina/0000-0003-1291-7468	SAGARPA (Mexican Government agency), CIMMYT project [R0153]	SAGARPA (Mexican Government agency), CIMMYT project	Seeds of Discovery was funded by SAGARPA (Mexican Government agency), http://www.sagarpa.gob.mx/Paginas/default.aspx, CIMMYT project # R0153.	[Anonymous], 2013, CROP BREEDING J; [Anonymous], 1997, MOL BIOL BIOTECHNOLO; [Anonymous], 2002, BREAD WHEAT IMPROVEM; Bass C, 2006, GENOME, V49, P1140, DOI 10.1139/G06-064; Brisson N, 2010, FIELD CROP RES, V119, P201, DOI 10.1016/j.fcr.2010.07.012; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chao SM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-727; Chao SM, 2009, MOL BREEDING, V23, P23, DOI 10.1007/s11032-008-9210-6; Chen F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-199; Chen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044510; Christiansen MJ, 2002, MOL BREEDING, V9, P1, DOI 10.1023/A:1019234323372; Donini P, 2000, THEOR APPL GENET, V100, P912, DOI 10.1007/s001220051370; Dreisigacker S, 2008, AUST J AGR RES, V59, P413, DOI 10.1071/AR07225; Dreisigacker S, 2012, MOL BREEDING, V29, P529, DOI 10.1007/s11032-011-9569-7; El Bouhssini M, 2011, PLANT BREEDING, V130, P96, DOI 10.1111/j.1439-0523.2010.01814.x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; FAO repository, 2009, GLOB AGR 2050 ROM FA; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Fu YB, 2011, PLANT GENOME-US, V4, P226, DOI 10.3835/plantgenome2011.08.0022; Graybosch RA, 2010, CROP SCI, V50, P1882, DOI 10.2135/cropsci2009.11.0685; Heslot N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074612; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; HOISINGTON D, 1994, LAB PROTOCOLS CIMMYT; Huang XQ, 2002, THEOR APPL GENET, V105, P699, DOI 10.1007/s00122-002-0959-4; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Ito M, 2011, BREEDING SCI, V61, P281, DOI 10.1270/jsbbs.61.281; Keilwagen J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05231; Kihara H., 1983, P 6 INT WHEAT GEN S; Kilian B, 2012, BRIEF FUNCT GENOMICS, V11, P38, DOI 10.1093/bfgp/elr046; Koebner RMD, 2003, THEOR APPL GENET, V106, P550, DOI 10.1007/s00122-002-1065-3; Liu L, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-124; Lu H, 2001, THEOR APPL GENET, V103, P613, DOI 10.1007/PL00002917; Manickavelu A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0320-5; Manifesto MM, 2001, CROP SCI, V41, P682, DOI 10.2135/cropsci2001.413682x; Martin JM, 2001, CROP SCI, V41, P228, DOI 10.2135/cropsci2001.411228x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nielsen NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094000; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Perrier X., 2006, DARWIN SOFTWARE; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Rajaram S., 2001, WORLD WHEAT BOOK HIS, P579; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Reif JC, 2005, THEOR APPL GENET, V110, P859, DOI 10.1007/s00122-004-1881-8; Roussel V, 2005, THEOR APPL GENET, V111, P162, DOI 10.1007/s00122-005-2014-8; Roussel V, 2004, THEOR APPL GENET, V108, P920, DOI 10.1007/s00122-003-1502-y; Russell JR, 2000, MOL BREEDING, V6, P553, DOI 10.1023/A:1011372312962; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Singh S, 2014, PLANT AN GEN C SAN D, P207; Smale M, 2002, CROP SCI, V42, P1766, DOI 10.2135/cropsci2002.1766; Solh M, 2014, WEATHER CLIM EXTREME, V3, P62, DOI 10.1016/j.wace.2014.03.003; Somers DJ, 2003, GENOME, V46, P431, DOI 10.1139/G03-027; Sultan B, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014040; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trethowan RM, 2008, CROP SCI, V48, P1255, DOI 10.2135/cropsci2007.08.0477; van Ginkel M, 2007, FIELD CROP RES, V104, P86, DOI 10.1016/j.fcr.2007.02.005; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Warburton ML, 2006, EUPHYTICA, V149, P289, DOI 10.1007/s10681-005-9077-0; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Zhang LY, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-42; Zhang PZ, 2005, MOL BREEDING, V15, P1, DOI 10.1007/s11032-004-1167-5	60	65	65	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132112	10.1371/journal.pone.0132112	http://dx.doi.org/10.1371/journal.pone.0132112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176697	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600083
J	Silva, RC; Dautel, M; Di Genova, BM; Amberg, DC; Castilho, BA; Sattlegger, E				Silva, Richard C.; Dautel, Martina; Di Genova, Bruno M.; Amberg, David C.; Castilho, Beatriz A.; Sattlegger, Evelyn			The Gcn2 Regulator Yih1 Interacts with the Cyclin Dependent Kinase Cdc28 and Promotes Cell Cycle Progression through G2/M in Budding Yeast	PLOS ONE			English	Article							INITIATION-FACTOR 2-ALPHA; AMINO-ACID CONTROL; RIBOSOME ENTRY SITE; PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; GLOBAL ANALYSIS; INCREASED PHOSPHORYLATION; TRANSLATIONAL REGULATION; INTRINSIC DISORDER; BINDING-PROTEIN	The Saccharomyces cerevisiae protein Yih1, when overexpressed, inhibits the eIF2 alpha kinase Gcn2 by competing for Gcn1 binding. However, deletion of YIH1 has no detectable effect on Gcn2 activity, suggesting that Yih1 is not a general inhibitor of Gcn2, and has no phenotypic defect identified so far. Thus, its physiological role is largely unknown. Here, we show that Yih1 is involved in the cell cycle. Yeast lacking Yih1 displays morphological patterns and DNA content indicative of a delay in the G2/M phases of the cell cycle, and this phenotype is independent of Gcn1 and Gcn2. Accordingly, the levels of phosphorylated eIF2a, which show a cell cycle-dependent fluctuation, are not altered in cells devoid of Yih1. We present several lines of evidence indicating that Yih1 is in a complex with Cdc28. Yih1 pulls down endogenous Cdc28 in vivo and this interaction is enhanced when Cdc28 is active, suggesting that Yih1 modulates the function of Cdc28 in specific stages of the cell cycle. We also demonstrate, by Bimolecular Fluorescence Complementation, that endogenous Yih1 and Cdc28 interact with each other, confirming Yih1 as a bona fide Cdc28 binding partner. Amino acid substitutions within helix H2 of the RWD domain of Yih1 enhance Yih1- Cdc28 association. Overexpression of this mutant, but not of wild type Yih1, leads to a phenotype similar to that of YIH1 deletion, supporting the view that Yih1 is involved through Cdc28 in the regulation of the cell cycle. We further show that IMPACT, the mammalian homologue of Yih1, interacts with CDK1, the mammalian counterpart of Cdc28, indicating that the involvement with the cell cycle is conserved. Together, these data provide insights into the cellular function of Yih1/IMPACT, and provide the basis for future studies on the role of this protein in the cell cycle.	[Silva, Richard C.; Di Genova, Bruno M.; Castilho, Beatriz A.] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil; [Dautel, Martina; Sattlegger, Evelyn] Massey Univ, Inst Nat & Math Sci, Auckland, New Zealand; [Amberg, David C.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	Universidade Federal de Sao Paulo (UNIFESP); Massey University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Castilho, BA (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil.	bacastilho@unifesp.br; e.sattlegger@massey.ac.nz	Castilho, Beatriz A/C-2503-2012	Castilho, Beatriz A/0000-0003-4509-5237; Silva, Richard/0000-0003-2767-2053	Fundacao da Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [09/52047-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [478903/2012-0, 309860/2011-3]; Health Research Council of New Zealand Emerging Researcher grant [06/410]; Auckland Medical Research Foundation; Maurice AMP; Phyllis Paykel Trust; National Institutes of Health [GM-56189]; CNPq [153660/2010-4]; CAPES-PSDE fellowship (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)) [1915-13-4]; Massey University; Institute of Natural and Mathematical Sciences; FAPESP; Massey University Research Fund	Fundacao da Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Health Research Council of New Zealand Emerging Researcher grant; Auckland Medical Research Foundation; Maurice AMP; Phyllis Paykel Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-PSDE fellowship (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Massey University; Institute of Natural and Mathematical Sciences; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Massey University Research Fund	This work was supported by grants 09/52047-5 (Fundacao da Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), http://www.fapesp.br/), 478903/2012-0 and and 309860/2011-3 (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), http://www.cnpq.br/) to B.A.C., Health Research Council of New Zealand Emerging Researcher grant (06/410, http://www.hrc.govt.nz/), Auckland Medical Research Foundation (http://www.medicalresearch.org.nz/), Maurice & Phyllis Paykel Trust (http://www.paykeltrust.co.nz/), and Massey University Research Fund (http://www.massey.ac.nz) to E.S. and by grant GM-56189 (National Institutes of Health, http://www.nih.gov/) awarded to D.A.R.C.S. was a recipient of a CNPq doctoral fellowship (153660/2010-4) and a CAPES-PSDE fellowship (1915-13-4, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), http://www.capes.gov.br/). M.D was supported in part by the Massey University doctoral scholarship and the Institute of Natural and Mathematical Sciences. B.M.D.G received a doctoral fellowship from FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberghina L, 2004, J CELL BIOL, V167, P433, DOI 10.1083/jcb.200405102; AMBERG DC, 1995, NAT STRUCT BIOL, V2, P28, DOI 10.1038/nsb0195-28; AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; Bittencourt S, 2008, J COMP NEUROL, V507, P1811, DOI 10.1002/cne.21652; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cambiaghi TD, 2014, BIOCHEM BIOPH RES CO, V443, P592, DOI 10.1016/j.bbrc.2013.12.021; Castilho BA, 2014, BBA-MOL CELL RES, V1843, P1948, DOI 10.1016/j.bbamcr.2014.04.006; Chymkowitch P, 2012, P NATL ACAD SCI USA, V109, P10450, DOI 10.1073/pnas.1200067109; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Datta B, 1999, EXP CELL RES, V250, P223, DOI 10.1006/excr.1999.4508; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; Farrell A, 2000, MOL CELL BIOL, V20, P749, DOI 10.1128/MCB.20.3.749-754.2000; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hagiwara Y, 1997, P NATL ACAD SCI USA, V94, P9249, DOI 10.1073/pnas.94.17.9249; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Hashimoto NN, 2002, BIOCHEM J, V367, P359, DOI 10.1042/BJ20020556; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Humphrey T, 2005, CELL CYCLE MOL MECH, P3; Jeoung DI, 1998, MOL CELL BIOL, V18, P433, DOI 10.1128/MCB.18.1.433; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; KRANENBURG O, 1995, J CELL BIOL, V131, P227, DOI 10.1083/jcb.131.1.227; Kronja I, 2011, PHILOS T R SOC B, V366, P3638, DOI 10.1098/rstb.2011.0084; Kubota H, 2000, J BIOL CHEM, V275, P20243, DOI 10.1074/jbc.C000262200; LEW DJ, 1995, J CELL BIOL, V129, P739, DOI 10.1083/jcb.129.3.739; Lew DJ, 1997, MOL CELLULAR BIOL YE, P607; Li YC, 2010, ANTI-CANCER DRUG, V21, P389, DOI 10.1097/CAD.0b013e328336b383; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Manderson EN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001500; Martin R, 2013, J CELL SCI, V126, P3010, DOI 10.1242/jcs.118067; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; Menacho-Marquez M, 2007, CELL CYCLE, V6, P2302, DOI 10.4161/cc.6.18.4668; MENDENHALL MD, 1987, CELL, V50, P927, DOI 10.1016/0092-8674(87)90519-8; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Miao YS, 2013, P NATL ACAD SCI USA, V110, pE4446, DOI 10.1073/pnas.1314000110; Myster DL, 2000, CURR BIOL, V10, pR302, DOI 10.1016/S0960-9822(00)00435-8; Pereira CM, 2005, J BIOL CHEM, V280, P28316, DOI 10.1074/jbc.M408571200; PETER M, 1994, SCIENCE, V265, P1228, DOI 10.1126/science.8066461; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Roffe M, 2013, J BIOL CHEM, V288, P10860, DOI 10.1074/jbc.M113.461970; Rojas M, 2014, P NATL ACAD SCI USA, V111, pE1344, DOI 10.1073/pnas.1400129111; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Sattlegger E, 2000, EMBO J, V19, P6622, DOI 10.1093/emboj/19.23.6622; Sattlegger E, 2004, J BIOL CHEM, V279, P29952, DOI 10.1074/jbc.M404009200; Sattlegger E., 2011, PROTOC EXCH, DOI [10.1038/protex.2011.212, DOI 10.1038/PROTEX.2011.212]; Sattlegger E, 2011, J BIOL CHEM, V286, P10341, DOI 10.1074/jbc.M110.171587; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Tantos A, 2012, MOL CELL ENDOCRINOL, V348, P457, DOI 10.1016/j.mce.2011.07.015; Tinton SA, 2005, BIOCHEM J, V385, P155, DOI 10.1042/BJ20040963; Tvegard T, 2007, GENE DEV, V21, P649, DOI 10.1101/gad.421807; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Waller T, 2012, FEBS J, V279, P1761, DOI 10.1111/j.1742-4658.2012.08553.x; WEK RC, 1992, MOL CELL BIOL, V12, P5700, DOI 10.1128/MCB.12.12.5700; Wiedemann M, 2013, NATURE PROTOCOL EXCH, DOI [10.1038/protex.2013.095, DOI 10.1038/PROTEX.2013.095]; WITTENBERG C, 1989, MOL CELL BIOL, V9, P4064, DOI 10.1128/MCB.9.9.4064; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81	65	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131070	10.1371/journal.pone.0131070	http://dx.doi.org/10.1371/journal.pone.0131070			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176233	Green Submitted, gold, Green Published			2022-12-27	WOS:000358197600035
J	Van Belle, V; Van Calster, B				Van Belle, Vanya; Van Calster, Ben			Visualizing Risk Prediction Models	PLOS ONE			English	Article							CLINICAL DECISION-SUPPORT; ODDS RATIO; LOGISTIC-REGRESSION; VALIDATION; SYSTEMS; SCORE	Objective Risk prediction models can assist clinicians in making decisions. To boost the uptake of these models in clinical practice, it is important that end-users understand how the model works and can efficiently communicate its results. We introduce novel methods for interpretable model visualization. Methods The proposed visualization techniques are applied to two prediction models from the Framingham Heart Study for the prediction of intermittent claudication and stroke after atrial fibrillation. We represent models using color bars, and visualize the risk estimation process for a specific patient using patient-specific contribution charts. Results The color-based model representations provide users with an attractive tool to instantly gauge the relative importance of the predictors. The patient-specific representations allow users to understand the relative contribution of each predictor to the patient's estimated risk, potentially providing insightful information on which to base further patient management. Extensions towards non-linear models and interactions are illustrated on an artificial dataset. Conclusion The proposed methods summarize risk prediction models and risk predictions for specific patients in an alternative way. These representations may facilitate communication between clinicians and patients.	[Van Belle, Vanya] Katholieke Univ Leuven, Dept Elect Engn ESAT, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Leuven, Belgium; [Van Belle, Vanya] Katholieke Univ Leuven, iMinds Med IT, Leuven, Belgium; [Van Calster, Ben] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium	KU Leuven; IMEC; KU Leuven; KU Leuven	Van Belle, V (corresponding author), Katholieke Univ Leuven, Dept Elect Engn ESAT, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Leuven, Belgium.	vanya.vanbelle@esat.kuleuven.be	Van Calster, Ben/F-9150-2010	Van Calster, Ben/0000-0003-1613-7450	Research Council KUL (GOA MaNet) [PFV/10/002]; Flemish Government (Research Foundation Flanders (FWO)) [G049312N]; Flemish Government (Agency for Innovation by Science and Technology (IWT)) [IWT-TBM 070706-IOTA3]; Flemish Government (iMinds); Belgian Federal Science Policy Office IUAP P7 (DYSCO, Dynamical systems, control and optimization)	Research Council KUL (GOA MaNet); Flemish Government (Research Foundation Flanders (FWO)); Flemish Government (Agency for Innovation by Science and Technology (IWT))(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Flemish Government (iMinds); Belgian Federal Science Policy Office IUAP P7 (DYSCO, Dynamical systems, control and optimization)(Belgian Federal Science Policy Office)	Research supported by: Research Council KUL (GOA MaNet, PFV/10/002 (OPTEC)), Flemish Government (Research Foundation Flanders (FWO) project G049312N, Agency for Innovation by Science and Technology (IWT) project IWT-TBM 070706-IOTA3, and iMinds); Belgian Federal Science Policy Office IUAP P7 (DYSCO, Dynamical systems, control and optimization, 2012-2017). VVB is a postdoctoral fellow of the FWO.	Agrawal D, 2005, PEDIATRICS, V116, P1612, DOI 10.1542/peds.2005-2269; Altman DG, 1998, BRIT MED J, V317, P1318, DOI 10.1136/bmj.317.7168.1318; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Bjork J, 2012, J CLIN EPIDEMIOL, V65, P335, DOI 10.1016/j.jclinepi.2011.06.019; Borkin MA, 2011, IEEE T VIS COMPUT GR, V17, P2479, DOI 10.1109/TVCG.2011.192; Borland D, 2007, IEEE COMPUT GRAPH, V27, P14, DOI 10.1109/MCG.2007.323435; Brabanter J.D., 2002, LEAST SQUARES SUPPOR, DOI DOI 10.1142/9789812776655; Chalmers J, 2013, EUR J CARDIO-THORAC, V43, P688, DOI 10.1093/ejcts/ezs406; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; Edwards A, 2002, BMJ-BRIT MED J, V324, P827, DOI 10.1136/bmj.324.7341.827; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Harrell FE, 2001, REGRESSION MODELING; Harrower M, 2003, CARTOGR J, V40, P27, DOI 10.1179/000870403235002042; Karakiewicz PI, 2005, J UROLOGY, V173, P1930, DOI 10.1097/01.ju.0000158039.94467.5d; Karvanen J, 2009, STAT MED, V28, P1957, DOI 10.1002/sim.3591; Kattan MW, 2010, SEMIN ONCOL, V37, P23, DOI 10.1053/j.seminoncol.2009.12.003; Kattan MW, 2005, NAT CLIN PRACT UROL, V2, P183, DOI 10.1038/ncpuro0144; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Lamina C, 2012, J CLIN EPIDEMIOL, V65, P855, DOI 10.1016/j.jclinepi.2012.02.013; Lipkus I M, 1999, J Natl Cancer Inst Monogr, P149; Murabito JM, 1997, CIRCULATION, V96, P44; Musen MA, 2006, BIOMEDICAL INFORM CO, P698, DOI DOI 10.1007/0-387-36278-920; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Newcombe RG, 2006, STAT MED, V25, P4235, DOI 10.1002/sim.2683; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Royston P., 2008, MULTIVARIABLE MODEL; Sackett DL, 1996, EVIDENCE BASED MED, V1, P164, DOI DOI 10.1136/EBM.1996.1.164; Steyerberg E., 2009, CLIN PREDICTION MODE; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; Strumbelj E, 2010, J MACH LEARN RES, V11, P1; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Timmerman D, 2005, J CLIN ONCOL, V23, P8794, DOI 10.1200/JCO.2005.01.7632; Vapnik V., 1998, STAT LEARNING THEORY; Vickers AJ, 2011, CA-CANCER J CLIN, V61, P315, DOI 10.3322/caac.20118; Waldron CA, 2011, PATIENT EDUC COUNS, V82, P169, DOI 10.1016/j.pec.2010.04.014; Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539	41	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132614	10.1371/journal.pone.0132614	http://dx.doi.org/10.1371/journal.pone.0132614			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176945	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600131
J	Wickens, S; Perry, C				Wickens, Steven; Perry, Conrad			What Do You Mean by That?! An Electrophysiological Study of Emotional and Attitudinal Prosody	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; TEMPORAL DYNAMICS; RIGHT-HEMISPHERE; SARCASTIC IRONY; PERCEPTION; SPEECH; IDENTIFICATION; VOCALIZATIONS; SEMANTICS; SENTENCE	The use of prosody during verbal communication is pervasive in everyday language and whilst there is a wealth of research examining the prosodic processing of emotional information, much less is known about the prosodic processing of attitudinal information. The current study investigated the online neural processes underlying the prosodic processing of non-verbal emotional and attitudinal components of speech via the analysis of event-related brain potentials related to the processing of anger and sarcasm. To examine these, sentences with prosodic expectancy violations created by cross-splicing a prosodically neutral head ('he has') and a prosodically neutral, angry, or sarcastic ending (e.g., 'a serious face') were used. Task demands were also manipulated, with participants in one experiment performing prosodic classification and participants in another performing probe-verification. Overall, whilst minor differences were found across the tasks, the results suggest that angry and sarcastic prosodic expectancy violations follow a similar processing time-course underpinned by similar neural resources.	[Wickens, Steven; Perry, Conrad] Swinburne Univ Technol, Hawthorn, Vic 3122, Australia	Swinburne University of Technology	Perry, C (corresponding author), Swinburne Univ Technol, Hawthorn, Vic 3122, Australia.	cperry@swin.edu.au		Perry, Conrad/0000-0002-3429-0240	Australian Research Council [DP120100883]	Australian Research Council(Australian Research Council)	Australian Research Council (DP120100883) grant awarded to CP.	Astesano C, 2004, COGNITIVE BRAIN RES, V18, P172, DOI 10.1016/j.cogbrainres.2003.10.002; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Bidelman GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060676; Blanc JM, 2003, COGNITIVE BRAIN RES, V17, P693, DOI 10.1016/S0926-6410(03)00195-2; Boersma P., 2013, PRAAT DOING PHONETIC; Breitenstein C, 2001, COGNITION EMOTION, V15, P57, DOI 10.1080/0269993004200114; Bryant GA, 2005, LANG SPEECH, V48, P257, DOI 10.1177/00238309050480030101; Cheang HS, 2008, SPEECH COMMUN, V50, P366, DOI 10.1016/j.specom.2007.11.003; Chen XH, 2011, BIOL PSYCHOL, V86, P158, DOI 10.1016/j.biopsycho.2010.11.004; Culpeper J, 1996, J PRAGMATICS, V25, P349, DOI 10.1016/0378-2166(95)00014-3; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eckstein K, 2005, COGNITIVE BRAIN RES, V25, P130, DOI 10.1016/j.cogbrainres.2005.05.003; Gandour J. T, 2006, ENCY LANGUAGE LINGUI, V12, P751, DOI DOI 10.1016/B0-08-044854-2/04796-9; Grichkovtsova I, 2012, SPEECH COMMUN, V54, P414, DOI 10.1016/j.specom.2011.10.005; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Hirst D., 1998, INTONATION SYSTEMS A; Jorgensen J, 1996, J PRAGMATICS, V26, P613, DOI 10.1016/0378-2166(95)00067-4; Kochunov P, 2003, NEUROREPORT, V14, P961, DOI 10.1097/01.wnr.0000075417.59944.00; Kotz SA, 2003, BRAIN LANG, V86, P366, DOI 10.1016/S0093-934X(02)00532-1; Kotz SA, 2007, BRAIN RES, V1151, P107, DOI 10.1016/j.brainres.2007.03.015; Liu TS, 2012, NEUROREPORT, V23, P108, DOI 10.1097/WNR.0b013e32834ea757; Loevenbruck H, 2013, PROCEEDINGS OF INTER; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Mitchell RLC, 2013, NEUROSCI BIOBEHAV R, V37, P471, DOI 10.1016/j.neubiorev.2013.01.027; Morlec Y, 2001, SPEECH COMMUN, V33, P357, DOI 10.1016/S0167-6393(00)00065-0; Mozziconacci SJ, 2011, USER MODELING AND US, V11, P297; Naatanen R, 1995, Int J Neurosci, V80, P317, DOI 10.3109/00207459508986107; Paulmann S, 2008, BRAIN LANG, V105, P59, DOI 10.1016/j.bandl.2007.11.005; Paulmann S, 2008, NEUROREPORT, V19, P209, DOI 10.1097/WNR.0b013e3282f454db; Paulmann S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00345; Paulmann S, 2012, NEUROPSYCHOLOGIA, V50, P1609, DOI 10.1016/j.neuropsychologia.2012.03.014; Pell MD, 2006, PROG BRAIN RES, V156, P303, DOI 10.1016/S0079-6123(06)56017-0; Pell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027256; Pell MD, 2009, J PHONETICS, V37, P417, DOI 10.1016/j.wocn.2009.07.005; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Regel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096840; Regel S, 2011, J COGNITIVE NEUROSCI, V23, P277, DOI 10.1162/jocn.2010.21411; Rigoulot S, 2014, BRAIN RES, V1565, P48, DOI 10.1016/j.brainres.2014.04.022; Rockwell P, 2000, J PSYCHOLINGUIST RES, V29, P483, DOI 10.1023/A:1005120109296; Sauter DA, 2010, J COGNITIVE NEUROSCI, V22, P474, DOI 10.1162/jocn.2009.21215; Scherer KR, 2003, SPEECH COMMUN, V40, P227, DOI 10.1016/S0167-6393(02)00084-5; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Sidtis John J., 2003, Seminars in Speech and Language, V24, P93, DOI 10.1055/s-2003-38901; Sobin C, 1999, J PSYCHOLINGUIST RES, V28, P347, DOI 10.1023/A:1023237014909; Spachtholz P, 2014, J EXP PSYCHOL GEN, V143, P1450, DOI 10.1037/xge0000012; Thonnessen H, 2010, NEUROIMAGE, V50, P250, DOI 10.1016/j.neuroimage.2009.11.082; Toplak M, 2000, J PRAGMATICS, V32, P1467, DOI 10.1016/S0378-2166(99)00101-0; VANLANCKER D, 1992, J SPEECH HEAR RES, V35, P963, DOI 10.1044/jshr.3505.963; Warren P., 2005, LANG VAR CHANGE, V17, P209, DOI [10.1017/S095439450505009X, DOI 10.1017/S095439450505009X]; Wichmann Anne, 2000, P ISCA WORKSHOP SPEE, P143; Wildgruber D, 2004, CEREB CORTEX, V14, P1384, DOI 10.1093/cercor/bhh099; Witteman J, 2011, NEUROPSYCHOLOGIA, V49, P3722, DOI 10.1016/j.neuropsychologia.2011.09.028; Woodman GF, 2010, ATTEN PERCEPT PSYCHO, V72, P2031, DOI 10.3758/APP.72.8.2031; Yildirim S., 2004, 8 INT C SPOK LANG PR, P2193	55	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132947	10.1371/journal.pone.0132947	http://dx.doi.org/10.1371/journal.pone.0132947			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26176622	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600187
J	Zhang, L; Ma, RJ; Hu, J; Ding, XL; Xu, YX				Zhang, Liang; Ma, Rujun; Hu, Jin; Ding, Xiaolin; Xu, Yinxue			Sirtuin Inhibition Adversely Affects Porcine Oocyte Meiosis	PLOS ONE			English	Article							IN-VITRO; MOUSE OOCYTES; DEVELOPMENTAL COMPETENCE; HISTONE DEACETYLASE; ASYMMETRIC DIVISION; MEIOTIC MATURATION; ORGANIZATION; CYTOSKELETON; POLARITY; NUCLEAR	Sirtuins have been implicated in diverse biological processes, including oxidative stress, energy metabolism, cell migration, and aging. Here, we employed Sirtuin inhibitors, nicotinamide (NAM) and Sirtinol, to investigate their effects on porcine oocyte maturation respectively. The rate of polar body extrusion in porcine oocytes decreased after treatment with NAM and Sirtinol, accompanied with the failure of cumulus cell expansion. We further found that NAM and Sirtinol significantly disrupted oocyte polarity, and inhibited the formation of actin cap and cortical granule-free domain (CGFD). Moreover, the abnormal spindles and misaligned chromosomes were readily detected during porcine oocyte maturation after treatment with NAM and Sirtinol. Together, these results suggest that Sirtuins are involved in cortical polarity and spindle organization in porcine oocytes.	[Zhang, Liang; Hu, Jin; Ding, Xiaolin; Xu, Yinxue] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Ma, Rujun] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Xu, YX (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	xuyinxue@njau.edu.cn			Research Fund for the Doctoral Program of the Ministry of Education of China [20130097110020];  [CXLX12-0301]	Research Fund for the Doctoral Program of the Ministry of Education of China; 	This work was supported by Research Fund for the Doctoral Program of the Ministry of Education of China (20130097110020) and The Innovative Project for Postgraduates (CXLX12-0301).	Azoury J, 2009, BIOL CELL, V101, P69, DOI 10.1042/BC20080003; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; Brunet S, 2011, HUM REPROD UPDATE, V17, P68, DOI 10.1093/humupd/dmq044; Combelles CMH, 2003, HUM REPROD, V18, P2124, DOI 10.1093/humrep/deg419; Damiani P, 1996, MOL REPROD DEV, V45, P521, DOI 10.1002/(SICI)1098-2795(199612)45:4&lt;521::AID-MRD15&gt;3.0.CO;2-Z; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Deng MQ, 2005, DEV BIOL, V278, P358, DOI 10.1016/j.ydbio.2004.11.013; Eppig JJ, 1996, REPROD FERT DEVELOP, V8, P485, DOI 10.1071/RD9960485; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kawamura Y, 2010, J CLIN INVEST, V120, P2817, DOI 10.1172/JCI42020; Kim NH, 1996, MOL REPROD DEV, V43, P513, DOI 10.1002/(SICI)1098-2795(199604)43:4&lt;513::AID-MRD14&gt;3.0.CO;2-#; Kim NH, 1998, HUM REPROD, V13, P2217, DOI 10.1093/humrep/13.8.2217; Kwak SS, 2012, THERIOGENOLOGY, V78, P1597, DOI 10.1016/j.theriogenology.2012.07.006; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Li GP, 2005, MOL REPROD DEV, V71, P220, DOI 10.1002/mrd.20255; Liu MY, 2013, HUM REPROD, V28, P707, DOI 10.1093/humrep/des437; Liu XY, 2005, HUM REPROD, V20, P3402, DOI 10.1093/humrep/dei265; Maddox AS, 2012, CYTOSKELETON, V69, P855, DOI 10.1002/cm.21064; Miao YL, 2007, THERIOGENOLOGY, V68, P640, DOI 10.1016/j.theriogenology.2007.04.061; Miyara F, 2003, HUM REPROD, V18, P1494, DOI 10.1093/humrep/deg272; Mukherjee A, 2014, J ASSIST REPROD GEN, V31, P229, DOI 10.1007/s10815-013-0116-9; Spricigo J., 2015, REPRODUCTION FERTILI, V27, P115, DOI [10.1071/RDV27N1AB45, DOI 10.1071/RDV27N1AB45]; Su YQ, 2002, ENDOCRINOLOGY, V143, P2221, DOI 10.1210/en.143.6.2221; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; Takeo S, 2014, J REPROD DEVELOP, V60, P92, DOI 10.1262/jrd.2013-102; Tremoleda JL, 2001, MOL REPROD DEV, V60, P260, DOI 10.1002/mrd.1086; TSAI FCH, 1994, FERTIL STERIL, V61, P376; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Wang Q, 2007, REPROD FERT DEVELOP, V19, P1, DOI 10.1071/RD06103; Yi KX, 2012, CYTOSKELETON, V69, P727, DOI 10.1002/cm.21048; Zhang L, 2014, FASEB J, V28, P1435, DOI 10.1096/fj.13-244111; Zhang Y, 2014, THERIOGENOLOGY, V82, P49, DOI 10.1016/j.theriogenology.2014.02.020	34	18	20	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132941	10.1371/journal.pone.0132941	http://dx.doi.org/10.1371/journal.pone.0132941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176547	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600186
J	Bozin, I; Ge, YL; Kuchling, J; Dusek, P; Chawla, S; Harms, L; Ruprecht, K; Niendorf, T; Paul, F; Kister, I; Sinnecker, T; Wuerfel, J				Bozin, Ivan; Ge, Yulin; Kuchling, Joseph; Dusek, Petr; Chawla, Sanjeev; Harms, Lutz; Ruprecht, Klemens; Niendorf, Thoralf; Paul, Friedemann; Kister, Ilya; Sinnecker, Tim; Wuerfel, Jens			Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration	PLOS ONE			English	Article							7 TESLA; BIOPHYSICAL MECHANISMS; LESION MORPHOLOGY; IRON DEPOSITION; MRI; MATTER; CONTRAST; DAMAGE	Objective The analysis of the MR phase provides additional information on the tissue microstructure. In multiple sclerosis (MS) lesions phase alterations may reflect different stages of inflammatory activity. Here we investigated lesion morphology in MS patients with short and long disease duration on T2* weighted, phase, magnitude and susceptibility weighted imaging (SWI) at 7 Tesla (T). Methods 17 MS or clinically isolated syndrome patients with short (<60 months) and 11 with long (>60 months) disease duration underwent 7T MRI. Lesions were subsequently analyzed side-by-side with regard to morphology and visibility on T2* weighted, SWI, magnitude and SWI-filtered phase images. Results 126 of 192 T2* weighted lesions (65.6%) were characterized by a phase alteration pattern, and hence could be differentiated on phase images. In detail, a significantly reduced proportion of lesions showing phase alterations was detectable in patients with longer disease duration (mean +/- SD 51 +/- 37%, range 0-100%) compared to patients with short disease duration (mean +/- SD 90 +/- 19.5%, range 50-100%, p = 0.003). Conclusion This cross-sectional study identified different patterns of phase changes in lesions of MS patients with short and long standing disease. Longitudinal studies are warranted to prove that MR phase imaging is useful in determining the activity and the developmental stage of individual MS plaques.	[Bozin, Ivan; Kuchling, Joseph; Paul, Friedemann; Sinnecker, Tim; Wuerfel, Jens] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Ge, Yulin; Chawla, Sanjeev] NYU, Sch Med, Dept Radiol, New York, NY USA; [Dusek, Petr; Wuerfel, Jens] Univ Med Goettingen, Inst Neuroradiol, Gottingen, Germany; [Dusek, Petr] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Dusek, Petr] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Dusek, Petr] Gen Univ Hosp, Prague, Czech Republic; [Harms, Lutz; Ruprecht, Klemens; Paul, Friedemann] Charite, Clin & Expt Multiple Sclerosis Res Ctr, D-13353 Berlin, Germany; [Harms, Lutz; Ruprecht, Klemens; Paul, Friedemann] Charite, Dept Neurol, D-13353 Berlin, Germany; [Niendorf, Thoralf; Wuerfel, Jens] Max Delbrueck Ctr Mol Med, Berlin Ultrahigh Field Facil, Berlin, Germany; [Niendorf, Thoralf; Paul, Friedemann; Wuerfel, Jens] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Niendorf, Thoralf; Paul, Friedemann; Wuerfel, Jens] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Kister, Ilya] NYU, Sch Med, Dept Neurol, Multiple Sclerosis Care Ctr, New York, NY USA; [Sinnecker, Tim] Asklepios Fachklinikum Teupitz, Dept Neurol, Teupitz, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; New York University; Charles University Prague; Charles University Prague; General University Hospital Prague; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; New York University	Paul, F (corresponding author), Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany.	friedemann.paul@charite.de	Ge, Yulin/L-7052-2019; Ge, Yulin/D-9060-2019; Paul, Friedemann/ABF-9415-2020; Dusek, Petr/F-9084-2017	Ge, Yulin/0000-0002-2320-6031; Dusek, Petr/0000-0003-4877-9642; Kister, Ilya/0000-0003-3549-949X; paul, friedemann/0000-0002-6378-0070; Wuerfel, Jens/0000-0002-0034-8053	German Research Foundation [DFG Exc 257]; German Ministry of Education and Research (Competence Network Multiple Sclerosis KKNMS); Guthy Jackson Charitable Foundation/the National Multiple Sclerosis Society of the USA	German Research Foundation(German Research Foundation (DFG)); German Ministry of Education and Research (Competence Network Multiple Sclerosis KKNMS); Guthy Jackson Charitable Foundation/the National Multiple Sclerosis Society of the USA	This work was supported by the German Research Foundation (DFG Exc 257 to F.P.) and by the German Ministry of Education and Research (Competence Network Multiple Sclerosis KKNMS to F.P. and J.W.) and a research grant from the Guthy Jackson Charitable Foundation/the National Multiple Sclerosis Society of the USA (F.P. and J.W.).	Absinta M, 2013, ANN NEUROL, V74, P669, DOI 10.1002/ana.23959; ADAMS CWM, 1988, J NEUROL NEUROSUR PS, V51, P260, DOI 10.1136/jnnp.51.2.260; Bagnato F, 2011, BRAIN, V134, P3599, DOI 10.1093/brain/awr278; Bakshi R, 2002, ARCH NEUROL-CHICAGO, V59, P62, DOI 10.1001/archneur.59.1.62; Bian W, 2013, MULT SCLER J, V19, P69, DOI 10.1177/1352458512447870; Chen WW, 2014, RADIOLOGY, V271, P183, DOI 10.1148/radiol.13130353; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; CRAELIUS W, 1982, ARCH PATHOL LAB MED, V106, P397; de Graaf WL, 2012, EUR RADIOL, V22, P221, DOI 10.1007/s00330-011-2242-z; Dixon JE, 2013, EUR J RADIOL, V82, P719, DOI 10.1016/j.ejrad.2011.09.023; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Ge YL, 2009, J MAGN RESON IMAGING, V29, P1190, DOI 10.1002/jmri.21758; Grabner G, 2011, J MAGN RESON IMAGING, V33, P543, DOI 10.1002/jmri.22452; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2009, J MAGN RESON IMAGING, V29, P537, DOI 10.1002/jmri.21676; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Hametner S, 2013, ANN NEUROL, V74, P848, DOI 10.1002/ana.23974; He X, 2009, P NATL ACAD SCI USA, V106, P13558, DOI 10.1073/pnas.0904899106; Kuchling J, 2014, MULT SCLER J, V20, P1866, DOI 10.1177/1352458514531084; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Mehta V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057573; Mistry N, 2013, JAMA NEUROL, V70, P623, DOI 10.1001/jamaneurol.2013.1405; Muller K, 2014, J NEUROL, V261, P2032, DOI 10.1007/s00415-014-7460-2; Nielsen AS, 2012, J MAGN RESON IMAGING, V35, P537, DOI 10.1002/jmri.22847; Pitt D, 2010, ARCH NEUROL-CHICAGO, V67, P812, DOI 10.1001/archneurol.2010.148; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Sinnecker T, 2015, EUR RADIOL, V25, P122, DOI 10.1007/s00330-014-3358-8; Sinnecker T, 2013, MULT SCLER J, V19, P316, DOI 10.1177/1352458512451941; Sinnecker T, 2012, NEUROLOGY, V79, P708, DOI 10.1212/WNL.0b013e3182648bc8; Sinnecker T, 2012, ARCH NEUROL-CHICAGO, V69, P739, DOI 10.1001/archneurol.2011.2450; Stephenson E, 2014, NAT REV NEUROL, V10, P459, DOI 10.1038/nrneurol.2014.118; Sukstanskii AL, 2014, MAGN RESON MED, V71, P345, DOI 10.1002/mrm.24629; Tallantyre EC, 2011, NEUROLOGY, V76, P534, DOI 10.1212/WNL.0b013e31820b7630; Wuerfel J, 2008, BRAIN, V131, P2332, DOI 10.1093/brain/awn171; Wuerfel J, 2012, MULT SCLER J, V18, P1592, DOI 10.1177/1352458512441270; Yablonskiy DA, 2012, P NATL ACAD SCI USA, V109, P14212, DOI 10.1073/pnas.1206037109; Yao B, 2012, RADIOLOGY, V262, P206, DOI 10.1148/radiol.11110601	38	16	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0128386	10.1371/journal.pone.0128386	http://dx.doi.org/10.1371/journal.pone.0128386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186349	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000358198700003
J	Yakovis, E; Artemieva, A				Yakovis, Eugeniy; Artemieva, Anna			Bored to Death: Community-Wide Effect of Predation on a Foundation Species in a Low-Disturbance Arctic Subtidal System	PLOS ONE			English	Article							WHITE SEA; LATITUDINAL VARIATION; BARNACLES; RECRUITMENT; ASCIDIANS; DIET; PREY; COMPETITION; AGGREGATIONS; GASTROPODA	The strength of top-down control by consumers is predicted to decrease with latitude, but most data confirming this assumption come from latitudes <60 degrees, while empirical studies of predation in sub-arctic and arctic marine habitats are few. A barnacle Balanus crenatus is a native foundation species in the shallow subtidal of the White Sea (65 degrees N), hosting a diverse (250+ species) assemblage of macrobenthic organisms. On mixed sediments live barnacles share primary substrates (shells and gravel) with numerous empty barnacle tests, 7% of which had drill holes of an unidentified origin. We manipulated the densities of (i) adult muricid whelks Boreotrophon clathratus (of previously unknown feeding habits), to check if they prey on barnacles, (ii) other predators to reveal their effect on juvenile Boreotrophon, and (iii) empty tests to assess the community-wide effect of predation on barnacles. The abundance of drilled empty tests in the field correlated with that of Boreotrophon. A year-long caging experiment clearly confirmed predation, showing the highest barnacle mortality and proportion of drilled tests in whelk enclosures, and the lowest-in predator exclosure treatments. Boreotrophon preferred the barnacles attached to conspecifics to those from primary substrates. Because of its scarcity Boreotrophon had a minor direct effect on barnacle abundance in the field. Yet, initially defaunated empty tests and live barnacles developed markedly different macrobenthic assemblages, suggesting a strong indirect effect of the predation. Juvenile Boreotrophon were 5-6 times less abundant in open and partial cages than in exclosures and enclosures, which indicates that the recruitment and, consequently, the abundance of Boreotrophon and its predation on Balanus are top-down controlled by apex predators. In contrast, in tropical and temperate intertidal the predation on barnacles is stronger and primarily limited by environmental stress and prey availability.	[Yakovis, Eugeniy; Artemieva, Anna] St Petersburg State Univ, Dept Invertebrate Zool, St Petersburg 199034, Russia	Saint Petersburg State University	Yakovis, E (corresponding author), St Petersburg State Univ, Dept Invertebrate Zool, St Petersburg 199034, Russia.	eugene@yakovis.com	Yakovis, Eugeniy/M-8540-2019; Yakovis, Evgeny L./A-9680-2008; Artemieva, Anna/AAD-9578-2019	Yakovis, Eugeniy/0000-0003-3489-3671; Yakovis, Evgeny L./0000-0003-3489-3671; Artemieva, Anna/0000-0002-1935-7021	Russian Foundation for Basic Research [13-04-10178, 14-04-00972, 14-04-10124]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The research was supported by Russian Foundation for Basic Research (http://www.rfbr.ru) grant numbers 13-04-10178, 14-04-00972, and 14-04-10124 received by EY.	AITKEN AE, 1988, LETHAIA, V21, P339, DOI 10.1111/j.1502-3931.1988.tb01762.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aristov D, 2015, J MAR BIOL ASSOC UK, V95, P1601, DOI 10.1017/S0025315415000454; Artemieva A.V., 2004, Vestnik Sankt-Peterburgskogo Universiteta Seriya 3 Biologiya, V4, P5; Barnes H, 1954, J ANIM ECOL, V23, P84; Belogrudov EA., 1973, STUDIES FISH BIOL CO, V4, P84; Bertness MD, 2014, ECOL LETT, V17, P830, DOI 10.1111/ele.12287; BERTNESS MD, 1989, ECOLOGY, V70, P257, DOI 10.2307/1938431; BROS WE, 1987, J EXP MAR BIOL ECOL, V105, P275, DOI 10.1016/0022-0981(87)90176-6; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Chiba S, 2014, J SHELLFISH RES, V33, P137, DOI 10.2983/035.033.0113; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Claverie T, 2008, J MAR BIOL ASSOC UK, V88, P157, DOI 10.1017/S0025315408000064; DUDLEY EC, 1978, PALEOBIOLOGY, V4, P436, DOI 10.1017/S0094837300006175; Ellis JC, 2007, ECOLOGY, V88, P853, DOI 10.1890/06-0593; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; FAIRWEATHER PG, 1990, AUST J ECOL, V15, P453, DOI 10.1111/j.1442-9993.1990.tb01470.x; Foster BA., 1987, BARNACLE BIOL, V5, P113; Freestone AL, 2011, ECOLOGY, V92, P983, DOI 10.1890/09-2379.1; Grischankov A.V., 1997, Vestnik Sankt-Peterburgskogo Universiteta Seriya 3 Biologiya, V1, P3; Harley CDG, 2011, OECOLOGIA, V166, P531, DOI 10.1007/s00442-010-1864-1; HIMMELMAN JH, 1993, MAR BIOL, V116, P423, DOI 10.1007/BF00350059; Hjelset AM, 1999, POLAR BIOL, V21, P186, DOI 10.1007/s003000050351; JERNAKOFF P, 1986, MAR ECOL PROG SER, V28, P259, DOI 10.3354/meps028259; KANTOR YI, 1994, VELIGER, V37, P119; Kristjansson TO, 2013, POLAR BIOL, V36, P51, DOI 10.1007/s00300-012-1238-8; MENGE BA, 1972, ECOLOGY, V53, P635, DOI 10.2307/1934777; MENGE BA, 1976, ECOL MONOGR, V46, P355, DOI 10.2307/1942563; MENGE BA, 1978, OECOLOGIA, V34, P17, DOI 10.1007/BF00346238; Merkel FR, 2007, POLAR BIOL, V30, P227, DOI 10.1007/s00300-006-0176-8; Mokievsky VO, 2012, ZOOL ZH, V91, P887; Moles AT, 2003, J BIOGEOGR, V30, P105, DOI 10.1046/j.1365-2699.2003.00781.x; Nadeau M, 2009, J EXP MAR BIOL ECOL, V374, P134, DOI 10.1016/j.jembe.2009.04.014; Peco B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091256; Pennings SC, 2005, ECOLOGY, V86, P2310, DOI 10.1890/04-1022; QIAN PY, 1990, J EXP MAR BIOL ECOL, V142, P63, DOI 10.1016/0022-0981(90)90137-2; Quijon PA, 2005, MAR ECOL PROG SER, V285, P137, DOI 10.3354/meps285137; REAKAKUDLA ML, 1997, BIODIVERSITY, V2, P83; ROBICHAUD DA, 1991, FISH B-NOAA, V89, P669; Roginskaya I.S., 1987, MOLLUSCS WHITE SEA K, V151, P155; ROY K, 1994, PALAIOS, V9, P413, DOI 10.2307/3515059; Sanford E, 2003, SCIENCE, V300, P1135, DOI 10.1126/science.1083437; SCHUBART CD, 1995, J EXP MAR BIOL ECOL, V186, P143, DOI 10.1016/0022-0981(94)00142-Z; SHEILD CJ, 1993, J EXP MAR BIOL ECOL, V166, P107, DOI 10.1016/0022-0981(93)90081-X; SPIGHT TM, 1974, MAR BIOL, V24, P229, DOI 10.1007/BF00391898; TAYLOR JD, 1978, J CONCHOL, V29, P309; Varfolomeeva M, 2008, J EXP MAR BIOL ECOL, V363, P42, DOI 10.1016/j.jembe.2008.06.012; WAHL M, 1989, MAR ECOL PROG SER, V58, P175, DOI 10.3354/meps058175; Wahl M, 1997, HYDROBIOLOGIA, V355, P49, DOI 10.1023/A:1003054802699; Yakovis EL, 2005, J EXP MAR BIOL ECOL, V327, P210, DOI 10.1016/j.jembe.2005.06.015; Yakovis EL, 2004, J EXP MAR BIOL ECOL, V309, P155, DOI 10.1016/j.jembe.2004.03.015; Yakovis EL, 2008, OECOLOGIA, V155, P785, DOI 10.1007/s00442-007-0945-2; Yakovis EL, 2007, MAR ECOL PROG SER, V348, P117, DOI 10.3354/meps07060; Yakovis EL, 2013, HYDROBIOLOGIA, V706, P69, DOI 10.1007/s10750-012-1340-5; Yershov P.N., 2010, VESTNIK SPBGU SER 3, V2, P55	55	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132973	10.1371/journal.pone.0132973	http://dx.doi.org/10.1371/journal.pone.0132973			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186648	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700079
J	Zavala, K; Opazo, JC				Zavala, Kattina; Opazo, Juan C.			Lineage-Specific Expansion of the Chalcone Synthase Gene Family in Rosids	PLOS ONE			English	Article							DISEASE RESISTANCE GENES; ARABIDOPSIS-THALIANA; POLYKETIDE SYNTHASES; NUCLEOTIDE-SEQUENCES; EVOLUTION; ENZYMES; ISOFLAVONOIDS; SUBSTITUTION; DUPLICATION; PROTEIN	Rosids are a monophyletic group that includes approximately 70,000 species in 140 families, and they are found in a variety of habitats and life forms. Many important crops such as fruit trees and legumes are rosids. The evolutionary success of this group may have been influenced by their ability to produce flavonoids, secondary metabolites that are synthetized through a branch of the phenylpropanoid pathway where chalcone synthase is a key enzyme. In this work, we studied the evolution of the chalcone synthase gene family in 12 species belonging to the rosid clade. Our results show that the last common ancestor of the rosid clade possessed six chalcone synthase gene lineages that were differentially retained during the evolutionary history of the group. In fact, of the six gene lineages that were present in the last common ancestor, 7 species retained 2 of them, whereas the other 5 only retained one gene lineage. We also show that one of the gene lineages was disproportionately expanded in species that belonged to the order Fabales (soybean, barrel medic and Lotus japonicas). Based on the available literature, we suggest that this gene lineage possesses stress-related biological functions (e.g., response to UV light, pathogen defense). We propose that the observed expansion of this clade was a result of a selective pressure to increase the amount of enzymes involved in the production of phenylpropanoid pathway-derived secondary metabolites, which is consistent with the hypothesis that suggested that lineage-specific expansions fuel plant adaptation.	[Zavala, Kattina; Opazo, Juan C.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile	Universidad Austral de Chile	Opazo, JC (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile.	jopazo@gmail.com		Opazo, Juan C./0000-0001-7938-4083	Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1120032]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 1120032) grant to JCO.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; AKADA S, 1995, PLANT MOL BIOL, V29, P189, DOI 10.1007/BF00043645; AKADA S, 1993, PLANT PHYSIOL, V102, P699, DOI 10.1104/pp.102.2.699; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Baumgarten A, 2003, GENETICS, V165, P309; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Dakora FD, 1996, PHYSIOL MOL PLANT P, V49, P1, DOI 10.1006/pmpp.1996.0035; Dixon RA, 1999, TRENDS PLANT SCI, V4, P394, DOI 10.1016/S1360-1385(99)01471-5; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; FEINBAUM RL, 1988, MOL CELL BIOL, V8, P1985, DOI 10.1128/MCB.8.5.1985; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Fischer I, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-151; Flores-Sanchez IJ, 2009, PLANT PHYSIOL BIOCH, V47, P167, DOI 10.1016/j.plaphy.2008.11.005; Force A, 1999, GENETICS, V151, P1531; Forkman G, 1993, FLAVONOIDS ADV RES 1, P583; FukadaTanaka S, 1997, PLANT CELL PHYSIOL, V38, P754, DOI 10.1093/oxfordjournals.pcp.a029232; Gil M, 2013, MOL BIOL EVOL, V30, P1270, DOI 10.1093/molbev/mst034; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Harborne J.B., 1995, J CHEM EDUC, V72, pA73, DOI [10.1021/ED072PA73.11, DOI 10.1021/ED072PA73.11]; Harborne J.B., 2013, FLAVONOIDS ADV RES 1; HELARIUTTA Y, 1995, PLANT MOL BIOL, V28, P47, DOI 10.1007/BF00042037; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Judd WS, PLANT SYSTEMATICS PH; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; LANZ T, 1991, J BIOL CHEM, V266, P9971; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Lozovaya VV, 2007, PLANTA, V225, P665, DOI 10.1007/s00425-006-0368-z; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Magallon S, 1999, ANN MISS BOT GAR, P292; McKhann H I, 1994, Curr Top Microbiol Immunol, V192, P139; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Ohno S., 1970, EVOLUTION GENE DUPLI; Shimizu T, 1999, PLANT MOL BIOL, V39, P785, DOI 10.1023/A:1006124219945; Soltis D, 2005, PHYLOGENY EVOLUTION; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Vanneste K, 2014, GENOME RES, V24, P1334, DOI 10.1101/gr.168997.113; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Zabala G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-26	39	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133400	10.1371/journal.pone.0133400	http://dx.doi.org/10.1371/journal.pone.0133400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181912	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198200063
J	Blanco, F; Barberia, I; Matute, H				Blanco, Fernando; Barberia, Itxaso; Matute, Helena			Individuals Who Believe in the Paranormal Expose Themselves to Biased Information and Develop More Causal Illusions than Nonbelievers in the Laboratory	PLOS ONE			English	Article							PROBABILITY MISJUDGMENT; PSYCHOLOGICAL-RESEARCH; CRITICAL THINKING; CONTINGENCY; JUDGMENTS; STRATEGY; STUDENTS; SAMPLE; LOCUS; CUE	In the reasoning literature, paranormal beliefs have been proposed to be linked to two related phenomena: a biased perception of causality and a biased information-sampling strategy (believers tend to test fewer hypotheses and prefer confirmatory information). In parallel, recent contingency learning studies showed that, when two unrelated events coincide frequently, individuals interpret this ambiguous pattern as evidence of a causal relationship. Moreover, the latter studies indicate that sampling more cause-present cases than cause-absent cases strengthens the illusion. If paranormal believers actually exhibit a biased exposure to the available information, they should also show this bias in the contingency learning task: they would in fact expose themselves to more cause-present cases than cause-absent trials. Thus, by combining the two traditions, we predicted that believers in the paranormal would be more vulnerable to developing causal illusions in the laboratory than nonbelievers because there is a bias in the information they experience. In this study, we found that paranormal beliefs (measured using a questionnaire) correlated with causal illusions (assessed by using contingency judgments). As expected, this correlation was mediated entirely by the believers' tendency to expose themselves to more cause-present cases. The association between paranormal beliefs, biased exposure to information, and causal illusions was only observed for ambiguous materials (i.e., the noncontingent condition). In contrast, the participants' ability to detect causal relationships which did exist (i.e., the contingent condition) was unaffected by their susceptibility to believe in paranormal phenomena.	[Blanco, Fernando; Matute, Helena] Univ Deusto, Labpsico, Dept Fundamentos & Metodos Psicol, Bilbao, Spain; [Barberia, Itxaso] Univ Barcelona, Fac Psicol, Event Lab, Barcelona, Spain; [Barberia, Itxaso] Univ Barcelona, Fac Psicol, Dept Psicol Basica, Barcelona, Spain	University of Deusto; University of Barcelona; University of Barcelona	Blanco, F (corresponding author), Univ Deusto, Labpsico, Dept Fundamentos & Metodos Psicol, Bilbao, Spain.	fernandoblanco@deusto.es	BARBERIA, ITXASO/L-8477-2014; Blanco, Fernando/E-8941-2010; Matute, Helena/A-8256-2011	BARBERIA, ITXASO/0000-0003-3045-2289; Blanco, Fernando/0000-0003-1283-8313; Matute, Helena/0000-0001-7221-1366	Direccion General de Investigacion (Spanish Government) [PSI2011-26965]; Departamento de Educacion, Universidades e Investigacion (Basque Government) [IT363-10]	Direccion General de Investigacion (Spanish Government); Departamento de Educacion, Universidades e Investigacion (Basque Government)	This research was supported by Direccion General de Investigacion (Spanish Government; Grant PSI2011-26965) and Departamento de Educacion, Universidades e Investigacion (Basque Government; Grant IT363-10).	ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441; BAKER AG, 1989, Q J EXP PSYCHOL-B, V41, P65; Barberia I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071303; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beck J, 2007, HUM NATURE-INT BIOS, V18, P35, DOI 10.1007/BF02820845; BLACKMORE S, 1985, BRIT J PSYCHOL, V76, P459, DOI 10.1111/j.2044-8295.1985.tb01969.x; Blackmore SJ, 1997, BRIT J PSYCHOL, V88, P683, DOI 10.1111/j.2044-8295.1997.tb02665.x; Blanco F, 2013, LEARN BEHAV, V41, P333, DOI 10.3758/s13420-013-0108-8; Blanco F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046203; Blanco F, 2011, Q J EXP PSYCHOL, V64, P1290, DOI 10.1080/17470218.2011.552727; Blanco F, 2010, PSYCHON B REV, V17, P117, DOI 10.3758/PBR.17.1.117; Brugger P, 1997, Cogn Neuropsychiatry, V2, P251, DOI 10.1080/135468097396270; Burger J. M., 1979, MOTIV EMOTION, V3, P381, DOI DOI 10.1007/BF00994052; Dag I, 1999, PERS INDIV DIFFER, V26, P723, DOI 10.1016/S0191-8869(98)00184-6; De Miguel Calvo JM, 2013, SPAN J PSYCHOL, V15, P1432; Diaz-Vilela L, 2004, J PARAPSYCHOL, V68, P405; ECKBLAD M, 1983, J CONSULT CLIN PSYCH, V51, P215, DOI 10.1037/0022-006X.51.2.215; European Commission, 2010, SPEC EUR 340 SCI TEC; French C. C., 2007, TALL TALES MIND BRAI, P3, DOI DOI 10.1093/ACPROF:OSO/9780198568773.003.0002; Gianotti LRR, 2001, PSYCHIAT CLIN NEUROS, V55, P595, DOI 10.1046/j.1440-1819.2001.00911.x; Groth-Marnat G, 1998, SOC BEHAV PERSONAL, V26, P291, DOI 10.2224/sbp.1998.26.3.291; Hannah S, 2007, BEHAV PROCESS, V74, P265, DOI 10.1016/j.beproc.2006.09.007; IRWIN HJ, 1993, J AM SOC PSYCHICAL R, V87, P1; Ferrando PJ, 2011, PSICOTHEMA, V23, P282; Judd CM, 2001, PSYCHOL METHODS, V6, P115, DOI 10.1037/1082-989X.6.2.115; Katagiri M, 2007, BEHAV PROCESS, V74, P251, DOI 10.1016/j.beproc.2006.09.001; Keinan G, 2002, PERS SOC PSYCHOL B, V28, P102, DOI 10.1177/0146167202281009; KILLEN P, 1974, PSYCHOL REP, V34, P1158, DOI 10.2466/pr0.1974.34.3c.1158; KLAYMAN J, 1987, PSYCHOL REV, V94, P211, DOI 10.1037/0033-295X.94.2.211; Lilienfeld SO, 2009, PERSPECT PSYCHOL SCI, V4, P390, DOI 10.1111/j.1745-6924.2009.01144.x; Liljeholm M, 2009, J EXP PSYCHOL LEARN, V35, P157, DOI 10.1037/a0013972; Lindeman M, 2012, REV GEN PSYCHOL, V16, P241, DOI 10.1037/a0027158; Mandel DR, 2009, Q J EXP PSYCHOL, V62, P2388, DOI 10.1080/17470210902794148; Matute H, 1996, PSYCHOL SCI, V7, P289, DOI 10.1111/j.1467-9280.1996.tb00376.x; Matute H, 2012, ENCY SCI LEARNING, DOI [10.1007/SpringerReference_301904, DOI 10.1007/SPRINGERREFERENCE_301904]; Matute H, 2007, CYBERPSYCHOL BEHAV, V10, P176, DOI 10.1089/cpb.2006.9971; Matute H, 2011, BRIT J PSYCHOL, V102, P392, DOI 10.1348/000712610X532210; McKay RT, 2009, BEHAV BRAIN SCI, V32, P493, DOI 10.1017/S0140525X09990975; McKenzie CRM, 2007, COGNITIVE PSYCHOL, V54, P33, DOI 10.1016/j.cogpsych.2006.04.004; MILL D, 1994, CAN J BEHAV SCI, V26, P246, DOI 10.1037/0008-400X.26.2.246; Moore David W., 2005, 3 4 AM BELIEVE PARAN; Musch J, 2002, BRIT J PSYCHOL, V93, P169, DOI 10.1348/000712602162517; Perales JC, 2007, PSYCHON B REV, V14, P577, DOI 10.3758/BF03196807; Roe CA, 1999, BRIT J PSYCHOL, V90, P85, DOI 10.1348/000712699161288; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Royalty J, 1995, J GENET PSYCHOL, V156, P477, DOI 10.1080/00221325.1995.9914838; Schmaltz R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00336; Schmied-Knittel I., 2005, EUROPEAN J PARAPSYCH, V20, P3; SHANKS DR, 1987, PSYCHOL LEARN MOTIV, V21, P229; Tobacyk Jerome., 2004, INT J TRANSPERSONAL, V23, P94, DOI [DOI 10.24972/IJTS.2004.23.1.94, DOI 10.1037/T14015-000]; Vadillo MA, 2005, LEARN BEHAV, V33, P172; van Elk M, 2013, CONSCIOUS COGN, V22, P1041, DOI 10.1016/j.concog.2013.07.004; Vazquez-Alonso A, 1997, ENSEN CIENC, V15, P199; WASSERMAN EA, 1990, J EXP PSYCHOL LEARN, V16, P509, DOI 10.1037/0278-7393.16.3.509; WASSERMAN EA, 1990, PSYCHOL LEARN MOTIV, V26, P27, DOI DOI 10.1016/S0079-7421(08)60051-1; Wiseman R, 2004, PERS INDIV DIFFER, V37, P1533, DOI 10.1016/j.paid.2004.02.009	56	29	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131378	10.1371/journal.pone.0131378	http://dx.doi.org/10.1371/journal.pone.0131378			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177025	Green Submitted, gold, Green Published			2022-12-27	WOS:000358197600042
J	Humphries, DJ; Finch, FM; Bell, MBV; Ridley, AR				Humphries, David J.; Finch, Fiona M.; Bell, Matthew B. V.; Ridley, Amanda R.			Calling Where It Counts: Subordinate Pied Babblers Target the Audience of Their Vocal Advertisements	PLOS ONE			English	Article							KIN RECOGNITION; INBREEDING DEPRESSION; DELAYED DISPERSAL; SPATIAL STRUCTURE; LIFE-HISTORY; FAIRY-WRENS; AVOIDANCE; EVOLUTION; COSTS; TERRITORIALITY	For territorial group-living species, opportunities to reproduce on the natal territory can be limited by a number of factors including the availability of resources within a territory, access to unrelated individuals, and monopolies on reproduction by dominant group members. Individuals looking to reproduce are therefore faced with the options of either waiting for a breeding opportunity to arise in the natal territory, or searching for reproductive opportunities in non-natal groups. In the cooperatively breeding Southern pied babbler, Turdoides bicolor, most individuals who achieve reproductive success do so through taking up dominant breeding positions within non-natal groups. For subordinate pied babblers therefore, searching for breeding opportunities in non-natal groups is of primary importance as this represents the major route to reproductive success. However, prospecting (where individuals leave the group to search for reproductive opportunities within other groups) is costly and individuals rapidly lose weight when not part of a group. Here we demonstrate that subordinate pied babblers adopt an alternative strategy for mate attraction by vocal advertisement from within their natal territories. We show that subordinates focus their calling efforts on the edges of their territory, and specifically near boundaries with neighbouring groups that have potential breeding partners (unrelated individuals of the opposite sex). In contrast to prospecting, calling individuals showed no body mass loss associated with this behaviour, suggesting that calling from within the group may provide a 'cheap' advertisement strategy. Additionally, we show that subordinates use information regarding the composition of neighbouring groups to target the greatest number of potential mating partners.	[Humphries, David J.; Ridley, Amanda R.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Bell, Matthew B. V.] Univ Edinburgh, Inst Evolutionary Biol, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland; [Ridley, Amanda R.] Univ Cape Town, Percy FitzPatrick Inst, DST NRF Ctr Excellence, ZA-7925 Cape Town, Western Cape, South Africa; [Humphries, David J.; Finch, Fiona M.; Bell, Matthew B. V.; Ridley, Amanda R.] Kuruman River Reserve, Pied Babbler Res Project, Van Zylsrus, South Africa; [Ridley, Amanda R.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Perth, WA 6009, Australia	Macquarie University; University of Edinburgh; National Research Foundation - South Africa; University of Cape Town; University of Western Australia	Humphries, DJ (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	davidhumphries@outlook.com	Ridley, Amanda/D-2636-2011	Ridley, Amanda/0000-0001-5886-0992	iMQRES PhD Scholarship	iMQRES PhD Scholarship	This work was funded through an iMQRES PhD Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonadonna F, 2012, ANIM BEHAV, V84, P509, DOI 10.1016/j.anbehav.2012.06.014; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Boulinier T, 1996, J AVIAN BIOL, V27, P252, DOI 10.2307/3677230; BROOKER M, 1995, J ANIM ECOL, V64, P614, DOI 10.2307/5804; BUCKLEY PA, 1970, AUK, V87, P1; Calenge C, 2007, J STAT SOFTWARE, V22; Cant MA, 2002, ETHOLOGY, V108, P541, DOI 10.1046/j.1439-0310.2002.00795.x; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Clutton-Brock TH, 1999, J ANIM ECOL, V68, P672, DOI 10.1046/j.1365-2656.1999.00317.x; Covas R, 2007, P ROY SOC B-BIOL SCI, V274, P1349, DOI 10.1098/rspb.2007.0117; Dale J, 2001, AM NAT, V158, P75, DOI 10.1086/320861; Doerr ED, 2005, OECOLOGIA, V142, P1, DOI 10.1007/s00442-004-1707-z; Doolan SP, 1996, J ZOOL, V240, P59, DOI 10.1111/j.1469-7998.1996.tb05486.x; du Plessis KL, 2012, GLOBAL CHANGE BIOL, V18, P3063, DOI 10.1111/j.1365-2486.2012.02778.x; Ekman J, 2001, J ANIM ECOL, V70, P317, DOI 10.1046/j.1365-2656.2001.00490.x; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Golabek KA, 2013, BEHAVIOUR, V150, P691, DOI 10.1163/1568539X-00003074; Golabek KA, 2012, ANIM BEHAV, V83, P613, DOI 10.1016/j.anbehav.2011.11.034; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Griffiths SW, 2002, J ANIM ECOL, V71, P480, DOI 10.1046/j.1365-2656.2002.00614.x; Hale AM, 2003, AUK, V120, P446, DOI 10.1642/0004-8038(2003)120[0446:TANAIB]2.0.CO;2; Hass CC, 2002, BEHAV ECOL SOCIOBIOL, V51, P570, DOI 10.1007/s00265-002-0463-5; Hatchwell BJ, 2001, J ANIM ECOL, V70, P820, DOI 10.1046/j.0021-8790.2001.00541.x; Hatchwell BJ, 2001, P ROY SOC B-BIOL SCI, V268, P885, DOI 10.1098/rspb.2001.1598; Hatchwell BJ, 2000, ANIM BEHAV, V59, P1079, DOI 10.1006/anbe.2000.1394; Henzi SP, 1998, ANIM BEHAV, V55, P1421, DOI 10.1006/anbe.1997.0716; Kahlenberg SM, 2008, ANIM BEHAV, V76, P1497, DOI 10.1016/j.anbehav.2008.05.029; KELLER L, 1994, TRENDS ECOL EVOL, V9, P98, DOI 10.1016/0169-5347(94)90204-6; Kitchen AM, 2005, J ANIM ECOL, V74, P1173, DOI 10.1111/j.1365-2656.2005.01017.x; Koenig WD, 1998, AM NAT, V151, P243, DOI 10.1086/286115; KOENIG WD, 1992, Q REV BIOL, V67, P111, DOI 10.1086/417552; Komdeur J, 2001, P ROY SOC B-BIOL SCI, V268, P2007, DOI 10.1098/rspb.2001.1742; Kraaijeveld K, 2001, ANIM BEHAV, V61, P109, DOI 10.1006/anbe.2000.1591; Krause ET, 2012, BIOL LETTERS, V8, P327, DOI 10.1098/rsbl.2011.1093; Legge S, 2000, BEHAV ECOL SOCIOBIOL, V47, P220, DOI 10.1007/s002650050659; Magrath Robert D., 2004, P157, DOI 10.1017/CBO9780511606816.011; Mares R, 2012, P ROYAL SOC B; Mares R, 2012, EXTRATERRITORIAL PRO; MCGREGOR PK, 1993, PHILOS T ROY SOC B, V340, P237, DOI 10.1098/rstb.1993.0063; MULDER RA, 1994, P ROY SOC B-BIOL SCI, V255, P223, DOI 10.1098/rspb.1994.0032; Nelson-Flower MJ, 2012, J ANIM ECOL, V81, P876, DOI 10.1111/j.1365-2656.2012.01983.x; Nelson-Flower MJ, 2011, BEHAV ECOL, V22, P559, DOI 10.1093/beheco/arr018; Nelson-Flower MJ, 2010, TURDIODES BICOLOR; Nielsen JF, 2012, MOL ECOL, V21, P2788, DOI 10.1111/j.1365-294X.2012.05565.x; Otter K, 1999, P ROY SOC B-BIOL SCI, V266, P1305, DOI 10.1098/rspb.1999.0779; PAYNE RB, 1988, ANIM BEHAV, V36, P1341, DOI 10.1016/S0003-3472(88)80203-3; Price JJ, 1999, ANIM BEHAV, V57, P483, DOI 10.1006/anbe.1998.1018; Radford AN, 2006, CURR BIOL, V16, P1700, DOI 10.1016/j.cub.2006.06.053; Raihani NJ, 2010, J AVIAN BIOL, V41, P681, DOI 10.1111/j.1600-048X.2010.05211.x; Reed J. Michael, 1999, Current Ornithology, V15, P189; Ridley AR, 2007, BEHAV ECOL, V18, P324, DOI 10.1093/beheco/arl092; Ridley AR, 2008, J AVIAN BIOL, V39, P389, DOI 10.1111/j.2008.0908-8857.04479.x; Schjorring S, 1999, ANIM BEHAV, V57, P647, DOI 10.1006/anbe.1998.0993; SERA WE, 1994, ECOLOGY, V75, P1560, DOI 10.2307/1939617; Sharp SP, 2005, NATURE, V434, P1127, DOI 10.1038/nature03522; Stacey P.B., 1990, COOPERATIVE BREEDING; STODDARD PK, 1983, AUK, V100, P795, DOI 10.1093/auk/100.4.795; Stoen OG, 2005, BEHAV ECOL SOCIOBIOL, V59, P191, DOI 10.1007/s00265-005-0024-9; Walker FM, 2008, MOL ECOL, V17, P1361, DOI 10.1111/j.1365-294X.2008.03670.x; Young AJ, 2005, ANIM BEHAV, V70, P829, DOI 10.1016/j.anbehav.2005.01.019; Young AJ, 2007, P ROY SOC B-BIOL SCI, V274, P1603, DOI 10.1098/rspb.2007.0316; Young AJ, 2009, BIOL LETTERS, V5, P439, DOI 10.1098/rsbl.2009.0032; ZACK S, 1990, ETHOLOGY, V86, P265	64	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130795	10.1371/journal.pone.0130795	http://dx.doi.org/10.1371/journal.pone.0130795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177094	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600028
J	Li, L; Honda-Okubo, Y; Li, C; Sajkov, D; Petrovsky, N				Li, Lei; Honda-Okubo, Yoshikazu; Li, Connie; Sajkov, Dimitar; Petrovsky, Nikolai			Delta Inulin Adjuvant Enhances Plasmablast Generation, Expression of Activation-Induced Cytidine Deaminase and B-Cell Affinity Maturation in Human Subjects Receiving Seasonal Influenza Vaccine	PLOS ONE			English	Article							POLYSACCHARIDE ADJUVANT; NEUTRALIZING ANTIBODY; MONOCLONAL-ANTIBODIES; VIRUS-INFECTION; T-CELL; PROTECTION; ADVAX(TM); IMMUNOGLOBULIN; ENCEPHALITIS; IMMUNITY	There is a major need for new adjuvants to improve the efficacy of seasonal and pandemic influenza vaccines. Advax is a novel polysaccharide adjuvant based on delta inulin that has been shown to enhance the immunogenicity of influenza vaccine in animal models and human clinical trials. To better understand the mechanism for this enhancement, we sought to assess its effect on the plasmablast response in human subjects. This pilot study utilised cryopreserved 7 day post-vaccination (7dpv) peripheral blood mononuclear cell samples obtained from a subset of 25 adult subjects from the FLU006-12 trial who had been immunized intramuscularly with a standard dose of 2012 trivalent inactivated influenza vaccine (TIV) alone (n=9 subjects) or combined with 5mg (n=8) or 10mg (n=8) of Advax adjuvant. Subjects receiving Advax adjuvant had increased 7dpv plasmablasts, which in turn exhibited a 2-3 fold higher rate of non-silent mutations in the B-cell receptor CDR3 region associated with higher expression of activation-induced cytidine deaminase (AID), the major enzyme controlling BCR affinity maturation. Together, these data suggest that Advax adjuvant enhances influenza immunity in immunized subjects via multiple mechanisms including increased plasmablast generation, AID expression and CDR3 mutagenesis resulting in enhanced BCR affinity maturation and increased production of high avidity antibody. How Advax adjuvant achieves these beneficial effects on plasmablasts remains the subject of ongoing investigation.	[Li, Lei; Honda-Okubo, Yoshikazu; Li, Connie; Petrovsky, Nikolai] Flinders Med Ctr, Vaxine Pty Ltd, Adelaide, SA, Australia; [Sajkov, Dimitar] Flinders Med Ctr, Australian Resp & Sleep Med Inst, Adelaide, SA, Australia; [Petrovsky, Nikolai] Flinders Univ S Australia, Flinders Med Ctr, Dept Endocrinol, Adelaide, SA 5001, Australia	Flinders Medical Centre; Flinders Medical Centre; Flinders Medical Centre; Flinders University South Australia	Petrovsky, N (corresponding author), Flinders Med Ctr, Vaxine Pty Ltd, Adelaide, SA, Australia.	nikolai.petrovsky@flinders.edu.au	Honda-Okubo, Yoshikazu/AAH-3306-2019; Petrovsky, Nikolai/P-1912-2017; Honda-Okubo, Yoshikazu/AAM-5898-2021	Petrovsky, Nikolai/0000-0002-1580-5245; Honda-Okubo, Yoshikazu/0000-0002-2872-8621	National Institutes of Health, National Institute of Allergy and Infectious Diseases [U01-AI061142, HHSN272200800039C]; Vaxine Pty Ltd; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI061142] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Vaxine Pty Ltd; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Development of Advax adjuvant was supported by Contracts U01-AI061142 and HHSN272200800039C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases. Vaxine Pty Ltd was the trial sponsor for FLU006-12. Vaxine Pty Ltd provided support in the form of salaries for authors LL, YHO, CL and NP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barnett LG, 2014, J IMMUNOL; Feinen B, 2014, CLIN VACCINE IMMUNOL, V21, P580, DOI 10.1128/CVI.00019-14; Gordon D, 2014, VACCINE, V32, P6469, DOI 10.1016/j.vaccine.2014.09.034; Gordon DL, 2012, VACCINE, V30, P5407, DOI 10.1016/j.vaccine.2012.06.009; Honda-Okubo Y, 2014, VACCINE, V32, P4651, DOI 10.1016/j.vaccine.2014.06.057; Honda-Okubo Y, 2012, VACCINE, V30, P5373, DOI 10.1016/j.vaccine.2012.06.021; Larena M, 2013, J VIROL, V87, P4395, DOI 10.1128/JVI.03144-12; Layton RC, 2011, VACCINE, V29, P6242, DOI 10.1016/j.vaccine.2011.06.078; Lefranc MP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00022; Liberman G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00274; Lobigs M, 2010, J GEN VIROL, V91, P1407, DOI 10.1099/vir.0.019190-0; Matthews AJ, 2014, ADV IMMUNOL, V122, P1, DOI 10.1016/B978-0-12-800267-4.00001-8; Nguyen HH, 2007, J VIROL, V81, P9331, DOI 10.1128/JVI.00751-07; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; NOSSAL GJV, 1975, ACTA ENDOCRINOL-COP, V78, P96; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Petrovsky N, 2013, TRIAL VACCINOL, V2, P39; Petrovsky N, 2008, EXPERT REV VACCINES, V7, P7, DOI 10.1586/14760584.7.1.7; Petrovsky N, 2013, J VIROL, V87, P10324, DOI 10.1128/JVI.00480-13; Petrovsky N, 2011, EXPERT REV VACCINES, V10, P523, DOI [10.1586/erv.11.30, 10.1586/ERV.11.30]; Reynaud CA, 2012, CELL MOL LIFE SCI, V69, P1625, DOI 10.1007/s00018-012-0971-z; Roy-Ghanta S, 2014, J INFECT DIS, V210, P1419, DOI 10.1093/infdis/jiu284; Saade F, 2013, VACCINE, V31, P1999, DOI 10.1016/j.vaccine.2012.12.077; Sasaki S, 2011, J CLIN INVEST, V121, P3109, DOI 10.1172/JCI57834; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; TOMAI MA, 1989, J BIOL RESP MODIF, V8, P625; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yi AK, 1996, J IMMUNOL, V156, P558	33	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132003	10.1371/journal.pone.0132003	http://dx.doi.org/10.1371/journal.pone.0132003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177480	Green Submitted, gold, Green Published			2022-12-27	WOS:000358197600077
J	Mukherjee, A; Syeb, K; Concannon, J; Callegari, K; Soto, C; Glicksman, MA				Mukherjee, Abhisek; Syeb, Kathleen; Concannon, John; Callegari, Keri; Soto, Claudio; Glicksman, Marcie A.			Development of a Fluorescent Quenching Based High Throughput Assay to Screen for Calcineurin Inhibitors	PLOS ONE			English	Article							PROTEIN PHOSPHATASE CALCINEURIN; CALMODULIN-BINDING PROTEIN; AMYLOID-BETA; NERVOUS-SYSTEM; CATALYTIC SUBUNIT; ESCHERICHIA-COLI; MEMORY; DISEASE; ACTIVATION; BRAIN	Currently there is no effective treatment available for major neurodegenerative disorders associated to protein misfolding, including Alzheimer's and Parkinson's disease. One of most promising therapeutic approaches under development focuses on inhibiting the misfolding and aggregation pathway. However, it is likely that by the time clinical symptoms appear, there is a large accumulation of misfolded aggregates and a very substantial damage to the brain. Thus, it seems that at the clinical stage of the disease it is necessary also to develop strategies aiming to prevent the neuronal damage produced by already formed misfolded aggregates. Chronic activation of calcineurin (CaN), a type IIB phosphatase, has been implicated as a pivotal molecule connecting synaptic loss and neuronal damage to protein misfolding. The fact that the crystal structure of CaN is also well established makes it an ideal target for drug discovery. CaN activity assays for High Throughput Screening (HTS) reported so far are based on absorbance. In this article we report the development of a fluorescent quenching based CaN activity assay suitable for robotic screening of large chemical libraries to find novel inhibitors. The assay yielded a Z score of 0.84 with coefficient of variance <= 15%. Our results also show that this assay can be used to identify CaN inhibitors with a wide range of potencies.	[Mukherjee, Abhisek; Callegari, Keri; Soto, Claudio] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA; [Syeb, Kathleen; Concannon, John; Glicksman, Marcie A.] Brigham & Womens Hosp, Dept Neurol, Lab Drug Discovery Neurodegenerat, Cambridge, MA USA; [Syeb, Kathleen; Concannon, John; Glicksman, Marcie A.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	University of Texas System; University of Texas Health Science Center Houston; Harvard University; Brigham & Women's Hospital; Harvard University	Glicksman, MA (corresponding author), ORIG3N INC, Boston, MA 02210 USA.	Abhisek.Mukherjee@uth.tmc.edu; marcie@orig3n.com		Callegari, Keri/0000-0003-1433-6659	National Center for Drug Discovery in Neurodegeneration; NIH National Institute of Neurological Disorders and Stroke (NINDS) Cooperative Agreement Award [(U24) NS04933901]; Harvard NeuroDiscovery Center	National Center for Drug Discovery in Neurodegeneration; NIH National Institute of Neurological Disorders and Stroke (NINDS) Cooperative Agreement Award; Harvard NeuroDiscovery Center	This work was supported by National Center for Drug Discovery in Neurodegeneration, NIH National Institute of Neurological Disorders and Stroke (NINDS) Cooperative Agreement Award (U24) NS04933901 and the Harvard NeuroDiscovery Center.	Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Agostinho P, 2008, NEUROCHEM INT, V52, P1226, DOI 10.1016/j.neuint.2008.01.005; AUSSEL C, 1995, J BIOL CHEM, V270, P8032, DOI 10.1074/jbc.270.14.8032; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Dineley KT, 2007, NEUROBIOL LEARN MEM, V88, P217, DOI 10.1016/j.nlm.2007.03.010; Dineley KT, 2010, J NEUROSCI RES, V88, P2923, DOI 10.1002/jnr.22445; ENZ A, 1994, ANAL BIOCHEM, V216, P147, DOI 10.1006/abio.1994.1018; GIRI PR, 1992, DNA CELL BIOL, V11, P415, DOI 10.1089/dna.1992.11.415; Jiang HS, 1997, MOL IMMUNOL, V34, P663, DOI 10.1016/S0161-5890(97)00054-0; Jin L, 2002, P NATL ACAD SCI USA, V99, P13522, DOI 10.1073/pnas.212504399; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; Kingsbury TJ, 2007, J NEUROCHEM, V103, P761, DOI 10.1111/j.1471-4159.2007.04801.x; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Lehotsky J, 2003, PHYSIOL RES, V52, P269; LI HC, 1984, J BIOL CHEM, V259, P8801; Liu EH, 2007, NAT IMMUNOL, V8, P25, DOI 10.1038/ni1429; Liu F, 2005, J BIOL CHEM, V280, P37755, DOI 10.1074/jbc.M507475200; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Martin ZS, 2012, J NEUROCHEM, V120, P440, DOI 10.1111/j.1471-4159.2011.07576.x; Miyata Y, 2010, J BIOMOL SCREEN, V15, P1211, DOI 10.1177/1087057110380571; Mondragon A, 1997, BIOCHEMISTRY-US, V36, P4934, DOI 10.1021/bi9631935; Mukherjee A, 2011, CURR OPIN CELL BIOL, V23, P223, DOI 10.1016/j.ceb.2010.12.006; Mukherjee A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001138; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; Pineda JR, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-33; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Reese LC, 2008, AGING CELL, V7, P824, DOI 10.1111/j.1474-9726.2008.00434.x; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sellar KJ, 2006, ANAL BIOCHEM, V358, P104, DOI 10.1016/j.ab.2006.08.013; Sieber M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-25; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Taglialatela G, 2009, BEHAV BRAIN RES, V200, P95, DOI 10.1016/j.bbr.2008.12.034; Tang XH, 2012, J BIOMOL SCREEN, V17, P314, DOI 10.1177/1087057111429595; Usuda N, 1996, J HISTOCHEM CYTOCHEM, V44, P13, DOI 10.1177/44.1.8543776; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; WOOD JG, 1980, J CELL BIOL, V84, P66, DOI 10.1083/jcb.84.1.66; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Yamamoto-Sasaki M, 1999, BRAIN RES, V824, P300, DOI 10.1016/S0006-8993(99)01220-2; Zuck P, 2005, ANAL BIOCHEM, V342, P254, DOI 10.1016/j.ab.2005.04.029	41	2	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131297	10.1371/journal.pone.0131297	http://dx.doi.org/10.1371/journal.pone.0131297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176772	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600039
J	Nodvig, CS; Nielsen, JB; Kogle, ME; Mortensen, UH				Nodvig, Christina S.; Nielsen, Jakob B.; Kogle, Martin E.; Mortensen, Uffe H.			A CRISPR-Cas9 System for Genetic Engineering of Filamentous Fungi	PLOS ONE			English	Article							ASPERGILLUS-NIDULANS; SACCHAROMYCES-CEREVISIAE; CAS SYSTEMS; GUIDE RNAS; SPECIFICITY; TRANSFORMATION; ENDONUCLEASE; CRISPR/CAS9; EXPRESSION; EFFECTORS	The number of fully sequenced fungal genomes is rapidly increasing. Since genetic tools are poorly developed for most filamentous fungi, it is currently difficult to employ genetic engineering for understanding the biology of these fungi and to fully exploit them industrially. For that reason there is a demand for developing versatile methods that can be used to genetically manipulate non-model filamentous fungi. To facilitate this, we have developed a CRISPR-Cas9 based system adapted for use in filamentous fungi. The system is simple and versatile, as RNA guided mutagenesis can be achieved by transforming a target fungus with a single plasmid. The system currently contains four CRISPR- Cas9 vectors, which are equipped with commonly used fungal markers allowing for selection in a broad range of fungi. Moreover, we have developed a script that allows identification of protospacers that target gene homologs in multiple species to facilitate introduction of common mutations in different filamentous fungi. With these tools we have performed RNA-guided mutagenesis in six species of which one has not previously been genetically engineered. Moreover, for a wild-type Aspergillus aculeatus strain, we have used our CRISPR Cas9 system to generate a strain that contains an AACU_pyrG marker and demonstrated that the resulting strain can be used for iterative gene targeting.	[Nodvig, Christina S.; Nielsen, Jakob B.; Kogle, Martin E.; Mortensen, Uffe H.] Tech Univ Denmark, Dept Syst Biol, Sect Eukaryot Biotechnol, Eukaryot Mol Cell Biol, DK-2800 Lyngby, Denmark	Technical University of Denmark	Mortensen, UH (corresponding author), Tech Univ Denmark, Dept Syst Biol, Sect Eukaryot Biotechnol, Eukaryot Mol Cell Biol, DK-2800 Lyngby, Denmark.	um@bio.dtu.dk	Mortensen, Uffe/AAQ-1150-2021; Hoof, Jakob Blæsbjerg/L-6019-2015	Hoof, Jakob Blæsbjerg/0000-0002-7650-9300	Danish Council for Strategic Research [11-116803]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by Grant 11-116803 from The Danish Council for Strategic Research.	Aleksenko A, 1997, FUNGAL GENET BIOL, V21, P373, DOI 10.1006/fgbi.1997.0980; Arnaud MB, 2012, NUCLEIC ACIDS RES, V40, pD653, DOI 10.1093/nar/gkr875; BALLANCE DJ, 1983, BIOCHEM BIOPH RES CO, V112, P284, DOI 10.1016/0006-291X(83)91828-4; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Fleissner A, 2010, APPL MICROBIOL BIOT, V87, P1255, DOI 10.1007/s00253-010-2672-6; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; GEMS D, 1991, GENE, V98, P61, DOI 10.1016/0378-1119(91)90104-J; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hansen BG, 2011, APPL ENVIRON MICROB, V77, P3044, DOI 10.1128/AEM.01768-10; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jacobs JZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6344; Jakounas T, 2015, METAB ENG, V28, P213, DOI 10.1016/j.ymben.2015.01.008; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaminskyj SGW., 2001, FUNGAL GENET REP, V48, P25, DOI [10.4148/1941-4765.1175, DOI 10.4148/1941-4765.1175]; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kitamoto N, 1998, APPL MICROBIOL BIOT, V50, P85, DOI 10.1007/s002530051260; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moretti A, 2013, INT J FOOD MICROBIOL, V167, P57, DOI 10.1016/j.ijfoodmicro.2013.06.033; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nielsen ML, 2006, FUNGAL GENET BIOL, V43, P54, DOI 10.1016/j.fgb.2005.09.005; Nissim L, 2014, MULTIPLEXED PROGRAMM; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Nour-Eldin HH, 2010, METHODS MOL BIOL, V643, P185, DOI 10.1007/978-1-60761-723-5_13; OHARA EB, 1989, GENETICS, V121, P249; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ruiz-Diez B, 2002, J APPL MICROBIOL, V92, P189, DOI 10.1046/j.1365-2672.2002.01516.x; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Tamano K, 2013, APPL MICROBIOL BIOT, V97, P269, DOI 10.1007/s00253-012-4193-y; Wu F, 2014, ANNU REV FOOD SCI T, V5, P351, DOI 10.1146/annurev-food-030713-092431; YUILL EDWARD, 1950, TRANS BRIT MYCOL SOC, V33, P324; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	46	329	374	29	357	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133085	10.1371/journal.pone.0133085	http://dx.doi.org/10.1371/journal.pone.0133085			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177455	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600212
J	Olsen, AB; Hjortaas, M; Tengs, T; Hellberg, H; Johansen, R				Olsen, Anne Berit; Hjortaas, Monika; Tengs, Torstein; Hellberg, Hege; Johansen, Renate			First Description of a New Disease in Rainbow Trout (Oncorhynchus mykiss (Walbaum)) Similar to Heart and Skeletal Muscle Inflammation (HSMI) and Detection of a Gene Sequence Related to Piscine Orthoreovirus (PRV)	PLOS ONE			English	Article							SALMON SALMO-SALAR; RT-PCR ASSAY; ATLANTIC SALMON; REOVIRUS PRV; ALPHAVIRUS SAV; VIRUS; NORWAY; VALIDATION; TAQMAN(R); INFECTION	In fall 2013, anorexia, lethargy and mortalities up to 10-12,000 dead fish per week were observed in rainbow trout Oncorhynchus mykiss in three fresh water hatcheries (salinity 0-1 %) on the west coast of Norway. The fish (25-100 g) showed signs of circulatory failure with haemorrhages, ascites and anaemia. The histopathological findings comprised inflammation of the heart and red muscle and liver necrosis. The affected fish had a common origin. Disease and mortalities were also observed up to four months after sea water transfer. Microbiological examination did not reveal presence of any known pathogens. Based on histopathological similarities to heart and skeletal inflammation (HSMI) in Atlantic salmon, associated with piscine orthoreovirus (PRV), extended investigations to detect a virus within the family Reoviridae were conducted. By the use of primer sets targeting the PRV genome, a sequence with 85% identity to a part of segment S1 of PRV was obtained. Further analysis showed that the virus sequence could only be aligned with PRV and no other reoviruses both on amino acid and nucleotide level. Two PCR assays were developed for specific detection of the virus. High amounts of the virus were detected in diseased fish at all affected farms and low amounts were detected in low prevalence at the broodfish farms. Further investigations are needed to determine if the virus is associated with the new disease in rainbow trout and to further characterize the virus with respect to classification, relationship with PRV, virulence, pathology and epidemiology.	[Olsen, Anne Berit; Hellberg, Hege] Norwegian Vet Inst, Bergen, Norway; [Hjortaas, Monika; Tengs, Torstein; Johansen, Renate] Norwegian Vet Inst, Oslo, Norway	Norwegian Veterinary Institute; Norwegian Veterinary Institute	Olsen, AB (corresponding author), Norwegian Vet Inst, Bergen, Norway.	anne-berit.olsen@vetinst.no			Norwegian Veterinary Institute	Norwegian Veterinary Institute	This work has been financed by internal funding at the Norwegian Veterinary Institute.	ANACKER RL, 1959, J BACTERIOL, V78, P33, DOI 10.1128/JB.78.1.33-40.1959; Blindheim S, 2015, ARCH VIROL, V160, P91, DOI 10.1007/s00705-014-2235-8; Evensen O, 1996, DIS AQUAT ORGAN, V25, P53, DOI 10.3354/dao025053; Finstad OW, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-35; Finstad OW, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-27; Garseth AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082202; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hjeltnes B., 2014, FISH HLTH REPORT 201; Hodneland K, 2006, J VIROL METHODS, V131, P184, DOI 10.1016/j.jviromet.2005.08.012; Jansen MD, 2010, J FISH DIS, V33, P391, DOI 10.1111/j.1365-2761.2009.01131.x; Jansen MD, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-188; Jonstrup SP, 2013, J FISH DIS, V36, P9, DOI 10.1111/j.1365-2761.2012.01416.x; Kibenge MJT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-230; Kongtorp RT, 2009, J FISH DIS, V32, P253, DOI 10.1111/j.1365-2761.2008.00983.x; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; Kongtorp RT., 2008, SERIES OF DISSERTATI, V47; Liu ZX, 2008, J VIROL METHODS, V149, P103, DOI 10.1016/j.jviromet.2007.12.017; Lovoll M, 2012, DIS AQUAT ORGAN, V99, P7, DOI 10.3354/dao02451; Lovoll M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-309; Lupiani Blanca, 1995, Annual Review of Fish Diseases, V5, P175, DOI 10.1016/0959-8030(95)00006-2; MacWilliams C, 2007, DIS AQUAT ORGAN, V78, P1, DOI 10.3354/dao01866; Meyers TR, 2007, DIS AQUAT ORGAN, V76, P169, DOI 10.3354/dao076169; Nilsen H, 2011, J FISH DIS, V34, P403, DOI 10.1111/j.1365-2761.2011.01249.x; Orpetveit I, 2010, J VET DIAGN INVEST, V22, P886, DOI 10.1177/104063871002200606; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Rodger HD, 2007, J FISH DIS, V30, P411, DOI 10.1111/j.1365-2761.2007.00831.x; Seng EK, 2004, J VIROL METHODS, V118, P111, DOI 10.1016/j.jviromet.2004.01.023; Snow M, 2006, DEV BIOLOGICALS, V126, P133	28	57	59	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131638	10.1371/journal.pone.0131638	http://dx.doi.org/10.1371/journal.pone.0131638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176955	Green Published, gold			2022-12-27	WOS:000358197600056
J	Stergiopoulos, V; Gozdzik, A; Misir, V; Skosireva, A; Connelly, J; Sarang, A; Whisler, A; Hwang, SW; O'Campo, P; McKenzie, K				Stergiopoulos, Vicky; Gozdzik, Agnes; Misir, Vachan; Skosireva, Anna; Connelly, Jo; Sarang, Aseefa; Whisler, Adam; Hwang, Stephen W.; O'Campo, Patricia; McKenzie, Kwame			Effectiveness of Housing First with Intensive Case Management in an Ethnically Diverse Sample of Homeless Adults with Mental Illness: A Randomized Controlled Trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; COMMUNITY ABILITY SCALE; FULLY CONDITIONAL SPECIFICATION; PSYCHIATRIC DISABILITIES; HEALTH-CARE; MULTIPLE IMPUTATION; ALCOHOL-PROBLEMS; ILL CONSUMERS; MISSING DATA; SERVICE USE	Housing First (HF) is being widely disseminated in efforts to end homelessness among homeless adults with psychiatric disabilities. This study evaluates the effectiveness of HF with Intensive Case Management (ICM) among ethnically diverse homeless adults in an urban setting. 378 participants were randomized to HF with ICM or treatment-as-usual (TAU) in Toronto (Canada), and followed for 24 months. Measures of effectiveness included housing stability, physical (EQ5D-VAS) and mental (CSI, GAIN-SS) health, social functioning (MCAS), quality of life (QoLI20), and health service use. Two-thirds of the sample (63%) was from racialized groups and half (50%) were born outside Canada. Over the 24 months of follow-up, HF participants spent a significantly greater percentage of time in stable residences compared to TAU participants (75.1% 95% CI 70.5 to 79.7 vs. 39.3% 95% CI 34.3 to 44.2, respectively). Similarly, community functioning (MCAS) improved significantly from baseline in HF compared to TAU participants (change in mean difference = +1.67 95% CI 0.04 to 3.30). There was a significant reduction in the number of days spent experiencing alcohol problems among the HF compared to TAU participants at 24 months (ratio of rate ratios = 0.47 95% CI 0.22 to 0.99) relative to baseline, a reduction of 53%. Although the number of emergency department visits and days in hospital over 24 months did not differ significantly between HF and TAU participants, fewer HF participants compared to TAU participants had 1 or more hospitalizations during this period (70.4% vs. 81.1%, respectively; P=0.044). Compared to non-racialized HF participants, racialized HF participants saw an increase in the amount of money spent on alcohol (change in mean difference = $112.90 95% CI 5.84 to 219.96) and a reduction in physical community integration (ratio of rate ratios = 0.67 95% CI 0.47 to 0.96) from baseline to 24 months. Secondary analyses found a significant reduction in the number of days experiencing problems due to alcohol use among foreign-born (vs. Canadian-born) HF participants at 24 months (ratio of rate ratios = 0.19 95% 0.04 to 0.88), relative to baseline. Compared to usual care, HF with ICM can improve housing stability and community functioning and reduce the days of alcohol related problems in an ethnically diverse sample of homeless adults with mental illness within 2-years.	[Stergiopoulos, Vicky; Gozdzik, Agnes; Misir, Vachan; Skosireva, Anna; Whisler, Adam; Hwang, Stephen W.; O'Campo, Patricia] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Stergiopoulos, Vicky; McKenzie, Kwame] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Connelly, Jo] Toronto North Support Serv, Toronto, ON, Canada; [Sarang, Aseefa] Across Boundaries, Toronto, ON, Canada; [Hwang, Stephen W.] Univ Toronto, Dept Med, Div Gen Internal Med, Toronto, ON, Canada; [O'Campo, Patricia] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [McKenzie, Kwame] Ctr Addict & Mental Hlth, Hlth Serv & Hlth Equity Res, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Stergiopoulos, V (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, 30 Bond St, Toronto, ON M5B 1W8, Canada.	Stergiopoulosv@smh.ca	Hwang, Stephen W./GVR-7773-2022; Hwang, Stephen/D-2297-2011	Hwang, Stephen/0000-0002-1276-1101; mckenzie, kwame/0000-0001-6419-8130	Mental Health Commission of Canada via funds from Health Canada	Mental Health Commission of Canada via funds from Health Canada	This study was funded by the Mental Health Commission of Canada via funds from Health Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BARKER S, 1994, COMMUNITY MENT HLT J, V30, P459, DOI 10.1007/BF02189063; BARKER S, 1994, COMMUNITY MENT HLT J, V30, P363, DOI 10.1007/BF02207489; Barrio C, 2003, PSYCHIAT SERV, V54, P1264, DOI 10.1176/appi.ps.54.9.1264; Bassani DG, 2009, PSYCHIAT RES, V167, P178, DOI 10.1016/j.psychres.2008.01.005; Bhui K, 2003, BRIT J PSYCHIAT, V182, P105, DOI 10.1192/bjp.182.2.105; Block S., 2011, CANADAS COLOUR CODED; Boothroyd RA, 2008, ADM POLICY MENT HLTH, V35, P370, DOI 10.1007/s10488-008-0179-6; Brown P, 2006, 2006 STREET NEEDS AS; Caton CL, 2007, 2007 NAT S HOM RES; City of Toronto Shelter Support and Housing Administration, 2008, WHAT HOUSING FIRST M; City of Toronto Shelter Support and Housing Administration, 2010, 2009 STREET NEEDS AS; Collins SE, 2012, AM J PUBLIC HEALTH, V102, P511, DOI 10.2105/AJPH.2011.300403; Culhane DP, 2002, HOUS POLICY DEBATE, V13, P107, DOI 10.1080/10511482.2002.9521437; Davis TD, 2011, PSYCHIAT SERV, V62, P1282, DOI 10.1176/ps.62.11.pss6211_1282; Dennis ML, 2006, AM J ADDICTION, V15, P80, DOI 10.1080/10550490601006055; Dickerson FB, 2003, COMMUNITY MENT HLT J, V39, P131, DOI 10.1023/A:1022610620391; DURBIN J, 2004, CANADIAN J PROGRAM E, V19, P135; Fitzpatrick-Lewis D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-638; Frane JW, 1998, DRUG INF J, V32, P423, DOI 10.1177/009286159803200213; Gilmer TP, 2010, ARCH GEN PSYCHIAT, V67, P645, DOI 10.1001/archgenpsychiatry.2010.56; Goering PN, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000323; Golden A., 1999, TAKING RESPONSIBILIT; Graham JW., 2012, MISSING DATA; Greenwood RM, 2005, AM J COMMUN PSYCHOL, V36, P223, DOI 10.1007/s10464-005-8617-z; Gulcur L, 2003, J COMMUNITY APPL SOC, V13, P171, DOI 10.1002/casp.723; Hansson E., 2010, IMPROVING MENTAL HLT; Hansson EK, 2012, CAN J PSYCHIAT, V57, P111, DOI 10.1177/070674371205700208; Harris KM, 2005, MED CARE, V43, P775, DOI 10.1097/01.mlr.0000170405.66264.23; Hwang SW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-787; Hwang SW, 2010, AM J PUBLIC HEALTH, V100, P1454, DOI 10.2105/AJPH.2009.182022; Hwang SW, 2005, AM J PREV MED, V29, P311, DOI 10.1016/j.amepre.2005.06.017; Jarvis GE, 2007, CAN J PSYCHIAT, V52, P287, DOI 10.1177/070674370705200503; Kertesz SG, 2009, MILBANK Q, V87, P495, DOI 10.1111/j.1468-0009.2009.00565.x; Kirmayer LJ, 2011, CAN MED ASSOC J, V183, pE959, DOI 10.1503/cmaj.090292; Klimidis S, 2000, SOC PSYCH PSYCH EPID, V35, P554, DOI 10.1007/s001270050279; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; Lee KJ, 2010, AM J EPIDEMIOL, V171, P624, DOI 10.1093/aje/kwp425; Lehman AF, 1996, SOC PSYCH PSYCH EPID, V31, P78, DOI 10.1007/BF00801903; Mares AS, 2010, J BEHAV HEALTH SER R, V37, P167, DOI 10.1007/s11414-009-9171-5; Mares AS, NATL PERFORMANCE OUT; Morgan C, 2005, BRIT J PSYCHIAT, V186, P290, DOI 10.1192/bjp.186.4.290; Nelson G, 2007, ADM POLICY MENT HLTH, V34, P89, DOI 10.1007/s10488-006-0083-x; O'Connell MJ, 2009, PSYCHOL SERV, V6, P190, DOI 10.1037/a0014921; Padgett DK, 2006, RES SOCIAL WORK PRAC, V16, P74, DOI 10.1177/1049731505282593; Perlman J, 2006, DENVER HOUSING FIRST; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Rosenheck R, 2003, ARCH GEN PSYCHIAT, V60, P940, DOI 10.1001/archpsyc.60.9.940; Sadowski LS, 2009, JAMA-J AM MED ASSOC, V301, P1771, DOI 10.1001/jama.2009.561; Salize HJ, 2013, CURR OPIN PSYCHIATR, V26, P355, DOI 10.1097/YCO.0b013e328361e596; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schenker N, 2006, J AM STAT ASSOC, V101, P924, DOI 10.1198/016214505000001375; Schiff R, 2010, CANADIAN JOURNAL OF, V19, P108, DOI [DOI 10.1177/0020764009354838, 10.1177/0020764009354838]; Segal Steven P., 1978, MENTALLY ILL COMMUNI; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shepherd S., 2003, 2003 TORONTO REPORT; Shern DL, 1997, PSYCHIATR SERV, V48, P239; Skosireva A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-376; Statistics Canada, 2008, CAN ETHN MOS 2006 CE; Statistics Canada, DEF DAT SOURC METH V; Stergiopoulos V, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-345; Tsemberis S, 1999, J COMMUNITY PSYCHOL, V27, P225, DOI 10.1002/(SICI)1520-6629(199903)27:2<225::AID-JCOP9>3.0.CO;2-Y; Tsemberis S, 2004, AM J PUBLIC HEALTH, V94, P651, DOI 10.2105/AJPH.94.4.651; Tsemberis S, 2000, PSYCHIATR SERV, V51, P487, DOI 10.1176/appi.ps.51.4.487; Tsemberis S., 2011, HOUSING 1 PATHWAYS M; Tsemberis S, 2007, J COMMUNITY PSYCHOL, V35, P29, DOI 10.1002/jcop.20132; Tsemberis SJ, 2003, AM J COMMUN PSYCHOL, V32, P305, DOI 10.1023/B:AJCP.0000004750.66957.bf; US Department of Health and Human Services, 2001, MENT HLTH CULT RAC E; Uttaro T, 1999, EVAL PROGRAM PLANN, V22, P41, DOI 10.1016/S0149-7189(98)00039-1; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Weich S, 2004, PSYCHOL MED, V34, P1543, DOI 10.1017/S0033291704002715; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zerger S, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0353-1	73	59	59	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130281	10.1371/journal.pone.0130281	http://dx.doi.org/10.1371/journal.pone.0130281			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26176621	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600022
J	Verma, D; Das, L; Gambhir, V; Dikshit, KL; Varshney, GC				Verma, Deepshikha; Das, Lahari; Gambhir, Vandana; Dikshit, Kanak Lata; Varshney, Grish C.			Heterogeneity among Homologs of Cutinase-Like Protein Cut5 in Mycobacteria	PLOS ONE			English	Article							PE-PGRS PROTEINS; GENOME EVOLUTION; TUBERCULOSIS; GENES; PURIFICATION; FAMILY; GROWTH; IDENTIFICATION; EXPRESSION; BIOMARKERS	The study of genomic variability within various pathogenic and non-pathogenic strains of mycobacteria provides insight into their evolution and pathogenesis. The mycobacterial genome encodes seven cutinase-like proteins and each one of these exhibit distinct characteristics. We describe the presence of Cut5, a member of the cutinase family, in mycobacteria and the existence of a unique genomic arrangement in the cut5 gene of M. tuberculosis (Mtb) strains. A single nucleotide (T) insertion is observed in the cut5 gene, which is specific for Mtb strains. Using in silico analysis and RT-PCR, we demonstrate the transcription of Rv3724/cut5 as Rv3724a/cut5a and Rv3724b/cut5b in Mtb H37Rv and as full length cut5 in M. bovis. Cut5b protein of Mtb H37Rv (MtbCut5b) was found to be antigenically similar to its homologs in M. bovis and M. smegmatis, without any observed cross-reactivity with other Mtb cutinases. Also, the presence of Cut5b in Mtb and its homologs in M. bovis and M. smegmatis were confirmed by western blotting using antibodies raised against recombinant Cut5b. In Mtb H37Rv, Cut5b was found to be localized in the cell wall, cytosol and membrane fractions. We also report the vast prevalence of Cut5 homologs in pathogenic and non pathogenic species of mycobacteria. In silico analysis revealed that this protein has three possible organizations in mycobacteria. Also, a single nucleotide (T) insertion in Mtb strains and varied genomic arrangements within mycobacterial species make Rv3724/Cut5 a potential candidate that can be exploited as a biomarker in Mtb infection.	[Verma, Deepshikha; Das, Lahari; Gambhir, Vandana; Dikshit, Kanak Lata; Varshney, Grish C.] CSIR, Inst Microbial Technol, Cell Biol & Immunol Div, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Varshney, GC (corresponding author), CSIR, Inst Microbial Technol, Cell Biol & Immunol Div, Chandigarh, India.	grish@imtech.res.in			Council of scientific and industrial research [GENESIS BSC0121, SIP 10, SPLenDID BSC 0104]	Council of scientific and industrial research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the GENESIS BSC0121 of Council of scientific and industrial research grant numbers SIP 10, SPLenDID BSC 0104 to DV LD VG GCV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Bashiri G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045003; Belbahri L, 2008, GENE, V408, P1, DOI 10.1016/j.gene.2007.10.019; Bentrup KHZ, 1999, J BACTERIOL, V181, P7161; Bhaduri A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088090; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brust B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025078; Chegou NN, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-10; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Dedieu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066913; Fukuda Y, 1999, NUCLEIC ACIDS RES, V27, P1847, DOI 10.1093/nar/27.8.1847; Gamieldien J, 2002, TRENDS GENET, V18, P5, DOI 10.1016/S0168-9525(01)02529-X; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grover A, 2006, PROTEIN EXPRES PURIF, V48, P274, DOI 10.1016/j.pep.2006.03.010; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Kaur R, 2002, J HISTOCHEM CYTOCHEM, V50, P863, DOI 10.1177/002215540205000612; Krakauer DC, 2000, EVOLUTION, V54, P731, DOI 10.1111/j.0014-3820.2000.tb00075.x; Ocampo M, 2012, AMINO ACIDS, V42, P2067, DOI 10.1007/s00726-011-0938-7; Parker SK, 2007, J BACTERIOL, V189, P4153, DOI 10.1128/JB.01909-06; Parker SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004281; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Rosas-Magallanes V, 2006, MOL BIOL EVOL, V23, P1129, DOI 10.1093/molbev/msj120; Sartain MJ, 2006, MOL CELL PROTEOMICS, V5, P2102, DOI 10.1074/mcp.M600089-MCP200; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Schue M, 2010, FASEB J, V24, P1893, DOI 10.1096/fj.09-144766; Skamnioti P, 2008, NEW PHYTOL, V180, P711, DOI 10.1111/j.1469-8137.2008.02598.x; Springer B, 2004, MOL MICROBIOL, V53, P1601, DOI 10.1111/j.1365-2958.2004.04231.x; Sreenu VB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-78; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vizcaino C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000824; WALSH JB, 1987, GENETICS, V117, P543; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wanner RM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-249; Weldingh K, 1998, INFECT IMMUN, V66, P3492, DOI 10.1128/IAI.66.8.3492-3500.1998; West NP, 2008, VACCINE, V26, P3853, DOI 10.1016/j.vaccine.2008.05.007; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; Wolf YI, 2000, GENOME BIOL, V1; Yang Y, 2014, CELL HOST MICROBE, V15, P153, DOI 10.1016/j.chom.2014.01.008	42	5	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133186	10.1371/journal.pone.0133186	http://dx.doi.org/10.1371/journal.pone.0133186			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177502	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600228
J	Johnston, BA; Steele, JD; Tolomeo, S; Christmas, D; Matthews, K				Johnston, Blair A.; Steele, J. Douglas; Tolomeo, Serenella; Christmas, David; Matthews, Keith			Structural MRI-Based Predictions in Patients with Treatment-Refractory Depression (TRD)	PLOS ONE			English	Article							TREATMENT-RESISTANT DEPRESSION; VOXEL-BASED MORPHOMETRY; LATE-LIFE DEPRESSION; MAJOR DEPRESSION; HIPPOCAMPAL NEUROGENESIS; VENTRICULAR ENLARGEMENT; UNIPOLAR DEPRESSION; CAUDATE-NUCLEUS; MOOD DISORDERS; INSULAR CORTEX	The application of machine learning techniques to psychiatric neuroimaging offers the possibility to identify robust, reliable and objective disease biomarkers both within and between contemporary syndromal diagnoses that could guide routine clinical practice. The use of quantitative methods to identify psychiatric biomarkers is consequently important, particularly with a view to making predictions relevant to individual patients, rather than at a group-level. Here, we describe predictions of treatment-refractory depression (TRD) diagnosis using structural T-1-weighted brain scans obtained from twenty adult participants with TRD and 21 never depressed controls. We report 85% accuracy of individual subject diagnostic prediction. Using an automated feature selection method, the major brain regions supporting this significant classification were in the caudate, insula, habenula and periventricular grey matter. It was not, however, possible to predict the degree of 'treatment resistance' in individual patients, at least as quantified by the Massachusetts General Hospital (MGH-S) clinical staging method; but the insula was again identified as a region of interest. Structural brain imaging data alone can be used to predict diagnostic status, but not MGH-S staging, with a high degree of accuracy in patients with TRD.	[Johnston, Blair A.; Steele, J. Douglas; Tolomeo, Serenella; Matthews, Keith] Univ Dundee, Ninewells Hosp & Med Sch, Div Neurosci, Med Res Inst, Dundee DD1 9SY, Scotland; [Steele, J. Douglas; Christmas, David; Matthews, Keith] Univ Dundee, Ninewells Hosp & Med Sch, NHS Tayside, Adv Intervent Serv, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee	Johnston, BA (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Neurosci, Med Res Inst, Dundee DD1 9SY, Scotland.	b.a.johnston@dundee.ac.uk	Steele, Douglas/AAB-9889-2019; Steele, J Douglas/A-8972-2017; Tolomeo, Serenella/AHE-4118-2022; Christmas, David/C-7300-2011	Steele, Douglas/0000-0002-9822-8753; Steele, J Douglas/0000-0002-9822-8753; Tolomeo, Serenella/0000-0003-0740-7893; Christmas, David/0000-0002-6565-8722; Matthews, Keith/0000-0002-4478-5888	SINAPSE; SINAPSE-SPIRIT; Siemens Medical	SINAPSE; SINAPSE-SPIRIT; Siemens Medical	The project was supported by two awards from an Anonymous Trust administered by the University of Dundee and, in part, by staff resource from the Scottish Mental Health Research Network (SMHRN). BAJ was partially supported by a SINAPSE (www.sinapse.ac.uk) studentship, which included a SINAPSE-SPIRIT industry partnership with Siemens Medical. The funding sources played no part in the design of the study, analysis and interpretation of the data, nor manuscript preparation.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDREASEN NC, 1982, AM J PSYCHIAT, V139, P297; Ashburner J., 2012, SPM8 MANUAL; Bennabi D, 2015, J AFFECT DISORDERS, V171, P137, DOI 10.1016/j.jad.2014.09.020; Bishop C. M, 2006, PATTERN RECOGNITION; Bluhm R, 2009, PSYCHIAT CLIN NEUROS, V63, P754, DOI 10.1111/j.1440-1819.2009.02030.x; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Butters MA, 2009, AM J GERIAT PSYCHIAT, V17, P4, DOI 10.1097/JGP.0b013e31816ff72b; Costafreda SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006353; Craig AD, 2009, DO YOU FEEL NOW ANTE; Crozier R, GOODNESS FIT GFIT2; Doree JP, 2007, CURR MED RES OPIN, V23, P333, DOI 10.1185/030079906X162809; ELKIS H, 1995, ARCH GEN PSYCHIAT, V52, P735; Fava M, 2003, BIOL PSYCHIAT, V53, P649, DOI 10.1016/S0006-3223(03)00231-2; Frodl T, 2008, J PSYCHIATR NEUROSCI, V33, P423; FU C, 2003, NEUROIMAGING PSYCHIA; Furtado CP, 2008, PSYCHIAT RES-NEUROIM, V163, P133, DOI 10.1016/j.pscychresns.2007.11.005; Haubold A, 2012, J CHILD PSYCHOL PSYC, V53, P519, DOI 10.1111/j.1469-7610.2012.02539.x; Hazari H, 2013, J AFFECT DISORDERS, V150, P231, DOI 10.1016/j.jad.2013.03.030; Hoexter MQ, 2013, J AFFECT DISORDERS, V150, P1213, DOI 10.1016/j.jad.2013.05.041; Hwang JP, 2010, J GERIATR PSYCH NEUR, V23, P171, DOI 10.1177/0891988710363713; Johnston BA, 2013, EUR CHILD ADOLES PSY, V22, P733, DOI 10.1007/s00787-012-0319-0; Kempton MJ, 2011, ARCH GEN PSYCHIAT, V68, P675, DOI 10.1001/archgenpsychiatry.2011.60; Kim AJ, 2008, PSYCHIAT RES-NEUROIM, V164, P114, DOI 10.1016/j.pscychresns.2007.12.020; Kipli K, 2013, P 2013 ICME INT C CO; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; KRISHNAN KRR, 1992, ARCH GEN PSYCHIAT, V49, P553; Lacerda ALT, 2003, PSYCHIAT RES-NEUROIM, V124, P129, DOI 10.1016/S0925-4927(03)00123-9; Lawson RP, 2013, NEUROIMAGE, V64, P722, DOI 10.1016/j.neuroimage.2012.08.076; Lenze EJ, 1999, AM J PSYCHIAT, V156, P1989; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Maller JJ, 2012, HIPPOCAMPUS, V22, P9, DOI 10.1002/hipo.20873; McRobbie D W, 2010, MRI PICTURE PROTON; Moore GJ, 2000, LANCET, V356, P1241, DOI 10.1016/S0140-6736(00)02793-8; Mwangi B, 2012, BRAIN, V135, P1508, DOI 10.1093/brain/aws084; Mwangi B, 2012, J MAGN RESON IMAGING, V35, P64, DOI 10.1002/jmri.22806; Nelson HE., 1982, NATL ADULT READING T; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parashos IA, 1998, PSYCHIAT RES-NEUROIM, V84, P7, DOI 10.1016/S0925-4927(98)00042-0; Petersen T, 2005, J CLIN PSYCHOPHARM, V25, P336, DOI 10.1097/01.jcp.0000169036.40755.16; Pillay SS, 1998, PSYCHIAT RES-NEUROIM, V84, P61, DOI 10.1016/S0925-4927(98)00048-1; Ranft K, 2010, PSYCHOL MED, V40, P557, DOI 10.1017/S0033291709990821; Rapaport MH, 2003, J CLIN PSYCHIAT, V64, P1065, DOI 10.4088/JCP.v64n0912; Redlich R, 2014, JAMA PSYCHIAT, V71, P1222, DOI 10.1001/jamapsychiatry.2014.1100; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Sackeim HA, 2001, J CLIN PSYCHIAT, V62, pS10; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 2001, P NATL ACAD SCI USA, V98, P12320, DOI 10.1073/pnas.231475998; Sartorius A, 2007, MED HYPOTHESES, V69, P1305, DOI 10.1016/j.mehy.2007.03.021; Savitz JB, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-7; Savitz JB, 2011, BIOL PSYCHIAT, V69, P336, DOI 10.1016/j.biopsych.2010.09.027; Schermuly I, 2011, J AFFECT DISORDERS, V135, P405, DOI 10.1016/j.jad.2011.07.017; Schrouff J., 2013, NEUROINFORMATICS; Schwaighofer A, SVM TOOLBOX 2 51; Shah PJ, 2002, BRIT J PSYCHIAT, V180, P434, DOI 10.1192/bjp.180.5.434; Shah PJ, 1998, BRIT J PSYCHIAT, V172, P527, DOI 10.1192/bjp.172.6.527; Sheehan DV, 1992, MINIINTERNATIONAL PS, V5; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Soares JC, 1997, BIOL PSYCHIAT, V41, P86, DOI 10.1016/S0006-3223(96)00006-6; Soriano-Mas C, 2011, BIOL PSYCHIAT, V69, P318, DOI 10.1016/j.biopsych.2010.07.029; Sprengelmeyer R, 2011, J AFFECT DISORDERS, V133, P120, DOI 10.1016/j.jad.2011.04.004; Stonnington CM, 2010, NEUROIMAGE, V51, P1405, DOI 10.1016/j.neuroimage.2010.03.051; Takahashi T, 2010, J AFFECT DISORDERS, V121, P231, DOI 10.1016/j.jad.2009.06.003; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Wang Y, 2010, NEUROIMAGE, V50, P1519, DOI 10.1016/j.neuroimage.2009.12.092; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Zimmerman M, 2013, J AFFECT DISORDERS, V150, P384, DOI 10.1016/j.jad.2013.04.028	71	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132958	10.1371/journal.pone.0132958	http://dx.doi.org/10.1371/journal.pone.0132958			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186455	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700076
J	Li, XQ; Ye, D; Liang, HW; Zhu, HG; Qin, L; Zhu, YL; Wen, YG				Li, Xiaoqiong; Ye, Duo; Liang, Hongwen; Zhu, Hongguang; Qin, Lin; Zhu, Yuling; Wen, Yuanguang			Effects of Successive Rotation Regimes on Carbon Stocks in Eucalyptus Plantations in Subtropical China Measured over a Full Rotation	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; MECHANICAL SITE PREPARATION; RESIDUE MANAGEMENT; WEED-CONTROL; CUNNINGHAMIA-LANCEOLATA; UNDERSTORY VEGETATION; PINE PLANTATION; CLIMATE-CHANGE; AGE-SEQUENCE; BULK-DENSITY	Plantations play an important role in carbon sequestration and the global carbon cycle. However, there is a dilemma in that most plantations are managed on short rotations, and the carbon sequestration capacities of these short-rotation plantations remain understudied. Eucalyptus has been widely planted in the tropics and subtropics due to its rapid growth, high adaptability, and large economic return. Eucalyptus plantations are primarily planted in successive rotations with a short rotation length of 6 similar to 8 years. In order to estimate the carbon-stock potential of eucalyptus plantations over successive rotations, we chose a first rotation (FR) and a second rotation (SR) stand and monitored the carbon stock dynamics over a full rotation from 1998 to 2005. Our results showed that carbon stock in eucalyptus trees (TC) did not significantly differ between rotations, while understory vegetation (UC) and soil organic matter (SOC) stored less carbon in the SR (1.01 vs. 2.76 Mg.ha(-1) and 70.68 vs. 81.08 Mg.ha(-1), respectively) and forest floor carbon (FFC) conversely stored more (2.80 vs. 2.34 Mg.ha(-1)). The lower UC and SOC stocks in the SR stand resulted in 1.13 times lower overall ecosystem carbon stock. Mineral soils and overstory trees were the two dominant carbon pools in eucalyptus plantations, accounting for 73.77%similar to 75.06% and 20.50%similar to 22.39%, respectively, of the ecosystem carbon pool. However, the relative contribution (to the ecosystem pool) of FFC stocks increased 1.38 times and that of UC decreased 2.30 times in the SR versus FR stand. These carbon pool changes over successive rotations were attributed to intensive successive rotation regimes of eucalyptus plantations. Our eight year study suggests that for the sustainable development of short-rotation plantations, a sound silvicultural strategy is required to achieve the best combination of high wood yield and carbon stock potential.	[Li, Xiaoqiong; Ye, Duo; Liang, Hongwen; Zhu, Hongguang; Qin, Lin; Zhu, Yuling; Wen, Yuanguang] Guangxi Univ, Coll Forestry, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi, Peoples R China; [Li, Xiaoqiong; Ye, Duo; Liang, Hongwen; Zhu, Hongguang; Qin, Lin; Zhu, Yuling; Wen, Yuanguang] Guangxi Univ, Guangxi Coll & Univ, Coll Forestry, Key Lab Forestry Sci & Engn, Nanning 530004, Guangxi, Peoples R China	Guangxi University; Guangxi University	Wen, YG (corresponding author), Guangxi Univ, Coll Forestry, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi, Peoples R China.	wenyg@263.net			Chinese National Natural Science Foundation [31460121]; Chinese Postdoctoral Science Foundation [2014M552286]; Ministry of Science and Technology [2012BAD22B01]; Chairman Foundation of Guangxi Zhuang Autonomous Region [11166-01]; Natural Science Foundation of Guangxi Zhuang Autonomous Region [1123014, 11199001]; Forestry Bureau of Guangxi Zhuang Autonomous Region	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chairman Foundation of Guangxi Zhuang Autonomous Region; Natural Science Foundation of Guangxi Zhuang Autonomous Region(National Natural Science Foundation of Guangxi Province); Forestry Bureau of Guangxi Zhuang Autonomous Region	This study was funded by the Chinese National Natural Science Foundation (31460121), the Chinese Postdoctoral Science Foundation (2014M552286), the Ministry of Science and Technology (2012BAD22B01), the Chairman Foundation of Guangxi Zhuang Autonomous Region (11166-01), the Natural Science Foundation of Guangxi Zhuang Autonomous Region (1123014 and 11199001) and the Forestry Bureau of Guangxi Zhuang Autonomous Region.	Archibold OW, 2000, FOREST ECOL MANAG, V131, P127, DOI 10.1016/S0378-1127(99)00205-4; Bauhus J, 2001, FOREST ECOL MANAG, V144, P275, DOI 10.1016/S0378-1127(00)00403-5; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Canadell JG, 2008, SCIENCE, V320, P1456, DOI 10.1126/science.1155458; Carneiro A, 2008, FOREST ECOL MANAG, V255, P591, DOI 10.1016/j.foreco.2007.09.028; Chen DM, 2011, AGR FOREST METEOROL, V151, P1214, DOI 10.1016/j.agrformet.2011.04.011; Choi SD, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001914; Devine WD, 2007, AGR FOREST METEOROL, V145, P125, DOI 10.1016/j.agrformet.2007.04.009; Fabiao A, 2002, FOREST ECOL MANAG, V171, P87, DOI 10.1016/S0378-1127(02)00463-2; Fernandez C, 2004, FOREST ECOL MANAG, V195, P85, DOI 10.1016/j.foreco.2004.02.052; Fialho RC, 2014, LAND DEGRAD DEV, V25, P428, DOI 10.1002/ldr.2158; Follett RF, 2001, SOIL TILL RES, V61, P77, DOI 10.1016/S0167-1987(01)00180-5; Fonseca F, 2014, FOREST SYST, V23, P84, DOI 10.5424/fs/2014231-04233; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Grigal DF, 1998, BIOMASS BIOENERG, V14, P371, DOI 10.1016/S0961-9534(97)10073-3; Haeussler S, 1999, CAN J FOREST RES, V29, P1084, DOI 10.1139/cjfr-29-7-1084; [韩艺师 HAN YiShi], 2008, [生态学报, Acta Ecologica Sinica], V28, P4609; Huang XM, 2014, SOIL BIOL BIOCHEM, V73, P42, DOI 10.1016/j.soilbio.2014.01.021; Ibell PT, 2013, PLANT SOIL, V369, P199, DOI 10.1007/s11104-012-1554-3; IUSS-Working-Group-WRB, 2006, WORLD REF BAS SOIL R; Jandl R, 2007, GEODERMA, V137, P253, DOI 10.1016/j.geoderma.2006.09.003; Jouquet P, 2012, BIOL FERT SOILS, V48, P561, DOI 10.1007/s00374-011-0652-3; Keith AM, 2015, GCB BIOENERGY, V7, P541, DOI 10.1111/gcbb.12168; Laclau JP, 2010, FOREST ECOL MANAG, V260, P2148, DOI 10.1016/j.foreco.2010.09.007; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Lemma B, 2006, GEODERMA, V136, P886, DOI 10.1016/j.geoderma.2006.06.008; Li X, 2011, J PLANT BIOL, V54, P33, DOI 10.1007/s12374-010-9140-9; Liu SR, 1998, ECOL ENG, V10, P75, DOI 10.1016/S0925-8574(97)10024-6; Liu Wen-fei, 2009, Shengtaixue Zazhi, V28, P1928; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Mendham DS, 2003, FOREST ECOL MANAG, V181, P357, DOI 10.1016/S0378-1127(03)00007-0; Ming AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109730; da Silva PHM, 2011, FOREST ECOL MANAG, V261, P2075, DOI 10.1016/j.foreco.2011.03.001; Nave LE, 2010, FOREST ECOL MANAG, V259, P857, DOI 10.1016/j.foreco.2009.12.009; NEARY DG, 1990, FOREST ECOL MANAG, V30, P271, DOI 10.1016/0378-1127(90)90142-X; Newmaster SG, 2007, FOREST ECOL MANAG, V246, P196, DOI 10.1016/j.foreco.2007.03.058; O'Connell AM, 2004, SOIL BIOL BIOCHEM, V36, P39, DOI 10.1016/j.soilbio.2003.08.017; Pei SF, 2008, AGR ECOSYST ENVIRON, V124, P33, DOI 10.1016/j.agee.2007.08.008; Peichl M, 2006, AGR FOREST METEOROL, V140, P51, DOI 10.1016/j.agrformet.2006.08.004; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; QI SX., 2002, EUCALYPTUS IN CHINA; Ramovs BV, 2003, ECOL APPL, V13, P1682, DOI 10.1890/02-5237; Ranatunga K, 2008, FOREST ECOL MANAG, V255, P2407, DOI 10.1016/j.foreco.2008.01.002; Seiwa K, 2012, FOREST ECOL MANAG, V269, P177, DOI 10.1016/j.foreco.2011.12.014; Subedi P, 2014, SOIL SCI SOC AM J, V78, pS152, DOI 10.2136/sssaj2013.08.0345nafsc; Throop HL, 2012, J ARID ENVIRON, V77, P66, DOI 10.1016/j.jaridenv.2011.08.020; Tian HQ, 1998, NATURE, V396, P664, DOI 10.1038/25328; Turner J, 2000, FOREST ECOL MANAG, V133, P231, DOI 10.1016/S0378-1127(99)00236-4; Wang H, 2013, FOREST ECOL MANAG, V300, P4, DOI 10.1016/j.foreco.2012.04.005; Wang QK, 2008, FOREST ECOL MANAG, V255, P1210, DOI 10.1016/j.foreco.2007.10.026; Wang WJ, 2011, GLOBAL CHANGE BIOL, V17, P2657, DOI 10.1111/j.1365-2486.2011.02447.x; Wang XK, 2001, FOREST ECOL MANAG, V148, P117, DOI 10.1016/S0378-1127(00)00482-5; Wen Y. G., 2005, CHIN J APPL ECOL, V16, P1667; Wen YG, 2006, PLANT DIVERSITY ECOS; Wen YG, 2010, J FOREST RES-JPN, V15, P252, DOI 10.1007/s10310-010-0179-8; Yanai RD, 2003, ECOSYSTEMS, V6, P197, DOI 10.1007/s10021-002-0206-5; Yang M, 2012, J SOIL WATER CONSERV, V2, P035; Zhang JW, 2013, FORESTRY, V86, P3, DOI 10.1093/forestry/cps054; Zhang XQ, 2004, FOREST ECOL MANAG, V202, P131, DOI 10.1016/j.foreco.2004.07.032; Zinn YL, 2011, SOIL RES, V49, P614, DOI 10.1071/SR11264	60	14	17	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132858	10.1371/journal.pone.0132858	http://dx.doi.org/10.1371/journal.pone.0132858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186367	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700067
J	Lavoue, R; Trumel, C; Smets, PMY; Braun, JP; Aresu, L; Daminet, S; Concordet, D; Palanche, F; Peeters, D				Lavoue, Rachel; Trumel, Catherine; Smets, Pascale M. Y.; Braun, Jean-Pierre; Aresu, Luca; Daminet, Sylvie; Concordet, Didier; Palanche, Florence; Peeters, Dominique			Characterization of Proteinuria in Dogue de Bordeaux Dogs, a Breed Predisposed to a Familial Glomerulonephropathy: A Retrospective Study	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; AGAROSE GEL-ELECTROPHORESIS; TO-CREATININE RATIO; REFERENCE INTERVALS; GLOMERULAR-DISEASE; URINARY PROTEIN; RENAL-DISEASE; CANINE URINE; KIDNEY	Dogue de Bordeaux dog has been reported to be predisposed to a familial glomerulonephropathy that displays some morphological modifications reported in focal and segmental glomerulosclerosis. Prevalence of quantitatively abnormal renal proteinuria was recently reported to be 33% in this breed. The nature of the proteinuria was assessed by sodium dodecyl sulfate-agarose gel electrophoresis and determinations of urinary markers (urinary retinol-binding protein, urinary N-acetyl-beta-glucosaminidase, urinary albumin and urinary immunoglobulin G) on stored specimens. Diagnostic performances of sodium dodecyl sulfate-agarose gel electrophoresis to identify dogs with elevated urinary biomarkers were assessed. Samples from 102 adult Dogue de Bordeaux dogs (47 non-proteinuric [urine protein-to-creatinine ratio <= 0.2], 20 borderline-proteinuric [0.2 < urine protein-to-creatinine ratio <= 0.5] and 35 proteinuric dogs [urine protein-to-creatinine ratio > 0.5]) were used, of which 2 were suffering from familial glomerulonephropathy. The electrophoretic protein patterns, for all but one proteinuric dog, were indicative of a glomerular origin and, in all dogs, the urinary albumin concentration related to creatinine concentration and the urinary immunoglobulin G concentration related to creatinine concentration were above the upper limit of the reference interval established for the breed. Sensitivity and specificity of sodium dodecyl sulfate-agarose gel electrophoresis identifying dogs with elevated urinary albumin concentration were 94% and 92%, respectively, while diagnostic performance of sodium dodecyl sulfate-agarose gel electrophoresis in detecting dogs with elevated urinary immunoglobulin G concentration yielded sensitivity and specificity of 90% and 74%, respectively. These results suggest that all proteinuric and some borderline-proteinuric Dogue de Bordeaux dogs likely have underlying glomerular lesions and that sodium dodecyl sulfate-agarose gel electrophoresis and urinary markers might be useful to screen dogs with borderline-proteinuria. Additional investigations are warranted to assess if these findings are related to the familial glomerulonephropathy.	[Lavoue, Rachel] INP ENVT, Internal Med Unit, Toulouse, France; [Trumel, Catherine; Braun, Jean-Pierre; Palanche, Florence] Univ Toulouse, UPS, INP, ENVT,Lab Cent Biol Med,UMS006, Toulouse, France; [Trumel, Catherine; Braun, Jean-Pierre] INSERM, Lab Cent Biol Med, UMS 006, Toulouse, France; [Smets, Pascale M. Y.; Daminet, Sylvie] Univ Ghent, Fac Vet Med, Dept Med & Clin Biol Small Anim, Merelbeke, Belgium; [Aresu, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy; [Concordet, Didier] INP ENVT, INRA, UMR Toxalim 1331, Toulouse, France; [Peeters, Dominique] Univ Liege, Fac Vet Med, Dept Compan Anim Clin Sci, Liege, Belgium	Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Ghent University; University of Padua; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; University of Liege	Lavoue, R (corresponding author), INP ENVT, Internal Med Unit, Toulouse, France.	r.lavoue@envt.fr	Concordet, Didier/AAT-1120-2020; Aresu, Luca/J-9788-2018	Concordet, Didier/0000-0003-3916-577X; Daminet, Sylvie/0000-0001-6733-7925; Lavoue, Rachel/0000-0003-3461-5532; Aresu, Luca/0000-0002-7893-1740; trumel, cathy/0000-0001-9717-5808				Amer H, 2013, AM J TRANSPLANT, V13, P676, DOI 10.1111/ajt.12044; Aresu L, 2010, J COMP PATHOL, V143, P190, DOI 10.1016/j.jcpa.2009.12.016; Beaufays F, 2008, THERIOGENOLOGY, V70, P1057, DOI 10.1016/j.theriogenology.2008.06.026; Bourdaud'hui P, 2012, SIMULATION PREDICTIV, P264; BROWN JS, 2010, VET CLIN PATH, V39, P556; CENTER SA, 1985, J AM VET MED ASSOC, V187, P820; Christensen EI, 1999, J AM SOC NEPHROL, V10, P685; Clinical and Laboratory Standards Institute C, 2008, C28A3 I CALS; Costigan MG, 1996, CLIN CHIM ACTA, V255, P133, DOI 10.1016/0009-8981(96)06400-5; D'Amico G, 2003, KIDNEY INT, V63, P809, DOI 10.1046/j.1523-1755.2003.00840.x; de Mik SML, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-74; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; Geffre A, 2009, VET CLIN PATH, V38, P477, DOI 10.1111/j.1939-165X.2009.00155.x; Geffre A, 2009, VET CLIN PATH, V38, P288, DOI 10.1111/j.1939-165X.2009.00179.x; Giori L, 2011, J VET DIAGN INVEST, V23, P682, DOI 10.1177/1040638711407900; GRAUER GF, 1985, AM J VET RES, V46, P2116; Grauer GF, 2011, TOP COMPANION ANIM M, V26, P121, DOI 10.1053/j.tcam.2011.04.002; Hebert LA, 2000, KIDNEY INT, V57, P1962, DOI 10.1046/j.1523-1755.2000.00045.x; International Renal Interest Society I, 2009, STAGING CKD; Jefferson JA, 2014, ADV CHRONIC KIDNEY D, V21, P398, DOI 10.1053/j.ackd.2014.05.008; Kania K, 2010, ANN CLIN BIOCHEM, V47, P151, DOI 10.1258/acb.2009.009247; Lavoue R, 2014, VET CLIN PATH, V43, P352, DOI 10.1111/vcp.12151; Lavoue R, 2013, VET CLIN PATH, V42, P346, DOI 10.1111/vcp.12067; Lavoue R, 2010, J VET INTERN MED, V24, P314, DOI 10.1111/j.1939-1676.2010.0474.x; Lee RS, 2008, J PROTEOME RES, V7, P4022, DOI 10.1021/pr800301h; Lees GE, 1999, AM J VET RES, V60, P373; Lees GE, 1998, J AM ANIM HOSP ASSOC, V34, P189, DOI 10.5326/15473317-34-3-189; Lees GE, 2005, J VET INTERN MED, V19, P377, DOI 10.1892/0891-6640(2005)19[377:AAMOPI]2.0.CO;2; Lees GE, 2011, TOP COMPANION ANIM M, V26, P143, DOI 10.1053/j.tcam.2011.04.006; Li YH, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-29; LILLEHOJ EP, 1986, EXP PATHOL-JENA, V29, P1; Maachi M, 2004, CLIN CHEM, V50, P1834, DOI 10.1373/clinchem.2004.035691; Maddens B, 2011, J VET INTERN MED, V25, P1075, DOI [10.1111/j.1939-1676.2011.0772.x, 10.1111/j.1939-1676.2011.00772.x]; Maddens B, 2010, J VET INTERN MED, V24, P1263, DOI 10.1111/j.1939-1676.2010.0603.x; Maddens BEJ, 2010, VET IMMUNOL IMMUNOP, V134, P259, DOI 10.1016/j.vetimm.2009.09.003; Nabity MB, 2012, J VET INTERN MED, V26, P282, DOI 10.1111/j.1939-1676.2012.00891.x; Nabity MB, 2011, VET CLIN PATH, V40, P222, DOI 10.1111/j.1939-165X.2011.00307.x; Raila J, 2010, AM J VET RES, V71, P1387, DOI 10.2460/ajvr.71.11.1387; SCARPIONI L, 1976, CLIN CHIM ACTA, V68, P107, DOI 10.1016/0009-8981(76)90409-5; Schellenberg S, 2008, J VET INTERN MED, V22, P273, DOI 10.1111/j.1939-1676.2007.0039.x; Schultze A. E., 1989, Veterinary Clinical Pathology, V18, P93, DOI 10.1111/j.1939-165X.1989.tb00527.x; Smets PMY, 2010, J VET INTERN MED, V24, P65, DOI 10.1111/j.1939-1676.2009.0426.x; Smets PMY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031702; Smets PMY, 2010, J VET DIAGN INVEST, V22, P896, DOI 10.1177/104063871002200607; Stokes MB, 2014, ADV CHRONIC KIDNEY D, V21, P400, DOI 10.1053/j.ackd.2014.02.010; Vaden SL, 2011, TOP COMPANION ANIM M, V26, P128, DOI 10.1053/j.tcam.2011.04.003; Vinge L, 2010, NEPHROL DIAL TRANSPL, V25, P2458, DOI 10.1093/ndt/gfq044; WHITE JV, 1984, J AM VET MED ASSOC, V185, P882; Yalcin A, 2004, REV MED VET-TOULOUSE, V155, P104; Yee J, 2014, ADV CHRONIC KIDNEY D, V21, P395, DOI 10.1053/j.ackd.2014.07.001; Zaragoza C, 2004, THERIOGENOLOGY, V61, P1259, DOI 10.1016/j.theriogenology.2003.07.019; Zatelli F, 2002, J VET INTERN MED, V16, P389; Zini E, 2004, AM J VET RES, V65, P964, DOI 10.2460/ajvr.2004.65.964	53	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133311	10.1371/journal.pone.0133311	http://dx.doi.org/10.1371/journal.pone.0133311			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181659	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198200061
J	Damij, N; Levnajic, Z; Skrt, VR; Suklan, J				Damij, Nadja; Levnajic, Zoran; Skrt, Vesna Rejec; Suklan, Jana			What Motivates Us for Work? Intricate Web of Factors beyond Money and Prestige	PLOS ONE			English	Article							PERFORMANCE	Efficiency at doing a certain task, at the workplace or otherwise, is strongly influenced by how motivated individuals are. Exploring new ways to motivate employees is often at the top of a company's agenda. Traditionally identified motivators in Western economies primarily include salary and prestige, often complemented by meaning, creation, challenge, ownership, identity, etc. We report the results of a survey conducted in Slovenia, involving an ensemble of highly educated employees from various public and private organizations. Employing new methodologies such as network analysis, we find that Slovenians are stimulated by an intricate web of interdependent factors, largely in contrast to the traditional understanding that mainly emphasizes money and prestige. In fact, these key motivators only weakly correlate with the demographic parameters. Unexpectedly, we found the evidence of a general optimism in Slovenian professional life - a tendency of the employees to look at the "bright side of things", thus seeing more clearly the benefits of having something than the drawbacks of not having it. We attribute these particularities to Slovenian recent history, which revolves around gradually embracing the Western (economic) values.	[Damij, Nadja; Levnajic, Zoran] Fac Informat Studies Novo Mesto, Novo Mesto, Slovenia; [Levnajic, Zoran; Suklan, Jana] Sch Adv Social Studies, Nova Gorica, Slovenia; [Levnajic, Zoran] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia; [Skrt, Vesna Rejec] Varsi Doo, Ljubljana, Slovenia; [Suklan, Jana] Univ Ljubljana, Interdisciplinary Doctoral Study Programme Stat, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Levnajic, Z (corresponding author), Fac Informat Studies Novo Mesto, Novo Mesto, Slovenia.	zoran.levnajic@fis.unm.si	Suklan, Jana/AAJ-7025-2020; Suklan, Jana/AAB-1004-2020	Suklan, Jana/0000-0001-8665-6593	Creative Core 'Simulations' - European Union, The European Regional Development Fund [FISNM-3330-13-500033]; Slovenian Research Agency (ARRS) [P1-0383, J1-5454]; company Varsi d.o.o.; H2020-MSCA-ITN project [COSMOS 642563]	Creative Core 'Simulations' - European Union, The European Regional Development Fund; Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); company Varsi d.o.o.; H2020-MSCA-ITN project	This work was supported by Creative Core FISNM-3330-13-500033 'Simulations' funded by the European Union, The European Regional Development Fund. The operation was carried out within the framework of the Operational Programme for Strengthening Regional Development Potentials for the period 2007-2013, Development Priority 1: Competitiveness and research excellence, Priority Guideline 1.1: Improving the competitive skills and research excellence. This work was also supported by the H2020-MSCA-ITN-2015 project COSMOS 642563 and by the Slovenian Research Agency (ARRS) via program P1-0383 and project J1-5454. The company Varsi d.o.o. provided support in the form of salaries for author VRS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Alderfer C., 1972, EXISTENCE RELATEDNES; [Anonymous], 1987, IND WEEK; Ariely D., 2012, WHAT MAKES US FEEL G; Bassett-Jones N, 2005, J MANAG DEV, V24, P929, DOI 10.1108/02621710510627064; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Evans MG, 1970, J APPL PSYCHOL, V2, P17; Grant AM, 2008, J APPL PSYCHOL, V93, P48, DOI 10.1037/0021-9010.93.1.48; HARDIN E, 1965, J APPL PSYCHOL, V49, P363, DOI 10.1037/h0022521; Herzberg F, 1959, MOTIVATION WORK; Herzberg F., 2011, MOTIVATION WORK; Herzberg F, 1968, ONE MORE TIME DO YOU; Hoseyni SN, 2014, IRAN J MED ED, V13, P1040; HULIN CL, 1965, J APPL PSYCHOL, V49, P209, DOI 10.1037/h0022164; Jansen A, 2014, MEDITERR J SOC SCI, V5, P53; Lange HC, 2009, J LIB SOC, V1, P6; Lee DJ, 2014, TOURISM MANAGE, V45, P171, DOI 10.1016/j.tourman.2014.04.002; LOCKE EA, 1981, PSYCHOL BULL, V90, P125, DOI 10.1037/0033-2909.90.1.125; Manjunath S, 2014, INT J MANAG SOC SCI, V2, P28; Marginean S, 2009, REV EC, V47, P114; Maslow A. H., 1954, PERSONALITY MOTIVATI; McClelland D.C., 1961, ACHIEVING SOC, P23; McGregor D., 1961, TECHNOL REV, V63, P25; McGregor D., 1960, HUMAN SIDE ENTERPRIS; Newman M.E.J., 2010, NETWORKS INTRO; Richard A., 2012, JOB SATISFACTION HER; Vroom V., 1964, WORK MOTIVATION; Wasserman S, 1994, SOCIAL NETWORK ANAL; Zinovieva IL, 1998, WHY DO PEOPLE WORK I	28	19	19	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132641	10.1371/journal.pone.0132641	http://dx.doi.org/10.1371/journal.pone.0132641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177271	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000358197600135
J	Dias, FC; Gomes-Pereira, J; Tojeira, I; Souto, M; Afonso, A; Calado, A; Madureira, P; Campos, A				Dias, Frederico Carvalho; Gomes-Pereira, Jose; Tojeira, Ines; Souto, Miguel; Afonso, Andreia; Calado, Antonio; Madureira, Pedro; Campos, Aldino			Area Estimation of Deep-Sea Surfaces from Oblique Still Images	PLOS ONE			English	Article							SOFTWARE	Estimating the area of seabed surfaces from pictures or videos is an important problem in seafloor surveys. This task is complex to achieve with moving platforms such as submersibles, towed or remotely operated vehicles (ROV), where the recording camera is typically not static and provides an oblique view of the seafloor. A new method for obtaining seabed surface area estimates is presented here, using the classical set up of two laser devices fixed to the ROV frame projecting two parallel lines over the seabed. By combining lengths measured directly from the image containing the laser lines, the area of seabed surfaces is estimated, as well as the camera's distance to the seabed, pan and tilt angles. The only parameters required are the distance between the parallel laser lines and the camera's horizontal and vertical angles of view. The method was validated with a controlled in situ experiment using a deep-sea ROV, yielding an area estimate error of 1.5%. Further applications and generalizations of the method are discussed, with emphasis on deep-sea applications.	[Dias, Frederico Carvalho; Gomes-Pereira, Jose; Tojeira, Ines; Souto, Miguel; Afonso, Andreia; Calado, Antonio; Madureira, Pedro; Campos, Aldino] Task Grp Extens Continental Shelf EMEPC, Paco De Arcos, Portugal; [Gomes-Pereira, Jose] Univ Acores, Ctr IMAR, Dept Oceanog & Pescas, MARE Marine & Environm Sci Ctr, Horta, Portugal	Universidade dos Acores	Dias, FC (corresponding author), Task Grp Extens Continental Shelf EMEPC, Paco De Arcos, Portugal.	frederico.dias@emepc.mam.gov.pt	Tojeira, Ines/GYU-7749-2022	Tojeira, Ines/0000-0001-5778-6196; Madureira, Pedro Miguel/0000-0003-4762-6273	Regional Directorate for Education, Science and Culture of the Regional Government of the Azores [M3.1.2/F/062/2011]	Regional Directorate for Education, Science and Culture of the Regional Government of the Azores	JG-P was supported by the doctoral grant from the Regional Directorate for Education, Science and Culture of the Regional Government of the Azores (M3.1.2/F/062/2011). URL: http://educacaocienciaculturaazoresgov.pai.pt/. The other authors received no specific funding for this work.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Argus [Internet], 2010, ARG HD SDI CAM 10 X; Barker BAJ, 1999, CONT SHELF RES, V19, P1161, DOI 10.1016/S0278-4343(99)00017-5; Coggan R., 2007, REV STANDARDS PROTOC, P152; International Seabed Authority, 2010, ISA TECHN STUD; JPI Oceans, EC ASP DEEP SEA MIN; Masson DG, 2011, DEEP-SEA RES PT II, V58, P2369, DOI 10.1016/j.dsr2.2011.04.003; Parry DM, 2003, J EXP MAR BIOL ECOL, V285, P497, DOI 10.1016/S0022-0981(02)00546-4; Pham CK, 2013, DEEP-SEA RES PT II, V98, P204, DOI 10.1016/j.dsr2.2013.01.011; Pham CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095839; Pilgrim DA, 2000, UNDERWATER TECHNOL, V24, P93, DOI 10.3723/175605400783259684; Schoening T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038179; Service M, 2001, MARINE MONITORING HD, P331; Sharma R, 2011, MAR TECHNOL SOC J, V45, P28, DOI 10.4031/MTSJ.45.5.2; SMITH KL, 1994, LIMNOL OCEANOGR, V39, P1101, DOI 10.4319/lo.1994.39.5.1101; Stierhoff K., 2012, NAT MAR FISH SERV AU, P13; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; Teixido N, 2011, MAR ECOL PROG SER, V431, P45, DOI 10.3354/meps09127; Tong RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043534; Trygonis V, 2012, J EXP MAR BIOL ECOL, V424, P99, DOI 10.1016/j.jembe.2012.04.018; Tusting RF, 1993, DIVING SCI 1993, P157; Van Rooij D, 2010, DEEP-SEA RES PT I, V57, P1561, DOI 10.1016/j.dsr.2010.09.002; WAKEFIELD WW, 1987, DEEP-SEA RES, V34, P469, DOI 10.1016/0198-0149(87)90148-8; White J., 2007, SEAFLOOR VIDEO MAPPI; [No title captured]	25	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133290	10.1371/journal.pone.0133290	http://dx.doi.org/10.1371/journal.pone.0133290			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177287	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600240
J	Imai, H; Nakao, H; Shinohara, H; Watarai, M; Matsumoto, N; Yamagishi, T; Saito, M; Kitamura, T				Imai, Hirohisa; Nakao, Hiroyuki; Shinohara, Hisae; Watarai, Mutsuko; Matsumoto, Noriko; Yamagishi, Takuya; Saito, Masuko; Kitamura, Tadaichi			Prevalence, Potential Predictors, and Genotype-Specific Prevalence of Human Papillomavirus Infection among Sexually Active Students in Japan	PLOS ONE			English	Article							RISK-FACTORS; HPV INFECTION; WOMEN	Background and Methods We conducted a community-based study to evaluate genotype-specific prevalence of high-risk HPV (HR-HPV) and potential predictors of its presence in young, asymptomatic, female college students. Self-administered surveys and vaginal swabs for self collection were distributed to students of participating schools. A sufficient cellular component in cervical samples was verified by examining for the presence of human beta-globin DNA by PCR. A total of 1,118 valid cervical samples were subjected to screening for HR-HPV infection with the Digene Hybrid Capture 2 assay, followed by identification of HPV genotypes with GENOSEARCH HPV31 kit. Logistic regression was used to adjust for confounding factors associated with HR-HPV positivity and the adjusted odds ratio (AOR) was calculated. Results The median age of recruited students was 20 years. Of the 1,118 women who provided valid cervical samples for testing, 770 had sexual intercourse in the past, of which 125 (16.2%) were positive for HR-HPV. Logistic regression analysis revealed that HR-HPV infection was associated with smoking history (AOR 2.13; 95% confidence interval [CI] 1.98 to 5.05; p < 0.01), total number of partners (AOR 4.72; 95% CI 1.97 to 11.32 if > 5 partners; p < 0.001), number of partners in the past 6 months (AOR 3.12; 95% CI 1.42 to 6.87; p < 0.01), improper use of condoms (AOR 2.21; 95% CI 1.25 to 3.90; p < 0.01), and chlamydia infection (AOR 2.61; 95% CI 1.28 to 5.34; p < 0.01). The most common HR-HPV genotype was type 52 (6.4%), followed by 16 (3.1%), 56 (3.0%), and 58 (2.6%). Conclusion Compared with previous reports in East Asian coutries, the prevalence of HR-HPV infection among young, asymptomatic, female students before the nationwide use of vaccination in Japan was in the intermediate range. The most common HR-HPV genotypes were HPV 52, 16, 56, and 58.	[Imai, Hirohisa] Natl Inst Publ Hlth, Dept Epidemiol & Hlth Policy, Wako, Saitama 3510197, Japan; [Nakao, Hiroyuki; Matsumoto, Noriko] Miyazaki Prefectural Nursing Univ, Dept Epidemiol, Miyazaki, Japan; [Shinohara, Hisae] Miyazaki Univ, Fac Educ & Culture, Miyazaki, Japan; [Watarai, Mutsuko] Tokyo Healthcare Univ, Fac Healthcare, Div Nursing, Shinagawa Ku, Tokyo, Japan; [Yamagishi, Takuya] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Shinjuku Ku, Tokyo 1628640, Japan; [Saito, Masuko] Teikyo Univ Sci, Dept Nursing, Adachi Ku, Tokyo, Japan; [Kitamura, Tadaichi] Asoka Hosp, Dept Urol, Koto Ku, Tokyo, Japan	National Institute of Public Health - Japan; University of Miyazaki; National Institute of Infectious Diseases (NIID)	Imai, H (corresponding author), Natl Inst Publ Hlth, Dept Epidemiol & Hlth Policy, Wako, Saitama 3510197, Japan.	imaihiro@niph.go.jp			Japanese Foundation for Sexual Health Medicine	Japanese Foundation for Sexual Health Medicine	This study was made possible by funding from the Japanese Foundation for Sexual Health Medicine, a public benefit corporation (http://www.jfshm.org/). HI received the funding. There is no grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammatuna P, 2008, CANCER EPIDEM BIOMAR, V17, P2002, DOI 10.1158/1055-9965.EPI-08-0180; [Anonymous], 2006, FDA Consum, V40, P37; Castle PE, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2569; Cercato MC, 2010, J MED VIROL, V82, P1921, DOI 10.1002/jmv.21887; Dillner J, 2015, SEMIN ONCOL, V42, P272, DOI 10.1053/j.seminoncol.2014.12.028; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gaydos CA, 1998, NEW ENGL J MED, V339, P739, DOI 10.1056/NEJM199809103391105; Iftner T, 2010, J MED VIROL, V82, P1928, DOI 10.1002/jmv.21910; Johnson AM, 2012, SEX TRANSM INFECT, V88, P212, DOI 10.1136/sextrans-2011-050306; Kim MA, 2010, OBSTET GYNECOL, V116, P932, DOI 10.1097/AOG.0b013e3181edbeba; Kim S, 2011, SEX TRANSM DIS, V38, P587, DOI 10.1097/OLQ.0b013e31820a9324; Kliucinskas M, 2006, GYNECOL OBSTET INVES, V62, P173, DOI 10.1159/000093572; Leigh BC, 2008, J STUD ALCOHOL DRUGS, V69, P773, DOI 10.15288/jsad.2008.69.773; Louvanto K, 2010, J CLIN MICROBIOL, V48, P2665, DOI 10.1128/JCM.00783-10; Oakeshott P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4168; Soboe T, 2012, WHITE PAPER CANC 201; Sun LL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-153; Uuskula A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-63; Verteramo R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-16; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284	22	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132462	10.1371/journal.pone.0132462	http://dx.doi.org/10.1371/journal.pone.0132462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176861	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600115
J	Maia, S; Cardoso, M; Pinto, P; Pinheiro, M; Santos, C; Peixoto, A; Bento, MJ; Oliveira, J; Henrique, R; Jeronimo, C; Teixeira, MR				Maia, Sofia; Cardoso, Marta; Pinto, Pedro; Pinheiro, Manuela; Santos, Catarina; Peixoto, Ana; Bento, Maria Jose; Oliveira, Jorge; Henrique, Rui; Jeronimo, Carmen; Teixeira, Manuel R.			Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients	PLOS ONE			English	Article							G84E MUTATION; P.GLY84GLU MUTATION; INCREASED RISK; GENE; MEN; BREAST; BRCA2; ASSOCIATION; POPULATION; PREVALENCE	The HOXB13 germline variant G84E (rs138213197) was recently described in men of European descent, with the highest prevalence in Northern Europe. The G84E mutation has not been found in patients of African or Asian ancestry, which may carry other HOXB13 variants, indicating allelic heterogeneity depending on the population. In order to gain insight into the full scope of coding HOXB13 mutations in Portuguese prostate cancer patients, we decided to sequence the entire coding region of the HOXB13 gene in 462 early-onset or familial/hereditary cases. Additionally, we searched for somatic HOXB13 mutations in 178 prostate carcinomas to evaluate their prevalence in prostate carcinogenesis. Three different patients were found to carry in their germline DNA two novel missense variants, which were not identified in 132 control subjects. Both variants are predicted to be deleterious by different in silico tools. No somatic mutations were found. These findings further support the hypothesis that different rare HOXB13 mutations may be found in different ethnic groups. Detection of mutations predisposing to prostate cancer may require re-sequencing rather than genotyping, as appropriate to the population under investigation.	[Maia, Sofia; Cardoso, Marta; Pinto, Pedro; Pinheiro, Manuela; Santos, Catarina; Peixoto, Ana; Teixeira, Manuel R.] Portuguese Oncol Inst Porto, Dept Genet, Oporto, Portugal; [Maia, Sofia; Cardoso, Marta; Pinto, Pedro; Pinheiro, Manuela; Santos, Catarina; Peixoto, Ana; Teixeira, Manuel R.] Portuguese Oncol Inst Porto, Canc Genet Grp CI IPOP, Oporto, Portugal; [Bento, Maria Jose] Portuguese Oncol Inst Porto, Dept Epidemiol, Oporto, Portugal; [Bento, Maria Jose] Portuguese Oncol Inst Porto, North Reg Canc Registry, Oporto, Portugal; [Bento, Maria Jose; Henrique, Rui; Jeronimo, Carmen; Teixeira, Manuel R.] Univ Porto, Biomed Sci Inst ICBAS, P-4100 Oporto, Portugal; [Oliveira, Jorge] Portuguese Oncol Inst Porto, Dept Urol, Oporto, Portugal; [Henrique, Rui; Jeronimo, Carmen] Portuguese Oncol Inst Porto, Canc Biol & Epigenet Grp CI IPOP, Oporto, Portugal; [Henrique, Rui] Portuguese Oncol Inst Porto, Dept Pathol, Oporto, Portugal	Portuguese Institute of Oncology; Portuguese Institute of Oncology; Portuguese Institute of Oncology; Portuguese Institute of Oncology; Universidade do Porto; Portuguese Institute of Oncology; Portuguese Institute of Oncology; Portuguese Institute of Oncology	Teixeira, MR (corresponding author), Portuguese Oncol Inst Porto, Dept Genet, Oporto, Portugal.	manuel.teixeira@ipoporto.min-saude.pt	Teixeira, Manuel AC/AAZ-7251-2020; Henrique, Rui Manuel Ferreira/I-2757-2013; Pinheiro, Manuela/AAV-4114-2020; Jerónimo, Carmen/H-3284-2013; Pinheiro, Manuela/AAG-2543-2021; Teixeira, Manuel António Rodrigues/E-4885-2011	Teixeira, Manuel AC/0000-0002-1959-0624; Henrique, Rui Manuel Ferreira/0000-0003-3171-4666; Pinheiro, Manuela/0000-0001-8228-3435; Jerónimo, Carmen/0000-0003-4186-5345; Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Santos, Catarina/0000-0002-9102-757X; Pinto, Pedro/0000-0001-6289-5792; Cardoso, Marta/0000-0002-3633-1659; Peixoto, Ana/0000-0002-1404-5897	Portuguese Foundation for Science and Technology [SFRH/BD/71397/2010]; Portuguese Oncology Institute-Porto [CI-IPOP 16-2012]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Portuguese Oncology Institute-Porto	SM was awarded a PhD grant (SFRH/BD/71397/2010) by the Portuguese Foundation for Science and Technology (http://www.fct.pt/index.phtml.en). MC and MP are research fellows of the Portuguese Cancer League (http://www.ligacontracancro.pt/). The project was funded by the Portuguese Oncology Institute-Porto (http://www.ipoporto.pt/en/; grant reference: CI-IPOP 16-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akbari MR, 2013, CANCER EPIDEMIOL, V37, P424, DOI 10.1016/j.canep.2013.03.003; Akbari MR, 2012, BREAST CANCER RES TR, V136, P907, DOI 10.1007/s10549-012-2295-y; Akbari MR, 2012, J NATL CANCER I, V104, P1260, DOI 10.1093/jnci/djs288; Alanee S, 2013, FAM CANCER, V12, P597, DOI 10.1007/s10689-013-9618-y; Alanee S, 2012, NEW ENGL J MED, V367, P480, DOI 10.1056/NEJMc1205138; Breyer JP, 2012, CANCER EPIDEM BIOMAR, V21, P1348, DOI 10.1158/1055-9965.EPI-12-0495; Bruner DW, 2003, INT J CANCER, V107, P797, DOI 10.1002/ijc.11466; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; CARTER BS, 1993, J UROLOGY, V150, P797, DOI 10.1016/S0022-5347(17)35617-3; Castro E, 2012, ASIAN J ANDROL, V14, P409, DOI 10.1038/aja.2011.150; Chen Z, 2013, CARCINOGENESIS, V34, P1260, DOI 10.1093/carcin/bgt055; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Edwards SM, 2003, AM J HUM GENET, V72, P1, DOI 10.1086/345310; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hoffmann TJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004930; Jung CY, 2004, CANCER RES, V64, P3046, DOI 10.1158/0008-5472.CAN-03-2614; Karlsson R, 2014, EUR UROL, V65, P169, DOI 10.1016/j.eururo.2012.07.027; Kim SD, 2010, ANAT CELL BIOL, V43, P284, DOI 10.5115/acb.2010.43.4.284; Kim YR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-124; Kluzniak W, 2013, PROSTATE, V73, P542, DOI 10.1002/pros.22594; Kote-Jarai Z, 2015, ANN ONCOL, V26, P756, DOI 10.1093/annonc/mdv004; Laitinen VH, 2013, CANCER EPIDEM BIOMAR, V22, P452, DOI 10.1158/1055-9965.EPI-12-1000-T; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lin XL, 2013, PROSTATE, V73, P169, DOI 10.1002/pros.22552; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Okuda H, 2006, ONCOGENE, V25, P1733, DOI 10.1038/sj.onc.1209200; Paulo P, 2012, GENE CHROMOSOME CANC, V51, P240, DOI 10.1002/gcc.20948; Pertea M, 2001, NUCLEIC ACIDS RES, V29, P1185, DOI 10.1093/nar/29.5.1185; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Simard J, 2002, ENDOCRINOLOGY, V143, P2029, DOI 10.1210/en.143.6.2029; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; Witte JS, 2013, CANCER EPIDEM BIOMAR, V22, P675, DOI 10.1158/1055-9965.EPI-12-1154; Xu JF, 2013, HUM GENET, V132, P5, DOI 10.1007/s00439-012-1229-4; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	49	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132728	10.1371/journal.pone.0132728	http://dx.doi.org/10.1371/journal.pone.0132728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176944	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600146
J	Maurer, JM; Schellekens, RCA; van Rieke, HM; Wanke, C; Iordanov, V; Stellaard, F; Wutzke, KD; Dijkstra, G; van der Zee, M; Woerdenbag, HJ; Frijlink, HW; Kosterink, JGW				Maurer, Jacoba M.; Schellekens, Reinout C. A.; van Rieke, Helen M.; Wanke, Christoph; Iordanov, Ventzeslav; Stellaard, Frans; Wutzke, Klaus D.; Dijkstra, Gerard; van der Zee, Margot; Woerdenbag, Herman J.; Frijlink, Henderik W.; Kosterink, Jos G. W.			Gastrointestinal pH and Transit Time Profiling in Healthy Volunteers Using the IntelliCap System Confirms Ileo-Colonic Release of ColoPulse Tablets	PLOS ONE			English	Article							INTRALUMINAL PH; DOSAGE FORMS; LUMINAL PH; DELIVERY; BEHAVIOR	Introduction ColoPulse tablets are an innovative development in the field of oral dosage forms characterized by a distal ileum and colon-specific release. Previous studies in humans showed release in the ileo-colonic region, but the relationship between gastrointestinal pH and release was not experimentally proven in vivo. This information will complete the in vivo release-profile of ColoPulse tablets. Materials and Methods Release from ColoPulse tablets was studied in 16 healthy volunteers using the dual label isotope strategy. To determine gastrointestinal pH profiles and transit times the IntelliCap system was used. A ColoPulse tablet containing C-13-urea and an uncoated, immediate release tablet containing N-15(2)-urea were taken simultaneously followed by a standardized breakfast after three hours. Five minutes after intake of the tablets the IntelliCap capsule was swallowed and pH was measured until excretion in the feces. Breath and urine samples were collected for isotope analysis. Results Full analysis could be performed in 12 subjects. Median bioavailability of C-13-urea was 82% (95% CI 74-94%, range 61-114%). The median lag time (5% release of C-13) was 5: 42 h (95% CI 5: 18-6: 18 h, range 2: 36-6: 36 h,) There was no statistically significant difference between lag time based on isotope signal and colon arrival time (CAT) based on pH (median 5: 42 vs 5: 31 h p = 0.903). In all subjects an intestinal pH value of 7.0 was reached before release of C-13 from the ColoPulse tablet occurred. Discussion and Conclusions From the combined data from the IntelliCap system and the C-13-isotope signal it can be concluded that release from a ColoPulse tablet in vivo is not related to transit times but occurs in the ileo-colonic region after pH 7.0 is reached. This supports our earlier findings and confirms that the ColoPulse system is a promising delivery system for targeting the distal ileum and colon.	[Maurer, Jacoba M.; Schellekens, Reinout C. A.; van Rieke, Helen M.; Kosterink, Jos G. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Wanke, Christoph; Iordanov, Ventzeslav] Medimetr Personalized Drug Delivery BV, Eindhoven, Netherlands; [Stellaard, Frans] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Wutzke, Klaus D.] Univ Rostock, Childrens Hosp, Res Lab Gastroenterol & Nutr, D-18055 Rostock, Germany; [Dijkstra, Gerard] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [van der Zee, Margot; Woerdenbag, Herman J.; Frijlink, Henderik W.] Univ Groningen, Dept Pharm, Sect Pharmaceut Technol & Biopharm, Groningen, Netherlands; [Kosterink, Jos G. W.] Univ Groningen, Sect Pharmacotherapy & Pharmaceut Care, Dept Pharm, Groningen, Netherlands	University of Groningen; University of Groningen; University of Rostock; University of Groningen; University of Groningen; University of Groningen	Maurer, JM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.	m.maurer@umcg.nl	Woerdenbag, Herman/HDM-2961-2022; Frijlink, Henderik Willem/AAD-7382-2020	Frijlink, Henderik Willem/0000-0001-7901-8198; Kosterink, Jos/0000-0001-8358-765X; Woerdenbag, Herman/0000-0002-9450-5880; /0000-0003-4563-7462	Medimetrics Personalized Drug Delivery, Eindhoven, The Netherlands; IntelliCap systems	Medimetrics Personalized Drug Delivery, Eindhoven, The Netherlands; IntelliCap systems	Medimetrics Personalized Drug Delivery, Eindhoven, The Netherlands, provided support in the form of salaries for authors CW and VI and IntelliCap systems, but did not have any role in study design and decision to publish. The specific roles of these authors are articulated in the author contributions section.	DAVIS SS, 1986, GUT, V27, P886, DOI 10.1136/gut.27.8.886; EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035; Ewe K, 1999, DIGEST DIS SCI, V44, P1434, DOI 10.1023/A:1026664105112; FALLINGBORG J, 1993, DIGEST DIS SCI, V38, P1989, DOI 10.1007/BF01297074; Fallingborg J, 1998, DIGEST DIS SCI, V43, P702, DOI 10.1023/A:1018893409596; FALLINGBORG J, 1989, ALIMENT PHARM THERAP, V3, P605; Koziolek M, 2015, J PHARM SCI-US, V104, P2855, DOI 10.1002/jps.24274; Lalezari D, 2012, ANN GASTROENTEROL, V25, P333; Maqbool S, 2009, DIGEST DIS SCI, V54, P2167, DOI 10.1007/s10620-009-0899-9; Maurer JM, 2013, J CONTROL RELEASE, V172, P618, DOI 10.1016/j.jconrel.2013.09.021; Maurer MJM, 2013, ISOT ENVIRON HEALT S, V49, P473, DOI 10.1080/10256016.2013.803099; Maurer MJM, 2012, PHARM RES-DORDR, V29, P2070, DOI 10.1007/s11095-012-0735-3; McConnell EL, 2009, J DRUG TARGET, V17, P335, DOI 10.1080/10611860902839502; MELDRUM SJ, 1972, BRIT MED J, V2, P104; Nugent SG, 2001, GUT, V48, P571, DOI 10.1136/gut.48.4.571; Press AG, 1998, ALIMENT PHARM THER, V12, P673; RAIMUNDO A H, 1992, Gastroenterology, V102, pA681; Rubin DT, 2009, GASTROENTEROLOGY S1, V136, pM1097; Sasaki Y, 1997, AM J GASTROENTEROL, V92, P114; Schellekens RCA, 2007, EUR J PHARM SCI, V30, P15, DOI 10.1016/j.ejps.2006.09.004; Schellekens RCA, 2010, J CONTROL RELEASE, V146, P334, DOI 10.1016/j.jconrel.2010.05.028; Schellekens RCA, 2009, BRIT J PHARMACOL, V158, P532, DOI 10.1111/j.1476-5381.2009.00302.x; Schellekens RCA, 2012, PHARM DEV TECHNOL, V17, P40, DOI 10.3109/10837450.2010.513986; Schiller C, 2005, ALIMENT PHARM THER, V22, P971, DOI 10.1111/j.1365-2036.2005.02683.x; Singh Brahma N, 2007, Recent Pat Drug Deliv Formul, V1, P53, DOI 10.2174/187221107779814122; van der Schaar PJ, 2013, GASTROINTEST ENDOSC, V78, P520, DOI 10.1016/j.gie.2013.03.170	27	53	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0129076	10.1371/journal.pone.0129076	http://dx.doi.org/10.1371/journal.pone.0129076			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177019	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600012
J	Perelygina, L; Adebayo, A; Metcalfe, M; Icenogle, J				Perelygina, Ludmila; Adebayo, Adebola; Metcalfe, Maureen; Icenogle, Joseph			Differences in Establishment of Persistence of Vaccine and Wild Type Rubella Viruses in Fetal Endothelial Cells	PLOS ONE			English	Article							UNKNOWINGLY PREGNANT-WOMEN; DOUBLE-STRANDED-RNA; NEGATIVE-STRAND; FOLLOW-UP; REPLICATION; INTERFERON; ELIMINATION; ANTIBODIES; AMERICA; MEASLES	Both wild type (WT) and vaccine rubella virus (RV) can pass through the placenta to infect a human fetus, but only wtRV routinely causes pathology. To investigate possible reasons for this, we compared establishment of persistence of wtRV and RA27/3 vaccine strains in fetal endothelial cells. We showed that yields of RA27/3 and wtRV were similar after the first round of replication, but then only vaccine-infected cultures went through a crisis characterized by partial cell loss and gradual decline of virus titer followed by recovery and establishment of persistent cultures with low levels of RA27/3 secretion. We compared various steps of virus replication, but we were unable to identify changes, which might explain the 2-log difference in RA27/3 and wtRV yields in persistently infected cultures. Whole genome sequencing did not reveal selection of virus variants in either the wtRV or RA27/3 cultures. Quantitative single-cell analysis of RV replication by in situ hybridization detected, on average, 1-4 copies of negative-strand RNA and similar to 50 copies of positive-strand genomic RNA in cells infected with both vaccine and WT viruses. The distinct characteristics of RA27/3 replication were the presence of large amounts of negative-strand RV RNA and RV dsRNA at the beginning of the crisis and the accumulation of high amounts of genomic RNA in a sub-population of infected cells during crisis and persistence. These results suggest that RA27/3 can persist in fetal endothelial cells, but the characteristics of persistence and mechanisms for the establishment and maintenance of persistence are different from wtRV.	[Perelygina, Ludmila; Adebayo, Adebola; Metcalfe, Maureen; Icenogle, Joseph] Ctr Dis Control & Prevent, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Icenogle, J (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30329 USA.	jci1@cdc.gov		Perelygina, Ludmila/0000-0003-0812-8124	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by core funding from the Centers for Disease Control and Prevention. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy E, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-32; Abernathy E, 2009, J CLIN MICROBIOL, V47, P182, DOI 10.1128/JCM.01231-08; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; BANATVALA JE, 1981, LANCET, V1, P392; BERNSTEIN DI, 1980, J PEDIATR-US, V97, P467, DOI 10.1016/S0022-3476(80)80208-3; BOWDEN DS, 1985, J GEN VIROL, V66, P201, DOI 10.1099/0022-1317-66-1-201; Castillo-Solorzano C, 2011, J INFECT DIS, V204, pS713, DOI 10.1093/infdis/jir489; Castillo-Solorzano C, 2011, J INFECT DIS, V204, pS571, DOI 10.1093/infdis/jir472; Chen MH, 2007, J VIROL METHODS, V146, P414, DOI 10.1016/j.jviromet.2007.08.021; Sa GRDE, 2011, J INFECT DIS, V204, pS722, DOI 10.1093/infdis/jir408; Davidkin I, 2008, J INFECT DIS, V197, P950, DOI 10.1086/528993; Feng X, 2003, J VIROL, V77, P13389, DOI 10.1128/JVI.77.24.13389-13395.2003; Ginart P, 2014, NAT BIOTECHNOL, V32, P543, DOI 10.1038/nbt.2921; Hobman T. C., 2013, FIELDS VIROLOGY, P687; Hofmann J, 2000, J MED VIROL, V61, P155, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;155::AID-JMV25&gt;3.0.CO;2-O; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; Jumat MR, 2015, ANTIVIR RES, V114, P11, DOI 10.1016/j.antiviral.2014.11.007; Kaiser WJ, 2004, J IMMUNOL, V172, P1699, DOI 10.4049/jimmunol.172.3.1699; LEE JY, 1994, VIROLOGY, V200, P307, DOI 10.1006/viro.1994.1192; LERMAN SJ, 1981, PEDIATRICS, V68, P18; Liang YY, 2001, VIROLOGY, V282, P307, DOI 10.1006/viro.2001.0862; Mai JB, 2009, J VIROL, V83, P8553, DOI 10.1128/JVI.00056-09; MIFUNE K, 1970, Infection and Immunity, V2, P132; MIKI NPH, 1992, CLIN EXP RHEUMATOL, V10, P3; Papania MJ, 2014, JAMA PEDIATR, V168, P148, DOI 10.1001/jamapediatrics.2013.4342; Perelygina L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073014; Plotkin S., 2011, INFECT DIS FETUS NEW, P861; Plotkin S A, 1976, Dev Biol Stand, V37, P291; PLOTKIN SA, 1973, JAMA-J AM MED ASSOC, V225, P585, DOI 10.1001/jama.225.6.585; Pugachev KV, 1997, ARCH VIROL, V142, P1165, DOI 10.1007/s007050050150; Rowe R D, 1973, Cardiovasc Clin, V5, P61; Sato HK, 2011, J INFECT DIS, V204, pS737, DOI 10.1093/infdis/jir419; Schneider WM, 2014, ANN REV IMMUNOL; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Soares RC, 2011, J INFECT DIS, V204, pS729, DOI 10.1093/infdis/jir429; STANWICK TL, 1974, INFECT IMMUN, V10, P810, DOI 10.1128/IAI.10.4.810-815.1974; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tillieux SL, 2009, VACCINE, V27, P2265, DOI 10.1016/j.vaccine.2009.01.112; VAHERI A, 1969, J GEN VIROL, V5, P39, DOI 10.1099/0022-1317-5-1-39; Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12; VETRO S W, 1989, Fetal Therapy, V4, P82; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Woods MW, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-95	43	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133267	10.1371/journal.pone.0133267	http://dx.doi.org/10.1371/journal.pone.0133267			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177032	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600237
J	Polgar, Z; Miklosi, A; Gacsi, M				Polgar, Zita; Miklosi, Adam; Gacsi, Marta			Strategies Used by Pet Dogs for Solving Olfaction-Based Problems at Various Distances	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; CANIS-FAMILIARIS; SEARCH BEHAVIOR; SPATIAL MEMORY; EFFICACY; ODOR; CUES	The olfactory acuity of domestic dogs has been well established through numerous studies on trained canines, however whether untrained dogs spontaneously utilize this ability for problem solving is less clear. In the present paper we report two studies that examine what strategies family dogs use in two types of olfaction-based problems as well as their success at various distances. In Study 1, thirty dogs were tasked with distinguishing a target, either their covered owner (Exp 1) or baited food (Exp 2), from three visually identical choices at distances of 0m (touching distance), 1m, and 3m. There were nine consecutive trials for each target. We found that in Exp 1 the dogs successfully chose their owners over strangers at 0m and 1m, but not at 3m, where they used a win-stay strategy instead. In Exp 2 the dogs were only successful in choosing the baited pot at 0m. They used the win-stay strategy at 1m, but chose randomly at 3m. In Study 2, a different group of dogs was tested with their owners (Exp 1) and baited food (Exp 2) at just the 3m distance with two possible targets in 10-10 trials. In Exp 1 the dogs' overall performance was at chance level; however, when analyzed by trial, we noticed that despite tending to find their owners on the first trial, they generally switched to a win-stay strategy in subsequent trials, only to return to correctly choosing their owners based on olfaction in the later trials. In Exp 2, the dogs chose randomly throughout. We also found that dogs who relied on visual information in the warm-up trials were less successful in the olfaction-based test. Our results suggest that despite their ability to successfully collect information through olfaction, family dogs often prioritize other strategies to solve basic choice tasks.	[Polgar, Zita; Miklosi, Adam] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Miklosi, Adam; Gacsi, Marta] MTA ELTE Comparat Ethol Res Grp, Budapest, Hungary	Eotvos Lorand University; MTA-ELTE Comparative Ethology Research Group	Polgar, Z (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.	zita@polgarweb.com	Miklosi, Adam/N-5147-2017	Miklosi, Adam/0000-0003-4831-8985; Gacsi, Marta/0000-0003-3080-7545	Hungarian Academy of Sciences [MTA 01 031]; Hungarian Scientific Research Fund [OTKA K 100695/ K 84036]	Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The research was supported by the Hungarian Academy of Sciences (MTA 01 031) (http://mta.hu/english/) and Hungarian Scientific Research Fund (OTKA K 100695/ K 84036) (http://www.otka.hu/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton R, 2009, J VET BEHAV, V4, P50; Bijland LR, 2013, NETH J MED, V71, P300; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Cablk ME, 2008, SENSORS-BASEL, V8, P2208, DOI 10.3390/s8042208; Dumas C, 1998, BEHAV PROCESS, V42, P101, DOI 10.1016/S0376-6357(97)00071-5; FENTON V, 1992, J WILDERNESS MED, V3, P292, DOI 10.1580/0953-9859-3.3.292; Furton KG, 2001, TALANTA, V54, P487, DOI 10.1016/S0039-9140(00)00546-4; Gacsi M, 2009, ANIM COGN, V12, P471, DOI 10.1007/s10071-008-0208-6; GAGNON S, 1992, J COMP PSYCHOL, V106, P58, DOI 10.1037/0735-7036.106.1.58; Gazit I, 2003, APPL ANIM BEHAV SCI, V82, P65, DOI 10.1016/S0168-1591(03)00051-0; Hare B, 1999, J COMP PSYCHOL, V113, P173, DOI 10.1037/0735-7036.113.2.173; Horowitz A, 2013, LEARN MOTIV, V44, P207, DOI 10.1016/j.lmot.2013.02.002; Jezierski T, 2014, FORENSIC SCI INT, V237, P112, DOI 10.1016/j.forsciint.2014.01.013; Kerepesi A, 2014, DOGS THEIR HUMAN COM; Lakatos G, 2012, ANIM COGN, V15, P201, DOI 10.1007/s10071-011-0446-x; Macpherson K, 2010, J COMP PSYCHOL, V124, P47, DOI 10.1037/a0018084; Miklosi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; Panzacchi M, 2009, J ANIM ECOL, V78, P1124, DOI 10.1111/j.1365-2656.2009.01584.x; Plourde V, 2013, LEARN MOTIV, V44, P282, DOI 10.1016/j.lmot.2013.03.004; Pongracz P, 2013, ANIM COGN, V16, P721, DOI 10.1007/s10071-013-0607-1; Reed SE, 2011, J WILDLIFE MANAGE, V75, P243, DOI 10.1002/jwmg.8; Rolland Rosalind M., 2006, Journal of Cetacean Research and Management, V8, P121; Salvin HE, 2011, J EXP ANAL BEHAV, V95, P109, DOI 10.1901/jeab.2011.95-109; Shivik JA, 2002, WILDLIFE SOC B, V30, P721; SONERUD GA, 1985, OIKOS, V44, P287, DOI 10.2307/3544702; Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X; Udell MAR, 2008, ANIM BEHAV, V76, P1767, DOI 10.1016/j.anbehav.2008.07.028; Udell MAR, 2010, ANIM BEHAV, V79, pE9, DOI 10.1016/j.anbehav.2009.11.033; Wells DL, 2003, APPL ANIM BEHAV SCI, V84, P297, DOI 10.1016/j.applanim.2003.08.009	30	22	23	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131610	10.1371/journal.pone.0131610	http://dx.doi.org/10.1371/journal.pone.0131610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176609	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600052
J	Puxty, RJ; Perez-Sepulveda, B; Rihtman, B; Evans, DJ; Millard, AD; Scanlan, DJ				Puxty, Richard J.; Perez-Sepulveda, Blanca; Rihtman, Branko; Evans, David J.; Millard, Andrew D.; Scanlan, David J.			Spontaneous Deletion of an "ORFanage" Region Facilitates Host Adaptation in a "Photosynthetic" Cyanophage	PLOS ONE			English	Article							MARINE VIRUSES; ANTAGONISTIC COEVOLUTION; T4-LIKE MYOVIRUSES; SYNECHOCOCCUS; GENOME; GENES; BACTERIOPHAGE; EVOLUTION; CASSETTES; FITNESS	Viruses have been suggested to be the largest source of genetic diversity on Earth. Genome sequencing and metagenomic surveys reveal that novel genes with unknown functions are abundant in viral genomes. Yet few observations exist for the processes and frequency by which these genes are gained and lost. The surface waters of marine environments are dominated by marine picocyanobacteria and their co-existing viruses (cyanophages). Recent genome sequencing of cyanophages has revealed a vast array of genes that have been acquired from their cyanobacterial hosts. Here, we re-sequenced the cyanophage S-PM2 genome after 10 years of near continuous passage through its marine Synechococcus host. During this time a spontaneous mutant (S-PM2d) lacking 13% of the S-PM2 ORFs became dominant in the cyanophage population. These ORFs are found at one loci and are not homologous to any proteins in any other sequenced organism (ORFans). We demonstrate a fitness cost to S-PM2(WT) associated with possession of these ORFs under standard laboratory growth. Metagenomic surveys reveal these ORFs are present in various aquatic environments, are likely of cyanophage origin and appear to be enriched in environments from the extremes of salinity (freshwater and hypersaline). We posit that these ORFs contribute to the flexible gene content of cyanophages and offer a distinct fitness advantage in freshwater and hypersaline environments.	[Puxty, Richard J.; Perez-Sepulveda, Blanca; Rihtman, Branko; Evans, David J.; Scanlan, David J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Millard, Andrew D.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Scanlan, DJ (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	D.J.Scanlan@warwick.ac.uk	Evans, David/C-7553-2012; Scanlan, David J/G-4080-2016; Perez-Sepulveda, Blanca/R-9410-2017	Scanlan, David J/0000-0003-3093-4245; Perez-Sepulveda, Blanca/0000-0002-2891-4010; Rihtman, Branko/0000-0002-3226-5500; Evans, David J./0000-0002-1315-4258	National Environment Research Council Studentship; Warwick University Chancellors International Scholarship; Natural Environment Research Council [NE/J02273X/1, NBAF010002] Funding Source: researchfish; NERC [NE/J02273X/1, NBAF010002] Funding Source: UKRI	National Environment Research Council Studentship; Warwick University Chancellors International Scholarship; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this work was provided by National Environment Research Council Studentship (http://www.nerc.ac.uk/) to RJP, Warwick University Chancellors International Scholarship (http://www2.warwick.ac.uk/services/academicoffice/gsp/scholarship/typesoffunding/chancellorsinternational/) to BPS, and Warwick University Chancellors International Scholarship (http://www2.warwick.ac.uk/services/academicoffice/gsp/scholarship/typesoffunding/chancellorsinternational/) to BR.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alam TI, 2008, MOL MICROBIOL, V69, P1180, DOI 10.1111/j.1365-2958.2008.06344.x; Arbiol C, 2010, GENOME BIOL EVOL, V2, P140, DOI 10.1093/gbe/evq006; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bragg JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003550; Breitbart M, 2007, OCEANOGRAPHY, V20, P135, DOI 10.5670/oceanog.2007.58; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Casjens Sherwood R., 2009, V502, P91, DOI 10.1007/978-1-60327-565-1_7; Clokie MRJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-291; Clokie Martha Rj, 2011, Bacteriophage, V1, P31, DOI 10.4161/bact.1.1.14942; Comeau AM, 2014, GENOME BIOL EVOL, V6, P1611, DOI 10.1093/gbe/evu129; Enav H, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-9; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; GROSSI GF, 1983, Z NATURFORSCH C, V38, P294; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hellweger FL, 2009, ENVIRON MICROBIOL, V11, P1386, DOI 10.1111/j.1462-2920.2009.01866.x; Hyman Paul, 2009, V501, P175, DOI 10.1007/978-1-60327-164-6_18; Ignacio-Espinoza J Cesar, 2013, Curr Opin Virol, V3, P566, DOI 10.1016/j.coviro.2013.07.004; Ignacio-Espinoza JC, 2012, ENVIRON MICROBIOL, V14, P2113, DOI 10.1111/j.1462-2920.2012.02704.x; Joshi N. A., 2011, SICKLE SLIDING WINDO; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li SF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097189, 10.1371/journal.pone.0085806]; Lin HC, 1998, VIROLOGY, V242, P118, DOI 10.1006/viro.1997.9019; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Marston MF, 2012, P NATL ACAD SCI USA, V109, P4544, DOI 10.1073/pnas.1120310109; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martiny JBH, 2014, ANNU REV MAR SCI, V6, P393, DOI 10.1146/annurev-marine-010213-135108; Millard AD, 2009, ENVIRON MICROBIOL, V11, P2370, DOI 10.1111/j.1462-2920.2009.01966.x; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Philosof A, 2011, ISME J, V5, P1568, DOI 10.1038/ismej.2011.43; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sharon I, 2011, ISME J, V5, P1178, DOI 10.1038/ismej.2011.2; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Thompson LR, 2011, P NATL ACAD SCI USA, V108, pE757, DOI 10.1073/pnas.1102164108; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; WYMAN M, 1985, SCIENCE, V230, P818, DOI 10.1126/science.230.4727.818; Zeng QL, 2012, CURR BIOL, V22, P124, DOI 10.1016/j.cub.2011.11.055	43	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132642	10.1371/journal.pone.0132642	http://dx.doi.org/10.1371/journal.pone.0132642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177354	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600136
J	Sarachana, T; Dahiya, N; Simhadri, VL; Pandey, GS; Saini, S; Guelcher, C; Guerrera, MF; Kimchi-Sarfaty, C; Sauna, ZE; Atreya, CD				Sarachana, Tewarit; Dahiya, Neetu; Simhadri, Vijaya L.; Pandey, Gouri Shankar; Saini, Surbhi; Guelcher, Christine; Guerrera, Michael F.; Kimchi-Sarfaty, Chava; Sauna, Zuben E.; Atreya, Chintamani D.			Small ncRNA Expression-Profiling of Blood from Hemophilia A Patients Identifies miR-1246 as a Potential Regulator of Factor 8 Gene	PLOS ONE			English	Article							FACTOR-VIII; MUTATION; MICRORNAS; RNAS	Hemophilia A (HA) is a bleeding disorder caused by deficiency of functional plasma clotting factor VIII (FVIII). Genetic mutations in the gene encoding FVIII (F8) have been extensively studied. Over a thousand different mutations have been reported in the F8 gene. These span a diverse range of mutation types, namely, missense, splice-site, deletions of single and multiple exons, inversions, etc. There is nonetheless evidence that other molecular mechanisms, in addition to mutations in the gene encoding the FVIII protein, may be involved in the pathobiology of HA. In this study, global small ncRNA expression profiling analysis of whole blood from HA patients, and controls, was performed using high-throughput ncRNA microarrays. Patients were further sub-divided into those that developed neutralizing-anti-FVIII antibodies (inhibitors) and those that did not. Selected differentially expressed ncRNAs were validated by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis. We identified several ncRNAs, and among them hsa-miR-1246 was significantly up-regulated in HA patients. In addition, miR-1246 showed a six-fold higher expression in HA patients without inhibitors. We have identified an miR-1246 target site in the noncoding region of F8 mRNA and were able to confirm the suppressory role of hsa-miR-1246 on F8 expression in a stable lymphoblastoid cell line expressing FVIII. These findings suggest several testable hypotheses vis-a-vis the role of nc-RNAs in the regulation of F8 expression. These hypotheses have not been exhaustively tested in this study as they require carefully curated clinical samples.	[Sarachana, Tewarit; Dahiya, Neetu; Atreya, Chintamani D.] US FDA, Lab Cellular Hematol, Div Hematol Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Sarachana, Tewarit] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Bangkok 10330, Thailand; [Simhadri, Vijaya L.; Pandey, Gouri Shankar; Saini, Surbhi; Kimchi-Sarfaty, Chava; Sauna, Zuben E.] US FDA, Lab Hemostasis, Div Hematol Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Saini, Surbhi; Guelcher, Christine; Guerrera, Michael F.] Childrens Natl Med Ctr, Ctr Canc & Blood Disorders, Washington, DC 20010 USA; [Guerrera, Michael F.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20037 USA	US Food & Drug Administration (FDA); Chulalongkorn University; US Food & Drug Administration (FDA); Children's National Health System; George Washington University	Sauna, ZE (corresponding author), US FDA, Lab Hemostasis, Div Hematol Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	zuben.sauna@fda.hhs.gov; chintamani.atreya@fda.hhs.gov	Sauna, Zuben E./AAA-7149-2019; Saini, Surbhi/HCH-3424-2022	Guelcher, Christine/0000-0001-9226-2347; Kimchi-Sarfaty, Chava/0000-0002-9355-8585	Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, D. C; CBER, FDA intramural funding	Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, D. C; CBER, FDA intramural funding	Research conducted in the laboratories of CDA and ZES is funded by the CBER, FDA intramural funding. SS received a fellowship from the Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, D. C.	Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Bloem E, 2012, J BIOL CHEM, V287, P5775, DOI 10.1074/jbc.M111.308627; Bolton-Maggs PHB, 2003, LANCET, V361, P1801, DOI 10.1016/S0140-6736(03)13405-8; Chang TR, 2014, CLIN APPL THROMB-HEM, V20, P124, DOI 10.1177/1076029613488936; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chu TM, 2002, MATH BIOSCI, V176, P35, DOI 10.1016/S0025-5564(01)00107-9; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gouw SC, 2012, BLOOD, V119, P2922, DOI 10.1182/blood-2011-09-379453; Graw J, 2005, NAT REV GENET, V6, P488, DOI 10.1038/nrg1617; Hwang Sung Ho, 2011, Korean J Hematol, V46, P49, DOI 10.5045/kjh.2011.46.1.49; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; Kraaijenhagen RA, 2000, THROMB HAEMOSTASIS, V83, P5; Lillicrap D, 2010, CURR OPIN HEMATOL, V17, P393, DOI 10.1097/MOH.0b013e32833c06c6; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; ODonnell J, 1997, THROMB HAEMOSTASIS, V77, P825; Pandey GS, 2013, NAT MED, V19, P1318, DOI 10.1038/nm.3270; Payne AB, 2013, HUM MUTAT, V34, pE2382, DOI 10.1002/humu.22247; Pezeshkpoor B, 2013, J THROMB HAEMOST, V11, P1679, DOI 10.1111/jth.12339; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Summers RJ, 2011, BLOOD, V117, P3190, DOI 10.1182/blood-2010-09-307074; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wight J, 2003, HAEMOPHILIA, V9, P418, DOI 10.1046/j.1365-2516.2003.00780.x	25	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132433	10.1371/journal.pone.0132433	http://dx.doi.org/10.1371/journal.pone.0132433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176629	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600112
J	Sivagnanalingam, U; Balys, M; Eberhardt, A; Wang, N; Myers, JR; Ashton, JM; Becker, MW; Calvi, LM; Mendler, JH				Sivagnanalingam, Umayal; Balys, Marlene; Eberhardt, Allison; Wang, Nancy; Myers, Jason R.; Ashton, John M.; Becker, Michael W.; Calvi, Laura M.; Mendler, Jason H.			Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia	PLOS ONE			English	Article							RUNX1 MUTATIONS; OLDER PATIENTS; UP-REGULATION; AML CELLS; BONE	Cytogenetically normal acute myeloid leukemia (CN-AML) patients harboring RUNX1 mutations have a dismal prognosis with anthracycline/cytarabine-based chemotherapy. We aimed to develop an in vivo model of RUNX1-mutated, CN-AML in which the nature of residual disease in this molecular disease subset could be explored. We utilized a well-characterized patient-derived, RUNX1-mutated CN-AML line (CG-SH). Tail vein injection of CG-SH into NOD scid gamma mice led to leukemic engraftment in the bone marrow, spleen, and peripheral blood within 6 weeks. Treatment of leukemic mice with anthracycline/ cytarabine-based chemotherapy resulted in clearance of disease from the spleen and peripheral blood, but persistence of disease in the bone marrow as assessed by flow cytometry and secondary transplantation. Whole exome sequencing of CG-SH revealed mutations in ASXL1, CEBPA, GATA2, and SETBP1, not previously reported. We conclude that CG-SH xenografts are a robust, reproducible in vivo model of CN-AML in which to explore mechanisms of chemotherapy resistance and novel therapeutic approaches.	[Sivagnanalingam, Umayal; Balys, Marlene; Eberhardt, Allison; Becker, Michael W.; Calvi, Laura M.; Mendler, Jason H.] Univ Rochester, Med Ctr, Dept Med, James P Wilmot Canc Inst, Rochester, NY 14642 USA; [Wang, Nancy] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Myers, Jason R.; Ashton, John M.] Univ Rochester, Med Ctr, Genom Res Ctr, Rochester, NY 14642 USA; [Ashton, John M.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, James P Wilmot Canc Inst, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Mendler, JH (corresponding author), Univ Rochester, Med Ctr, Dept Med, James P Wilmot Canc Inst, Rochester, NY 14642 USA.	jason_mendler@urmc.rochester.edu	Calvi, Laura/P-6988-2019	Calvi, Laura/0000-0001-6969-239X; Ashton, John/0000-0001-9875-5994; Mendler, Jason/0000-0001-5605-5324	Wilmot Cancer Research Fellowship; National Institutes of Health [NCI: CA166280]; Department of Defense [BM110106]; NATIONAL CANCER INSTITUTE [R01CA166280] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER	Wilmot Cancer Research Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	JHM is supported by the Wilmot Cancer Research Fellowship. LMC and MWB are supported by the National Institutes of Health (NCI: CA166280) and the Department of Defense (BM110106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Duan CW, 2014, CANCER CELL, V25, P778, DOI 10.1016/j.ccr.2014.04.015; Gaidzik VI, 2011, J CLIN ONCOL, V29, P1364, DOI 10.1200/JCO.2010.30.7926; Greif PA, 2012, HAEMATOL-HEMATOL J, V97, P1909, DOI 10.3324/haematol.2012.064667; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jacamo R, 2014, BLOOD, V123, P2691, DOI 10.1182/blood-2013-06-511527; Konopleva M, 2002, LEUKEMIA, V16, P1713, DOI 10.1038/sj.leu.2402608; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Mendler JH, 2012, J CLIN ONCOL, V30, P3109, DOI 10.1200/JCO.2011.40.6652; Metzeler KH, 2011, BLOOD, V118, P6920, DOI 10.1182/blood-2011-08-368225; Munker R, 2009, LEUKEMIA RES, V33, P1405, DOI 10.1016/j.leukres.2009.04.008; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Schnittger S, 2011, BLOOD, V117, P2348, DOI 10.1182/blood-2009-11-255976; Tang JL, 2009, BLOOD, V114, P5352, DOI 10.1182/blood-2009-05-223784; Wunderlich M, 2013, BLOOD, V121, pE90, DOI 10.1182/blood-2012-10-464677	18	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132375	10.1371/journal.pone.0132375	http://dx.doi.org/10.1371/journal.pone.0132375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177509	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600108
J	Subramanian, N; Kanwar, JR; Kanwar, RK; Sreemanthula, J; Biswas, J; Khetan, V; Krishnakumar, S				Subramanian, Nithya; Kanwar, Jagat R.; Kanwar, Rupinder K.; Sreemanthula, JagadeeshBabu; Biswas, Jyotirmay; Khetan, Vikas; Krishnakumar, Subramanian			EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer	PLOS ONE			English	Article							CELL ADHESION MOLECULE; DRUG-DELIVERY; BREAST-CANCER; RNA MOLECULES; STEM-CELLS; IN-VITRO; RETINOBLASTOMA; SELECTION; THERAPY; DNA	Epithelial cell adhesion molecule (EpCAM), a cancer stem cell (CSC) marker is over expressed in epithelial cancers and in retinoblastoma (RB). We fabricated an EpCAM targeting aptamer-siRNA chimera and investigated its anti-tumor property and EpCAM intracellular domain (EpICD) mediated signaling in epithelial cancer. The anti-tumor efficacy of EpCAM aptamer-siEpCAM chimera (EpApt-siEp) was evaluated by qPCR, northern and Western blotting in WERI-Rb1-RB cell line, primary RB tumor cells and in MCF7-breast cancer cell line. Anti-tumor activity of EpApt-siEp was studied in vivo using epithelial cancer (MCF7) mice xenograft model. The mechanism and pathways involved in the anti-tumor activity was further studied using protein arrays and qPCR. EpApt-siEp chimera was processed in vitro by dicer enzyme. Treatment of the WERI-Rb1 and MCF7 cells with EpApt-siEp revealed statistically significant down regulation of EpCAM expression (P<0.005) and concomitant reduction in cellular proliferation. In primary RB cells cultured from RB tumors, EpApt-siEp silenced EpCAM, significantly inhibited (P<0.01) cell proliferation and induced cytotoxicity. Knockdown of EpICD expressed in RB primary tumors led to repression of pluripotency markers, SOX2, OCT4, NANOG, and CD133. In vivo studies showed complete tumor growth regression without any toxicity in animals (P<0.001) and tumor tissues showed significant downregulation (P<0.05) of EpCAM, MRP1, ABCG2, stathmin, survivin and upregulation of ATM (P<0.05) leading to apoptosis by intrinsic pathway with minor alteration in cytokines. Our results revealed that EpApt-siEp potentially eradicated EpCAM positive cancer cells through CSC marker suppression and apoptosis, while sparing normal EpCAM negative adjacent cells.	[Subramanian, Nithya; Krishnakumar, Subramanian] Kamalnayan Bajaj Inst Res Vis & Ophthalmol, Vis Res Fdn, Dept Nanobiotechnol, Madras, Tamil Nadu, India; [Subramanian, Nithya; Kanwar, Jagat R.; Kanwar, Rupinder K.] Deakin Univ, Fac Hlth, Nanomed Lab Immunol & Mol Biomed Res, Ctr Mol & Med Res,Sch Med SoM, Geelong, Vic 3217, Australia; [Sreemanthula, JagadeeshBabu; Biswas, Jyotirmay; Krishnakumar, Subramanian] Vis Res Fdn, L&T Ocular Pathol Dept, Kamalnayan Bajaj Inst Res Vis & Ophthalmol, Chennai, Tamil Nadu, India; [Khetan, Vikas] Sankara Nethralaya, Med Res Fdn, Dept Ocular Oncol & Vitreoretina, Chennai, Tamil Nadu, India	Deakin University	Kanwar, JR (corresponding author), Deakin Univ, Fac Hlth, Nanomed Lab Immunol & Mol Biomed Res, Ctr Mol & Med Res,Sch Med SoM, Geelong, Vic 3217, Australia.	jagat.kanwar@deakin.edu.au; drkrishnakumar_2000@yahoo.com		Khetan, Vikas/0000-0003-4396-9877	Department of Biotechnology- Indo-Australian grant [BT/Indo-Aus/06/08/2011]; Department of Biotechnology- COE-Grant [BT/01/CE1B/11/V/16];  [BARC-2010/35/19/BRNS]	Department of Biotechnology- Indo-Australian grant; Department of Biotechnology- COE-Grant; 	This work was supported by BARC-2010/35/19/BRNS and in part from Department of Biotechnology- Indo-Australian grant- BT/Indo-Aus/06/08/2011 and COE-Grant BT/01/CE1B/11/ V/16-programme support on RB.	Angele S, 2000, CLIN CANCER RES, V6, P3536; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Bagalkot V, 2011, ACS NANO, V5, P8131, DOI 10.1021/nn202772p; Bellaousov S, 2013, NUCLEIC ACIDS RES, V41, pW471, DOI 10.1093/nar/gkt290; Bruno JG, 2013, PHARMACEUTICALS, V6, P340, DOI 10.3390/ph6030340; Dassie JP, 2009, NAT BIOTECHNOL, V27, P839, DOI 10.1038/nbt.1560; Davidson BL, 2006, NAT BIOTECHNOL, V24, P951, DOI 10.1038/nbt0806-951; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Du WQ, 2009, J CANCER RES CLIN, V135, P1277, DOI 10.1007/s00432-009-0569-5; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Germer Katherine, 2013, Int J Biochem Mol Biol, V4, P27; Gires O, 2009, NAT REV CANCER, V9, P143, DOI 10.1038/nrc2499-c1; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Kandalam MM, 2012, MOL VIS, V18, P2279; Kanwar JR, 2014, DRUG DISCOV TODAY, V19, P1309, DOI 10.1016/j.drudis.2014.02.009; Kanwar JR, 2011, CRIT REV BIOCHEM MOL, V46, P459, DOI 10.3109/10409238.2011.614592; Krishnakumar S, 2004, INVEST OPHTH VIS SCI, V45, P4247, DOI 10.1167/iovs.04-0591; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Li LY, 2014, BIOMATERIALS, V35, P3840, DOI 10.1016/j.biomaterials.2014.01.019; Liu HY, 2013, SCI REP-UK, V3, DOI 10.1038/srep03129; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Marton S, 2010, MOLECULES, V15, P4610, DOI 10.3390/molecules15074610; Mitra M, 2012, MOL VIS, V18, P290; Mitra M, 2010, MOL VIS, V16, P828; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Ogura E, 1998, ANTICANCER RES, V18, P3669; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Salomon J, 2014, HUM GENET, V133, P299, DOI 10.1007/s00439-013-1380-6; Schmidt M, 2010, ANN ONCOL, V21, P275, DOI 10.1093/annonc/mdp314; Schnell U, 2013, BIOSCIENCE REP, V33, P321, DOI 10.1042/BSR20120128; Semple JI, 2007, CELL DEATH DIFFER, V14, P1433, DOI 10.1038/sj.cdd.4402134; Shigdar S, 2013, CANCER LETT, V330, P84, DOI 10.1016/j.canlet.2012.11.032; Shigdar S, 2011, CANCER SCI, V102, P991, DOI 10.1111/j.1349-7006.2011.01897.x; Simon M, 2013, EXPERT OPIN DRUG DEL, V10, P451, DOI 10.1517/17425247.2013.759938; Singh S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-73; Somasunderam A, 2010, BIOCHEMISTRY-US, V49, P9106, DOI 10.1021/bi1009503; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; Song LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025454; Song YL, 2013, ANAL CHEM, V85, P4141, DOI 10.1021/ac400366b; Subramanian N, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-014-0108-9; Subramanian N, 2014, CHEM COMMUN, V50, P11810, DOI 10.1039/c4cc02996h; Subramanian N, 2012, MOL VIS, V18, P2783; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Wang CS, 2006, ANN CLIN LAB SCI, V36, P23; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Zhou Jiehua, 2010, Silence, V1, P4, DOI 10.1186/1758-907X-1-4; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	29	32	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132407	10.1371/journal.pone.0132407	http://dx.doi.org/10.1371/journal.pone.0132407			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176230	Green Published, gold			2022-12-27	WOS:000358197600110
J	Yang, SY; Walther, BA; Weng, GJ				Yang, Shu-Yi; Walther, Bruno A.; Weng, Guo-Jing			Stop and Smell the Pollen: The Role of Olfaction and Vision of the Oriental Honey Buzzard in Identifying Food	PLOS ONE			English	Article							RECEPTOR GENE REPERTOIRES; CATHARTES-MELAMBROTUS; ODOR RECOGNITION; BIRDS; COLOR; NAVIGATION; EVOLUTION; SCENT; CUES; AVOIDANCE	The importance of olfaction for various avian behaviors has become increasingly evident. So far, the use of olfaction for food detection among raptors has only been demonstrated for Cathartes vultures. The Oriental honey buzzard (Pernis orientalis) is a resident and migrant in Taiwan and regularly forages in apiaries. One of its foods in apiaries is yellow pollen dough, a softball-sized mixture of pollen, soybeans, and sugar that beekeepers provide as a supplementary food for bees. Given that pollen dough is not similar to any naturally occurring food, we hypothesized that buzzards identify the dough's nutritious contents using olfaction, perhaps in combination with vision. Using a series of choice experiments in which individuals could choose between two doughs, we showed that (1) buzzards almost unerringly chose pollen-containing over pollen lacking doughs when otherwise the doughs were identical in size, shape, and yellow color; (2) buzzards always preferred yellow over black or green doughs if both doughs contained pollen; (3) buzzards still preferred pollen-containing over pollen-lacking doughs when both doughs were black, but at a lower rate than in (1). We statistically excluded the possible influences of the doughs' relative brightness or of repeat visits by the same individuals. Our experiments thus suggest the use of a 'multi-modal foraging strategy' among buzzards whereby olfaction and vision are likely to be both used in identifying food at close distances. We also estimated the olfactory receptor gene repertoire size in the buzzard's genome which is almost five times as large as that of three other raptor species. Therefore, olfaction is likely of far greater ecological importance to this species than to other raptor species. We suggest that olfaction should be considered in the design of behavioral and genetic studies to better understand the use of multiple senses in avian behaviors.	[Yang, Shu-Yi; Weng, Guo-Jing] Natl Pingtung Univ Sci & Technol, Coll Vet Med, Inst Wildlife Conservat, Pingtung, Taiwan; [Walther, Bruno A.] Taipei Med Univ, Coll Publ Hlth & Nutr, Program Global Hlth & Dev, Taipei, Taiwan	National Pingtung University Science & Technology; Taipei Medical University	Weng, GJ (corresponding author), Natl Pingtung Univ Sci & Technol, Coll Vet Med, Inst Wildlife Conservat, Pingtung, Taiwan.	gjw@mail.npust.edu.tw						Almeida-Muradian LB, 2005, J FOOD COMPOS ANAL, V18, P105, DOI 10.1016/j.jfca.2003.10.008; Amo L, 2008, FUNCT ECOL, V22, P289, DOI 10.1111/j.1365-2435.2007.01361.x; Amo L, 2013, ECOL LETT, V16, P1348, DOI 10.1111/ele.12177; Avni D, 2014, J INSECT PHYSIOL, V69, P65, DOI 10.1016/j.jinsphys.2014.07.001; Balthazart J, 2009, BEHAV BRAIN RES, V200, P248, DOI 10.1016/j.bbr.2008.08.036; Bonadonna F, 2004, SCIENCE, V306, P835, DOI 10.1126/science.1103001; Brazil M., 2009, BIRDS E ASIA CHINA T; Caro SP, 2010, J COMP PHYSIOL A, V196, P751, DOI 10.1007/s00359-010-0534-4; Cunningham SJ, 2009, ANIM BEHAV, V78, P899, DOI 10.1016/j.anbehav.2009.07.015; Del Hoyo J, 1994, HDB BIRDS WORLD, V2; Doyle JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095599; Gagliardo A, 2013, J EXP BIOL, V216, P2798, DOI 10.1242/jeb.085738; Gagliardo A, 2013, J EXP BIOL, V216, P2165, DOI 10.1242/jeb.070250; Gess SK, 1996, POLLEN WASPS ECOLOGY, DOI [10.4159/harvard.9780674281684, DOI 10.4159/HARVARD.9780674281684]; GOMEZ LG, 1994, IBIS, V136, P193, DOI 10.1111/j.1474-919X.1994.tb01084.x; GRAVES GR, 1992, J RAPTOR RES, V26, P38; Gwinner H, 2008, ANIM BEHAV, V75, P971, DOI 10.1016/j.anbehav.2007.08.008; Hagelin JC, 2007, AUK, V124, P741, DOI 10.1642/0004-8038(2007)124[741:BOAOCS]2.0.CO;2; Houston DC, 1994, HDB BIRDS WORLD, V2, P24; Huang KY, 2004, J RAPTOR RES, V38, P367; Human H, 2006, PHYTOCHEMISTRY, V67, P1486, DOI 10.1016/j.phytochem.2006.05.023; Hunt JH, 2007, EVOLUTION SOCIAL WAS; Jetz W, 2001, BEHAV ECOL, V12, P134, DOI 10.1093/beheco/12.2.134; Jorge P. E., 2011, BIOL ODORS SOURCES O, P207; Lind O, 2013, J EXP BIOL, V216, P1819, DOI 10.1242/jeb.082834; Lindstrom L, 1999, BEHAV ECOL, V10, P317, DOI 10.1093/beheco/10.3.317; Mardon J, 2010, J EXP BIOL, V213, P558, DOI 10.1242/jeb.032979; MARPLES NM, 1994, ANIM BEHAV, V48, P967, DOI 10.1006/anbe.1994.1322; Marples NM, 1996, ANIM BEHAV, V51, P1417, DOI 10.1006/anbe.1996.0145; Martin GR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000198; Mihailova M, 2014, ANIM BEHAV, V95, P155, DOI 10.1016/j.anbehav.2014.07.012; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Roper TJ, 1997, ANIM BEHAV, V53, P1241, DOI 10.1006/anbe.1996.0384; Roper TJ, 1999, ADV STUD BEHAV, V28, P247, DOI 10.1016/S0065-3454(08)60219-3; Roth TC, 2008, ANIM BEHAV, V76, P2021, DOI 10.1016/j.anbehav.2008.08.022; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Severinghaus L., 2010, AVIFAUNA TAIWAN; Severinghaus LL, 2007, CONSERVATION RES SER, V95-01; Severinghaus LL, 2005, CONSERVATION RES SER, V93-03; Severinghaus LL., 2010, CONSERVATION RES SER, V98-04; Smith HR, 2002, J RAPTOR RES, V36, P144; Steiger SS, 2008, P ROY SOC B-BIOL SCI, V275, P2309, DOI 10.1098/rspb.2008.0607; TROLLE M, 2004, COTINGA, V22, P81; Van Buskirk RW, 2008, J EVOLUTION BIOL, V21, P67, DOI 10.1111/j.1420-9101.2007.01465.x; Wallraff HG, 2004, ANIM BEHAV, V67, P189, DOI 10.1016/j.anbehav.2003.06.007; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Wenzel BM, 2007, J ORNITHOL, V148, pS191, DOI 10.1007/s10336-007-0147-z; WENZEL BM, 1968, NATURE, V220, P1133, DOI 10.1038/2201133a0; Zhan XJ, 2013, NAT GENET, V45, P563, DOI 10.1038/ng.2588; Zidar J, 2012, ANIM BEHAV, V84, P547, DOI 10.1016/j.anbehav.2012.06.006	51	15	15	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130191	10.1371/journal.pone.0130191	http://dx.doi.org/10.1371/journal.pone.0130191			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177533	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600019
J	Al-Daghri, NM; Al-Saleh, Y; Aljohani, N; Alokail, M; Al-Attas, O; Alnaami, AM; Sabico, S; Alsulaimani, M; Al-Harbi, M; Alfawaz, H; Chrousos, GP				Al-Daghri, Nasser M.; Al-Saleh, Yousef; Aljohani, Naji; Alokail, Majed; Al-Attas, Omar; Alnaami, Abdullah M.; Sabico, Shaun; Alsulaimani, Maha; Al-Harbi, Mohammed; Alfawaz, Hanan; Chrousos, George P.			Vitamin D Deficiency and Cardiometabolic Risks: A Juxtaposition of Arab Adolescents and Adults	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; HYPOVITAMINOSIS-D; INSULIN SENSITIVITY; 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; OVERWEIGHT; ASSOCIATIONS; POPULATION; PATTERNS	The recent exponential surge in vitamin D research reflects the global epidemic of vitamin D deficiency and its potential impact on several chronic diseases in both children and adults. Several subpopulations, including Arab adolescent boys and girls, remain understudied. This study aims to fill this gap. A total of 2225 apparently healthy Saudi adolescents (1187 boys and 1038 girls, aged 13-17 years old) and 830 adults (368 men and 462 women, aged 18-50 years old) were respectively recruited from different public schools and medical practices within Riyadh, Saudi Arabia. Anthropometrics were taken and fasting blood samples withdrawn to examine serum glucose and lipid profile by routine analysis and 25-hydroxyvitamin D by ELISA. Almost half of the girls (47.0%) had vitamin D deficiency as compared to only 19.4% of the boys (p<0.001), 36.8% of the adult women and 17.7% of the adult men (p<0.001). Furthermore, in boys there were more significant inverse associations between serum 25(OH) vitamin D levels and cardiometabolic indices than girls, while in contrast women had more significant associations than men. Vitamin D deficiency was significantly associated with diabetes mellitus type 2 (DMT2) [OR 3.47 (CI1.26-5.55); p<0.05] and pre-DM [OR 2.47 (CI 1.48-4.12); p<0.01] in boys. Furthermore, vitamin D insufficiency was significantly associated with abdominal obesity in boys [OR 2.75 (CI 1.1-7.1); p<0.05]. These associations for DMT2 and abdominal obesity were not observed in adult males, girls and adult women. Vitamin D deficiency/insufficiency and hyperglycemia is high among Arab adolescents. Vitamin D deficiency is mostly associated with cardiometabolic risk factors in adolescent Arab boys. This indicates a sex-and age-related disadvantage for boys with low vitamin D status and challenges the extra-skeletal protection of vitamin D correction in adolescent females.	[Al-Daghri, Nasser M.; Alokail, Majed; Al-Attas, Omar; Alnaami, Abdullah M.; Sabico, Shaun; Chrousos, George P.] King Saud Univ, Coll Sci, Dept Biochem, Biomarkers Res Program, Riyadh 11451, Saudi Arabia; [Al-Daghri, Nasser M.; Al-Saleh, Yousef; Aljohani, Naji; Alokail, Majed; Al-Attas, Omar; Alnaami, Abdullah M.; Sabico, Shaun] King Saud Univ, Coll Sci, Dept Biochem, Prince Mutaib Chair Biomarkers Osteoporosis, Riyadh 11451, Saudi Arabia; [Al-Saleh, Yousef] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, King Abdulaziz Med City, Riyadh 11426, Saudi Arabia; [Aljohani, Naji] King Saud Bin Abdulaziz Univ Hlth Sci, Fac Med, Specialized Diabet & Endocrine Ctr, King Fahad Med City, Riyadh 11525, Saudi Arabia; [Alsulaimani, Maha] King Saud Univ, Coll Sci, Dept Biochem, Riyadh 11451, Saudi Arabia; [Al-Harbi, Mohammed] Diabet Ctr, Riyadh, Saudi Arabia; [Al-Harbi, Mohammed] Minist Hlth, Unit Adm, Riyadh, Saudi Arabia; [Alfawaz, Hanan] King Saud Univ, Coll Food Sci & Agr, Dept Food Sci & Nutr, Riyadh 11451, Saudi Arabia; [Chrousos, George P.] Univ Athens, Sch Med, Dept Pediat 1, GR-11527 Athens, Greece	King Saud University; King Saud University; King Saud Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz University for Health Sciences; King Saud University; Ministry of Health - Saudi Arabia; King Saud University; Athens Medical School; National & Kapodistrian University of Athens	Al-Daghri, NM (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Biomarkers Res Program, Riyadh 11451, Saudi Arabia.	aldaghri2011@gmail.com	Al-okail, Majed S/E-5565-2016; Al-Daghri, Nasser/A-8360-2011; Al-Daghri, Nasser/G-7736-2011; Sabico, Shaun/C-9086-2011	Al-okail, Majed S/0000-0001-8147-3499; Al-Daghri, Nasser/0000-0001-5472-1725; Al-Daghri, Nasser/0000-0001-5472-1725; Sabico, Shaun/0000-0002-5248-2350	Deanship of Scientific Research, Prolific Research Group Program, Vice Rectorate for Graduate Studies and Scientific Research in King Saud University (KSU), Riyadh, Saudi Arabia [PRG-1436-15]	Deanship of Scientific Research, Prolific Research Group Program, Vice Rectorate for Graduate Studies and Scientific Research in King Saud University (KSU), Riyadh, Saudi Arabia	The authors thank the Deanship of Scientific Research, Prolific Research Group Program (PRG-1436-15), Vice Rectorate for Graduate Studies and Scientific Research in King Saud University (KSU), Riyadh, Saudi Arabia for funding the study.	Al Mheid I, 2013, EUR HEART J, V34, P3691, DOI 10.1093/eurheartj/eht166; Al-Daghri NM, 2013, J ENDOCRINOL INVEST, V36, P1, DOI 10.3275/8183; Al-Daghri NM, 2014, J PROTEOME RES, V13, P5094, DOI 10.1021/pr5003406; Al-Daghri NM, 2013, MOLECULES, V18, P10671, DOI 10.3390/molecules180910671; Al-Daghri NM, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-85; Al-Daghri NM, 2012, METABOLISM, V61, P661, DOI 10.1016/j.metabol.2011.09.017; Al-Daghri NM, 2012, CLIN ENDOCRINOL, V76, P346, DOI 10.1111/j.1365-2265.2011.04219.x; Al-Daghri NM, 2010, CENT EUR J MED, V5, P752, DOI 10.2478/s11536-010-0045-2; Al-Hazzaa HM, 2014, J PHYS ACT HEALTH, V11, P1202, DOI 10.1123/jpah.2012-0427; Al-Mogbel ES, 2012, INT J HEALTH SCI-IJH, V6, P116, DOI 10.12816/0005987; Alemzadeh R, 2008, METABOLISM, V57, P183, DOI 10.1016/j.metabol.2007.08.023; Alkharfy KM, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-113; Ashraf AP, 2011, OBESITY, V19, P2214, DOI 10.1038/oby.2011.110; Bassil D, 2013, DERM-ENDOCRINOL, V5, P274, DOI 10.4161/derm.25111; Beveridge LA, 2013, OSTEOPOROSIS INT, V24, P2167, DOI 10.1007/s00198-013-2281-1; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de las Heras J, 2013, DIABETES CARE, V36, P2048, DOI 10.2337/dc12-1288; Erdonmez D, 2011, J CLIN RES PEDIATR E, V3, P198, DOI 10.4274/jcrpe.507; Gulseth HL, 2013, CURR VASC PHARMACOL, V11, P968, DOI 10.2174/15701611113119990169; Hughes AM, 2011, PEDIAT ALLERG IMM-UK, V22, P327, DOI 10.1111/j.1399-3038.2010.01099.x; Jang Han Byul, 2013, Osong Public Health Res Perspect, V4, P179, DOI 10.1016/j.phrp.2013.06.004; Kardas F, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/503270; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Kelishadi R, 2014, NUTRITION, V30, P33, DOI 10.1016/j.nut.2013.05.018; Kim SH, 2013, J CLIN ENDOCR METAB, V98, pE1716, DOI 10.1210/jc.2013-1166; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Meddeb N, 2005, OSTEOPOROSIS INT, V16, P180, DOI 10.1007/s00198-004-1658-6; Muhairi SJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-33; Palacios C, 2014, J STEROID BIOCHEM, V144, P138, DOI 10.1016/j.jsbmb.2013.11.003; Pirgon O, 2013, OBES RES CLIN PRACT, V7, pE275, DOI 10.1016/j.orcp.2012.01.004; Reid IR, 2014, LANCET, V383, P146, DOI 10.1016/S0140-6736(13)61647-5; Rosano GMC, 2007, CLIMACTERIC, V10, P19, DOI 10.1080/13697130601114917; Stanley T, 2013, METAB SYNDR RELAT D, V11, P56, DOI 10.1089/met.2012.0102; Tester J, 2013, DIABETES METAB SYND, V7, P161, DOI 10.1016/j.dsx.2013.06.002; Verdoia M, 2014, EUR J CLIN INVEST, V44, P634, DOI 10.1111/eci.12281; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105; Winzenberg T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7254	37	41	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131315	10.1371/journal.pone.0131315	http://dx.doi.org/10.1371/journal.pone.0131315			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186591	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700014
J	Ding, LL; Zhang, XY; Guo, HL; Yuan, JL; Li, SJ; Hu, WL; Golden, T; Wu, N				Ding, Lingling; Zhang, Xiaoyu; Guo, Hongliang; Yuan, Junliang; Li, Shujuan; Hu, Wenli; Golden, Teresa; Wu, Ning			The Functional Study of a Chinese Herbal Compounded Antidepressant Medicine - Jie Yu Chu Fan Capsule on Chronic Unpredictable Mild Stress Mouse Model	PLOS ONE			English	Article							BANXIA-HOUPU DECOCTION; MAJOR DEPRESSIVE DISORDER; EXTRACELLULAR SEROTONIN; GARDENIA-JASMINOIDES; SUCROSE PREFERENCE; OXIDATIVE STRESS; NEUROPEPTIDE-Y; RATS; FLUOXETINE; BRAIN	Jie Yu Chu Fan capsule (JYCF) is a new compounded Chinese herbal medicine for the treatment of depression. The present study was designed to explore the antidepressant effects and the possible mechanisms of JYCF by using chronic unpredictable mild stress (CUMS) mouse model and comparing results to that of fluoxetine. Behavioral tests including an open field test, sucrose preference test and forced swim test were performed to evaluate the antidepressant effects of JYCF. The concentrations of monoamine neurotransmitters and metabolic products including norepinephrine (NE), 5-hydroxytryptamine (5-HT), dopamine (DA), 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA) and 3,4dihydroxyphenylacetic acid (DOPAC) in the cerebral cortex and hippocampus of mice were determined by means of high performance liquid chromatography with electrochemical detection (HPLC-EC). The results show that a successful mouse CUMS model was established through 5 weeks of continuous unpredictable stimulation, as indicated by the significant decrease in sucrose preference and locomotor activity and increase in immobility time in the forced swim test. Chronic treatment of JYCF (1.25, 2.5 and 5 g/kg) and fluoxetine (20mg/kg) significantly reversed the CUMS-induced behavioral abnormalities. JYCF (1.25, 2.5 and 5 g/kg) significantly increased NE in CUMS mouse prefrontal cortex (P < 0.01, P < 0.01, P < 0.05 respectively) and 5-HT in hippocampus (P < 0.05). In summary, our findings suggest that JYCF exerts comparable antidepressant-like effects to that of fluoxetine in CUMS mice. Besides, the antidepressant-like effect of JYCF is mediated by the increase of monoaminergic transmitters including 5-HT and NE.	[Ding, Lingling; Zhang, Xiaoyu; Guo, Hongliang; Yuan, Junliang; Li, Shujuan; Hu, Wenli] Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China; [Golden, Teresa; Wu, Ning] Southeastern Oklahoma State Univ, Dept Biol Sci, Durant, OK USA	Capital Medical University	Hu, WL (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China.	huwenli@sina.com	Zhang, xiaoyu/GXA-3206-2022					Becker AE, 2013, NEW ENGL J MED, V369, P66, DOI 10.1056/NEJMra1110827; Brunner E, 2014, NEUROPSYCHOPHARMACOL, V39, P2549, DOI 10.1038/npp.2014.101; Casarotto PC, 2007, EUR NEUROPSYCHOPHARM, V17, P735, DOI 10.1016/j.euroneuro.2007.03.001; D'Aquila PS, 2000, EUR J PHARMACOL, V399, P43, DOI 10.1016/S0014-2999(00)00332-0; Elhwuegi AS, 2004, PROG NEURO-PSYCHOPH, V28, P435, DOI 10.1016/j.pnpbp.2003.11.018; Gao S, 2013, BEHAV BRAIN RES, V238, P79, DOI 10.1016/j.bbr.2012.10.015; Guo YS, 2004, PHYTOTHER RES, V18, P204, DOI 10.1002/ptr.1394; Hou CL, 2006, BRAIN RES, V1095, P154, DOI 10.1016/j.brainres.2006.04.026; Huang CK, 2015, NEUROCHEM RES, V40, P27, DOI 10.1007/s11064-014-1461-5; Iguchi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114024; Invernizzi R, 1996, PHARMACOL BIOCHEM BE, V54, P143, DOI 10.1016/0091-3057(95)02159-0; Jindal A, 2013, PHARMACOL BIOCHEM BE, V105, P63, DOI 10.1016/j.pbb.2013.01.020; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Kim JH, 2012, BIOMOL THER, V20, P214, DOI 10.4062/biomolther.2012.20.2.214; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Li JM, 2003, LIFE SCI, V74, P55, DOI 10.1016/j.lfs.2003.06.030; Liu DX, 2014, BEHAV BRAIN RES, V264, P9, DOI 10.1016/j.bbr.2014.01.039; Liu Y, 2013, PHARMACOL BIOCHEM BE, V104, P27, DOI 10.1016/j.pbb.2012.12.024; Lucca G, 2009, NEUROCHEM INT, V54, P358, DOI 10.1016/j.neuint.2009.01.001; Luo DD, 2008, BRAIN RES BULL, V77, P8, DOI 10.1016/j.brainresbull.2008.05.010; Ma XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020955; Ma ZQ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/213739; Mahar I, 2014, NEUROSCI BIOBEHAV R, V38, P173, DOI 10.1016/j.neubiorev.2013.11.009; Mao QQ, 2011, PROG NEURO-PSYCHOPH, V35, P1144, DOI 10.1016/j.pnpbp.2011.03.017; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Perez-Caballero L, 2014, EXPERT OPIN DRUG DIS, V9, P567, DOI 10.1517/17460441.2014.907790; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Qiu J, 2014, J ETHNOPHARMACOL, V152, P320, DOI 10.1016/j.jep.2014.01.004; Russo E, 2013, NEUROPHARMACOLOGY, V64, P371, DOI 10.1016/j.neuropharm.2012.06.039; RUTTER JJ, 1994, NEUROSCI LETT, V171, P183, DOI 10.1016/0304-3940(94)90635-1; Saenz JCB, 2006, BEHAV BRAIN RES, V169, P57, DOI 10.1016/j.bbr.2005.12.001; Shaft S, 2014, PHARMACOL BIOCHEM BE, V122, P234, DOI 10.1016/j.pbb.2014.03.029; Sun YQ, 2012, PHYTOTHER RES, V26, P67, DOI 10.1002/ptr.3516; Tao WW, 2014, MOLECULES, V19, P19350, DOI 10.3390/molecules191219350; Tian JS, 2010, NEUROSCI LETT, V479, P236, DOI 10.1016/j.neulet.2010.05.069; Walker FR, 2013, NEUROPHARMACOLOGY, V67, P304, DOI 10.1016/j.neuropharm.2012.10.002; Wang YM, 2005, PHYTOTHER RES, V19, P526, DOI 10.1002/ptr.1697; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Williamson EM, 2001, PHYTOMEDICINE, V8, P401, DOI 10.1078/0944-7113-00060; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Yi LT, 2009, PROG NEURO-PSYCHOPH, V33, P616, DOI 10.1016/j.pnpbp.2009.03.001; Zhang WY, 2004, PHYTOTHER RES, V18, P200, DOI 10.1002/ptr.1391; Zhou XJ, 2012, J ETHNOPHARMACOL, V139, P422, DOI 10.1016/j.jep.2011.11.027	45	18	20	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133405	10.1371/journal.pone.0133405	http://dx.doi.org/10.1371/journal.pone.0133405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186537	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700133
J	Elmore, MT; Brosnan, JT; Armel, GR; Kopsell, DA; Best, MD; Mueller, TC; Sorochan, JC				Elmore, Matthew T.; Brosnan, James T.; Armel, Gregory R.; Kopsell, Dean A.; Best, Michael D.; Mueller, Thomas C.; Sorochan, John C.			Cytochrome P450 Inhibitors Reduce Creeping Bentgrass (Agrostis stolonifera) Tolerance to Topramezone	PLOS ONE			English	Article							SMOOTH CRABGRASS CONTROL; MIXED-FUNCTION OXIDASE; HERBICIDE SAFENERS; CHLOROPHYLL FLUORESCENCE; ECHINOCHLOA-PHYLLOPOGON; PERENNIAL RYEGRASS; RESISTANCE; METABOLISM; CHLORTOLURON; SELECTIVITY	Creeping bentgrass (Agrostis stolonifera L.) is moderately tolerant to the p-hydroxyphenylpyruvate dioxygenase-inhibiting herbicide topramezone. However, the contribution of plant metabolism of topramezone to this tolerance is unknown. Experiments were conducted to determine if known cytochrome P450 monooxygenase inhibitors 1-aminobenzotriazole (ABT) and malathion alone or in combination with the herbicide safener cloquintocet-mexyl influence creeping bentgrass tolerance to topramezone. Creeping bentgrass in hydroponic culture was treated with ABT (70 mu M), malathion (70 mu m and 1000 g ha(-1)), or cloquintocet-mexyl (70 mu M and 1000 g ha(-1)) prior to topramezone (8 g ha(-1)) application. Topramezone-induced injury to creeping bentgrass increased from 22% when applied alone to 79 and 41% when applied with malathion or ABT, respectively. Cloquintocet-mexyl (70 mu M and 1000 g ha(-1)) reduced topramezone injury to 1% and increased creeping bentgrass biomass and PSII quantum yield. Cloquintocet-mexyl mitigated the synergistic effects of ABT more than those of malathion. The effects of malathion on topramezone injury were supported by creeping bentgrass biomass responses. Responses to ABT and malathion suggest that creeping bentgrass tolerance to topramezone is influenced by cytochrome P450-catalyzed metabolism. Future research should elucidate primary topramezone metabolites and determine the contribution of cytochrome P450 monooxygenases and glutathione S-transferases to metabolite formation in safened and non-safened creeping bentgrass.	[Elmore, Matthew T.] Texas A&M AgriLife Extens Serv, Dept Soil & Crop Sci, Dallas, TX 75252 USA; [Brosnan, James T.; Armel, Gregory R.; Kopsell, Dean A.; Mueller, Thomas C.; Sorochan, John C.] Univ Tennessee, Dept Plant Sci, Knoxville, TN 37996 USA; [Best, Michael D.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville	Elmore, MT (corresponding author), Texas A&M AgriLife Extens Serv, Dept Soil & Crop Sci, Dallas, TX 75252 USA.	matthew.elmore@ag.tamu.edu		Kopsell, Dean/0000-0002-0299-1624; Elmore, Matthew/0000-0002-3049-3892	Tennessee Agricultural Experiment Station	Tennessee Agricultural Experiment Station	This work was supported by the Tennessee Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PYLEX SPECIMEN LABEL; Beckie HJ, 2012, WEED SCI, V60, P10, DOI 10.1614/WS-D-11-00110.1; Brazier M, 2002, PHYTOCHEMISTRY, V59, P149, DOI 10.1016/S0031-9422(01)00458-7; Brosnan JT, 2013, WEED TECHNOL, V27, P138, DOI 10.1614/WT-D-12-00119.1; BURNET MWM, 1993, PLANTA, V190, P182, DOI 10.1007/BF00196610; CABANNE F, 1987, PESTIC BIOCHEM PHYS, V28, P371, DOI 10.1016/0048-3575(87)90133-7; Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311; CHRISTOPHER JT, 1994, PESTIC BIOCHEM PHYS, V49, P172, DOI 10.1006/pest.1994.1045; Davies J, 1999, PESTIC SCI, V55, P1043, DOI 10.1002/(SICI)1096-9063(199911)55:11&lt;1043::AID-PS60&gt;3.0.CO;2-L; deBoer GJ, 2011, PEST MANAG SCI, V67, P279, DOI 10.1002/ps.2062; Dernoeden PH, 2013, CREEPING BENTGRASS MANAGEMENT, 2ND EDITION, P1; Dernoeden PH, 2003, HORTSCIENCE, V38, P607, DOI 10.21273/HORTSCI.38.4.607; DERNOEDEN PH, 1992, HORTSCIENCE, V27, P1001; Elmore MT, 2011, CROP SCI, V51, P2840, DOI 10.2135/cropsci2010.11.0656; Elmore MT, 2012, WEED SCI, V60, P480, DOI 10.1614/WS-D-11-00169.1; Elmore MT, WEED TECHNO IN PRESS; FREAR DS, 1969, PHYTOCHEMISTRY, V8, P2157, DOI 10.1016/S0031-9422(00)88175-3; GAILLARDON P, 1985, WEED RES, V25, P397, DOI 10.1111/j.1365-3180.1985.tb00661.x; Grossmann K, 2007, PEST MANAG SCI, V63, P429, DOI 10.1002/ps.1341; Hart SE, 2004, WEED TECHNOL, V18, P375, DOI 10.1614/WT-03-106R; Hatzios KK, 2004, WEED SCI, V52, P454, DOI 10.1614/P2002-168C; Henry GM, 2004, HORTSCIENCE, V39, P1768, DOI 10.21273/HORTSCI.39.7.1768; Hoagland DR, 1950, CAL AGR EXP STN CIRC, V347, DOI [DOI 10.1016/S0140-6736(00)73482-9, 10.1016/S0140-6736(00)73482-9]; JOHNSON BJ, 1994, HORTSCIENCE, V29, P880, DOI 10.21273/HORTSCI.29.8.880; Kaspar M, 2011, WEED SCI, V59, P232, DOI 10.1614/WS-D-10-00120.1; Kocurek V, 2009, CEREAL RES COMMUN, V37, P289; Kreuz K, 1996, PLANT PHYSIOL, V111, P349, DOI 10.1104/pp.111.2.349; KREUZ K, 1991, Z NATURFORSCH C, V46, P901; Lyman G. T., 2007, Applied Turfgrass Science, P1107; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MCINTOSH MS, 1983, AGRON J, V75, P153, DOI 10.2134/agronj1983.00021962007500010041x; Menendez J, 2006, WEED SCI, V54, P237; Mitchell G, 2001, PEST MANAG SCI, V57, P120, DOI 10.1002/1526-4998(200102)57:2<120::AID-PS254>3.0.CO;2-E; Ohba K, 1997, J PESTIC SCI, V22, P277; Osuna MD, 2002, PESTIC BIOCHEM PHYS, V73, P9, DOI 10.1016/S0048-3575(02)00010-X; Preston C, 1996, PESTIC BIOCHEM PHYS, V54, P123, DOI 10.1006/pest.1996.0016; Riechers DE, 1996, PESTIC BIOCHEM PHYS, V56, P88, DOI 10.1006/pest.1996.0063; Riechers DE, 2010, PLANT PHYSIOL, V153, P3, DOI 10.1104/pp.110.153601; SANG RS, 1992, HORTSCIENCE, V27, P237; Siminszky Balazs, 2006, Phytochemistry Reviews, V5, P445, DOI 10.1007/s11101-006-9011-7; Smith A, 2013, P SO WEED SCI SOC, V66, P3; Taylor VL, 2013, ENVIRON EXP BOT, V88, P93, DOI 10.1016/j.envexpbot.2011.12.030; Thies F, 1996, PLANT PHYSIOL, V112, P361, DOI 10.1104/pp.112.1.361; Venner KA, 2014, P NE WEED SCI SOC, P90; Werck-Reichhart D, 2000, TRENDS PLANT SCI, V5, P116, DOI 10.1016/S1360-1385(00)01567-3; Williams MM, 2010, WEED SCI, V58, P289, DOI 10.1614/WS-D-09-00058.1; Yasuor H, 2009, J AGR FOOD CHEM, V57, P3653, DOI 10.1021/jf8039999; Yun MS, 2001, PEST MANAG SCI, V57, P283, DOI 10.1002/ps.298	48	5	6	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0130947	10.1371/journal.pone.0130947	http://dx.doi.org/10.1371/journal.pone.0130947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186714	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700008
J	Gasse, B; Liu, X; Corre, E; Sire, JY				Gasse, Barbara; Liu, Xi; Corre, Erwan; Sire, Jean-Yves			Amelotin Gene Structure and Expression during Enamel Formation in the Opossum Monodelphis domestica	PLOS ONE			English	Article							RNA-SEQ DATA; JUNCTIONAL EPITHELIUM; REFERENCE GENOME; MINERALIZATION; EVOLUTION; PROTEIN; ALIGNMENT; TISSUE	Amelotin (AMTN) is an ameloblast-secreted protein that belongs to the secretory calcium-binding phosphoprotein family, which also includes the enamel matrix proteins amelogenin, ameloblastin and enamelin. Although AMTN is supposed to play an important role in enamel formation, data were long limited to the rodents, in which it is expressed during the maturation stage. Recent comparative studies in sauropsids and amphibians revealed that (i) AMTN was expressed earlier, i.e. as soon as ameloblasts are depositing the enamel matrix, and (ii) AMTN structure was different, a change which mostly resulted from an intraexonic splicing in the large exon 8 of an ancestral mammal. The present study was performed to know whether the differences in AMTN structure and expression in rodents compared to non-mammalian tetrapods dated back to an early ancestral mammal or were acquired later in mammalian evolution. We sequenced, assembled and screened the jaw transcriptome of a neonate opossum Monodelphis domestica, a marsupial. We found two AMTN transcripts. Variant 1, representing 70.8% of AMTN transcripts, displayed the structure known in rodents, whereas variant 2 (29.2%) exhibited the nonmammalian tetrapod structure. Then, we studied AMTN expression during amelogenesis in a neonate specimen. We obtained similar data as those reported in rodents. These findings indicate that more than 180 million years ago, before the divergence of marsupials and placentals, changes occurred in AMTN function and structure. The spatiotemporal expression was delayed to the maturation stage of amelogenesis and the intraexonic splicing gave rise to isoform 1, encoded by variant 1 and lacking the RGD motif. The ancestral isoform 2, housing the RGD, was initially conserved, as demonstrated here in a marsupial, then secondarily lost in the placental lineages. These findings bring new elements towards our understanding of the non-prismatic to prismatic enamel transition that occurred at the onset of mammals.	[Gasse, Barbara; Liu, Xi; Sire, Jean-Yves] Univ Paris 06, Sorbonne Univ, IBPS, UMR7138, F-75005 Paris, France; [Gasse, Barbara; Liu, Xi; Sire, Jean-Yves] CNRS, IBPS, UMR7138, F-75005 Paris, France; [Liu, Xi; Corre, Erwan] Univ Paris 06, Sorbonne Univ, Stn Biol Roscoff, Plateforme ABiMS Anal & Bioinformat Marine Sci, F-29680 Roscoff, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Sire, JY (corresponding author), Univ Paris 06, Sorbonne Univ, IBPS, UMR7138, F-75005 Paris, France.	jean-yves.sire@upmc.fr	corre, erwan/O-4669-2019	corre, erwan/0000-0001-6354-2278	Centre national de la recherche scientifique, Universite Pierre et Marie Curie; Project "Jaws" [ANR-12-BSV7-020]	Centre national de la recherche scientifique, Universite Pierre et Marie Curie(Centre National de la Recherche Scientifique (CNRS)); Project "Jaws"	This study was financially supported by Centre national de la recherche scientifique, Universite Pierre et Marie Curie, and by the Project "Jaws" (ANR-12-BSV7-020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbarin N, 2015, J BONE MINER RES, V30, P775, DOI 10.1002/jbmr.2411; Al-Hashimi N, 2010, MOL BIOL EVOL, V27, P2078, DOI 10.1093/molbev/msq098; Gasse B, 2012, J DENT RES, V91, P1085, DOI 10.1177/0022034512460551; Gasse B, 2015, BMC EVOL BIOL, V15, P329; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Iwasaki K, 2005, J DENT RES, V84, P1127, DOI 10.1177/154405910508401207; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Kawasaki K, 2007, CELLS TISSUES ORGANS, V186, P7, DOI 10.1159/000102678; Kawasaki K, 2014, J EXP ZOOL PART B, V322, P390, DOI 10.1002/jez.b.22546; Lacruz RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Madsen Ole, 2009, P459; Moffatt P, 2006, BIOCHEM J, V399, P37, DOI 10.1042/BJ20060662; Nishio C, 2013, PERIODONTOL 2000, V63, P59, DOI 10.1111/prd.12031; Somogyi-Ganss E, 2012, CELLS TISSUES ORGANS, V195, P535, DOI 10.1159/000329255; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wood C. B., 1999, Journal of Mammalian Evolution, V6, P177, DOI 10.1023/A:1020624222324	19	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133314	10.1371/journal.pone.0133314	http://dx.doi.org/10.1371/journal.pone.0133314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186457	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700124
J	Lang, YH; Fu, FM; Sun, DL; Xi, CH; Chen, FY				Lang, Yuhuang; Fu, Fengming; Sun, Dalong; Xi, Chenhui; Chen, Fengyuan			Labetalol Prevents Intestinal Dysfunction Induced by Traumatic Brain Injury	PLOS ONE			English	Article							SEVERE HEAD-INJURY; TIGHT-JUNCTION; BARRIER FUNCTION; NERVOUS-SYSTEM; MAGUK PROTEIN; NITRIC-OXIDE; X-RECEPTOR; APOPTOSIS; ALPHA; RAT	Background Beta-adrenergic blockade has been hypothesized to have a protective effect on intestinal dysfunction and increased intestinal permeability associated with the epinephrine surge after traumatic brain injury (TBI). Methods Wister rats were subjected to either a weight drop TBI, and intraperitoneally injected or not with labetalol, or a sham procedure (18 rats per group). After 3, 6, or 12h (6 rats per subgroup), intestinal permeability to 4.4 kDa FITC-Dextran and plasma epinephrine levels were measured as was intestinal tight junction protein ZO-1 expression at 12h. Terminal ileum was harvested to measure levels of intestinal tumor necrosis factor (TNF)-alpha and to evaluate histopathology. Results In TBI group vs. sham group, intestinal permeability (P<0.01) was significantly higher at all time-points, and intestinal ZO-1 expression was lower at 12h. In TBI with vs. without labetalol group, 1) intestinal permeability was significantly lower at 6 and 12h (94.31 +/- 7.64 vs. 102.16 +/- 6.40 mu g/mL; 110.21 +/- 7.52 vs. 118.95 +/- 7.11 mu g/mL, respectively); 2) levels of plasma epinephrine and intestinal TNF-alpha were significantly lower at 3, 6 and 12h; and 3) intestinal ZO-1 expression was higher at 3, 6 and 12h (p=0.018). Histopathological evaluation showed that labetalol use preserved intestinal architecture throughout. Conclusion In a rat model of TBI, labetalol reduced TBI-induced sympathetic hyperactivity, and prevented histopathological intestinal injury accompanied by changes in gut permeability and gut TNF-alpha expression.	[Lang, Yuhuang; Xi, Chenhui] Fudan Univ, Shanghai Hosp Affiliated 5, Dept Emergency, Shanghai 200433, Peoples R China; [Fu, Fengming] Fudan Univ, Shanghai Canc Ctr, Intens Care Unit, Shanghai 200433, Peoples R China; [Sun, Dalong; Chen, Fengyuan] Fudan Univ, Shanghai Hosp Affiliated 5, Dept Gastroenterol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Chen, FY (corresponding author), Fudan Univ, Shanghai Hosp Affiliated 5, Dept Gastroenterol, Shanghai 200433, Peoples R China.	cfy429@163.com			Science and Technology Committee of Minhang District, Shanghai, China [2012MHZ013]	Science and Technology Committee of Minhang District, Shanghai, China	This work has been kindly supported by Grant 2012MHZ013 from the Science and Technology Committee of Minhang District, Shanghai, China.	Adachi M, 2006, MOL CELL BIOL, V26, P9003, DOI 10.1128/MCB.01811-05; Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Chavez AM, 1999, CRIT CARE MED, V27, P2246, DOI 10.1097/00003246-199910000-00030; Chen LW, 2003, ARCH SURG-CHICAGO, V138, P1219, DOI 10.1001/archsurg.138.11.1219; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Costantini TW, 2009, SHOCK, V31, P416, DOI 10.1097/SHK.0b013e3181863080; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; ELENKOV IJ, 1995, J NEUROIMMUNOL, V61, P123, DOI 10.1016/0165-5728(95)00080-L; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2007, J SURG RES, V137, P53, DOI 10.1016/j.jss.2006.06.026; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; He Q, 2014, CIRC-HEART FAIL, V7, P1032, DOI 10.1161/CIRCHEARTFAILURE.114.001260; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Jiang XW, 2011, J CARDIOVASC MED, V12, P732, DOI 10.2459/JCM.0b013e32834a6697; Johnson JD, 2005, J APPL PHYSIOL, V99, P1789, DOI 10.1152/japplphysiol.00390.2005; Lang YH, 2012, J TRAUMA SURG, V14, P51; MACCARTHY EP, 1983, PHARMACOTHERAPY, V3, P193; Maheras KJ, 2013, J NEUROSCI METH, V219, P61, DOI 10.1016/j.jneumeth.2013.07.004; McNeil JJ, 1979, BR J CLIN PHARM, V8, P157; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; MOREL DR, 1984, INTENS CARE MED, V10, P133, DOI 10.1007/BF00265802; Pedersen ME, 2007, CURR HYPERTENS REP, V9, P269, DOI 10.1007/s11906-007-0050-2; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Pu J, 2014, J AM COLL CARDIOL, V63, P2220, DOI 10.1016/j.jacc.2014.02.576; Pu J, 2013, EUR HEART J, V34, P1834, DOI 10.1093/eurheartj/ehs011; Pu J, 2012, EUR HEART J, V33, P372, DOI 10.1093/eurheartj/ehr387; Shan PR, 2008, BIOCHEM BIOPH RES CO, V375, P628, DOI 10.1016/j.bbrc.2008.08.074; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tong S, 2014, LAB ANIM SCI, V31, P52; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang YB, 2011, WORLD J GASTROENTERO, V17, P657, DOI 10.3748/wjg.v17.i5.657; Wang Yan-bin, 2010, Zhonghua Nei Ke Za Zhi, V49, P869; Yao TB, 2015, ANTIOXID REDOX SIGN, V22, P633, DOI 10.1089/ars.2014.5887; Zacharia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065969; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	49	11	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133215	10.1371/journal.pone.0133215	http://dx.doi.org/10.1371/journal.pone.0133215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186619	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700110
J	Lee, J; Kagamihara, Y; Kakei, S				Lee, Jongho; Kagamihara, Yasuhiro; Kakei, Shinji			A New Method for Functional Evaluation of Motor Commands in Patients with Cerebellar Ataxia	PLOS ONE			English	Article							MULTIJOINT ARM MOVEMENTS; TRACKING MOVEMENT; MANUAL TRACKING; FREQUENCY-RESPONSE; VOLUNTARY MOVEMENT; KINEMATIC ANALYSIS; ABNORMAL CONTROL; PURKINJE-CELLS; SOLEUS MUSCLE; HUMAN WRIST	Quantitative evaluation of motor functions of patients with cerebellar ataxia is vital for evidence-based treatments and has been a focus in previous investigations of movement kinematics. Due to redundancy of the musculoskeletal system, muscle activities contain more information than the movement kinematics. Therefore, it is preferable to analyze causal anomalies of muscle activities to evaluate motor functions in patients. Here we propose a new method to evaluate the motor functions at the level of muscle activities and movement kinematics. Nineteen patients and 10 control subjects performed two movement tasks of the wrist joint, a step-tracking task and a pursuit task, with a manipulandum. The movements of the wrist joint and activities of the four wrist prime movers were recorded. We developed a linear model for the wrist joint to approximate the causal relationship between muscle activities and movement kinematics in terms of the wrist joint torque. We used a canonical correlation analysis to verify the causality between the muscle activities and the movement kinematics in the model. We found that the activities of the four muscles were related almost entirely to the position and velocity, with negligible correlation with the acceleration of the wrist joint. Moreover, the ratio of the weights for position-and velocity-related torque components characterized the contents of the muscle activities in terms of the movement kinematics. Next, we compared the ratios for the two movement tasks between the controls and patients. In control subjects, the ratios indicated clear task-specific changes that conformed to the functional requirements of the tasks. In contrast, in patients, the task-specific changes diminished highly significantly. The present results indicate that this ability to accommodate motor commands to the task requirements provides a novel quantitative parameter to characterize motor functions in patients with cerebellar ataxia.	[Lee, Jongho; Kakei, Shinji] Tokyo Metropolitan Inst Med Sci, Movement Disorders Project, Tokyo 1568506, Japan; [Kagamihara, Yasuhiro] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Fuchu, Tokyo 1830042, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute for Neuroscience	Kakei, S (corresponding author), Tokyo Metropolitan Inst Med Sci, Movement Disorders Project, Tokyo 1568506, Japan.	kakei-sj@igakuken.or.jp		Kakei, Shinji/0000-0001-5111-5789	Tokyo Metropolitan Institute of Medical Science; Japan Science and Technology Agency (A-STEP); Ministry of Education, Culture, Sports, Science and Technology in Japan [14580784, 15016008, 16015212, 20033029, 21500319, 21700229, 24650304]	Tokyo Metropolitan Institute of Medical Science; Japan Science and Technology Agency (A-STEP); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Tokyo Metropolitan Institute of Medical Science and grants-in-aid from the Japan Science and Technology Agency (A-STEP) to SK (http://www.jst.go.jp/), from the Ministry of Education, Culture, Sports, Science and Technology in Japan (http://www.mext.go.jp/) (No. 14580784, No. 15016008, No. 16015212, No. 20033029, No. 21500319) to SK, and (No. 21700229, No. 24650304) to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAZAWA K, 1983, J NEUROPHYSIOL, V49, P16, DOI 10.1152/jn.1983.49.1.16; Alciatore DG, 2011, INTRO MECHATRONICS M, P139; Bastian AJ, 1996, J NEUROPHYSIOL, V76, P492, DOI 10.1152/jn.1996.76.1.492; Bastian AJ, 2000, J NEUROPHYSIOL, V83, P3019, DOI 10.1152/jn.2000.83.5.3019; BECKER JD, 1990, J BIOMECH ENG-T ASME, V112, P1, DOI 10.1115/1.2891121; BENNETT DJ, 1992, EXP BRAIN RES, V88, P433, DOI 10.1007/BF02259118; BEPPU H, 1984, BRAIN, V107, P787, DOI 10.1093/brain/107.3.787; Bonnefoi-Kyriacou B, 1998, EXP BRAIN RES, V119, P460, DOI 10.1007/s002210050361; Charles SK, 2011, J BIOMECH, V44, P614, DOI 10.1016/j.jbiomech.2010.11.016; Day BL, 1998, BRAIN, V121, P357, DOI 10.1093/brain/121.2.357; DESERRES SJ, 1991, EXP BRAIN RES, V86, P451, DOI 10.1007/BF00228972; DIENER HC, 1992, MOVEMENT DISORD, V7, P95, DOI 10.1002/mds.870070202; Engel KC, 2000, J NEUROPHYSIOL, V83, P3483, DOI 10.1152/jn.2000.83.6.3483; GIELEN CCAM, 1984, J NEUROPHYSIOL, V52, P553, DOI 10.1152/jn.1984.52.3.553; Grey MJ, 1997, THESIS S FRASER U BU, P51; Halaki M, 2006, J BIOMECH, V39, P2171, DOI 10.1016/j.jbiomech.2005.06.022; HALLETT M, 1975, J NEUROL NEUROSUR PS, V38, P1163, DOI 10.1136/jnnp.38.12.1163; Hardle W. K., 2003, APPL MULTIVARIATE ST, P321; Haruno M, 2005, J NEUROPHYSIOL, V94, P4244, DOI 10.1152/jn.00404.2005; Hewitt AL, 2011, J NEUROPHYSIOL, V106, P2232, DOI 10.1152/jn.00886.2010; HOFFER JA, 1981, J NEUROPHYSIOL, V45, P267, DOI 10.1152/jn.1981.45.2.267; Hoffman DS, 1999, J NEUROPHYSIOL, V81, P319, DOI 10.1152/jn.1999.81.1.319; Holmes G, 1939, BRAIN, V62, P1, DOI 10.1093/brain/62.1.1; Kakei S, 2003, NEUROSCI RES, V46, P1, DOI 10.1016/S0168-0102(03)00031-2; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KOIKE Y, 1995, BIOL CYBERN, V73, P291, DOI 10.1007/BF00199465; Lee J, 2012, CEREBELLUM, V11, P426, DOI 10.1007/s12311-012-0370-x; Lee J, 2008, IEEE ENG MED BIO, P181, DOI 10.1109/IEMBS.2008.4649120; MANNARD A, 1973, J PHYSIOL-LONDON, V229, P275, DOI 10.1113/jphysiol.1973.sp010138; MANO N, 1980, J NEUROPHYSIOL, V43, P713, DOI 10.1152/jn.1980.43.3.713; Manto M, 1996, EUR NEUROL, V36, P333, DOI 10.1159/000117289; Massaquoi S, 1996, CAN J NEUROL SCI, V23, P3, DOI 10.1017/S0317167100039123; Menegoni F, 2009, EUR J NEUROL, V16, P232, DOI 10.1111/j.1468-1331.2008.02396.x; MILNER TE, 1993, EXP BRAIN RES, V94, P522; Milner TE, 1998, EXP BRAIN RES, V122, P309, DOI 10.1007/s002210050519; Nakanishi R, 1992, Rinsho Shinkeigaku, V32, P251; Pasalar S, 2006, NAT NEUROSCI, V9, P1404, DOI 10.1038/nn1783; Rijnveld N, 2007, INT C REHAB ROBOT, P43, DOI 10.1109/ICORR.2007.4428404; Roitman AV, 2005, J NEUROSCI, V25, P9244, DOI 10.1523/JNEUROSCI.1886-05.2005; Roitman AV, 2004, J NEUROPHYSIOL, V91, P901, DOI 10.1152/jn.00261.2003; Sanguineti V, 2003, HUM MOVEMENT SCI, V22, P189, DOI 10.1016/S0167-9457(02)00159-8; Shin D, 2009, J NEUROPHYSIOL, V101, P387, DOI 10.1152/jn.00584.2007; SINKJAER T, 1989, J BIOMECH, V22, P1133, DOI 10.1016/0021-9290(89)90215-7; Staudenmann D, 2010, J ELECTROMYOGR KINES, V20, P375, DOI 10.1016/j.jelekin.2009.08.005; Topka H, 1998, EXP BRAIN RES, V119, P493, DOI 10.1007/s002210050365; Topka H, 1998, EXP BRAIN RES, V119, P483, DOI 10.1007/s002210050364	46	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132983	10.1371/journal.pone.0132983	http://dx.doi.org/10.1371/journal.pone.0132983			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186225	gold, Green Submitted, Green Published			2022-12-27	WOS:000358198700082
J	Suchow, JW				Suchow, Jordan W.			Building a Social Network One Choice at a Time	PLOS ONE			English	Article							PREFERENTIAL ATTACHMENT	Newcomers to a social network show preferential attachment, a tendency to befriend those with many friends. Here, we show that preferential attachment is equivalent to a form of 'probability matching' commonly found in studies of decision-making. This equivalence, whereby newcomers probability match to a social signal akin to popularity, marries network science to the study of decision-making and raises new questions about how individual psychology impacts the social structure of groups. We asked people to view a visualization of a social network and to select group members whom they would like to meet and befriend. People varied in how strongly they weighed popularity and this was mildly correlated with aspects of their personality. Individual differences in preferential attachment affect the structure and connectivity of the network that emerges.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	Suchow, JW (corresponding author), Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA.	suchow@post.harvard.edu						AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andrieu C, 2003, MACH LEARN, V50, P5, DOI 10.1023/A:1020281327116; Ashton MC, 2002, J PERS SOC PSYCHOL, V83, P245, DOI 10.1037//0022-3514.83.1.245; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Bostock M, 2011, IEEE T VIS COMPUT GR, V17, P2301, DOI 10.1109/TVCG.2011.185; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; D'Souza RM, 2007, EUR PHYS J B, V59, P535, DOI 10.1140/epjb/e2007-00310-5; Dereich S, 2009, ELECTRON J PROBAB, V14, P1222, DOI 10.1214/EJP.v14-647; ESTES WK, 1957, AM PSYCHOL, V12, P609, DOI 10.1037/h0046778; Gabel A, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/02/P02043; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Ipeirotis P., 2010, CEDER1001 NYU; Jeong H, 2003, EUROPHYS LETT, V61, P567, DOI 10.1209/epl/i2003-00166-9; Kobourov S. G., 2012, ARXIV12013011; Krapivsky PL, 2000, PHYS REV LETT, V85, P4629, DOI 10.1103/PhysRevLett.85.4629; Kumar R, 1999, PROCEEDINGS OF THE TWENTY-FIFTH INTERNATIONAL CONFERENCE ON VERY LARGE DATA BASES, P639; Luce R.D, 1959, INDIVIDUAL CHOICE BE; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.025102; Papadopoulos F, 2012, NATURE, V489, P537, DOI 10.1038/nature11459; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Ross Joel, 2010, P 28 INT C HUM FACT; Suchow JW, 2013, J VISION, V13, DOI 10.1167/13.10.9; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Vul E., 2009, P 31 ANN C COGN SCI; Vul E, 2010, THESIS MIT	29	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133463	10.1371/journal.pone.0133463	http://dx.doi.org/10.1371/journal.pone.0133463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186607	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700142
J	Gowthaman, R; Lyskov, S; Karanicolas, J				Gowthaman, Ragul; Lyskov, Sergey; Karanicolas, John			DARC 2.0: Improved Docking and Virtual Screening at Protein Interaction Sites	PLOS ONE			English	Article							CONFORMER GENERATION; SWARM OPTIMIZATION; SMALL MOLECULES; DRUG DISCOVERY; BINDING-SITES; TARGETS; INTERFACES; NETWORKS; CHALLENGES; INHIBITORS	Over the past decade, protein-protein interactions have emerged as attractive but challenging targets for therapeutic intervention using small molecules. Due to the relatively flat surfaces that typify protein interaction sites, modern virtual screening tools developed for optimal performance against "traditional" protein targets perform less well when applied instead at protein interaction sites. Previously, we described a docking method specifically catered to the shallow binding modes characteristic of small-molecule inhibitors of protein interaction sites. This method, called DARC (Docking Approach using Ray Casting), operates by comparing the topography of the protein surface when "viewed" from a vantage point inside the protein against the topography of a bound ligand when "viewed" from the same vantage point. Here, we present five key enhancements to DARC. First, we use multiple vantage points to more accurately determine protein-ligand surface complementarity. Second, we describe a new scheme for rapidly determining optimal weights in the DARC scoring function. Third, we incorporate sampling of ligand conformers "on-the-fly" during docking. Fourth, we move beyond simple shape complementarity and introduce a term in the scoring function to capture electrostatic complementarity. Finally, we adjust the control flow in our GPU implementation of DARC to achieve greater speedup of these calculations. At each step of this study, we evaluate the performance of DARC in a "pose recapitulation" experiment: predicting the binding mode of 25 inhibitors each solved in complex with its distinct target protein (a protein interaction site). Whereas the previous version of DARC docked only one of these inhibitors to within 2 angstrom RMSD of its position in the crystal structure, the newer version achieves this level of accuracy for 12 of the 25 complexes, corresponding to a statistically significant performance improvement (p < 0.001). Collectively then, we find that the five enhancements described here - which together make up DARC 2.0 - lead to dramatically improved speed and performance relative to the original DARC method.	[Gowthaman, Ragul; Karanicolas, John] Univ Kansas, Ctr Computat Biol, Lawrence, KS 66045 USA; [Lyskov, Sergey] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Karanicolas, John] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas; Johns Hopkins University; University of Kansas	Karanicolas, J (corresponding author), Univ Kansas, Ctr Computat Biol, 2030 Becker Dr, Lawrence, KS 66045 USA.	johnk@ku.edu		Gowthaman, Ragul/0000-0002-0008-6401	National Institute of General Medical Sciences of National Institutes of Health [R01GM099959]; National Science Foundation [MCB130049]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099959] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of National Institutes of Health; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of General Medical Sciences of the National Institutes of Health (R01GM099959) and by the National Science Foundation through XSEDE allocation MCB130049. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourgeas R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009598; Call ST, 2007, J COMPUT CHEM, V28, P1177, DOI 10.1002/jcc.20621; Chen HM, 2007, J COMPUT CHEM, V28, P612, DOI 10.1002/jcc.20542; Coleman RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075992; Cross JB, 2009, J CHEM INF MODEL, V49, P1455, DOI 10.1021/ci900056c; Damm-Ganamet KL, 2013, J CHEM INF MODEL, V53, P1853, DOI 10.1021/ci400025f; Fuller JC, 2009, DRUG DISCOV TODAY, V14, P155, DOI 10.1016/j.drudis.2008.10.009; Gonzalez MW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002819; Gordo S, 2009, PROTEIN SCI, V18, P481, DOI 10.1002/pro.43; Gowthaman R, 2015, J MED CHEM FORTHCOMI; Gowthaman R, 2013, J CHEM INF MODEL, V53, P2073, DOI 10.1021/ci4002316; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Higueruelo AP, 2009, CHEM BIOL DRUG DES, V74, P457, DOI 10.1111/j.1747-0285.2009.00889.x; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Ivanov AA, 2013, TRENDS PHARMACOL SCI, V34, P393, DOI 10.1016/j.tips.2013.04.007; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Johnson DK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002951; Kennedy JER, 1995, PROCEEDINGS OF THE I; Khar KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070661; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Liu Y, 2013, J COMPUT CHEM, V34, P67, DOI 10.1002/jcc.23108; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Makley LN, 2013, CHEM BIOL DRUG DES, V81, P22, DOI 10.1111/cbdd.12066; McCoy AJ, 1997, J MOL BIOL, V268, P570, DOI 10.1006/jmbi.1997.0987; McGann M, 2011, J CHEM INF MODEL, V51, P578, DOI 10.1021/ci100436p; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mukherjee S, 2010, J CHEM INF MODEL, V50, P1986, DOI 10.1021/ci1001982; Namasivayam V, 2007, CHEM BIOL DRUG DES, V70, P475, DOI 10.1111/j.1747-0285.2007.00588.x; Nero TL, 2014, NAT REV CANCER, V14, P248, DOI 10.1038/nrc3690; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; R Core Team, 2014, R A LANGUAGE AND ENV; Sevimoglu T, 2014, COMPUT STRUCT BIOTEC, V11, P22, DOI 10.1016/j.csbj.2014.08.008; Smith MC, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.10; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Villoutreix BO, 2014, MOL INFORM, V33, P414, DOI 10.1002/minf.201400040; Voet A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075762; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; White Alex W., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000641; Zinzalla G, 2009, FUTURE MED CHEM, V1, P65, DOI [10.4155/fmc.09.12, 10.4155/FMC.09.12]	47	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0131612	10.1371/journal.pone.0131612	http://dx.doi.org/10.1371/journal.pone.0131612			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181386	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198200008
J	Huang, XB; Kanwal, JS; Jiang, TL; Long, ZY; Luo, B; Yue, XK; Gu, YB; Feng, J				Huang, Xiaobin; Kanwal, Jagmeet S.; Jiang, Tinglei; Long, Zhenyu; Luo, Bo; Yue, Xinke; Gu, Yongbo; Feng, Jiang			Situational and Age-Dependent Decision Making during Life Threatening Distress in Myotis macrodactylus	PLOS ONE			English	Article							PREDATION-RISK; ESCAPE BEHAVIOR; MOUSTACHED BAT; DEFENSIVE BEHAVIOR; AUDITORY-CORTEX; CALLS; RESPONSES; ECHOLOCATION; COMMUNICATION; CONSPECIFICS	Echolocation and audiovocal communication have been studied extensively in bats. The manner in which these abilities are incorporated within escape behaviors during life-threatening distress is largely unknown. Here we tested the hypothesis that behavioral response profiles expressed during distress are relatively stereotypic given their evolutionary adaptations to avoid predators. We subjected juvenile and adult big-footed myotis (Myotis macrodactylus) to a sequence of three types of life threatening distress: 1) trapping them in a mist-net (environmental threat), 2) approaching them when trapped (predator threat), and 3) partially restraining their freedom to move (arrest), and recorded their escape behavior in each of the three conditions. Response profiles differed across individuals and with the context in which they were expressed. During environmental and predator threat, bats displayed significantly more biting and wing-flapping behaviors and emitted more echolocation pulses than during arrest. Response profiles also varied with age. During arrest, juveniles were more likely than adults to emit distress calls and vice-versa for biting and wing flapping during environmental and predator threat. Overall, individualized response profiles were classified into ten clusters that were aligned along two divergent response trajectories when viewed within two-dimensional, multifactorial decision space. Juvenile behaviors tended to follow a predominantly "social-dependence" trajectory, whereas adult behaviors were mostly aligned along a "self-reliance" trajectory. We conclude that bats modify their vocal behavior and make age-appropriate and contextually adaptive decisions when distressed. This decision-making ability is consistent with observations in other social species, including humans.	[Huang, Xiaobin; Jiang, Tinglei; Long, Zhenyu; Luo, Bo; Yue, Xinke; Gu, Yongbo; Feng, Jiang] NE Normal Univ, Jilin Prov Key Lab Anim Resource Conservat & Util, Changchun, Peoples R China; [Huang, Xiaobin; Jiang, Tinglei; Long, Zhenyu; Luo, Bo; Yue, Xinke; Gu, Yongbo; Feng, Jiang] NE Normal Univ, Key Lab Wetland Ecol & Vegetat Restorat Natl Envi, Changchun, Peoples R China; [Kanwal, Jagmeet S.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA; [Kanwal, Jagmeet S.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Kanwal, Jagmeet S.] Georgetown Univ, Med Ctr, Dept Psychol, Washington, DC 20007 USA	Northeast Normal University - China; Northeast Normal University - China; Georgetown University; Georgetown University; Georgetown University	Jiang, TL (corresponding author), NE Normal Univ, Jilin Prov Key Lab Anim Resource Conservat & Util, Changchun, Peoples R China.	jiangtl730@nenu.edu.cn; fengj@nenu.edu.cn	Jiang, Tinglei/GQQ-9485-2022; Kanwal, Jagmeet S./D-2145-2009	Kanwal, Jagmeet S./0000-0002-4529-3631	National Natural Science Foundation of China [31030011, 31470457, 31100280]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China (grant no. 31030011, 31470457, 31100280). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya L, 1999, CAN J ZOOL, V77, P27, DOI 10.1139/cjz-77-1-27; AUGUST PV, 1985, SOUTHWEST NAT, V30, P371, DOI 10.2307/3671269; Baxter DJM, 2006, ETHOLOGY, V112, P977, DOI 10.1111/j.1439-0310.2006.01249.x; Bernard JF, 1998, J COMP NEUROL, V401, P429; Boyles JG, 2007, BEHAVIOUR, V144, P1019, DOI 10.1163/156853907781871806; Branch CL, 2012, BEHAV ECOL, V23, P854, DOI 10.1093/beheco/ars041; Branstetter BK, 2010, J ACOUST SOC AM, V128, P2484; Breviglieri CPB, 2013, OECOLOGIA, V173, P905, DOI 10.1007/s00442-013-2677-9; Brunet-Rossinni Anja K., 2009, P315; BURGER J, 1990, J COMP PSYCHOL, V104, P388, DOI 10.1037/0735-7036.104.4.388; Casar C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0535; Chelini MC, 2009, BEHAV PROCESS, V82, P153, DOI 10.1016/j.beproc.2009.06.001; Conner WE, 2012, ANNU REV ENTOMOL, V57, P21, DOI 10.1146/annurev-ento-121510-133537; CONOVER MR, 1994, BEHAVIOUR, V131, P19, DOI 10.1163/156853994X00190; Cooper WE, 2009, AMPHIBIA-REPTILIA, V30, P99, DOI 10.1163/156853809787392720; Creel S, 2014, BEHAV ECOL, V25, P773, DOI 10.1093/beheco/aru050; de Barros FC, 2010, ANIM BEHAV, V79, P83, DOI 10.1016/j.anbehav.2009.10.006; DEAR SP, 1995, J NEUROPHYSIOL, V73, P1084, DOI 10.1152/jn.1995.73.3.1084; Dechmann DN, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00066; DILL LM, 1990, OECOLOGIA, V83, P473, DOI 10.1007/BF00317197; Edelaar P, 2012, BEHAV ECOL, V23, P619, DOI 10.1093/beheco/ars006; Edut S, 2004, BEHAV BRAIN RES, V155, P207, DOI 10.1016/j.bbr.2004.04.018; Ellis JMS, 2008, ETHOLOGY, V114, P154, DOI 10.1111/j.1439-0310.2007.01439.x; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; FENTON MB, 1979, CAN J ZOOL, V57, P1271, DOI 10.1139/z79-163; Ferrara FJ, 2005, J MAMMAL, V86, P729, DOI 10.1644/1545-1542(2005)086[0729:COPSBD]2.0.CO;2; Floresco SB, 2007, CEREB CORTEX, V17, P251, DOI 10.1093/cercor/bhj143; Frid A, 2002, CONSERV ECOL, V6; Ganesh A, 2010, J COMP PHYSIOL A, V196, P155, DOI 10.1007/s00359-009-0502-z; Goerlitz HR, 2010, CURR BIOL, V20, P1568, DOI 10.1016/j.cub.2010.07.046; Gregory PT, 2008, ETHOLOGY, V114, P768, DOI 10.1111/j.1439-0310.2008.01524.x; Gregory PT, 2007, J COMP PSYCHOL, V121, P123, DOI 10.1037/0735-7036.121.2.123; Griesser M, 2008, CURR BIOL, V18, P69, DOI 10.1016/j.cub.2007.11.069; Henderson LE, 2008, J MAMMAL, V89, P952, DOI 10.1644/07-MAMM-A-214.1; Honma A, 2006, P ROY SOC B-BIOL SCI, V273, P1631, DOI 10.1098/rspb.2006.3501; Jiang Ting-Lei, 2008, Acta Zootaxonomica Sinica, V33, P212; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; KANWAL JS, 1994, J ACOUST SOC AM, V96, P1229, DOI 10.1121/1.410273; KLUMP GM, 1984, Z TIERPSYCHOL, V66, P189; KOENIG WD, 1991, CONDOR, V93, P637, DOI 10.2307/1368195; Krama T, 2005, BEHAV ECOL, V16, P37, DOI 10.1093/beheco/arh116; Kunz TH, 2006, BAT ECOLOGY; Laiolo P, 2004, P ROY SOC B-BIOL SCI, V271, pS513, DOI 10.1098/rsbl.2004.0239; Lamprea MR, 2002, BRAIN RES, V950, P186, DOI 10.1016/S0006-8993(02)03036-6; Landova E, 2013, BEHAV ECOL SOCIOBIOL, V67, P1113, DOI 10.1007/s00265-013-1536-3; LEAL M, 1995, COPEIA, P155; Lienart GDH, 2014, ANIM BEHAV, V89, P199, DOI 10.1016/j.anbehav.2013.12.031; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lima SL, 2013, BIOL REV, V88, P626, DOI 10.1111/brv.12021; Liu Y, 2009, ACTA CHIROPTEROL, V11, P105, DOI 10.3161/150811009X465721; Ma J, 2006, J COMP PHYSIOL A, V192, P535, DOI 10.1007/s00359-006-0094-9; Ma J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00055; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; Marko Gabor, 2013, Ornis Hungarica, V21, P12; Martin J, 2005, CAN J ZOOL, V83, P1189, DOI 10.1139/Z05-114; Michelena P, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016014, 10.1371/journal.pone.0018631]; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; Miyatake T, 2004, P ROY SOC B-BIOL SCI, V271, P2293, DOI 10.1098/rspb.2004.2858; NORRIS RA, 1965, BIRD BANDING, V36, P83, DOI 10.2307/4511148; OLSEN JF, 1991, J NEUROPHYSIOL, V65, P1254, DOI 10.1152/jn.1991.65.6.1254; Palmer CR, 2011, CURR OPIN NEUROBIOL, V21, P520, DOI 10.1016/j.conb.2011.05.003; Pascual J, 2014, ANIM BEHAV, V90, P297, DOI 10.1016/j.anbehav.2014.02.002; PERRONE M, 1980, WILSON BULL, V92, P404; Prescott T. J., 2008, SCHOLARPEDIA, V3, P2705, DOI DOI 10.4249/SCHOLARPEDIA.2705; Rajala M, 2012, IBIS, V154, P189, DOI 10.1111/j.1474-919X.2011.01188.x; Ratcliffe JM, 2005, BEHAV ECOL SOCIOBIOL, V58, P157, DOI 10.1007/s00265-005-0912-z; Russ JM, 2004, ANIM BEHAV, V67, P1005, DOI 10.1016/j.anbehav.2003.09.003; Russ JM, 1998, ANIM BEHAV, V55, P705, DOI 10.1006/anbe.1997.0665; Russo D, 2011, MAMM BIOL, V76, P87, DOI 10.1016/j.mambio.2009.08.002; SCHNITZLER HU, 1987, J COMP PHYSIOL A, V161, P267, DOI 10.1007/BF00615246; Segalowitz SJ, 2004, BRAIN COGNITION, V55, P116, DOI 10.1016/s0278-2626(03)00283-5; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; SUGA N, 1987, J NEUROPHYSIOL, V58, P643, DOI 10.1152/jn.1987.58.4.643; SUGA N, 1986, J NEUROPHYSIOL, V55, P776, DOI 10.1152/jn.1986.55.4.776; Suga N, 1995, HDB BRAIN THEORY NEU, P344; Ulanovsky N, 2008, P NATL ACAD SCI USA, V105, P8491, DOI 10.1073/pnas.0703550105; Wang L, 2014, ACTA THERIOL, V59, P435, DOI 10.1007/s13364-014-0182-0; Wheeler BC, 2008, ANIM BEHAV, V76, P1465, DOI 10.1016/j.anbehav.2008.06.023; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Zimmer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018977	81	11	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132817	10.1371/journal.pone.0132817	http://dx.doi.org/10.1371/journal.pone.0132817			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RQ	26181328	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198200037
J	Braun, DL; Rauch, A; Aouri, M; Durisch, N; Eberhard, N; Anagnostopoulos, A; Ledergerber, B; Mullhaupt, B; Metzner, KJ; Decosterd, L; Boni, J; Weber, R; Fehr, J				Braun, Dominique L.; Rauch, Andri; Aouri, Manel; Durisch, Nina; Eberhard, Nadia; Anagnostopoulos, Alexia; Ledergerber, Bruno; Muellhaupt, Beat; Metzner, Karin J.; Decosterd, Laurent; Boeni, Juerg; Weber, Rainer; Fehr, Jan		Swiss HIV Cohort Study	A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients	PLOS ONE			English	Article							GENOTYPE 1 INFECTION; HEPATITIS-C; TREATMENT FAILURE; OPEN-LABEL; TELAPREVIR; SOFOSBUVIR; PHARMACOKINETICS; RETREATMENT; RESISTANCE; LEDIPASVIR	Background The efficacy of first-generation protease inhibitor based triple-therapy against hepatitis C virus (HCV) infection is limited in HIV/HCV-coinfected patients with advanced liver fibrosis and non-response to previous peginterferon-ribavirin. These patients have a low chance of achieving a sustained virologic response (SVR) using first generation triple-therapy, with a success rate of only 20%. We investigated the efficacy and safety of lead-in therapy with intravenous silibinin followed by triple-therapy in this difficult-to-treat patient group. Methodology Inclusion criteria were HIV/HCV coinfection with advanced liver fibrosis and documented previous treatment failure on peginterferon-ribavirin. The intervention was a lead-in therapy with intravenous silibinin 20 mg/kg/day for 14 days, followed by triple-therapy (peginterferon- ribavirin and telaprevir) for 12 weeks, and peginterferon-ribavirin alone for 36 weeks. Outcome measurements were HCV-RNA after silibinin lead-in and during triple-therapy, SVR data at week 12, and safety and tolerability of silibinin. Results We examined sixteen HIV/HCV-coinfected patients with previous peginterferon-ribavirin failure, of whom 14 had a fibrosis grade METAVIR >= F3. All were on successful antiretroviral therapy. Median (IQR) HCV-RNA decline after silibinin therapy was 2.65 (2.1-2.8) log10 copies/mL. Fifteen of sixteen patients (94%) had undetectable HCV RNA at weeks 4 and 12, eleven patients (69%) showed end-of-treatment response (i.e., undetectable HCV-RNA at week 48), and ten patients (63%) reached SVR at week 12 (SVR 12). Six of the sixteen patients (37%) did not reach SVR 12: One patient had rapid virologic response (RVR) (i.e., undetectable HCV-RNA at week 4) but stopped treatment at week 8 due to major depression. Five patients had RVR, but experienced viral breakthroughs at week 21, 22, 25, or 32, or a relapse at week 52. The HIV RNA remained below the limit of detection in all patients during the complete treatment period. No serious adverse events and no significant drug-drug interactions were associated with silibinin. Conclusion A lead-in with silibinin before triple-therapy was safe and highly effective in difficult-to-treat HIV/HCV coinfected patients, with a pronounced HCV-RNA decline during the lead-in phase, which translates into 63% SVR. An add-on of intravenous silibinin to standard of care HCV treatment is worth further exploration in selected difficult-to-treat patients.	[Braun, Dominique L.; Durisch, Nina; Eberhard, Nadia; Anagnostopoulos, Alexia; Ledergerber, Bruno; Metzner, Karin J.; Weber, Rainer; Fehr, Jan] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Braun, Dominique L.; Metzner, Karin J.] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Rauch, Andri] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland; [Rauch, Andri] Univ Bern, Bern, Switzerland; [Aouri, Manel; Decosterd, Laurent] Univ Lausanne, Div Clin Pharmacol, Univ Hosp Ctr, Lausanne, Switzerland; [Muellhaupt, Beat] Univ Zurich, Univ Zurich Hosp, Clin Gastroenterol & Hepatol, Zurich, Switzerland; [Boeni, Juerg] Univ Zurich, Inst Med Virol, Swiss Natl Ctr Retroviruses, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Bern; University Hospital of Bern; University of Bern; University of Lausanne; University of Zurich; University Zurich Hospital; University of Zurich	Braun, DL (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	dominique.braun@usz.ch; jan.fehr@usz.ch	Boeni, Juerg/B-8386-2015; Metzner, Karin J/G-5319-2011; Fehr, Jan S/V-7499-2017; Weber, Rainer/D-5175-2012; Anagnostopoulos, Alexia/D-3687-2018; Ledergerber, Bruno/B-5656-2009; Rauch, Andri/E-9948-2017; Decosterd, Laurent/E-8494-2019; Mullhaupt, Beat/O-3744-2016; Kouyos, Roger/G-6226-2014	Metzner, Karin J/0000-0003-4862-1503; Fehr, Jan S/0000-0003-1113-9895; Anagnostopoulos, Alexia/0000-0001-6197-3023; Ledergerber, Bruno/0000-0002-6881-4401; Rauch, Andri/0000-0001-5297-6062; Decosterd, Laurent/0000-0002-9840-1325; Mullhaupt, Beat/0000-0002-9020-8192; Kouyos, Roger/0000-0002-9220-8348; TARR, Philip/0000-0002-1488-5407; Egger, Matthias/0000-0001-7462-5132; Braun, Dominique Laurent/0000-0003-4036-1030	Swiss National Science Foundation [33CS30_134277, 688]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study has been conducted within the framework of the Swiss HIV Cohort Study (SHCS), which is funded by the Swiss National Science Foundation (grant number 33CS30_134277, SHCS project 688). The investigational medicine product was provided by Rottapharm vertical bar Madaus. The members of the Swiss HIV Cohort Study are: Aubert V, Barth J, Battegay M, Bernasconi E, Boni J, Bucher HC, Burton-Jeangros C, Calmy A, Cavassini M, Egger M, Elzi L, Fehr J, Fellay J, Furrer H (Chairman of the Clinical and Laboratory Committee), Fux CA, Gorgievski M, Gunthard H (President of the SHCS), Haerry D (deputy of "Positive Council"), Hasse B, Hirsch HH, Hosli I, Kahlert C, Kaiser L, Keiser O, Klimkait T, Kouyos R, Kovari H, Ledergerber B, Martinetti G, Martinez de Tejada B, Metzner K, Muller N, Nadal D, Pantaleo G, Rauch A (Chairman of the Scientific Board), Regenass S, Rickenbach M (Head of Data Center), Rudin C (Chairman of the Mother & Child Substudy), Schoni-Affolter F, Schmid P, Schultze D, Schupbach J, Speck R, Tarr P, Telenti A, Trkola A, Vernazza P, Weber R, Yerly S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Ahmed-Belcacem H, 2014, 2 SIL WORKSH MAY 23; [Anonymous], 2013, GUID US ANT AG HIV 1; Arab-Alameddine M, 2014, J ANTIMICROB CHEMOTH, V69, P2489, DOI 10.1093/jac/dku131; Berg T, 2011, 62 ANN M AASLD SAN F; Bichoupan K, 2014, CURR HIV AIDS REP; Blaising J, 2014, 2 SIL WORKSH MAY 23; Braun DL, 2014, HIV MED, V15, P625, DOI 10.1111/hiv.12166; Colombo S, 2006, ANTIMICROB AGENTS CH, V50, P3801, DOI 10.1128/AAC.00098-06; De Meyer S, 2012, HEPATOLOGY, V56, P2106, DOI 10.1002/hep.25962; Dienstag JL, 2011, HEPATOLOGY, V54, P396, DOI 10.1002/hep.24370; Fayet A, 2009, J CHROMATOGR B, V877, P1057, DOI 10.1016/j.jchromb.2009.02.057; Feeney ER, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3308; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Karageorgopoulos DE, 2014, CURR OPIN INFECT DIS, V27, P36, DOI 10.1097/QCO.0000000000000034; Lawitz E, 2014, LANCET; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lubomirov R, 2013, PHARMACOGENET GENOM, V23, P9, DOI 10.1097/FPC.0b013e32835ade82; Martinot-Peignoux M, 2010, HEPATOLOGY, V51, P1122, DOI 10.1002/hep.23444; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Miailhes P, 2013, C EUR AIDS CLIN SOC; Molto J, 2012, ANTIMICROB AGENTS CH, V56, P2837, DOI 10.1128/AAC.00025-12; Osinusi A, 2014, ANN INTERN MED, V161, P634, DOI 10.7326/M14-1211; Polyak S, 2014, 2 SIL WORKSH MAY 23; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poveda E, 2014, ANTIVIR RES, V108, P181, DOI 10.1016/j.antiviral.2014.05.015; Sala F, 2014, J CHROMATOGR B, V945, P1, DOI 10.1016/j.jchromb.2013.11.028; Solhi H, 2014, CASP J INTERN MED, V5, P9; Sulkowski MS, 2014, J HEPATOL, V61, pS108, DOI 10.1016/j.jhep.2014.08.006; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Vargas-Mendoza N, 2014, WORLD J HEPATOL, V6, P144, DOI 10.4254/wjh.v6.i3.144; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	32	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133028	10.1371/journal.pone.0133028	http://dx.doi.org/10.1371/journal.pone.0133028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176696	Green Published, gold, Green Accepted			2022-12-27	WOS:000358197600203
J	Chen, HJ; Chen, CL; Hsieh, HL				Chen, Huai-Ju; Chen, Cheng-Ling; Hsieh, Hsu-Liang			Far-Red Light-Mediated Seedling Development in Arabidopsis Involves FAR-RED INSENSITIVE 219/JASMONATE RESISTANT 1-Dependent and -Independent Pathways	PLOS ONE			English	Article							HELIX TRANSCRIPTION FACTOR; JASMONIC ACID; PLANT-GROWTH; LAND PLANTS; DEFENSE; GENES; MYC2; PHYTOCHROME; MECHANISM; RESPONSES	Plant growth and development is often regulated by the interaction of environmental factors such as light and various phytohormones. Arabidopsis FAR-RED INSENSITIVE 219 (FIN219)/JASMONATE RESISTANT 1 (JAR1) participates in phytochrome A-mediated far-red (FR) light signaling and interacts with different light signaling regulators. FIN219/JAR1 is a jasmonic acid (JA)-conjugating enzyme responsible for the formation of JA-isoleucine. However, how FIN219/JAR1 integrates FR light and JA signaling remains largely unknown. We used a microarray approach to dissect the effect of fin219 mutation on the interaction of FR light and JA signaling. The fin219-2 mutant was less sensitive than the wild type to various concentrations of methyl jasmonate (MeJA) under low and high FR light. High FR light reduced the sensitivity of Arabidopsis seedlings to MeJA likely through FIN219. Intriguingly, in response to MeJA, FIN219 levels showed a negative feedback regulation. Further microarray assay revealed that FR light could regulate gene expression by FIN219-dependent or-independent pathways. The expression profiles affected in fin219-2 indicated that FIN219/JAR1 plays a critical role in the integration of multiple hormone-related signaling. In particular, FIN219 regulates a number of transcription factors (TFs), including 94 basic helix-loophelix (bHLH) TFs, in response to FR light and MeJA. Loss-of-function mutants of some bHLH TFs affected by FIN219 showed altered responses to MeJA in the regulation of hypocotyl and root elongation. Thus, FIN219/JAR1 is tightly regulated in response to exogenous MeJA. It also interacts with multiple plant hormones to modulate hypocotyl and root elongation of Arabidopsis seedlings likely by regulating a group of TFs.	[Chen, Huai-Ju; Chen, Cheng-Ling; Hsieh, Hsu-Liang] Natl Taiwan Univ, Inst Plant Biol, Coll Life Sci, Taipei 106, Taiwan	National Taiwan University	Hsieh, HL (corresponding author), Natl Taiwan Univ, Inst Plant Biol, Coll Life Sci, Taipei 106, Taiwan.	hlhsieh@ntu.edu.tw		Hsieh, Hsu-Liang/0000-0003-3201-3677	National Science Council, Taiwan [NSC 100-2811-B-002-100, NSC 99-2311-B-002-001, NSC 101-2311-B-002-002-MY3]; Excellence Research Program of National Taiwan University [97R0061-03]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Excellence Research Program of National Taiwan University(National Taiwan University)	H.J.C. is a postdoc fellow supported by the National Science Council, Taiwan (NSC 100-2811-B-002-100). This work was supported by the National Science Council, Taiwan (NSC 99-2311-B-002-001 & NSC 101-2311-B-002-002-MY3) and Excellence Research Program of National Taiwan University (97R0061-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Alabadi D, 2009, PLANT MOL BIOL, V69, P409, DOI 10.1007/s11103-008-9400-y; BERGER S, 1995, PLANT MOL BIOL, V27, P933, DOI 10.1007/BF00037021; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Bruex A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002446; Cerrudo I, 2012, PLANT PHYSIOL, V158, P2042, DOI 10.1104/pp.112.193359; Chen IC, 2007, PLANT PHYSIOL, V143, P1189, DOI 10.1104/pp.106.094185; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Collados R, 2006, FEBS LETT, V580, P4934, DOI 10.1016/j.febslet.2006.07.087; De Geyter N, 2012, TRENDS PLANT SCI, V17, P349, DOI 10.1016/j.tplants.2012.03.001; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Gremski K, 2007, DEVELOPMENT, V134, P3593, DOI 10.1242/dev.011510; Hong GJ, 2012, PLANT CELL, V24, P2635, DOI 10.1105/tpc.112.098749; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; Jang G, 2011, DEVELOPMENT, V138, P2273, DOI 10.1242/dev.060582; Jin J, 2011, PLANT J, V65, P319, DOI 10.1111/j.1365-313X.2010.04424.x; Katsir L, 2008, CURR OPIN PLANT BIOL, V11, P428, DOI 10.1016/j.pbi.2008.05.004; Kazan K, 2011, J EXP BOT, V62, P4087, DOI 10.1093/jxb/err142; Lau OS, 2010, CURR OPIN PLANT BIOL, V13, P571, DOI 10.1016/j.pbi.2010.07.001; Laudert D, 1998, PLANT J, V15, P675, DOI 10.1046/j.1365-313x.1998.00245.x; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; Menand B, 2007, SCIENCE, V316, P1477, DOI 10.1126/science.1142618; Moreno JE, 2009, P NATL ACAD SCI USA, V106, P4935, DOI 10.1073/pnas.0900701106; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Robson F, 2010, PLANT CELL, V22, P1143, DOI 10.1105/tpc.109.067728; Routaboul JM, 2012, J EXP BOT, V63, P1435, DOI 10.1093/jxb/err381; Sambrook J, 2001, SDS POYLACRYLAMIDE G; Shan XY, 2012, CURR OPIN PLANT BIOL, V15, P84, DOI 10.1016/j.pbi.2011.09.006; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shin J, 2012, PLANT CELL, V24, P2470, DOI 10.1105/tpc.111.095430; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Stelmach BA, 1999, PHYTOCHEMISTRY, V51, P187, DOI 10.1016/S0031-9422(99)00017-5; Stenzel I, 2003, PLANT J, V33, P577, DOI 10.1046/j.1365-313X.2003.01647.x; Stenzel I, 2012, J EXP BOT, V63, P6125, DOI 10.1093/jxb/ers261; Suzuki A, 2011, P NATL ACAD SCI USA, V108, P16837, DOI 10.1073/pnas.1105892108; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Vanstraelen M, 2012, ANNU REV CELL DEV BI, V28, P463, DOI 10.1146/annurev-cellbio-101011-155741; Wang JG, 2011, PLANT PHYSIOL, V156, P631, DOI 10.1104/pp.111.177667; Yadav V, 2005, PLANT CELL, V17, P1953, DOI 10.1105/tpc.105.032060; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yang DL, 2012, P NATL ACAD SCI USA, V105, P7100; Zhai QZ, 2007, PLANT CELL PHYSIOL, V48, P1061, DOI 10.1093/pcp/pcm076; Zhu CH, 2006, J EXP BOT, V57, P1299, DOI 10.1093/jxb/erj103; Zhu ZQ, 2011, P NATL ACAD SCI USA, V108, P12539, DOI 10.1073/pnas.1103959108	52	1	1	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132723	10.1371/journal.pone.0132723	http://dx.doi.org/10.1371/journal.pone.0132723			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176841	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600145
J	Jiang, SH; Zou, ZZ; Nie, PP; Wen, RL; Xiao, YY; Tang, J				Jiang, Suhua; Zou, Zhengzhi; Nie, Peipei; Wen, Ruiling; Xiao, Yingying; Tang, Jun			Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells	PLOS ONE			English	Article							TUMOR METABOLISM; MAMMALIAN TARGET; UP-REGULATION; CANCER; AUTOPHAGY; AKT; PHOSPHORYLATION; PATHWAY; KINASE; RICTOR	Cancer metabolism has greatly interested researchers. Mammalian target of rapamycin (mTOR) is dysregulated in a variety of cancers and considered to be an appealing therapeutic target. It has been proven that growth factor signal, mediated by mTOR complex 1 (mTORC1), drives cancer metabolism by regulating key enzymes in metabolic pathways. However, the role of mTORC2 in cancer metabolism has not been thoroughly investigated. In this study, by employing automated spectrophotometry, we found the level of glucose uptake was decreased in non-small-cell lung carcinoma (NSCLC) A549, PC-9 and SK-MES- 1 cells treated with rapamycin or siRNA against Raptor, indicating that the inhibition of mTORC1 attenuated glycolytic metabolism in NSCLC cells. Moreover, the inhibition of AKT reduced glucose uptake in the cells as well, suggesting the involvement of AKT pathway in mTORC1 mediated glycolytic metabolism. Furthermore, our results showed a significant decrease in glucose uptake in rictor down-regulated NSCLC cells, implying a critical role of mTORC2 in NSCLC cell glycolysis. In addition, the experiments for MTT, ATP, and clonogenic assays demonstrated a reduction in cell proliferation, cell viability, and colony forming ability in mTOR inhibiting NSCLC cells. Interestingly, the combined application of mTORC1/2 inhibitors and glycolysis inhibitor not only suppressed the cell proliferation and colony formation, but also induced cell apoptosis, and such an effect of the combined application was stronger than that caused by mTORC1/2 inhibitors alone. In conclusion, this study reports a novel effect of mTORC2 on NSCLC cell metabolism, and reveals the synergistic effects between mTOR complex 1/2 and glycolysis inhibitors, suggesting that the combined application of mTORC1/2 and glycolysis inhibitors may be a new promising approach to treat NSCLC.	[Jiang, Suhua] Guangzhou Med Univ, Affiliated Hosp 2, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Zou, Zhengzhi; Nie, Peipei; Wen, Ruiling; Xiao, Yingying; Tang, Jun] Guangzhou Med Univ, KingMed Diagnost, Guangzhou, Guangdong, Peoples R China; [Zou, Zhengzhi; Nie, Peipei; Wen, Ruiling; Xiao, Yingying; Tang, Jun] Guangzhou Med Univ, KingMed Sch Lab Med, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Tang, J (corresponding author), Guangzhou Med Univ, KingMed Diagnost, Guangzhou, Guangdong, Peoples R China.	jtanguc@gmail.com			Medical Science Research Grant of Guangdong Province [A2010248]; Science and Information Technology Bureau of Guangzhou [2011Y1-00022, [2012]224-8]; Science and Information Technology Bureau of Guangzhou Haizhu District grant [2012-ZD-02]	Medical Science Research Grant of Guangdong Province; Science and Information Technology Bureau of Guangzhou; Science and Information Technology Bureau of Guangzhou Haizhu District grant	This work was supported by the Medical Science Research Grant of Guangdong Province (A2010248, to S. Jiang), http://www.gdwst.gov.cn/; the Science and Information Technology Bureau of Guangzhou (2011Y1-00022 and [2012]224-8, to J. Tang), http://www.gzsi.gov.cn/; and the Science and Information Technology Bureau of Guangzhou Haizhu District grant (2012-ZD-02, to J. Tang), http:// www.hzkxj.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birsoy K, 2012, NAT MED, V18, P1022, DOI 10.1038/nm.2870; Blagosklonny MV, 2013, AUTOPHAGY, V9, P260, DOI 10.4161/auto.22783; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Crazzolara R, 2009, AUTOPHAGY, V5, P727, DOI 10.4161/auto.5.5.8507; de Mattos SF, 2000, BIOCHEM J, V349, P59; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Esen E, 2013, CELL METAB, V17, P745, DOI 10.1016/j.cmet.2013.03.017; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gridelli C, 2008, ONCOLOGIST, V13, P139, DOI 10.1634/theoncologist.2007-0171; Guerra JLL, 2013, ANN ONCOL, V24, P67, DOI 10.1093/annonc/mds274; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Heesom KJ, 1999, FEBS LETT, V457, P489, DOI 10.1016/S0014-5793(99)01094-7; Hsu PP, 2008, CANC CELL METABOLISM; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Li W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064924; Liu LL, 2013, MOL CANCER RES, V11, P1326, DOI 10.1158/1541-7786.MCR-13-0172; Lou YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097719; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sattler UGA, 2010, CURR MED CHEM, V17, P96, DOI 10.2174/092986710790112657; Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Sini P, 2010, AUTOPHAGY, V6, P553, DOI 10.4161/auto.6.4.11671; Soliman GA, 2011, CELL CYCLE, V10, P861, DOI 10.4161/cc.10.6.14930; Sommermann TG, 2011, CANCER RES, V71, P7291, DOI 10.1158/0008-5472.CAN-11-1715; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tang J, 2010, J BIOL CHEM, V285, P34072, DOI 10.1074/jbc.M110.137380; Teicher BA, 2012, CLIN CANCER RES, V18, P5537, DOI 10.1158/1078-0432.CCR-12-2587; Toschi A, 2010, CANCER LETT, V299, P72, DOI 10.1016/j.canlet.2010.08.006; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Wang XR, 2008, CANCER RES, V68, P7409, DOI 10.1158/0008-5472.CAN-08-1522; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60; Zou ZZ, 2012, AUTOPHAGY, V8, P1798, DOI 10.4161/auto.22110	48	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132880	10.1371/journal.pone.0132880	http://dx.doi.org/10.1371/journal.pone.0132880			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176608	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600172
J	Konno, M; Koseki, J; Kawamoto, K; Nishida, N; Matsui, H; Dewi, DL; Ozaki, M; Noguchi, Y; Mimori, K; Gotoh, N; Tanuma, N; Shima, H; Doki, Y; Mori, M; Ishii, H				Konno, Masamitsu; Koseki, Jun; Kawamoto, Koichi; Nishida, Naohiro; Matsui, Hidetoshi; Dewi, Dyah Laksmi; Ozaki, Miyuki; Noguchi, Yuko; Mimori, Koshi; Gotoh, Noriko; Tanuma, Nobuhiro; Shima, Hiroshi; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi			Embryonic MicroRNA-369 Controls Metabolic Splicing Factors and Urges Cellular Reprograming	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; UP-REGULATION; MOUSE; TRANSLATION; ACTIVATION; REPRESSION; CHROMATIN; PATHWAYS; CANCER; GENES	Noncoding microRNAs inhibit translation and lower the transcript stability of coding mRNA, however miR-369 s, in aberrant silencing genomic regions, stabilizes target proteins under cellular stress. We found that in vitro differentiation of embryonic stem cells led to chromatin methylation of histone H3K4 at the miR-369 region on chromosome 12qF in mice, which is expressed in embryonic cells and is critical for pluripotency. Proteomic analyses revealed that miR-369 stabilized translation of pyruvate kinase (Pkm2) splicing factors such as HNRNPA2B1. Overexpression of miR-369 stimulated Pkm2 splicing and enhanced induction of cellular reprogramming by induced pluripotent stem cell factors, whereas miR-369 knockdown resulted in suppression. Furthermore, immunoprecipitation analysis showed that the Argonaute complex contained the fragile X mental retardation-related protein 1 and HNRNPA2B1 in a miR-369-depedent manner. Our findings demonstrate a unique role of the embryonic miR-369-HNRNPA2B1 axis in controlling metabolic enzyme function, and suggest a novel pathway linking epigenetic, transcriptional, and metabolic control in cell reprogramming.	[Konno, Masamitsu; Kawamoto, Koichi; Nishida, Naohiro; Dewi, Dyah Laksmi; Ozaki, Miyuki; Noguchi, Yuko; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi] Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Grad Sch Med, Osaka 5650871, Japan; [Koseki, Jun; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi] Osaka Univ, Dept Canc Profiling Discovery, Grad Sch Med, Osaka 5650871, Japan; [Kawamoto, Koichi; Dewi, Dyah Laksmi; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Dept Gastrointestinal Surg, Grad Sch Med, Osaka 5650871, Japan; [Matsui, Hidetoshi] Kyushu Univ, Fac Sci, Fukuoka 8190395, Japan; [Mimori, Koshi] Kyushu Univ, Dept Mol & Surg Oncol, Beppu, Oita 8740838, Japan; [Gotoh, Noriko] Kanazawa Univ, Div Canc Cell Biol, Canc Res Inst, Kanazawa, Ishikawa 9201192, Japan; [Tanuma, Nobuhiro; Shima, Hiroshi] Miyagi Canc Ctr Res Inst, Div Canc Chemotherapy, Natori, Miyagi 9811293, Japan	Osaka University; Osaka University; Osaka University; Kyushu University; Kyushu University; Kanazawa University; Miyagi Cancer Center	Mori, M (corresponding author), Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Grad Sch Med, Osaka 5650871, Japan.	mmori@gesurg.med.osaka-u.ac.jp; hishii@gesurg.med.osaka-u.ac.jp	Matsui, Hidetoshi/AAM-1339-2020; Koseki, Jun/ABH-7420-2020; GOTOH, Noriko/D-8430-2015; Dewi, Dyah Laksmi/GOP-2412-2022; Ishii, Hideshi/AAV-5317-2020	Matsui, Hidetoshi/0000-0002-6286-5072; Gotoh, Noriko/0000-0003-3733-260X; Dewi, Dyah Laksmi/0000-0001-7937-4221; Mimori, Koshi/0000-0003-3897-9974	Ministry of Education, Culture, Sports, Science, and Technology [23390199, 25112708, 25134711, 30253420, 26670604]; Ministry of Health, Labor and Welfare [H23-003]; National Institute of Biomedical Innovation [12-4]; Osaka University Drug Discovery Funds; Takeda Science and Medical Research Foundation; Princess Takamatsu Cancer Research Fund; Suzuken Memorial Foundation; Yasuda Medical Foundation; Pancreas Research Foundation; Nakatani Foundation; Nakatomi Foundation of Japan	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Osaka University Drug Discovery Funds; Takeda Science and Medical Research Foundation; Princess Takamatsu Cancer Research Fund; Suzuken Memorial Foundation; Yasuda Medical Foundation; Pancreas Research Foundation; Nakatani Foundation; Nakatomi Foundation of Japan	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (http://www.mext.go.jp/english/; #23390199, #25112708, #25134711, #30253420, #26670604; M.M., K.M., H.I.); a Grant-in-Aid from the Ministry of Health, Labor and Welfare (http://www.mhlw.go.jp/english/; #H23-003; M.M., H.I.); a grant from the National Institute of Biomedical Innovation (http://www.nibio.go.jp/english/index.html; #12-4; M.M., H.I.); and a grant from the Osaka University Drug Discovery Funds (http://www.osaka-u.ac.jp/en/index.html; M.M., H.I.). Partial support was received from Takeda Science and Medical Research Foundation (http://www.takeda-sci.or.jp/index.html; M.M., H.I.), Princess Takamatsu Cancer Research Fund (http://www.ptcrf.or.jp/english; M.M., H.I.), Suzuken Memorial Foundation (http://www.suzukenzaidan.or.jp; M.K.), Yasuda Medical Foundation (http://www.yasuda-mf.or.jp; N.N.), Pancreas Research Foundation (http://www.jprf.or.jp/shoreisho.html; K.K.), Nakatani Foundation (http://www.nakatani-foundation.jp; H.I.), and Nakatomi Foundation of Japan (https://www.nakatomi.or.jp/en/index.html; M.K.). Institutional endowments were received partially from Taiho Pharmaceutical Co., Ltd. (http://www.taiho.co.jp/english/), Evidence Based Medical (EBM) Research Center (http://ebmrce.co.jp/index.html), Chugai Co., Ltd. (http://www.chugai-pharm.co.jp/english/index.html), Yakult Honsha Co., Ltd. (http://www.yakult.co.jp/english/index.html), and Merck Co., Ltd. (http://www.merck.co.jp/en/index.html); those funders had no role in main experimental equipments, supplies expenses, study design, data collection and analysis, decision to publish, or preparation of the manuscript, in this work.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Hu J, 2012, BIOCHEM J, V447, P407, DOI 10.1042/BJ20120256; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Konno M, 2015, REGENERATIV IN PRESS; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Lin SL, 2010, CANCER RES, V70, P9473, DOI 10.1158/0008-5472.CAN-10-2746; Liu XH, 2012, MOL CELL, V46, P507, DOI 10.1016/j.molcel.2012.03.010; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288	36	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132789	10.1371/journal.pone.0132789	http://dx.doi.org/10.1371/journal.pone.0132789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176628	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600157
J	Kortum, F; Harms, FL; Hennighausen, N; Rosenberger, G				Kortuem, Fanny; Harms, Frederike Leonie; Hennighausen, Natascha; Rosenberger, Georg			alpha PIX Is a Trafficking Regulator that Balances Recycling and Degradation of the Epidermal Growth Factor Receptor	PLOS ONE			English	Article							INTERACTING EXCHANGE FACTOR; GTPASE-ACTIVATING PROTEINS; KINASE-BINDING PROTEINS; RHO-GTPASES; EGF RECEPTOR; MEMBRANE-TRANSPORT; DOWN-REGULATION; C-CBL; P21-ACTIVATED KINASES; MENTAL-RETARDATION	Endosomal sorting is an essential control mechanism for signaling through the epidermal growth factor receptor (EGFR). We report here that the guanine nucleotide exchange factor alpha PIX, which modulates the activity of Rho-GTPases, is a potent bimodal regulator of EGFR trafficking. alpha PIX interacts with the E3 ubiquitin ligase c-Cbl, an enzyme that attaches ubiquitin to EGFR, thereby labelling this tyrosine kinase receptor for lysosomal degradation. We show that EGF stimulation induces alpha PIX::c-Cbl complex formation. Simultaneously, c-Cbl ubiquitin ligase activity. Through interaction alpha PIX sequesters c-Cbl from EGFR and this results in reduced EGFR ubiquitination and decreased EGFR degradation upon EGF treatment. However, quantitatively more decisive for cellular EGFR distribution than impaired EGFR degradation is a strong stimulating effect of alpha PIX on EGFR recycling to the cell surface. This function depends on the GIT binding domain of alpha PIX but not on interaction with c-Cbl or alpha PIX exchange activity. In summary, our data demonstrate a previously unappreciated function of alpha PIX as a strong promoter of EGFR recycling. We suggest that the novel recycling regulator alpha PIX and the degradation factor c-Cbl closely cooperate in the regulation of EGFR trafficking: uncomplexed alpha PIX and c-Cbl mediate a positive and a negative feedback on EGFR signaling, respectively; alpha PIX::c-Cbl complex formation, however, results in mutual inhibition, which may reflect a stable condition in the homeostasis of EGF-induced signal flow.	[Kortuem, Fanny; Harms, Frederike Leonie; Hennighausen, Natascha; Rosenberger, Georg] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Rosenberger, G (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany.	rosenberger@uke.de		Harms, Frederike Leonie/0000-0003-2610-0600	DFG [KO 4576/1-1]; Deutsche Forschungsgemeinschaft [FOR 885/IRP5]	DFG(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the DFG (KO 4576/1-1 to F. Kortum). GR was supported by a grant from the Deutsche Forschungsgemeinschaft (FOR 885/IRP5). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A, 1998, Front Biosci, V3, pd729; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Baird D, 2005, CURR BIOL, V15, P1, DOI 10.1016/j.cub.2004.12.040; Bitler BG, 2010, J CELL SCI, V123, P1716, DOI 10.1242/jcs.062661; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Dikic I, 2003, CELL MOL LIFE SCI, V60, P1805, DOI 10.1007/s00018-003-3029-4; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Eden ER, 2012, TRAFFIC, V13, P329, DOI 10.1111/j.1600-0854.2011.01305.x; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng QY, 2006, NAT CELL BIOL, V8, P945, DOI 10.1038/ncb1453; Feng QY, 2004, EMBO J, V23, P3492, DOI 10.1038/sj.emboj.7600331; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Flanders JA, 2003, FEBS LETT, V550, P119, DOI 10.1016/S0014-5793(03)00853-6; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gringel A, 2006, J CELL PHYSIOL, V209, P568, DOI 10.1002/jcp.20777; Grovdal LM, 2008, EXP CELL RES, V314, P1292, DOI 10.1016/j.yexcr.2007.12.017; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Hua KT, 2011, CANCER CELL, V19, P218, DOI 10.1016/j.ccr.2010.11.010; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Koh CG, 2001, J CELL SCI, V114, P4239; Kong KF, 2014, NAT IMMUNOL, V15, P465, DOI 10.1038/ni.2866; Korthals M, 2014, J IMMUNOL, V192, P3228, DOI 10.4049/jimmunol.1302585; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lin Q, 2006, METHOD ENZYMOL, V406, P614, DOI 10.1016/S0076-6879(06)06048-4; Llavero F, 2015, J BIOL CHEM, V290, P9171, DOI 10.1074/jbc.M114.608414; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Matafora V, 2001, J CELL SCI, V114, P4509; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mazaki Y, 2006, NAT IMMUNOL, V7, P724, DOI 10.1038/ni1349; Missy K, 2008, MOL CELL BIOL, V28, P3776, DOI 10.1128/MCB.00507-07; Node-Langlois R, 2006, J CELL SCI, V119, P4986, DOI 10.1242/jcs.03273; Phee H, 2005, NAT IMMUNOL, V6, P608, DOI 10.1038/ni1199; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Premont RT, 2000, J BIOL CHEM, V275, P22373, DOI 10.1074/jbc.275.29.22373; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Ramakers GJA, 2012, HUM MOL GENET, V21, P268, DOI 10.1093/hmg/ddr457; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Rosenberger G, 2006, EUR J CELL BIOL, V85, P265, DOI 10.1016/j.ejcb.2005.10.007; Rosenberger G, 2005, J BIOL CHEM, V280, P6879, DOI 10.1074/jbc.M412119200; Rosenberger G, 2003, HUM MOL GENET, V12, P155, DOI 10.1093/hmg/ddg019; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schlenker O, 2009, J MOL BIOL, V386, P280, DOI 10.1016/j.jmb.2008.12.050; Schmidt MHH, 2006, ONCOGENE, V25, P3071, DOI 10.1038/sj.onc.1209329; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Schmidt Mirko H. H., 2006, V327, P131; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Seong MW, 2014, BIOCHEM BIOPH RES CO, V455, P153, DOI 10.1016/j.bbrc.2014.10.129; Shtiegman K, 2007, ONCOGENE, V26, P6968, DOI 10.1038/sj.onc.1210503; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Sorkin A, 2010, CURR PROTOC CELL BIO, DOI [10. 1002/0471143030. cb1514s46, DOI 10.1002/0471143030.CB1514S46]; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Stofega MR, 2004, MOL BIOL CELL, V15, P2965, DOI 10.1091/mbc.E03-08-0604; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Thien CBF, 2005, GROWTH FACTORS, V23, P161, DOI 10.1080/08977190500153763; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Totaro A, 2012, BIOL CELL, DOI [10.1111/boc.201200006, DOI 10.1111/BOC.201200006]; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Turvy D N, 2001, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1807s36; Valdes JL, 2011, J BIOL CHEM, V286, P39403, DOI 10.1074/jbc.M111.260802; van Weert AWM, 2000, EUR J CELL BIOL, V79, P394, DOI 10.1078/0171-9335-00062; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yokota T, 2006, ACTA NEUROPATHOL, V111, P29, DOI 10.1007/s00401-005-1085-6; Yoshii S, 1999, ONCOGENE, V18, P5680, DOI 10.1038/sj.onc.1202936; Yoshii S, 2001, MOL CELL BIOL, V21, P6796, DOI 10.1128/MCB.21.20.6796-6807.2001; Yoshimi R, 2006, J IMMUNOL, V176, P3611, DOI 10.4049/jimmunol.176.6.3611; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	87	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132737	10.1371/journal.pone.0132737	http://dx.doi.org/10.1371/journal.pone.0132737			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177020	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600147
J	Li, GQ; Du, S; Guo, K				Li, Guoqing; Du, Sheng; Guo, Ke			Evaluation of Limiting Climatic Factors and Simulation of a Climatically Suitable Habitat for Chinese Sea Buckthorn	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; POTENTIAL GEOGRAPHICAL-DISTRIBUTION; LANTANA-CAMARA; DISTRIBUTIONS; PREDICTION; CLIMEX; TREE; SOIL; QUEENSLAND; IMPACTS	Chinese sea buckthorn (Hippophae rhamnoides subsp. sinensis) has considerable economic potential and plays an important role in reclamation and soil and water conservation. For scientific cultivation of this species across China, we identified the key climatic factors and explored climatically suitable habitat in order to maximize survival of Chinese sea buckthorn using MaxEnt and GIS tools, based on 98 occurrence records from herbarium and publications and 13 climatic factors from Bioclim, Holdridge life zone and Kria' index variables. Our simulation showed that the MaxEnt model performance was significantly better than random, with an average test AUC value of 0.93 with 10-fold cross validation. A jackknife test and the regularized gain change, which were applied to the training algorithm, showed that precipitation of the driest month (PDM), annual precipitation (AP), coldness index (CI) and annual range of temperature (ART) were the most influential climatic factors in limiting the distribution of Chinese sea buckthorn, which explained 70.1% of the variation. The predicted map showed that the core of climatically suitable habitat was distributed from the southwest to northwest of Gansu, Ningxia, Shaanxi and Shanxi provinces, where the most influential climate variables were PDM of 1.0-7.0 mm, AP of 344.0-1089.0 mm, CI of -47.7-0.0 degrees C, and ART of 26.1-45.0 degrees C. We conclude that the distribution patterns of Chinese sea buckthorn are related to the northwest winter monsoon, the southwest summer monsoon and the southeast summer monsoon systems in China.	[Li, Guoqing; Du, Sheng] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Peoples R China; [Guo, Ke] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China; [Li, Guoqing; Du, Sheng] Chinese Acad Sci & Minist Water Resources, Inst Soil & Water Conservat, Yangling 712100, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources	Guo, K (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China.	guoke@ibcas.ac.cn	DU, SHENG/A-7528-2008	DU, SHENG/0000-0002-5580-399X; Li, Guoqing/0000-0003-1767-3052	National Nature Science Foundation of China [31300407]; Public Welfare Scientific Research Project, Ministry of Environmental Protection of China [201209028]; Institute of Soil and Water Conservation, Chinese Academy of Sciences and Ministry of Water Resources [A315021441]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Welfare Scientific Research Project, Ministry of Environmental Protection of China; Institute of Soil and Water Conservation, Chinese Academy of Sciences and Ministry of Water Resources	The project was supported financially by the National Nature Science Foundation of China (No. 31300407), http://www.nsfc.gov.cn/; Public Welfare Scientific Research Project, Ministry of Environmental Protection of China (No. 201209028), http://www.zhb.gov.cn/; and Institute of Soil and Water Conservation, Chinese Academy of Sciences and Ministry of Water Resources (A315021441), http://www.iswc.ac.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An BL, 2004, GLOBAL SEABUCK RES D, V2, P12; BOOTH TH, 1988, FOREST ECOL MANAG, V23, P47, DOI 10.1016/0378-1127(88)90013-8; Booth TH, 2014, DIVERS DISTRIB, V20, P1, DOI 10.1111/ddi.12144; Brambilla M, 2012, J ANIM ECOL, V81, P781, DOI 10.1111/j.1365-2656.2012.01970.x; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Chen X L, 2007, HIPPOPHAE, V20, P1; Chen YM, 2004, SCI SOIL WATER CONSE, V2, P88; Delectis Florae Reipublicae Popularis Sinicae Agendae Academiae Sinicae Edita, 1994, FLORA REIPUBLICAE PO; Editorial Committee for Physical Geography of China, 1985, PHYS GEOGR CHIN; Editorial Committee for Vegetation Atlas of China, 2001, 1 100 MILL VEG ATL C; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; ESRI, 2012, ARCGIS 9 3; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franklin J, 2009, MAPPING SPECIES DIST; Gaston A, 2014, NEW FOREST, V45, P641, DOI 10.1007/s11056-014-9427-7; Gormley AM, 2011, J APPL ECOL, V48, P25, DOI 10.1111/j.1365-2664.2010.01911.x; Gu H, 2008, INT RES DEVEL SEABUC, V6, P10; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Guisan A, 2011, J BIOGEOGR, V38, P1433, DOI 10.1111/j.1365-2699.2011.02550.x; Guo K, 2010, FOREST ECOL MANAG, V259, P2197, DOI 10.1016/j.foreco.2009.11.034; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; Hodder DP, 2014, WILDLIFE BIOL, V20, P238, DOI 10.2981/wlb.00037; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; HOU HY, 1983, ANN MO BOT GARD, V70, P509, DOI 10.2307/2992085; Kira T., 1945, NEW CLASSIFICATION C; Li GQ, 2014, FORESTS, V5, P2773, DOI 10.3390/f5112773; [李国庆 Li Guoqing], 2013, [生态学报, Acta Ecologica Sinica], V33, P4827; Li GQ, 2012, ECOL RES, V27, P427, DOI 10.1007/s11284-011-0914-4; Li T. S. C., 1996, HortTechnology, V6, P370; Lian Y, 1996, HIPPOPHAE, V9, P15; Lian YS, 1992, ACTA PHYTOTAX SINICA, V30, P349; Liu HY, 2015, APPL VEG SCI, V18, P43, DOI 10.1111/avsc.12139; Liu HY, 2002, PLANT ECOL, V158, P139, DOI 10.1023/A:1015515332254; Macfadyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040313; McKenzie D, 2003, J BIOGEOGR, V30, P1093, DOI 10.1046/j.1365-2699.2003.00921.x; Navarro-Cerrillo RM, 2011, APPL VEG SCI, V14, P256, DOI 10.1111/j.1654-109X.2010.01112.x; Nazeri M, 2014, ECOL INFORM, V20, P27, DOI 10.1016/j.ecoinf.2014.01.006; Nazeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048104; Nori J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025718; Pattison RR, 2008, GLOBAL CHANGE BIOL, V14, P813, DOI 10.1111/j.1365-2486.2007.01528.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2011, ECOLOGICAL NICHES GE; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2013, ECOLOGY, V94, P1409, DOI 10.1890/12-1520.1; Poutsma J, 2008, BIOCONTROL, V53, P103, DOI 10.1007/s10526-007-9140-y; Shabani F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083404; Shabani F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048021; Small E, 1996, BIODIVERISTY, V3, P25; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Taylor S, 2012, WEED RES, V52, P391, DOI 10.1111/j.1365-3180.2012.00930.x; Taylor S, 2013, J ENVIRON MANAGE, V114, P414, DOI 10.1016/j.jenvman.2012.10.039; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035565; Toledo M, 2011, J ECOL, V99, P254, DOI 10.1111/j.1365-2745.2010.01741.x; Wellenreuther M, 2012, ECOLOGY, V93, P1353; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Worldclim, 2014, GLOB CLIM DAT FREE C; Xiong B.Q., 2004, CHIN WILD PLANT RES, V23, P25; Xu W., 1985, CHINESE J ECOL, V3, P35; Yonow T, 1998, AUST J AGR RES, V49, P935, DOI 10.1071/A97152	66	27	28	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131659	10.1371/journal.pone.0131659	http://dx.doi.org/10.1371/journal.pone.0131659			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177033	gold, Green Published			2022-12-27	WOS:000358197600057
J	Monteagudo, A; Santos, J				Monteagudo, Angel; Santos, Jose			Treatment Analysis in a Cancer Stem Cell Context Using a Tumor Growth Model Based on Cellular Automata	PLOS ONE			English	Article							THERAPEUTIC IMPLICATIONS; RESISTANCE; PERSPECTIVES; STRATEGIES; HALLMARKS; DYNAMICS	Cancer can be viewed as an emergent behavior in terms of complex system theory and artificial life, Cellular Automata (CA) being the tool most used for studying and characterizing the emergent behavior. Different approaches with CA models were used to model cancer growth. The use of the abstract model of acquired cancer hallmarks permits the direct modeling at cellular level, where a cellular automaton defines the mitotic and apoptotic behavior of cells, and allows for an analysis of different dynamics of the cellular system depending on the presence of the different hallmarks. A CA model based on the presence of hallmarks in the cells, which includes a simulation of the behavior of Cancer Stem Cells (CSC) and their implications for the resultant growth behavior of the multicellular system, was employed. This modeling of cancer growth, in the avascular phase, was employed to analyze the effect of cancer treatments in a cancer stem cell context. The model clearly explains why, after treatment against non-stem cancer cells, the regrowth capability of CSCs generates a faster regrowth of tumor behavior, and also shows that a continuous low-intensity treatment does not favor CSC proliferation and differentiation, thereby allowing an unproblematic control of future tumor regrowth. The analysis performed indicates that, contrary to the current attempts at CSC control, trying to make CSC proliferation more difficult is an important point to consider, especially in the immediate period after a standard treatment for controlling non-stem cancer cell proliferation.	[Monteagudo, Angel; Santos, Jose] Univ A Coruna, Dept Comp Sci, La Coruna 15071, Spain	Universidade da Coruna	Santos, J (corresponding author), Univ A Coruna, Dept Comp Sci, Campus Elvina S-N, La Coruna 15071, Spain.	santos@udc.es	Santos, Jose/H-8569-2014	Santos, Jose/0000-0002-4212-1367	Ministry of Economy and Competitiveness of Spain [TIN2013-40981-R]	Ministry of Economy and Competitiveness of Spain(Spanish Government)	This work was supported by Ministry of Economy and Competitiveness of Spain (project TIN2013-40981-R) (JS).	Abbott RG, 2006, ARTIF LIFE, V12, P617, DOI 10.1162/artl.2006.12.4.617; Adami C., 1998, INTRO ARTIFICIAL LIF; Basanta D, 2011, MATH BIOSCI, V229, P22, DOI 10.1016/j.mbs.2010.10.005; Chen K, 2013, ACTA PHARMACOL SIN, V34, P732, DOI 10.1038/aps.2013.27; Cortes-Dericks L, 2010, INT J ONCOL, V37, P437, DOI 10.3892/ijo_00000692; De Pillis LG, 2003, MATH COMPUT MODEL, V37, P1221, DOI 10.1016/S0895-7177(03)00133-X; Eisen MM, 1977, MATH MODELS CELL BIO; Enderling H, 2011, PROG BIOPHYS MOL BIO, V106, P391, DOI 10.1016/j.pbiomolbio.2011.03.007; Enderling H, 2010, ACTA BIOTHEOR, V58, P341, DOI 10.1007/s10441-010-9111-z; Gardner S.N., 2000, J THEOR MED, V2, P215, DOI [DOI 10.1080/10273660008833047, 10.1080/10273660008833047]; Gerlee P, 2007, J THEOR BIOL, V246, P583, DOI 10.1016/j.jtbi.2007.01.027; Gevertz JL, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036010; Gibbs WW, 2003, SCI AM, V289, P56, DOI 10.1038/scientificamerican0703-56; Gil J, 2008, J APPL GENET, V49, P193, DOI 10.1007/BF03195612; Han L, 2013, ACTA PHARM SIN B, V3, P65, DOI 10.1016/j.apsb.2013.02.006; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hillen T, 2013, B MATH BIOL, V75, P161, DOI 10.1007/s11538-012-9798-x; Ilachinski A, 2001, CELLULAR AUTOMATA DE; Isaeva OG, 2009, COMPUT MATH METHOD M, V10, P253, DOI 10.1080/17486700802536054; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; LANGTON CG, 1992, SFI S SCI C, V10, P41; Lavi O, 2012, DRUG RESIST UPDATE, V15, P90, DOI 10.1016/j.drup.2012.01.003; Monteagudo Angel, 2013, Natural and Artificial Computation in Engineering and Medical Applications. 5th International Work-Conference on the Interplay Between Natural and Artificial Computation, IWINAC 2013. Proceedings: LNCS 7931, P21, DOI 10.1007/978-3-642-38622-0_3; Monteagudo A, 2014, BIOSYSTEMS, V115, P46, DOI 10.1016/j.biosystems.2013.11.001; Morton CI, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-48; NORTON L, 1977, CANCER TREAT REP, V61, P1307; Patel M, 2010, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-3-642-15603-8; Rejniak KA, 2011, WIRES SYST BIOL MED, V3, P115, DOI 10.1002/wsbm.102; Ribba B, 2004, LECT NOTES COMPUT SC, V3305, P444; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Santos Jose, 2012, Parallel Problem Solving from Nature - PPSN XII. Proceedings of the 12th International Conference, P489, DOI 10.1007/978-3-642-32937-1_49; Santos J, 2015, IET SYST BIOL, V9, P75, DOI 10.1049/iet-syb.2014.0015; Savage N, 2012, NATURE, V491, pS62, DOI 10.1038/491S62a; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Simon R, 2006, NAT CLIN PRACT ONCOL, V3, P406, DOI 10.1038/ncponc0560; Sottoriva A, 2010, CANCER RES, V70, P46, DOI 10.1158/0008-5472.CAN-09-3663; Spencer SL, 2006, PLOS COMPUT BIOL, V2, P939, DOI 10.1371/journal.pcbi.0020108; SWAN GW, 1990, MATH BIOSCI, V101, P237, DOI 10.1016/0025-5564(90)90021-P; Swierniak A, 1996, CELL PROLIFERAT, V29, P117, DOI 10.1046/j.1365-2184.1996.00995.x; Swierniak A, 2009, EUR J PHARMACOL, V625, P108, DOI 10.1016/j.ejphar.2009.08.041; Vainstein V, 2012, J THEOR BIOL, V298, P32, DOI 10.1016/j.jtbi.2011.12.016; Wodarz D, 2012, TRENDS GENET, V23, P32; Yap IKS, 2013, IEJSME, V7, pS19	44	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132306	10.1371/journal.pone.0132306	http://dx.doi.org/10.1371/journal.pone.0132306			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176702	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600098
J	Pawela, L; Gawron, P; Miszczak, JA; Sadowski, P				Pawela, Lukasz; Gawron, Piotr; Miszczak, Jaroslaw Adam; Sadowski, Przemyslaw			Generalized Open Quantum Walks on Apollonian Networks	PLOS ONE			English	Article							SCALE-FREE	We introduce the model of generalized open quantum walks on networks using the Transition Operation Matrices formalism. We focus our analysis on the mean first passage time and the average return time in Apollonian networks. These results differ significantly from a classical walk on these networks. We show a comparison of the classical and quantum behaviour of walks on these networks.	[Pawela, Lukasz; Gawron, Piotr; Miszczak, Jaroslaw Adam; Sadowski, Przemyslaw] Polish Acad Sci, Inst Theoret & Appl Informat, PL-44100 Gliwice, Poland	Polish Academy of Sciences; Institute of Theoretical & Applied Informatics of the Polish Academy of Sciences	Pawela, L (corresponding author), Polish Acad Sci, Inst Theoret & Appl Informat, Baltycka 5, PL-44100 Gliwice, Poland.	lpawela@iitis.pl	Gawron, Piotr/F-2255-2011; Pawela, Łukasz/B-4629-2013; Sadowski, Przemysław/K-5535-2015; Miszczak, Jarosław Adam/A-7772-2010	Gawron, Piotr/0000-0001-7476-9160; Pawela, Łukasz/0000-0002-0476-7132; Miszczak, Jarosław Adam/0000-0001-8790-101X; Sadowski, Przemyslaw/0000-0002-3150-0724	Polish Ministry of Science and Higher Education [IP2012 051272, 0064/DIA/2013/42c]; Polish National Science Centre [UMO-2011/03/D/ST6/00413, N N516 481840]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish National Science Centre	Work by LP was supported by the Polish Ministry of Science and Higher Education (http://www.nauka.gov.pl/) under the project number IP2012 051272). PS was supported by the Polish Ministry of Science and Higher Education (http://www.nauka.gov.pl/) within "Diamond Grant" Programme under the project number 0064/DIA/2013/42. JAM would like to acknowledge the support by the Polish National Science Centre (http://www.ncn.gov.pl) under the research project UMO-2011/03/D/ST6/00413. Research of PG was supported by the Grant N N516 481840 financed by Polish National Science Centre (http://www.ncn.gov.pl).	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Andrade JS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018702; Andrade RFS, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056131; Attal S, 2012, J STAT PHYS, V147, P832, DOI 10.1007/s10955-012-0491-0; Attal S, 2012, PHYS LETT A, V376, P1545, DOI 10.1016/j.physleta.2012.03.040; Attal S, 2012, ARXIV12061472; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bengtsson I., 2006, GEOMETRY QUANTUM STA; Bernardes MC, 2000, INTERNATIONAL SYMPOSIUM ON SOFTWARE ENGINEERING FOR PARALLEL AND DISTRIBUTED SYSTEMS, PROCEEDINGS, P158, DOI 10.1109/PDSE.2000.847862; BOYD DW, 1973, MATHEMATIKA, V20, P170, DOI 10.1112/S0025579300004745; BOYD DW, 1973, CAN J MATH, V25, P303, DOI 10.4153/CJM-1973-030-5; Doye JPK, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016128; Frieze A, 2012, P 9 WORKSH ALG MOD W; Gudder S, 2008, J MATH PHYS, V49, DOI 10.1063/1.2953952; Huang ZG, 2006, EUR PHYS J B, V51, P549, DOI 10.1140/epjb/e2006-00257-y; Jansen WA, 2002, COMPUT COMMUN, V25, P1392, DOI 10.1016/S0140-3664(02)00040-3; Kempe J, 2003, CONTEMP PHYS, V44, P307, DOI 10.1080/00107151031000110776; Lange DB, 1999, COMMUN ACM, V42, P88, DOI 10.1145/295685.298136; Miszczak JA, 2014, FLUCT NOISE LETT, V13, DOI 10.1142/S0219477514500126; Miszczak JA, 2014, QUANTUM INF COMPUT, V14, P1238; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Pawela L, 2013, PHYSICA D, V256, P51, DOI 10.1016/j.physd.2013.04.010; Pawela L, 2013, PHYSICA A, V392, P910, DOI 10.1016/j.physa.2012.10.034; Pellegrini G, 2007, ARXIVQBIO0701045; Sadowski P, 2014, ARXIV 1406 0339; Sadowski P, 2016, QUANTUM INF PROCESS, V15, P2725, DOI 10.1007/s11128-016-1314-z; Serva M, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042823; Sinayskiy I, 2014, INT J QUANTUM INF, V12, DOI 10.1142/S0219749914610103; Sinayskiy I, 2013, J PHYS CONF SER, V442, DOI 10.1088/1742-6596/442/1/012003; Sinayskiy I, 2012, PHYS SCRIPTA, VT151, DOI 10.1088/0031-8949/2012/T151/014077; Souza AMC, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/14/145102; Sweke R, 2013, J PHYS B-AT MOL OPT, V46, DOI 10.1088/0953-4075/46/10/104004; Szegedy M, 2004, ANN IEEE SYMP FOUND, P32, DOI 10.1109/FOCS.2004.53; Watts D.J., 1999, SMALL WORLDS DYNAMIC; Xu XP, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.052103; Zhang ZZ, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/10006; Zhang ZZ, 2006, PHYSICA A, V364, P610, DOI 10.1016/j.physa.2005.09.042; Zhou T, 2004, ARXIVCONDMAT0409414	38	12	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130967	10.1371/journal.pone.0130967	http://dx.doi.org/10.1371/journal.pone.0130967			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177452	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600032
J	Rogers, RL; Cridland, JM; Shao, L; Hu, TT; Andolfatto, P; Thornton, KR				Rogers, Rebekah L.; Cridland, Julie M.; Shao, Ling; Hu, Tina T.; Andolfatto, Peter; Thornton, Kevin R.			Tandem Duplications and the Limits of Natural Selection in Drosophila yakuba and Drosophila simulans	PLOS ONE			English	Article							PARALLEL MOLECULAR EVOLUTION; COPY-NUMBER POLYMORPHISM; AMINO-ACID SUBSTITUTIONS; CONVERGENT EVOLUTION; GENETIC ARCHITECTURE; RAPID EVOLUTION; GENOME ANALYSIS; PATTERNS; DNA; DIVERGENCE	Tandem duplications are an essential source of genetic novelty, and their variation in natural populations is expected to influence adaptive walks. Here, we describe evolutionary impacts of recently-derived, segregating tandem duplications in Drosophila yakuba and Drosophila simulans. We observe an excess of duplicated genes involved in defense against pathogens, insecticide resistance, chorion development, cuticular peptides, and lipases or endopeptidases associated with the accessory glands across both species. The observed agreement is greater than expectations on chance alone, suggesting large amounts of convergence across functional categories. We document evidence of widespread selection on the D. simulans X, suggesting adaptation through duplication is common on the X. Despite the evidence for positive selection, duplicates display an excess of low frequency variants consistent with largely detrimental impacts, limiting the variation that can effectively facilitate adaptation. Standing variation for tandem duplications spans less than 25% of the genome in D. yakuba and D. simulans, indicating that evolution will be strictly limited by mutation, even in organisms with large population sizes. Effective whole gene duplication rates are low at 1.17 x 10(-9) per gene per generation in D. yakuba and 6.03 x 10(-10) per gene per generation in D. simulans, suggesting long wait times for new mutations on the order of thousands of years for the establishment of sweeps. Hence, in cases where adaptation depends on individual tandem duplications, evolution will be severely limited by mutation. We observe low levels of parallel recruitment of the same duplicated gene in different species, suggesting that the span of standing variation will define evolutionary outcomes in spite of convergence across gene ontologies consistent with rapidly evolving phenotypes.	[Rogers, Rebekah L.] Univ Calif Berkeley, Ecol & Evolutionary Biol, Berkeley, CA 94720 USA; [Cridland, Julie M.] Univ Calif Davis, Ecol & Evolutionary Biol, Davis, CA 95616 USA; [Shao, Ling; Thornton, Kevin R.] Univ Calif Irvine, Ecol & Evolutionary Biol, Irvine, CA USA; [Hu, Tina T.; Andolfatto, Peter] Princeton Univ, Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Hu, Tina T.; Andolfatto, Peter] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Irvine; Princeton University; Princeton University	Rogers, RL (corresponding author), Univ Calif Berkeley, Ecol & Evolutionary Biol, Berkeley, CA 94720 USA.	bekah@berkeley.edu		Andolfatto, Peter/0000-0003-3393-4574; Thornton, Kevin/0000-0003-0743-4445	NIH Ruth Kirschstein National Research Service Award [F32-GM099377]; NIH [R01-GM085183, R01-GM083228]; National Cancer Institute of the National Institutes of Health [P30CA062203]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085183, F32GM099377, R01GM083228] Funding Source: NIH RePORTER	NIH Ruth Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RLR is supported by NIH Ruth Kirschstein National Research Service Award F32-GM099377 (http://www.nih.gov/). Research funds were provided by NIH grant R01-GM085183 to KRT and R01-GM083228 to PA. All sequencing was performed at the UC Irvine High Throughput Genomics facility, which is supported by the National Cancer Institute of the National Institutes of Health under Award Number P30CA062203. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2007, GENOME RES, V17, P1755, DOI 10.1101/gr.6691007; Andolfatto P, 2011, GENOME BIOL EVOL, V3, P114, DOI 10.1093/gbe/evq086; Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189; Beckerman AP, 2013, ECOL EVOL, V3, P5119, DOI 10.1002/ece3.766; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Bhutkar A, 2008, GENETICS, V179, P1657, DOI 10.1534/genetics.107.086108; Brodie ED, 2010, CURR BIOL, V20, pR152, DOI 10.1016/j.cub.2009.12.029; Burke MK, 2010, NATURE, V467, P587, DOI 10.1038/nature09352; Cardoso-Moreira M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002340; Carneiro M, 2010, P NATL ACAD SCI USA, V107, P1747, DOI 10.1073/pnas.0906192106; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; CHAO A, 1984, SCAND J STAT, V11, P265; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Claycomb JM, 2005, TRENDS GENET, V21, P149, DOI 10.1016/j.tig.2005.01.009; Clemente F, 2012, J EVOLUTION BIOL, V25, P1975, DOI 10.1111/j.1420-9101.2012.02580.x; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Coop G, 2012, GENETICS, V192, P205, DOI 10.1534/genetics.112.141861; Cridland JM, 2010, GENOME BIOL EVOL, V2, P83, DOI 10.1093/gbe/evq001; Cui Y, 2002, P NATL ACAD SCI USA, V99, P809, DOI 10.1073/pnas.022240299; Dopman EB, 2007, P NATL ACAD SCI USA, V104, P19920, DOI 10.1073/pnas.0709888104; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; EWENS WJ, 1974, THEOR POPUL BIOL, V6, P143, DOI 10.1016/0040-5809(74)90020-3; Eyre-Walker A, 2002, MOL BIOL EVOL, V19, P2142, DOI 10.1093/oxfordjournals.molbev.a004039; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Gillespie J.H., 1991, CAUSES MOL EVOLUTION, P232; Giver L, 1998, CURR OPIN CHEM BIOL, V2, P335, DOI 10.1016/S1367-5931(98)80006-9; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Haddrill PR, 2008, MOL BIOL EVOL, V25, P1825, DOI 10.1093/molbev/msn125; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; Hartl DL., 2007, PRINCIPLES POPULATIO, V4th Edition, P652; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Hu TT, 2013, GENOME RES, V23, P89, DOI 10.1101/gr.141689.112; Jensen JD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000198; Jones CD, 2005, P NATL ACAD SCI USA, V102, P11373, DOI 10.1073/pnas.0503528102; KAPLAN NL, 1989, GENETICS, V123, P887; Karasov T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000924; Katju V, 2006, MOL BIOL EVOL, V23, P1056, DOI 10.1093/molbev/msj114; Khadjeh S, 2012, P NATL ACAD SCI USA, V109, P4921, DOI 10.1073/pnas.1116421109; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; Lazarro BP, 2012, RAPIDLY EVOLVING GEN; LEMEUNIER F, 1976, PROC R SOC SER B-BIO, V193, P275, DOI 10.1098/rspb.1976.0046; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Llopart A, 2005, GENETICS, V171, P197, DOI 10.1534/genetics.104.033597; LONG MY, 1993, SCIENCE, V260, P91, DOI 10.1126/science.7682012; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M., 2007, ORIGINS GENOME ARCHI, P494; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Magwire MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002337; Martin A, 2012, P NATL ACAD SCI USA, V109, P12632, DOI 10.1073/pnas.1204800109; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moxon ER, 1998, PERSPECT BIOL MED, V42, P154; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Ohno S., 1970, EVOLUTION GENE DUPLI; Orozco-TerWengel P, 2012, MOL ECOL, V21, P4931, DOI 10.1111/j.1365-294X.2012.05673.x; Panhuis TM, 2006, PHILOS T R SOC B, V361, P261, DOI 10.1098/rstb.2005.1793; Parsch J, 2010, MOL BIOL EVOL, V27, P1226, DOI 10.1093/molbev/msq046; Presgraves DC, 2008, TRENDS GENET, V24, P336, DOI 10.1016/j.tig.2008.04.007; Reinhardt JA, 2014, GENETICS, V197, P361, DOI 10.1534/genetics.114.161463; Riehle MM, 2001, P NATL ACAD SCI USA, V98, P525, DOI 10.1073/pnas.021448998; Rogers RL, 2014, MOL BIOL EVOL, V31, P1750, DOI 10.1093/molbev/msu124; Rogers RL, 2012, MOL BIOL EVOL, V29, P517, DOI 10.1093/molbev/msr184; Rogers RL, 2009, GENETICS, V181, P313, DOI 10.1534/genetics.108.091538; Rosenberg NA, 2003, EVOLUTION, V57, P1465, DOI 10.1554/03-012; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Shapiro MD, 2009, CURR BIOL, V19, P1140, DOI 10.1016/j.cub.2009.05.029; Shih HJ, 2008, GENETICS, V180, P1261, DOI 10.1534/genetics.108.090068; SMITH JM, 1971, J THEOR BIOL, V30, P319, DOI 10.1016/0022-5193(71)90058-0; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stern DL, 2013, NAT REV GENET, V14, P751, DOI 10.1038/nrg3483; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tanaka K, 2009, P NATL ACAD SCI USA, V106, P4764, DOI 10.1073/pnas.0807875106; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Thornton K, 2005, MOL BIOL EVOL, V22, P273, DOI 10.1093/molbev/msi015; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Thornton K, 2002, MOL BIOL EVOL, V19, P918, DOI 10.1093/oxfordjournals.molbev.a004149; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Wakeley J., 2009, COALESCENT THEORY IN, P97; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Zhang JM, 2004, P NATL ACAD SCI USA, V101, P16246, DOI 10.1073/pnas.0407066101; Zhang YE, 2010, GENOME RES, V20, P1526, DOI 10.1101/gr.107334.110; Zhen Y, 2012, SCIENCE, V337, P1634, DOI 10.1126/science.1226630; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108; Zichner T, 2013, GENOME RES, V23, P568, DOI 10.1101/gr.142646.112	95	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132184	10.1371/journal.pone.0132184	http://dx.doi.org/10.1371/journal.pone.0132184			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176952	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600086
J	Smith-McCune, K; Chen, JC; Greenblatt, RM; Shanmugasundaram, U; Shacklett, BL; Hilton, JF; Johnson, B; Irwin, JC; Giudice, LC				Smith-McCune, Karen; Chen, Joseph C.; Greenblatt, Ruth M.; Shanmugasundaram, Uma; Shacklett, Barbara L.; Hilton, Joan F.; Johnson, Brittni; Irwin, Juan C.; Giudice, Linda C.			Unexpected Inflammatory Effects of Intravaginal Gels (Universal Placebo Gel and Nonoxynol-9) on the Upper Female Reproductive Tract: A Randomized Crossover Study	PLOS ONE			English	Article							T-LYMPHOCYTES; SEX WORKERS; INFECTION; CELLS; HIV-1; RECRUITMENT; PHENOTYPE; CYTOKINES; SUBSETS; PATHWAY	Intravaginal anti-HIV microbicides could provide women with a self- controlled means for HIV prevention, but results from clinical trials have been largely disappointing. We postulated that unrecognized effects of intravaginal gels on the upper female reproductive tract might contribute to the lower-than-expected efficacy of HIV microbicides. Our objective was to study the effects of intravaginal gels on the immune microenvironment of the cervix and uterus. In this randomized crossover study, 27 healthy female volunteers used a nightly application of intravaginal nonoxynol-9 (N9) gel as a "failed" microbicide or the universal placebo gel (UPG) as a "safe" gel (intervention cycles), or nothing (control cycle) from the end of menses to the mid-luteal phase. At a specific time-point following ovulation, all participants underwent sample collection for measurements of T-cell phenotypes, gene expression, and cytokine/chemokine protein concentrations from 3 anatomic sites above the vagina: the cervical transformation zone, the endocervix and the endometrium. We used hierarchical statistical models to estimate mean (95% CI) intervention effects, for N9 and UPG relative to control. Exposure to N9 gel and UPG generated a common "harm signal" that included transcriptional up-regulation of inflammatory genes chemokine (C-C motif) ligand 20 (macrophage inflammatory factor-3alpha) and interleukin 8 in the cervix, decreased protein concentrations of secretory leukocyte protease inhibitor, and transcriptional up-regulation of inflammatory mediators glycodelin-A and osteopontin in the endometrium. These results need to be replicated with a larger sample, but underscore the need to consider the effects of microbicide agents and gel excipients on the upper female reproductive tract in studies of vaginal microbicides.	[Smith-McCune, Karen; Chen, Joseph C.; Johnson, Brittni; Irwin, Juan C.; Giudice, Linda C.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA; [Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA; [Greenblatt, Ruth M.; Hilton, Joan F.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Shanmugasundaram, Uma; Shacklett, Barbara L.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis	Smith-McCune, K (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	kmccune@obgyn.ucsf.edu	Shacklett, Barbara/A-7288-2009	Shacklett, Barbara/0000-0002-7067-732X	NIH/NIAID [AI083050]; NIH Eunice Kennedy Shriver NICHD Specialized Cooperative Centers Program in Reproduction and Infertility Research [U54HD055764]; Ruth L. Kirschstein National Research Service [NICHD 1F32HD074423-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD055764, F32HD074423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083050] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Eunice Kennedy Shriver NICHD Specialized Cooperative Centers Program in Reproduction and Infertility Research; Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by NIH/NIAID P01 grant # AI083050 (PI: Warner Greene), the NIH Eunice Kennedy Shriver NICHD Specialized Cooperative Centers Program in Reproduction and Infertility Research U54HD055764 (to L.C.G.), and the Ruth L. Kirschstein National Research Service Awards NICHD 1F32HD074423-02 (to J.C.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Barnes TC, 2011, INT J RHEUMATOL, V2011, DOI DOI 10.1155/2011/721608; Bouhlal H, 2002, J IMMUNOL, V169, P3301, DOI 10.4049/jimmunol.169.6.3301; Chen JC, 2013, FERTIL STERIL, V100, P1132, DOI 10.1016/j.fertnstert.2013.06.007; Dezzutti CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023136; Doncel GF, 2010, ANTIVIR RES, V88, pS10, DOI 10.1016/j.antiviral.2010.09.018; Drannik AG, 2011, BIOCHEM SOC T, V39, P1427, DOI 10.1042/BST0391427; Dube PH, 2001, P NATL ACAD SCI USA, V98, P10880, DOI 10.1073/pnas.191214498; Duchene J, 2007, J IMMUNOL, V179, P4849, DOI 10.4049/jimmunol.179.7.4849; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Grant RM, 2008, SCIENCE, V321, P532, DOI 10.1126/science.1160355; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hernandez-Rodriguez J, 2004, RHEUMATOLOGY, V43, P294, DOI 10.1093/rheumatology/keh058; Jenh CH, 2001, CYTOKINE, V15, P113, DOI 10.1006/cyto.2001.0923; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keele BF, 2011, BLOOD, V118, P839, DOI 10.1182/blood-2010-12-325860; Lanca T, 2013, J IMMUNOL, V190, P6673, DOI 10.4049/jimmunol.1300434; Lee CL, 2012, J BIOL CHEM, V287, P36999, DOI 10.1074/jbc.M112.385336; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Lieberman JA, 2008, CLIN VACCINE IMMUNOL, V15, P49, DOI 10.1128/CVI.00216-07; Lo JC, 2003, J CLIN INVEST, V112, P1495, DOI 10.1172/JCI200319188; Mauck CK, 2013, AIDS RES HUMAN RETRO; NAKAGAWA H, 1993, BIOCHEM BIOPH RES CO, V194, P1181, DOI 10.1006/bbrc.1993.1947; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Poynten IM, 2009, AIDS, V23, P1245, DOI 10.1097/QAD.0b013e32832b4271; Rajalingam Raja, 2012, Methods Mol Biol, V882, P391, DOI 10.1007/978-1-61779-842-9_23; Richardson BA, 2001, SEX TRANSM DIS, V28, P394, DOI 10.1097/00007435-200107000-00006; Richardson BA, 2013, J ACQUIRED IMMUNE DE; Roddy RE, 2002, JAMA-J AM MED ASSOC, V287, P1117, DOI 10.1001/jama.287.9.1117; Rodriguez-Garcia M, 2013, J REPROD IMMUNOL, V97, P74, DOI 10.1016/j.jri.2012.10.010; Rohan LC, 2000, CLIN DIAGN LAB IMMUN, V7, P45, DOI 10.1128/CDLI.7.1.45-48.2000; Rustomjee R, 1999, AIDS, V13, P1511, DOI 10.1097/00002030-199908200-00011; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Scapini P, 2001, EUR J IMMUNOL, V31, P1981, DOI 10.1002/1521-4141(200107)31:7<1981::AID-IMMU1981>3.0.CO;2-X; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Schwartz JL, 2007, CONTRACEPTION, V75, P136, DOI 10.1016/j.contraception.2006.09.003; Shanmugasundaram U, 2014, AM J REPROD IMMUNOL, V71, P95, DOI 10.1111/aji.12182; Southern PJ, 2013, TRENDS MICROBIOL, V21, P245, DOI 10.1016/j.tim.2013.02.002; Su HI, 2011, CONTRACEPTION, V84, P525, DOI 10.1016/j.contraception.2011.02.010; Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845; Tjomsland V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023542; Touqui Lhousseine, 2001, Current Molecular Medicine (Hilversum), V1, P739, DOI 10.2174/1566524013363258; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Velarde MC, 2009, ENDOCRINOLOGY, V150, P4701, DOI 10.1210/en.2009-0389; Whitney JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018589; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4	47	26	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0129769	10.1371/journal.pone.0129769	http://dx.doi.org/10.1371/journal.pone.0129769			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177352	Green Published, gold			2022-12-27	WOS:000358197600016
J	Wu, ZY; Zhang, SL; Li, J; Chen, S; Li, P; Sun, F; Wen, XT; Zheng, WJ; Zhang, FC; Li, YZ				Wu, Ziyan; Zhang, Shulan; Li, Jing; Chen, Si; Li, Ping; Sun, Fei; Wen, Xiaoting; Zheng, Wenjie; Zhang, Fengchun; Li, Yongzhe			Association between MEFV Mutations M694V and M680I and Behcet's Disease: A Meta-Analysis	PLOS ONE			English	Article							FAMILIAL MEDITERRANEAN FEVER; GENOME-WIDE ASSOCIATION; SAMPLE-SIZE CALCULATIONS; GENE-MUTATIONS; SUSCEPTIBILITY LOCI; TURKISH PATIENTS; MESSENGER-RNA; PYRIN; IL23R-IL12RB2; PREVALENCE	Objective Several studies have identified an association between Behcet's disease (BD) and mutations in the Mediterranean fever (MEFV) gene, which was originally linked to the autosomal recessive disease, Familial Mediterranean fever. However, no consensus has been reached. Here, a meta-analysis was conducted on published data to comprehensively evaluate this relationship. Methods Literature searches were performed in Pubmed, Embase, the Web of Science, and HuGE Navigator databases, in order to identify studies pertaining to the association between MEFV mutations and BD. Two investigators independently extracted and evaluated the data from eligible studies. The association between MEFV mutations (M694V, M680I, and E148Q) and BD was estimated overall by the odds ratio (OR) and 95% confidence intervals (95% CI). Further analysis was conducted with STATA 12.0 software (Stata Corp.; College Station, TX). Results Eligible studies (n=8) included genotyping data obtained from 2538 BD patients and 2792 healthy controls. Of the three mutations, M694V (pooled OR: 2.60, 95% CI: 2.02-3.34) and M680I (pooled OR: 1.74, 95% CI: 1.23-2.46) were found to be associated with BD in the overall analysis. The third mutation, E148Q, however, was not found to be linked with BD (pooled OR: 1.26, 95% CI: 0.69-2.31). Subgroup analysis furthermore revealed that M694V and M680I were risk loci for BD specifically in Turkish patients. Conclusions The meta-analysis confirmed that MEFV mutations M694V and M680I were associated with BD. Additional studies from other ethnic populations and functional experiments are necessary to determine the extent to which the MEFV gene underlies the development of BD.	[Li, Yongzhe] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China; Peking Union Med Coll, Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, YZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China.	yongzhelipumch@126.com	zhang, shulan/AAS-6912-2020		Research Special Fund for Public Welfare Industry of Health [201202004]; National Natural Science Foundation of China [81373188, 81172857, 81302592]; Chinese National High Technology Research and Development Program, Ministry of Science and Technology Grant [2011AA02A113]; National Science Technology Pillar Program in the 12nd Five-year Plan [2014BAI07B00]; capital health research and development of special grants [2014-1-4011]	Research Special Fund for Public Welfare Industry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National High Technology Research and Development Program, Ministry of Science and Technology Grant(National High Technology Research and Development Program of China); National Science Technology Pillar Program in the 12nd Five-year Plan; capital health research and development of special grants	This work was supported by the Research Special Fund for Public Welfare Industry of Health No. 201202004 (to F-C. Z.); the National Natural Science Foundation of China Grants No. 81373188, 81172857 (to Y.-Z. L.), and 81302592 (to S.-L. Z.); the Chinese National High Technology Research and Development Program, Ministry of Science and Technology Grant No. 2011AA02A113; the National Science Technology Pillar Program in the 12nd Five-year Plan No. 2014BAI07B00; and the capital health research and development of special grants No. 2014-1-4011 (to Y.-Z. L.).	Akkurt ZM, 2015, J CLIN LAB ANAL, V29, P317, DOI 10.1002/jcla.21772; Aksentijevich I, 1997, CELL, V90, P797; Akyuz F, 2013, J CLIN GASTROENTEROL, V47, pE23, DOI 10.1097/MCG.0b013e3182597992; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Atagunduz P, 2003, CLIN EXP RHEUMATOL, V21, pS35; Azizlerli G, 2003, INT J DERMATOL, V42, P803, DOI 10.1046/j.1365-4362.2003.01893.x; Baruch Y, 2011, CLIN EXP RHEUMATOL, V29, pS24; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Ben-Chetrit E, 2002, J RHEUMATOL, V29, P530; Bernot A, 1997, NAT GENET, V17, P25; Bilginer Y, 2010, CLIN RHEUMATOL, V29, P209, DOI 10.1007/s10067-009-1279-8; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Cosan F, 2010, ARTHRITIS RHEUM-US, V62, P3232, DOI 10.1002/art.27683; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Esmaeili M, 2011, SCAND J RHEUMATOL, V40, P383, DOI 10.3109/03009742.2011.562532; Espinosa G, 2005, CLIN EXP RHEUMATOL, V23, pS64; Gershoni-Baruch R, 2001, EUR J HUM GENET, V9, P634, DOI 10.1038/sj.ejhg.5200672; Gul A, 2014, CURR OPIN RHEUMATOL, V26, P56, DOI 10.1097/BOR.0000000000000003; HAMZAOUI K, 1990, J RHEUMATOL, V17, P1428; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hou SP, 2012, ARTHRITIS RHEUM-US, V64, P4104, DOI 10.1002/art.37708; Imirzalioglu N, 2005, SCAND J RHEUMATOL, V34, P56, DOI 10.1080/03009740510017931; Jiang ZX, 2010, ANN RHEUM DIS, V69, P1325, DOI 10.1136/ard.2009.119420; Kirino Y, 2013, P NATL ACAD SCI USA, V110, P8134, DOI 10.1073/pnas.1306352110; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Konstantopoulos K, 2012, W INDIAN MED J, V61, P28, DOI 10.7727/wimj.2011.041; Lee YJ, 2013, ANN RHEUM DIS, V72, P1510, DOI 10.1136/annrheumdis-2011-200288; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; Lo CKL, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-45; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Mat MC, 2014, CLIN DERMATOL, V32, P435, DOI 10.1016/j.clindermatol.2013.11.012; Matsuda M, 2006, INTERNAL MED, V45, P799, DOI 10.2169/internalmedicine.45.1560; Meguro A, 2010, ANN RHEUM DIS, V69, P747, DOI 10.1136/ard.2009.108571; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Mobini Maryam, 2011, Caspian J Intern Med, V2, P344; Notarnicola C, 2002, ARTHRITIS RHEUM-US, V46, P2785, DOI 10.1002/art.10575; Omenetti A, 2014, ANN RHEUM DIS, V73, P462, DOI 10.1136/annrheumdis-2012-202774; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Salanti G, 2005, GENET MED, V7, P13, DOI 10.1097/01.GIM.0000151839.12032.1A; Schwartz T, 2000, SEMIN ARTHRITIS RHEU, V29, P286, DOI 10.1016/S0049-0172(00)80015-3; Seshadri S, 2007, J IMMUNOL, V179, P1274, DOI 10.4049/jimmunol.179.2.1274; Tasliyurt T, 2013, GENE, V530, P100, DOI 10.1016/j.gene.2013.08.026; Touitou I, 2004, HUM MUTAT, V24, P194, DOI 10.1002/humu.20080; Touitou I, 2001, EUR J HUM GENET, V9, P473, DOI 10.1038/sj.ejhg.5200658; Touitou I, 2000, HUM MUTAT, V16, DOI 10.1002/1098-1004(200009)16:3<271::AID-HUMU16>3.0.CO;2-A; Ustek D, 2007, ARTHRITIS RHEUM, V56, P345, DOI 10.1002/art.22320; Yazici A, 2012, RHEUMATOL INT, V32, P3025, DOI 10.1007/s00296-011-2011-y; Yazici H, 2012, CLIN REV ALLERG IMMU, V43, P275, DOI 10.1007/s12016-012-8319-x; Yu HS, 2014, J MOL MED, V92, P961, DOI 10.1007/s00109-014-1159-9; Zhou QY, 2014, ANN RHEUM DIS, V73, P170, DOI 10.1136/annrheumdis-2012-201627	56	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132704	10.1371/journal.pone.0132704	http://dx.doi.org/10.1371/journal.pone.0132704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176758	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600144
J	Zhang, PZ; Howell, K; Krstic, M; Herderich, M; Barlow, EWR; Fuentes, S				Zhang, Pangzhen; Howell, Kate; Krstic, Mark; Herderich, Markus; Barlow, Edward William R.; Fuentes, Sigfredo			Environmental Factors and Seasonality Affect the Concentration of Rotundone in Vitis vinifera L. cv. Shiraz Wine	PLOS ONE			English	Article							NINO-SOUTHERN-OSCILLATION; RED WINE; SURFACE-TEMPERATURE; SENSORY ATTRIBUTES; VINEYARD VARIATION; WINEGRAPE QUALITY; BERRY DEVELOPMENT; WITHIN-VINEYARD; AROMA COMPOUND; CLIMATE-CHANGE	Rotundone is a sesquiterpene that gives grapes and wine a desirable 'peppery' aroma. Previous research has reported that growing grapevines in a cool climate is an important factor that drives rotundone accumulation in grape berries and wine. This study used historical data sets to investigate which weather parameters are mostly influencing rotundone concentration in grape berries and wine. For this purpose, wines produced from 15 vintages from the same Shiraz vineyard (The Old Block, Mount Langi Ghiran, Victoria, Australia) were analysed for rotundone concentration and compared to comprehensive weather data and minimal temperature information. Degree hours were obtained by interpolating available temperature information from the vineyard site using a simple piecewise cubic hermite interpolating polynomial method (PCHIP). Results showed that the highest concentrations of rotundone were consistently found in wines from cool and wet seasons. The Principal Component Analysis (PCA) showed that the concentration of rotundone in wine was negatively correlated with daily solar exposure and grape bunch zone temperature, and positively correlated with vineyard water balance. Finally, models were constructed based on the Gompertz function to describe the dynamics of rotundone concentration in berries through the ripening process according to phenological and thermal times. This characterisation is an important step forward to potentially predict the final quality of the resultant wines based on the evolution of specific compounds in berries according to critical environmental and micrometeorological variables. The modelling techniques described in this paper were able to describe the behaviour of rotundone concentration based on seasonal weather conditions and grapevine phenological stages, and could be potentially used to predict the final rotundone concentration early in future growing seasons. This could enable the adoption of precision irrigation and canopy management strategies to effectively mitigate adverse impacts related to climate change and microclimatic variability, such as heat waves, within a vineyard on wine quality.	[Zhang, Pangzhen; Howell, Kate; Barlow, Edward William R.; Fuentes, Sigfredo] Univ Melbourne, Dept Agr & Food Syst, Parkville, Vic 3052, Australia; [Krstic, Mark] Australian Wine Res Inst, Port Melbourne, Vic, Australia; [Herderich, Markus] Australian Wine Res Inst, Urrbrae, SA, Australia	University of Melbourne; Australian Wine Research Institute; Australian Wine Research Institute	Fuentes, S (corresponding author), Univ Melbourne, Dept Agr & Food Syst, Parkville, Vic 3052, Australia.	sfuentes@unimelb.edu.au	Howell, Kate/M-2370-2013; Fuentes, Sigfredo/J-6238-2015	Howell, Kate/0000-0001-6498-0472; Fuentes, Sigfredo/0000-0002-0377-5085; Zhang, Pangzhen/0000-0002-9794-2269	Rathbone Wine Group; University of Melbourne; Australian Wine Research Institute (AWRI); Australia Grape and Wine Authority; Australian Government [GWR Ph1203]; Faculty of Veterinary and Agricultural Sciences, University of Melbourne; Australian Wine Research Institute	Rathbone Wine Group; University of Melbourne(University of Melbourne); Australian Wine Research Institute (AWRI); Australia Grape and Wine Authority(Australian Grape and Wine Authority); Australian Government(Australian GovernmentCGIAR); Faculty of Veterinary and Agricultural Sciences, University of Melbourne; Australian Wine Research Institute	This work was jointly sponsored by the Rathbone Wine Group, The University of Melbourne, The Australian Wine Research Institute (AWRI) and Australia Grape and Wine Authority. The work was performed at University of Melbourne and AWRI, and supported by Australia's grape growers and winemakers through their investment body, the Australia Grape and Wine Authority, with matching funds from the Australian Government (Grant number: GWR Ph1203). Funding was also received from the Faculty of Veterinary and Agricultural Sciences, University of Melbourne. Co-authors Mark Krstic and Markus Herderich are employed by Australian Wine Research Institute. Australian Wine Research Institute provided support in the form of salaries for authors MK and MH, and provided support in data collection, but did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Rathbone Wine Group had a role in data collection, but had no role in study design, data analysis, decision to publish, or preparation of the manuscript. Australia Grape and Wine Authority had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bramley RGV, 2011, AUST J GRAPE WINE R, V17, P217, DOI 10.1111/j.1755-0238.2011.00136.x; Bramley RGV, 2004, AUST J GRAPE WINE R, V10, P32, DOI 10.1111/j.1755-0238.2004.tb00006.x; Capone DL, 2012, J AGR FOOD CHEM, V60, P2281, DOI 10.1021/jf204499h; Chaves MM, 2007, ANN APPL BIOL, V150, P237, DOI 10.1111/j.1744-7348.2006.00123.x; Chiew FHS, 1998, J HYDROL, V204, P138, DOI 10.1016/S0022-1694(97)00121-2; CSIRO and Bureau of Meteorology, 2015, TECHNICAL REPORT; DEARDORFF JW, 1978, J GEOPHYS RES-OCEANS, V83, P1889, DOI 10.1029/JC083iC04p01889; Deluc LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-212; Downey MO, 2004, AUST J GRAPE WINE R, V10, P55, DOI 10.1111/j.1755-0238.2004.tb00008.x; Geffroy O, 2014, AUST J GRAPE WINE R, V20, P401, DOI 10.1111/ajgw.12084; Gholami M., 1995, Australian Journal of Grape and Wine Research, V1, P19, DOI 10.1111/j.1755-0238.1995.tb00073.x; Gil M, 2012, PHYTOCHEMISTRY, V77, P89, DOI 10.1016/j.phytochem.2011.12.011; Gladstones J, 2004, VITICULTURE RESOURCE, V1, P90; Gladstones J. S., 1992, VITICULTURE ENV STUD; Gowan E, 1995, J CHEM ECOL, V21, P1781, DOI 10.1007/BF02033676; Herderich MJ., 2012, ACS SYM SER, V1104, P3, DOI DOI 10.1021/BK-2012-1104.CH001; Huang AC, 2014, J AGR FOOD CHEM, V62, P10809, DOI 10.1021/jf504693e; Jeffery D. W., 2009, TECHNICAL REV, V180, P11; Jones DA, 2000, INT J CLIMATOL, V20, P697, DOI 10.1002/1097-0088(20000615)20:7&lt;697::AID-JOC499&gt;3.0.CO;2-A; Jones DA, 2009, AUST METEOROL OCEAN, V58, P233, DOI 10.22499/2.5804.003; LINACRE ET, 1977, AGR METEOROL, V18, P409, DOI 10.1016/0002-1571(77)90007-3; Marais J., 2001, South African Journal of Enology and Viticulture, V22, P22; May B, 2012, FLAVOUR FRAG J, V27, P280, DOI 10.1002/ffj.3096; Murphy BF, 2008, INT J CLIMATOL, V28, P859, DOI 10.1002/joc.1627; Ou CR, 2010, J AGR FOOD CHEM, V58, P12890, DOI 10.1021/jf102587x; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pudney S, 2004, SOIL IRRIGATION NUTR, P148; Scarlett NJ, 2014, AUST J GRAPE WINE R, V20, P214, DOI 10.1111/ajgw.12075; Siebert T. E, 2010, P 14 AUSTR WIN IND T; Siebert TE, 2008, J AGR FOOD CHEM, V56, P3745, DOI 10.1021/jf800184t; Skinkis PA, 2010, AM J ENOL VITICULT, V61, P147; SMART RE, 1985, AM J ENOL VITICULT, V36, P230; Soar CJ, 2008, AUST J GRAPE WINE R, V14, P78, DOI 10.1111/j.1755-0238.2008.00011.x; Turgeon R, 2004, PLANT PHYSIOL, V136, P3795, DOI 10.1104/pp.104.042036; Webb LB, 2008, CLIM RES, V36, P89, DOI 10.3354/cr00739; Webb LB, 2008, CLIM RES, V36, P99, DOI 10.3354/cr00740; Webb LB, 2013, AUST J GRAPE WINE R, V19, P331, DOI 10.1111/ajgw.12045; Williamson PO, 2012, AUST J GRAPE WINE R, V18, P256, DOI 10.1111/j.1755-0238.2012.00201.x; Winter E, 2010, VERAISON HARVEST GRO; Wood C, 2008, J AGR FOOD CHEM, V56, P3738, DOI 10.1021/jf800183k; Zhang HH, 2014, FOOD CHEM, V164, P242, DOI 10.1016/j.foodchem.2014.05.012; Zhang PZ, 2015, J AGR FOOD CHEM, V63, P4276, DOI 10.1021/acs.jafc.5b00590	42	30	30	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133137	10.1371/journal.pone.0133137	http://dx.doi.org/10.1371/journal.pone.0133137			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176692	gold, Green Published			2022-12-27	WOS:000358197600218
J	Zhou, YY; Ji, XF; Fu, JP; Zhu, XJ; Li, RH; Mu, CK; Wang, CL; Song, WW				Zhou, Yue-Yue; Ji, Xiong-Fei; Fu, Jian-Ping; Zhu, Xiao-Juan; Li, Rong-Hua; Mu, Chang-Kao; Wang, Chun-Lin; Song, Wei-Wei			Gene Transcriptional and Metabolic Profile Changes in Mimetic Aging Mice Induced by D-Galactose	PLOS ONE			English	Article							AMELIORATES COGNITION DEFICITS; ATTENUATES OXIDATIVE DAMAGE; SMOOTH-MUSCLE-CELLS; CARDIOVASCULAR-DISEASE; LYSOPHOSPHATIDIC ACID; JAGGED1 EXPRESSION; INSULIN-RESISTANCE; ADVANCED GLYCATION; ENDOTHELIAL-CELLS; MEMORY IMPAIRMENT	D-galactose injection has been shown to induce many changes in mice that represent accelerated aging. This mouse model has been widely used for pharmacological studies of anti-aging agents. The underlying mechanism of D-galactose induced aging remains unclear, however, it appears to relate to glucose and 1ipid metabolic disorders. Currently, there has yet to be a study that focuses on investigating gene expression changes in D-galactose aging mice. In this study, integrated analysis of gas chromatography/mass spectrometry- based metabonomics and gene expression profiles was used to investigate the changes in transcriptional and metabolic profiles in mimetic aging mice injected with D-galactose. Our findings demonstrated that 48 mRNAs were differentially expressed between control and D-galactose mice, and 51 potential biomarkers were identified at the metabolic level. The effects of D-galactose on aging could be attributed to glucose and 1ipid metabolic disorders, oxidative damage, accumulation of advanced glycation end products (AGEs), reduction in abnormal substance elimination, cell apoptosis, and insulin resistance.	[Zhou, Yue-Yue; Ji, Xiong-Fei; Fu, Jian-Ping; Zhu, Xiao-Juan; Li, Rong-Hua; Mu, Chang-Kao; Wang, Chun-Lin; Song, Wei-Wei] Ningbo Univ, Key Lab Minist Educ Appl Marine Biotechnol, Ningbo 315211, Zhejiang, Peoples R China; [Zhou, Yue-Yue; Ji, Xiong-Fei; Fu, Jian-Ping; Zhu, Xiao-Juan; Li, Rong-Hua; Mu, Chang-Kao; Wang, Chun-Lin; Song, Wei-Wei] Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University; Ningbo University	Wang, CL (corresponding author), Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China.	wangchunlin@nbu.edu.cn; songweiwei@nbu.edu.cn			National Natural Science Foundation of China [41176124, 41206114]; Zhejiang Province Science and Technology Hall [LQ12C19002, ZX2013000403]; Zhejiang Province Department of Education [Y201224605]; Ningbo University [XKL11D2102, XYL12005]; K. C. Wong Magana Fund, Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Science and Technology Hall; Zhejiang Province Department of Education; Ningbo University; K. C. Wong Magana Fund, Ningbo University	Funding provided by 41176124, National Natural Science Foundation of China to WWS, 41206114, National Natural Science Foundation of China to WWS, LQ12C19002, Zhejiang Province Science and Technology Hall to WWS, ZX2013000403, Zhejiang Province Science and Technology Hall to WWS, Y201224605, Zhejiang Province Department of Education to WWS, XKL11D2102, Ningbo University to WWS, XYL12005, Ningbo University to WWS, and K. C. Wong Magana Fund, Ningbo University to WWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MH, 2014, SCAND J GASTROENTERO, V49, P521, DOI 10.3109/00365521.2014.894119; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Beger RD, 2010, TOXICOL APPL PHARM, V243, P154, DOI 10.1016/j.taap.2009.11.019; Bektas M, 2005, J CELL BIOL, V169, P801, DOI 10.1083/jcb.200407123; Bosch AM, 2006, J INHERIT METAB DIS, V29, P516, DOI 10.1007/s10545-006-0382-0; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Cui X, 2004, BIOGERONTOLOGY, V5, P317, DOI 10.1007/s10522-004-2570-3; Cuvillier O, 2002, BBA-MOL CELL BIOL L, V1585, P153, DOI 10.1016/S1388-1981(02)00336-0; Deng HB, 2006, BIOMED ENVIRON SCI, V19, P432; Du ZY, 2011, LIPIDS, V46, P647, DOI 10.1007/s11745-011-3569-6; ETHIER MF, 1989, MECH AGEING DEV, V50, P159, DOI 10.1016/0047-6374(89)90011-0; FRATTALI AL, 1994, CLIN CHEM, V40, P1991; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; Hao L, 2014, NEUROSCI LETT, V571, P45, DOI 10.1016/j.neulet.2014.04.038; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206; Imam MU, 2014, J FUNCT FOODS, V8, P193, DOI 10.1016/j.jff.2014.03.013; Katiyar SK, 2007, FREE RADICAL BIO MED, V42, P299, DOI 10.1016/j.freeradbiomed.2006.10.049; Kawatani M, 2008, P NATL ACAD SCI USA, V105, P11691, DOI 10.1073/pnas.0712239105; LaRocca TJ, 2013, MECH AGEING DEV, V134, P314, DOI 10.1016/j.mad.2013.04.004; Leclercq IA, 2007, J HEPATOL, V47, P142, DOI 10.1016/j.jhep.2007.04.002; Lightle SA, 2000, MECH AGEING DEV, V120, P111, DOI 10.1016/S0047-6374(00)00191-3; Liu CT, 1998, CANCER GENE THER, V5, P3; Loomes KM, 1999, HUM MOL GENET, V8, P2443, DOI 10.1093/hmg/8.13.2443; Lu J, 2006, BEHAV BRAIN RES, V171, P251, DOI 10.1016/j.bbr.2006.03.043; Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007; Lundwall A, 2008, CELL MOL LIFE SCI, V65, P2019, DOI 10.1007/s00018-008-8024-3; Madeo F, 2010, AUTOPHAGY, V6, P160, DOI 10.4161/auto.6.1.10600; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Melon I, 2009, NEUROSCIENCE, V159, P657, DOI 10.1016/j.neuroscience.2008.11.056; Mobley AS, 2014, TRENDS NEUROSCI, V37, P77, DOI 10.1016/j.tins.2013.11.004; Moran O, 2003, Pediatr Diabetes, V4, P101, DOI 10.1034/j.1399-5448.2003.00017.x; Morishita K, 2001, J NUTR, V131, P3182, DOI 10.1093/jn/131.12.3182; Nass N, 2007, Z GERONTOL GERIATR, V40, P349, DOI 10.1007/s00391-007-0484-9; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Qian DH, 2011, INT J MOL MED, V28, P207, DOI 10.3892/ijmm.2011.671; Racape M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019321; Rothschild SC, 2007, DEV DYNAM, V236, P295, DOI 10.1002/dvdy.21005; SALGANIK RI, 1994, BIOCHEM BIOPH RES CO, V199, P726, DOI 10.1006/bbrc.1994.1289; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHANG F, 1995, BIOCHEM J, V307, P297, DOI 10.1042/bj3070297; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Shimokata H., 2012, ANTIAGING MED, V9, P185; Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6; Sotiropoulou G, 2009, J BIOL CHEM, V284, P32989, DOI 10.1074/jbc.R109.027946; Spiegel S, 1998, ANN NY ACAD SCI, V845, P11, DOI 10.1111/j.1749-6632.1998.tb09658.x; Sugiura T, 2002, J LIPID RES, V43, P2049, DOI 10.1194/jlr.M200242-JLR200; Sun JH, 2015, MOL NEUROBIOL, V51, P947, DOI 10.1007/s12035-014-8749-y; Takeda E, 2004, BIOFACTORS, V21, P345, DOI 10.1002/biof.552210167; Tian ES, 2013, FOOD DRUG, V15, P168; Toroser D, 2007, BIOCHEM J, V405, P583, DOI 10.1042/BJ20061868; Vina J, 2013, ANTIOXID REDOX SIGN, V19, P779, DOI 10.1089/ars.2012.5111; Waggoner DW, 2004, J BIOL CHEM, V279, P38228, DOI 10.1074/jbc.M405932200; Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003; Willems L, 2003, EXP GERONTOL, V38, P1169, DOI 10.1016/j.exger.2003.08.003; Wu XJ, 2008, CARDIOVASC RES, V77, P800, DOI 10.1093/cvr/cvm105; Yang SH, 2005, J CHENGDE MED COLL, V22, P99; Yang ZH, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-120; Yoder JA, 2002, GENOMICS, V79, P750, DOI 10.1006/geno.2002.6768; Yu X, 2011, EMBO J, V30, P3754, DOI 10.1038/emboj.2011.277; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zhang D, 2006, J ETHNOPHARMACOL, V104, P250, DOI 10.1016/j.jep.2005.09.010; Zhang XL, 2007, PHARMACOL BIOCHEM BE, V88, P64, DOI 10.1016/j.pbb.2007.07.004; Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005; Zhong C, 2012, INT J PHARM MED, V18, P1844; Zhong Y, 2007, CHINESE REMEDIES CLI, V7, P576; Zhu Ya-zhen, 2007, Fudan Xuebao (Yixueban), V34, P617	70	35	37	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132088	10.1371/journal.pone.0132088	http://dx.doi.org/10.1371/journal.pone.0132088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176541	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600081
J	Chanzu, NM; Mwanda, W; Oyugi, J; Anzala, O				Chanzu, Nadia Musimbi; Mwanda, Walter; Oyugi, Julius; Anzala, Omu			Mucosal Blood Group Antigen Expression Profiles and HIV Infections: A Study among Female Sex Workers in Kenya	PLOS ONE			English	Article							ECTOCERVICAL MUCOSA; BINDING; ABO; POLYMORPHISM; ACTIVATION; CELLS; FUT2	Background The ABO blood group antigens are carbohydrate moieties expressed on human red blood cells however; these antigens can also be expressed on some other cells particularly the surface of epithelial cells and may be found in mucosal secretions. In many human populations 80% secrete ABO antigens (termed 'secretors') while 20% do not (termed 'non-secretors'). Furthermore, there are disease conditions that are associated with secretor status. Objective To investigate correlations between secretor status and HIV infection among female sex workers in Nairobi, Kenya. Methodology This cross-sectional study recruited 280 female sex workers aged 18-65 years from the Pumwani Majengo cohort, Kenya. Blood typing was determined by serological techniques using monoclonal antibodies to the ABO blood group antigens. Secretor phenotyping was determined using anti-H specific lectins specific to salivary, vaginal and cervical blood group H antigen using the agglutination inhibition technique and correlated to individual HIV sero-status. Participants were additionally screened for Bacterial vaginosis, Neisseria gonorrhoea and Trichomonas vaginalis. Results Out of the 280 participants, 212 (75.7%) were secretors and 68 (24.3%) were non-secretors. The incidence of all infections: HIV, Bacterial vaginosis, Neisseria gonorrhoea and Trichomonas vaginalis was higher among secretors compared to non-secretors. However, this difference was only statistically significant for HIV infection incidence rates: HIV infected secretors (83.7%) versus HIV un-infected secretors (71.8%) (p = 0.029) Based on ABO phenotype stratification, the incidence of HIV infection was higher among blood group A secretors (26/52 = 50%), in comparison to B (12/39 = 33.3%: p = 0.066), AB (3/9 = 33.3%: p = 0.355), and O secretors (36/112 = 32.1%: p = 0.028). Conclusion This is the first report to document the variable expression of the ABH blood group antigens profiling secretor and non-secretor phenotypes in the female genital tract among a high-risk population in a Kenyan population. These findings suggest the non-secretor phenotype may confer a certain degree of protection against HIV infection.	[Chanzu, Nadia Musimbi; Mwanda, Walter] Univ Nairobi, Coll Hlth Sci, Inst Trop & Infect Dis, Nairobi, Kenya; [Oyugi, Julius] Univ Nairobi, Coll Hlth Sci, Dept Med Microbiol, Nairobi, Kenya; [Anzala, Omu] Univ Nairobi, Coll Hlth Sci, KAVI Inst Clin Res, Nairobi, Kenya	University of Nairobi; University of Nairobi; University of Nairobi	Chanzu, NM (corresponding author), Univ Nairobi, Coll Hlth Sci, Inst Trop & Infect Dis, Nairobi, Kenya.	nadiachanzu@gmail.com		Ikumi, Nadia/0000-0002-6096-3533	Global Health Research Initiative under the HIV/AIDS Prevention Trial Capacity Building Grants Program [107005-001]	Global Health Research Initiative under the HIV/AIDS Prevention Trial Capacity Building Grants Program	The study was funded by a grant from the Global Health Research Initiative under the HIV/AIDS Prevention Trial Capacity Building Grants Program (Phase 2) (Project Number: 107005-001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2000, J INFECT DIS, V181, P737, DOI 10.1086/315234; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Anstee DJ, 2010, BLOOD, V115, P4635, DOI 10.1182/blood-2010-01-261859; ARENDRUP M, 1991, AIDS, V5, P441, DOI 10.1097/00002030-199104000-00014; Egene J., 2004, NIGER J PHYSL SCI, V19, P7; Ferrer-Admetlla A, 2009, MOL BIOL EVOL, V26, P1993, DOI 10.1093/molbev/msp108; Gelmon L, 2009, KENYA HIV PREVENTION; Gibbs A, 2014, J IMMUNOL, V192, P3947, DOI 10.4049/jimmunol.1302826; Gouws E, 2006, SEX TRANSM INFECT, V82, pIII51, DOI 10.1136/sti.2006.020164; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Higgins MA, 2009, J MOL BIOL, V388, P299, DOI 10.1016/j.jmb.2009.03.012; Hirbod T, 2013, J IMMUNOL, V191, P3948, DOI 10.4049/jimmunol.1301220; Kindberg E, 2006, AIDS, V20, P685, DOI 10.1097/01.aids.0000216368.23325.bc; Koda Y, 2001, GENETICS, V158, P747; Lajoie J, 2014, J INFECT DIS, V210, P319, DOI 10.1093/infdis/jiu023; National AIDS and STI Control Programme, 2013, KEN AIDS IND SURV 20; Neil SJD, 2005, BLOOD, V105, P4693, DOI 10.1182/blood-2004-11-4267; Perry H E, 2007, Immunohematology, V23, P100; Preece AF, 2002, BLOOD, V99, P2477, DOI 10.1182/blood.V99.7.2477; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Sayal S K, 1996, Indian J Dermatol Venereol Leprol, V62, P295; STAPLETON A, 1992, J CLIN INVEST, V90, P965, DOI 10.1172/JCI115973; Storry J R, 2009, Immunohematology, V25, P48; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Tan M, 2011, TRENDS MICROBIOL, V19, P382, DOI 10.1016/j.tim.2011.05.007; Zhang XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069379	26	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133049	10.1371/journal.pone.0133049	http://dx.doi.org/10.1371/journal.pone.0133049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186209	Green Published, gold			2022-12-27	WOS:000358198700090
J	Leischik, R; Foshag, P; Strauss, M; Littwitz, H; Garg, P; Dworrak, B; Horlitz, M				Leischik, Roman; Foshag, Peter; Strauss, Markus; Littwitz, Henning; Garg, Pankaj; Dworrak, Birgit; Horlitz, Marc			Aerobic Capacity, Physical Activity and Metabolic Risk Factors in Firefighters Compared with Police Officers and Sedentary Clerks	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR RISK; LIFE-STYLE; ACTIVITY QUESTIONNAIRE; ANAEROBIC THRESHOLD; CIVIL-SERVANTS; GAS-EXCHANGE; HEALTH	Background This study examined the association between the physical work environment and physiological performance measures, physical activity levels and metabolic parameters among German civil servants. A main focus in this study was to examine the group differences rather than measuring the absolute values in an occupational group. Methods We prospectively examined 198 male German civil servants (97 firefighters [FFs], 55 police officers [POs] and 46 sedentary clerks [SCs]). For each parameter, the groups were compared using a linear regression adjusted for age. Results The 97 FFs showed a similar maximal aerobic power (VO2max l/min) of 3.17 +/- 0.44 l/min compared with the POs, who had a maximal aerobic power of 3.13 +/- 0.62 l/min (estimated difference, POs vs. FFs: 0.05, CI: -0.12-0.23, p=0.553). The maximal aerobic power of the FFs was slightly higher than that of the SCs, who had a maximal aerobic power of 2.85 +/- 0.52 l/min (-0.21, CI: -0.39-0.04, p=0.018 vs. FFs). The average physical activity (in metabolic equivalents [METS]/week) of the FFs was 3818.8 +/- 2843.5, whereas those of the POs and SCs were 2838.2 +/- 2871.9 (-808.2, CI: 1757.6-141.2, p=0.095) and 2212.2 +/- 2292.8 (vs. FFs: -1417.1, CI: -2302-531.88, p=0.002; vs. POs: -2974.4, CI: -1611.2-393.5, p=0.232), respectively. For the FFs, the average body fat percentage was 17.7%+/- 6.2, whereas it was 21.4%+/- 5.6 for the POs (vs. FFs: 2.75, CI: 0.92-4.59, p=0.004) and 20.8%+/- 6.5 for the SCs (vs. FFs: 1.98, CI: -0.28-4.25, p=0.086; vs. POs: -0.77, CI: 3.15-1.61, p=0.523). The average waist circumference was 89.8 cm +/- 10.0 for the FFs, 97.8 cm +/- 12.4 (5.63, CI: 2.10-9.15, p=0.002) for the POs, and 97.3 +/- 11.7 (vs. FFs: -4.89, CI: 1.24-8.55, p=0.009; vs. POs: -0.73, CI: -5.21-3.74, p=0.747) for the SCs. Conclusions The FFs showed significantly higher physical activity levels compared with the SCs. The PO group had the highest cardiovascular risk of all of the groups because it included more participants with metabolic syndrome; furthermore, the POs had an average of 2.75% higher body fat, lower HDL cholesterol values and higher waist circumferences compared with the FFs and higher LDL cholesterol values compared with the SCs. Our data indicate that sedentary occupations appear to be linked to obesity and metabolic syndrome in middle-aged men.	[Leischik, Roman; Foshag, Peter; Strauss, Markus; Littwitz, Henning; Dworrak, Birgit] Univ Witten Herdecke, Fac Hlth, Sch Med, Dept Cardiol, Hagen, Germany; [Garg, Pankaj] Univ Leeds, Leeds Inst Cardiovasc & Metab Med LICAMM, Leeds, W Yorkshire, England; [Horlitz, Marc] Univ Witten Herdecke, Fac Hlth, Sch Med, Dept Cardiol, Cologne, Germany	Witten Herdecke University; University of Leeds; Witten Herdecke University	Leischik, R (corresponding author), Univ Witten Herdecke, Fac Hlth, Sch Med, Dept Cardiol, Hagen, Germany.	info@dr-leischik.de	Leischik, Roman/V-1496-2017; Garg, Pankaj/Q-9987-2016	Garg, Pankaj/0000-0002-5483-169X				Ackland TR, 2012, SPORTS MED, V42, P227, DOI 10.2165/11597140-000000000-00000; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Angermayr L, 2010, ANN BEHAV MED, V40, P49, DOI 10.1007/s12160-010-9206-4; Atlantis E, 2006, HEALTH PROMOT INT, V21, P191, DOI 10.1093/heapro/dal012; Baur DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-480; Baur DM, 2012, J STRENGTH COND RES, V26, P2331, DOI 10.1519/JSC.0b013e31823e9b19; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bureau of Labor Statistics, 2009, THE EMPLOYMENT SITUA; Clemes SA, 2014, OCCUP MED-OXFORD, V64, P188, DOI 10.1093/occmed/kqt164; Cooper AJM, 2014, DIABETOLOGIA, V57, P73, DOI 10.1007/s00125-013-3069-8; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Sousa ACPD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102299; Drew-Nord DC, 2011, J OCCUP MED TOXICOL,, V6, DOI 10.1186/1745-6673-6-25; Duque I, 2011, EUR SPINE J, V20, P87, DOI 10.1007/s00586-010-1561-0; Durand G, 2011, MED SCI SPORT EXER, V43, P1752, DOI 10.1249/MSS.0b013e318215cf25; Fogelholm M, 2006, MED SCI SPORT EXER, V38, P753, DOI 10.1249/01.mss.0000194075.16960.20; Fong Daniel Y T, 2012, BMJ, V344, pe70, DOI 10.1136/bmj.e70; Gutierrez-Fisac JL, 2002, OBES RES, V10, P270, DOI 10.1038/oby.2002.37; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hartley Tara A, 2011, Int J Emerg Ment Health, V13, P243; Hartley Tara A, 2011, Int J Emerg Ment Health, V13, P211; Hartley TA, 2011, J OCCUP ENVIRON MED, V53, P553, DOI 10.1097/JOM.0b013e3182171995; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Holtermann A, 2012, BRIT J SPORT MED, V46, P291, DOI 10.1136/bjsm.2010.079582; Jackson AS, 2009, ARCH INTERN MED, V169, P1781, DOI 10.1001/archinternmed.2009.312; Kales SN, 2007, NEW ENGL J MED, V356, P1207, DOI 10.1056/NEJMoa060357; Kennedy RA, 2007, J SPORT SCI MED, V6, P448; Kraushaar LE, 2014, PREV SCI, V15, P579, DOI 10.1007/s11121-013-0398-2; Kurtze N, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-63; Lagestad P., 2014, INT J POLICE SCI MAN, V16, P76, DOI DOI 10.1350/IJPS.2014.16.1.329; Lakoski SG, 2011, AM J CARDIOL, V108, P34, DOI 10.1016/j.amjcard.2011.02.338; Leischik R, 2005, DEUT MED WOCHENSCHR, V130, P2518, DOI 10.1055/s-2005-918598; Leischik R, 2014, INT J ENV RES PUB HE, V11, P9082, DOI 10.3390/ijerph110909082; Leischik R, 2014, KARDIOL POL, V72, P587, DOI 10.5603/KP.a2014.0089; MACKENBACH JP, 1992, SOC SCI MED, V34, P213, DOI 10.1016/0277-9536(92)90264-Q; Mares N E, 1988, Ned Tijdschr Geneeskd, V132, P1109; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1986, LANCET, V2, P274; MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244; Meyer T, 2005, INT J SPORTS MED, V26, pS38, DOI 10.1055/s-2004-830514; MORRIS JN, 1953, BRIT J IND MED, V10, P245; Peate WF, 2002, J OCCUP ENVIRON MED, V44, P546, DOI 10.1097/00043764-200206000-00017; POLLOCK ML, 1978, J OCCUP ENVIRON MED, V20, P393; Puder JJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6195; Ramey SL, 2014, J OCCUP ENVIRON MED, V56, P338, DOI 10.1097/JOM.0000000000000108; Ramli A, 2013, MALAYS J MED SCI, V20, P54; RHODES EC, 1992, CAN J SPORT SCI, V17, P228; Chaparro MAS, 2011, NUTR METAB CARDIOVAS, V21, P231, DOI 10.1016/j.numecd.2009.10.001; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Shiroma EJ, 2010, CIRCULATION, V122, P743, DOI 10.1161/CIRCULATIONAHA.109.914721; SICONOLFI SF, 1985, AM J EPIDEMIOL, V122, P101, DOI 10.1093/oxfordjournals.aje.a114068; Silva-Batista C, 2013, J STRENGTH COND RES, V27, P3481, DOI 10.1519/JSC.0b013e31828f1efa; Simmons RK, 2008, DIABETOLOGIA, V51, P787, DOI 10.1007/s00125-008-0949-4; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Soteriades ES, 2011, CARDIOL REV, V19, P202, DOI 10.1097/CRD.0b013e318215c105; Soteriades ES, 2005, OBES RES, V13, P1756, DOI 10.1038/oby.2005.214; Spitler D L, 1987, Br J Sports Med, V21, P154; Steding K, 2010, CLIN PHYSIOL FUNCT I, V30, P146, DOI 10.1111/j.1475-097X.2009.00918.x; Tharkar Shabana, 2008, J Assoc Physicians India, V56, P845; Thayyil J, 2012, N AM J MED SCI, V4, P630, DOI 10.4103/1947-2714.104313; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Violanti John M, 2013, Int J Emerg Ment Health, V15, P217; Waldburger R, 2014, EXP CLIN ENDOCR DIAB, V122, P190, DOI 10.1055/s-0034-1367006; Wasserman K, 1997, CHEST, V112, P1091, DOI 10.1378/chest.112.4.1091; WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236; Wilkinson ML, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140091; Williams-Bell FM, 2009, MED SCI SPORT EXER, V41, P653, DOI 10.1249/MSS.0b013e31818ad117; World Health Organization, 2009, GLOBAL HEALTH RISKS; Yoo C, 2014, J PHYS THER SCI, V26, P1575, DOI 10.1589/jpts.26.1575	73	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133113	10.1371/journal.pone.0133113	http://dx.doi.org/10.1371/journal.pone.0133113			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186442	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000358198700092
J	Miftode, EG; Dorneanu, OS; Leca, DA; Juganariu, G; Teodor, A; Hurmuzache, M; Nastase, EV; Anton-Paduraru, DT				Miftode, Egidia G.; Dorneanu, Olivia S.; Leca, Daniela A.; Juganariu, Gabriela; Teodor, Andra; Hurmuzache, Mihnea; Nastase, Eduard V.; Anton-Paduraru, Dana T.			Tuberculous Meningitis in Children and Adults: A 10-Year Retrospective Comparative Analysis	PLOS ONE			English	Article							NERVOUS-SYSTEM TUBERCULOSIS; INFECTION; DIAGNOSIS	Background Tuberculous meningitis (TBM) is the most lethal form of Mycobacterium tuberculosis infection, which has a high rate of neurological complications and sequelae. Objectives Our study offers a real-world infectious disease clinic perspective, being thus representative for the clinical environment of developing countries. Methods We performed a retrospective analysis of the 127 adult and 77 pediatric cases diagnosed with TBM in the Infectious Disease Hospital of the School of Medicine of Iasi, Romania between 2004-2013. Results Definite diagnosis of TBM was established in 31% of children but in only 20% of adults (p = 0.043). A contact with an individual with pulmonary tuberculosis was documented in 30% of children vs. 13% of adults (p = 0.0007). Coma occurred in 19% of patients (similar in children and adults); other consciousness abnormalities were seen in 27% of children and in 72% of adults (p = 0.000001). Cranial nerve palsies occurred prior to therapy in 9% of cases (12% vs 7% of children and adults, respectively, p>0.05), and developed 2-7 days after treatment initiation in 10%(12 vs 9%). CSF cultures were positive for M. tuberculosis in 24% of patients (31% vs. 20%, p>0.05). Overall mortality was 7.35%, similar for children and adults. Yet, permanent neurological sequelae, which were seen in 23% of patients occurred significantly more frequent in children vs. adults (36% vs. 14%, respectively, p = 0.0121). In conclusion, our retrospective analysis on a significant number of cases of TBM identified striking differences between children and adults: while children were in an earlier stage at the admission, they associated a higher frequency of neurological sequelae and miliary pattern, and they were more likely to have normal CSF protein levels and positive cultures of CSF.	[Miftode, Egidia G.; Leca, Daniela A.; Juganariu, Gabriela; Teodor, Andra; Hurmuzache, Mihnea; Nastase, Eduard V.] Univ Med & Pharm Grigore T Popa, Dept Infect Dis, Iasi, Romania; [Dorneanu, Olivia S.] Univ Med & Pharm Grigore T Popa, Dept Microbiol, Iasi, Romania; [Anton-Paduraru, Dana T.] Univ Med & Pharm Grigore T Popa, Dept Pediat, Iasi, Romania	Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy	Miftode, EG (corresponding author), Univ Med & Pharm Grigore T Popa, Dept Infect Dis, Iasi, Romania.	emiftode@yahoo.co.uk	Miftode, Egidia/AAX-7894-2020; Dorneanu, Olivia/AAV-7263-2021	Dorneanu, Olivia/0000-0001-7720-4499				[Anonymous], 2003, AM J RESP CRIT CARE, V167, P1313; Blount RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097267; Chin JH, 2013, CURR INFECT DIS REP, V15, P631, DOI 10.1007/s11908-013-0385-6; Desai D, 2006, RES MICROBIOL, V157, P967, DOI 10.1016/j.resmic.2006.08.002; Didilescu Cristian, 2013, Pneumologia, V62, P10; Donald PR, 2011, PEDIATRIC REP, V3, P51, DOI 10.4081/pr.2011.e16; Garg RK, 2010, ACTA NEUROL SCAND, V122, P75, DOI 10.1111/j.1600-0404.2009.01316.x; Gordon A, 1972, BRIT J HOSP MED, V7, P651; Hosoglu S, 1998, INT J TUBERC LUNG D, V2, P553; Hristea A, 2012, INT J INFECT DIS, V16, pE758, DOI 10.1016/j.ijid.2012.04.013; Maltezou HC, 2000, ARCH DIS CHILD, V83, P342, DOI 10.1136/adc.83.4.342; Marais S, 2010, LANCET INFECT DIS, V10, P803, DOI 10.1016/S1473-3099(10)70138-9; Nienhuis WA, 2012, CLIN INFECT DIS, V54, P519, DOI 10.1093/cid/cir856; Rock RB, 2008, CLIN MICROBIOL REV, V21, P243, DOI 10.1128/CMR.00042-07; Sutlas PN, 2003, INFECTION, V31, P387, DOI 10.1007/s15010-003-3179-1; Thakur Rajeev, 2010, J Lab Physicians, V2, P21, DOI 10.4103/0974-2727.66705; Thilothammal N, 1995, Indian Pediatr, V32, P641; Thwaites GE, 2005, J INFECT DIS, V192, P2134, DOI 10.1086/498220; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2003, J INFECT DIS, V188, P1105, DOI 10.1086/378642; Thwaites GE, 2005, LANCET NEUROL, V4, P160, DOI 10.1016/S1474-4422(05)01013-6; Thwaites G, 2009, J INFECTION, V59, P167, DOI 10.1016/j.jinf.2009.06.011; van Well Gijs T J, 2009, Pediatrics, V123, pe1, DOI 10.1542/peds.2008-1353; *WHO, 2006, TREATM TUB GUID NAT	24	36	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133477	10.1371/journal.pone.0133477	http://dx.doi.org/10.1371/journal.pone.0133477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186004	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700145
J	Pearman, JK; Irigoien, X				Pearman, John K.; Irigoien, Xabier			Assessment of Zooplankton Community Composition along a Depth Profile in the Central Red Sea	PLOS ONE			English	Article							VERTICAL-DISTRIBUTION; SURFACE ZOOPLANKTON; EPIPELAGIC ZONE; GULF; AQABA; COPEPODS; MESOZOOPLANKTON; DIVERSITY; SEQUENCES; ABUNDANCE	The composition of zooplankton in the water column has received limited attention in the main body of the Red Sea and this study investigates the change in the community both spatially and temporally across 11 stations in the central Red Sea. Using molecular methods to target the v9 region of the 18S rRNA gene a total of approximately 11.5 million reads were sequenced resulting in 2528 operational taxonomic units (OTUs) at 97% similarity. The phylum Arthropoda dominated in terms of reads accounting for on average 86.2% and 65.3% for neuston nets and vertical multinets respectively. A reduction in the number of OTUs was noticed with depth for both total metazoa and Maxillopoda whilst there was also a significant change in the composition of the Maxillopoda community. The genus Corycaeus had a higher proportion of reads in the epipelagic zone with Pleuromamma becoming increasingly dominant with depth. No significant difference was observed in the community between night and day sampling however there was a significant difference in the zooplankton community between two sampling periods separated by 10 days.	[Pearman, John K.; Irigoien, Xabier] KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology	Pearman, JK (corresponding author), KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia.	john.pearman@kaust.edu.sa	Irigoien, Xabier/B-8171-2009	Irigoien, Xabier/0000-0002-5411-6741; Pearman, John Kenneth/0000-0002-2237-9723	King Abdullah University of Science and Technology	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	The research was supported by baseline funding provided by King Abdullah University of Science and Technology to Prof. Xabier Irigoien. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Najjar Tariq H., 2008, Jordan Journal of Biological Sciences, V1, P55; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; [Anonymous], 2007, RES J ENV SCI, DOI DOI 10.3923/RJES.2007.200.210; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Becker RA, 2014, ORIGINAL S CODE R VE; Bottger-Schnack R, 2008, J PLANKTON RES, V30, P529, DOI 10.1093/plankt/fbn018; Bottger R., 1987, Biological Oceanography, V4, P383; BOTTGERSCHNACK R, 1994, HYDROBIOLOGIA, V293, P271; BOTTGERSCHNACK R, 1995, MAR ECOL PROG SER, V118, P81, DOI 10.3354/meps118081; Bucklin A., 2000, P533, DOI 10.1016/B978-012327645-2/50012-8; Bucklin A, 2003, MAR BIOL, V142, P333, DOI 10.1007/s00227-002-0943-1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Comils A, 2007, J MARINE SYST, V68, P278, DOI 10.1016/j.jmarsys.2007.01.001; Cornils A, 2007, J PLANKTON RES, V29, P57; Cornils A, 2005, J PLANKTON RES, V27, P505, DOI 10.1093/plankt/fbi023; Cornils A, 2010, DEEP-SEA RES PT II, V57, P2076, DOI 10.1016/j.dsr2.2010.09.011; Dorgham MM, 2012, OCEANOLOGIA, V54, P473, DOI 10.5697/oc.54-3.473; ECHELMAN T, 1990, MAR BIOL, V107, P179, DOI 10.1007/BF01313255; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Farstey V, 2002, MAR ECOL PROG SER, V238, P91, DOI 10.3354/meps238091; HAURY LR, 1988, HYDROBIOLOGIA, V167, P335, DOI 10.1007/BF00026322; Hirai J, 2015, MOL ECOL RESOUR, V15, P68, DOI 10.1111/1755-0998.12294; Kelley D., OCE ANAL OCEANOGRAPH; Khalil MT, 1997, J PLANKTON RES, V19, P927, DOI 10.1093/plankt/19.7.927; Kosobokova K, 2000, DEEP-SEA RES PT I, V47, P2029, DOI 10.1016/S0967-0637(00)00015-7; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lindeque PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081327; Logares R, 2012, ISME J, V6, P1823, DOI 10.1038/ismej.2012.36; LONGHURST A, 1979, Journal of Plankton Research, V1, P1, DOI 10.1093/plankt/1.1.1; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Machida RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046180; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mitra A, 2014, PROG OCEANOGR, V129, P176, DOI 10.1016/j.pocean.2014.04.025; MOORE E, 1976, ESTUAR COAST MAR SCI, V4, P589, DOI 10.1016/0302-3524(76)90068-2; Nishikawa J, 2007, DEEP-SEA RES PT II, V54, P114, DOI 10.1016/j.dsr2.2006.09.005; Oksanen J., **DATA OBJECT**; PANCUCCIPAPADOPOULOU MA, 1992, OCEANOL ACTA, V15, P365; Pearman JK, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00027; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raitsos DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064909; SCHNEIDER G, 1994, MAR BIOL, V119, P191, DOI 10.1007/BF00349556; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WEIKERT H, 1982, MAR ECOL PROG SER, V8, P129, DOI 10.3354/meps008129	46	19	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133487	10.1371/journal.pone.0133487	http://dx.doi.org/10.1371/journal.pone.0133487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186220	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700146
J	Tan, DW; Russell-Smith, SN; Simons, JM; Maybery, MT; Leung, D; Ng, HLH; Whitehouse, AJO				Tan, Diana Weiting; Russell-Smith, Suzanna N.; Simons, Jessica M.; Maybery, Murray T.; Leung, Doris; Ng, Honey L. H.; Whitehouse, Andrew J. O.			Perceived Gender Ratings for High and Low Scorers on the Autism-Spectrum Quotient Consistent with the Extreme Male Brain Account of Autism	PLOS ONE			English	Article							4TH DIGIT RATIO; FETAL TESTOSTERONE; 2ND; DISORDERS; CHILDREN	The Extreme Male Brain (EMB) theory posits that autistic traits are linked to excessive exposure to testosterone in utero. While findings from a number of studies are consistent with this theory, other studies have produced contradictory results. For example, some findings suggest that rather than being linked to hypermasculinization for males, or defeminization for females, elevated levels of autistic traits are instead linked to more androgynous physical features. The current study provided further evidence relevant to the EMB and androgony positions by comparing groups of males selected for high or low scores on the Autism-spectrum Quotient (AQ) as to the rated masculinity of their faces and voices, and comparable groups of females as to the rated femininity of their faces and voices. The voices of High-AQ males were rated as more masculine than those of Low-AQ males, while the faces of High-AQ females were rated as less feminine than those of Low-AQ females. There was no effect of AQ group on femininity ratings for female voices or on masculinity ratings for male faces. The results thus provide partial support for a link between high levels of autistic-like traits and hypermasculinization for males and defeminization for females, consistent with the EMB theory.	[Tan, Diana Weiting; Russell-Smith, Suzanna N.; Simons, Jessica M.; Maybery, Murray T.; Leung, Doris; Ng, Honey L. H.] Univ Western Australia, Sch Psychol, Neurocognit Dev Unit, Perth, WA 6009, Australia; [Tan, Diana Weiting; Whitehouse, Andrew J. O.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia	University of Western Australia; Telethon Kids Institute; University of Western Australia	Tan, DW (corresponding author), Univ Western Australia, Sch Psychol, Neurocognit Dev Unit, Perth, WA 6009, Australia.	diana.tan@research.uwa.edu.au	Tan, Diana/I-3523-2019; Whitehouse, Andrew J.O./AGJ-2519-2022	Tan, Diana/0000-0002-6394-8435; Whitehouse, Andrew J.O./0000-0001-8722-1575; Maybery, Murray/0000-0002-3760-1382	National Health and Medical Research Council [APP1003424]; Australian Research Council [DP120104713]; International Postgraduate Research Scholarship in Australia	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); International Postgraduate Research Scholarship in Australia	This research was partly supported by a National Health and Medical Research Council project grant (#APP1003424) and an Australian Research Council Discovery grant (DP120104713). DWT is supported by the International Postgraduate Research Scholarship in Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1969, VOICE ARTICULATION D; Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S, 2014, PLOS ONE, V9, P1, DOI DOI 10.1371/J0URNAL.P0NE.0102251; Baron-Cohen S, 2014, MOL PSYCHIATR, V48, P1; Baron-Cohen S., 2003, ESSENTIAL DIFFERENCE; BARONCOHEN S, 2004, PRENATAL TESTOSTERON; Bejerot S, 2012, BRIT J PSYCHIAT, V201, P116, DOI 10.1192/bjp.bp.111.097899; Cartei V, 2014, HORM BEHAV, V66, P569, DOI 10.1016/j.yhbeh.2014.08.006; de Vries ALC, 2010, J AUTISM DEV DISORD, V40, P930, DOI 10.1007/s10803-010-0935-9; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; Grinter EJ, 2009, J AUTISM DEV DISORD, V39, P670, DOI 10.1007/s10803-008-0658-3; Honekopp J, 2012, AUTISM RES, V5, P221, DOI 10.1002/aur.1230; Ingudomnuku E, 2007, HORM BEHAV, V51, P597, DOI 10.1016/j.yhbeh.2007.02.001; Jones RM, 2012, J AUTISM DEV DISORD, V42, P301, DOI 10.1007/s10803-011-1227-8; Knickmeyer RC, 2006, J CHILD NEUROL, V21, P825, DOI 10.1177/08830738060210101601; Koehler N, 2004, P ROY SOC B-BIOL SCI, V271, pS233, DOI 10.1098/rsbl.2003.0146; LIPPA R, 1978, J RES PERS, V12, P1, DOI 10.1016/0092-6566(78)90078-8; Lutchmaya S, 2002, INFANT BEHAV DEV, V25, P327, DOI 10.1016/S0163-6383(02)00094-2; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Majewska MD, 2014, EUR CHILD ADOLES PSY, V23, P485, DOI 10.1007/s00787-013-0472-0; Manning JT, 2001, DEV MED CHILD NEUROL, V43, P160, DOI 10.1017/S0012162201000317; Meindl K, 2012, P ROY SOC B-BIOL SCI, V279, P2457, DOI 10.1098/rspb.2011.2351; Mitteroecker P, 2015, PLOS ONE, P1; Neave N, 2003, P ROY SOC B-BIOL SCI, V270, P2167, DOI 10.1098/rspb.2003.2502; Pellicano E, 2006, DEV PSYCHOPATHOL, V18, P77, DOI 10.1017/S0954579406060056; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P229, DOI 10.1016/j.evolhumbehav.2004.04.003; Pohl A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-27; Robinson EB, 2011, ARCH GEN PSYCHIAT, V68, P1113, DOI 10.1001/archgenpsychiatry.2011.119; Russell-Smith SN, 2010, J AUTISM DEV DISORD, V40, P968, DOI 10.1007/s10803-010-0945-7; Ruta L, 2011, PSYCHONEUROENDOCRINO, V36, P1154, DOI 10.1016/j.psyneuen.2011.02.007; Sarachana T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017116; Scott N, 2015, CURRENT ISSUES TOURI, P1; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Teatero ML, 2013, J AUTISM DEV DISORD, V43, P2664, DOI 10.1007/s10803-013-1819-6; Whitehouse AJO, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-25; Whitehouse AJO, 2012, J CHILD PSYCHOL PSYC, V53, P726, DOI 10.1111/j.1469-7610.2011.02523.x	38	19	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131780	10.1371/journal.pone.0131780	http://dx.doi.org/10.1371/journal.pone.0131780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186689	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700023
J	Hu, DN; Mou, CH; Chao, SC; Lin, CY; Nien, CW; Kuan, PT; Jonas, JB; Sung, FC				Hu, Dan-Ning; Mou, Chih-Hsin; Chao, Shih-Chun; Lin, Ching-Yang; Nien, Chan-Wei; Kuan, Pei-Tzu; Jonas, Jost B.; Sung, Fung-Chang			Incidence of Non-Traumatic Subconjunctival Hemorrhage in a Nationwide Study in Taiwan from 2000 to 2011	PLOS ONE			English	Article							RISK; POLYMORPHISM; STROKE	Objective To determine the nationwide incidence of non-traumatic subconjunctival hemorrhage (NTSCH) in Taiwan from 2000-2011 and to analyze the risk factors for NTSCH using a case-control analysis. Methods This is a population-based cohort administrative database study. Randomly selected 1,000,000 residents from the Taiwan National Health Insurance Research Database in 2000 and followed for 12 years to determine the population incidence of NTSCH. Individuals with the first diagnosis of subconjunctival hemorrhage were identified by the corresponding International Classification of Diseases code (ICD) 372.72. Traumatic subconjunctival hemorrhages (ICD-9 codes 921, 871, 850-854 and 959.01) were excluded. The association of NTSCH with various demographic factors, comorbidities and use of medications was studied by a population based case-control analysis using data of 2008-2011. Results A total of 67,720 patients with a first-time diagnosis of NTSCH were identified during the 12 years period. The mean annual incidence was 65 per 10,000 individuals (crude incidence) and 60 per 10,000 individuals (age-and sex-standardized incidence). The incidence rate of NTSCH was higher in women than in men, [men-women ratio: 0.80 (95% confidence interval: 0.78-0.81)]. The age-specific incidence decreased from childhood to the group of teenagers, after which it increased to a maximal value of 136.2 per 10,000 people in the age group of 60-69 years. Case-control analysis showed that comorbidities of hypertension, purpura and thrombocytopenia, and the use of aspirin were significantly associated with the risk of NTSCH. Conclusions This study indicates that NTSCH is a common eye disease that occurs once in 167 individuals in a general East Asian population per year. It occurs more often in women than in men and the age-specific incidence peaked in the age group of 60-69 years. Hypertension, purpura and thrombocytopenia, and the use of aspirin are the major risk factors for NTSCH.	[Hu, Dan-Ning] New York Eye & Ear Infirm Mt Sinai, Dept Ophthalmol, Icahn Sch Med Mt Sinai, New York, NY 10003 USA; [Hu, Dan-Ning; Chao, Shih-Chun; Lin, Ching-Yang; Nien, Chan-Wei; Kuan, Pei-Tzu] Show Chwan Mem Hosp, Dept Ophthalmol, Changhua, Taiwan; [Mou, Chih-Hsin; Sung, Fung-Chang] China Med Univ, Inst Clin & Med Sci, Taichung, Taiwan; [Mou, Chih-Hsin; Sung, Fung-Chang] China Med Univ & Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chao, Shih-Chun] Natl Chiao Tung Univ, Inst Elect & Comp Engn, Hsinchu, Taiwan; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany	Icahn School of Medicine at Mount Sinai; New York Eye & Ear Infirmary of Mount Sinai; Show Chwan Memorial Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; Ruprecht Karls University Heidelberg	Jonas, JB (corresponding author), Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany.	jost.jonas@medma.uni-heidelberg.de; fcsung@mail.cmu.edu.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]; China Medical University Hospital [1MS1]; National Sciences Council, Executive Yuan [NSC 100-2621-M-039-001]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; National Sciences Council, Executive Yuan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002), China Medical University Hospital (grant number 1MS1), National Sciences Council, Executive Yuan (grant number NSC 100-2621-M-039-001).	BLACK RA, 1982, ANN OPHTHALMOL, V14, P1024; Bodack Marie I, 2007, Optometry, V78, P113, DOI 10.1016/j.optm.2006.10.015; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Chang CH, 2001, CORNEA, V20, P295, DOI 10.1097/00003226-200104000-00011; Chang YS, 2012, AM J OPHTHALMOL, V154, P645, DOI 10.1016/j.ajo.2012.03.046; Duke-Elder S, 1977, SYSTEM OPHTHALMOLO 1, V8, P27; Engin A, 2009, AM J OPHTHALMOL, V147, P634, DOI 10.1016/j.ajo.2008.11.014; FUKUYAMA J, 1990, OPHTHALMOLOGICA, V200, P63, DOI 10.1159/000310079; Hebel JR, 2012, EPIDEMIOLOGY BIOSTAT, P23; Herr S, 2004, PEDIATRICS, V113, P1658, DOI 10.1542/peds.113.6.1658; Incorvaia C, 2002, AM J OPHTHALMOL, V134, P927, DOI 10.1016/S0002-9394(02)01812-3; KATZMAN GH, 1992, CLIN PEDIATR, V31, P149, DOI 10.1177/000992289203100304; Kiratli H, 2012, CAN J OPHTHALMOL, V47, P318, DOI 10.1016/j.jcjo.2012.02.002; Kobayashi H, 2010, J CATARACT REFR SURG, V36, P1115, DOI 10.1016/j.jcrs.2010.01.017; Kumar N, 2006, J CATARACT REFR SURG, V32, P1022, DOI 10.1016/j.jcrs.2006.02.035; Leiker LL, 2009, OPTOMETRY, V80, P227, DOI 10.1016/j.optm.2008.10.018; Mimura T, 2010, OPHTHALMOLOGICA, V224, P133, DOI 10.1159/000236038; Mimura T, 2010, OPHTHALMOLOGICA, V224, P90, DOI 10.1159/000235798; Murthy R, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-4; Parmeggiani F, 2004, AM J OPHTHALMOL, V138, P481, DOI 10.1016/j.ajo.2004.03.017; Sodhi PK, 2003, JPN J OPHTHALMOL, V47, P316, DOI 10.1016/S0021-5155(03)00017-0; STUART MJ, 1982, NEW ENGL J MED, V307, P909, DOI 10.1056/NEJM198210073071502; Tarlan B, 2013, CLIN OPHTHALMOL, V7, P1163, DOI 10.2147/OPTH.S35062; Wang TJ, 2013, ACTA OPHTHALMOL, V91, P226, DOI 10.1111/j.1755-3768.2011.02359.x; YANCEY MK, 1991, OBSTET GYNECOL, V78, P646	25	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132762	10.1371/journal.pone.0132762	http://dx.doi.org/10.1371/journal.pone.0132762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181776	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198200032
J	Zhu, XJ; Yang, ZF; Zhou, JY; Liu, L; Sun, XM; Fan, ZF; Hu, SY; Chen, YC; Li, WX; Cao, M; Wang, LX				Zhu, Xue-Jun; Yang, Zhong-Fa; Zhou, Jin-Yong; Liu, Li; Sun, Xue-Mei; Fan, Zhen-Fang; Hu, Shou-You; Chen, Yu-Chao; Li, Wei-Xia; Cao, Meng; Wang, Li-Xin			Progression of Large Lymphoma Is Significantly Impeded with a Combination of Gemcitabine Chemotherapy and Dendritic Cells Intra-Tumor Vaccination	PLOS ONE			English	Article							MYELOID SUPPRESSOR-CELLS; CANCER-IMMUNOTHERAPY; IMMUNE-RESPONSES; NK CELLS; T-CELLS; EXPANSION; MICE; EXPRESSION; CARCINOMA; CD4(+)	Relapsed, refractory lymphoma remains to be a challenge and lacks efficient treatment. Some tumor cells escape from treatment, become resistant to chemotherapeutic agents, and rapidly regenerate into large tumors. Lymphoma cells induce accumulation of Gr-1(+-)CD11b(+) myeloid derived suppressor cells (MDSCs) in lymphatic organs and their vicinity. MDSCs enable tumor cells to escape from immune cells mediated surveillance and attack. Gemcitabine is a chemotherapeutic agent that eliminates both tumor cells and MDSCs, improving the immune environment favorable for subsequent treatment. We evaluated the effects of low dose gemcitabine combined with intra-tumorally delivered dendritic cells (DCs) for the treatment of A20 large-size lymphoma. We showed that MDSCs increased markedly in lymphoma-bearing mice, and that gemcitabine significantly increased the apoptosis of MDSCs. Treatment of lymphoma with either gemcitabine or intra-tumoral DCs alone could not inhibit tumor growth or rescue lymphoma-bearing mice. Treatment of lymphoma with small dose gemcitabine followed by intra-tumorally injected DCs significantly improved the efficacy of either individual treatment by reducing MDSCs, inducing onsite DCs maturation, eliminating tumor cells, inhibiting tumor growth and relapse, and extending the survival of the lymphoma-bearing mice, partly through the induction of the IFN gamma secreting cells and the activation of cytotoxic lymphocytes. We showed that NK cells and CD8(+) T cells were the major effectors to mediate the inhibition of tumor growth. Thus, the observation that gemcitabine synergizes DCs mediated immunotherapy to improve the efficacy of large size lymphoma treatment provides an experimental basis for the combination of chemotherapy and immunotherapy for the efficient treatment of relapsed or refractory lymphoma.	[Zhu, Xue-Jun; Li, Wei-Xia; Cao, Meng; Wang, Li-Xin] Southeast Univ, Sch Med, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Zhu, Xue-Jun; Zhou, Jin-Yong; Liu, Li; Sun, Xue-Mei; Fan, Zhen-Fang; Hu, Shou-You; Chen, Yu-Chao] Jiangsu Prov Tradit Chinese Med Hosp, Dept Med, Div Hematol, Nanjing, Jiangsu, Peoples R China; [Yang, Zhong-Fa] Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA 01605 USA	Southeast University - China; University of Massachusetts System; University of Massachusetts Worcester	Zhu, XJ (corresponding author), Southeast Univ, Sch Med, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China.	Zhuxj2@hotmail.com; lxwang@seu.edu.cn			National Natural Science Foundation of China [31170857, 30972783, 300771999, 81001299]; Top Six Elite Scholar Program of Jiangsu Province China [2010-WS-012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Top Six Elite Scholar Program of Jiangsu Province China	This work is funded by National Natural Science Foundation of China (31170857, 30972783, 300771999, 81001299) (http://www.nsfc.gov.cn/Portal0/default166.htm) and the Top Six Elite Scholar Program of Jiangsu Province China #2010-WS-012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C, 2005, BLOOD, V106, P338, DOI 10.1182/blood-2004-09-3775; Adam C, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-16; Bauer C, 2007, GUT, V56, P1275, DOI 10.1136/gut.2006.108621; Briones J, 2008, CLIN TRANSL ONCOL, V10, P543, DOI 10.1007/s12094-008-0249-4; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; De Velde ALRV, 2008, B CANCER, V95, P320, DOI 10.1684/bdc.2008.0602; Di Nicola M, 2009, BLOOD, V113, P18, DOI 10.1182/blood-2008-06-165654; Donnou Sabrina, 2012, Adv Hematol, V2012, P701704, DOI 10.1155/2012/701704; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Hanson EM, 2009, J IMMUNOL, V183, P937, DOI 10.4049/jimmunol.0804253; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Khaled YS, 2013, IMMUNOL CELL BIOL, V91, P493, DOI 10.1038/icb.2013.29; Komaru A, 2009, J IMMUNOL, V183, P4211, DOI 10.4049/jimmunol.0803845; Kusmartsev S, 2003, CANCER RES, V63, P4441; Le HK, 2009, INT IMMUNOPHARMACOL, V9, P900, DOI 10.1016/j.intimp.2009.03.015; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Li YH, 2008, CANCER RES, V68, P6889, DOI 10.1158/0008-5472.CAN-08-0161; Lion E, 2012, ONCOLOGIST, V17, P1256, DOI 10.1634/theoncologist.2011-0122; Liu CR, 2007, BLOOD, V109, P4336, DOI 10.1182/blood-2006-09-046201; Liu L, 2009, LYMPHOMA LEUKEMIA, V18, P502; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; Nowak AK, 2002, CANCER RES, V62, P2353; Palucka K, 2011, J INTERN MED, V269, P64, DOI 10.1111/j.1365-2796.2010.02317.x; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Serafini P, 2004, CANCER IMMUNOL IMMUN, V53, P64, DOI 10.1007/s00262-003-0443-2; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Song WR, 2005, CANCER RES, V65, P5958, DOI 10.1158/0008-5472.CAN-05-0406; Steinman RM, 2002, J CLIN INVEST, V109, P1519, DOI 10.1172/JCI200215962; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Timmerman JM, 2002, BLOOD, V99, P1517, DOI 10.1182/blood.V99.5.1517; Vieweg J, 2007, CLIN CANCER RES, V13, p727S, DOI 10.1158/1078-0432.CCR-06-1924; Wang LX, 2005, CANCER RES, V65, P10569, DOI 10.1158/0008-5472.CAN-05-2117; Watanabe S, 2008, J IMMUNOL, V181, P3291, DOI 10.4049/jimmunol.181.5.3291; Young MRI, 1997, INT J CANCER, V74, P69, DOI 10.1002/(SICI)1097-0215(19970220)74:1<69::AID-IJC12>3.0.CO;2-D; Young MRI, 1996, J IMMUNOL, V156, P1916	39	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132799	10.1371/journal.pone.0132799	http://dx.doi.org/10.1371/journal.pone.0132799			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181041	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198200036
J	Chernysh, S; Gordya, N; Suborova, T				Chernysh, Sergey; Gordya, Natalia; Suborova, Tatyana			Insect Antimicrobial Peptide Complexes Prevent Resistance Development in Bacteria	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; CALLIPHORA-VICINA; EVOLUTION; MECHANISMS	In recent decades much attention has been paid to antimicrobial peptides (AMPs) as natural antibiotics, which are presumably protected from resistance development in bacteria. However, experimental evolution studies have revealed prompt resistance increase in bacteria to any individual AMP tested. Here we demonstrate that naturally occurring compounds containing insect AMP complexes have clear advantage over individual peptide and small molecule antibiotics in respect of drug resistance development. As a model we have used the compounds isolated from bacteria challenged maggots of Calliphoridae flies. The compound isolated from blow fly Calliphora vicina was found to contain three distinct families of cell membrane disrupting/permeabilizing peptides (defensins, cecropins and diptericins), one family of proline rich peptides and several unknown antimicrobial substances. Resistance changes under long term selective pressure of the compound and reference antibiotics cefotaxime, meropenem and polymyxin B were tested using Escherichia coli, Klebsiella pneumonia and Acinetobacter baumannii clinical strains. All the strains readily developed resistance to the reference antibiotics, while no signs of resistance growth to the compound were registered. Similar results were obtained with the compounds isolated from 3 other fly species. The experiments revealed that natural compounds containing insect AMP complexes, in contrast to individual AMP and small molecule antibiotics, are well protected from resistance development in bacteria. Further progress in the research of natural AMP complexes may provide novel solutions to the drug resistance problem.	[Chernysh, Sergey; Gordya, Natalia] St Petersburg State Univ, Fac Biol, Lab Insect Biopharmacol & Immunol, St Petersburg 199034, Russia; [Suborova, Tatyana] Kirov Mil Med Acad, Res Ctr, St Petersburg, Russia	Saint Petersburg State University	Chernysh, S (corresponding author), St Petersburg State Univ, Fac Biol, Lab Insect Biopharmacol & Immunol, St Petersburg 199034, Russia.	sichernysh1951@gmail.com	Tulin, Dmitry/N-1039-2013	Tulin, Dmitry/0000-0001-6357-0228	St.Petersburg State University [1.39.323.2014]	St.Petersburg State University	This work was supported by St.Petersburg State University (URL http://spbu.ru), grant number 1.39.323.2014 - SC, NG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell G, 2003, MICROBIOL-SGM, V149, P1367, DOI 10.1099/mic.0.26265-0; BULET P, 1991, J BIOL CHEM, V266, P24520; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; Chernysh S, 2002, P NATL ACAD SCI USA, V99, P12628, DOI 10.1073/pnas.192301899; Chernysh SI, 2011, J EVOL BIOCHEM PHYS+, V47, P524, DOI 10.1134/S0022093011060032; Chernysh S.I., 2010, INFEKTS KHIRURG, V8, P47; Chernysh Sergey I., 2000, Entomological Science, V3, P139; CHERNYSH SI, 1995, EUR J ENTOMOL, V92, P203; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dobson AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076521; Fehri LF, 2005, ANTIMICROB AGENTS CH, V49, P4154, DOI 10.1128/AAC.49.10.4154-4165.2005; Ge YG, 1999, ANTIMICROB AGENTS CH, V43, P782, DOI 10.1128/AAC.43.4.782; Giacometti A, 1999, J ANTIMICROB CHEMOTH, V44, P641, DOI 10.1093/jac/44.5.641; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Gueguen Y, 2009, MOL IMMUNOL, V46, P516, DOI 10.1016/j.molimm.2008.07.021; Habets MGJL, 2012, BIOL LETTERS, V8, P416, DOI 10.1098/rsbl.2011.1203; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hegreness M, 2008, P NATL ACAD SCI USA, V105, P13977, DOI 10.1073/pnas.0805965105; Kaur G, 2011, MICROB DRUG RESIST, V17, P197, DOI 10.1089/mdr.2010.0054; KEPPI E, 1989, ARCH INSECT BIOCHEM, V10, P229, DOI 10.1002/arch.940100306; Lambert RJW, 2004, J APPL MICROBIOL, V97, P699, DOI 10.1111/j.1365-2672.2004.02345.x; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Leonard SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042103; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Lin MF, 2014, WORLD J CLIN CASES, V2, P787, DOI 10.12998/wjcc.v2.i12.787; Michel JB, 2008, P NATL ACAD SCI USA, V105, P14918, DOI 10.1073/pnas.0800944105; Napier BA, 2013, MBIO, V4, DOI 10.1128/mBio.00021-13; NESIN AP, 1995, APPL ENTOMOL ZOOL, V30, P351; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; U.S. department of health and human services, 2013, ANT RES THEATS US; Vinogradova EB, 1984, BLOWFLY CALLIPHORA V; Wiesner J, 2011, BIOL INSPIR SYST, V2, P29, DOI 10.1007/978-90-481-9641-8_3; Wilmes M, 2011, NAT PROD REP, V28, P1350, DOI 10.1039/c1np00022e; World Health Organization, 2014, ANT RES GLOB REP SUR; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	39	52	60	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130788	10.1371/journal.pone.0130788	http://dx.doi.org/10.1371/journal.pone.0130788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177023	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600027
J	Kollgaard, T; Ugurel-Becker, S; Idorn, M; Andersen, MH; Becker, JC; Straten, PT				Kollgaard, Tania; Ugurel-Becker, Selma; Idorn, Manja; Andersen, Mads Hald; Becker, Juergen C.; Straten, Per Thor			Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes	PLOS ONE			English	Article							SUPPRESSOR-CELLS; MELANOMA PATIENTS; PATIENT SURVIVAL; CANCER-PATIENTS; TUMOR-IMMUNITY; T(H)17; BLOOD	Various subsets of immune regulatory cells are suggested to influence the outcome of therapeutic antigen-specific anti-tumor vaccinations. We performed an exploratory analysis of a possible correlation of pre-vaccination Th17 cells, MDSCs, and Tregs with both vaccination-induced T-cell responses as well as clinical outcome in metastatic melanoma patients vaccinated with survivin-derived peptides. Notably, we observed dysfunctional Th1 and cytotoxic T cells, i.e. down-regulation of the CD3 zeta chain (p=0.001) and an impaired IFN gamma-production (p=0.001) in patients compared to healthy donors, suggesting an altered activity of immune regulatory cells. Moreover, the frequencies of Th17 cells (p=0.03) and Tregs (p=0.02) were elevated as compared to healthy donors. IL-17-secreting CD4(+) T cells displayed an impact on the immunological and clinical effects of vaccination: Patients characterized by high frequencies of Th17 cells at pre-vaccination were more likely to develop survivin-specific T-cell reactivity post-vaccination (p=0.03). Furthermore, the frequency of Th17 (p=0.09) and Th17/IFN gamma(+) (p=0.19) cells associated with patient survival after vaccination. In summary, our explorative, hypothesis-generating study demonstrated that immune regulatory cells, in particular Th17 cells, play a relevant role for generation of the vaccine-induced anti-tumor immunity in cancer patients, hence warranting further investigation to test for validity as predictive biomarkers.	[Kollgaard, Tania; Idorn, Manja; Andersen, Mads Hald; Straten, Per Thor] Copenhagen Univ Hosp, Dept Hematol, Ctr Canc Immune Therapy, Herlev, Denmark; [Ugurel-Becker, Selma] Univ Wurzburg, Dept Dermatol, Wurzburg, Germany; [Becker, Juergen C.] Med Univ Graz, Gen Dermatol, Graz, Austria	University of Copenhagen; University of Wurzburg; Medical University of Graz	Straten, PT (corresponding author), Copenhagen Univ Hosp, Dept Hematol, Ctr Canc Immune Therapy, Herlev, Denmark.	per.thor.straten@regionh.dk	Idorn, Manja/AAY-6260-2021	Idorn, Manja/0000-0002-6769-9165; thor Straten, Per/0000-0002-4731-4969; Andersen, Mads Hald/0000-0002-2914-9605	Danish Cancer Society [R72-A4396-13-S2]; Danish Medical Research Council [DFF - 1331-00095B]; Toyota Fonden [BG-8228]; The Danish Cancer Society [R72-A4396, R72-A4460] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Toyota Fonden; The Danish Cancer Society(Danish Cancer Society)	PTS received funding from The Danish Cancer Society. www.cancer.dk. Grant number: R72-A4396-13-S2. PTS received funding from Danish Medical Research Council. http://ufm.dk/en/research-and-innovation/funding-programmes-for-research-and-innovation/find-danish-funding-programmes/dff-the-danish-council-for-independent-research. Grant number: DFF - 1331-00095B. PTS received funding from Toyota Fonden, Grant number: BG-8228. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Becker JC, 2014, CANCER IMMUNOL IMMUN, V63, P313, DOI 10.1007/s00262-013-1512-9; Becker JC, 2013, CANCER IMMUNOL IMMUN, V62, P1137, DOI 10.1007/s00262-013-1434-6; Becker JC, 2012, CANCER IMMUNOL IMMUN, V61, P2091, DOI 10.1007/s00262-012-1266-9; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; De Boniface J, 2012, INT J CANCER, V131, P129, DOI 10.1002/ijc.26355; Derhovanessian E, 2009, INT J CANCER, V125, P1372, DOI 10.1002/ijc.24497; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Greten TF, 2011, INT IMMUNOPHARMACOL, V11, P802, DOI 10.1016/j.intimp.2011.01.003; Hemdan NYA, 2013, IMMUNOL LETT, V149, P123, DOI 10.1016/j.imlet.2012.11.002; Meyer C, 2011, P NATL ACAD SCI USA, V108, P17111, DOI 10.1073/pnas.1108121108; Montero AJ, 2012, J IMMUNOTHER, V35, P107, DOI 10.1097/CJI.0b013e318242169f; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Nagaraj S, 2010, J IMMUNOL, V184, P3106, DOI 10.4049/jimmunol.0902661; Ogino S, 2013, MODERN PATHOL, V26, P465, DOI 10.1038/modpathol.2012.214; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Pohla H, 2012, MOL MED, V18, P1499, DOI 10.2119/molmed.2012.00221; Poschke I, 2012, CANCER IMMUNOL IMMUN, V61, P827, DOI 10.1007/s00262-011-1143-y; Samaik AA, 2011, CLIN CANCER RES, V17, P896, DOI 10.1158/1078-0432.CCR-10-2463; Scheibenbogen C, 1997, CLIN CANCER RES, V3, P221; Sfanos KS, 2008, CLIN CANCER RES, V14, P3254, DOI 10.1158/1078-0432.CCR-07-5164; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Umansky V, 2012, SEMIN CANCER BIOL, V22, P319, DOI 10.1016/j.semcancer.2012.02.003; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883; Weide B, 2013, CLIN CANCER RES, V10, P11; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Ye J, 2013, AM J PATHOL, V182, P10, DOI 10.1016/j.ajpath.2012.08.041; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	34	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131934	10.1371/journal.pone.0131934	http://dx.doi.org/10.1371/journal.pone.0131934			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176858	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600070
J	Tran, NT; Taylor, R; Antierens, A; Staderini, N				Nguyen-Toan Tran; Taylor, Richard; Antierens, Annick; Staderini, Nelly			Cholera in Pregnancy: A Systematic Review and Meta-Analysis of Fetal, Neonatal, and Maternal Mortality	PLOS ONE			English	Article							THERAPY; WOMEN	Background Maternal infection with cholera may negatively affect pregnancy outcomes. The objective of this research is to systematically review the literature and determine the risk of fetal, neonatal and maternal death associated with cholera during pregnancy. Materials and Methods Medline, Global Health Library, and Cochrane Library databases were searched using the key terms cholera and pregnancy for articles published in any language and at any time before August 2013 to quantitatively summarize estimates of fetal, maternal, and neonatal mortality. 95% confidence intervals (CIs) were calculated for each selected study. Random-effect non-linear logistic regression was used to calculate pooled rates and 95% CIs by time period. Studies from the recent period (1991-2013) were compared with studies from 1969-1990. Relative risk (RR) estimates and 95% CIs were obtained by comparing mortality of selected recent studies with published national normative data from the closest year. Results The meta-analysis included seven studies that together involved 737 pregnant women with cholera from six countries. The pooled fetal death rate for 4 studies during 1991-2013 was 7.9% (95% CIs 5.3-10.4), significantly lower than that of 3 studies from 1969-1990 (31.0%, 95% CIs 25.2-36.8). There was no difference in fetal death rate by trimester. The pooled neonatal death rate for 1991-2013 studies was 0.8% (95% CIs 0.0-1.6), and 6.4% (95% CIs 0.0-20.8) for 1969-1990. The pooled maternal death rate for 1991-2013 studies was 0.2% (95% CIs 0.0-0.7), and 5.0% (95% CIs 0.0-16.0) for 1969-1990. Compared with published national mortality estimates, the RR for fetal death of 5.8 (95% CIs 2.9-11.3) was calculated for Haiti (2013), 1.8 (95% CIs 0.3-10.4) for Senegal (2007), and 2.6 (95% CIs 0.5-14.9) for Peru (1991); there were no significant differences in the RR for neonatal or maternal death. Conclusion Results are limited by the inconsistencies found across included studies but suggest that maternal cholera is associated with adverse pregnancy outcomes, particularly fetal death. These findings can inform a research agenda on cholera in pregnancy and guidance for the timely management of pregnant women with cholera.	[Nguyen-Toan Tran; Antierens, Annick; Staderini, Nelly] Med Sans Frontieres, Geneva, Switzerland; [Nguyen-Toan Tran; Taylor, Richard] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	Doctors Without Borders; University of New South Wales Sydney	Staderini, N (corresponding author), Med Sans Frontieres, Geneva, Switzerland.	nelly.staderini@geneva.msf.org		Tran, Nguyen-Toan/0000-0001-7134-7878	Medecins Sans Frontieres (MSF) Switzerland	Medecins Sans Frontieres (MSF) Switzerland	The work was funded by Medecins Sans Frontieres (MSF) Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WKLY EPIDEMIOL REC, V86, P325; AYANGADE O, 1981, International Journal of Gynecology and Obstetrics, V19, P403, DOI 10.1016/0020-7292(81)90025-4; Center for Disease Control and Prevention, 2011, HAIT CHOL TRAIN MAN; Ciglenecki I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002368; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Diop SA, 2007, MED MALADIES INFECT, V37, P816, DOI 10.1016/j.medmal.2007.05.010; Fournier JM, 2007, PRESSE MED, V36, P727, DOI 10.1016/j.lpm.2006.11.029; Grados Pablo, 1994, Boletin de la Oficina Sanitaria Panamericana, V116, P198; Harris JB, 2010, LANCET, V376, P1961, DOI 10.1016/S0140-6736(10)62172-1; HIRSCHHORN N, 1969, LANCET, V1, P1230; Khan P K, 1969, Int Surg, V51, P138; LINDENBAUM J, 1967, B WORLD HEALTH ORGAN, V37, P529; Proegler C, 1871, BOSTON MED SURG J, V85, P200, DOI [10.1056/nejm187109280851306, DOI 10.1056/NEJM187109280851306, 10.1056/NEJM187109280851306]; RUXIN JN, 1994, MED HIST, V38, P363, DOI 10.1017/S0025727300036905; SAONA P, 1991, REV MED HERED, V2, P112; United Nations Children's Fund, 2012, LEV TRENDS CHILD MOR; Wang XB, 2003, FERTIL STERIL, V79, P577, DOI 10.1016/S0015-0282(02)04694-0; WHO, 2004, CHOL OUTBR ASS OUTBR; WHO World Health Organization, 2010, CHOL; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; World Health Organization, 2010, 1 STEPS MAN OUTBR AC; World Health Organization, 2005, TREATM DIARRH MAN PH; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	23	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132920	10.1371/journal.pone.0132920	http://dx.doi.org/10.1371/journal.pone.0132920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177291	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600180
J	Nicholson, DB; Mayhew, PJ; Ross, AJ				Nicholson, David B.; Mayhew, Peter J.; Ross, Andrew J.			Changes to the Fossil Record of Insects through Fifteen Years of Discovery	PLOS ONE			English	Article							PERMIAN WELLINGTON FORMATION; EOCENE BALTIC AMBER; CZECH-REPUBLIC INSECTA; HEMIPTERA FULGOROMORPHA FULGOROIDEA; CRETACEOUS BEETLES COLEOPTERA; 1ST GLOSSELYTRODEA INSECTA; FORMATION BERMEJO BASIN; MUSEUM-FUR-NATURKUNDE; FAM. NOV INSECTA; NEW-SOUTH-WALES	The first and last occurrences of hexapod families in the fossil record are compiled from publications up to end-2009. The major features of these data are compared with those of previous datasets (1993 and 1994). About a third of families (>400) are new to the fossil record since 1994, over half of the earlier, existing families have experienced changes in their known stratigraphic range and only about ten percent have unchanged ranges. Despite these significant additions to knowledge, the broad pattern of described richness through time remains similar, with described richness increasing steadily through geological history and a shift in dominant taxa, from Palaeoptera and Polyneoptera to Paraneoptera and Holometabola, after the Palaeozoic. However, after detrending, described richness is not well correlated with the earlier datasets, indicating significant changes in shorter-term patterns. There is reduced Palaeozoic richness, peaking at a different time, and a less pronounced Permian decline. A pronounced Triassic peak and decline is shown, and the plateau from the mid Early Cretaceous to the end of the period remains, albeit at substantially higher richness compared to earlier datasets. Origination and extinction rates are broadly similar to before, with a broad decline in both through time but episodic peaks, including end-Permian turnover. Origination more consistently exceeds extinction compared to previous datasets and exceptions are mainly in the Palaeozoic. These changes suggest that some inferences about causal mechanisms in insect macroevolution are likely to differ as well.	[Nicholson, David B.; Mayhew, Peter J.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Nicholson, David B.; Ross, Andrew J.] Natl Museum Scotland, Dept Nat Sci, Edinburgh, Midlothian, Scotland	University of York - UK	Nicholson, DB (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	david.nicholson@nhm.ac.uk	; Mayhew, Peter John/I-6363-2012	Nicholson, David/0000-0002-1296-5673; Mayhew, Peter John/0000-0002-7346-6560	Natural Environment Research Council [NE/G524236/1]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	DBN was supported by a Natural Environment Research Council studentship grant NE/G524236/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain JM, 2000, SCIENCE, V289, P110, DOI 10.1126/science.289.5476.110; Alonso J, 2000, J PALEONTOL, V74, P158, DOI 10.1666/0022-3360(2000)074<0158:ANFRWB>2.0.CO;2; Alroy J, 2000, GEOLOGY, V28, P1023, DOI 10.1130/0091-7613(2000)28<1023:SAODCT>2.0.CO;2; Alroy J, 2004, EVOL ECOL RES, V6, P1; Alroy J, 2010, SCIENCE, V329, P1191, DOI 10.1126/science.1189910; Alroy J, 2000, PALEOBIOLOGY, V26, P707, DOI 10.1666/0094-8373(2000)026<0707:NMFQMP>2.0.CO;2; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Alroy J, 2010, PALEONTOLOGICAL SOC, V16, P55, DOI [10.1017/S1089332600001819, DOI 10.1017/S1089332600001819]; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Amorim DD, 2006, SYST ENTOMOL, V31, P508, DOI 10.1111/j.1365-3113.2006.00326.x; AMORIM DD, 2008, NEOTROPICAL DIPTERA, V4, P1; Andersen N.M., 1998, BIOL SKRIFTER, V50, P1; Andersen NM, 2001, INSECT SYST EVOL, V32, P381; Andersen S, 2001, INSECT SYST EVOL, V32, P419, DOI 10.1163/187631201X00290; [Anonymous], 2004, J SYST PALAEONTOL, V2, P133, DOI 10.1017/S1477201904001191; [Anonymous], 2004, J SYST PALAEONTOL, V2, P109, DOI 10.1017/S1477201904001166; [Anonymous], 1998, PALEONTOLOGICAL J; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 1998, AMURIAN ZOOLOGICAL J, V72, P281; [Anonymous], OSNABRUCKER NATURWIS; Ansorge J, 2001, NEUES JAHRB GEOL P-M, P553; ANSORGE J, 1952, PALAEONTOL Z, V70, P475; Ansorge Joerg, 2002, Nova Supplementa Entomologica, V15, P55; Ansorge Joerg, 1995, Palaeontologische Zeitschrift, V69, P167; Ansorge Joerg, 2002, Studia Dipterologica, V9, P21; Ansorge Joerg, 2003, Acta Zoologica Cracoviensia, V46, P285; Ansorge Joerg, 1993, Palaeontologische Zeitschrift, V67, P287; Ansorge Jorg, 2003, Acta Zoologica Cracoviensia, V46, P291; Ansorge Jorg, 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V275, P1; Ansorge Jorg, 1996, Neue Palaeontologische Abhandlungen, V2, P1; Archibald SB, 2006, ANN ENTOMOL SOC AM, V99, P487, DOI 10.1603/0013-8746(2006)99[487:BAOTEO]2.0.CO;2; Archibald SB, 2009, ZOOTAXA, P51, DOI 10.11646/zootaxa.2249.1.5; Archibald SB, 2005, CAN J EARTH SCI, V42, P119, DOI 10.1139/E04-073; Archibald SB, 2005, ANN ENTOMOL SOC AM, V98, P503, DOI 10.1603/0013-8746(2005)098[0503:EADOCE]2.0.CO;2; Arillo Antonio, 2005, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V352, P1; Arillo A, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3539[1:RCIBAN]2.0.CO;2; Arillo A, 2009, ZOOTAXA, P33, DOI 10.11646/zootaxa.2026.1.3; Aristov DS, 2008, PALEONTOL J+, V42, P269, DOI 10.1134/S0031030108030088; Aristov DS, 2008, PALEONTOL J+, V42, P159, DOI 10.1134/S0031030108020068; Aristov DS, 2006, PALEONTOL J+, V40, P79, DOI 10.1134/S0031030106010096; Aristov D.S., 2009, Far Eastern Entomologist, V192, P1; Aristov D.S., 2008, Far Eastern Entomologist, V188, P1; Aristov D.S., 2000, Far Eastern Entomologist, V85, P1; Aristov DS, 2009, AFR INVERTEBR, V50, P279, DOI 10.5733/afin.050.0205; Aristov DS, 2009, PALEONTOL J+, V43, P643, DOI 10.1134/S0031030109060070; Aristov DS, 2009, PALEONTOL J+, V43, P418, DOI 10.1134/S0031030109040091; Aristov DS, 2009, PALEONTOL J+, V43, P272, DOI 10.1134/S0031030109030046; Aristov DS, 2009, PALEONTOL J+, V43, P178, DOI 10.1134/S0031030109020087; Aristov Danil S., 2009, Russian Entomological Journal, V18, P257; Aristov Danil S., 2008, Russian Entomological Journal, V17, P327; Aristov DS, 2005, PALEONTOL J+, V39, P173; Aristov DS, 2004, PALEONTOL J+, V38, P514; Aristov DS, 2004, PALEONTOL J+, V38, pS80; Aristov DS, 2004, PALEONTOL J+, V38, pS146; ARISTOV DS, 2000, PALEONTOL J, V34, P519; Aspock U, 2004, SYST ENTOMOL, V29, P11, DOI 10.1111/j.1365-3113.2004.00245.x; Azar D, 2004, ANN SOC ENTOMOL FR, V40, P185, DOI 10.1080/00379271.2004.10697415; Azar D, 2007, CR PALEVOL, V6, P151, DOI 10.1016/j.crpv.2006.10.004; Azar D, 2008, ANN SOC ENTOMOL FR, V44, P459, DOI 10.1080/00379271.2008.10697581; Azar D, 2008, ANN SOC ENTOMOL FR, V44, P451, DOI 10.1080/00379271.2008.10697580; Azar D, 2009, GEODIVERSITAS, V31, P117, DOI 10.5252/g2009n1a10; Bambach RK, 1999, GEOBIOS-LYON, V32, P131, DOI 10.1016/S0016-6995(99)80025-4; Barraclough David A., 2006, African Invertebrates, V47, P117; Basibuyuk HH, 2002, INSECT SYST EVOL, V33, P23, DOI 10.1163/187631202X00037; Baz A, 2000, ANN ENTOMOL SOC AM, V93, P367, DOI 10.1603/0013-8746(2000)093[0367:AANFOP]2.0.CO;2; Baz A, 2001, CRETACEOUS RES, V22, P575, DOI 10.1006/cres.2001.0275; Beattie R, 2007, AFR INVERTEBR, V48, P41; Bechly G., 1998, International Journal of Odonatology, V1, P33; Bechly G, 1998, ODONATOLOGICA, V27, P149; Bechly G., 2007, CRATO FOSSIL BEDS BR, P239; BECHLY G, JURACORDULIA SCHIEME; BECHLY G, 2007, CRATO FOSSIL BEDS BR, P387; Bechly G, 2007, CRATO FOSSIL BEDS BR, P313; BECHLY G, 2005, STUTTG BEITR NATUR B, P1; Bechly G., 2007, CRATO FOSSIL BEDS BR, P184; Bechly G., 2007, CRATO FOSSIL BEDS BR, P249; Bechly Guenter, 2002, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V328, P1; Bechly Guenter, 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V289, P1; Bechly Guenter, 2001, Neue Palaeontologische Abhandlungen, V4, P1; Bechly Guenter, 2003, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V339, P1; Bechly Guenter, 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V296, P1; Bechly Guenter, 2008, Palaeodiversity, P37; Bechly Gunter, 1998, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V264, P1; Bechly Gunter, 1996, Petalura Special-Volume, V2, P1; Bechly Gunter, 1997, Rivista del Museo Civico di Scienze Naturali "Enrico Caffi", V19, P31; Beckemeyer RJ, 2004, J KANSAS ENTOMOL SOC, V77, P215, DOI 10.2317/0309.04.1; Beckemeyer RJ, 2004, J KANSAS ENTOMOL SOC, V77, P132, DOI 10.2317/0306.12.1; Beckemeyer RJ, 2009, COLEOPTERISTS B, V112, P45; Beckemeyer Roy J., 2009, Transactions of the Kansas Academy of Science, V112, P45, DOI 10.1660/062.112.0207; Beckemeyer Roy J., 2009, Transactions of the Kansas Academy of Science, V112, P103, DOI 10.1660/062.112.0213; Beckemeyer Roy J., 2000, Kansas School Naturalist, V46, P1; Beckemeyer RJ, 2009, J KANSAS ENTOMOL SOC, V82, P300, DOI 10.2317/JKES809.30.1; Beckemeyer Roy J., 2007, Transactions of the Kansas Academy of Science, V110, P23, DOI 10.1660/0022-8443(2007)110[23:PITIHP]2.0.CO;2; Bennett Daniel J., 2005, Acta Zoologica Cracoviensia, V48B, P1, DOI 10.3409/173491505783995608; Bennett DJ, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3529[1:ANMWID]2.0.CO;2; Benson RBJ, 2012, BIOL LETTERS, V8, P127, DOI 10.1098/rsbl.2011.0460; Benton M. J., 2003, LIFE NEARLY DIED GRE; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; BENTON MJ, 1991, NUMERICAL PALAEOBIOL, P249; Berger H., 2001, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V103B, P301; Bernard EL, 2010, ACTA PALAEONTOL POL, V55, P229, DOI 10.4202/app.2009.0025; Bethoux O, 2008, J IBER GEOL, V34, P109; Bethoux O., 2002, Journal of Orthoptera Research, V11, P223, DOI 10.1665/1082-6467(2002)011[0223:NDOTP]2.0.CO;2; Bethoux O, 2007, ALCHERINGA, V31, P285, DOI 10.1080/03115510701484739; Bethoux O., 2003, Journal of Orthoptera Research, V12, P57, DOI 10.1665/1082-6467(2003)012[0057:PDBALB]2.0.CO;2; Bethoux O, 2005, J SYST PALAEONTOL, V3, P403, DOI 10.1017/S147720190500163X; Bethoux O, 2005, J PALEONTOL, V79, P125, DOI 10.1666/0022-3360(2005)079<0125:NDOPGI>2.0.CO;2; Bethoux O, 2004, PALAIOS, V19, P408, DOI 10.1669/0883-1351(2004)019<0408:EEOIEO>2.0.CO;2; Bethoux O, 2004, ANN ZOOL, V54, P289; Bethoux O, 2004, PALAEONTOLOGY, V47, P13, DOI 10.1111/j.0031-0239.2004.00344.x; Bethoux O, 2003, EUR J ENTOMOL, V100, P581, DOI 10.14411/eje.2003.087; Bethoux O, 2003, J PALEONTOL, V77, P1016, DOI 10.1666/0022-3360(2003)077<1016:RODSAN>2.0.CO;2; Bethoux O, 2003, GEOBIOS-LYON, V36, P275, DOI 10.1016/S0016-6995(03)00030-5; Bethoux O, 2003, GEOBIOS-LYON, V36, P131, DOI 10.1016/S0016-6995(03)00002-0; Bethoux O, 2002, GEOBIOS-LYON, V35, P293, DOI 10.1016/S0016-6995(02)00027-X; Bethoux O, 2002, EUR J ENTOMOL, V99, P111, DOI 10.14411/eje.2002.019; Bethoux O, 2001, GEOBIOS-LYON, V34, P405, DOI 10.1016/S0016-6995(01)80004-8; BETHOUX O, 1911, B PEABODY MUS NAT HI, V47, P29; Bethoux O., 2002, ZOOTAXA, V96, P1, DOI DOI 10.11646/ZOOTAXA.96.1.1; BETHOUX O, 2009, ALAVESIA, V3, P81; Bethoux O., 2005, J SYSTEMATIC PALAEON, V2, P285, DOI DOI 10.1017/; Bethoux O, 2009, EUR J ENTOMOL, V106, P145, DOI 10.14411/eje.2009.017; Bethoux Oliver, 2007, Alavesia, V1, P41; Bethoux Olivier, 2007, Arthropod Systematics & Phylogeny, V65, P135; Bethoux O, 2008, SYST ENTOMOL, V33, P529, DOI 10.1111/j.1365-3113.2008.00419.x; Bethoux O, 2007, GEOBIOS-LYON, V40, P181, DOI 10.1016/j.geobios.2006.04.001; Bethoux Olivier, 2003, Bulletin de la Societe Entomologique de France, V108, P237; Bethoux Olivier, 2007, Alavesia, V1, P49; Bethoux O, 2009, J PALEONTOL, V83, P931, DOI 10.1666/08-158.1; Bethoux O, 2009, ZOOL J LINN SOC-LOND, V156, P79, DOI 10.1111/j.1096-3642.2008.00485.x; Bethoux Olivier, 2008, Arthropod Systematics & Phylogeny, V66, P145; Bethoux Olivier, 2007, Alavesia, V1, P3; Beutel RG, 2008, J ZOOL SYST EVOL RES, V46, P346, DOI 10.1111/j.1439-0469.2008.00473.x; Bitsch J, 1999, ANN SOC ENTOMOL FR, V35, P17; Blagoderov V, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)433<0001:FSDICA>2.0.CO;2; Blagoderov V. A., 2002, HIST INSECTS, P227; Blagoderov V.A., 1998, AMBA PROJECTS, P11; Blagoderov V, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)509[1:HTFFFD]2.0.CO;2; Blagoderov VV, 2001, GEOBIOS-LYON, V34, P63, DOI 10.1016/S0016-6995(01)80045-0; Blank SM, 2009, ZOOTAXA, P1; Bocher J., 1995, MONOGRAPH FOSSIL INS, V33, P1; Bocher Jens, 1995, Meddelelser om Gronland Geoscience, V33, P1; Bolton H., 1912, Quarterly Journal of the Geological Society of London, V68; Bordy EM, 2009, S AFR J SCI, V105, P356; Borkent A, 2008, ZOOTAXA, P1; Borkent Art, 1997, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V249, P1; Borner C., 1904, ZOOLOGISCHER ANZEIGE, V27, P511; Bouchard P, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.88.807; Bourgoin T, 2002, ANN ZOOL, V52, P583; Bourgoin T, 2008, B INSECTOL, V61, P107; Braby MF, 2005, INVERTEBR SYST, V19, P113, DOI 10.1071/IS04020; Brasero Nicolas, 2009, Denisia, P41; Brauckmann C., 2001, Boletin Geologico y Minero (Madrid), V112, P57; Brauckmann C., 1993, Jahresberichte des Naturwissenschaftlichen Vereins in Wuppertal, V46, P115; Brauckmann C., 1985, Geologie und Palaeontologie in Westfalen, V3, P1; Brauckmann C., 1980, Palaeontologische Zeitschrift, V54, P301; Brauckmann C., 1996, NEUES JB GEOLOGIE PA, V1996, P17; BRAUCKMANN C, 2003, GEOLOGIE PALAONTOLOG, V59, P5; Brauckmann Carsten, 1991, Osnabruecker Naturwissenschaftliche Mitteilungen, V17, P25; Brauckmann Carsten, 2005, Courier Forschungsinstitut Senckenberg, V254, P87; Bridges C.A., 1994, CATALOGUE FAMILY GRO; Britt BB, 2008, ICHNOS, V15, P59, DOI 10.1080/10420940701193284; Brodsky A. K., 1994, EVOLUTION INSECT FLI; Brongniart C., 1885, Bulletin de la Societe Rouen, P50; BRONGNIART C, 1893, THESIS FACULTE SCI P, V821, P495; BROOKS DR, 1995, J PARASITOL, V81, P762, DOI 10.2307/3283969; Brothers Denis J., 2003, Acta Zoologica Cracoviensia, V46, P101; Brothers Denis J., 2008, Alavesia, V2, P73; Brothers DJ, 2003, AFR ENTOMOL, V11, P221; Brothers DJ, 2003, EXPEDITION SCI MOREE, V46, P101; BRUES CT, 1915, KEY FAMILIES N AM IN; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Burmeister H, 1838, HDB ENTOMOLOGIE; BUTSCHLI O, 1889, KLASSEN ORDNUNGEN TH, V1, P1842; Bybee SM, 2008, CLADISTICS, V24, P477, DOI 10.1111/j.1096-0031.2007.00191.x; Cairncross B., 1995, South African Journal of Geology, V98, P452; Carle F. L., 1995, Odonatologica, V24, P383; CARPENTER F. M., 1963, PSYCHE, V70, P240, DOI 10.1155/1963/59263; CARPENTER F. M., 1951, JOUR PALEONTOL, V25, P336; CARPENTER F M, 1991, Psyche (Cambridge), V98, P87, DOI 10.1155/1991/45391; CARPENTER F M, 1985, Psyche (Cambridge), V92, P575, DOI 10.1155/1985/62623; CARPENTER F. M., 1963, PSYCHE, V70, P44, DOI 10.1155/1963/10721; Carpenter FM, 1951, TREATISE INVERTEBR R, V25, P336; Carpenter Frank M., 1997, P184; CARPENTER FRANK M., 1950, PROC AMER ACAD ARTS AND SCI, V78, P187, DOI 10.2307/20023577; Carpenter Frank M., 1992, Psyche (Cambridge), V99, P141, DOI 10.1155/1992/31052; CARVALHO J C M, 1985, Revista Brasileira de Biologia, V45, P249; Chandler P, 2002, ANN SOC ENTOMOL FR, V38, P101; Chang HL, 2009, ANN ZOOL, V59, P7, DOI 10.3161/000345409X432547; CHEN S, 1973, Acta Entomologica Sinica, V16, P169; Christiansen K, 2002, CRETACEOUS RES, V23, P165, DOI 10.1006/cres.2002.0313; Christiansen K, 2006, CRETACEOUS RES, V27, P318, DOI 10.1016/j.cretres.2005.07.003; Cifuentes-Ruiz P, 2006, GEOL CARPATH, V57, P347; CLIFFORD E, 1994, P DORSET NATURAL HIS, V115, P143; Coram R., 2000, Paleontological Journal, V34, pS370; Coram RA, 1999, CRETACEOUS RES, V20, P853, DOI 10.1006/cres.1999.0186; Coram Robert A., 2009, Palaeodiversity, P205; Costa C, 2006, ANN ENTOMOL SOC AM, V99, P409, DOI 10.1603/0013-8746(2006)99[409:ROTFBC]2.0.CO;2; Dalgleish RC, 2006, SYST ENTOMOL, V31, P648, DOI 10.1111/j.1365-3113.2006.00342.x; Damgaard J, 2008, MOL PHYLOGENET EVOL, V47, P443, DOI 10.1016/j.ympev.2008.01.026; Damgaard Jakob, 2008, Acta Entomologica Musei Nationalis Pragae, V48, P251; Damgaard J, 2008, INSECT SYST EVOL, V39, P431, DOI 10.1163/187631208788784264; Davis RB, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-252; De Geer C., 1773, MEMOIRES SERVIR HIST, V3; de Jong Rienk, 2007, Tijdschrift voor Entomologie, V150, P319; Delclos X, 2008, NEUES JAHRB GEOL P-A, V247, P353, DOI 10.1127/0077-7749/2008/0247-0353; Delclos X, 2007, CR PALEVOL, V6, P135, DOI 10.1016/j.crpv.2006.09.003; Dikow T, 2009, B AM MUS NAT HIST, P1, DOI 10.1206/603.1; Dmitriev V.Yu., 1988, P208; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Engel M. S., 2006, Vestnik Zoologii, V40, P175; Engel M.S., 2004, BIODIVERSIDAD TAXONO, VIV, P175; Engel MS, 2008, J KANSAS ENTOMOL SOC, V81, P168, DOI 10.2317/JKES-712.11.1; Engel Michael S., 2006, Polskie Pismo Entomologiczne, V75, P443; Engel MS, 2006, J KANSAS ENTOMOL SOC, V79, P359, DOI 10.2317/0604.26.1; Engel Michael S., 2004, Transactions of the Kansas Academy of Science, V107, P119, DOI 10.1660/0022-8443(2004)107[0119:TAOKMS]2.0.CO;2; Engel Michael S., 2003, Transactions of the Kansas Academy of Science, V106, P115, DOI 10.1660/0022-8443(2003)106[0115:TEOKWA]2.0.CO;2; Engel Michael S., 2008, Alavesia, V2, P233; Engel Michael S., 2008, Alavesia, V2, P215; Engel Michael S., 2009, Transactions of the Kansas Academy of Science, V112, P1, DOI 10.1660/062.112.0201; Engel Michael S., 2008, Acta Entomologica Slovenica, V16, P127; Engel MS, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)475[1:CSAPOT]2.0.CO;2; Engel Michael S., 2006, American Museum Novitates, V3514, P1, DOI 10.1206/0003-0082(2006)3514[1:TEWIE]2.0.CO;2; Engel MS, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3515[1:TFCSWH]2.0.CO;2; Engel Michael S., 2009, Transactions of the Kansas Academy of Science, V112, P40, DOI 10.1660/062.112.0206; Engel MS, 2009, AM MUS NOVIT, P1, DOI 10.1206/651.1; Engel MS, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3587[1:TNFODA]2.0.CO;2; Engel MS, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)539[1:FNFED]2.0.CO;2; Engel Michael S., 2009, Denisia, P53; Engel MS, 2009, ZOOKEYS, P61, DOI 10.3897/zookeys.25.267; Engel Michael S., 2008, Nova Supplementa Entomologica, V20, P1; Engel Michael S., 2006, Transactions of the Kansas Academy of Science, V109, P236, DOI 10.1660/0022-8443(2006)109[236:ANOTRS]2.0.CO;2; Engel Michael S., 2005, Memoirs of the Queensland Museum, V51, P558; Engel Michael S., 2007, Transactions of the Kansas Academy of Science, V110, P159, DOI 10.1660/0022-8443(2007)110[159:NFFWIC]2.0.CO;2; Engel Michael S., 2000, American Museum Novitates, V3296, P1, DOI 10.1206/0003-0082(2000)3296<0001:ANIOTO>2.0.CO;2; Engel MS, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)485[0001:PNAICA]2.0.CO;2; Engel MS, 2004, J PALEONTOL, V78, P1192, DOI 10.1666/0022-3360(2004)078<1192:TFMSWH>2.0.CO;2; Engel MS, 2004, J PALEONTOL, V78, P1018, DOI 10.1666/0022-3360(2004)078<1018:APEICA>2.0.CO;2; Engel MS, 2003, J KANSAS ENTOMOL SOC, V76, P616; Engel MS, 2003, CAN ENTOMOL, V135, P63; Engel MS, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)363<0001:TSSRMA>2.0.CO;2; Engel MS, 2001, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2001)259<0001:AMOTBA>2.0.CO;2; ENGEL MS, 2007, STUTTG BEITR NA 1228, P1; Etter W, 2000, PALAEONTOLOGY, V43, P967, DOI 10.1111/1475-4983.00157; EVANS J. W., 1956, AUSTRALIAN JOUR ZOOL, V4, P165, DOI 10.1071/ZO9560165; Evenhuis N.L., 2002, ENTOMOLOGICAE SYSTEM, V10, P1; Evenhuis N.L., 1994, CATALOGUE FOSSIL FLI; Evenhuis Neal L., 2002, Bishop Museum Bulletins in Entomology, V10, P1; Ezard THG, 2011, SCIENCE, V332, P349, DOI 10.1126/science.1203060; Fernandez-Rubio Fidel, 2000, Boletin de la SEA, V27, P7; Fernandez-Rubio Fidel, 1999, Boletin de la SEA, V26, P521; Fitzgerald PC, 2006, PALEOBIOLOGY, V32, P367, DOI 10.1666/05029.1; Fleck G, 2004, GEODIVERSITAS, V26, P33; Fleck G, 2003, ANN SOC ENTOMOL FR, V39, P55, DOI 10.1080/00379271.2003.10697363; Fleck G, 2001, INSECT SYST EVOL, V32, P285, DOI 10.1163/187631201X00227; Fleck G, 1999, CRETACEOUS RES, V20, P655, DOI 10.1006/cres.1999.0166; Fleck G, 2009, ZOOTAXA, P52, DOI 10.11646/zootaxa.1985.1.5; Fleck Guenther, 2003, Zoologica (Stuttgart), V153, P1; Fleck Guenther, 2008, Palaeodiversity, P19; FOLDI I, 2005, ANN SOC ENTOMOLOGIQU, V41, P18; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Fujiyama Ienori, 1994, Natural History Research, V3, P1; Gaimari S.D., 2000, Bulletin of the Natural History Museum Geology Series, V56, P43; Gall JC, 2005, CR PALEVOL, V4, P637, DOI 10.1016/j.crpv.2005.04.007; GALL LF, 1983, SCIENCE, V219, P507, DOI 10.1126/science.219.4584.507; Gao TP, 2009, ANN ENTOMOL SOC AM, V102, P588, DOI 10.1603/008.102.0402; Garrouste R, 2009, CR PALEVOL, V8, P49, DOI 10.1016/j.crpv.2008.11.008; Geertsema H., 2002, Palaeontologia Africana, V38, P19; Gentilini G, 2006, INSTRUMENTAS BIODIVE, V7, P85; Gentilini Giuseppe, 2002, Studi e Ricerche sui Giacimenti Terziari di Bolca, V9, P7; Gibson GAP, 2007, J HYMENOPT RES, V16, P51; Gibson Gary A.P., 2008, Zootaxa, V1730, P1; Godunko RJ, 2006, ANN ZOOL, V56, P175; Godunko RJ, 2008, ANN ZOOL, V58, P105; Godunko RJ, 2006, ANN ZOOL, V56, P785; Godunko RJ, 2009, AQUAT INSECT, V31, P125, DOI 10.1080/01650420802611187; GOLDENBERG CF, 1877, FAUNA SARAEPONTANA 2; Golub VB, 2008, PALEONTOL J+, V42, P86, DOI 10.1134/S0031030108010140; Golub Viktor B., 2003, Acta Zoologica Cracoviensia, V46, P109; Golub Viktor B., 2000, P231; Gonzalez JAC, 2006, ZOOTAXA, P1; Gorjunova R.V., 1988, NOVYYE NOV, P10; Gorochov AV, 2007, PALEONTOL J+, V41, P621, DOI 10.1134/S0031030107060056; Gorochov A.V., 1988, Trudy Zoologicheskogo Instituta, V178, P32; Gorochov AV, 2006, PALEONTOL J+, V40, P646, DOI 10.1134/S0031030106060074; Gorochov A.V., 1994, Zoosystematica Rossica, V3, P53; Gorochov A.V., 1986, Trudy Zoologicheskogo Instituta, V143, P65; Gorochov A.V., 1988, Paleontologicheskii Zhurnal, V1988, P54; Gorochov A.V., 1987, Vestnik Zoologii, V1987, P20; Gorochov A.V., 1995, P ZOOLOGICAL I RAS, V260, P1; Gorochov A.V., 1985, PALEONTOL J, V19, P56; Gorochov A.V., 1988, CRETACEOUS BIOCOENOT, P145; Gorochov A.V, 2000, PALEONTOL J+, V34, P295; Gorochov AV, 2006, CRETACEOUS RES, V27, P641, DOI 10.1016/j.cretres.2006.03.007; Gorochov AV, 2005, PALEONTOL J+, V39, P272; Gorochov AV., 2002, HIST INSECTS, P293, DOI DOI 10.1007/0-306-47577-4; Gorokhov A.V., 1987, Vestnik Zoologii, V1987, P18; GOROKHOV AV, 1995, ZOOL ZH, V74, P39; Gorokhov AV., 2006, PALEONTOL J, V40, P646; Gratshev V.G., 1994, Paleontological Journal, V27, P148; Gratshev Vadim G., 2003, Acta Zoologica Cracoviensia, V46, P129; Grazia J, 2008, CLADISTICS, V24, P932, DOI 10.1111/j.1096-0031.2008.00224.x; Greenwood DR, 2005, CAN J EARTH SCI, V42, P167, DOI 10.1139/E04-100; Grimaldi D, 1999, B AM MUS NAT HIST, P1; Grimaldi D, 2006, P ROY SOC B-BIOL SCI, V273, P625, DOI 10.1098/rspb.2005.3337; Grimaldi D, 2005, INSECT SYST EVOL, V36, P443, DOI 10.1163/187631205794761021; Grimaldi D, 2005, INSECT SYST EVOL, V36, P1, DOI 10.1163/187631205788912787; Grimaldi D, 2004, J PALEONTOL, V78, P941, DOI 10.1666/0022-3360(2004)078<0941:MTAEEO>2.0.CO;2; Grimaldi D, 1999, ANN MO BOT GARD, V86, P373, DOI 10.2307/2666181; Grimaldi D, 2003, J PALEONTOL, V77, P368, DOI 10.1666/0022-3360(2003)077<0368:TMFADI>2.0.CO;2; Grimaldi D, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)412<0001:AROCMA>2.0.CO;2; Grimaldi D.A., 2007, CRATO FOSSIL BEDS BR, P234; Grimaldi DA, 2003, INSECT SYST EVOL, V34, P329, DOI 10.1163/187631203788964746; Grimaldi DA, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)361<0001:FCAFMB>2.0.CO;2; Grimaldi David, 2005, pi; Grimaldi David, 2008, Alavesia, V2, P259; Grimaldi D, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3523[1:EFOTGF]2.0.CO;2; Grimaldi DA, 2008, P ENTOMOL SOC WASH, V110, P543, DOI 10.4289/07-072.1; Grimaldi DA, 2008, AM MUS NOVIT, P1, DOI 10.1206/616.1; Grimaldi DA, 2008, AM MUS NOVIT, P1, DOI 10.1206/610.1; Grimaldi DA, 2008, AM MUS NOVIT, P1, DOI 10.1206/602.1; Grimaldi DA, 2008, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2008)3611[1:AUPPIH]2.0.CO;2; Grimaldi DA, 2009, ZOOTAXA, P34, DOI 10.11646/zootaxa.2078.1.2; Gumovsky Alex V., 2005, Entomological Problems, V35, P123; Gumovsky Alex V., 2001, Phegea, V29, P125; Gutierrez PR, 2000, AMEGHINIANA, V37, P375; Haas F., 2007, CRATO FOSSIL BEDS BR, P222; HAECKEL E, 1896, ZWEITER THEIL SYSTEM; Haenni Jean-Paul, 2003, Acta Zoologica Cracoviensia, V46, P407; Haliday A. H., 1836, ENTOMOLOGICAL MAGAZI, V3, P439; Hall JPW, 2004, P ROY SOC B-BIOL SCI, V271, P797, DOI 10.1098/rspb.2004.2691; Hamilton K.G.A., 1990, B AM MUS NAT HIST, V195, P82; HAMILTON KGA, 1992, ANN ENTOMOL SOC AM, V85, P423, DOI 10.1093/aesa/85.4.423; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Handlirsch A, 1911, AM J SCI, V31, P297; Handlirsch A., 1906, Proceedings of the United States National Museum Smithsonian Institution Washington, V29; Handlirsch A., 1937, ANN NATURHISTORISCHE, V48, P1; Handlirsch A., 1939, ANN NATURHISTORISCHE, V49, P1; Handlirsch A., 1906, HDB PALAONTOLOGEN ZO; Handlirsch A, 1906, MATH NATURWISSENSCHA, V29, P661; Hannisdal B, 2011, SCIENCE, V334, P1121, DOI 10.1126/science.1210695; Harbach RE, 2007, ZOOTAXA, P591; Harris AC, 2002, J ROY SOC NEW ZEAL, V32, P457, DOI 10.1080/03014223.2002.9517704; Hauser M, 2007, ANN ENTOMOL SOC AM, V100, P152, DOI 10.1603/0013-8746(2007)100[152:ANFGOS]2.0.CO;2; Hava J., 2006, ACTA SOC ZOOLOGICAE, V69, P281; Heads SW, 2008, PALAEONTOLOGY, V51, P499, DOI 10.1111/j.1475-4983.2008.00756.x; Heads Sam W., 2009, Denisia, P75; Heads Sam W., 2009, Denisia, P69; Heads Sam W., 2008, British Journal of Entomology and Natural History, V21, P247; Heie O.E., 1987, World Crop Pests, V2A, P367; Heie OE, 2000, ANN ENTOMOL SOC AM, V93, P1222, DOI 10.1603/0013-8746(2000)093[1222:TNSOAF]2.0.CO;2; HEIE OE, 1992, CAN ENTOMOL, V124, P1027, DOI 10.4039/Ent1241027-6; Heie OE, 1985, AMBA PROJECTS, P101; HEIE OE, 1985, EVOLUTION BIOSYSTEMA, P101; Heie Olee, 1998, Annals of the Upper Silesian Museum in Bytom Entomology, V8-9, P159; Heraty JM, 2009, ZOOTAXA, P1; Herczek A, 2001, GEOLOGICAL B CHINA, V10-11, P121; Herczek Aleksander, 2001, Annals of the Upper Silesian Museum in Bytom Entomology, V10-11, P121; Herd K.J., 2006, OSNABRUCKER NATURWIS, V30, P19; Hong Y., 1980, Geological Review (Beijing), V26, P89; HONG Y, 1985, Entomotaxonomia, V7, P83; Hong Y.-c., 1990, P44; Hong Y.-c., 1984, Acta Palaeontologica Sinica, V23, P782; Hong Y.-c., 1980, Acta Zootaxonomica Sinica, V5, P63; Hong Y. C., 1983, MIDDLE JURASSIC FOSS; Hong Y.C, 2002, ATLAS AMBER INSECTS; Hong Y.C., 2002, AMBER INSECTS CHINA; HONG YC, 2003, ACTA ZOOTAXON SIN, V28, P715; Hong You-chong, 2006, Dizhi Tongbao, V25, P560; [Hong You-chong 洪友崇], 2009, [地质通报, Geological Bulletin of China], V28, P11; Hong You-Chong, 2009, Acta Zootaxonomica Sinica, V34, P423; Hong You-Chong, 2007, Acta Zootaxonomica Sinica, V32, P875; Hong You-Chong, 2007, Entomotaxonomia, V29, P26; Hong You-Chong, 2007, Acta Entomologica Sinica, V50, P271; Hong You-Chong, 2007, Acta Zootaxonomica Sinica, V32, P261; Hong You-Chong, 2004, Acta Zootaxonomica Sinica, V29, P224; Hong Youchong, 1998, Geoscience, V12, P40; Hong YC, 2009, J PALEONTOL, V83, P826, DOI 10.1666/07-135.1; Hong Youchong, 1998, Entomologia Sinica, V5, P283; Hornschemeyer T, 2001, NEUES JAHRB GEOL P-A, V221, P81; HORNSCHEMEYER T, 1998, AMBA PROJECTS, V1999, P57; Hornschemeyer T., 2005, HDB ZOOLOGIE, P29; HORNSCHEMEYER T, 1999, TERRA NOSTRA SCHRIFT, V8, P98; Huang DY, 2009, CRETACEOUS RES, V30, P429, DOI 10.1016/j.cretres.2008.08.005; Huang DY, 2008, NATURWISSENSCHAFTEN, V95, P947, DOI 10.1007/s00114-008-0412-x; Huang DY, 2008, GEOBIOS-LYON, V41, P461, DOI 10.1016/j.geobios.2007.11.003; Huang DY, 2008, ZOOL J LINN SOC-LOND, V152, P17, DOI 10.1111/j.1096-3642.2007.00351.x; Huang DY, 2007, EUR J ENTOMOL, V104, P837, DOI 10.14411/eje.2007.104; Huang DY, 2007, NEUES JAHRB GEOL P-A, V246, P63, DOI 10.1127/0077-7749/2007/0246-0063; Huang DY, 2009, ZOOL J LINN SOC-LOND, V156, P889, DOI 10.1111/j.1096-3642.2008.00499.x; Huang Di-ying, 2007, Bulletin de la Societe Entomologique de France, V112, P179; Huang D, 2008, PALAEONTOLOGY, V51, P715, DOI 10.1111/j.1475-4983.2008.00773.x; Huang DY, 2003, CRETACEOUS RES, V24, P141, DOI 10.1016/S0195-6671(03)00027-2; Huang Jian-Dong, 2007, Acta Zootaxonomica Sinica, V32, P391; HUBBARD MD, 1987, FOSSILIUM CATALOGUS, V129, P1; Huber John T., 2005, Acta Societatis Zoologicae Bohemicae, V69, P167; Huguet A, 2002, GEOBIOS-LYON, V35, P537, DOI 10.1016/S0016-6995(02)00071-2; Hyatt A., 1890, GUIDES SCI TEACHING; Ivanov V., 2006, ENTOMOL REV, V86, P568, DOI [10.1134/S0013873806050083, DOI 10.1134/S0013873806050083]; Ivanov VD, 2006, PALEONTOL J+, V40, P178, DOI 10.1134/S0031030106020080; Ivanov V.D., 2002, HIST INSECTS, P194; Ivanov V.D., 1992, PALEONTOL J+, V26, P36; Jablonski D, 2003, SCIENCE, V300, P1133, DOI 10.1126/science.1083246; Jacobus LM, 2008, T AM ENTOMOL SOC, V134, P185, DOI 10.3157/0002-8320(2008)134[185:ROEGE]2.0.CO;2; Jacobus LM, 2006, T AM ENTOMOL SOC, V132, P81; Jakobsen, 2008, DANEKRAE DANMARKS BE; JARZEMBOWSKI E A, 1990, Odonatologica, V19, P27; Jarzembowski EA, 2007, GEOL MAG, V144, P449, DOI 10.1017/S0016756807003421; Jarzembowski EA, 1996, CRETACEOUS RES, V17, P67, DOI 10.1006/cres.1996.0005; Jarzembowski EA, 1998, CRETACEOUS RES, V19, P403, DOI 10.1006/cres.1997.0113; Jarzembowski EA, 2002, P GEOLOGIST ASSOC, V113, P165, DOI 10.1016/S0016-7878(02)80018-9; Jarzembowski EA, 1995, CRETACEOUS RES, V16, P695, DOI 10.1006/cres.1995.1043; Jarzembowski EA, 1996, GEOL SOC SPEC PUBL, V102, P65, DOI 10.1144/GSL.SP.1996.001.01.05; JARZEMBOWSKI EA, 1996, P DORSET NATURAL HIS, V1996, P119; Jarzembowski EA, 1996, P DORSET NATURAL HIS, V1996, P119; Jarzembowski Ed. A., 1999, Palaeontological Association Field Guides to Fossils, V9, P149; Jaschhof M, 2007, PALEONTOL J+, V41, P103, DOI 10.1134/S003103010701011X; JASCHHOF M., 2002, STUDIA DIPTEROLOGI S, V11, P1; Jell P. A., 2004, Memoirs of the Queensland Museum, V50, P1; Jennings JT, 2009, INSECT SYST EVOL, V40, P201, DOI 10.1163/187631209X440069; Jepson JE, 2007, PALAEOGEOGR PALAEOCL, V248, P109, DOI 10.1016/j.palaeo.2006.11.015; Jepson James E., 2008, Alavesia, V2, P193; Jepson JE, 2009, CRETACEOUS RES, V30, P1325, DOI 10.1016/j.cretres.2009.07.012; Johnson NF, 2001, INSECT SYST EVOL, V32, P191, DOI 10.1163/187631201X00146; Johnson NF, 2008, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2008)3603[1:TCSGPB]2.0.CO;2; Kaddumi H.F., 2005, AMBER JORDAN OLDEST; KALUGINA NS, 1985, 2 WINGED INSECTS JUR; Kania Iwona, 2008, Monografie Faunistyczne, V25, P5; KEVAN DKM, 1981, CAN J EARTH SCI, V18, P1824, DOI 10.1139/e81-170; KINZELBACH R, 1984, Palaeontologische Zeitschrift, V58, P247; Kirby W, 1815, T LINNEAN SOC LONDON, V11, P86, DOI [10.1111/j.1096-3642.1813.tb00040.x, DOI 10.1111/J.1096-3642.1813.TB00040.X]; KIRBY W, 1815, INTRO ENTOMOLOGY, V1; Kirejtshuk A.G., 2008, Zoosystematica Rossica, V17, P107; Kirejtshuk A. G., 1994, PALAEONTOGICAL J, V28, P69; Kirejtshuk AG, 2006, P ENTOMOL SOC WASH, V108, P155; Kirejtshuk Alexander G., 2009, Denisia, P119; Kirejtshuk Alexander G., 2009, Denisia, P103; Kirejtshuk Alexander G., 2009, Denisia, P99; Kirejtshuk Alexander G., 2008, Alavesia, V2, P15; Kirejtshuk AG, 2008, ANN SOC ENTOMOL FR, V44, P419, DOI 10.1080/00379271.2008.10697578; Kirejtshuk AG, 2009, SYST ENTOMOL, V34, P101, DOI 10.1111/j.1365-3113.2008.00442.x; Kirk-Spriggs AH, 2007, MITTEILUNGEN GEOLOGI, V6, P13; KIRKSPRIGGS AH, 1937, ANN E CAPE MUSEUMS, V6, P13; Klass KD, 2002, SCIENCE, V296, P1456, DOI 10.1126/science.1069397; Klimaszewski SM, 1997, HIST INSECTS, V80, P151; Kluge N.J., 2004, PHYLOGENETIC SYSTEM; Kluge N. J., 1996, ZOOSYSTEMATICA ROSSI, V4, P71; Kluge N. J., 1996, PALEONTOL J, V4, P71; Kluge NJ, 2006, ANN ZOOL, V56, P181; Kocak Ahmet Omer, 2008, Centre for Entomological Studies Miscellaneous Papers, V141, P1; Kopylov D, 2009, PALEONTOL J+, V43, P83, DOI 10.1134/S0031030109010092; KOTEJA J, 1989, Annales Zoologici (Warsaw), V43, P77; Koteja J, 2001, P ENTOMOL SOC WASH, V103, P356; Koteja Jan, 2008, Alavesia, V2, P133; Koteja Jan, 2008, Prace Muzeum Ziemi, V49, P19; Koteja Jan, 2000, Polskie Pismo Entomologiczne, V69, P187; Koteja Jan, 2000, P147; Kotrba M, 2009, SPIXIANA, V32, P187; Kozlov M.V., 2002, HIST INSECTS, P220; Kozlov M. V., 1988, CRETACEOUS BIOCOENOT, P16; Kraemer MMS, 2007, PALAEONTOGR ABT A, V282, P1; Krassilov VA, 2007, AFR INVERTEBR, V48, P13; KRELL FT, 2007, 20078 DENV MUS NAT S; Krishna K, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)390<0001:TFCRIA>2.0.CO;2; Kristensen N.P., 1999, BITTERFELDER BERNSTE, V1, P7; Kristensen Niels P., 1999, Handbuch der Zoologie (Berlin), V4, P7; Krzeminska E, 2009, MONOGRAPH OF FOSSIL TRICHOCERIDAE (DIPTERA): OVER 180 MILLION YEARS OF EVOLUTION, P9; Krzeminska Ewa, 1993, Acta Zoologica Cracoviensia, V35, P581; Krzeminski W, 2002, ANN ZOOL, V52, P211; KRZEMINSKI W, 1992, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V65, P39; KRZEMINSKI W, 1992, Acta Zoologica Cracoviensia, V35, P45; Krzeminski W, 2001, RIV ITAL PALEONTOL S, V107, P69, DOI 10.13130/2039-4942/5424; Krzeminski W, 1992, AFRICAN INVERTEBRATE, V65, P39; Krzeminski W, 2005, POL PISMO ENTOMOL, V74, P369; KRZEMINSKI W, 2000, CONTRIBUTIONS MANUAL, V1, P535; Krzeminski Wieslaw, 2005, Polskie Pismo Entomologiczne, V74, P369; Krzeminski Wieslaw, 2003, Acta Zoologica Cracoviensia, V46, P153; Krzeminski Wieslaw, 1994, Acta Zoologica Cracoviensia, V37, P95; Krzeminski Wieslaw, 1993, Acta Zoologica Cracoviensia, V35, P593; Ksepka DT, 2012, PALEOBIOLOGY, V38, P112, DOI 10.1666/10059.1; Kubisz Daniel, 2000, Polskie Pismo Entomologiczne, V69, P225; KUKALOVA J, 1969, Psyche (Cambridge), V76, P163, DOI 10.1155/1969/74019; Kukalova J., 1964, PALEONTOLOGIE 2, V3, P39; KUKALOVA J, 1969, PSYCHE, V76, P349; KUKALOVA-PECK J, 1975, Psyche (Cambridge), V82, P1, DOI 10.1155/1975/78215; KUKALOVAPECK J, 1985, CAN J ZOOL, V63, P933, DOI 10.1139/z85-139; KUKALOVAPECK J, 1990, CAN J ZOOL, V68, P1104, DOI 10.1139/z90-163; KUKALOVAPECK J, 1992, CAN J ZOOL, V70, P229, DOI 10.1139/z92-036; KUKALOVAPECK J, 1987, CAN J ZOOL, V65, P2327, DOI 10.1139/z87-352; Kumar Prabhat, 2004, Journal of the Palaeontological Society of India, V49, P159; Kupryjanowicz J., 2001, AMBER TREASURE TRO 1, P19; Kusnezov N, 1903, REV RUSSE ENTOMOLOGI, V3, P208; Kvacek Zlatko, 2004, Journal of the Czech Geological Society, V49, P1; Labandeira CC, 2002, P NATL ACAD SCI USA, V99, P2061, DOI 10.1073/pnas.042492999; Labandeira Conrad C., 1994, Milwaukee Public Museum Contributions in Biology and Geology, V88, P1; Loveridge, 2007, CRATO FOSSIL BEDS BR, P265; 1998, ARCHAEOPTERYX, V16, P29; 1998, PALAONTOLOGISCHE Z, V72, P281; [Anonymous], 1998, PALEONTOL J+; [Anonymous], [No title captured]; Brunner C. De Wattenwyl, 1893, Annali del Museo Genova, V(2), P1; Brunner von Wattenwyl K., 1882, PRODROMUS EUROPAISCH; Klopy Popov YA., 1990, ANN NATURHISTORISC A, V239, P20; Labandeira C.C., 2014, EVOLUTIONARY BIOL GE, P261, DOI DOI 10.1007/978-3-319-07623-2_13; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; LABANDEIRA CC, 2001, PALAEOBIOLOGY, V2, P82; Labandeira CC, 2007, TAXON, V56, P663, DOI 10.2307/25065853; Labandeira Conrad C., 2002, Rocky Mountain Geology, V37, P31, DOI 10.2113/gsrocky.37.1.31; Labandeira Conrad C., 2005, American Entomologist, V51, P14; Latreille P.A., 1802, ORTHOPTERA, V3, P267, DOI 10.5962/bhl.title.15764; Latreille P.A., 1825, FAMILLES NATURELLES, DOI DOI 10.5962/BHL.TITLE.16094; Laurentiaux D., 1986, ANN SOC GEOLOGIQUE N, V105, P187; Laurentiaux-Vieira F, 1986, ANNOTATED CHECKLIST, V105, P187; Lawrence JF, 2008, ANN ZOOL, V58, P689, DOI 10.3161/000345408X396620; Lefebvre F, 2004, FOSSIL PLANTHOPPERS; Legalov A.A., 2009, Amurskii Zoologicheskii Zhurnal, V1, P200; Legalov A.A., 2009, Amurskii Zoologicheskii Zhurnal, V1, P117; LEWIS SE, 1977, P ENTOMOL SOC WASH, V79, P583; Li TT, 2009, PROG NAT SCI-MATER, V19, P1837, DOI 10.1016/j.pnsc.2009.06.011; [李祥辉 Li Xianghui], 2009, [地学前缘, Earth Science Frontiers], V16, P63; Li YL, 2008, ZOOTAXA, P38, DOI 10.11646/zootaxa.1929.1.2; Li Z, 2007, ZOOTAXA, P53, DOI 10.11646/zootaxa.1660.1.4; Liang Jun-Hui, 2006, Acta Zootaxonomica Sinica, V31, P102; Liang JH, 2009, ZOOTAXA, P17; Lienhard C., 2002, Psocoptera (Insecta): world catalogue and bibliography; Lin Q, 2004, ODONATOLOGICA, V33, P437; Lin Q.-b., 1992, Acta Palaeontologica Sinica, V31, P313; Lin Q.B., 1980, DIVISION CORRELATION, P211; LIN QB, 1994, CRETACEOUS RES, V15, P305, DOI 10.1006/cres.1994.1019; Lin QB, 2008, ANN ZOOL, V58, P521, DOI 10.3161/000345408X364346; Lin Qi-Bin, 2007, Zootaxa, V1469, P59; Lin QB, 2006, PROG NAT SCI-MATER, V16, P303; Linnaeus C, 1766, SYSTEMA NATURAE REGN; Liu M, 2008, CRETACEOUS RES, V29, P445, DOI 10.1016/j.cretres.2008.01.006; Liu YS, 2009, PALEONTOL J+, V43, P183, DOI 10.1134/S0031030109020099; Liu Yu-Shuang, 2006, Acta Zootaxonomica Sinica, V31, P758; Liu YS, 2008, PROG NAT SCI-MATER, V18, P1039, DOI 10.1016/j.pnsc.2008.03.014; Liu YS, 2008, ACTA GEOL SIN-ENGL, V82, P249; Liu YS, 2007, CRETACEOUS RES, V28, P322, DOI 10.1016/j.cretres.2006.08.003; Liu YS, 2006, ANN ZOOL, V56, P549; Liu Z, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3583[1:PAGHOT]2.0.CO;2; Lopez-Vaamonde C, 2006, J EVOLUTION BIOL, V19, P1314, DOI 10.1111/j.1420-9101.2005.01070.x; Lopez-Vaamonde C, 2009, MOL PHYLOGENET EVOL, V52, P715, DOI 10.1016/j.ympev.2009.05.028; LUBBOCK JW, 1871, NOTES THYSANURA 4, V27, P277; Lukashevich ED, 2008, PALEONTOL J+, V42, P66, DOI 10.1134/S0031030108010115; Lukashevich E.D., 2000, Paleontological Journal, V34, pS352; Lukashevich Elena D., 2006, Studia Dipterologica, V13, P127; Lukashevitch ED., 2000, AMBA PROJECTS, V34, pS352; Lukashevitch ED., 2008, PALEONTOL J, V42, P66; MacLeay W.S, 1825, ANNULOSA JAVANICA AT; Makarkin V.N., 1990, Annales de la Societe Entomologique de France, V26, P125; Makarkin V. N., 1999, NEUES JB GEOLOGIE PA, V1999, P705; Makarkin VN, 2007, CRETACEOUS RES, V28, P743, DOI 10.1016/j.cretres.2006.11.003; Makarkin Vladimir N., 1998, Tertiary Research, V18, P77; Makarkin VN, 2010, ANN SOC ENTOMOL FR, V46, P254, DOI 10.1080/00379271.2010.10697666; Makarkin VN, 2009, ANN ENTOMOL SOC AM, V102, P964, DOI 10.1603/008.102.0606; Makarkin Vladimjr N., 2009, Denisia, P137; Makarkin VN, 2005, CRETACEOUS RES, V26, P801, DOI 10.1016/j.cretres.2005.05.009; Makarkin VN, 2005, ZOOTAXA, P15; Makarkin VN, 2003, ANN ENTOMOL SOC AM, V96, P171, DOI 10.1603/0013-8746(2003)096[0171:FAOTGP]2.0.CO;2; Manley DG, 2003, P ENTOMOL SOC WASH, V105, P1069; Marchal-Papier F., 2000, Acta Geologica Hispanica, V35, P5; Marshall SA, 2009, ZOOTAXA, P1; MARTILL DM, 2007, CRATO FOSSIL BEDS BR, P582; Martin Sarah K., 2008, Alavesia, V2, P253; Martins Neto Rafael Gioia, 2005, Arquivos do Museu Nacional Rio de Janeiro, V63, P471; MARTINS-NETO R G, 1989, Revista Brasileira de Entomologia, V33, P367; Martins-Neto RG, 2007, AFR INVERTEBR, V48, P87; Martins-Neto R.G., 2007, CRATO FOSSIL BEDS BR, P328; Martins-Neto R. G, 2005, GAEA, V1, P68; Martins-Neto Rafael G., 2008, Alavesia, V2, P47; Martins-Neto Rafael Gioia, 1992, Revista Brasileira de Entomologia, V36, P803; Martins-Neto RG, 2007, ALCHERINGA, V31, P199, DOI 10.1080/03115510701305173; Martins-Neto RG, 2006, AMEGHINIANA, V43, P591; Martins-Neto Rafael Gioia, 2003, Acta Zoologica Cracoviensia, V46, P205; Martins-Neto Rafael Gioia, 1995, Revista Brasileira de Entomologia, V39, P311; Martins-Neto Rafael Gioia, 2009, Gaea, V5, P15; Martins-Neto Rafael Gioia, 1995, Revista Brasileira de Entomologia, V39, P321; Martins-Neto Rafael Gioia, 2007, Gaea, V3, P3; Martins-Neto RG, 2009, ZOOTAXA, P21, DOI 10.11646/zootaxa.2080.1.2; Martins-Neto Rafael Giola, 2006, Polskie Pismo Entomologiczne, V75, P185; Martins-Neto RG, 2005, AMEGHINIANA, V42, P705; Martins-Neto RG., 2002, ACTA GEOLOGICA LEOPO, V25, P35; Martins-Neto RG, 2001, ACTA GEOLOGICA LEOPO, V24, P115; MARTYNOV A. B., 1927, ZOOL ANZ, V72, P99; MARTYNOV A. V., 1938, IZVESTIIA AKADEMII NAUK SSSR OTDELENIE MATEMATICHESKIKH I ESTESTVENNYKH NAUK SERIIA BIOL [BULL ACAD SCI URSS CL SCI MATH ET NAT SER BIOL], V1938, P187; MAXWELL WD, 1990, PALEOBIOLOGY, V16, P322, DOI 10.1017/S0094837300010022; Mayhew PJ, 2008, P ROY SOC B-BIOL SCI, V275, P47, DOI 10.1098/rspb.2007.1302; Mayhew PJ, 2007, BIOL REV, V82, P425, DOI 10.1111/j.1469-185X.2007.00018.x; Mayhew PJ, 2012, P NATL ACAD SCI USA, V109, P15141, DOI 10.1073/pnas.1200844109; Mayhew PJ, 2002, P ROY SOC B-BIOL SCI, V269, P969, DOI 10.1098/rspb.2002.1957; Mazzarolo LA, 2000, INSECT SYST EVOL, V31, P91, DOI 10.1163/187631200X00336; McCafferty W. P., 1997, Bulletin de la Societe d'Histoire Naturelle de Toulouse, V133, P77; McCafferty WP, 2008, ENTOMOL NEWS, V119, P492, DOI 10.3157/0013-872X-119.5.492; McCafferty WP, 2004, ENTOMOL NEWS, V115, P84; MCCAFFERTY WP, 1991, ANN ENTOMOL SOC AM, V84, P343, DOI 10.1093/aesa/84.4.343; MCCAFFERTY WP, 1990, B AM MUS NAT HIST, V195, P25; McKellar RC, 2008, CAN J EARTH SCI, V45, P1061, DOI 10.1139/E08-049; Melnitsky SI, 2009, PALEONTOL J+, V43, P296, DOI 10.1134/S0031030109030071; Mendes LF, 2004, P ENTOMOL SOC WASH, V106, P102; Menon F, 2007, CRATO FOSSIL BEDS BR, P283; Menon F, 2008, PALAEONTOLOGY, V51, P149, DOI 10.1111/j.1475-4983.2007.00740.x; Mey Eberhard, 2005, Anzeiger des Vereins Thueringer Ornithologen, V5, P201; Meyer H.W, 2003, FOSSILFLORISSANT; MICHELSEN V, 2009, STUDIA DIPTEROLOGICA, V15, P211; Michelsen V, 2009, AMBA PROJECTS, V15, P211; Michelsen Verner, 2000, Studia Dipterologica, V7, P11; Michez D, 2007, ZOOL J LINN SOC-LOND, V150, P701, DOI 10.1111/j.1096-3642.2007.00307.x; Michez D, 2009, ZOOL SCR, V38, P171, DOI 10.1111/j.1463-6409.2008.00362.x; Mockford EL, 2006, J NEW YORK ENTOMOL S, V114, P108, DOI 10.1664/0028-7199(2007)114[108:SOPFNA]2.0.CO;2; Mostovski M. B., 2003, Journal of Systematic Palaeontology, V1, P59, DOI 10.1017/S1477201903001020; Mostovski MB, 2003, PALEONTOL J+, V37, P162; MOSTOVSKI MB, 1997, PALEONTOL J, V31, P72; Mostovski Mike B., 2009, Palaeontologia Africana, V44, P121; Mostovski Mikhail B., 2000, Entomological Problems, V31, P137; Mostovsky M.B., 1995, Paleontologicheskii Zhurnal, V4, P86; Mound LA, 2007, ZOOTAXA, P395; NAGATOMI A, 1994, ACTA ZOOL HUNG, V40, P203; NAGATOMI A, 1991, ZOOL SCI, V8, P579; Nagatomi Akira, 1998, Entomologist's Monthly Magazine, V134, P95; NAUMANN ID, 1985, AUST J ZOOL, V33, P761, DOI 10.1071/ZO9850761; Navas L., 1916, MEMORIAS REAL ACAD C, V12, P507; Nazarenko VY, 2009, PALEONTOL J+, V43, P1097, DOI 10.1134/S003103010909010X; Nel A, 2007, CRETACEOUS RES, V28, P1039, DOI 10.1016/j.cretres.2007.02.002; Nel A, 2005, J SYST PALAEONTOL, V3, P371, DOI 10.1017/S1477201905001598; Nel A, 2005, ANN SOC ENTOMOL FR, V41, P29, DOI 10.1080/00379271.2005.10697440; Nel A, 2005, NEUES JAHRB GEOL P-A, V235, P343; Nel A, 2005, GEOBIOS-LYON, V38, P219, DOI 10.1016/j.geobios.2003.10.007; Nel A, 2005, NEUES JAHRB GEOL P-A, V235, P51; Nel A, 2004, DEUT ENTOMOL Z, V51, P253; Nel A, 2004, ANN SOC ENTOMOL FR, V40, P31, DOI 10.1080/00379271.2004.10697402; Nel A, 2004, ACTA PALAEONTOL POL, V49, P283; Nel A, 2004, EUR J ENTOMOL, V101, P145, DOI 10.14411/eje.2004.019; Nel A, 2003, ECLOGAE GEOL HELV, V96, P503, DOI 10.1007/s00015-003-1104-3; Nel A, 2002, ORG DIVERS EVOL, V2, P313, DOI 10.1078/1439-6092-00053; Nel A, 1999, PALAEONTOLOGY, V42, P83, DOI 10.1111/1475-4983.00063; Nel A, 1999, GEOBIOS-LYON, V32, P63, DOI 10.1016/S0016-6995(99)80083-7; Nel A, 1999, GEOBIOS-LYON, V32, P883, DOI 10.1016/S0016-6995(99)80870-5; Nel A., 2005, Bulletin de la Societe Entomologique de France, V110, P185; Nel A, 2001, ANN SOC ENTOMOL FR, V37, P501; Nel A, 1998, CRETACEOUS RES, V19, P393, DOI 10.1006/cres.1998.0110; Nel A, 1996, EUR J ENTOMOL, V93, P223; Nel A., 1992, B SOC ENTOMOLOGIQUE, V97, P381; NEL A, 1918, ANN PALEONTOL, V88, P189; Nel A., 1993, NUMERO HORS SERIE, V3, P1; NEL A, 1907, B MUSEUM NATL HI 4 C, V11, P15; Nel A, 2008, ACTA PALAEONTOL POL, V53, P163; Nel Andre, 1994, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V194, P143; Nel A, 2007, ANN SOC ENTOMOL FR, V43, P349, DOI 10.1080/00379271.2007.10697531; Nel A, 2006, ANN SOC ENTOMOL FR, V42, P179, DOI 10.1080/00379271.2006.10700621; Nel Andre, 2003, Geodiversitas, V25, P109; Nel A, 2013, NATURE, V503, P257, DOI 10.1038/nature12629; Nel Andre, 1994, Annales de Paleontologie, V80, P1; Nel Andre, 2001, Revue Francaise d'Entomologie (Nouvelle Serie), V23, P257; Nel Andre, 2009, Palaeodiversity, P209; Nel Andre, 2009, Palaeodiversity, P199; Nel Andre, 1992, Nouvelle Revue d'Entomologie, V9, P305; Nel Andre, 2001, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V314, P1; Nel Andre, 1998, Paleontologia Lombarda, V10, P1; Nel Andre, 1996, Paleontologia Lombarda, V5, P25; Nel A, 2009, ANN ZOOL, V59, P281, DOI 10.3161/000345409X476350; Nel A, 2009, PALAEONTOGR ABT A, V289, P89; Nel Andre, 2005, Journal of Systematic Palaeontology, V3, P187, DOI 10.1017/S1477201905001549; Nel A, 2009, J NAT HIST, V43, P57, DOI 10.1080/00222930802528182; Nel Andre, 1994, Nouvelle Revue d'Entomologie, V11, P321; Nel Andre, 2006, Bulletin de la Societe Entomologique de France, V111, P190; Nel P, 2007, CRETACEOUS RES, V28, P1033, DOI 10.1016/j.cretres.2007.02.003; NELSON C R, 1987, Psyche (Cambridge), V94, P309, DOI 10.1155/1987/52032; Neto Rafael Gioia Martins, 2006, Journal of the Entomological Research Society, V8, P63; Nicholson DB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1823; Novokschonov Viktor, 1997, Palaontologische Zeitschrift, V71, P89; Novokshonov V.G., 2000, Paleontological Journal, V34, pS284; Novokshonov V.G., 1992, PALEONTOL J+, V26, P136; Novokshonov V.G., 2002, PALEONTOL J+, V36, P157; Novokshonov V.G., 1994, PALEONTOL J+, V28, P79; Novokshonov VG, 2004, PALEONTOL J+, V38, pS204; Novokshonov VG, 2004, PALEONTOL J+, V38, pS173; Novokshonov VG, 2004, PALEONTOL J+, V38, P60; Novokshonov VG, 2002, PALEONTOL J, V36, P644; NOVOKSHONOV VG, 2000, PALEONTOL J, V34, P513; Novokshonov VG, 2002, PALEONTOL J, V36, P157; Novokshonov VG., 1992, PALEONTOL J, V26, P136; Novokshonov VG, 2000, PALEONTOL J, V34, pS284; Novokshonov VG, 1997, PALEONTOL J, V71, P89; Novokshonov VG, 1997, PALEONTOL J, V31, P383; Novokshonov VG, 1997, PALEONTOL J, V31, P65; Novokshonov VG, 1998, PALEONTOL J, V32, P46; NOVOKSHONOV VG, 1994, PALEONTOL J, V27, P90; Nyman T, 2006, SYST ENTOMOL, V31, P569, DOI 10.1111/j.1365-3113.2006.00336.x; Oberprieler RG, 2007, CONCISE GEOLOGIC TIM, V1668, P419, DOI DOI 10.1017/S0016756809006207; OBERPRIELER RG, 2007, ZOOTAXA, V1668, P419; Ogden TH, 2009, SYST ENTOMOL, V34, P616, DOI 10.1111/j.1365-3113.2009.00488.x; Ogg JG, 2008, ENCY METHODIQUE DICT, DOI 10.1017/S0016756809006207; Ohl M, 2004, J KANSAS ENTOMOL SOC, V77, P332, DOI 10.2317/E12.1; Ortega-Blanco J, 2008, ZOOTAXA, P39, DOI 10.11646/zootaxa.1937.1.3; Osten T., 2007, CRATO FOSSIL BEDS BR, P350, DOI [10.1017/S0016756808005657, DOI 10.1017/S0016756808005657]; Ozdikmen Huseyin, 2008, Munis Entomology & Zoology, V3, P745; Ozdikmen Huseyin, 2008, Munis Entomology & Zoology, V3, P731; Packard A.S., 1886, NEW ARRANGEMENT ORDE, V20, P808; Papier Francine, 1997, Palaontologische Zeitschrift, V71, P71; Papier Francine, 2001, Palaeontologische Zeitschrift, V74, P533; Penalver E, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3519[1:NDOMBI]2.0.CO;2; Penalver Enrique, 1996, Treballs del Museu de Geologia de Barcelona, V5, P15; Penalver Enrique, 2007, Alavesia, V1, P63; Penalver Enrique, 1999, Revista Espanola de Paleontologia, V14, P231; Peng Decheng, 2005, Dizhi Tongbao, V24, P219; Perez Daniel E., 1997, Journal of Orthoptera Research, V6, P139; Perez-Gelabert Daniel E., 2006, Journal of Orthoptera Research, V15, P241, DOI 10.1665/1082-6467(2006)15[241:FIOHEG]2.0.CO;2; Perez-Gelabert DE, 2008, ZOOTAXA, P1; Perkovsky EE, 2007, AFR INVERTEBR, V48, P229; Perkovsky E.E., 2001, Vestnik Zoologii, V35, P79; Perkovsky Evgeny E., 2003, Russian Entomological Journal, V12, P119; Perrichot V, 2004, EUR J ENTOMOL, V101, P577, DOI 10.14411/eje.2004.081; Perrichot V., 2004, Geologica Acta, V2, P9; Perrichot V, 2003, GEOL MAG, V140, P669, DOI 10.1017/S0016756803008355; Perrichot V, 2002, CRETACEOUS RES, V23, P307, DOI 10.1006/cres.2002.1011; Perrichot V, 2009, ZOOL SCR, V38, P79, DOI 10.1111/j.1463-6409.2008.00358.x; Perrichot V, 2008, NEUES JAHRB GEOL P-A, V248, P91, DOI 10.1127/0077-7749/2008/0248-0091; Perrichot V, 2007, AFR INVERTEBR, V48, P213; Perrichot V, 2006, ZOOTAXA, P57; Perrichot Vincent, 2009, Paleontological Contributions, P1; Perrichot Vincent, 2008, Alavesia, V2, P203; Perrichot V, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3598[1:ECSLIA]2.0.CO;2; Perrichot V, 2009, GEODIVERSITAS, V31, P7, DOI 10.5252/g2009n1a1; Pescador ML, 2009, AQUAT INSECT, V31, P137, DOI 10.1080/01650420903148519; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; Petrulevicius JF, 2004, PALAEONTOLOGY, V47, P109, DOI 10.1111/j.0031-0239.2004.00350.x; Petrulevicius JF, 2003, J NAT HIST, V37, P2909, DOI 10.1080/0022293021000007543; Petrulevicius JF, 2003, CRETACEOUS RES, V24, P31, DOI 10.1016/S0195-6671(03)00025-9; Petrulevicius JF, 1999, PALAEONTOLOGY, V42, P677, DOI 10.1111/1475-4983.00091; Petrulevicius JF, 2002, PALAEONTOLOGY, V45, P751, DOI 10.1111/1475-4983.00258; Petrulevicius JF, 2009, J PALEONTOL, V83, P994, DOI 10.1666/08-073.1; Petrulevicius Julian F., 2007, Alavesia, V1, P15; Petrulevicius JF, 2009, CR PALEVOL, V8, P385, DOI 10.1016/j.crpv.2008.12.004; Petrulevicius JF, 2007, ANN SOC ENTOMOL FR, V43, P341, DOI 10.1080/00379271.2007.10697530; Petrulevicus JF, 2005, J PALEONTOL, V79, P658, DOI 10.1666/0022-3360(2005)079[0658:AANFOD]2.0.CO;2; Pinto I. D, 1986, PESQUISAS ZOOLOGIA, V18, P23; Pinto I.D., 1996, NEUES JB GEOL PALAON, P43; PINTO ID, 1999, AMBA PROJECTS AM PFI, P117; PINTO ID, 1991, PESQUISAS, V18, P93; Pinto Iraja Damiani, 1995, Universidade Federal do Rio Grande do Sul Instituto de Geociencias Pesquisas, V21, P85; Pionar G, 2008, WHAT BUGGED THE DINOSAURS INSECTS, DISEASE, AND DEATH IN THE CRETACEOUS, P1; Pohl H, 2005, ZOOL SCR, V34, P57, DOI 10.1111/j.1463-6409.2005.00173.x; Pohl H, 2009, INSECT SYST EVOL, V40, P333, DOI 10.1163/139956009X12470378015541; Poinar G, 2005, P ENTOMOL SOC WASH, V107, P835; Poinar G.O., 2001, LEBANESE AMBER OLDES; Poinar GO, 2006, SCIENCE, V314, P614, DOI 10.1126/science.1134103; Poinar G. O. Jr., 2000, Acta Geologica Hispanica, V35, P119; Poinar G, 2007, P ENTOMOL SOC WASH, V109, P649; Poinar G, 2006, P ENTOMOL SOC WASH, V108, P734; Poinar G, 2009, CRETACEOUS RES, V30, P1000, DOI 10.1016/j.cretres.2009.03.003; Poinar G, 2009, P ENTOMOL SOC WASH, V111, P38, DOI 10.4289/0013-8797-111.1.38; Poinar G, 2009, PALAEONTOLOGY, V52, P483, DOI 10.1111/j.1475-4983.2008.00840.x; Poinar GO, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-12; Poinar GO., 1992, LIFE AMBER; Poinar Jr. G.O., 1999, AMBER FOREST; POLHEMUS JT, 2000, BULLETIN, V16, P284; Ponomarenko A, 2008, PALEONTOL J+, V42, P600, DOI 10.1134/S0031030108060051; Ponomarenko A.G., 2000, Paleontological Journal, V34, pS312; Ponomarenko AG, 2009, PALEONTOL J+, V43, P282, DOI 10.1134/S003103010903006X; Ponomarenko A.G., 2000, Paleontological Journal, V34, pS309; Ponomarenko A.G., 1985, Annalen des Naturhistorischen Museums in Wien Serie A Mineralogie und Petrographie Geologie und Palaeontologie Anthropologie und Praehistorie, V87, P135; Ponomarenko A.G, 2002, HIST INSECTS, P164; Ponomarenko A.G., 2002, HIST INSECTS, P176; Ponomarenko A. G., 1996, RUSS ENTOMOL J, V4, P73; Ponomarenko AG, 2004, PALEONTOL J+, V38, pS197; PONOMARENKO AG, 1992, PALEONTOL J, V26, P56; PONOMARENKO AG, 1994, PALEONTOL J, V27, P182; Ponomarenko AG, 2000, JOINT SOVIET MONGOLI, V34, pS309; Ponomarenko AG, 1986, PALEONTOL J, V28, P84, DOI DOI 10.1134/S0031030109020154; Ponomarenko Aleksandr G., 2003, Annals of the Upper Silesian Museum in Bytom Entomology, V12, P87; Ponomarenko Alexandr G., 2005, African Invertebrates, V46, P253; Ponomarenko Alexandr G., 2003, Acta Zoologica Cracoviensia, V46, P319; Popov Y, 2007, CRATO FOSSIL BEDS BR, P317; Popov Y.A., 1991, Geologica et Palaeontologica, V25, P215; Popov Y. A., 1994, T JOINT SOVIET MONGO, V5, P307; Popov Yu.A., 1990, Trudy Paleontologicheskogo Instituta, V239, P20; Popov YA, 2007, PALAEONTOL Z, V81, P429, DOI 10.1007/BF02990254; Popov Yuri A., 1994, Genus (Wroclaw), V5, P307; Popov Yuri A., 2008, Acta Entomologica Musei Nationalis Pragae, V48, P497; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Pritykina LN, 2006, PALEONTOL J+, V40, P636, DOI 10.1134/S0031030106060062; PRITYKINA L N, 1986, Odonatologica, V15, P169; Prokop J, 2005, GEOBIOS-LYON, V38, P383, DOI 10.1016/j.geobios.2003.11.006; Prokop J, 2004, EUR J ENTOMOL, V101, P583, DOI 10.14411/eje.2004.082; Prokop J, 2004, GEOL CARPATH, V55, P469; PROKOP J, 2007, ACTA MUSEI NATL PR B, V63, P209; Prokop J, 2007, AFR INVERTEBR, V48, P77; Prokop J, 2007, EUR J ENTOMOL, V104, P267, DOI 10.14411/eje.2007.041; Prokop J, 2006, CR PALEVOL, V5, P867, DOI 10.1016/j.crpv.2006.03.008; Prokop J, 2009, SYST ENTOMOL, V34, P610, DOI 10.1111/j.1365-3113.2009.00495.x; Puchalski SS, 2008, AM MALACOL BULL, V25, P87, DOI 10.4003/0740-2783-25.1.87; Pulawski Wojciech J., 2000, Journal of Hymenoptera Research, V9, P34; Putz A, 2004, INSECT SYST EVOL, V35, P329, DOI 10.1163/187631204788920257; Rainford JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109085; Rainford JL, 2014, HIST INSECTS, V9, DOI 10.1371/journal.pone.0109085; Rasnitsyn AP, 2006, PALEONTOL J+, V40, pS679, DOI 10.1134/S003103010612001X; Rasnitsyn A.P., 2002, P437; Rasnitsyn A.P., 1988, Vestnik Zoologii, V1988, P18; Rasnitsyn A. P., 2008, Russian Entomological Journal, V17, P299; Rasnitsyn A. P., 2000, Acta Geologica Hispanica, V35, P65; Rasnitsyn A.P., 2000, Bulletin of the Natural History Museum Geology Series, V56, P21; Rasnitsyn A.P., 2002, HIST INSECTS, P194; Rasnitsyn A.P., 2002, HIST INSECTS, P69; Rasnitsyn A. P., 2002, HIST INSECTS, P75; Rasnitsyn A. P., 2002, HIST INSECTS, P256; Rasnitsyn AP, 2009, AFR INVERTEBR, V50, P191, DOI 10.5733/afin.050.0108; Rasnitsyn AP, 2006, PALAEONTOLOGY, V49, P907, DOI 10.1111/j.1475-4983.2006.00574.x; Rasnitsyn AP, 2007, AFR INVERTEBR, V48, P193; Rasnitsyn Alexandr P., 1996, Memoirs of the Entomological Society of Washington, V17, P183; Rasnitsyn Alexandr P., 2003, Acta Zoologica Cracoviensia, V46, P85; Rasnitsyn AR, 2006, INSECT SYST EVOL, V37, P179, DOI 10.1163/187631206788831137; Rasnitsyn AP, 2005, PALEONTOL J+, V39, P404; Rasnitsyn AP, 2004, PALAEONTOLOGY, V47, P1507, DOI 10.1111/j.0031-0239.2004.00416.x; RASNITSYN AP, 1990, DOKL AKAD NAUK SSSR+, V310, P973; Rasnitsyn AP, 2004, INSECT SYST EVOL, V35, P123, DOI 10.1163/187631204788912391; Rasnitsyn AP, 1998, CRETACEOUS RES, V19, P329; Rasnitsyn AP, 2004, PALEONTOL J+, V38, pS158; Rasnitsyn AP, 2003, NEUES JAHRB GEOL P-A, V227, P321; Rasnitsyn AP, 2000, CONTRIB ZOOL, V69, P251, DOI 10.1163/18759866-06904003; RASNITSYN AP, 1938, HIST INSECTS, P254; Rasnitsyn AP, 1975, HIST INSECTS, V174, P1; Rasnitsyn AP, 2002, RUSSIAN ENTOMOLOGICA, P242; Rasnitsyn AP, 1925, HIST INSECTS, P106; Rasnitsyn AP, 2002, HIST INSECTS, DOI [10.1007/0-306-47577-4, DOI 10.1007/0-306-47577-4]; Rasnitsyn AP, 2002, RUSSIAN ENTOMOLOGICA, P256; RASNITSYN AP, 1975, T PALEONTOLOGICHESKO, V174, P1; RASNITSYN AP, 2004, NEW MEXICO MUSEUM NA, V25, P215; Rasnitsyn AP, 2002, HIST INSECTS, P128; RASNITSYN AP, 2002, HIST INSECTS, P161; Rasnitsyn AP, 2002, HIST INSECTS, P161; Rasnitsyn AP., 2002, PSYCHE, P88; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Rehn AC, 2003, SYST ENTOMOL, V28, P181, DOI 10.1046/j.1365-3113.2003.00210.x; Ren D., 2010, SILENT STORIES INSEC; Ren D, 2008, J KANSAS ENTOMOL SOC, V81, P161, DOI 10.2317/JKES-0804.15.1; Ren D, 2008, INSECT SYST EVOL, V39, P223, DOI 10.1163/187631208788784075; Ren Dong, 2003, Acta Entomologica Sinica, V46, P622; Ren D, 2007, ANN ZOOL, V57, P211; Ren Dong, 2002, Acta Entomologica Sinica, V45, P234; [任东 Ren Dong], 2002, [地质通报, Geological Bulletin of China], V21, P584; Ren Dong, 2002, Entomologia Sinica, V9, P53; Ren Dong, 1998, Acta Zootaxonomica Sinica, V23, P65; Ren Dong, 1995, Entomologia Sinica, V2, P300; Ren D, 2009, SCIENCE, V326, P840, DOI 10.1126/science.1178338; Ren D, 2009, CRETACEOUS RES, V30, P1217, DOI 10.1016/j.cretres.2009.06.004; Ren Dong, 1998, Acta Zootaxonomica Sinica, V23, P281; Ren Dong, 2005, Acta Zootaxonomica Sinica, V30, P275; Resh VH, 2009, ZOOTAXA; Resh VH., 2009, ENCY INSECTS; RIEK E F, 1976, Palaeontologia Africana, V19, P141; Rindal DSAE, 2007, FUNDAMENTALS PALEONT, V1535, P1; Rognes K, 1997, CLADISTICS, V13, P27, DOI 10.1111/j.1096-0031.1997.tb00240.x; Rohdendorf BB, 1991, T ROY SOC EDINBURGH, V9; Ross A.J., 1993, P363; Ross A.J., 2000, Bulletin of the Natural History Museum Geology Series, V56, P11; Ross AJ., 2010, 2 INT C PAL, P90; Ross AJ, 1993, BULLETIN, P363; Ross AJ, 2004, 5 INT C FOSS INS 4 W, V94, P319; Ross Andrew, 2010, P208; Ross Andrew J., 2013, Bulletin of Zoological Nomenclature, V70, P291; Ross Andrew J., 2000, P288, DOI 10.1017/CBO9780511535505.020; ROSS ES, 2003, OCCASIONAL PAPERS CA, V154, P1; Rust J, 2008, PALAEONTOLOGY, V51, P709, DOI 10.1111/j.1475-4983.2008.00780.x; Rust J, 2010, P NATL ACAD SCI USA, V107, P18360, DOI 10.1073/pnas.1007407107; Rust Jes, 1998, Palaeontologische Zeitschrift, V72, P41; Sabrosky Curtis W., 1999, Myia, V10, P1; Schliephake Gert, 2001, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V85, P197; Schluter Thomas, 2003, Acta Zoologica Cracoviensia, V46, P345; Schmied H, 2009, ZOOTAXA, P17, DOI 10.11646/zootaxa.1993.1.2; Schneider J., 1983, FREIBERGER FORSCH C, V382, P106; Schneider J.W., 1984, FREIBERGER FORSCH C, V391, P5; Schneider Joerg W., 2006, Geological Society Special Publication, V265, P325, DOI 10.1144/GSL.SP.2006.265.01.15; Schneider JW., 2004, NEW MEXICO MUSEUM NA, V25, P247; Schultz, 1982, GEOLOGICAL SOC AM SP, V190, P291, DOI DOI 10.1130/SPE190-P291; Selden Paul A., 2009, Contributions to Natural History (Bern), V12, P1269; SEPKOSKI JJ, 1993, PALEOBIOLOGY, V19, P43, DOI 10.1017/S0094837300012306; Sharov A.G., 1977, Paleontologicheskii Zhurnal, V1977, P48; Shcherbakov DE, 2008, PALEONTOL J+, V42, P15, DOI 10.1134/S0031030108010036; SHCHERBAKOV D E, 1991, Psyche (Cambridge), V98, P81, DOI 10.1155/1991/87106; Shcherbakov D.E., 2000, Bulletin of the Natural History Museum Geology Series, V56, P29; Shcherbakov D. E., 2008, Russian Entomological Journal, V17, P343; Shcherbakov D. E., 2007, Russian Entomological Journal, V16, P401; Shcherbakov D. E., 2000, PALEONTOL J, V3, P251; Shcherbakov D.E., 1995, INT J DIPTEROLOGICAL, V6, P75; Shcherbakov D.E., 2002, HIST INSECTS, P152; Shcherbakov D. Y., 2007, Russian Entomological Journal, V16, P47; Shcherbakov D. Ye., 2002, HIST INSECTS, P288; Shcherbakov DE, 1992, N JB GEOL PALAONT MH, V1992, P39; SHCHERBAKOV DE, 1988, T JOINT SOVIET MONGO, V33, P60; Shcherbakov Dmitry E., 2006, Russian Entomological Journal, V15, P315; Shcherbakov Dmitry E., 2008, Alavesia, V2, P125; Shcherbakov Dmitry E., 2009, Russian Entomological Journal, V18, P7; Shcherbakov Dmitry E., 2008, Alavesia, V2, P113; Shcherbakov Dmitry E., 2007, Russian Entomological Journal, V16, P259; Shcherbakov Dmitry E., 2007, Russian Entomological Journal, V16, P139; Shi GH, 2012, CRETACEOUS RES, V37, P155, DOI 10.1016/j.cretres.2012.03.014; Shih CK, 2009, ANN ENTOMOL SOC AM, V102, P20, DOI 10.1603/008.102.0103; Shmakov AS, 2008, PALEONTOL J+, V42, P47, DOI 10.1134/S0031030108010073; Shmakov AS, 2009, PALEONTOL J+, V43, P428, DOI 10.1134/S003103010904011X; Silvestri F., 1913, BOLL LAB ZOOL GEN AG, V7, P193; Simon E., 1886, Annales de la Societe Entomologique de France, V(6), P393; SIMON E., 1879, ANN SOC ENTOMOLOGIQU, V22, P183; Simon E, 1886, PALEONTOL J, V6, P393; Simutnik S. A., 2006, Vestnik Zoologii, V40, P283; Sinitshenkova N.D., 2000, Bulletin of the Natural History Museum Geology Series, V56, P25; Sinitshenkova N.D., 2002, P388; Sinitshenkova N.D., 2000, Paleontological Journal, V34, pS275; Sinitshenkova N.D., 1981, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Geologicheskii, V56, P116; Sinitshenkova N.D., 1987, Trudy Paleontologicheskogo Instituta, V221, P1; Sinitshenkova N.D., 1990, PALEONTOL ZH, V24, P62; Sinitshenkova N.D., 1992, PALEONTOL J+, V26, P43; Sinitshenkova N.D., 1998, PALEONTOL J+, V32, P167; Sinitshenkova N. D., 2002, HIST INSECTS, P281; Sinitshenkova N.D, 1989, PALEONTOL J+, V23, P26; Sinitshenkova ND, 2004, PALEONTOL J+, V38, pS164; Sinitshenkova ND, 2002, PALEONTOL J, V35, P270; Sinitshenkova ND, 2002, PALEONTOL J, P388; Sinitshenkova ND, 2000, PALEONTOL J, V34, pS275; Sinitshenkova ND., 2002, HIST INSECTS, P115; Sinitshenkova Nina D., 2005, Palaeontologische Zeitschrift, V79, P377; Sinitshenkova Nina D., 2000, P111; Sinitshenkova Nina D., 2003, Acta Zoologica Cracoviensia, V46, P381; Skalski Andrzej W., 1992, Nota Lepidopterologica Supplement, V4, P144; Smith AB, 2007, PALEOBIOLOGY, V33, P310, DOI 10.1666/06073.1; Smith VS, 2007, SYST ENTOMOL, V32, P196, DOI 10.1111/j.1365-3113.2007.00371.x; Sobczyk Thomas, 2009, Nota Lepidopterologica, V32, P13; Soriano C, 2006, CR PALEVOL, V5, P779, DOI 10.1016/j.crpv.2006.03.006; Soriano C, 2006, CRETACEOUS RES, V27, P555, DOI 10.1016/j.cretres.2005.10.015; Soriano Carmen, 2007, Alavesia, V1, P81; Soriano C, 2009, GEODIVERSITAS, V31, P99, DOI 10.5252/g2009n1a8; SPAHR U, 1990, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), P1; Spahr U, 1992, CRATO FOSSIL BEDS BR, V194, P1; Spahr U, 1992, STUTTG BEITR NATUR B, V194, P1; Staniczek AH., 2007, PALEONTOL J, P163; Staniczek AH, 2007, CRATO FOSSIL BEDS BR, P163; Storozhenko, 1992, PALEONTOL J, V26, P85; STOROZHENKO S, 1992, ENTOMOL FENNICA, V3, P21, DOI 10.33338/ef.83569; STOROZHENKO S, 1992, Spixiana, V15, P67; Storozhenko S.Y., 1995, Far Eastern Entomologist, V19, P1; Storozhenko S. Yu., 1997, Far Eastern Entomologist, V42, P1; Storozhenko S. Yu, 1996, Far Eastern Entomologist, V26, P18; Storozhenko Sergey, 1994, Spixiana, V17, P27; Storozhenko Sergey, 1996, Spixiana, V19, P115; Storozhenko SY., 1988, PALEONTOL J, V22, P45; Storozhenko SYu., 2002, HIST INSECTS, P278; Stuke Jens-Hermann, 2003, Studia Dipterologica, V10, P91; Stuke JH, 2003, PALEONTOL J, V10, P91; Sturm H, 1998, DEUT ENTOMOL Z, V45, P43; Sukacheva I.D., 2000, Paleontological Journal, V34, pS347; Sukacheva ID, 2004, PALEONTOL J+, V38, P182; Sukatsheva ID, 2001, CRETACEOUS RES, V22, P685, DOI 10.1006/cres.2001.0292; Sukatsheva ID, 2007, AFR INVERTEBR, V48, P245; Sun Jian-Hai, 2007, Acta Zootaxonomica Sinica, V32, P881; Sun Jian-Hai, 2007, Acta Zootaxonomica Sinica, V32, P865; Svenson GJ, 2009, CLADISTICS, V25, P468, DOI 10.1111/j.1096-0031.2009.00263.x; SYu Storozhenko, 1996, RUSSIAN ENTOMOLOGICA, V19, P115; Szwedo J, 2007, CRATO FOSSIL BEDS BR, P297; Szwedo J, 2007, AFR INVERTEBR, V48, P127; Szwedo J, 2008, B INSECTOL, V61, P111; Szwedo J, 2008, B INSECTOL, V61, P109; Szwedo J, 2006, ANN ZOOL, V56, P555; Szwedo J, 2009, ZOOTAXA, P40, DOI 10.11646/zootaxa.2281.1.3; Szwedo Jacek, 2008, Palaeodiversity, P75; Szwedo J, 2009, GEODIVERSITAS, V31, P105, DOI 10.5252/g2009n1a9; Szwedo J, 2008, ENTOMOL GEN, V31, P231; Szwedo Jacek, 2006, Russian Entomological Journal, V15, P327; Tan J.J., 2009, MESOZOIC ARCHOSTEMAT; Tan JJ, 2007, ANN ENTOMOL SOC AM, V100, P666, DOI 10.1603/0013-8746(2007)100[666:TEWCCA]2.0.CO;2; Tan JJ, 2007, ANN ZOOL, V57, P231; TASCH P, 1962, J PALEONTOL, V36, P1319; THOMSON C. G., 1859, SKANDINAVIENS COLEOP, VI; TILGNER E, 2001, INSECT SYST EVOL, V31, P473, DOI DOI 10.1163/187631200X00507; van Dijk D.E., 1999, Annals of the Natal Museum, V40, P137; van Dijk DE, 2004, AFR ENTOMOL, V12, P268; Vasilenko DV, 2007, PALEONTOL J+, V41, P1156, DOI 10.1134/S0031030107110147; Vasilenko DV, 2005, PALEONTOL J+, V39, P280; Vilhelmsen L, 2004, BIOL J LINN SOC, V82, P139, DOI 10.1111/j.1095-8312.2004.00327.x; von Tschirnhaus Michael, 2009, Denisia, P171; Vrsansky P., 2000, Paleontological Journal, V34, pS374; Vrsansky P, 2001, CRETACEOUS RES, V22, P157, DOI 10.1006/cres.2000.0244; Vrsansky P, 2002, HIST INSECTS, P263; Vrsansky P, 2008, DEUT ENTOMOL Z, V55, P215, DOI 10.1002/mmnd.200800022; Vrsansky Peter, 2008, Acta Palaeontologica Polonica, V53, P129, DOI 10.4202/app.2008.0109; Vrsansky P, 2007, AFR INVERTEBR, V48, P103; Vrsansky P, 2007, BIOLOGIA, V62, P588, DOI 10.2478/s11756-007-0116-2; Vrsansky Peter, 2005, Entomological Problems, V35, P163; Vrsansky P, 2008, ZOOTAXA, P41, DOI 10.11646/zootaxa.1958.1.4; Vrsansky Peter, 2002, AMBA Projekty, V6; Vrsansky P, 2009, GEOL CARPATH, V60, P449, DOI 10.2478/v10096-009-0033-0; Vrsansky P, 2009, GEODIVERSITAS, V31, P73, DOI 10.5252/g2009n1a7; Vrsanskyy P., 2007, ENTOMOLOGICAL PROBLE, V62, P588; Vrsanskyy P., 2003, AMBA PROJEKTY, V32, P51; Wagner R, 2000, SYST ENTOMOL, V25, P115, DOI 10.1046/j.1365-3113.2000.025001115.x; Wagner R, 2008, HYDROBIOLOGIA, V595, P489, DOI 10.1007/s10750-007-9127-9; Wang B, 2009, PALEONTOL J+, V43, P652, DOI 10.1134/S0031030109060082; [No title captured]; Wang Bo, 2006, Palaeoworld, V15, P115, DOI 10.1016/j.palwor.2006.03.006; Wang B, 2009, SCI CHINA SER D, V52, P1953, DOI 10.1007/s11430-009-0160-6; Wang B, 2009, PALAEONTOLOGY, V52, P53, DOI 10.1111/j.1475-4983.2008.00826.x; Wang MX, 2009, PROG NAT SCI-MATER, V19, P1427, DOI 10.1016/j.pnsc.2009.01.012; Wang Ying, 2006, Acta Zootaxonomica Sinica, V31, P294; Wappler T, 2004, P ROY SOC B-BIOL SCI, V271, pS255, DOI 10.1098/rsbl.2003.0158; Wappler T., 2003, MAINZER NATURWISSENS, V27, P1; Wappler Torsten, 2005, Polskie Pismo Entomologiczne, V74, P227; Wappler T, 2009, P ROY SOC B-BIOL SCI, V276, P4271, DOI 10.1098/rspb.2009.1255; Wappler Torsten, 2007, Alavesia, V1, P69; Wappler T, 2008, ACTA PALAEONTOL POL, V53, P627, DOI 10.4202/app.2008.0407; Ware JL, 2008, SYST ENTOMOL, V33, P429, DOI 10.1111/j.1365-3113.2008.00424.x; Wedmann S, 2007, ZOOL J LINN SOC-LOND, V149, P701, DOI 10.1111/j.1096-3642.2007.00273.x; Wedmann S, 2007, P NATL ACAD SCI USA, V104, P565, DOI 10.1073/pnas.0606937104; Wegierek P, 2002, GEOBIOS-LYON, V35, P745, DOI 10.1016/S0016-6995(02)00086-4; Wegierek P., 1991, Paleontologicheskii Zhurnal, V1991, P114; WEGIEREK P, 1989, PALEONTOL J, V23, P40; Wegrzynowicz P, 2007, ANN ZOOL, V57, P757; Weitschat W., 2002, ATLAS PLANTS ANIMALS; Whalley P.E.S., 1985, Bulletin of the British Museum (Natural History) Geology, V39, P107; Whalley P.E.S., 1988, Bulletin of the British Museum (Natural History) Geology, V44, P45; Whalley P.E.S., 1985, Bulletin of the British Museum (Natural History) Geology, V38, P381; White Russell D., 1995, Postilla, V209, P1; Whiting MF, 2008, CLADISTICS, V24, P677, DOI 10.1111/j.1096-0031.2008.00211.x; Wichard W, 2005, INSECT SYST EVOL, V36, P279, DOI 10.1163/187631205788838410; Wichard W., 2009, AQUATIC INSECTS BALT; WICHARD W, 2003, MITT GEOL PALAONTOL, V87, P162; Wichard W, 2006, ZOOTAXA, P37, DOI 10.11646/zootaxa.1378.1.3; Wichard Wilfried, 1996, Entomologische Mitteilungen aus dem Loebbecke Museum und Aquazoo Beiheft, V4, P1; Wilkommen J., 2007, CRATO FOSSIL BEDS BR, P369; Willmann R, 1989, ABH SENCKENB NAT, V544, P1; Willmann R, 1978, FOSS CAT ANIM, V124, P1; Willmann Rainer, 1998, Palaeontologische Zeitschrift, V72, P281; Wills MA, 2001, GEOL J, V36, P187, DOI 10.1002/gj.882; Wilson HM, 2001, PALAEONTOLOGY, V44, P1025, DOI 10.1111/1475-4983.00213; Winkler J.R., 1987, Mitteilungen Muenchener Entomologischen Gesellschaft, V77, P51; Wolf-Schwenninger K., 2007, CRATO FOSSIL BEDS BR, P340; Wootton RJ, 2000, BIOL REV, V75, P129, DOI 10.1017/S0006323199005459; Yang AS, 2001, EVOL DEV, V3, P59, DOI 10.1046/j.1525-142x.2001.003002059.x; Yao Yun-Zhi, 2004, Acta Zootaxonomica Sinica, V29, P33; Yao YZ, 2007, EUR J ENTOMOL, V104, P827, DOI 10.14411/eje.2007.103; Yao Y, 2006, ZOOTAXA, P41; Yao YZ, 2006, ZOOTAXA, P1; YOSHIMOTO CM, 1975, CAN ENTOMOL, V107, P499, DOI 10.4039/Ent107499-5; Yoshimoto CM, 1975, DOKL AKAD NAUK SSSR, V107, P499; Yunzhi Y, 2008, ACTA GEOL SIN-ENGL, V82, P35; Zajic Jaroslav, 2004, Acta Musei Reginaehradecensis Series A Scientiae Naturales, V30, P5; Zalessky G, 1955, MITTEILUNGSBLATT ENT, V104, P630; Zamboni J.C., 2001, ACTA GEOL LEOPOLD, V24, P129; ZESSIN W, 2005, MITTEILUNGSBLATT ENT, V8, P54; Zessin Wolfgang, 2009, Virgo, V12, P22; Zessin Wolfgang, 1997, Veroeffentlichungen des Naturkundemuseums Erfurt, V16, P172; Zessin Wolfgang, 2006, Virgo, V9, P37; Zhang Guangxue, 1999, Entomologia Sinica, V6, P127; Zhang HC, 2010, SCI CHINA EARTH SCI, V53, P1908, DOI 10.1007/s11430-010-4098-5; Zhang HC, 2008, J SYST PALAEONTOL, V6, P463, DOI 10.1017/S1477201907002428; Zhang JF, 2006, PALEONTOL J+, V40, P553, DOI 10.1134/S0031030106050091; Zhang J.-f., 1986, Acta Palaeontologica Sinica, V25, P49; Zhang J.F., 1994, MIOCENE INSECTS SPID; Zhang JF, 2005, CRETACEOUS RES, V26, P783, DOI 10.1016/j.cretres.2005.05.004; Zhang JF, 2005, GEOBIOS-LYON, V38, P865, DOI 10.1016/j.geobios.2004.05.003; Zhang JF, 2004, CRETACEOUS RES, V25, P797, DOI 10.1016/j.cretres.2004.08.001; Zhang JF, 2004, GEOBIOS-LYON, V37, P687, DOI 10.1016/j.geobios.2003.04.007; Zhang JF, 2007, ORIENT INSECTS, V41, P351, DOI 10.1080/00305316.2007.10417519; Zhang JF, 2006, ORIENT INSECTS, V40, P115, DOI 10.1080/00305316.2006.10417463; Zhang Jun-feng, 1993, Acta Palaeontologica Sinica, V32, P141; Zhang Jun-feng, 2002, Acta Micropalaeontologica Sinica, V19, P348; Zhang JF, 2007, CRETACEOUS RES, V28, P302, DOI 10.1016/j.cretres.2006.05.012; Zhang JF, 2007, CRETACEOUS RES, V28, P289, DOI 10.1016/j.cretres.2006.05.009; Zhang JF, 2007, CRETACEOUS RES, V28, P281, DOI 10.1016/j.cretres.2006.05.008; Zhang KY, 2008, ZOOTAXA, P61, DOI 10.11646/zootaxa.1879.1.7; Zhang KY, 2007, ZOOTAXA, P27; Zhang KY, 2009, ZOOTAXA, P61, DOI 10.11646/zootaxa.1984.1.4; ZHANG XW, 2009, ACTA GEOL SINICA, V84, P38; Zhang Zhi-Qiang, 2002, Fauna of China, V4, P77; [张志军 Zhang Zhijun], 2003, [地质通报, Geological Bulletin of China], V22, P452; Zhang ZL, 1997, SEDIMENT GEOL, V112, P123, DOI 10.1016/S0037-0738(97)00029-8; Zhang ZQ., 2002, ACTA PALAEONTOLOGICA, V4, P77; Zherikhin V.V., 2000, Paleontological Journal, V34, pS333; Zherikhin V.V., 1994, Paleontological Journal, V27, P50; Zherikhin V.V., 2002, P331; ZHERIKHIN V. V., 2002, HIST INSECTS, P273, DOI [10.1007/0-306-47577-4, DOI 10.1007/0-306-47577-4]; Zherikhin V.V., 1993, T PALEONTOLOGICHESKO, V252, P20; Zherikhin VV, 2004, PALEONTOL J+, V38, P528; Zherikin V. V., 2002, HIST INSECTS, P133; Zhou CF, 2003, FLA ENTOMOL, V86, P345, DOI 10.1653/0015-4040(2003)086[0345:TNOSCA]2.0.CO;2; ZLOBIN V, 2007, INT J DIPTEROLOGICAL, V18, P129; Zompro Oliver, 2005, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V89, P85; Zompro Oliver, 2001, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V85, P229	1089	46	46	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0128554	10.1371/journal.pone.0128554	http://dx.doi.org/10.1371/journal.pone.0128554			61	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176667	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000358197600008
J	Stitt, CA; Harker, NJ; Hallam, KR; Paraskevoulakos, C; Banos, A; Rennie, S; Jowsey, J; Scott, TB				Stitt, C. A.; Harker, N. J.; Hallam, K. R.; Paraskevoulakos, C.; Banos, A.; Rennie, S.; Jowsey, J.; Scott, T. B.			An Investigation on the Persistence of Uranium Hydride during Storage of Simulant Nuclear Waste Packages	PLOS ONE			English	Article							WATER-VAPOR; CORROSION; MECHANISMS; KINETICS; OXYGEN; METAL; TEMPERATURES; SYNCHROTRON; INCLUSIONS	Synchrotron X-rays have been used to study the oxidation of uranium and uranium hydride when encapsulated in grout and stored in de-ionised water for 10 months. Periodic synchrotron X-ray tomography and X-ray powder diffraction have allowed measurement and identification of the arising corrosion products and the rates of corrosion. The oxidation rates of the uranium metal and uranium hydride were slower than empirically derived rates previously reported for each reactant in an anoxic water system, but without encapsulation in grout. This was attributed to the grout acting as a physical barrier limiting the access of oxidising species to the uranium surface. Uranium hydride was observed to persist throughout the 10 month storage period and industrial consequences of this observed persistence are discussed.	[Stitt, C. A.; Hallam, K. R.; Paraskevoulakos, C.; Banos, A.; Rennie, S.; Scott, T. B.] Univ Bristol, HH Wills Phys Lab, Interface Anal Ctr, Bristol BS8 1TL, Avon, England; [Harker, N. J.] European Synchrotron Radiat Facil, F-38043 Grenoble, Rhone Alpes, France; [Jowsey, J.] Sellafield Ltd, Seascale, Cumbria, England	University of Bristol; European Synchrotron Radiation Facility (ESRF); Sellafield Ltd	Scott, TB (corresponding author), Univ Bristol, HH Wills Phys Lab, Interface Anal Ctr, Tyndall Ave, Bristol BS8 1TL, Avon, England.	T.B.Scott@bristol.ac.uk	Paraskevoulakos, Charilaos/HCI-1395-2022	Paraskevoulakos, Charilaos/0000-0003-4445-500X; Banos, Antonios/0000-0001-8688-2865; Stitt, Camilla/0000-0002-5507-3501	Sellafield Ltd; Centre of Expertise for Uranium and Reactive Metals; EPSRC-NDA grant [EP/I036397/1]; EPSRC [EP/I036397/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1338575, EP/I036397/1] Funding Source: researchfish	Sellafield Ltd; Centre of Expertise for Uranium and Reactive Metals; EPSRC-NDA grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is primarily supported by a jointly funded EPSRC-NDA grant (EP/I036397/1) entitled 'In situ time-dependent characterisation of corrosion processes in nuclear waste storage and GDF environments' with TBS as the CoI and lead for the part of the project focused on uranium corrosion. Much of the project has been conducted by PhD student CAS. The materials and additional financial support for this project has come from Sellafield Ltd as part of a platform grant associated with the Centre of Expertise for Uranium and Reactive Metals. In the writing of this paper both Sellafield and the NDA (now RWM Ltd) have had input and provided permission to publish.	BAKER MM, 1966, T FARADAY SOC, V62, P2513, DOI 10.1039/tf9666202513; Bloch J, 1997, J ALLOY COMPD, V253, P529, DOI 10.1016/S0925-8388(96)03070-8; BLOCH J, 1981, J LESS-COMMON MET, V81, P301, DOI 10.1016/0022-5088(81)90036-9; COLMENARES CA, 1984, PROG SOLID STATE CH, V15, P257, DOI 10.1016/0079-6786(84)90003-7; Cordfunke EHP, 1969, CHEM URANIUM LLC; Danon A, 1999, LANGMUIR, V15, P5913, DOI 10.1021/la981210g; Delegard C. H., 2008, URANIUM METAL REACTI; Dinh LN, 2011, J NUCL MATER, V408, P171, DOI 10.1016/j.jnucmat.2010.11.026; Divsholi BS, 2014, INT J CONCR STRUCT M, V8, P157, DOI 10.1007/s40069-013-0063-y; Golovich E. C., 2011, SUMMARY URANIUM SOLU; Grenthe I., 2003, CHEM THERMODYN, V2nd; Harker NJ, 2013, SOLID STATE IONICS, V241, P46, DOI 10.1016/j.ssi.2013.04.004; Hart ML, 2013, J APPL CRYSTALLOGR, V46, P1249, DOI 10.1107/S0021889813022437; Haschke J. M., 1995, REACTIONS PLUTONIUM; HASCHKE JM, 1987, J LESS-COMMON MET, V133, P155, DOI 10.1016/0022-5088(87)90469-3; Haschke JM, 1998, J ALLOY COMPD, V278, P149, DOI 10.1016/S0925-8388(98)00639-2; Haschke JM, 2001, J ALLOY COMPD, V314, P78, DOI 10.1016/S0925-8388(00)01222-6; LANGMUIR D, 1978, GEOCHIM COSMOCHIM AC, V42, P547, DOI 10.1016/0016-7037(78)90001-7; Le Guyadec F, 2010, J NUCL MATER, V396, P294, DOI 10.1016/j.jnucmat.2009.11.007; Loui A., 2012, HYDROGEN CORROSION U; Macphee DE, 2011, MRS P, V127, P475; MULFORD RNR, 1954, J AM CHEM SOC, V76, P297, DOI 10.1021/ja01630a094; NDA, 2014, RADIOACTIVE WASTES U; NEWTON AS, 1949, NUCLEONICS, V4, P17; Powell GL, 2004, MINER MET MAT SOC; RITCHIE AG, 1984, J LESS-COMMON MET, V98, P193, DOI 10.1016/0022-5088(84)90294-7; RITCHIE AG, 1981, J NUCL MATER, V102, P170, DOI 10.1016/0022-3115(81)90557-2; RUNDLE RE, 1948, J AM CHEM SOC, V70, P99, DOI 10.1021/ja01181a029; Scott TB, 2011, J HAZARD MATER, V195, P115, DOI 10.1016/j.jhazmat.2011.08.011; Stitt CA, 2015, J HAZARD MATER, V285, P221, DOI 10.1016/j.jhazmat.2014.11.035; Totemeier TC, 2000, J NUCL MATER, V278, P301, DOI 10.1016/S0022-3115(99)00245-7; WOOD DH, 1994, J NUCL MATER, V209, P113, DOI 10.1016/0022-3115(94)90253-4	32	17	17	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132284	10.1371/journal.pone.0132284	http://dx.doi.org/10.1371/journal.pone.0132284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176551	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600096
J	Tsuda, S; Sakakura, T; Fujii, S; Suzuki, H; Yomo, T				Tsuda, Soichiro; Sakakura, Tatsuya; Fujii, Satoshi; Suzuki, Hiroaki; Yomo, Tetsuya			Shape Transformations of Lipid Vesicles by Insertion of Bulky-Head Lipids	PLOS ONE			English	Article							UNILAMELLAR VESICLES; PHOSPHOLIPID-VESICLES; GENE-EXPRESSION; GIANT VESICLES; LIPOSOMES; MEMBRANES; MICELLES; STABILITY; DYNAMICS; FISSION	Lipid vesicles, in particular Giant Unilamellar Vesicles (GUVs), have been increasingly important as compartments of artificial cells to reconstruct living cell-like systems in a bottom-up fashion. Here, we report shape transformations of lipid vesicles induced by polyethylene glycol-lipid conjugate (PEG lipids). Statistical analysis of deformed vesicle shapes revealed that shapes vesicles tend to deform into depended on the concentration of the PEG lipids. When compared with theoretically simulated vesicle shapes, those shapes were found to be more energetically favorable, with lower membrane bending energies than other shapes. This result suggests that the vesicle shape transformations can be controlled by externally added membrane molecules, which can serve as a potential method to control the replications of artificial cells.	[Tsuda, Soichiro; Fujii, Satoshi; Suzuki, Hiroaki; Yomo, Tetsuya] Japan Sci & Technol Agcy, ERATO, Yomo Dynam Microscale React Environm Project, Suita, Osaka 5650871, Japan; [Sakakura, Tatsuya; Suzuki, Hiroaki; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Japan Science & Technology Agency (JST); Osaka University; Osaka University	Yomo, T (corresponding author), Japan Sci & Technol Agcy, ERATO, Yomo Dynam Microscale React Environm Project, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	yomo@ist.osaka-u.ac.jp	Suzuki, Hiroaki/T-8989-2019; LARIJANI, Professor Banafshe/H-3909-2015	Suzuki, Hiroaki/0000-0002-8899-0955; LARIJANI, Professor Banafshe/0000-0003-4735-1169	Japan Society for the Promotion of Science (JSPS) [24740290]; YOMO Dynamical Micro-scale Reaction Environment, The Exploratory Research for Advanced Technology (ERATO) from Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [26289038] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); YOMO Dynamical Micro-scale Reaction Environment, The Exploratory Research for Advanced Technology (ERATO) from Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by following: Grant-in-Aid for Young Scientists (B) No. 24740290 from Japan Society for the Promotion of Science (JSPS) https://www.jsps.go.jp/english/ and YOMO Dynamical Micro-scale Reaction Environment, The Exploratory Research for Advanced Technology (ERATO) research funding program from Japan Science and Technology Agency (JST) http://www.jst.go.jp/erato/en/about/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andes-Koback M, 2011, J AM CHEM SOC, V133, P9545, DOI 10.1021/ja202406v; Ashok B, 2004, J PHARM SCI-US, V93, P2476, DOI 10.1002/jps.20150; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; BERNDL K, 1990, EUROPHYS LETT, V13, P659, DOI 10.1209/0295-5075/13/7/015; BROWN RE, 1992, BIOCHIM BIOPHYS ACTA, V1113, P375, DOI 10.1016/0304-4157(92)90007-W; Caschera F, 2011, LANGMUIR, V27, P13082, DOI 10.1021/la202648h; DOBEREINER HG, 1993, BIOPHYS J, V65, P1396; Fujii S, 2013, P NATL ACAD SCI USA, V110, P16796, DOI 10.1073/pnas.1314585110; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Ishikawa K, 2004, FEBS LETT, V576, P387, DOI 10.1016/j.febslet.2004.09.046; KAS J, 1991, BIOPHYS J, V60, P825, DOI 10.1016/S0006-3495(91)82117-8; Kastantin M, 2009, LANGMUIR, V25, P7279, DOI 10.1021/la900310k; Khairy K, 2011, SOFT MATTER, V7, P2138, DOI 10.1039/c0sm01193b; Kita H, 2008, CHEMBIOCHEM, V9, P2403, DOI 10.1002/cbic.200800360; Kurihara K, 2011, NATURE CHEM, P3; McPhee CI, 2013, BIOPHYS J, V105, P1414, DOI 10.1016/j.bpj.2013.07.048; Nishikawa T, 2012, ANAL CHEM; Nishimura K, 2009, LANGMUIR, V25, P10439, DOI 10.1021/la902237y; Noireaux V, 2004, P NATL ACAD SCI USA, V101, P17669, DOI 10.1073/pnas.0408236101; Nomura S, 2003, CHEMBIOCHEM, V4, P1172, DOI 10.1002/cbic.200300630; Pautot S, 2003, P NATL ACAD SCI USA, V100, P10718, DOI 10.1073/pnas.1931005100; Pautot S, 2003, LANGMUIR, V19, P2870, DOI 10.1021/la026100v; Sakakura T, 2012, ANAL METHODS-UK, V4, P1648, DOI 10.1039/c2ay25105a; Sakashita A, 2012, SOFT MATTER, V8, P8569, DOI 10.1039/c2sm25759a; Seifert U., 1995, P403; Seifert U, 1997, ADV PHYS, V46, P13, DOI 10.1080/00018739700101488; Shiomi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101820; Soga H, 2014, ACS SYNTH BIOL, V3, P372, DOI 10.1021/sb400094c; Stepniewski M, 2011, LANGMUIR, V27, P7788, DOI 10.1021/la200003n; Sunami T, 2010, LANGMUIR, V26, P15098, DOI 10.1021/la102689v; SVETINA S, 1989, EUR BIOPHYS J BIOPHY, V17, P101, DOI 10.1007/BF00257107; Tanaka T, 2004, LANGMUIR, V20, P9526, DOI 10.1021/la049481g; Terasawa H, 2012, P NATL ACAD SCI US; Tsuda S, 2014, SOFT MATTER, V10, P6038, DOI 10.1039/c4sm00992d; Ueda, 2014, ANGEW CHEM, V126, P7665, DOI [10.1002/ange.201403929, DOI 10.1002/ANGE.201403929]; Vukovic L, 2011, J AM CHEM SOC, V133, P13481, DOI 10.1021/ja204043b; WIMLEY WC, 1991, BIOCHEMISTRY-US, V30, P1702, DOI 10.1021/bi00220a036; Yanagisawa M, 2012, SOFT MATTER, V8, P488, DOI 10.1039/c1sm06381b; Yu Y, 2010, J AM CHEM SOC, V132, P195, DOI 10.1021/ja9059014; Zhu TF, 2009, J AM CHEM SOC, V131, P5705, DOI 10.1021/ja900919c	40	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132963	10.1371/journal.pone.0132963	http://dx.doi.org/10.1371/journal.pone.0132963			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176953	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000358197600191
J	Liu, SH; Chen, R; Hagedorn, CH				Liu, Shuanghu; Chen, Ren; Hagedorn, Curt H.			Tannic Acid Inhibits Hepatitis C Virus Entry into Huh7.5 Cells	PLOS ONE			English	Article							RNA REPLICATION; IN-VITRO; NEUTRALIZING ANTIBODIES; LIVER-TRANSPLANTATION; HYDROLYZABLE TANNINS; VIRAL-HEPATITIS; INFECTION; POLYPHENOLS; EXPRESSION; CULTURE	Chronic infection with the hepatitis C virus (HCV) is a cause of cirrhosis and hepatocellular carcinoma worldwide. Although antiviral therapy has dramatically improved recently, a number of patients remain untreated and some do not clear infection with treatment. Viral entry is an essential step in initiating and maintaining chronic HCV infections. One dramatic example of this is the nearly 100% infection of newly transplanted livers in patients with chronic hepatitis C. HCV entry inhibitors could play a critical role in preventing HCV infection of newly transplanted livers. Tannic acid, a polymer of gallic acid and glucose molecules, is a plant-derived polyphenol that defends some plants from insects and microbial infections. It has been shown to have a variety of biological effects, including antiviral activity, and is used as a flavoring agent in foods and beverages. In this study, we demonstrate that tannic acid is a potent inhibitor of HCV entry into Huh7.5 cells at low concentrations (IC50 5.8 mu M). It also blocks cell-to-cell spread in infectious HCV cell cultures, but does not inhibit HCV replication following infection. Moreover, experimental results indicate that tannic acid inhibits an early step of viral entry, such as the docking of HCV at the cell surface. Gallic acid, tannic acid's structural component, did not show any anti-HCV activity including inhibition of HCV entry or replication at concentrations up to 25 mu M. It is possible the tannin structure is related on the effect on HCV inhibition. Tannic acid, which is widely distributed in plants and foods, has HCV antiviral activity in cell culture at low micromolar concentrations, may provide a relative inexpensive adjuvant to direct-acting HCV antivirals and warrants future investigation.	[Liu, Shuanghu] Univ Utah, Coll Pharm, Dept Med Chem, Salt Lake City, UT 84112 USA; [Liu, Shuanghu; Chen, Ren; Hagedorn, Curt H.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Hagedorn, Curt H.] Univ Arkansas Med Sci, Dept Med, Little Rock, AR 72205 USA; [Hagedorn, Curt H.] Univ Arkansas Med Sci, Genet Program, Little Rock, AR 72205 USA; [Hagedorn, Curt H.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Hagedorn, CH (corresponding author), Univ Utah, Dept Med, Salt Lake City, UT 84112 USA.	chhagedorn@uams.edu			Guangzhou General Hospital, Guangzhou, China; National Institutes of Health [CA148068, CA176130]; NATIONAL CANCER INSTITUTE [R21CA176130, R21CA148068] Funding Source: NIH RePORTER	Guangzhou General Hospital, Guangzhou, China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R.C. was supported in part by a fellowship from Guangzhou General Hospital, Guangzhou, China. This work was supported in part by National Institutes of Health Grants CA148068 and CA176130 (CHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe I, 2001, BIOCHEM BIOPH RES CO, V281, P122, DOI 10.1006/bbrc.2001.4325; Asselah T, 2011, LIVER INT, V31, P68, DOI 10.1111/j.1478-3231.2010.02411.x; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Baldick CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001086; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bartosch B, 2010, VIRUSES, V2; Bialek Stephanie R, 2006, Clin Liver Dis, V10, P697, DOI 10.1016/j.cld.2006.08.003; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; BRAVO L, 1994, BRIT J NUTR, V71, P933, DOI 10.1079/BJN19940197; Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803; Chung KT, 1998, CRIT REV FOOD SCI, V38, P421, DOI 10.1080/10408699891274273; Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610; Crespo G, 2012, GASTROENTEROLOGY, V142, P1373, DOI 10.1053/j.gastro.2012.02.011; DEVI MA, 1993, CANCER LETT, V69, P191, DOI 10.1016/0304-3835(93)90174-8; Di Pasquale G, 2012, GENE THER, V19, P576, DOI 10.1038/gt.2011.138; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Farquhar MJ, 2011, BIOCHEM SOC T, V39, P532, DOI 10.1042/BST0390532; Fofana I, 2012, GASTROENTEROLOGY, V143, P223, DOI 10.1053/j.gastro.2012.04.006; Gin H, 1999, METABOLISM, V48, P1179, DOI 10.1016/S0026-0495(99)90135-X; GLICK Z, 1970, J NUTR, V100, P509, DOI 10.1093/jn/100.5.509; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Koide T, 1999, CANCER BIOTHER RADIO, V14, P231, DOI 10.1089/cbr.1999.14.231; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Le Bourvellec C, 2012, CRITICAL REV FOOD SC, V52; Lin LT, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-187; Liu SH, 2014, J GEN VIROL, V95, P423, DOI 10.1099/vir.0.055772-0; Liu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044965; Liu XQ, 2005, J NUTR, V135, P165, DOI 10.1093/jn/135.2.165; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Meuleman P, 2008, HEPATOLOGY, V48, P1761, DOI 10.1002/hep.22547; Meyer K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09012; Okuda T, 1995, Fortschr Chem Org Naturst, V66, P1; Ono K, 2004, BIOCHIM BIOPHYS ACTA, V1690; Pan MH, 1999, EUR J PHARMACOL, V381, P171, DOI 10.1016/S0014-2999(99)00549-X; Papic N, 2012, VIRUSES-BASEL, V4, P581, DOI 10.3390/v4040581; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; POTTER DK, 1968, J NUTR, V96, P187, DOI 10.1093/jn/96.2.187; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Sakagami H, 2000, PHYTOMEDICINE, V7, P39, DOI 10.1016/S0944-7113(00)80020-3; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; SAVOLAINEN H, 1992, J APPL TOXICOL, V12, P191, DOI 10.1002/jat.2550120307; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shiina Masaaki, 2006, Hepatology, V43, P1395, DOI 10.1002/hep.21210; TERRILL TH, 1994, BRIT J NUTR, V72, P467, DOI 10.1079/BJN19940048; Theisen LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088062; Tikoo K, 2008, TOXICOL LETT, V177, P90, DOI 10.1016/j.toxlet.2007.12.012; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Tsao R, 2010, NUTRIENTS, V2, P1231, DOI 10.3390/nu2121231; Uchiumi F, 1996, BIOCHEM BIOPH RES CO, V220, P411, DOI 10.1006/bbrc.1996.0419; Uchiumi F, 1998, J BIOL CHEM, V273, P12499, DOI 10.1074/jbc.273.20.12499; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang CC, 2000, CANCER LETT, V149, P77, DOI 10.1016/S0304-3835(99)00344-4; Yi M, 2007, J VIROL, V81; Zeisel MB, 2013, CURR TOP MICROBIOL, V369, P87, DOI 10.1007/978-3-642-27340-7_4; Zeisel MB, 2013, J HEPATOL, V58, P375, DOI 10.1016/j.jhep.2012.09.022; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zhang XF, 2012, BIOORGAN MED CHEM, V20, P1616, DOI 10.1016/j.bmc.2011.11.040; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; ZHU J, 1995, VET HUM TOXICOL, V37, P436; Zhu J, 1992, RES VET SCI, V53	67	25	28	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131358	10.1371/journal.pone.0131358	http://dx.doi.org/10.1371/journal.pone.0131358			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186636	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700015
J	Mainka, A; Poznyakovskiy, A; Platzek, I; Fleischer, M; Sundberg, J; Murbe, D				Mainka, Alexander; Poznyakovskiy, Anton; Platzek, Ivan; Fleischer, Mario; Sundberg, Johan; Muerbe, Dirk			Lower Vocal Tract Morphologic Adjustments Are Relevant for Voice Timbre in Singing	PLOS ONE			English	Article							AREA FUNCTIONS; MRI; UPRIGHT; SUPINE; SHAPE	The vocal tract shape is crucial to voice production. Its lower part seems particularly relevant for voice timbre. This study analyzes the detailed morphology of parts of the epilaryngeal tube and the hypopharynx for the sustained German vowels /a/, /e/, /i/, /o/, and /u/ by thirteen male singer subjects who were at the beginning of their academic singing studies. Analysis was based on two different phonatory conditions: a natural, speech-like phonation and a singing phonation, like in classical singing. 3D models of the vocal tract were derived from magnetic resonance imaging and compared with long-term average spectrum analysis of audio recordings from the same subjects. Comparison of singing to the speech-like phonation, which served as reference, showed significant adjustments of the lower vocal tract: an average lowering of the larynx by 8 mm and an increase of the hypopharyngeal cross-sectional area (+21:9%) and volume (+16:8%). Changes in the analyzed epilaryngeal portion of the vocal tract were not significant. Consequently, lower larynx-to-hypopharynx area and volume ratios were found in singing compared to the speech-like phonation. All evaluated measures of the lower vocal tract varied significantly with vowel quality. Acoustically, an increase of high frequency energy in singing correlated with a wider hypopharyngeal area. The findings offer an explanation how classical male singers might succeed in producing a voice timbre with increased high frequency energy, creating a singer's formant cluster.	[Mainka, Alexander; Muerbe, Dirk] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Otorhinolaryngol, Div Phoniatr & Audiol, D-01062 Dresden, Germany; [Mainka, Alexander; Muerbe, Dirk] Hsch Musik Carl Maria von Weber, Voice Res Lab, Dresden, Germany; [Poznyakovskiy, Anton; Fleischer, Mario] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Otorhinolaryngol, D-01062 Dresden, Germany; [Platzek, Ivan] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Radiol, D-01062 Dresden, Germany; [Sundberg, Johan] KTH CSC, Sch Comp Sci & Commun, Dept Speech Mus & Hearing, Stockholm, Sweden	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Royal Institute of Technology	Mainka, A (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Otorhinolaryngol, Div Phoniatr & Audiol, D-01062 Dresden, Germany.	alexander.mainka@uniklinikum-dresden.de	Platzek, Ivan/AAZ-8124-2020	Platzek, Ivan/0000-0002-5933-8108; Fleischer, Mario/0000-0002-6186-8298	German Research Foundation; Open Access Publication Funds of the TU Dresden	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the TU Dresden	We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade PA, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2011.10.006; Bartholomew WT, 1934, J ACOUST SOC AM, V6, P25, DOI 10.1121/1.1915685; Clement P, 2007, J VOICE, V21, P522, DOI 10.1016/j.jvoice.2006.01.005; Demolin D, 2002, CR BIOL, V325, P547, DOI 10.1016/S1631-0691(02)01458-0; DETWEILER RF, 1994, J VOICE, V8, P303, DOI 10.1016/S0892-1997(05)80278-4; Echternach M, 2014, J VOICE, V28; Echternach M, 2011, J ACOUST SOC AM, V129, P3955, DOI 10.1121/1.3589249; Echternach M, 2010, J VOICE, V24, P133, DOI 10.1016/j.jvoice.2008.06.004; Fant G., 1960, ACOUSTIC THEORY SPEE; Fleischer M, 2014, BIOMECH MODEL MECHAN; HAMMARBERG B, 1980, ACTA OTO-LARYNGOL, V90, P441, DOI 10.3109/00016488009131746; Helmholtz H, 1896, LEHRE TONEMPFINDUNGE; INGARD U, 1953, J ACOUST SOC AM, V25, P1037, DOI 10.1121/1.1907235; Kitamura T, 2005, ACOUST SCI TECHNOL, V26, P16, DOI 10.1250/ast.26.16; Kitamura T, 2005, ACOUST SCI TECHNOL, V26, P465, DOI 10.1250/ast.26.465; Nordenberg Maria, 2004, Logoped Phoniatr Vocol, V29, P183, DOI 10.1080/14015430410004689; Omori K, 1996, J VOICE, V10, P228, DOI 10.1016/S0892-1997(96)80003-8; Poznyakovskiy AA, 2008, HEARING RES, V243, P95, DOI 10.1016/j.heares.2008.06.008; Poznyakovskiy AA, 2011, HEARING RES, V282, P25, DOI 10.1016/j.heares.2011.06.009; Roers F, 2009, J VOICE, V23, P408, DOI 10.1016/j.jvoice.2007.12.003; SHIPP T, 1975, J ACOUST SOC AM, V58, P1104, DOI 10.1121/1.380776; Story BH, 1996, J ACOUST SOC AM, V100, P537, DOI 10.1121/1.415960; Story BH, 2001, J ACOUST SOC AM, V109, P1651, DOI 10.1121/1.1352085; SUNDBERG J, 1974, J ACOUST SOC AM, V55, P838, DOI 10.1121/1.1914609; Takemoto H, 2006, J ACOUST SOC AM, V119, P1037, DOI 10.1121/1.2151823; Takemoto H, 2006, J ACOUST SOC AM, V120, P2228, DOI 10.1121/1.2261270; Titze IR, 1997, J ACOUST SOC AM, V101, P2234, DOI 10.1121/1.418246; Traser L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112405; Traser L, 2013, J VOICE, V27, P141, DOI 10.1016/j.jvoice.2012.11.002; Vennard W., 1967, SINGING MECH TECHNIC; [No title captured]	31	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132241	10.1371/journal.pone.0132241	http://dx.doi.org/10.1371/journal.pone.0132241			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186691	gold, Green Submitted, Green Published			2022-12-27	WOS:000358198700031
J	Mitogawa, K; Makanae, A; Satoh, A; Satoh, A				Mitogawa, Kazumasa; Makanae, Aki; Satoh, Ayano; Satoh, Akira			Comparative Analysis of Cartilage Marker Gene Expression Patterns during Axolotl and Xenopus Limb Regeneration	PLOS ONE			English	Article							FIBROBLAST DEDIFFERENTIATION; CELLULAR CONTRIBUTION; AMBYSTOMA-MEXICANUM; SUPERNUMERARY LIMBS; II COLLAGEN; CELLS; BLASTEMA; TISSUES; FROGLET; MODEL	Axolotls (Ambystoma mexicanum) can completely regenerate lost limbs, whereas Xenopus laevis frogs cannot. During limb regeneration, a blastema is first formed at the amputation plane. It is thought that this regeneration blastema forms a limb by mechanisms similar to those of a developing embryonic limb bud. Furthermore, Xenopus laevis frogs can form a blastema after amputation; however, the blastema results in a terminal cone-shaped cartilaginous structure called a "spike." The causes of this patterning defect in Xenopus frog limb regeneration were explored. We hypothesized that differences in chondrogenesis may underlie the patterning defect. Thus, we focused on chondrogenesis. Chondrogenesis marker genes, type I and type II collagen, were compared in regenerative and nonregenerative environments. There were marked differences between axolotls and Xenopus in the expression pattern of these chondrogenesis-associated genes. The relative deficit in the chondrogenic capacity of Xenopus blastema cells may account for the absence of total limb regenerative capacity.	[Mitogawa, Kazumasa; Makanae, Aki; Satoh, Akira] Okayama Univ, Res Core Interdisciplinary Sci, Okayama, Japan; [Mitogawa, Kazumasa; Satoh, Ayano] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan; [Mitogawa, Kazumasa] Japan Soc Promot Sci, Tokyo, Japan	Okayama University; Okayama University; Japan Society for the Promotion of Science	Satoh, A (corresponding author), Okayama Univ, Res Core Interdisciplinary Sci, Okayama, Japan.	satoha@cc.okayama-u.ac.jp	Satoh, Ayano/B-2423-2011; Satoh, Akira/B-2420-2011	Satoh, Ayano/0000-0003-3736-1283; 	Japan Society for the Promotion of Science [25124707, 15J07688]; Grants-in-Aid for Scientific Research [15J07688] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research on Innovative Areas (No. 25124707 to Akira S.) and Grant-in-Aid for JSPS Fellows (No. 15J07688 to KM), http://www.jsps.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahina K, 1999, DEV DYNAM, V216, P59, DOI 10.1002/(SICI)1097-0177(199909)216:1<59::AID-DVDY8>3.0.CO;2-B; Carlson MRJ, 1998, J EXP ZOOL, V282, P715, DOI 10.1002/(SICI)1097-010X(19981215)282:6<715::AID-JEZ7>3.0.CO;2-F; Christensen RN, 2000, DEV DYNAM, V217, P216, DOI 10.1002/(SICI)1097-0177(200002)217:2<216::AID-DVDY8>3.0.CO;2-8; DENT JN, 1962, J MORPHOL, V110, P61, DOI 10.1002/jmor.1051100105; DEVLIN CJ, 1988, DEVELOPMENT, V103, P111; Endo T, 2000, DEV BIOL, V220, P296, DOI 10.1006/dbio.2000.9641; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Gardiner DM, 2002, SEMIN CELL DEV BIOL, V13, P345, DOI 10.1016/S1084952102000903; GARDINER DM, 1986, DEV BIOL, V118, P488, DOI 10.1016/0012-1606(86)90020-5; Hirata A, 2010, DEV GROWTH DIFFER, V52, P343, DOI 10.1111/j.1440-169X.2009.01165.x; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050615; Makanae A, 2014, REGENERATION, V1, P1, DOI 10.1002/reg2.16; Makanae A, 2014, DEV BIOL, V396, P57, DOI 10.1016/j.ydbio.2014.09.021; Makanae A, 2013, DEV BIOL, V381, P213, DOI 10.1016/j.ydbio.2013.05.010; Makanae A, 2012, ANAT REC, V295, P1566, DOI 10.1002/ar.22529; Mitogawa K, 2014, REGENERATION, V1, P26, DOI 10.1002/reg2.11; MUNEOKA K, 1984, DEV BIOL, V105, P166, DOI 10.1016/0012-1606(84)90272-0; MUNEOKA K, 1984, DEV BIOL, V105, P179, DOI 10.1016/0012-1606(84)90273-2; MUNEOKA K, 1982, NATURE, V298, P369, DOI 10.1038/298369a0; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; RG H, 1969, ORG DEV EMBRYO; Satoh A, 2005, DEV DYNAM, V233, P337, DOI 10.1002/dvdy.20349; Satoh A, 2007, DEV BIOL, V312, P231, DOI 10.1016/j.ydbio.2007.09.021; Satoh A, 2010, DEV BIOL, V337, P444, DOI 10.1016/j.ydbio.2009.11.023; Satoh A, 2008, DEV GROWTH DIFFER, V50, P743, DOI 10.1111/j.1440-169X.2008.01072.x; SESSIONS SK, 1988, J EXP ZOOL, V247, P39, DOI 10.1002/jez.1402470106; Suzuki M, 2006, THESCIENTIFICWORLDJO, V6, P26, DOI 10.1100/tsw.2006.325; Torok MA, 1999, J EXP ZOOL, V284, P197, DOI 10.1002/(SICI)1097-010X(19990701)284:2<197::AID-JEZ9>3.0.CO;2-F; VONDERMARK K, 1976, DEV BIOL, V53, P153, DOI 10.1016/0012-1606(76)90220-7	30	12	12	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133375	10.1371/journal.pone.0133375	http://dx.doi.org/10.1371/journal.pone.0133375			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186213	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700130
J	Pailler, S; Naidoo, R; Burgess, ND; Freeman, OE; Fisher, B				Pailler, Sharon; Naidoo, Robin; Burgess, Neil D.; Freeman, Olivia E.; Fisher, Brendan			Impacts of Community-Based Natural Resource Management on Wealth, Food Security and Child Health in Tanzania	PLOS ONE			English	Article							PARTICIPATORY FOREST MANAGEMENT; DECENTRALIZATION; POVERTY; LIVELIHOODS; BENEFITS; WILDLIFE; LOCATION; REDD	Community-based natural resource management (CBNRM) is a major global strategy for enhancing conservation outcomes while also seeking to improve rural livelihoods; however, little evidence of socioeconomic outcomes exists. We present a national-level analysis that empirically estimates socioeconomic impacts of CBNRM across Tanzania, while systematically controlling for potential sources of bias. Specifically, we apply a difference-indifferences model to national-scale, cross-sectional data to estimate the impact of three different CBNRM governance regimes on wealth, food security and child health, considering differential impacts of CBNRM on wealthy and poor populations. We also explore whether or not longer-standing CBNRM efforts provide more benefits than recently-established CBNRM areas. Our results show significant improvements in household food security in CBNRM areas compared with non-CBNRM areas, but household wealth and health outcomes in children are generally not significantly different. No one CBNRM governance regime demonstrates consistently different welfare outcomes than the others. Wealthy households benefit more from CBNRM than poor households and CBNRM benefits appear to increase with longer periods of implementation. Perhaps evidence of CBNRM benefits is limited because CBNRM hasn't been around long enough to yield demonstrable outcomes. Nonetheless, achieving demonstrable benefits to rural populations will be crucial for CBNRM's future success in Tanzania.	[Pailler, Sharon] Clark Univ, Dept Econ, Worcester, MA 01610 USA; [Naidoo, Robin; Fisher, Brendan] World Wildlife Fund, Washington, DC 20037 USA; [Burgess, Neil D.] UNEP, World Conservat Monitoring Ctr, Cambridge, England; [Burgess, Neil D.] Nat Hist Museum, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Freeman, Olivia E.] World Agroforestry Ctr, ASB Partnership Trop Forest Margins, Nairobi, Kenya; [Fisher, Brendan] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Gund Inst Ecol Econ, Burlington, VT USA	Clark University; World Wildlife Fund; CGIAR; World Agroforestry (ICRAF); University of Vermont	Pailler, S (corresponding author), Clark Univ, Dept Econ, Worcester, MA 01610 USA.	spailler@clarku.edu						Agrawal A, 2001, POLIT SOC, V29, P485, DOI 10.1177/0032329201029004002; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Andam KS, 2010, P NATL ACAD SCI USA, V107, P9996, DOI 10.1073/pnas.0914177107; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], TANZANIA DEMOGRAPHIC; Baird TD, 2014, ECOL SOC, V19, DOI 10.5751/ES-06184-190104; Benjaminsen TA, 2013, DEV CHANGE, V44, P1087, DOI 10.1111/dech.12055; Blomley T., 2009, PARTICIPATORY FOREST; Blomley T, 2008, ORYX, V42, P380, DOI 10.1017/S0030605308071433; Bowler DE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/147-2458-10-456; Burgess ND, 2010, ORYX, V44, P339, DOI 10.1017/S0030605310000554; Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106; Danielsen F, 2013, ECOL SOC, V18, DOI 10.5751/ES-05464-180341; Ferraro PJ, 2014, P NATL ACAD SCI USA, V111, P4332, DOI 10.1073/pnas.1307712111; IFAD, 2014, INVESTING IN RURAL P; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kariuki PC, 2007, INTERNATIONAL LIVEST; KENNEDY E, 1992, WORLD DEV, V20, P1077, DOI 10.1016/0305-750X(92)90001-C; Kennedy P., 2003, A GUIDE TO ECONOMETR; Lund JF, 2007, PUBLIC ADMIN DEVELOP, V27, P307, DOI 10.1002/pad.467; Lund JF, 2008, WORLD DEV, V36, P2780, DOI 10.1016/j.worlddev.2008.01.014; Mackenzie CA, 2012, ECOL ECON, V76, P119, DOI 10.1016/j.ecolecon.2012.02.013; Meshack CK, 2006, AFR J ECOL, V44, P468, DOI 10.1111/j.1365-2028.2006.00659.x; Ministry of Natural Resources and Tourism (MNRT), 2012, PARTICIPATORY FOREST; Ministry of Natural Resources and Tourism (MNRT), 2009, SELECTED CASE STUDIE; Mustalahti I, 2010, SOC NATUR RESOUR, V23, P31, DOI 10.1080/08941920802213433; Naidoo R, 2011, ENVIRON RESOUR ECON, V48, P321, DOI 10.1007/s10640-010-9412-3; National Bureau of Statistics (NBS), 2002, TANZANIA POPULATION; National Bureau of Statistics (NBS) [Tanzania] and Macro International Inc, 2000, TANZANIA REPRODUCTIV; Nielsen MR, 2012, WORLD DEV, V40, P1224, DOI 10.1016/j.worlddev.2011.11.009; Ostrom E., 1990, GOVERNING THE COMMON; Persha L, 2011, SCIENCE, V331, P1606, DOI 10.1126/science.1199343; Persha L, 2009, CONSERV BIOL, V23, P1485, DOI 10.1111/j.1523-1739.2009.01276.x; Pfaff A, 2014, WORLD DEV, V55, P7, DOI 10.1016/j.worlddev.2013.01.011; Ribot JC, 2010, ENVIRON CONSERV, V37, P35, DOI 10.1017/S0376892910000329; Robinson EJZ, 2013, NAT RESOUR FORUM, V37, P141, DOI 10.1111/1477-8947.12018; Runsten L., 2013, USING SPATIAL INFORM; Rutstein S., 2004, DHS COMPARATIVE REPO; Schaafsma M., 2012, MAPPING NTFP COLLECT; Schreckenberg K, 2009, INT FOREST REV, V11, P221, DOI 10.1505/ifor.11.2.221; Sims KRE, 2010, J ENVIRON ECON MANAG, V60, P94, DOI 10.1016/j.jeem.2010.05.003; Tanzania Commission for AIDS (TACAIDS), 2005, TANZANIA HIV AIDS IN; Tanzania Commission for AIDS (TACAIDS) Zanzibar AIDS Commission (NBS) National Bureau of Statistics Office of the Chief Government Statistician (OCGS) Inc MI, 2008, TANZANIA HIV AIDS AN; Tanzania Commission for AIDS (TACAIDS) Zanzibar AIDS Commission (NBS) National Bureau of Statistics [Tanzania] Office of the Chief Government Statistician (OCGS) ICF International, 2013, TANZANIA HIV AIDS AN; Trabucco A, 2009, CGIAR CONSORT SPATIA; Treue T, 2014, INT FOREST REV, V16, P23, DOI 10.1505/146554814811031279; Vyamana VG, 2009, INT FOREST REV, V11, P293; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; World Wildlife Fund (WWF), 2014, TANZANIAS WILDLIFE M	49	38	38	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133252	10.1371/journal.pone.0133252	http://dx.doi.org/10.1371/journal.pone.0133252			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186210	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700114
J	Park, EM; Lim, YS; Ahn, BY; Hwang, SB				Park, Eun-Mee; Lim, Yun-Sook; Ahn, Byung-Yoon; Hwang, Soon B.			AAM-B Interacts with Nonstructural 4B and Regulates Hepatitis C Virus Propagation	PLOS ONE			English	Article							LIPID DROPLETS; REPLICATION; PROTEIN; ORGANELLE; GENOME; TIP47	Hepatitis C virus (HCV) usurps host cellular lipid metabolism for production of infectious virus particles. Recently, we have screened a siRNA library targeting host factors that control lipid metabolism and lipid droplet (LD) formation in cell culture grown HCV (HCVcc)-infected cells. Of 10 final candidates, we selected the gene encoding AAM-B for further characterization. We showed that siRNA-mediated knockdown of AAM-B impaired HCV propagation in Jc1-infected cells. More precisely, knockdown of AAM-B abrogated production of infectious HCV particles in both Jc1 RNA electroporated cells and Jc1-infected cells. It is worth noting that knockdown of AAM-B exerted no effect on lipid droplet formation. Moreover, AAM-B interacted with nonstructural 4B (NS4B) through the C-terminal region of NS4B. Protein interplay between AAM-B and NS4B was verified in the context of HCV replication. Using either transient or stable expression of AAM-B, we verified that AAM-B colocalized with NS4B in the cytoplasm. Immunofluorescence data further showed that AAM-B might be involved in recruitment of NS4B to sites in close proximity to LDs to facilitate HCV propagation. Collectively, this study provides new insight into how HCV utilizes cellular AAM-B to facilitate viral propagation.	[Park, Eun-Mee; Lim, Yun-Sook; Hwang, Soon B.] Hallym Univ, Natl Res Lab Hepatitis C Virus, Anyang, South Korea; [Park, Eun-Mee; Lim, Yun-Sook; Hwang, Soon B.] Hallym Univ, Ilsong Inst Life Sci, Anyang, South Korea; [Ahn, Byung-Yoon] Korea Univ, Sch Sci & Biotechnol, Seoul, South Korea	Hallym University; Hallym University; Korea University	Hwang, SB (corresponding author), Hallym Univ, Natl Res Lab Hepatitis C Virus, Anyang, South Korea.	sbhwang@hallym.ac.kr			Ministry of Science, ICT and Future Planning, Korea [2012026351]; Korean Health Technology RD Project [HI13C1746]; Ministry of Health and Welfare, Korea	Ministry of Science, ICT and Future Planning, Korea; Korean Health Technology RD Project; Ministry of Health and Welfare, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Basic Science Research Program (2012026351) from the Ministry of Science, ICT and Future Planning, Korea and by the Korean Health Technology R&D Project (HI13C1746), Ministry of Health and Welfare, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligo J, 2009, VIROLOGY, V393, P68, DOI 10.1016/j.virol.2009.07.033; Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Gouttenoire J, 2010, REV MED VIROL, V20, P117, DOI 10.1002/rmv.640; Han QX, 2013, J VIROL, V87, P7409, DOI 10.1128/JVI.03523-12; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hugle T, 2001, VIROLOGY, V284, P70, DOI 10.1006/viro.2001.0873; Jones DM, 2009, J VIROL, V83, P2163, DOI 10.1128/JVI.01885-08; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Ngo HTT, 2013, J VIROL, V87, P5718, DOI 10.1128/JVI.03353-12; Nguyen LN, 2014, J VIROL, V88, P12311, DOI 10.1128/JVI.01678-14; Park CY, 2009, J BIOL CHEM, V284, P9237, DOI 10.1074/jbc.M808773200; Park EM, 2014, FEBS LETT, V588, P1813, DOI 10.1016/j.febslet.2014.03.043; Paul D, 2011, J VIROL, V85, P6963, DOI 10.1128/JVI.00502-11; Ploen D, 2013, EUR J CELL BIOL, V92, P374, DOI 10.1016/j.ejcb.2013.12.003; Ploen D, 2013, J HEPATOL, V58, P1081, DOI 10.1016/j.jhep.2013.01.022; Salloum S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003513; Vogt DA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003302; Zehmer JK, 2008, J CELL SCI, V121, P1852, DOI 10.1242/jcs.012013; Zehmer JK, 2009, J CELL SCI, V122, P3694, DOI 10.1242/jcs.054700	26	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132839	10.1371/journal.pone.0132839	http://dx.doi.org/10.1371/journal.pone.0132839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185986	gold, Green Submitted, Green Published			2022-12-27	WOS:000358198700065
J	Bray, DJ; Walsh, TR; Noro, MG; Notman, R				Bray, David J.; Walsh, Tiffany R.; Noro, Massimo G.; Notman, Rebecca			Complete Structure of an Epithelial Keratin Dimer: Implications for Intermediate Filament Assembly	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; MECHANICAL-PROPERTIES; COILED-COIL; TAIL DOMAIN; VIMENTIN; ORGANIZATION; PROTEINS; KERATODERMA; SEGMENTS; MUTATION	Keratins are cytoskeletal proteins that hierarchically arrange into filaments, starting with the dimer sub-unit. They are integral to the structural support of cells, in skin, hair and nails. In skin, keratin is thought to play a critical role in conferring the barrier properties and elasticity of skin. In general, the keratin dimer is broadly described by a tri-domain structure: a head, a central rod and a tail. As yet, no atomistic-scale picture of the entire dimer structure exists; this information is pivotal for establishing molecular-level connections between structure and function in intermediate filament proteins. The roles of the head and tail domains in facilitating keratin filament assembly and function remain as open questions. To address these, we report results of molecular dynamics simulations of the entire epithelial human K1/K10 keratin dimer. Our findings comprise: (1) the first three-dimensional structural models of the complete dimer unit, comprising of the head, rod and tail domains; (2) new insights into the chirality of the rod-domain twist gained from analysis of the full domain structure; (3) evidence for tri-subdomain partitioning in the head and tail domains; and, (4) identification of the residue characteristics that mediate non-covalent contact between the chains in the dimer. Our findings are immediately applicable to other epithelial keratins, such as K8/K18 and K5/K14, and to intermediate filament proteins in general.	[Bray, David J.; Notman, Rebecca] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Bray, David J.; Notman, Rebecca] Univ Warwick, Ctr Comp Sci, Coventry CV4 7AL, W Midlands, England; [Walsh, Tiffany R.] Deakin Univ, Inst Frontier Mat, Geelong, Vic 3217, Australia; [Noro, Massimo G.] Unilever R&D Port Sunlight, Wirral, Merseyside, England	University of Warwick; University of Warwick; Deakin University; Unilever	Walsh, TR (corresponding author), Deakin Univ, Inst Frontier Mat, Geelong, Vic 3217, Australia.	tiffany.walsh@deakin.edu.au; r.notman@warwick.ac.uk	Walsh, Tiffany R/C-2667-2009; Walsh, Tiffany/ABB-9072-2020; Notman, Rebecca/C-2066-2009	Walsh, Tiffany R/0000-0002-0233-9484; Notman, Rebecca/0000-0002-9721-0375; Bray, David/0000-0002-6107-0091	Unilever RD; Royal Society University Research Fellowship; veski Innovation Fellowship	Unilever RD(Unilever); Royal Society University Research Fellowship(Royal Society of London); veski Innovation Fellowship	This work was funded by Unilever R&D. The authors gratefully acknowledge computing resource from the Centre for Scientific Computing, University of Warwick. RN was supported by a Royal Society University Research Fellowship. TRW was supported by a veski Innovation Fellowship. The Royal Society and veski had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Massimo G. Noro is employed by Unilever R&D. Unilever R&D provided support in the form of salary for author MGN, and MGN played an additional role in the study design, decision to publish and preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aziz A, 2010, J BIOL CHEM, V285, P15278, DOI 10.1074/jbc.M109.075598; Azoia NG, 2012, PROTEINS, V80, P1409, DOI 10.1002/prot.24037; Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063; Chamcheu JC, 2011, ARCH BIOCHEM BIOPHYS, V508, P123, DOI 10.1016/j.abb.2010.12.019; Chernyatina AA, 2012, J STRUCT BIOL, V177, P46, DOI 10.1016/j.jsb.2011.11.014; Chou CC, 2012, BIOMACROMOLECULES, V13, P3522, DOI 10.1021/bm301254u; Coulombe PA, 2000, TRENDS CELL BIOL, V10, P420, DOI 10.1016/S0962-8924(00)01828-6; Guharoy M, 2013, CYTOSKELETON, V70, P550, DOI 10.1002/cm.21118; HATZFELD M, 1994, J CELL SCI, V107, P1959; Hess JF, 2013, PROTEIN SCI, V22, P47, DOI 10.1002/pro.2182; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JOKURA Y, 1995, J INVEST DERMATOL, V104, P806, DOI 10.1111/1523-1747.ep12607005; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KIMONIS V, 1994, J INVEST DERMATOL, V103, P764, DOI 10.1111/1523-1747.ep12412771; Kirfel J, 2003, CELL MOL LIFE SCI, V60, P56, DOI 10.1007/s000180300004; Kreplak L, 2004, EXP CELL RES, V301, P77, DOI 10.1016/j.yexcr.2004.08.021; Lee CH, 2012, NAT STRUCT MOL BIOL, V19, P707, DOI 10.1038/nsmb.2330; Lee CH, 2009, J CELL BIOL, V186, P409, DOI 10.1083/jcb.200810196; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Meier M, 2009, J MOL BIOL, V390, P245, DOI 10.1016/j.jmb.2009.04.067; Neukirch S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.038105; Nicolet S, 2010, J STRUCT BIOL, V170, P369, DOI 10.1016/j.jsb.2010.02.012; Norlen L, 2007, EXP CELL RES, V313, P2217, DOI 10.1016/j.yexcr.2007.03.037; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Parry DAD, 2001, J BIOL CHEM, V276, P39253, DOI 10.1074/jbc.M104604200; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qin Z., 2011, ADV CELL MECH, P117, DOI 10.1007/978-3-642-17590-9_4; Qin Z, 2011, J MOL MODEL, V17, P37, DOI 10.1007/s00894-010-0696-6; Qin Z, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425101; Qin Z, 2010, J BIOMECH, V43, P15, DOI 10.1016/j.jbiomech.2009.09.004; Qin Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007294; Richardson ES, 2006, J INVEST DERMATOL, V126, P79, DOI 10.1038/sj.jid.5700025; Smith TA, 2008, J STRUCT BIOL, V162, P139, DOI 10.1016/j.jsb.2007.11.005; STEINERT PM, 1985, J BIOL CHEM, V260, P7142; STEINERT PM, 1993, J BIOL CHEM, V268, P2878; STEINERT PM, 1991, INT J BIOL MACROMOL, V13, P130, DOI 10.1016/0141-8130(91)90037-U; Straussman R, 2007, J MOL BIOL, V366, P1232, DOI 10.1016/j.jmb.2006.11.083; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442; Strnad P, 2011, J CELL SCI, V124, P4221, DOI 10.1242/jcs.089516; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Tanner DE, 2011, J CHEM THEORY COMPUT, V7, P3635, DOI 10.1021/ct200563j; Utiu L, 2011, CHEM PHYS LETT, V517, P86, DOI 10.1016/j.cplett.2011.10.036; Wallace L, 2012, J CELL SCI, V125, P1750, DOI 10.1242/jcs.097139	47	19	21	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132706	10.1371/journal.pone.0132706	http://dx.doi.org/10.1371/journal.pone.0132706			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181054	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198200026
J	Damasio, LDA; Lopes, PFM; Guariento, RD; Carvalho, AR				Alves Damasio, Ludmila de Melo; Lopes, Priscila F. M.; Guariento, Rafael D.; Carvalho, Adriana R.			Matching Fishers' Knowledge and Landing Data to Overcome Data Missing in Small-Scale Fisheries	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; RESOURCE-MANAGEMENT; TRENDS; INFORMATION; ABUNDANCE; ECOSYSTEM; IMPROVE; CATCH	Background In small-scale fishery, information provided by fishers has been useful to complement current and past lack of knowledge on species and environment. Methodology Through interviews, 82 fishers from the largest fishing communities on the north and south borders of a Brazilian northeastern coastal state provided estimates of the catch per unit effort (CPUE) and rank of species abundance of their main target fishes for three time points: current year (2013 at the time of the research), 10, and 20 years past. This information was contrasted to other available data sources: scientific sampling of fish landing (2013), governmental statistics (2003), and information provided by expert fishers (1993), respectively. Principal Findings Fishers were more accurate when reporting information about their maximum CPUE for 2013, but except for three species, which they estimated accurately, fishers overestimated their mean CPUE per species. Fishers were also accurate at establishing ranks of abundance of their main target species for all periods. Fishers' beliefs that fish abundance has not changed over the last 10 years (2003-2013) were corroborated by governmental and scientific landing data. Conclusions The comparison between official and formal landing records and fishers' perceptions revealed that fishers are accurate when reporting maximum CPUE, but not when reporting mean CPUE. Moreover, fishers are less precise the less common a species is in their catches, suggesting that they could provide better information for management purposes on their current target species.	[Alves Damasio, Ludmila de Melo] Univ Fed Rio Grande do Norte, UFRN, Graduat Program Dev & Environm, BR-59072970 Natal, RN, Brazil; [Lopes, Priscila F. M.; Carvalho, Adriana R.] Univ Fed Rio Grande do Norte, UFRN, Dept Ecol, BR-59072970 Natal, RN, Brazil; [Lopes, Priscila F. M.] Fisheries & Food Inst, Santos, SP, Brazil; [Guariento, Rafael D.] Univ Mato Grosso Sul, UFMS, Ctr Biol & Hlth Sci, Campo Grande, MS, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal de Mato Grosso do Sul	Damasio, LDA (corresponding author), Univ Fed Rio Grande do Norte, UFRN, Graduat Program Dev & Environm, BR-59072970 Natal, RN, Brazil.	ludmila.damasio@hotmail.com	Guariento, Rafael Dettogni/Q-3602-2019; Lopes, Priscila/H-2028-2012; Carvalho, Adriana Rosa/E-2382-2016; GUARIENTO, RAFAEL DETTOGNI/J-1211-2014	Guariento, Rafael Dettogni/0000-0003-2035-2030; Lopes, Priscila/0000-0002-6774-5117; 	Coordination for the Improvement of Higher Education Personnel (CAPES); Rio Grande do Norte Research Foundation, through the First Research Program Call	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Rio Grande do Norte Research Foundation, through the First Research Program Call	LMAD received a masters' grant from Coordination for the Improvement of Higher Education Personnel (CAPES) (http://www.capes.gov.br/). PFML received a research grant from Rio Grande do Norte Research Foundation, through the First Research Program Call (http://www.fapern.rn.gov.br/).	Andrew NL, 2007, FISH FISH, V8, P227, DOI 10.1111/j.1467-2679.2007.00252.x; Bene C, 2010, DEV POLICY REV, V28, P325, DOI 10.1111/j.1467-7679.2010.00486.x; Carvalho AR, 2009, FISH RES, V96, P119, DOI 10.1016/j.fishres.2008.08.017; Christophe Bene, 2005, SMALL SCALE FISHERIE, P46; Cisneros-Montemayor AM, 2013, MAR POLICY, V39, P283, DOI 10.1016/j.marpol.2012.12.003; Daw TM, 2010, ANIM CONSERV, V13, P534, DOI 10.1111/j.1469-1795.2010.00418.x; Eddy TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013670; Food and Agriculture Organization (FAO), 2012, STATE WORLD FISHERIE; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; Garcia-Allut A., 2007, COASTAL MANAGEMENT S, V4, P227; Hallwass G, 2013, ECOL APPL, V23, P392, DOI 10.1890/12-0429.1; Hood GM, 2010, POPTOOLS; JOHANNES RE, 1981, B MAR SCI, V31, P673; Johannes RE, 1998, TRENDS ECOL EVOL, V13, P243, DOI 10.1016/S0169-5347(98)01384-6; Johannes RE, 2000, FISH FISH, V1, P257, DOI 10.1046/j.1467-2979.2000.00019.x; Johnson TR, 2007, ICES J MAR SCI, V64, P834, DOI 10.1093/icesjms/fsm014; Karper MAM, 2014, MAR POLICY, V44, P457, DOI 10.1016/j.marpol.2013.10.012; Kleisner K, 2014, MAR ECOL PROG SER, V512, P185, DOI 10.3354/meps10949; Le Fur J, 2011, CAN J FISH AQUAT SCI, V68, P1454, DOI 10.1139/F2011-061; Leitao F, 2014, FISH RES, V155, P33, DOI 10.1016/j.fishres.2014.02.012; Matlin MW, 2004, COGNITIVE ILLUSIONS: A HANDBOOK ON FALLACIES AND BIASES IN THINKING, JUDGEMENT AND MEMORY, P255; Ministerio da Pesca e Aquicultura-MPA, 2011, B EST PESC AQ, P60; MMA (Ministerio do Meio Ambiente, 2006, REL FIN PROJ MON AT REL FIN PROJ MON AT, P328; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pauly D, 2013, NATURE, V494, P303, DOI 10.1038/494303a; PITCHER TJ, 1997, P 2 WORLD FISH C, V2, P143; Poizat G, 1997, ENVIRON BIOL FISH, V50, P435, DOI 10.1023/A:1007317423165; Rochet MJ, 2008, ICES J MAR SCI, V65, P1057, DOI 10.1093/icesjms/fsn062; Rosa R, 2014, OCEAN COAST MANAGE, V102, P258, DOI 10.1016/j.ocecoaman.2014.10.004; Silvius, 2009, P 42 HAW INT C SYST, P1; Teh LSL, 2011, FISH RES, V110, P450, DOI 10.1016/j.fishres.2011.06.001; Tesfamichael D, 2014, ECOL SOC, V19, DOI 10.5751/ES-06151-190118; VASCONCELOS EMS, 2003, B TECNICO CIENTIFICO, V11, P277; Williams A, 2007, FISHERS KNOWLEDGE FI, P41; Zeller D, 2015, CORAL REEFS, V34, P25, DOI 10.1007/s00338-014-1219-1; Zeller D, 2011, FISH RES, V108, P356, DOI 10.1016/j.fishres.2010.10.024; Zeller D, 2006, MAR RESOUR ECON, V21, P355, DOI DOI 10.1086/MRE.21.4.42629521	37	40	41	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133122	10.1371/journal.pone.0133122	http://dx.doi.org/10.1371/journal.pone.0133122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176538	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600216
J	Fern, EB; Watzke, H; Barclay, DV; Roulin, A; Drewnowski, A				Fern, Edward B.; Watzke, Heribert; Barclay, Denis V.; Roulin, Anne; Drewnowski, Adam			The Nutrient Balance Concept: A New Quality Metric for Composite Meals and Diets	PLOS ONE			English	Article							NUTRITIONAL QUALITY; RICH FOODS; INDIVIDUAL FOODS; ENERGY COSTS; VALIDATION; DENSITY; INDEX; PROFESSIONALS; TOOL	Background Combinations of foods that provide suitable levels of nutrients and energy are required for optimum health. Currently, however, it is difficult to define numerically what are 'suitable levels'. Objective To develop new metrics based on energy considerations-the Nutrient Balance Concept (NBC)-for assessing overall nutrition quality when combining foods and meals. Method The NBC was developed using the USDA Food Composition Database (Release 27) and illustrated with their MyPlate 7-day sample menus for a 2000 calorie food pattern. The NBC concept is centered on three specific metrics for a given food, meal or diet-a Qualifying Index (QI), a Disqualifying Index (DI) and a Nutrient Balance (NB). The QI and DI were determined, respectively, from the content of 27 essential nutrients and 6 nutrients associated with negative health outcomes. The third metric, the Nutrient Balance (NB), was derived from the Qualifying Index (QI) and provided key information on the relative content of qualifying nutrients in the food. Because the Qualifying and Disqualifying Indices (QI and DI) were standardized to energy content, both become constants for a given food/meal/diet and a particular consumer age group, making it possible to develop algorithms for predicting nutrition quality when combining different foods. Results Combining different foods into composite meals and daily diets led to improved nutrition quality as seen by QI values closer to unity (indicating nutrient density was better equilibrated with energy density), DI values below 1.0 (denoting an acceptable level of consumption of disqualifying nutrients) and increased NB values (signifying complementarity of foods and better provision of qualifying nutrients). Conclusion The Nutrient Balance Concept (NBC) represents a new approach to nutrient profiling and the first step in the progression from the nutrient evaluation of individual foods to that of multiple foods in the context of meals and total diets.	[Fern, Edward B.; Watzke, Heribert; Barclay, Denis V.; Roulin, Anne] Nestec Ltd, Int Headquarters, Vevey, Switzerland; [Drewnowski, Adam] Univ Washington, Ctr Publ Hlth Nutr, Seattle, WA 98195 USA	Nestle SA; University of Washington; University of Washington Seattle		ed.fern@bluewin.ch; adamdrew@uw.edu	Drewnowski, Adam/HCI-4117-2022		Nestec Ltd. (part of the Nestle Group); Nestec Ltd.	Nestec Ltd. (part of the Nestle Group); Nestec Ltd.(Nestle SA)	Nestec Ltd. (part of the Nestle Group) was the commercial funder of this research study. The funder provided support in the form of salaries for the following authors: Edward Fern, Heribert Watzke, Denis Barclay and Anne Roulin. The fifth author Adam Drewnowski is a consultant to Nestle and has received consulting fees from Nestec Ltd. The funder Nestec did not have any additional role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	AFSSA, 2008, DEF PROF NUTR ACC AL; Arambepola C, 2008, VALIDATING NUTR PROF; Arsenault JE, 2012, J ACAD NUTR DIET, V112, P1968, DOI 10.1016/j.jand.2012.08.032; Azais-Braesco V, 2006, PUBLIC HEALTH NUTR, V9, P613, DOI 10.1079/PHN2006966; Darmon N, 2005, J AM DIET ASSOC, V105, P1881, DOI 10.1016/j.jada.2005.09.005; Darmon N, 2009, AM J CLIN NUTR, V89, P1227, DOI 10.3945/ajcn.2008.26465; Drewnowski A, 2005, AM J CLIN NUTR, V82, P721, DOI 10.1093/ajcn/82.4.721; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Drewnowski A, 2008, NUTR REV, V66, P23, DOI 10.1111/j.1753-4887.2007.00003.x; Drewnowski A, 2011, J AM DIET ASSOC, V111, P280, DOI 10.1016/j.jada.2010.10.045; Drewnowski A, 2009, J AM COLL NUTR, V28, p421S, DOI 10.1080/07315724.2009.10718106; Friday J, 2008, MYPYRAMID EQUIVALENT; Fulgoni VL, 2009, J NUTR, V139, P1549, DOI 10.3945/jn.108.101360; Global Alliance for Improved Nutrition, 2013, ACC NUTR IND; Institute of Medicine (US) Food and Nutrition Board, 1998, DIET REF INT RISK AS; Labouze E, 2007, PUBLIC HEALTH NUTR, V10, P690, DOI 10.1017/S1368980007382505; Maillot M, 2008, J NUTR, V138, P1107, DOI 10.1093/jn/138.6.1107; Maillot M, 2007, J NUTR, V137, P1815, DOI 10.1093/jn/137.7.1815; Maillot M, 2011, J NUTR, V141, P333, DOI 10.3945/jn.110.131920; Maillot M, 2010, PUBLIC HEALTH NUTR, V13, P1178, DOI 10.1017/S1368980009993028; Nijman CAJ, 2007, EUR J CLIN NUTR, V61, P461, DOI 10.1038/sj.ejcn.1602548; Saxholt E, 2009, DANISH FOOD COMPOSIT; Scarborough P, 2007, PUBLIC HEALTH NUTR, V10, P337, DOI 10.1017/S1368980007666671; Scarborough P, 2007, PUBLIC HEALTH NUTR, V10, P346, DOI 10.1017/S1368980007666683; Tetens I, 2007, EUR J NUTR, V46, P4, DOI 10.1007/s00394-007-2003-6; U.S. Department of Agriculture, 2012, SAMPL MEN 2000 CAL F; U.S. Department of Agriculture, 2014, DIET REF INT; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; USDA, 2014, NAT NUTR DAT STAND R; Volatier JL, 2007, EUR J NUTR, V46, P29, DOI 10.1007/s00394-007-2004-5	30	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130491	10.1371/journal.pone.0130491	http://dx.doi.org/10.1371/journal.pone.0130491			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176770	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600024
J	Fuess, LE; Eisenlord, ME; Closek, CJ; Tracy, AM; Mauntz, R; Gignoux-Wolfsohn, S; Moritsch, MM; Yoshioka, R; Burge, CA; Harvell, CD; Friedman, CS; Hewson, I; Hershberger, PK; Roberts, SB				Fuess, Lauren E.; Eisenlord, Morgan E.; Closek, Collin J.; Tracy, Allison M.; Mauntz, Ruth; Gignoux-Wolfsohn, Sarah; Moritsch, Monica M.; Yoshioka, Reyn; Burge, Colleen A.; Harvell, C. Drew; Friedman, Carolyn S.; Hewson, Ian; Hershberger, Paul K.; Roberts, Steven B.			Up in Arms: Immune and Nervous System Response to Sea Star Wasting Disease	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ARACHIDONIC-ACID METABOLISM; STRONGYLOCENTROTUS-PURPURATUS; EXPRESSION ANALYSIS; CONNECTIVE-TISSUE; SIGNALING PATHWAY; GENE-EXPRESSION; BINDING LECTIN; URCHIN GENOME; DROSOPHILA	Echinoderms, positioned taxonomically at the base of deuterostomes, provide an important system for the study of the evolution of the immune system. However, there is little known about the cellular components and genes associated with echinoderm immunity. The 2013-2014 sea star wasting disease outbreak is an emergent, rapidly spreading disease, which has led to large population declines of asteroids in the North American Pacific. While evidence suggests that the signs of this disease, twisting arms and lesions, may be attributed to a viral infection, the host response to infection is still poorly understood. In order to examine transcriptional responses of the sea star Pycnopodia helianthoides to sea star wasting disease, we injected a viral sized fraction (0.2 mu m) homogenate prepared from symptomatic P. helianthoides into apparently healthy stars. Nine days following injection, when all stars were displaying signs of the disease, specimens were sacrificed and coelomocytes were extracted for RNA-seq analyses. A number of immune genes, including those involved in Toll signaling pathways, complement cascade, melanization response, and arachidonic acid metabolism, were differentially expressed. Furthermore, genes involved in nervous system processes and tissue remodeling were also differentially expressed, pointing to transcriptional changes underlying the signs of sea star wasting disease. The genomic resources presented here not only increase understanding of host response to sea star wasting disease, but also provide greater insight into the mechanisms underlying immune function in echinoderms.	[Fuess, Lauren E.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Eisenlord, Morgan E.; Tracy, Allison M.; Yoshioka, Reyn; Burge, Colleen A.; Harvell, C. Drew] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Closek, Collin J.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Mauntz, Ruth] Donald P Shiley Biosci Ctr, San Diego, CA USA; [Gignoux-Wolfsohn, Sarah] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA; [Moritsch, Monica M.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Burge, Colleen A.; Friedman, Carolyn S.; Roberts, Steven B.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Hewson, Ian] Cornell Univ, Dept Microbiol, Ithaca, NY USA; [Hershberger, Paul K.] US Geol Survey, Western Fisheries Res Ctr, Marrowstone Marine Field Stn, Nordland, WA USA	University of Texas System; University of Texas Arlington; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Northeastern University; University of California System; University of California Santa Cruz; University of Washington; University of Washington Seattle; Cornell University; United States Department of the Interior; United States Geological Survey	Fuess, LE (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	fuess@uta.edu	Fuess, Lauren E/S-6456-2019	Fuess, Lauren E/0000-0003-0197-7326; Gignoux-Wolfsohn, Sarah/0000-0002-9037-1088; Roberts, Steven/0000-0001-8302-1138; Moritsch, Monica/0000-0002-3890-1264; Mauntz, Ruth/0000-0003-0376-3313; Eisenlord, Morgan/0000-0002-9353-6642; Closek, Collin/0000-0003-4431-221X	National Science Foundation (OCE) [1215977]; Division Of Ocean Sciences [1215977] Funding Source: National Science Foundation	National Science Foundation (OCE)(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was completed as part of the Ecology of Infectious Marine Diseases Research Coordination Network Workshop, funded by the National Science Foundation (OCE #1215977; http://www.eeb.cornell.edu/ecologymarinedisease/Home/Home.html; http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=11691&org=OCE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2013, UNPRECEDENTED SEA ST; [Anonymous], 2014, SEA STAR WAST DIS SA; ARAKI M, 2009, RECENT RES DEV NEURO, V3, P111; Bates AE, 2009, DIS AQUAT ORGAN, V86, P245, DOI 10.3354/dao02125; Beck G, 1996, CYTOKINE, V8, P507, DOI 10.1006/cyto.1996.0069; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bulgakov AA, 2013, MAR BIOTECHNOL, V15, P73, DOI 10.1007/s10126-012-9460-5; Burke RD, 2006, DEV BIOL, V300, P434, DOI 10.1016/j.ydbio.2006.08.007; Cameron RA, 2009, NUCLEIC ACIDS RES, V37, pD750, DOI 10.1093/nar/gkn887; CANICATTI C, 1989, J INVERTEBR PATHOL, V53, P152, DOI 10.1016/0022-2011(89)90002-5; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chi ZK, 2012, DEV CELL, V22, P707, DOI 10.1016/j.devcel.2012.02.011; Cuadrado A, 2014, J BIOL CHEM, V289, P15244, DOI 10.1074/jbc.M113.540633; DAVIES P, 1984, ANNU REV IMMUNOL, V2, P335, DOI 10.1146/annurev.immunol.2.1.335; DAYTON PK, 1975, ECOL MONOGR, V45, P137, DOI 10.2307/1942404; Dheilly NM, 2013, DEV COMP IMMUNOL, V40, P35, DOI 10.1016/j.dci.2013.01.007; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; DUGGINS DO, 1983, ECOLOGY, V64, P1610, DOI 10.2307/1937514; Eckert GL., 1999, P 5 CAL ISL S SANT B, P390; Elenkov IJ, 1998, J IMMUNOL, V161, P2586; Elphick MR, 2001, J EXP BIOL, V204, P875; Finberg RW, 2007, REV MED VIROL, V17, P35, DOI 10.1002/rmv.525; Franco CF, 2011, PROTEOMICS, V11, P3587, DOI 10.1002/pmic.201000745; Franzenburg S, 2012, P NATL ACAD SCI USA, V109, P19374, DOI 10.1073/pnas.1213110109; Gowda NM, 2013, J FLUORESC, V23, P1147, DOI 10.1007/s10895-013-1244-4; Gudenkauf BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128150; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; HIDAKA M, 1983, J EXP BIOL, V103, P1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HULTMARK D, 1994, BIOCHEM BIOPH RES CO, V199, P144, DOI 10.1006/bbrc.1994.1206; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Katow H, 2008, INT J DEV BIOL, V52, P1077, DOI 10.1387/ijdb.082684hk; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Krishnan A, 2013, GENE, V526, P122, DOI 10.1016/j.gene.2013.05.005; Li C, 2010, DEV COMP IMMUNOL, V34, P959, DOI 10.1016/j.dci.2010.04.004; Li HM, 2013, NAT CELL BIOL, V15, P773, DOI 10.1038/ncb2791; Libro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081821; Ma JX, 2002, BIOCHEM PHARMACOL, V64, P1447, DOI 10.1016/S0006-2952(02)01393-X; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Messier-Solek C, 2010, SEMIN IMMUNOL, V22, P39, DOI 10.1016/j.smim.2009.11.007; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Mogilenko DA, 2010, MOL BIOL+, V44, P67, DOI 10.1134/S0026893310010097; Moreira R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-267; Nair SV, 2005, PHYSIOL GENOMICS, V22, P33, DOI 10.1152/physiolgenomics.00052.2005; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PAINE R T, 1974, Oecologia (Berlin), V15, P93, DOI 10.1007/BF00345739; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Quinones JL, 2002, DEV BIOL, V250, P181, DOI 10.1006/dbio.2002.0778; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Rauta PR, 2014, IMMUNOL LETT, V158, P14, DOI 10.1016/j.imlet.2013.11.013; Ribeiro AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049016; Roberts S, 2015, EIMD SSWD V1 0 SUPPL; SCOTT WA, 1982, J EXP MED, V155, P1148, DOI 10.1084/jem.155.4.1148; Smith LC, 2010, DIS MODEL MECH, V3, P274, DOI 10.1242/dmm.004697; Smith LC, 1999, IMMUNOPHARMACOLOGY, V42, P107, DOI 10.1016/S0162-3109(99)00009-0; SMITH VJ, 1991, DEV COMP IMMUNOL, V15, P251, DOI 10.1016/0145-305X(91)90018-T; Sugni M, 2014, MAR ENVIRON RES, V93, P123, DOI 10.1016/j.marenvres.2013.07.010; Sun HJ, 2013, FISH SHELLFISH IMMUN, V34, P147, DOI 10.1016/j.fsi.2012.10.014; Todgham AE, 2009, J EXP BIOL, V212, P2579, DOI 10.1242/jeb.032540; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; WAITE M, 1979, BIOCHEM BIOPH RES CO, V90, P984, DOI 10.1016/0006-291X(79)91924-7; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Yamaguchi Y, 2010, J INVEST DERMATOL, V130, P645, DOI 10.1038/jid.2009.378; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102	75	29	29	1	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133053	10.1371/journal.pone.0133053	http://dx.doi.org/10.1371/journal.pone.0133053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176852	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600205
J	Fujii, H; Luo, ZJ; Kim, HJ; Newbigging, S; Gassas, A; Keating, A; Egeler, RM				Fujii, Hisaki; Luo, Zhi-Juan; Kim, Hye Jin; Newbigging, Susan; Gassas, Adam; Keating, Armand; Egeler, R. Maarten			Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2r gamma-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation	PLOS ONE			English	Article							CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; BONE-MARROW; CLINICAL-TRIALS; CHRONIC GVHD; MOUSE MODEL; STEM-CELLS; CRITERIA; IMATINIB; LIVER	Chronic graft-versus-host disease (cGvHD) is the major source of late phase morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Humanized acute GvHD (aGvHD) in vivo models using NOD-SCID il2r gamma-/-(NSG) mice are well described and are important tools for investigating pathogenicity of human cells in vivo. However, there have been only few reported humanized cGvHD mouse models. We evaluated if prolonged inflammation driven by low dose G-CSF-mobilized human PBMCs (G-hPBMCs) would lead to cGvHD following cyclophosphamide (CTX) administration and total body irradiation (TBI) in NSG mice. Engraftment was assessed in peripheral blood (PB) and in specific target organs by either flow cytometry or immunohistochemistry (IHC). Tissue samples were harvested 56 days post transplantation and were evaluated by a pathologist. Some mice were kept for up to 84 days to evaluate the degree of fibrosis. Mice that received CTX at 20mg/kg did not show aGvHD with stable expansion of human CD45(+) CD3(+) T-cells in PB (mean; 5.8 to 23.2%). The pathology and fibrosis scores in the lung and the liver were significantly increased with aggregation of T-cells and hCD68(+) macrophages. There was a correlation between liver pathology score and the percentage of hCD68(+) cells, suggesting the role of macrophage in fibrogenesis in NSG mice. In order to study long-term survival, 6/9 mice who survived more than 56 days showed increased fibrosis in the lung and liver at the endpoint, which suggests the infiltrating hCD68(+) macrophages may be pathogenic. It was shown that the combination of CTX and TBI with a low number of G-hPBMCs (1x10(6)) leads to chronic lung and liver inflammation driven by a high infiltration of human macrophage and mature human T cells from the graft, resulting in fibrosis of lung and liver in NSG mice. In conclusion this model may serve as an important pre-clinical model to further current understanding of the roles of human macrophages in cGvHD.	[Fujii, Hisaki; Gassas, Adam; Egeler, R. Maarten] Hosp Sick Children, Hematol Oncol BMT, Toronto, ON M5G 1X8, Canada; [Fujii, Hisaki; Luo, Zhi-Juan; Kim, Hye Jin; Egeler, R. Maarten] Hosp Sick Children, Dev Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Newbigging, Susan] Toronto Ctr Phenogen, Toronto, ON, Canada; [Keating, Armand] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Egeler, RM (corresponding author), Hosp Sick Children, Hematol Oncol BMT, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	maarten.egeler@sickkids.ca		Keating, Armand/0000-0002-7676-6059	David Smyth fellowship from Canadian Blood and Marrow Transplantation Grou; Sears Cancer Research Fellowship; Garron Family Cancer Centre Research Fellowship	David Smyth fellowship from Canadian Blood and Marrow Transplantation Grou; Sears Cancer Research Fellowship; Garron Family Cancer Centre Research Fellowship	HF is supported by David Smyth fellowship from Canadian Blood and Marrow Transplantation Group, a Sears Cancer Research Fellowship and a Garron Family Cancer Centre Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044219; Anasetti C, 2012, NEW ENGL J MED, V367, P1487, DOI 10.1056/NEJMoa1203517; Arai S, 2011, BLOOD, V118, P4242, DOI 10.1182/blood-2011-03-344390; Blazar BR, 1998, BLOOD, V92, P3949, DOI 10.1182/blood.V92.10.3949.422k26_3949_3959; Chen GL, 2011, BLOOD, V118, P4070, DOI 10.1182/blood-2011-03-341693; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Fujii H, 2008, BLOOD, V111, P3276, DOI 10.1182/blood-2007-08-106286; Fuschiotti P, 2013, ARTHRITIS RHEUM-US, V65, P236, DOI 10.1002/art.37706; Greenblatt MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044664; Gregoire-Gauthier J, 2012, BONE MARROW TRANSPL, V47, P439, DOI 10.1038/bmt.2011.93; Hirayama M, 2013, HAEMATOL-HEMATOL J, V98, P41, DOI 10.3324/haematol.2012.069815; Holtick U, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010189.pub2; Inamoto Y, 2011, CURR OPIN HEMATOL, V18, P414, DOI 10.1097/MOH.0b013e32834ba87d; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; Lockridge JL, 2013, BIOL BLOOD MARROW TR, V19, P1310, DOI 10.1016/j.bbmt.2013.06.007; Malard F, 2014, BONE MARROW TRANSPL, V49, P539, DOI 10.1038/bmt.2013.215; Nishiwaki S, 2009, BLOOD, V114, P3113, DOI 10.1182/blood-2009-03-209635; Notta F, 2010, BLOOD, V115, P3704, DOI 10.1182/blood-2009-10-249326; Olivieri A, 2013, BLOOD, V122, P4111, DOI 10.1182/blood-2013-05-494278; Quaglia A, 2007, HISTOPATHOLOGY, V50, P727, DOI 10.1111/j.1365-2559.2007.02679.x; Sato M, 2006, J ORAL PATHOL MED, V35, P33, DOI 10.1111/j.1600-0714.2005.00372.x; Schroeder MA, 2011, DIS MODEL MECH, V4, P318, DOI 10.1242/dmm.006668; SCHULTZ KR, 1995, BONE MARROW TRANSPL, V16, P289; Shulman HM, 2006, BIOL BLOOD MARROW TR, V12, P31, DOI 10.1016/j.bbmt.2005.10.023; Stadler M, 2009, BLOOD, V114, P3718, DOI 10.1182/blood-2009-07-231159; van Rijn RS, 2003, BLOOD, V102, P2522, DOI 10.1182/blood-2002-10-3241; Zorn E, 2005, BLOOD, V106, P2903, DOI 10.1182/blood-2005-03-1257	30	7	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133216	10.1371/journal.pone.0133216	http://dx.doi.org/10.1371/journal.pone.0133216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176698	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600233
J	Joo, YH; Lee, SS; Han, KD; Park, KH				Joo, Young-Hoon; Lee, Seong-Soo; Han, Kyung-do; Park, Kyung-Ho			Association between Chronic Laryngitis and Particulate Matter Based on the Korea National Health and Nutrition Examination Survey 2008-2012	PLOS ONE			English	Article							AIR-POLLUTION EXPOSURE; CIGARETTE-SMOKING; INFECTION; CHILDREN; ASTHMA; SIZE	Background Chronic laryngitis (CL) has been described as chronic inflammation of the larynx. CL have various causes such as long-term smoking, acid reflux, voice overuse, bronchitis, allergies, pneumonia, excessive exposure to toxic chemicals and complications from the flu or a chronic cold. However, the prevalence of CL and role of air pollution in the etiology is uncertain. Objective The aim of this study was to investigate the relationship between CL and particulate matter with aerodynamic diameter less than 10 mu m (PM10) in South Korea using data from the Korea National Health and Nutrition Examination Surveys (KNHANES) during 2008-2012. Methods KNHANES is a cross-sectional survey of the civilian, non-institutionalized population of South Korea (n = 21,116). A field survey team that included an otolaryngologist moved with a mobile examination unit and performed interviews and physical examinations. The mean annual concentrations of ambient PM10, SO2, O3, NO2, and CO levels in Korea were determined from monitoring station data. Multiple logistic regression was used to examine the relationship of air pollution to CL. Results Among the population >= 19 years of age, the weighted prevalence of CL was 3.37 +/- 0.30% (95% confidence interval, 2.79-3.95%). CL was more prevalent in men, current smokers, and those with lower household income and prevalence increased with age. A significant decrease over time was observed in the prevalence of CL (P for trend = 0.0049) and the annual average concentrations of PM10 (P for trend < 0.0001) from 2008 to 2012. In a multivariate model, the factors associated with CL included PM10 (odds ratio [OR], 1.378, p = 0.0457), age (OR, 1.020, p<0.0001), sex (OR, 0.734, p = 0.0179), and smoking status (OR, 1.438, p = 0.0054). Conclusion Elevated PM10 exposures could be associated with increased risk of CL in South Koreans. Further epidemiological and experimental studies are necessary to clarify the impact of chronic PM10 exposure on CL.	[Joo, Young-Hoon; Park, Kyung-Ho] Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Lee, Seong-Soo] Catholic Univ Korea, Coll Med, Dept Endocrinol, Seoul, South Korea; [Han, Kyung-do] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Park, KH (corresponding author), Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	khpent@catholic.ac.kr	Joo, Young Hoon/AAU-7285-2020	Joo, Young Hoon/0000-0002-4662-1916				Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Baletic N, 2005, IND HEALTH, V43, P302, DOI 10.2486/indhealth.43.302; Bitar K, 2011, NEUROGASTROENT MOTIL, V23, P490, DOI 10.1111/j.1365-2982.2011.01678.x; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Carvalho-Oliveira R, 2005, ENVIRON RES, V98, P349, DOI 10.1016/j.envres.2004.10.002; Chen HK, 2012, AUSTRALAS MED J, V5, P175, DOI 10.4066/AMJ.2012.1101; Coyle SM, 2001, J VOICE, V15, P424, DOI 10.1016/S0892-1997(01)00043-1; Delfino RJ, 1997, ENVIRON HEALTH PERSP, V105, P622, DOI 10.2307/3433608; Dua K, 2002, GUT, V51, P771, DOI 10.1136/gut.51.6.771; Dworkin JP, 2008, OTOLARYNG CLIN N AM, V41, P419, DOI 10.1016/j.otc.2007.11.011; Fukuda K, 2011, AUST NZ J PUBL HEAL, V35, P163, DOI 10.1111/j.1753-6405.2010.00620.x; Joo YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131247; Kelly FJ, 2012, ATMOS ENVIRON, V60, P504, DOI 10.1016/j.atmosenv.2012.06.039; Kim KH, 2015, ENVIRON INT, V74, P136, DOI 10.1016/j.envint.2014.10.005; Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96; Korean Association of Smoking and Health, NAT SMOK PREV SURV; MARCY TW, 1987, CLIN CHEST MED, V8, P381; Merati AL, 2010, CUMMINGS OTOLARYNGOL, V5th, P901; Murin S, 2005, CLEV CLIN J MED, V72, P916, DOI 10.3949/ccjm.72.10.916; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Neupane B, 2010, AM J RESP CRIT CARE, V181, P47, DOI [10.1164/rccm.200901-0160oc, 10.1164/rccm.200901-0160OC]; Ostro B, 2001, EPIDEMIOLOGY, V12, P200, DOI 10.1097/00001648-200103000-00012; Park SU, 2004, ATMOS ENVIRON, V38, P2155, DOI 10.1016/j.atmosenv.2004.01.024; Soukup JM, 2000, INHAL TOXICOL, V12, P401; Stanek LW, 2011, TOXICOL SCI, V120, pS8, DOI 10.1093/toxsci/kfq367; Stein DJ, 2013, ANN OTO RHINOL LARYN, V122, P771, DOI 10.1177/000348941312201207; Sun QH, 2010, CIRCULATION, V121, P2755, DOI 10.1161/CIRCULATIONAHA.109.893461	28	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133180	10.1371/journal.pone.0133180	http://dx.doi.org/10.1371/journal.pone.0133180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177353	Green Submitted, gold, Green Published			2022-12-27	WOS:000358197600226
J	Marcotuli, I; Houston, K; Waugh, R; Fincher, GB; Burton, RA; Blanco, A; Gadaleta, A				Marcotuli, Ilaria; Houston, Kelly; Waugh, Robbie; Fincher, Geoffrey B.; Burton, Rachel A.; Blanco, Antonio; Gadaleta, Agata			Genome Wide Association Mapping for Arabinoxylan Content in a Collection of Tetraploid Wheats	PLOS ONE			English	Article							CANDIDATE GENES; GRAIN; IDENTIFICATION	Background Arabinoxylans (AXs) are major components of plant cell walls in bread wheat and are important in bread-making and starch extraction. Furthermore, arabinoxylans are components of soluble dietary fibre that has potential health-promoting effects in human nutrition. Despite their high value for human health, few studies have been carried out on the genetics of AX content in durum wheat. Results The genetic variability of AX content was investigated in a set of 104 tetraploid wheat genotypes and regions attributable to AX content were identified through a genome wide association study (GWAS). The amount of arabinoxylan, expressed as percentage (w/w) of the dry weight of the kernel, ranged from 1.8% to 5.5% with a mean value of 4.0%. The GWAS revealed a total of 37 significant marker-trait associations (MTA), identifying 19 quantitative trait loci (QTL) associated with AX content. The highest number of MTAs was identified on chromosome 5A (seven), where three QTL regions were associated with AX content, while the lowest number of MTAs was detected on chromosomes 2B and 4B, where only one MTA identified a single locus. Conservation of synteny between SNP marker sequences and the annotated genes and proteins in Brachypodium distachyon, Oryza sativa and Sorghum bicolor allowed the identification of nine QTL coincident with candidate genes. These included a glycosyl hydrolase GH35, which encodes Gal7 and a glucosyltransferase GT31 on chromosome 1A; a cluster of GT1 genes on chromosome 2B that includes TaUGT1 and cisZog1; a glycosyl hydrolase that encodes a CelC gene on chromosome 3A; Ugt12887 and TaUGT1 genes on chromosome 5A; a (1,3)-beta-D-glucan synthase (Gsl12 gene) and a glucosyl hydrolase (Cel8 gene) on chromosome 7A. Conclusions This study identifies significant MTAs for the AX content in the grain of tetraploid wheat genotypes. We propose that these may be used for molecular breeding of durum wheat varieties with higher soluble fibre content.	[Marcotuli, Ilaria; Blanco, Antonio; Gadaleta, Agata] Univ Bari Aldo Moro, Sect Genet & Plant Breeding, Dept Soil Plant & Food Sci, Bari, Italy; [Houston, Kelly; Waugh, Robbie] James Hutton Inst, Dundee, Scotland; [Fincher, Geoffrey B.; Burton, Rachel A.] Univ Adelaide, Australian Res Council, Ctr Excellence Plant Cell Walls, Sch Agr Food & Wine, Glen Osmond, SA, Australia	Universita degli Studi di Bari Aldo Moro; James Hutton Institute; University of Adelaide	Gadaleta, A (corresponding author), Univ Bari Aldo Moro, Sect Genet & Plant Breeding, Dept Soil Plant & Food Sci, Via G Amendola 165-A, Bari, Italy.	agata.gadaleta@uniba.it	Gadaleta, Agata/H-2627-2012; Burton, Rachel A/C-4441-2011	Gadaleta, Agata/0000-0002-6312-249X; Burton, Rachel A/0000-0002-0638-4709; Marcotuli, Ilaria/0000-0002-0146-5286; , Kelly/0000-0003-2136-245X	Ministero dell'Istruzione, dell'Universita' e della Ricerca ['PON-01_01145]; BBSRC [BB/J014869/1]; Australian Research Council; South Australia-Puglia Awards scheme of South Australia; BBSRC [BB/L026317/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L026317/1, BB/J014869/1] Funding Source: researchfish	Ministero dell'Istruzione, dell'Universita' e della Ricerca(Ministry of Education, Universities and Research (MIUR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Australian Research Council(Australian Research Council); South Australia-Puglia Awards scheme of South Australia; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research project was supported by grants from Ministero dell'Istruzione, dell'Universita' e della Ricerca, project 'PON-01_01145 "ISCOCEM' and from BBSRC responsive mode scheme (BB/J014869/1). Additional support was received from the Australian Research Council and the South Australia-Puglia Awards scheme of South Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Alan Dabney JDS, 2010, QVALUE Q VALUE ESTIM; Burton RA, 2011, PLANT BIOTECHNOL J, V9, P117, DOI 10.1111/j.1467-7652.2010.00532.x; Charmet G, 2009, EUPHYTICA, V170, P155, DOI 10.1007/s10681-009-0019-0; Ciccoritti R, 2011, INT J MOL SCI, V12, P4536, DOI 10.3390/ijms12074536; Colasuonno P, 2014, MOL BREEDING, V34, P1563, DOI 10.1007/s11032-014-0183-3; Collins HM, 2010, CEREAL CHEM, V87, P272, DOI 10.1094/CCHEM-87-4-0272; Courtin CM, 2002, J CEREAL SCI, V35, P225, DOI 10.1006/jcrs.2001.0433; Coutinho PM, 1999, ROY SOC CH, P3; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Izydorczyk MS, 1995, CARBOHYD POLYM, V28, P33, DOI 10.1016/0144-8617(95)00077-1; Laido G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067280; Lempereur I, 1997, J CEREAL SCI, V25, P103, DOI 10.1006/jcrs.1996.0090; Lovegrove A, 2013, PLANT PHYSIOL, V163, P95, DOI 10.1104/pp.113.222653; Martinant JP, 1998, THEOR APPL GENET, V97, P1069, DOI 10.1007/s001220050993; Mitchell RAC, 2007, PLANT PHYSIOL, V144, P43, DOI 10.1104/pp.106.094995; Pellny TK, 2012, PLANT PHYSIOL, V158, P612, DOI 10.1104/pp.111.189191; Quraishi UM, 2011, FUNCT INTEGR GENOMIC, V11, P71, DOI 10.1007/s10142-010-0183-2; Saulnier L, 2007, J CEREAL SCI, V46, P261, DOI 10.1016/j.jcs.2007.06.014; Sears E.R., 1954, MISSOURI AGR EXP STA, V572, P1; Shewry PR, 2012, TRENDS FOOD SCI TECH, V25, P70, DOI 10.1016/j.tifs.2012.01.003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Nguyen VL, 2011, CROP SCI, V51, P1143, DOI 10.2135/cropsci2010.08.0484; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Xiao J, 1996, THEOR APPL GENET, V92, P230, DOI 10.1007/BF00223380; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	27	30	32	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132787	10.1371/journal.pone.0132787	http://dx.doi.org/10.1371/journal.pone.0132787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176552	Green Submitted, gold, Green Published			2022-12-27	WOS:000358197600156
J	Bolotin, S; Deeks, SL; Marchand-Austin, A; Rilkoff, H; Dang, V; Walton, R; Hashim, A; Farrell, D; Crowcroft, NS				Bolotin, Shelly; Deeks, Shelley L.; Marchand-Austin, Alex; Rilkoff, Heather; Dang, Vica; Walton, Ryan; Hashim, Ahmed; Farrell, David; Crowcroft, Natasha S.			Correlation of Real Time PCR Cycle Threshold Cut-Off with Bordetella pertussis Clinical Severity	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; OUTBREAK; EPIDEMIOLOGY; ADOLESCENTS; DIAGNOSIS; CHILDREN; ADULTS; ASSAY; DNA	Bordetella pertussis testing performed using real-time polymerase chain reaction (RT-PCR) is interpreted based on a cycle threshold (Ct) value. At Public Health Ontario Laboratories (PHOL), a Ct value <36 is reported as positive, and Ct values >= 36 and <40 are reported as indeterminate. PHOL reported indeterminate results to physicians and public health units until May 2012, after which these results were only reported to physicians. We investigated the association between Ct value and disease symptom and severity to examine the significance of indeterminate results clinically, epidemiologically and for public health reporting. B. pertussis positive and indeterminate RT-PCR results were linked to pertussis cases reported in the provincial Integrated Public Health Information System (iPHIS), using deterministic linkage. Patients with positive RT-PCR results had a lower median age of 10.8 years compared to 12.0 years for patients with indeterminate results (p = 0.24). Hospitalized patients had significantly lower Ct values than non-hospitalized patients (median Ct values of 20.7 vs. 31.6, p<0.001). The proportion of patients reporting the most indicative symptoms of pertussis did not differ between patients with positive vs. indeterminate RT-PCR results. Taking the most indicative symptoms of pertussis as the gold-standard, the positive predictive value of the RT-PCR test was 68.1%. RT-PCR test results should be interpreted in the context of the clinical symptoms, age, vaccination status, prevalence, and other factors. Further information on interpretation of indeterminate RT-PCR results may be needed, and the utility of reporting to public health practitioners should be re-evaluated.	[Bolotin, Shelly; Deeks, Shelley L.; Marchand-Austin, Alex; Rilkoff, Heather; Dang, Vica; Walton, Ryan; Hashim, Ahmed; Farrell, David; Crowcroft, Natasha S.] Publ Hlth Ontario, Toronto, ON, Canada; [Bolotin, Shelly; Deeks, Shelley L.; Crowcroft, Natasha S.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Marchand-Austin, Alex; Farrell, David; Crowcroft, Natasha S.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University of Toronto	Crowcroft, NS (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.	natasha.crowcroft@oahpp.ca		Marchand-Austin, Alex/0000-0001-5932-2037				Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Bidet P, 2008, J CLIN MICROBIOL, V46, P3636, DOI 10.1128/JCM.01308-08; Centers for Disease Control and Prevention, 2013, PERT WHOOP COUGH SUR; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; DeVincenzo JP, 2013, DIAGN MICR INFEC DIS, V76, P10, DOI 10.1016/j.diagmicrobio.2012.12.015; Gao FX, 2014, J CLIN MICROBIOL, V52, P302, DOI 10.1128/JCM.01656-13; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Guthrie JL, 2008, J CLIN MICROBIOL, V46, P3798, DOI 10.1128/JCM.01551-08; Guthrie JL, 2010, J CLIN MICROBIOL, V48, P1435, DOI 10.1128/JCM.02417-09; He QS, 1996, J INFECT DIS, V174, P1288, DOI 10.1093/infdis/174.6.1288; Health Protection Agency, 2013, HLTH PROTECTION REPO, V7; Horby P, 2005, EPIDEMIOL INFECT, V133, P229, DOI 10.1017/S0950268804003401; McIntyre PB, 2013, CLIN INFECT DIS, V56, P332, DOI 10.1093/cid/cis897; Nakamura Y, 2011, CLIN MICROBIOL INFEC, V17, P365, DOI 10.1111/j.1469-0691.2010.03255.x; Ontario Ministry of Health and Long Term Care, 2013, INF DIS PROT 2013 AP; Papenburg J, 2009, PEDIATR INFECT DIS J, V28, P1143, DOI 10.1097/INF.0b013e3181bd4e1f; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Riffelmann M, 2005, J CLIN MICROBIOL, V43, P4925, DOI 10.1128/JCM.43.10.4925-4929.2005; Riffelmann M, 2013, EUR J CLIN MICROBIOL; Tatti KM, 2008, DIAGN MICR INFEC DIS, V61, P264, DOI 10.1016/j.diagmicrobio.2008.02.017; Tizolova A, 2013, EUR J CLIN MICROBIOL, V32, P89, DOI 10.1007/s10096-012-1718-3; Vestrheim DF, 2012, J CLIN MICROBIOL, V50, P4114, DOI 10.1128/JCM.01553-12; Waters V, 2009, PEDIATR INFECT DIS J, V28, P582, DOI 10.1097/INF.0b013e318197fac1; Wood N, 2008, PAEDIATR RESPIR REV, V9, P201, DOI 10.1016/j.prrv.2008.05.010; World Health Organization, 2010, WHO REC SURV STAND P; ZANARDI L, 1997, MMWR-MORBID MORTAL W, V51, P73	27	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133209	10.1371/journal.pone.0133209	http://dx.doi.org/10.1371/journal.pone.0133209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186564	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700109
J	Nakajima, K; Fujita, J; Matsui, M; Tohyama, S; Tamura, N; Kanazawa, H; Seki, T; Kishino, Y; Hirano, A; Okada, M; Tabei, R; Sano, M; Goto, S; Tabata, Y; Fukuda, K				Nakajima, Kazuaki; Fujita, Jun; Matsui, Makoto; Tohyama, Shugo; Tamura, Noriko; Kanazawa, Hideaki; Seki, Tomohisa; Kishino, Yoshikazu; Hirano, Akinori; Okada, Marina; Tabei, Ryota; Sano, Motoaki; Goto, Shinya; Tabata, Yasuhiko; Fukuda, Keiichi			Gelatin Hydrogel Enhances the Engraftment of Transplanted Cardiomyocytes and Angiogenesis to Ameliorate Cardiac Function after Myocardial Infarction	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; STEM-CELLS; ISCHEMIC CARDIOMYOPATHY; HEART; THERAPY; INTRACORONARY; BIOMATERIALS; REGENERATION; MYOCYTES; TRIAL	Cell transplantation therapy will mean a breakthrough in resolving the donor shortage in cardiac transplantation. Cardiomyocyte (CM) transplantation, however, has been relatively inefficient in restoring cardiac function after myocardial infarction (MI) due to low engraftment of transplanted CM. In order to ameliorate engraftment of CM, the novel transplantation strategy must be invented. Gelatin hydrogel (GH) is a biodegradable water-soluble polymer gel. Gelatin is made of collagen. Although we observed that collagen strongly induced the aggregation of platelets to potentially cause coronary microembolization, GH did not enhance thrombogenicity. Therefore, GH is a suitable biomaterial in the cell therapy after heart failure. To assess the effect of GH on the improvement of cardiac function, fetal rat CM (5x10(6) or 1x10(6) cells) were transplanted with GH (10 mg/ml) to infarcted hearts. We compared this group with sham operated rats, CM in phosphate buffered saline (PBS), only PBS, and only GH-transplanted groups. Three weeks after transplantation, cardiac function was evaluated by echocardiography. The echocardiography confirmed that transplantation of 5x10(6) CM with GH significantly improved cardiac systolic function, compared with the CM+PBS group (fractional area change: 75.1 +/- 3.4% vs. 60.7 +/- 5.9%, p<0.05), only PBS, and only GH groups (60.1 +/- 6.5%, 65.0 +/- 2.8%, p<0.05). Pathological analyses demonstrated that in the CM+GH group, CM were efficiently engrafted in infarcted myocardium (p<0.01) and angiogenesis was significantly enhanced (p<0.05) in both central and peripheral areas of the scar. Moreover, quantitative RT-PCR revealed that angiogenic cytokines, such as basic fibroblast growth factor, vascular endothelial growth factor, and hepatocyte growth factor, were significantly enriched in the CM+GH group (p<0.05). Here, we report that GH confined the CM effectively in infarcted myocardium after transplantation, and that CM transplanted with GH improved cardiac function with a direct contraction effect and enhanced angiogenesis.	[Nakajima, Kazuaki; Fujita, Jun; Tohyama, Shugo; Kanazawa, Hideaki; Seki, Tomohisa; Kishino, Yoshikazu; Okada, Marina; Tabei, Ryota; Sano, Motoaki; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan; [Hirano, Akinori] Keio Univ, Sch Med, Dept Cardiovasc Surg, Shinjuku Ku, Tokyo, Japan; [Matsui, Makoto; Tabata, Yasuhiko] Kyoto Univ, Dept Biomat, Inst Frontier Med Sci, Field Tissue Engn,Sakyo Ku, Kyoto, Japan; [Tamura, Noriko; Goto, Shinya] Tokai Univ, Sch Med, Dept Med Cardiol, Isehara, Kanagawa 25911, Japan; [Tohyama, Shugo] Japan Soc Promot Sci, Tokyo, Japan	Keio University; Keio University; Kyoto University; Tokai University; Japan Society for the Promotion of Science	Fujita, J (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, 35 Shinanomachi, Tokyo, Japan.	jfujita@a6.keio.jp	Goto, Shinya/AAU-6045-2020; Fukuda, Keiichi/L-3777-2013; Seki, Tomohisa/L-3524-2013; Sano, Motoaki/L-3405-2013	Goto, Shinya/0000-0002-6821-1504; Kishino, Yoshikazu/0000-0003-3291-2795; Seki, Tomohisa/0000-0002-4281-135X	Highway Program for Realization of Regenerative Medicine from Japan Science and Technology Agency	Highway Program for Realization of Regenerative Medicine from Japan Science and Technology Agency	The present work was supported by the Highway Program for Realization of Regenerative Medicine from Japan Science and Technology Agency (to KF, http://www.jst.go.jp/saisei-nw/highway/research/b.html).	Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005; Fujita J, 2012, AM J PHYSIOL-HEART C, V303, pH1169, DOI 10.1152/ajpheart.00376.2012; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Goto SY, 2002, CIRCULATION, V106, P266, DOI 10.1161/01.CIR.0000021427.87256.7E; Hato N, 2012, OTOLARYNG HEAD NECK, V146, P641, DOI 10.1177/0194599811431661; Hattan N, 2005, CARDIOVASC RES, V65, P334, DOI 10.1016/j.cardiores.2004.10.004; Hayashi K, 2011, ACTA BIOMATER, V7, P2797, DOI 10.1016/j.actbio.2011.04.013; Hemmi N, 2014, STEM CELL TRANSL MED, V3, P1473, DOI 10.5966/sctm.2014-0072; Kardami E, 2007, HEART FAIL REV, V12, P267, DOI 10.1007/s10741-007-9027-0; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Lund LH, 2013, J HEART LUNG TRANSPL, V32, P951, DOI 10.1016/j.healun.2013.08.006; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Marui A, 2007, CIRC J, V71, P1181, DOI 10.1253/circj.71.1181; Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137; Ono K, 1997, CIRCULATION, V95, P2552, DOI 10.1161/01.CIR.95.11.2552; Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0; Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001; Strauer BE, 2011, J AM COLL CARDIOL, V58, P1095, DOI 10.1016/j.jacc.2011.06.016; Tabata Y, 1998, BIOMATERIALS, V19, P807, DOI 10.1016/S0142-9612(98)00233-6; Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0; Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus; Van Belle E, 1998, CIRCULATION, V97, P381; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; YANAGISAWAMIWA A, 1992, SCIENCE, V257, P1401, DOI 10.1126/science.1382313; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	27	32	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133308	10.1371/journal.pone.0133308	http://dx.doi.org/10.1371/journal.pone.0133308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186362	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700123
J	Spithoven, AWM; Bijttebier, P; Van den Noortgate, W; Colpin, H; Verschueren, K; Van Leeuwen, K; Claes, S; Goossens, L				Spithoven, Annette W. M.; Bijttebier, Patricia; Van den Noortgate, Wim; Colpin, Hilde; Verschueren, Karine; Van Leeuwen, Karla; Claes, Stephan; Goossens, Luc			Adolescent Loneliness and the Interaction between the Serotonin Transporter Gene (5-HTTLPR) and Parental Support: A Replication Study	PLOS ONE			English	Article							ENVIRONMENT INTERACTION RESEARCH; BEHAVIOR; HEALTH; TRAJECTORIES; PERCEPTIONS; ADJUSTMENT; DEPRESSION; ADULTS; RISK	Gene-by-environment interaction (GxEs) studies have gained popularity over the last decade, but the robustness of such observed interactions has been questioned. The current study contributes to this debate by replicating the only study on the interaction between the serotonin transporter gene (5-HTTLPR) and perceived parental support on adolescents' peer-related loneliness. A total of 1,111 adolescents (51% boys) with an average age of 13.70 years (SD = 0.93) participated and three annual waves of data were collected. At baseline, adolescent-reported parental support and peer-related loneliness were assessed and genetic information was collected. Assessment of peer-related loneliness was repeated at Waves 2 and 3. Using a cohort-sequential design, a Latent Growth Curve Model was estimated. Overall, a slight increase of loneliness over time was found. However, the development of loneliness over time was found to be different for boys and girls: girls' levels of loneliness increased over time, whereas boys' levels of loneliness decreased. Parental support was inversely related to baseline levels of loneliness, but unrelated to change of loneliness over time. We were unable to replicate the main effect of 5-HTTLPR or the 5-HTTLPR x Support interaction effect. In the Discussion, we examine the implications of our non-replication.	[Spithoven, Annette W. M.; Bijttebier, Patricia; Colpin, Hilde; Verschueren, Karine; Goossens, Luc] Katholieke Univ Leuven, Dept Sch Psychol & Child & Adolescent Dev, Leuven, Belgium; [Van den Noortgate, Wim] Katholieke Univ Leuven, Dept Methodol Educ Sci, Leuven, Belgium; [Van Leeuwen, Karla] Katholieke Univ Leuven, Dept Parenting & Special Educ, Leuven, Belgium; [Claes, Stephan] Katholieke Univ Leuven, Dept Neurosci, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven	Spithoven, AWM (corresponding author), Katholieke Univ Leuven, Dept Sch Psychol & Child & Adolescent Dev, Leuven, Belgium.	Annette.Spithoven@ppw.kuleuven.be	Van Leeuwen, Karla/AAF-6095-2020; Van den Noortgate, Wim/AAB-5969-2020	Van Leeuwen, Karla/0000-0002-6628-3483; Van den Noortgate, Wim/0000-0003-4011-219X; /0000-0002-5173-1917; Bijttebier, Patricia/0000-0002-0648-7388; Claes, Stephan/0000-0002-1175-492X; Goossens, Luc/0000-0003-3851-0412; Verschueren, Karine/0000-0003-2172-1424	KU Leuven Research Fund [GOA/12/009]	KU Leuven Research Fund(KU Leuven)	The authors received a Concerted Research Action grant from the KU Leuven Research Fund (GOA/12/009 - http://www.kuleuven.be/research/researchdatabase/project/3H11/3H110263.htm). The authors who received the funding are LG WVDN HC KV KVL and SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belsky DW, 2014, BIODEMOGR SOC BIOL, V60, P137, DOI 10.1080/19485565.2014.946591; Boomsma DI, 2005, BEHAV GENET, V35, P745, DOI 10.1007/s10519-005-6040-8; Corsano P, 2006, ADOLESCENCE, V41, P341; Delhaye M, 2012, PSYCHOL BELG, V52, P289, DOI 10.5334/pb-52-4-289; Dick DM, 2015, PERSPECT PSYCHOL SCI, V10, P37, DOI 10.1177/1745691614556682; Distel MA, 2010, BEHAV GENET, V40, P480, DOI 10.1007/s10519-010-9341-5; Domitrovich CE, 2001, MERRILL PALMER QUART, V47, P235, DOI 10.1353/mpq.2001.0010; Duncan LE, 2014, AM PSYCHOL, V69, P249, DOI 10.1037/a0036320; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Eisenberger NI, 2012, NAT NEUROSCI, V15, P669, DOI 10.1038/nn.3086; Galambos NL, 2003, CHILD DEV, V74, P578, DOI 10.1111/1467-8624.7402017; Gaylord NK, 2003, PARENT-SCI PRACT, V3, P23, DOI 10.1207/S15327922PAR0301_02; Goosby BJ, 2013, SOCIOL INQ, V83, P505, DOI 10.1111/soin.12018; Goossens L, 2015, PERSPECT PSYCHOL SCI, V10, P213, DOI 10.1177/1745691614564878; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Heinrich LA, 2006, CLIN PSYCHOL REV, V26, P695, DOI 10.1016/j.cpr.2006.04.002; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Koenig L. J., 1999, LONELINESS CHILDHOOD, P296, DOI [10.1017/CBO9780511551888.015, DOI 10.1017/CBO9780511551888.015]; Mahon NE, 2006, NURS RES, V55, P308, DOI 10.1097/00006199-200609000-00003; Manuck SB, 2014, ANNU REV PSYCHOL, V65, P41, DOI 10.1146/annurev-psych-010213-115100; MARCOEN A, 1987, J YOUTH ADOLESCENCE, V16, P561, DOI 10.1007/BF02138821; Maurizi LK, 2012, J YOUTH ADOLESCENCE, V41, P1035, DOI 10.1007/s10964-011-9741-8; McGuire S, 2000, PSYCHOL SCI, V11, P487, DOI 10.1111/1467-9280.00293; Moffitt TE, 2006, PERSPECT PSYCHOL SCI, V1, P5, DOI 10.1111/j.1745-6916.2006.00002.x; Munafo MR, 2014, J CHILD PSYCHOL PSYC, V55, P1092, DOI 10.1111/jcpp.12261; Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Nelson D. A., 2002, INTRUSIVE PARENTING, P161, DOI DOI 10.1037/10422-006; Nulty DD, 2008, ASSESS EVAL HIGH EDU, V33, P301, DOI 10.1080/02602930701293231; Pluess M, 2012, AM J PSYCHIAT, V169, P222, DOI 10.1176/appi.ajp.2011.11111614; Research Department of the Flemish Government, 2011, SCHOL BEV 25 64 JAAR; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Rotenberg K.J., 1999, LONELINESS CHILDHOOD, P176, DOI 10.1017/CBO9780511551888; Scharf M, 2011, INT J PSYCHOL, V46, P177, DOI 10.1080/00207594.2010.528424; Schinka KC, 2013, J ADOLESCENCE, V36, P1251, DOI 10.1016/j.adolescence.2013.08.002; Shanahan MJ, 2011, DYNAMIC GENOME MENTA, P58; SoftGenetics, 2010, GENEMARKER; Stanley DJ, 2014, PERSPECT PSYCHOL SCI, V9, P305, DOI 10.1177/1745691614528518; Van Leeuwen KG, 2004, DEV PSYCHOL, V40, P1028, DOI 10.1037/0012-1649.40.6.1028; van Roekel E, 2011, J CHILD PSYCHOL PSYC, V52, P1044, DOI 10.1111/j.1469-7610.2011.02424.x; van Roekel E, 2010, J CHILD PSYCHOL PSYC, V51, P747, DOI 10.1111/j.1469-7610.2010.02225.x; Vanhalst J, 2012, J YOUTH ADOLESCENCE, V41, P776, DOI 10.1007/s10964-011-9726-7; Verhagen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092768; Victor CR, 2012, J PSYCHOL, V146, P85, DOI 10.1080/00223980.2011.613875	46	5	5	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133430	10.1371/journal.pone.0133430	http://dx.doi.org/10.1371/journal.pone.0133430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186217	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700138
J	Suslak, TJ; Watson, S; Thompson, KJ; Shenton, FC; Bewick, GS; Armstrong, JD; Jarman, AP				Suslak, Thomas J.; Watson, Sonia; Thompson, Karen J.; Shenton, Fiona C.; Bewick, Guy S.; Armstrong, J. Douglas; Jarman, Andrew P.			Piezo Is Essential for Amiloride-Sensitive Stretch-Activated Mechanotransduction in Larval Drosophila Dorsal Bipolar Dendritic Sensory Neurons	PLOS ONE			English	Article							MAMMALIAN MUSCLE-SPINDLES; NEUROMUSCULAR-JUNCTION; MATHEMATICAL-MODEL; MANDUCA-SEXTA; RECEPTOR; CHANNELS; ADAPTATION; PICKPOCKET; TRANSDUCER; GLUTAMATE	Stretch-activated afferent neurons, such as those of mammalian muscle spindles, are essential for proprioception and motor co-ordination, but the underlying mechanisms of mechanotransduction are poorly understood. The dorsal bipolar dendritic (dbd) sensory neurons are putative stretch receptors in the Drosophila larval body wall. We have developed an in vivo protocol to obtain receptor potential recordings from intact dbd neurons in response to stretch. Receptor potential changes in dbd neurons in response to stretch showed a complex, dynamic profile with similar characteristics to those previously observed for mammalian muscle spindles. These profiles were reproduced by a general in silico model of stretch-activated neurons. This in silico model predicts an essential role for a mechanosensory cation channel (MSC) in all aspects of receptor potential generation. Using pharmacological and genetic techniques, we identified the mechanosensory channel, DmPiezo, in this functional role in dbd neurons, with TRPA1 playing a subsidiary role. We also show that rat muscle spindles exhibit a ruthenium red-sensitive current, but found no expression evidence to suggest that this corresponds to Piezo activity. In summary, we show that the dbd neuron is a stretch receptor and demonstrate that this neuron is a tractable model for investigating mechanisms of mechanotransduction.	[Suslak, Thomas J.; Armstrong, J. Douglas] Univ Edinburgh, Doctoral Training Ctr Neuroinformat & Neural Comp, Edinburgh, Midlothian, Scotland; [Suslak, Thomas J.; Armstrong, J. Douglas; Jarman, Andrew P.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Armstrong, J. Douglas] Univ Edinburgh, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland; [Watson, Sonia; Thompson, Karen J.; Bewick, Guy S.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Shenton, Fiona C.] Univ Newcastle, Inst Ageing, Newcastle Upon Tyne, Tyne & Wear, England	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Aberdeen; Newcastle University - UK	Suslak, TJ (corresponding author), Univ Edinburgh, Doctoral Training Ctr Neuroinformat & Neural Comp, Edinburgh, Midlothian, Scotland.	thomas.suslak@gmail.com; andrew.jarman@ed.ac.uk	Suslak, Thomas/GYA-1309-2022; Bewick, Guy/AAL-8214-2021	Bewick, Guy/0000-0001-8266-7797; Armstrong, Douglas/0000-0002-5397-3864; Jarman, Andrew/0000-0003-4036-5701	UK Engineering and Physical Sciences Research Council (EPSRC) [EP/F500385/1, BB/F529254/1]; UK Biotechnology and Biological Sciences Research Council (BBSRC); UK Medical Research Council (MRC); Tenovus Scotland Moulton-Barrett Research Scholarship [OL-532, G13/08]; Scottish Universities Life Sciences Alliance (SULSA) BioSkape grant; Eli Lilly	UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tenovus Scotland Moulton-Barrett Research Scholarship; Scottish Universities Life Sciences Alliance (SULSA) BioSkape grant; Eli Lilly(Eli Lilly)	TJS supported in part by grants EP/F500385/1 and BB/F529254/1 for the University of Edinburgh School of Informatics Doctoral Training Centre in Neuroinformatics and Computational Neuroscience (http://www.anc.ed.ac.uk/dtc/) from the UK Engineering and Physical Sciences Research Council (EPSRC), UK Biotechnology and Biological Sciences Research Council (BBSRC), and the UK Medical Research Council (MRC). KJT is supported by a Tenovus Scotland Moulton-Barrett Research Scholarship (OL-532) and Research Grant (G13/08). SW is supported by a Scottish Universities Life Sciences Alliance (SULSA) BioSkape grant in collaboration with Eli Lilly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Baines RA, 1998, J NEUROSCI, V18, P4673; Banke TG, 2011, BRAIN RES, V1381, P21, DOI 10.1016/j.brainres.2011.01.021; Bewick GS, 2005, J PHYSIOL-LONDON, V562, P381, DOI 10.1113/jphysiol.2004.074799; Bewick GS, 2014, EUR J PHYSL, P1; Bobkov YV, 2011, BBA-BIOMEMBRANES, V1808, P1120, DOI 10.1016/j.bbamem.2010.12.024; CAMPBELL DL, 1988, J PHYSIOL-LONDON, V403, P267, DOI 10.1113/jphysiol.1988.sp017249; Carr MJ, 2001, BRIT J PHARMACOL, V133, P1255, DOI 10.1038/sj.bjp.0704197; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Faucherre A, 2013, J NEUROSCI, V 33, P17089, DOI 10.1523/JNEUROSCI.0522-13.2013; FINLAYSON LH, 1958, PROC R SOC SER B-BIO, V148, P433, DOI 10.1098/rspb.1958.0037; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; HUNT CC, 1978, J GEN PHYSIOL, V71, P683, DOI 10.1085/jgp.71.6.683; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE JW, 1991, J PHYSIOL-LONDON, V441, P347, DOI 10.1113/jphysiol.1991.sp018755; Lennartson B., 1988, J ANAT, V130, P279; LILEY AW, 1956, J PHYSIOL-LONDON, V132, P650, DOI 10.1113/jphysiol.1956.sp005555; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; Nair Amit, 2010, BMC Res Notes, V3, P154, DOI 10.1186/1756-0500-3-154; OTTOSON D, 1982, BRAIN RES, V244, P337, DOI 10.1016/0006-8993(82)90093-2; OTTOSON D, 1985, BRAIN RES, V336, P1, DOI 10.1016/0006-8993(85)90409-3; Peyronnet R, 2013, EMBO REP, V14, P1143, DOI 10.1038/embor.2013.170; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; RYDQVIST B, 1993, J PHYSIOL-LONDON, V469, P193, DOI 10.1113/jphysiol.1993.sp019811; Schrader S, 2007, ARTHROPOD STRUCT DEV, V36, P157, DOI 10.1016/j.asd.2006.08.014; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; Simon A, 2010, J PHYSIOL-LONDON, V588, P171, DOI 10.1113/jphysiol.2009.182683; Simon MA, 2009, J EXP BIOL, V212, P1021, DOI 10.1242/jeb.023507; Staruschenko A, 2010, J BIOL CHEM, V285, P15167, DOI 10.1074/jbc.M110.106153; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Suslak TJ, 2011, NETWORK-COMP NEURAL, V22, P133, DOI 10.3109/0954898X.2011.638967; Swerup C, 1996, J NEUROPHYSIOL, V76, P2211, DOI 10.1152/jn.1996.76.4.2211; Tamarkin DA, 1996, J NEUROPHYSIOL, V76, P1597, DOI 10.1152/jn.1996.76.3.1597; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251	41	21	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0130969	10.1371/journal.pone.0130969	http://dx.doi.org/10.1371/journal.pone.0130969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186008	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000358198700009
J	Torkildsen, S; Gorunova, L; Beiske, K; Tjonnfjord, GE; Heim, S; Panagopoulos, I				Torkildsen, Synne; Gorunova, Ludmila; Beiske, Klaus; Tjonnfjord, Geir E.; Heim, Sverre; Panagopoulos, Ioannis			Novel ZEB2-BCL11B Fusion Gene Identified by RNA-Sequencing in Acute Myeloid Leukemia with t(2;14)(q22;q32)	PLOS ONE			English	Article							RISK-STRATIFICATION; FLT3 MUTATIONS; RETINOIC ACID; BCL11B; TRANSCRIPTION; DIAGNOSIS; UPDATE; ROLES	RNA-sequencing of a case of acute myeloid leukemia with the bone marrow karyotype 46, XY,t(2;14)(q22;q32)[5]/47, XY, idem,+?4, del(6)(q13q21)[cp6]/46, XY[4] showed that the t (2; 14) generated a ZEB2-BCL11B chimera in which exon 2 of ZEB2 (nucleotide 595 in the sequence with accession number NM_014795.3) was fused to exon 2 of BCL11B (nucleotide 554 in the sequence with accession number NM_022898.2). RT-PCR together with Sanger sequencing verified the presence of the above-mentioned fusion transcript. All functional domains of BCL11B are retained in the chimeric protein. Abnormal expression of BCL11B coding regions subjected to control by the ZEB2 promoter seems to be the leukemogenic mechanism behind the translocation.	[Torkildsen, Synne; Gorunova, Ludmila; Heim, Sverre; Panagopoulos, Ioannis] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Genet & Informat, Sect Canc Cytogenet, Oslo, Norway; [Torkildsen, Synne; Gorunova, Ludmila; Heim, Sverre; Panagopoulos, Ioannis] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Torkildsen, Synne; Tjonnfjord, Geir E.] Oslo Univ Hosp, Dept Hematol, Oslo, Norway; [Beiske, Klaus] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Tjonnfjord, Geir E.] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Panagopoulos, I (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Genet & Informat, Sect Canc Cytogenet, Oslo, Norway.	ioannis.panagopoulos@rr-research.no	Tjønnfjord, Geir Erland/AAH-8739-2020		Norwegian Cancer Society; Norwegian Radium Hospital Foundation	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Radium Hospital Foundation	This work was supported by grants from the Norwegian Cancer Society and the Norwegian Radium Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2014, HAEMATOLOGICA, V99, P848, DOI 10.3324/haematol.2013.095604; Annala MJ, 2013, CANCER LETT, V340, P192, DOI 10.1016/j.canlet.2013.01.011; Barragan E, 2011, HAEMATOL-HEMATOL J, V96, P1470, DOI 10.3324/haematol.2011.044933; Bezrookove V, 2004, CANCER GENET CYTOGEN, V149, P72, DOI 10.1016/S0165-4608(03)00302-9; Deschler B, 2006, CANCER-AM CANCER SOC, V107, P2099, DOI 10.1002/cncr.22233; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Estey EH, 2014, AM J HEMATOL, V89, P1063, DOI 10.1002/ajh.23834; Estey EH, 2013, AM J HEMATOL, V88, P317, DOI 10.1002/ajh.23404; Estey EH, 2012, AM J HEMATOL, V87, P90, DOI 10.1002/ajh.22246; Facchetti F., 2008, WHO CLASSIFICATION T, V4th ed; Gervais C, 2008, LEUKEMIA, V22, P1567, DOI 10.1038/leu.2008.128; Goossens S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6794; Huang X, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-22; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Katoh M, 2009, INT J ONCOL, V34, P1737, DOI 10.3892/ijo_00000304; Kayser S, 2009, BLOOD, V114, P2386, DOI 10.1182/blood-2009-03-209999; Kobayashi S, 2014, INT J ONCOL, V44, P1193, DOI 10.3892/ijo.2014.2291; Levis M, 2013, HEMATOL-AM SOC HEMAT, P220, DOI 10.1182/asheducation-2013.1.220; Liu PT, 2010, IMMUNOL REV, V238, P138, DOI 10.1111/j.1600-065X.2010.00953.x; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Mitelman F, 2009, CANC CYTOGENETICS; Nicorici, 2014, BIORXIV, DOI [10.1101/011650, DOI 10.1101/011650V1]; Panagopoulos I, 2014, INT J BIOCHEM CELL B, V53, P462, DOI 10.1016/j.biocel.2014.05.018; Panagopoulos I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096570; Sanchez-Tillo E, 2011, AM J CANCER RES, V1, P897; SCHAFFER LG, 2009, ISCN 2009 AN INTERNA; Schlenk RF, 2014, BLOOD, V124, P3441, DOI 10.1182/blood-2014-05-578070; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8	28	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132736	10.1371/journal.pone.0132736	http://dx.doi.org/10.1371/journal.pone.0132736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186352	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700059
J	Buck, JC; Hua, J; Brogan, WR; Dang, TD; Urbina, J; Bendis, RJ; Stoler, AB; Blaustein, AR; Relyea, RA				Buck, Julia C.; Hua, Jessica; Brogan, William R., III; Dang, Trang D.; Urbina, Jenny; Bendis, Randall J.; Stoler, Aaron B.; Blaustein, Andrew R.; Relyea, Rick A.			Effects of Pesticide Mixtures on Host-Pathogen Dynamics of the Amphibian Chytrid Fungus	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS INFECTION; ANTIMICROBIAL PEPTIDE DEFENSES; GLOBAL DECLINE; CHYTRIDIOMYCOSIS IMPACTS; IMMUNE DEFENSES; EXPOSURE; EXTINCTION; DISEASE; GROWTH; SUSCEPTIBILITY	Anthropogenic and natural stressors often interact to affect organisms. Amphibian populations are undergoing unprecedented declines and extinctions with pesticides and emerging infectious diseases implicated as causal factors. Although these factors often co-occur, their effects on amphibians are usually examined in isolation. We hypothesized that exposure of larval and metamorphic amphibians to ecologically relevant concentrations of pesticide mixtures would increase their post-metamorphic susceptibility to the fungus Batrachochytrium dendrobatidis (Bd), a pathogen that has contributed to amphibian population declines worldwide. We exposed five anuran species (Pacific treefrog, Pseudacris regilla; spring peeper, Pseudacris crucifer; Cascades frog, Rana cascadae; northern leopard frog, Lithobates pipiens; and western toad, Anaxyrus boreas) from three families to mixtures of four common insecticides (chlorpyrifos, carbaryl, permethrin, and endosulfan) or herbicides (glyphosate, acetochlor, atrazine, and 2,4-D) or a control treatment, either as tadpoles or as newly metamorphic individuals (metamorphs). Subsequently, we exposed animals to Bd or a control inoculate after metamorphosis and compared survival and Bd load. Bd exposure significantly increased mortality in Pacific treefrogs, spring peepers, and western toads, but not in Cascades frogs or northern leopard frogs. However, the effects of pesticide exposure on mortality were negligible, regardless of the timing of exposure. Bd load varied considerably across species; Pacific treefrogs, spring peepers, and western toads had the highest loads, whereas Cascades frogs and northern leopard frogs had the lowest loads. The influence of pesticide exposure on Bd load depended on the amphibian species, timing of pesticide exposure, and the particular pesticide treatment. Our results suggest that exposure to realistic pesticide concentrations has minimal effects on Bd-induced mortality, but can alter Bd load. This result could have broad implications for risk assessment of amphibians; the outcome of exposure to multiple stressors may be unpredictable and can differ between species and life stages.	[Buck, Julia C.] Sam Houston State Univ, Texas Res Inst Environm Studies, Huntsville, TX 77340 USA; [Buck, Julia C.; Dang, Trang D.; Blaustein, Andrew R.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Hua, Jessica; Brogan, William R., III; Bendis, Randall J.; Stoler, Aaron B.; Relyea, Rick A.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Urbina, Jenny; Blaustein, Andrew R.] Oregon State Univ, Environm Sci Grad Program, Corvallis, OR 97331 USA	Texas State University System; Sam Houston State University; Oregon State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oregon State University	Buck, JC (corresponding author), Sam Houston State Univ, Texas Res Inst Environm Studies, Huntsville, TX 77340 USA.	julia.buck@gmail.com		Weitemier, Trang/0000-0002-9567-3771; Buck, Julia/0000-0003-3202-7665; Hua, Jessica/0000-0002-9553-902X; Urbina, Jenny/0000-0003-2461-9572	National Science Foundation [DEB 11-19430]	National Science Foundation(National Science Foundation (NSF))	This material is based on work supported under a National Science Foundation grant to R.A.R. and A.R.B. (DEB 11-19430). URL of funder's website: nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RA, 1988, AM NAT, V131, P91, DOI 10.1086/284775; Bancroft BA, 2011, BIODIVERS CONSERV, V20, P1911, DOI 10.1007/s10531-011-0066-4; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Boone MD, 2013, AQUAT TOXICOL, V130, P139, DOI 10.1016/j.aquatox.2012.12.022; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Bradford DF, 2011, ENVIRON TOXICOL CHEM, V30, P682, DOI 10.1002/etc.425; Buck JC, 2012, FRESHWATER BIOL, V57, P61, DOI 10.1111/j.1365-2427.2011.02695.x; Carey C, 1999, DEV COMP IMMUNOL, V23, P459, DOI 10.1016/S0145-305X(99)00028-2; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davidson C, 2004, ECOL APPL, V14, P1892, DOI 10.1890/03-5224; Davidson C, 2007, ENVIRON SCI TECHNOL, V41, P1771, DOI 10.1021/es0611947; Egea-Serrano A, 2012, ECOL EVOL, V2, P1382, DOI 10.1002/ece3.249; Environmental Protection Agency, 2010, EPAHQOPP20020262; Gahl MK, 2011, ECOL APPL, V21, P2521, DOI 10.1890/10-2319.1; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Gervasi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054490; Gilliom RJ, 2007, ENVIRON SCI TECHNOL, V41, P3407; Gosner K. L., 1960, Herpetologica, V16, P183; Groner ML, 2013, ECOL APPL, V23, P1443, DOI 10.1890/12-1572.1; Grube A, 2011, PESTICIDE IND SALES; Hammond JI, 2012, EVOL APPL, V5, P593, DOI 10.1111/j.1752-4571.2011.00237.x; Hanlon SM, 2014, ENVIRON TOXICOL CHEM, V33, P216, DOI 10.1002/etc.2419; Hanlon SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043573; Hanlon SM, 2012, ARCH ENVIRON CON TOX, V63, P137, DOI 10.1007/s00244-011-9744-1; Hayes TB, 2010, J EXP BIOL, V213, P921, DOI 10.1242/jeb.040865; Hayes TB, 2006, ENVIRON HEALTH PERSP, V114, P40, DOI 10.1289/ehp.8051; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Howe GE, 1998, ENVIRON TOXICOL CHEM, V17, P519, DOI [10.1002/etc.5620170324, 10.1897/1551-5028(1998)017&lt;0519:EOCSAL&gt;2.3.CO;2]; Johnson PTJ, 2011, FUNCT ECOL, V25, P726, DOI 10.1111/j.1365-2435.2010.01830.x; Kiesecker JM, 2011, ECOL RES, V26, P897, DOI 10.1007/s11284-010-0702-6; Kleinhenz P, 2012, J HERPETOL, V46, P625, DOI 10.1670/11-070; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Kriger KM, 2007, CONSERV BIOL, V21, P1280, DOI 10.1111/j.1523-1739.2007.00777.x; KURIS AM, 1980, AM NAT, V116, P570, DOI 10.1086/283647; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Laskowski R, 2010, SCI TOTAL ENVIRON, V408, P3763, DOI 10.1016/j.scitotenv.2010.01.043; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Mann RM, 2009, ENVIRON POLLUT, V157, P2903, DOI 10.1016/j.envpol.2009.05.015; Marcogliese DJ, 2011, TRENDS PARASITOL, V27, P123, DOI 10.1016/j.pt.2010.11.002; McCallum ML, 2007, J HERPETOL, V41, P483, DOI 10.1670/0022-1511(2007)41[483:ADOECD]2.0.CO;2; McMahon TA, 2013, ENVIRON SCI TECHNOL, V47, P7958, DOI 10.1021/es401725s; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Newman M.C., 2009, FUNDAMENTALS ECOTOXI; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Paetow LJ, 2012, ECOTOX ENVIRON SAFE, V80, P372, DOI 10.1016/j.ecoenv.2012.04.006; Parris MJ, 2004, OECOLOGIA, V140, P626, DOI 10.1007/s00442-004-1631-2; Pesticide Management Education Program, 2008, EXT TOX NETW PEST IN; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Relyea RA, 2004, ENVIRON TOXICOL CHEM, V23, P1737, DOI 10.1897/03-493; Relyea RA, 2009, OECOLOGIA, V159, P363, DOI [10.1007/s00442-008-1141-8, 10.1007/s00442-008-1213-9]; Rohr JR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1502; Rollins-Smith LA, 2005, INTEGR COMP BIOL, V45, P137, DOI 10.1093/icb/45.1.137; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Rollins-Smith LA, 2001, IMMUNOL RES, V23, P273, DOI 10.1385/IR:23:2-3:273; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Smith KG, 2007, DIS AQUAT ORGAN, V74, P159, DOI 10.3354/dao074159; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Symonds EP, 2007, J WILDLIFE DIS, V43, P48, DOI 10.7589/0090-3558-43.1.48; Venesky MD, 2009, ECOHEALTH, V6, P565, DOI 10.1007/s10393-009-0272-7; Venesky MD, 2010, J PARASITOL, V96, P552, DOI 10.1645/GE-2353.1; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105	72	22	22	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132832	10.1371/journal.pone.0132832	http://dx.doi.org/10.1371/journal.pone.0132832			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181492	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000358198200039
J	Liabeuf, S; Desjardins, L; Diouf, M; Temmar, M; Renard, C; Choukroun, G; Massy, ZA				Liabeuf, Sophie; Desjardins, Lucie; Diouf, Momar; Temmar, Mohamed; Renard, Cedric; Choukroun, Gabriel; Massy, Ziad A.			The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; ALL-CAUSE MORTALITY; EVENTS; IMPACT; ATHEROSCLEROSIS; PREDICTION; STIFFNESS; INDEXES	Background Although a variety of non-invasive methods for measuring cardiovascular (CV) risk (such as carotid intima media thickness, pulse wave velocity (PWV), coronary artery and aortic calcification scores (measured either by CT scan or X-ray) and the ankle brachial index (ABI)) have been evaluated separately in chronic kidney disease (CKD) cohorts, few studies have evaluated these methods simultaneously. Here, we looked at whether the addition of non-invasive methods to traditional risk factors (TRFs) improves prediction of the CV risk in patients at different CKD stages. Methods We performed a prospective, observational study of the relationship between the outputs of non-invasive measurement methods on one hand and mortality and CV outcomes in 143 patients at different CKD stages on the other. During the follow-up period, 44 patients died and 30 CV events were recorded. We used Cox models to calculate the relative risk for outcomes. To assess the putative clinical value of each method, we also determined the categorical net reclassification improvement (NRI) and the integrated discrimination improvement. Results Vascular calcification, PWV and ABI predicted all-cause mortality and CV events in univariate analyses. However, after adjustment for TRFs, only aortic and coronary artery calcification scores were found to be significant, independent variables. Moreover, the addition of coronary artery calcification scores to TRFs improved the specificity of prediction by 20%. Conclusion The addition of vascular calcification scores (especially the coronary artery calcification score) to TRFs appears to improve CV risk assessment in a CKD population.	[Liabeuf, Sophie; Desjardins, Lucie; Temmar, Mohamed; Choukroun, Gabriel; Massy, Ziad A.] Jules Verne Univ Picardy Amiens, INSERM, U1088, Amiens, France; [Liabeuf, Sophie; Desjardins, Lucie; Temmar, Mohamed] Amiens Univ Hosp, Clin Res Ctr, Amiens, France; [Liabeuf, Sophie; Desjardins, Lucie; Temmar, Mohamed] Amiens Univ Hosp, Div Clin Pharmacol, Amiens, France; [Liabeuf, Sophie; Desjardins, Lucie; Temmar, Mohamed] Jules Verne Univ Picardy, Amiens, France; [Diouf, Momar] Amiens Univ Hosp, Dept Biostat, Amiens, France; [Renard, Cedric] Amiens Univ Hosp, Div Radiol, Amiens, France; [Choukroun, Gabriel] Amiens Univ Hosp, Div Nephrol, Amiens, France; [Massy, Ziad A.] Univ Paris Ouest Versailles St Quentin En Yveline, Ambroise Pare Univ Hosp, AP HP, Div Nephrol, Boulogne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Massy, ZA (corresponding author), Jules Verne Univ Picardy Amiens, INSERM, U1088, Amiens, France.	ziad.massy@aphp.fr	Gabriel, Choukroun/AAL-4969-2021; , liabeuf/AFB-7848-2022		Amiens University Medical Center [PHRC: 2006/0100]	Amiens University Medical Center	This study was funded by a grant from Amiens University Medical Center (PHRC: 2006/0100 (27 March 2006)). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; ASMAR R, 1995, HYPERTENSION, V26, P485, DOI 10.1161/01.HYP.26.3.485; Benedetto FA, 2001, J AM SOC NEPHROL, V12, P2458, DOI 10.1681/ASN.V12112458; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Ekart R, 2005, ARTIF ORGANS, V29, P615, DOI 10.1111/j.1525-1594.2005.29098.x; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Gluba-Brzozka A, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-135; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Graham G, 2012, ATHEROSCLEROSIS, V225, P432, DOI 10.1016/j.atherosclerosis.2012.08.014; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Karras A, 2012, HYPERTENSION, V60, P1451, DOI 10.1161/HYPERTENSIONAHA.112.197210; Kato A, 2003, KIDNEY INT, V64, P1472, DOI 10.1046/j.1523-1755.2003.00205.x; Kauppila LI, 1997, ATHEROSCLEROSIS, V132, P245, DOI 10.1016/S0021-9150(97)00106-8; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Matsushita K, 2015, J AM SOC NEPHROL, V26, P439, DOI 10.1681/ASN.2014020173; Nishizawa Y, 2003, AM J KIDNEY DIS, V41, pS76, DOI 10.1053/ajkd.2003.50090; Ono K, 2003, J AM SOC NEPHROL, V14, P1591, DOI 10.1097/01.ASN.0000065547.98258.3D; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Reddy KS, 1998, CIRCULATION, V97, P596; Riley Ward A, 2004, Curr Atheroscler Rep, V6, P225, DOI 10.1007/s11883-004-0036-3; Sigrist MK, 2007, CLIN J AM SOC NEPHRO, V2, P1241, DOI 10.2215/CJN.02190507; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Szeto CC, 2007, J AM SOC NEPHROL, V18, P1966, DOI 10.1681/ASN.2006101184; Temmar M, 2010, J HYPERTENS, V28, P163, DOI 10.1097/HJH.0b013e328331b81e; Verbeke F, 2011, CLIN J AM SOC NEPHRO, V6, P153, DOI 10.2215/CJN.05120610; Wade AN, 2009, CLIN J AM SOC NEPHRO, V4, P1883, DOI 10.2215/CJN.07611009; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624; Yoshitomi R, 2014, HYPERTENS RES, V37, P1050, DOI 10.1038/hr.2014.120; Zoungas S, 2007, AM J KIDNEY DIS, V50, P622, DOI 10.1053/j.ajkd.2007.07.012; Zureik M, 2002, J HYPERTENS, V20, P85, DOI 10.1097/00004872-200201000-00013	34	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0131707	10.1371/journal.pone.0131707	http://dx.doi.org/10.1371/journal.pone.0131707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181592	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198200010
J	Iwelunmor, J; Plange-Rhule, J; Airhihenbuwa, CO; Ezepue, C; Ogedegbe, O				Iwelunmor, Juliet; Plange-Rhule, Jacob; Airhihenbuwa, Collins O.; Ezepue, Chizoba; Ogedegbe, Olugbenga			A Narrative Synthesis of the Health Systems Factors Influencing Optimal Hypertension Control in Sub-Saharan Africa	PLOS ONE			English	Article							SOUTH-AFRICA; HUMAN-RESOURCES; BLOOD-PRESSURE; PRIMARY-CARE; MANAGEMENT; BARRIERS; DISEASE; PROFESSIONALS; DETERMINANTS; FACILITIES	Introduction In sub-Saharan Africa (SSA), an estimated 74.7 million individuals are hypertensive. Reducing the growing burden of hypertension in sub-Saharan Africa will require a variety of strategies one of which is identifying the extent to which actions originating at the health systems level improves optimal management and control. Methods and Results We conducted a narrative synthesis of available papers examining health systems factors influencing optimal hypertension in SSA. Eligible studies included those that analyzed the impact of health systems on hypertension awareness, treatment, control and medication adherence. Twenty-five articles met the inclusion criteria and the narrative synthesis identified the following themes: 1) how physical resources influence mechanisms supportive of optimal hypertension control; 2) the role of human resources with enabling and/or inhibiting hypertension control goals; 3) the availability and/or use of intellectual resources; 4) how health systems financing facilitate and/or compromise access to products necessary for optimal hypertension control. Conclusion The findings highlight the need for further research on the health systems factors that influence management and control of hypertension in the region.	[Iwelunmor, Juliet] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; [Plange-Rhule, Jacob] Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Sch Med Sci, Kumasi, Ghana; [Airhihenbuwa, Collins O.] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA; [Ezepue, Chizoba] Georgia Regents Univ, Dept Neurol, Augusta, GA USA; [Ogedegbe, Olugbenga] NYU, Dept Med, Langone Med Ctr, Ctr Healthful Behav Change,Div Gen Internal Med, New York, NY 10016 USA	University of Illinois System; University of Illinois Urbana-Champaign; Kwame Nkrumah University Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Georgia; Augusta University; New York University; NYU Langone Medical Center	Iwelunmor, J (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA.	jiwez@illinois.edu			Fogarty International Center (NIH/FIC) [D43TW009140]; National Heart Lung and Blood Institute (NIH/NHLBI) [U01HL114198]; FOGARTY INTERNATIONAL CENTER [D43TW009140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL111315, U01HL114198] Funding Source: NIH RePORTER	Fogarty International Center (NIH/FIC); National Heart Lung and Blood Institute (NIH/NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grant D43TW009140 (PI: Gbenga Ogedegbe) funded by the Fogarty International Center (NIH/FIC) and grant U01HL114198 funded by the National Heart Lung and Blood Institute (NIH/NHLBI).	Adair-Rohani H, 2013, GLOB HEALTH-SCI PRAC, V1, P249, DOI 10.9745/GHSP-D-13-00037; Ali MK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005121; Ambaw AD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-282; Betancourt J R, 1999, Curr Hypertens Rep, V1, P482, DOI 10.1007/BF03215777; Bradley HA, 2007, ETHNIC DIS, V17, P49; Buabeng KO, 2004, J PHARM PHARM SCI, V7, P350; Daniels A, 2000, S AFR MED J, V90, P1206; Dennison CR, 2007, ETHNIC DIS, V17, P484; DeSavigny D, 2009, SYSTEMS THINKING FOR HEALTH SYSTEMS STRENGTHENING, P1; Dzudie A, 2011, BMJ OPEN, V2, P17; Frenk J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000089; Gombet T R, 2009, Med Trop (Mars), V69, P45; Hagopian Amy, 2004, Hum Resour Health, V2, P17, DOI 10.1186/1478-4491-2-17; Hendriks M, 2011, PLOS ONE, V7; Hendriks ME, 2014, JAMA INTERN MED, V174, P555, DOI 10.1001/jamainternmed.2013.14458; IJsselmuiden C, 2012, SAMJ S AFR MED J, V102, P228; Ilesanmi OS, 2012, PAN AFR MED J, V12; Iwelunmor J, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-42; Kagee A, 2007, J HEALTH PSYCHOL, V12, P444, DOI 10.1177/1359105307076232; Kalk A, 2010, TROP MED INT HEALTH, V15, P94, DOI 10.1111/j.1365-3156.2009.02424.x; Kaufman J, 1992, ETHNIC DIS, V3, pS83; Kengne AP, 2009, J CLIN HYPERTENS, V11, P564, DOI 10.1111/j.1751-7176.2009.00165.x; Kmet L.M., 2004, STANDARD QUALITY ASS; Labhardt ND, 2011, TROP MED INT HEALTH, V16, P1276, DOI 10.1111/j.1365-3156.2011.02827.x; Labhardt ND, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-339; Maimaris W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001490; Mayosi BM, 2013, HEART; Mbacke CSM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-S2-S15; Mbouemboue OP, 2012, INT J COLLAB RES INT, V4, P1663; McCord GC, 2013, B WORLD HEALTH ORGAN, V91, P244, DOI 10.2471/BLT.12.109660; Meessen B, 2011, HEALTH POLICY PLANN, V26, pII16, DOI 10.1093/heapol/czr062; Mendis S, 2004, J HYPERTENS, V22, P59, DOI 10.1097/00004872-200401000-00013; Mills A, 2012, LANCET, V380, P126, DOI 10.1016/S0140-6736(12)60357-2; Mounier-Jack S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-278; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; Mutale W, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-S2-S9; Ndou T, 2013, GLOBAL HLTH ACTION, V6; Ngoungou EB, 2012, ARCH CARDIOVASC DIS, V105, P77, DOI 10.1016/j.acvd.2011.12.005; Odedosu T, 2012, CLEV CLIN J MED, V79, P46, DOI 10.3949/ccjm.79a.11068; Ogah OS, 2013, HEART; Ogedegbe G, 2008, J CLIN HYPERTENS, V10, P644, DOI 10.1111/j.1751-7176.2008.08329.x; OLUBODUN JOB, 1995, INT J CARDIOL, V51, P193, DOI 10.1016/0167-5273(95)02409-P; Ono Agbani Ejaife, 2006, Sao Paulo Med. J., V124, P105, DOI 10.1590/S1516-31802006000200011; Osamor PE, 2011, J HEALTH POPUL NUTR, V29, P619; Pang T, 2002, BMJ-BRIT MED J, V324, P499, DOI 10.1136/bmj.324.7336.499; Parker A, 2011, CARDIOVASC J AFR, V22, P186, DOI 10.5830/CVJA-2010-066; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Popay J., 2006, GUIDANCE CONDUCT NAR; Rayner B, 2010, NEPHRON CLIN PRACT, V116, pC269, DOI 10.1159/000318788; Rayner B, 2009, CARDIOVASC J AFR, V20, P224; Reich MR, 2009, LANCET, V373, P508, DOI 10.1016/S0140-6736(08)61899-1; Rispel LC, 2010, SAMJ S AFR MED J, V100, P801, DOI 10.7196/SAMJ.4439; Salako B L, 2003, East Afr Med J, V80, P529; Schneider H, 2006, REPROD HEALTH MATTER, V14, P12, DOI 10.1016/S0968-8080(06)27232-X; Steyn Krisela, 1999, Ethnicity and Disease, V9, P441; Thorogood M, 2007, SCAND J PUBLIC HEALT, V35, P52, DOI 10.1080/14034950701355411; Webster J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065437; Yusuff KB, 2005, J PHARM PHARM SCI, V8, P235	58	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130193	10.1371/journal.pone.0130193	http://dx.doi.org/10.1371/journal.pone.0130193			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176223	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600020
J	Li, J; He, NP; Wei, XH; Gao, Y; Zuo, Y				Li, Jie; He, Nianpeng; Wei, Xuehong; Gao, Yang; Zuo, Yao			Changes in Temperature Sensitivity and Activation Energy of Soil Organic Matter Decomposition in Different Qinghai-Tibet Plateau Grasslands	PLOS ONE			English	Article							CARBON DECOMPOSITION; MICROBIAL BIOMASS; CO2 PRODUCTION; RESPIRATION; NITROGEN; CLIMATE; QUALITY; DEPENDENCE; FEEDBACKS; RESPONSES	Qinghai-Tibet Plateau grasslands are unique geographical regions and store substantial soil organic matter (SOM) in the soil surface, which make them very sensitive to global climate change. Here, we focused on three main grassland types (alpine meadow, steppe, and desert) and conducted a soil incubation experiment at five different temperatures (5, 10, 15, 20, and 25 degrees C) to investigate SOM decomposition rates (R), temperature sensitivity (Q(10)), and activation energy (E-a). The results showed that grassland type and incubation temperature had significant impact on R (P < 0.001), and the values of R were exponential correlated with incubation temperature in three alpine grasslands. At the same temperature, R was in the following order: alpine meadow > alpinesteppe > alpine desert. The Q(10) values differed significantly among different grasslands, and the overall trends were as follows: alpine meadow (1.56 +/- 0.09) < alpine steppe (1.88 +/- 0.23) < alpine desert (2.39 +/- 0.32). Moreover, the E-a values differed significantly across different grassland types (P < 0.001) and increased with increasing incubation time. The exponential negative correlations between E-a and R at 20 degrees C across all grassland types (all Ps < 0.001) indicated that the substrate-quality temperature hypothesis is applicable to the alpine grasslands. Our findings provide new insights for understanding the responses of SOM decomposition and storage to warming scenarios in this Plateau.	[Li, Jie; He, Nianpeng; Gao, Yang; Zuo, Yao] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China; [Li, Jie] NE Normal Univ, Inst Grassland Sci, Changchun 130024, Peoples R China; [Li, Jie] Minist Educ, Key Lab Vegetat Ecol, Changchun 130024, Peoples R China; [Wei, Xuehong] Tibet Univ, Agr & Anim Husb Coll, Linzhi 860000, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Northeast Normal University - China; Tibet University	He, NP (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China.	henp@igsnrr.ac.cn; wxueh@yahoo.com.cn	Gao, Yang/A-4128-2017	Gao, Yang/0000-0002-2053-0418; he, nianpeng/0000-0002-0458-5953	Natural Science Foundation of China [31470506, 31270519]; Chinese Academy of Sciences Strategic Priority Research Program [XDA05050702]; Program for Kezhen Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS [2013RC102]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Strategic Priority Research Program; Program for Kezhen Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS	Funding for this work came from the Natural Science Foundation of China (31470506, 31270519), the Chinese Academy of Sciences Strategic Priority Research Program (XDA05050702), and the Program for Kezhen Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS (2013RC102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2002, SOIL BIOL BIOCHEM, V34, P129, DOI 10.1016/S0038-0717(01)00156-0; Akatsuka T, 2011, LIMNOLOGY, V12, P127, DOI 10.1007/s10201-010-0329-x; [Anonymous], 2007, AGENDA; Avery B.W., 1974, SOIL SURVEY LAB METH; Balser TC, 2009, GLOBAL CHANGE BIOL, V15, P2935, DOI 10.1111/j.1365-2486.2009.01946.x; Bekku YS, 2003, APPL SOIL ECOL, V22, P205, DOI 10.1016/S0929-1393(02)00158-0; Billings SA, 2013, GLOBAL CHANGE BIOL, V19, P90, DOI 10.1111/gcb.12029; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; Cheng GD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000631; Conant RT, 2008, ECOLOGY, V89, P2384, DOI 10.1890/08-0137.1; Conant RT, 2008, GLOBAL CHANGE BIOL, V14, P868, DOI 10.1111/j.1365-2486.2008.01541.x; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Craine J, 2010, SOIL BIOL BIOCHEM, V42, P373, DOI 10.1016/j.soilbio.2009.10.024; Craine JM, 2013, BIOGEOCHEMISTRY, V113, P359, DOI 10.1007/s10533-012-9762-8; Craine JM, 2010, NAT GEOSCI, V3, P854, DOI [10.1038/ngeo1009, 10.1038/NGEO1009]; Dalias P, 2001, GLOBAL CHANGE BIOL, V7, P181, DOI 10.1046/j.1365-2486.2001.00386.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; De Nobili M, 2006, SOIL BIOL BIOCHEM, V38, P2871, DOI 10.1016/j.soilbio.2006.04.044; Dijkstra FA, 2006, SOIL BIOL BIOCHEM, V38, P2519, DOI 10.1016/j.soilbio.2006.02.020; Eliasson PE, 2005, GLOBAL CHANGE BIOL, V11, P167, DOI 10.1111/j.1365-2486.2004.00878.x; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Feng XJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000743; Fierer N, 2005, ECOLOGY, V86, P320, DOI 10.1890/04-1254; Fierer N, 2003, GLOBAL CHANGE BIOL, V9, P1322, DOI 10.1046/j.1365-2486.2003.00663.x; Fierer N, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002644; Fisk MC, 2003, SOIL BIOL BIOCHEM, V35, P591, DOI 10.1016/S0038-0717(03)00053-1; Flanagan LB, 2005, AGR FOREST METEOROL, V130, P237, DOI 10.1016/j.agrformet.2005.04.002; GALLAHER RN, 1976, SOIL SCI SOC AM J, V40, P887, DOI 10.2136/sssaj1976.03615995004000060026x; Gershenson A, 2009, GLOBAL CHANGE BIOL, V15, P176, DOI 10.1111/j.1365-2486.2008.01827.x; Haddix ML, 2011, SOIL SCI SOC AM J, V75, P56, DOI 10.2136/sssaj2010.0118; Hartley IP, 2008, SOIL BIOL BIOCHEM, V40, P1567, DOI 10.1016/j.soilbio.2008.01.007; He NP, 2013, ECOL EVOL, V3, P5045, DOI 10.1002/ece3.881; Iqbal J, 2010, AGR ECOSYST ENVIRON, V137, P294, DOI 10.1016/j.agee.2010.02.015; Ise T, 2006, BIOGEOCHEMISTRY, V80, P217, DOI 10.1007/s10533-006-9019-5; Jing X, 2014, BIOGEOCHEMISTRY, V117, P39, DOI 10.1007/s10533-013-9844-2; Jones CD, 2003, TELLUS B, V55, P642, DOI 10.1034/j.1600-0889.2003.01440.x; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Larionova AA, 2007, BIOGEOSCIENCES, V4, P1073, DOI 10.5194/bg-4-1073-2007; Leifeld J, 2005, BIOGEOCHEMISTRY, V75, P433, DOI 10.1007/s10533-005-2237-4; Leifeld J, 2014, BIOL FERT SOILS, V50, P147, DOI 10.1007/s00374-013-0822-6; Lorenz K, 2007, GEODERMA, V142, P1, DOI 10.1016/j.geoderma.2007.07.013; McGuire AD, 1992, GLOBAL BIOGEOCHEM CY, V6, P101, DOI 10.1029/92GB00219; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Min K, 2014, SOIL BIOL BIOCHEM, V76, P193, DOI 10.1016/j.soilbio.2014.05.021; Qi Y, 2002, ECOL MODEL, V153, P131, DOI 10.1016/S0304-3800(01)00506-3; Shan JY, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00599; Sharkhuu A, 2013, BIOGEOCHEMISTRY, V115, P333, DOI 10.1007/s10533-013-9839-z; Sokolov AP, 2008, J CLIMATE, V21, P3776, DOI 10.1175/2008JCLI2038.1; Song MH, 2010, EUR J SOIL BIOL, V46, P375, DOI 10.1016/j.ejsobi.2010.09.003; Sun SH, 2013, PLANT SOIL, V372, P597, DOI 10.1007/s11104-013-1758-1; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wagai R, 2013, GLOBAL CHANGE BIOL, V19, P1114, DOI 10.1111/gcb.12112; Wang GX, 2008, GEODERMA, V143, P143, DOI 10.1016/j.geoderma.2007.10.023; Wang SQ, 2013, PLANT SOIL, V363, P243, DOI 10.1007/s11104-012-1304-6; Wetterstedt JAM, 2010, GLOBAL CHANGE BIOL, V16, P1806, DOI 10.1111/j.1365-2486.2009.02112.x; Xiang W, 2009, ENVIRON GEOL, V58, P499, DOI 10.1007/s00254-008-1523-6; Xu X, 2012, SOIL BIOL BIOCHEM, V50, P142, DOI 10.1016/j.soilbio.2012.03.007; Yang YH, 2008, GLOBAL CHANGE BIOL, V14, P1592, DOI 10.1111/j.1365-2486.2008.01591.x; Zhang QG, 2006, CHINESE GEOGR SCI, V16, P351, DOI 10.1007/s11769-006-0351-4; Zhou YC, 2013, SCI CHINA EARTH SCI, V56, P311, DOI 10.1007/s11430-012-4498-9	62	20	20	7	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132795	10.1371/journal.pone.0132795	http://dx.doi.org/10.1371/journal.pone.0132795			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176705	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600158
J	Song, HQ; Long, HX; Zuo, XM; Yu, CS; Liu, B; Wang, ZQ; Wang, Q; Wang, F; Han, Y; Jia, JP				Song, Haiqing; Long, Haixia; Zuo, Xiumei; Yu, Chunshui; Liu, Bing; Wang, Zhiqun; Wang, Qi; Wang, Fen; Han, Ying; Jia, Jianping			APOE Effects on Default Mode Network in Chinese Cognitive Normal Elderly: Relationship with Clinical Cognitive Performance	PLOS ONE			English	Article							REGIONAL BRAIN ATROPHY; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; FUNCTIONAL MRI; GENETIC RISK; CONNECTIVITY; ALLELE; CARRIERS; ADULTS	Background Functional connectivity in default mode network (DMN) may be changed in Alzheimer's disease (AD) patients and related risk populations, such as amnestic mild cognitive impairment (aMCI) patients and APOE epsilon 4 carriers. Exploring DMN changes and related behavioral performance of APOE epsilon 4 population might provide valuable evidence for better understanding the development of AD. Methods Subjects were enrolled from a population-based cohort established in a multi-center study in China. Forty-nine cognitive normal individuals were enrolled after standardized cognitive evaluations, MRI examination and APOE genotyping. Regions of interest (ROI)-based functional connectivity analyses were performed, and voxel-based analyses were used to validate these findings. The correlation between DMN functional connectivity and behavioral performance was further evaluated between APOE epsilon 4 epsilon 3 and epsilon 3 epsilon 3 carriers. Results Comparing to epsilon 3 epsilon 3 carriers, functional connectivity between left parahippocampal gyrus and right superior frontal cortex (LPHC-R.Sup.F), left parahippocampal gyrus and medial prefrontal cortex (ventral) (LPHC-vMPFC) were significantly increased in epsilon 4 epsilon 3 carriers, while connectivity between cerebellar tonsils and retrosplenial was decreased. LPHC-R.Sup.F connectivity was positively correlated with the changes of delay recall from baseline to follow-up (r = 0.768, p = 0.009), while LPHC-vMPFC connectivity had a positive correlation with MMSE at baseline (r = 0.356, p = 0.018), and a negative correlation with long-delayed recognition at follow-up (r = -0.677, p = 0.031). Significantly increased functional connectivity in vMPFC was confirmed in voxel-based analyses by taking LPHC as seed region. Conclusion APOE epsilon 4 carriers present both increased and decreased functional connectivity in DMN, which is correlated with clinical cognitive performances. DMN changes might be an early sign for cognitive decline.	[Song, Haiqing; Zuo, Xiumei; Wang, Qi; Wang, Fen; Han, Ying; Jia, Jianping] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Long, Haixia; Liu, Bing] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China; [Yu, Chunshui; Wang, Zhiqun] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Sciences; Institute of Automation, CAS; Capital Medical University	Jia, JP (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China.	jiajp@vip.126.com	Zuo, Xi-Nian/A-7273-2009; Han, Ying/H-7111-2017	Zuo, Xi-Nian/0000-0001-9110-585X; liu, bing/0000-0003-2029-5187; Jia, Jianping/0000-0003-4624-0336; Yu, Chunshui/0000-0001-5648-5199	CHINA-CANADA Joint Initiative on Alzheimer's Disease and Related Disorders [81261120571]; National Science and Technology Major Projects for "Major New Drug Innovation and Development" [2011ZX09307-001-02]; major project of the Science and Technology Plan of the Beijing Municipal Science & Technology Commission [SCW 2011-10]; National Key Technology RD Program [2006BAI02B01]; National Natural Science Foundation of China [30830045, 31371007, 30970823]	CHINA-CANADA Joint Initiative on Alzheimer's Disease and Related Disorders; National Science and Technology Major Projects for "Major New Drug Innovation and Development"; major project of the Science and Technology Plan of the Beijing Municipal Science & Technology Commission; National Key Technology RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by CHINA-CANADA Joint Initiative on Alzheimer's Disease and Related Disorders (81261120571), the National Science and Technology Major Projects for "Major New Drug Innovation and Development" of the Twelfth 5-year Plan Period (2011ZX09307-001-02), the major project of the Science and Technology Plan of the Beijing Municipal Science & Technology Commission (SCW 2011-10), the National Key Technology R&D Program in the Eleventh Five-year Plan Period (2006BAI02B01) and the key project (30830045) and general projects (31371007, 30970823) of the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Camargo A, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-15; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; Dennis NA, 2010, ALZHEIMERS DEMENT, V6, P303, DOI 10.1016/j.jalz.2009.07.003; Filippini N, 2011, NEUROIMAGE, V54, P602, DOI 10.1016/j.neuroimage.2010.08.009; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fleisher AS, 2009, NEUROIMAGE, V47, P1678, DOI 10.1016/j.neuroimage.2009.06.021; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Heise V, 2011, MOL PSYCHIATR, V16, P908, DOI 10.1038/mp.2010.90; Koch W, 2012, NEUROBIOL AGING, V33, P466, DOI 10.1016/j.neurobiolaging.2010.04.013; Liu B, 2010, J NEUROSCI, V30, P64, DOI 10.1523/JNEUROSCI.3941-09.2010; Machulda MM, 2011, ARCH NEUROL-CHICAGO, V68, P1131, DOI 10.1001/archneurol.2011.108; Mevel Katell, 2011, Int J Alzheimers Dis, V2011, P535816, DOI 10.4061/2011/535816; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Mosconi L, 2008, J NUCL MED, V49, P390, DOI 10.2967/jnumed.107.045385; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; Song M, 2009, IEEE ENG MED BIO, P2212, DOI 10.1109/IEMBS.2009.5334874; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sowell ER, 2008, NAT NEUROSCI, V11, P637, DOI 10.1038/nn.2121; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Westlye ET, 2011, J NEUROSCI, V31, P7775, DOI 10.1523/JNEUROSCI.1230-11.2011; Wishart HA, 2006, NEUROLOGY, V67, P1221, DOI 10.1212/01.wnl.0000238079.00472.3a; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	31	13	13	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133179	10.1371/journal.pone.0133179	http://dx.doi.org/10.1371/journal.pone.0133179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177270	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600225
J	van Havre, Z; White, N; Rousseau, J; Mengersen, K				van Havre, Zoe; White, Nicole; Rousseau, Judith; Mengersen, Kerrie			Overfitting Bayesian Mixture Models with an Unknown Number of Components	PLOS ONE			English	Article							CHAIN-MONTE-CARLO; DENSITY-ESTIMATION; MARGINAL LIKELIHOOD; INFERENCE	This paper proposes solutions to three issues pertaining to the estimation of finite mixture models with an unknown number of components: the non-identifiability induced by overfitting the number of components, the mixing limitations of standard Markov Chain Monte Carlo (MCMC) sampling techniques, and the related label switching problem. An overfitting approach is used to estimate the number of components in a finite mixture model via a Zmix algorithm. Zmix provides a bridge between multidimensional samplers and test based estimation methods, whereby priors are chosen to encourage extra groups to have weights approaching zero. MCMC sampling is made possible by the implementation of prior parallel tempering, an extension of parallel tempering. Zmix can accurately estimate the number of components, posterior parameter estimates and allocation probabilities given a sufficiently large sample size. The results will reflect uncertainty in the final model and will report the range of possible candidate models and their respective estimated probabilities from a single run. Label switching is resolved with a computationally light-weight method, Zswitch, developed for overfitted mixtures by exploiting the intuitiveness of allocation-based relabelling algorithms and the precision of label-invariant loss functions. Four simulation studies are included to illustrate Zmix and Zswitch, as well as three case studies from the literature. All methods are available as part of the R package Zmix, which can currently be applied to univariate Gaussian mixture models.	[van Havre, Zoe; White, Nicole] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [van Havre, Zoe; Rousseau, Judith; Mengersen, Kerrie] Univ Paris 09, CEREMADE, F-75775 Paris, France	Queensland University of Technology (QUT); UDICE-French Research Universities; PSL Research University Paris; Universite Paris-Dauphine	van Havre, Z (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia.	zoe.vanhavre@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022; Rousseau, Judith/A-8625-2018	Mengersen, Kerrie/0000-0001-8625-9168; van Havre, Zoe/0000-0002-4418-226X; White, Nicole/0000-0002-9292-0773; Rousseau, Judith/0000-0002-0998-6174	Australian Postgraduate Award; Australian Research Council	Australian Postgraduate Award(Australian Government); Australian Research Council(Australian Research Council)	This study was partially funded by an Australian Postgraduate Award and the Australian Research Council.	Aitkin M, 2001, STAT MODEL, V1, P287, DOI 10.1177/1471082X0100100404; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; [Anonymous], 2013, TEXTS STAT SCI SERIE; Baragatti M, 2013, STAT COMPUT, V23, P535, DOI 10.1007/s11222-012-9328-6; BECHTEL YC, 1993, CLIN PHARMACOL THER, V54, P134, DOI 10.1038/clpt.1993.124; Cameron E, 2014, STAT SCI, V29, P397, DOI 10.1214/13-STS465; CARLIN BP, 1995, J ROY STAT SOC B MET, V57, P473; Celeux G, 2000, J AM STAT ASSOC, V95, P957, DOI 10.2307/2669477; Celeux G., 1998, COMPSTAT 98, P227; Chib S, 1995, J AM STAT ASSOC, V90, P1313, DOI 10.2307/2291521; CRAWFORD SL, 1994, J AM STAT ASSOC, V89, P259, DOI 10.2307/2291222; da Silva ARF, 2007, MED IMAGE ANAL, V11, P169, DOI 10.1016/j.media.2006.12.002; Earl DJ, 2005, PHYS CHEM CHEM PHYS, V7, P3910, DOI 10.1039/b509983h; ESCOBAR MD, 1995, J AM STAT ASSOC, V90, P577, DOI 10.2307/2291069; Fruhwirth-Schnatter S., 2006, FINITE MIXTURE MARKO; Gelfand A. E., 1996, MARKOV CHAIN MONTE C; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Grun B, 2009, J MULTIVARIATE ANAL, V100, P851, DOI 10.1016/j.jmva.2008.09.006; Heckman J J, 1994, Stat Methods Med Res, V3, P279, DOI 10.1177/096228029400300306; Hurn M, 2003, J COMPUT GRAPH STAT, V12, P55, DOI 10.1198/1061860031329; Jasra A, 2005, STAT SCI, V20, P50, DOI 10.1214/088342305000000016; Lewin A, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1314; Lin TI, 2007, STAT SINICA, V17, P909; Marin JM, 2005, HANDB STAT, V25, P459, DOI 10.1016/S0169-7161(05)25016-2; McLachlan G., 2000, WILEY SER PROB STAT; Nobile A., 2007, ARXIV07110458; Phillips DV, 1996, MARKOV CHAIN MONTE C, P215; REYNOLDS DA, 1995, IEEE T SPEECH AUDI P, V3, P72, DOI 10.1109/89.365379; Richardson S, 1997, J ROY STAT SOC B MET, V59, P731, DOI 10.1111/1467-9868.00095; Robert C, 2011, STAT SCI, V26, P102, DOI 10.1214/10-STS351; Robert E., 1997, JOURNAL OF THE ROYAL, V59, P731, DOI 10.1111/1467-9868.00095; Roeder K, 1997, J AM STAT ASSOC, V92, P894, DOI 10.2307/2965553; Rousseau J, 2011, J R STAT SOC B, V73, P689, DOI 10.1111/j.1467-9868.2011.00781.x; Stauffer C., 1999, Proceedings. 1999 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No PR00149), P246, DOI 10.1109/CVPR.1999.784637; Stephens M, 2000, ANN STAT, V28, P40, DOI 10.1214/aos/1016120364; Stephens M, 2000, J ROY STAT SOC B, V62, P795, DOI 10.1111/1467-9868.00265; SWENDSEN RH, 1986, PHYS REV LETT, V57, P2607, DOI 10.1103/PhysRevLett.57.2607; TANNER MA, 1987, J AM STAT ASSOC, V82, P528, DOI 10.2307/2289457; White N, 2010, STAT METHODS MED RES	42	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131739	10.1371/journal.pone.0131739	http://dx.doi.org/10.1371/journal.pone.0131739			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177375	Green Published, gold			2022-12-27	WOS:000358197600061
J	Waggoner, JJ; Balassiano, I; Mohamed-Hadley, A; Vital-Brazil, JM; Sahoo, MK; Pinsky, BA				Waggoner, Jesse J.; Balassiano, Ilana; Mohamed-Hadley, Alisha; Vital-Brazil, Juliana Magalhaes; Sahoo, Malaya K.; Pinsky, Benjamin A.			Reverse-Transcriptase PCR Detection of Leptospira: Absence of Agreement with Single-Specimen Microscopic Agglutination Testing	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; DIAGNOSTIC-TESTS; DENGUE; OUTBREAK	Background Reference diagnostic tests for leptospirosis include nucleic acid amplification tests, bacterial culture, and microscopic agglutination testing (MAT) of acute and convalescent serum. However, clinical laboratories often do not receive paired specimens. In the current study, we tested serum samples using a highly sensitive real-time nucleic acid amplification test for Leptospira and compared results to MAT performed on the same specimens. Methods/Principal Findings 478 serum samples from suspected leptospirosis cases in Rio de Janeiro were tested using a real-time RT-PCR for the diagnosis of leptospirosis, malaria and dengue (the Lepto-MD assay). The Lepto-MD assay detects all species of Leptospira (saprophytic, intermediate, and pathogenic), and in the current study, we demonstrate that this assay amplifies both Leptospira RNA and DNA. Dengue virus RNA was identified in 10 patients, and no cases of malaria were detected. A total of 65 samples (13.6%) were positive for Leptospira: 35 samples (7.3%) in the Lepto-MD assay, 33 samples (6.9%) by MAT, and 3 samples tested positive by both (kappa statistic 0.02). Poor agreement between methods was consistent regardless of the titer used to define positive MAT results or the day of disease at sample collection. Leptospira nucleic acids were detected in the Lepto-MD assay as late as day 22, and cycle threshold values did not differ based on the day of disease. When Lepto-MD assay results were added to the MAT results for all patients in 2008 (n=818), the number of detected leptospirosis cases increased by 30.4%, from 102 (12.5%) to 133 (16.3%). Conclusions/Significance This study demonstrates a lack of agreement between nucleic acid detection of Leptospira and single-specimen MAT, which may result from the clearance of bacteremia coinciding with the appearance of agglutinating antibodies. A combined testing strategy for acute leptospirosis, including molecular and serologic testing, appears necessary to maximize case detection.	[Waggoner, Jesse J.; Pinsky, Benjamin A.] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Sch Med, Stanford, CA 94305 USA; [Balassiano, Ilana; Vital-Brazil, Juliana Magalhaes] Fiocruz MS, Ctr Referencia Nacl Leptospirose, Lab Zoonoses Bacterianas, Colecao Leptospira,WHO PAHO Ctr Colaborador Lepto, BR-21045900 Rio De Janeiro, Brazil; [Mohamed-Hadley, Alisha; Sahoo, Malaya K.; Pinsky, Benjamin A.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Fundacao Oswaldo Cruz; Stanford University	Waggoner, JJ (corresponding author), Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Sch Med, Stanford, CA 94305 USA.	waggo001@stanford.edu	Sahoo, Malaya Kumar/AAS-6907-2020; Balassiano, Ilana/GXH-4826-2022	Sahoo, Malaya Kumar/0000-0001-9837-4032; Balassiano, Ilana/0000-0001-8036-1081; Pinsky, Benjamin/0000-0001-8751-4810	National Institutes of Health [K08AI110528]; Thrasher Research Fund [11979]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI110528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thrasher Research Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institutes of Health grant K08AI110528, www.NIH.gov (JJW, salary support) and the Thrasher Research Fund Award 11979, www.thrasherresearch.org (JJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agampodi SB, 2012, CLIN INFECT DIS, V54, P1249, DOI 10.1093/cid/cis035; [Anonymous], 2003, LANCET INFECT DIS, DOI DOI 10.1016/S1473-3099(03)00830-2; [Anonymous], 2011, 2 M LEPT BURD EP REF; [Anonymous], AM J TROP M IN PRESS; [Anonymous], 2003, HUM LEPT GUID DIAGN; Bruce MG, 2005, ACTA TROP, V96, P36, DOI 10.1016/j.actatropica.2005.07.001; Cumberland P, 1999, AM J TROP MED HYG, V61, P731, DOI 10.4269/ajtmh.1999.61.731; Galloway RL, 2015, DIAGN MICR INFEC DIS, V82, P199, DOI [10.1016/j.diagmicrobio2015.03.024, 10.1016/j.diagmicrobio.2015.03.024]; Goris MGA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002290; Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064; Karande S, 2005, J TROP PEDIATRICS, V51, P174, DOI 10.1093/tropej/fmh100; LaRocque RC, 2005, EMERG INFECT DIS, V11, P766, DOI 10.3201/eid1105.041212; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Limmathurotsakul D, 2012, CLIN INFECT DIS, V55, P322, DOI 10.1093/cid/cis403; MERIEN F, 1995, J INFECT DIS, V172, P281, DOI 10.1093/infdis/172.1.281; Picardeau M, 2014, DIAGN MICR INFEC DIS, V78, P1, DOI 10.1016/j.diagmicrobio.2013.09.012; Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228; Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13; Spichler A, 2012, AM J TROP MED HYG, V86, P306, DOI 10.4269/ajtmh.2012.11-0308; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Thaipadunpanit J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016236; Waggoner JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112356; Waggoner JJ, 2014, J CLIN MICROBIOL, V52, P2011, DOI 10.1128/JCM.00341-14; WHO, 2012, WORLD MALARIA REPORT 2012, P1	24	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132988	10.1371/journal.pone.0132988	http://dx.doi.org/10.1371/journal.pone.0132988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177295	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600195
J	Yang, CW; Li, CI; Li, TC; Liu, CS; Lin, CH; Lin, WY; Lin, CC				Yang, Chuan-Wei; Li, Chia-Ing; Li, Tsai-Chung; Liu, Chiu-Shong; Lin, Chih-Hsueh; Lin, Wen-Yuan; Lin, Cheng-Chieh			Association of Sarcopenic Obesity with Higher Serum High-Sensitivity C-Reactive Protein Levels in Chinese Older Males - A Community-Based Study (Taichung Community Health Study-Elderly, TCHS-E)	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; NECROSIS-FACTOR-ALPHA; PHYSICAL-ACTIVITY; METABOLIC SYNDROME; BODY-COMPOSITION; WOMEN; STRENGTH; MEN; INTERLEUKIN-6; PERFORMANCE	The prevalence of obesity and sarcopenia is high among the elderly. The simultaneous occurrence of these two disorders results in sarcopenic obesity. Research suggests that inflammation has an important role in the pathogenesis of obesity and sarcopenia. This study explores the impact of sarcopenic obesity on inflammatory markers, including interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), and tumor necrosis factoralpha (TNF-alpha). This study is a community-based cross-sectional study. The study sample consisted of 844 community-dwelling people aged 65 years and older (448 men and 396 women). Sarcopenia was characterized by low muscle mass (skeletal muscle index < 6.87 and 5.46 kg/m(2) for men and women, respectively), and obesity was characterized by excess body fat (body fat percentage greater than the 60th percentile of the study sample by sex [27.82% in men and 37.61% in women]). Older individuals identified with sarcopenic obesity were those who had both sarcopenia and obesity. Inflammatory markers such as IL-6, hs-CRP, and TNF-alpha were measured. The prevalence rates of obesity only, sarcopenia only, and sarcopenic obesity were 32.94%, 11.85%, and 7.23%, respectively. No difference was observed in the serum levels of IL-6 and TNF-alpha among the four groups of combined sarcopenia and obesity status. After multivariate adjustment, the serum hs-CRP levels in the obesity only and in the sarcopenic obesity groups were 0.14 and 0.16 mg/dL among males, respectively, which were significantly higher than that in the normal group (P=0.012 and 0.036). Our results provide evidence that obesity and sarcopenic obesity are associated with increased levels of serum hs-CRP among males.	[Yang, Chuan-Wei; Lin, Cheng-Chieh] China Med Univ, PhD Program Aging, Coll Med, Taichung, Taiwan; [Yang, Chuan-Wei; Li, Chia-Ing; Liu, Chiu-Shong; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Li, Chia-Ing; Liu, Chiu-Shong; Lin, Chih-Hsueh; Lin, Wen-Yuan; Lin, Cheng-Chieh] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Coll Publ Hlth, Grad Inst Biostat, Taichung, Taiwan; [Lin, Cheng-Chieh] Asia Univ, Coll Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan; [Liu, Chiu-Shong; Lin, Chih-Hsueh; Lin, Wen-Yuan; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lin, CC (corresponding author), China Med Univ, PhD Program Aging, Coll Med, Taichung, Taiwan.	cclin@mail.cmuh.org.tw	Lin, Cheng-Chieh/P-2564-2015; Li, Tsai-Chung/P-2052-2015	Lin, Cheng-Chieh/0000-0002-9625-6216; Li, Tsai-Chung/0000-0002-3346-7462	Taiwan National Health Research Institutes [NHRI-EX100-9838PI]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH100-TD-B-111-004]	Taiwan National Health Research Institutes; Taiwan Department of Health Clinical Trial and Research Center of Excellence	This study was supported by grants from Taiwan National Health Research Institutes (NHRI-EX100-9838PI) and Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004).	Atkins JL, 2014, J AM GERIATR SOC, V62, P253, DOI 10.1111/jgs.12652; Baumgartner RN, 2004, OBES RES, V12, P1995, DOI 10.1038/oby.2004.250; Bouchard DR, 2009, OBESITY, V17, P2082, DOI 10.1038/oby.2009.109; Brien SE, 2006, APPL PHYSIOL NUTR ME, V31, P40, DOI 10.1139/H05-024; Brooks GC, 2010, AM J CARDIOL, V106, P56, DOI 10.1016/j.amjcard.2010.02.017; Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1; Chang PC, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-193; Clark BC, 2008, J GERONTOL A-BIOL, V63, P829, DOI 10.1093/gerona/63.8.829; DiGirolamo N, 1997, J LEUKOCYTE BIOL, V61, P667, DOI 10.1002/jlb.61.6.667; Flores MBS, 2012, GASTROENTEROLOGY, V143, P741, DOI 10.1053/j.gastro.2012.05.045; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; GOODMAN MN, 1991, AM J PHYSIOL, V260, pE727, DOI 10.1152/ajpendo.1991.260.5.E727; GOODMAN MN, 1994, P SOC EXP BIOL MED, V205, P182; Henry CJK, 2000, EUR J CLIN NUTR, V54, pS77, DOI 10.1038/sj.ejcn.1601029; Huang CF, 2010, HEPATOL INT, V4, P621, DOI 10.1007/s12072-010-9200-8; Illan-Gomez F, 2012, OBES SURG, V22, P950, DOI 10.1007/s11695-012-0643-y; Isasi CR, 2003, PEDIATRICS, V111, P332, DOI 10.1542/peds.111.2.332; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Kim J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-624; Kim TN, 2009, INT J OBESITY, V33, P885, DOI 10.1038/ijo.2009.130; Kim TN, 2013, CLIN ENDOCRINOL, V78, P525, DOI 10.1111/j.1365-2265.2012.04433.x; Kleppinger A, 2010, J WOMENS HEALTH, V19, P1651, DOI 10.1089/jwh.2009.1853; Lafortuna CL, 2005, INT J OBESITY, V29, P833, DOI 10.1038/sj.ijo.0802955; Landi F, 1999, J AM GERIATR SOC, V47, P1072, DOI 10.1111/j.1532-5415.1999.tb05229.x; Lazzer S, 2010, OBESITY, V18, P71, DOI 10.1038/oby.2009.162; Lee JSW, 2007, GERONTOLOGY, V53, P404, DOI 10.1159/000107355; Martel GF, 2006, EXP PHYSIOL, V91, P457, DOI 10.1113/expphysiol.2005.032771; McDade TW, 2008, J NUTR, V138, P2442, DOI 10.3945/jn.108.092700; Moran LJ, 2007, J CLIN ENDOCR METAB, V92, P2944, DOI 10.1210/jc.2006-2336; Obisesan TO, 2004, ARTERIOSCL THROM VAS, V24, P1874, DOI 10.1161/01.ATV.0000140060.13203.22; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Pedrero-Chamizo R, 2015, J NUTR HEALTH AGING, V19, P211, DOI 10.1007/s12603-014-0530-4; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Rolland Y, 2009, AM J CLIN NUTR, V89, P1895, DOI 10.3945/ajcn.2008.26950; ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231, DOI 10.1093/ajcn/50.5.1231; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Sayer AA, 2005, DIABETES CARE, V28, P2541, DOI 10.2337/diacare.28.10.2541; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schrager MA, 2007, J APPL PHYSIOL, V102, P919, DOI 10.1152/japplphysiol.00627.2006; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Stenholm S, 2008, J AM GERIATR SOC, V56, P462, DOI 10.1111/j.1532-5415.2007.01567.x; Szulc P, 2004, AM J CLIN NUTR, V80, P496, DOI 10.1093/ajcn/80.2.496; Taaffe DR, 2000, J GERONTOL A-BIOL, V55, pM709, DOI 10.1093/gerona/55.12.M709; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Visser M, 1998, J GERONTOL A-BIOL, V53, pM214, DOI 10.1093/gerona/53A.3.M214; Visser M, 2002, J GERONTOL A-BIOL, V57, pM326, DOI 10.1093/gerona/57.5.M326; Visser M, 2002, J AM GERIATR SOC, V50, P897, DOI 10.1046/j.1532-5415.2002.50217.x; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yang XL, 2008, MED SCI SPORT EXER, V40, P1424, DOI 10.1249/MSS.0b013e318172ced4; Yeh CJ, 2011, ASIA PAC J CLIN NUTR, V20, P292; Zamboni M, 2008, NUTR METAB CARDIOVAS, V18, P388, DOI 10.1016/j.numecd.2007.10.002	55	26	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132908	10.1371/journal.pone.0132908	http://dx.doi.org/10.1371/journal.pone.0132908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177029	Green Published, gold			2022-12-27	WOS:000358197600177
J	Ahmad, K; Zwi, AB; Tarantola, DJM; Soomro, AQ; Baig, R; Azam, SI				Ahmad, Khabir; Zwi, Anthony B.; Tarantola, Daniel J. M.; Soomro, Abdul Qadeem; Baig, Rashid; Azam, Syed Iqbal			Gendered Disparities in Quality of Cataract Surgery in a Marginalised Population in Pakistan: The Karachi Marine Fishing Communities Eye and General Health Survey	PLOS ONE			English	Article							NATIONAL BLINDNESS; VISUAL IMPAIRMENT; OUTCOMES	Background Marine fishing communities are among the most marginalised and hard-to-reach groups and have been largely neglected in health research. We examined the quality of cataract surgery and its determinants, with an emphasis on gender, in marine fishing communities in Karachi, Pakistan, using multiple indicators of performance. Methods and Findings The Karachi Marine Fishing Communities Eye and General Health Survey was a door-to-door, cross-sectional study conducted between March 2009 and April 2010 in fishing communities living on 7 islands and in coastal areas in Keamari, Karachi, located on the Arabian Sea. A population-based sample of 638 adults, aged >= 50 years, was studied. A total of 145 eyes (of 97 persons) had undergone cataract surgery in this sample. Cataract surgical outcomes assessed included vision (presenting and best-corrected with a reduced logMAR chart), satisfaction with surgery, astigmatism, and pupil shape. Overall, 65.5% of the operated eyes had some form of visual loss (presenting visual acuity [PVA] < 6/12). 55.2%, 29.0%, and 15.9% of these had good, borderline, and poor visual outcomes based on presenting vision; with best correction, these values were: 68.3 %, 18.6%, and 13.1%, respectively. Of 7 covariates evaluated in the multivariable generalized estimating equations (GEE) analyses, gender was the only significant independent predictor of visual outcome. Women's eyes were nearly 4.38 times more likely to have suboptimal visual outcome (PVA<6/18) compared with men's eyes (adjusted odds ratio 4.38, 95% CI 1.96-9.79; P<0.001) after adjusting for the effect of household financial status. A higher proportion of women's than men's eyes had an irregular pupil (26.5% vs. 14.8%) or severe/very severe astigmatism (27.5% vs. 18.2%). However, these differences did not reach statistical significance. Overall, more than one fourth (44/144) of cataract surgeries resulted in dissatisfaction. The only significant predictor of satisfaction was visual outcome (P <0.001). Conclusions The quality of cataract surgery in this marginalised population, especially among women, falls well below the WHO recommended standards. Gender disparities, in particular, deserve proactive attention in policy, service delivery, research and evaluation.	[Ahmad, Khabir; Zwi, Anthony B.] Univ New S Wales, Fac Arts & Social Sci, Sch Social Sci, Sydney, NSW, Australia; [Ahmad, Khabir; Baig, Rashid] Aga Khan Univ, Dept Surg, Sect Ophthalmol, Karachi, Pakistan; [Ahmad, Khabir] Aga Khan Univ, Dept Surg, Off Surg Res, Karachi, Pakistan; [Tarantola, Daniel J. M.] Univ New S Wales, Fac Med, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Soomro, Abdul Qadeem] Al Ibrahim Eye Hosp, Isra Postgrad Inst Ophthalmol, Karachi, Pakistan; [Azam, Syed Iqbal] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan	University of New South Wales Sydney; Aga Khan University; Aga Khan University; University of New South Wales Sydney; Aga Khan University	Ahmad, K (corresponding author), Univ New S Wales, Fac Arts & Social Sci, Sch Social Sci, Sydney, NSW, Australia.	khabir.ahmad@aku.edu	Zwi, Anthony/AAP-7026-2021; Zwi, Anthony/AAP-8731-2020	Zwi, Anthony/0000-0001-6902-6602; 	Fred Hollows Foundation, Australia	Fred Hollows Foundation, Australia	The Fred Hollows Foundation, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Z, A TURBULENT YEAR; Ahmad K, 2015, OPHTHAL EPIDEMIOL, V22, P370, DOI 10.3109/09286586.2015.1012592; Ahmad K, 2015, INVEST OPHTH VIS SCI, V56, P1023, DOI 10.1167/iovs.14-16019; [Anonymous], 2002, Community Eye Health, V15, P49; [Anonymous], HLTH ACT CRIS; Bene C, 2011, PROG DEV STUD, V11, P119, DOI 10.1177/146499341001100203; Bourne R, 2007, BRIT J OPHTHALMOL, V91, P420, DOI 10.1136/bjo.2006.106724; Congdon N, 2013, LANCET GLOB HEALTH, V1, pE37, DOI 10.1016/S2214-109X(13)70003-2; Dineen B, 2007, BRIT J OPHTHALMOL, V91, P1005, DOI 10.1136/bjo.2006.108035; Gruskin S, 2007, LANCET, V370, P449, DOI 10.1016/S0140-6736(07)61200-8; Khanna R, 2011, CURR OPIN OPHTHALMOL, V22, P10, DOI 10.1097/ICU.0b013e3283414f50; Khanna RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035701; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Tabin G, 2008, CURR OPIN OPHTHALMOL, V19, P55, DOI 10.1097/ICU.0b013e3282f154bd; West S, 2007, OPHTHAL EPIDEMIOL, V14, P173, DOI 10.1080/09286580701423151; Yorston D, 2005, EYE, V19, P1083, DOI 10.1038/sj.eye.6701966; Yorston D, 2002, BRIT J OPHTHALMOL, V86, P543, DOI 10.1136/bjo.86.5.543	17	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131774	10.1371/journal.pone.0131774	http://dx.doi.org/10.1371/journal.pone.0131774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186605	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700022
J	Choi, E; Lee, YY; Yoon, HJ; Lee, S; Suh, M; Park, B; Jun, JK; Kim, Y; Choi, KS				Choi, Eunji; Lee, Yoon Young; Yoon, Hyo Joong; Lee, Sangeun; Suh, Mina; Park, Boyoung; Jun, Jae Kwan; Kim, Yeol; Choi, Kui Son			Relationship between Cancer Worry and Stages of Adoption for Breast Cancer Screening among Korean Women	PLOS ONE			English	Article							TRANSTHEORETICAL MODEL; PERCEIVED RISK; GASTRIC-CANCER; MAMMOGRAPHY; POPULATION; BEHAVIOR; MORTALITY	Background The possibility of developing breast cancer is a concern for all women; however, few studies have examined the relationship between cancer worry and the stages of adoption for breast cancer screening in Korea. Here, we investigated the associations between cancer worry, the stages of adopting breast cancer screening, and socio-demographic factors known to influence screening behaviors. Methods This study was based on the 2013 Korean National Cancer Screening Survey, an annual cross-sectional survey that utilized nationally representative random sampling to investigate cancer screening rates. Data were analyzed from 1,773 randomly selected women aged 40-74 years. Chi-squared tests and multinomial logistic analyses were conducted to determine the associations between cancer worry and the stages of adoption for breast cancer screening and to outline the factors associated with each stage. Results Korean women were classified into the following stages of adoption for breast cancer screening: pre-contemplation (24.7%), contemplation (13.0%), action/maintenance (50.8%), relapse risk (8.9%), and relapse (2.6%). Women in the action/maintenance stages reported more moderate to higher levels of worry about getting cancer than those in the pre-contemplation stage. Further, age of 40-49 years and having private cancer insurance were associated with women in the action/maintenance stages. Conclusion Interventions to address breast cancer worry may play an important role in increasing participation and equity in breast cancer screening.	[Choi, Eunji; Lee, Sangeun; Jun, Jae Kwan; Choi, Kui Son] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Goyang, Gyeonggi Do, South Korea; [Lee, Yoon Young; Yoon, Hyo Joong; Suh, Mina; Park, Boyoung; Jun, Jae Kwan; Kim, Yeol; Choi, Kui Son] Natl Canc Ctr, Natl Canc Control Inst, Goyang, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Choi, KS (corresponding author), Natl Canc Ctr, Grad Sch Canc Sci & Policy, Goyang, Gyeonggi Do, South Korea.	kschoi@ncc.re.kr			National Cancer Center of Korea [1310232]	National Cancer Center of Korea	This study was supported by a Grant-in-Aid for Cancer Research and Control from the National Cancer Center of Korea (http://www.ncc.re.kr) (#1310232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MR, 2003, CANCER EPIDEM BIOMAR, V12, P314; Bowen DJ, 2003, J SOC CLIN PSYCHOL, V22, P213, DOI 10.1521/jscp.22.2.213.22875; Cameron LD, 2001, J HEALTH PSYCHOL, V6, P47, DOI 10.1177/135910530100600104; Chamot E, 2001, EUR J CANCER, V37, P1869, DOI 10.1016/S0959-8049(01)00234-9; Consedine NS, 2004, CANCER EPIDEM BIOMAR, V13, P501; Diefenbach MA, 1996, J SOC DISTRESS HOMEL, V5, P11, DOI 10.1007/BF02090456; Hay JL, 2005, PSYCHO-ONCOLOGY, V14, P517, DOI 10.1002/pon.864; Hirai K, 2013, PSYCHO-ONCOLOGY, V22, P2339, DOI 10.1002/pon.3293; Ho SSM, 2014, PUBLIC HEALTH, V128, P1009, DOI 10.1016/j.puhe.2014.09.001; JANI S, 1962, J ABNORM PSYCHOL, V65, P403; Jung KW, 2013, CANCER RES TREAT, V45, P1, DOI 10.4143/crt.2013.45.1.1; Jung KW, 2014, CANCER RES TREAT, V46, P109, DOI 10.4143/crt.2014.46.2.109; Kiin SE, 2008, ARCH INTERN MED, V168, P728, DOI 10.1001/archinte.168.7.728; Kwak MS, 2009, PSYCHO-ONCOLOGY, V18, P708, DOI 10.1002/pon.1458; Kwak MS, 2009, PREV MED, V49, P48, DOI 10.1016/j.ypmed.2009.05.007; Lee MH, 2013, ASIAN PAC J CANCER P, V14, P6095, DOI 10.7314/APJCP.2013.14.10.6095; LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657; LERMAN C, 1991, HEALTH PSYCHOL, V10, P259, DOI 10.1037/0278-6133.10.4.259; LEVENTHAL H, 1987, PATIENT EDUC COUNS, V10, P117, DOI 10.1016/0738-3991(87)90093-0; McCaul KD, 1998, J BEHAV MED, V21, P565, DOI 10.1023/A:1018748712987; McCaul KD, 1996, HEALTH PSYCHOL, V15, P430, DOI 10.1037/0278-6133.15.6.430; Miller AM, 1997, WOMEN HEALTH, V26, P41, DOI 10.1300/J013v26n01_04; Moser K, 2009, BMJ, V338; O'Sullivan I, 2001, J MED SCREEN, V8, P145, DOI 10.1136/jms.8.3.145; Oh D, 2011, ASIAN PAC J CANCER P, V12, P2865; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; Rakowski W, 1996, ANN BEHAV MED, V18, P91, DOI 10.1007/BF02909581; Robb KA, 2004, CANCER EPIDEM BIOMAR, V13, P366; Shin DW, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-133; Shiryazdi SM, 2014, ASIAN PAC J CANCER P, V15, P9817, DOI 10.7314/APJCP.2014.15.22.9817; Skinner CS, 1998, AM J PREV MED, V14, P54, DOI 10.1016/S0749-3797(97)00008-1; Suh M, 2013, ASIAN PAC J CANCER P, V14, P6459, DOI 10.7314/APJCP.2013.14.11.6459; Trauth JM, 2003, HEALTH EDUC BEHAV, V30, P322, DOI 10.1177/1090198103030003007; Vernon SW, 1997, CANCER EPIDEM BIOMAR, V6, P825; Youlden Danny R., 2014, Cancer Biology Medicine, V11, P101, DOI 10.7497/j.issn.2095-3941.2014.02.005	35	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132351	10.1371/journal.pone.0132351	http://dx.doi.org/10.1371/journal.pone.0132351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186652	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700039
J	Kwok, JJM; Lee, DY				Kwok, Jeremy Jie Ming; Lee, Dong-Yup			Coopetitive Supply Chain Relationship Model: Application to the Smartphone Manufacturing Network	PLOS ONE			English	Article							COLLABORATION	Previous researches for understanding supply chain relationship have mostly focused on its vertical collaboration between buyers and suppliers. However, there have been some instances of volatile and stable collaborative relationships amongst competitors such as Apple-Samsung product manufacturer-component supplier relationship and airline alliances, respectively, which is recognized as coopetition. Even though there have been several qualitative studies and a number of game theory models on coopetition, it is rare to find any attempts on quantitative characterization of such coopetitive dynamic behavior in supply chain relationship. Hence, in this work, we formulated a MINLP model mathematically representing coopetitive relationships in a cost efficient supply chain network. In particular, the coopetition factor was newly introduced to measure the degree of coopetition among supply chain players and determine the optimal level of coopetition to engage in. The utility and practicality of the model were strongly demonstrated using a case study of a hypothetical smartphone supply chain network under different scenarios, thus proposing their strategically viable optimal interactions. Therefore, this exploratory study can herald a new era of global coopetitive business.	[Kwok, Jeremy Jie Ming; Lee, Dong-Yup] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117548, Singapore; [Kwok, Jeremy Jie Ming; Lee, Dong-Yup] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Lee, Dong-Yup] ASTAR, Bioproc Technol Inst, Singapore, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI)	Lee, DY (corresponding author), Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117548, Singapore.	cheld@nus.edu.sg	Lee, Dong-Yup/D-6650-2011	Lee, Dong-Yup/0000-0003-0901-708X				Agomuoh F., 2013, INT BUSINESS TIMES; ARTHUR WB, 1994, AM ECON REV, V84, P406; Barnes J, 2012, INT J PRODUCT EC; Barratt M, 2004, SUPPLY CHAIN MANAG, V9, P30, DOI 10.1108/13598540410517566; Cao M, 2011, J OPER MANAG, V29, P163, DOI 10.1016/j.jom.2010.12.008; Chen X, 2012, MCOMM; Christopher M, 2011, INT J PHYS DISTR LOG, V41, P63, DOI 10.1108/09600031111101439; Conlisk J, 1996, J ECON LIT, V34, P669; Cusumano MA, 2013, COMMUN ACM, V56, P28, DOI 10.1145/2398356.2398366; Fan T, 2001, J AIR TRANSP MANAG, V7, P349, DOI 10.1016/S0969-6997(01)00027-8; Gnyawali DR, 2011, RES POLICY, V40, P650, DOI 10.1016/j.respol.2011.01.009; Gurnani H, 2007, EUR J OPER RES, V180, P228, DOI 10.1016/j.ejor.2006.02.047; Kraemer K., 2011, CAPTURING VALUE GLOB; Lee J-A., 2012, WALL STREET J; Lin DY, 2013, POL MARIT RES, V20, P5, DOI 10.2478/pomr-2013-0022; Nomura, 2012, 2012 SMARTPH GUID 20; Patel M, 2012, EM APPL INF TECHN EA; Pathak SD, 2014, J OPER MANAG, V32, P254, DOI 10.1016/j.jom.2014.04.001; Prabhakar M. N., 2013, INTERJ CARBOHYD CHEM, V2013, P1, DOI [10.1155/2013/243695, DOI 10.1155/2013/243695]; Sheu C, 2006, INT J OPER PROD MAN, V26, P24, DOI 10.1108/01443570610637003; Simatupang T.M., 2002, INT J LOGIST MANAG, V13, P15, DOI [10.1108/09574090210806333, DOI 10.1108/09574090210806333]; Soloviev VI., 2009, 2009 INT C MAN SCI E; Tawarmalani M, 2005, MATH PROGRAM, V103, P225, DOI 10.1007/s10107-005-0581-8; Vergara R. A. G., 2012, AM INT J CONT RES, V2, P77; Zhang J, 2011, DECIS SUPPORT SYST, V51, P853, DOI 10.1016/j.dss.2011.02.004; Zineldin M., 2004, MARKETING INTELLIGEN, V22, P780, DOI [10.1108/02634500410568600, DOI 10.1108/02634500410568600]	26	5	5	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132844	10.1371/journal.pone.0132844	http://dx.doi.org/10.1371/journal.pone.0132844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186227	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700066
J	Li, T; Wang, BY; Wang, ZH; Ragaz, J; Zhang, J; Sun, S; Cao, J; Lv, FF; Wang, LP; Zhang, S; Ni, C; Wu, ZH; Xie, J; Hu, XC				Li, Ting; Wang, Biyun; Wang, Zhonghua; Ragaz, Joseph; Zhang, Jian; Sun, Si; Cao, Jun; Lv, Fangfang; Wang, Leiping; Zhang, Sheng; Ni, Chen; Wu, Zhenhua; Xie, Jie; Hu, Xichun			Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial	PLOS ONE			English	Article							1ST-LINE TREATMENT; COLORECTAL-CANCER; OPEN-LABEL; NEOADJUVANT CHEMOTHERAPY; 2ND-LINE TREATMENT; PLUS CAPECITABINE; NON-INFERIORITY; DOUBLE-BLIND; OXALIPLATIN; PACLITAXEL	Background Bevacizumab combined with modified FOLFOX6 is a standard regimen for colorectal cancer. The present study was to determine the efficacy and safety of bevacizumab-modified FOLFOX6 regimen in heavily pretreated patients with human epidermal growth factor receptor 2 (HER2/neu)-negative MBC. Methods Bevacizumab, 5 mg/kg every two weeks or 7.5 mg/kg every three weeks, was administered with modified FOLFOX6 (oxaliplatin 85 mg/m(2), leucovorin 400 mg/m(2), 5-FU 400 mg/m(2) on day 1, followed by 5-FU 2400 mg/m(2) intravenous infusion over 46 hours every 2 weeks) to patients who failed at least 1 chemotherapy regimen in the metastatic setting. The primary objective was progression free survival (PFS). Secondary objectives included objective response rate (ORR), clinical benefit rate (CBR), overall survival (OS), safety, and the change of tumor size and Eastern Cooperative Oncology Group (ECOG) performance status. Results 69 patients were enrolled. The median PFS was 6.8 months (95% CI, 5.0 to 8.5 months), ORR was 50.0% and median OS was 10.5 months (95% CI, 7.9 to 13.1 months). Patients showing objective responses had a 4.2-month median PFS gain and 5.7-month median OS gain compared with those who did not (P < 0.05). Grade 3 or 4 adverse events occurring in more than one patient were neutropenia (53/69, 76.8%), leukopenia (36/69, 52.2%), thrombocytopenia (13/69, 18.8%), anemia (3/69, 4.3%) and hypertension (3/69, 4.3%). Conclusions Adding bevacizumab to modified FOLFOX6 does have significant anti-tumor activity and good safety profile in heavily pretreated HER2/neu-negative MBC patients. Further trials are required to confirm whether the high ORR can translate into a long-term PFS and even OS benefit.	[Li, Ting; Wang, Biyun; Wang, Zhonghua; Zhang, Jian; Sun, Si; Cao, Jun; Lv, Fangfang; Zhang, Sheng; Ni, Chen; Wu, Zhenhua; Xie, Jie; Hu, Xichun] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200032, Peoples R China; [Li, Ting; Wang, Biyun; Wang, Zhonghua; Zhang, Jian; Sun, Si; Cao, Jun; Lv, Fangfang; Wang, Leiping; Zhang, Sheng; Ni, Chen; Wu, Zhenhua; Xie, Jie; Hu, Xichun] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Ragaz, Joseph] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z4, Canada	Fudan University; Fudan University; University of British Columbia	Hu, XC (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200032, Peoples R China.	huxicun@gmail.com			Natural Science Foundation of China [81372846]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This is an investigator-initiated clinical trial (IIT). All of the work including study design, running of the trial and data collection was done by the investigators. The cost for protocol review and revision as well as statistics came from the grant of Natural Science Foundation of China (grant number: 81372846; the URL: http://www.nsfc.gov.cn/). The medical insurance for recruited patients in the trial was provided by the Fudan University Shanghai Cancer Center, the authors' institution. No financial support was from pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JS, 1995, J CLIN ONCOL, V13, P2056, DOI 10.1200/JCO.1995.13.8.2056; Allegra CJ, 2009, J CLIN ONCOL, V27, P3385, DOI 10.1200/JCO.2009.21.9220; Aogi K, 2012, ANN ONCOL, V23, P1441, DOI 10.1093/annonc/mdr444; Bagri A, 2010, CLIN CANCER RES, V16, P3887, DOI 10.1158/1078-0432.CCR-09-3100; Bear HD, 2012, NEW ENGL J MED, V366, P310, DOI 10.1056/NEJMoa1111097; Brufsky AM, 2011, J CLIN ONCOL, V29, P4286, DOI 10.1200/JCO.2010.34.1255; Chia SK, 2007, CANCER, V110, P973, DOI 10.1002/cncr.22867; Choueiri TK, 2011, J CLIN ONCOL, V29, P632, DOI 10.1200/JCO.2010.31.9129; Cortes J, 2012, EUR J CANCER, V48, P475, DOI 10.1016/j.ejca.2011.11.021; Cortes J, 2010, J CLIN ONCOL, V28, P3922, DOI 10.1200/JCO.2009.25.8467; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fan MH, 2014, BREAST CANCER RES TR, V143, P141, DOI 10.1007/s10549-013-2793-6; Fumoleau P, 2009, AM J CLIN ONCOL-CANC, V32, P375, DOI 10.1097/COC.0b013e31818f2d2f; Garufi C, 2001, ANN ONCOL, V12, P179, DOI 10.1023/A:1008386419047; Geiger-Gritsch S, 2010, ONCOLOGIST, V15, P1179, DOI 10.1634/theoncologist.2009-0155; Gligorov J, 2014, LANCET ONCOL, V15, P1351, DOI 10.1016/S1470-2045(14)70444-9; Hochster HS, 2008, J CLIN ONCOL, V26, P3523, DOI 10.1200/JCO.2007.15.4138; Hu XC, 2014, INT J CANCER, V135, P1961, DOI 10.1002/ijc.28829; Huang HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089960; Izzedine H, 2010, EUR J CANCER, V46, P439, DOI 10.1016/j.ejca.2009.11.001; Khoja L, 2014, J CLIN GASTROENTEROL, V48, P430, DOI 10.1097/MCG.0b013e3182a8804c; Lang I, 2013, LANCET ONCOL, V14, P125, DOI 10.1016/S1470-2045(12)70566-1; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Miller K, 2014, J CLIN ONCOL S, V32, p5s; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Mir O, 2011, ONCOLOGIST, V16, P1325, DOI 10.1634/theoncologist.2010-0002; Modi Shanu, 2005, Clin Breast Cancer, V6, P55, DOI 10.3816/CBC.2005.n.009; National Comprehensive Cancer Network (NCCN), 2015, NCCN CLIN PRACT GUID; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pectasides D, 2003, ANN ONCOL, V14, P537, DOI 10.1093/annonc/mdg172; Polyzos A, 2011, CANCER CHEMOTH PHARM, V68, P217, DOI 10.1007/s00280-010-1475-x; Rha SU, 2005, BREAST CANCER RES TR, V90, P215, DOI 10.1007/s10549-004-2468-4; Rivera E, 2000, CANCER, V89, P2195, DOI 10.1002/1097-0142(20001201)89:11<2195::AID-CNCR7>3.0.CO;2-W; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; Rugo HS, 2012, J CLIN ONCOL, V30, DOI 10.1200/jco.2012.30.27_suppl.75; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Scartozzi M, 2009, ANN ONCOL, V20, P227, DOI 10.1093/annonc/mdn637; Schmoll HJ, 2012, J CLIN ONCOL, V30, P3588, DOI 10.1200/JCO.2012.42.5355; Schneider BP, 2013, CLIN CANCER RES, V19, P1281, DOI 10.1158/1078-0432.CCR-12-3029; Seo HY, 2011, INVEST NEW DRUG, V29, P360, DOI 10.1007/s10637-009-9357-y; Sikov WM, 2015, J CLIN ONCOL, V33, P13, DOI 10.1200/JCO.2014.57.0572; Smorenburg CH, 2001, BREAST CANCER RES TR, V66, P83, DOI 10.1023/A:1010679127390; SPSS Inc, 2010, IBM SPSS ADVANCED ST; Sun S, 2012, MED ONCOL, V29, P418, DOI 10.1007/s12032-011-9839-6; US Department Of Health nd Human Services National Institutes of Health National Cancer Institute, 2010, COMM TERM CRIT ADV E; Vaziri SAJ, 2010, CURR ONCOL REP, V12, P102, DOI 10.1007/s11912-010-0085-4; von Minckwitz G, 2014, LANCET ONCOL, V15, P1269, DOI 10.1016/S1470-2045(14)70439-5; von Minckwitz G, 2012, NEW ENGL J MED, V366, P299, DOI 10.1056/NEJMoa1111065; Yamada Y, 2013, LANCET ONCOL, V14, P1278, DOI 10.1016/S1470-2045(13)70490-X; Zelek L, 2002, J CLIN ONCOL, V20, P2551, DOI 10.1200/JCO.2002.06.164	51	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133133	10.1371/journal.pone.0133133	http://dx.doi.org/10.1371/journal.pone.0133133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186012	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700097
J	Oliveira, HC; Stolf-Moreira, R; Martinez, CBR; Grillo, R; de Jesus, MB; Fraceto, LF				Oliveira, Halley Caixeta; Stolf-Moreira, Renata; Reis Martinez, Claudia Bueno; Grillo, Renato; de Jesus, Marcelo Bispo; Fraceto, Leonardo Fernandes			Nanoencapsulation Enhances the Post-Emergence Herbicidal Activity of Atrazine against Mustard Plants	PLOS ONE			English	Article							NANOPARTICLES; PROTECTION; RELEASE; DAMAGE	Poly(epsilon-caprolactone) (PCL) nanocapsules have been recently developed as a modified release system for atrazine, an herbicide that can have harmful effects in the environment. Here, the post-emergence herbicidal activity of PCL nanocapsules containing atrazine was evaluated using mustard (Brassica juncea) as target plant species model. Characterization of atrazine-loaded PCL nanocapsules by nanoparticle tracking analysis indicated a concentration of 7.5 x 10(12) particles mL(-1) and an average size distribution of 240.7 nm. The treatment of mustard plants with nanocapsules carrying atrazine at 1 mg mL(-1) resulted in a decrease of net photosynthesis and PSII maximum quantum yield, and an increase of leaf lipid peroxidation, leading to shoot growth inhibition and the development of severe symptoms. Time course analysis until 72 h after treatments showed that nanoencapsulation of atrazine enhanced the herbicidal activity in comparison with a commercial atrazine formulation. In contrast to the commercial formulation, ten-fold dilution of the atrazine-containing nanocapsules did not compromise the herbicidal activity. No effects were observed when plants were treated with nanocapsules without herbicide compared to control leaves sprayed with water. Overall, these results demonstrated that atrazine-containing PCL nanocapsules provide very effective post-emergence herbicidal activity. More importantly, the use of nanoencapsulated atrazine enables the application of lower dosages of the herbicide, without any loss of efficiency, which could provide environmental benefits.	[Oliveira, Halley Caixeta; Stolf-Moreira, Renata] UEL Univ Londrina, Dept Anim & Plant Biol, Londrina, Parana, Brazil; [Reis Martinez, Claudia Bueno] UEL Univ Londrina, Dept Physiol Sci, Londrina, Parana, Brazil; [Grillo, Renato; Fraceto, Leonardo Fernandes] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Biochem, Campinas, SP, Brazil; [Grillo, Renato; Fraceto, Leonardo Fernandes] Univ Estadual Paulista, UNESP, Dept Environm Engn, Sorocaba, SP, Brazil; [de Jesus, Marcelo Bispo] Univ Estadual Campinas, UNICAMP, Inst Biol, Nanocell Interact Lab, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas	Oliveira, HC (corresponding author), UEL Univ Londrina, Dept Anim & Plant Biol, Londrina, Parana, Brazil.	halley@uel.br; leonardo@sorocaba.unesp.br	Grillo, Renato/H-6532-2013; Fraceto, Leonardo/C-4468-2012; Oliveira, Halley C/I-8539-2012; de Jesus, Marcelo Bispo/C-6736-2013; Fraceto, Leonardo Fernandes/ABF-2797-2021; Moreira, Renata Stolf/Q-4776-2019	Grillo, Renato/0000-0002-0284-5782; Oliveira, Halley C/0000-0002-5487-4964; de Jesus, Marcelo Bispo/0000-0003-0812-1491; Fraceto, Leonardo Fernandes/0000-0002-2827-2038; Moreira, Renata Stolf/0000-0002-3146-7848	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/12322-2, 2011/01872-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundunesp; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; CBRM: INCT-TA/CNPq [573949/2008-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundunesp; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CBRM: INCT-TA/CNPq	This work was supported by the following sources of funding. LFF: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2013/12322-2), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundunesp and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. RG: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2011/01872-6), CBRM: INCT-TA/CNPq (573949/2008-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortoluzzi Edson C., 2006, Rev. bras. eng. agríc. ambient., V10, P881, DOI 10.1590/S1415-43662006000400015; Brain RA, 2012, ECOTOX ENVIRON SAFE, V79, P55, DOI 10.1016/j.ecoenv.2011.12.001; Camejo G, 1998, Methods Mol Biol, V108, P377; CAMPOS EVR, 2014, ADV SCI ENG MED, V6, P1, DOI DOI 10.1166/ASEM.2014.1538; Chen HD, 2011, TRENDS FOOD SCI TECH, V22, P585, DOI 10.1016/j.tifs.2011.09.004; Clemente Z, 2014, J NANOSCI NANOTECHNO, V14, P4911, DOI 10.1166/jnn.2014.8681; Dalton RL, 2010, ENVIRON TOXICOL CHEM, V29, P2304, DOI 10.1002/etc.277; de Oliveira JL, 2015, J AGR FOOD CHEM, V63, P422, DOI 10.1021/jf5059045; Gammon DW, 2005, PEST MANAG SCI, V61, P331, DOI 10.1002/ps.1000; Ghormade V, 2011, BIOTECHNOL ADV, V29, P792, DOI 10.1016/j.biotechadv.2011.06.007; Graymore M, 2001, ENVIRON INT, V26, P483, DOI 10.1016/S0160-4120(01)00031-9; Grillo R, 2014, J HAZARD MATER, V278, P163, DOI 10.1016/j.jhazmat.2014.05.079; Grillo R, 2012, J HAZARD MATER, V231, P1, DOI 10.1016/j.jhazmat.2012.06.019; Grillo R, 2010, J POLYM ENVIRON, V18, P26, DOI 10.1007/s10924-009-0153-8; Guillette LJ, 2012, SCIENCE, V337, P1614, DOI 10.1126/science.1226985; Hess FD, 2000, WEED SCI, V48, P160, DOI 10.1614/0043-1745(2000)048[0160:LDHAO]2.0.CO;2; Hoagland D. R., 1950, CALIFORNIA AGR EXPT, P347; Kah M, 2013, CRIT REV ENV SCI TEC, V43, P1823, DOI 10.1080/10643389.2012.671750; Kah M, 2014, ENVIRON INT, V63, P224, DOI 10.1016/j.envint.2013.11.015; Khot LR, 2012, CROP PROT, V35, P64, DOI 10.1016/j.cropro.2012.01.007; Kumar S, 2014, CARBOHYD POLYM, V101, P1061, DOI 10.1016/j.carbpol.2013.10.025; Rondina ABL, 2014, J TROP ECOL, V30, P599, DOI 10.1017/S0266467414000509; Murchie EH, 2013, J EXP BOT, V64, P3983, DOI 10.1093/jxb/ert208; Namasivayam SKR, 2014, RES J BIOTECHNOL, V9, P19; Pereira AES, 2014, J HAZARD MATER, V268, P207, DOI 10.1016/j.jhazmat.2014.01.025; Quina FH, 2004, QUIM NOVA, V27, P1028, DOI 10.1590/S0100-40422004000600031; RODRIGUES BN, 2011, GUIA HERBICIDAS; Roy A, 2014, CENT EUR J CHEM, V12, P453, DOI 10.2478/s11532-013-0405-2; Santos TG, 2012, CHEMOSPHERE, V89, P1118, DOI 10.1016/j.chemosphere.2012.05.096; Vitor SC, 2013, PLANTA, V238, P475, DOI 10.1007/s00425-013-1906-0; Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002	31	40	40	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132971	10.1371/journal.pone.0132971	http://dx.doi.org/10.1371/journal.pone.0132971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186597	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700078
J	Onushko, T; Schmit, BD; Hyngstrom, A				Onushko, Tanya; Schmit, Brian D.; Hyngstrom, Allison			The Effect of Antagonist Muscle Sensory Input on Force Regulation	PLOS ONE			English	Article							CONSTANT ISOMETRIC CONTRACTIONS; ELBOW FLEXOR MUSCLES; SPINAL-CORD-INJURY; PRESYNAPTIC INHIBITION; VOLUNTARY MOVEMENT; HOFFMANN REFLEX; LOWER-EXTREMITY; GREATER AMOUNT; OLDER-ADULTS; H-REFLEX	The purpose of this study was to understand how stretch-related sensory feedback from an antagonist muscle affects agonist muscle output at different contraction levels in healthy adults. Ten young (25.3 +/- 2.4 years), healthy subjects performed constant isometric knee flexion contractions (agonist) at 6 torque levels: 5%, 10%, 15%, 20%, 30%, and 40% of their maximal voluntary contraction. For half of the trials, subjects received patellar tendon taps (antagonist sensory feedback) during the contraction. We compared error in targeted knee flexion torque and hamstring muscle activity, with and without patellar tendon tapping, across the 6 torque levels. At lower torque levels (5%, 10%, and 15%), subjects produced greater knee torque error following tendon tapping compared with the same torque levels without tendon tapping. In contrast, we did not find any difference in torque output at higher target levels (20%, 30%, and 40%) between trials with and without tendon tapping. We also observed a load-dependent increase in the magnitude of agonist muscle activity after tendon taps, with no associated load-dependent increase in agonist and antagonist co-activation, or reflex inhibition from the antagonist tapping. The findings suggest that at relatively low muscle activity there is a deficiency in the ability to correct motor output after sensory disturbances, and cortical centers (versus sub-cortical) are likely involved.	[Onushko, Tanya; Schmit, Brian D.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA; [Hyngstrom, Allison] Marquette Univ, Dept Phys Therapy, Milwaukee, WI 53233 USA	Marquette University; Marquette University	Hyngstrom, A (corresponding author), Marquette Univ, Dept Phys Therapy, Milwaukee, WI 53233 USA.	allison.hyngstrom@marquette.edu			National Center for Advancing Translational Sciences, National Institutes of Health [8KL2TR000056]	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This publication [or project] was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number 8KL2TR000056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimonetti JM, 2000, EXP BRAIN RES, V133, P391, DOI 10.1007/s002210000423; Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P705, DOI 10.1007/s00167-009-0813-1; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; Baweja HS, 2012, EXP BRAIN RES, V222, P355, DOI 10.1007/s00221-012-3219-0; Baweja HS, 2010, EUR J APPL PHYSIOL, V108, P935, DOI 10.1007/s00421-009-1301-5; Baweja HS, 2009, EXP BRAIN RES, V197, P35, DOI 10.1007/s00221-009-1883-5; Billot M, 2011, SCAND J MED SCI SPOR, V21, pE273, DOI 10.1111/j.1600-0838.2010.01278.x; Billot M, 2014, AGE, V36, P899, DOI 10.1007/s11357-014-9616-5; Brown P, 2000, PROG NEUROBIOL, V60, P97, DOI 10.1016/S0301-0082(99)00029-5; Buckthorpe M, 2014, EXP PHYSIOL, V99, P964, DOI 10.1113/expphysiol.2013.075614; Buckthorpe MW, 2012, MUSCLE NERVE, V46, P566, DOI 10.1002/mus.23322; Chen YT, 2012, EXP GERONTOL, V47, P519, DOI 10.1016/j.exger.2012.04.007; Christou EA, 2003, J MOTOR BEHAV, V35, P322, DOI 10.1080/00222890309603153; Chu VW, 2015, CLIN NEUROPHYSIOL, V126, P372, DOI 10.1016/j.clinph.2014.06.047; Crone C, 2003, BRAIN, V126, P495, DOI 10.1093/brain/awg036; FARMER SF, 1993, J PHYSIOL-LONDON, V470, P127, DOI 10.1113/jphysiol.1993.sp019851; Grunte I, 2010, GERONTOLOGY, V56, P533, DOI 10.1159/000311935; Hagbarth KE, 1995, ADV EXP MED BIOL, V384, P259; HULTBORN H, 1987, J PHYSIOL-LONDON, V389, P757, DOI 10.1113/jphysiol.1987.sp016681; Hyngstrom AS, 2014, MUSCLE NERVE, V49, P225, DOI 10.1002/mus.23886; Jankowska E, 2001, J PHYSIOL-LONDON, V533, P31, DOI 10.1111/j.1469-7793.2001.0031b.x; JONES LA, 1985, EXP NEUROL, V87, P35, DOI 10.1016/0014-4886(85)90131-1; Kennedy DM, 2011, EXP BRAIN RES, V213, P351, DOI 10.1007/s00221-011-2777-x; Krishnan C, 2011, MUSCLE NERVE, V43, P563, DOI 10.1002/mus.21981; KUDINA L P, 1976, Neirofiziologiya, V8, P624; Lodha N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083468; Lodha N, 2010, CLIN NEUROPHYSIOL, V121, P1952, DOI 10.1016/j.clinph.2010.04.005; Matthews P. B. C., 1972, MAMMALIAN MUSCLE REC; Misiaszek JE, 2003, MUSCLE NERVE, V28, P144, DOI 10.1002/mus.10372; Morita H, 2001, BRAIN, V124, P826, DOI 10.1093/brain/124.4.826; Nielsen JB, 2004, J APPL PHYSIOL, V96, P1961, DOI 10.1152/japplphysiol.01073.2003; Onushko T, 2007, J NEUROPHYSIOL, V98, P1849, DOI 10.1152/jn.00461.2007; Palmieri RM, 2004, J ATHL TRAINING, V39, P268; Pereira HM, 2015, EUR J APPL PHYSIOL, V115, P1367, DOI 10.1007/s00421-015-3113-0; Rudroff T, 2010, EXP BRAIN RES, V203, P307, DOI 10.1007/s00221-010-2233-3; Salenius S, 1997, J NEUROPHYSIOL, V77, P3401, DOI 10.1152/jn.1997.77.6.3401; Simonsen EB, 1999, J PHYSIOL-LONDON, V515, P929, DOI 10.1111/j.1469-7793.1999.929ab.x; Taylor AM, 2003, J NEUROPHYSIOL, V90, P1350, DOI 10.1152/jn.00056.2003; THOMPSON S, 1990, EXP BRAIN RES, V79, P365, DOI 10.1007/BF00608246; Tracy BL, 2007, EXP BRAIN RES, V176, P448, DOI 10.1007/s00221-006-0631-3; Tracy BL, 2007, MED SCI SPORT EXER, V39, P469, DOI 10.1249/mss.0b013e31802d3ad3; Voerman GE, 2005, DISABIL REHABIL, V27, P33, DOI 10.1080/09638280400014600	42	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133561	10.1371/journal.pone.0133561	http://dx.doi.org/10.1371/journal.pone.0133561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186590	Green Submitted, gold, Green Published			2022-12-27	WOS:000358198700158
J	Shehadeh, A; Loots, G; Vanderfaeillie, J; Derluyn, I				Shehadeh, Amer; Loots, Gerrit; Vanderfaeillie, Johan; Derluyn, Ilse			The Impact of Parental Detention on the Psychological Wellbeing of Palestinian Children	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE; MENTAL-HEALTH; WAR; INCARCERATION; STRENGTHS; SYMPTOMS; DISTRESS; FAMILIES; EXPOSURE; TRAUMA	Background Since 1967, the Palestinian Occupied Territories are marked by a political conflict between Palestinians and Israel. During this conflict, about one fifth of the Palestinian population has been detained; about one quarter of these are parents. Although we know that father's incarceration might impact their children's psychological wellbeing, little is known about the impact of father's imprisonment on young children (under 11 years old), and when the incarceration is framed in contexts of political conflict. Therefore, this study aimed at gaining insight into the impact of parental detention on young children's psychological wellbeing, and the impact of witnessing the detention process itself. Methods Based on the list of imprisoned Palestinian men with children living in the West Bank, a group of 79 (3- to 10-years old) children was randomly composed. Above, through schools and health centers, a comparison sample of 99 children who didn't experience imprisonment of a family member was selected. Mothers of these children completed two cross-culturally validated questionnaires on their children's psychological wellbeing, the UCLA-PTSD-Index and the Strength and Difficulties Questionnaire (SDQ). Results Results showed higher levels of PTSD and general mental health problems associated with father's capturing. Above, when the children watched the arrest process of their fathers, scores still increased further. Younger children tended to show higher SDQ scores, and children living in villages reported higher posttraumatic stress scores compared to children living in urban areas or refugee camps. Little gender differences were found. Conclusion This study shows the important impact of parental detention on the psychological wellbeing for young children and urges for more psychological care and support for family members in particular children - of detainees.	[Shehadeh, Amer; Loots, Gerrit] Vrije Univ Brussel, Res Grp Interpersonal Discurs & Narrat Studies ID, Brussels, Belgium; [Shehadeh, Amer; Loots, Gerrit] Vrije Univ Brussel, CCVS, Brussels, Belgium; [Shehadeh, Amer] Directorate Educ, Minist Educ, Bethlehem, Palestine; [Loots, Gerrit] Univ Catolica Boliviana San Pablo La Paz, IICC, Dept Psicol, La Paz, Bolivia; [Vanderfaeillie, Johan] Vrije Univ Brussel, Dept Clin & Lifespan Psychol, Brussels, Belgium; [Derluyn, Ilse] Univ Ghent, Dept Social Welf Studies, B-9000 Ghent, Belgium; [Derluyn, Ilse] Univ Ghent, Ctr Children Vulnerable Situat, B-9000 Ghent, Belgium	Vrije Universiteit Brussel; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Ghent University; Ghent University	Shehadeh, A (corresponding author), Vrije Univ Brussel, Res Grp Interpersonal Discurs & Narrat Studies ID, Brussels, Belgium.	amershehadeh2008@yahoo.com	Wilson, Gregory/AAA-9035-2021	Derluyn, Ilse/0000-0001-5450-1239; Loots, VUB/0000-0001-5015-9202; Vanderfaeillie, Johan/0000-0002-1504-1185	Erasmus Mundus External Cooperation Window (EM ECW) [2010-5000 - 001-001-EMA2]	Erasmus Mundus External Cooperation Window (EM ECW)	This work was financially supported by the framework of the Erasmus Mundus External Cooperation Window (EM ECW) under the terms of the Grant Agreement nr 2010-5000 - 001-001-EMA2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen Z, 2008, INT J BEHAV DEV, V32, P290, DOI 10.1177/0165025408092220; Addameer, 2011, PAL PRIS ISR PRIS SU; [Anonymous], 2002, HOWARD J, DOI DOI 10.1111/1468-2311.00222; Arditti JA, 2005, FAM SOC, V86, P251, DOI 10.1606/1044-3894.2460; Arditti JA, 2003, FAM RELAT, V52, P195, DOI 10.1111/j.1741-3729.2003.00195.x; B'Tselem, 2012, ISR INF CTR HUM RIGH; Comfort M, 2007, ANNU REV LAW SOC SCI, V3, P271, DOI 10.1146/annurev.lawsocsci.3.081806.112829; Dawson A, 2012, CHILD YOUTH SERV REV, V34, P2433, DOI 10.1016/j.childyouth.2012.09.003; El-Helah A, 2010, AM I NOT HUMAN BEING; Geller A, 2009, SOC SCI QUART, V90, P1186, DOI 10.1111/j.1540-6237.2009.00653.x; Genty P, 2002, FORDHAM URBAN LAW J, V30, P1671; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Hadi F, 2006, J TRAUMA STRESS, V19, P653, DOI 10.1002/jts.20153; Husain SA, 1998, AM J PSYCHIAT, V155, P1718, DOI 10.1176/ajp.155.12.1718; JENSEN PS, 1993, J AM ACAD CHILD PSY, V32, P697, DOI 10.1097/00004583-199307000-00001; Kinner SA, 2007, J CHILD PSYCHOL PSYC, V48, P1148, DOI 10.1111/j.1469-7610.2007.01785.x; Laor N, 2001, AM J PSYCHIAT, V158, P1020, DOI 10.1176/appi.ajp.158.7.1020; Llabre MM, 1997, J CLIN CHILD PSYCHOL, V26, P247, DOI 10.1207/s15374424jccp2603_3; Malone PS, 2004, STRUCT EQU MODELING, V11, P401, DOI 10.1207/s15328007sem1103_6; Massad S, 2009, CHILD ADOL MENT H-UK, V14, P89, DOI 10.1111/j.1475-3588.2009.00528.x; Miller KM, 2006, CHILD ADOLESC SOC WO, V23, P472, DOI 10.1007/s10560-006-0065-6; Miller T, 1999, Med Confl Surviv, V15, P368, DOI 10.1080/13623699908409478; Murray J., 2005, EFFECTS IMPRISONMENT, P442, DOI DOI 10.4324/; Nolan C, 2003, CHILDREN ARRESTED PA; Prisoners Support and Human Rights Association, 2011, EXT REP PAL DET ISR, P2; Rodriguez N, 1999, UCLA PTSD INDEX DSM, V5; Rosenberg J, 2009, HUMAN RIGHTS REFUGEE, P1; Sack W.H., 1978, LAW HUMAN BEHAV, V2, P261, DOI [DOI 10.1007/BF01039083, https://doi.org/10.1007/BF01039083]; Sherman LW, 2005, J EXPT CRIMINOLOGY, V1, P367, DOI [10.1007/s11292-005-8126-y, DOI 10.1007/S11292-005-8126-Y]; Smith P, 2001, J CHILD PSYCHOL PSYC, V42, P395, DOI 10.1017/S0021963001007065; Steinberg Alan M, 2004, Curr Psychiatry Rep, V6, P96, DOI 10.1007/s11920-004-0048-2; Thabet AA, 2008, EUR CHILD ADOLES PSY, V17, P191, DOI 10.1007/s00787-007-0653-9; Thabet A. A., 2001, Eastern Mediterranean Health Journal, V7, P413; Thabet A. A., 2006, PROTECTION CHILDREN, P123; Thabet A. M., 2010, Eastern Mediterranean Health Journal, V16, P505; Thabet AA, 2000, INT J SOC PSYCHIATR, V46, P266, DOI 10.1177/002076400004600404; Thabet AAM, 2004, J CHILD PSYCHOL PSYC, V45, P533, DOI 10.1111/j.1469-7610.2004.00243.x; Thabet Abdelazis, 2013, HEALTH-LONDON, V5, P994, DOI DOI 10.4236/HEALTH.2013.56132; Thabet AZ, 2000, CHILD ABUSE NEGLECT, V24, P291, DOI 10.1016/S0145-2134(99)00127-1; The Ministry of Detainees and Ex-Detainees Affairs, 2012, MIN DET EX DE DET AF; Udwin O, 2000, J CHILD PSYCHOL PSYC, V41, P969, DOI 10.1111/1469-7610.00685; Wilbur MB, 2007, PEDIATRICS, V120, pE678, DOI 10.1542/peds.2006-2166; Wildeman C, 2009, DEMOGRAPHY, V46, P265, DOI 10.1353/dem.0.0052	44	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133347	10.1371/journal.pone.0133347	http://dx.doi.org/10.1371/journal.pone.0133347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186687	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700127
J	Kolko, M; Horwitz, A; Thygesen, J; Jeppesen, J; Torp-Pedersen, C				Kolko, Miriam; Horwitz, Anna; Thygesen, John; Jeppesen, Jorgen; Torp-Pedersen, Christian			The Prevalence and Incidence of Glaucoma in Denmark in a Fifteen Year Period: A Nationwide Study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; EYE; TRENDS; TRIAL	Purpose The purpose of the present study was to describe the prevalence, incidence and geographic variation of glaucoma in Denmark in the period from 1996 to 2011. Moreover, the aim was to identify the treatment patterns of glaucoma within the studied period. Methods All Danish citizens were included throughout the study period. The National Prescription Registry was used to identify all claimed prescriptions for glaucoma medication. Results A total of 116,592 incident glaucoma patients were identified. Average age at onset was 66 years (range: 0-105 years), 55% were women. The prevalence of glaucoma increased from 0.79% to 1.72% during the investigated period. In 2011 glaucoma affected 3.76% of the population above 50 years and 10% in patients above 80 years. The age-specific incidence rate of glaucoma seemed to be constant and the increasing prevalence was primarily attributed to an aging population. We found the highest prevalence of glaucoma in the capital region of Denmark. Within the studied period the use of prostaglandin analogs and combination drugs increased, whereas the use of beta-blockers, carbon anhydrase inhibitors and parasympathomimetic drugs decreased (p<0.001). Finally, the use of alpha 2-adrenergic agonists remained unchanged. A total of 75% of the patients were treated with two or more glaucoma medications. Conclusions Over all, the present study is the first to assess the frequency and the development of glaucoma in Denmark over a 15-year period. We find that glaucoma affects a little less than 2% of the total population and increases with age to reach a prevalence of more than 10% amongst people above 80 years. Generally, the present study is the largest nation-wide study ever made and must be a close-to-real-life-picture of the utilization of glaucoma medication on a national scale. Our findings confirm other recent estimations on an increasing burden of glaucoma globally.	[Kolko, Miriam] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Kolko, Miriam; Horwitz, Anna] Roskilde Univ Hosp, Dept Ophthalmol, Roskilde, Denmark; [Kolko, Miriam] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Thygesen, John] Univ Copenhagen, Glostrup Hosp, Dept Ophthalmol, Glostrup, Denmark; [Jeppesen, Jorgen] Univ Copenhagen, Glostrup Hosp, Dept Cardiol, Glostrup, Denmark; [Torp-Pedersen, Christian] Aalborg Univ Hosp, Dept Hlth Sci & Technol, Aalborg, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Aalborg University; Aalborg University Hospital	Kolko, M (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	mkolko@dadlnet.dk	Thygesen, John/AAG-8403-2020	Kolko, Miriam/0000-0001-8697-0734				Blumenthal D, 2003, NEW ENGL J MED, V349, P2452, DOI 10.1056/NEJMhpr035460; CAIRNS JE, 1968, AM J OPHTHALMOL, V66, P673, DOI 10.1016/0002-9394(68)91288-9; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P350, DOI 10.1111/j.1442-9071.2011.02563.x; Connor AJ, 2014, EYE, V28, P863, DOI 10.1038/eye.2014.114; GOLDSCHMIDT E, 1989, ACTA OPHTHALMOL, V67, P204; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Heijl A, 2013, OPHTHALMOLOGY, V120, P1541, DOI 10.1016/j.ophtha.2013.01.043; Heijl A, 2009, OPHTHALMOLOGY, V116, P2271, DOI 10.1016/j.ophtha.2009.06.042; KATZ J, 1991, ARCH OPHTHALMOL-CHIC, V109, P1684, DOI 10.1001/archopht.1991.01080120068028; Lam BL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1345, DOI 10.1001/archophthalmol.2011.142; LESKE MC, 1994, ARCH OPHTHALMOL-CHIC, V112, P821, DOI 10.1001/archopht.1994.01090180121046; Lundberg L U, 2000, Ugeskr Laeger, V162, P3028; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Olsen J, 2013, ACTA OPHTHALMOL, V91, P25, DOI 10.1111/j.1755-3768.2011.02212.x; Razeghinejad MR, 2011, OPTOMETRY VISION SCI, V88, pE39, DOI 10.1097/OPX.0b013e3181fe2226; Realini T, 2011, OPTOMETRY VISION SCI, V88, P36, DOI 10.1097/OPX.0b013e3182058ead; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Topouzis F, 2007, AM J OPHTHALMOL, V144, P511, DOI 10.1016/j.ajo.2007.06.029; van der Valk R, 2005, OPHTHALMOLOGY, V112, P1177, DOI 10.1016/j.ophtha.2005.01.042	20	35	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132048	10.1371/journal.pone.0132048	http://dx.doi.org/10.1371/journal.pone.0132048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182236	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198200014
J	Bowyer, JF; Tranter, KM; Hanig, JP; Crabtree, NM; Schleimer, RP; George, NI				Bowyer, John F.; Tranter, Karen M.; Hanig, Joseph P.; Crabtree, Nathaniel M.; Schleimer, Robert P.; George, Nysia I.			Evaluating the Stability of RNA-Seq Transcriptome Profiles and Drug-Induced Immune-Related Expression Changes in Whole Blood	PLOS ONE			English	Article							GENE-EXPRESSION; DENDRITIC CELLS; INFLAMMATION; MOLECULES; DISEASE; HYPERTHERMIA; PATHOGENESIS; MACROPHAGES; ACTIVATION; MECHANISMS	Methods were developed to evaluate the stability of rat whole blood expression obtained from RNA sequencing (RNA-seq) and assess changes in whole blood transcriptome profiles in experiments replicated over time. Expression was measured in globin-depleted RNA extracted from the whole blood of Sprague-Dawley rats, given either saline (control) or neurotoxic doses of amphetamine (AMPH). The experiment was repeated four times (paired control and AMPH groups) over a 2-year span. The transcriptome of the control and AMPH-treated groups was evaluated on: 1) transcript levels for ribosomal protein subunits; 2) relative expression of immune-related genes; 3) stability of the control transcriptome over 2 years; and 4) stability of the effects of AMPH on immune-related genes over 2 years. All, except one, of the 70 genes that encode the 80s ribosome had levels that ranked in the top 5% of all mean expression levels. Deviations in sequencing performance led to significant changes in the ribosomal transcripts. The overall expression profile of immune-related genes and genes specific to monocytes, T-cells or B-cells were well represented and consistent within treatment groups. There were no differences between the levels of ribosomal transcripts in time-matched control and AMPH groups but significant differences in the expression of immune-related genes between control and AMPH groups. AMPH significantly increased expression of some genes related to monocytes but down-regulated those specific to T-cells. These changes were partially due to changes in the two types of leukocytes present in blood, which indicate an activation of the innate immune system by AMPH. Thus, the stability of RNA-seq whole blood transcriptome can be verified by assessing ribosomal protein subunits and immune-related gene expression. Such stability enables the pooling of samples from replicate experiments to carry out differential expression analysis with acceptable power.	[Bowyer, John F.; Tranter, Karen M.; Crabtree, Nathaniel M.] US FDA, Natl Ctr Toxicol Res, Div Neurotoxicol, Jefferson, AR 72079 USA; [George, Nysia I.] US FDA, Natl Ctr Toxicol Res, Div Bioinformat & Biostat, Jefferson, AR 72079 USA; [Hanig, Joseph P.] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Schleimer, Robert P.] Northwestern Feinberg Sch Med, Div Allergy & Immunol, Chicago, IL USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Northwestern University; Feinberg School of Medicine	Bowyer, JF (corresponding author), US FDA, Natl Ctr Toxicol Res, Div Neurotoxicol, Jefferson, AR 72079 USA.	john.bowyer@fda.hhs.gov			NCTR/FDA [E7295, E7519]; National Institute of General Medical Sciences under the Institutional Development Award (IDeA) Program of the National Institutes of Health (NIH); NIH [R37HL068546, R01HL078860, U19AI106683]; Ernest S. Bazley Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL068546, R01HL078860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI106683] Funding Source: NIH RePORTER	NCTR/FDA; National Institute of General Medical Sciences under the Institutional Development Award (IDeA) Program of the National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ernest S. Bazley Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research animals, their housing and reagents were funded under NCTR/FDA protocols E7295 and E7519. Nathan Crabtree is a graduate student in Bioinformatics, Department of Information Science, at the University of Arkansas Little Rock and his research is supported by E7519 and Arkansas IDeA Network of Biomedical Research Excellence (Arkansas INBRE) which received funds from the National Institute of General Medical Sciences under the Institutional Development Award (IDeA) Program of the National Institutes of Health (NIH). Dr. Schleimer was supported by NIH grants R37HL068546, R01HL078860 and U19AI106683 from the NIH and by the Ernest S. Bazley Foundation.	Akira S, 2013, DIABETES OBES METAB, V15, P10, DOI 10.1111/dom.12151; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Bellinger DL, 2014, AUTON NEUROSCI-BASIC, V182, P15, DOI 10.1016/j.autneu.2014.01.006; BIERER BE, 1988, FASEB J, V2, P2584, DOI 10.1096/fasebj.2.10.2838364; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Boles KS, 2001, IMMUNOL REV, V181, P234, DOI 10.1034/j.1600-065X.2001.1810120.x; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Bowyer JF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-147; Bowyer JF, 2008, ANN NY ACAD SCI, V1139, P127, DOI 10.1196/annals.1432.005; Broderick G, 2013, BRAIN BEHAV IMMUN, V28, P159, DOI 10.1016/j.bbi.2012.11.007; Brouard S, 2007, P NATL ACAD SCI USA, V104, P15448, DOI 10.1073/pnas.0705834104; Cai JH, 2007, BIOTECHNIQUES, V42, P503, DOI 10.2144/000112400; COOK DN, 1995, SCIENCE, V269, P1583, DOI 10.1126/science.7667639; Di Santo JP, 2014, IMMUNOL REV, V261, P169, DOI 10.1111/imr.12202; Dorr C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125045; FELTEN DL, 1987, IMMUNOL REV, V100, P225, DOI 10.1111/j.1600-065X.1987.tb00534.x; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; George NI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125224; George NI, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-92; Hendgen-Cotta UB, 2010, J EXP BIOL, V213, P2734, DOI 10.1242/jeb.041178; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kam SHY, 2012, J ASTHMA, V49, P219, DOI 10.3109/02770903.2011.654300; Kim Y, 2013, PSYCHIAT RES, V210, P287, DOI 10.1016/j.psychres.2013.05.026; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Krause SW, 2000, BIOCHEM J, V346, P729, DOI 10.1042/0264-6021:3460729; Kupfer DM, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-26; Lauvau G, 2014, CELL IMMUNOL, V291, P32, DOI 10.1016/j.cellimm.2014.07.007; Lehning EJ, 2002, NEUROTOXICOLOGY, V23, P397, DOI 10.1016/S0161-813X(02)00083-9; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li S, 2014, NAT BIOTECHNOL, V32, P915, DOI 10.1038/nbt.2972; Locke BA, 2014, CLIN REV ALLERG IMMU, V46, P154, DOI 10.1007/s12016-014-8412-4; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mahajan SD, 2006, MOL DIAGN THER, V10, P257, DOI 10.1007/BF03256465; Mansson R, 2012, P NATL ACAD SCI USA, V109, P21028, DOI 10.1073/pnas.1211427109; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martinez-Beamonte R, 2011, J BIOTECHNOL, V151, P325, DOI 10.1016/j.jbiotec.2010.12.017; Mastrokolias A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-28; Menard-Katcher C, 2014, DIGEST DIS, V32, P102, DOI 10.1159/000357295; Merzaban JS, 2011, BLOOD, V118, P1774, DOI 10.1182/blood-2010-11-320705; Mirantes C, 2014, EXP CELL RES; MIYAKE K, 1995, J IMMUNOL, V154, P3333; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; MORETTA A, 1989, IMMUNOL REV, V111, P145, DOI 10.1111/j.1600-065X.1989.tb00545.x; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; O'Loughlin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-250; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Rabinovitch M, 2014, CIRC RES, V115, P165, DOI 10.1161/CIRCRESAHA.113.301141; Raghavachari N, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-28; Raghavachari N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006484; Safaee M, 2013, INT J ONCOL, V43, P1343, DOI 10.3892/ijo.2013.2075; Sheridan C, 2014, NAT BIOTECHNOL, V32, P111, DOI [10.1038/nbt0214-115a, 10.1038/nbt0214-111]; Shin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091041; Sigal LH, 2012, JCR-J CLIN RHEUMATOL, V18, P443, DOI 10.1097/RHU.0b013e31827732f1; Signorelli SS, 2014, INT J MOL MED, V33, P777, DOI 10.3892/ijmm.2014.1657; SONSALLA PK, 1989, SCIENCE, V243, P398, DOI 10.1126/science.2563176; Subrahmanyam YVBK, 2001, BLOOD, V97, P2457, DOI 10.1182/blood.V97.8.2457; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visconti L, 2014, BIOMARK MED, V8, P297, DOI 10.2217/bmm.13.122; Wiseman S, 2014, CEREBROVASC DIS, V37, P64, DOI 10.1159/000356789; Wu DD, 2014, J ASTHMA, V51, P847, DOI 10.3109/02770903.2014.917659; Yusupova G, 2014, ANNU REV BIOCHEM, V83, P467, DOI 10.1146/annurev-biochem-060713-035445; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	66	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133315	10.1371/journal.pone.0133315	http://dx.doi.org/10.1371/journal.pone.0133315			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177368	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600241
J	Chen, JQ; Zheng, FZ; Guo, RX				Chen, Jianqiu; Zheng, Fengzhu; Guo, Ruixin			Algal Feedback and Removal Efficiency in a Sequencing Batch Reactor Algae Process (SBAR) to Treat the Antibiotic Cefradine	PLOS ONE			English	Article							WASTE-WATER TREATMENT; ENVIRONMENTAL RISK-ASSESSMENT; TANDEM MASS-SPECTROMETRY; VETERINARY ANTIBIOTICS; AQUATIC ORGANISMS; SURFACE-WATER; DEGRADATION; TOXICITY; PRODUCTS; GENES	Many previous studies focused on the removal capability for contaminants when the algae grown in an unexposed, unpolluted environment and ignored whether the feedback of algae to the toxic stress influenced the removal capability in a subsequent treatment batch. The present research investigated and compared algal feedback and removal efficiency in a sequencing batch reactor algae process (SBAR) to remove cefradine. Three varied pollution load conditions (10, 30 and 60 mg/L) were considered. Compared with the algal characteristics in the first treatment batch at 10 and 30 mg/L, higher algal growth inhibition rates were observed in the second treatment batch (11.23% to 20.81%). In contrast, algae produced more photosynthetic pigments in response to cefradine in the second treatment batch. A better removal efficiency (76.02%) was obtained during 96 h when the alga treated the antibiotic at 60 mg/L in the first treatment batch and at 30 mg/L in the second treatment batch. Additionally, the removal rate per unit algal density was also improved when the alga treated the antibiotic at 30 or 60 mg/L in the first treatment batch, respectively and at 30 mg/L in the second treatment batch. Our result indicated that the green algae were also able to adapt to varied pollution loads in different treatment batches.	[Chen, Jianqiu; Zheng, Fengzhu; Guo, Ruixin] China Pharmaceut Univ, Dept Environm Sci, Nanjing 210009, Jiangsu, Peoples R China	China Pharmaceutical University	Guo, RX (corresponding author), China Pharmaceut Univ, Dept Environm Sci, Nanjing 210009, Jiangsu, Peoples R China.	grxcpu@163.com						Abdel-Aty AM, 2013, J ADV RES, V4, P367, DOI 10.1016/j.jare.2012.07.004; Alcock RE, 1999, CHEMOSPHERE, V38, P2247, DOI 10.1016/S0045-6535(98)00444-5; Beale SI, 2005, TRENDS PLANT SCI, V10, P309, DOI 10.1016/j.tplants.2005.05.005; Boxall ABA, 2003, ENVIRON SCI TECHNOL, V37, p286A, DOI 10.1021/es032519b; Brown KD, 2006, SCI TOTAL ENVIRON, V366, P772, DOI 10.1016/j.scitotenv.2005.10.007; Cha JM, 2006, J CHROMATOGR A, V1115, P46, DOI 10.1016/j.chroma.2006.02.086; Chen JQ, 2012, J HAZARD MATER, V209, P520, DOI 10.1016/j.jhazmat.2012.01.041; Chen JQ, 2015, CHEMOSPHERE, V119, P318, DOI 10.1016/j.chemosphere.2014.06.073; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; de Godos I, 2012, J HAZARD MATER, V229, P446, DOI 10.1016/j.jhazmat.2012.05.106; Ebert I, 2011, ENVIRON TOXICOL CHEM, V30, P2786, DOI 10.1002/etc.678; Gartiser S, 2007, CHEMOSPHERE, V67, P604, DOI 10.1016/j.chemosphere.2006.08.038; Gonzalez-Pleiter M, 2013, WATER RES, V47, P2050, DOI 10.1016/j.watres.2013.01.020; Guo RX, 2015, CHEM ENG J, V260, P550, DOI 10.1016/j.cej.2014.09.053; Hernando MD, 2006, TALANTA, V69, P334, DOI 10.1016/j.talanta.2005.09.037; Jiang MX, 2010, CHEMOSPHERE, V80, P1399, DOI 10.1016/j.chemosphere.2010.05.048; Jin ZP, 2012, CHEMOSPHERE, V87, P278, DOI 10.1016/j.chemosphere.2011.12.071; Jonsson CM, 2007, CHEMOSPHERE, V69, P849, DOI 10.1016/j.chemosphere.2007.06.024; Kemper N, 2008, ECOL INDIC, V8, P1, DOI 10.1016/j.ecolind.2007.06.002; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Lai HT, 2009, ECOTOX ENVIRON SAFE, V72, P329, DOI 10.1016/j.ecoenv.2008.03.005; Li R, 2009, ECOTOX ENVIRON SAFE, V72, P321, DOI 10.1016/j.ecoenv.2008.05.012; Liu BY, 2011, J ENVIRON SCI-CHINA, V23, P1558, DOI 10.1016/S1001-0742(10)60608-0; Liu Y, 2012, ECOTOX ENVIRON SAFE, V86, P23, DOI 10.1016/j.ecoenv.2012.09.004; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Sekomo CB, 2012, ECOL ENG, V44, P102, DOI 10.1016/j.ecoleng.2012.03.003; Tamtam F, 2008, SCI TOTAL ENVIRON, V393, P84, DOI 10.1016/j.scitotenv.2007.12.009; Watkinson AJ, 2009, SCI TOTAL ENVIRON, V407, P2711, DOI 10.1016/j.scitotenv.2008.11.059; Wollenberger L, 2000, CHEMOSPHERE, V40, P723, DOI 10.1016/S0045-6535(99)00443-9; Xu WH, 2007, ENVIRON POLLUT, V145, P672, DOI 10.1016/j.envpol.2006.05.038; Yue XiaLi, 2007, Agricultural Sciences in China, V6, P316, DOI 10.1016/S1671-2927(07)60051-0; Zhang SA, 2011, ECOTOXICOLOGY, V20, P337, DOI 10.1007/s10646-010-0583-z; Zhang Z.S., 1991, METHOD STUDY FRESHWA	34	27	27	8	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133273	10.1371/journal.pone.0133273	http://dx.doi.org/10.1371/journal.pone.0133273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177093	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600238
J	Jung, PS; Kim, DY; Lee, SW; Park, JY; Suh, DS; Kim, JH; Kim, YM; Kim, YT; Nam, JH				Jung, Phill-Seung; Kim, Dae-Yeon; Lee, Shin-Wha; Park, Jeong-Yeol; Suh, Dae-Shik; Kim, Jong-Hyeok; Kim, Yong-Man; Kim, Young-Tak; Nam, Joo-Hyun			Clinical Role of Adjuvant Chemotherapy after Radical Hysterectomy for FIGO Stage IB-IIA Cervical Cancer: Comparison with Adjuvant RT/CCRT Using Inverse-Probability-of-Treatment Weighting	PLOS ONE			English	Article							PELVIC RADIATION-THERAPY; NEOADJUVANT CHEMOTHERAPY; INTERMEDIATE-RISK; RANDOMIZED-TRIAL; UTERINE CERVIX; CARCINOMA; TRACHELECTOMY; COMPLICATIONS; RADIOTHERAPY; SURGERY	Objective To evaluate the clinical role of adjuvant chemotherapy (AC) in FIGO stage IB-IIA cervical cancer patients. Study Design A cohort of 262 patients with cervical cancer who received radical hysterectomy (RH) and adjuvant therapy at Asan Medical Center between 1992 and 2012 was enrolled. In this cohort, 85 patients received adjuvant chemotherapy (AC), and 177 received adjuvant radiotherapy or concurrent chemoradiation therapy (AR). Oncologic outcomes and adverse events in both treatment arms were compared using weighted Cox proportional hazards regression models with inverse-probability-of-treatment weighting (IPTW) to reduce the impact of treatment selection bias and potential confounding factors. Results During a 46.8-month median follow-up duration, 39 patients (14.9%) had recurrences, and 18 patients (6.9%) died of disease. In multivariate analysis, the hazard ratio (HR) for recurrence and death was not significantly different in patients in either treatment arm (p=0.62 and 0.12, respectively). Also, after IPTW matching, the HR for recurrence did not significantly differ between the arms (HR 1.57, 95% CI 0.68-3.62, p=0.29). Similarly, disease-free survival and overall survival were not significantly different between the arms (p=0.47 and 0.13, respectively). In addition, patients with AC had a much lower prevalence of long-term complications (lymphedema: n=8 (9.4%) vs. 46 (26.0%), p=0.03; ureteral stricture: n=0 vs. 9 (6.2%), p=0.05). Conclusion Patients with FIGO stage IB-IIA cervical cancer can benefit from AC after RH with fewer long-term complications and non-inferior therapeutic effect to AR. Chemotherapy may therefore be an alternative adjuvant treatment option for cervical cancer, particularly in younger patients.	[Jung, Phill-Seung; Kim, Dae-Yeon; Lee, Shin-Wha; Park, Jeong-Yeol; Suh, Dae-Shik; Kim, Jong-Hyeok; Kim, Yong-Man; Kim, Young-Tak; Nam, Joo-Hyun] Univ Ulsan, Div Gynecol Oncol, Dept Obstet & Gynecol, Coll Med,Asan Med Ctr, Seoul, South Korea	University of Ulsan	Nam, JH (corresponding author), Univ Ulsan, Div Gynecol Oncol, Dept Obstet & Gynecol, Coll Med,Asan Med Ctr, Seoul, South Korea.	jhnam@amc.seoul.kr						Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bosch F Xavier, 2003, J Natl Cancer Inst Monogr, P3; EIFEL PJ, 1995, INT J RADIAT ONCOL, V32, P1289, DOI 10.1016/0360-3016(95)00118-I; Hosaka M, 2008, J OBSTET GYNAECOL RE, V34, P552, DOI 10.1111/j.1447-0756.2008.00739.x; Hosaka M, 2012, J SURG ONCOL, V105, P612, DOI 10.1002/jso.22136; Huguet F, 2008, INT J RADIAT ONCOL, V72, P1508, DOI 10.1016/j.ijrobp.2008.03.054; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lahousen M, 1999, GYNECOL ONCOL, V73, P196, DOI 10.1006/gyno.1999.5343; Lanowska M, 2014, INT J GYNECOL CANCER, V24, P586, DOI 10.1097/IGC.0000000000000080; Lee KB, 2008, INT J GYNECOL CANCER, V18, P1027, DOI 10.1111/j.1525-1438.2007.01136.x; Lee MY, 2007, GYNECOL ONCOL, V104, P95, DOI 10.1016/j.ygyno.2006.07.021; Lee YH, 2012, J GYNECOL ONCOL, V23, P16, DOI 10.3802/jgo.2012.23.1.16; Marchiole P, 2011, GYNECOL ONCOL, V122, P484, DOI 10.1016/j.ygyno.2011.05.010; Matsuura Y, 2006, INT J GYNECOL CANCER, V16, P294, DOI 10.1111/j.1525-1438.2006.00354.x; Monk BJ, 2005, GYNECOL ONCOL, V96, P721, DOI 10.1016/j.ygyno.2004.11.007; Mossa B, 2010, EUR J GYNAECOL ONCOL, V31, P545; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; Plante M, 2013, INT J GYNECOL CANCER, V23, P982, DOI 10.1097/IGC.0b013e318295906b; Rotman M, 2006, INT J RADIAT ONCOL, V65, P169, DOI 10.1016/j.ijrobp.2005.10.019; Sedlis A, 1999, GYNECOL ONCOL, V73, P177, DOI 10.1006/gyno.1999.5387; Sugihara M, 2010, PHARM STAT, V9, P21, DOI 10.1002/pst.365; Takeshima N, 2006, GYNECOL ONCOL, V103, P618, DOI 10.1016/j.ygyno.2006.04.019; Viswanathan AN, 2014, CANCER-AM CANCER SOC, V120, P3870, DOI 10.1002/cncr.28849	23	8	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132298	10.1371/journal.pone.0132298	http://dx.doi.org/10.1371/journal.pone.0132298			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176626	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600097
J	Kurose, T; Hashimoto, M; Ozawa, J; Kawamata, S				Kurose, Tomoyuki; Hashimoto, Masakazu; Ozawa, Junya; Kawamata, Seiichi			Analysis of Gene Expression in Experimental Pressure Ulcers in the Rat with Special Reference to Inflammatory Cytokines	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; SUBCUTANEOUS CONNECTIVE-TISSUE; MODEL; SKIN	Pressure ulcers have been investigated in a few animal models, but the molecular mechanisms of pressure ulcers are not well understood. We hypothesized that pressure results in up-regulation of inflammatory cytokines and those cytokines contribute to the formation of pressure ulcers. We measured genome-wide changes in transcript levels after compression, and focused especially on inflammatory cytokines. The abdominal wall of rats was compressed at 100 mmHg for 4 hours by two magnets. Specimens were obtained 12 hours, 1, or 3 days after compression, and analyzed by light microscopy, microarray, Real-Time PCR, and ELISA. The skin and subcutaneous tissue in the compressed area were markedly thickened. The microarray showed that numerous genes were up-regulated after the compression. Up-regulated genes were involved in apoptosis, inflammation, oxidative stress, proteolysis, hypoxia, and so on. Real-Time PCR showed the up-regulation of granulocyte-macrophage colony stimulating factor (GM-CSF), interferon. (IFN-gamma), interleukin 1 beta (IL-1 beta), interleukin 1 receptor antagonist gene (IL1Ra), interleukin 6 (IL-6), interleukin 10 (IL-10), matrix metalloproteinase 3 (MMP-3), tissue inhibitor of metalloproteinase 1 (TIMP-1), and tumor necrosis factor a (TNF-alpha) at 12 hours, IFN-gamma, IL-6, IL-10, MMP-3, and TIMP-1 at 1 day, and IFN-gamma, IL-6, and MMP-3 at 3 days. Some genes from subcutaneous tissue were up-regulated temporarily, and others were kept at high levels of expression. ELISA data showed that the concentrations of IL-1 beta and IL-6 proteins were most notably increased following compression. Prolonged up-regulation of IL-1 beta, and IL-6 might enhance local inflammation, and continuous local inflammation may contribute to the pressure ulcer formation. In addition, GM-CSF, IFN-gamma, MMP-3, and TIMP-1 were not reported previously in the wound healing process, and those genes may have a role in development of the pressure ulcers. Expression data from Real-Time PCR were generally in good agreement with those of the microarray. Our microarray data were useful for identifying genes involved in pressure ulcer formation. However, the expression levels of the genes didn't necessarily correspond with protein production. As such, the functions of these cytokines need to be further investigated.	[Kurose, Tomoyuki; Hashimoto, Masakazu; Kawamata, Seiichi] Hiroshima Univ, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Ozawa, Junya] Hiroshima Int Univ, Fac Hlth Sci, Hiroshima, Japan	Hiroshima University	Kurose, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Hiroshima, Japan.	kurose@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [19592492, 19700435, 22500461]; Grants-in-Aid for Scientific Research [26350645] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants in Aid from the Japan Society for the Promotion of Science (Nos. 19592492, 19700435, 22500461).	Bronneberg D, 2006, ANN BIOMED ENG, V34, P506, DOI 10.1007/s10439-005-9062-8; Chen L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-471; Daitoku D, 2007, ARCH HISTOL CYTOL, V70, P29, DOI 10.1679/aohc.70.29; Dallegri F, 1997, INFLAMM RES, V46, P382, DOI 10.1007/s000110050208; Dalton SJ, 2007, J INVEST DERMATOL, V127, P958, DOI 10.1038/sj.jid.5700651; Feldmann M, 2000, CYTOKINE REFERENCE C, P291; Furuichi K, 2003, J AM SOC NEPHROL, V14, P1066, DOI 10.1097/01.ASN.0000059339.14780.E4; Furuichi K, 2006, CRIT CARE MED, V34, P2447, DOI 10.1097/01.CCM.0000233878.36340.10; Goldstein B, 1998, ARCH PHYS MED REHAB, V79, P265, DOI 10.1016/S0003-9993(98)90005-3; Gomez-Cambronero J, 2003, J IMMUNOL, V171, P6846, DOI 10.4049/jimmunol.171.12.6846; Hashimoto M, 2008, ARCH HISTOL CYTOL, V71, P303, DOI 10.1679/aohc.71.303; Kawamata S, 2003, ARCH HISTOL CYTOL, V66, P273, DOI 10.1679/aohc.66.273; Kawamata S, ARCH HISTOL IN PRESS; King A, 2014, ADV WOUND CARE, V3, P315, DOI 10.1089/wound.2013.0461; KOSIAK M, 1959, Arch Phys Med Rehabil, V40, P62; Langevin HM, 2005, AM J PHYSIOL-CELL PH, V288, pC747, DOI 10.1152/ajpcell.00420.2004; METCALF D, 1987, EXP HEMATOL, V15, P1; Peirce SM, 2000, WOUND REPAIR REGEN, V8, P68, DOI 10.1046/j.1524-475x.2000.00068.x; Reid RR, 2004, J SURG RES, V116, P172, DOI 10.1016/S0022-4804(03)00227-0; Saito Y, 2008, J INVEST DERMATOL, V128, P1838, DOI 10.1038/sj.jid.5701258; Salcido R, 1994, Adv Wound Care, V7, P23; Salcido R, 1994, ADV WOUND CARE, V4, P28; Salcido R, 1994, ADV WOUND CARE, V4, P26; Salcido R, 2007, J SPINAL CORD MED, V30, P107, DOI 10.1080/10790268.2007.11753921; Sato Y, 1999, BIOCHEM BIOPH RES CO, V265, P194, DOI 10.1006/bbrc.1999.1455; SMITH JW, 1992, J CLIN ONCOL, V10, P1141, DOI 10.1200/JCO.1992.10.7.1141; Stojadinovic O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069223; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Yanai H., 2011, STATCEL USEFUL ADD I, P172	29	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132622	10.1371/journal.pone.0132622	http://dx.doi.org/10.1371/journal.pone.0132622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177082	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600133
J	Osterman, CJD; Lynch, JC; Leaf, P; Gonda, A; Bennit, HRF; Griffiths, D; Wall, NR				Osterman, Carlos J. Diaz; Lynch, James C.; Leaf, Patrick; Gonda, Amber; Bennit, Heather R. Ferguson; Griffiths, Duncan; Wall, Nathan R.			Curcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function	PLOS ONE			English	Article							FACTOR-KAPPA-B; CANCER-CELL; LIPOSOMAL CURCUMIN; TUMOR-GROWTH; EXTRACELLULAR VESICLES; DOWN-REGULATION; GEMCITABINE; PROLIFERATION; INHIBITION; DELIVERY	Pancreatic cancer has the highest mortality rates of all cancer types. One potential explanation for the aggressiveness of this disease is that cancer cells have been found to communicate with one another using membrane-bound vesicles known as exosomes. These exosomes carry pro-survival molecules and increase the proliferation, survival, and metastatic potential of recipient cells, suggesting that tumor-derived exosomes are powerful drivers of tumor progression. Thus, to successfully address and eradicate pancreatic cancer, it is imperative to develop therapeutic strategies that neutralize cancer cells and exosomes simultaneously. Curcumin, a turmeric root derivative, has been shown to have potent anti-cancer and anti-inflammatory effects in vitro and in vivo. Recent studies have suggested that exosomal curcumin exerts anti-inflammatory properties on recipient cells. However, curcumin's effects on exosomal pro-tumor function have yet to be determined. We hypothesize that curcumin will alter the pro-survival role of exosomes from pancreatic cancer cells toward a pro-death role, resulting in reduced cell viability of recipient pancreatic cancer cells. The main objective of this study was to determine the functional alterations of exosomes released by pancreatic cancer cells exposed to curcumin compared to exosomes from untreated pancreatic cancer cells. We demonstrate, using an in vitro cell culture model involving pancreatic adenocarcinoma cell lines PANC-1 and MIA PaCa-2, that curcumin is incorporated into exosomes isolated from curcumin-treated pancreatic cancer cells as observed by spectral studies and fluorescence microscopy. Furthermore, curcumin is delivered to recipient pancreatic cancer cells via exosomes, promoting cytotoxicity as demonstrated by Hoffman modulation contrast microscopy as well as AlamarBlue and Trypan blue exclusion assays. Collectively, these data suggest that the efficacy of curcumin may be enhanced in pancreatic cancer cells through exosomal facilitation.	[Osterman, Carlos J. Diaz; Lynch, James C.; Leaf, Patrick; Bennit, Heather R. Ferguson; Wall, Nathan R.] Loma Linda Univ, Div Biochem, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA; [Gonda, Amber] Loma Linda Univ, Sch Med, Dept Anat, Loma Linda, CA 92350 USA; [Griffiths, Duncan] Malvern Instruments Inc, Rancho Cucamonga, CA USA	Loma Linda University; Loma Linda University	Wall, NR (corresponding author), Loma Linda Univ, Div Biochem, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA.	nwall@llu.edu	Wall, Nathan R./H-7368-2015	Wall, Nathan R./0000-0002-3235-4386	National Institute of Health Disparities and Minority Health of the National Institutes of Health [p20MD0016321, P20MD006988, 2R25 GM060507]; Department of the Army [DAMD17-97-2-7016]; Malvern Instruments Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060507] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006988] Funding Source: NIH RePORTER	National Institute of Health Disparities and Minority Health of the National Institutes of Health; Department of the Army; Malvern Instruments Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Research reported in this publication was supported by the National Institute of Health Disparities and Minority Health of the National Institutes of Health under award numbers p20MD0016321, P20MD006988 and 2R25 GM060507. a National Merit Test Bed (NMTB) award sponsored by the Department of the Army under Cooperative Agreement Number DAMD17-97-2-7016 (NRW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The PI's personal funds have also contributed to this work. The contribution by Malvern's associate, Mr. Duncan Griffiths was to supply us with the use of their nanosight instrument to detect and measure exosomes in our samples and modest interpretation of the data we collected using their instrument. Malvern Instruments Inc. also provided support in the form of a salary for author DG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	American Cancer Society, 2013, CANCER FACTS FIGURES; American Cancer Society, 2015, CANCER FACTS FIGURES; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Atai NA, 2013, J NEURO-ONCOL, V115, P343, DOI 10.1007/s11060-013-1235-y; Atay Safinur, 2014, Commun Integr Biol, V7, pe28231, DOI 10.4161/cib.28231; Beckler MD, 2013, MOL CELL PROTEOMICS, V12, P343, DOI 10.1074/mcp.M112.022806; Bimonte S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/810423; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Diaz Osterman CJ, 2015, PANCREAS IN PRESS; Epelbaum R, 2010, NUTR CANCER, V62, P1137, DOI 10.1080/01635581.2010.513802; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Ferrucci LM, 2010, ASIAN PAC J CANCER P, V11, P1621; Franzen CA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/619829; Ghalandarlaki N, 2014, NANOTECHNOLOGY APPLI, V2014, DOI [10.1155/2014/394264, DOI 10.1155/2014/394264]; Glienke W, 2010, CANCER INVEST, V28, P166, DOI 10.3109/07357900903287006; Gupta SC, 2013, MOL NUTR FOOD RES, V57, P1510, DOI 10.1002/mnfr.201100741; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Gupta V, 2009, INT J NANOMED, V4, P115; Jung T, 2009, NEOPLASIA, V11, P1093, DOI 10.1593/neo.09822; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Kanai M, 2014, WORLD J GASTROENTERO, V20, P9384, DOI 10.3748/wjg.v20.i28.9384; Kanai M, 2013, CANCER CHEMOTH PHARM, V71, P1521, DOI 10.1007/s00280-013-2151-8; Kanai M, 2012, CANCER CHEMOTH PHARM, V69, P65, DOI 10.1007/s00280-011-1673-1; Kanai M, 2011, CANCER CHEMOTH PHARM, V68, P157, DOI 10.1007/s00280-010-1470-2; Khan S, 2009, BRIT J CANCER, V100, P1073, DOI 10.1038/sj.bjc.6604978; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; Kharaziha P, 2012, BBA-REV CANCER, V1826, P103, DOI 10.1016/j.bbcan.2012.03.006; Kunnumakkara AB, 2007, CANCER RES, V67, P3853, DOI 10.1158/0008-5472.CAN-06-4257; Kunwar A, 2008, BBA-GEN SUBJECTS, V1780, P673, DOI 10.1016/j.bbagen.2007.11.016; Kunwar A, 2006, BBA-GEN SUBJECTS, V1760, P1513, DOI 10.1016/j.bbagen.2006.06.012; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Lev-Ari S, 2007, CANCER INVEST, V25, P411, DOI 10.1080/07357900701359577; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Li L, 2004, CANCER-AM CANCER SOC, V101, P2351, DOI 10.1002/cncr.20605; Lin YG, 2007, CLIN CANCER RES, V13, P3423, DOI 10.1158/1078-0432.CCR-06-3072; Martinez-Lorenzo MJ, 2004, EXP CELL RES, V295, P315, DOI 10.1016/j.yexcr.2003.12.024; Matabudul D, 2012, ANTICANCER RES, V32, P4359; Nardo L, 2011, J FLUORESC, V21, P627, DOI 10.1007/s10895-010-0750-x; Neoptolemos JP, 2011, EUR J CANCER, V47, pS378, DOI 10.1016/S0959-8049(11)70210-6; Ramachandran C, 2010, ONCOL REP, V23, P1529, DOI 10.3892/or_00000792; Rana S, 2013, NEOPLASIA, V15, P281, DOI 10.1593/neo.122010; Ranjan AP, 2013, ANTICANCER RES, V33, P3603; Rieu S, 2000, EUR J BIOCHEM, V267, P583, DOI 10.1046/j.1432-1327.2000.01036.x; Ryan DP, 2014, NEW ENGL J MED, V371, P2140, DOI 10.1056/NEJMc1412266; Sahu A, 2008, ACTA BIOMATER, V4, P1752, DOI 10.1016/j.actbio.2008.04.021; Sasaki H, 2011, BIOL PHARM BULL, V34, P660, DOI 10.1248/bpb.34.660; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Shaikh J, 2009, EUR J PHARM SCI, V37, P223, DOI 10.1016/j.ejps.2009.02.019; Shehzad A, 2013, BIOFACTORS, V39, P56, DOI 10.1002/biof.1068; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Shi HS, 2012, INT J NANOMED, V7, P2601, DOI 10.2147/IJN.S31439; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sun DM, 2010, MOL THER, V18, P1606, DOI 10.1038/mt.2010.105; Taylor D D, 1986, Dev Biol (N Y 1985), V3, P33; Taylor DD, 2002, GYNECOL ONCOL, V84, P443, DOI 10.1006/gyno.2001.6551; van der Meel R, 2014, J CONTROL RELEASE, V195, P72, DOI 10.1016/j.jconrel.2014.07.049; Yallapu MM, 2013, MOL CANCER THER, V12, P1471, DOI 10.1158/1535-7163.MCT-12-1227; Yang CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037960; Youns M, 2013, J CELL BIOCHEM, V114, P2654, DOI 10.1002/jcb.24612	60	67	69	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132845	10.1371/journal.pone.0132845	http://dx.doi.org/10.1371/journal.pone.0132845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177391	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600166
J	Porta, A; Faes, L; Nollo, G; Bari, V; Marchi, A; De Maria, B; Takahashi, ACM; Catai, AM				Porta, Alberto; Faes, Luca; Nollo, Giandomenico; Bari, Vlasta; Marchi, Andrea; De Maria, Beatrice; Takahashi, Anielle C. M.; Catai, Aparecida M.			Conditional Self-Entropy and Conditional Joint Transfer Entropy in Heart Period Variability during Graded Postural Challenge	PLOS ONE			English	Article							ARTERIAL-PRESSURE VARIABILITIES; RESPIRATORY SINUS ARRHYTHMIA; CARDIAC SYMPATHETIC TONE; LOW-FREQUENCY POWER; TIME-SERIES; SYMPATHOVAGAL BALANCE; BAROREFLEX GAIN; SURROGATE DATA; MODEL; COMPLEXITY	Self-entropy (SE) and transfer entropy (TE) are widely utilized in biomedical signal processing to assess the information stored into a system and transferred from a source to a destination respectively. The study proposes a more specific definition of the SE, namely the conditional SE (CSE), and a more flexible definition of the TE based on joint TE (JTE), namely the conditional JTE (CJTE), for the analysis of information dynamics in multivariate time series. In a protocol evoking a gradual sympathetic activation and vagal withdrawal proportional to the magnitude of the orthostatic stimulus, such as the graded head-up tilt, we extracted the beat-to-beat spontaneous variability of heart period (HP), systolic arterial pressure (SAP) and respiratory activity (R) in 19 healthy subjects and we computed SE of HP, CSE of HP given SAP and R, JTE from SAP and R to HP, CJTE from SAP and R to HP given SAP and CJTE from SAP and R to HP given R. CSE of HP given SAP and R was significantly smaller than SE of HP and increased progressively with the amplitude of the stimulus, thus suggesting that dynamics internal to HP and unrelated to SAP and R, possibly linked to sympathetic activation evoked by head-up tilt, might play a role during the orthostatic challenge. While JTE from SAP and R to HP was independent of tilt table angle, CJTE from SAP and R to HP given R and from SAP and R to HP given SAP showed opposite trends with tilt table inclination, thus suggesting that the importance of the cardiac baroreflex increases and the relevance of the cardiopulmonary pathway decreases during head-up tilt. The study demonstrates the high specificity of CSE and the high flexibility of CJTE over real data and proves that they are particularly helpful in disentangling physiological mechanisms and in assessing their different contributions to the overall cardiovascular regulation.	[Porta, Alberto] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Porta, Alberto; Bari, Vlasta] IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, Milan, Italy; [Faes, Luca; Nollo, Giandomenico] Univ Trento, Dept Ind Engn, BIOtech, Trento, Italy; [Faes, Luca; Nollo, Giandomenico] IRCS PAT FBK, Trento, Italy; [Marchi, Andrea] Politecn Milan, Dept Elect Informat & Bioengn, I-20133 Milan, Italy; [De Maria, Beatrice] IRCCS Fdn Salvatore Maugeri, Dept Rehabil Med, Milan, Italy; [Takahashi, Anielle C. M.; Catai, Aparecida M.] Univ Fed Sao Carlos, Dept Physiotherapy, BR-13560 Sao Carlos, SP, Brazil	University of Milan; IRCCS Policlinico San Donato; University of Trento; Fondazione Bruno Kessler; Polytechnic University of Milan; Istituti Clinici Scientifici Maugeri IRCCS; Universidade Federal de Sao Carlos	Porta, A (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.	alberto.porta@unimi.it	De Maria, Beatrice/K-3293-2018; Bari, Vlasta/J-8591-2016; Faes, Luca/E-5156-2012; Takahashi, Anielle C M/B-5957-2012; Takahashi, Anielle C M/I-5880-2014; Marchi, Andrea/J-7205-2016; Catai, Aparecida Maria/G-4612-2012; Porta, Alberto/K-4390-2016	De Maria, Beatrice/0000-0001-5360-3137; Bari, Vlasta/0000-0002-5346-2677; Faes, Luca/0000-0002-3271-5348; Takahashi, Anielle C M/0000-0003-1263-2833; Takahashi, Anielle C M/0000-0003-1263-2833; Marchi, Andrea/0000-0001-5846-4164; Porta, Alberto/0000-0002-6720-9824; Nollo, Giandomenico/0000-0002-9837-083X	FAPESP [Process 2010/52070-4]; CAPES-PVE [Process 23028.007721/2013-4]; CNPq [Process: 311938/2013-2]; Healthcare Research and Innovation Program of the Autonomous Province of Trento, IRCS-PAT-FBK, Trento, Italy	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES-PVE(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Healthcare Research and Innovation Program of the Autonomous Province of Trento, IRCS-PAT-FBK, Trento, Italy	This research was supported by FAPESP (Process 2010/52070-4) to A.M.C., CAPES-PVE (Process 23028.007721/2013-4) to A.M.C., A.C.M.T. and A.P., CNPq (Process: 311938/2013-2) to A.M.C and Healthcare Research and Innovation Program of the Autonomous Province of Trento, IRCS-PAT-FBK, Trento, Italy to G.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andrzejak RG, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.066202; Barnett L, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051914; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Baselli G, 1997, IEEE T BIO-MED ENG, V44, P1092, DOI 10.1109/10.641336; BASELLI G, 1994, MED BIOL ENG COMPUT, V32, P143, DOI 10.1007/BF02518911; BERGER RD, 1989, AM J PHYSIOL, V256, pH142, DOI 10.1152/ajpheart.1989.256.1.H142; Chicharro D, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041901; Cohen MA, 2002, J PHYSIOL-LONDON, V542, P669, DOI 10.1113/jphysiol.2002.017483; Cooke WH, 1999, J PHYSIOL-LONDON, V517, P617, DOI 10.1111/j.1469-7793.1999.0617t.x; DEBOER RW, 1987, AM J PHYSIOL, V253, pH680, DOI 10.1152/ajpheart.1987.253.3.H680; Eckberg DL, 2003, J PHYSIOL-LONDON, V548, P339, DOI 10.1113/jphysiol.2002.037192; ECKBERG DL, 1976, J PHYSIOL-LONDON, V258, P769, DOI 10.1113/jphysiol.1976.sp011445; Eckberg DL, 1997, CIRCULATION, V96, P3224, DOI 10.1161/01.CIR.96.9.3224; Eckberg DL, 2009, J APPL PHYSIOL, V106, P1740, DOI 10.1152/japplphysiol.91107.2008; Faes L, 2015, ENTROPY-SWITZ, V17, P277, DOI 10.3390/e17010277; Faes L, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051112; Furlan R, 2000, CIRCULATION, V101, P886, DOI 10.1161/01.CIR.101.8.886; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; Heart rate variability: standards of measurement physiological interpretation and clinical use, 1996, AQUACULTURE, V93, P1043, DOI [10.1111/j.1542-474X.1996.tb00275.x, DOI 10.1161/STR.0b013e3182587839]; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Kugiumtzis D, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062918; Lindner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-119; Lizier JT, 2010, EUR PHYS J B, V73, P605, DOI 10.1140/epjb/e2010-00034-5; Lizier JT, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026110; Martelli D, 2014, AM J PHYSIOL-HEART C, V307, pH1005, DOI 10.1152/ajpheart.00361.2014; McEliece R. J., 2002, THEORY INFORM CODING; Montalto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109462; MONTANO N, 1994, CIRCULATION, V90, P1826, DOI 10.1161/01.CIR.90.4.1826; Nollo G, 2002, AM J PHYSIOL-HEART C, V283, pH1200, DOI 10.1152/ajpheart.00882.2001; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Palus M, 1997, PHYS LETT A, V235, P341, DOI 10.1016/S0375-9601(97)00635-X; PARLOW J, 1995, HYPERTENSION, V25, P1058, DOI 10.1161/01.HYP.25.5.1058; Patton DJ, 1996, AM J PHYSIOL-HEART C, V270, pH1240, DOI 10.1152/ajpheart.1996.270.4.H1240; Porta A, 2000, AM J PHYSIOL-HEART C, V279, pH2558, DOI 10.1152/ajpheart.2000.279.5.H2558; Porta A, 2000, IEEE T BIO-MED ENG, V47, P1555, DOI 10.1109/10.887936; Porta A, 2012, J APPL PHYSIOL, V113, P1810, DOI 10.1152/japplphysiol.00755.2012; Porta A, 2003, MED BIOL ENG COMPUT, V41, P52, DOI 10.1007/BF02343539; Porta A, 2007, J APPL PHYSIOL, V103, P1143, DOI 10.1152/japplphysiol.00293.2007; Porta A, 2007, IEEE T BIO-MED ENG, V54, P94, DOI 10.1109/TBME.2006.883789; Porta A, 2012, IEEE T BIO-MED ENG, V59, P832, DOI 10.1109/TBME.2011.2180379; Porta A, 2012, COMPUT BIOL MED, V42, P298, DOI 10.1016/j.compbiomed.2011.04.019; Porta A, 2011, AM J PHYSIOL-REG I, V300, pR378, DOI 10.1152/ajpregu.00553.2010; PRICHARD D, 1994, PHYS REV LETT, V73, P951, DOI 10.1103/PhysRevLett.73.951; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Soderstrom T., 1988, SYSTEM IDENTIFICATIO; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; TRIEDMAN JK, 1995, AM J PHYSIOL-HEART C, V268, pH2232, DOI 10.1152/ajpheart.1995.268.6.H2232; Vejmelka M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026214; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Wibral M, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00001; Xiao XS, 2005, PHYSIOL MEAS, V26, pR41, DOI 10.1088/0967-3334/26/3/R01	55	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132851	10.1371/journal.pone.0132851	http://dx.doi.org/10.1371/journal.pone.0132851			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177517	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600168
J	Shrestha, R; Karki, P; Suwal, A; Copenhaver, M				Shrestha, Roman; Karki, Pramila; Suwal, Asha; Copenhaver, Michael			Sex Trafficking Related Knowledge, Awareness, and Attitudes among Adolescent Female Students in Nepal: A Cross-Sectional Study	PLOS ONE			English	Article								Background Sex trafficking has been a long-standing concern in Nepal. Very little has been achieved, however, in terms of actual reduction in the number of victims despite numerous anti-sex trafficking programs. This situation may be attributable to a lack of empirical evidence upon which to formulate anti-sexual trafficking interventions. This study aimed to assess sex trafficking-related knowledge, awareness and attitudes, and factors associated with sex trafficking awareness and attitudes towards the victims of sex trafficking and/or anti-sex trafficking campaigns among adolescent female students in Nepal. Methods A cross-sectional study was conducted between August-September 2013 among 292 adolescent female students (> 10 years old) using systematic random sampling from three high schools in Sindhupalchowk district, Nepal. As an initial step, descriptive analyses were employed to characterize the data and multivariate logistic regression analyses were used to explore factors associated with sex trafficking awareness and related attitudes. Results Seventy-six percent of sampled students reported that they were aware of sex trafficking and 94.6% indicated media (i.e., radio or television) as the primary sources of their knowledge. Fifty-one percent mentioned relatives/friends as mediators of sex trafficking, 60.4% reported promise for better jobs as the primary attraction behind sex trafficking, and 48.6% mentioned adolescent females as the most vulnerable group for sex trafficking. Over half (56.8%) of the respondents had positive attitudes towards the victims of sex trafficking and/or anti-sex trafficking campaigns. Age (OR = 3.38, 95% CI: 2.51-4.55), parents' occupation (OR = 3.89, 95% CI: 1.58-9.58), and having a radio/TV at home (OR = 6.67, 95% CI: 3.99-9.54) were significantly associated with awareness, whereas being younger (OR = 0.67, 95% CI: 0.55-0.79) and having joint-family (OR = 2.67, 95% CI: 1.49-4.80) were significantly associated with having a positive attitudes towards the victims of sex trafficking and/or anti-sex trafficking campaigns. Conclusion Findings presented have important implications for anti- trafficking programs, in particular those designed to educate the adolescent females who are at most-risk of sex trafficking. Educational programs need to include specific interventions to improve knowledge and attitudes towards sex trafficking among adolescent females in Nepal.	[Shrestha, Roman] Univ Connecticut, Ctr Hlth, Dept Community Med & Hlth Care, Farmington, CT 06030 USA; [Shrestha, Roman; Copenhaver, Michael] Univ Connecticut, Ctr Hlth Intervent & Prevent, Storrs, CT USA; [Karki, Pramila; Suwal, Asha] Nobel Coll, Dept Nursing, Kathmandu, Nepal; [Karki, Pramila; Copenhaver, Michael] Univ Connecticut, Dept Allied Hlth Sci, Storrs, CT USA	University of Connecticut; University of Connecticut; University of Connecticut	Shrestha, R (corresponding author), Univ Connecticut, Ctr Hlth, Dept Community Med & Hlth Care, Farmington, CT 06030 USA.	Roman.Shrestha@UConn.edu	Shrestha, Roman/H-8004-2019	Shrestha, Roman/0000-0003-4340-3101	NATIONAL INSTITUTE ON DRUG ABUSE [K02DA033139] Funding Source: NIH RePORTER; NIDA NIH HHS [K02 DA033139] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		[Anonymous], 1998, HUMAN DEV REPORT; Azage M, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-85; CBS, NAT POP HOUS CENS 20; Crawford M, 2008, VIOLENCE AGAINST WOM, V14, P905, DOI 10.1177/1077801208320906; Ghimire D, 2001, TECHN CONS M ANT PRO; Hennink M, 2004, SEX TRAFFICKING NEPA; Huda S, 2006, INT J GYNECOL OBSTET, V94, P374, DOI 10.1016/j.ijgo.2006.04.027; IOM, 2010, ASS TRAFF WOM CHILDR; Kaufman MR, 2011, VIOLENCE AGAINST WOM, V17, P651, DOI 10.1177/1077801211407431; Khatri N, 2002, 7 ANN M AS PAC FOR N; MoWCSW, 2013, REP ANT TRAFF IN LED; NHRC (National Human Rights Commission), 2012, TRAFF PERS ESP WOM C; Okonofua FE, 2004, SOC SCI MED, V59, P1315, DOI 10.1016/j.socscimed.2004.01.010; Omorodion Francisca Isi, 2009, Afr J Reprod Health, V13, P33; Perry KM, 2013, HEALTH HUM RIGHTS, V15, P138; Poudel P, 2000, Gend Dev, V8, P74, DOI 10.1080/741923626; Simkhada P, 2008, CHILD SOC, V22, P235, DOI 10.1111/j.1099-0860.2008.00154.x; Subedi G, 2009, PAKISTAN J WOMENS ST, V16, P121; United Nations Office of Drugs and C. Protocol to Prevent, PROT PREV SUPPR PU S; UNODC, 2010, GLOB CRIM TRANSN ORG; UNODC, 2012, GLOB REP TRAFF PERS; USDS, TRAFF PERS REP 2014	22	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133508	10.1371/journal.pone.0133508	http://dx.doi.org/10.1371/journal.pone.0133508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177534	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600259
J	Wang, GJ; Sun, Y; Zhang, K; Jia, TT; Hao, MJ; Zhang, D; Chang, L; Zhang, L; Zhang, R; Lin, GG; Peng, RX; Li, JM				Wang, Guojing; Sun, Yu; Zhang, Kuo; Jia, Tingting; Hao, Mingju; Zhang, Dong; Chang, Le; Zhang, Lei; Zhang, Rui; Lin, Guigao; Peng, Rongxue; Li, Jinming			External Quality Assessment of Molecular Detection of Ebola Virus in China	PLOS ONE			English	Article							SIERRA-LEONE; ARMORED RNA; WEST-AFRICA; EPIDEMIC	In 2014, Ebola hemorrhagic fever broke out in West Africa. As contact between China and West Africa is frequent, the possibility that Ebola virus would enter China was high. Thus, an external assessment of the quality of Ebola virus detection was organized by the National Center for Clinical Laboratories in China. Virus-like particles encapsulating known sequences of epidemic strains of Ebola virus from 2014 were prepared as positive quality controls. The sample panel, which was composed of seven positive and three negative samples, was dispatched to 19 laboratories participating in this assessment of Ebola virus detection. Accurate detection was reported at 14 of the 19 participating laboratories, with a sensitivity of 91.43% and a specificity of 100%. Four participants (21.05%) reported false-negative results and were classified as "acceptable." One participant (5.26%) did not detect any positive samples and was thus classified as "improvable." Based on the results returned, the ability to detect weakly positive Ebola specimens should be improved. Furthermore, commercial assays and the standard primers offered by the Chinese Centers for Disease Control and Prevention were found to be most accurate and dependable for Ebola detection. A two-target detection approach is recommended for Ebola screening; this approach could reduce the probability of false-negative results. Additionally, standardization of operations and punctual adjustment of instruments are necessary for the control and prevention of Ebola virus.	[Wang, Guojing; Sun, Yu; Zhang, Kuo; Jia, Tingting; Hao, Mingju; Zhang, Dong; Chang, Le; Zhang, Lei; Zhang, Rui; Lin, Guigao; Peng, Rongxue; Li, Jinming] Natl Hlth & Family Planning Commiss, Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China; [Wang, Guojing; Jia, Tingting; Hao, Mingju; Zhang, Dong; Chang, Le; Peng, Rongxue] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China; [Zhang, Lei] Peking Univ, Sch Clin Med 5, Beijing 100871, Peoples R China	Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University	Li, JM (corresponding author), Natl Hlth & Family Planning Commiss, Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China.	jmli@nccl.org.cn	Chang, Le/AAO-2318-2020; Chang, Le/GWU-9821-2022	Chang, Le/0000-0002-6154-7304; Chang, Le/0000-0002-6154-7304; Hao, Mingju/0000-0002-2714-3998	National High Technology Research and Development Program of China 863 program [2011AA02A116]; "AIDS and hepatitis, and other major infectious disease control and prevention" Program of China [2013ZX10004805]	National High Technology Research and Development Program of China 863 program; "AIDS and hepatitis, and other major infectious disease control and prevention" Program of China	This work was supported by the National High Technology Research and Development Program of China 863 program (grant No. 2011AA02A116) and "AIDS and hepatitis, and other major infectious disease control and prevention" Program of China (No. 2013ZX10004805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Briand S, 2014, NEW ENGL J MED, V371, P1180, DOI 10.1056/NEJMp1409858; Chinese Center for disease control and prevention, LAB DET SCHEM EB HAE; Dhillon RS, 2015, LANCET INFECT DIS, V15, P147, DOI 10.1016/S1473-3099(14)71035-7; Drazen JM, 2015, NEW ENGL J MED, V372, P563, DOI 10.1056/NEJMe1415398; Drazen JM, 2014, NEW ENGL J MED, V371, P2029, DOI 10.1056/NEJMe1413139; Fan HJ, 2015, DISASTER MED PUBLIC, V9, P64, DOI 10.1017/dmp.2014.152; Feldmann H, 2014, NEW ENGL J MED, V371, P1375, DOI 10.1056/NEJMp1405314; Frieden TR, 2014, NEW ENGL J MED, V371, P1177, DOI 10.1056/NEJMp1409903; Gao GF, 2014, SCIENCE, V346, P666, DOI 10.1126/science.346.6209.666; Goodman JL, 2014, NEW ENGL J MED, V371, P1086, DOI 10.1056/NEJMp1409817; Leroy EM, 2002, J GEN VIROL, V83, P67, DOI 10.1099/0022-1317-83-1-67; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Song LQ, 2011, J CLIN MICROBIOL, V49, P3591, DOI 10.1128/JCM.00686-11; Sun Y, 2013, J CLIN MICROBIOL, V51, P4055, DOI 10.1128/JCM.02018-13; World Health Organization, 2015, EB RESP ROADM SIT RE; Zhang BK, 2015, SCI CHINA LIFE SCI, V58, P114, DOI 10.1007/s11427-014-4787-y	18	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132659	10.1371/journal.pone.0132659	http://dx.doi.org/10.1371/journal.pone.0132659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177537	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600139
J	Zlatic, V; Gabbi, G; Abraham, H				Zlatic, Vinko; Gabbi, Giampaolo; Abraham, Hrvoje			Reduction of Systemic Risk by Means of Pigouvian Taxation	PLOS ONE			English	Article							CAPITAL REQUIREMENTS	We analyze the possibility of reduction of systemic risk in financial markets through Pigouvian taxation of financial institutions, which is used to support the rescue fund. We introduce the concept of the cascade risk with a clear operational definition as a subclass and a network related measure of the systemic risk. Using financial networks constructed from real Italian money market data and using realistic parameters, we show that the cascade risk can be substantially reduced by a small rate of taxation and by means of a simple strategy of the money transfer from the rescue fund to interbanking market subjects. Furthermore, we show that while negative effects on the return on investment (ROI) are direct and certain, an overall positive effect on risk adjusted return on investments (ROIRA) is visible. Please note that the taxation is introduced as a monetary/regulatory, not as a_scal measure, as the term could suggest. The rescue fund is implemented in a form of a common reserve fund.	[Zlatic, Vinko] Rudjer Boskovic Inst, Div Theoret Phys, POB 180, HR-10002 Zagreb, Croatia; [Gabbi, Giampaolo] Univ Siena, Dept Management & Law, I-53100 Siena, Italy; [Gabbi, Giampaolo] SDA Bocconi Sch Management, I-20136 Milan, Italy; [Abraham, Hrvoje] Artes Calculi, HR-10002 Zagreb, Croatia	Rudjer Boskovic Institute; University of Siena; Bocconi University	Zlatic, V (corresponding author), Rudjer Boskovic Inst, Div Theoret Phys, POB 180, HR-10002 Zagreb, Croatia.	vinko.zlatic@irb.hr	Zlatić, Vinko/AAW-2781-2020; Zlatic, Vinko/H-9321-2012	Zlatic, Vinko/0000-0001-7101-2154; GABBI, GIAMPAOLO/0000-0001-8137-233X	EU FP7 FET OPEN project FOC (Forecasting financial crises) [255987]; EU FP7 FET project MULTIPLEX (Foundational Research on MULTIlevel comPLEX networks and systems) [317532]; Artes Calculi	EU FP7 FET OPEN project FOC (Forecasting financial crises); EU FP7 FET project MULTIPLEX (Foundational Research on MULTIlevel comPLEX networks and systems); Artes Calculi	The authors acknowledge support from EU FP7 FET OPEN project FOC (Forecasting financial crises, grant no. 255987). VZ also acknowledges support from EU FP7 FET project MULTIPLEX (Foundational Research on MULTIlevel comPLEX networks and systems, grant no. 317532). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hrvoje Abraham is employed by Artes Calculi. Artes Calculi provided support in the form of salary for author HA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	Acharya V., 2012, CEPR DISCUSSION PAPE; Agur I, 2010, TECHNICAL REPORT; Angelini P, 1996, J BANK FINANC, V20, P853, DOI 10.1016/0378-4266(95)00029-1; Battiston S, 2012, J ECON DYN CONTROL, V36, P1121, DOI 10.1016/j.jedc.2012.04.001; Battiston S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00541; Battiston S, 2012, J FINANC STABIL, V8, P138, DOI 10.1016/j.jfs.2012.01.002; Boss M, 2004, QUANT FINANC, V4, P677, DOI 10.1080/14697680400020325; Brownlees CT, 2010, VOLATILITY CO UNPUB; Brunnermeier M.K., 2011, NBER WORKING PAPER S; Cont R, 2011, NETWORK STRUCTURE SY; D'Agostino G, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/68006; Darvas Z., 2011, SOC EC, V33, P449, DOI [https://doi.org/10.1556/SocEc.33.2011.3.2, DOI 10.1556/SOCEC.33.2011.3.2, 10.1556/SocEc.33.2011.3.2]; Drehmann M, 2013, J FINANC INTERMED, V22, P586, DOI 10.1016/j.jfi.2013.08.001; Eisenberg L, 2001, MANAGE SCI, V47, P236, DOI 10.1287/mnsc.47.2.236.9835; Finger K, 2012, TECHNICAL REPORT; Freixas X, 2000, J MONEY CREDIT BANK, V32, P611, DOI 10.2307/2601198; Fricke D., 2012, KIEL WORKING PAPERS; Gauthier C, 2012, J FINANC INTERMED, V21, P594, DOI 10.1016/j.jfi.2012.01.005; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Hart O, 2011, AM LAW ECON REV, V13, P453, DOI 10.1093/aler/ahr001; Hatzopoulos V, 2015, QUANT FINANC, V15, P693, DOI 10.1080/14697688.2014.969889; Hellwig M, 2010, TECHNICAL REPORT; Hojman DA, 2008, J ECON THEORY, V139, P295, DOI 10.1016/j.jet.2007.07.007; Horvath BL, 2013, DISTURBING INTERACTI; Hu DN, 2012, MIS QUART, V36, P1269; Iakova D, 2001, FINANCIAL SECTOR EVO; Iori G, 2001, PHYSICA A, V299, P205, DOI 10.1016/S0378-4371(01)00297-7; Iori G, 2008, J ECON DYN CONTROL, V32, P259, DOI 10.1016/j.jedc.2007.01.032; Iori G, 2006, J ECON BEHAV ORGAN, V61, P525, DOI 10.1016/j.jebo.2004.07.018; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; O'Brien YYC, 2007, RESERVE REQUIREMENT; Poledna S, 2014, ARXIV14018026; Raddant M, 2013, J INT MONEY FINANCE; Schafer D, 2012, INTERECONOMICS, V47, P76, DOI [10.1007/s10272-012-0409-8, DOI 10.1007/S10272-012-0409-8]; Schluter T, 2012, TECHNICAL REPORT; Thakor AV, 1996, J FINANC, V51, P279, DOI 10.2307/2329310; Upper C, 2011, J FINANC STABIL, V7, P111, DOI 10.1016/j.jfs.2010.12.001; Whelan K, 2009, TECHNICAL REPORT; Xuqing H, 2013, SCI REP, V3; Zlatic V, 2009, EUR PHYS J B, V67, P271, DOI 10.1140/epjb/e2009-00007-9	40	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0114928	10.1371/journal.pone.0114928	http://dx.doi.org/10.1371/journal.pone.0114928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177351	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600001
J	Arshad, A; Yang, B; Bienemann, AS; Barua, NU; Wyatt, MJ; Woolley, M; Johnson, DE; Edler, KJ; Gill, SS				Arshad, Azeem; Yang, Bin; Bienemann, Alison S.; Barua, Neil U.; Wyatt, Marcella J.; Woolley, Max; Johnson, Dave E.; Edler, Karen J.; Gill, Steven S.			Convection-Enhanced Delivery of Carboplatin PLGA Nanoparticles for the Treatment of Glioblastoma	PLOS ONE			English	Article							MALIGNANT GLIOMA; GLIADEL WAFERS; BRAIN; DRUG; RELEASE; TRIAL; FLOW	We currently use Convection-Enhanced Delivery (CED) of the platinum-based drug, carboplatin as a novel treatment strategy for high grade glioblastoma in adults and children. Although initial results show promise, carboplatin is not specifically toxic to tumour cells and has been associated with neurotoxicity at high infused concentrations in pre-clinical studies. Our treatment strategy requires intermittent infusions due to rapid clearance of carboplatin from the brain. In this study, carboplatin was encapsulated in lactic acid-glycolic acid copolymer (PLGA) to develop a novel drug delivery system. Neuronal and tumour cytotoxicity were assessed in primary neuronal and glioblastoma cell cultures. Distribution, tissue clearance and toxicity of carboplatin nanoparticles following CED was assessed in rat and porcine models. Carboplatin nanoparticles conferred greater tumour cytotoxicity, reduced neuronal toxicity and prolonged tissue half-life. In conclusion, this drug delivery system has the potential to improve the prognosis for patients with glioblastomas.	[Arshad, Azeem; Bienemann, Alison S.; Barua, Neil U.; Wyatt, Marcella J.; Gill, Steven S.] Univ Bristol, Sch Clin Sci, Funct Neurosurg Res Grp, Bristol, Avon, England; [Woolley, Max; Johnson, Dave E.] Renishaw Plc, Neurol Applicat Div, London, Glos, England; [Yang, Bin; Edler, Karen J.] Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England	University of Bristol; Renishaw plc; University of Bath	Gill, SS (corresponding author), Univ Bristol, Sch Clin Sci, Funct Neurosurg Res Grp, Bristol, Avon, England.	steven.gill@nbt.nhs.uk	Edler, Karen/A-7324-2011	Edler, Karen/0000-0001-5822-0127; Yang, Bin/0000-0002-6810-9585	Medical Research Council [MR/J005134/1]; MRC [MR/J005134/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Medical Research Council (http://www.mrc.ac.uk) Ref number: MR/J005134/1. Co-authors M. Woolley and D.E. Johnson are employed by Renishaw Plc. Renishaw Plc., were involved in the Medical Research Council grant application where they provided 'in kind contribution' support for the grant application MR/J005134/1 and provided support in the form of salaries for authors M. Woolley and D.E. Johnson, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barua NU, 2013, ACTA NEUROCHIR, V155, P1459, DOI 10.1007/s00701-013-1700-6; Barua NU, 2013, J NEUROSCI METH, V214, P223, DOI 10.1016/j.jneumeth.2013.02.007; Barua NU, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-2; Barua NU, 2014, DRUG DELIVERY; Barua NU, 2013, ACTA NEUROCHIR WIEN; Bienemann A, 2012, J NEUROSCI METH, V203, P284, DOI 10.1016/j.jneumeth.2011.10.002; Birks SM, 2011, NEURO-ONCOLOGY, V13, P950, DOI 10.1093/neuonc/nor108; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Bogdahn U, 2011, NEURO-ONCOLOGY, V13, P132, DOI 10.1093/neuonc/noq142; Bregy A, 2013, EXPERT REV ANTICANC, V13, P1453, DOI 10.1586/14737140.2013.840090; Bruce JN, 2011, NEUROSURGERY; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Fleming AB, 2002, CLIN PHARMACOKINET, V41, P403, DOI 10.2165/00003088-200241060-00002; Govender T, 1999, J CONTROL RELEASE, V57, P171, DOI 10.1016/S0168-3659(98)00116-3; Groothuis DR, 2007, J CEREBR BLOOD F MET, V27, P43, DOI 10.1038/sj.jcbfm.9600315; MacKay JA, 2005, BRAIN RES, V1035, P139, DOI 10.1016/j.brainres.2004.12.007; Mehta Ankit I, 2012, Curr Drug Discov Technol, V9, P305; Nance EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003594; PARDRIDGE WM, 1989, NEUROBIOL AGING, V10, P636, DOI 10.1016/0197-4580(89)90160-7; Parker KA, 2006, APOPTOSIS OF HUMAN M; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Saito R, 2006, J NEUROSCI METH, V154, P225, DOI 10.1016/j.jneumeth.2005.12.027; Sawyer AJ, 2011, DRUG DELIV TRANSL RE, V1, P34, DOI 10.1007/s13346-010-0001-3; Skinner EK, 2012, CHEM COMMUN, V48, P9260, DOI 10.1039/c2cc34926d; Song XR, 2010, J PHARM SCI-US, V99, P4874, DOI 10.1002/jps.22200; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2007, J CLIN ONCOL, V25, P4127, DOI 10.1200/JCO.2007.11.8554; WALLNER KE, 1989, INT J RADIAT ONCOL, V16, P1405, DOI 10.1016/0360-3016(89)90941-3; Westphal M, 2003, NEURO-ONCOLOGY, V5, P79, DOI 10.1215/15228517-5-2-79; White E, 2012, J NEURO-ONCOL, V108, P77, DOI 10.1007/s11060-012-0833-4; White E, 2012, CONTEMP CLIN TRIALS, V33, P320, DOI 10.1016/j.cct.2011.10.010; White E, 2011, J NEUROSCI METH, V199, P87, DOI 10.1016/j.jneumeth.2011.04.027; Whittle IR, 1999, BRIT J NEUROSURG, V13, P132, DOI 10.1080/02688699943871; Yanamandra N, 2004, ONCOGENE, V23, P2339, DOI 10.1038/sj.onc.1207406; Zhang ZP, 2008, PHARM RES-DORDR, V25, P1925, DOI 10.1007/s11095-008-9611-6; Zhou JB, 2013, P NATL ACAD SCI USA, V110, P11751, DOI 10.1073/pnas.1304504110	36	54	54	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132266	10.1371/journal.pone.0132266	http://dx.doi.org/10.1371/journal.pone.0132266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186224	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700034
J	Bodi, Z; Bottley, A; Archer, N; May, ST; Fray, RG				Bodi, Zsuzsanna; Bottley, Andrew; Archer, Nathan; May, Sean T.; Fray, Rupert G.			Yeast m(6)A Methylated mRNAs Are Enriched on Translating Ribosomes during Meiosis, and under Rapamycin Treatment	PLOS ONE			English	Article							REVEALS; N-6-METHYLADENOSINE; N6-METHYLADENOSINE; SPORULATION; SUBUNIT; PROGRAM; IME4; M6A	Interest in mRNA methylation has exploded in recent years. The sudden interest in a 40 year old discovery was due in part to the finding of FTO's (Fat Mass Obesity) N6-methyl-adenosine (m(6)A) deaminase activity, thus suggesting a link between obesity-associated diseases and the presence of m(6)A in mRNA. Another catalyst of the sudden rise in mRNA methylation research was the release of mRNA methylomes for human, mouse and Saccharomyces cerevisiae. However, the molecular function, or functions of this mRNA 'epimark' remain to be discovered. There is supportive evidence that m(6)A could be a mark for mRNA degradation due to its binding to YTH domain proteins, and consequently being chaperoned to P bodies. Nonetheless, only a subpopulation of the methylome was found binding to YTHDF2 in HeLa cells. The model organism Saccharomyces cerevisiae, has only one YTH domain protein (Pho92, Mrb1), which targets PHO4 transcripts for degradation under phosphate starvation. However, mRNA methylation is only found under meiosis inducing conditions, and PHO4 transcripts are apparently non-methylated. In this paper we set out to investigate if m(6)A could function alternatively to being a degradation mark in S. cerevisiae; we also sought to test whether it can be induced under non-standard sporulation conditions. We find a positive association between the presence of m(6)A and message translatability. We also find m(6)A induction following prolonged rapamycin treatment.	[Bodi, Zsuzsanna; Bottley, Andrew; Archer, Nathan; Fray, Rupert G.] Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England; [May, Sean T.] Univ Nottingham, NASC, Loughborough LE12 5RD, Leics, England	University of Nottingham; University of Nottingham	Fray, RG (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough LE12 5RD, Leics, England.	rupert.fray@nottingham.ac.uk	Archer, Nathan/T-7120-2019; may, sean t/B-6838-2012; Fray, Rupert G/A-9059-2016	Archer, Nathan/0000-0002-3356-6161; may, sean t/0000-0001-5282-3250; Fray, Rupert G/0000-0002-3935-8945; Bodi, Zsuzsa/0000-0002-3219-9224	Biotechnology and Biological Sciences Research Council [BB/K013637/1]; BBSRC [BB/M008606/1]; University of Nottingham; BBSRC [BB/L010100/1, BB/E022758/1, BB/E01772X/1, BB/K013637/1, BB/I001271/1, BB/J018961/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E022758/1, BB/L010100/1, 976176, BB/M008606/1, BB/J018961/1, G17764, G18881, BB/E01772X/1, BB/I001271/1, BBS/B/1356X] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Nottingham; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by a Biotechnology and Biological Sciences Research Council (http://www.bbsrc.co.uk) grant for RNA methylation work in Rupert Fray's lab BB/K013637/1, and is currently supported by BBSRC grant BB/M008606/1. Additional support was provided by the University of Nottingham.	Agarwala SD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002732; Bodi Z, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00048; Bodi Z, 2010, NUCLEIC ACIDS RES, V38, P5327, DOI 10.1093/nar/gkq266; Bokar JA, 1997, RNA, V3, P1233; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; HOROWITZ S, 1984, P NATL ACAD SCI-BIOL, V81, P5667, DOI 10.1073/pnas.81.18.5667; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; KANE SE, 1985, MOL CELL BIOL, V5, P2298, DOI 10.1128/MCB.5.9.2298; Kang HJ, 2014, BIOCHEM J, V457, P391, DOI 10.1042/BJ20130862; KASSIR Y, 1991, METHOD ENZYMOL, V194, P94; Kruse S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00126; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Luo GZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6630; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Nakazawa N, 2012, J BIOSCI BIOENG, V113, P491, DOI 10.1016/j.jbiosc.2011.11.026; NICHOLS JL, 1981, PLANT SCI LETT, V21, P75, DOI 10.1016/0304-4211(81)90071-7; PERRY RP, 1974, CELL, V1, P37, DOI 10.1016/0092-8674(74)90153-6; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Sambrook J., 2001, MOL CLONING LAB MANU; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Tomoo K, 2002, BIOCHEM J, V362, P539, DOI 10.1042/0264-6021:3620539; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; WEI CM, 1976, BIOCHEMISTRY-US, V15, P397, DOI 10.1021/bi00647a024; Zheng XF, 1997, P NATL ACAD SCI USA, V94, P3070, DOI 10.1073/pnas.94.7.3070; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883	35	50	56	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132090	10.1371/journal.pone.0132090	http://dx.doi.org/10.1371/journal.pone.0132090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186436	gold, Green Submitted, Green Published			2022-12-27	WOS:000358198700028
J	Falissard, B; Barry, C; Hassler, C; Letrait, M; Macher, G; Marty, F; Ramos, E; Revah-Levy, A; Robert, P; de Singly, F				Falissard, Bruno; Barry, Caroline; Hassler, Christine; Letrait, Muriel; Macher, Guillaume; Marty, Francois; Ramos, Elsa; Revah-Levy, Anne; Robert, Philippe; de Singly, Francois			When Assessing Intra-Familial Relationships, Are Sociologists, Psychoanalysts and Psychiatrists Really Considering Different Constructs? An Empirical Study	PLOS ONE			English	Article							ADOLESCENT; VALIDATION	This paper aimed to look for the existence of a common core when envisaging intra-familial interactions as perceived by adolescents, which could be shared by sociology, psychoanalysis and child and adolescent psychiatry. An empirical study based on a mixed-method design collected the responses of 194 adolescents to the instruction "In the next half hour, would you please write as freely as you wish about your relationships in your family, explaining how things are". All answers were then analyzed and 18 dimensions related to 3 different theoretical frameworks were rated blind using numerical scores by two independent raters from each discipline. Inter-rater reliability was good. A parallel analysis evidenced a strong underlying factor explaining a large amount of variance (>50%). This factor is bipolar, it reflects the level of positivity/negativity in the adolescent's point of view concerning his/her intra-familial relationships. A second factor can marginally be considered (10% of the variance). The 2-factor analysis found one factor related to positive feelings and the other to negative feelings. This finding of unidimensionality supports family study as an intervention science.	[Falissard, Bruno; Barry, Caroline; Hassler, Christine; Revah-Levy, Anne] Univ Paris Sud, INSERM, U669, Paris, France; [Falissard, Bruno; Barry, Caroline; Hassler, Christine; Revah-Levy, Anne] Univ Paris 05, Paris, France; [Letrait, Muriel; Macher, Guillaume; Ramos, Elsa; de Singly, Francois] Univ Paris 05, CERLIS, Paris, France; [Marty, Francois; Robert, Philippe] Univ Paris 05, EA 4046, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Falissard, B (corresponding author), Univ Paris Sud, INSERM, U669, Paris, France.	falissard_b@wanadoo.fr		Marty, Francois/0000-0003-2824-7278; revah-levy, anne/0000-0003-1805-6275; barry, caroline/0000-0001-6668-524X	Fondation Nestle; Fondation Pfizer; ATP "adolescence", Universite Paris-Descartes	Fondation Nestle(Nestle SA); Fondation Pfizer; ATP "adolescence", Universite Paris-Descartes	The study had the benefit of unconditional grants from the Fondation Nestle, the Fondation Pfizer and ATP "adolescence", Universite Paris-Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger P.L, 1966, SOCIAL CONSTRUCTION; Bion W. R., 1962, LEARNING EXPERIENCE; BRENT DA, 1994, ACTA PSYCHIAT SCAND, V89, P52, DOI 10.1111/j.1600-0447.1994.tb01485.x; Canguilhem G., 1943, NORMAL PATHOLOGIQUE, VVolume 2015; Carlson C., 2001, HDB FAMILY MEASUREME, P1; De Singly F., 2005, SOI COUPLE FAMILLE F; Evans S, 2007, PLOS CLIN TRIALS, V2, DOI DOI 10.1371/journal.pone.0000551; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Gavazzi SM, 2011, FAMILIES ADOLESCENTS, P139; Honneth A., 1996, STRUGGLE RECOGNITION; Kadouri A, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-7; Lance CE, 2006, ORGAN RES METHODS, V9, P202, DOI 10.1177/1094428105284919; Masten AS, 1999, DEV PSYCHOPATHOL, V11, P143, DOI 10.1017/S0954579499001996; Mead G.M., 1934, MIND SELF SOC STANDP; RobinsonWhelen S, 1997, J PERS SOC PSYCHOL, V73, P1345, DOI 10.1037/0022-3514.73.6.1345; Rosenblum G. D., 2006, BLACKWELL HDB ADOLES, P269, DOI DOI 10.1002/9780470756607.CH13/SUMMARY; Rouquette A, 2011, INT J METH PSYCH RES, V20, P235, DOI 10.1002/mpr.352; SAVINWILLIAMS RC, 1986, DEV PSYCHOL, V22, P342, DOI 10.1037/0012-1649.22.3.342; Singly F., 2010, SOCIOLOGIE FAMILLE C; Snyder DK, 2000, FAMILY PSYCHOL INTER; Touliatos J, 2001, HDB FAMILY MEASUREME	21	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132153	10.1371/journal.pone.0132153	http://dx.doi.org/10.1371/journal.pone.0132153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186606	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700030
J	Fisher-Hoch, SP; Vatcheva, KP; Rahbar, MH; McCormick, JB				Fisher-Hoch, Susan P.; Vatcheva, Kristina P.; Rahbar, Mohammad H.; McCormick, Joseph B.			Undiagnosed Diabetes and Pre-Diabetes in Health Disparities	PLOS ONE			English	Article							INSULIN-RESISTANCE; UNITED-STATES; SOCIOECONOMIC-STATUS; HIP RATIO; POPULATION; PREVALENCE; GLUCOSE; RISK; RACE/ETHNICITY; REGRESSION	Globally half of all diabetes mellitus is undiagnosed. We sought to determine the extent and characteristics of undiagnosed type 2 diabetes mellitus and pre-diabetes in Mexican Americans residing in the United States. This disadvantaged population with 50% lifetime risk of diabetes is a microcosm of the current pandemic. We accessed baseline data between 2004 and 2014 from 2,838 adults recruited to our Cameron County Hispanic Cohort (CCHC); a two-stage randomly selected 'Framingham-like' cohort of Mexican Americans on the US Mexico border with severe health disparities. We examined prevalence, risk factors and metabolic health in diagnosed and undiagnosed diabetes and pre-diabetes. Two thirds of this Mexican American population has diabetes or pre-diabetes. Diabetes prevalence was 28.0%, nearly half undiagnosed, and pre-diabetes 31.6%. Mean BMI among those with diabetes was 33.5 kg/m(2) compared with 29.0 kg/m(2) for those without diabetes. Significant risk factors were low income and educational levels. Most with diabetes had increased waist/hip ratio. Lack of insurance and access to health services played a decisive role in failure to have diabetes diagnosed. Participants with undiagnosed diabetes and pre-diabetes had similar measures of poor metabolic health similar but generally not as severe as those with diagnosed diabetes. More than 50% of a minority Mexican American population in South Texas has diabetes or pre-diabetes and is metabolically unhealthy. Only a third of diabetes cases were diagnosed. Sustained efforts are imperative to identify, diagnose and treat individuals in underserved communities.	[Fisher-Hoch, Susan P.; Vatcheva, Kristina P.; McCormick, Joseph B.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol, Brownsville, TX 77030 USA; [Rahbar, Mohammad H.] Univ Texas Houston, Sch Publ Hlth, Sch Med, Dept Internal Med,Div Clin & Translat Sci,Div Epi, Houston, TX 77030 USA; [Rahbar, Mohammad H.] Univ Texas Hlth Sci Ctr Houston, Ctr Clin & Translat Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston	Fisher-Hoch, SP (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol, Brownsville Campus, Brownsville, TX 77030 USA.	susan.p.fisher-hoch@uth.tmc.edu		Vatcheva, Kristina/0000-0002-7260-2524; McCormick, Joseph/0000-0002-5844-8102	National Institute on Minority Health and Health Disparities [MD000170 P2]; National Center for Advancing Translational Science [CTSA UL1 TR000371]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371, UL1TR001120] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD000170] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center for Advancing Translational Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institute on Minority Health and Health Disparities (http://www.nimhd.nih.gov/), Grant # MD000170 P2 and the National Center for Advancing Translational Science (http://www.ncats.nih.gov/), Grant # CTSA UL1 TR000371. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Balluz LS, 2008, ETHNIC DIS, V18, P450; Borrell LN, 2006, AM J PUBLIC HEALTH, V96, P1637, DOI 10.2105/AJPH.2005.072884; Boyle JP, 2001, DIABETES CARE, V24, P1936, DOI 10.2337/diacare.24.11.1936; Brancati FL, 1996, ANN EPIDEMIOL, V6, P67, DOI 10.1016/1047-2797(95)00095-X; Danaei Goodarz, 2009, Popul Health Metr, V7, P16, DOI 10.1186/1478-7954-7-16; Davis K, 2014, NEW ENGL J MED, V371, P1567, DOI 10.1056/NEJMp1406707; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; Diaz-Apodaca BA, 2010, REV PANAM SALUD PUBL, V28, P174, DOI 10.1590/S1020-49892010000900007; Ennis S.R., 2011, C20108804 US CENS BU; Fisher-Hoch SP, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110298; Fisher-Hoch SP, 2010, PREV CHRONIC DIS, V7; Gellad WF, 2007, J GEN INTERN MED, V22, P1572, DOI 10.1007/s11606-007-0385-z; Gregg EW, 2014, LANCET DIABETES ENDO, V2, P867, DOI 10.1016/S2213-8587(14)70161-5; HAFFNER SM, 1995, DIABETES, V44, P1386, DOI 10.2337/diabetes.44.12.1386; International Diabetes Federation, 2013, IDF DIAB ATL; Li Q, 2012, CLIN INVEST MED, V35, pL237; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Lipscombe LL, 2014, LANCET DIABETES 0812; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Molarius A, 1999, INT J OBESITY, V23, P116, DOI 10.1038/sj.ijo.0800772; Pan American Health Organization, 2009, US MEX BORD AR, P1; Pan JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021515; Pan JJ, 2015, WORLD J HEPATO UNPUB; Perreault L, 2012, LANCET, V379, P2243, DOI 10.1016/S0140-6736(12)60525-X; Qu HQ, 2012, DIABETES CARE, V35, P2591, DOI 10.2337/dc12-0636; Reininger BM, 2014, J IMMIGR MINOR HEALT, V16, P218, DOI 10.1007/s10903-012-9714-3; Reininger BM, 2010, HEALTH PROMOT PRACT, V11, P347, DOI 10.1177/1524839908321486; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; United States Census Bureau, 2012, USA QUICKFACTS; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Weston SR, 2005, HEPATOLOGY, V41, P372, DOI 10.1002/hep.20554; World Health Organization, 2011, WAIST CIRC WAIST HIP	36	51	51	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133135	10.1371/journal.pone.0133135	http://dx.doi.org/10.1371/journal.pone.0133135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186342	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700099
J	Gouveia-Figueira, S; Spath, J; Zivkovic, AM; Nording, ML				Gouveia-Figueira, Sandra; Spath, Jana; Zivkovic, Angela M.; Nording, Malin L.			Profiling the Oxylipin and Endocannabinoid Metabolome by UPLC-ESI-MS/MS in Human Plasma to Monitor Postprandial Inflammation	PLOS ONE			English	Article							C-REACTIVE PROTEIN; FATTY-ACID LEVELS; ARACHIDONIC-ACID; N-ACYLETHANOLAMINES; ANANDAMIDE; OBESE; OVERWEIGHT; MEDIATORS; MARKERS; ALPHA	Bioactive lipids, including oxylipins, endocannabinoids, and related compounds may function as specific biochemical markers of certain aspects of inflammation. However, the postprandial responsiveness of these compounds is largely unknown; therefore, changes in the circulating oxylipin and endocannabinoid metabolome in response to a challenge meal were investigated at six occasions in a subject who freely modified her usual diet. The dietary change, and especially the challenge meal itself, represented a modification of precursor fatty acid status, with expectedly subtle effects on bioactive lipid levels. To detect even the slightest alteration, highly sensitive ultra-performance liquid chromatography (UPLC) coupled to electrospray ionization (ESI) tandem mass spectrometry (MS/MS) methods for bioactive lipid profiling was employed. A previously validated UPLC-ESI-MS/MS method for profiling the endocannabinoid metabolome was used, while validation of an UPLC-ESI-MS/MS method for oxylipin analysis was performed with acceptable outcomes for a majority of the parameters according to the US Food and Drug Administration guidelines for linearity (0.9938 < R-2 < 0.9996), limit of detection (0.0005-2.1 pg on column), limit of quantification (0.0005-4.2 pg on column), inter-and intraday accuracy (85-115%) and precision (<5%), recovery (40-109%) and stability (40-105%). Forty-seven of fifty-two bioactive lipids were detected in plasma samples at fasting and in the postprandial state (0.5, 1, and 3 hours after the meal). Multivariate analysis showed a significant shift of bioactive lipid profiles in the postprandial state due to inclusion of dairy products in the diet, which was in line with univariate analysis revealing seven compounds (NAGly, 9-HODE, 13-oxo-ODE, 9(10)-EpOME, 12(13)-EpOME, 20-HETE, and 11,12-DHET) that were significantly different between background diets in the postprandial state (but not at fasting). The only change in baseline levels at fasting was displayed by TXB2. Furthermore, postprandial responsiveness was detected for seven compounds (POEA, SEA, 9(10)-DiHOME, 12(13)-DiHOME, 13-oxo-ODE, 9-HODE, and 13-HODE). Hence, the data confirm that the UPLC-ESI-MS/MS method performance was sufficient to detect i) a shift, in the current case most notably in the postprandial bioactive lipid metabolome, caused by changes in diet and ii) responsiveness to a challenge meal for a subset of the oxylipin and endocannabinoid metabolome. To summarize, we have shown proof-of-concept of our UPLC-ESI-MS/MS bioactive lipid protocols for the purpose of monitoring subtle shifts, and thereby useful to address lipid-mediated postprandial inflammation.	[Gouveia-Figueira, Sandra; Spath, Jana; Nording, Malin L.] Umea Univ, Dept Chem, Umea, Sweden; [Zivkovic, Angela M.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Zivkovic, Angela M.] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA	Umea University; University of California System; University of California Davis; University of California System; University of California Davis	Nording, ML (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	malin.nording@chem.umu.se		Zivkovic, Angela/0000-0002-2828-7862; Nording, Malin/0000-0002-1732-8147	MLN The Vinnova grant [2010-02070]; Sweden's innovation agency Vinnova; MLN Formas grant (MLN) [2010-303]; Swedish Research Council Formas; AMZ University of California Discovery Program [09 GEB-02 NHB]; SG-F Postdoctoral Kempe foundation	MLN The Vinnova grant; Sweden's innovation agency Vinnova(Vinnova); MLN Formas grant (MLN); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); AMZ University of California Discovery Program; SG-F Postdoctoral Kempe foundation	This work was supported by MLN The Vinnova grant: 2010-02070, Sweden's innovation agency Vinnova, http://www.vinnova.se/en/; MLN Formas grant (MLN): 2010-303, The Swedish Research Council Formas, http://www.formas.se/en/; AMZ University of California Discovery Program 09 GEB-02 NHB; and SG-F Postdoctoral Kempe foundation grant http://www.kempe.com/index_english.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 1997, PROSTAG LEUKOTR ESS, V56, P219, DOI 10.1016/S0952-3278(97)90538-X; Anuurad E, 2009, ATHEROSCLEROSIS, V205, P290, DOI 10.1016/j.atherosclerosis.2008.11.028; Arya F, 2010, BRIT J NUTR, V104, P724, DOI 10.1017/S0007114510001042; Baer DJ, 2004, AM J CLIN NUTR, V79, P969; Balvers MGJ, 2012, METABOLOMICS, V8, P1130, DOI 10.1007/s11306-012-0421-9; Blackburn P, 2006, OBESITY, V14, P1747, DOI 10.1038/oby.2006.201; Blackburn R, 2001, ARTERIOSCL THROM VAS, V21, P1962, DOI 10.1161/hq1201.099433; Burdge GC, 2005, BRIT J NUTR, V93, P3, DOI 10.1079/BJN20041282; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Di Marzo V, 1998, BBA-LIPID LIPID MET, V1392, P153, DOI 10.1016/S0005-2760(98)00042-3; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Dumlao DS, 2011, BBA-MOL CELL BIOL L, V1811, P724, DOI 10.1016/j.bbalip.2011.06.005; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Fowler CJ, 2012, TRENDS PHARMACOL SCI, V33, P468, DOI 10.1016/j.tips.2012.05.003; Fride E, 2005, EXP BIOL MED, V230, P225; Gachet MS, 2015, J CHROMATOGR B, V976, P6, DOI 10.1016/j.jchromb.2014.11.001; Gatta-Cherifi B, 2012, INT J OBESITY, V36, P880, DOI 10.1038/ijo.2011.165; Ghafouri N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027257; Gouveia-Figueira S, 2014, ANAL CHEM, V86, P1186, DOI 10.1021/ac403352e; Grapov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048852; Joosten MM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-49; Katcher HI, 2008, AM J CLIN NUTR, V87, P79, DOI 10.1093/ajcn/87.1.79; Liou YA, 2007, J NUTR, V137, P945, DOI 10.1093/jn/137.4.945; Maccarrone M, 2010, ANNU REV NUTR, V30, P423, DOI 10.1146/annurev.nutr.012809.104701; Manning PJ, 2008, OBESITY, V16, P2046, DOI 10.1038/oby.2008.334; Margioris AN, 2009, CURR OPIN CLIN NUTR, V12, P129, DOI 10.1097/MCO.0b013e3283232a11; Marowsky A, 2009, NEUROSCIENCE, V163, P646, DOI 10.1016/j.neuroscience.2009.06.033; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Masson CJ, 2011, J NUTR, V141, P816, DOI 10.3945/jn.110.136432; Meijerink J, 2013, BRIT J PHARMACOL, V169, P772, DOI 10.1111/bph.12030; Monteleone P, 2012, J CLIN ENDOCR METAB, V97, pE917, DOI 10.1210/jc.2011-3018; Moran LJ, 2007, J CLIN ENDOCR METAB, V92, P2944, DOI 10.1210/jc.2006-2336; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Naughton SS, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/361895; Neuhouser ML, 2012, J NUTR, V142, P369, DOI 10.3945/jn.111.149807; Nicholls SJ, 2006, J AM COLL CARDIOL, V48, P715, DOI 10.1016/j.jacc.2006.04.080; Nording ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076575; OLEFSKY JM, 1976, AM J CLIN NUTR, V29, P535, DOI 10.1093/ajcn/29.5.535; Payette C, 2009, METABOLISM, V58, P1593, DOI 10.1016/j.metabol.2009.05.011; Pellis L, 2012, METABOLOMICS, V8, P347, DOI 10.1007/s11306-011-0320-5; Pietraszek Anna, 2011, Rev Diabet Stud, V8, P477, DOI 10.1900/RDS.2011.8.477; Pintus S, 2013, BRIT J NUTR, V109, P1453, DOI 10.1017/S0007114512003224; Poppitt SD, 2008, NUTRITION, V24, P322, DOI 10.1016/j.nut.2007.12.012; Schuchardt JP, 2014, PROSTAG LEUKOTR ESS, V90, P27, DOI 10.1016/j.plefa.2013.12.008; Shearer GC, 2009, CURR ATHEROSCLER REP, V11, P403, DOI 10.1007/s11883-009-0061-3; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Sinclair AJ, 1996, J NUTR, V126, pS1110, DOI 10.1093/jn/126.suppl_4.1110S; Smilowitz JT, 2013, MOL NUTR FOOD RES, V57, P1319, DOI 10.1002/mnfr.201200808; Strassburg K, 2014, MOL NUTR FOOD RES, V58, P591, DOI 10.1002/mnfr.201300321; Strassburg K, 2012, ANAL BIOANAL CHEM, V404, P1413, DOI 10.1007/s00216-012-6226-x; Tulk HMF, 2009, METABOLISM, V58, P1709, DOI 10.1016/j.metabol.2009.05.031; Wang Y, 2014, J CHROMATOGR A, V1359, P60, DOI 10.1016/j.chroma.2014.07.006; Wong A, 2014, J LIPID RES, V55, P1902, DOI 10.1194/jlr.M048694; Yang J, 2012, FREE RADICAL BIO MED, V53, P160, DOI 10.1016/j.freeradbiomed.2012.05.001; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n; Zhang MJ, 2012, ANNU REV NUTR, V32, P203, DOI 10.1146/annurev-nutr-071811-150726; Zivkovic AM, 2009, METABOLOMICS, V5, P209, DOI 10.1007/s11306-008-0136-0; Zoerner AA, 2011, BBA-MOL CELL BIOL L, V1811, P706, DOI 10.1016/j.bbalip.2011.08.004	58	44	44	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132042	10.1371/journal.pone.0132042	http://dx.doi.org/10.1371/journal.pone.0132042			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186333	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700027
J	Guzman, CE; Bereza-Malcolm, LT; De Groef, B; Franks, AE				Guzman, Cesar E.; Bereza-Malcolm, Lara T.; De Groef, Bert; Franks, Ashley E.			Presence of Selected Methanogens, Fibrolytic Bacteria, and Proteobacteria in the Gastrointestinal Tract of Neonatal Dairy Calves from Birth to 72 Hours	PLOS ONE			English	Article							RUMEN; ESTABLISHMENT; COMMUNITY; NEWBORN; BORN; DNA	The microbial communities in the gastrointestinal tract of a young calf are essential for the anatomical and physiological development that permits a transition from milk to solid feed. Selected methanogens, fibrolytic bacteria, and proteobacteria were quantified in the rumen fluid and tissue, abomasum fluid, cecum fluid and tissue, and feces of Holstein bull calves on day 0 (0-20 mins after birth), day 1 (24 +/- 1 h after birth), day 2 (48 +/- 1 h after birth), and day 3 (72 +/- 1 h after birth). Methanogens, fibrolytic bacteria, and Geobacter spp. were found to be already present from birth, indicating that microbial colonization of the gastrointestinal tract occurred before or during delivery. The abundance of methanogens and Geobacter spp. differed between the days tested and between compartments of the digestive tract and feces, but such difference was not observed for fibrolytic bacteria. Our findings suggests that methanogens might have an alternative hydrogen provider such as Geobacter spp. during these early stages of postnatal development. In addition, fibrolytic bacteria were present in the rumen well before the availability of fibrous substrates, suggesting that they might use nutrients other than cellulose and hemicellose.	[Guzman, Cesar E.; Bereza-Malcolm, Lara T.; De Groef, Bert; Franks, Ashley E.] La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia	La Trobe University	Guzman, CE (corresponding author), La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia.	cerod12@outlook.com	Bereza-Malcolm, Lara/AAZ-5425-2020	De Groef, Bert/0000-0003-3191-852X; Franks, Ashley/0000-0003-1664-6060	Defence Science Institute, Defence Science and Technology Organisation, Office of Naval Research Global [N626909-13-1-N259]; Australian Research Council [LP140100459]	Defence Science Institute, Defence Science and Technology Organisation, Office of Naval Research Global; Australian Research Council(Australian Research Council)	LTBM and AEF, as part of Applied and Environmental Microbiology Laboratory at La Trobe University, receive support from the Defence Science Institute, Defence Science and Technology Organisation, Office of Naval Research Global (Award no. N626909-13-1-N259) and the Australian Research Council (Award no. LP140100459).	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Ardissone AN, 2014, PLOS ONE, V9; ASH RW, 1964, J PHYSIOL-LONDON, V172, P425, DOI 10.1113/jphysiol.1964.sp007430; Baldwin R L, 2004, J DAIRY SCI, V87, pE55, DOI [10.3168/jds.2012-5970, DOI 10.3168/JDS.S0022-0302(04)70061-2]; Denman SE, 2006, FEMS MICROBIOL ECOL, V58, P572, DOI 10.1111/j.1574-6941.2006.00190.x; Deppenmeier U, 2002, PROG NUCLEIC ACID RE, V71, P223, DOI 10.1016/S0079-6603(02)71045-3; Di Mauro A, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-15; DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; FONTY G, 1988, CAN J MICROBIOL, V34, P235, DOI 10.1139/m88-044; FONTY G, 1987, J GEN MICROBIOL, V133, P1835; Fonty G, 2007, APPL ENVIRON MICROB, V73, P6391, DOI 10.1128/AEM.00181-07; GILBERT WM, 1993, SEMIN PERINATOL, V17, P150; Guzman CE, 2015, ANIM SCI; Hammon HM, 2012, DOMEST ANIM ENDOCRIN, V43, P171, DOI 10.1016/j.domaniend.2012.02.005; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jung S, 2011, APPL ENVIRON MICROB, V77, P564, DOI 10.1128/AEM.01392-10; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Khan MA, 2011, J DAIRY SCI, V94, P1071, DOI 10.3168/jds.2010-3733; Krause DO, 2003, FEMS MICROBIOL REV, V27, P663, DOI 10.1016/S0168-6445(03)00072-X; LATEURROWET HJM, 1983, VET QUART, V5, P68, DOI 10.1080/01652176.1983.9693874; Leahy SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008926; Malmuthuge N, 2014, APPL ENVIRON MICROB, V80, P2021, DOI 10.1128/AEM.03864-13; Malmuthuge N, 2013, J DAIRY SCI, V96, P3189, DOI 10.3168/jds.2012-6200; McBee R. H., 1971, A Rev Ecol Syst, V2, P165, DOI 10.1146/annurev.es.02.110171.001121; MINATO H, 1992, J GEN APPL MICROBIOL, V38, P447, DOI 10.2323/jgam.38.447; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Morita M, 2011, MBIO, V2, DOI 10.1128/mBio.00159-11; MORVAN B, 1994, FEMS MICROBIOL LETT, V117, P249, DOI 10.1111/j.1574-6968.1994.tb06775.x; Rey M, 2014, J APPL MICROBIOL, V116, P245, DOI 10.1111/jam.12405; Rey M, 2012, J DAIRY SCI, V95, P1500, DOI 10.3168/jds.2011-4902; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Skillman LC, 2004, ANAEROBE, V10, P277, DOI 10.1016/j.anaerobe.2004.05.003; St-Pierre B, 2013, MOL BIOL REP, V40, P369, DOI 10.1007/s11033-012-2070-5; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; Xia Y, 2014, J APPL MICROBIOL, V116, P14, DOI 10.1111/jam.12356; Xu JL, 2013, MICROB ECOL, V66, P950, DOI 10.1007/s00248-013-0271-7; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	42	74	82	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133048	10.1371/journal.pone.0133048	http://dx.doi.org/10.1371/journal.pone.0133048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186002	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700089
J	Harmon, D; Lagi, M; de Aguiar, MAM; Chinellato, DD; Braha, D; Epstein, IR; Bar-Yam, Y				Harmon, Dion; Lagi, Marco; de Aguiar, Marcus A. M.; Chinellato, David D.; Braha, Dan; Epstein, Irving R.; Bar-Yam, Yaneer			Anticipating Economic Market Crises Using Measures of Collective Panic	PLOS ONE			English	Article							STOCK; DYNAMICS; BEHAVIOR; INDICATORS; ARBITRAGE; RISK	Predicting panic is of critical importance in many areas of human and animal behavior, notably in the context of economics. The recent financial crisis is a case in point. Panic may be due to a specific external threat or self-generated nervousness. Here we show that the recent economic crisis and earlier large single-day panics were preceded by extended periods of high levels of market mimicry-direct evidence of uncertainty and nervousness, and of the comparatively weak influence of external news. High levels of mimicry can be a quite general indicator of the potential for self-organized crises.	[Harmon, Dion; Lagi, Marco; de Aguiar, Marcus A. M.; Chinellato, David D.; Braha, Dan; Epstein, Irving R.; Bar-Yam, Yaneer] New England Complex Syst Inst, Cambridge, MA 02142 USA; [de Aguiar, Marcus A. M.; Chinellato, David D.] Univ Estadual Campinas, Campinas, SP, Brazil; [Braha, Dan] Univ Massachusetts, Dartmouth, MA USA; [Epstein, Irving R.] Brandeis Univ, Waltham, MA USA	Universidade Estadual de Campinas; University of Massachusetts System; University Massachusetts Dartmouth; Brandeis University	Braha, D (corresponding author), New England Complex Syst Inst, Cambridge, MA 02142 USA.	braha@necsi.edu	de Aguiar, Marcus A M/C-9137-2012; Chinellato, David D/D-3092-2012; de Aguiar, Marcus A. M./N-1377-2019	de Aguiar, Marcus A M/0000-0003-1379-7568; Chinellato, David D/0000-0002-9982-9577; 				Adrian T, 2009, AM ECON REV, V99, P600, DOI 10.1257/aer.99.2.600; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], 1988, EC EVOLVING COMPLEX; Bar-yam Y., 2019, DYNAMICS COMPLEX SYS; Bekaert G, 2000, REV FINANC STUD, V13, P1, DOI 10.1093/rfs/13.1.1; Berg A, 1999, J INT MONEY FINANC, V18, P561, DOI 10.1016/S0261-5606(99)00024-8; Bikhchandani S, 1998, J ECON PERSPECT, V12, P151, DOI 10.1257/jep.12.3.151; Bonanno G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046130; Bordo M., 2002, INT FINANC, V4, P139, DOI DOI 10.1111/1468-2362.00092; Borio C, 2002, PREPRINT; Braha D, 2002, IEEE T SEMICONDUCT M, V15, P91, DOI 10.1109/66.983448; Braha D, 2006, COMPLEXITY, V12, P59, DOI 10.1002/cplx.20156; Bree DS, 2010, PREPRINT; Bury T, 2014, PHYSICA A, V404, P79, DOI 10.1016/j.physa.2014.02.044; Calomiris C.W., 1990, FINANCIAL MARKETS FI, P109; CANNINGS C, 1975, ADV APPL PROBAB, V7, P264, DOI 10.2307/1426077; Caporale G.M., 2005, J EMPIR FINANC, V12, P476, DOI [DOI 10.1016/J.JEMPFIN.2004.02.005, 10.1016/j.jempfin.2004.02.005]; Carlson Mark A., 2007, FINANCE EC DISCUSSIO; CHAMBERLAIN G, 1983, ECONOMETRICA, V51, P1281, DOI 10.2307/1912275; Chinellato DD, 2015, J STAT PHYS, V159, P221, DOI 10.1007/s10955-015-1189-x; Chinellato DD, 2007, PREPRINT; Cho A, 2009, SCIENCE, V325, P408, DOI 10.1126/science.325_408; CHRISTIE AA, 1982, J FINANC ECON, V10, P407, DOI 10.1016/0304-405X(82)90018-6; Corsetti G, 1999, JPN WORLD ECON, V11, P305, DOI 10.1016/S0922-1425(99)00019-5; CUTLER DM, 1989, J PORTFOLIO MANAGE, V15, P4, DOI 10.3905/jpm.1989.409212; de Aguiar MAM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.031901; DELONG JB, 1990, J FINANC, V45, P379, DOI 10.2307/2328662; DELONG JB, 1990, J POLIT ECON, V98, P703, DOI 10.1086/261703; DIAMOND DW, 1983, J POLIT ECON, V91, P401, DOI 10.1086/261155; Dow Jones Averages, DOW JON IND AV; Eichengreen B., 1995, ECON POLICY, V10, P251, DOI DOI 10.2307/1344591; Emmert-Streib F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012884; Ewens W. J., 1979, MATH POPULATION GENE; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Feigenbaum JA, 1996, INT J MOD PHYS B, V10, P3737, DOI 10.1142/S021797929600204X; Forbes KJ, 2002, J FINANC, V57, P2223, DOI 10.1111/0022-1082.00494; Galbraith John Kenneth, 1954, THE GREAT CRASH 1929; Garas A, 2008, EUR PHYS J B, V63, P265, DOI 10.1140/epjb/e2008-00237-3; GLADSTEIN K, 1978, SIAM J APPL MATH, V34, P630, DOI 10.1137/0134050; GLAUBER RJ, 1963, J MATH PHYS, V4, P294, DOI 10.1063/1.1703954; Gopikrishnan P, 1998, EUR PHYS J B, V3, P139, DOI 10.1007/s100510050292; Grech D, 2004, PHYSICA A, V336, P133, DOI 10.1016/j.physa.2004.01.018; Guillaume D, 1997, FINANC STOCH, V1, P95, DOI [10.1007/s007800050018, DOI 10.1007/S007800050018]; Harmon D, 2011, PREPRINT; Harmon D, 2010, PREPRINT; Hill SA, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046105; Hommes C, 2009, HANDB FINANC, P217, DOI 10.1016/B978-012374258-2.50008-7; Jorion P, 2006, VALUE RISK NEW BENCH; Kaminsky G, 1998, INT MONET FUND S PAP, V45, P1; KARDAR M, 1986, PHYS REV LETT, V56, P889, DOI 10.1103/PhysRevLett.56.889; Kardar M., 2007, STAT PHYS FIELDS; Kenett DY, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S0218127412501817; Kenett DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015032; Kindleberger C., 1978, MANIAS PANICS CRASHE; Kritzman M, 2011, J PORTFOLIO MANAGE, V37, P112, DOI 10.3905/jpm.2011.37.4.112; Lagi M, 2011, PREPRINT; LeBaron B, 1999, J ECON DYN CONTROL, V23, P1487, DOI 10.1016/S0165-1889(98)00081-5; Levy M., 2000, MICROSCOPIC SIMULATI; Longin F, 2001, J FINANC, V56, P649, DOI 10.1111/0022-1082.00340; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Majdandzic A, 2014, NAT PHYS, V10, P34, DOI [10.1038/nphys2819, 10.1038/NPHYS2819]; MANN L, 1976, SOCIOMETRY, V39, P223, DOI 10.2307/2786515; Mantegna R. N., 2000, INTRO ECONOPHYSICS; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; Mawson AR, 2005, PSYCHIATRY, V68, P95, DOI 10.1521/psyc.2005.68.2.95; Morris G., 2005, COMPLETE GUIDE MARKE; NELSON DB, 1991, ECONOMETRICA, V59, P347, DOI 10.2307/2938260; Onnela JP, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.056110; Preis T, 2010, PHILOS T R SOC A, V368, P5707, DOI 10.1098/rsta.2010.0284; Preis T, 2010, J STAT PHYS, V138, P431, DOI 10.1007/s10955-009-9914-y; Quarantelli E., 2001, INT ENCY SOCIAL BEHA, P11020, DOI 10.1016/B0-08-043076-7/01867-2; Rose AK, 2011, EUR ECON REV, V55, P309, DOI 10.1016/j.euroecorev.2010.12.006; ROSS SA, 1976, J ECON THEORY, V13, P341, DOI 10.1016/0022-0531(76)90046-6; Russell Investments, RUSS US EQ IND CONST; SCHARFSTEIN DS, 1990, AM ECON REV, V80, P465; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Shapira Y, 2011, AIP ADV, V1, DOI 10.1063/1.3598412; Smelser N. J., 1963, THEORY COLLECTIVE BE; Smith RD, 2009, J KOREAN PHYS SOC, V54, P2460, DOI 10.3938/jkps.54.2460; Sornette D, 1996, J PHYS I, V6, P167, DOI 10.1051/jp1:1996135; Sornette D, 2003, WHY STOCK MARKETS CRASH: CRITICAL EVENTS IN COMPLEX FINANCIAL SYSTEMS, P1; Sornette D., 2001, Quantitative Finance, V1, P452, DOI 10.1088/1469-7688/1/4/305; Sornette D, 1997, PHYSICA A, V245, P411, DOI 10.1016/S0378-4371(97)00318-X; Sornette D, 2002, SCI DISASTERS, P411; Sornette D, 2006, FRONTIERS COLL, P95; Vandewalle N, 2000, PREPRINT; WATTERSON G, 1961, ANN MATH STAT, V32, P716, DOI 10.1214/aoms/1177704967; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wolfenstein M., 1957, DISASTER; Wu GJ, 2001, REV FINANC STUD, V14, P837, DOI 10.1093/rfs/14.3.837	94	27	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131871	10.1371/journal.pone.0131871	http://dx.doi.org/10.1371/journal.pone.0131871			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26185988	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700025
J	Kasoji, SK; Pattenden, SG; Malc, EP; Jayakody, CN; Tsuruta, JK; Mieczkowski, PA; Janzen, WP; Dayton, PA				Kasoji, Sandeep K.; Pattenden, Samantha G.; Malc, Ewa P.; Jayakody, Chatura N.; Tsuruta, James K.; Mieczkowski, Piotr A.; Janzen, William P.; Dayton, Paul A.			Cavitation Enhancing Nanodroplets Mediate Efficient DNA Fragmentation in a Bench Top Ultrasonic Water Bath	PLOS ONE			English	Article							LIBRARY CONSTRUCTION; PARTIAL DIGESTION; CONTRAST AGENTS; MICROBUBBLES; DESTRUCTION; SHEARING; IMPACT; PCR	A perfluorocarbon nanodroplet formulation is shown to be an effective cavitation enhancement agent, enabling rapid and consistent fragmentation of genomic DNA in a standard ultrasonic water bath. This nanodroplet-enhanced method produces genomic DNA libraries and next-generation sequencing results indistinguishable from DNA samples fragmented in dedicated commercial acoustic sonication equipment, and with higher throughput. This technique thus enables widespread access to fast bench-top genomic DNA fragmentation.	[Kasoji, Sandeep K.; Tsuruta, James K.; Dayton, Paul A.] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Kasoji, Sandeep K.; Tsuruta, James K.; Dayton, Paul A.] N Carolina State Univ, Raleigh, NC USA; [Pattenden, Samantha G.; Jayakody, Chatura N.; Janzen, William P.] Univ N Carolina, Ctr Integrat Chem Biol & Drug Discovery, Eshelman Sch Pharm, Chapel Hill, NC USA; [Malc, Ewa P.; Mieczkowski, Piotr A.] Univ N Carolina, Dept Genet High Throughput Sequencing Facil, Chapel Hill, NC USA; [Tsuruta, James K.] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dayton, PA (corresponding author), Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA.	padayton@email.unc.edu		Kasoji, Sunny/0000-0002-4219-3424; Malc, Ewa/0000-0002-4596-1142; Mieczkowski, Piotr/0000-0003-2418-0096	National Institutes of Health [R21CA173124]; NATIONAL CANCER INSTITUTE [R21CA173124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by the National Institutes of Health R21CA173124. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NUCLEIC ACIDS RES, V9, P3015, DOI 10.1093/nar/9.13.3015; Aparicio Oscar, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1707s23; Bortz PDS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026015; Brachmann CB, 1998, YEAST, V14, P115; Burger G, 2007, NAT PROTOC, V2, P603, DOI 10.1038/nprot.2007.59; Chomas JE, 2000, APPL PHYS LETT, V77, P1056, DOI 10.1063/1.1287519; Chomas JE, 2001, J BIOMED OPT, V6, P141, DOI 10.1117/1.1352752; Gingrich JC, 1996, BIOTECHNIQUES, V21, P99; Gonzalez-Garay ML, 2014, PERS MED, V11, P523, DOI 10.2217/PME.14.34; Hengen PN, 1997, TRENDS BIOCHEM SCI, V22, P273, DOI 10.1016/S0968-0004(97)01080-3; HOHEISEL JD, 1989, NUCLEIC ACIDS RES, V17, P9571, DOI 10.1093/nar/17.23.9571; Knierim E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028240; Laugharn JA, 2013, Method and system for acoustically treating material, Patent No. [US8459121 B2, 8459121]; Martin KH, 2013, WIRES NANOMED NANOBI, V5, P329, DOI 10.1002/wnan.1219; Morey M, 2013, MOL GENET METAB, V110, P3, DOI 10.1016/j.ymgme.2013.04.024; Oefner PJ, 1996, NUCLEIC ACIDS RES, V24, P3879, DOI 10.1093/nar/24.20.3879; OKPODU CM, 1994, BIOTECHNIQUES, V16, P154; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Poptsova MS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04532; Roe Bruce A, 2004, Methods Mol Biol, V255, P171; SEED B, 1982, GENE, V19, P201, DOI 10.1016/0378-1119(82)90007-5; Shah Y. T., 2012, CAVITATION REACTION; Sheeran PS, 2015, ULTRASOUND MED BIOL, V41, P814, DOI 10.1016/j.ultrasmedbio.2014.10.020; Sheeran PS, 2012, CURR PHARM DESIGN, V18, P2152; Sheeran PS, 2012, BIOMATERIALS, V33, P3262, DOI 10.1016/j.biomaterials.2012.01.021; Sheeran PS, 2011, ULTRASOUND MED BIOL, V37, P1518, DOI 10.1016/j.ultrasmedbio.2011.05.021; Shi WT, 2000, ULTRASOUND MED BIOL, V26, P1009, DOI 10.1016/S0301-5629(00)00223-4; Teytelman L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006700; Thomas F, 2014, CURR OPIN ONCOL, V26, P347, DOI 10.1097/CCO.0000000000000078; Thorstenson YR, 1998, GENOME RES, V8, P848, DOI 10.1101/gr.8.8.848; Wong KK, 1997, NUCLEIC ACIDS RES, V25, P4169, DOI 10.1093/nar/25.20.4169	31	27	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133014	10.1371/journal.pone.0133014	http://dx.doi.org/10.1371/journal.pone.0133014			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186461	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700084
J	Ho, TH; Nateras, RN; Yan, H; Park, JG; Jensen, S; Borges, C; Lee, JH; Champion, MD; Tibes, R; Bryce, AH; Carballido, EM; Todd, MA; Joseph, RW; Wong, WW; Parker, AS; Stanton, ML; Castle, EP				Ho, Thai H.; Nateras, Rafael Nunez; Yan, Huihuang; Park, Jin G.; Jensen, Sally; Borges, Chad; Lee, Jeong Heon; Champion, Mia D.; Tibes, Raoul; Bryce, Alan H.; Carballido, Estrella M.; Todd, Mark A.; Joseph, Richard W.; Wong, William W.; Parker, Alexander S.; Stanton, Melissa L.; Castle, Erik P.			A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; CHROMATIN IMMUNOPRECIPITATION; SULFENIC ACID; PLASMA-ALBUMIN; REDOX STATE; STORAGE; PATHOLOGY; CYSTEINYLATION; PROCUREMENT; EXPRESSION	To address the need to study frozen clinical specimens using next-generation RNA, DNA, chromatin immunoprecipitation (ChIP) sequencing and protein analyses, we developed a biobank work flow to prospectively collect biospecimens from patients with renal cell carcinoma (RCC). We describe our standard operating procedures and work flow to annotate pathologic results and clinical outcomes. We report quality control outcomes and nucleic acid yields of our RCC submissions (N=16) to The Cancer Genome Atlas (TCGA) project, as well as newer discovery platforms, by describing mass spectrometry analysis of albumin oxidation in plasma and 6 ChIP sequencing libraries generated from nephrectomy specimens after histone H3 lysine 36 trimethylation (H3K36me3) immunoprecipitation. From June 1, 2010, through January 1, 2013, we enrolled 328 patients with RCC. Our mean (SD) TCGA RNA integrity numbers (RINs) were 8.1 (0.8) for papillary RCC, with a 12.5% overall rate of sample disqualification for RIN <7. Banked plasma had significantly less albumin oxidation (by mass spectrometry analysis) than plasma kept at 25 degrees C (P<.001). For ChIP sequencing, the FastQC score for average read quality was at least 30 for 91% to 95% of paired-end reads. In parallel, we analyzed frozen tissue by RNA sequencing; after genome alignment, only 0.2% to 0.4% of total reads failed the default quality check steps of Bowtie2, which was comparable to the disqualification ratio (0.1%) of the 786-O RCC cell line that was prepared under optimal RNA isolation conditions. The overall correlation coefficients for gene expression between Mayo Clinic vs TCGA tissues ranged from 0.75 to 0.82. These data support the generation of high-quality nucleic acids for genomic analyses from banked RCC. Importantly, the protocol does not interfere with routine clinical care. Collections over defined time points during disease treatment further enhance collaborative efforts to integrate genomic information with outcomes.	[Ho, Thai H.; Tibes, Raoul; Bryce, Alan H.; Carballido, Estrella M.] Mayo Clin, Div Hematol & Oncol, Scottsdale, AZ 85259 USA; [Nateras, Rafael Nunez; Castle, Erik P.] Mayo Clin Hosp, Dept Urol, Phoenix, AZ USA; [Yan, Huihuang] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Park, Jin G.] Arizona State Univ, Biodesign Inst, Ctr Personalized Diagnost, Tempe, AZ USA; [Jensen, Sally; Borges, Chad] Arizona State Univ, Dept Chem & Biochem, Biodesign Inst, Ctr Personalized Diagnost, Tempe, AZ USA; [Lee, Jeong Heon] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Champion, Mia D.] Mayo Clin, Div Biomed Stat & Informat, Scottsdale, AZ USA; [Todd, Mark A.] Mayo Clin, Div Anat Pathol, Scottsdale, AZ USA; [Joseph, Richard W.] Mayo Clin, Div Hematol & Oncol, Jacksonville, FL 32224 USA; [Wong, William W.] Mayo Clin, Dept Radiat Oncol, Scottsdale, AZ USA; [Parker, Alexander S.] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA; [Stanton, Melissa L.] Mayo Clin, Dept Lab Med Pathol, Scottsdale, AZ USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Ho, TH (corresponding author), Mayo Clin, Div Hematol & Oncol, Scottsdale, AZ 85259 USA.	ho.thai@mayo.edu	Bryce, Alan/W-1765-2019; Tibes, Raoul/AAV-1683-2020	Bryce, Alan/0000-0002-0206-3895; Tibes, Raoul/0000-0002-1372-8733; Ho, Thai/0000-0003-0023-2939; Joseph, Richard/0000-0001-6102-4661	Mayo Clinic Center for Individualized Medicine Epigenomics Program; K12 grant from the National Institutes of Health [CA90628]; Career Development Award from the Fraternal Order of Eagles; Kathryn H. and Roger Penske Career Development Award; NATIONAL CANCER INSTITUTE [K12CA090628] Funding Source: NIH RePORTER	Mayo Clinic Center for Individualized Medicine Epigenomics Program; K12 grant from the National Institutes of Health; Career Development Award from the Fraternal Order of Eagles; Kathryn H. and Roger Penske Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	T.H.H. was supported by funding from the Mayo Clinic Center for Individualized Medicine Epigenomics Program; a K12 grant CA90628 from the National Institutes of Health; a Career Development Award from the Fraternal Order of Eagles; and a Kathryn H. and Roger Penske Career Development Award to Support Medical Research. H. Y., J.H.L., and M.D.C. were supported by funding from the Mayo Clinic Center for Individualized Medicine Epigenomics Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson A, 2013, BIOPRESERV BIOBANK, V11, P366, DOI 10.1089/bio.2013.0038; [Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Bar-Or D, 2005, PRENATAL DIAG, V25, P245, DOI 10.1002/pd.1122; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Borges CR, 2014, MOL CELL PROTEOMICS, V13, P1890, DOI 10.1074/mcp.M114.038455; Carmignani L, 2012, PATHOL ONCOL RES, V18, P663, DOI 10.1007/s12253-011-9492-6; Chantalat S, 2011, GENOME RES, V21, P1426, DOI 10.1101/gr.118091.110; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choueiri TK, 2014, ANN ONCOL, V25, P2178, DOI 10.1093/annonc/mdu445; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Esgueva R, 2012, DIAGN MOL PATHOL, V21, P61, DOI 10.1097/PDM.0b013e31823b6da6; Fanelli M, 2011, NAT PROTOC, V6, P1905, DOI 10.1038/nprot.2011.406; Fanelli M, 2010, P NATL ACAD SCI USA, V107, P21535, DOI 10.1073/pnas.1007647107; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Ho TH, ONCOGENE HH IN PRESS, P1; Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0; Kang Byunghak, 2013, Genomics & Informatics, V11, P211, DOI 10.5808/GI.2013.11.4.211; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu NW, 2013, CLIN CANCER RES, V19, P42, DOI 10.1158/1078-0432.CCR-12-2606; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagumo K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085216; Nakanishi T, 2003, KIDNEY INT, V63, P1137, DOI 10.1046/j.1523-1755.2003.00808.x; Nunez-Nateras R, 2014, UROL ONCOL, V32; Olson JE, 2014, MAYO CLIN PROC, V89, P276, DOI 10.1016/j.mayocp.2013.12.007; Olson JE, 2013, MAYO CLIN PROC, V88, P952, DOI 10.1016/j.mayocp.2013.06.006; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Regazzoni L, 2013, FREE RADICAL RES, V47, P172, DOI 10.3109/10715762.2012.756139; Rehder DS, 2010, BIOCHEMISTRY-US, V49, P7748, DOI 10.1021/bi1008694; Shabihkhani M, 2014, CLIN BIOCHEM, V47, P258, DOI 10.1016/j.clinbiochem.2014.01.002; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Soejima A, 2004, BLOOD PURIFICAT, V22, P525, DOI 10.1159/000082524; Sun H, 2015, ANN SURG ONCOL; Turell L, 2009, BRAZ J MED BIOL RES, V42, P305, DOI 10.1590/S0100-879X2009000400001; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Turell L, 2009, J CHROMATOGR B, V877, P3384, DOI 10.1016/j.jchromb.2009.03.035; Wu WQ, 2015, UROLOGY, V85, P299, DOI 10.1016/j.urology.2014.10.030; Yan HH, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-280; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	45	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132831	10.1371/journal.pone.0132831	http://dx.doi.org/10.1371/journal.pone.0132831			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181416	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198200038
J	Zhao, GF; Xue, M; Hu, YY; Lai, SC; Chen, SJ; Wang, LJ				Zhao, Guangfeng; Xue, Meng; Hu, Yingying; Lai, Sanchuan; Chen, Shujie; Wang, Liangjing			How Commonly Is the Diagnosis of Gastric Low Grade Dysplasia Upgraded following Endoscopic Resection? A Meta-Analysis	PLOS ONE			English	Article							FORCEPS BIOPSY; EPITHELIAL NEOPLASIA; VIENNA CLASSIFICATION; MUCOSAL RESECTION; GASTROINTESTINAL-TRACT; SUBMUCOSAL DISSECTION; MAGNIFYING ENDOSCOPY; LESIONS; ACCURACY; POLYPS	Gastric dysplasia is a well-known precancerous lesion. Though the diagnosis of gastric low grade dysplasia (LGD) is generally made from endoscopic forceps biopsy (EFB), the accuracy is doubtful after numerous EFB-proven gastric LGD were upgraded to gastric high grade dysplasia (HGD) or even carcinoma (CA) by further diagnostic test with the procedure of endoscopic resection (ER). We aimed to evaluate the upgraded diagnosis rate (UDR) and the risk factors by ER in EFB-proven gastric LGD lesions. Two investigators independently searched studies reporting the UDR by ER in EFB-proven gastric LGD lesions from databases and analyzed the overall UDR, HGD-UDR and CA-UDR. The pooled UDR by ER in EFB-proven gastric LGD lesions was 25.0%(95% CI, 20.2%-29.8%), made up of HGD-UDR and CA-UDR by rates of 16.7% (95% CI, 12.8%-20.6%) and 6.9% (95% CI, 4.2%-9.6%) respectively. Lesion size larger than 2 cm, surface with depression and nodularity under endoscopic examinations were the major risk factors associated with UDR. In conclusion, one quarter of EFB-proven gastric LGD lesions will be diagnosed as advanced lesions, including gastric HGD (16.7%) and gastric CA (6.9%) by ER. The diagnosis of those LGD lesions with an endoscopic diameter larger than 2cm, and depressed or nodular surface are more likely to be upgraded after ER.	[Zhao, Guangfeng] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Emergency, Hangzhou 310003, Zhejiang, Peoples R China; [Xue, Meng; Hu, Yingying; Wang, Liangjing] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Guangfeng; Xue, Meng; Hu, Yingying; Lai, Sanchuan; Chen, Shujie; Wang, Liangjing] Zhejiang Univ, Inst Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Lai, Sanchuan; Chen, Shujie] Zhejiang Univ, Sch Med, Sir Runrun Shaw Hosp, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Wang, LJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	wanglj76@hotmail.com	Hu, Ying/GQZ-8100-2022		National Natural Science Foundation of China [81472214, 81302070, 81272678]; National Basic Research Program of China (973 Program) [2012CB945004]; Science and technology innovation team of Zhejiang Province [2013TD13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Science and technology innovation team of Zhejiang Province	National Natural Science Foundation of China (81472214, 81302070, 81272678) (http://www.nsfc.gov.cn/); National Basic Research Program of China (973 Program), (2012CB945004) (http://www.973.gov.cn/English/Index.aspx); Science and technology innovation team of Zhejiang Province (2013TD13) (http://www.zjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004276.pub3; Cho SJ, 2011, ENDOSCOPY, V43, P465, DOI 10.1055/s-0030-1256236; Choi CW, 2014, DIGEST DIS SCI, V59, P421, DOI 10.1007/s10620-013-2874-8; Correa P, 2012, J DIGEST DIS, V13, P2, DOI 10.1111/j.1751-2980.2011.00550.x; Dinis-Ribeiro M, 2012, ENDOSCOPY, V44, P74, DOI 10.1055/s-0031-1291491; Du YQ, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-21; Graham D., 2010, WHO CLASSIFICATION T, V4th; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Hwang EJ, 2012, GASTROENTEROL ENDOSC, V54, pS1131; Jeon HK, 2014, GASTRIC CANCER, V17, P661, DOI 10.1007/s10120-013-0322-2; Keswani RN, 2011, GASTROINTEST ENDOSC, V74, P411, DOI 10.1016/j.gie.2011.03.1238; Kim HS, 2006, GASTROINTEST ENDOSC, V63, pAB150, DOI 10.1016/j.gie.2006.03.283; Kim Ji Ho, 2012, Korean J Gastroenterol, V59, P354; Kim MK, 2014, DIGEST DIS SCI, V59, P428, DOI 10.1007/s10620-013-2805-8; Kim YJ, 2010, ENDOSCOPY, V42, P620, DOI 10.1055/s-0030-1255524; Koulaouzidis A, 2012, GASTROINTEST ENDOSC, V76, P983, DOI 10.1016/j.gie.2012.07.035; LANSDOWN M, 1990, GUT, V31, P977, DOI 10.1136/gut.31.9.977; Lauwers GY, 2004, MODERN PATHOL, V17, P2, DOI 10.1038/modpathol.3800012; Lee CK, 2010, J GASTROEN HEPATOL, V25, P1507, DOI 10.1111/j.1440-1746.2010.006367.x; Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185; Lim H, 2014, SURG ENDOSC, V28, P1256, DOI 10.1007/s00464-013-3316-6; Mei M, 2013, GASTROINTEST ENDOSC, V77, P578, DOI 10.1016/j.gie.2012.09.035; Muehldorfer SM, 2002, GUT, V50, P465, DOI 10.1136/gut.50.4.465; NAGAYO T, 1981, GANN, V72, P813; Othman MO, 2011, CLIN RES HEPATOL GAS, V35, P288, DOI 10.1016/j.clinre.2011.02.006; Park DI, 2001, ENDOSCOPY, V33, P501, DOI 10.1055/s-2001-15089; Pech Oliver, 2011, Gastrointest Endosc Clin N Am, V21, P81, DOI 10.1016/j.giec.2010.10.001; Rugge M, 2003, GUT, V52, P1111, DOI 10.1136/gut.52.8.1111; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Sharma P, 2013, PATHOLOGY, V45, P273, DOI 10.1097/PAT.0b013e32835f21d7; Stolte M, 2003, VIRCHOWS ARCH, V442, P99, DOI 10.1007/s00428-002-0680-3; Sung HY, 2009, EUR J GASTROEN HEPAT, V21, P190, DOI 10.1097/MEG.0b013e3283140ebd; Suriani R, 2011, DIGEST LIVER DIS, V43, pS229, DOI 10.1016/S1590-8658(11)60474-X; Szaloki T, 2006, SCAND J GASTROENTERO, V41, P1105, DOI 10.1080/00365520600615880; Testino G, 2006, PANMINERVA MED, V48, P109; Tsuji Y, 2012, GASTRIC CANCER, V15, P414, DOI 10.1007/s10120-011-0133-2; Walker E, 2008, CLEV CLIN J MED, V75, P431, DOI 10.3949/ccjm.75.6.431; Wears RL, 2002, ACAD EMERG MED, V9, P330, DOI 10.1197/aemj.9.4.330; Won CS, 2011, GUT LIVER, V5, P187, DOI 10.5009/gnl.2011.5.2.187; Yamada H, 2004, ENDOSCOPY, V36, P390, DOI 10.1055/s-2004-814330; Yao K, 2009, ENDOSCOPY, V41, P462, DOI 10.1055/s-0029-1214594; Yeh JM, 2010, CANCER-AM CANCER SOC, V116, P2941, DOI 10.1002/cncr.25030; YOU WC, 1993, CANCER RES, V53, P1317; Zhou Y, 2014, STAT MED, V33, P2701, DOI 10.1002/sim.6115	44	19	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132699	10.1371/journal.pone.0132699	http://dx.doi.org/10.1371/journal.pone.0132699			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182344	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198200025
J	Altarelli, F; Braunstein, A; Dall'Asta, L				Altarelli, Fabrizio; Braunstein, Alfredo; Dall'Asta, Luca			Statics and Dynamics of Selfish Interactions in Distributed Service Systems	PLOS ONE			English	Article							CONGESTION GAMES; EQUILIBRIA	We study a class of games which models the competition among agents to access some service provided by distributed service units and which exhibits congestion and frustration phenomena when service units have limited capacity. We propose a technique, based on the cavity method of statistical physics, to characterize the full spectrum of Nash equilibria of the game. The analysis reveals a large variety of equilibria, with very different statistical properties. Natural selfish dynamics, such as best-response, usually tend to large-utility equilibria, even though those of smaller utility are exponentially more numerous. Interestingly, the latter actually can be reached by selecting the initial conditions of the best-response dynamics close to the saturation limit of the service unit capacities. We also study a more realistic stochastic variant of the game by means of a simple and effective approximation of the average over the random parameters, showing that the properties of the average-case Nash equilibria are qualitatively similar to the deterministic ones.	[Altarelli, Fabrizio; Braunstein, Alfredo; Dall'Asta, Luca] Politecn Torino, Dept Appl Sci & Technol, Turin, Italy; [Altarelli, Fabrizio; Braunstein, Alfredo; Dall'Asta, Luca] Politecn Torino, Ctr Computat Sci, Turin, Italy; [Altarelli, Fabrizio; Braunstein, Alfredo; Dall'Asta, Luca] Coll Carlo Alberto, Moncalieri, Italy; [Braunstein, Alfredo] Human Genet Fdn, Turin, Italy	Polytechnic University of Turin; Polytechnic University of Turin; Collegio Carlo Alberto	Braunstein, A (corresponding author), Politecn Torino, Dept Appl Sci & Technol, Turin, Italy.	alfredo.braunstein@polito.it; luca.dallasta@polito.it	Braunstein, Alfredo/E-6924-2012	Braunstein, Alfredo/0000-0002-4562-3610	European Grant ERC Advanced Grant [267915]; Italian Futuro in Ricerca-FIRB [RBFR10QUW4]	European Grant ERC Advanced Grant; Italian Futuro in Ricerca-FIRB	The authors acknowledge the European Grant ERC Advanced Grant, Project No. 267915, http://erc.europa.eu; and the Italian Futuro in Ricerca 2010"-FIRB, Project No. RBFR10QUW4, http://futuroinricerca.miur.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann H, 2006, LECT NOTES COMPUT SC, V4286, P50; Altarelli F, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/09/P09011; Altarelli F, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07002; Altman E, 2006, COMPUT OPER RES, V33, P286, DOI 10.1016/j.cor.2004.06.005; Anderson SP, 2007, J ECON BEHAV ORGAN, V63, P120, DOI 10.1016/j.jebo.2005.05.006; [Anonymous], 2010, SOCIAL EC NETWORKS; Anshelevich E, 2008, SIAM J COMPUT, V38, P1602, DOI 10.1137/070680096; Baldassi C, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/12/P12013; Bhawalkar K, 2010, LECT NOTES COMPUT SC, V6347, P17, DOI 10.1007/978-3-642-15781-3_2; Braunstein A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030201; Challet, 2013, MINORITY GAMES INTER; Correa JR, 2004, MATH OPER RES, V29, P961, DOI 10.1287/moor.1040.0098; Culyer AJ., 1990, COMPETITION HLTH CAR; Czumaj A, 2008, ACM T ALGORITHMS, V4, DOI 10.1145/1367064.1367071; Dall'Asta L, 2011, J PUBLIC ECON THEORY, V13, P885, DOI 10.1111/j.1467-9779.2011.01523.x; Dall'Asta L, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061136; Gourves Laurent, 2012, Algorithmic Game Theory. Proceedings 5th International Symposium, SAGT 2012, P204, DOI 10.1007/978-3-642-33996-7_18; Koutsoupias E, 1999, LECT NOTES COMPUT SC, V1563, P404; Kuhn R, 1996, Z PHYS B CON MAT, V100, P231, DOI 10.1007/s002570050117; Lakemeyer G., 2003, EXPLORING ARTIFICIAL, P239; Levy G, 2005, Q J ECON, V120, P1507, DOI 10.1162/003355305775097489; Lijesen M, 2007, PUBLIC PRIVATE ROLES, P146; Liu MY, 2008, ANN ALLERTON CONF, P1146; Mavronicolas M, 2007, LECT NOTES COMPUT SC, V4708, P633; Mezard M, 2003, J STAT PHYS, V111, P1, DOI 10.1023/A:1022221005097; Mezard M, 2001, EUR PHYS J B, V20, P217, DOI 10.1007/PL00011099; Mezard M., 2009, INFORM PHYS COMPUTAT, pp 584, DOI [10.1093/acprof:oso/9780198570837.001.0001, DOI 10.1093/ACPROF:OSO/9780198570837.001, DOI 10.1093/ACPROF:OSO/9780198570837.001.0001]; Milchtaich I, 1996, GAME ECON BEHAV, V13, P111, DOI 10.1006/game.1996.0027; Monderer D, 1996, GAME ECON BEHAV, V14, P124, DOI 10.1006/game.1996.0044; MORITA T, 1964, J MATH PHYS, V5, P1401, DOI 10.1063/1.1704075; Nisan N, 2007, ALGORITHMIC GAME THEORY, P1, DOI 10.1017/CBO9780511800481; Ostrom E, 2008, TRAGEDY COMMONS NEW, P3573; Panagopoulou PN, 2007, J EXPT ALGORITHMICS, V11; Ramezanpour A, 2011, EUR PHYS J B, V81, P327, DOI 10.1140/epjb/e2011-10963-x; Rhim H, 2003, EUR J OPER RES, V149, P211, DOI 10.1016/S0377-2217(02)00445-9; Rosenthal R. W., 1973, International Journal of Game Theory, V2, P65, DOI 10.1007/BF01737559; Roughgarden T, 2004, GAME ECON BEHAV, V47, P389, DOI 10.1016/j.geb.2003.06.004; Roughgarden T, 2002, J ACM, V49, P236, DOI 10.1145/506147.506153; Suri S., 2004, P 16 ANN ACM S PAR A, P188; Yedidia JS, 2000, ADV NEURAL INFORM PR, V13, P689	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0119286	10.1371/journal.pone.0119286	http://dx.doi.org/10.1371/journal.pone.0119286			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177449	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600002
J	Chen, ML; Wu, YK; Narimatsu, H; Li, XQ; Wang, CM; Luo, JY; Zhao, GM; Chen, ZW; Xu, WH				Chen, Mingling; Wu, Yikang; Narimatsu, Hiroto; Li, Xueqing; Wang, Chunmei; Luo, Jianyong; Zhao, Genming; Chen, Zhongwen; Xu, Wanghong			Socioeconomic Status and Physical Activity in Chinese Adults: A Report from a Community-Based Survey in Jiaxing, China	PLOS ONE			English	Article							HEALTH; PATTERNS; LEISURE; COMPENDIUM; INACTIVITY; OBESITY; BURDEN; UPDATE; URBAN; AGE	Objectives This study examines the associations of socioeconomic status (SES) with intensity of different types of physical activity (PA) in Chinese adults, aimed at outlining and projecting socioeconomic disparities in PA among the population undergoing a rapid nutrition transition. Methods A community-based survey was conducted among 3,567 residents aged 30-65 years old in Jiaxing, China, in 2010. SES and PA were assessed by a structured questionnaire. SES was assessed as socioeconomic index (SEI) score based on self-reported educational attainment, household income and occupation. Metabolic equivalents (METs) were calculated for each subject to quantify the total amount of PA from occupation, exercise, transportation and housework. Results Intensity of overall PA in this population was 165 MET-hours/week, in which energy expenditure in occupational PA accounted for 82%. Both types and intensity of PA were significantly different by SES: middle SES groups had higher intensity of occupational activities; lower SES subjects engaged in more household work; whereas higher SES subjects were more likely to exercise, more active during commuting and had longer sedentary time. All the three components of SES, education attainment, income and occupation, contributed to socioeconomic disparities in PA in this population. Conclusions Our results suggest an overall insufficiency and socioeconomic inequalities in PA among Chinese adults in Jiaxing, a typical city experiencing a rapid urbanization in China. There is an urgent need to promote leisure-time activities in this population.	[Chen, Mingling; Zhao, Genming; Xu, Wanghong] Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Chen, Mingling; Zhao, Genming; Xu, Wanghong] Fudan Univ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Wu, Yikang; Li, Xueqing; Luo, Jianyong; Chen, Zhongwen] Jiaxing Ctr Dis Control & Prevent, Jiaxing, Peoples R China; [Narimatsu, Hiroto] Yamagata Univ, Grad Sch Med, Dept Publ Hlth, Yamagata 990, Japan; [Wang, Chunmei] Tongxiang Ctr Dis Control & Prevent, Tongxiang, Peoples R China	Fudan University; Fudan University; Yamagata University	Chen, ZW (corresponding author), Jiaxing Ctr Dis Control & Prevent, Jiaxing, Peoples R China.	czw2007@sohu.com; wanghong.xu@fudan.edu.cn	Narimatsu, Hiroto/ABC-9150-2021	Narimatsu, Hiroto/0000-0002-5302-5872; xu, wanghong/0000-0003-2045-2218; Chen, Mingling/0000-0001-7992-1838	Consulting Service for Center of Excellence in Global Health Policy Development and Governance in China [GHSP-CS-OP3-02]; Bureau of Science and Technology in Jiaxing, Zhejiang Province [2013AY21051-2]	Consulting Service for Center of Excellence in Global Health Policy Development and Governance in China; Bureau of Science and Technology in Jiaxing, Zhejiang Province	This work was supported by funding provided by the Consulting Service for Center of Excellence in Global Health Policy Development and Governance in China (No. GHSP-CS-OP3-02) and the Bureau of Science and Technology in Jiaxing, Zhejiang Province (No. 2013AY21051-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; Beenackers MA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-116; Borodulin K, 2008, J PHYS ACT HEALTH, V5, P242, DOI 10.1123/jpah.5.2.242; Cerin E, 2008, SOC SCI MED, V66, P2596, DOI 10.1016/j.socscimed.2008.02.012; Chen CM, 2006, GUIDELINE PREVENTING; Chen J, 2007, CATENA, V69, P1, DOI 10.1016/j.catena.2006.04.019; Cleland V, 2012, SOC SCI MED, V74, P1578, DOI 10.1016/j.socscimed.2012.01.031; Duncan O., 1961, SOCIOECONOMIC INDEX, P109; El-Sayed AM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-18; Farrell L, 2013, SOCIOECONOMIC GRADIE; Finger JD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1079; Gidlow C., 2006, HEALTH EDUC J, V65, P338, DOI DOI 10.1177/0017896906069378; Hamer M, 2012, J EPIDEMIOL COMMUN H, V66, P1110, DOI 10.1136/jech-2011-200505; Hu G, 2002, B WORLD HEALTH ORGAN, V80, P933; Jurj AL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-213; Kesaniemi YA, 2001, MED SCI SPORT EXER, V33, pS351; Khan KM, 2012, LANCET, V380, P59, DOI 10.1016/S0140-6736(12)60865-4; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee SA, 2007, MED SCI SPORT EXER, V39, P1700, DOI 10.1249/mss.0b013e3181238a52; Li Q, 2010, SOCIAL CLASS CURRENT; Liu HG, 2014, J NE NORMAL U PHILOS, P256; Maria Kamphuis CB, 2008, MED SCI SPORT EXER, V40, P71, DOI 10.1249/mss.0b013e318158e467; MORRIS JN, 1953, LANCET, V265, P1053; National Institute for Health and Clinical Excellence, 2008, PROM CREAT BUILT NAT; Ng SW, 2014, OBES REV, V15, P27, DOI 10.1111/obr.12127; Ng SW, 2012, OBES REV, V13, P659, DOI 10.1111/j.1467-789X.2011.00982.x; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; Organization WH, 2009, GLOB HLTH RISKS MORT; Parks SE, 2003, J EPIDEMIOL COMMUN H, V57, P29, DOI 10.1136/jech.57.1.29; Patro BK, 2012, INDIAN J PEDIATR, V79, P395, DOI 10.1007/s12098-011-0517-7; Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322; Rachel C, 2009, HLTH SURVEY ENGLAND; Saito Y, 2013, INT J ENV RES PUB HE, V10, P2028, DOI 10.3390/ijerph10052028; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wilson DK, 2004, ANN BEHAV MED, V28, P20, DOI 10.1207/s15324796abm2801_4; World Health Organization, 2003, GLOB PHYS ACT QUEST; Xu H.Z., 2012, CHIN LAND SCI, V26, P74; Zhang JY, 2012, CONSUMER EC, V28	41	31	33	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132918	10.1371/journal.pone.0132918	http://dx.doi.org/10.1371/journal.pone.0132918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177205	Green Published, gold			2022-12-27	WOS:000358197600179
J	Fan, JB; Chen, K; Amombo, E; Hu, ZR; Chen, L; Fu, JM				Fan, Jibiao; Chen, Ke; Amombo, Erick; Hu, Zhengrong; Chen, Liang; Fu, Jinmin			Physiological and Molecular Mechanism of Nitric Oxide (NO) Involved in Bermudagrass Response to Cold Stress	PLOS ONE			English	Article							STIMULATES SEED-GERMINATION; CHLOROPHYLL FLUORESCENCE; ELECTRON-TRANSPORT; FREEZING TOLERANCE; GENE-EXPRESSION; PLANT; ACCLIMATION; COUNTERACTS; TEMPERATURE; METABOLISM	Bermudagrass is widely utilized in parks, lawns, and golf courses. However, cold is a key factor limiting resource use in bermudagrass. Therefore, it is meaningful to study the mechanism of bermudagrass response to cold. Nitric oxide (NO) is a crucial signal molecule with multiple biological functions. Thus, the objective of this study was to investigate whether NO play roles in bermudagrass response to cold. Sodium nitroprusside (SNP) was used as NO donor, while 2-phenyl-4,4,5,5-tetramentylimidazoline-l-oxyl-3-xide (PTIO) plus NG-nitro-Larginine methyl ester (L-NAME) were applied as NO inhibitor. Wild bermudagrass was subjected to 4 degrees C in a growth chamber under different treatments (Control, SNP, PTIO + L-NAME). The results indicated lower levels of malondialdehyde (MDA) content and electrolyte leakage (EL), higher value for chlorophyll content, superoxide dismutase (SOD) and peroxidase (POD) activities after SNP treatment than that of PTIO plus L-NAME treatments under cold stress. Analysis of Chlorophyll (Chl) a fluorescence transient displayed that the OJIP transient curve was higher after treatment with SNP than that of treated with PTIO plus L-NAME under cold stress. The values of photosynthetic fluorescence parameters were higher after treatment with SNP than that of treated with PTIO plus L-NAME under cold stress. Expression of cold-responsive genes was altered under cold stress after treated with SNP or PTIO plus L-NAME. In summary, our findings indicated that, as an important strategy to protect bermudagrass against cold stress, NO could maintain the stability of cell membrane, up-regulate the antioxidant enzymes activities, recover process of photosystem II (PSII) and induce the expression of cold-responsive genes.	[Fan, Jibiao; Chen, Ke; Amombo, Erick; Hu, Zhengrong; Chen, Liang; Fu, Jinmin] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan 430074, Hubei, Peoples R China; [Fan, Jibiao; Amombo, Erick; Hu, Zhengrong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, L (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan 430074, Hubei, Peoples R China.	chenliang1034@126.com; jfu@wbgcas.cn	Amombo, Erick/P-2440-2019		China National Science Foundation (NSFC) [31272194, 31401915]; China-Africa Center for Research and Education [SAJC201325]; Hubei Province National Science Foundation Sciences [ZRY1326]; outstanding young talent program of CAS Key Laboratory of Plant Germplasm Enhancement and Specialty Agriculture [Y452341X01]	China National Science Foundation (NSFC)(National Natural Science Foundation of China (NSFC)); China-Africa Center for Research and Education; Hubei Province National Science Foundation Sciences; outstanding young talent program of CAS Key Laboratory of Plant Germplasm Enhancement and Specialty Agriculture	This work was supported by the China National Science Foundation (NSFC) (Grant Nos. 31272194 and 31401915), China-Africa Center for Research and Education (Grant No. SAJC201325), the Hubei Province National Science Foundation Sciences (Grant No. ZRY1326) and the outstanding young talent program of CAS Key Laboratory of Plant Germplasm Enhancement and Specialty Agriculture (Grant No. Y452341X01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 1996, J PLANT PHYSIOL, V148, P384, DOI 10.1016/S0176-1617(96)80270-7; Beligni MV, 2002, PLANT CELL ENVIRON, V25, P737, DOI 10.1046/j.1365-3040.2002.00857.x; Beligni MV, 1999, PLANTA, V208, P337, DOI 10.1007/s004250050567; Beligni MV, 2000, PLANTA, V210, P215, DOI 10.1007/PL00008128; Chen LA, 2011, PLANT CELL REP, V30, P463, DOI 10.1007/s00299-010-0952-3; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Fan JB, 2014, J AM SOC HORTIC SCI, V139, P699, DOI 10.21273/JASHS.139.6.699; HETHERINGTON SE, 1989, PLANT PHYSIOL, V90, P1609, DOI 10.1104/pp.90.4.1609; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Hou Y- D., 2010, PLANT SCI, V5, P125, DOI DOI 10.3923/jps.2010.125.136; Hu LX, 2012, J PLANT PHYSIOL, V169, P146, DOI 10.1016/j.jplph.2011.08.020; Jasid S, 2006, PLANT PHYSIOL, V142, P1246, DOI 10.1104/pp.106.086918; Kopyra M, 2003, PLANT PHYSIOL BIOCH, V41, P1011, DOI 10.1016/j.plaphy.2003.09.003; Le MQ, 2008, CRYOBIOLOGY, V57, P104, DOI 10.1016/j.cryobiol.2008.06.004; Leshem YY, 1998, PLANT PHYSIOL BIOCH, V36, P825, DOI 10.1016/S0981-9428(99)80020-5; Li HY, 2012, J AM SOC HORTIC SCI, V137, P80, DOI 10.21273/JASHS.137.2.80; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; Neill SJ, 2003, NEW PHYTOL, V159, P11, DOI 10.1046/j.1469-8137.2003.00804.x; Palavan-Unsal N, 2009, BOT REV, V75, P203, DOI 10.1007/s12229-009-9031-2; Samson G, 1999, PHOTOSYNTHETICA, V37, P163, DOI 10.1023/A:1007095619317; Santa-Cruz DM, 2010, PHYTOCHEMISTRY, V71, P1700, DOI 10.1016/j.phytochem.2010.07.009; Seregelyes C, 2003, PLANT SCI, V165, P541, DOI 10.1016/S0168-9452(03)00213-9; Shao RX, 2010, J PLANT PHYSIOL, V167, P472, DOI 10.1016/j.jplph.2009.10.020; Singh SP, 2009, POSTHARVEST BIOL TEC, V53, P101, DOI 10.1016/j.postharvbio.2009.04.007; Srivastava A, 1997, BBA-BIOENERGETICS, V1320, P95, DOI 10.1016/S0005-2728(97)00017-0; Stitt M, 2002, CURR OPIN PLANT BIOL, V5, P199, DOI 10.1016/S1369-5266(02)00258-3; Strasser BJ, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P977; Strasser R.J., 1999, CROP IMPROVEMENT FOO, P60; Strauss AJ, 2006, ENVIRON EXP BOT, V56, P147, DOI 10.1016/j.envexpbot.2005.01.011; Tao DL, 1998, CRYOBIOLOGY, V37, P38, DOI 10.1006/cryo.1998.2096; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Uchida A, 2002, PLANT SCI, V163, P515, DOI 10.1016/S0168-9452(02)00159-0; Wang HM, 2013, SCI WORLD J, DOI [10.1155/2013/658793, 10.1155/2013/865645]; Wang L., 2011, HUNAN AGR SCI, V62, P56; Wang L, 2011, HUNAN AGR SCI, V11, P62; Wanner LA, 1999, PLANT PHYSIOL, V120, P391, DOI 10.1104/pp.120.2.391; Wodala B, 2008, PLANT PHYSIOL, V146, P1920, DOI 10.1104/pp.107.110205; Zhang XZ, 2006, CROP SCI, V46, P2598, DOI 10.2135/cropsci2006.02.0108; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010	40	26	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132991	10.1371/journal.pone.0132991	http://dx.doi.org/10.1371/journal.pone.0132991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177459	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600197
J	Habka, D; Mann, D; Landes, R; Soto-Gutierrez, A				Habka, Dany; Mann, David; Landes, Ronald; Soto-Gutierrez, Alejandro			Future Economics of Liver Transplantation: A 20-Year Cost Modeling Forecast and the Prospect of Bioengineering Autologous Liver Grafts	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; ORTHOTOPIC TRANSPLANTATION; RESOURCE UTILIZATION; HEPATITIS-C; DISEASE; HEPATOCYTES; REGENERATION; FIBROBLASTS; THERAPY; UPDATE	During the past 20 years liver transplantation has become the definitive treatment for most severe types of liver failure and hepatocellular carcinoma, in both children and adults. In the U.S., roughly 16,000 individuals are on the liver transplant waiting list. Only 38% of them will receive a transplant due to the organ shortage. This paper explores another option: bioengineering an autologous liver graft. We developed a 20-year model projecting future demand for liver transplants, along with costs based on current technology. We compared these cost projections against projected costs to bioengineer autologous liver grafts. The model was divided into: 1) the epidemiology model forecasting the number of wait-listed patients, operated patients and postoperative patients; and 2) the treatment model forecasting costs (pre-transplant-related costs; transplant (admission)-related costs; and 10-year post-transplant-related costs) during the simulation period. The patient population was categorized using the Model for End- Stage Liver Disease score. The number of patients on the waiting list was projected to increase 23% over 20 years while the weighted average treatment costs in the pre-liver transplantation phase were forecast to increase 83% in Year 20. Projected demand for livers will increase 10% in 10 years and 23% in 20 years. Total costs of liver transplantation are forecast to increase 33% in 10 years and 81% in 20 years. By comparison, the projected cost to bioengineer autologous liver grafts is $9.7M based on current catalog prices for iPS-derived liver cells. The model projects a persistent increase in need and cost of donor livers over the next 20 years that's constrained by a limited supply of donor livers. The number of patients who die while on the waiting list will reflect this ever-growing disparity. Currently, bioengineering autologous liver grafts is cost prohibitive. However, costs will decline rapidly with the introduction of new manufacturing strategies and economies of scale.	[Habka, Dany] Hlth Syst Reform, Beirut, Lebanon; [Mann, David] Cellular Dynam Int, Madison, WI USA; [Landes, Ronald] Solving Organ Shortage, Austin, TX 78701 USA; [Soto-Gutierrez, Alejandro] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Soto-Gutierrez, Alejandro] Univ Pittsburgh, Thomas E Starzl Transplantat Inst, Pittsburgh, PA USA; [Soto-Gutierrez, Alejandro] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Soto-Gutierrez, Alejandro] SOS Whole Liver Res Community, Austin, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Landes, R (corresponding author), Solving Organ Shortage, Austin, TX 78701 USA.	rgl@sosorgans.org; sotogutierrez@upmc.edu			Health Systems Reform; Cellular Dynamics International; National Institutes of Health [DK099257]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099257] Funding Source: NIH RePORTER	Health Systems Reform; Cellular Dynamics International; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Dany Habka, a modeling and simulation expert with Health Systems Reform (www.healthsystemsreform.com), was engaged as a paid consultant by Solving Organ Shortage (www.solvingorganshortage.org) to develop the 20-year cost modeling forecast. Health Systems Reform provided support in the form of a salary for author Dany Habka, and Cellular Dynamics International (www.cellulardynamics.com) provided support in the form of a salary for author David A. Mann, but neither company had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Alejandro Soto-Gutierrez also receives support (DK099257) from The National Institutes of Health. The specific roles of these authors are articulated in the 'author contributions' section.	Alqahtani SA, 2012, CURR OPIN GASTROEN, V28, P230, DOI 10.1097/MOG.0b013e3283527f16; Ammori JB, 2008, J AM COLL SURGEONS, V206, P89, DOI 10.1016/j.jamcollsurg.2007.06.292; [Anonymous], 2014, HARVONI LEDIPASVIR S; Axelrod DA, 2014, AM J TRANSPLANT, V14, P70, DOI 10.1111/ajt.12494; Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067; Bentley TS, 2011, ORGAN TISSUE TRANSPL, P2; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Bredenkamp N, 2014, NAT CELL BIOL, V16, P902, DOI 10.1038/ncb3023; Buchanan P, 2009, LIVER TRANSPLANT, V15, P1270, DOI 10.1002/lt.21802; Busuttil RW, 2003, LIVER TRANSPLANT, V9, P651, DOI 10.1053/jlts.2003.50105; Ciria R, 2011, CURR OPIN ORGAN TRAN, V16, P489, DOI 10.1097/MOT.0b013e32834a94cf; Cooper DKC, 2013, J BIOMED RES, V27, P249, DOI 10.7555/JBR.27.20130063; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Geissler EK, 2013, CURR OPIN ORGAN TRAN, V18, P408, DOI 10.1097/MOT.0b013e328363319d; Graham JA, 2014, J HEPATOL, V61, P418, DOI 10.1016/j.jhep.2014.04.019; Hayden EC, 2014, NATURE, V507, P294, DOI 10.1038/507294a; Hoofnagle JH, 2014, NEW ENGL J MED, V370, P1552, DOI 10.1056/NEJMe1401508; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Inc. GS, 2015, HARV LED SOF TABL OR; Jimenez-Romero C, 2014, WORLD J GASTROENTERO, V20, P10691, DOI 10.3748/wjg.v20.i31.10691; Longworth L, 2003, LIVER TRANSPLANT, V9, P1295, DOI 10.1016/j.lts.2003.09.012; Ma XC, 2013, STEM CELL TRANSL MED, V2, P409, DOI 10.5966/sctm.2012-0160; Menzin J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-459; Nishikawa T, 2015, J CLIN INVEST, V125, P1533, DOI 10.1172/JCI73137; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Pawlotsky JM, 2015, GASTROENTEROLOGY, V148, P468, DOI 10.1053/j.gastro.2015.01.002; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Salvalaggio PR, 2011, LIVER TRANSPLANT, V17, P233, DOI 10.1002/lt.22230; Schnitzler MA, 2005, AM J TRANSPLANT, V5, P2289, DOI 10.1111/j.1600-6143.2005.01021.x; Schnitzler MA, 2001, AM J TRANSPLANT, V1, P360, DOI 10.1034/j.1600-6143.2001.10412.x; Showstack J, 1999, JAMA-J AM MED ASSOC, V281, P1381, DOI 10.1001/jama.281.15.1381; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Sohlenius-Sternbeck AK, 2006, TOXICOL IN VITRO, V20, P1582, DOI 10.1016/j.tiv.2006.06.003; Soltys KA, 2010, J HEPATOL, V53, P769, DOI 10.1016/j.jhep.2010.05.010; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Soto-Gutierrez A, 2012, J CLIN INVEST, V122, P3817, DOI 10.1172/JCI61974; (SRTR) OPaTNOaSRoTR, 2014, OPTN SRTR 2012 ANN D, P1; Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Torgerson D, 1999, BMJ-BRIT MED J, V318, P1413, DOI 10.1136/bmj.318.7195.1413; Ulvestad M, 2013, BIOCHEM PHARMACOL, V86, P691, DOI 10.1016/j.bcp.2013.06.029; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Washburn WK, 2006, AM J TRANSPLANT, V6, P2449, DOI 10.1111/j.1600-6143.2006.01490.x; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Yagi H, 2013, CELL TRANSPLANT, V22, P231, DOI 10.3727/096368912X654939; Yarbrough C, 2000, INT HUMAN GENOME SEQ; Yen EF, 2004, AM J TRANSPLANT, V4, P1703, DOI 10.1111/j.1600-6143.2004.00565.x; Zarrinpar A, 2013, NAT REV GASTRO HEPAT, V10, P434, DOI 10.1038/nrgastro.2013.88	52	44	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131764	10.1371/journal.pone.0131764	http://dx.doi.org/10.1371/journal.pone.0131764			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177505	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600063
J	Hafren, L; Einarsdottir, E; Kentala, E; Hammaren-Malmi, S; Bhutta, MF; MacArthur, CJ; Wilmot, B; Casselbrant, M; Conley, YP; Weeks, DE; Mandel, EM; Vaarala, O; Kallio, A; Melin, M; Nieminen, JK; Leinonen, E; Kere, J; Mattila, PS				Hafren, Lena; Einarsdottir, Elisabet; Kentala, Erna; Hammaren-Malmi, Sari; Bhutta, Mahmood F.; MacArthur, Carol J.; Wilmot, Beth; Casselbrant, Margaretha; Conley, Yvette P.; Weeks, Daniel E.; Mandel, Ellen M.; Vaarala, Outi; Kallio, Anna; Melin, Merit; Nieminen, Janne K.; Leinonen, Eira; Kere, Juha; Mattila, Petri S.			Predisposition to Childhood Otitis Media and Genetic Polymorphisms within the Toll-Like Receptor 4 (TLR4) Locus	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; EFFUSION; ASSOCIATION; HERITABILITY; PATHOGENESIS; RESPONSES; CHILDREN; LINKAGE; EPIDEMIOLOGY; SYMPTOMS	Background Predisposition to childhood otitis media (OM) has a strong genetic component, with polymorphisms in innate immunity genes suspected to contribute to risk. Studies on several genes have been conducted, but most associations have failed to replicate in independent cohorts. Methods We investigated 53 gene polymorphisms in a Finnish cohort of 624 cases and 778 controls. A positive association signal was followed up in a tagging approach and tested in an independent Finnish cohort of 205 cases, in a British cohort of 1269 trios, as well as in two cohorts from the United States (US); one with 403 families and the other with 100 cases and 104 controls. Results In the initial Finnish cohort, the SNP rs5030717 in the TLR4 gene region showed significant association (OR 1.33, P=.003) to OM. Tagging SNP analysis of the gene found rs1329060 (OR 1.33, P=.002) and rs1329057 (OR 1.29, P=.003) also to be associated. In the more severe phenotype the association was stronger. This finding was supported by an independent Finnish case cohort, but the associations failed to replicate in the British and US cohorts. In studies on TLR4 signaling in 20 study subjects, the three-marker risk haplotype correlated with a decreased TNF alpha secretion in myeloid dendritic cells. Conclusions The TLR4 gene locus, regulating the innate immune response, influences the genetic predisposition to childhood OM in a subpopulation of patients. Environmental factors likely modulate the genetic components contributing to the risk of OM.	[Hafren, Lena; Kentala, Erna; Hammaren-Malmi, Sari; Mattila, Petri S.] Univ Helsinki, Cent Hosp, Dept Otorhinolaryngol, Helsinki, Finland; [Einarsdottir, Elisabet; Kere, Juha] Karolinska Inst, Ctr Innovat Med, Dept Biosci & Nutr, Huddinge, Sweden; [Bhutta, Mahmood F.] UCL Ear Inst, London, England; [MacArthur, Carol J.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Wilmot, Beth] Oregon Hlth & Sci Univ, Oregon Clin & Translat Res Inst, Portland, OR 97201 USA; [Wilmot, Beth] Oregon Hlth & Sci Univ, Div Bioinformat & Computat Biol, Portland, OR 97201 USA; [Casselbrant, Margaretha; Mandel, Ellen M.] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA; [Conley, Yvette P.] Univ Pittsburgh, Dept Nursing & Human Genet, Pittsburgh, PA USA; [Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Vaarala, Outi] Univ Helsinki, Inst Clin Med, Helsinki, Finland; [Kallio, Anna; Melin, Merit; Nieminen, Janne K.] Natl Inst Hlth & Welf THL, Dept Vaccinat & Immune Protect, Helsinki, Finland; [Leinonen, Eira; Kere, Juha] Univ Helsinki, Mol Neurol Res Program, Helsinki, Finland; [Leinonen, Eira; Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; University of London; University College London; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki	Hafren, L (corresponding author), Univ Helsinki, Cent Hosp, Dept Otorhinolaryngol, Helsinki, Finland.	lena.hafren@helsinki.fi; petri.mattila@helsinki.fi	Weeks, Daniel E/B-2995-2012; Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021	Weeks, Daniel E/0000-0001-9410-7228; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Conley, Yvette/0000-0002-1784-6067; Bhutta, Mahmood/0000-0002-4688-1670; Leinonen, Eira/0000-0001-5278-5426; Nieminen, Janne/0000-0003-4089-163X; Einarsdottir, Elisabet/0000-0003-3101-2285; Hafren, Lena/0000-0002-4968-4357	Finska Lakaresallskapet; Helsinki University Central Hospital Research Funds; Paivikki and Sakari Sohlberg Foundation; Sigrid Juselius Foundation; Swedish Research Council Formas; Wellcome Trust; Oregon Clinical and Translational Research Institute; National Center for Advancing Translational Sciences [UL1TR000128]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	Finska Lakaresallskapet; Helsinki University Central Hospital Research Funds; Paivikki and Sakari Sohlberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Wellcome Trust(Wellcome TrustEuropean Commission); Oregon Clinical and Translational Research Institute; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by Finska Lakaresallskapet (http://fls.fi/sallskapet/ to LH), the Helsinki University Central Hospital Research Funds (http://www.hus.fi/tutkijalle/Sivut/HUSn-sisainenhankeohje.aspx to PM), the Paivikki and Sakari Sohlberg Foundation (http://www.pss-saatio.fi/english.htm to PM), the Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation to JK), the Swedish Research Council Formas (http://www.formas.se/en/Financing/ to JK), the Wellcome Trust (http://www.wellcome.ac.uk/ to MB), the Oregon Clinical and Translational Research Institute (http://www.ohsu.edu/xd/research/centers-institutes/octri/ to CM), and the National Center for Advancing Translational Sciences, grant number UL1TR000128 (http://www.ncats.nih.gov/ to CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EK, 2013, JARO-J ASSOC RES OTO, V14, P791, DOI 10.1007/s10162-013-0411-2; Alles R, 2001, PEDIAT ALLERG IMM-UK, V12, P102, DOI 10.1046/j.0905-6157.2000.00008.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bhutta MF, 2014, AUDIOL NEURO-OTOL, V19, P210, DOI 10.1159/000358549; Casselbrant ML, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-85; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; Chantzi FM, 2006, ALLERGY, V61, P332, DOI 10.1111/j.1398-9995.2006.00971.x; Chen WM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-124; Daly KA, 2004, AM J HUM GENET, V75, P988, DOI 10.1086/426061; Daly KA, 2010, INT J PEDIATR OTORHI, V74, P231, DOI 10.1016/j.ijporl.2009.09.006; Darwiche SS, 2013, J TRAUMA ACUTE CARE, V74, P1454, DOI 10.1097/TA.0b013e3182905ed2; Deng MH, 2013, J IMMUNOL, V190, P5152, DOI 10.4049/jimmunol.1300496; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; GOYCOOLEA MV, 1991, OTOLARYNG CLIN N AM, V24, P757; Hafren L, 2012, CURR ALLERGY ASTHM R, V12, P582, DOI 10.1007/s11882-012-0292-1; Hafren L, 2012, INT J PEDIATR OTORHI, V76, P41, DOI 10.1016/j.ijporl.2011.09.026; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hammaren-Malmi S, 2005, ACTA OTO-LARYNGOL, V125, P1051, DOI 10.1080/00016480510038040; Kvestad E, 2004, TWIN RES, V7, P239, DOI 10.1375/twin.7.3.239; Leichtle A, 2011, CURR ALLERGY ASTHM R, V11, P78, DOI 10.1007/s11882-010-0158-3; Leichtle A, 2009, INNATE IMMUN-LONDON, V15, P205, DOI 10.1177/1753425909103170; MacArthur CJ, 2014, LARYNGOSCOPE, V124, P1229, DOI 10.1002/lary.24349; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342; Mucha SM, 2003, CURR ALLERGY ASTHM R, V3, P232, DOI 10.1007/s11882-003-0045-2; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenfeld RM, 2004, PEDIATRICS, V113, P1412, DOI 10.1542/peds.113.5.1412; Rovers M, 2002, AM J EPIDEMIOL, V155, P958, DOI 10.1093/aje/155.10.958; Rye MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048215; Rye MS, 2012, LARYNGOSCOPE, V122, P665, DOI 10.1002/lary.22506; Sale M, 2008, ASSOCRESOTOLARYNGOL, V31; Sale MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022297; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Umapathy D, 2007, INT J PEDIATR OTORHI, V71, P705, DOI 10.1016/j.ijporl.2006.12.017; Yazji I, 2013, P NATL ACAD SCI USA, V110, P9451, DOI 10.1073/pnas.1219997110; Ziakas PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081047	43	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132551	10.1371/journal.pone.0132551	http://dx.doi.org/10.1371/journal.pone.0132551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177520	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000358197600123
J	Ochieng, C; Ahenda, P; Vittor, AY; Nyoka, R; Gikunju, S; Wachira, C; Waiboci, L; Umuro, M; Kim, AA; Nderitu, L; Juma, B; Montgomery, JM; Breiman, RF; Fields, B				Ochieng, Caroline; Ahenda, Petronella; Vittor, Amy Y.; Nyoka, Raymond; Gikunju, Stella; Wachira, Cyrus; Waiboci, Lilian; Umuro, Mamo; Kim, Andrea A.; Nderitu, Leonard; Juma, Bonventure; Montgomery, Joel M.; Breiman, Robert F.; Fields, Barry			Seroprevalence of Infections with Dengue, Rift Valley Fever and Chikungunya Viruses in Kenya, 2007	PLOS ONE			English	Article							ARBOVIRAL INFECTIONS; ENTOMOLOGIC INVESTIGATIONS; EPIDEMIC; ISLAND; OUTBREAKS; FEATURES; COMOROS; FRANCE; ADULTS; UNION	Arthropod-borne viruses are a major constituent of emerging infectious diseases worldwide, but limited data are available on the prevalence, distribution, and risk factors for transmission in Kenya and East Africa. In this study, we used 1,091 HIV-negative blood specimens from the 2007 Kenya AIDS Indicator Survey (KAIS 2007) to test for the presence of IgG antibodies to dengue virus (DENV), chikungunya virus (CHIKV) and Rift Valley fever virus (RVFV). The KAIS 2007 was a national population-based survey conducted by the Government of Kenya to provide comprehensive information needed to address the HIV/AIDS epidemic. Antibody testing for arboviruses was performed on stored blood specimens from KAIS 2007 through a two-step sandwich IgG ELISA using either commercially available kits or CDC-developed assays. Out of the 1,091 samples tested, 210 (19.2%) were positive for IgG antibodies against at least one of the three arboviruses. DENV was the most common of the three viruses tested (12.5% positive), followed by RVFV and CHIKV (4.5% and 0.97%, respectively). For DENV and RVFV, the participant's province of residence was significantly associated (P <=.01) with seropositivity. Seroprevalence of DENV and RVFV increased with age, while there was no correlation between province of residence/age and seropositivity for CHIKV. Females had twelve times higher odds of exposure to CHIK as opposed to DENV and RVFV where both males and females had the same odds of exposure. Lack of education was significantly associated with a higher odds of previous infection with either DENV or RVFV (p < 0.01). These data show that a number of people are at risk of arbovirus infections depending on their geographic location in Kenya and transmission of these pathogens is greater than previously appreciated. This poses a public health risk, especially for DENV.	[Ochieng, Caroline; Ahenda, Petronella; Gikunju, Stella; Wachira, Cyrus] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Nairobi, Kenya; [Nyoka, Raymond; Kim, Andrea A.; Juma, Bonventure; Montgomery, Joel M.; Breiman, Robert F.; Fields, Barry] US Ctr Dis Control & Prevent, Global Dis Detect Program, Nairobi, Kenya; [Vittor, Amy Y.] Univ Florida, Emerging Pathogens Inst, Div Infect Dis & Global Med, Gainesville, FL USA; [Umuro, Mamo] Minist Publ Hlth & Sanitat, Nairobi, Kenya; [Breiman, Robert F.] Emory Univ, Atlanta, GA 30322 USA; [Waiboci, Lilian] Univ Nairobi, Nairobi, Kenya; [Nderitu, Leonard] Africa Biomed Labs, Nairobi, Kenya	Kenya Medical Research Institute; State University System of Florida; University of Florida; Emory University; University of Nairobi	Ochieng, C (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Nairobi, Kenya.	caochieng@kemricdc.org			United States Department of Defense, Defense Threat Reduction Agency (DTRA) [KE 02]	United States Department of Defense, Defense Threat Reduction Agency (DTRA)	This study was funded by the United States Department of Defense, Defense Threat Reduction Agency (DTRA), grant number KE 02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyangu AS, 2010, AM J TROP MED HYG, V83, P14, DOI 10.4269/ajtmh.2010.09-0293; Ayu SM, 2010, AM J TROP MED HYG, V83, P1245, DOI 10.4269/ajtmh.2010.10-0279; BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Blaylock JM, 2011, TRAVEL MED INFECT DI, V9, P246, DOI 10.1016/j.tmaid.2011.06.005; Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; JOHNSON BK, 1982, E AFR MED J, V59, P781; Kenya Ministry of Health, 2013, E AFR PUBL HLTH LAB, P1; Kularatne SAM, 2009, POSTGRAD MED J, V85, P342, DOI 10.1136/pgmj.2007.066746; Kuniholm MH, 2006, AM J TROP MED HYG, V74, P1078, DOI 10.4269/ajtmh.2006.74.1078; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664; Lutomiah J, 2013, J VECTOR ECOL, V38, P134, DOI 10.1111/j.1948-7134.2013.12019.x; Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16; Maina WK, 2014, JAIDS-J ACQ IMM DEF, V66, pS130, DOI 10.1097/QAI.0000000000000123; Mease LE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-371; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Nguku PM, 2010, AM J TROP MED HYG, V83, P5, DOI 10.4269/ajtmh.2010.09-0288; Ochieng C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-140; Pincus LB, 2008, J AM ACAD DERMATOL, V58, P308, DOI 10.1016/j.jaad.2007.08.042; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Renault P, 2007, AM J TROP MED HYG, V77, P727; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Saifur RGM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030919; Sang R, 2010, AM J TROP MED HYG, V83, P28, DOI 10.4269/ajtmh.2010.09-0319; Sang RC, 2008, AM J TROP MED HYG, V78, P77; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Sergon K, 2007, AM J TROP MED HYG, V76, P1189, DOI 10.4269/ajtmh.2007.76.1189; Sutherland LJ, 2011, AM J TROP MED HYG, V85, P158, DOI 10.4269/ajtmh.2011.10-0203; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635	33	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132645	10.1371/journal.pone.0132645	http://dx.doi.org/10.1371/journal.pone.0132645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177451	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600137
J	Poldervaart, JM; Rottger, E; Dekker, MS; Zuithoff, NPA; Verheggen, PWHM; de Vrey, EA; Wildbergh, TX; van 't Hof, AWJ; Mosterd, A; Hoes, AW				Poldervaart, Judith M.; Rottger, Emma; Dekker, Marieke S.; Zuithoff, Nicolaas P. A.; Verheggen, Peter W. H. M.; de Vrey, Evelyn A.; Wildbergh, Thierry X.; van 't Hof, Arnoud W. J.; Mosterd, Arend; Hoes, Arno W.			No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-15; RISK STRATIFICATION; MYOCARDIAL-INFARCTION; UNIVERSAL DEFINITION; TROPONIN-T; RAPID RULE; COPEPTIN	Background Despite the availability of high-sensitive troponin (hs-cTnT), there is still room for improvement in the diagnostic assessment of patients suspected of acute coronary syndrome (ACS). Apart from serial biomarker testing, which is time-consuming, novel biomarkers like copeptin have been proposed to expedite the early diagnosis of suspected ACS in addition to hs-cTnT. We determined whether placenta derived growth factor (PlGF), soluble Fms-like tyrosine kinase 1 (sFlt-1), myoglobin, N-terminal prohormone B-type Natriuretic Peptide (NT-proBNP), growth-differentiation factor 15 (GDF-15) and copeptin improved early assessment of chest pain patients. Methods This prospective, single centre diagnostic FAME-ER study included patients presenting to the ED with symptoms suggestive of ACS. Blood was collected to measure biomarkers, notably, hs-cTnT was retrospectively assessed. Added value of markers was judged by increase in AUC using multivariable logistic regression. Results Of 453 patients enrolled, 149 (33%) received a final diagnosis of ACS. Hs-cTnT had the highest diagnostic value in both univariable and multivariable analysis. PPVs of the biomarkers ranged from 23.5% (PlGF) to 77.9% (hs-cTnT), NPVs from 67.0% (PlGF) to 86.4% (hs-cTnT). Only myoglobin yielded diagnostic value in addition to clinical symptoms and electrocardiography (ECG) (AUC of clinical model 0.80) with AUC of 0.84 (p<0.001). However, addition of hs-cTnT was superior (AUC 0.89, p<0.001). Addition of the biomarkers to our clinical model and hs-cTnT did not or only marginally (GDF-15) improved diagnostic performance. Conclusion When assessing patients suspected of ACS, only myoglobin had added diagnostic value beyond clinical symptoms and ECG. However, when combined with hs-cTnT, it yields no additional diagnostic value. PlGF, sFlt-1, NT-proBNP, GDF-15 and copeptin had no added value to the clinical model or hs-cTnT.	[Poldervaart, Judith M.; Zuithoff, Nicolaas P. A.; Hoes, Arno W.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, NL-3584 CG Utrecht, Netherlands; [Rottger, Emma] Univ Utrecht, Fac Med, NL-3584 CG Utrecht, Netherlands; [Dekker, Marieke S.; van 't Hof, Arnoud W. J.] Isala Clin, Dept Cardiol, NL-8025 AB Zwolle, Netherlands; [Dekker, Marieke S.; Verheggen, Peter W. H. M.; de Vrey, Evelyn A.; Wildbergh, Thierry X.; Mosterd, Arend] Meander Med Ctr, Dept Cardiol, NL-3813 TZ Amersfoort, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Isala Clinics; Meander Medisch Centrum	Poldervaart, JM (corresponding author), Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	j.poldervaart@umcutrecht.nl						Apple FS, 2009, CLIN CHEM, V55, P93, DOI 10.1373/clinchem.2008.102905; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Bertens LCM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001531; Bohyn E, 2013, AM J EMERG MED, V3, P829; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Dekker MS, 2010, HEART, V96, P1001, DOI 10.1136/hrt.2009.189886; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Eggers KM, 2008, EUR HEART J, V29, P2327, DOI 10.1093/eurheartj/ehn339; Eggers KM, 2012, CLIN CHIM ACTA, V413, P1135, DOI 10.1016/j.cca.2012.03.011; Giannitsis E, 2011, CLIN CHEM, V57, P1452, DOI 10.1373/clinchem.2010.161265; Guder G, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-13; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heeschen C, 2004, JAMA-J AM MED ASSOC, V291, P435, DOI 10.1001/jama.291.4.435; Hochholzer W, 2011, EUR HEART J, V32, P326, DOI 10.1093/eurheartj/ehq429; Kehl DW, 2012, TRANSL RES, V159, P252, DOI 10.1016/j.trsl.2011.11.002; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Kurz K, 2011, CLIN RES CARDIOL, V100, P209, DOI 10.1007/s00392-010-0230-y; Maisel A, 2013, J AM COLL CARDIOL, V62, P150, DOI 10.1016/j.jacc.2013.04.011; Matveeva EG, 2005, J IMMUNOL METHODS, V302, P26, DOI 10.1016/j.jim.2005.04.020; Meune C, 2011, ARCH CARDIOVASC DIS, V104, P4, DOI 10.1016/j.acvd.2010.11.002; Mockel M, 2015, EUR HEART J, V36, P369, DOI 10.1093/eurheartj/ehu178; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P633, DOI 10.1016/S0895-4356(02)00408-0; Morgenthaler Nils G, 2010, Congest Heart Fail, V16 Suppl 1, pS37, DOI 10.1111/j.1751-7133.2010.00177.x; Morrow DA, 2003, CIRCULATION, V108, P250, DOI 10.1161/01.CIR.0000078080.37974.D2; Ottenbacher KJ, 2004, J CLIN EPIDEMIOL, V57, P1147, DOI 10.1016/j.jclinepi.2003.05.003; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Reichlin T, 2009, J AM COLL CARDIOL, V54, P60, DOI 10.1016/j.jacc.2009.01.076; Schaub N, 2012, CLIN CHEM, V58, P441, DOI 10.1373/clinchem.2011.173310; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Thygesen K, 2012, EUR HEART J, V33, P2252, DOI 10.1093/eurheartj/ehs154; Wu AHB, 2007, BIOMARK MED, V1, P45, DOI 10.2217/17520363.1.1.45	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132000	10.1371/journal.pone.0132000	http://dx.doi.org/10.1371/journal.pone.0132000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177390	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600076
J	Reguero, BG; Losada, IJ; Diaz-Simal, P; Mendez, FJ; Beck, MW				Reguero, Borja G.; Losada, Inigo J.; Diaz-Simal, Pedro; Mendez, Fernando J.; Beck, Michael W.			Effects of Climate Change on Exposure to Coastal Flooding in Latin America and the Caribbean	PLOS ONE			English	Article							STORM SURGES; FUTURE	This study considers and compares several of the most important factors contributing to coastal flooding in Latin American and the Caribbean (LAC) while accounting for the variations of these factors with location and time. The study assesses the populations, the land areas and the built capital exposed at present and at the middle and end of the 21st century for a set of scenarios that include both climatic and non-climatic drivers. Climatic drivers include global mean sea level, natural modes of climate variability such as El Nino, natural subsidence, and extreme sea levels resulting from the combination of projected local sea-level rise, storm surges and wave setup. Population is the only human-related driver accounted for in the future. Without adaptation, more than 4 million inhabitants will be exposed to flooding from relative sea-level rise by the end of the century, assuming the 8.5 Wm(-2) trajectory of the Representative Concentration Pathways (RCPs), or RCP8.5. However, the contributions from El Nino events substantially raise the threat in several Pacific-coast countries of the region and sooner than previously anticipated. At the tropical Pacific coastlines, the exposure by the mid-century for an event similar to El Nino 1998 would be comparable to that of the RCP4.5 relative sea-level rise by the end of the century. Furthermore, more than 7.5 million inhabitants, 42,600 km(2) and built capital valued at 334 billion USD are currently situated at elevations below the 100-year extreme sea level. With sea levels rising and the population increasing, it is estimated that more than 9 million inhabitants will be exposed by the end of the century for either of the RCPs considered. The spatial distribution of exposure and the comparison of scenarios and timeframes can serve as a guide in future adaptation and risk reduction policies in the region.	[Reguero, Borja G.; Losada, Inigo J.; Diaz-Simal, Pedro; Mendez, Fernando J.] Univ Cantabria, Environm Hydraul Inst IH Cantabria, E-39005 Santander, Cantabria, Spain; [Reguero, Borja G.; Beck, Michael W.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Reguero, Borja G.; Beck, Michael W.] US Amer & Nat Conservancy, Arlington, VA USA	Universidad de Cantabria; IHCantabria - Instituto de Hidraulica Ambiental de la Universidad de Cantabria; University of California System; University of California Santa Cruz; Nature Conservancy	Losada, IJ (corresponding author), Univ Cantabria, Environm Hydraul Inst IH Cantabria, E-39005 Santander, Cantabria, Spain.	losadai@unican.es	Diaz-Simal, Pedro/P-5873-2015; Losada, Iñigo J/F-9001-2012; Beck, Michael W./AAB-2844-2019; Reguero, Borja/L-8621-2014	Diaz-Simal, Pedro/0000-0002-8645-952X; Losada, Iñigo J/0000-0002-9651-9709; Beck, Michael W./0000-0002-5107-9973; Reguero, Borja/0000-0001-5526-7157				Barros V, 2005, CAMBIO CLIMATICO RIO, P41; Bojanowski A, 2011, NAT GEOSCI, V4, P657, DOI 10.1038/ngeo1280; Brown S., 2013, COASTAL HAZARDS, P117, DOI [10.1007/978-94-007-5234-4, DOI 10.1007/978-94-007-5234-4_5]; Center for International Earth Science Information Network [CIESIN], 2011, GLOB RUR URB MAPP PR; Church JA, 2011, SURV GEOPHYS, V32, P585, DOI 10.1007/s10712-011-9119-1; D'Onofrio EE, 2008, J COASTAL RES, V24, P260, DOI 10.2112/05-0588.1; Dasgupta S, 2011, CLIMATIC CHANGE, V106, P567, DOI 10.1007/s10584-010-9959-6; Dodman D., 2009, POPULATION DYNAMICS, P64; ECLAC, 2013, STAT YB LAT AM CAR; Field C.B., 2014, CLIM CHANG 2014 IMP, P1, DOI [DOI 10.1038/446727A, 10.1017/CBO9781107415379]; Fiore MME, 2009, CONT SHELF RES, V29, P1643, DOI 10.1016/j.csr.2009.05.004; Garcia-Herrera R, 2000, NINO CLIMATOLOGIA EF; Gitay H, 2013, BUILDING RESILIENCE; Hallegatte S, 2013, NAT CLIM CHANGE, V3, P802, DOI [10.1038/nclimate1979, 10.1038/NCLIMATE1979]; Hardoy J, 2011, CURR OPIN ENV SUST, V3, P158, DOI 10.1016/j.cosust.2011.01.004; Hinkel J, 2014, P NATL ACAD SCI USA, V111, P3292, DOI 10.1073/pnas.1222469111; Hinkel J, 2009, GLOBAL ENVIRON CHANG, V19, P384, DOI 10.1016/j.gloenvcha.2009.03.002; Intergov Panel Clim Chg, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P1, DOI 10.1017/CBO9781139177245; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Jongman B, 2012, GLOBAL ENVIRON CHANG, V22, P823, DOI 10.1016/j.gloenvcha.2012.07.004; Kelman I, 2015, INT J DISAST RISK SC, V6, P21, DOI 10.1007/s13753-015-0038-5; Kron W, 2013, NAT HAZARDS, V66, P1363, DOI 10.1007/s11069-012-0215-4; Losada IJ, 2013, GLOBAL PLANET CHANGE, V104, P34, DOI 10.1016/j.gloplacha.2013.02.006; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; Menendez M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005997; Mondal P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048191; Neumann B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118571; Nicholls RJ, 2004, GLOBAL ENVIRON CHANG, V14, P69, DOI 10.1016/j.gloenvcha.2003.10.007; Nurse LA, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1613; Peltier WR., 2000, INT ASS GEOD S 2000; Pielke RA, 2005, SCIENCE, V310, P1615; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Reguero BG, 2013, GLOBAL PLANET CHANGE, V100, P70, DOI 10.1016/j.gloplacha.2012.09.005; Satterthwaite D, 2009, HUMAN SETTLEMENTS DI; Seneviratne SI, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P109; Slangen ABA, 2014, CLIMATIC CHANGE, V124, P317, DOI 10.1007/s10584-014-1080-9; Smolka M. O., 2008, NEW GLOBAL FRONTIER, P99; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; UNFPA United Nations Fund for Population Activities, 2012, LINK POP DYN URB PRO; Vargas G, 2011, ANDEAN GEOL, V38, P219, DOI 10.5027/andgeoV38n1-a12; Walsh KJE, 2012, GLOBAL PLANET CHANGE, V80-81, P149; Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361	42	52	52	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133409	10.1371/journal.pone.0133409	http://dx.doi.org/10.1371/journal.pone.0133409			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177285	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600255
J	Sek, AC; Xie, ZH; Terai, K; Long, LM; Nelson, C; Dudek, AZ; Druey, KM				Sek, Albert C.; Xie, Zhihui; Terai, Kaoru; Long, Lauren M.; Nelson, Celeste; Dudek, Arkadiusz Z.; Druey, Kirk M.			Endothelial Expression of Endothelin Receptor A in the Systemic Capillary Leak Syndrome	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; CELLS; ESTABLISHMENT; PERMEABILITY; DISEASE; EDEMA	Idiopathic systemic capillary leak syndrome (SCLS) is a rare and potentially fatal vascular disorder characterized by reversible bouts of hypotension and edema resulting from fluid and solute escape into soft tissues. Although spikes in permeability-inducing factors have been linked to acute SCLS flares, whether or not they act on an inherently dysfunctional endothelium is unknown. To assess the contribution of endothelial-intrinsic mechanisms in SCLS, we derived blood-outgrowth endothelial cells (BOEC) from patients and healthy controls and examined gene expression patterns. Ednra, encoding Endothelin receptor A (ETA)-the target of Endothelin 1 (ET-1)-was significantly increased in SCLS BOEC compared to healthy controls. Although vasoconstriction mediated by ET-1 through ETA activation on vascular smooth muscle cells has been well characterized, the expression and function of ETA receptors in endothelial cells (ECs) has not been described. To determine the role of ETA and its ligand ET-1 in SCLS, if any, we examined ET-1 levels in SCLS sera and functional effects of endothelial ETA expression. ETA overexpression in EAhy926 endothelioma cells led to ET-1-induced hyper-permeability through canonical mechanisms. Serum ET-1 levels were elevated in acute SCLS sera compared to remission and healthy control sera, suggesting a possible role for ET-1 and ETA in SCLS pathogenesis. However, although ET-1 alone did not induce hyper-permeability of patient-derived BOEC, an SCLS-related mediator (CXCL10) increased Edrna quantities in BOEC, suggesting a link between SCLS and endothelial ETA expression. These results demonstrate that ET-1 triggers classical mechanisms of vascular barrier dysfunction in ECs through ETA. Further studies of the ET-1-ETA axis in SCLS and in more common plasma leakage syndromes including sepsis and filovirus infection would advance our understanding of vascular integrity mechanisms and potentially uncover new treatment strategies.	[Sek, Albert C.; Xie, Zhihui; Long, Lauren M.; Nelson, Celeste; Druey, Kirk M.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Terai, Kaoru; Dudek, Arkadiusz Z.] Univ Illinois, Dept Med, Div Hematol Oncol, Chicago, IL USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Druey, KM (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	kdruey@niaid.nih.gov	Dudek, Arkadiusz Zbigniew/HGD-1339-2022; Sek, Albert/Q-6543-2019	Dudek, Arkadiusz Zbigniew/0000-0002-9114-8945; Sek, Albert/0000-0002-8170-3749	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health [AI001083]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001083] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (AI001083 to KMD) (http://www.niaid.nih.gov/Pages/default.aspx.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SM, 2008, FEBS LETT, V582, P4039, DOI 10.1016/j.febslet.2008.10.043; CLARKSON B, 1960, AM J MED, V29, P193, DOI 10.1016/0002-9343(60)90018-8; Druey KM, 2010, ANN INTERN MED, V153, P90, DOI 10.7326/0003-4819-153-2-201007200-00005; Dudek AZ, 2007, BRIT J CANCER, V97, P513, DOI 10.1038/sj.bjc.6603883; Dunmore BJ, 2013, HUM MOL GENET, V22, P3667, DOI 10.1093/hmg/ddt216; Erbilgin A, 2013, ARTERIOSCL THROM VAS, V33, P2509, DOI 10.1161/ATVBAHA.113.301989; Galie N, 2004, CARDIOVASC RES, V61, P227, DOI 10.1016/j.cardiores.2003.11.026; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gousseff M, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00004; Horinouchi T, 2007, EUR J PHARMACOL, V566, P28, DOI 10.1016/j.ejphar.2007.03.019; Horinouchi T, 2013, J PHARMACOL SCI, V123, P85, DOI 10.1254/jphs.13R02CR; Kapoor P, 2010, MAYO CLIN PROC, V85, P905, DOI 10.4065/mcp.2010.0159; Kawabe S, 2002, INTERNAL MED, V41, P211, DOI 10.2169/internalmedicine.41.211; Kitazawa T, 2011, GENE EXPR PATTERNS, V11, P371, DOI 10.1016/j.gep.2011.04.001; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Kuklin V, 2005, CRIT CARE, V9, pR677, DOI 10.1186/cc3882; Lambert M, 2008, CRIT CARE MED, V36, P2184, DOI 10.1097/CCM.0b013e31817d7c71; Martin-Ramirez J, 2012, NAT PROTOC, V7, P1709, DOI 10.1038/nprot.2012.093; Mazzuca MQ, 2012, BIOCHEM PHARMACOL, V84, P147, DOI 10.1016/j.bcp.2012.03.020; Medina RJ, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/346735; Medina RJ, 2010, INVEST OPHTH VIS SCI, V51, P5906, DOI 10.1167/iovs.09-4951; Meier LA, 2014, J CARDIOVASC TRANSL, V7, P242, DOI 10.1007/s12265-013-9539-z; Middleton J, 2005, J PATHOL, V206, P260, DOI 10.1002/path.1788; Milbauer LC, 2008, BLOOD, V111, P3872, DOI 10.1182/blood-2007-06-097188; Niu J, 2015, MOL MED REP, V11, P3981, DOI 10.3892/mmr.2014.3138; Rautureau Y, 2012, CURR OPIN NEPHROL HY, V21, P128, DOI 10.1097/MNH.0b013e32834f0092; Rodriguez-Pascual F, 2011, PHARMACOL RES, V63, P463, DOI 10.1016/j.phrs.2011.01.014; Rossi P, 2004, SHOCK, V21, P543, DOI 10.1097/01.shk.0000126147.76311.18; Sakamoto TM, 2013, MICROVASC RES, V90, P173, DOI 10.1016/j.mvr.2013.10.002; Somani A, 2007, TRANSL RES, V150, P30, DOI 10.1016/j.trsl.2007.02.002; Wang JW, 2013, BLOOD, V121, P2762, DOI 10.1182/blood-2012-06-434373; Wang JB, 2012, PEPTIDES, V38, P457, DOI 10.1016/j.peptides.2012.09.007; Xie ZH, 2013, RARE DIS, V1, DOI 10.4161/rdis.27445; Xie ZH, 2015, AM J MED, V128, P91, DOI 10.1016/j.amjmed.2014.08.015; Xie ZH, 2014, AM J RESP CRIT CARE, V189, P1145, DOI 10.1164/rccm.201310-1746LE; Xie ZH, 2012, BLOOD, V119, P4321, DOI 10.1182/blood-2011-08-375816; Yang Z, 2012, AM J RESP CELL MOL, V46, P823, DOI 10.1165/rcmb.2011-0110OC	37	20	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133266	10.1371/journal.pone.0133266	http://dx.doi.org/10.1371/journal.pone.0133266			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176954	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600236
J	Smith, T; Codrea, V				Smith, Thierry; Codrea, Vlad			Red Iron-Pigmented Tooth Enamel in a Multituberculate Mammal from the Late Cretaceous Transylvanian "Hateg Island"	PLOS ONE			English	Article							EVOLUTION; DINOSAUR; EXTINCT; BASIN; VERTEBRATES; MORPHOLOGY; PALEOCENE; RADIATION; TEETH; VENOM	Mammals that inhabit islands are characterized by peculiar morphologies in comparison to their mainland relatives. Here we report the discovery of a partial skull associated with the lower jaws of a Late Cretaceous (approximate to 70 Ma) multituberculate mammal from the Carpathian "Hateg Island" of Transylvania, Romania. The mammal belongs to the Kogaionidae, one of the rare families that survived the Cretaceous-Paleogene mass extinction in Europe. The excellent preservation of this specimen allows for the first time description of the complete dentition of a kogaionid and demonstration that the enigmatic Barbatodon transylvanicus presents a mosaic of primitive and derived characters, and that it is phylogenetically basal among the Cimolodonta. Another peculiarity is the presence of red pigmentation in its tooth enamel. The red coloration is present on the anterior side of the incisors and on the cusps of most of the teeth. Energy-dispersive X-ray spectrometry (EDS) analysis reveals that the pigmented enamel contains iron, as in living placentals. Such a red pigmentation is known in living soricine shrews and many families of rodents, where it is thought to increase the resistance of the enamel to the abrasion that occurs during "grinding" mastication. The extended pattern of red pigment distribution in Barbatodon is more similar to that in eulipotyplan insectivores than to that in rodents and suggests a very hard diet and, importantly, demonstrates that its grasping incisors were not ever-growing. As inferred for other endemic Transylvanian vertebrates such as dwarf herbivorous dinosaurs and unusual theropod dinosaurs, insularity was probably the main factor of survival of such a primitive mammalian lineage relative to other mainland contemporaries of the Northern hemisphere.	[Smith, Thierry] Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, Brussels, Belgium; [Codrea, Vlad] Univ Babes Bolyai, Fac Biol & Geol, R-3400 Cluj Napoca, Romania	Royal Belgian Institute of Natural Sciences; Babes Bolyai University from Cluj	Smith, T (corresponding author), Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, Brussels, Belgium.	thierry.smith@naturalsciences.be	Codrea, Vlad/C-2721-2011	Codrea, Vlad/0000-0002-5575-4139; Smith, Thierry/0000-0002-1795-2564; Codrea, Vlad Aurel/0000-0002-3992-955X	Royal Belgian Institute of Natural Sciences; Fonds National de la Recherche; Belgian Science Policy Office [MO/36/001-004]; Romanian National Research Council CNCS grant [PN-II-ID-PCE-2011-3-0381]	Royal Belgian Institute of Natural Sciences; Fonds National de la Recherche(Luxembourg National Research Fund); Belgian Science Policy Office(Belgian Federal Science Policy Office); Romanian National Research Council CNCS grant(Consiliul National al Cercetarii Stiintifice (CNCS))	Fieldwork was supported by the Royal Belgian Institute of Natural Sciences and by travel grants from the Fonds National de la Recherche (to TS). Field vehicles and technical equipments were kindly supplied by Belgian companies Fabricom and Ford Motor. Funding for this research was provided by the Belgian Science Policy Office Projects MO/36/001-004 (to Pierre Bultynck and TS) and the Romanian National Research Council CNCS grant PN-II-ID-PCE-2011-3-0381 (to VC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenbroad Larry D., 2009, P 7 CAL ISL S, P15; Akersten William A., 2002, Journal of Vertebrate Paleontology, V22, p31A; Asher RJ, 2002, B AM MUS NAT HIST, P1; Benton MJ, 2010, PALAEOGEOGR PALAEOCL, V293, P438, DOI 10.1016/j.palaeo.2010.01.026; Blanco A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115837; Brooker LR, 2012, ADVANCED TOPICS IN BIOMINERALIZATION, P65; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; CARLSON S J, 1985, Contributions from the Museum of Paleontology University of Michigan, V27, P1; Codrea AV., 2005, STUD U BABES-BOL GEO, V50, P19, DOI [10.5038/1937-8602.50.1.3, DOI 10.5038/1937-8602.50.1.3]; Codrea V, 2002, CR PALEVOL, V1, P173, DOI 10.1016/S1631-0683(02)00021-0; Codrea VA, 2008, CR PALEVOL, V7, P289, DOI 10.1016/j.crpv.2008.03.008; Codrea Vlad A., 2012, P570; Codrea VA, 2014, CR PALEVOL, V13, P489, DOI 10.1016/j.crpv.2014.01.003; Csiki Z, 2000, ACTA PALAEONTOL POL, V45, P85; Csiki Z., 2001, ACTA PALAEONTOL ROM, V3, P87; Csiki Z, 2010, P NATL ACAD SCI USA, V107, P15357, DOI 10.1073/pnas.1006970107; Csiki Zoltan, 2005, Acta Palaeontologica Romaniae, V5, P73; Csiki-Sava Z, 2015, ZOOKEYS, P1, DOI 10.3897/zookeys.469.8439; Csontos L, 2004, PALAEOGEOGR PALAEOCL, V210, P1, DOI 10.1016/j.palaeo.2004.02.033; Delfino M, 2008, J VERTEBR PALEONTOL, V28, P111, DOI 10.1671/0272-4634(2008)28[111:ACSOAP]2.0.CO;2; Dercourt J., 2000, PALAEOGEOGRAPHICAL M; DOTSCH C, 1978, Z SAUGETIERKD, V43, P65; Dumont M, 2014, J STRUCT BIOL, V186, P38, DOI 10.1016/j.jsb.2014.02.006; Feild TS, 2011, P NATL ACAD SCI USA, V108, P8363, DOI 10.1073/pnas.1014456108; Folinsbee KE, 2013, CR PALEVOL, V12, P531, DOI 10.1016/j.crpv.2013.05.004; Fosse G, 2001, ACTA PALAEONTOL POL, V46, P437; FOSTER JB, 1964, NATURE, V202, P234, DOI 10.1038/202234a0; Fox RC, 2005, NATURE, V435, P1091, DOI 10.1038/nature03646; Freudenthal M., 1972, Scripta geol, V14, P1; Gheerbrant E, 1999, ECLOGAE GEOL HELV, V92, P517; Goloboff P, 2003, CLADISTICS, V24, P1; Gordon LM, 2015, SCIENCE, V347, P746, DOI 10.1126/science.1258950; Goswami A, 2011, P NATL ACAD SCI USA, V108, P16333, DOI 10.1073/pnas.1108723108; Grellet-Tinner G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032051; Grigorescu D., 1987, Geologica et Palaeontologica, V21, P237; Jordana X, 2012, P ROY SOC B-BIOL SCI, V279, P3339, DOI 10.1098/rspb.2012.0689; Kielan-Jaworowska Z, 2001, PALAEONTOLOGY, V44, P389, DOI 10.1111/1475-4983.00185; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; KOZAWA Y, 1988, HISTOCHEMISTRY, V90, P61, DOI 10.1007/BF00495708; Krause DW, 2014, NATURE, V515, P512, DOI 10.1038/nature13922; KRAUSE DW, 1987, J MAMMAL, V68, P755, DOI 10.2307/1381552; KRAUSE DW, 1982, PALEOBIOLOGY, V8, P265, DOI 10.1017/S0094837300006989; Leinders J.J.M., 1984, SCRIPTA GEOLOGICA, V70, P1; Mao F.-Y., ACTA PALAEO IN PRESS; Mao FY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128243; Miao Desui, 1986, Contributions to Geology University of Wyoming, V24, P65; MOTTA PJ, 1987, CAN J ZOOL, V65, P106, DOI 10.1139/z87-016; Nopcsa F., 1914, VERHANDLUNGEN ZOOLOG, V54, P12; PALOMBO MR, 2001, WORLD ELEPHANTS, P486; PANAIOTU C, 2002, 7 EUR WORKSH VERT PA, P61; Panaiotu CG, 2010, PALAEOGEOGR PALAEOCL, V293, P343, DOI 10.1016/j.palaeo.2009.11.017; Pelaez-Campomanes P, 2000, J PALEONTOL, V74, P701, DOI 10.1666/0022-3360(2000)074<0701:TEMOTE>2.0.CO;2; Radulescu C., 1996, ANUARUL INSTITUTULUI, V69, P177; Radulescu C., 1986, CR HEBD ACAD SCI, V304, P1825; RANDALL M, 1966, NATURE, V210, P1325, DOI 10.1038/2101325a0; Repenning C. A., 1967, Professional Papers US Geological Survey, V565, P1; ROUGIER GW, 1997, AM MUS NOVIT, P1; RUNHAM NW, 1969, Z ZELLFORSCH MIK ANA, V99, P608, DOI 10.1007/BF00340948; SELVIG KA, 1975, SCAND J DENT RES, V83, P88; SHELLIS RP, 1976, J ZOOL, V180, P69; Smith Thierry, 2002, Studia Universitatis Babes-Bolyai Geologia, P321; Smith T, 2010, NATURWISSENSCHAFTEN, V97, P417, DOI 10.1007/s00114-010-0651-5; Stein K, 2010, P NATL ACAD SCI USA, V107, P9258, DOI 10.1073/pnas.1000781107; Strait SG, 2006, J MAMMAL, V87, P700, DOI 10.1644/05-MAMM-A-265R4.1; Van Itterbeeck J, 2005, GEOL CARPATH, V56, P137; VIANEY-LIAUD M, 1986, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V191, P85; Vianey-Liaud M., 1979, Palaeovertebrata (Montpellier), V9, P117; vonKoenigswald W, 1997, TOOTH ENAMEL MICROSTRUCTURE, P137; Wall C.E., 1992, Journal of Vertebrate Paleontology, V12, P172; Weil A, 2008, EVOLUTION OF TERTIARY MAMMALS OF NORTH AMERICA, VOL 2, P19; Weishampel DB, 2010, PALAEOGEOGR PALAEOCL, V293, P419, DOI 10.1016/j.palaeo.2010.03.024; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Worthy TH, 2006, P NATL ACAD SCI USA, V103, P19419, DOI 10.1073/pnas.0605684103; Wu SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046445; Yuan CX, 2013, SCIENCE, V341, P779, DOI 10.1126/science.1237970	75	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132550	10.1371/journal.pone.0132550	http://dx.doi.org/10.1371/journal.pone.0132550			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177465	Green Submitted, gold, Green Published			2022-12-27	WOS:000358197600122
J	Straatman, J; Harmsen, AMK; Cuesta, MA; Berkhof, J; Jansma, EP; van der Peet, DL				Straatman, Jennifer; Harmsen, Annelieke M. K.; Cuesta, Miguel A.; Berkhof, Johannes; Jansma, Elise P.; van der Peet, Donald L.			Predictive Value of C-Reactive Protein for Major Complications after Major Abdominal Surgery: A Systematic Review and Pooled-Analysis	PLOS ONE			English	Review							POSTOPERATIVE INFECTIVE COMPLICATIONS; LOW ANTERIOR RESECTION; GOAL-DIRECTED THERAPY; ANASTOMOTIC LEAKAGE; COLORECTAL SURGERY; INFLAMMATORY COMPLICATIONS; SURGICAL COMPLICATIONS; SEVERE SEPSIS; PROCALCITONIN; CANCER	Background Early diagnosis and treatment of complications after major abdominal surgery can decrease associated morbidity and mortality. Postoperative CRP levels have shown a strong correlation with complications. Aim of this systematic review and pooled-analysis was to assess postoperative values of CRP as a marker for major complications and construct a prediction model. Study design A systematic review was performed for CRP levels as a predictor for complications after major abdominal surgery (MAS). Raw data was obtained from seven studies, including 1427 patients. A logit regression model assessed the probability of major complications as a function of CRP levels on the third postoperative day. Two practical cut-offs are proposed: an optimal cut-off for safe discharge in a fast track protocol and another for early identification of patients with increased risk for major complications. Results A prediction model was calculated for major complications as a function of CRP levels on the third postoperative day. Based on the model several cut-offs for CRP are proposed. For instance, a two cut-off system may be applied, consisting of a safe discharge criterion with CRP levels below 75 mg/L, with a negative predictive value of 97.2%. A second cut-off is set at 215 mg/L (probability 20%) and serves as a predictor of complications, indicating additional CT-scan imaging. Conclusions The present study provides insight in the interpretation of CRP levels after major abdominal surgery, proposing a prediction model for major complications as a function of CRP on postoperative day 3. Cut-offs for CRP may be implemented for safe early-discharge in a fast-track protocol and, secondly as a threshold for additional examinations, such as CT-scan imaging, even in absence of clinical signs, to confirm or exclude major complications. The prediction model allows for setting a cut-off at the discretion of individual surgeons or surgical departments.	[Straatman, Jennifer; Harmsen, Annelieke M. K.; Cuesta, Miguel A.; van der Peet, Donald L.] Vrije Univ Amsterdam, Med Ctr, Dept Gastrointestinal Surg, Amsterdam, Netherlands; [Berkhof, Johannes] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Jansma, Elise P.] Vrije Univ Amsterdam, Med Ctr, Med Lib, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Straatman, J (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Gastrointestinal Surg, Amsterdam, Netherlands.	je.straatman@vumc.nl	Jansma, Elise P/E-8358-2016; Jansma, Elise/AAG-7983-2020	Jansma, Elise P/0000-0002-1516-2171; van der Peet, Donald L./0000-0003-3883-3705				Adamina M, 2014, SURG ENDOSC, V28, P2939, DOI 10.1007/s00464-014-3556-0; Almeida AB, 2012, INT J SURG, V10, P87, DOI 10.1016/j.ijsu.2011.12.006; Castelli GP, 2009, CRIT CARE MED, V37, P1845, DOI 10.1097/CCM.0b013e31819ffd5b; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Deitmar S, 2009, ZBL CHIR, V134, P83, DOI 10.1055/s-0028-1098768; den Dulk M, 2009, EJSO-EUR J SURG ONC, V35, P420, DOI 10.1016/j.ejso.2008.04.009; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; DUBROW RA, 1995, AM J ROENTGENOL, V165, P567, DOI 10.2214/ajr.165.3.7645472; Dutta S, 2011, WORLD J SURG, V35, P1017, DOI 10.1007/s00268-011-1002-1; Eckmann C, 2004, INT J COLORECTAL DIS, V19, P128, DOI 10.1007/s00384-003-0498-8; Garcia-Granero A, 2013, DIS COLON RECTUM, V56, P475, DOI 10.1097/DCR.0b013e31826ce825; Hyman N, 2007, ANN SURG, V245, P254, DOI 10.1097/01.sla.0000225083.27182.85; Khoury W, 2009, J GASTROINTEST SURG, V13, P1454, DOI 10.1007/s11605-009-0925-4; Korner H, 2009, J GASTROINTEST SURG, V13, P1599, DOI 10.1007/s11605-009-0928-1; KRAGSBJERG P, 1995, EUR J SURG, V161, P17; Lagoutte N, 2012, J VISC SURG, V149, pE345, DOI 10.1016/j.jviscsurg.2012.09.003; Lane JC, 2013, COLORECTAL DIS, V15, P224, DOI 10.1111/j.1463-1318.2012.03125.x; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; MacKay GJ, 2011, COLORECTAL DIS, V13, P583, DOI 10.1111/j.1463-1318.2010.02236.x; Mokart D, 2005, BRIT J ANAESTH, V94, P767, DOI 10.1093/bja/aei143; Nason GJ, 2014, SURG LAPARO ENDO PER, V24, P57, DOI 10.1097/SLE.0b013e31828fa03e; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nesbakken A, 2005, COLORECTAL DIS, V7, P576, DOI 10.1111/j.1463-1318.2005.00870.x; Oberhofer D, 2012, CROAT MED J, V53, P612, DOI 10.3325/cmj.2012.53.612; Ortega-Deballon P, 2010, WORLD J SURG, V34, P808, DOI 10.1007/s00268-009-0367-x; Pedersen T, 2012, DAN MED J, V59; Platt JJ, 2012, ANN SURG ONCOL, V19, P4168, DOI 10.1245/s10434-012-2498-9; Power N, 2007, CLIN RADIOL, V62, P37, DOI 10.1016/j.crad.2006.08.004; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rivers EP, 2008, CURR OPIN ANESTHESIO, V21, P128, DOI 10.1097/ACO.0b013e3282f4db7a; Scepanovic MS, 2013, TECH COLOPROCTOL, V17, P541, DOI 10.1007/s10151-013-1013-z; Singh PP, 2014, BRIT J SURG, V101, P339, DOI 10.1002/bjs.9354; Straatman J, 2014, REV ESP ENFERM DIG, V106, P515; Strong VE, 2009, ANN SURG ONCOL, V16, P1507, DOI 10.1245/s10434-009-0386-8; Velasco E, 1996, AM J INFECT CONTROL, V24, P1, DOI 10.1016/S0196-6553(96)90046-2; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; Warschkow R, 2012, J HEPATO-BIL-PAN SCI, V19, P492, DOI 10.1007/s00534-011-0462-x; Warschkow R, 2012, ANN SURG, V256, P245, DOI 10.1097/SLA.0b013e31825b60f0; Warschkow R, 2012, LANGENBECK ARCH SURG, V397, P727, DOI 10.1007/s00423-012-0944-6; Warschkow R, 2011, INT J COLORECTAL DIS, V26, P1405, DOI 10.1007/s00384-011-1262-0; Welsch T, 2007, INT J COLORECTAL DIS, V22, P1499, DOI 10.1007/s00384-007-0354-3; Welsch T, 2008, SURGERY, V143, P20, DOI 10.1016/j.surg.2007.06.010; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	44	40	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132995	10.1371/journal.pone.0132995	http://dx.doi.org/10.1371/journal.pone.0132995			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177542	Green Submitted, gold, Green Published			2022-12-27	WOS:000358197600199
J	Torres, M; Palomares, O; Quiralte, J; Pauli, G; Rodriguez, R; Villalba, M				Torres, Maria; Palomares, Oscar; Quiralte, Joaquin; Pauli, Gabrielle; Rodriguez, Rosalia; Villalba, Mayte			An Enzymatically Active beta-1,3-Glucanase from Ash Pollen with Allergenic Properties: A Particular Member in the Oleaceae Family	PLOS ONE			English	Article							LATEX-FRUIT SYNDROME; YEAST PICHIA-PASTORIS; OLIVE POLLEN; MAJOR ALLERGEN; CROSS-REACTIVITY; BETA-GLUCANASES; MOLECULAR-BASIS; CHE A-3; BINDING; 1,3-BETA-GLUCANASE	Endo-beta-1,3-glucanases are widespread enzymes with glycosyl hydrolitic activity involved in carbohydrate remodelling during the germination and pollen tube growth. Although members of this protein family with allergenic activity have been reported, their effective contribution to allergy is little known. In this work, we identified Fra e 9 as a novel allergenic beta-1,3-glucanase from ash pollen. We produced the catalytic and carbohydrate-binding domains as two independent recombinant proteins and characterized them from structural, biochemical and immunological point of view in comparison to their counterparts from olive pollen. We showed that despite having significant differences in biochemical activity Fra e 9 and Ole e 9 display similar IgE-binding capacity, suggesting that beta-1,3-glucanases represent an heterogeneous family that could display intrinsic allergenic capacity. Specific cDNA encoding Fra e 9 was cloned and sequenced. The full-length cDNA encoded a polypeptide chain of 461 amino acids containing a signal peptide of 29 residues, leading to a mature protein of 47760.2 Da and a pI of 8.66. An N-terminal catalytic domain and a C-terminal carbohydrate-binding module are the components of this enzyme. Despite the phylogenetic proximity to the olive pollen beta-1,3-glucanase, Ole e 9, there is only a 39% identity between both sequences. The N- and C-terminal domains have been produced as independent recombinant proteins in Escherichia coli and Pichia pastoris, respectively. Although a low or null enzymatic activity has been associated to long alpha-1,3-glucanases, the recombinant N-terminal domain has 200-fold higher hydrolytic activity on laminarin than reported for Ole e 9. The C-terminal domain of Fra e 9, a cysteine-rich compact structure, is able to bind laminarin. Both molecules retain comparable IgE-binding capacity when assayed with allergic sera. In summary, the structural and functional comparison between these two closely phylogenetic related enzymes provides novel insights into the complexity of alpha-1,3-glucanases, representing a heterogeneous protein family with intrinsic allergenic capacity.	[Torres, Maria; Palomares, Oscar; Rodriguez, Rosalia; Villalba, Mayte] Univ Madrid, Biochem & Mol Biol Dept Complutense, Madrid 3, Spain; [Quiralte, Joaquin] Virgen del Rocio Univ, Hosp Seville, Seville, Spain; [Pauli, Gabrielle] Hop Univ Strasbourg, Hop Lyautey, Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Villalba, M (corresponding author), Univ Madrid, Biochem & Mol Biol Dept Complutense, Madrid 3, Spain.	mvillalb@quim.ucm.es	Palomares, Oscar/ABG-5229-2020; IBIS, ALERGICAS/C-1733-2016; Villalba, María Teresa/AAW-1067-2020; Torres, Maria/GVU-3391-2022; RODRIGUEZ, ROSALIA/K-4993-2014	Villalba, María Teresa/0000-0002-0042-9953; RODRIGUEZ, ROSALIA/0000-0002-4280-3691; Palomares, Oscar/0000-0003-4516-0369	PROYECTOS DE INVESTIGACION FUNDAMENTAL NO ORIENTADA (SAF) [2008-04053, 2011-26716]	PROYECTOS DE INVESTIGACION FUNDAMENTAL NO ORIENTADA (SAF)	PROYECTOS DE INVESTIGACION FUNDAMENTAL NO ORIENTADA (SAF) (2008-04053) RR, PROYECTOS DE INVESTIGACION FUNDAMENTAL NO ORIENTADA (SAF) (2011-26716) MV.	ALENIUS H, 1995, CLIN EXP ALLERGY, V25, P659, DOI 10.1111/j.1365-2222.1995.tb01114.x; Andersson K, 2003, INT ARCH ALLERGY IMM, V130, P87, DOI 10.1159/000069013; Barber D, 2008, ALLERGY, V63, P1550, DOI 10.1111/j.1398-9995.2008.01807.x; Barderas R, 2006, ANN ALLERG ASTHMA IM, V96, P557, DOI 10.1016/S1081-1206(10)63550-8; Barderas R, 2004, J ALLERGY CLIN IMMUN, V113, P1192, DOI 10.1016/j.jaci.2003.12.587; Barral P, 2005, PROTEIN EXPRES PURIF, V44, P147, DOI 10.1016/j.pep.2005.04.012; Barral P, 2005, BIOCHEM J, V390, P77, DOI 10.1042/BJ20050456; Barre A, 2009, MOL IMMUNOL, V46, P1595, DOI 10.1016/j.molimm.2008.12.007; Batanero E, 1996, EUR J BIOCHEM, V241, P772, DOI 10.1111/j.1432-1033.1996.00772.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHEN L, 1995, J BIOL CHEM, V270, P8093, DOI 10.1074/jbc.270.14.8093; Dahl R, 2004, RESP MED, V98, P398, DOI 10.1016/j.rmed.2003.11.015; DAMATO G, 1988, CLIN ALLERGY, V18, P541, DOI 10.1111/j.1365-2222.1988.tb02905.x; El-Katatny MH, 2001, APPL MICROBIOL BIOT, V56, P137, DOI 10.1007/s002530100646; Fuchs KP, 2003, MICROBIOL-SGM, V149, P1021, DOI 10.1099/mic.0.26153-0; Garcia BE, 2011, J INVEST ALLERG CLIN, V21, P34; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; HIRD DL, 1993, PLANT J, V4, P1023, DOI 10.1046/j.1365-313X.1993.04061023.x; Huecas S, 1999, EUR J BIOCHEM, V261, P539, DOI 10.1046/j.1432-1327.1999.00307.x; Huecas S, 2001, J BIOL CHEM, V276, P27959, DOI 10.1074/jbc.M103041200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mas S, 2014, J ALLERGY CLIN IMMUN, V133, P923, DOI 10.1016/j.jaci.2013.10.061; MEMELINK J, 1990, PLANT MOL BIOL, V14, P119, DOI 10.1007/BF00018553; Nelson N, 1944, J BIOL CHEM, V153, P375; Palomares O, 2003, BIOCHEM J, V369, P593, DOI 10.1042/BJ20020423; Palomares O, 2005, CLIN EXP ALLERGY, V35, P345, DOI 10.1111/j.1365-2222.2004.02186.x; Palomares O, 2006, ANN ALLERG ASTHMA IM, V97, P61, DOI 10.1016/S1081-1206(10)61371-3; Peumans WJ, 2000, EUR J BIOCHEM, V267, P1188, DOI 10.1046/j.1432-1327.2000.01117.x; Popolo L, 2008, J BIOL CHEM, V283, P18553, DOI 10.1074/jbc.M801562200; Receveur-Brechot V, 2006, PROTEINS, V63, P235, DOI 10.1002/prot.20876; Rodriguez R, 2007, J INVEST ALLERG CLIN, V17, P4; Salamanca G, 2010, FEBS J, V277, P2729, DOI 10.1111/j.1742-4658.2010.07689.x; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Thomas BR, 2000, INT J BIOL MACROMOL, V27, P145, DOI 10.1016/S0141-8130(00)00110-0; Thomas BR, 2000, INT J BIOL MACROMOL, V27, P139, DOI 10.1016/S0141-8130(00)00109-4; Trevino MA, 2008, PROTEIN SCI, V17, P371, DOI 10.1110/ps.073230008; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Verdino P, 2008, J IMMUNOL, V180, P2313, DOI 10.4049/jimmunol.180.4.2313; Verma DPS, 2005, TRENDS PLANT SCI, V10, P159, DOI 10.1016/j.tplants.2005.02.004; VOGELILANGE R, 1994, PLANT MOL BIOL, V25, P299, DOI 10.1007/BF00023245; Wagner S, 2004, CLIN EXP ALLERGY, V34, P1739, DOI 10.1111/j.1365-2222.2004.02103.x; WARD ER, 1991, PLANT PHYSIOL, V96, P390, DOI 10.1104/pp.96.2.390; WATANABE T, 1992, J BACTERIOL, V174, P186, DOI 10.1128/jb.174.1.186-190.1992; Wojtkowiak A, 2012, ACTA CRYSTALLOGR D, V68, P713, DOI 10.1107/S090744491200995X; WORRALL D, 1992, PLANT CELL, V4, P759, DOI 10.1105/tpc.4.7.759; Yi SY, 1997, MOL CELLS, V7, P408	46	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133066	10.1371/journal.pone.0133066	http://dx.doi.org/10.1371/journal.pone.0133066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177095	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000358197600208
J	You, ZQ; Han, XP; Lu, LY; Yeung, CH				You, Zhi-Qiang; Han, Xiao-Pu; Lu, Linyuan; Yeung, Chi Ho			Empirical Studies on the Network of Social Groups: The Case of Tencent QQ	PLOS ONE			English	Article							GENDER-DIFFERENCES; EVOLUTION; DYNAMICS	Background Participation in social groups are important but the collective behaviors of human as a group are difficult to analyze due to the difficulties to quantify ordinary social relation, group membership, and to collect a comprehensive dataset. Such difficulties can be circumvented by analyzing online social networks. Methodology/Principal Findings In this paper, we analyze a comprehensive dataset released from Tencent QQ, an instant messenger with the highest market share in China. Specifically, we analyze three derivative networks involving groups and their members-the hypergraph of groups, the network of groups and the user network-to reveal social interactions at microscopic and mesoscopic level. Conclusions/Significance Our results uncover interesting behaviors on the growth of user groups, the interactions between groups, and their relationship with member age and gender. These findings lead to insights which are difficult to obtain in social networks based on personal contacts.	[You, Zhi-Qiang; Han, Xiao-Pu; Lu, Linyuan] Hangzhou Normal Univ, Alibaba Res Ctr Complex Sci, Hangzhou 311121, Zhejiang, Peoples R China; [Yeung, Chi Ho] Hong Kong Inst Educ, Dept Sci & Environm Studies, Hong Kong, Hong Kong, Peoples R China	Hangzhou Normal University; Education University of Hong Kong (EdUHK)	Han, XP (corresponding author), Hangzhou Normal Univ, Alibaba Res Ctr Complex Sci, Hangzhou 311121, Zhejiang, Peoples R China.	xp@hznu.edu.cn	Han, Xiao-Pu/E-8401-2010; Yeung, Chi Ho/H-9673-2013	Yeung, Chi Ho/0000-0001-6207-7597	National Natural Science Foundation of China [11205040, 11205042, 11105024, 11305043]; Hangzhou Normal University; EU FP7 Grant [611272]; CCF-Tencent Open Research Fund; Xinmiao Talent Program of Zhejiang Province [ZX13005002062]; HKIEd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hangzhou Normal University; EU FP7 Grant; CCF-Tencent Open Research Fund; Xinmiao Talent Program of Zhejiang Province; HKIEd	This work is supported by the National Natural Science Foundation of China (11205040, 11205042, 11105024, 11305043), and the research startup fund of Hangzhou Normal University, and the EU FP7 Grant 611272 (project GROWTHCOM), and CCF-Tencent Open Research Fund. ZQY acknowledges the Xinmiao Talent Program of Zhejiang Province (Grant No. ZX13005002062). CHY acknowledges the Internal Research Grant of HKIEd.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Anghel M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.058701; Backstrom L, 2012, WEBSCI 2012 JUN 22 2; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Bashan A, 2013, NAT PHYS, V9, P667, DOI 10.1038/NPHYS2727; Berge C., 1973, GRAPHS HYPERGRAPHS, V6; Berge C., 1989, HYPERGRAPHS COMBINAT, V45; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Broos A, 2005, CYBERPSYCHOL BEHAV, V8, P21, DOI 10.1089/cpb.2005.8.21; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Christakis NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012948; Cui AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050702; Fuller JE, 2004, SOC SCI QUART, V85, P938, DOI 10.1111/j.0038-4941.2004.00252.x; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066123; Hadzibeganovic T, 2015, BEHAV PROCESS, V113, P86, DOI 10.1016/j.beproc.2015.01.003; Hargittai E, 2006, SOC SCI QUART, V87, P432, DOI 10.1111/j.1540-6237.2006.00389.x; Holme P, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.056107; Hong W, 2009, CHINESE PHYS LETT, V26, DOI 10.1088/0256-307X/26/2/028902; Jiang ZQ, 2013, P NATL ACAD SCI USA, V110, P1600, DOI 10.1073/pnas.1220433110; Kairam S., 2012, P CHI 12, P1065, DOI [10.1145/2207676.2208552, DOI 10.1145/2207676.2208552]; Karinthy F, 1929, STRUCTURE DYNAMICS N; Mazman SG, 2011, TURK ONLINE J EDUC T, V10, P133; Muscanell NL, 2012, COMPUT HUM BEHAV, V28, P107, DOI 10.1016/j.chb.2011.08.016; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Palchykov Vasyl, 2012, Sci Rep, V2, P370, DOI 10.1038/srep00370; Phillip MV, 2004, J ADVERTISING RES, V44, P360, DOI 10.1017/S0021849904040383; Rybski D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00560; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; Shang MS, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/48006; Szell M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01214; Ugander J, 2011, ARXIV114503; Wang P, 2014, PHYSICA A, V398, P145, DOI 10.1016/j.physa.2013.12.014; Wu Y, 2010, P NATL ACAD SCI USA, V107, P18803, DOI 10.1073/pnas.1013140107; Zhao ZD, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/6/068901; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115; Zhou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020648	39	12	12	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130538	10.1371/journal.pone.0130538	http://dx.doi.org/10.1371/journal.pone.0130538			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26176850	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600025
J	Pan, SM; Li, YK; Xu, ZQ; Chong, YW				Pan, Shaoming; Li, Yongkai; Xu, Zhengquan; Chong, Yanwen			Distributed Storage Algorithm for Geospatial Image Data Based on Data Access Patterns	PLOS ONE			English	Article								Declustering techniques are widely used in distributed environments to reduce query response time through parallel I/O by splitting large files into several small blocks and then distributing those blocks among multiple storage nodes. Unfortunately, however, many small geospatial image data files cannot be further split for distributed storage. In this paper, we propose a complete theoretical system for the distributed storage of small geospatial image data files based on mining the access patterns of geospatial image data using their historical access log information. First, an algorithm is developed to construct an access correlation matrix based on the analysis of the log information, which reveals the patterns of access to the geospatial image data. Then, a practical heuristic algorithm is developed to determine a reasonable solution based on the access correlation matrix. Finally, a number of comparative experiments are presented, demonstrating that our algorithm displays a higher total parallel access probability than those of other algorithms by approximately 10-15% and that the performance can be further improved by more than 20% by simultaneously applying a copy storage strategy. These experiments show that the algorithm can be applied in distributed environments to help realize parallel I/O and thereby improve system performance.	[Pan, Shaoming; Xu, Zhengquan; Chong, Yanwen] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan, Hubei, Peoples R China; [Li, Yongkai] Wuhan Univ, Comp Sch, Wuhan, Hubei, Peoples R China; [Pan, Shaoming; Xu, Zhengquan] Collaborat Innovat Ctr Geospatial Technol, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University	Xu, ZQ (corresponding author), Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan, Hubei, Peoples R China.	xuzq@whu.edu.cn			National Nature Science Foundation of China [41271398]; National Key Basic Research and Development Program of China [2011CB302306]; Fundamental Research Funds for the Central Universities [2042014kf0263, 2042014kf0242]; Fund of SAST [SAST201425]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fund of SAST	This research was sponsored by the National Nature Science Foundation of China (Project No. 41271398) (SMP), the National Key Basic Research and Development Program of China (Project No. 2011CB302306) (ZQX), the Fundamental Research Funds for the Central Universities (Project No. 2042014kf0263 (SMP), 2042014kf0242 (YWC)) and supported by the Fund of SAST (Project No. SAST201425) (YWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay T, 2006, IEEE INTERNET COMPUT, V10, P16, DOI 10.1109/MIC.2006.95; Bell David G., 2007, 2007 IEEE Aerospace Conference, P1, DOI 10.1109/AERO.2007.352954; Boschetti L, 2008, INT J REMOTE SENS, V29, P3067, DOI 10.1080/01431160701733023; Carns P, 2009, INT PARALL DISTRIB P, P524, DOI 10.1079/9781845933975.0001; Cuthill E., 1969, P 24 NAT C ACM, P157, DOI DOI 10.1145/800195.805928; Dong B., 2010, P IEEE INT C SERV CO, DOI DOI 10.1109/SCC.2010.72; Dong B, 2012, J NETW COMPUT APPL, V35, P1847, DOI 10.1016/j.jnca.2012.07.009; Fisher D, 2007, IEEE T VIS COMPUT GR, V13, P1184, DOI 10.1109/TVCG.2007.70561; Fister I, 2015, APPL MATH COMPUT, V262, P178, DOI 10.1016/j.amc.2015.04.004; Garcia Martin R, 2013, INT J GEOGR INF SCI, V27, P614, DOI 10.1080/13658816.2012.721555; GHEMAWAT S, 2003, ACM SIGOPS OPERATING, V37, P29, DOI [10.1145/1165389.945450, DOI 10.1145/1165389.945450, 10.1145/945445.945450]; GIBBS NE, 1976, SIAM J NUMER ANAL, V13, P236, DOI 10.1137/0713023; Gibin M., 2008, APPL SPAT ANAL POLIC, V1, P85, DOI [10.1007/s12061-008-9005-5, DOI 10.1007/S12061-008-9005-5]; Giuliani G, 2012, COMPUT GEOSCI-UK, V47, P20, DOI 10.1016/j.cageo.2011.10.009; GRIFFIOEN J, 1994, PROCEEDINGS OF THE SUMMER 1994 USENIX CONFERENCE, P197; Hendricks J, 2006, 06104 CARN MELL U PA; Kroeger T. M., 1999, Proceedings of the Seventh Workshop on Hot Topics in Operating Systems, P14, DOI 10.1109/HOTOS.1999.798371; Lee DH, 2002, LECT NOTES COMPUT SC, V2457, P213; Li R, 2012, INT J GEOGR INF SCI, V26, P1831, DOI 10.1080/13658816.2012.659184; Liu XD, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045203; Lu XF, 2011, SCI CHINA TECHNOL SC, V54, P3220, DOI 10.1007/s11431-011-4549-z; MCCULLOCH CM, 1985, IEEE T COMPUT, V34, P387, DOI 10.1109/TC.1985.5009393; Pan SM, 2013, PROCEEDINGS OF THE 2013 8TH INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE & EDUCATION (ICCSE 2013), P1423; [潘少明 PAN Shaoming], 2009, [测绘学报, Acta Geodetica et Cartographica Sinica], V38, P236; Roselli D, 2000, USENIX ASSOCIATION PROCEEDINGS OF THE 2000 USENIX ANNUAL TECHNICAL CONFERENCE, P41; Samo R, 2015, 0201 U LJUBLJ U MAR; Sample JT, 2010, TILE-BASED GEOSPATIAL INFORMATION SYSTEMS: PRINCIPLES AND PRACTICES, P1, DOI 10.1007/978-1-4419-7631-4; Shafer J, 2010, INT SYM PERFORM ANAL, P122, DOI 10.1109/ISPASS.2010.5452045; Trujillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030546; Wang Hao, 2010, Geomatics and Information Science of Wuhan University, V35, P356; Weil S. A., 2007, P 2007 ACM PET DAT S; [颜安 YAN An], 2009, [地球信息科学, Geo-information Science], V11, P250; Yu Zhanwu, 2008, Geomatics and Information Science of Wuhan University, V33, P285; Zhu YF, 2006, CLUSTER COMPUT, V9, P433, DOI 10.1007/s10586-006-0011-6; Zukerman I, 1999, CISM COURSES LECT, P275	35	3	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133029	10.1371/journal.pone.0133029	http://dx.doi.org/10.1371/journal.pone.0133029			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181628	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198200050
J	Dong, Y; Chen, J; Chen, ZQ; Tian, CY; Lu, HS; Ruan, JG; Yang, WJ				Dong, Ying; Chen, Jing; Chen, Zhiqiang; Tian, Chaoyong; Lu, Huaisheng; Ruan, Jigang; Yang, Wenjun			Evaluating the Association of Eight Polymorphisms with Cancer Susceptibility in a Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMA; LOCI; PLCE1; C20ORF54; STAT3; RISK	Background The identification of susceptibility genes for specific types of cancer can provide necessary information for the complete characterization of cancer syndromes. Eight single nucleotide polymorphisms (SNPs), rs465498, rs17728461, rs4488809, rs753955, rs13361707, rs9841504, rs2274223, and rs13042395, were reported by genome wide association studies (GWASs) to be closely related to the susceptibility of lung cancer (LC), gastric cancer (GC) or esophageal cancer (EC) in Han population from northern or southern China. However, Chinese Han people from different geographic areas may have different genetic backgrounds. This study aims to assess the genetic associations of the eight SNPs mentioned above with three cancers risk in a Han population from northwest China. Methods A total of 186 cancer-free controls and 436 cases with non-small cell lung cancer (NSCLC) (159 cases), non-cardia GC (167 cases) or EC (110 cases) were enrolled in this study. Chi-square test and polytomous logistic regression analyses were used to estimate the association between eight cancer-related SNPs and three cancers in a Han Chinese population from northwest China. The logistic regression results were adjusted for confounding factors and Benjamini and Hochberg False Discovery Rate (FDR) method was used to adjust the multiple hypothesis tests. Association analyses by cigarette smoking or alcohol drinking status were analyzed by crossover analyses. Results One of the eight SNPs, rs17728461 was associated with NSCLC susceptibility (in a heterozygous model, OR = 0.44, 95% CI = 0.27-0.72, p = 0.001). Two SNPs, rs753955 and rs13042395, were associated with the risk of non-cardia GC in different genetic models (p < 0.05). No SNPs were associated with EC. The crossover analyses showed that the rs13042395 CT genotype, combined with cigarette smoking or alcohol drinking, could further increase the risk for non-cardia GC (p < 0.05). Conclusions These results indicated that rs17728461 may be specifically associated with the risk of NSCLC. rs753955 and rs13042395 were specifically associated with susceptibility to non-cardia GC in Ningxia Han Chinese. Susceptibility-associated polymorphisms in the northwestern Han Chinese were not very consistent with those in the northern Han Chinese or southern Han Chinese. The validation of these findings with a functional evaluation and a larger population is still required.	[Dong, Ying; Yang, Wenjun] Ningxia Med Univ, Dept Med Oncol, Gen Hosp, Ningxia, Peoples R China; [Dong, Ying; Chen, Jing; Tian, Chaoyong; Yang, Wenjun] Ningxia Med Univ, Key Lab Ningxia Reprod & Hered, Ningxia, Peoples R China; [Chen, Zhiqiang] Ningxia Med Univ, Dept Radiol, Gen Hosp, Ningxia, Peoples R China; [Lu, Huaisheng] Ningxia Peoples Hosp, Dept Pathol, Ningxia, Peoples R China; [Ruan, Jigang] Ningxia Med Univ, Gen Hosp, Digest Dept, Ningxia, Peoples R China	Ningxia Medical University; Ningxia Medical University; Ningxia Medical University; Ningxia Medical University	Yang, WJ (corresponding author), Ningxia Med Univ, Dept Med Oncol, Gen Hosp, Ningxia, Peoples R China.	yw001@nxmu.edu.cn	小建, 于/N-3224-2015	Yang, Wenjun/0000-0001-5671-1344	National Natural Science Foundation of China [81460434, 81160249, 81260339, 81301886, 81160252]; Ningxia Natural Science Foundation [NZ13057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ningxia Natural Science Foundation	This work was supported by the National Natural Science Foundation of China (grant numbers 81460434, 81160249, 81260339, 81301886, and 81160252 to WJY, JC, and HSL; http://www.nsfc.gov.cn/), the Ningxia Natural Science Foundation (grant number NZ13057 to WJY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen BF, 2014, J MOL NEUROSCI, V52, P481, DOI 10.1007/s12031-013-0160-z; Chen YL, 2010, CANCER RES, V70, P8917, DOI 10.1158/0008-5472.CAN-10-0518; Chew A, 2000, GENOMICS, V65, P104, DOI 10.1006/geno.2000.6162; Dura P, 2013, EUR J CANCER PREV, V22, P417, DOI 10.1097/CEJ.0b013e32835c7f53; Ferlay J, 2012, IARC CANCERBASE; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gu HY, 2012, MOL BIOL REP, V39, P9105, DOI 10.1007/s11033-012-1782-x; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hutter CM, 2011, CANCER EPIDEM BIOMAR, V20, P1950, DOI 10.1158/1055-9965.EPI-11-0524; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Palmer AJ, 2012, EUR J CANCER PREV, V21, P541, DOI 10.1097/CEJ.0b013e3283529b79; Piao JM, J 0B013E3283529B79; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Walker CL, 2012, NAT REV CANCER, V12, P479, DOI 10.1038/nrc3220; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	21	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132797	10.1371/journal.pone.0132797	http://dx.doi.org/10.1371/journal.pone.0132797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176862	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600160
J	el Din, FA; Patri, S; Thoreau, V; Rodriguez-Ballesteros, M; Hamade, E; Bailly, S; Gilbert-Dussardier, B; Abou Merhi, R; Kitzis, A				el Din, Ferdos Alaa; Patri, Sylvie; Thoreau, Vincent; Rodriguez-Ballesteros, Montserrat; Hamade, Eva; Bailly, Sabine; Gilbert-Dussardier, Brigitte; Abou Merhi, Raghida; Kitzis, Alain			Functional and splicing defect analysis of 23 ACVRL1 mutations in a cohort of patients affected by Hereditary Hemorrhagic Telangiectasia	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; JUVENILE POLYPOSIS; I RECEPTORS; ALK1; ANGIOGENESIS; ACTIVIN; IDENTIFICATION; MECHANISMS; BMP9	Hereditary Hemorrhagic Telangiectasia syndrome (HHT) or Rendu-Osler-Weber (ROW) syndrome is an autosomal dominant vascular disorder. Two most common forms of HHT, HHT1 and HHT2, have been linked to mutations in the endoglin (ENG) and activin receptor-like kinase 1 (ACVRL1 or ALK1) genes respectively. This work was designed to examine the pathogenicity of 23 nucleotide variations in ACVRL1 gene detected in more than 400 patients. Among them, 14 missense mutations and one intronic variant were novels, and 8 missense mutations were previously identified with questionable implication in HHT2. The functionality of missense mutations was analyzed in response to BMP9 (specific ligand of ALK1), the maturation of the protein products and their localization were analyzed by western blot and fluorescence microscopy. The splicing impairment of the intronic and of two missense mutations was examined by minigene assay. Functional analysis showed that 18 out of 22 missense mutations were defective. Splicing analysis revealed that one missense mutation (c. 733A>G, p.Ile245Val) affects the splicing of the harboring exon 6. Similarly, the intronic mutation outside the consensus splicing sites (c. 1048+5G>A in intron 7) was seen pathogenic by splicing study. Both mutations induce a frame shift creating a premature stop codon likely resulting in mRNA degradation by NMD surveillance mechanism. Our results confirm the haploinsufficiency model proposed for HHT2. The affected allele of ACVRL1 induces mRNA degradation or the synthesis of a protein lacking the receptor activity. Furthermore, our data demonstrate that functional and splicing analyses together, represent two robust diagnostic tools to be used by geneticists confronted with novel or conflicted ACVRL1 mutations.	[el Din, Ferdos Alaa; Patri, Sylvie; Thoreau, Vincent; Rodriguez-Ballesteros, Montserrat; Gilbert-Dussardier, Brigitte; Kitzis, Alain] Univ Poitiers, Genet Rare Dis, Poitiers, France; [Patri, Sylvie; Rodriguez-Ballesteros, Montserrat; Gilbert-Dussardier, Brigitte; Kitzis, Alain] Univ Hosp Poitiers, Dept Genet, Poitiers, France; [el Din, Ferdos Alaa; Hamade, Eva; Abou Merhi, Raghida] Fac Sci EDST, Hadath, Lebanon; [Bailly, Sabine] CEA Grenoble, INSERM, U1036, F-38054 Grenoble, France; [Gilbert-Dussardier, Brigitte] Univ Hosp Poitiers, Competence Ctr Rendu Osler, Poitiers, France	Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Poitiers; Universite de Poitiers	Patri, S (corresponding author), Univ Poitiers, Genet Rare Dis, Poitiers, France.	sylvie.patri@chu-poitiers.fr; raboumerhi@ul.edu.lb	bailly, sabine/G-3540-2013	bailly, sabine/0000-0003-1043-7030; GILBERT-DUSSARDIER, Brigitte/0000-0001-7182-9914; Hamade, Eva/0000-0001-5152-913X	LASER LIBANESE UNIVERSITY; Association francaise Maladie de Rendu Osler Weber (AMRO)	LASER LIBANESE UNIVERSITY; Association francaise Maladie de Rendu Osler Weber (AMRO)	This work was supported by LASER LIBANESE UNIVERSITY: FAD, and the Association francaise Maladie de Rendu Osler Weber (AMRO) to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SA, 2006, J MED GENET, V43, P97, DOI 10.1136/jmg.2005.030833; Ali BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026206; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Bayrak-Toydemir P, 2006, AM J MED GENET A, V140A, P2155, DOI 10.1002/ajmg.a.31450; Bernabeu C, 2010, J APPL BIOMED, V8, P169, DOI 10.2478/v10136-009-0020-x; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Chen YG, 1999, J BIOL CHEM, V274, P3672, DOI 10.1074/jbc.274.6.3672; Cole SG, 2005, J MED GENET, V42, P577, DOI 10.1136/jmg.2004.028712; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fernandez-L A, 2006, CLIN MED RES, V4, P66, DOI 10.3121/cmr.4.1.66; Gallione C, 2010, AM J MED GENET A, V152A, P333, DOI 10.1002/ajmg.a.33206; Gallione CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Govani FS, 2009, EUR J HUM GENET, V17, P860, DOI 10.1038/ejhg.2009.35; Gu Y, 2006, BLOOD, V107, P1951, DOI 10.1182/blood-2005-05-1834; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Hume AN, 2013, MOL CELL BIOCHEM, V373, P247, DOI 10.1007/s11010-012-1496-3; Johnson DW, 1995, 2 LOCUS HEREDITARY H, P21; Johnson DW, 1996, MUTATIONS ACTIVIN RE, P189; Kjeldsen AD, 1999, J INTERN MED, V245, P31, DOI 10.1046/j.1365-2796.1999.00398.x; Klaus Daniel J., 1998, Human Mutation, V12, P137, DOI 10.1002/(SICI)1098-1004(1998)12:2<137::AID-HUMU15>3.0.CO;2-M; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; Lesca Gaetan, 2006, Hum Mutat, V27, P598, DOI 10.1002/humu.9421; Mallet C, 2014, HUM MOL GENET; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MCALLISTER KA, 1994, J MED GENET, V31, P927, DOI 10.1136/jmg.31.12.927; McAllister KA, 1994, ENDOGLIN TGF BETA BI, V1, P345; McDonald J, 2010, MOL DIAGNOSIS HEREDI, P335; Nielsen KB, 2007, AM J HUM GENET, V80, P416, DOI 10.1086/511992; Novoyatleva T, 2006, PROG MOLEC, V44, P27; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Pagani F, 2005, P NATL ACAD SCI USA, V102, P6368, DOI 10.1073/pnas.0502288102; Ricard N, 2010, BLOOD, V116, P1604, DOI 10.1182/blood-2010-03-276881; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Tang Y, 2005, ANAL ALTERNATIVE SPL, P755; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; WEISBERG RA, 1983, J MOL BIOL, V170, P319, DOI 10.1016/S0022-2836(83)80151-X; Wooderchak-Donahue WL, 2013, AM J HUM GENET, V93, P530, DOI 10.1016/j.ajhg.2013.07.004; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200	47	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132111	10.1371/journal.pone.0132111	http://dx.doi.org/10.1371/journal.pone.0132111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176610	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600082
J	Kim, J; Nadella, P; Kim, DJ; Brodmerkel, C; da Rosa, JC; Krueger, JG; Suarez-Farinas, M				Kim, Jaehwan; Nadella, Pranay; Kim, Dong Joo; Brodmerkel, Carrie; da Rosa, Joel Correa; Krueger, James G.; Suarez-Farinas, Mayte			Histological Stratification of Thick and Thin Plaque Psoriasis Explores Molecular Phenotypes with Clinical Implications	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; TO-SEVERE PSORIASIS; GENE-EXPRESSION; MONOCLONAL-ANTIBODY; DISEASE SEVERITY; TNF-ALPHA; ARTHRITIS; MODERATE; METAANALYSIS; USTEKINUMAB	Psoriasis, which presents as red, scaly patches on the body, is a common, autoimmune skin disease that affects 2 to 3 percent of the world population. To leverage recent molecular findings into the personalized treatment of psoriasis, we need a strategy that integrates clinical stratification with molecular phenotyping. In this study, we sought to stratify psoriasis patients by histological measurements of epidermal thickness, and to compare their molecular characterizations by gene expression, serum cytokines, and response to biologics. We obtained histological measures of epidermal thickness in a cohort of 609 psoriasis patients, and identified a mixture of two subpopulations-thick and thin plaque psoriasis-from which they were derived. This stratification was verified in a subcohort of 65 patients from a previously published study with significant differences in inflammatory cell infiltrates in the psoriatic skin. Thick and thin plaque psoriasis shared 84.8% of the meta-analysis-derived psoriasis transcriptome, but a stronger dysregulation of the meta-analysis-derived psoriasis transcriptome was seen in thick plaque psoriasis on microarray. RT-PCR revealed that gene expression in thick and thin plaque psoriasis was different not only within psoriatic lesional skin but also in peripheral non-lesional skin. Additionally, differences in circulating cytokines and their changes in response to biologic treatments were found between the two subgroups. All together, we were able to integrate histological stratification with molecular phenotyping as a way of exploring clinical phenotypes with different expression levels of the psoriasis transcriptome and circulating cytokines.	[Kim, Jaehwan; Nadella, Pranay; Kim, Dong Joo; Krueger, James G.] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; [Nadella, Pranay] Harvard Univ, Cambridge, MA 02138 USA; [Kim, Dong Joo] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA; [Brodmerkel, Carrie] Janssen Res & Dev, Immunol & Biomarkers, Radnor, PA USA; [da Rosa, Joel Correa; Suarez-Farinas, Mayte] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA; [Suarez-Farinas, Mayte] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Rockefeller University; Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Rockefeller University; Icahn School of Medicine at Mount Sinai	Krueger, JG (corresponding author), Rockefeller Univ, Invest Dermatol Lab, 1230 York Ave, New York, NY 10021 USA.	kruegej@rockefeller.edu; farinam@rockefeller.edu	Da Rosa, Joel/AAU-1238-2020; Correa da Rosa, Joel/Q-4753-2017	Da Rosa, Joel/0000-0003-4221-1976; Correa da Rosa, Joel/0000-0003-4221-1976; Nadella, Pranay/0000-0003-3002-1200; Kim, Jaehwan/0000-0002-7586-1425	Janssen Research Development	Janssen Research Development	Janssen Research & Development provided support in the form of data collection and salaries for author C.B. The specific roles of these authors are articulated in the 'author contributions' section.	Ainali C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-472; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Bhalerao J, 1998, HUM MOL GENET, V7, P1537, DOI 10.1093/hmg/7.10.1537; Boehncke WH, 2011, EXP DERMATOL, V20, P303, DOI 10.1111/j.1600-0625.2011.01261.x; Bowcock AM, 2001, HUM MOL GENET, V10, P1793, DOI 10.1093/hmg/10.17.1793; Chandran V, 2010, J AUTOIMMUN, V34, pJ314, DOI 10.1016/j.jaut.2009.12.001; Christensen TE, 2006, J INVEST DERMATOL, V126, P2397, DOI 10.1038/sj.jid.5700489; Christophers E, 2014, BRIT J DERMATOL, V170, P59, DOI 10.1111/bjd.12631; Cohen AD, 2008, ISR MED ASSOC J, V10, P419; DEMPSTER WJ, 1977, JPN HEART J, V18, P491; Devrimci-Ozguven H, 2000, J EUR ACAD DERMATOL, V14, P267, DOI 10.1046/j.1468-3083.2000.00085.x; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Gottlieb A, 2009, LANCET, V373, P633, DOI 10.1016/S0140-6736(09)60140-9; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Jabbari A, 2012, J INVEST DERMATOL, V132, P246, DOI 10.1038/jid.2011.267; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; Keermann M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1508-2; Kim J, 2015, DERMATOL CLIN, V33, P13, DOI 10.1016/j.det.2014.09.002; Koo J, 1996, DERMATOL CLIN, V14, P485, DOI 10.1016/S0733-8635(05)70376-4; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Leavy O., 2012, NAT REV IMMUNOL, V12, P322; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; McLachlan GJ, 2004, FINITE MIXTURE MODEL, DOI [10.1002/0471721182, DOI 10.1002/0471721182]; Mussi A, 1996, J BIOL REGULATORS HO, V11, P115; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Rasband W, 2009, IMAGEJ; Reich K, 2012, BRIT J DERMATOL, V166, P179, DOI 10.1111/j.1365-2133.2011.10583.x; Schmitt J, 2008, BRIT J DERMATOL, V159, P513, DOI 10.1111/j.1365-2133.2008.08732.x; Schon MP, 2005, LANCET, V366, P1333, DOI 10.1016/S0140-6736(05)67542-3; Suarez-Farinas M, 2012, J INVESTIGATIVE DERM; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; Swindell WR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-527; Swindell WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034594; Tian SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044274; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737	40	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132454	10.1371/journal.pone.0132454	http://dx.doi.org/10.1371/journal.pone.0132454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176783	Green Submitted, gold, Green Published			2022-12-27	WOS:000358197600114
J	Tan, JY; Suen, LKP; Wang, T; Molassiotis, A				Tan, Jing-Yu; Suen, Lorna K. P.; Wang, Tao; Molassiotis, Alexander			Sham Acupressure Controls Used in Randomized Controlled Trials: A Systematic Review and Critique	PLOS ONE			English	Article							REDUCING POSTOPERATIVE NAUSEA; P6 ACUPRESSURE; DOUBLE-BLIND; PREHOSPITAL ANALGESIA; SPINAL-ANESTHESIA; SANYINJIAO POINT; ACUPUNCTURE; EFFICACY; PAIN; PREVENTION	Objectives To explore the commonly utilized sham acupressure procedures in existing acupressure trials, and to assess whether different types of sham interventions yield different therapeutic outcomes, and, as far as possible, to identify directions for the future development of an adequate sham acupressure method. Methods Randomized controlled trials comparing true acupressure with sham interventions were included. Thirteen electronic databases were adopted to locate relevant studies from inception to July 3, 2014. Meanwhile, eight Chinese journals on complementary and alternative medicine were manually searched to locate eligible articles. In addition, eligible studies listed in the reference lists of the included papers and other related systematic reviews on acupressure were also screened to further search any potentially eligible trials. Methodological quality of the included studies was evaluated using the risk of bias assessment tool developed by the Cochrane Back Review Group. Descriptive analysis was adopted to summarize the therapeutic outcomes. Results Sixty-six studies with 7265 participants were included. Methodological quality of the included trials was generally satisfactory. Six types of sham acupressure approaches were identified and "non-acupoint" stimulation was the most frequently utilized sham point while an acupressure device was the most commonly used approach for administering sham treatments. Acupressure therapy was a beneficial approach in managing a variety of health problems and the therapeutic effect was found to be more effective in the true acupressure groups than that in the sham comparative groups. No clear association could be identified between different sham acupressure modalities and the reported treatment outcomes. Conclusions A great diversity of sham acupressure controls have been used in clinical practice and research. A solid conclusion whether different sham alternatives are related to different treatment outcomes cannot be derived because of significant clinical heterogeneity among the analyzed trials. Non-acupoints are generally recommended but the definite locations should be identified with caution. For studies using single sham acupoints on hands or legs, it is suggested to apply identical acupressure devices on the same acupoint as in the active intervention without any stimulation. While for studies on pain, stimulation of sham acupoints should be avoided.	[Tan, Jing-Yu; Suen, Lorna K. P.; Molassiotis, Alexander] Hong Kong Polytech Univ, Sch Nursing, Kowloon, Hong Kong, Peoples R China; [Tan, Jing-Yu] Fujian Univ Tradit Chinese Med, Sch Nursing, Fuzhou, Fujian, Peoples R China; [Wang, Tao] Fujian Univ Tradit Chinese Med, Affiliated Peoples Hosp 2, Fuzhou, Fujian, Peoples R China	Hong Kong Polytechnic University; Fujian University of Traditional Chinese Medicine; Fujian University of Traditional Chinese Medicine	Molassiotis, A (corresponding author), Hong Kong Polytech Univ, Sch Nursing, Kowloon, Hong Kong, Peoples R China.	alex.molasiotis@polyu.edu.hk	Suen, Lorna KP/F-5077-2014; Tan, Jing-Yu/AAE-5262-2022	Suen, Lorna KP/0000-0002-0126-6674; Tan, Jing-Yu/0000-0002-1609-6890; MOLASIOTIS, Alex/0000-0002-5225-1739; WANG, Tao/0000-0001-9845-3988; Molassiotis, Alex/0000-0001-6351-9991				Adib-Hajbaghery M, 2013, J RES MED SCI, V18, P482; Agarwal A, 2000, CAN J ANAESTH, V47, P319, DOI 10.1007/BF03020945; Alessandrini M, 2012, J ALTERN COMPLEM MED, V18, P1121, DOI 10.1089/acm.2011.0384; Alkaissi A, 1999, ACTA ANAESTH SCAND, V43, P270, DOI 10.1034/j.1399-6576.1999.430306.x; Alkaissi A, 2005, CAN J ANAESTH, V52, P703, DOI 10.1007/BF03016557; Alkaissi A, 2002, CAN J ANAESTH, V49, P1034, DOI 10.1007/BF03017897; Atrian MK, 2013, IRAN RED CRESCENT ME, V15, P848, DOI 10.5812/ircmj.12719; Azad A, 2013, J CLIN ONCOL, V31, P2057, DOI 10.1200/JCO.2012.47.8750; Bao T, 2011, J PAIN SYMPTOM MANAG, V41, P995, DOI 10.1016/j.jpainsymman.2010.08.012; BAYREUTHER J, 1994, COMPLEMENT THER MED, V2, P70, DOI DOI 10.1016/0965-2299(94)90002-7; BELLUOMINI J, 1994, OBSTET GYNECOL, V84, P245; Bertalanffy P, 2004, ANESTH ANALG, V98, P220, DOI 10.1213/01.ANE.0000093252.56986.29; Chang KKP, 2011, AM J CHINESE MED, V39, P1139, DOI 10.1142/S0192415X11009469; Chao Hui-Lin, 2013, Oncol Nurs Forum, V40, pE61, DOI 10.1188/13.ONF.E61-E68; Chen LL, 2003, AM J CHINESE MED, V31, P781, DOI 10.1142/S0192415X03001466; Dent HE, 2003, COMPLEMENT THER MED, V11, P72, DOI 10.1016/S0965-2299(03)00058-X; Dincer F, 2003, COMPLEMENT THER MED, V11, P235, DOI 10.1016/S0965-2299(03)00124-9; Duggal KN, 1998, INT J OBSTET ANESTH, V7, P231, DOI 10.1016/S0959-289X(98)80044-7; Ebrahim Soltani Ali Reza, 2011, Acta Med Iran, V49, P208; Ernst E, 1997, SCAND J RHEUMATOL, V26, P444, DOI 10.3109/03009749709065717; Fan CF, 1997, ANESTH ANALG, V84, P821, DOI 10.1097/00000539-199704000-00023; Felhendler D, 1996, CLIN J PAIN, V12, P326, DOI 10.1097/00002508-199612000-00012; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Hamidzadeh A, 2012, J MIDWIFERY WOM HEAL, V57, P133, DOI 10.1111/j.1542-2011.2011.00138.x; Harmon D, 2000, BRIT J ANAESTH, V84, P463; Harmon D, 1999, BRIT J ANAESTH, V82, P387, DOI 10.1093/bja/82.3.387; Heazell A, 2006, AM J OBSTET GYNECOL, V194, P815, DOI 10.1016/j.ajog.2005.08.042; Hjelmstedt A, 2010, ACTA OBSTET GYN SCAN, V89, P1453, DOI 10.3109/00016349.2010.514323; Ho CM, 2006, ANESTH ANALG, V102, P900, DOI 10.1213/01.ane.0000195553.82409.00; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; Hsu W., 2006, J EVID BASED NURS, V2, P331; Hughes JG, 2013, BMC COMPLEM ALTERN M, V13, P1; Hughes JG, 2014, COMPLEMENT THER MED, V22, P903, DOI 10.1016/j.ctim.2014.07.005; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; Itoh Kazunori, 2006, Acupunct Med, V24, P5; Kashanian M, 2010, J MATERN-FETAL NEO M, V23, P638, DOI 10.3109/14767050903277662; Kashefi F, 2011, J ALTERN COMPLEM MED, V17, P1141, DOI 10.1089/acm.2010.0589; Kelley JM, 2009, PSYCHOSOM MED, V71, P789, DOI 10.1097/PSY.0b013e3181acee12; Klein AA, 2004, J CARDIOTHOR VASC AN, V18, P68, DOI 10.1053/j.jvca.2003.10.014; Kober A, 2002, ANESTH ANALG, V95, P723, DOI 10.1097/00000539-200209000-00035; KONDZIOLKA D, 1994, J NEUROSURG, V80, P993, DOI 10.3171/jns.1994.80.6.0993; Lang T, 2007, AM J EMERG MED, V25, P887, DOI 10.1016/j.ajem.2007.01.016; Lee MK, 2004, J ALTERN COMPLEM MED, V10, P959; LEWIS IH, 1991, BRIT J ANAESTH, V67, P73, DOI 10.1093/bja/67.1.73; Linde K, 2005, JAMA-J AM MED ASSOC, V293, P2118, DOI 10.1001/jama.293.17.2118; Linde K, 2010, FORSCH KOMPLEMENTMED, V17, P259, DOI 10.1159/000320374; Lund Irene, 2009, Chin Med, V4, P1, DOI 10.1186/1749-8546-4-1; Lundeberg Thomas, 2007, Acupunct Med, V25, P100; Lundeberg T, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep049; Lundeberg T, 2008, ACUPUNCT MED, V26, P239, DOI 10.1136/aim.26.4.239; Maa SH, 2007, J CLIN NURS, V16, P794, DOI 10.1111/j.1365-2702.2005.01515.x; MacPherson H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000261; Majholm B, 2011, EUR J ANAESTH, V28, P412, DOI 10.1097/EJA.0b013e32833f6f42; McFadden KL, 2012, COMPLEMENT THER MED, V20, P175, DOI 10.1016/j.ctim.2011.12.003; McFadden KL, 2011, J NEUROTRAUM, V28, P21, DOI 10.1089/neu.2010.1515; McFadden KL, 2010, COMPLEMENT THER MED, V18, P42, DOI 10.1016/j.ctim.2010.01.001; McGovern DPB., 2001, KEY TOPICS EVIDENCE, P26; Mirbagher-Ajorpaz Neda, 2011, Complement Ther Clin Pract, V17, P33, DOI 10.1016/j.ctcp.2010.06.005; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Molassiotis A, 2013, HEALTH TECHNOL ASSES, V17, DOI 10.3310/hta17260; Molsberger AF, 2010, PAIN, V151, P146, DOI 10.1016/j.pain.2010.06.036; Nilsson I, 2015, J NEUROSURG ANESTH, V27, P42, DOI 10.1097/ANA.0000000000000089; Nordio M, 2008, Minerva Med, V99, P539; Norheim AJ, 2001, SCAND J PRIM HEALTH, V19, P43, DOI 10.1080/028134301300034666; Noroozinia Heydar, 2013, Acta Med Iran, V51, P163; OBrien B, 1996, AM J OBSTET GYNECOL, V174, P708, DOI 10.1016/S0002-9378(96)70454-4; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Pan Li-Jia, 2014, Zhongguo Zhen Jiu, V34, P83; Rad MN, 2012, IRAN RED CRESCENT ME, V14, P697, DOI 10.5812/ircmj.2153; Reza Hoseinabadi, 2010, Complement Ther Clin Pract, V16, P81, DOI 10.1016/j.ctcp.2009.07.003; Samad K, 2003, J Pak Med Assoc, V53, P68; Scharf HP, 2006, ANN INTERN MED, V145, P12, DOI 10.7326/0003-4819-145-1-200607040-00005; Schultz AA, 2003, APPL NURS RES, V16, P256, DOI 10.1016/S0897-1897(03)00057-0; Sehhatie-Shafaie Fahimeh, 2013, J Caring Sci, V2, P123, DOI 10.5681/jcs.2013.015; Shapiro AK, 1978, HDB PSYCHOTHERAPY BE, P371; Shin HS, 2007, J ADV NURS, V59, P510, DOI 10.1111/j.1365-2648.2007.04342.x; Sinha A, 2011, INT J OBSTET ANESTH, V20, P110, DOI 10.1016/j.ijoa.2010.10.005; Soltanzadeh M, 2012, LIFE SCI J, V9, P871; Steele N M, 2001, J Obstet Gynecol Neonatal Nurs, V30, P61; Suh Eunyoung Eunice, 2012, Oncol Nurs Forum, V39, pE1, DOI 10.1188/12.ONF.E1-E9; Sun JL, 2010, INT J NURS STUD, V47, P798, DOI 10.1016/j.ijnurstu.2009.12.003; Sun Y, 2008, ANESTH ANALG, V107, P2038, DOI 10.1213/ane.0b013e318187c76a; Tang WR, 2014, COMPLEMENT THER MED, V22, P581, DOI 10.1016/j.ctim.2014.05.006; Tsay SL, 2003, INT J NURS STUD, V40, P1, DOI 10.1016/S0020-7489(02)00019-6; Turgut S, 2007, EUR J ANAESTH, V24, P87, DOI 10.1017/S0265021506001190; Valiee S, 2012, J PERIANESTH NURS, V27, P259, DOI 10.1016/j.jopan.2012.05.003; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; Wang SM, 2008, ANESTH ANALG, V107, P811, DOI 10.1213/ane.0b013e3181804441; Wang SM, 2005, ANESTH ANALG, V101, P666, DOI 10.1213/01.ANE.0000175212.17642.45; White PF, 2012, ANESTH ANALG, V115, P31, DOI 10.1213/ANE.0b013e3182536f27; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Woods RM, 1999, PERICARDIUM 6 ACUPRE; Wu HS, 2004, J ADV NURS, V45, P252, DOI 10.1046/j.1365-2648.2003.02886.x; Wu HS, 2007, J ALTERN COMPLEM MED, V13, P253, DOI 10.1089/acm.2006.5342; Zhang CS, 2014, J ALTERN COMPLEM MED, V20, P147, DOI 10.1089/acm.2013.0238; Zhang Hong-wei, 2003, Zhongguo Zhong Xi Yi Jie He Za Zhi, V23, P247; Zhang Hongwei, 2010, Chin Med, V5, P1, DOI 10.1186/1749-8546-5-1	97	45	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132989	10.1371/journal.pone.0132989	http://dx.doi.org/10.1371/journal.pone.0132989			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177378	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600196
J	Yamashita, JM; de Moura-Grec, PG; de Freitas, AR; Sales-Peres, A; Groppo, FC; Ceneviva, R; Sales-Peres, SHD				Yamashita, Joselene Martinelli; de Moura-Grec, Patrcia Garcia; de Freitas, Adriana Rodrigues; Sales-Peres, Arsenio; Groppo, Francisco Carlos; Ceneviva, Reginaldo; de Carvalho Sales-Peres, Silvia Helena			Assessment of Oral Conditions and Quality of Life in Morbid Obese and Normal Weight Individuals: A Cross-Sectional Study	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; BARIATRIC SURGERY; PERIODONTAL-DISEASE; DENTAL-CARIES; BODY-WEIGHT; TOOTH WEAR; FLOW-RATE; ASSOCIATION; HEALTH; PREVALENCE	The aim of this study was to identify the impact of oral disease on the quality of life of morbid obese and normal weight individuals. Cohort was composed of 100 morbid-obese and 50 normal-weight subjects. Dental caries, community periodontal index, gingival bleeding on probing (BOP), calculus, probing pocket depth, clinical attachment level, dental wear, stimulated salivary flow, and salivary pH were used to evaluate oral diseases. Socioeconomic and the oral impacts on daily performances (OIDP) questionnaires showed the quality of life in both groups. Unpaired Student, Fisher's Exact, Chi-Square, Mann-Whitney, and Multiple Regression tests were used (p<0.05). Obese showed lower socio-economic level than control group, but no differences were found considering OIDP. No significant differences were observed between groups considering the number of absent teeth, bruxism, difficult mastication, calculus, initial caries lesion, and caries. However, saliva flow was low, and the salivary pH was changed in the obese group. Enamel wear was lower and dentine wear was higher in obese. More BOP, insertion loss, and periodontal pocket, especially the deeper ones, were found in obese subjects. The regression model showed gender, smoking, salivary pH, socio-economic level, periodontal pocket, and periodontal insertion loss significantly associated to obesity. However, both OIDP and BOP did not show significant contribution to the model. The quality of life of morbid obese was more negatively influenced by oral disease and socio-economic factors than in normal weight subjects.	[Yamashita, Joselene Martinelli; de Moura-Grec, Patrcia Garcia; de Freitas, Adriana Rodrigues; Sales-Peres, Arsenio; de Carvalho Sales-Peres, Silvia Helena] Univ Sao Paulo, Bauru Sch Dent, Dept Pediat Dent Orthodont & Publ Hlth, Bauru, SP, Brazil; [Groppo, Francisco Carlos] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Surg & Anat, Ribeirao Preto, SP, Brazil; [Ceneviva, Reginaldo] Univ Estadual Campinas, Dept Physiol Sci, Piracicaba Dent Sch, Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas	Sales-Peres, SHD (corresponding author), Univ Sao Paulo, Bauru Sch Dent, Dept Pediat Dent Orthodont & Publ Hlth, Bauru, SP, Brazil.	shcperes@usp.br	Sales-Peres, SILVIA/C-2714-2012; groppo, francisco carlos/HIK-2053-2022	Sales-Peres, SILVIA/0000-0003-3811-7899; groppo, francisco carlos/0000-0002-8513-773X	CNPq; CAPES; FAPESP [558366/2010-4, 2014/09550-6]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors would like to thank CNPq, CAPES, and FAPESP for financial support through grants 558366/2010-4 and 2014/09550-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adulyanon S., 1997, MEASURING ORAL HLTH, P151; Al-Zahrani MS, 2003, J PERIODONTOL, V74, P610, DOI 10.1902/jop.2003.74.5.610; Al-Zarea Bader K, 2012, ISRN Dent, V2012, P161565, DOI 10.5402/2012/161565; Amar S, 2013, MOL ORAL MICROBIOL, V28, P331, DOI 10.1111/omi.12035; Atlantis E, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3868; Baceviciene M, 2009, MEDICINA-LITHUANIA, V45, P565, DOI 10.3390/medicina45070075; Barron Robert P, 2003, J Can Dent Assoc, V69, P84; Bastos A, 2005, BRAZILIAN RES PEDIAT, V5, P57; Biccas Beatriz N., 2009, Arq. Gastroenterol., V46, P15, DOI 10.1590/S0004-28032009000100008; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Cnop M, 2002, DIABETES, V51, P1005, DOI 10.2337/diabetes.51.4.1005; Curran AE, 2010, J AM DENT ASSOC, V141, P1307, DOI 10.14219/jada.archive.2010.0075; Sales-Peres SHD, 2008, PUBLIC HEALTH, V122, P942, DOI 10.1016/j.puhe.2007.12.008; de Moura-Grec PG, 2012, EUR J GASTROEN HEPAT, V24, P84, DOI 10.1097/MEG.0b013e32834bebb3; Dodson MV, 2011, J LIPIDS, V2011, DOI 10.1155/2011/721686; Dodson MV, 2013, EXP BIOL MED, V238, P491, DOI 10.1177/1535370213477603; El-Serag HB, 2005, GUT, V54, P11, DOI 10.1136/gut.2004.040337; Fenoll-Palomares C, 2004, REV ESP ENFERM DIG, V96, P773; Ferreira J, 2005, DIAGNOSTICO TRATAMEN, P161; Figueiredo Wagner, 2005, Ciênc. saúde coletiva, V10, P105, DOI 10.1590/S1413-81232005000100017; Gordon NF, 1997, AM J CARDIOL, V79, P763, DOI 10.1016/S0002-9149(96)00864-8; Graciano MIG, 1980, SERV SOCIAL SOC, V1, P181; Grisius MM, 2001, ORAL SURG ORAL MED O, V92, P156, DOI 10.1067/moe.2001.116601; Gugliucci Alejandro, 2000, Journal of the American Osteopathic Association, V100, P621; Ibiyemi O, 2012, ETHIOP J HEALTH SCI, V22, P189; Isaksson H, 2013, SWEDISH DENT J S, P1; Ismail AI, 2007, COMMUNITY DENT ORAL, V35, P170, DOI 10.1111/j.1600-0528.2007.00347.x; Jung RT, 1997, BRIT MED BULL, V53, P307, DOI 10.1093/oxfordjournals.bmb.a011615; Kolotkin R L, 2001, Obes Rev, V2, P219, DOI 10.1046/j.1467-789X.2001.00040.x; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kozlowski F., 2001, THESIS U ESTADUAL CA; Krebs N, 2014, J TRACE ELEM MED BIO, V28, P1, DOI 10.1016/j.jtemb.2013.09.006; Levine R, 2012, BRIT DENT J, V213, P453, DOI 10.1038/sj.bdj.2012.1009; Lussi A, 2012, CARIES RES, V46, P507, DOI 10.1159/000339783; Lussi Adrian, 2004, Oral Health Prev Dent, V2 Suppl 1, P321; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; Marsicano JA, 2013, EUR J GASTROEN HEPAT, V25, P135, DOI 10.1097/MEG.0b013e32835ae8f7; Mathier MA, 2008, CHEST, V134, P670, DOI 10.1378/chest.08-1518; McMahon FG, 2002, J HUM HYPERTENS, V16, P5, DOI 10.1038/sj.jhh.1001298; Meneghim MD, 2007, CIENC SAUDE COLETIVA, V12, P523, DOI 10.1590/S1413-81232007000200028; Mirijello A, 2015, J AFFECT DISORDERS, V179, P95, DOI 10.1016/j.jad.2015.03.030; Moazzez R, 2004, J DENT, V32, P489, DOI 10.1016/j.jdent.2004.03.004; Modeer T, 2010, OBESITY, V18, P2367, DOI 10.1038/oby.2010.63; Moura-Grec PG, 2012, ABCD-ARQ BRAS CIR DI, V25, P173, DOI 10.1590/S0102-67202012000300008; Organization WH, 1998, WELLB MEAS PRIM HLTH; Ostberg AL, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-50; Pataro AL, 2012, CLIN ORAL INVEST, V16, P727, DOI 10.1007/s00784-011-0554-7; Pataro AL, 2012, J PERIODONTOL, V83, P257, DOI 10.1902/jop.2011.100782; Pischon N, 2007, J DENT RES, V86, P400, DOI 10.1177/154405910708600503; Serratine ACP, 2009, PESQUI BRAS ODONTOPE, V9, P217, DOI 10.4034/1519.0501.2009.0092.0014; Saito T, 2005, J PERIODONTAL RES, V40, P346, DOI 10.1111/j.1600-0765.2005.00813.x; Samnieng P, 2012, COMMUNITY DENT HLTH, V29, P117, DOI 10.1922/CDH_2690Ueno07; Sarlati F, 2008, INT DENT J, V58, P36; Sutin AR, 2010, J RES PERS, V44, P402, DOI 10.1016/j.jrp.2010.03.006; Suvan J, 2013, J DENT RES; Touger-Decker R, 2010, J AM DENT ASSOC, V141, P167, DOI 10.14219/jada.archive.2010.0135; Tremblay M, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-40; Trombelli L, 2013, Minerva Stomatol, V62, P207; Turner MD, 2007, J AM DENT ASSOC, V138, p15S, DOI 10.14219/jada.archive.2007.0358; WHO, 2003, DIET NUTR PREVENTION, V916; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th; World Health Organization, 2000, WHO TECHN REP SER, V894; Ylostalo P, 2008, J CLIN PERIODONTOL, V35, P297, DOI 10.1111/j.1600-051X.2008.01203.x; Yuan JCC, 2012, J DENT EDUC, V76, P1129	65	19	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0129687	10.1371/journal.pone.0129687	http://dx.doi.org/10.1371/journal.pone.0129687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177268	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600015
J	Zhuang, LL; Yuan, XY; Chen, Y; Xu, B; Yang, ZM; Huang, BR				Zhuang, Lili; Yuan, Xiuyun; Chen, Yu; Xu, Bin; Yang, Zhimin; Huang, Bingru			PpCBF3 from Cold-Tolerant Kentucky Bluegrass Involved in Freezing Tolerance Associated with Up-Regulation of Cold-Related Genes in Transgenic Arabidopsis thaliana	PLOS ONE			English	Article							BINDING TRANSCRIPTION FACTOR; CONFERS ELEVATED TOLERANCE; STRESS TOLERANCE; LOW-TEMPERATURE; HETEROLOGY EXPRESSION; FUNCTIONAL-ANALYSIS; COR15A GENE; DREB1A GENE; DROUGHT; DEHYDRATION	Dehydration-Responsive Element Binding proteins (DREB)/C-repeat (CRT) Binding Factors (CBF) have been identified as transcriptional activators during plant responses to cold stress. The objective of this study was to determine the physiological roles of a CBF gene isolated from a cold-tolerant perennial grass species, Kentucky bluegrass (Poa pratensis L.), which designated as PpCBF3, in regulating plant tolerance to freezing stress. Transient transformation of Arabidopsis thaliana mesophyll protoplast with PpCBF3-eGFP fused protein showed that PpCBF3 was localized to the nucleus. RT-PCR analysis showed that PpCBF3 was specifically induced by cold stress (4 degrees C) but not by drought stress [induced by 20% polyethylene glycol 6000 solution (PEG-6000)] or salt stress (150 mM NaCl). Transgenic Arabidopsis overexpressing PpCBF3 showed significant improvement in freezing (-20 degrees C) tolerance demonstrated by a lower percentage of chlorotic leaves, lower cellular electrolyte leakage (EL) and H2O2 and O-2(center dot-) content, and higher chlorophyll content and photochemical efficiency compared to the wild type. Relative mRNA expression level analysis by qRT-PCR indicated that the improved freezing tolerance of transgenic Arabidopsis plants overexpressing PpCBF3 was conferred by sustained activation of downstream cold responsive (COR) genes. Other interesting phenotypic changes in the PpCBF3-transgenic Arabidopsis plants included late flowering and slow growth or 'dwarfism', both of which are desirable phenotypic traits for perennial turfgrasses. Therefore, PpCBF3 has potential to be used in genetic engineering for improvement of turfgrass freezing tolerance and other desirable traits.	[Zhuang, Lili; Yuan, Xiuyun; Chen, Yu; Xu, Bin; Yang, Zhimin] Nanjing Agr Univ, Coll Agrograssland Sci, Nanjing, Jiangsu, Peoples R China; [Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA	Nanjing Agricultural University; Rutgers State University New Brunswick	Yang, ZM (corresponding author), Nanjing Agr Univ, Coll Agrograssland Sci, Nanjing, Jiangsu, Peoples R China.	nauyzm@njau.edu.cn; huang@aesop.rutgers.edu						Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Artus NN, 1996, P NATL ACAD SCI USA, V93, P13404, DOI 10.1073/pnas.93.23.13404; ASADA K, 1992, PHYSIOL PLANTARUM, V85, P235, DOI 10.1111/j.1399-3054.1992.tb04728.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fry J., 2004, APPL TURFGRASS SCI P; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; HAJELA RK, 1990, PLANT PHYSIOL, V93, P1246, DOI 10.1104/pp.93.3.1246; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hsieh TH, 2002, PLANT PHYSIOL, V129, P1086, DOI 10.1104/pp.003442; Igarashi Y, 1997, PLANT MOL BIOL, V33, P857, DOI 10.1023/A:1005702408601; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; James VA, 2008, TRANSGENIC RES, V17, P93, DOI 10.1007/s11248-007-9086-y; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kidokoro S, 2015, PLANT J, V81, P505, DOI 10.1111/tpj.12746; Kourosh V, 2013, EXTREME TEMPERATURE, P169; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; Li XL, 2014, PLANT CELL REP, V33, P767, DOI 10.1007/s00299-014-1602-y; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Marcum KB, 1998, CROP SCI, V38, P1214, DOI 10.2135/cropsci1998.0011183X003800050017x; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Maruyama K, 2012, DNA RES, V19, P37, DOI 10.1093/dnares/dsr040; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Morran S, 2011, PLANT BIOTECHNOL J, V9, P230, DOI 10.1111/j.1467-7652.2010.00547.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nilsen ET, 2004, ABIOTIC FACTORS; Pellegrineschi A, 2004, GENOME, V47, P493, DOI 10.1139/G03-140; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sanghera GS, 2011, CURR GENOMICS, V12, P30, DOI 10.2174/138920211794520178; Shen YG, 2003, THEOR APPL GENET, V106, P923, DOI 10.1007/s00122-002-1131-x; Shinwari ZK, 1998, BIOCHEM BIOPH RES CO, V250, P161, DOI 10.1006/bbrc.1998.9267; Steponkus PL, 1998, P NATL ACAD SCI USA, V95, P14570, DOI 10.1073/pnas.95.24.14570; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Tang MJ, 2005, PLANT PHYSIOL BIOCH, V43, P233, DOI 10.1016/j.plaphy.2005.01.015; Thomashow MF, 1998, PLANT PHYSIOL, V118, P1, DOI 10.1104/pp.118.1.1; Wang LH, 2015, MOL BIOL REP, V42, P937, DOI 10.1007/s11033-014-3831-0; Wanner LA, 1999, PLANT PHYSIOL, V120, P391, DOI 10.1104/pp.120.2.391; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Xiong YW, 2006, PLANTA, V224, P878, DOI 10.1007/s00425-006-0273-5; Xue GP, 2011, MOL PLANT, V4, P697, DOI 10.1093/mp/ssr013; Yang S, 2011, J PLANT PHYSIOL, V168, P1804, DOI 10.1016/j.jplph.2011.05.017; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhao H, 2008, MOL GENET GENOMICS, V279, P585, DOI 10.1007/s00438-008-0335-4	53	63	75	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132928	10.1371/journal.pone.0132928	http://dx.doi.org/10.1371/journal.pone.0132928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177510	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600183
J	Biondi-Zoccai, G; Cerrato, E; Peruzzi, M; D'Ascenzo, F; De Falco, E; Chimenti, I; Sciarretta, S; Marullo, AGM; Cavarretta, E; Greco, E; Benedetto, U; Pompilio, G; Escaned, J; Abbate, A; Carpentier, A; Chachques, JC; Frati, G				Biondi-Zoccai, Giuseppe; Cerrato, Enrico; Peruzzi, Mariangela; D'Ascenzo, Fabrizio; De Falco, Elena; Chimenti, Isotta; Sciarretta, Sebastiano; Marullo, Antonino G. M.; Cavarretta, Elena; Greco, Ernesto; Benedetto, Umberto; Pompilio, Giulio; Escaned, Javier; Abbate, Antonio; Carpentier, Alain; Chachques, Juan Carlos; Frati, Giacomo			An International Survey on Taking Up a Career in Cardiovascular Research: Opportunities and Biases toward Would-Be Physician-Scientists	PLOS ONE			English	Article							CARDIOLOGISTS; ATTITUDES; MEDICINE; OUTCOMES; MENTOR	Background Cardiovascular research is the main shaper of clinical evidence underpinning decision making, with its cyclic progression of junior researchers to mature faculty members. Despite efforts at improving cardiovascular research training, several unmet needs persist. We aimed to appraise current perceptions on cardiovascular research training with an international survey. Methods and Results We administered a 20-closed-question survey to mentors and mentees belonging to different international institutions. A total of 247 (12%) surveys were available (out of 2,000 invitations). Overall, mentees and mentors were reasonably satisfied with the educational and research resources. Significant differences were found analyzing results according to gender, geographic area, training and full-time researcher status. Specifically, women proved significantly less satisfied than men, disclosed access to fewer resources and less support from mentors (all P<0.05). People working in institutions not located in North America or Northern/Central Europe were significantly less satisfied and disclosed much less support (both P<0.05). Those in training reported limited opportunities for collaboration (P = 0.009), and non-full-time researchers disclosed more limited access to tutors and formal grant writing training (both P<0.05). Conclusions Several potential biases appear to be present in the way training in cardiovascular research is provided worldwide, including one against women. If confirmed, these data require proactive measures to decrease discriminations and improve the cardiovascular research training quality.	[Biondi-Zoccai, Giuseppe; Peruzzi, Mariangela; De Falco, Elena; Chimenti, Isotta; Marullo, Antonino G. M.; Cavarretta, Elena; Frati, Giacomo] Univ Roma La Sapienza, Dept Medicosurg Sci & Biotechnol, Latina, Italy; [Biondi-Zoccai, Giuseppe] Eleonora Lorillard Spencer Cenci Fdn, Rome, Italy; [Cerrato, Enrico] Rivoli Hosp, Div Cardiol, Rivoli, Italy; [Cerrato, Enrico; Escaned, Javier] Hosp Clin San Carlos, Div Cardiol, Madrid, Spain; [D'Ascenzo, Fabrizio] Univ Turin, Citta Salute & Sci San Giovanni Battista, Div Cardiol, Turin, Italy; [Sciarretta, Sebastiano] Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ USA; [Greco, Ernesto] Univ Roma La Sapienza, Policlin Umberto I, Dept Cardiovasc Resp Nephrol Anesthesiol & Geriat, Latina, Italy; [Benedetto, Umberto] Oxford Univ Hosp, Oxford Heart Ctr, Oxford, England; [Pompilio, Giulio] IRCCS, Ctr Cardiol Monzino, Lab Vasc Biol & Regenerat Med, Milan, Italy; [Abbate, Antonio] Virginia Commonwealth Univ, Pauley Heart Ctr, Richmond, VA USA; [Carpentier, Alain; Chachques, Juan Carlos] Univ Paris 05, Pompidou Hosp, Alain Carpentier Fdn, Lab Biosurg Res, Paris, France; [Sciarretta, Sebastiano; Frati, Giacomo] IRCCS Neuromed, Dept AngioCardioNeurol, Pozzilli, Italy	Sapienza University Rome; Hospital Clinico San Carlos; University of Turin; Rutgers State University New Brunswick; Rutgers State University Medical Center; Sapienza University Rome; IRCCS Centro Cardiologico Monzino; Virginia Commonwealth University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; IRCCS Neuromed	Peruzzi, M (corresponding author), Univ Roma La Sapienza, Dept Medicosurg Sci & Biotechnol, Latina, Italy.	mariangela.peruzzi@uniroma1.it	Abbate, Antonio/G-8805-2016; Cerrato, Enrico/AAO-6799-2020; Cavarretta, Elena/K-4468-2016; Frati, Giacomo/ABI-7410-2020; D'Ascenzo, Fabrizio/D-2447-2012; Escaned, Javier/I-5424-2017; Peruzzi, Mariangela/AAG-5367-2019; Biondi-Zoccai, Giuseppe/C-9670-2012; Pompilio, Giulio/J-6701-2014; Chimenti, Isotta/D-2661-2015; Sciarretta, Sebastiano/K-5161-2016	Abbate, Antonio/0000-0002-1930-785X; Cerrato, Enrico/0000-0002-1260-7534; Cavarretta, Elena/0000-0003-0221-6000; D'Ascenzo, Fabrizio/0000-0002-6646-9317; Biondi-Zoccai, Giuseppe/0000-0001-6103-8510; Pompilio, Giulio/0000-0003-2581-5735; Chimenti, Isotta/0000-0002-0865-8814; Frati, Giacomo/0000-0003-2703-3761; Sciarretta, Sebastiano/0000-0002-8633-6896	Sapienza University of Rome [prot. C26H13X2NL]; MIUR-PRIN [prot. 2010RNXM9C_007]	Sapienza University of Rome; MIUR-PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This study was supported by Sapienza University of Rome (year 2013, prot. C26H13X2NL) to Dr. Biondi-Zoccai and by MIUR-PRIN 2011 (Year 2012, prot. 2010RNXM9C_007) to Prof. Frati.	Ardehali H, 2014, CIRC RES, V114, P1231, DOI 10.1161/CIRCRESAHA.114.303695; Balke CW, MENTORING HDB AM HEA; Bettmann M, 2009, CIRCULATION, V119, P1832, DOI 10.1161/CIRCULATIONAHA.107.752683; Brewer Stacey L, 2013, J Extra Corpor Technol, V45, P173; Chieffo A, 2010, CATHETER CARDIO INTE, V75, P145, DOI 10.1002/ccd.22327; Ducrocq G, 2013, EUROINTERVENTION, V9, P903, DOI 10.4244/EIJV9I8A152; Fuster V, 2009, CIRCULATION, V119, P754, DOI 10.1161/CIRCULATIONAHA.108.792564; Hayes BW, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-5; Heckenberg A, 2010, WIEN KLIN WOCHENSCHR, V122, P141, DOI 10.1007/s00508-010-1302-8; Holmes DR, 2010, CIRCULATION, V121, P336, DOI 10.1161/CIRCULATIONAHA.108.798321; Homer, 2005, ILIAD ODYSSEY; Knowlton AA, 2013, CTS-CLIN TRANSL SCI, V6, P339, DOI 10.1111/cts.12068; Kohno T, 2014, AM J CARDIOL, V114, P629, DOI 10.1016/j.amjcard.2014.05.046; Kosiborod M, 2009, CIRCULATION, V120, P76, DOI 10.1161/CIRCULATIONAHA.107.752733; Mayer AP, 2014, ACAD MED, V89, P312, DOI 10.1097/ACM.0000000000000089; Riviere Etienne, 2013, Presse Med, V42, pe417, DOI 10.1016/j.lpm.2013.07.015; Smith F, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-10; Studnicki J, 2011, ARCH SURG-CHICAGO, V146, P1307, DOI 10.1001/archsurg.2011.265; Taylor J, 2010, EUR HEART J, V31, P2312; Tong CW, 2014, J AM COLL CARDIOL, V63, P2199, DOI 10.1016/j.jacc.2014.03.011; Yeo H, 2009, JAMA-J AM MED ASSOC, V302, P1301, DOI 10.1001/jama.2009.1386	21	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131900	10.1371/journal.pone.0131900	http://dx.doi.org/10.1371/journal.pone.0131900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186203	Green Published, gold			2022-12-27	WOS:000358198700026
J	Fallon, N; Li, XY; Stancak, A				Fallon, Nicholas; Li, Xiaoyun; Stancak, Andrej			Pain Catastrophising Affects Cortical Responses to Viewing Pain in Others	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS PAIN; EVENT-RELATED POTENTIALS; NEURAL RESPONSES; ACTIVITY INTOLERANCE; SOURCE LOCALIZATION; EMOTIONAL PICTURES; AROUSING PICTURES; BACK-PAIN; EMPATHY; BRAIN	Pain catastrophising is an exaggerated cognitive attitude implemented during pain or when thinking about pain. Catastrophising was previously associated with increased pain severity, emotional distress and disability in chronic pain patients, and is also a contributing factor in the development of neuropathic pain. To investigate the neural basis of how pain catastrophising affects pain observed in others, we acquired EEG data in groups of participants with high (High-Cat) or low (Low-Cat) pain catastrophising scores during viewing of pain scenes and graphically matched pictures not depicting imminent pain. The High-Cat group attributed greater pain to both pain and non-pain pictures. Source dipole analysis of even-trelated potentials during picture viewing revealed activations in the left (PHGL) and right (PHGR) paraphippocampal gyri, rostral anterior (rACC) and posterior cingulate (PCC) cortices. The late source activity (600-1100 ms) in PHGL and PCC was augmented in High-Cat, relative to Low-Cat, participants. Conversely, greater source activity was observed in the Low-Cat group during the mid-latency window (280-450 ms) in the rACC and PCC. Low-Cat subjects demonstrated a significantly stronger correlation between source activity in PCC and pain and arousal ratings in the long latency window, relative to high pain catastrophisers. Results suggest augmented activation of limbic cortex and higher order pain processing cortical regions during the late processing period in high pain catastrophisers viewing both types of pictures. This pattern of cortical activations is consistent with the distorted and magnified cognitive appraisal of pain threats in high pain catastrophisers. In contrast, high pain catastrophising individuals exhibit a diminished response during the midlatency period when attentional and top-down resources are ascribed to observed pain.	[Fallon, Nicholas; Li, Xiaoyun; Stancak, Andrej] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Fallon, N (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England.	nickfal@liverpool.ac.uk	Fallon, Nicvk/ABE-4809-2021					Akitsuki Y, 2009, NEUROIMAGE, V47, P722, DOI 10.1016/j.neuroimage.2009.04.091; [Anonymous], 2011, OXFORD HDB EVENT REL; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen CY, 2012, SOC NEUROSCI-UK, V7, P578, DOI 10.1080/17470919.2012.686924; Cheng YW, 2007, CURR BIOL, V17, P1708, DOI 10.1016/j.cub.2007.09.020; Crombez G, 2004, CLIN J PAIN, V20, P98, DOI 10.1097/00002508-200403000-00006; Davis M, 1980, JSAS CATALOG SELECTE, V10; DeCarlo LT, 1998, PSYCHOL METHODS, V3, P186, DOI 10.1037/1082-989X.3.2.186; Decety J, 2010, NEUROIMAGE, V50, P1676, DOI 10.1016/j.neuroimage.2010.01.025; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Edwards RR, 2004, PAIN, V111, P335, DOI 10.1016/j.pain.2004.07.012; Fallon N, 2015, J PAIN; Fan Y, 2008, NEUROPSYCHOLOGIA, V46, P160, DOI 10.1016/j.neuropsychologia.2007.07.023; Fan YT, 2014, SOC COGN AFFECT NEUR, V9, P1203, DOI 10.1093/scan/nst101; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Foti D, 2009, PSYCHOPHYSIOLOGY, V46, P521, DOI 10.1111/j.1469-8986.2009.00796.x; Geisser ME, 2003, PAIN, V102, P243, DOI 10.1016/S0304-3959(02)00417-7; Glascher J, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-45; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Gu XS, 2007, NEUROIMAGE, V36, P256, DOI 10.1016/j.neuroimage.2007.02.025; Gutschalk A, 2005, J NEUROSCI, V25, P5382, DOI 10.1523/JNEUROSCI.0347-05.2005; Hajcak G, 2008, EMOTION, V8, P250, DOI 10.1037/1528-3542.8.2.250; Hajcak G, 2007, BEHAV NEUROSCI, V121, P1156, DOI 10.1037/0735-7044.121.6.1156; Hajcak G, 2006, EMOTION, V6, P517, DOI 10.1037/1528-3542.6.3.517; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Hamalainen JA, 2011, NEUROIMAGE, V54, P1910, DOI 10.1016/j.neuroimage.2010.10.016; Hoechstetter K., 2010, BESA RES TUTORIAL 4; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Ibanez A, 2011, BRAIN RES, V1398, P72, DOI 10.1016/j.brainres.2011.05.014; Ikezawa S, 2014, SOC COGN AFFECT NEUR, V9, P1561, DOI 10.1093/scan/nst148; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Jacobsen PB, 1996, J BEHAV MED, V19, P17, DOI 10.1007/BF01858172; KEEFE FJ, 1989, PAIN, V37, P51, DOI 10.1016/0304-3959(89)90152-8; Keefe FJ, 2000, PAIN, V87, P325, DOI 10.1016/S0304-3959(00)00296-7; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lefebvre JC, 2002, CLIN J PAIN, V18, P56, DOI 10.1097/00002508-200201000-00009; Lehmann D., 1987, HDB ELECTROENCEPHALO, V1, P309; Leutgeb V, 2012, BIOL PSYCHOL, V90, P97, DOI 10.1016/j.biopsycho.2012.02.008; Leutgeb V, 2009, BIOL PSYCHOL, V82, P293, DOI 10.1016/j.biopsycho.2009.09.003; Li W, 2010, NEUROSCI LETT, V469, P328, DOI 10.1016/j.neulet.2009.12.021; Lin CS, 2013, J DENT RES, V92, P130, DOI 10.1177/0022034512467804; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; MacNamara A, 2009, NEUROPSYCHOLOGIA, V47, P2975, DOI 10.1016/j.neuropsychologia.2009.06.026; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Martel MO, 2008, PAIN, V139, P562, DOI 10.1016/j.pain.2008.06.010; Martin A, 1999, HIPPOCAMPUS, V9, P62, DOI 10.1002/(SICI)1098-1063(1999)9:1<62::AID-HIPO7>3.0.CO;2-K; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; Mella N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00501; Muhlberger A, 2006, J ABNORM PSYCHOL, V115, P580, DOI 10.1037/0021-843X.115.3.580; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pavlin DJ, 2005, CLIN J PAIN, V21, P83, DOI 10.1097/00002508-200501000-00010; Peters ML, 2005, PAIN, V113, P45, DOI 10.1016/j.pain.2004.09.033; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; Scharmuller W, 2011, BRAIN RES, V1397, P10, DOI 10.1016/j.brainres.2011.04.018; Schlereth T, 2003, NEUROIMAGE, V20, P441, DOI 10.1016/S1053-8119(03)00345-8; Seminowicz DA, 2006, PAIN, V120, P297, DOI 10.1016/j.pain.2005.11.008; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Stancak A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019744; Sullivan MJL, 2006, PAIN, V122, P282, DOI 10.1016/j.pain.2006.02.001; Sullivan MJL, 2006, PAIN, V123, P37, DOI 10.1016/j.pain.2006.02.007; Sullivan M, 2009, PAIN, V143, P123, DOI 10.1016/j.pain.2009.02.011; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Sullivan MJL, 2004, PAIN, V107, P220, DOI 10.1016/j.pain.2003.11.003; Sullivan MJL, 2002, PAIN, V100, P47, DOI 10.1016/S0304-3959(02)00206-3; Sullivan MJL, 2001, PAIN, V91, P147, DOI 10.1016/S0304-3959(00)00430-9; Sullivan MJL, 1999, PAIN, V79, P155, DOI 10.1016/S0304-3959(98)00163-8; Swinkels-Meewisse IEJ, 2006, PAIN, V120, P36, DOI 10.1016/j.pain.2005.10.005; TARKKA IM, 1993, J CLIN NEUROPHYSIOL, V10, P513, DOI 10.1097/00004691-199310000-00009; Thibault P, 2008, PAIN, V139, P47, DOI 10.1016/j.pain.2008.02.029; Turner JA, 2002, PAIN, V98, P127, DOI 10.1016/S0304-3959(02)00045-3; Turner JA, 2001, CLIN J PAIN, V17, P65, DOI 10.1097/00002508-200103000-00009; Valentini E, 2012, NEUROIMAGE, V59, P1571, DOI 10.1016/j.neuroimage.2011.08.069; Valentini E, 2012, HUM BRAIN MAPP, V33, P2873, DOI 10.1002/hbm.21408; Van Damme S, 2004, PAIN, V107, P70, DOI 10.1016/j.pain.2003.09.023; Van Damme S, 2002, PAIN, V100, P111, DOI 10.1016/S0304-3959(02)00290-7; Vase L, 2012, EXP BRAIN RES, V218, P407, DOI 10.1007/s00221-012-3027-6; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242; Wideman TH, 2009, PAIN, V145, P45, DOI 10.1016/j.pain.2009.04.022	87	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133504	10.1371/journal.pone.0133504	http://dx.doi.org/10.1371/journal.pone.0133504			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186545	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700149
J	Feldheiser, A; Pavlova, V; Weimann, K; Hunsicker, O; Stockmann, M; Koch, M; Giebels, A; Wernecke, KD; Spies, CD				Feldheiser, Aarne; Pavlova, Velizara; Weimann, Karin; Hunsicker, Oliver; Stockmann, Martin; Koch, Mandy; Giebels, Alexander; Wernecke, Klaus-Dieter; Spies, Claudia D.			Haemodynamic Optimization by Oesophageal Doppler and Pulse Power Wave Analysis in Liver Surgery: A Randomised Controlled Trial	PLOS ONE			English	Article							CENTRAL VENOUS-PRESSURE; CARDIAC-OUTPUT; SURGICAL-PATIENTS; BLOOD-LOSS; POSTOPERATIVE COMPLICATIONS; CONSECUTIVE PATIENTS; BOWEL SURGERY; STROKE VOLUME; HIGH-RISK; HEPATECTOMY	Liver surgery is still associated with a high rate of morbidity and mortality. We aimed to compare different haemodynamic treatments in liver surgery. In a prospective, blinded, randomised, controlled pilot trial patients undergoing liver resection were randomised to receive haemodynamic management guided by conventional haemodynamic parameters or by oesophageal Doppler monitor (ODM, CardioQ-ODM) or by pulse power wave analysis (PPA, LiDCOrapid) within a goal-directed algorithm adapted for liver surgery. The primary endpoint was stroke volume index before intra-operative start of liver resection. Secondary endpoints were the haemodynamic course during surgery and postoperative pain levels. Due to an unbalance in the extension of the surgical procedures with a high rate of only minor procedures the conventional group was dropped from the analysis. Eleven patients in the ODM group and 10 patients in the PPA group were eligible for statistical analysis. Stroke volume index before start of liver resection was 49 (37; 53) ml/m(2) and 48 (41; 56) ml/m(2) in the ODM and PPA group, respectively (p=0.397). The ODM guided group was haemodynamically stable as shown by ODM and PPA measurements. However, the PPA guided group showed a significant increase of pulse-pressure-variability (p=0.002) that was not accompanied by a decline of stroke volume index displayed by the PPA (p=0.556) but indicated by a decline of stroke volume index by the ODM (p<0.001). The PPA group had significantly higher postoperative pain levels than the ODM group (p=0.036). In conclusion, goal-directed optimization by ODM and PPA showed differences in intraoperative cardiovascular parameters indicating that haemodynamic optimization is not consistent between the two monitors.	[Feldheiser, Aarne; Pavlova, Velizara; Weimann, Karin; Hunsicker, Oliver; Koch, Mandy; Giebels, Alexander; Spies, Claudia D.] Charite, Dept Anaesthesiol & Intens Care Med, D-13353 Berlin, Germany; [Stockmann, Martin] Charite, Dept Gen Visceral & Transplantat Surg, D-13353 Berlin, Germany; [Wernecke, Klaus-Dieter] Charite, D-13353 Berlin, Germany; [Wernecke, Klaus-Dieter] SOSTANA GmbH Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Sostana GmbH	Spies, CD (corresponding author), Charite, Dept Anaesthesiol & Intens Care Med, Campus Charite Mitte & Campus Virchow Klinikum, D-13353 Berlin, Germany.	claudia.spies@charite.de	Feldheiser, Aarne/GRS-9593-2022; Feldheiser, Aarne/AAH-1503-2019	Feldheiser, Aarne/0000-0002-0014-8879; Spies, Claudia/0000-0002-1062-0495; Hunsicker, Oliver/0000-0002-3998-409X	Charite - Universitatsmedizin Berlin; Deltex Medical	Charite - Universitatsmedizin Berlin; Deltex Medical	This research was an investigator-initiated pilot study. Support to perform the study was provided from Charite - Universitatsmedizin Berlin. Material but not financial support to perform the study was offered by the LiDCO Group Plc. The implementation of the ODM technology in the department was supported by Deltex Medical by an unrestricted grant unrelated to this study. However, both companies had no inputinto, or control over, study design, data collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Bjorne H, 2013, BRIT J ANAESTH, V110, P661, DOI 10.1093/bja/aet039; Carstensen B., 2008, INT J BIOSTAT, V4, P16, DOI DOI 10.2202/1557-4679.1107; Cecconi M, 2009, CRIT CARE, V13, DOI 10.1186/cc7129; Chen H, 2000, J GASTROINTEST SURG, V4, P162, DOI 10.1016/S1091-255X(00)80052-9; Conway DH, 2013, EUR J ANAESTH, V30, P501, DOI 10.1097/EJA.0b013e3283603250; Critchley LAH, 1999, J CLIN MONIT COMPUT, V15, P85, DOI 10.1023/A:1009982611386; Critchley LA, 2011, J CARDIOTHOR VASC AN, V25, P536, DOI 10.1053/j.jvca.2011.01.003; Critchley LA, 2010, ANESTH ANALG, V111, P1180, DOI 10.1213/ANE.0b013e3181f08a5b; Cunningham SC, 2009, WORLD J SURG, V33, P1099, DOI 10.1007/s00268-008-9881-5; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Fan ST, 1999, ANN SURG, V229, P322, DOI 10.1097/00000658-199903000-00004; Feldheiser A, 2012, J INT MED RES, V40, P1227, DOI 10.1177/147323001204000402; FLAIM SF, 1979, AM J PHYSIOL, V236, pH698, DOI 10.1152/ajpheart.1979.236.5.H698; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Hamilton MA, 2011, ANESTH ANALG, V112, P1392, DOI 10.1213/ANE.0b013e3181eeaae5; HamiltonDavies C, 1997, INTENS CARE MED, V23, P276, DOI 10.1007/s001340050328; Holte K, 2007, BRIT J ANAESTH, V99, P500, DOI 10.1093/bja/aem211; Jamagin WR, 2002, ANN SURG, V236, P397, DOI 10.1097/01.SLA.0000029003.66466.B3; Jones RM, 1998, BRIT J SURG, V85, P1058; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; Melendez JA, 1998, J AM COLL SURGEONS, V187, P620, DOI 10.1016/S1072-7515(98)00240-3; Meregalli A, 2004, CRIT CARE, V8, pR60, DOI 10.1186/cc2423; Garcia MIM, 2013, CRIT CARE, V17, DOI 10.1186/cc12785; Moug SJ, 2007, EJSO-EUR J SURG ONC, V33, P1036, DOI 10.1016/j.ejso.2007.01.028; MYTHEN MG, 1994, INTENS CARE MED, V20, P99, DOI 10.1007/BF01707662; Nordstrom J, 2013, BRIT J ANAESTH, V110, P374, DOI 10.1093/bja/aes399; Polonen P, 2000, ANESTH ANALG, V90, P1052; Poon RT, 2004, ANN SURG, V240, P698, DOI 10.1097/01.sla.0000141195.66155.0c; SCALEA TM, 1994, CRIT CARE MED, V22, P1610; Wakeling HG, 2005, BRIT J ANAESTH, V95, P634, DOI 10.1093/bja/aei223; Wang WD, 2006, WORLD J GASTROENTERO, V12, P935, DOI 10.3748/wjg.v12.i6.935; Webb A R, 2001, Minerva Anestesiol, V67, P185	32	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132715	10.1371/journal.pone.0132715	http://dx.doi.org/10.1371/journal.pone.0132715			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186702	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700056
J	Jeon, MJ; Kim, WG; Jang, EK; Choi, YM; Song, DE; Sung, TY; Yoon, JH; Chung, KW; Hong, SJ; Ryu, JS; Han, JM; Kim, TY; Shong, YK; Kim, WB				Jeon, Min Ji; Kim, Won Gu; Jang, Eun Kyung; Choi, Yun Mi; Song, Dong Eun; Sung, Tae-Yon; Yoon, Jong Ho; Chung, Ki-Wook; Hong, Suck Joon; Ryu, Jin-Sook; Han, Ji Min; Kim, Tae Yong; Shong, Young Kee; Kim, Won Bae			Sub-Classification of Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma by Pathologic Criteria	PLOS ONE			English	Article							DISTANT METASTASES; RADIOACTIVE IODINE; PROGNOSTIC-FACTORS; NECK DISSECTION; LUNG METASTASIS; TUMOR SIZE; CANCER; RISK; RECURRENCE; SURVIVAL	Background Lateral cervical lymph node (LCLN) metastasis, or pathologic N1b disease, is an important risk factor in papillary thyroid carcinoma (PTC). However, many patients have favorable prognosis even with pathologic N1b patients in clinical practice. The study aims to identify high-and intermediate-risk groups based on initial pathologic characteristics in these patients. Patients This study included 518 classical PTC patients confirmed as pathologic N1b at initial surgery between 2001 and 2010. All patients underwent a single fixed activity (5.6 GBq) of radioactive I-131 remnant ablation. Results Patients with a primary tumor larger than 4 cm, gross extrathyroidal extension, metastatic LN larger than 3 cm, or greater than 10 metastatic LCLN were classified as high-risk group. These comprehensive pathologic criteria were retrieved from cox proportional hazard models. Twenty two percent of patients (n = 113) were classified as high-risk and 78% (n = 405) as intermediate-risk group. Successful ablation was identified in only 32% of the patients in the high-risk group and 61% in the intermediate-risk group (p < 0.001). The difference between the two risk groups was independent to gender. There was a significant difference in disease-free survival between the high-and intermediate-risk N1b groups during 5.1 years of median follow-up (84% vs. 59%, p < 0.001). Distant metastasis was more prevalent in the high-risk group (20%) than in the intermediate-risk group (4%, p < 0.001). Conclusions The prognosis of PTC patients with LCLN metastasis varies depending on initial pathologic characteristics. We proposed the comprehensive pathologic criteria for sub-classification of N1b into high- and intermediate-risk groups and this sub-classification may permit personalized management of N1b PTC patients.	[Jeon, Min Ji; Kim, Won Gu; Jang, Eun Kyung; Choi, Yun Mi; Kim, Tae Yong; Shong, Young Kee; Kim, Won Bae] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea; [Song, Dong Eun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Sung, Tae-Yon; Yoon, Jong Ho; Chung, Ki-Wook; Hong, Suck Joon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea; [Ryu, Jin-Sook] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nucl Med, Seoul, South Korea; [Han, Ji Min] Sungkyunkwan Univ, Sch Med, Dept Med, Samsung Changwon Hosp, Chang Won, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, WG (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea.	wongukim@amc.seoul.kr	Kim, Tae Yong/C-1272-2009; Kim, Won Gu/AAG-2096-2019	Kim, Tae Yong/0000-0003-4982-4441; Kim, Won Gu/0000-0002-8404-7759; Choi, Yun Mi/0000-0001-8209-874X; Shong, Young Kee/0000-0002-7911-9471; Kim, Won Bae/0000-0003-4544-1750; Jeon, Min Ji/0000-0002-1297-107X	Asan Institute for Life Sciences, Seoul, Korea [2015-582]	Asan Institute for Life Sciences, Seoul, Korea	This study was supported by a grant (2015-582) from the Asan Institute for Life Sciences, Seoul, Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BYAR DP, 1979, EUR J CANCER, V15, P1033, DOI 10.1016/0014-2964(79)90291-3; CADY B, 1988, SURGERY, V104, P947; Chung JK, 2014, ENDOCRINOL METAB, V29, P233, DOI 10.3803/EnM.2014.29.3.233; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; de Meer SGA, 2012, WORLD J SURG, V36, P1262, DOI 10.1007/s00268-012-1427-1; Ferro DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020706; Goffredo P, 2013, WORLD J SURG, V37, P1599, DOI 10.1007/s00268-013-2006-9; Greene FL, 2002, AJCC CANCER STAGING; Haymart MR, 2009, ONCOLOGIST, V14, P216, DOI 10.1634/theoncologist.2008-0194; Ibrahimpasic T, 2012, SURGERY, V152, P1096, DOI 10.1016/j.surg.2012.08.034; Ito Y, 2012, ENDOCR J, V59, P457, DOI 10.1507/endocrj.EJ12-0013; Ito Y, 2012, WORLD J SURG, V36, P1274, DOI 10.1007/s00268-012-1423-5; Ito Y, 2012, WORLD J SURG, V36, P593, DOI 10.1007/s00268-011-1391-1; Jeon MJ, 2014, CLIN ENDOCRINOL, V81, P593, DOI 10.1111/cen.12463; Jeon MJ, 2014, EUR J ENDOCRINOL, V170, P23, DOI 10.1530/EJE-13-0524; Jeon MJ, 2013, EUR J ENDOCRINOL, V168, P219, DOI 10.1530/EJE-12-0744; Kim SJ, 2014, ANNALS OF SURGICAL O; Kim SJ, 2014, ANN SURG ONCOL, V21, P1884, DOI 10.1245/s10434-014-3507-y; Kim TY, 2014, ENDOCRINOL METAB, V29, P217, DOI 10.3803/EnM.2014.29.3.217; Kim WG, 2011, ENDOCRINOL METAB, V26, P53, DOI 10.3803/EnM.2011.26.1.53; Leboulleux S, 2005, J CLIN ENDOCR METAB, V90, P5723, DOI 10.1210/jc.2005-0285; Lee YS, 2011, ANN SURG ONCOL, V18, P3486, DOI 10.1245/s10434-011-1763-7; Machens A, 2012, J CLIN ENDOCR METAB, V97, P4375, DOI 10.1210/jc.2012-1257; Metze K, 2011, J AM COLL SURGEONS, V212, P132, DOI 10.1016/j.jamcollsurg.2010.10.004; Nixon IJ, 2013, THYROID, V23, P683, DOI 10.1089/thy.2012.0307; Randolph GW, 2012, THYROID, V22, P1144, DOI 10.1089/thy.2012.0043; Reis-Alves SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081048; Sabra M, 2014, THYROID; Schlumberger M, 2012, NEW ENGL J MED, V366, P1663, DOI 10.1056/NEJMoa1108586; Smith VA, 2012, J SURG ONCOL, V106, P357, DOI 10.1002/jso.23090; Verburg FA, 2013, J CLIN ENDOCR METAB, V98, P172, DOI 10.1210/jc.2012-2458; Wang LY, 2015, ANN SURG ONCOL, V22, P3530, DOI 10.1245/s10434-015-4398-2; Yim JH, 2011, J CLIN ENDOCR METAB, V96, P2049, DOI 10.1210/jc.2010-2298	34	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133625	10.1371/journal.pone.0133625	http://dx.doi.org/10.1371/journal.pone.0133625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186205	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700162
J	Kolahian, S; Sadri, H; Shahbazfar, AA; Amani, M; Mazadeh, A; Mirani, M				Kolahian, Saeed; Sadri, Hassan; Shahbazfar, Amir Ali; Amani, Morvarid; Mazadeh, Anis; Mirani, Mehdi			The Effects of Leucine, Zinc, and Chromium Supplements on Inflammatory Events of the Respiratory System in Type 2 Diabetic Rats	PLOS ONE			English	Article							ANTIOXIDANT PROPERTIES; RECEPTOR; EFFICACY; SAFETY; ULTRASTRUCTURE; INVOLVEMENT; MELLITUS; STRESS; CELLS; MODEL	Diabetes mellitus is a major cause of serious micro- and macrovascular diseases that affect nearly every system in the body, including the respiratory system. Non-enzymatic protein glycation due to hyperglycaemic stress has fundamental implications due to the large capillary network and amount of connective tissue in the lung. The current study was designed to determine whether leucine, zinc, and chromium supplementations influence the function and histological structure of the respiratory tract in a rat model of type 2 diabetes. Seventy-seven rats were divided into eleven groups, consisting of 7 animals each. One group served as negative control and insulin and glibenclamide were used as positive control drugs. Thus, eight groups received the nutritional supplements alone or in combination with each other. Nutritional supplements and glibenclamide were added to the drinking water and neutral protamine Hagedorn insulin was subcutaneously injected during the 4 weeks of treatment period. The induction of type 2 diabetes in the rats caused an infiltration of mononuclear cells and edema in the submucosa of the trachea and lung, severe fibrosis around the vessels and airways, and perivascular and peribronchial infiltration of inflammatory cells and fibrin. In the diabetic group, the total inflammation score and Reid index significantly increased. Diabetes induction significantly reduced the total antioxidant status and elevated the lipid peroxidation products in the serum, lung lavage and lung tissue of the diabetic animals. Treatment with nutritional supplements significantly decreased the histopathological changes and inflammatory indices in the diabetic animals. Supplementation of diabetic rats with leucine, zinc, and chromium, alone and in combination, significantly increased the total antioxidant status and lipid peroxidation level in the diabetic animals. The nutritional supplements improved the enzymatic antioxidant activity of catalase, glutathione peroxidase, myeloperoxidase, and superoxide dismutase in the diabetic rats. The present results demonstrate beneficial effects and amelioration of inflammation in the respiratory system of type 2 diabetic rats by leucine, zinc, and chromium supplements, probably due to their hypoglycaemic and antioxidant properties. Using safe and effective nutritional supplements, such as leucine, chromium and zinc, to replace proven conventional medical treatments may help to control diabetes and/or its complications.	[Kolahian, Saeed] Univ Tabriz, Fac Vet Med, Dept Basic Sci, Tabriz, Iran; [Sadri, Hassan] Univ Bonn, Inst Anim Sci, Physiol & Hyg Unit, Bonn, Germany; [Sadri, Hassan] Univ Tabriz, Dept Clin Sci, Fac Vet Med, Tabriz, Iran; [Shahbazfar, Amir Ali] Univ Tabriz, Dept Pathobiol, Fac Vet Med, Tabriz, Iran; [Amani, Morvarid; Mazadeh, Anis; Mirani, Mehdi] Univ Tabriz, Fac Vet Med, Tabriz, Iran	University of Tabriz; University of Bonn; University of Tabriz; University of Tabriz; University of Tabriz	Kolahian, S (corresponding author), Univ Tabriz, Fac Vet Med, Dept Basic Sci, Tabriz, Iran.	skolahian@tabrizu.ac.ir			Tuberculosis and Lung Research Center of Tabriz University of Medical Sciences; Research Council of University of Tabriz	Tuberculosis and Lung Research Center of Tabriz University of Medical Sciences; Research Council of University of Tabriz	This study was financially supported by the Tuberculosis and Lung Research Center of Tabriz University of Medical Sciences and the Research Council of University of Tabriz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Ahmed R, 2005, MED J ISLAMIC WORLD, V15, P31; Bao SY, 2006, AM J PHYSIOL-LUNG C, V290, pL433, DOI 10.1152/ajplung.00341.2005; Bembde AS, 2012, INDIAN J HEMATOL BLO, V28, P105, DOI 10.1007/s12288-011-0116-9; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Buege J A, 1978, Methods Enzymol, V52, P302; Ceglia L, 2006, ANN INTERN MED, V145, P665, DOI 10.7326/0003-4819-145-9-200611070-00009; Davis CM, 1997, BIOCHEMISTRY-US, V36, P4382, DOI 10.1021/bi963154t; Davis CM, 1997, INORG CHEM, V36, P5316, DOI 10.1021/ic970568h; Del Maestro R., 1985, CRC HDB METHODS OXYG, V1, P294; Flanagan AM, 2008, J NUTR BIOCHEM, V19, P505, DOI 10.1016/j.jnutbio.2007.06.005; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gomez NN, 2006, NITRIC OXIDE-BIOL CH, V14, P30, DOI 10.1016/j.niox.2005.09.001; Hsia CCW, 2008, DIABETES CARE, V31, P828, DOI 10.2337/dc08-0103; Jakus V, 2004, PHYSIOL RES, V53, P131; Kahn SE, 1990, ELLENBERG RIFKINS DI, P436; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kaparianos A, 2008, Chron Respir Dis, V5, P101, DOI 10.1177/1479972307086313; Kelleher SL, 2011, ADV NUTR, V2, P101, DOI 10.3945/an.110.000232; KIDA K, 1983, AM REV RESPIR DIS, V128, P125, DOI 10.1164/arrd.1983.128.1.125; Kodolova IM, 1982, ARKH PATOL, V44, P3840; Kuitert L M E, 2008, Chron Respir Dis, V5, P67, DOI 10.1177/1479972308091408; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Murgia C, 2006, CURR DRUG TARGETS, V7, P607, DOI 10.2174/138945006776818683; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Onderci M, 2003, BIOL TRACE ELEM RES, V92, P139, DOI 10.1385/BTER:92:2:139; Oteiza Patricia I., 2005, Molecular Aspects of Medicine, V26, P245, DOI 10.1016/j.mam.2005.07.012; PLOPPER CG, 1978, LAB INVEST, V38, P143; PLOPPER CG, 1979, AM REV RESPIR DIS, V120, P1137; Rachdi L, 2012, DIABETES, V61, P409, DOI 10.2337/db11-0765; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Richter M, 2003, CHEST, V123, p446S, DOI 10.1378/chest.123.3_suppl.446S; Rosenstock J, 2008, DIABETES CARE, V31, P2177, DOI 10.2337/dc08-0315; Rosenstock J, 2008, DIABETES CARE, V31, P1723, DOI 10.2337/dc08-0159; Sahin K, 2011, BIOL TRACE ELEM RES, V143, P1018, DOI 10.1007/s12011-010-8905-9; Sahin N, 2003, ARCH ANIM NUTR, V57, P207, DOI 10.1080/0003942031000136639; SATOH K, 1978, CLIN CHIM ACTA, V90, P37; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Song MK, 2009, BRIT J PHARMACOL, V158, P442, DOI 10.1111/j.1476-5381.2009.00201.x; Swaminath G, 2003, J BIOL CHEM, V278, P352, DOI 10.1074/jbc.M206424200; Swaminath G, 2002, MOL PHARMACOL, V61, P65, DOI 10.1124/mol.61.1.65; Tang ZL, 2002, MOL CELL BIOCHEM, V234, P211, DOI 10.1023/A:1015930927407; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Teeter John G, 2008, Diabetes Care, V31, pe82, DOI 10.2337/dc08-1090; Varvarovska J, 2003, J DIABETES COMPLICAT, V17, P7, DOI 10.1016/S1056-8727(01)00228-8; VRACKO R, 1979, AM REV RESPIR DIS, V120, P973; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Yang J, 2012, J BIOL CHEM, V287, P24795, DOI 10.1074/jbc.M112.344259; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Zemel MB, 2012, NUTRIENTS, V4, P529, DOI 10.3390/nu4060529; Zemel MB, 2010, AM J CLIN NUTR, V91, P16, DOI 10.3945/ajcn.2009.28468; Zivic Sasa, 2008, Med Pregl, V61, P458; Zou J, 2004, J BIOL CHEM, V279, P9818, DOI 10.1074/jbc.M309696200	55	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133374	10.1371/journal.pone.0133374	http://dx.doi.org/10.1371/journal.pone.0133374			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185997	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700129
J	Labouba, I; Le Page, C; Communal, L; Kristessen, T; You, XT; Peant, B; Barres, V; Gannon, PO; Mes-Masson, AM; Saad, F				Labouba, Ingrid; Le Page, Cecile; Communal, Laudine; Kristessen, Torbjoern; You, Xiaotian; Peant, Benjamin; Barres, Veronique; Gannon, Philippe O.; Mes-Masson, Anne-Marie; Saad, Fred			Potential Cross-Talk between Alternative and Classical NF-kappa B Pathways in Prostate Cancer Tissues as Measured by a Multi-Staining Immunofluorescence Co-Localization Assay	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION; TRANSCRIPTION FACTORS; PROGNOSTIC-SIGNIFICANCE; RELB; EXPRESSION; ACTIVATION; ALPHA; CARCINOGENESIS; APOPTOSIS; CELLS	Background While the classical NF-kappa B/p65 pathway is known to be involved in prostate cancer progression and is associated with poor patient outcome, the role of the NF-kappa B/RelB alternative protein is not well defined. Here we analyzed the activation of both NF-kappa B pathways in prostate cancer tissues and correlate this activation with clinical features of the disease. Methods A multiple immunofluorescence technique was employed to concomitantly and quantitatively visualize the nuclear localization of p65 and RelB in 200 paraffin embedded samples. Epithelia were defined using appropriate fluorochrome markers and the resulting immunofluorescent signals were quantified with an automated scoring system. Results The nuclear frequency of p65 was found to be significantly increased in tumor tissues as compared with normal adjacent tissue, whereas the frequency for RelB was decreased (p < 0.001, Wilcoxon test). As previously reported, p65 nuclear frequency was associated with a risk of biochemical recurrence. Although, RelB nuclear frequency alone did not predict recurrence, the presence of activated RelB reduced the risk of recurrence associated with the activation of p65. Conclusion For the first time p65/RelB co-distribution was assessed in prostate cancer tissues and suggested a negative crosstalk between the two NF-kappa B pathways in prostate cancer progression.	[Labouba, Ingrid; Le Page, Cecile; Communal, Laudine; You, Xiaotian; Peant, Benjamin; Barres, Veronique; Gannon, Philippe O.; Mes-Masson, Anne-Marie; Saad, Fred] CRCHUM, Inst Canc Montreal, Montreal, PQ, Canada; [Kristessen, Torbjoern] Visiopharm, Horsholm, Denmark; [Mes-Masson, Anne-Marie] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Saad, Fred] Univ Montreal, CHUM, Div Urol, Montreal, PQ H3C 3J7, Canada; [Saad, Fred] Univ Montreal, Dept Surg, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Saad, F (corresponding author), CRCHUM, Inst Canc Montreal, 900 Rue St Denis, Montreal, PQ, Canada.	fred.saad.chum@ssss.gouv.qc.ca	Le Page, Cecile/B-3215-2010	Le Page, Cecile/0000-0002-8020-1544; Mes-Masson, Anne-Marie/0000-0002-6498-266X; Peant, Benjamin/0000-0001-5090-0558	Chair en Cancer de la prostate (Universite de montreal); CUOG award; Reseau de recheche en cancer	Chair en Cancer de la prostate (Universite de montreal); CUOG award; Reseau de recheche en cancer	Chair en Cancer de la prostate (Universite de montreal, http://www.recherche.umontreal.ca/en/research-at-udem/our-research-units/profile/unite/449/pid/15/) CUOG award (http://www.cuog.ca) Reseau de recheche en cancer (http://www.rrcancer.ca/fr/scientifique/biobanques/lister/2). Visiopharm' provided support in the form of a salary for author TK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Annunziata CM, 2010, CANCER-AM CANCER SOC, V116, P3276, DOI 10.1002/cncr.25190; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Benedetti G, 2013, MOL PHARMACOL, V84, P128, DOI 10.1124/mol.112.084053; Campa VM, 2014, ONCOTARGET, V5, P8173, DOI 10.18632/oncotarget.2303; Demicco EG, 2005, MOL CELL BIOL, V25, P10136, DOI 10.1128/MCB.25.22.10136-10147.2005; Domingo-Domenech J, 2005, BRIT J CANCER, V93, P1285, DOI 10.1038/sj.bjc.6602851; Fournier G, 2004, ANN UROL, V38, P207, DOI 10.1016/j.anuro.2004.06.003; Fradet V, 2004, CLIN CANCER RES, V10, P8460, DOI 10.1158/1078-0432.CCR-04-0764; Gannon PO, 2013, EUR J CANCER, V49, P2441, DOI 10.1016/j.ejca.2013.02.026; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Hatano K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031234; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Jacque E, 2013, ONCOGENE, V32, P2661, DOI 10.1038/onc.2012.282; Koumakpayi IH, 2010, BRIT J CANCER, V102, P1163, DOI 10.1038/sj.bjc.6605571; Labouba I, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-67; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Le Page C, 2005, PROSTATE, V65, P130, DOI 10.1002/pros.20234; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Lessard L, 2003, BJU INT, V91, P417, DOI 10.1046/j.1464-410X.2003.04104.x; Lessard L, 2006, B CANCER, V93, P891; Lessard L, 2006, CLIN CANCER RES, V12, P5741, DOI 10.1158/1078-0432.CCR-06-0330; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Li YW, 2006, CANCER RES, V66, P4816, DOI 10.1158/0008-5472.CAN-05-3752; Long RM, 2005, CLIN SCI, V108, P1, DOI 10.1042/CS20040241; McCall P, 2012, BRIT J CANCER, V107, P1554, DOI 10.1038/bjc.2012.372; NAGLE RB, 1991, AM J PATHOL, V138, P119; Nguyen DP, 2014, BJU INT, V114, P168, DOI [10.1111/bju.12488, 10.1111/j.1464-410X.2013.11397_10.x]; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Qu Y, 2011, J CLIN PATHOL, V64, P695, DOI 10.1136/jclinpath-2011-200017; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Rosa-Ribeiro R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097080; Ross JS, 2004, CLIN CANCER RES, V10, P2466, DOI 10.1158/1078-0432.CCR-0543-3; Sartor AO, 2008, UROLOGY, V72, P12, DOI 10.1016/j.urology.2008.10.004; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Shukla S, 2004, NEOPLASIA, V6, P390, DOI 10.1593/neo.04112; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sun ZW, 2002, SHOCK, V18, P99, DOI 10.1097/00024382-200208000-00001; Tabruyn SP, 2007, CELL DEATH DIFFER, V14, P1393, DOI 10.1038/sj.cdd.4402156; Van der Kwast TH, 2013, NAT REV UROL, V10, P473, DOI 10.1038/nrurol.2013.112; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Xu Y, 2008, MOL CANCER THER, V7, P2367, DOI 10.1158/1535-7163.MCT-08-0238; Xu Y, 2007, MOL CANCER THER, V6, P2048, DOI 10.1158/1535-7163.MCT-06-0700; Xu Y, 2010, MOL CANCER THER, V9, P803, DOI 10.1158/1535-7163.MCT-09-1001; Xu Y, 2009, CANCER RES, V69, P3267, DOI 10.1158/0008-5472.CAN-08-4635; Zhu HC, 2015, MOL MED REP, V11, P1167, DOI 10.3892/mmr.2014.2857; Zhu L, 2014, BIOMED REP, V2, P354, DOI 10.3892/br.2014.250	51	13	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131024	10.1371/journal.pone.0131024	http://dx.doi.org/10.1371/journal.pone.0131024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186215	gold, Green Submitted, Green Published			2022-12-27	WOS:000358198700010
J	Li, L; Gong, YX; Yin, H; Gong, DC				Li, Li; Gong, Yuxuan; Yin, Hao; Gong, Decai			Different Types of Peptide Detected by Mass Spectrometry among Fresh Silk and Archaeological Silk Remains for Distinguishing Modern Contamination	PLOS ONE			English	Article							FIBROIN; PROTEIN; DEGRADATION; PROTEOMICS; FIBERS	Archaeological silk provides abundant information for studying ancient technologies and cultures. However, due to the spontaneous degradation and the damages from burial conditions, most ancient silk fibers which suffered the damages for thousands of years were turned into invisible molecular residues. For the obtained rare samples, extra care needs to be taken to accurately identify the genuine archaeological silk remains from modern contaminations. Although mass spectrometry (MS) is a powerful tool for identifying and analyzing the ancient protein residues, the traditional approach could not directly determine the dating and contamination of each sample. In this paper, a series of samples with a broad range of ages were tested by MS to find an effective and innovative approach to determine whether modern contamination exists, in order to verify the authenticity and reliability of the ancient samples. The new findings highlighted that the detected peptide types of the fibroin light chain can indicate the degradation levels of silk samples and help to distinguish contamination from ancient silk remains.	[Li, Li; Gong, Yuxuan; Gong, Decai] Univ Sci & Technol China, Basic Res Ctr Heritage Conservat Sci, Dept Hist Sci & Sci Archaeol, Hefei 230026, Peoples R China; [Yin, Hao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Gong, DC (corresponding author), Univ Sci & Technol China, Basic Res Ctr Heritage Conservat Sci, Dept Hist Sci & Sci Archaeol, Hefei 230026, Peoples R China.	gdclucky@ustc.edu.cn		Li, Li/0000-0001-5033-0911				Ajisawa A., 1998, J SERICULTURAL SCI J; [Anonymous], CURRENT PROTOCOLS PR; Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393; Brown KA, 2013, ANNU REV ANTHROPOL, V42, P159, DOI 10.1146/annurev-anthro-092412-155455; Buckley M, 2010, J ARCHAEOL SCI, V37, P13, DOI 10.1016/j.jas.2009.08.020; Calvert P, 1998, NATURE, V393, P309, DOI 10.1038/30610; Cappellini E, 2012, J PROTEOME RES, V11, P917, DOI 10.1021/pr200721u; Gong DC, 2013, POLYM DEGRAD STABIL, V98, P1780, DOI 10.1016/j.polymdegradstab.2013.05.011; Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020; Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]; Ki CS, 2009, MACROMOL RES, V17, P935, DOI 10.1007/BF03218639; Lu QA, 2011, BIOMACROMOLECULES, V12, P1080, DOI 10.1021/bm101422j; Matsumoto A, 2008, MACROMOL BIOSCI, V8, P1006, DOI 10.1002/mabi.200800020; Oonk S, 2012, ORG GEOCHEM, V50, P57, DOI 10.1016/j.orggeochem.2012.06.012; Scheibel T, 2005, CURR OPIN BIOTECH, V16, P427, DOI 10.1016/j.copbio.2005.05.005; Solazzo C, 2014, J ARCHAEOLOGICAL SCI; Solazzo C, 2012, PHOTOCHEM PHOTOBIOL, V88, P1217, DOI 10.1111/j.1751-1097.2012.01167.x; Solazzo C, 2011, ANTIQUITY, V85, P1418, DOI 10.1017/S0003598X00062141; Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013; Wadbua P, 2010, INT J BIOL MACROMOL, V46, P493, DOI 10.1016/j.ijbiomac.2010.03.007; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zhang XM, 2010, CHINESE J CHEM, V28, P656, DOI 10.1002/cjoc.201090128; Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078; Zhu Z, 2013, ARCHAEOMETRY	24	6	7	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132827	10.1371/journal.pone.0132827	http://dx.doi.org/10.1371/journal.pone.0132827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CN1RV	26186676	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700063
J	Lou, YH; Hu, LX; Chen, LA; Sun, XY; Yang, Y; Liu, HM; Xu, QG				Lou, Yanhong; Hu, Longxing; Chen, Liang; Sun, Xiaoyan; Yang, Yong; Liu, Hongmei; Xu, Qingguo			Association Analysis of Simple Sequence Repeat (SSR) Markers with Agronomic Traits in Tall Fescue (Festuca arundinacea Schreb.)	PLOS ONE			English	Article							NORTH-AFRICAN VARIETIES; GENOME-WIDE ASSOCIATION; GENETIC DIVERSITY; CANDIDATE GENES; MOLECULAR DIVERSITY; FLOWERING-TIME; MAIZE; IDENTIFICATION; RESISTANCE; GERMPLASM	Tall fescue is widely used in temperate regions throughout the world as a dominant forage grass as well as a turfgrass, in pastoral and turf industry. However, the utilization of tall fescue was limited because of its leaf roughness, poor regeneration ability and poor stress resistance. New cultivars were desirable in modern pastoral industries exceed the potential of existing cultivars. Therefore, well understanding the agronomic traits and describing germplasms would help to overcome these constraints, and morphological evaluation of tall fescue germplasm is the key component in selecting rational parents for hybridization breeding. However, describing the morphological traits of tall fescue germplasm is costly and time-consuming. Fortunately, biotechnology approaches can supplement conventional breeding efforts for tall fescue improvement. Association mapping, as a powerful approach to identify association between agronomic traits and molecular markers has been widely used for enhancing the utilization, conservation and management of the tall fescue germplasms. Therefore, in the present research, 115 tall fescue accessions from different origins (25 accessions are cultivars; 31 accessions from America; 32 accessions from European; 7 accessions from Africa; 20 accessions from Asia), were evaluated for agronomic traits and genetic diversity with 90 simple sequence repeat (SSR) markers. The panel displayed significant variation in spike count per plant (SCP) and spike weight (SW). However, BCS performed the lowest CV among all the observed agronomic traits. Three subpopulations were identified within the collections but no obvious relative kinship (K) was found. The GLM model was used to describe the association between SSR and agronomic traits. Fifty-one SSR markers associated with agronomic traits were observed. Twelve single-associated markers were associated with PH; six single-associated markers were associated with BCS; eight single-associated markers were associated with SW; five single-associated markers were associated with SC; seven single-associated markers were associated with SCP; three single-associated markers were associated with SL. Especially, we observed that the genetic variation of SW was explained 11.6 % by M37 marker. It is interesting to observe that nine markers (M1, M2, M35, M54 marker was associated with both BCS and SC; M3, M4 markers were associated with BCS, SW, and SC; M19 marker was associated with both pH and PD, M40 marker was associated with both SCP and SW; and M193 marker was associated with both PH and SL) were associated with more than two agronomic traits. Notably, Branch count per spike (BCS) was explained by four markers (M1, M2, M3, and M4) exceeding 10 %. These identified marker alleles associated with agronomic traits could provide important information and markers for molecular-assisted breeding that facilitate the breeding process in tall fescue.	[Lou, Yanhong; Liu, Hongmei; Xu, Qingguo] Hunan Agr Univ, Coll Agron, Changsha 410128, Hunan, Peoples R China; [Lou, Yanhong; Hu, Longxing; Chen, Liang; Sun, Xiaoyan] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan 430074, Hubei, Peoples R China; [Yang, Yong] Hunan Int Econ Univ, Golf Coll, Changsha 410205, Hunan, Peoples R China	Hunan Agricultural University; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Xu, QG (corresponding author), Hunan Agr Univ, Coll Agron, Nongda Rd, Changsha 410128, Hunan, Peoples R China.	huxu0309@aliyun.com	Hu, Longxing/AAS-8287-2020; lou, yanhong/AAE-8504-2020		Research in crop genetics and breeding technology, Hunan Provincial Education Department [KC2011B023]	Research in crop genetics and breeding technology, Hunan Provincial Education Department	Research in crop genetics and breeding technology, Hunan Provincial Education Department, KC2011B023, Qingguo Xu. Research design.	Abdurakhmonov Ibrokhim Y, 2008, Int J Plant Genomics, V2008, P574927, DOI 10.1155/2008/574927; Ashfaq S, 2014, J BIOL AGR HEALTHCAR, V4, P10; BACON CW, 1995, J ANIM SCI, V73, P861; Bradbury P, 2011, CROP SCI, V51, P52, DOI 10.2135/cropsci2010.02.0064; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Buckler ES, 2002, CURR OPIN PLANT BIOL, V5, P107, DOI 10.1016/S1369-5266(02)00238-8; Buckner R.C., 1979, TALL FESCUE, V20, P1, DOI DOI 10.2134/AGRONMONOGR20.C1; BUGGE G, 1987, PLANT BREEDING, V98, P149, DOI 10.1111/j.1439-0523.1987.tb01108.x; Busti A, 2004, GENET RESOUR CROP EV, V51, P443, DOI 10.1023/B:GRES.0000023459.62679.e8; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; Chakanda R, 2013, GENET RESOUR CROP EV, V60, P1237, DOI 10.1007/s10722-012-9914-7; Chtourou-Ghorbel N, 2011, INT J AGRON, V2011, DOI 10.1155/2011/349240; Cross JW, 2013, HORTSCIENCE, V48, P1562, DOI 10.21273/HORTSCI.48.12.1562; Couto EGD, 2013, CIENC AGROTEC, V37, P25, DOI 10.1590/S1413-70542013000100003; Dutta P, 2013, UNIJ AGR RES, V1, P85, DOI DOI 10.13189/UJAR.2013.010308; Ebrahimiyan M, 2013, GRASS FORAGE SCI, V68, P59, DOI 10.1111/j.1365-2494.2012.00869.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Finger FL, 2010, GENET MOL RES, V9, P1852, DOI 10.4238/vol9-3gmr891; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Frankel OH, 1981, CONSERVATION EVOLUTI; Gonzalez-Martinez SC, 2006, GENETICS, V172, P1915, DOI 10.1534/genetics.105.047126; Gowda SJM, 2012, GENET RESOUR CROP EV, V59, P179, DOI 10.1007/s10722-011-9674-9; Han B, 2013, CURR OPIN PLANT BIOL, V16, P133, DOI 10.1016/j.pbi.2013.03.006; Hannaway D.B., 2005, TALL FESCUE ON LINE; Hey J, 2003, NAT REV GENET, V4, P535, DOI 10.1038/nrg1112; Hoagland D.R., 1950, 347 CAL AGR EXP STAT; HUMPHREYS MO, 1991, HEREDITY, V66, P437, DOI 10.1038/hdy.1991.53; Jha AB, 2013, GENET RESOUR CROP EV, V60, P747, DOI 10.1007/s10722-012-9871-1; Klepo T, 2013, SCI HORTIC-AMSTERDAM, V152, P92, DOI 10.1016/j.scienta.2012.12.010; Lee M, 1995, ADV AGRON, V55, P265, DOI 10.1016/S0065-2113(08)60542-8; Li HuiYing, 2010, Acta Prataculturae Sinica, V19, P208; Li XJ, 2012, CROP PASTURE SCI, V63, P303, DOI 10.1071/CP11302; Lou YH, 2015, HORTSCI IN PRESS FEB; Lu YL, 2012, MOL BREEDING, V30, P407, DOI 10.1007/s11032-011-9631-5; Majidi M. M., 2006, Pakistan Journal of Biological Sciences, V9, P1869, DOI 10.3923/pjbs.2006.1869.1876; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Matus IA, 2002, GENOME, V45, P1095, DOI 10.1139/G02-071; Niazkhani S.M., 2014, BASIC RES J AGR SCI, V3, P1; Pritchard JK, 2000, GENETICS, V155, P945; ROBSON MJ, 1968, J APPL ECOL, V5, P191, DOI 10.2307/2401283; ROBSON MJ, 1968, J APPL ECOL, V5, P179, DOI 10.2307/2401282; Roy JK, 2010, MOL BREEDING, V26, P243, DOI 10.1007/s11032-010-9402-8; Saha MC, 2006, THEOR APPL GENET, V113, P1449, DOI 10.1007/s00122-006-0391-2; Saha MC, 2005, THEOR APPL GENET, V110, P323, DOI 10.1007/s00122-004-1843-1; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; SEAL AG, 1983, HEREDITY, V50, P225, DOI 10.1038/hdy.1983.26; Shi C, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-52; Shimelis H. A., 2006, South African Journal of Plant and Soil, V23, P305; Skot L, 2007, GENETICS, V177, P535, DOI 10.1534/genetics.107.071522; SMITH JSC, 1989, MAYDICA, V34, P151; SMITH SE, 1991, CROP SCI, V31, P1159, DOI 10.2135/cropsci1991.0011183X003100050016x; Soto-Cerda BJ, 2014, J INTEGR PLANT BIOL, V56, P75, DOI 10.1111/jipb.12118; Sun DF, 2011, EUPHYTICA, V178, P31, DOI 10.1007/s10681-010-0260-6; Sun XY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0494-5; Sun XY, 2014, EUPHYTICA, V199, P247, DOI 10.1007/s10681-014-1122-4; Szalma SJ, 2005, THEOR APPL GENET, V110, P1324, DOI 10.1007/s00122-005-1973-0; Topal A, 2004, FIELD CROP RES, V87, P1, DOI 10.1016/j.fcr.2003.08.015; Xie Y., 2012, African Journal of Biotechnology, V11, P7659; Xu S, 2006, ENVIRON EXP BOT, V56, P274, DOI 10.1016/j.envexpbot.2005.03.002; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111508; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	64	13	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133054	10.1371/journal.pone.0133054	http://dx.doi.org/10.1371/journal.pone.0133054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186338	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700091
J	Rhee, H; Jang, KS; Shin, MJ; Lee, JW; Kim, IY; Song, SH; Lee, DW; Lee, SB; Kwak, IS; Seong, EY				Rhee, Harin; Jang, Keum Sook; Shin, Min Ji; Lee, Jang Won; Kim, Il Young; Song, Sang Heon; Lee, Dong Won; Lee, Soo Bong; Kwak, Ihm Soo; Seong, Eun Young			Use of Multifrequency Bioimpedance Analysis in Male Patients with Acute Kidney Injury Who Are Undergoing Continuous Veno-Venous Hemodiafiltration	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; CRITICALLY-ILL PATIENTS; RENAL REPLACEMENT THERAPY; BODY-COMPOSITION; FLUID OVERLOAD; PHASE-ANGLE; WHOLE-BODY; MORTALITY; HEMODIALYSIS; FAILURE	Introduction Fluid overload is a well-known predictor of mortality in patients with acute kidney injury (AKI). Multifrequency bioimpedance analysis (MF-BIA) is a promising tool for quantifying volume status. However, few studies have analyzed the effect of MF-BIA-defined volume status on the mortality of critically ill patients with AKI. This retrospective medical research study aimed to investigate this issue. Methods We retrospectively reviewed the medical records of patients with AKI who underwent continuous veno-venous hemodiafiltration (CVVHDF) from Jan. 2013 to Feb. 2014. Female patients were excluded to control for sex-based differences. Volume status was measured using MF-BIA (Inbody S20, Seoul, Korea) at the time of CVVHDF initiation, and volume parameters were adjusted with height squared (H-2). Binary logistic regression analyses were performed to test independent factors for prediction of in-hospital mortality. Results A total of 208 male patients were included in this study. The mean age was 65.19 +/- 12.90 years. During the mean ICU stay of 18.29 +/- 27.48 days, 40.4% of the patients died. The inhospital mortality rate increased with increasing total body water (TBW)/H-2 quartile. In the multivariable analyses, increased TBW/H-2 (OR 1.312(1.009-1.705), p=0.043) and having lower serum albumin (OR 0.564(0.346-0.919, p=0.022) were independently associated with higher in-hospital mortality. When the intracellular water (ICW)/H-2 or extracellular water (ECW)/H-2 was adjusted instead of the TBW/H-2, only excess ICW/H-2 was independently associated with increased mortality (OR 1.561(1.012-2.408, p=0.044). Conclusions MF-BIA-defined excess TBW/H-2 and ICW/H-2 are independently associated with higher in-hospital mortality in male patients with AKI undergoing CVVHDF.	[Rhee, Harin; Shin, Min Ji; Lee, Jang Won; Kim, Il Young; Song, Sang Heon; Lee, Dong Won; Lee, Soo Bong; Kwak, Ihm Soo; Seong, Eun Young] Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea; [Rhee, Harin; Shin, Min Ji; Lee, Jang Won; Song, Sang Heon; Kwak, Ihm Soo; Seong, Eun Young] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Jang, Keum Sook] Pusan Natl Univ Hosp, Dept Nursing, Busan, South Korea	Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Seong, EY (corresponding author), Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea.	sey02200@paran.com	Kim, Il Young/ABG-2156-2021; Kim, Il Young/ABG-2153-2021	Kim, Il Young/0000-0002-1731-6357	Biomedical Institute of Pusan National University Hospital	Biomedical Institute of Pusan National University Hospital	This study was supported by the Biomedical Institute of Pusan National University Hospital.	Bagshaw SM, 2008, CRIT CARE, V12, DOI 10.1186/cc6948; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Bellomo R, 2010, CONTRIB NEPHROL, V165, P299, DOI 10.1159/000313770; Buchholz Andrea C, 2004, Nutr Clin Pract, V19, P433, DOI 10.1177/0115426504019005433; Cerda J, 2010, BLOOD PURIFICAT, V29, P331, DOI 10.1159/000287776; Chamney PW, 2007, AM J CLIN NUTR, V85, P80, DOI 10.1093/ajcn/85.1.80; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; CORNISH BH, 1993, PHYS MED BIOL, V38, P337, DOI 10.1088/0031-9155/38/3/001; Dabrowski W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122193; Dabrowski W, 2014, CLIN NEPHROL, V82, P41, DOI 10.5414/CN108015; Davies SJ, 2014, KIDNEY INT, V86, P489, DOI 10.1038/ki.2014.207; Goovaerts HG, 1998, PHYSIOL MEAS, V19, P517, DOI 10.1088/0967-3334/19/4/006; Gupta D, 2004, AM J CLIN NUTR, V80, P1634, DOI 10.1093/ajcn/80.6.1634; Heering P, 1997, INTENS CARE MED, V23, P288, DOI 10.1007/s001340050330; Ismael S, 2014, CRIT CARE, V18, DOI 10.1186/cc13794; Jaeger JQ, 1999, J AM SOC NEPHROL, V10, P392; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P864, DOI 10.1016/j.ajkd.2003.07.016; Kalantari K, 2013, KIDNEY INT, V83, P1017, DOI 10.1038/ki.2012.424; Kaysen GA, 2005, AM J CLIN NUTR, V82, P988, DOI 10.1093/ajcn/82.5.988; Koh KH, 2011, PERITON DIALYSIS INT, V31, P574, DOI 10.3747/pdi.2009.00140; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Kyle UG, 2002, J AM DIET ASSOC, V102, P944, DOI 10.1016/S0002-8223(02)90216-6; Kyle UG, 2006, NUTRITION, V22, P1103, DOI 10.1016/j.nut.2006.08.003; Mager JR, 2008, CLIN NUTR, V27, P832, DOI 10.1016/j.clnu.2008.06.007; Maioli M, 2014, J AM COLL CARDIOL, V63, P1387, DOI 10.1016/j.jacc.2014.01.025; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Metnitz PGH, 2002, CRIT CARE MED, V30, P2051, DOI 10.1097/00003246-200209000-00016; Moissl U, 2013, CLIN J AM SOC NEPHRO, V8, P1575, DOI 10.2215/CJN.12411212; Nisula S, 2013, INTENS CARE MED, V39, P420, DOI 10.1007/s00134-012-2796-5; O'Lone EL, 2014, NEPHROL DIAL TRANSPL, V29, P1430, DOI 10.1093/ndt/gfu049; OTT M, 1995, J ACQ IMMUN DEF SYND, V9, P20; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Peacock WF, 2010, CONTRIB NEPHROL, V165, P226, DOI 10.1159/000313762; Piccoli A, 2005, CONTRIB NEPHROL, V149, P150, DOI 10.1159/000085478; PICCOLI A, 1994, KIDNEY INT, V46, P534, DOI 10.1038/ki.1994.305; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; Ronco C, 2012, SEMIN NEPHROL, V32, P129, DOI 10.1016/j.semnephrol.2011.11.016; Schwenk A, 2000, AM J CLIN NUTR, V72, P496; Toso S, 2000, NUTRITION, V16, P120, DOI 10.1016/S0899-9007(99)00230-0; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uchino S, 2007, INTENS CARE MED, V33, P1563, DOI 10.1007/s00134-007-0754-4; Vaara ST, 2012, CRIT CARE, V16, DOI 10.1186/cc11158; Vesconi S, 2009, CRIT CARE, V13, DOI 10.1186/cc7784; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707	45	25	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133199	10.1371/journal.pone.0133199	http://dx.doi.org/10.1371/journal.pone.0133199			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186370	gold, Green Submitted, Green Published			2022-12-27	WOS:000358198700107
J	Sbardella, D; Tundo, GR; Sciandra, F; Bozzi, M; Gioia, M; Ciaccio, C; Tarantino, U; Brancaccio, A; Coletta, M; Marini, S				Sbardella, Diego; Tundo, Grazia Raffaella; Sciandra, Francesca; Bozzi, Manuela; Gioia, Magda; Ciaccio, Chiara; Tarantino, Umberto; Brancaccio, Andrea; Coletta, Massimo; Marini, Stefano			Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution	PLOS ONE			English	Article							26S PROTEASOME; OXIDATIVE STRESS; OXIDIZED PROTEINS; UBIQUITIN SYSTEM; DEGRADATION; CELLS; SUBSTRATE; PEPTIDE; PATHWAY; ARCHITECTURE	Insulin-Degrading-Enzyme (IDE) is a Zn2+-dependent peptidase highly conserved throughout evolution and ubiquitously distributed in mammalian tissues wherein it displays a prevalent cytosolic localization. We have recently demonstrated a novel Heat Shock Protein-like behaviour of IDE and its association with the 26S proteasome. In the present study, we examine the mechanistic and molecular features of IDE-26S proteasome interaction in a cell experimental model, extending the investigation also to the effect of IDE on the enzymatic activities of the 26S proteasome. Further, kinetic investigations indicate that the 26S proteasome activity undergoes a functional modulation by IDE through an extra-catalytic mechanism. The IDE-26S proteasome interaction was analyzed during the Heat Shock Response and we report novel findings on IDE intracellular distribution that might be of critical relevance for cell metabolism.	[Sbardella, Diego; Tundo, Grazia Raffaella; Gioia, Magda; Ciaccio, Chiara; Tarantino, Umberto; Coletta, Massimo; Marini, Stefano] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, I-00133 Rome, Italy; [Sbardella, Diego; Tundo, Grazia Raffaella; Gioia, Magda; Ciaccio, Chiara; Tarantino, Umberto; Coletta, Massimo; Marini, Stefano] Univ Roma Tor Vergata, Ctr Space Biomed, I-00133 Rome, Italy; [Sciandra, Francesca; Brancaccio, Andrea] Univ Cattolica Sacro Cuore, Ist Chim Riconoscimento Mol CNR, I-00168 Rome, Italy; [Bozzi, Manuela] Univ Cattolica Sacro Cuore, Ist Biochim & Biochim Clin, I-00168 Rome, Italy; [Brancaccio, Andrea] Univ Walk, Sch Biochem, Bristol B58 1TD, Avon, England	University of Rome Tor Vergata; University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Bristol	Marini, S (corresponding author), Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Via Montpellier 1, I-00133 Rome, Italy.	stefano.marini@uniroma2.it	Coletta, Massimiliano/GSN-5927-2022; Coletta, Massimo/N-9049-2015; Sciandra, Francesca/AAY-4650-2020; Sbardella, Diego/N-9187-2015; Marini, Stefano/B-1161-2012; Gioia, Magda/AAD-4781-2022; Sbardella, Diego/K-7519-2016; Brancaccio, Andrea/C-5876-2009; Gioia, Magda/ABF-8909-2020	Sciandra, Francesca/0000-0002-2123-1516; Marini, Stefano/0000-0003-1299-6696; Sbardella, Diego/0000-0002-9924-7761; Brancaccio, Andrea/0000-0003-4690-8826; COLETTA, Massimiliano/0000-0002-5489-9467; TUNDO, Grazia Raffaella/0000-0002-3866-3171; Gioia, Magda/0000-0003-0352-3547	Italian Ministry of the University and Research [MiUR FIRB RBNE03PX83]; Italian Space Agency (ASI SMEMCO) [DC-DTE-2011-033]	Italian Ministry of the University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Space Agency (ASI SMEMCO)	The financial support is from the Italian Ministry of the University and Research (MiUR FIRB RBNE03PX83 to M.C.) and the Italian Space Agency (ASI SMEMCO n. DC-DTE-2011-033 to U.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; BENNETT RG, 1994, BIOCHEM BIOPH RES CO, V202, P1047, DOI 10.1006/bbrc.1994.2034; Bennett RG, 2000, ENDOCRINOLOGY, V141, P2508, DOI 10.1210/en.141.7.2508; Bennett RG, 2003, J ENDOCRINOL, V177, P399, DOI 10.1677/joe.0.1770399; Beuzelin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067705; Bozidis Petros, 2007, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0327s37; Bulloj A, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-22; Ciaccio C, 2009, J MOL BIOL, V385, P1556, DOI 10.1016/j.jmb.2008.11.025; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Cuccioloni M, 2009, J MOL RECOGNIT, V22, P46, DOI 10.1002/jmr.929; Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; de Tullio MB, 2008, PRION, V2, P51, DOI 10.4161/pri.2.2.6710; Fernandez-Gamba A, 2009, CURR PHARM DESIGN, V15, P3644, DOI 10.2174/138161209789271799; Glebov K, 2011, J BIOL CHEM, V286, P22711, DOI 10.1074/jbc.C110.217893; Glickman MH, 2005, FEBS LETT, V579, P3214, DOI 10.1016/j.febslet.2005.04.048; Grasso G, 2008, BBA-PROTEINS PROTEOM, V1784, P1122, DOI 10.1016/j.bbapap.2008.04.011; Grasso G, 2011, CHEM-EUR J, V17, P2752, DOI 10.1002/chem.201002809; Grune T, 2011, FREE RADICAL BIO MED, V51, P1355, DOI 10.1016/j.freeradbiomed.2011.06.015; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hersh LB, 2006, CELL MOL LIFE SCI, V63, P2432, DOI 10.1007/s00018-006-6238-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; KIRSCHNER RJ, 1983, J BIOL CHEM, V258, P967; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Konstantinova IM, 2008, INT REV CEL MOL BIO, V267, P59, DOI 10.1016/S1937-6448(08)00602-3; Kurochkin IV, 1998, FEBS LETT, V427, P153, DOI 10.1016/S0014-5793(98)00422-0; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lee SH, 2010, J BIOL CHEM, V285, P41280, DOI 10.1074/jbc.M110.182188; Maupin-Furlow JA, 2006, CURR TOP DEV BIOL, V75, P125, DOI 10.1016/S0070-2153(06)75005-0; Naujokat C, 2002, LAB INVEST, V82, P965, DOI 10.1097/01.LAB.0000022226.23741.37; Noinaj N, 2012, J BIOL CHEM, V287, P48, DOI 10.1074/jbc.M111.264614; Parmentier N, 2010, NAT IMMUNOL, V11, P449, DOI 10.1038/ni.1862; Pick E, 2013, FEBS LETT, V587, P389, DOI 10.1016/j.febslet.2013.01.014; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Radulescu RT, 2010, BIOCHEM BIOPH RES CO, V395, P196, DOI 10.1016/j.bbrc.2010.03.157; Ralat LA, 2011, J MOL BIOL, V406, P454, DOI 10.1016/j.jmb.2010.12.026; RAMACHANDRA KR, 2003, J BIOL CHEM, V278, P20915; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V377, P65, DOI 10.1006/abbi.2000.1717; Sbardella D, 2012, MOL ASPECTS MED, V33, P119, DOI 10.1016/j.mam.2011.10.015; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Seta KA, 1997, BIOCHEM BIOPH RES CO, V231, P167, DOI 10.1006/bbrc.1997.6066; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Tanaka Keiji, 2013, Keio Journal of Medicine, V62, P1, DOI 10.2302/kjm.2012-0006-RE; Taylor DM, 2005, CELL STRESS CHAPERON, V10, P230, DOI 10.1379/CSC-119R.1; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Tundo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034376; Tundo GR, 2015, J BIOL INORG CHEM, V20, P101, DOI 10.1007/s00775-014-1217-3; Tundo GR, 2013, J BIOL CHEM, V288, P2281, DOI 10.1074/jbc.M112.393108; Vigneron N, 2012, CURR OPIN IMMUNOL, V24, P84, DOI 10.1016/j.coi.2011.12.002; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232; Yfanti C, 2008, INT J MOL MED, V22, P421, DOI 10.3892/ijmm_00000038; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4	58	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132455	10.1371/journal.pone.0132455	http://dx.doi.org/10.1371/journal.pone.0132455			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186340	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700043
J	Yu, SJ; Reiner, D; Shen, H; Wu, KJ; Liu, QR; Wang, Y				Yu, Seong-Jin; Reiner, David; Shen, Hui; Wu, Kou-Jen; Liu, Qing-Rong; Wang, Yun			Time-Dependent Protection of CB2 Receptor Agonist in Stroke	PLOS ONE			English	Article							CANNABINOID RECEPTORS; CEREBRAL INFARCTION; MICROGLIAL CELLS; BINDING-SITES; BRAIN; ACTIVATION; RATS; LOCALIZATION; TRANSIENT; NEUROPROTECTION	Recent studies have indicated that type 2 cannabinoid receptor (CB2R) agonists reduce neurodegeneration after brain injury through anti-inflammatory activity. The purpose of this study was to examine the time-dependent interaction of CB2R and inflammation in stroke brain. Adult male rats were subjected to right middle cerebral artery occlusion (MCAo). CB2R mRNA expression was significantly elevated >20 fold on day 2, peaked >40-fold on day 5, and normalized on day 10 post-stroke. Inflammatory markers IBA1 and TLR4 were significantly upregulated 15 fold until day 5 after MCAo. Because of the delayed upregulation of CB2R and IBA1, we next treated animals daily with CB2R agonist AM1241 or anti-inflammatory PPAR-gamma agonist pioglitazone from 2 to 5 days after MCAo. Delayed treatment with pioglitazone significantly reduced abnormal neurological scores and body asymmetry as well as brain infarction in stroke animals. No behavioral improvement or reduction in brain infarction was found in animals receiving AM1241. Pioglitazone, but not AM1241, significantly reduced IBA1 expression in the stroke cortex, suggesting that delayed treatment with AM1241 failed to alter ischemia-mediated IBA-1 upregulation. In contrast, pretreatment with AM1241 significantly reduced brain infarction and neurological deficits. In conclusion, our data support a time-dependent neuroprotection of CB2 agonist in an animal model of stroke. Delayed post- treatment with PPAR-gamma agonist induced behavioral recovery and microglial suppression; early treatment with CB2R agonist suppressed neurodegeneration in stroke animals.	[Yu, Seong-Jin; Wu, Kou-Jen; Wang, Yun] Natl Hlth Res Inst, Ctr Neuropsychiat, Zhunan, Taiwan; [Reiner, David; Shen, Hui; Liu, Qing-Rong; Wang, Yun] Natl Inst Drug Abuse, Neural Protect & Regenerat Sect, NIH, Baltimore, MD USA	National Health Research Institutes - Taiwan; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Wang, Y (corresponding author), Natl Hlth Res Inst, Ctr Neuropsychiat, Zhunan, Taiwan.	ywang@nhri.org.tw	Liu, Qing-Rong/A-3059-2012	Liu, Qing-Rong/0000-0001-8477-6452	Ministry of Science and Technology, Taiwan [MOST 03-2314-B-400-016-MY2]; National Institute on Drug Abuse, NIH, USA	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Institute on Drug Abuse, NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	Funding for this study was received from the Ministry of Science and Technology, Taiwan (MOST 03-2314-B-400-016-MY2) and from the National Institute on Drug Abuse, NIH, USA (intramural). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assis LC, 2014, NEUROSCIENCE, V279, P220, DOI 10.1016/j.neuroscience.2014.08.043; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bingham B, 2007, BRIT J PHARMACOL, V151, P1061, DOI 10.1038/sj.bjp.0707303; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Borlongan CV, 1998, NEUROREPORT, V9, P3615, DOI 10.1097/00001756-199811160-00012; Brusco A, 2008, ANN NY ACAD SCI, V1139, P450, DOI 10.1196/annals.1432.037; Capettini LSA, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/824093; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Chang CF, 2002, NEUROPHARMACOLOGY, V43, P418, DOI 10.1016/S0028-3908(02)00092-8; Contartese A, 2012, PHARMACOL RES, V66, P555, DOI 10.1016/j.phrs.2012.08.003; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Fernandez-Lopez D, 2012, NEUROSCIENCE, V207, P307, DOI 10.1016/j.neuroscience.2012.01.008; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Gatley SJ, 1996, EUR J PHARMACOL, V307, P331, DOI 10.1016/0014-2999(96)00279-8; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Hayakawa K, 2007, LIFE SCI, V80, P1466, DOI 10.1016/j.lfs.2007.01.014; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jin KL, 2000, ANN NEUROL, V48, P257, DOI 10.1002/1531-8249(200008)48:2<257::AID-ANA18>3.0.CO;2-P; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Liu HS, 2011, NEUROIMAGE, V56, P280, DOI 10.1016/j.neuroimage.2011.02.049; Luo Y, 2013, J CEREBR BLOOD F MET, V33, P300, DOI 10.1038/jcbfm.2012.172; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; LYNN AB, 1994, J PHARMACOL EXP THER, V268, P1612; Malan TP, 2001, PAIN, V93, P239, DOI 10.1016/S0304-3959(01)00321-9; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Muthian S, 2004, NEUROSCIENCE, V129, P743, DOI 10.1016/j.neuroscience.2004.08.044; Nagayama T, 1999, J NEUROSCI, V19, P2987; Nunez E, 2004, SYNAPSE, V53, P208, DOI 10.1002/syn.20050; Onaivi ES, 2006, ANN NY ACAD SCI, V1074, P514, DOI 10.1196/annals.1369.052; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Parmentier-Batteur S, 2002, J NEUROSCI, V22, P9771, DOI 10.1523/jneurosci.22-22-09771.2002; RinaldiCarmona M, 1996, LIFE SCI, V58, P1239, DOI 10.1016/0024-3205(96)00085-9; Shen H, 2010, J NEUROSCI METH, V186, P150, DOI 10.1016/j.jneumeth.2009.11.008; Sidney S, 2002, J CLIN PHARMACOL, V42, p64S, DOI 10.1002/j.1552-4604.2002.tb06005.x; Sundararajan S, 2005, NEUROSCIENCE, V130, P685, DOI 10.1016/j.neuroscience.2004.10.021; Ternianov A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.012; Tumati S, 2012, J NEUROIMMUNOL, V244, P23, DOI 10.1016/j.jneuroim.2011.12.021; Wei Y, 2009, MOL VIS, V15, P1243; Wilkerson JL, 2012, BRAIN BEHAV, V2, P155, DOI 10.1002/brb3.44; Xi ZX, 2011, NAT NEUROSCI, V14, P1160, DOI 10.1038/nn.2874; Zarruk JG, 2012, STROKE, V43, P211, DOI 10.1161/STROKEAHA.111.631044; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1387, DOI 10.1038/sj.jcbfm.9600447; Zhang M, 2009, MICROVASC RES, V78, P86, DOI 10.1016/j.mvr.2009.03.005	43	42	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132487	10.1371/journal.pone.0132487	http://dx.doi.org/10.1371/journal.pone.0132487			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186541	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700045
J	Zhou, GF; Zhang, QS; Zhang, XQ; Tan, C; Li, CD				Zhou, Gaofeng; Zhang, Qisen; Zhang, Xiao-qi; Tan, Cong; Li, Chengdao			Construction of High-Density Genetic Map in Barley through Restriction-Site Associated DNA Sequencing	PLOS ONE			English	Article							CONSENSUS MAP; DART MARKERS; QTL ANALYSIS; LOCI; SSR; DISCOVERY; TRAITS	Genetic maps in barley are usually constructed from a limited number of molecular markers such as SSR (simple sequence repeat) and DarT (diversity arrays technology). These markers must be first developed before being used for genotyping. Here, we introduce a new strategy based on sequencing progeny of a doubled haploid population from Baudin x AC Metcalfe to construct a genetic map in barley. About 13,547 polymorphic SNP tags with >93% calling rate were selected to construct the genetic map. A total of 12,998 SNP tags were anchored to seven linkage groups which spanned a cumulative 967.6 cM genetic distance. The high-density genetic map can be used for QTL mapping and the assembly of WGS and BAC contigs. The genetic map was evaluated for its effectiveness and efficiency in QTL mapping and candidate gene identification. A major QTL for plant height was mapped at 105.5 cM on chromosome 3H. This QTL with LOD value of 13.01 explained 44.5% of phenotypic variation. This strategy will enable rapid and efficient establishment of high-density genetic maps in other species.	[Zhou, Gaofeng; Li, Chengdao] Dept Agr & Food, S Perth, WA, Australia; [Zhang, Qisen; Li, Chengdao] Australian Export Grains Innovat Ctr, S Perth, WA, Australia; [Zhang, Xiao-qi; Tan, Cong; Li, Chengdao] Murdoch Univ, Western Australian State Agr Biotechnol Ctr, Murdoch, WA 6150, Australia	Government of Western Australia; Department of Agriculture & Food - Western Australia; Murdoch University	Li, CD (corresponding author), Dept Agr & Food, S Perth, WA, Australia.	c.li@murdoch.edu.au		tan, cong/0000-0003-0158-4442	Grains Research and Development Corporation (GRDC) of Australia [DAW00233]; Department of Agriculture and Food Western Australia; Western Australian State Agricultural Biotechnology Centre (SABC)	Grains Research and Development Corporation (GRDC) of Australia(Grains R&D Corp); Department of Agriculture and Food Western Australia; Western Australian State Agricultural Biotechnology Centre (SABC)	This work was supported by the fund from Grains Research and Development Corporation (GRDC) of Australia (DAW00233.), Department of Agriculture and Food Western Australia, and Western Australian State Agricultural Biotechnology Centre (SABC).	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Cakir M, 2011, CROP PASTURE SCI, V62, P152, DOI 10.1071/CP10154; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Hearnden PR, 2007, THEOR APPL GENET, V115, P383, DOI 10.1007/s00122-007-0572-7; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jia QJ, 2011, THEOR APPL GENET, V122, P1451, DOI 10.1007/s00122-011-1544-5; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Yang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064799, 10.1371/journal.pone.0064058]; Zhang XQ, 2012, EUPHYTICA, V188, P103, DOI 10.1007/s10681-011-0576-x	22	21	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133161	10.1371/journal.pone.0133161	http://dx.doi.org/10.1371/journal.pone.0133161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182149	gold, Green Published			2022-12-27	WOS:000358198200053
J	Bonura, C; Giuffre, M; Aleo, A; Fasciana, T; Di Bernardo, F; Stampone, T; Giammanco, A; Palma, DM; Mammina, C				Bonura, Celestino; Giuffre, Mario; Aleo, Aurora; Fasciana, Teresa; Di Bernardo, Francesca; Stampone, Tomaso; Giammanco, Anna; Palma, Daniela Maria; Mammina, Caterina		MDR-GN Working Grp	An Update of the Evolving Epidemic of bla(KPC) Carrying Klebsiella pneumoniae in Sicily, Italy, 2014: Emergence of Multiple Non-ST258 Clones	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; SEQUENCE TYPE 258; BETA-LACTAMASES; GENES; ENTEROBACTERIACEAE; RESISTANCE; HOSPITALS; COLISTIN; OUTBREAK; CARBAPENEMASES	Background In Italy, Klebsiella pneumoniae carbapenemase producing K. pneumoniae (KPC-Kp) strains are highly endemic and KPC producing CC258 is reported as the widely predominating clone. In Palermo, Italy, previous reports have confirmed this pattern. However, recent preliminary findings suggest that an epidemiological change is likely ongoing towards a polyclonal KPC-Kp spread. Here we present the results of molecular typing of 94 carbapenem non susceptible K. pneumoniae isolates detected during 2014 in the three different hospitals in Palermo, Italy. Methods and Results Ninety-four consecutive, non replicate carbapenem non susceptible isolates were identified in the three largest acute general hospitals in Palermo, Italy, in the six-month period March-August 2014. They were characterized by PCR for beta-lactam, aminoglycoside and plasmid mediated fluoroquinolone resistance genetic determinants. The mgrB gene of the colistin resistant isolates was amplified and sequenced. Clonality was assessed by pulsed field gel electrophoresis and multilocus sequence typing. Eight non-CC258 sequence types (STs) were identified accounting for 60% of isolates. In particular, ST307 and ST273 accounted for 29% and 18% of isolates. CC258 isolates were more frequently susceptible to gentamicin and non-CC258 isolates to amikacin. Colistin non susceptibility was found in 42% of isolates. Modifications of mgrB were found in 32 isolates. Conclusions Concurrent clonal expansion of some STs and lateral transmission of genetic resistance determinants are likely producing a thorough change of the KPC-Kp epidemiology in Palermo, Italy. In our setting mgrB inactivation proved to substantially contribute to colistin resistance. Our findings suggest the need to continuously monitor the KPC-Kp epidemiology and to assess by a nationwide survey the possible shifting towards a polyclonal epidemic.	[Bonura, Celestino; Giuffre, Mario; Aleo, Aurora; Fasciana, Teresa; Giammanco, Anna; Mammina, Caterina] Univ Palermo, Dept Sci Hlth Promot & Mother Child Care GD Aless, Palermo, Italy; [Di Bernardo, Francesca] ARNAS Civico Di Cristina & Benfratelli, Microbiol Lab, Palermo, Italy; [Stampone, Tomaso] Azienda Osped Osped Riuniti Villa Sofia V Cervell, Microbiol Lab, Palermo, Italy; [Giammanco, Anna] Azienda Osped Univ Paolo Giaccone, Microbiol Lab, Palermo, Italy; [Palma, Daniela Maria] ARNAS Civico Di Cristina & Benfratelli, Intens Care Unit 2, Palermo, Italy	University of Palermo; A.R.N.A.S. Ospedali Civico Di Cristina Benfratelli; University of Palermo; Policlinico Paolo Giaccone; A.R.N.A.S. Ospedali Civico Di Cristina Benfratelli	Mammina, C (corresponding author), Univ Palermo, Dept Sci Hlth Promot & Mother Child Care GD Aless, Palermo, Italy.	caterina.mammina@unipa.it	Giuffre, Mario/AAO-6913-2021; Mammina, Caterina/M-9339-2013; Giuffrè, Mario/J-7804-2016	Giuffre, Mario/0000-0001-9576-1635; Mammina, Caterina/0000-0003-2881-8018; Giuffrè, Mario/0000-0001-9576-1635; Geraci, Daniela Maria/0000-0002-4684-1273; SAPORITO, Laura/0000-0002-9756-0957				Ageevets VA, 2014, INT J ANTIMICROB AG, V44, P152, DOI 10.1016/j.ijantimicag.2014.05.004; Agodi A, 2011, J HOSP INFECT, V77, P279, DOI 10.1016/j.jhin.2010.10.007; Cannatelli A, 2014, ANTIMICROB AGENTS CH, V58, P5696, DOI 10.1128/AAC.03110-14; Castanheira M, 2013, MICROB DRUG RESIST, V19, P295, DOI 10.1089/mdr.2012.0238; Chen L, 2014, TRENDS MICROBIOL, V22, P686, DOI 10.1016/j.tim.2014.09.003; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; EUCAST, 2013, BREAKPOINT TABLES FO; European Centre for Disease Prevention and Control, 2014, ANNUAL REPORT OF THE; Geraci DM, 2015, CLIN MICROBIOL INFEC, V21, pE15, DOI 10.1016/j.cmi.2014.08.022; Giani T, 2013, EURO SURVEILL, V18; Giani T, 2009, J CLIN MICROBIOL, V47, P3793, DOI 10.1128/JCM.01773-09; Giuffre M, 2013, J HOSP INFECT, V85, P233, DOI 10.1016/j.jhin.2013.08.004; Gomez-Simmonds A, 2015, J CLIN MICROBIOL; Habeeb MA, 2013, INT J ANTIMICROB AG, V41, P524, DOI 10.1016/j.ijantimicag.2013.02.017; Hu L, 2014, EPIDEMIOL INFECT, V142, P1972, DOI 10.1017/S0950268813002975; Mammina C, 2012, EUROSURVEILLANCE, V17; Mammina C, 2010, INT J ANTIMICROB AG, V36, P576, DOI 10.1016/j.ijantimicag.2010.08.004; Mammina C, 2010, J CLIN MICROBIOL, V48, P1506, DOI 10.1128/JCM.00315-10; Mezzatesta ML, 2011, CLIN MICROBIOL INFEC, V17, P1444, DOI 10.1111/j.1469-0691.2011.03572.x; Migliavacca R, 2015, 25TH EUROPEAN CONGRE; Monaco M, 2014, EURO SURVEILL, V19; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Poirel L, 2015, J ANTIMICROB CHEMOTH, V70, P75, DOI 10.1093/jac/dku323; Ruiz-Garbajosa P, 2013, J ANTIMICROB CHEMOTH, V68, P2487, DOI 10.1093/jac/dkt237; Tofteland S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059015; Tsakris A, 2010, J ANTIMICROB CHEMOTH, V65, P1664, DOI 10.1093/jac/dkq210; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI DOI 10.1093/jac/dki412	27	70	72	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132936	10.1371/journal.pone.0132936	http://dx.doi.org/10.1371/journal.pone.0132936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177547	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600184
J	Gao, CH; Wang, JY; Zhang, S; Yang, YT; Wang, Y				Gao, Chun-hua; Wang, Jun-yun; Zhang, Song; Yang, Yue-tao; Wang, Yong			Survey of Wild and Domestic Mammals for Infection with Leishmania infantum following an Outbreak of Desert Zoonotic Visceral Leishmaniasis in Jiashi, People's Republic of China	PLOS ONE			English	Article							RABBITS ORYCTOLAGUS-CUNICULUS; CANINE LEISHMANIASIS; RESERVOIR HOSTS; CATS	In 2008 and 2009, an outbreak of desert-subtype zoonotic visceral leishmaniasis occurred in Jiashi county, Xinjiang, China. So far, no animal reservoir has been identified for this type of visceral leishmaniasis. Therefore, we surveyed the most common mammals (wild and domestic) for Leishmania infections during the outbreak in 2008 and 2009 in order to identify the source of the visceral leishmaniasis in this region. Spleen, liver, bone marrow and blood samples collected from 86 wood mice (Apodemus sylvaticus), 61 midday jirds (Meriones meridianus) and 27 Yarkand hares (Lepus yarkandensis) were tested for the presence of Leishmania by microscopy, culture and PCR. All of the animals were found to be negative for Leishmania infections; On the other hand, Leishmania DNA was detected in blood samples collected from livestock reared in the outbreak area: 30.36% (17/56) of sheep, 21.57% (11/51) of goats, 17.78% (8/45) of cattle, and 21.62 (8/37) of donkeys were positive for Leishmania DNA by PCR. The amplified kDNA sequences from the livestock samples matched Leishmania DNA sequences isolated from patients with visceral leishmaniasis in the study area. We suggest that these domestic mammals are a possible reservoir host for Leishmania infantum in the outbreak area.	[Gao, Chun-hua; Wang, Jun-yun; Yang, Yue-tao] Chinese Minist Hlth, Natl Inst Parasit Dis, Chinese Ctr Dis Control & Prevent,WHO Collaborati, Key Lab Parasite & Vector Biol,Natl Ctr Int Res T, Shanghai 200025, Peoples R China; [Zhang, Song] Ctr Dis Control & Prevent Xinjiang Uygur Autonomo, Urumqi 830002, Peoples R China; [Wang, Yong] Cent S Univ, Sch Basic Med Sci, Dept Immunol, Changsha 410013, Hunan, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; Central South University	Wang, JY (corresponding author), Chinese Minist Hlth, Natl Inst Parasit Dis, Chinese Ctr Dis Control & Prevent,WHO Collaborati, Key Lab Parasite & Vector Biol,Natl Ctr Int Res T, Shanghai 200025, Peoples R China.	wang_junyun@yahoo.com			China's National S & T Major Program [2008ZX10004-011, 2012ZX10004-220]	China's National S & T Major Program	This work was supported by China's National S & T Major Program (grant nos. 2008ZX10004-011 and 2012ZX10004-220).	Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Ashford RW, 1996, CLIN DERMATOL, V14, P523, DOI 10.1016/0738-081X(96)00041-7; AYDOGDU I, 1995, TROP GEOGR MED, V47, P231; Banuls AL, 2007, ADV PARASIT, V64, P1, DOI 10.1016/S0065-308X(06)64001-3; Bhattarai NR, 2010, EMERG INFECT DIS, V16, P231, DOI 10.3201/eid1602.090623; Carrillo E, 2013, TRENDS PARASITOL, V29, P579, DOI 10.1016/j.pt.2013.10.007; Diaz-Saez V, 2014, VET PARASITOL, V202, P119, DOI 10.1016/j.vetpar.2014.03.029; Elnaiem DA, 2001, PARASITOLOGY, V122, P531, DOI 10.1017/S0031182001007594; GUAN L-R, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P291; GUAN LR, 1991, B WORLD HEALTH ORGAN, V69, P595; Jimenez M, 2014, VET PARASITOL, V202, P296, DOI 10.1016/j.vetpar.2014.03.027; Maia C, 2010, VET PARASITOL, V174, P336, DOI 10.1016/j.vetpar.2010.08.030; Maia C, 2008, VECTOR-BORNE ZOONOT, V8, P555, DOI 10.1089/vbz.2007.0247; Maia C, 2011, TRENDS PARASITOL, V27, P341, DOI 10.1016/j.pt.2011.03.008; Molina R, 2012, VET PARASITOL, V190, P268, DOI 10.1016/j.vetpar.2012.05.006; Moreno I, 2014, VET PARASITOL, V199, P264, DOI 10.1016/j.vetpar.2013.10.010; Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4; Palatnik-de-Sousa CB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-197; Prina E, 2007, MICROBES INFECT, V9, P1307, DOI 10.1016/j.micinf.2007.06.005; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; Reithinger Richard, 2002, Trends in Parasitology, V18, P289, DOI 10.1016/S1471-4922(02)02296-1; Sastre N, 2008, VET PARASITOL, V158, P117, DOI 10.1016/j.vetpar.2008.08.008; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang JY, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-31; Wang JY, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-69; Wang JY, 2010, PARASITOL INT, V59, P331, DOI 10.1016/j.parint.2010.04.002; Wang JunYun, 2006, Chinese Journal of Zoonoses, V22, P734; WHO, 2010, CONTR LEISHM, P186	28	9	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132493	10.1371/journal.pone.0132493	http://dx.doi.org/10.1371/journal.pone.0132493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177101	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600118
J	Hillson, R; Alejandre, JD; Jacobsen, KH; Ansumana, R; Bockarie, AS; Bangura, U; Lamin, JM; Stenger, DA				Hillson, Roger; Alejandre, Joel D.; Jacobsen, Kathryn H.; Ansumana, Rashid; Bockarie, Alfred S.; Bangura, Umaru; Lamin, Joseph M.; Stenger, David A.			Stratified Sampling of Neighborhood Sections for Population Estimation: A Case Study of Bo City, Sierra Leone	PLOS ONE			English	Article								There is a need for better estimators of population size in places that have undergone rapid growth and where collection of census data is difficult. We explored simulated estimates of urban population based on survey data from Bo, Sierra Leone, using two approaches: (1) stratified sampling from across 20 neighborhoods and (2) stratified single-stage cluster sampling of only four randomly-sampled neighborhoods. The stratification variables evaluated were (a) occupants per individual residence, (b) occupants per neighborhood, and (c) residential structures per neighborhood. For method (1), stratification variable (a) yielded the most accurate re-estimate of the current total population. Stratification variable (c), which can be estimated from aerial photography and zoning type verification, and variable (b), which could be ascertained by surveying a limited number of households, increased the accuracy of method (2). Small household-level surveys with appropriate sampling methods can yield reasonably accurate estimations of urban populations.	[Hillson, Roger; Alejandre, Joel D.] Naval Res Lab, Div Informat Technol, Washington, DC USA; [Jacobsen, Kathryn H.] George Mason Univ, Dept Global & Community Hlth, Fairfax, VA 22030 USA; [Ansumana, Rashid; Bockarie, Alfred S.] Njala Univ, Bo, Sierra Leone; [Ansumana, Rashid; Bockarie, Alfred S.; Bangura, Umaru; Lamin, Joseph M.] Mercy Hosp Res Lab, Bo, Sierra Leone; [Stenger, David A.] Naval Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; George Mason University; Njala University; United States Department of Defense; United States Navy; Naval Research Laboratory	Stenger, DA (corresponding author), Naval Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA.	david.stenger@nrl.navy.mil	Ansumana, Rashid/AGQ-7401-2022; Jacobsen, Kathryn H./B-5857-2008	Jacobsen, Kathryn H./0000-0002-4198-6246	Defense Threat Reduction Agency, Joint Science and Technology Office; NRL; George Mason University	Defense Threat Reduction Agency, Joint Science and Technology Office(United States Department of DefenseDefense Threat Reduction Agency); NRL; George Mason University	This work was funded by the Defense Threat Reduction Agency, Joint Science and Technology Office (http://www.dvidshub.net/unit/DTRA-CB#.UoUqZ9wo5zk) via contract to myself at the Naval Research Laboratory. A subcontract from NRL with George Mason University was used to provide support for contractors (Rashid Ansumana, Alfred Bockarie, Umaru Bangura and Joseph Lamin) working at Mercy Hospital Research Laboratory in Bo, Sierra Leone. There is no past, present or future Intellectual Property associated with the work described in the paper, and none of the authors have any financial interests or conflicts in the outcome of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansumana R, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.34.2291; Ansumana R, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-56; Archer BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049482; Baillargeon S, 2012, PACKAGE STRATIFICATI; Baillargeon S, 2011, SURV METHODOL, V37, P53; Checchi F, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-4; Croarkin C, 2015, NIST SEMATECH E HDB; Dalgaard P., 2013, INTRO STAT R; Fox J, 2014, PACKAGE CAR COMPANIO; Glasser J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012777; Gomez-Elipe A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-129; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; HIDIROGLOU MA, 1993, J BUS ECON STAT, V11, P397, DOI 10.2307/1391630; Hillson R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112241; Hinkley DV, 1997, BOOTSTRAP METHODS AN, DOI 10.2307/1271471; Jacobsen KH, 2012, INT HEALTH, V4, P307, DOI 10.1016/j.inhe.2012.09.004; Jacobsen KH, 2012, ACTA OBSTET GYN SCAN, V91, P750, DOI 10.1111/j.1600-0412.2012.01384.x; Kozak M., 2004, STAT TRANSITION, V6, P797; Kozak M.R., 2006, SURV METHODOL, V32, P157; Lavallee P., 1988, SURV METHODOL, V14, P33; Levey PS, 2008, SAMPLING POPULATION; Magalhaes RJS, 2011, ADV PARASIT, V74, P267, DOI 10.1016/B978-0-12-385897-9.00005-7; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; OVERTON WS, 1995, AM STAT, V49, P261, DOI 10.2307/2684196; Quatember A, 2014, AUST J STAT, V43, P93, DOI 10.17713/ajs.v43i2.10; Ripley B, 2013, PACKAGE BOOT BOOTSTR; Tille Y, PACKAGE SAMPLING R S; Tille Y, 2010, ICOTS; White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136	30	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132850	10.1371/journal.pone.0132850	http://dx.doi.org/10.1371/journal.pone.0132850			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177479	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600167
J	Murase, Y; Jo, HH; Torok, J; Kertesz, J; Kaski, K				Murase, Yohsuke; Jo, Hang-Hyun; Toeroek, Janos; Kertesz, Janos; Kaski, Kimmo			Modeling the Role of Relationship Fading and Breakup in Social Network Formation	PLOS ONE			English	Article								In social networks of human individuals, social relationships do not necessarily last forever as they can either fade gradually with time, resulting in "link aging," or terminate abruptly, causing "link deletion," as even old friendships may cease. In this paper, we study a social network formation model where we introduce several ways by which a link termination takes place. If we adopt the link aging, we get a more modular structure with more homogeneously distributed link weights within communities than when link deletion is used. By investigating distributions and relations of various network characteristics, we find that the empirical findings are better reproduced with the link deletion model. This indicates that link deletion plays a more prominent role in organizing social networks than link aging.	[Murase, Yohsuke] RIKEN, Adv Inst Computat Sci, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Murase, Yohsuke] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Jo, Hang-Hyun] Pohang Univ Sci & Technol, Phys Div BK21plus, Pohang 790784, South Korea; [Jo, Hang-Hyun] Pohang Univ Sci & Technol, Dept Phys, Pohang 790784, South Korea; [Jo, Hang-Hyun; Kertesz, Janos; Kaski, Kimmo] Aalto Univ, Sch Sci, Dept Comp Sci, Espoo, Finland; [Toeroek, Janos; Kertesz, Janos] Budapest Univ Technol & Econ, Dept Theoret Phys, H-1111 Budapest, Hungary; [Toeroek, Janos; Kertesz, Janos] Cent European Univ, Ctr Network Sci, H-1051 Budapest, Hungary	RIKEN; Japan Science & Technology Agency (JST); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Aalto University; Budapest University of Technology & Economics; Central European University	Murase, Y (corresponding author), RIKEN, Adv Inst Computat Sci, Chuo Ku, 7-1-26 Minatojima Minami Machi, Kobe, Hyogo 6500047, Japan.	yohsuke.murase@gmail.com	Kaski, Kimmo K K/G-8067-2012; Jo, Hang-Hyun/F-4666-2012; Murase, Yohsuke/C-8680-2016; Török, János/A-9944-2012; Kaski, Kimmo/AAO-4320-2021	Jo, Hang-Hyun/0000-0002-4214-9204; Murase, Yohsuke/0000-0002-5872-420X; Török, János/0000-0002-4275-2396; Kaski, Kimmo/0000-0002-3805-9687	Aalto University; Mid-career Researcher Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2014030018]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2014046922]; EU [FP7 317532 (MULTIPLEX)]	Aalto University; Mid-career Researcher Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; EU(European Commission)	H-HJ acknowledges financial support by Aalto University postdoctoral program and by Mid-career Researcher Program through the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT and Future Planning (2014030018), and Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT and Future Planning (2014046922). JT and JK acknowledge support from EU grant no. FP7 317532 (MULTIPLEX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Blondel VD, 2015, ARXIV150203406; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Burt RS, 2000, SOC NETWORKS, V22, P1, DOI 10.1016/S0378-8733(99)00015-5; Dunbar R. I. M., 2014, J EVOLUTIONARY PSYCH, V12, P109, DOI DOI 10.1556/JEP-D-13-00024; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Jo HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022687; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Kumpula JM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228701; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Murase Y., 2014, PHYS PROCEDIA, V57, P73, DOI [10.1016/j.phpro.2014.08.134, DOI 10.1016/J.PHPRO.2014.08.134]; Murase Y, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.052810; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Onnela JP, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/179; Saramaki J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.027105; Sen P., 2013, SOCIOPHYSICS INTRO; Ugander J., 2011, ANATOMY FACEBOOK SOC; Xu B., 2013, PROC 2013 C COMPUTER, P871, DOI DOI 10.1145/2441776.2441875	22	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133005	10.1371/journal.pone.0133005	http://dx.doi.org/10.1371/journal.pone.0133005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26176224	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600200
J	Winstedt, L; Jarnum, S; Nordahl, EA; Olsson, A; Runstrom, A; Bockermann, R; Karlsson, C; Malmstrom, J; Palmgren, GS; Malmqvist, U; Bjorck, L; Kjellman, C				Winstedt, Lena; Jarnum, Sofia; Nordahl, Emma Andersson; Olsson, Andreas; Runstrom, Anna; Bockermann, Robert; Karlsson, Christofer; Malmstrom, Johan; Palmgren, Gabriella Samuelsson; Malmqvist, Ulf; Bjorck, Lars; Kjellman, Christian			Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS - A Novel Therapeutic Opportunity	PLOS ONE			English	Article							INTRAVENOUS IMMUNE GLOBULIN; STREPTOCOCCAL ENDOPEPTIDASE; RECOMBINANT STAPHYLOKINASE; CYSTEINE PROTEINASE; STRICT SPECIFICITY; CLEAVAGE; TRANSPLANTATION; IMMUNOGLOBULIN; STREPTOKINASE; INDUCTION	IdeS is a streptococcal protease that cleaves IgG antibodies into F(ab')(2) and Fc fragments with a unique degree of specificity, thereby providing a novel treatment opportunity of IgG-driven autoimmune conditions and antibody mediated transplant rejection. Here we report the results from a first in man, double blinded and randomized study with single ascending doses of IdeS in healthy, male subjects. Twenty healthy subjects were given intravenous single ascending doses of IdeS. With impressive efficacy IdeS cleaved the entire plasma IgG-pool only minutes after dosing. IgG reached nadir 6-24 hours after dosing and then slowly recovered. The half-life of IdeS was 4.9 (+/- 2.8) hours at 0.24 mg/kg with the main fraction eliminated during 24 hours. Already two hours after IdeS-dosing, the phagocytic capacity of IgG/IgG-fragments was reduced to background levels. Importantly, IdeS has the capacity to inactivate Fc-mediated effector function in vivo, was considered safe with no serious adverse events, and without dose limiting toxicity in this study. The complete, rapid, but temporary removal of IgG provides a new potent therapeutic opportunity in IgG-mediated pathogenic conditions.	[Winstedt, Lena; Jarnum, Sofia; Nordahl, Emma Andersson; Olsson, Andreas; Runstrom, Anna; Bockermann, Robert; Kjellman, Christian] Hansa Med AB, SE-22007 Lund, Sweden; [Karlsson, Christofer; Malmstrom, Johan; Bjorck, Lars] Lund Univ, Dept Clin Sci, SE-22184 Lund, Sweden; [Palmgren, Gabriella Samuelsson; Malmqvist, Ulf] Skane Univ Hosp, Clin Trials Unit, Lund, Sweden	Lund University; Lund University; Skane University Hospital	Bjorck, L (corresponding author), Lund Univ, Dept Clin Sci, SE-22184 Lund, Sweden.	lars.bjorck@med.lu.se; christian.kjellman@hansamedical.com	Malmström, Johan A/B-7660-2009	Malmström, Johan A/0000-0002-2889-7169	Hansa Medical AB; Swedish Research Council [7480]; Swedish Government Funds for Clinical Research (ALF); Foundation of Knut and Alice Wallenberg; Foundation of Torsten and Ragnar Soderberg; Foundation of Alfred Osterlund; Foundation of Greta and Johan Kock	Hansa Medical AB; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Government Funds for Clinical Research (ALF); Foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Foundation of Torsten and Ragnar Soderberg; Foundation of Alfred Osterlund; Foundation of Greta and Johan Kock	Hansa Medical AB was the formal sponsor and funder of the clinical trial. LB received funding from the following funders. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript: Swedish Research Council (project 7480), Swedish Government Funds for Clinical Research (ALF), The Foundations of Knut and Alice Wallenberg, Torsten and Ragnar Soderberg, Alfred Osterlund, and Greta and Johan Kock. LW, SJ, EAN, AO, AR, RB, and CK are employed by Hansa Medical AB. Hansa Medical AB provided support in the form of salaries for authors LW, SJ, EAN, AO, AR, RB, and CK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Agniswamy J, 2004, J BIOL CHEM, V279, P52789, DOI 10.1074/jbc.M410698200; Akesson P, 2004, J INFECT DIS, V189, P797, DOI 10.1086/381982; Brezski RJ, 2009, P NATL ACAD SCI USA, V106, P17864, DOI 10.1073/pnas.0904174106; BUCHALTER MB, 1993, BRIT HEART J, V70, P101; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Collen D, 1997, CIRCULATION, V95, P455; DECLERCK PJ, 1994, THROMB HAEMOSTASIS, V71, P129; Ismail N, 2007, HDB DIALYSIS, V3, P231; Iyer SP, 2014, J AM SOC NEPHROL; Johansson BP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001692; Jordan SC, 2004, J AM SOC NEPHROL, V15, P3256, DOI 10.1097/01.ASN.0000145878.92906.9F; Karlsson C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2297; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mainet D, 1998, FIBRINOLYSIS PROTEOL, V12, P301, DOI 10.1016/S0268-9499(98)80023-4; Montgomery RA, 2000, TRANSPLANTATION, V70, P887, DOI 10.1097/00007890-200009270-00006; Nandakumar KS, 2007, ARTHRITIS RHEUM-US, V56, P3253, DOI 10.1002/art.22930; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; Ryan MH, 2008, MOL IMMUNOL, V45, P1837, DOI 10.1016/j.molimm.2007.10.043; Teleman J, 2013, J PROTEOMICS, V95, P77, DOI 10.1016/j.jprot.2013.03.029; Tradtrantip L, 2013, MOL PHARMACOL, V83, P1268, DOI 10.1124/mol.113.086470; Vincents B, 2004, BIOCHEMISTRY-US, V43, P15540, DOI 10.1021/bi048284d; Vindebro R, 2013, FEBS LETT, V587, P1818, DOI 10.1016/j.febslet.2013.04.039; Vo AA, 2008, AM J TRANSPLANT, V8, P144, DOI 10.1111/j.1600-6143.2007.02017.x; Vo AA, 2008, NEW ENGL J MED, V359, P242, DOI 10.1056/NEJMoa0707894; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; von Pawel-Rammingen U, 2002, NAT MED, V8, P1043, DOI 10.1038/nm1002-1044; Wenig K, 2004, P NATL ACAD SCI USA, V101, P17371, DOI 10.1073/pnas.0407965101; Yang R, 2010, NEPHROL DIAL TRANSPL, V25, P2479, DOI 10.1093/ndt/gfq115	29	62	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132011	10.1371/journal.pone.0132011	http://dx.doi.org/10.1371/journal.pone.0132011			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177518	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600078
J	Adinan, J; Damian, DJ; Msuya, SE				Adinan, Juma; Damian, Damian J.; Msuya, Sia E.			Factors Associated with Testing and Prompt Use of Recommended Antimalarials following Malaria Diagnosis: A Secondary Analysis of 2011-12 Tanzania HIV and Malaria Indicator Survey Data	PLOS ONE			English	Article							CASE-MANAGEMENT; FEVER; FACILITIES; DISTRICTS; BEHAVIOR; CHILDREN; QUALITY	Introduction Malaria is still a public health problem in Sub-Saharan Africa. Malaria causes mortality mostly in children under-five years. Early detection and prompt treatment using recommended antimalarials is key to malaria control. However, in Tanzania, contrary to the national goals, a large proportion of children with fever taken to health facilities are not tested for malaria and those tested positive are not promptly treated using recommended antimalarials. The aim of this study was to determine factors associated with malaria testing and prompt use of recommended antimalarials among under-five children with fever in Tanzania. Methods This was a secondary analysis of Tanzania HIV and Malaria Indicator Survey (THMIS) data 2011-12 obtained from a national cross sectional survey. The analysis involved children aged 6-59 months whose mothers reported they had fever two weeks preceding the survey. Factors associated with testing and uses of recommended antimalarials were obtained using logistic regression. Results Of the 1675 under-five children with fever, 951 (56.8%) were taken to the health facilities. Of the 951 children, only 394 (41.48%) febrile children were tested for malaria. Of those tested, 291 (78.91%) were diagnosed with malaria. Of those diagnosed with malaria, only 124 (42.68%) children used recommended antimalarials within 1st 24 hours of diagnosis. In multivariate analysis, children taken to health centers (OR 1.79; 95%CI: 1.07-3.00) and to the hospitals (OR 3.4; 95%CI: 1.75-6.77) had higher odds of being tested compared to those taken to dispensary and other lower level health facilities. Children were more likely to use recommended antimalarial promptly if they had a caretaker with secondary or higher education (OR: 4.07; 95%CI: 0.61-2.68) or living in the rural area (OR: 3.21; 95%CI: 1.09-9.44) compared to those with an uneducated caretaker or from an urban area. Conclusion Training on malaria testing and treatment guidelines should be provided, and preventing stock outs of malaria testing kits and medications at dispensary level should be made available as it is the first point of health care for most Tanzanians. Reasons on why urban people are less likely to use recommended antimalarials need to be investigated and addressed for proper malaria management.	[Adinan, Juma; Damian, Damian J.; Msuya, Sia E.] Kilimanjaro Christian Med Univ Coll KCMU Co, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi, Tanzania; [Adinan, Juma; Damian, Damian J.; Msuya, Sia E.] Kilimanjaro Christian Med Univ Coll KCMU Co, Inst Publ Hlth, Dept Community Hlth, Moshi, Tanzania; [Adinan, Juma; Damian, Damian J.; Msuya, Sia E.] KCMC Hosp, Dept Community Hlth, Moshi, Tanzania; [Adinan, Juma] KCMC Hosp, Gen Teaching Coll, AMO, Moshi, Tanzania		Adinan, J (corresponding author), Kilimanjaro Christian Med Univ Coll KCMU Co, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi, Tanzania.	adinanjuma@gmail.com	Adinan, Juma/N-8259-2015	Adinan, Juma/0000-0002-7964-2879				[Anonymous], 2012, TANZANIA HIV AIDS MA; Bryce J, 2014, FULFILLING HLTH AGEN; Chanda-Kapata Pascalina, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P498, DOI 10.12980/APJTB.4.2014C153; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Comoe CC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1089; Derua YA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-78; Elmardi KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-128; Getahun A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-320; Hetzel MW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-317; Juma E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-1; Kahabuka C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058789; Kyabayinze DJ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-200; Leslie T, 2012, BMJ-BRIT MED J, V345, P5; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Masanja IM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-221; Ministry of Health and Social Welfare, 2007, UN REP TANZ MIN HLTH, P2007; Ministry of Health and Social Welfare, 2013, MIDT REV HLTH SECT S; Ministry of Health and Social Welfare (MoHSW), TANZ SERV AV READ AS; Ministry of Health and Social Welfare (Tanzania), 2011, NAT GUID DIAGN TREAT, V11; Mubi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019753; Mukanga D, 2012, AM J TROP MED HYG, V87, P21, DOI 10.4269/ajtmh.2012.11-0816; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BMJ-BRIT MED J, V2007, DOI [10.1136/bmj.39073.496829, DOI 10.1136/BMJ.39073.496829]; Simba DO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012104; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-333; Sserwanga A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016316; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; WHO, WORLD MAL REP 2013; WHO, MAL UPD 2014; WHO, 2010, GUID TREATM MAL, V2nd	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132964	10.1371/journal.pone.0132964	http://dx.doi.org/10.1371/journal.pone.0132964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186547	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700077
J	Chang, YC; Wu, CC; Lin, CH; Wu, YW; Yang, YC; Chang, TJ; Jiang, YD; Chuang, LM				Chang, Yi-Cheng; Wu, Chau-Chung; Lin, Chih-Hung; Wu, Yen-Wen; Yang, Ying-Chieh; Chang, Tien-Jyun; Jiang, Yi-Der; Chuang, Lee-Ming			Early Myocardial Repolarization Heterogeneity Is Detected by Magnetocardiography in Diabetic Patients with Cardiovascular Risk Factors	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; QT DISPERSION; METABOLIC SYNDROME; VENTRICULAR REPOLARIZATION; CARDIAC DEATH; ALL-CAUSE; DIAGNOSIS; INFARCTION; MORTALITY; INTERVAL	Multi-channel magnetocardiography (MCG) is a sensitive technique to map spatial ventricular repolarization with high resolution and reproducibility. Spatial ventricular repolarization heterogeneity measured by MCG has been shown to accurately detect and localize myocardial ischemia. Here, we explored whether these measurements correlated with cardiovascular risk factors in patients with type 2 diabetes. Two hundreds and seventy-seven type 2 diabetic patients without known coronary artery disease (CAD) and arrhythmia were recruited consecutively from the outpatient clinic of National Taiwan University Hospital. The spatially distributed QTc contour maps were constructed with 64-channel MCG using the superconducting quantum interference device (SQUID) system. Indices of myocardial repolarization heterogeneity including the smoothness index of QTc (SI-QTc) and QTc dispersion were derived and analyzed for association with conventional cardiovascular risk factors. SI-QTc correlated strongly with the QTc dispersion (r = 0.70, p < 0.0001). SI-QTc was significantly higher in patients with presence of metabolic syndrome in comparison to those without metabolic syndrome (8.56 vs. 7.96 ms, p = 0.02). In univariate correlation analyses, QTc dispersion was associated with smoking status (average 79.90, 83.83, 86.51, and 86.00 ms for never smokers, ex-smokers, current smokers reporting less than 10 cigarettes daily, and current smoker reporting more than 10 cigarettes daily, respectively, p = 0.03), body weight (r = 0.15, p = 0.01), and hemoglobin A1c (r = 0.12, p = 0.04). In step-wise multivariate regression analyses, QTc dispersion was associated with smoking (p = 0.02), body weight (p = 0.04), total cholesterol levels (p = 0.05), and possibly estimated glomerular filtration rate (p = 0.07). In summary, spatial heterogeneity of myocardial repolarization measured by MCG is positively associated cardiovascular risk factors including adiposity, smoking, and total cholesterol levels.	[Chang, Yi-Cheng] Natl Taiwan Univ, Grad Inst Med Genom & Prote, Taipei 10764, Taiwan; [Chang, Yi-Cheng; Yang, Ying-Chieh] Natl Taiwan Univ, Dept Internal Med, HsinChu Branch, Hsinchu, Taiwan; [Chang, Yi-Cheng; Wu, Chau-Chung; Wu, Yen-Wen; Chang, Tien-Jyun; Jiang, Yi-Der; Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chang, Yi-Cheng; Chang, Tien-Jyun; Jiang, Yi-Der; Chuang, Lee-Ming] Natl Taiwan Univ, Coll Med, Dept Med, Taipei 10764, Taiwan; [Wu, Chau-Chung] Natl Taiwan Univ, Coll Med, Dept Primary Care Med, Taipei 10764, Taiwan; [Lin, Chih-Hung] Taipei Med Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Cardiovasc Med Ctr, Dept Nucl Med, New Taipei City, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Cardiovasc Med Ctr, Div Cardiol, New Taipei City, Taiwan; [Wu, Yen-Wen] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Wu, Yen-Wen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Coll Publ Hlth, Inst Prevent Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Taipei Medical University; Taipei Medical University Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; National Taiwan University	Chuang, LM (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	leeming@ntu.edu.tw	Chuang, Lee-Ming/AAF-3324-2019; Chang, Yi-cheng/O-1334-2018	Chang, Yi-cheng/0000-0002-8077-5011; CHUANG, LEE-MING/0000-0003-0978-2662; WU, YEN-WEN/0000-0003-1520-1166; CHANG, TIEN-JYUN/0000-0001-9437-5847; YANG, YING-CHIEH/0000-0003-1599-635X	National Science Council, Executive Yuan, Taipei, Taiwan [99-2314-B-002-141-MY3]; Diabetes Research Fund of the National Taiwan University Hospital, Taipei, Taiwan	National Science Council, Executive Yuan, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); Diabetes Research Fund of the National Taiwan University Hospital, Taipei, Taiwan	This work was supported by National Science Council (99-2314-B-002-141-MY3), Executive Yuan, Taipei, Taiwan and the Diabetes Research Fund of the National Taiwan University Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2012, ANN NONINVAS ELECTRO, V17, P291, DOI 10.1111/j.1542-474X.2012.00538.x; Antzelevitch C, 2006, J INTERN MED, V259, P48, DOI 10.1111/j.1365-2796.2005.01587.x; BARRY J, 1989, JAMA-J AM MED ASSOC, V261, P398, DOI 10.1001/jama.261.3.398; Bonow RO, 2011, BRAUNWALDS HEART DIS; Chen CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086524; Coumel P, 1998, CIRCULATION, V97, P2491, DOI 10.1161/01.CIR.97.25.2491; Dilaveris P, 2001, AM HEART J, V142, P833, DOI 10.1067/mhj.2001.118737; Fenici R, 2005, EXPERT REV MOL DIAGN, V5, P291, DOI 10.1586/14737159.5.3.291; Girola A, 2001, OBES RES, V9, P71, DOI 10.1038/oby.2001.9; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gupta Anoop K, 2002, Indian Heart J, V54, P399; Haddock RE, 2011, J PHYSIOL-LONDON, V589, P3289, DOI 10.1113/jphysiol.2011.207944; Hailer B, 2004, Neurol Clin Neurophysiol, V2004, P82; International Diabetes Federation (IDF), IDF CONS WORLDW DEF; IOANNIDIS PJ, 1973, CARDIOLOGY, V58, P139, DOI 10.1159/000169628; Iribarren C, 2006, J AM COLL CARDIOL, V48, P1800, DOI 10.1016/j.jacc.2006.03.070; Kwon H, 2010, CIRC J, V74, P1424, DOI 10.1253/circj.CJ-09-0975; Kwong JSW, 2013, INT J CARDIOL, V167, P1835, DOI 10.1016/j.ijcard.2012.12.056; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Liehr M, 2005, ANN BIOMED ENG, V33, P240, DOI 10.1007/s10439-005-8983-6; Lim HK, 2009, AM J CARDIOL, V103, P448, DOI 10.1016/j.amjcard.2008.10.013; Liu YB, 2003, CIRC RES, V92, P1145, DOI 10.1161/01.RES.0000072999.51484.92; Malik M, 2000, J CARDIOVASC ELECTR, V11, P835, DOI 10.1111/j.1540-8167.2000.tb00061.x; Malik M, 2000, J AM COLL CARDIOL, V36, P1749, DOI 10.1016/S0735-1097(00)00962-1; Marfella R, 2001, AM J CLIN NUTR, V73, P27; Marroquin OC, 2004, CIRCULATION, V109, P714, DOI 10.1161/01.CIR.0000115517.26897.A7; Mshui ME, 1999, P SOC EXP BIOL MED, V220, P133, DOI 10.1046/j.1525-1373.1999.d01-20.x; Naas AAO, 1998, BRIT MED J, V316, P745, DOI 10.1136/bmj.316.7133.745; Nam HK, 2003, CIRC J, V33, P58; Nenonen J, 1996, BIOMEDICAL LIFE PHYS; Oikarinen L, 1998, PACE, V21, P1934, DOI 10.1111/j.1540-8159.1998.tb00013.x; Okin PM, 2000, CIRCULATION, V101, P61, DOI 10.1161/01.CIR.101.1.61; Okin PM, 2004, DIABETES, V53, P434, DOI 10.2337/diabetes.53.2.434; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Sahu P, 2000, QJM-MON J ASSOC PHYS, V93, P425, DOI 10.1093/qjmed/93.7.425; Seyfeli E, 2006, INT J OBESITY, V30, P957, DOI 10.1038/sj.ijo.0803233; Soydinc S, 2006, ANN NONINVAS ELECTRO, V11, P313, DOI 10.1111/j.1542-474X.2006.00123.x; Stroink G, 1999, PACE, V22, P1718, DOI 10.1111/j.1540-8159.1999.tb00403.x; Tsukada K, 2000, INT J CARDIAC IMAG, V16, P55, DOI 10.1023/A:1006376326755; VANCAPELLE FJL, 1980, CIRC RES, V47, P454, DOI 10.1161/01.RES.47.3.454; VEMURI R, 1988, BIOCHIM BIOPHYS ACTA, V937, P258, DOI 10.1016/0005-2736(88)90248-9; Wu CC, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2433036; Wu YW, 2014, ACTA CARDIOL SIN, V30, P445; Wu YW, 2013, CIRC J, V77, P1783, DOI 10.1253/circj.CJ-12-1170; Zabel M, 1998, CIRCULATION, V97, P2543, DOI 10.1161/01.CIR.97.25.2543; Zabel M, 2001, J ELECTROCARDIOL, V34, P27, DOI 10.1054/jelc.2001.28822	46	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133192	10.1371/journal.pone.0133192	http://dx.doi.org/10.1371/journal.pone.0133192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185995	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700105
J	Sasada, T; Hinoi, T; Saito, Y; Adachi, T; Takakura, Y; Kawaguchi, Y; Sotomaru, Y; Sentani, K; Oue, N; Yasui, W; Ohdan, H				Sasada, Tatsunari; Hinoi, Takao; Saito, Yasufumi; Adachi, Tomohiro; Takakura, Yuji; Kawaguchi, Yasuo; Sotomaru, Yusuke; Sentani, Kazuhiro; Oue, Naohide; Yasui, Wataru; Ohdan, Hideki			Chlorinated Water Modulates the Development of Colorectal Tumors with Chromosomal Instability and Gut Microbiota in Apc-Deficient Mice	PLOS ONE			English	Article							MULTIPLE INTESTINAL NEOPLASIA; DRINKING-WATER; MICROSATELLITE INSTABILITY; COMMENSAL BACTERIA; REPEAT MARKERS; BY-PRODUCTS; CANCER; MUTATION; EXPRESSION; RECEPTOR	The gastrointestinal tract is continuously exposed to a variety of chemicals and commensal bacteria. Recent studies have shown that changes in gut microbial populations caused by chlorine or other chemicals in the drinking water influence the development of human colorectal cancer, although the mechanism of tumorigenesis in the gut epithelium is obfuscated by the diversity of microflora and complexity of the tumor microenvironment. In this regard, mouse models that recapitulate human colorectal cancer are an invaluable tool. In this study, we used two conditional adenomatous polyposis coli (Apc) knockout mouse models to investigate the effect of chlorinated water on tumorigenesis in the digestive tract. Mice with colon-specific carcinoma-caused by either chromosomal (CDX2P9.5-NLS Cre; Apc(+/flox), abbreviated to CPC;Apc) or microsatellite (CDX2P9.5-G19Cre;Apc(flox/flox) and CDX2P9.5-G22Cre;Apc(flox/flox)) instability, respectively-were administered chlorinated (10.0 mg/L chlorine) or tap (0.7 mg/L chlorine) water and evaluated for colon polyp formation. In CPC; Apc mice given chlorinated drinking water, tumors tended to develop in the colon, whereas in those that drank tap water, tumors were mostly observed in the small intestine. There was no difference in the rate of tumor formation of CDX2P9.5-G19Cre;Apc(flox/flox) and CDX2P9.5-G22Cre;Apc(flox/flox) mice consuming chlorinated as compared to tap water, suggesting that microsatellite instability in the Apc gene does not significantly affect tumorigenesis. Chlorinated water altered the enteric environment by reducing the fecal populations of the obligatory anaerobes Clostridium perfringens and C. difficile, as well as species belonging to the Atopobiumcluster, including Enterobacteriaceae and Staphylococcus sp., which was associated with colon tumorigenesis in CPC;Apcmice. These results suggest that differences in tumorigenesis among CPC; Apc mice consuming chlorinated versus tap water may be due to differences in gastrointestinal commensal populations.	[Sasada, Tatsunari; Hinoi, Takao; Saito, Yasufumi; Adachi, Tomohiro; Takakura, Yuji; Kawaguchi, Yasuo; Ohdan, Hideki] Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan; [Sotomaru, Yusuke] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima, Japan; [Sentani, Kazuhiro; Oue, Naohide; Yasui, Wataru] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol Pathol, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University	Hinoi, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan.	thinoi@hiroshima-u.ac.jp	Sotomaru, Yusuke/G-5508-2019; Ohdan, Hideki/G-4719-2019; Hinoi, Takao/AAI-1443-2020	Ohdan, Hideki/0000-0002-9066-1288; Hinoi, Takao/0000-0003-0462-6177	JSPS [22390257]; Japanese Society of Gastroenterology; Japan Science and Technology Agency (JST) [AS231Z04862F]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Society of Gastroenterology(Japanese Society of Gastroenterology); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (B) (http://www.jsps.go.jp/j-grantsinaid/)(Grant Number 22390257) TH, and The Japanese Society of Gastroenterology (http://www.jsge.or.jp/english/english.html) Grant-in-Aid 2010 TH, and Japan Science and Technology Agency (JST) A-STEP (http://www.jst.go.jp/)(Grant Number AS231Z04862F) TH.	Akyol A, 2008, NAT METHODS, V5, P231, DOI 10.1038/NMETH.1182; Albuquerque C, 2010, GENE CHROMOSOME CANC, V49, P746, DOI 10.1002/gcc.20786; Arnold CN, 2005, CANCER-AM CANCER SOC, V104, P2035, DOI 10.1002/cncr.21462; Bacher JW, 2005, MOL CARCINOGEN, V44, P285, DOI 10.1002/mc.20146; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boorman GA, 1999, ENVIRON HEALTH PERSP, V107, P207, DOI 10.2307/3434484; CRUMP KS, 1982, ANNU REV PUBL HEALTH, V3, P339, DOI 10.1146/annurev.pu.03.050182.002011; Doyle TJ, 1997, AM J PUBLIC HEALTH, V87, P1168, DOI 10.2105/AJPH.87.7.1168; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Edelmann W, 1997, CELL, V91, P467, DOI 10.1016/S0092-8674(00)80433-X; Engle SJ, 2002, CANCER RES, V62, P6362; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; HOMBERGER FR, 1993, LAB ANIM SCI, V43, P635; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jansen GJ, 1999, J MICROBIOL METH, V37, P215, DOI 10.1016/S0167-7012(99)00049-4; Jeon Min Kyung, 2013, World J Gastrointest Pathophysiol, V4, P94, DOI 10.4291/wjgp.v4.i4.94; Kabbarah O, 2003, MOL CARCINOGEN, V38, P155, DOI 10.1002/mc.10157; Kado S, 2001, CANCER RES, V61, P2395; Kanno T, 2009, BIOCHEM BIOPH RES CO, V381, P666, DOI 10.1016/j.bbrc.2009.02.109; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Koivusalo M, 1997, CANCER CAUSE CONTROL, V8, P192, DOI 10.1023/A:1018420229802; Lemercier C, 2015, CELL MOL LIFE SCI, V72, P2665, DOI 10.1007/s00018-015-1900-8; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Ohara T, 2010, HEPATO-GASTROENTEROL, V57, P1411; Ohtani N, 2015, SEMIN IMMUNOPATHOL, V37, P65, DOI 10.1007/s00281-014-0457-1; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Science NRCoNAo, 2011, GUIDE FOR THE CARE A; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Shoemaker AR, 1997, BBA-REV CANCER, V1332, pF25, DOI 10.1016/S0304-419X(96)00041-8; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Thorstensen L, 2005, NEOPLASIA, V7, P99, DOI 10.1593/neo.04448; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Wang KP, 2014, IMMUNITY, V41, P1052, DOI 10.1016/j.immuni.2014.11.009; Wang XM, 2007, GASTROENTEROLOGY, V132, P551, DOI 10.1053/j.gastro.2006.11.040; Wang XM, 2015, GUT, V64, P459, DOI 10.1136/gutjnl-2014-307213; WHO, GUIDELINES FOR DRINK; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; Yao Q, 2010, BIOCHEM BIOPH RES CO, V398, P413, DOI 10.1016/j.bbrc.2010.06.089; Yao X, 1999, P NATL ACAD SCI USA, V96, P6850, DOI 10.1073/pnas.96.12.6850	48	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132435	10.1371/journal.pone.0132435	http://dx.doi.org/10.1371/journal.pone.0132435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186212	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700042
J	Soares, LASS; Faria, D; Velez-Garcia, F; Vieira, EM; Talora, DC; Cazetta, E				Soares, Leiza Aparecida S. S.; Faria, Deborah; Velez-Garcia, Felipe; Vieira, Emerson M.; Talora, Daniela C.; Cazetta, Eliana			Implications of Habitat Loss on Seed Predation and Early Recruitment of a Keystone Palm in Anthropogenic Landscapes in the Brazilian Atlantic Rainforest	PLOS ONE			English	Article							EUTERPE-EDULIS; SOUTHERN BAHIA; FRAGMENTATION; DISPERSAL; GERMINATION; EXTINCTION; SURVIVAL; CONNECTIVITY; COVER; BIRDS	Habitat loss is the main driver of the loss of global biodiversity. Knowledge on this subject, however, is highly concentrated on species richness and composition patterns, with little discussion on the consequences of habitat loss for ecological interactions. Therefore, a systemic approach is necessary to maximize the success of conservation efforts by providing more realistic information about the effects of anthropogenic disturbances on natural environmental processes. We investigated the implications of habitat loss for the early recruitment of Euterpe edulis Martius, a keystone palm in the Brazilian Atlantic Forest, in nine sampling sites located in landscapes with different percentages of forest cover (9%-83%). We conducted a paired experiment using E. Edulis seeds set up in experimental stations composed of a vertebrate exclosure versus an open treatment. We used ANCOVA models with treatments as factors to assess the influence of habitat loss on the number of germinated seeds, predation by vertebrates and invertebrates, infestation by fungi, and number of seedlings established. Habitat loss did not affect the probability of transition from a dispersed to a germinated seed. However, when seeds were protected from vertebrate removal, seedling recruitment showed a positive relationship with the amount of forest cover. Seed infestation by fungi was not significant, and seed predation was the main factor limiting seed recruitment. The loss of forest cover antagonistically affected the patterns of seed predation by vertebrates and invertebrates; predation by invertebrates was higher in less forested areas, and predation by vertebrates was higher in forested areas. When seeds were exposed to the action of all biotic mortality factors, the number of recruited seedlings was very low and unrelated to habitat loss. This result indicates that the opposite effects of seed predation by vertebrates and invertebrates mask a differential response of E. edulis recruitment to habitat loss.	[Soares, Leiza Aparecida S. S.; Faria, Deborah; Velez-Garcia, Felipe; Talora, Daniela C.; Cazetta, Eliana] Univ Estadual Santa Cruz, Programa Posgrad Ecol & Conservacao Biodiversidad, Lab Ecol Aplicada Conservacao, Ilheus, Bahia, Brazil; [Vieira, Emerson M.] Univ Brasilia, Dept Ecol, Inst Ciencias Biol, Lab Ecol Vertebrados, Brasilia, DF, Brazil	Universidade Estadual de Santa Cruz; Universidade de Brasilia	Cazetta, E (corresponding author), Univ Estadual Santa Cruz, Programa Posgrad Ecol & Conservacao Biodiversidad, Lab Ecol Aplicada Conservacao, Ilheus, Bahia, Brazil.	eliana.cazetta@gmail.com	Faria, Deborah/F-2879-2010; Cazetta, Eliana/K-1880-2019; Cazetta, Eliana/F-3296-2010; Vieira, Emerson Monteiro/F-3562-2010; faria, deborah/ABC-2757-2021	Faria, Deborah/0000-0002-0375-2887; Cazetta, Eliana/0000-0002-2209-2554; Cazetta, Eliana/0000-0002-2209-2554; Vieira, Emerson Monteiro/0000-0003-3488-621X; faria, deborah/0000-0002-0375-2887	Brazilian Council of Science and Technology (CNPq) [Proc. 563216/2010-7]; Universidade Estadual de Santa Cruz [PROPP 00220.1100.1198]; FAPESB [BOL0303/2012, BOL08488/2012]; CNPq [307221/2012-1, 305981/2010-2]	Brazilian Council of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Estadual de Santa Cruz; FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The present study is a publication of REDE SISBIOTA, funded by the Brazilian Council of Science and Technology (CNPq Proc. 563216/2010-7) and with additional funding from Universidade Estadual de Santa Cruz (PROPP 00220.1100.1198). LSS and FVG received FAPESB fellowships (BOL0303/2012 and BOL08488/2012, respectively), and DF and EMV were granted CNPq fellowships ('Research Productivity' Grants 307221/2012-1 and 305981/2010-2, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ATL REM FLOR MAT ATL; Antongiovanni M, 2005, BIOL CONSERV, V122, P441, DOI 10.1016/j.biocon.2004.09.005; Arroyo-Rodriguez V, 2014, AM J PRIMATOL, V76, P901, DOI 10.1002/ajp.22282; Arroyo-Rodriguez V, 2013, LANDSCAPE ECOL, V28, P1717, DOI 10.1007/s10980-013-9929-2; AUGUST PV, 1983, ECOLOGY, V64, P1495, DOI 10.2307/1937504; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; BOVI M. L. A., 1976, BRAGANTIA, V34, P29, DOI [10.1590/S0100-6762200600050000, DOI 10.1590/S0100-6762200600050000]; Bovi MLA, 1992, B TECNICO I AGRONOMI, V137, P1; Breitbach N, 2012, OECOLOGIA, V168, P425, DOI 10.1007/s00442-011-2090-1; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Calvi G. P., 2004, Revista Universidade Rural. Serie Ciencias da Vida, V24, P107; Cassano CR, 2012, BIOTROPICA, V44, P818, DOI 10.1111/j.1744-7429.2012.00870.x; Castellon TD, 2006, CONSERV BIOL, V20, P135, DOI 10.1111/j.1523-1739.2006.00332.x; Clark DL, 2003, AM J BOT, V90, P730, DOI 10.3732/ajb.90.5.730; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Conte R, 2000, EUTERPE EDULIS MARTI, P106; Cordeiro NJ, 2003, P NATL ACAD SCI USA, V100, P14052, DOI 10.1073/pnas.2331023100; Cordeiro P.H.C., 2003, CORREDOR BIODIVERSID; Crowley BE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044538; da Silva JMC, 2000, NATURE, V404, P72, DOI 10.1038/35003563; Didham RK, 2014, PAC SCI, V68, P493, DOI 10.2984/68.4.4; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Dracxler CM, 2011, BIOTROPICA, V43, P8, DOI 10.1111/j.1744-7429.2010.00723.x; Estavillo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082369; Fadini RF, 2009, ACTA OECOL, V35, P188, DOI 10.1016/j.actao.2008.10.001; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Faria D, 2009, FOREST ECOL MANAG, V257, P2226, DOI 10.1016/j.foreco.2009.02.032; Fleury M, 2004, ACTA OECOL, V26, P179, DOI 10.1016/j.actao.2004.04.003; Fleury Marina, 2014, PLoS ONE, V9, pe90060, DOI 10.1371/journal.pone.0090060; Fortuna MA, 2013, OIKOS, V122, P938, DOI 10.1111/j.1600-0706.2012.00042.x; Fragoso JMV, 2003, ECOLOGY, V84, P1998, DOI 10.1890/01-0621; Galetti M, 2006, BOT J LINN SOC, V151, P141, DOI 10.1111/j.1095-8339.2006.00529.x; Galetti M, 1998, J APPL ECOL, V35, P286, DOI 10.1046/j.1365-2664.1998.00294.x; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Garmendia A, 2013, J TROP ECOL, V29, P331, DOI 10.1017/S0266467413000370; Rigueira DMG, 2013, BIODIVERS CONSERV, V22, P3141, DOI 10.1007/s10531-013-0575-4; Grass I, 2014, OIKOS, V123, P575, DOI 10.1111/j.1600-0706.2013.00920.x; Howes A, 2014, IBIS, V156, P341, DOI 10.1111/ibi.12136; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JANZEN DH, 1974, NAT HIST, V83, P48; Kurten EL, 2013, BIOL CONSERV, V163, P22, DOI 10.1016/j.biocon.2013.04.025; Landau EC, 2003, CORREDOR BIODIVERSID, P54; Leite AD, 2012, J TROP ECOL, V28, P615, DOI 10.1017/S0266467412000594; Lima MM, 2014, FOREST ECOL MANAG, V312, P260, DOI 10.1016/j.foreco.2013.09.003; Martensen AC, 2008, BIOL CONSERV, V141, P2184, DOI 10.1016/j.biocon.2008.06.008; Martensen AC, 2012, CONSERV BIOL, V26, P1100, DOI 10.1111/j.1523-1739.2012.01940.x; Martins Cibele C., 2004, Hortic. Bras., V22, P271, DOI 10.1590/S0102-05362004000200021; Matos DMS, 1998, BIOTROPICA, V30, P595, DOI 10.1111/j.1744-7429.1998.tb00099.x; Molofskyr J, 2013, ECOLOGY, V74, P261; Moran C, 2014, CONSERV BIOL, V28, P551, DOI 10.1111/cobi.12236; Mortelliti A, 2010, DIVERS DISTRIB, V16, P941, DOI 10.1111/j.1472-4642.2010.00701.x; Muler AE, 2014, FOREST ECOL MANAG, V324, P117, DOI 10.1016/j.foreco.2013.09.001; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Muscarella R, 2013, J ECOL, V101, P171, DOI 10.1111/1365-2745.12027; Nodari R. O., 1998, Revista Arvore, V22, P1; Nunez-Avila MC, 2013, J ECOL, V101, P1439, DOI 10.1111/1365-2745.12148; Orrock JL, 2006, J ECOL, V94, P838, DOI 10.1111/j.1365-2745.2006.01125.x; Paine CET, 2007, ECOLOGY, V88, P3076, DOI 10.1890/06-1835.1; Silva Maria das Graças C. Parada Costa, 2009, Braz. J. Bot., V32, P393, DOI 10.1590/S0100-84042009000200017; Pinto SRR, 2009, BRAZ J BIOL, V69, P763, DOI 10.1590/S1519-69842009000400003; Pizo MA, 2004, BIOTROPICA, V36, P417, DOI 10.1111/j.1744-7429.2004.tb00336.x; Pizo MA, 2001, ACTA OECOL, V22, P229, DOI 10.1016/S1146-609X(01)01108-0; Pizo MA, 2006, ACTA OECOL, V29, P311, DOI 10.1016/j.actao.2005.11.011; Rey PJ, 2002, FUNCT ECOL, V16, P773, DOI 10.1046/j.1365-2435.2002.00680.x; Rother DC, 2013, PERSPECT PLANT ECOL, V15, P86, DOI 10.1016/j.ppees.2012.12.004; Sambuichi RHR, 2003, THESIS U BRASILIA; Schroth G, 2011, BIODIVERS CONSERV, V20, P1635, DOI 10.1007/s10531-011-0052-x; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; SHOEMAKER CA, 1990, HORTSCIENCE, V25, P762, DOI 10.21273/HORTSCI.25.7.762; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Silva Paulo D., 2007, Braz. J. Bot., V30, P553, DOI 10.1590/S0100-84042007000300019; Sodhi NS, 2010, BIOL CONSERV, V143, P2375, DOI 10.1016/j.biocon.2009.12.029; Spiesman BJ, 2013, ECOLOGY, V94, P2688, DOI 10.1890/13-0977.1; Steffler Carla Elisabete, 2008, Palms, V52, P133; Stephens EL, 2012, AM MIDL NAT, V167, P223, DOI 10.1674/0003-0031-167.2.223; Tabarelli M, 2010, CONSERV BIOL, V24, P1654, DOI 10.1111/j.1523-1739.2010.01529.x; Thomas WW, 1998, BIODIVERS CONSERV, V7, P311, DOI 10.1023/A:1008825627656; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Valiente-Banuet A, 2015, FUNCT ECOL, V29, P299, DOI 10.1111/1365-2435.12356; Vieira EM, 2003, MAMMALIA, V67, P533; von Allmen C, 2004, J TROP ECOL, V20, P471, DOI 10.1017/S0266467404001348; Wenny DG, 2000, ECOL MONOGR, V70, P331, DOI 10.1890/0012-9615(2000)070[0331:SDSPAS]2.0.CO;2; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x; Wright SJ, 2001, BIOTROPICA, V33, P583, DOI 10.1111/j.1744-7429.2001.tb00217.x; Zuckerberg B, 2010, BIOL CONSERV, V143, P952, DOI 10.1016/j.biocon.2010.01.004	87	12	12	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133540	10.1371/journal.pone.0133540	http://dx.doi.org/10.1371/journal.pone.0133540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186339	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700155
J	Meissner, EG; Decalf, J; Casrouge, A; Masur, H; Kottilil, S; Albert, ML; Duffy, D				Meissner, Eric G.; Decalf, Jeremie; Casrouge, Armanda; Masur, Henry; Kottilil, Shyam; Albert, Matthew L.; Duffy, Darragh			Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; GENOTYPE 1 INFECTION; VIRUS-INFECTION; SPONTANEOUS CLEARANCE; PREDICTIVE-VALUE; ASSOCIATION; PROTEIN-10; CHEMOKINES; RIBAVIRIN; INDUCTION	Serum levels of the interferon (IFN)-stimulated chemokine CXCL10 are increased during chronic HCV infection and associate with outcome of IFN-based therapy. Elevated levels of NH2-terminal truncated CXCL10 (3-77aa), produced by DPP4 cleavage, negatively associate with spontaneous clearance of acute HCV infection and sustained virological response (SVR) with IFN-based therapy for chronic infection. The association of different CXCL10 forms and DPP4 with outcome during IFN-free HCV therapy has not been examined. Using novel Simoa assays, plasma was analyzed from HCV genotype-1 (GT1) subjects who relapsed (n = 11) or achieved SVR (n = 10) after sofosbuvir and ribavirin (SOF/RBV) treatment, and from SOF/RBV relapsers who achieved SVR with a subsequent SOF/ledipasvir regimen (n = 9). While the NH2-truncated form of CXCL10 was elevated in HCV infection relative to healthy controls, pre-treatment plasma concentrations of CXCL10 forms failed to stratify subjects based on treatment outcome to IFN-free regimens. However, a trend (statistically non-significant) towards elevated higher levels of total and long CXCL10 was observed pre-treatment in subjects who relapsed. All forms of CXCL10 decreased rapidly following treatment initiation and were again elevated in subjects who experienced HCV relapse, indicating that CXCL10 production may be associated with active viral replication. While soluble DPP4 (sDPP4) and NH2-truncated CXCL10 concentrations were highly correlated, on-treatment sDPP4 levels and activity declined more slowly than CXCL10, suggesting differential regulation.	[Meissner, Eric G.] Med Univ S Carolina, Dept Microbiol & Immunol, Div Infect Dis, Charleston, SC 29425 USA; [Meissner, Eric G.; Kottilil, Shyam] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Meissner, Eric G.; Masur, Henry] NIH, Dept Crit Care Med, Bethesda, MD 20892 USA; [Decalf, Jeremie; Casrouge, Armanda; Albert, Matthew L.; Duffy, Darragh] Inst Pasteur, Lab Dendrit Cell Immunobiol, Paris, France; [Decalf, Jeremie; Casrouge, Armanda; Albert, Matthew L.; Duffy, Darragh] INSERM, U818, Paris, France; [Kottilil, Shyam] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Albert, Matthew L.; Duffy, Darragh] Inst Pasteur, Ctr Human Immunol, Paris, France	Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); University System of Maryland; University of Maryland Baltimore; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Meissner, EG (corresponding author), Med Univ S Carolina, Dept Microbiol & Immunol, Div Infect Dis, Charleston, SC 29425 USA.	meissner@musc.edu; darragh.duffy@pasteur.fr	decalf, jeremie/AAE-2939-2020; Kottilil, Shyam/ABF-7605-2021	CASROUGE, Armanda/0000-0002-7356-0901	National Institute of Allergy and Infectious Diseases; PasteurInnov grant (Institut Pasteur); European Union [601851]; CLINICAL CENTER [ZIACL009021, ZIACL009010] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PasteurInnov grant (Institut Pasteur); European Union(European Commission); CLINICAL CENTER	This project was supported by federal funds from the intramural program of the National Institute of Allergy and Infectious Diseases, a PasteurInnov grant (Institut Pasteur), and the European Union FP7 grant PoC-HCV (GA no 601851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beinhardt S, 2012, GASTROENTEROLOGY, V142, P78, DOI 10.1053/j.gastro.2011.09.039; Brownell J, 2013, J HEPATOL, V59, P701, DOI 10.1016/j.jhep.2013.06.001; Casrouge A, 2012, CLIN EXP IMMUNOL, V167, P137, DOI 10.1111/j.1365-2249.2011.04488.x; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; Diago M, 2006, GUT, V55, P374, DOI 10.1136/gut.2005.074062; Hill A, 2014, SCIENCE, V345, P141, DOI 10.1126/science.1257737; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Larrubia JR, 2007, J HEPATOL, V47, P632, DOI 10.1016/j.jhep.2007.04.009; Martin B, 2014, J HEPATOL, V61, P538, DOI 10.1016/j.jhep.2014.05.043; Meissner EG, 2015, LIVER INT, V35, P295, DOI 10.1111/liv.12748; Meissner EG, 2014, J CLIN INVEST, V124, P3352, DOI 10.1172/JCI75938; Nguyen N, 2014, J GASTROEN HEPATOL, V29, P860, DOI 10.1111/jgh.12462; Osinusi A, 2014, ANN INTERN MED, V161, P634, DOI 10.7326/M14-1211; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Ragab D, 2013, CYTOKINE, V63, P105, DOI 10.1016/j.cyto.2013.04.016; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Riva A, 2014, HEPATOLOGY, V60, P487, DOI 10.1002/hep.27139; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423; Soderholm J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056991; Zeremski M, 2007, J VIRAL HEPATITIS, V14, P675, DOI 10.1111/j.1365-2893.2006.00838.x; Zeremski M, 2008, HEPATOLOGY, V48, P1440, DOI 10.1002/hep.22500; Zeremski M, 2011, J HEPATOL, V55, P545, DOI 10.1016/j.jhep.2010.12.033	25	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133236	10.1371/journal.pone.0133236	http://dx.doi.org/10.1371/journal.pone.0133236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181438	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198200059
J	Olanrewaju, AD; Jeffery, C; Crossland, N; Valadez, JJ				Olanrewaju, Ayobami D.; Jeffery, Caroline; Crossland, Nadine; Valadez, Joseph J.			Access to Education for Orphans and Vulnerable Children in Uganda: A Multi-District, Cross-Sectional Study Using Lot Quality Assurance Sampling from 2011 to 2013	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; LIVING ARRANGEMENTS; RURAL UGANDA; SOUTH-AFRICA; IMPACT; DIMENSIONS; HIV/AIDS; HIV	Objectives This study estimates the proportion of Orphans and Vulnerable Children (OVC) attending school in 89 districts of Uganda from 2011 - 2013 and investigates the factors influencing OVC access to education among this population. Methods This study used secondary survey data from OVCs aged 5 - 17 years, collected using Lot Quality Assurance Sampling in 87 Ugandan districts over a 3-year period (2011 - 2013). Estimates of OVC school attendance were determined for the yearly time periods. Logistic regression was used to investigate the factors influencing OVC access to education. Results 19,354 children aged 5-17 were included in the analysis. We estimated that 79.1% (95% CI: 78.5% - 79.7%) of OVCs attended school during the 3-year period. Logistic regression revealed the odds of attending school were lower among OVCs from Western (OR 0.88; 95% CI: 0.79 - 0.99) and Northern (OR 0.64; 95% CI: 0.56 - 0.73) regions compared to the Central region. Female OVCs had a significantly higher odds of attending school (OR 1.09; 95% CI: 1.02 - 1.17) compared to their male counterparts. When adjusting for all variables simultaneously, we found the odds of school attendance reduced by 12% between 2011 and 2012 among all OVCs (OR 0.88; 95% CI: 0.81 - 0.97). Conclusion Our findings reinforce the need to provide continuing support to OVC in Uganda, ensuring they have the opportunity to attain an education. The data indicate important regional and gender variation that needs to be considered for support strategies and in social policy. The results suggest the need for greater local empowerment to address the needs of OVCs. We recommend further research to understand why OVC access to education and attendance varies between regions and improvement of district level mapping of OVC access to education, and further study to understand the particular factors impacting the lower school attendance of male OVCs.	[Olanrewaju, Ayobami D.; Jeffery, Caroline; Crossland, Nadine; Valadez, Joseph J.] Univ Liverpool, Liverpool Sch Trop Med, Dept Int Publ Hlth, Monitoring & Evaluat Tech Assistance & Res Grp, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Jeffery, C (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Int Publ Hlth, Monitoring & Evaluat Tech Assistance & Res Grp, Liverpool L3 5QA, Merseyside, England.	Caroline.Jeffery@lstmed.ac.uk		Valadez, Joseph/0000-0002-6575-6592; Olanrewaju, Ayobami/0000-0003-3535-870X	American people through USAID [617-A-00-09-00006-00]	American people through USAID(United States Agency for International Development (USAID))	This work was supported by the American people through USAID under terms of the Cooperative agreement, grant number 617-A-00-09-00006-00. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abisa J., 2012, STANDARD OPERATING P; Ainsworth M., 2002, IMPACT ADULT MORTALI; Anker M, 1991, World Health Stat Q, V44, P94; [Anonymous], 2014, WASHINGTON POST; Atwine B, 2005, SOC SCI MED, V61, P555, DOI 10.1016/j.socscimed.2004.12.018; Bicego G, 2003, SOC SCI MED, V56, P1235, DOI 10.1016/S0277-9536(02)00125-9; Case A, 2004, DEMOGRAPHY, V41, P483, DOI 10.1353/dem.2004.0019; Chuong C, 2012, GLOB PUBLIC HEALTH, V7, P42, DOI 10.1080/17441692.2011.574147; Cluver L, 2007, J CHILD PSYCHOL PSYC, V48, P755, DOI 10.1111/j.1469-7610.2007.01757.x; Curley J, 2010, CHILD YOUTH SERV REV, V32, P1585, DOI 10.1016/j.childyouth.2009.07.016; DFID, 2013, SUMM DFIDS WORK UG 2; EMIS, ED SPORTS ECT FACT S; FENU, 2013, FENU ANN REP 2013 FO; France-Presse A., 2012, TIMELINE UGANDAS CIV; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Gregson S, 2003, J SOCIAL DEV AFRICA, V18, P7; Kalibala S., 2010, PROTECTING HOPE SITU; Kalibala S, 2012, PSYCHOL HEALTH MED, V17, P295, DOI 10.1080/13548506.2011.597771; Laver S, 2009, DEV OPERATIONALIZING; Machal G, 1996, IMPACT ARMED CONFLIC; Makame V, 2002, ACTA PAEDIATR, V91, P459, DOI 10.1080/080352502317371724; MFPED, 2013, MILL DEV GOALS REP U; MGLSD (Ministry of Gender Labour and Social Development), 2011, NAT STRAT PROGR PLAN; Mishra V, 2008, ORPHANS VULNERABLE C; Mishra V, 2007, AIDS EDUC PREV, V19, P383, DOI 10.1521/aeap.2007.19.5.383; Monasch R, 2004, ORPHANHOOD AND CHILD; Oleke C, 2007, AIDS CARE, V19, P361, DOI 10.1080/09540120600677987; OVCMiS, NAT OVC IND ONLINE20; Pagano M, 2010, INT J EPIDEMIOL, V39, P69, DOI 10.1093/ije/dyp406; Poverty EvansR., 2002, GENDER DEV, V10, P51, DOI DOI 10.1080/13552070215916; Pufall EL, 2014, AIDS CARE, V26, P1136, DOI 10.1080/09540121.2014.892564; Reinke WA, 1988, IND SAMPLING PLANS P; Robertson SE, 2006, SOC SCI MED, V63, P1648, DOI 10.1016/j.socscimed.2006.04.011; Robertson Susan E., 1997, World Health Statistics Quarterly, V50, P199; Robson S, 2007, EDUC RES-UK, V49, P259, DOI 10.1080/00131880701550508; Scott RS, 2008, REACHING OVC CASH TR; Shann MB M., 2013, ISRN PUBLIC HLTH, V2013, P1; Ssengonzi R, 2009, AIDS CARE, V21, P309, DOI 10.1080/09540120802183461; Ssewanyana SN, 2009, GROWTH INEQUALITY CA; Terway AD B., MOST VULNERABLE CHIL; Uganda Bureau of Statistics [UBOS] ICF International, 2012, UG DEM HLTH SURV; UNESCO, 2011, EFA GLOBAL MONITORIN; UNHCHR, 2011, DUST HAS NOT YET SET; UNICEF, 2013, MON SIT WOM CHILDR; UNICEF, 2008, ED STAT; UNICEF, 2006, AFR ORPH VULN GEN CH; *UNICEF UNAIDS USA, 2004, CHILDR BRINK 2004; Valadez JJ, 2007, ASSESSING COMMUNITY; Valadez JJ, 1991, ASSESSING CHILD SURV; Valadez JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093083; WHO. Millennium Development Goals (MDGs), 2014, MILL DEV GOALS MDGS; WorldBank, 2014, SCH ENR PRIM NET	52	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132905	10.1371/journal.pone.0132905	http://dx.doi.org/10.1371/journal.pone.0132905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RQ	26181056	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000358198200046
J	Lung, RI; Suciu, M; Gasko, N; Dumitrescu, D				Lung, Rodica Ioana; Suciu, Mihai; Gasko, Noemi; Dumitrescu, D.			Characterization and Detection of epsilon-Berge-Zhukovskii Equilibria	PLOS ONE			English	Article							NASH; COMMUNITY; BEHAVIOR; EXISTENCE; LONG	The Berge-Zhukovskii equilibrium is an alternate solution concept in non-cooperative game theory that formalizes cooperation in a noncooperative setting. In this paper, the epsilon-Berge-Zhukovskii equilibrium is introduced and characterized by using a generative relation. The generative relation also provides a solution to the problem of computing the epsilon-Berge-Zhukovskii equilibrium for large games, by using evolutionary algorithms. Numerical examples illustrate the approach and provide a possible application for this equilibrium concept.	[Lung, Rodica Ioana] Univ Babes Bolyai, Fac Econ & Business Adm, R-3400 Cluj Napoca, Romania; [Suciu, Mihai; Gasko, Noemi; Dumitrescu, D.] Univ Babes Bolyai, Fac Math & Comp Sci, R-3400 Cluj Napoca, Romania	Babes Bolyai University from Cluj; Babes Bolyai University from Cluj	Gasko, N (corresponding author), Univ Babes Bolyai, Fac Econ & Business Adm, R-3400 Cluj Napoca, Romania.	gaskonomi@cs.ubbcluj.ro	lung, rodica ioana I/C-4716-2011; Suciu, Mihai/B-4564-2014; Gaskó, Noémi/C-6210-2012	Suciu, Mihai/0000-0003-0659-4594; Gasko, Noemi/0000-0002-3915-8986; Lung, Rodica Ioana/0000-0002-5572-8141	OPEN-RES Academic Writing project [212/2012]	OPEN-RES Academic Writing project	This work was supported by OPEN-RES Academic Writing project 212/2012 (http://econ.ubbcluj.ro/similar to rodica.lung/openres/).	Abalo K, 2005, APPL MATH COMPUT, V169, P624, DOI 10.1016/j.amc.2004.09.080; Abalo KY, 2006, APPL MATH COMPUT, V182, P1840, DOI 10.1016/j.amc.2006.06.021; Berge Claude, 1957, THEORIE GEN JEUX PER; Bochet O, 2006, J ECON BEHAV ORGAN, V60, P11, DOI 10.1016/j.jebo.2003.06.006; Colman AM, 2011, J MATH PSYCHOL, V55, P166, DOI 10.1016/j.jmp.2011.02.001; Courtois P, 2015, ECON PHILOS, V31, P123, DOI 10.1017/S026626711400042X; De Jong Kenneth A., 2006, EVOLUTIONARY COMPUTA, DOI 10.1145/1274000.1274109; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Dumitrescu D, 2009, LECT NOTES COMPUT SC, V5484, P253, DOI 10.1007/978-3-642-01129-0_29; Dumitrescu D., 2009, P 11 ANN C GENETIC E, P1507; Eiben AE, 2003, INTRO EVOLUTIONARY C, DOI 10.1007/978-3-662-44874-8; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gasko N, 2011, COMPUTATIONAL INTELL; Gasko N, 2011, STUD COMPUT INTELL, V387, P149; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Larbani M, 2008, MATH SOC SCI, V55, P258, DOI 10.1016/j.mathsocsci.2007.07.004; Lung RI, 2008, INT J COMPUT COMMUN, V3, P364; Lung RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086891; Lung RI, 2011, STUD COMPUT INTELL, V387, P195; Lung RI, 2011, STUD COMPUT INTELL, V387, P121; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Muller L, 2008, J ECON BEHAV ORGAN, V67, P782, DOI 10.1016/j.jebo.2007.09.001; Murphy RO, 2006, EXP ECON, V9, P147, DOI 10.1007/s10683-006-7049-4; Musy O, 2012, INT GAME THEORY REV, V14, DOI 10.1142/S0219198912500053; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; Nessah R, 2007, APPL MATH LETT, V20, P926, DOI 10.1016/j.aml.2006.09.005; Nessah R, 2014, J MATH ANAL APPL, V414, P871, DOI 10.1016/j.jmaa.2014.01.030; RADNER R, 1980, J ECON THEORY, V22, P136, DOI 10.1016/0022-0531(80)90037-X; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Van Veldhuizen D. A., 2007, EVOLUTIONARY ALGORIT, V5; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhukovskii Vladislav I., 1994, LINEAR QUADRATIC DIF	37	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131983	10.1371/journal.pone.0131983	http://dx.doi.org/10.1371/journal.pone.0131983			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177217	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600074
J	Mundiyanapurath, S; Mohlenbruch, M; Ringleb, PA; Bosel, J; Wick, W; Bendszus, M; Radbruch, A				Mundiyanapurath, S.; Moehlenbruch, M.; Ringleb, P. A.; Boesel, J.; Wick, W.; Bendszus, M.; Radbruch, A.			Posterior Circulation Acute Stroke Prognosis Early Computed Tomography Score Using Hypointense Vessels on Susceptibility Weighted Imaging Independently Predicts Outcome in Patients with Basilar Artery Occlusion	PLOS ONE			English	Article							DIFFUSION LESION REVERSAL; MRI; THROMBOLYSIS; ANGIOGRAPHY	Purpose Appearance of hypointense vessels on susceptibility weighted imaging (SWI) has been reported to correlate with outcome in patients with ischemia of the anterior circulation. This study investigates the correlation between the appearance of hypointense vessels on SWI after recanalization therapy and outcome in patients with basilar artery occlusion. Methods Patients with basilar artery occlusion who were treated with endovascular recanalization or intravenous alteplase and received an MRI including SWI after therapy were retrieved from the hospital database for retrospective analysis. Posterior circulation Acute Stroke Prognosis Early Computed Tomography Score (pcASPECTS) was calculated based on regions displaying hypointense vessels on SWI and compared to lesions on diffusion weighted imaging (DWI). Subsequently, SWI based pcASPECTS was correlated with outcome determined with modified Rankin Scale (mRS), categorized as favorable outcome (mRS 0-2) or unfavorable outcome (3-6). Results Twenty-two MRI of patients with basilar artery occlusion were analyzed. In seven out of eight areas of the pcASPECTS hypointense vessels on SWI were significantly correlated to areas of restricted diffusion on DWI. In univariate analysis median pcASPECTS on SWI was significantly higher in patients with favorable outcome (7.5 vs. 5, p=0.02). In a multivariate analysis pcASPECTS on SWI was an independent predictor of favorable outcome (OR 2.02; CI [1.02; 3,99]; p=0.04). Conclusion pcASPECTS based on hypointense vessels on SWI after therapy predicts outcome in patients with basilar artery occlusion and might potentially be used as an additional imaging biomarker in the management of patients with stroke in the posterior circulation. This needs to be confirmed in larger prospective clinical trials.	[Mundiyanapurath, S.; Ringleb, P. A.; Boesel, J.; Wick, W.] Univ Heidelberg Hosp, Dept Neurol, Heidelberg, Germany; [Moehlenbruch, M.; Bendszus, M.; Radbruch, A.] Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany; [Radbruch, A.] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Radbruch, A (corresponding author), Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany.	a.radbruch@dkfz.de	Wick, Wolfgang/AAA-2545-2020; Radbruch, Alexander/ABA-6277-2021	Wick, Wolfgang/0000-0002-6171-634X; Radbruch, Alexander/0000-0001-6238-6525; Mundiyanapurath, Sibu/0000-0003-4637-4641				Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Kim SJ, 2010, CEREBROVASC DIS, V29, P382, DOI 10.1159/000286340; Kohrmann M, 2009, STROKE, V40, P1897, DOI 10.1161/STROKEAHA.108.532838; Labeyrie MA, 2012, STROKE, V43, P2986, DOI 10.1161/STROKEAHA.112.661009; Lescher S, 2014, AM J NEURORADIOL, V35, P1942, DOI 10.3174/ajnr.A3981; Lindsberg PJ, 2012, ANN NY ACAD SCI, V1268, P35, DOI 10.1111/j.1749-6632.2012.06687.x; Lou M, 2014, AM J NEURORADIOL, V35, P2061, DOI 10.3174/ajnr.A4017; Mattle HP, 2011, LANCET NEUROL, V10, P1002, DOI 10.1016/S1474-4422(11)70229-0; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Morita N, 2008, CEREBROVASC DIS, V26, P367, DOI 10.1159/000151640; Mucke J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120801; Nagel S, 2012, INT J STROKE, V7, P282, DOI 10.1111/j.1747-4949.2011.00705.x; Puetz V, 2008, STROKE, V39, P2485, DOI 10.1161/STROKEAHA.107.511162; Radbruch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063459; Reichenbach JR, 2001, NMR BIOMED, V14, P453, DOI 10.1002/nbm.722; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Rochon J, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-81; Santhosh K, 2009, CLIN RADIOL, V64, P74, DOI 10.1016/j.crad.2008.04.022; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Soize S, 2015, STROKE, V46, P704, DOI 10.1161/STROKEAHA.114.008322; Sun W, 2014, EUR J NEUROL, V21, P1411, DOI 10.1111/ene.12510; Tisserand M, 2014, STROKE, V45, P1167, DOI 10.1161/STROKEAHA.113.004000; Xia S, 2014, MAGN RESON IMAGING, V32, P1272, DOI 10.1016/j.mri.2014.08.012	23	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132587	10.1371/journal.pone.0132587	http://dx.doi.org/10.1371/journal.pone.0132587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176682	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600128
J	Rogowski, I; Creveaux, T; Triquigneaux, S; Mace, P; Gauthier, F; Sevrez, V				Rogowski, Isabelle; Creveaux, Thomas; Triquigneaux, Sylvain; Mace, Pierre; Gauthier, Fabien; Sevrez, Violaine			Tennis Racket Vibrations and Shock Transmission to the Wrist during Forehand Drive	PLOS ONE			English	Article							DAMPERS; IMPACTS; FOREARM; PERFORMANCE	This study aimed to investigate the effects of two different racket models and two different forehand drive velocities on the three-dimensional vibration behavior of the racket and shock transmission to the player's wrist under real playing conditions. Nine tennis players performed a series of crosscourt flat forehand drives at two velocities, using a lightly and a highly vibrant racket. Two accelerometers were fixed on the racket frame and the player's wrist. The analysis of vibration signals in both time and frequency domains showed no interaction effect of velocity and racket conditions either on the racket vibration behavior or on shock transmission. An increase in playing velocity enlarged the amount of vibrations at the racket and wrist, but weakly altered their frequency content. As compared to a racket perceived as highly vibrating, a racket perceived as lightly vibrating damped longer in the out-of-plane axis of the racket and shorter on the other axis of the racket and on the wrist, and displayed a lower amount of energy in the high frequency of the vibration signal at the racket and wrist. These findings indicated that the playing velocity must be controlled when investigating the vibration loads due to the racket under real playing conditions. Similarly, a reduced perception of vibration by the tennis player would be linked to decreased amplitude of the racket vibration signal, which may concentrate the signal energy in the low frequencies.	[Rogowski, Isabelle; Creveaux, Thomas; Sevrez, Violaine] Univ Lyon 1, Ctr Rech & Innovat Sport, EA 647, UFRSTAPS, F-69622 Villeurbanne, France; [Triquigneaux, Sylvain; Mace, Pierre; Gauthier, Fabien] Babolat VS, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Rogowski, I (corresponding author), Univ Lyon 1, Ctr Rech & Innovat Sport, EA 647, UFRSTAPS, F-69622 Villeurbanne, France.	isabelle.rogowski@univ-lyon1.fr		SEVREZ, Violaine/0000-0003-4697-3468	Agence Nationale pour la Recherche; "Pole de Competitivite Sporaltec" [ANR ACE] [2010-BLANC-901]; Babolat VS	Agence Nationale pour la Recherche(French National Research Agency (ANR)); "Pole de Competitivite Sporaltec" [ANR ACE](French National Research Agency (ANR)); Babolat VS	This work was funded by Agence Nationale pour la Recherche (www.agence-nationale-recherche.fr). Additional support was received from the "Pole de Competitivite Sporaltec" [ANR ACE no 2010-BLANC-901]. Co-authors Sylvain Triquigneaux, Pierre Mace and Fabien Gauthier are employed by Babolat VS. Babolat VS provided support in the form of salaries for authors ST, PM and FG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Banwell G, 2012, TOPICS MOD ANAL, V6, P649; BRODY H, 1989, INT J SPORT BIOMECH, V5, P451, DOI 10.1123/ijsb.5.4.451; BRODY H, 1987, INT J SPORT BIOMECH, V3, P293, DOI 10.1123/ijsb.3.3.293; Creveaux T, 2014, COMPUT METHOD BIOMEC, V17, P150, DOI 10.1080/10255842.2014.931610; CROSS R, 1998, SPORTS ENG, V1, P63, DOI DOI 10.1046/J.1460-2687.1999.00011.X; Ferrara L, 2013, PROCEDIA ENGINEER, V60, P397, DOI 10.1016/j.proeng.2013.07.015; Genevois C, 2013, J STRENGTH COND RES, V27, P677, DOI 10.1519/JSC.0b013e31825c3290; HENNIG EM, 1992, MED SCI SPORT EXER, V24, P1134; Hennig EM, 2007, EXERC SPORT SCI REV, V35, P62; Howell DC, 2013, STAT METHOD PSYCHOL, P457; KNUDSON DV, 1991, J SPORT MED PHYS FIT, V31, P527; Li FX, 2004, J SPORT SCI, V22, P1041, DOI 10.1080/02640410410001729982; Nass D, 1998, P 16 INT S BIOM SPOR, P229; Sarvazyan A, 2014, MED HYPOTHESES, V83, P6, DOI 10.1016/j.mehy.2014.04.020; Stroede CL, 1999, J SPORT SCI, V17, P379, DOI 10.1080/026404199365894; Timme N, 2009, J ACOUST SOC AM, V125, P3650, DOI 10.1121/1.3126343; Wei SH, 2006, CLIN J SPORT MED, V16, P129, DOI 10.1097/00042752-200603000-00008	17	9	10	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132925	10.1371/journal.pone.0132925	http://dx.doi.org/10.1371/journal.pone.0132925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177373	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600181
J	Segev, U; Kigel, J; Lubin, Y; Tielborger, K				Segev, Udi; Kigel, Jaime; Lubin, Yael; Tielboerger, Katja			Ant Abundance along a Productivity Gradient: Addressing Two Conflicting Hypotheses	PLOS ONE			English	Article							SPECIES-ENERGY RELATIONSHIPS; BODY-SIZE; FUNCTIONAL-GROUPS; COLONY SIZE; DESERT ANT; COMMUNITIES; PATTERNS; ORGANIZATION; COMPETITION; MASS	The number of individuals within a population or community and their body size can be associated with changes in resource supply. While these relationships may provide a key to better understand the role of abiotic vs. biotic constraints in animal communities, little is known about the way size and abundance of organisms change along resource gradients. Here, we studied this interplay in ants, addressing two hypotheses with opposite predictions regarding variation in population densities along resource gradients-the 'productivity hypothesis' and the 'productivity-based thinning hypothesis'. The hypotheses were tested in two functional groups of ground-dwelling ants that are directly primary consumers feeding on seeds: specialized seed-eaters and generalist species. We examined variations in colony density and foraging activity (a size measurement of the forager caste) in six ant assemblages along a steep productivity gradient in a semi-arid region, where precipitation and plant biomass vary 6-fold over a distance of 250km. An increase in the density or foraging activity of ant colonies along productivity gradients is also likely to affect competitive interactions among colonies, and consequently clinal changes in competition intensity were also examined. Ant foraging activity increased with productivity for both functional groups. However, colony density revealed opposing patterns: it increased with productivity for the specialized seed-eaters, but decreased for the generalist species. Competition intensity, evaluated by spatial partitioning of species at food baits and distribution of colonies, was uncorrelated with productivity in the specialized seed-eaters, but decreased with increasing productivity in the generalists. Our results provide support for two contrasting hypotheses regarding the effect of resource availability on the abundance of colonial organisms-the 'productivity hypothesis' for specialized seed-eaters and the 'productivity-based thinning hypothesis' for generalist species. These results also stress the importance of considering the role of functional groups in studies of community structure.	[Segev, Udi; Kigel, Jaime] Hebrew Univ Jerusalem, Inst Plant Sci, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Lubin, Yael] Ben Gurion Univ Negev, Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel; [Tielboerger, Katja] Univ Tubingen, Dept Plant Ecol, Tubingen, Germany	Hebrew University of Jerusalem; Ben Gurion University; Eberhard Karls University of Tubingen	Segev, U (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Mainz, Germany.	udi.segev@mail.huji.ac.il	Lubin, Yael D/F-1382-2012	Lubin, Yael D/0000-0003-3876-1668	German Federal Ministry of Education and Research (BMBF); Deutsche Forschungsgemeinschaft; University of Tubingen	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Tubingen	This study is part of the GLOWA Jordan River project, funded by the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The publication fee for this paper was partially supported by the Deutsche Forschungsgemeinschaft and the Open Access Publishing Fund of the University of Tubingen.	Aava B, 2001, OIKOS, V93, P205, DOI 10.1034/j.1600-0706.2001.930204.x; ADAMS ES, 1990, ANIM BEHAV, V39, P321, DOI 10.1016/S0003-3472(05)80877-2; Adler FR, 2007, AM NAT, V169, P323, DOI 10.1086/510759; Adler FR, 2003, AM NAT, V162, P529, DOI 10.1086/378856; Andersen AN, 1997, J BIOGEOGR, V24, P433, DOI 10.1111/j.1365-2699.1997.00137.x; ANDERSEN AN, 1995, J BIOGEOGR, V22, P15, DOI 10.2307/2846070; [Anonymous], 1971, INSECT SOC; Arnan X, 2011, OECOLOGIA, V166, P783, DOI 10.1007/s00442-011-1919-y; Avgar T, 2008, ECOL LETT, V11, P224, DOI 10.1111/j.1461-0248.2007.01140.x; BERGMAN E, 1991, CAN J FISH AQUAT SCI, V48, P536, DOI 10.1139/f91-068; Blackburn TM, 1999, ADV ECOL RES, V28, P181, DOI 10.1016/S0065-2504(08)60033-1; Brown J. H., 1995, MACROECOLOGY; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown William L. Jr, 2000, P45; Buckley LB, 2008, ECOLOGY, V89, P48, DOI 10.1890/07-0845.1; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; CRIST TO, 1992, ECOLOGY, V73, P1768, DOI 10.2307/1940028; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; DAVIDSON DW, 1977, ECOLOGY, V58, P725, DOI 10.2307/1936209; DESLIPPE RJ, 1994, J ANIM ECOL, V63, P756, DOI 10.2307/5253; DESLIPPE RJ, 1995, OIKOS, V72, P67, DOI 10.2307/3546039; Dunn RR, 2009, ECOL LETT, V12, P324, DOI 10.1111/j.1461-0248.2009.01291.x; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Ferguson-Gow H, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1411; Geraghty Melissa J., 2007, Myrmecological News, V10, P51; Golodets C, 2013, CLIMATIC CHANGE, V119, P785, DOI 10.1007/s10584-013-0758-8; Gordon DM, 2008, BEHAV ECOL, V19, P217, DOI 10.1093/beheco/arm125; Gotelli N.J., 2005, ECOSIM NULL MODELS S; Gotelli NJ, 2010, P NATL ACAD SCI USA, V107, P5030, DOI 10.1073/pnas.0914089107; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Holldobler B., 1990, pi; Holway DA, 2001, ANIM BEHAV, V61, P1181, DOI 10.1006/anbe.2000.1698; Hurlbert AH, 2004, ECOL LETT, V7, P714, DOI 10.1111/j.1461-0248.2004.00630.x; Huston MA, 2011, ECOL MONOGR, V81, P349, DOI 10.1890/10-1523.1; Kaspari M, 2005, P NATL ACAD SCI USA, V102, P5079, DOI 10.1073/pnas.0407827102; Kaspari M, 2000, P ROY SOC B-BIOL SCI, V267, P485, DOI 10.1098/rspb.2000.1026; Kaspari M, 2012, ECOGRAPHY, V35, P65, DOI 10.1111/j.1600-0587.2011.06971.x; King JR, 2010, ECOL ENTOMOL, V35, P287, DOI 10.1111/j.1365-2311.2010.01177.x; Kugler J, 1989, PLANTS ANIMALS LAND, V3; Meehan TD, 2004, ECOL LETT, V7, P532, DOI 10.1111/j.1461-0248.2004.00611.x; Ofer Y., 2000, LETS GO ANT; Olson VA, 2009, ECOL LETT, V12, P249, DOI 10.1111/j.1461-0248.2009.01281.x; Oster G.F., 1978, Monographs in Population Biology, pi; Palmer TM, 2004, ANIM BEHAV, V68, P993, DOI 10.1016/j.anbehav.2004.02.005; Ricklefs R.E., 1993, J EVOLUTION BIOL, DOI DOI 10.1046/J.1420-9101.1993.6020171.X; Rosenzweig Michael L., 1993, P52; ROSENZWEIG ML, 1968, AM NAT, V102, P67, DOI 10.1086/282523; RYTI RT, 1986, OECOLOGIA, V69, P446, DOI 10.1007/BF00377067; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x; Sanders NJ, 2003, ECOLOGY, V84, P1024, DOI 10.1890/0012-9658(2003)084[1024:RIATOO]2.0.CO;2; Sanders NJ, 2002, INSECT SOC, V49, P371, DOI 10.1007/PL00012661; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Segev U, 2014, ECOL ENTOMOL, V39, P427, DOI 10.1111/een.12115; Segev U, 2012, BEHAV ECOL SOCIOBIOL, V66, P623, DOI 10.1007/s00265-011-1310-3; Segev U, 2010, J ARID ENVIRON, V74, P646, DOI 10.1016/j.jaridenv.2009.11.001; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; STEINBERGER Y, 1992, J ARID ENVIRON, V23, P169, DOI 10.1016/S0140-1963(18)30528-7; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; TSCHINKEL WR, 1995, J ANIM ECOL, V64, P473, DOI 10.2307/5650; Tschinkel WR, 2006, FIRE ANTS; WELDEN CW, 1986, Q REV BIOL, V61, P23, DOI 10.1086/414724; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109	65	5	5	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131314	10.1371/journal.pone.0131314	http://dx.doi.org/10.1371/journal.pone.0131314			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176853	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600040
J	Vassbakk-Brovold, K; Berntsen, S; Fegran, L; Lian, H; Mjaland, O; Mjaland, S; Seiler, S; Kersten, C				Vassbakk-Brovold, Karianne; Berntsen, Sveinung; Fegran, Liv; Lian, Henrik; Mjaland, Odd; Mjaland, Svein; Seiler, Stephen; Kersten, Christian			Individualized Comprehensive Lifestyle Intervention in Patients Undergoing Chemotherapy with Curative or Palliative Intent: Who Participates?	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CANCER-PATIENTS; BREAST; CARE	Objective Knowledge about determinants of participation in lifestyle interventions in cancer patients undergoing chemotherapy, particularly with palliative intent, remains poor. The objective of the present study was to identify determinants of participating in a 12 month individualized, comprehensive lifestyle intervention, focusing on diet, physical activity, mental stress and smoking cessation, in cancer patients receiving chemotherapy with curative or palliative intent. The secondary objective was to identify participation determinants 4 months into the study. Methods Newly diagnosed cancer patients starting chemotherapy at the cancer center in Kristiansand/Norway (during a 16 month inclusion period) were screened. Demographic and medical data (age, sex, body mass index, education level, marital status, smoking status, Eastern Cooperative Oncology Group performance status (ECOG), diagnosis, tumor stage and treatment intention) was analyzed for screened patients. Results 100 of 161 invited patients participated. There were more females (69 vs. 48%; P = 0.004), breast cancer patients (46 vs. 25%; P = 0.007), non-smokers (87 vs. 74%; P = 0.041), younger (mean age 60 vs. 67 yrs; P < 0.001) and fitter (82 vs. 64% with EGOC 0; P = 0.036) participants vs. non-participants included. In multivariate logistic regression analyses, age (Odds Ratio 0.94, 95% Confidence Interval 0.91, 0.97) and smoking (0.42, 0.18, 0.99) were negatively associated with participation. After 4 months, 63 participants were still participating. Cancer type, smoking and age increased the probability of dropping out. Multivariate logistic regression revealed that age was the only significant determinant of 4 month participation (0.95, 0.91, 0.99). Patients aged > 70 years were less likely to participate at baseline and 4 months. Conclusion Individualized lifestyle interventions in cancer patients undergoing chemotherapy appear to facilitate a high participation rate that declines with increasing age; both during the enrollment process and completing the intervention. Neither oncologic nor socioeconomic variables deterred participation.	[Vassbakk-Brovold, Karianne; Mjaland, Svein; Kersten, Christian] Southern Hosp Trust, Dept Oncol, Kristiansand, Norway; [Vassbakk-Brovold, Karianne; Berntsen, Sveinung; Seiler, Stephen] Univ Agder, Fac Hlth Sport Sci, Dept Publ Hlth Sport & Nutr, Kristiansand, Norway; [Fegran, Liv] Univ Agder, Fac Hlth & Sport Sci, Dept Hlth & Nursing Sci, Kristiansand, Norway; [Lian, Henrik] Southern Hosp Trust, Dept Phys Med & Prevent, Kristiansand, Norway; [Mjaland, Odd] Southern Hosp Trust, Dept Surg, Kristiansand, Norway	University of Agder; University of Agder	Vassbakk-Brovold, K (corresponding author), Southern Hosp Trust, Dept Oncol, Kristiansand, Norway.	karianne.vassbakk.brovold@sshf.no	fegran, liv/AAW-2160-2020	Fegran, Liv/0000-0001-5470-8686	Oddrun Mjaland Foundation for Cancer Research	Oddrun Mjaland Foundation for Cancer Research	The salary of the PhD-student was funded by the Oddrun Mjaland Foundation for Cancer Research (KVB). Grant number or URL to funders website is NA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamsen L, 2006, SUPPORT CARE CANCER, V14, P116, DOI 10.1007/s00520-005-0864-x; Adamsen L, 2009, BMJ, V339; Brubaker PH, 2014, CURR GERIATR REP, V3, P291, DOI 10.1007/s13670-014-0104-7; Buffart LM, 2014, CANCER TREAT REV, V40, P327, DOI 10.1016/j.ctrv.2013.06.007; Cancer Registry of Norway, 2013, CANC NORW 2011 CANC; Courneya K, 2008, INT J BEHAV NUTR PHY, V5; Courneya KS, 2008, MED SCI SPORT EXER, V40, P1180, DOI 10.1249/MSS.0b013e318168da45; Courneya KS, 2008, ANN BEHAV MED, V35, P116, DOI 10.1007/s12160-007-9009-4; Courneya KS, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0085-0; Courneya KS, 2015, RES Q EXERC SPORTS, P1; DiaGraphIT AS-Clinical monitoring software, 2012, DIAGRAPHIT AS CLIN M; George SM, 2011, CANCER CAUSE CONTROL, V22, P589, DOI 10.1007/s10552-011-9732-9; Gibson TM, 2010, SEMIN ONCOL, V37, P282, DOI 10.1053/j.seminoncol.2010.05.011; Helsedirektoratet (The Norwegian Directorate of Health), 2011, KOSTR FREMM FOLK FOR; Helsedirektoratet (The Norwegian Directorate of Health), 2012, HELS PLAN SYST KUNNS; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Husebo AML, 2013, J CLIN NURS, V22, P4, DOI 10.1111/j.1365-2702.2012.04322.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim HS, 2002, CANCER NURS, V25, P425, DOI 10.1097/00002820-200212000-00004; Kreftregisteret (Cancer Registry of Norway), 2014, FAKT OM KREFT; Lutgendorf SK, 2010, J CLIN ONCOL, V28, P4094, DOI 10.1200/JCO.2009.26.9357; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; Midtgaard M, 2009, EUR J ONCOL NURS, V13, P116, DOI 10.1016/j.ejon.2009.01.006; Moller T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003556; NIoP Health, 2010, SMOK SMOK TOB NORW F; Nordin K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-167; Oldervoll Line M, 2005, Palliat Support Care, V3, P281; Oldervoll LM, 2006, J PAIN SYMPTOM MANAG, V31, P421, DOI 10.1016/j.jpainsymman.2005.10.004; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Pekmezi DW, 2011, ACTA ONCOL, V50, P167, DOI 10.3109/0284186X.2010.529822; Rock Cheryl L, 2012, CA Cancer J Clin, V62, P243, DOI 10.3322/caac.21142; Rubin H, 2013, P NATL ACAD SCI USA, V110, P13927, DOI 10.1073/pnas.1312831110; Sallis J F, 1990, Exerc Sport Sci Rev, V18, P307; Schulz MD, 2014, NATURE, V514, P508, DOI 10.1038/nature13398; Shiels MS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju294; Thomsen TG, 2010, J CLIN NURS, V19, P3410, DOI 10.1111/j.1365-2702.2009.03154.x; Tsianakas V, 2012, SUPPORT CARE CANCER, V20, P2639, DOI 10.1007/s00520-012-1470-3; Voerman B, 2007, PSYCHO-ONCOL, V16, P1092, DOI 10.1002/pon.1160; WHO, 2014, OB OV	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131355	10.1371/journal.pone.0131355	http://dx.doi.org/10.1371/journal.pone.0131355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26176950	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600041
J	Wormsbecker, AE; Wang, J; Rosella, LC; Kwong, JC; Seo, CY; Crowcroft, NS; Deeks, SL				Wormsbecker, Anne E.; Wang, Jun; Rosella, Laura C.; Kwong, Jeffrey C.; Seo, Chi Yon; Crowcroft, Natasha S.; Deeks, Shelley L.			Twenty Years of Medically-Attended Pediatric Varicella and Herpes Zoster in Ontario, Canada: A Population-Based Study	PLOS ONE			English	Article							VACCINATION PROGRAM; ACTIVE SURVEILLANCE; CARE OUTCOMES; UNITED-STATES; CHILDREN; EPIDEMIOLOGY; IMPACT; HOSPITALIZATIONS; IMPLEMENTATION; ADOLESCENTS	Objective To determine if reductions in medically-attended pediatric varicella and herpes zoster occurred in Ontario, Canada, after publicly-funded varicella immunization was implemented in 2004. Methods For fiscal years (FY) 1992-2011, we examined data on varicella and herpes zoster physician office visits, emergency department (ED) visits, hospitalizations (including for varicella-associated skin and soft tissue infections [SSTI]), and intensive care unit (ICU) admissions, among those aged < 18 years. The pre-vaccine, privately-available, and vaccine program eras were FY1992-1998, FY1999-2003, and FY2004-2011, respectively. We used Poisson regression and Kruskal-Wallis tests (all at the p<0.05 level of significance), and compared rates using incidence rate ratios (IRRs) and 95% confidence intervals (CIs). Results Incidence of varicella office visits declined over the study period from a high of 25.1/1,000 in FY1994 to a low of 3.2/1,000 in FY2011. ED visits and hospitalizations followed similar patterns of decreasing rates later in the study period. IRRs comparing the vaccine program versus pre-vaccine eras were 0.29 (95% CI: 0.26-0.32) for office visits, 0.29 (95% CI: 0.21-0.40) for ED visits, and 0.41 (95% CI: 0.10-1.69) for hospitalizations. Annual declines in varicella office visits were 7.7%, 9.1%, 8.4%, and 8.4% per year among children aged < 1 year, 1-4 years, 5-11 years, and >= 12 years, respectively (all p< 0.001). Age-specific rates of varicella-associated SSTI declined significantly among children < 12 years (p< 0.001) and rates of ICU admissions decreased significantly for children < 1 year (p = 0.02). (p<0.001) over the study period. For children aged 5-17 years, herpes zoster office visits decreased whereas ED visits increased (both p<0.001) and there was a small, non-significant (p = 0.07), decrease in hospitalizations. Conclusion Medically-attended varicella decreased during the study period, particularly since varicella vaccine was publicly-funded. Results suggest immunization program-related changes in varicella epidemiology, including herd effects, demonstrated by reductions in varicella in program-ineligible age groups. We did not observe a consistent impact on herpes zoster.	[Wormsbecker, Anne E.; Wang, Jun; Rosella, Laura C.; Kwong, Jeffrey C.; Seo, Chi Yon; Crowcroft, Natasha S.; Deeks, Shelley L.] Publ Hlth Ontario, Toronto, ON, Canada; [Wormsbecker, Anne E.] Hosp Sick Children, Div Paediat Med, Toronto, ON M5G 1X8, Canada; [Rosella, Laura C.; Kwong, Jeffrey C.; Crowcroft, Natasha S.; Deeks, Shelley L.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rosella, Laura C.; Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Deeks, SL (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.	shelley.deeks@oahpp.ca			Public Health Ontario	Public Health Ontario	Public Health Ontario provided the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI), 2010, ACS8 NACI, V36; Baxter R, 2013, PEDIATRICS, V131, pE1389, DOI 10.1542/peds.2012-3303; Chaves SS, 2011, PEDIATRICS, V128, P1071, DOI 10.1542/peds.2011-0017; Civen R, 2009, PEDIATR INFECT DIS J, V28, P954, DOI 10.1097/INF.0b013e3181a90b16; Eneli I, 2007, J PEDIATR-US, V151, P79, DOI 10.1016/j.jpeds.2007.02.019; French B, 2008, STAT MED, V27, P5005, DOI 10.1002/sim.3340; Galil K, 2002, NEW ENGL J MED, V347, P1909, DOI 10.1056/NEJMoa021662; Gil-Prieto R, 2014, VACCINE, V32, P7043, DOI 10.1016/j.vaccine.2014.10.076; Goldman GS, 2013, VACCINE, V31, P1680, DOI 10.1016/j.vaccine.2012.05.050; GUESS HA, 1985, PEDIATRICS, V76, P512; Guris D, 2008, J INFECT DIS, V197, pS71, DOI 10.1086/522156; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; Juurlink D, 2006, CANADIAN I HLTH INFO; Kwong JC, 2008, VACCINE, V26, P6006, DOI 10.1016/j.vaccine.2008.08.016; Lopez AS, 2006, PEDIATRICS, V117, pE1070, DOI 10.1542/peds.2005-2085; Marshall HS, 2013, PEDIATR INFECT DIS J, V32, P530, DOI 10.1097/INF.0b013e31827e92b7; Ontario Agency for Health Protection and Promotion, 2014, IMM COV REP SCH PUP; Ontario Ministry Health and Long-Term Care Corporate Services Division Supply Chain and Facilities Branch Ontario Government Pharmaceutical and Medical Supply Service, COMP ASS MAT MAN SYS; Pierik JGJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-110; Russell ML, 2014, VACCINE, V32, P6319, DOI 10.1016/j.vaccine.2013.09.018; Scales DC, 2006, J CLIN EPIDEMIOL, V59, P802, DOI 10.1016/j.jclinepi.2005.11.015; Scales DC, 2008, CRIT CARE, V12, DOI 10.1186/cc6923; Seo CY, 2013, ONT PUBL HLTH C APR; Seward JF, 2008, J INFECT DIS, V197, pS82, DOI 10.1086/522145; Statistics Canada, 2013, POP EST POP PROJ; Tan B, 2012, PEDIATR INFECT DIS J, V31, P956, DOI 10.1097/INF.0b013e318260cc4d; Tanuseputro P, 2011, VACCINE, V29, P8580, DOI 10.1016/j.vaccine.2011.09.024; Waye A, 2013, VACCINE, V31, P4744, DOI 10.1016/j.vaccine.2013.08.022	28	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0129483	10.1371/journal.pone.0129483	http://dx.doi.org/10.1371/journal.pone.0129483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177077	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600013
J	Fiset, C; Rioux, FM; Surette, ME; Fiset, S				Fiset, Catherine; Rioux, France M.; Surette, Marc E.; Fiset, Sylvain			Prenatal Iron Deficiency in Guinea Pigs Increases Locomotor Activity but Does Not Influence Learning and Memory	PLOS ONE			English	Article							ESSENTIAL FATTY-ACID; MORRIS WATER MAZE; BRAIN IRON; EICOSANOID METABOLISM; MONOAMINE METABOLISM; COGNITIVE DEFICITS; MATERNAL ANEMIA; SPATIAL MEMORY; MALE RATS; BEHAVIOR	The objective of the current study was to determine whether prenatal iron deficiency induced during gestation in guinea pigs affected locomotor activity and learning and memory processes in the progeny. Dams were fed either iron-deficient anemic or iron-sufficient diets throughout gestation and lactation. After weaning, all pups were fed an iron-sufficient diet. On postnatal day 24 and 40, the pups' locomotor activity was observed within an open-field test, and from postnatal day 25 to 40, their learning and memory processes were assessed within a Morris Water Maze. The behavioural and cognitive tests revealed that the iron deficient pup group had increased locomotor activity, but solely on postnatal day 40, and that there were no group differences in the Morris Water Maze. In the general discussion, we propose that prenatal iron deficiency induces an increase in nervousness due to anxiety in the progeny, which, in the current study, resulted in an increase of locomotor activity.	[Fiset, Catherine; Rioux, France M.] Univ Ottawa, Fac Sci Sante, Programme Nutr, Ottawa, ON, Canada; [Surette, Marc E.] Univ Moncton, Dept Chim & Biochim, Moncton, NB E1A 3E9, Canada; [Fiset, Sylvain] Univ Moncton, Secteur Sci Humaines, Edmundston, NB, Canada	University of Ottawa; University of Moncton; University of Moncton	Fiset, S (corresponding author), Univ Moncton, Secteur Sci Humaines, Campus Edmundston, Edmundston, NB, Canada.	sylvain.fiset@umoncton.ca	Fiset, Sylvain/J-5550-2019; Surette, Marc/AAW-1078-2021	Fiset, Sylvain/0000-0002-9173-8304; Fiset, Catherine/0000-0001-5593-4538	Canadian Institutes of Health Research [ME-298]; Corsortium National de Formation en Sante; Canada Research Chairs Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Corsortium National de Formation en Sante; Canada Research Chairs Program(Canada Research Chairs)	This study was supported by two research grants, one from the Canadian Institutes of Health Research (no. ME-298) [http://www.cihr-irsc.gc.ca] and another from the Corsortium National de Formation en Sante [http://cnfs.net/fr/]. M.E. Surette was also supported by the Canada Research Chairs Program [http://www.chairs-chaires.gc.ca].	[Anonymous], 2001, IRON DEFICIENCY ANAE; Baumgartner J, 2012, J NUTR, V142, P1472, DOI 10.3945/jn.111.156299; Baumgartner J, 2012, J NUTR, V142, P1463, DOI 10.3945/jn.111.156281; BHARGAVA M, 1991, J TROP PEDIATRICS, V37, P149, DOI 10.1093/tropej/37.4.149; Bourque SL, 2008, J NUTR, V138, P931, DOI 10.1093/jn/138.5.931; Briscoe TA, 2004, AM J OBSTET GYNECOL, V191, P847, DOI 10.1016/j.ajog.2004.01.050; Cesario J, 2014, PERSPECT PSYCHOL SCI, V9, P40, DOI 10.1177/1745691613513470; Chang SY, 2013, PEDIATRICS, V131, pE755, DOI 10.1542/peds.2011-3513; Daumas F, 1982, REV STAT APPL, V30, P23; deAndraca I, 1997, NUTR REV, V55, P125, DOI 10.1111/j.1753-4887.1997.tb06463.x; DOBBING J, 1970, BRAIN RES, V17, P115, DOI 10.1016/0006-8993(70)90311-2; Dringenberg HC, 2001, BEHAV BRAIN RES, V124, P97, DOI 10.1016/S0166-4328(01)00188-7; Erikson KM, 1997, J NUTR, V127, P2030, DOI 10.1093/jn/127.10.2030; Eseh R, 2005, BEHAV BRAIN RES, V164, P214, DOI 10.1016/j.bbr.2005.06.019; Felt BT, 2006, BEHAV BRAIN RES, V171, P261, DOI 10.1016/j.bbr.2006.04.001; Fu JY, 2012, BIOL TRACE ELEM RES, V149, P412, DOI 10.1007/s12011-012-9447-0; Gambling L, 2003, J NUTR, V133, p1554S, DOI 10.1093/jn/133.5.1554S; Girbovan C, 2009, NEUROBEHAVIOURAL PRO; Golub MS, 2006, AM J CLIN NUTR, V83, P647, DOI 10.1093/ajcn.83.3.647; Golub MS, 2006, NEUROTOXICOL TERATOL, V28, P3, DOI 10.1016/j.ntt.2005.10.005; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Graziano A, 2003, J NEUROSCI METH, V130, P33, DOI 10.1016/S0165-0270(03)00187-0; Harper LV, 1976, BIOL GUINEA PIG, P31, DOI DOI 10.1016/B978-0-12-730050-4.50010-7; Harvey L, 2014, BRAIN BEHAV IMMUN, V40, P27, DOI 10.1016/j.bbi.2014.06.005; Harvey L, 2014, BRAIN BEHAV IMMUN, V35, P144, DOI 10.1016/j.bbi.2013.09.009; Howell D.C., 2016, FUNDAMENTAL STAT BEH; IDJRADINATA P, 1993, LANCET, V341, P1, DOI 10.1016/0140-6736(93)92477-B; Jougleux JL, 2014, NUTR NEUROSCI, V17, P37, DOI 10.1179/1476830513Y.0000000067; Jougleux JL, 2011, J NUTR, V141, P1390, DOI 10.3945/jn.110.135715; Jougleux JL, 2014, NUTR NEUROSCI, DOI 10.1179.1476830514y.0000000140; Kwik-Uribe CL, 1999, NEUROTOXICOL TERATOL, V21, P661, DOI 10.1016/S0892-0362(99)00041-0; Kwik-Uribe CL, 2000, J NUTR, V130, P2040, DOI 10.1093/jn/130.8.2040; Leblanc CP, 2009, PROSTAG LEUKOTR ESS, V81, P1, DOI 10.1016/j.plefa.2009.05.023; LeBlanc CP, 2009, J NUTR, V139, P1653, DOI 10.3945/jn.109.106013; LIN JJ, 1968, PSYCHOL REP, V22, P431, DOI 10.2466/pr0.1968.22.2.431; LINDNER MD, 1992, BEHAV NEURAL BIOL, V58, P94, DOI 10.1016/0163-1047(92)90303-L; Lindner MD, 1997, NEUROBIOL LEARN MEM, V68, P203, DOI 10.1006/nlme.1997.3782; LINDNER MD, 1991, BEHAV BRAIN RES, V45, P45, DOI 10.1016/S0166-4328(05)80179-2; LOZOFF B, 1991, NEW ENGL J MED, V325, P687, DOI 10.1056/NEJM199109053251004; Lozoff B, 2000, PEDIATR RES, V48, P137, DOI 10.1203/00006450-200008000-00003; Lozoff B, 2007, FOOD NUTR BULL, V28, pS560, DOI 10.1177/15648265070284S409; Lozoff Betsy, 2006, Semin Pediatr Neurol, V13, P158, DOI 10.1016/j.spen.2006.08.004; MACDONALD VW, 1985, J LAB CLIN MED, V105, P11; McCann JC, 2007, AM J CLIN NUTR, V85, P931, DOI 10.1093/ajcn/85.4.931; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Nutrition SOLA Nutrition COA Agriculture BO Council NR, 1995, NUTR REQ LAB ANIM; Nyaradi A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00097; Olfert ED, 1993, GUIDE CARE USE EXPT, V1; Park LM, 2013, THESIS U KANSAS; Pinero DJ, 2001, J NUTR, V131, P311, DOI 10.1093/jn/131.2.311; POLLITT E, 1993, ANNU REV NUTR, V13, P521, DOI 10.1146/annurev.nu.13.070193.002513; Rodriguez A, 2004, Proceedings of the Fourth IASTED International Conference on Visualization, Imaging, and Image Processing, P647; Roncagliolo M, 1998, AM J CLIN NUTR, V68, P683, DOI 10.1093/ajcn/68.3.683; Rood J.P., 1972, Animal Behav Monogr, V5, P1; Russell JF, 2013, NATURE, V496, P7, DOI 10.1038/496007a; Rytych JL, 2012, J NUTR, V142, P2050, DOI 10.3945/jn.112.165522; Savoie N, 2002, CAN J PUBLIC HEALTH, V93, P203, DOI 10.1007/BF03405001; SCHIML PA, 1990, J COMP PSYCHOL, V104, P283, DOI 10.1037/0735-7036.104.3.283; Shadish W. R., 2001, EXPT QUASIEXPERIMENT, V2nd; Simons DJ, 2014, PERSPECT PSYCHOL SCI, V9, P76, DOI 10.1177/1745691613514755; Singla PN, 1997, J TROP PEDIATRICS, V43, P89, DOI 10.1093/tropej/43.2.89; Spink AJ, 2001, PHYSIOL BEHAV, V73, P731, DOI 10.1016/S0031-9384(01)00530-3; Stover KR, 2012, P MEASURING BEHAV, P353; Tapiero H, 2001, BIOMED PHARMACOTHER, V55, P324, DOI 10.1016/S0753-3322(01)00067-1; Terry Jr AV, 2001, METH NE FRO NEUROSCI, P164; Tran TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074876; TOBACH E, 1966, PSYCHOL REP, V18, P415, DOI 10.2466/pr0.1966.18.2.415; Unger EL, 2012, J NUTR, V142, P2040, DOI 10.3945/jn.112.162198; VAUGHN J, 1986, J NATL MED ASSOC, V78, P963; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wachs TD, 2005, DEV PSYCHOBIOL, V46, P141, DOI 10.1002/dev.20049; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; WILLIAMSON AM, 1980, PHYSIOL BEHAV, V24, P561, DOI 10.1016/0031-9384(80)90252-8; Wolfer DP, 1998, NEWS PHYSIOL SCI, V13, P118, DOI 10.1152/physiologyonline.1998.13.3.118; YEHUDA S, 1986, PHARMACOL BIOCHEM BE, V25, P141, DOI 10.1016/0091-3057(86)90244-3; Yong E, 2012, NATURE, V485, P298, DOI 10.1038/485298a; Zipser B, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-30	79	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133168	10.1371/journal.pone.0133168	http://dx.doi.org/10.1371/journal.pone.0133168			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186713	gold, Green Submitted, Green Published			2022-12-27	WOS:000358198700104
J	Guillermet, E; Dicko, HM; Mai, LTP; N'Diaye, M; Hane, F; Ba, SO; Gomis, K; Tho, NTT; Lien, NTP; Than, PD; Van Dinh, T; Jaillard, P; Gessner, BD; Colombini, A				Guillermet, Elise; Dicko, Hamadou M.; Le Thi Phuong Mai; N'Diaye, Mamadou; Hane, Fatoumata; Ba, Seydina Ousmane; Gomis, Khadidjatou; Nguyen Thi Thi Tho; Nguyen Thi Phuong Lien; Phan Dang Than; Tran Van Dinh; Jaillard, Philippe; Gessner, Bradford D.; Colombini, Anais			Acceptability and Feasibility of Delivering Pentavalent Vaccines in a Compact, Prefilled, Autodisable Device in Vietnam and Senegal	PLOS ONE			English	Article							SAFETY; SERVICES; VACCINATIONS; IMMUNIZATION	Background Prefilled syringes are the standard in developed countries but logistic and financial barriers prevent their widespread use in developing countries. The current study evaluated use of a compact, prefilled, autodisable device (CPAD) to deliver pentavalent vaccine by field actors in Senegal and Vietnam. Methods We conducted a logistic, programmatic, and anthropological study that included a) interviews of immunization staff at different health system levels and parents attending immunization sessions; b) observation of immunization sessions including CPAD use on oranges; and c) document review. Results Respondents perceived that the CPAD would improve safety by being non-reusable and preventing needle and vaccine exposure during preparation. Preparation was considered simple and may reduce immunization time for staff and caretakers. CPAD impact on cold storage requirements depended on the current pentavalent vaccine being used; in both countries, CPAD would reduce the weight and volume of materials and safety boxes thereby potentially improving outreach strategies and waste disposal. CPAD also would reduce stock outages by bundling vaccine and syringes and reduce wastage by using a non-breakable plastic presentation. Respondents also cited potential challenges including ability to distinguish between CPAD and other pharmaceuticals delivered via a similar mechanism (such as contraceptives), safety, and concerns related to design and ease of administration (such as activation, ease of delivery, and needle diameter and length). Conclusions Compared to current pentavalent vaccine presentations in Vietnam and Senegal, CPAD technology will address some of the main barriers to vaccination, such as supply chain issues and safety concerns among health workers and families. Most of the challenges we identified can be addressed with health worker training, minor design modifications, and health messaging targeting parents and communities. Potentially the largest remaining barrier is the marginal increase in pentavalent cost - if any - from CPAD use, which we did not assess in our study.	[Guillermet, Elise; Dicko, Hamadou M.; Jaillard, Philippe; Gessner, Bradford D.; Colombini, Anais] AMP, Ferney Voltaire, France; [Le Thi Phuong Mai; Nguyen Thi Thi Tho; Nguyen Thi Phuong Lien; Phan Dang Than; Tran Van Dinh] Minist Hlth, Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [N'Diaye, Mamadou; Ba, Seydina Ousmane; Gomis, Khadidjatou] Minist Hlth, Dakar, Senegal; [Hane, Fatoumata] Univ Ziguinchor, Ziguinchor, Senegal	National Institute of Hygiene & Epidemiology (NIHE)	Gessner, BD (corresponding author), AMP, Ferney Voltaire, France.	bgessner@aamp.org	HANE, Fatoumata/GQA-9196-2022	Le, Mai/0000-0001-7581-4058; Tran, Van Dinh/0000-0001-7590-6518	Crucell	Crucell	This work was supported by Crucell. The funding source for this study had no role in the study design, data collection, data analysis, data interpretation, or writing of the article. The corresponding authors had full access to all data and had final responsibility for the decision to submit or publication.	American Academy of Pediatrics, 2012, REP COMM INF DIS; Bieslich B, 2000, SOC SCI MED, V50, P703, DOI 10.1016/S0277-9536(99)00322-6; Birungi H, 1998, SOC SCI MED, V47, P1455, DOI 10.1016/S0277-9536(98)00194-4; Centers for Disease Control and Prevention, 2012, APP D VACC ADM GUID; Clements CJ, 2004, VACCINE, V22, P2054, DOI 10.1016/j.vaccine.2004.01.008; D'Alois LA, 2004, IMPACT DELIVERY TECH; Diggle L, 2006, BMJ-BRIT MED J, V333, P571, DOI 10.1136/bmj.38906.704549.7C; Duong DV, 2004, SOC SCI MED, V59, P2585, DOI 10.1016/j.socscimed.2004.04.007; Feldman-Savelsberg P, 2000, MED ANTHROPOL Q, V14, P159, DOI 10.1525/maq.2000.14.2.159; Fleming J, 2003, INTRO TT UNIJECT MAT; Glenton C, 2013, TROP MED INT HEALTH, V18, P1002, DOI 10.1111/tmi.12126; Glenton C, 2011, TROP MED INT HEALTH, V16, P1044, DOI 10.1111/j.1365-3156.2011.02813.x; Kasi SG, 2013, PEDIAT INFECT DIS, V5, P181; Kotwal A, 2005, SOC SCI MED, V60, P1133, DOI 10.1016/j.socscimed.2004.06.044; Levine MM, 2011, VACCINE, V29, pD116, DOI 10.1016/j.vaccine.2011.11.090; Lippert WC, 2008, PEDIATRICS, V122, pE556, DOI 10.1542/peds.2008-0374; NICHTER M, 1995, SOC SCI MED, V41, P617, DOI 10.1016/0277-9536(95)00034-5; Pereira CC, 2010, EXPERT REV VACCINES, V9, P1343, DOI [10.1586/erv.10.129, 10.1586/ERV.10.129]; Quiroga R, 1998, Rev Panam Salud Publica, V4, P20; Reeler AV, 2000, B WORLD HEALTH ORGAN, V78, P135; Schaetti C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-99; Scheifele DW, 2000, CAN J PUBLIC HEALTH, V91, P329, DOI 10.1007/BF03404801; Sepehri A, 2008, SOC SCI MED, V67, P1009, DOI 10.1016/j.socscimed.2008.06.005; STEINGLASS R, 1995, B WORLD HEALTH ORGAN, V73, P57; Streefland PH, 1999, B WORLD HEALTH ORGAN, V77, P722; Streefland PH, 2001, HEALTH POLICY, V55, P159, DOI 10.1016/S0168-8510(00)00132-9; Sutanto A, 1999, B WORLD HEALTH ORGAN, V77, P119; World Health Organization, COLD CHAIN LOG TOOLS	28	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132292	10.1371/journal.pone.0132292	http://dx.doi.org/10.1371/journal.pone.0132292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186456	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700036
J	Iwao, C; Shidoji, Y				Iwao, Chieko; Shidoji, Yoshihiro			Polyunsaturated Branched-Chain Fatty Acid Geranylgeranoic Acid Induces Unfolded Protein Response in Human Hepatoma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; 2ND PRIMARY TUMORS; AUTOPHAGIC RESPONSE; INDUCED APOPTOSIS; DOWN-REGULATION; ACTIVATION; PREVENTION; PALMITATE; INDUCTION; LINE	The acyclic diterpenoid acid geranylgeranoic acid (GGA) has been reported to induce autophagic cell death in several human hepatoma-derived cell lines; however, the molecular mechanism for this remains unknown. In the present study, several diterpenoids were examined for ability to induce XBP1 splicing and/or lipotoxicity for human hepatoma cell lines. Here we show that three groups of diterpenoids emerged: 1) GGA, 2,3-dihydro GGA and 9-cis retinoic acid induce cell death and XBP1 splicing; 2) all-trans retinoic acid induces XBP1 splicing but little cell death; and 3) phytanic acid, phytenic acid and geranylgeraniol induce neither cell death nor XBP1 splicing. GGA-induced ER stress/unfolded protein response (UPR) and its lipotoxicity were both blocked by co-treatment with oleic acid. The blocking activity of oleic acid for GGA-induced XBP1 splicing was not attenuated by methylation of oleic acid. These findings strongly suggest that GGA at micromolar concentrations induces the so-called lipid-induced ER stress response/UPR, which is oleate-suppressive, and shows its lipotoxicity in human hepatoma cells.	[Iwao, Chieko; Shidoji, Yoshihiro] Nagasaki Univ, Grad Sch Human Hlth Sci, Mol & Cellular Biol, Nagasaki 852, Japan	Nagasaki University	Shidoji, Y (corresponding author), Nagasaki Univ, Grad Sch Human Hlth Sci, Mol & Cellular Biol, Nagasaki 852, Japan.	shidoji@sun.ac.jp			University of Nagasaki [B-3]	University of Nagasaki	YS has received a research grant B-3 from the University of Nagasaki (URL:sun.ac.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biden TJ, 2014, TRENDS ENDOCRIN MET, V25, P389, DOI 10.1016/j.tem.2014.02.003; Bosma M, 2014, BBA-MOL CELL BIOL L, V1841, P1648, DOI 10.1016/j.bbalip.2014.09.012; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Coto-Montes A, 2012, MOL CELL ENDOCRINOL, V361, P12, DOI 10.1016/j.mce.2012.04.009; Dhayal S, 2011, FEBS LETT, V585, P2243, DOI 10.1016/j.febslet.2011.05.045; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Honda M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-191; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kitai Y, 2013, GENES CELLS, V18, P798, DOI 10.1111/gtc.12074; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Malaviya R, 2014, TOXICOL APPL PHARM, V275, P145, DOI 10.1016/j.taap.2013.12.022; Margariti A, 2013, J BIOL CHEM, V288, P859, DOI 10.1074/jbc.M112.412783; Muto Y, 1999, NEW ENGL J MED, V340, P1046, DOI 10.1056/NEJM199904013401315; Muto Y, 1996, NEW ENGL J MED, V334, P1561, DOI 10.1056/NEJM199606133342402; NAKAMURA N, 1995, BIOCHEM BIOPH RES CO, V207, P382, DOI 10.1006/bbrc.1995.1199; Nakamura N, 1996, BIOCHEM BIOPH RES CO, V219, P100, DOI 10.1006/bbrc.1996.0188; Okamoto K, 2011, BIOCHEM J, V440, P63, DOI 10.1042/BJ20110610; Sheng R, 2012, AUTOPHAGY, V8, P310, DOI 10.4161/auto.18673; Shidoji Y, 2006, J CELL BIOCHEM, V97, P178, DOI 10.1002/jcb.20627; Shidoji Y, 2004, J LIPID RES, V45, P1092, DOI 10.1194/jlr.M300502-JLR200; Shidoji Y, 1997, BIOCHEM BIOPH RES CO, V230, P58, DOI 10.1006/bbrc.1996.5883; Shimonishi S, 2012, NUTR CANCER, V64, P473, DOI 10.1080/01635581.2012.655401; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Sommerweiss D, 2013, BIOCHEM BIOPH RES CO, V441, P770, DOI 10.1016/j.bbrc.2013.10.130; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005	28	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132761	10.1371/journal.pone.0132761	http://dx.doi.org/10.1371/journal.pone.0132761			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186544	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700061
J	Legenzov, EA; Dirda, NDA; Hagen, BM; Kao, JPY				Legenzov, Eric A.; Dirda, Nathaniel D. A.; Hagen, Brian M.; Kao, Joseph P. Y.			Synthesis and Characterization of 8-O-Carboxymethylpyranine (CM-Pyranine) as a Bright, Violet-Emitting, Fluid-Phase Fluorescent Marker in Cell Biology	PLOS ONE			English	Article							INTRACELLULAR FATE; PRACTICAL ASPECTS; ENDOCYTOSIS; LIPOSOMES; TRANSPORTERS; MECHANISM; MIGRATION; PEPTIDES; BINDING; ACID	To avoid spectral interference with common fluorophores in multicolor fluorescence microscopy, a fluid-phase tracer with excitation and emission in the violet end of the visible spectrum is desirable. CM-pyranine is easily synthesized and purified. Its excitation and emission maxima at 401.5 nm and 428.5 nm, respectively, are well suited for excitation by 405-nm diode lasers now commonly available on laser-scanning microscopes. High fluorescence quantum efficiency (Q = 0.96) and strong light absorption (epsilon(405) > 25,000 M(-1)cm(-1)) together make CM-pyranine the brightest violet aqueous tracer. The fluorescence spectrum of CM-pyranine is invariant above pH 4, which makes it a good fluid-phase marker in all cellular compartments. CM-pyranine is very photostable, is retained for long periods by cells, does not self-quench, and has negligible excimer emission. The sum of its properties make CM-pyranine an ideal fluorescent tracer. The use of CM-pyranine as a fluid-phase marker is demonstrated by multicolor confocal microscopy of cells that are also labeled with lipid and nuclear markers that have green and red fluorescence emission, respectively.	[Kao, Joseph P. Y.] Univ Maryland, Ctr Biomed Engn & Technol, Sch Med, Baltimore, MD 21201 USA; Univ Maryland, Dept Physiol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Kao, JPY (corresponding author), Univ Maryland, Ctr Biomed Engn & Technol, Sch Med, 111 South Penn St, Baltimore, MD 21201 USA.	jkao@umaryland.edu		Kao, Joseph/0000-0002-8875-2180	National Institutes of Health (U.S.) [GM056481]; University of Maryland Baltimore Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056481] Funding Source: NIH RePORTER	National Institutes of Health (U.S.)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Baltimore Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health (U.S.) grant number GM056481 and the Nanobiology Fund of the University of Maryland Baltimore Foundation to JPYK.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ARBELOA IL, 1981, J CHEM SOC FARAD T 2, V77, P1735, DOI 10.1039/f29817701735; BIRKS JB, 1976, J RES NBS A PHYS CH, V80, P389, DOI 10.6028/jres.080A.038; BIRKS JB, 1963, SPECTROCHIM ACTA, V19, P401, DOI 10.1016/0371-1951(63)80051-X; Borkowski M., REFRACTIVE INDEX SUL; Bradke TM, 2008, CELL ADHES MIGR, V2, P153, DOI 10.4161/cam.2.3.6484; Budo A, 1956, ACTA PHYS CHEM SZEGE, V2, P18; Burks SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120982; Burks SR, 2009, BBA-BIOMEMBRANES, V1788, P2301, DOI 10.1016/j.bbamem.2009.08.007; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CHEN RF, 1988, ANAL BIOCHEM, V172, P61, DOI 10.1016/0003-2697(88)90412-5; Chia Pei Zhi Cheryl, 2013, Cells, V2, P105, DOI 10.3390/cells2010105; Clarke JDW, 1999, METH MOL B, V97, P319, DOI 10.1385/1-59259-270-8:319; DENHOLM EM, 1995, CYTOMETRY, V19, P366, DOI 10.1002/cyto.990190412; Esbjorner EK, 2007, BIOCHEMISTRY-US, V46, P13490, DOI 10.1021/bi701075y; Goppert-Mayer M., ELEMENTARAKTE ZWEI Q; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; Haugland RP, 1992, United States patent US, Patent No. 005132432; Humphries WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026626; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Kao JPY, 2010, METHOD CELL BIOL, V99, P113, DOI [10.1016/S0091-679X(10)99005-5, 10.1016/B978-0-12-374841-6.00005-0]; KAO JPY, 1994, METHOD CELL BIOL, V40, P155; KASHA M, 1950, DISCUSS FARADAY SOC, P14, DOI 10.1039/df9500900014; KELLER R, 1992, DEV DYNAM, V193, P199, DOI 10.1002/aja.1001930302; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; LEE KD, 1992, BIOCHIM BIOPHYS ACTA, V1103, P185, DOI 10.1016/0005-2736(92)90086-2; LEYENDEKKERS JV, 1977, J CHEM ENG DATA, V22, P427, DOI 10.1021/je60075a019; McNeil P L, 2001, Curr Protoc Cell Biol, VChapter 20, DOI 10.1002/0471143030.cb2001s18; MELHUISH WH, 1961, J PHYS CHEM-US, V65, P229, DOI 10.1021/j100820a009; MURPHY RF, 1984, J CELL BIOL, V98, P1757, DOI 10.1083/jcb.98.5.1757; PLANK C, 1994, J BIOL CHEM, V269, P12918; PLANT AL, 1986, PHOTOCHEM PHOTOBIOL, V44, P453, DOI 10.1111/j.1751-1097.1986.tb04692.x; Rosen GM, 2005, ORG BIOMOL CHEM, V3, P645, DOI 10.1039/B415586F; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Sohn YS, 2012, HAEMATOL-HEMATOL J, V97, P670, DOI 10.3324/haematol.2011.054858; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Srimaroeng C, 2008, XENOBIOTICA, V38, P889, DOI [10.1080/00498250801927435, 10.1080/00498250801927435 ]; STRAUBINGER RM, 1983, CELL, V32, P1069, DOI 10.1016/0092-8674(83)90291-X; STRAUBINGER RM, 1990, BIOCHEMISTRY-US, V29, P4929, DOI 10.1021/bi00472a025; WHITAKER JE, 1991, ANAL BIOCHEM, V198, P119, DOI 10.1016/0003-2697(91)90515-U; Wohlfarth C., 2008, LANDOLT HORNSTEIN GR, V47, P564; WOLFBEIS OS, 1983, FRESEN Z ANAL CHEM, V314, P119, DOI 10.1007/BF00482235; Wurth C, 2013, NAT PROTOC, V8, P1535, DOI 10.1038/nprot.2013.087; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	46	9	9	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133518	10.1371/journal.pone.0133518	http://dx.doi.org/10.1371/journal.pone.0133518			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186650	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700151
J	Yang, SS; Jin, YL; He, Y; Jiang, CQ; Cheng, KK; Zhang, WS; Lam, TH				Yang, Shanshan; Jin, Yali; He, Yao; Jiang, Chaoqiang; Cheng, Kar Keung; Zhang, Weisen; Lam, Tai Hing			Childhood Passive Smoking Exposure and Age at Menarche in Chinese Women Who Had Never Smoked: The Guangzhou Biobank Cohort Study	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; BREAST-CANCER; RISK-FACTORS; POPULATION; PREGNANCY; HORMONE; DISEASE; GROWTH; ADULTS; TIME	Objective We examined the associations between childhood passive smoking exposure and age at menarche in women who had never smoked in southern China. Methods Among 30,518 participants in Guangzhou Biobank Cohort Study (GBCS) from 2003-2008, 20,061 women who had never smoked and had complete outcome data were included. Childhood passive smoking exposure was defined as living with 1 or more smokers in the same household during childhood. Data on the number of smokers in the household and frequency of exposure (density and frequency) were also obtained. Age at menarche was measured as a continuous variable. Results 11,379 (56.7%) participants were exposed to passive smoking during childhood. Compared to those with no passive smoking exposure during childhood, those with exposure >= 5 days/week had menarche 0.19 year (95% confidence interval (CI): 0.13-0.25) earlier on average. Those exposed to more than two smokers had menarche 0.38 year earlier (95% CI: 0.290.47). Childhood exposure was associated with early age at menarche (<= 13 vs. >13 years), with an adjusted odds ratio of 1.34 (95% CI: 1.21-1.48) for high density, and 1.17 (95% CI: 1.09-1.26) for high frequency of exposure. Conclusion Childhood passive smoking exposure was associated with earlier age at menarche, with a dose-response relationship in Chinese women who had never smoked. If causal, the results support the promotion of smoking cessation in families with children, particularly young girls.	[Yang, Shanshan; He, Yao] Chinese Peoples Liberat Army Gen Hosp, Inst Geriatr, Beijing, Peoples R China; [Jin, Yali; Jiang, Chaoqiang; Zhang, Weisen] Guangzhou 12 Peoples Hosp, Guangzhou, Guangdong, Peoples R China; [Cheng, Kar Keung] Univ Birmingham, Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England; [Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Yang, Shanshan] CDC, Jinan Mil Area, Jinan 250014, Shandong, Peoples R China; [He, Yao] Chinese Peoples Liberat Army Gen Hosp, Beijing Key Lab Aging & Geriatr, Beijing, Peoples R China; [He, Yao] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; University of Birmingham; University of Hong Kong; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	He, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Geriatr, Beijing, Peoples R China.	yhe301@x263.net; cqjiang@hkucc.hku.hk	Cheng, Kar/AAL-8899-2021; Lam, Tai Hing/C-4317-2009	Cheng, Kar/0000-0002-1516-1857; Lam, Tai Hing/0000-0002-2033-9971; He, Yao/0000-0001-6205-7895	Guangdong Natural Science Foundation of China, Guangdong, China [9451062001003477]; Guangzhou Science and Information Bureau, Guangzhou, China [2012J5100041]; National Natural Science Foundation of China [81373080]; Beijing Municipal Science and Technology Commission [Z121107001012070]; Chinese PLA General Hospital Doctor Innovation Foundation [13BCZ07]	Guangdong Natural Science Foundation of China, Guangdong, China; Guangzhou Science and Information Bureau, Guangzhou, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Chinese PLA General Hospital Doctor Innovation Foundation	This study was supported by research grants from the Guangdong Natural Science Foundation of China, Guangdong, China (Grant number: 9451062001003477) - (http://www.nsfc.gov.cn/nsfc/cen/xmzn/2015xmzn/15/06.html), the Guangzhou Science and Information Bureau, Guangzhou, China (2012J5100041) - (http://www.gdstc.gov.cn/HTML/kjyw/tzgg/14067986446893065296778948092137.html), the National Natural Science Foundation of China (81373080) - (http://www.nsfc.gov.cn/), the Beijing Municipal Science and Technology Commission (Z121107001012070) -(http://www.bjkw.gov.cn/n8785584/index.html) and the Chinese PLA General Hospital Doctor Innovation Foundation (13BCZ07) (http://www.301hospital.com.cn/). The funders had roles in study design, data collection and analysis, decision to publish and preparation of the manuscript.	APTER D, 1983, J CLIN ENDOCR METAB, V57, P82, DOI 10.1210/jcem-57-1-82; Benedict MD, 2012, ENVIRON TOXICOL PHAR, V34, P761, DOI 10.1016/j.etap.2012.09.010; Chen CZ, 2005, ENVIRON HEALTH PERSP, V113, P412, DOI 10.1289/ehp.7436; Cho GJ, 2010, EUR J PEDIATR, V169, P89, DOI 10.1007/s00431-009-0993-1; Conway BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030625; Dossus L, 2012, ANN EPIDEMIOL, V22, P723, DOI 10.1016/j.annepidem.2012.07.007; Dossus L, 2010, INT J CANCER, V127, P442, DOI 10.1002/ijc.25050; Ferris JS, 2010, PAEDIATR PERINAT EP, V24, P515, DOI 10.1111/j.1365-3016.2010.01154.x; Fried PA, 2001, NEUROTOXICOL TERATOL, V23, P431, DOI 10.1016/S0892-0362(01)00161-1; Guldbrandsen K, 2014, HUM REPROD, V29, P2058, DOI 10.1093/humrep/deu153; He CY, 2010, AM J EPIDEMIOL, V171, P334, DOI 10.1093/aje/kwp372; Heys M, 2011, J EPIDEMIOL COMMUN H, V65, P522, DOI 10.1136/jech.2009.099143; Iniguez C, 2012, J EPIDEMIOL COMMUN H, V66, P563, DOI 10.1136/jech.2010.116756; Jiang CQ, 2006, INT J EPIDEMIOL, V35, P844, DOI 10.1093/ije/dyl131; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Lewington S, 2014, INT J EPIDEMIOLOGY; Ong KK, 2006, MOL CELL ENDOCRINOL, V254, P8, DOI 10.1016/j.mce.2006.04.018; Parsa P, 2009, ASIAN PAC J CANCER P, V10, P545; Qiu CS, 2013, J CLIN ENDOCR METAB, V98, P1612, DOI 10.1210/jc.2012-2919; Reynolds P, 2004, J WOMENS HEALTH, V13, P778, DOI 10.1089/jwh.2004.13.778; Rigon F, 2010, J ADOLESCENT HEALTH, V46, P238, DOI 10.1016/j.jadohealth.2009.07.009; Rock V. J., 2007, Morbidity and Mortality Weekly Report, V56, P1157; So L L, 1992, Z Morphol Anthropol, V79, P21; Tamakoshi K, 2011, EUR J EPIDEMIOL, V26, P771, DOI 10.1007/s10654-011-9623-0; Terry MB, 2009, AM J EPIDEMIOL, V170, P72, DOI 10.1093/aje/kwp095; Towne B, 2005, AM J PHYS ANTHROPOL, V128, P210, DOI 10.1002/ajpa.20106; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Weghofer A, 2013, FERTIL STERIL, V100, P1039, DOI 10.1016/j.fertnstert.2013.05.042; Windham GC, 2004, AM J EPIDEMIOL, V159, P862, DOI 10.1093/aje/kwh117; Xu L, 2011, INT J CARDIOL, V148, P189, DOI 10.1016/j.ijcard.2009.11.001; Yang Gong-huan, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P77; Yin P, 2007, LANCET, V370, P751, DOI 10.1016/S0140-6736(07)61378-6; ZACHARIAS L, 1969, NEW ENGL J MED, V280, P868, DOI 10.1056/NEJM196904172801606; Zou Zhi-yong, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P726	34	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0130429	10.1371/journal.pone.0130429	http://dx.doi.org/10.1371/journal.pone.0130429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186646	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700007
J	Hancock, KJ; Cunningham, NK; Lawrence, D; Zarb, D; Zubrick, SR				Hancock, Kirsten J.; Cunningham, Nadia K.; Lawrence, David; Zarb, David; Zubrick, Stephen R.			Playgroup Participation and Social Support Outcomes for Mothers of Young Children: A Longitudinal Cohort Study	PLOS ONE			English	Article							POSTPARTUM DEPRESSION; CHALLENGES; EXPERIENCE; SYMPTOMS; STRESS	Objective This study aimed to examine friendship networks and social support outcomes for mothers according to patterns of playgroup participation. Methods Data from the Longitudinal Study of Australian Children were used to examine the extent to which patterns of playgroup participation across the ages of 3-19 months (Wave 1) and 2-3 years (Wave 2) were associated with social support outcomes for mothers atWave 3 (4-5 years) and four years later at Wave 5 (8-9 years). Analyses were adjusted for initial friendship attachments atWave 1 and other socio-demographic characteristics. Results Log-binomial regression models estimating relative risks showed that mothers who never participated in a playgroup, or who participated at either Wave 1 or Wave 2 only, were 1.7 and 1.8 times as likely to report having no support from friends when the child was 4-5 years, and 2.0 times as likely to have no support at age 8-9 years, compared with mothers who persistently participated in playgroup at both Wave 1 and Wave 2. Conclusion These results provide evidence that persistent playgroup participation may acts as a protective factor against poor social support outcomes. Socially isolated parents may find playgroups a useful resource to build their social support networks.	[Hancock, Kirsten J.; Cunningham, Nadia K.; Lawrence, David; Zubrick, Stephen R.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Zarb, David] Playgrp WA Inc, North Perth, WA, Australia	Telethon Kids Institute; University of Western Australia	Hancock, KJ (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.	kirsten.hancock@telethonkids.org.au	Lawrence, David/C-8292-2009; Hancock, Kirsten/T-1836-2019; Zubrick, Stephen R/CAI-1970-2022	Lawrence, David/0000-0003-4700-1425; Zubrick, Stephen R/0000-0002-6369-1713; Hancock, Kirsten/0000-0001-6213-2488	National Health and Medical Research Council [572982]; Australian Research Council Centre of Excellence for Children and Families Over the Life Course [CE 140100027]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Centre of Excellence for Children and Families Over the Life Course(Australian Research Council)	This work was supported by the National Health and Medical Research Council (Australia, www.nhmrc.gov.au) Program Grant 572982 and the Australian Research Council Centre of Excellence for Children and Families Over the Life Course (CE 140100027, www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, 1 LSAC; Barclay L, 1997, J ADV NURS, V25, P719, DOI 10.1046/j.1365-2648.1997.t01-1-1997025719.x; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Cairney J, 2003, SOC PSYCH PSYCH EPID, V38, P442, DOI 10.1007/s00127-003-0661-0; COBB S, 1976, PSYCHOSOM MED, V38, P300, DOI 10.1097/00006842-197609000-00003; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Cooper PJ, 1998, BMJ-BRIT MED J, V316, P1884; CROCKENBERG SB, 1981, CHILD DEV, V52, P857, DOI 10.2307/1129087; Dennis CL, 2006, BIRTH-ISS PERINAT C, V33, P323, DOI 10.1111/j.1523-536X.2006.00130.x; Hancock K., 2012, AUST J EARLY CHILD, V37, P72, DOI DOI 10.1177/183693911203700211; Harrison LJ, 2010, CHILDRENS EXPERIENCE; Kalb G, 2009, AUST ECON REV, V42, P276, DOI 10.1111/j.1467-8462.2009.00545.x; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Leahy-Warren P, 2012, J CLIN NURS, V21, P388, DOI 10.1111/j.1365-2702.2011.03701.x; Leininger LJ, 2009, SOC SCI MED, V68, P2113, DOI 10.1016/j.socscimed.2009.03.013; Manuel JI, 2012, SOC SCI MED, V75, P2013, DOI 10.1016/j.socscimed.2012.07.034; Mathiesen KS, 1999, SOC PSYCH PSYCH EPID, V34, P61, DOI 10.1007/s001270050113; Matthey S, 2011, J AFFECT DISORDERS, V128, P142, DOI 10.1016/j.jad.2010.06.032; Misson S., 2007, WAVE 2 WEIGHTING NON; Mulcahy CM, 2010, LEISURE STUD, V29, P3, DOI 10.1080/02614360903266973; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Parry DC, 2013, J LEISURE RES, V45, P23, DOI 10.18666/jlr-2013-v45-i1-2941; Sarason IG, 2009, J SOC PERS RELAT, V26, P113, DOI 10.1177/0265407509105526; SAS Institute Inc, 2002, SAS WIND VERS 9 4; SCHAEFER C, 1981, Journal of Behavioral Medicine, V4, P381, DOI 10.1007/BF00846149; Schaffer M A, 1997, J Obstet Gynecol Neonatal Nurs, V26, P433, DOI 10.1111/j.1552-6909.1997.tb02725.x; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Shulver W, THESIS FLINDERS U; Sipthorp M., 2009, WAVE 3 WEIGHTING NON; Small Mario Luis, 2009, UNANTICIPATED GAINS; Sneddon J, 2003, EARLY INTERVENTION P; Soloff C., 2006, WAVE 1 WEIGHTING NON; Strange C, 2014, J ADV NURS, V70, P2835, DOI 10.1111/jan.12435; Strazdins L., 2007, AUSTR B LABOUR, V33, P202; Strazdins L, 2010, SOC SCI MED, V70, P2052, DOI 10.1016/j.socscimed.2010.02.041; Vangelisti AL, 2009, J SOC PERS RELAT, V26, P39, DOI 10.1177/0265407509105520; Whitton A, 1996, INT REV PSYCHIATR, V8, P73, DOI 10.3109/09540269609037819; Wilkinson RG, 2003, SOCIAL DETERMINANTS	39	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133007	10.1371/journal.pone.0133007	http://dx.doi.org/10.1371/journal.pone.0133007			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RQ	26181426	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198200048
J	Miura, M; Ito, K; Hayashi, M; Nakajima, M; Tanaka, T; Ogura, S				Miura, Mai; Ito, Kensuke; Hayashi, Maiko; Nakajima, Motowo; Tanaka, Tohru; Ogura, Shun-ichiro			The Effect of 5-Aminolevulinic Acid on Cytochrome P450-Mediated Prodrug Activation	PLOS ONE			English	Article							HUMAN LIVER-MICROSOMES; ABC TRANSPORTER ABCG2; IN-VITRO; BILE-SALTS; EXPRESSION; CANCER; CYCLOPHOSPHAMIDE; 5-FLUOROURACIL; THERAPY; ROLES	Of late, numerous prodrugs are widely used for therapy. The hemeprotein cytochrome P450 (CYP) catalyzes the activation of prodrugs to form active metabolites. Therefore, the activation of CYP function might allow the use of lower doses of prodrugs and decrease toxicity. We hypothesized that the addition of 5-aminolevulinic acid (ALA), a precursor in the porphyrin biosynthetic pathway, enhances the synthesis of heme, leading to the up-regulation of CYP activity. To test this hypothesis, we treated a human gastric cancer cell line with ALA and determined the effect on CYP-dependent prodrug activation. For this purpose, we focused on the anticancer prodrug tegafur, which is converted to its active metabolite 5-fluorouracil (5-FU) mainly by CYP2A6. We show here that ALA increased CYP2A6-dependent tegafur activation, suggesting that ALA elevated CYP activity and potentiated the activation of the prodrug.	[Miura, Mai; Ito, Kensuke; Hayashi, Maiko; Ogura, Shun-ichiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Nakajima, Motowo; Tanaka, Tohru] SBI Pharmaceut CO LTD, Minato Ku, Tokyo 1066020, Japan	Tokyo Institute of Technology; SBI Pharmaceuticals	Ogura, S (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, 4259 B47 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	sogura@bio.titech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [26430141]; SBI Pharma CO., LTD.	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SBI Pharma CO., LTD.	The studies in the authors' laboratories were supported by the Grant-in-Aid for Scientific Research (C) (No. 26430141) from the Ministry of Education, Culture, Sports, Science and Technology. SBI Pharma CO., LTD., provided support in the form of salaries for authors MN and TT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Bayeva M, 2013, CIRC RES, V113, P279, DOI 10.1161/CIRCRESAHA.113.301552; Chang TKH, 1997, CANCER RES, V57, P1946; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; Green RM, 2000, GENE, V241, P117, DOI 10.1016/S0378-1119(99)00460-6; Hagiya Y, 2013, PHOTODIAGN PHOTODYN, V10, P288, DOI 10.1016/j.pdpdt.2013.02.001; Hagiya Y, 2012, PHOTODIAGN PHOTODYN, V9, P204, DOI 10.1016/j.pdpdt.2011.12.004; Hagiya Yuichiro, 2008, J Exp Ther Oncol, V7, P153; Hagmann Wolfgang, 2010, Cancers (Basel), V3, P106, DOI 10.3390/cancers3010106; HENDRY GAF, 1980, J MED GENET, V17, P1, DOI 10.1136/jmg.17.1.1; Hirohashi T, 2000, J BIOL CHEM, V275, P2905, DOI 10.1074/jbc.275.4.2905; Hlavata I, 2012, MUTAGENESIS, V27, P187, DOI 10.1093/mutage/ger075; Ikeda K, 2000, CLIN CANCER RES, V6, P4409; Ishizuka M, 2011, INT IMMUNOPHARMACOL, V11, P358, DOI 10.1016/j.intimp.2010.11.029; Jounaidi Y, 2006, MOL CANCER THER, V5, P541, DOI 10.1158/1535-7163.MCT-05-0321; Komatsu T, 2000, DRUG METAB DISPOS, V28, P1457; Koskela S, 1999, BIOCHEM PHARMACOL, V57, P1407, DOI 10.1016/S0006-2952(99)00015-5; MORRISON GR, 1965, ANAL CHEM, V37, P1124, DOI 10.1021/ac60228a014; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; Ogura Shun-Ichiro, 2011, BMC Res Notes, V4, P66, DOI 10.1186/1756-0500-4-66; Pratt S, 2005, MOL CANCER THER, V4, P855, DOI 10.1158/1535-7163.MCT-04-0291; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Robey RW, 2005, CANCER BIOL THER, V4, P187; Rodriguez-Antona C, 2006, ONCOGENE, V25, P1679, DOI 10.1038/sj.onc.1209377; SASSA S, 1988, SEMIN HEMATOL, V25, P312; Schwartz PS, 2003, CANCER GENE THER, V10, P571, DOI 10.1038/sj.cgt.7700601; Sugiyama Y, 2014, ONCOL REP, V31, P1282, DOI 10.3892/or.2013.2945; Tamura A, 2007, DRUG METAB PHARMACOK, V22, P428, DOI 10.2133/dmpk.22.428; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Zhou S, 2005, BLOOD, V105, P2571, DOI 10.1182/blood-2004-04-1566	29	16	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0131793	10.1371/journal.pone.0131793	http://dx.doi.org/10.1371/journal.pone.0131793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181717	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198200011
J	Ortiz-Alvarez, R; de los Rios, A; Fernandez-Mendoza, F; Torralba-Burrial, A; Perez-Ortega, S				Ortiz-Alvarez, Ruediger; de los Rios, Asuncion; Fernandez-Mendoza, Fernando; Torralba-Burrial, Antonio; Perez-Ortega, Sergio			Ecological Specialization of Two Photobiont-Specific Maritime Cyanolichen Species of the Genus Lichina	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; LICHEN CETRARIA-ACULEATA; CYANOBIONT SELECTIVITY; POPULATION-STRUCTURE; HOST SPECIALIZATION; SALINITY GRADIENT; GENETIC DIVERSITY; CANARY-ISLANDS; TRNL INTRON; CYANOBACTERIA	All fungi in the class Lichinomycetes are lichen-forming and exclusively associate with cyanobacteria. Two closely related maritime species of the genus Lichina (L. confinis and L. pygmaea) show similar distribution ranges in the Northeast Atlantic, commonly co-occurring at the same rocky shores but occupying different littoral zones. By means of 16S rRNA and phycocyanin operon markers we studied a) the phylogenetic relationships of cyanobionts associated with these species, b) the match of divergence times between both symbionts, and c) whether Lichina species differ in photobiont association and in how geography and ecology affect selectivity. The cyanobionts studied are closely related to both marine and freshwater strains of the genus Rivularia. We found evidence of a high specificity to particular cyanobiont lineages in both species: Lichina pygmaea and L. confinis incorporate specific lineages of Rivularia that do not overlap at the haplotype nor the OTU levels. Dating divergences of the fungal and cyanobacterial partners revealed an asynchronous origin of both lineages. Within each fungal species, selectivity varied across the studied area, influenced by environmental conditions (both atmospheric and marine), although patterns were highly correlated between both lichen taxa. Ecological speciation due to the differential association of photobionts to each littoral zone is suspected to have occurred in marine Lichina.	[Ortiz-Alvarez, Ruediger] Spanish Council Res CEAB CSIC, Integrat Freshwater Ecol Grp, Ctr Adv Studies Blanes, Blanes, Girona, Spain; [de los Rios, Asuncion; Perez-Ortega, Sergio] MNCN CSIC, Dept Biogeochem & Microbial Ecol, Madrid, Spain; [Fernandez-Mendoza, Fernando] Karl Franzens Univ Graz, Inst Bot, A-8010 Graz, Austria; [Torralba-Burrial, Antonio] Biosfera Consultoria Medioambiental, Oviedo 33012, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Consejo Superior de Investigaciones Cientificas (CSIC); University of Graz	Perez-Ortega, S (corresponding author), MNCN CSIC, Dept Biogeochem & Microbial Ecol, Madrid, Spain.	s.perezortega@gmail.com	Torralba-Burrial, Antonio/C-3141-2008; Ortiz-Álvarez, Rüdiger/I-6365-2019; Pérez-Ortega, Sergio/G-1257-2016; de los Rios, Asuncion/L-3694-2014	Torralba-Burrial, Antonio/0000-0002-4957-2080; Ortiz-Álvarez, Rüdiger/0000-0002-8553-5420; Pérez-Ortega, Sergio/0000-0002-5411-3698; de los Rios, Asuncion/0000-0002-0266-3516	Spanish Ministry of Economy and Competitiveness [BES-2013-066105, CTM2012-38222-C02-02]; Microbial Ecology and Evolution Team, within the Integrative Freshwater Ecology Group; Biosfera Consultoria Medioambiental	Spanish Ministry of Economy and Competitiveness(Spanish Government); Microbial Ecology and Evolution Team, within the Integrative Freshwater Ecology Group; Biosfera Consultoria Medioambiental	Both ROA (BES-2013-066105) and SPO (CTM2012-38222-C02-02) were supported in the form of salary by grants from the Spanish Ministry of Economy and Competitiveness. The authors acknowledge the Microbial Ecology and Evolution Team, within the Integrative Freshwater Ecology Group for currently supporting ROA. Biosfera Consultoria Medioambiental provided support in the form of a salary for author ATB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	ADAMS DG, 2012, ECOLOGY CYANOBACTERI, V2, P593; Ahmadjian V, 1993, LICHEN SYMBIOSIS, P250; Bahl J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1167; Barberan A, 2014, ECOL LETT; Bastian M, 2009, INT AAAI CONF WEBLOG; Beck A, 1998, NEW PHYTOL, V139, P709, DOI 10.1046/j.1469-8137.1998.00231.x; Beck A, 2002, NEW PHYTOL, V153, P317, DOI 10.1046/j.0028-646X.2001.00315.x; Beimforde C, 2014, MOL PHYLOGENET EVOL, V78, P386, DOI 10.1016/j.ympev.2014.04.024; Benton MJ, 2003, TRENDS ECOL EVOL, V18, P358, DOI 10.1016/S0169-5347(03)00093-4; Berrendero E, 2008, INT J SYST EVOL MICR, V58, P447, DOI 10.1099/ijs.0.65273-0; Bittencourt-Oliveira MD, 2001, J PHYCOL, V37, P810; Boto L, 2010, P ROY SOC B-BIOL SCI, V277, P819, DOI 10.1098/rspb.2009.1679; Budel B, 2000, ERGEBNISSE WELTWEITE, P209; Budel B, 2003, PALMARUM HORTUS FRAN, V7; Carine MA, 2010, J BIOGEOGR, V37, P77, DOI 10.1111/j.1365-2699.2009.02181.x; Casamayor EO, 2000, FEMS MICROBIOL ECOL, V34, P113, DOI 10.1016/S0168-6496(00)00079-9; Castillo RV, 2012, FUNGAL BIOL-UK, V116, P665, DOI 10.1016/j.funbio.2012.04.001; Chappuis E, 2014, ESTUAR COAST SHELF S, V147, P113, DOI 10.1016/j.ecss.2014.05.031; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crump BC, 2009, P NATL ACAD SCI USA, V106, P21208, DOI 10.1073/pnas.0906149106; Cruz R, 2004, J EVOLUTION BIOL, V17, P288, DOI 10.1111/j.1420-9101.2003.00689.x; Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401; Dal-Forno M, 2013, FUNGAL BIOL-UK, V117, P584, DOI 10.1016/j.funbio.2013.05.006; Dale Virginia H., 2001, Ecological Indicators, V1, P3, DOI 10.1016/S1470-160X(01)00003-6; De Los Rios A, 2014, ANTARCT SCI, V26, P459, DOI 10.1017/S0954102014000194; Dominguez-Escobar J, 2011, FEMS MICROBIOL LETT, V316, P90, DOI 10.1111/j.1574-6968.2010.02195.x; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Egea J. M., 1996, BOCCONEA, V6, P19; Elvebakk A, 2008, J PHYCOL, V44, P1049, DOI 10.1111/j.1529-8817.2008.00556.x; Estrada M, 2004, FEMS MICROBIOL ECOL, V49, P281, DOI 10.1016/j.femsec.2004.04.002; Fedrowitz K, 2012, ECOL EVOL, V2, P2291, DOI 10.1002/ece3.343; Fernandez Mendoza F, 2014, GENETIC DIVERSITY AN; Fernandez-Mendoza F, 2011, MOL ECOL, V20, P1208, DOI 10.1111/j.1365-294X.2010.04993.x; Fernandez-Mendoza F, 2013, MOL ECOL, V22, P1961, DOI 10.1111/mec.12210; Fletcher A, 1973, CAMBRIDGE JOURNALS O, V5, P368; Fletcher A, 1973, CAMBRIDGE JOURNALS O, V5, P401; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Friedl T, 2008, LICHEN BIOLOGY, 2ND EDITION, P9, DOI 10.1017/CBO9780511790478.003; Friedman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053539; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Garcia-Pichel F, 2013, SCIENCE, V340, P1574, DOI 10.1126/science.1236404; Goloboff PA, 2003, CLADISTICS, V19, P91, DOI 10.1016/S0748-3007(03)00017-3; Gorley C.K., 2006, GETTING STARTED PRIM; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Han D, 2009, CURR MICROBIOL, V58, P170, DOI 10.1007/s00284-008-9302-x; Henning C, 2014, FPC FLEXIBLE PROCEDU; Herrera-Campos MD, 2005, MYCOLOGIA, V97, P356; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Honegger R, 2012, THE MYCOTINA IX FUNG, P293; Hutsemekersa V, 2011, P NATL ACAD SCI USA, V108, P18989, DOI 10.1073/pnas.1109119108; Janse I, 2003, APPL ENVIRON MICROB, V69, P6634, DOI 10.1128/AEM.69.11.6634-6643.2003; JANSON S, 1993, NEW PHYTOL, V124, P149, DOI 10.1111/j.1469-8137.1993.tb03805.x; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; KAUFMAN L, 1990, FINDING GROUPS IN DA; Kny, 1874, DIE ENTWICKLUNG DES, P95; Kruse I, 2004, J SEA RES, V51, P53, DOI 10.1016/j.seares.2003.05.004; Lewis JR, 1964, THE ECOLOGY OF ROCKY; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lobban CS, 1994, SEAWEED ECOLOGY AND; Lorrain Smith A., 1921, LICHENS; Lucking R, 2009, AM J BOT, V96, P1409, DOI 10.3732/ajb.0800258; Lucking R, 2014, LICHENOLOGIST, V46, P261, DOI 10.1017/S0024282913000352; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; MILLER M.A., 2010, 2010 GATEWAY COMPUTI; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Moreno PP, 1991, TAXONOMIA CARACTERES, P1; Muggia L, 2014, ANN BOT-LONDON, V114, P463, DOI 10.1093/aob/mcu146; Myllys L, 2007, NEW PHYTOL, V173, P621, DOI 10.1111/j.1469-8137.2006.01944.x; NEILAN BA, 1995, APPL ENVIRON MICROB, V61, P3875, DOI 10.1128/AEM.61.11.3875-3883.1995; Neiva J, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-78; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; O'Brien HE, 2005, EUR J PHYCOL, V40, P363, DOI 10.1080/09670260500342647; O'Brien HE, 2013, NEW PHYTOL, V198, P557, DOI 10.1111/nph.12165; Oksanen I, 2004, INT J SYST EVOL MICR, V54, P765, DOI 10.1099/ijs.0.02928-0; Olmanson LG, 2008, REMOTE SENS ENVIRON, V112, P4086, DOI 10.1016/j.rse.2007.12.013; Olsson S, 2012, CURR GENET, V58, P49, DOI 10.1007/s00294-011-0364-0; Otalora MAG, 2013, MICROB ECOL, V65, P517, DOI 10.1007/s00248-012-0136-5; Otalora MAG, 2010, MOL PHYLOGENET EVOL, V56, P1089, DOI 10.1016/j.ympev.2010.05.013; Paulsrud P, 2001, NEW PHYTOL, V152, P117, DOI 10.1046/j.0028-646x.2001.00234.x; Peksa O, 2011, MOL ECOL, V20, P3936, DOI 10.1111/j.1365-294X.2011.05168.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prieto M, 2013, PLOS ONE, V8; Quesada H, 2007, EVOLUTION, V61, P1600, DOI 10.1111/j.1558-5646.2007.00135.x; Rambold G, 1998, BRYOLOGIST, V101, P392; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Rikkinen J, 2002, SCIENCE, V297, P357, DOI 10.1126/science.1072961; Rikkinen J, 2013, MYCOKEYS, P3, DOI 10.3897/mycokeys.6.3869; RIPPKA R., 1992, PASTEUR CULTURE COLL, V1; Robertson BR, 2001, INT J SYST EVOL MICR, V51, P861, DOI 10.1099/00207713-51-3-861; Schirrmeister BE, 2013, P NATL ACAD SCI USA, V110, P1791, DOI 10.1073/pnas.1209927110; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schneider S, 1999, GENETICS, V152, P1079; Schultz M, 2000, PLANT BIOLOGY, V2, P482, DOI 10.1055/s-2000-5951; Schultz M, 2003, LICHENOLOGIST, V35, P151, DOI 10.1016/S0024-2829(03)00019-7; Schultz M, 2009, BIBL LICHENOL, P315; Serusiaux E, 2011, J BIOGEOGR, V38, P1138, DOI 10.1111/j.1365-2699.2010.02469.x; Sihvonen LM, 2007, FEMS MICROBIOL ECOL, V61, P74, DOI 10.1111/j.1574-6941.2007.00321.x; Smith CW, 2009, THE LICHENS OF GREAT, P556; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stenroos S, 2006, CLADISTICS, V22, P230, DOI 10.1111/j.1096-0031.2006.00101.x; Stolzer M, 2012, BIOINFORMATICS, V28, pI409, DOI 10.1093/bioinformatics/bts386; Summerfield TC, 2002, NEW PHYTOL, V155, P121, DOI 10.1046/j.1469-8137.2002.00431.x; TAJIMA F, 1983, GENETICS, V105, P437; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Tronholm A, 2010, J PHYCOL, V46, P1075, DOI 10.1111/j.1529-8817.2010.00912.x; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Whitton B.A., 1987, CYANOBACTERIA A COMP, P513; Whitton BA, 2012, ECOLOGY CYANOBACTERI, VII, P1, DOI [10.1007/978-94-007-3855-3_1, DOI 10.1007/978-94-007-3855-3_1]; Whitton BA, 2012, ECOLOGY OF CYANOBACT; Wirtz N, 2003, NEW PHYTOL, V160, P177, DOI 10.1046/j.1469-8137.2003.00859.x; Yahr R, 2006, NEW PHYTOL, V171, P847, DOI 10.1111/j.1469-8137.2006.01792.x; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zahlbruckner A., 1926, DIE NATURLICHEN PFLA	116	23	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132718	10.1371/journal.pone.0132718	http://dx.doi.org/10.1371/journal.pone.0132718			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181436	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198200029
J	Petti, CA; Stoddard, GJ; Sande, MA; Samore, MH; Simmon, KE; Hofmann, A				Petti, Cathy A.; Stoddard, Gregory J.; Sande, Merle A.; Samore, Matthew H.; Simmon, Keith E.; Hofmann, Aaron			The Suspected Infected Prosthetic Joint: Clinical Acumen and Added Value of Laboratory Investigations	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; TOTAL KNEE ARTHROPLASTY; C-REACTIVE PROTEIN; REVISION HIP; DIAGNOSIS; MANAGEMENT; PCR; AMPLIFICATION; IMPACT; FLUID	Consensus definitions have emerged for the discrimination between infected and uninfected prosthetic joints but diagnostic uncertainty often occurs. We examined the accuracy of orthopaedic surgeons' assessments to diagnose the infected prosthetic hip or knee and elucidated the added value of laboratory parameters. A prospective cohort study of patients undergoing revision arthroplasty of hip or knee was conducted over a one-year period. Orthopaedic surgeons' determinations prior to arthroplasty were recorded. A reference diagnostic standard was determined retrospectively by independent review from 3 infectious diseases physicians. Patients were followed up to 12 months. For 198 patients enrolled, 228 surgical encounters (110 knee, 118 hip) were classified by independent reviewers as 176 uninfected and 52 infected. Orthopaedic surgeons' preoperative diagnoses of infection had high diagnostic accuracy (sensitivity 89%, specificity 99%, PPV 98%, NPV 97%). Addition of intraoperative findings and histopathology improved their diagnostic accuracy. Addition of culture and PCR results improved sensitivity of diagnostic determinations but not specificity. We provide evidence that clinical acumen has high diagnostic accuracy using routine preoperative parameters. Histopathology from intraoperative specimens would improve surgeons' diagnostic accuracy but culture and PCR from intraoperative specimens could create greater diagnostic uncertainty. This study is critical to further our understanding of the added value, if any, of laboratory testing to support clinical decision making for the suspected infected joint and allow us to identify diagnostic gaps for emerging technologies to fill that will improve our ability to diagnose the infected prosthetic joint.	[Petti, Cathy A.; Stoddard, Gregory J.; Sande, Merle A.; Samore, Matthew H.] Univ Utah Hosp & Clin, Dept Med, Salt Lake City, UT 84132 USA; [Simmon, Keith E.] Associated Reg & Univ Pathol Labs, Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Hofmann, Aaron] Univ Utah Hosp & Clin, Dept Orthopaed Surg, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; University of Utah Hospital; Utah System of Higher Education; University of Utah; University of Utah Hospital	Petti, CA (corresponding author), Univ Utah Hosp & Clin, Dept Med, Salt Lake City, UT 84132 USA.	cpetti007@gmail.com			Atlantic Philanthropies; John A. Hartford Foundation; Association of Specialty Professors; Infectious Diseases Society of America	Atlantic Philanthropies; John A. Hartford Foundation; Association of Specialty Professors; Infectious Diseases Society of America	This study was partially funded by a competitive young investigator grant awarded to Dr. Petti by Atlantic Philanthropies, John A. Hartford Foundation, Association of Specialty Professors, and Infectious Diseases Society of America. The sponsors of the study had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Atkins BL, 1998, J CLIN MICROBIOL, V36, P2932, DOI 10.1128/JCM.36.10.2932-2939.1998; Austin MS, 2008, J ARTHROPLASTY, V23, P65, DOI 10.1016/j.arth.2007.09.005; Barrack RL, 2007, J ARTHROPLASTY, V22, P94, DOI 10.1016/j.arth.2007.03.029; Bauer TW, 2006, J BONE JOINT SURG AM, V88A, P869, DOI 10.2106/JBJS.E.01149; Bemer P, 2014, J CLIN MICROBIOL, V52, P3583, DOI 10.1128/JCM.01459-14; Berbari EF, 1998, CLIN INFECT DIS, V27, P1247, DOI 10.1086/514991; Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001; Blom AW, 2003, J BONE JOINT SURG BR, V85B, P956, DOI 10.1302/0301-620X.85B7.14095; Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P1746, DOI 10.2106/JBJS.D.02937; Centers for disease control and prevention, NAT HOSP DISCH SURV; Croskerry P, 2008, AM J MED, V121, P24, DOI 10.1016/j.amjmed.2008.02.001; Deirmengian C, 2014, J BONE JOINT SURG AM, V96A, P1439, DOI 10.2106/JBJS.M.01316; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; FEHRING TK, 1994, CLIN ORTHOP RELAT R, P229; Fenollar F, 2006, J CLIN MICROBIOL, V44, P1018, DOI 10.1128/JCM.44.3.1018-1028.2006; Fisman DN, 2001, CLIN INFECT DIS, V32, P419, DOI 10.1086/318502; Ghanem E, 2008, J BONE JOINT SURG AM, V90A, P1637, DOI 10.2106/JBJS.G.00470; Greenwood-Quaintance KE, 2014, J CLIN MICROBIOL, V52, P642, DOI 10.1128/JCM.03217-13; HALDANE JBS, 1956, ANN HUM GENET, V20, P309; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Lachiewicz PF, 1996, J BONE JOINT SURG AM, V78A, P749, DOI 10.2106/00004623-199605000-00015; Lonner JH, 1996, J BONE JOINT SURG AM, V78A, P1553, DOI 10.2106/00004623-199610000-00014; Osmon DR, 2013, CLIN INFECT DIS, V56, DOI [10.1093/cid/cis803, 10.1093/cid/cis966]; Parvizi J, 2011, CLIN ORTHOP RELAT R, V469, P3022, DOI 10.1007/s11999-011-1971-2; Peel TN, 2013, CLIN MICROBIOL INFEC, V19, P181, DOI 10.1111/j.1469-0691.2011.03758.x; Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818; Ryu SY, 2014, DIAGN MICR INFEC DIS, V79, P448, DOI 10.1016/j.diagmicrobio.2014.03.021; Saleh K, 2002, J ORTHOP RES, V20, P506, DOI 10.1016/S0736-0266(01)00153-X; Saleh KJ, 2003, J BONE JOINT SURG AM, V85A, P18, DOI 10.2106/00004623-200300001-00005; SANZEN L, 1989, J BONE JOINT SURG BR, V71, P638, DOI 10.1302/0301-620X.71B4.2768312; SCULCO TP, 1995, ORTHOPEDICS, V18, P871; Segawa H, 1999, J BONE JOINT SURG AM, V81A, P1434, DOI 10.2106/00004623-199910000-00008; Selvin S., 2004, STAT ANAL EPIDEMIOLO; Spangehl MJ, 1999, J BONE JOINT SURG AM, V81A, P672, DOI 10.2106/00004623-199905000-00008; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588; Virolainen P, 2002, Scand J Surg, V91, P178; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; Zmistowski Benjamin, 2014, J Arthroplasty, V29, P77, DOI 10.1016/j.arth.2013.09.040	38	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0131609	10.1371/journal.pone.0131609	http://dx.doi.org/10.1371/journal.pone.0131609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181332	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198200007
J	Pinskiy, V; Jones, J; Tolpygo, AS; Franciotti, N; Weber, K; Mitra, PP				Pinskiy, Vadim; Jones, Jamie; Tolpygo, Alexander S.; Franciotti, Neil; Weber, Kevin; Mitra, Partha P.			High-Throughput Method of Whole-Brain Sectioning, Using the Tape-Transfer Technique	PLOS ONE			English	Article							BONE	Cryostat sectioning is a popular but labor-intensive method for preparing histological brain sections. We have developed a modification of the commercially available CryoJane tape collection method that significantly improves the ease of collection and the final quality of the tissue sections. The key modification involves an array of UVLEDs to achieve uniform polymerization of the glass slide and robust adhesion between the section and slide. This report presents system components and detailed procedural steps, and provides examples of end results; that is, 20 mu m mouse brain sections that have been successfully processed for routine Nissl, myelin staining, DAB histochemistry, and fluorescence. The method is also suitable for larger brains, such as rat and monkey.	[Pinskiy, Vadim; Jones, Jamie; Tolpygo, Alexander S.; Franciotti, Neil; Weber, Kevin; Mitra, Partha P.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Pinskiy, Vadim] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Pinskiy, V (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	vpinskiy@gmail.com		Mitra, Partha/0000-0001-8818-6804	National Institutes of Health [RC1MH088659]; Office of NIH Director [R01MH087988]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087988, RC1MH088659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of NIH Director; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support was provided by the Challenge Grant from the National Institutes of Health (RC1MH088659), PPM; Transformative Award from the Office of the NIH Director (R01MH087988), PPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins MR, 2006, J COMP NEUROL, V499, P979, DOI 10.1002/cne.21147; [Anonymous], CRYOJANE OP MAN; [Anonymous], 2007, MICR HM550 CRYOST MI; Gallyas F, 1979, Neurol Res, V1, P203; Jacquet R, 2005, ANAL BIOCHEM, V337, P22, DOI 10.1016/j.ab.2004.09.033; Jiang X, 2005, J HISTOCHEM CYTOCHEM, V53, P593, DOI 10.1369/jhc.4A6401.2005; Laux A, 2011, J COMP NEUROL, V519, P2390, DOI 10.1002/cne.22633; Peters Sr, 2010, PRACTICAL GUIDE TO FROZEN SECTION TECHNIQUE, P1, DOI 10.1007/978-1-4419-1234-3; Pinskiy V, 2013, J NEUROSCI METH, V218, P206, DOI 10.1016/j.jneumeth.2013.03.004; Reiner A, 2000, J NEUROSCI METH, V103, P23, DOI 10.1016/S0165-0270(00)00293-4; Salie R, 2008, CALCIFIED TISSUE INT, V83, P212, DOI 10.1007/s00223-008-9154-1	11	23	24	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0102363	10.1371/journal.pone.0102363	http://dx.doi.org/10.1371/journal.pone.0102363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181725	Green Accepted, gold, Green Published			2022-12-27	WOS:000358198200001
J	van Kampen, SC; Tursynbayeva, A; Koptleuova, A; Murzabekova, Z; Bigalieva, L; Aubakirova, M; Pak, S; van den Hof, S				van Kampen, Sanne Christine; Tursynbayeva, Aigul; Koptleuova, Aliya; Murzabekova, Zauresh; Bigalieva, Lyazzat; Aubakirova, Moldir; Pak, Svetlana; van den Hof, Susan			Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study	PLOS ONE			English	Article							SURVEILLANCE	Background Xpert MTB/RIF (Xpert) was piloted in Kazakhstan to detect tuberculosis (TB) and rifampicin resistance (RR-) TB among individuals at risk of multidrug-resistant (MDR-) TB. This study assessed the performance of Xpert compared to conventional diagnostic methods, RR-TB case detection among various risk groups, treatment initiation and time to diagnosis and treatment. Methods Eligible individuals were tested with Xpert, smear microscopy, culture and drug-susceptibility testing (DST) at the national TB reference laboratory and three provincial laboratories. Data was collected prospectively from August 2012 to May 2013 from routine laboratory and treatment registers. Results A total of 5,611 Xpert tests were performed mostly targeting contacts of MDR-TB patients, 'other' presumptive MDR-TB patients, and retreatment cases (26%, 24% and 22%, respectively). Compared to phenotypic DST, the positive predictive value of Xpert to detect RR-TB was 93.1% and 96.4% and the negative predictive value was 94.6% and 92.7% using solid and liquid culture media, respectively. RR-TB detection was highest among (former) prisoners, retreatment cases, people living with HIV/AIDS (PLWHA), and TB patients with positive smears after intensive phase of treatment (59%, 58%, 54% and 53% among TB positives, respectively). 88.9% of RR-TB patients were registered to have started second-line TB treatment. Median time to diagnosis with Xpert was 0.0 days (IQR 0.0-1.0), time from diagnosis to start of first-line treatment 3.0 days (IQR 1.0-7.0), and to start of second-line treatment 7.0 days (IQR 4.0-16). Conclusions Compared to conventional culture and DST, Xpert had a shorter result turn-around-time and excellent concordance to detect RR-TB. Time from sputum collection to start of second-line treatment was reduced to one week. The yield of Xpert could be maximized by increasing referrals from penitentiary and HIV centers to TB centers.	[van Kampen, Sanne Christine; van den Hof, Susan] KNCV TB Fdn, Cent Off, The Hague, Netherlands; [Tursynbayeva, Aigul; Pak, Svetlana] KNCV TB Fdn, Cent Asia Off, Alma Ata, Kazakhstan; [Koptleuova, Aliya] Natl Ctr TB Control, Alma Ata, Kazakhstan; [Murzabekova, Zauresh] Akmola Reg TB Dispensary, Kokshetau, Kazakhstan; [Bigalieva, Lyazzat] East Kazakhstan Reg TB Dispensary, Oskemen, Kazakhstan; [Aubakirova, Moldir] Almaty City TB Dispensary, Alma Ata, Kazakhstan	KNCV Tuberculosis Foundation; KNCV Tuberculosis Foundation	van Kampen, SC (corresponding author), KNCV TB Fdn, Cent Off, The Hague, Netherlands.	sanne.vankampen@kncvtbc.org		van Kampen, Sanne/0000-0002-1519-5248	United States Agency for International Development under the USAID Tuberculosis CARE I [AID-OAA-A-10-000020]	United States Agency for International Development under the USAID Tuberculosis CARE I(United States Agency for International Development (USAID))	This study was funded by the United States Agency for International Development under the USAID Tuberculosis CARE I, Cooperative Agreement No. AID-OAA-A-10-000020. Funding was received by SK, AT, SP and SH. The funder was involved in conception of the study design and supervision of the project.	[Anonymous], 2010, MULTIDRUG EXTENSIVEL; Falzon D, 2013, LANCET INFECT DIS, V13, P690, DOI 10.1016/S1473-3099(13)70130-0; Klinkenberg E, 2012, INT J TUBERC LUNG D, V16, P615, DOI 10.5588/ijtld.11.0262; Medecins Sans Frontieres, 2011, 1 MSF GENEXPERT SUBG; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; TB CAREI, 2014, TB CARE 1 PROGR YEAR; TB CAREI, 2012, TB CARE 1 ANN REP YE; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; USAID, TREATM TB MOV HOSP H; van den Hof S, 2013, INT J TUBERC LUNG D, V17, P526, DOI 10.5588/ijtld.12.0703; Van Kampen SC, 2014, PLOS ONE IN PRESS; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2011, POL STAT AUT REAL TI; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health Organization, 2014, XPERT MTB RIF IMPL M; World Health Organization, 2010, WHOHTMTB20109; World Health Organization, 2011, TUB COUNTR WORK SUMM; World Health Organization, 2011, WHO PROGRESS REPORT	18	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132514	10.1371/journal.pone.0132514	http://dx.doi.org/10.1371/journal.pone.0132514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181578	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198200020
J	Beraud, G; Kazmercziak, S; Beutels, P; Levy-Bruhl, D; Lenne, X; Mielcarek, N; Yazdanpanah, Y; Boelle, PY; Hens, N; Dervaux, B				Beraud, Guillaume; Kazmercziak, Sabine; Beutels, Philippe; Levy-Bruhl, Daniel; Lenne, Xavier; Mielcarek, Nathalie; Yazdanpanah, Yazdan; Boelle, Pierre-Yves; Hens, Niel; Dervaux, Benoit			The French Connection: The First Large Population-Based Contact Survey in France Relevant for the Spread of Infectious Diseases	PLOS ONE			English	Article							SOCIAL CONTACTS; PANDEMIC INFLUENZA; MIXING PATTERNS; TRANSMISSION; MODELS; SCHOOL; BEHAVIOR; IMPACT; VIRUS	Background Empirical social contact patterns are essential to understand the spread of infectious diseases. To date, no such data existed for France. Although infectious diseases are frequently seasonal, the temporal variation of contact patterns has not been documented hitherto. Methods COMES-F is the first French large-scale population survey, carried out over 3 different periods (February-March, April, April-May) with some participants common to the first and the last period. Participants described their contacts for 2 consecutive days, and reported separately on professional contacts when typically over 20 per day. Results 2033 participants reported 38 881 contacts (weighted median [first quartile-third quartile]: 8[5-14] per day), and 54 378 contacts with supplementary professional contacts (9[5-17]). Contrary to age, gender, household size, holidays, weekend and occupation, period of the year had little influence on the number of contacts or the mixing patterns. Contact patterns were highly assortative with age, irrespective of the location of the contact, and gender, with women having 8% more contacts than men. Although most contacts occurred at home and at school, the inclusion of professional contacts modified the structure of the mixing patterns. Holidays and weekends reduced dramatically the number of contacts, and as proxies for school closure, reduced R-0 by 33% and 28%, respectively. Thus, school closures could have an important impact on the spread of close contact infections in France. Conclusions Despite no clear evidence for temporal variation, trends suggest that more studies are needed. Age and gender were found important determinants of the mixing patterns. Gender differences in mixing patterns might help explain gender differences in the epidemiology of infectious diseases.	[Beraud, Guillaume] Ctr Hosp Poitiers, Med Interne & Malad Infect, Poitiers, France; [Beraud, Guillaume; Dervaux, Benoit] Univ Lille 2, EA2694, Lille, France; [Beraud, Guillaume; Hens, Niel] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium; [Kazmercziak, Sabine] Univ Catholique Lille, CRESGE, Lille, France; [Beutels, Philippe; Hens, Niel] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Hlth Econ Res & Modeling Infect Dis, B-2020 Antwerp, Belgium; [Levy-Bruhl, Daniel] InVS, Dept Malad Infect, St Maurice, France; [Lenne, Xavier] Univ Lille Nord, CHU Lille, Dept Informat Med, Lille, France; [Mielcarek, Nathalie] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Mielcarek, Nathalie] INSERM, U1019, F-59045 Lille, France; [Mielcarek, Nathalie] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR8204, F-59019 Lille, France; [Mielcarek, Nathalie] Univ Lille Nord France, Lille, France; [Yazdanpanah, Yazdan] Hop Bichat Claude Bernard, Serv Malad Infect & Trop, F-75877 Paris 18, France; [Boelle, Pierre-Yves] INSERM, UMR S 707, Paris, France; [Dervaux, Benoit] CHU Lille, DRCI, F-59037 Lille, France	Universite de Poitiers; Universite de Lille - ISITE; Universite de Lille; Hasselt University; Universite Catholique de Lille; University of Antwerp; Institute of Public Health Surveillance; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille	Beraud, G (corresponding author), Ctr Hosp Poitiers, Med Interne & Malad Infect, Poitiers, France.	beraudguillaume@gmail.com	Calmette, Albert/Q-2318-2016; Beutels, Philippe/A-1919-2010; Béraud, Guillaume/O-6062-2017; Hens, Niel/M-4445-2017; Dervaux, Benoit/O-6002-2016	Calmette, Albert/0000-0002-1852-0122; Beutels, Philippe/0000-0001-5034-3595; Béraud, Guillaume/0000-0002-4705-0916; Hens, Niel/0000-0003-1881-0637; Levy-Bruhl, Daniel/0000-0002-4246-0932; Dervaux, Benoit/0000-0002-8429-2404; Mielcarek, Nathalie/0000-0002-5968-9442	GlaxoSmithKline; Hasselt University [BOF14BL07]	GlaxoSmithKline(GlaxoSmithKline); Hasselt University	GlaxoSmithKline provided an unconditional grant to Universite Catholique de Lille to which belong SK. GB acknowledges support from a bilateral special research fund from Hasselt University (BOF14BL07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara AM, 2012, CAN J PUBLIC HEALTH, V103, P69, DOI 10.1007/BF03404072; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chan TC, 2015, EPIDEMIOL INFECT, V143, P440, DOI 10.1017/S0950268814000843; Chowell G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008164; Cowling BJ, 2008, EPIDEMIOL INFECT, V136, P562, DOI 10.1017/S0950268807008722; De Cao E, 2014, BIOSTATISTICS, V15, P470, DOI 10.1093/biostatistics/kxu008; DeStefano F, 2011, EPIDEMIOL INFECT, V139, P1181, DOI 10.1017/S095026881000230X; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Eshima N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042261; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; Fu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045113; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Grijalva CG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118457; Gustafson PE, 1998, RISK ANAL, V18, P805, DOI 10.1023/B:RIAN.0000005926.03250.c0; Haslam N, 2014, J ROY SOC MED, V107, P157, DOI 10.1177/0141076813519439; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-187; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; INSEE: National Institute of Statistics and Economic Studies, 2009, REC POP; Keeling MJ., 2011, MODELING INFECT DIS, DOI [10.2307/j.ctvcm4gk0, DOI 10.2307/J.CTVCM4GK0]; Keogh-Brown MR, 2010, EUR J HEALTH ECON, V11, P543, DOI 10.1007/s10198-009-0210-1; Klein SL, 2012, J LEUKOCYTE BIOL, V92, P67, DOI 10.1189/jlb.0811427; Lapidus N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060127; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; McCaw JM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-345; Melegaro A, 2011, EPIDEMICS-NETH, V3, P143, DOI 10.1016/j.epidem.2011.04.001; Metcalf CJE, 2009, P ROY SOC B-BIOL SCI, V276, P4111, DOI 10.1098/rspb.2009.1058; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Ogunjimi B, 2009, MATH BIOSCI, V218, P80, DOI 10.1016/j.mbs.2008.12.009; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Read JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0268; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Smieszek T, 2012, EPIDEMIOL INFECT, V140, P744, DOI 10.1017/S0950268811001130; Stehle J, 2013, SOC NETWORKS, V35, P604, DOI 10.1016/j.socnet.2013.08.003; te Beest DE, 2014, EPIDEMICS-NETH, V7, P1, DOI 10.1016/j.epidem.2014.02.001; Vandendijck Y, ANN APPL STAT; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Williams LJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036161, 10.1371/journal.pone.0048695]; Wood SN, 2006, GEN ADDITIVE MODELS; World Health Organization, 2010, SEX GEND INFL; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220	45	94	94	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133203	10.1371/journal.pone.0133203	http://dx.doi.org/10.1371/journal.pone.0133203			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26176549	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600231
J	Hao, JJ; Hao, C; Zhang, LJ; Liu, X; Zhou, XL; Dun, YL; Li, HH; Li, GS; Zhao, XL; An, YY; Liu, JK; Yu, GL				Hao, Jiejie; Hao, Cui; Zhang, Lijuan; Liu, Xin; Zhou, Xiaolin; Dun, Yunlou; Li, Haihua; Li, Guangsheng; Zhao, Xiaoliang; An, Yuanyuan; Liu, Jiankang; Yu, Guangli			OM2, a Novel Oligomannuronate-Chromium (III) Complex, Promotes Mitochondrial Biogenesis and Lipid Metabolism in 3T3-L1 Adipocytes via the AMPK-PGC1 alpha Pathway	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ADIPOSE-TISSUE; SKELETAL-MUSCLE; ENERGY SENSOR; OLIGOSACCHARIDE; RATS; AMPK; FAT; ROSIGLITAZONE; PGC-1-ALPHA	Background In our previous studies, we prepared novel oligomannuronate-chromium(III) complexes (OM2, OM4) from marine alginate, and found that these compounds sensitize insulin action better than oligomannuronate(OM), chromium, and metformin in C2C12 skeletal muscle cells. In the present study, we studied their effects on mitochondrial biogenesis, lipid metabolism, and the underlying molecular mechanisms in differentiated 3T3-L1 adipocytes. Methodology/Principal Findings We firstly used the pGL3-PGC1 alpha and pGL3-ATGL promoter plasmids to compare their effects on PGC1 alpha and ATGL transcription activities. Then mitochondrial biogenesis was quantified by transmission electron microscopy and MitoTracker staining. Mitochondrial oxygen consumption and fatty acid oxidation were measured by an oxygen biosensor system and H-3-labelled water scintillation. The mitochondrial DNA and mRNA involved in mitochondrial biogenesis and lipid oxidation were evaluated by real-time PCR. AMPK together with other protein expression levels were measured by western blotting. The inhibitor compound C and siRNA of PGC1 alpha were used to inhibit the OM2-induced AMPK-PGC1 alpha signaling pathway. And we found that OM2 stimulated AMPK-PGC1 alpha pathway in the 3T3-L1 adipocytes, which were correlated with induced mitochondrial biogenesis, improved mitochondrial function, and reduced lipid accumulation by enhanced fatty acid beta-oxidation and augmented ATGL protein expression. Conclusions/Significance Our data indicated that the marine oligosaccharide-derived OM2 might represent a novel class of molecules that could be useful for type 2 diabetes prevention and treatment by upregulating AMPK-PGC1 alpha signaling pathway.	[Hao, Jiejie; Hao, Cui; Zhang, Lijuan; Liu, Xin; Zhou, Xiaolin; Dun, Yunlou; Li, Haihua; Li, Guangsheng; Zhao, Xiaoliang; An, Yuanyuan; Yu, Guangli] Ocean Univ China, Minist Educ, Key Lab Marine Drugs, Qingdao 266003, Peoples R China; [Hao, Jiejie; Hao, Cui; Zhang, Lijuan; Liu, Xin; Zhou, Xiaolin; Dun, Yunlou; Li, Haihua; Li, Guangsheng; Zhao, Xiaoliang; An, Yuanyuan; Yu, Guangli] Ocean Univ China, Shandong Prov Key Lab Glycosci & Glycotechnol, Qingdao 266003, Peoples R China; [Liu, Jiankang] Xi An Jiao Tong Univ, Ctr Mitochondrial Biol & Med, Key Lab Biomed Informat Engn, Minist Educ,Sch Life Sci & Technol, Xian 710049, Peoples R China; [Liu, Jiankang] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Peoples R China	Ocean University of China; Ocean University of China; Xi'an Jiaotong University; Xi'an Jiaotong University	Yu, GL (corresponding author), Ocean Univ China, Minist Educ, Key Lab Marine Drugs, 5 Yushan Rd, Qingdao 266003, Peoples R China.	glyu@ouc.edu.cn	Zhang, Li/GWM-7501-2022; Rui, Zhenhua/J-8195-2019; Liu, Jiankang/A-1610-2011	Rui, Zhenhua/0000-0001-6088-0845; 	NSFC-Shandong Joint Fund for Marine Science Research Centers [U1406402]; NSFC [81402982]; Special Fund for Marine Scientific Research in the Public Interest [201005024]; National Key Technology R&D Program of the Ministry of Science and Technology [2013BAB01B02]; 973 Program [2015CB553602]	NSFC-Shandong Joint Fund for Marine Science Research Centers; NSFC(National Natural Science Foundation of China (NSFC)); Special Fund for Marine Scientific Research in the Public Interest; National Key Technology R&D Program of the Ministry of Science and Technology(National Key Technology R&D Program); 973 Program(National Basic Research Program of China)	This study was supported by NSFC-Shandong Joint Fund for Marine Science Research Centers (U1406402), the NSFC (81402982), the Special Fund for Marine Scientific Research in the Public Interest (201005024), the National Key Technology R&D Program of the Ministry of Science and Technology (2013BAB01B02), and the 973 Program (2015CB553602). No potential conflicts of interest relevant to this article were reptorted. The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of data, or in the preparation, review, or approval of the manuscript.	Agheli N, 1998, J NUTR, V128, P1283, DOI 10.1093/jn/128.8.1283; An QD, 2009, J APPL MICROBIOL, V106, P161, DOI 10.1111/j.1365-2672.2008.03988.x; Bolten CW, 2007, GENE REGUL SYST BIO, V1, P73; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Chen WL, 2012, DIABETOLOGIA, V55, P1824, DOI 10.1007/s00125-012-2530-4; [陈秀敏 CHEN Xiumin], 2003, [中国生化药物杂志, Chinese Journal of Biochemical Pharmaceutics], V24, P1; Choi D, 2009, APPL BIOCHEM BIOTECH, V159, P438, DOI 10.1007/s12010-008-8514-7; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; Fruhbeck G, 2001, FASEB J, V15, P1996, DOI 10.1096/fj.00-0829hyp; Fruhbeck Gema, 2008, V456, P1, DOI 10.1007/978-1-59745-245-8_1; Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Geng M, 2004, China Patent, Patent No. [10023827.0, 10023827]; Gratia S, 2012, CARDIOVASC RES, V95, P290, DOI 10.1093/cvr/cvs134; Guan H, 2006, China Patent, Patent No. [200610044581.4, 200610044581]; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024598; Hao JJ, 2010, J NUTR BIOCHEM, V21, P634, DOI 10.1016/j.jnutbio.2009.03.012; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kim JN, 2009, ISLETS, V1, P111, DOI 10.4161/isl.1.2.9143; Krol E, 2010, FOOD CHEM TOXICOL, V48, P2791, DOI 10.1016/j.fct.2010.07.008; Langelueddecke C, 2012, CELL PHYSIOL BIOCHEM, V29, P75, DOI 10.1159/000337589; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Ma JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003774; Manabe N, DIS ESOPHAGUS; Morak M, 2012, MOL CELL PROTEOMICS, V11, P1777, DOI 10.1074/mcp.M111.015743; Moreira PI, 2011, HANDB EXP PHARMACOL, V203, P331, DOI 10.1007/978-3-642-17214-4_14; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Phielix E, 2010, DIABETOLOGIA, V53, P1714, DOI 10.1007/s00125-010-1764-2; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Sahin K, 2011, BIOL TRACE ELEM RES, V143, P1018, DOI 10.1007/s12011-010-8905-9; Shimabukuro M, 1997, P NATL ACAD SCI USA, V94, P4637, DOI 10.1073/pnas.94.9.4637; Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888; Strugala V, 2009, J PHARM PHARMACOL, V61, P1021, DOI 10.1211/jpp/61.08.0005; Szendroedi J, 2009, DIABETES CARE, V32, P677, DOI 10.2337/dc08-2078; Toseland CDN, 2001, DIABETES OBES METAB, V3, P163, DOI 10.1046/j.1463-1326.2001.00117.x; Tusi SK, 2011, BIOMATERIALS, V32, P5438, DOI 10.1016/j.biomaterials.2011.04.024; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yuan WP, 2009, WORLD J GASTROENTERO, V15, P1339, DOI 10.3748/wjg.15.1339; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	47	13	17	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131930	10.1371/journal.pone.0131930	http://dx.doi.org/10.1371/journal.pone.0131930			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176781	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600069
J	Jaberzadeh, S; Bastani, A; Zoghi, M; Morgan, P; Fitzgerald, PB				Jaberzadeh, Shapour; Bastani, Andisheh; Zoghi, Maryam; Morgan, Prue; Fitzgerald, Paul B.			Anodal Transcranial Pulsed Current Stimulation: The Effects of Pulse Duration on Corticospinal Excitability	PLOS ONE			English	Article							MOTOR CORTICAL EXCITABILITY; MAGNETIC STIMULATION; ELECTRICAL-STIMULATION; TACS; PERCEPTION; MODULATION; SAFETY; CORTEX	The aim is to investigate the effects of pulse duration (PD) on the modulatory effects of transcranial pulsed current (tPCS) on corticospinal excitability (CSE). CSE of the dominant primary motor cortex (M1) of right first dorsal interosseous muscle was assessed by motor evoked potentials, before, immediately, 10, 20 and 30 minutes after application of five experimental conditions: 1) anodal transcranial direct current stimulation (a-tDCS), 2) a-tPCS with 125 ms pulse duartion (a-tPCS(PD = 125)), 3) a-tPCS with 250 ms pulse duration (a-tPCS(PD = 250)), 4) a-tPCS with 500 ms pulse duration (a-tPCS(PD = 500)) and 5) sham a-tPCS. The total charges were kept constant in all experimental conditions except sham condition. Post-hoc comparisons indicated that a-tPCS(PD = 500) produced larger CSE compared to a-tPCS(PD = 125) (P<0.0001), a-tPCS(PD = 250) (P = 0.009) and a-tDCS (P = 0.008). Also, there was no significant difference between a-tPCS(PD = 250) and a-tDCS on CSE changes (P>0.05). All conditions except a-tPCS(PD = 125) showed a significant difference to the sham group (P<0.006). All participants tolerated the applied currents. It could be concluded that a-tPCS with a PD of 500ms induces largest CSE changes, however further studies are required to identify optimal values.	[Jaberzadeh, Shapour; Bastani, Andisheh; Morgan, Prue] Monash Univ, Dept Physiotherapy, Sch Primary Hlth Care, Fac Med, Melbourne, Vic 3004, Australia; [Bastani, Andisheh; Zoghi, Maryam] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia; [Fitzgerald, Paul B.] Monash Univ, Cent Clin Sch & Alfred, Monash Alfred Psychiat Res Ctr, Melbourne, Vic 3004, Australia	Monash University; Royal Melbourne Hospital; University of Melbourne; Monash University	Jaberzadeh, S (corresponding author), Monash Univ, Dept Physiotherapy, Sch Primary Hlth Care, Fac Med, Melbourne, Vic 3004, Australia.	shapour.jaberzadeh@monash.edu	Fitzgerald, Paul B/A-1225-2008; , Zoghi/AAF-9536-2019	Fitzgerald, Paul B/0000-0003-4217-8096; , Zoghi/0000-0002-1819-6895	Monash University; Postgraduate Publication Award scheme	Monash University(Monash University); Postgraduate Publication Award scheme	This work was supported by the Monash University, Faculty Grant, Strategic Grant Scheme (SJ, MZ, PM, PBF) and Postgraduate Publication Award scheme (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2008, BRAIN STIMUL, V1, P97, DOI 10.1016/j.brs.2007.10.001; Bastani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047582; Bergmann TO, 2009, J NEUROPHYSIOL, V102, P2303, DOI 10.1152/jn.00437.2009; Brunoni AR, 2011, INT J NEUROPSYCHOPH, V14, P1133, DOI 10.1017/S1461145710001690; Dundas JE, 2007, CLIN NEUROPHYSIOL, V118, P1166, DOI 10.1016/j.clinph.2007.01.010; Durand S, 2002, J PHYSIOL-LONDON, V540, P261, DOI 10.1113/jphysiol.2001.013364; George MS, 2010, NEUROPSYCHOPHARMACOL, V35, P301, DOI 10.1038/npp.2009.87; Gilmore K L, 1983, Aust J Physiother, V29, P3, DOI 10.1016/S0004-9514(14)60659-0; Groppa S, 2010, NEUROSCIENCE, V166, P1219, DOI 10.1016/j.neuroscience.2010.01.019; Hallett M, 1996, ANN NEUROL, V40, P344, DOI 10.1002/ana.410400303; Jaberzadeh S, 2014, CLIN NEUROPHYSIOL, V125, P344, DOI 10.1016/j.clinph.2013.08.025; Kanai R, 2010, CLIN NEUROPHYSIOL, V121, P1551, DOI 10.1016/j.clinph.2010.03.022; Kanai R, 2008, CURR BIOL, V18, P1839, DOI 10.1016/j.cub.2008.10.027; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kendall F., 2010, MUSCLES TESTING FUNC, V5th ed; Lakhanpal Rohit R, 2003, Curr Opin Ophthalmol, V14, P122, DOI 10.1097/00055735-200306000-00002; Nitsche MA, 2003, SUPPL CLIN NEUROPHYS, V56, P255; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Noordzij M, 2010, NEPHROL DIAL TRANSPL, P732; Oh S.J., 2003, CLIN ELECTROMYOGRAPH, DOI [10.1046/j.1468-1331.2003.00654.x, DOI 10.1046/J.1468-1331.2003.00654.X]; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pahn U, 2008, BRAIN STIMUL, V1, P386, DOI 10.1016/j.brs.2008.04.003; Paulus W, 2011, NEUROPSYCHOL REHABIL, V21, P602, DOI 10.1080/09602011.2011.557292; Pell GS, 2011, PROG NEUROBIOL, V93, P59, DOI 10.1016/j.pneurobio.2010.10.003; Perotto A., 2005, ANATOMICAL GUIDE ELE; Robertson V, 2006, ELECTROTHERAPY EXPLA, V4th; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Schwartz M. S., 2003, BIOFEEDBACK PRACTITI, V3rd; Turi Z, 2013, RESTOR NEUROL NEUROS, V31, P275, DOI 10.3233/RNN-120297; Wassermann E., 2008, OXFORD HDB TRANSCRAN; Zaghi S, 2010, NEUROSCI LETT, V479, P211, DOI 10.1016/j.neulet.2010.05.060	32	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131779	10.1371/journal.pone.0131779	http://dx.doi.org/10.1371/journal.pone.0131779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177541	Green Submitted, gold, Green Published			2022-12-27	WOS:000358197600064
J	Kuhle, S; Maguire, B; Ata, N; Hamilton, D				Kuhle, Stefan; Maguire, Bryan; Ata, Nicole; Hamilton, David			Percentile Curves for Anthropometric Measures for Canadian Children and Youth	PLOS ONE			English	Article							TO-HEIGHT RATIO; WAIST CIRCUMFERENCE PERCENTILES; CARDIOVASCULAR RISK-FACTORS; BODY-MASS INDEX; ABDOMINAL OBESITY; SKINFOLD THICKNESSES; GROWTH REFERENCE; FAT DISTRIBUTION; CENTILE CURVES; METABOLIC RISK	Body mass index (BMI) is commonly used to assess a child's weight status but it does not provide information about the distribution of body fat. Since the disease risks associated with obesity are related to the amount and distribution of body fat, measures that assess visceral or subcutaneous fat, such as waist circumference (WC), waist-to-height ratio (WHtR), or skinfolds thickness may be more suitable. The objective of this study was to develop percentile curves for BMI, WC, WHtR, and sum of 5 skinfolds (SF5) in a representative sample of Canadian children and youth. The analysis used data from 4115 children and adolescents between 6 and 19 years of age that participated in the Canadian Health Measures Survey Cycles 1 (2007/2009) and 2 (2009/2011). BMI, WC, WHtR, and SF5 were measured using standardized procedures. Age-and sex-specific centiles were calculated using the LMS method and the percentiles that intersect the adult cutpoints for BMI, WC, and WHtR at age 18 years were determined. Percentile curves for all measures showed an upward shift compared to curves from the pre-obesity epidemic era. The adult cutoffs for overweight and obesity corresponded to the 72nd and 91st percentile, respectively, for both sexes. The current study has presented for the first time percentile curves for BMI, WC, WHtR, and SF5 in a representative sample of Canadian children and youth. The percentile curves presented are meant to be descriptive rather than prescriptive as associations with cardiovascular disease markers or outcomes were not assessed.	[Kuhle, Stefan; Maguire, Bryan] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Kuhle, Stefan; Maguire, Bryan] Dalhousie Univ, Dept Obstet & Gynaecol, Halifax, NS, Canada; [Maguire, Bryan; Hamilton, David] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada; [Ata, Nicole] Dalhousie Univ, Sch Hlth & Human Performance, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	Kuhle, S (corresponding author), Dalhousie Univ, Dept Pediat, Halifax, NS, Canada.	stefan.kuhle@dal.ca	Kuhle, Stefan/X-5815-2019	Kuhle, Stefan/0000-0001-9417-3727	IWK Health Centre Establishment Grant award [09020]	IWK Health Centre Establishment Grant award	This work was supported by an IWK Health Centre (http://www.iwk.nshealth.ca) Establishment Grant awarded to Dr. Stefan Kuhle (# 09020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo OY, 2010, AM J CLIN NUTR, V91, P635, DOI 10.3945/ajcn.2009.28385; [Anonymous], 2014, R LANG ENV STAT COMP; Anzo M, 2014, ANN HUM BIOL, P1; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Brambilla P, 2006, INT J OBESITY, V30, P23, DOI 10.1038/sj.ijo.0803163; Brannsether B, 2011, ACTA PAEDIATR, V100, P1576, DOI 10.1111/j.1651-2227.2011.02370.x; Canadian Society for Exercise Physiology, 2003, CAN PHYS ACT FITN LI; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Daniels SR, 1999, CIRCULATION, V99, P541, DOI 10.1161/01.CIR.99.4.541; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; Freedman DS, 2009, PEDIATRICS, V124, pS23, DOI 10.1542/peds.2008-3586E; FREEDMAN DS, 1985, JAMA-J AM MED ASSOC, V254, P515, DOI 10.1001/jama.254.4.515; Freedman DS, 1999, AM J CLIN NUTR, V69, P308; Gonzalez AS, 2007, NUTRITION, V23, P36, DOI 10.1016/j.nut.2006.08.019; Gruson E, 2010, HEART, V96, P136, DOI 10.1136/hrt.2009.171447; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; JAMES WPT, 1988, EUR J CLIN NUTR, V42, P969; Katzmarzyk PT, 2004, EUR J CLIN NUTR, V58, P1011, DOI 10.1038/sj.ejcn.1601924; Kromeyer-Hauschild K, 2013, OBESITY FACTS, V6, P165, DOI 10.1159/000351066; Kromeyer-Hauschild K, 2011, INT J PEDIATR OBES, V6, pE129, DOI 10.3109/17477166.2010.490267; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Maffeis C, 2001, OBES RES, V9, P179, DOI 10.1038/oby.2001.19; Maffeis C, 2008, J PEDIATR-US, V152, P207, DOI 10.1016/j.jpeds.2007.09.021; MARKS GC, 1989, AM J EPIDEMIOL, V130, P578, DOI 10.1093/oxfordjournals.aje.a115372; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; McCarthy HD, 2001, EUR J CLIN NUTR, V55, P902, DOI 10.1038/sj.ejcn.1601240; Neuhauser H, 2011, REFERENZPERZENTILE A; Nooyens ACJ, 2007, AM J CLIN NUTR, V85, P1533, DOI 10.1093/ajcn/85.6.1533; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Rigby RA, 2004, STAT MED, V23, P3053, DOI 10.1002/sim.1861; Rigby RA, 2006, STAT MODEL, V6, P209, DOI 10.1191/1471082X06st122oa; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Statistics Canada, 2013, CAN HLTH MEAS SURV C; Statistics Canada, 2011, CAN HLTH MEAS SURV C; Statistics Canada, 2012, CAN HLTH MEAS SURV C; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; van Buuren S, 2001, STAT MED, V20, P1259, DOI 10.1002/sim.746; World Health Organization, 1995, PHYS STAT US INT ANT	44	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132891	10.1371/journal.pone.0132891	http://dx.doi.org/10.1371/journal.pone.0132891			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176769	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600174
J	Lian, M; Luo, WJ; Sui, YH; Li, ZP; Hua, J				Lian, Min; Luo, Wenjing; Sui, Yongheng; Li, Zhiping; Hua, Jing			Dietary n-3 PUFA Protects Mice from Con A Induced Liver Injury by Modulating Regulatory T Cells and PPAR-gamma Expression	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; POLYUNSATURATED FATTY-ACIDS; FISH-OIL; SYSTEMIC INFLAMMATION; ADIPOSE-TISSUE; IMMUNOREGULATION; GENERATION; RESPONSES; ROLES; RICH	Background Dietary n-3 polyunsaturated fatty acids (PUFA) exert anti-inflammatory and immunoregulatory effects through down-regulating the innate and adoptive immune response. However, the effect of dietary n-3 PUFA on CD4(+)CD25(+) regulatory T cells (Tregs) is unclear. Aims The current study was to examine the relationship between n-3 PUFA and Tregs as well as their immunoregulatory effect in immune-mediated liver injury. Methods The mice model feeding with n-3 PUFA-enriched diet was established and Tregs were analyzed. Effect of docosahexaenoic acid (DHA) on Tregs proliferation and induction was determined in vitro. The potential immunotherapeutic effect of dietary n-3 PUFA was investigated through Con A-induced hepatitis model. Results Long-term administration of dietary n-3 PUFA significantly increased hepatic Tregs and modulated their phenotype. n-3 PUFA or DHA directly increased natural Tregs (nTreg) proliferation but didn't increase inducible Tregs (iTreg). In addition, the expression of peroxisome proliferator activated receptor gamma (PPAR-gamma), transforming growth factor beta (TGF beta) and interleukin (IL)-10 were significantly up-regulated in n-3 PUFA-enriched diet-fed mice. Finally, n-3 PUFA-enriched diet alleviated liver injury induced by Con A and down-regulated pro-inflammatory cytokines expression, accompanied by increased PPAR-gamma expression. Conclusion Dietary n-3 PUFA enhanced Tregs generation through up-regulating PPAR-gamma and TGF-beta expression, and protected mice from Con A-induced liver injury. This finding provides a promising potential therapeutic method in treating inflammatory and autoimmune disease.	[Lian, Min; Luo, Wenjing; Sui, Yongheng; Hua, Jing] Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Div Gastroenterol & Hepatol, Ren Ji Hosp,Sch Med, Shanghai 200030, Peoples R China; [Li, Zhiping] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	Shanghai Jiao Tong University; Johns Hopkins University	Hua, J (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Div Gastroenterol & Hepatol, Ren Ji Hosp,Sch Med, Shanghai 200030, Peoples R China.	hua-jing88@hotmail.com			National Natural Science Foundation of China [81170374, 81470842]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (JH, NO. 81170374, NO. 81470842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anz D, 2011, INT J CANCER, V129, P2417, DOI 10.1002/ijc.25902; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Belluzzi A, 2000, AM J CLIN NUTR, V71, p339S, DOI 10.1093/ajcn/71.1.339s; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; BERGMEYER HU, 1978, CLIN CHEM, V24, P58; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Camuesco D, 2005, J NUTR, V135, P687, DOI 10.1093/jn/135.4.687; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Clark RB, 2000, J IMMUNOL, V164, P1364, DOI 10.4049/jimmunol.164.3.1364; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Ferramosca A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038797; Galli C, 2009, ANN NUTR METAB, V55, P123, DOI 10.1159/000228999; Gosset P, 2001, EUR J IMMUNOL, V31, P2857, DOI 10.1002/1521-4141(2001010)31:10<2857::AID-IMMU2857>3.0.CO;2-X; Hammad H, 2004, AM J PATHOL, V164, P263, DOI 10.1016/S0002-9440(10)63116-1; Han SC, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-44; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Hontecillas R, 2007, J IMMUNOL, V178, P2940, DOI 10.4049/jimmunol.178.5.2940; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Itariu BK, 2012, AM J CLIN NUTR, V96, P1137, DOI 10.3945/ajcn.112.037432; Iwami D, 2009, AM J TRANSPLANT, V9, P1294, DOI 10.1111/j.1600-6143.2009.02641.x; Iwami D, 2011, INT IMMUNOPHARMACOL, V11, P384, DOI 10.1016/j.intimp.2010.11.035; Jaudszus A, 2013, J LIPID RES, V54, P923, DOI 10.1194/jlr.P031260; Li CC, 2014, J NUTR BIOCHEM, V25, P19, DOI 10.1016/j.jnutbio.2013.08.010; Li J, 2014, MOL ENDOCRINOL, V28, P1316, DOI 10.1210/me.2014-1011; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Longhi MS, 2006, J IMMUNOL, V176, P4484, DOI 10.4049/jimmunol.176.7.4484; Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.jhep.2004.03.008; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Volker D, 2000, J RHEUMATOL, V27, P2343; Wan YSY, 2006, IMMUNOL REV, V212, P114, DOI 10.1111/j.0105-2896.2006.00407.x; Wei HX, 2008, J IMMUNOL, V181, P7221, DOI 10.4049/jimmunol.181.10.7221; Wohlfert EA, 2007, J IMMUNOL, V178, P4129, DOI 10.4049/jimmunol.178.7.4129; Yang XH, 2006, J HEPATOL, V45, P254, DOI 10.1016/j.jhep.2006.01.036; Yates CM, 2014, PHARMACOL THERAPEUT, V141, P272, DOI 10.1016/j.pharmthera.2013.10.010; Yessoufou A, 2009, J LIPID RES, V50, P2377, DOI 10.1194/jlr.M900101-JLR200; Zhao WP, 2013, CLIN IMMUNOL, V149, P119, DOI 10.1016/j.clim.2013.07.002	40	32	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132741	10.1371/journal.pone.0132741	http://dx.doi.org/10.1371/journal.pone.0132741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177196	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600149
J	Rokunuzzaman, M; Islam, MT; Arshad, H; Singh, MJ; Misran, N				Rokunuzzaman, Md.; Islam, Mohammad Tariqul; Arshad, Haslina; Singh, Mandeep Jit; Misran, Norbahiah			Design and Experimental Evaluation of Modified Square Loop Feeding for UHF RFID Tags	PLOS ONE			English	Article							ANTENNA	This paper addresses the performance evaluation of a modified square loop antenna design for UHF RFID applications that is excited through a narrow feed line connected to a square loop, an impedance matching network. The square loop dimensions are modified to reach a conjugate impedance matching. A gap is fixed between the feed-lines to link the chip. To achieve impedance matching, the structures of the feed-line are optimized accordingly. In addition, the antenna consists of a straightforward geometry. An 11.9-meter maximum read range is achieved using a compact size of 80 x 44 mm(2) and 3.2 W for the effective isotropic radiated power. Additional findings reveal that the proposed tag antenna is able to provide a stable resonance response in the near field of a large metallic surface.	[Rokunuzzaman, Md.; Islam, Mohammad Tariqul; Singh, Mandeep Jit; Misran, Norbahiah] Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Fac Engn & Built Environm, Bangi 43600, Selangor, Malaysia; [Arshad, Haslina] Univ Kebangsaan Malaysia, Sch Informat Technol, Fac Informat Sci & Technol, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Islam, MT (corresponding author), Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Fac Engn & Built Environm, Bangi 43600, Selangor, Malaysia.	tariqul@ukm.edu.my	Islam, Mohammad Tariqul/E-6380-2012; singh, mandeep/W-7242-2019; arshad, haslina/AAF-8737-2019; Misran, Norbahiah/U-1666-2019; Islam, Mohammad Tariqul/M-7377-2016; Singh, Mandeep/AAC-8680-2020	Islam, Mohammad Tariqul/0000-0002-4929-3209; Misran, Norbahiah/0000-0002-6142-8591; Islam, Mohammad Tariqul/0000-0002-4929-3209; Zaman, M. R./0000-0001-9715-4652	Universiti Kebangsaan Malaysia, University research grant [DIP-2014-029]	Universiti Kebangsaan Malaysia, University research grant	This work is supported by the Universiti Kebangsaan Malaysia, University research grant code no. DIP-2014-029.	Abdulhadi AE, 2012, IEEE ANTENN WIREL PR, V11, P248, DOI 10.1109/LAWP.2012.2187632; Chawla V, 2007, IEEE COMMUN MAG, P11; Cho C, 2005, ELECTRON LETT, V41, P1091, DOI 10.1049/el:20052337; Deavours DD, 2009, 2009 IEEE INT C 2009; Deleruyelle T, 2010, IEEE ANTENN PROPAG M, V52, P14, DOI 10.1109/MAP.2010.5638229; Dongho K, 2012, ANTENNAS PROPAGATION, V60, P2620, DOI [DOI 10.1109/TAP.2012.2194638, 10.1109/TAP.2012.2194638]; Gustafsson M, 2006, ANTENNAS PROPAGATION; Hong W, 2010, APPL COMPUT ELECTROM, V25, P190; Horng-Dean C, 2012, ANTENNAS PROPAGATION, V60, P2166, DOI [DOI 10.1109/TAP.2012.2189702, 10.1109/TAP.2012.2189702]; Jeongki R, 2012, ANTENNAS PROPAGATION, V60, P377, DOI [10.1109/TAP.2011.2167911, DOI 10.1109/TAP.2011.2167911]; Lingfei M, 2010, ANTENNAS PROPAGATION, V58, P3037, DOI [10.1109/TAP.2010.2052570, DOI 10.1109/TAP.2010.2052570]; Liu H-N, 2006, ANTENNAS PROPAGATION; Mo L, 2008, ELECTRON LETT, V44, P1173, DOI 10.1049/el:20089813; NXP, 2013, UCODE G2IL; Santiago AG, 2013, IEEE ANTENN WIREL PR, V12, P136, DOI 10.1109/LAWP.2013.2243400; Tae-Wan K, 2011, ANTENNAS WIRELESS PR, V10, P1010, DOI 10.1109/LAWP.2011.2166370; Vorobyov A, 2012, PROG ELECTROMA RES M, V22, P259, DOI 10.2528/PIERM11112306; Xu L, 2008, ELECTRON LETT, V44, P79, DOI 10.1049/el:20083009	18	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132530	10.1371/journal.pone.0132530	http://dx.doi.org/10.1371/journal.pone.0132530			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177376	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600121
J	Song, CG; Wang, JC; Mo, CP; Mu, SH; Jiang, XG; Li, XY; Zhong, SZ; Zhao, ZF; Zhou, GQ				Song, Chengang; Wang, Jiachuan; Mo, Cuiping; Mu, Shuhua; Jiang, Xiaogang; Li, Xiaoyun; Zhong, Shizhen; Zhao, Zhenfu; Zhou, Guangqian			Use of Ferritin Expression, Regulated by Neural Cell-Specific Promoters in Human Adipose Tissue-Derived Mesenchymal Stem Cells, to Monitor Differentiation with Magnetic Resonance Imaging In Vitro	PLOS ONE			English	Article							IRON-OXIDE; TRACKING; VIVO; TRANSPLANTATION; OVEREXPRESSION; SURVIVAL; REPORTER; HEART; MODEL; GENE	The purpose of this study was to establish a method for monitoring the neural differentiation of stem cells using ferritin transgene expression, under the control of a neural-differentiation-inducible promoter, and magnetic resonance imaging (MRI). Human adipose tissue-derived mesenchymal stem cells (hADMSCs) were transduced with a lentivirus containing the human ferritin heavy chain 1 (FTH1) gene coupled to one of three neural cell-specific promoters: human synapsin 1 promoter (SYN1p, for neurons), human glial fibrillary acidic protein promoter (GFAPp, for astrocytes), and human myelin basic protein promoter (MBPp, for oligodendrocytes). Three groups of neural-differentiation-inducible ferritin-expressing (NDIFE) hADMSCs were established: SYN1p-FTH1, GFAPp-FTH1, and MBPp-FTH1. The proliferation rate of the NDIFE hADMSCs was evaluated using a Cell Counting Kit-8 assay. Ferritin expression was assessed with western blotting and immunofluorescent staining before and after the induction of differentiation in NDIFE hADMSCs. The intracellular iron content was measured with Prussian blue iron staining and inductively coupled plasma mass spectrometry. R2 relaxation rates were measured with MRI in vitro. The proliferation rates of control and NDIFE hADMSCs did not differ significantly (P > 0.05). SYN1p-FTH1, GFAPp-FTH1, and MBPp-FTH1 hADMSCs expressed specific markers of neurons, astrocytes, and oligodendrocytes, respectively, after neural differentiation. Neural differentiation increased ferritin expression twofold, the intracellular iron content threefold, and the R2 relaxation rate two-to threefold in NDIFE hADMSCs, resulting in notable hypointensity in T2-weighted images (P < 0.05). These results were cross-validated. Thus, a link between neural differentiation and MRI signals (R2 relaxation rate) was established in hADMSCs. The use of MRI and neural-differentiation-inducible ferritin expression is a viable method for monitoring the neural differentiation of hADMSCs.	[Song, Chengang; Zhong, Shizhen] Southern Med Univ, Inst Clin Anat, Dept Anat, Guangzhou, Guangdong, Peoples R China; [Wang, Jiachuan; Mo, Cuiping; Mu, Shuhua; Zhao, Zhenfu; Zhou, Guangqian] Shenzhen Univ, Sch Med, Shenzhen, Peoples R China; [Wang, Jiachuan] Guangzhou Univ Tradit Chinese Med, Dept Pathol, Shenzhen Affiliated Hosp, Shenzhen, Peoples R China; [Jiang, Xiaogang] Southern Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Li, Xiaoyun] S China Normal Univ, Guangdong Prov Key Lab Biotechnol Plant Dev, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Shenzhen University; Guangzhou University of Chinese Medicine; Southern Medical University - China; South China Normal University	Zhong, SZ (corresponding author), Southern Med Univ, Inst Clin Anat, Dept Anat, Guangzhou, Guangdong, Peoples R China.	zhszh@fimmu.com; zhb@szu.edu.cn; gqzhou@szu.edu.cn	MU, shuhua/CAG-2304-2022; 王, 家传/ACG-4186-2022	王, 家传/0000-0001-9517-924X; mu, shuhua/0000-0002-4457-6795	Shenzhen Key Laboratory foundation [ZDSYS 20140509100746679]; Natural Science Foundation of Shenzhen University [201119]; Medical Science Foundation of Guangdong Province [A2014511]; science technology and innovation committee of Shenzhen for basic research projects [JYJC20130327093948937, JCYJ20130401164750005]	Shenzhen Key Laboratory foundation; Natural Science Foundation of Shenzhen University; Medical Science Foundation of Guangdong Province; science technology and innovation committee of Shenzhen for basic research projects	The Shenzhen Key Laboratory foundation (No. ZDSYS 20140509100746679), the Natural Science Foundation of Shenzhen University (No. 201119), the Medical Science Foundation of Guangdong Province (No. A2014511), and the science technology and innovation committee of Shenzhen for basic research projects (Grant Nos. JYJC20130327093948937 and JCYJ20130401164750005).	Bahat-Stroomza M, 2009, J MOL NEUROSCI, V39, P199, DOI 10.1007/s12031-008-9166-3; BARRES BA, 1993, DEVELOPMENT, V118, P283; Campan M, 2011, AM J PHYSIOL-HEART C, V300, pH2238, DOI 10.1152/ajpheart.00935.2010; Cecchi C, 2011, J ALZHEIMERS DIS, V27, P651, DOI 10.3233/JAD-2011-110590; Choong PF, 2007, CYTOTHERAPY, V9, P170, DOI 10.1080/14653240701196829; Guan M, 2014, EUR CYTOKINE NETW, V25, P58, DOI 10.1684/ecn.2014.0357; Guan YM, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-41; Hill PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025409; Hou ZL, 2013, CELL ADHES MIGR, V7, P404, DOI 10.4161/cam.26941; Janowski M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097631; Kuroda H, 2008, J GENE MED, V10, P1163, DOI 10.1002/jgm.1249; Lee JH, 2012, BIOMATERIALS, V33, P4861, DOI 10.1016/j.biomaterials.2012.03.035; Leite C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111059; Liu J, 2009, TISSUE ENG PART C-ME, V15, P739, DOI 10.1089/ten.TEC.2008.0678; Naumova AV, 2014, J CARDIOVASC PHARM T, V19, P358, DOI 10.1177/1074248414525999; Naumova AV, 2010, MOL IMAGING, V9, P201, DOI 10.2310/7290.2010.00020; Park HW, 2007, PROTEOMICS, V7, P2881, DOI 10.1002/pmic.200700089; Stacpoole SRL, 2013, STEM CELL REP, V1, P437, DOI 10.1016/j.stemcr.2013.09.006; Wang FF, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-52; WRABETZ L, 1993, J NEUROSCI RES, V36, P455, DOI 10.1002/jnr.490360412; Yan YF, 2014, NEURAL REGEN RES, V9, P798, DOI 10.4103/1673-5374.131596; Yin XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105118	22	6	8	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132480	10.1371/journal.pone.0132480	http://dx.doi.org/10.1371/journal.pone.0132480			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176961	Green Submitted, gold, Green Published			2022-12-27	WOS:000358197600116
J	Wu, JX; Zhang, ZG; Zhang, Q; Liu, YY; Zhu, BT; Cao, J; Li, ZP; Han, LZ; Jia, JZ; Zhao, GY; Sun, XH				Wu, Jinxia; Zhang, Zhiguo; Zhang, Qian; Liu, Yayun; Zhu, Butuo; Cao, Jian; Li, Zhanpeng; Han, Longzhi; Jia, Jizeng; Zhao, Guangyao; Sun, Xuehui			Generation of Wheat Transcription Factor FOX Rice Lines and Systematic Screening for Salt and Osmotic Stress Tolerance	PLOS ONE			English	Article							FULL-LENGTH CDNA; ABIOTIC STRESSES; FUNCTIONAL-ANALYSIS; EXPRESSION SYSTEM; DRAFT SEQUENCE; HUNTING SYSTEM; OF-FUNCTION; T-DNA; GENE; GENOME	Transcription factors (TFs) play important roles in plant growth, development, and responses to environmental stress. In this study, we collected 1,455 full-length (FL) cDNAs of TFs, representing 45 families, from wheat and its relatives Triticum urartu, Aegilops speltoides, Aegilops tauschii, Triticum carthlicum, and Triticum aestivum. More than 15,000 T-0 TF FOX (Full-length cDNA Over-eXpressing) rice lines were generated; of these, 10,496 lines set seeds. About 14.88% of the T-0 plants showed obvious phenotypic changes. T-1 lines (5,232 lines) were screened for salt and osmotic stress tolerance using 150 mM NaCl and 20% (v/v) PEG-4000, respectively. Among them, five lines (591, 746, 1647, 1812, and J4065) showed enhanced salt stress tolerance, five lines (591, 746, 898, 1078, and 1647) showed enhanced osmotic stress tolerance, and three lines (591, 746, and 1647) showed both salt and osmotic stress tolerance. Further analysis of the T-DNA flanking sequences showed that line 746 over-expressed TaEREB1, line 898 over-expressed TabZIPD, and lines 1812 and J4065 over-expressed TaOBF1a and TaOBF1b, respectively. The enhanced salt and osmotic stress tolerance of lines 898 and 1812 was confirmed by retransformation of the respective genes. Our results demonstrate that a heterologous FOX system may be used as an alternative genetic resource for the systematic functional analysis of the wheat genome.	[Wu, Jinxia; Zhang, Zhiguo; Zhang, Qian; Liu, Yayun; Zhu, Butuo; Li, Zhanpeng; Sun, Xuehui] Chinese Acad Agr Sci, Biotechnol Res Inst, Natl Key Facil Gene Resources & Gene Improvement, Beijing 100081, Peoples R China; [Cao, Jian; Han, Longzhi; Jia, Jizeng; Zhao, Guangyao] Chinese Acad Agr Sci, Inst Crop Sci, Chinese Natl Key Facil Gene Resources & Gene Impr, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhao, GY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Chinese Natl Key Facil Gene Resources & Gene Impr, Beijing 100081, Peoples R China.	zhaoguangyao@caas.cn; sunxuehui@caas.cn			National Special Grant for Transgenic Crops [ZX08001-003, ZX08009-24B]	National Special Grant for Transgenic Crops	This research was funded by National Special Grant for Transgenic Crops (ZX08001-003 and ZX08009-24B).	Albinsky D, 2010, MOL PLANT, V3, P125, DOI 10.1093/mp/ssp069; Baloglu MC, 2014, GENE, V550, P117, DOI 10.1016/j.gene.2014.08.025; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Chen RM, 2005, PLANT SCI, V169, P1146, DOI 10.1016/j.plantsci.2005.07.018; Chen WQJ, 2004, TRENDS PLANT SCI, V9, P591, DOI 10.1016/j.tplants.2004.10.007; Dubouzet JG, 2011, PLANT BIOTECHNOL J, V9, P466, DOI 10.1111/j.1467-7652.2010.00568.x; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Higuchi M, 2012, METHODS MOL BIOL, V847, P75, DOI 10.1007/978-1-61779-558-9_8; Higuchi M, 2011, METHODS MOL BIOL, V678, P77, DOI 10.1007/978-1-60761-682-5_7; Higuchi-Takeuchi M, 2013, INT J DEV BIOL, V57, P517, DOI 10.1387/ijdb.130176mm; Higuchi-Takeuchi M, 2011, PLANT PHYSIOL, V157, P96, DOI 10.1104/pp.111.181248; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kobayashi F, 2008, J EXP BOT, V59, P891, DOI 10.1093/jxb/ern014; Kovalchuk N, 2013, PLANT BIOTECHNOL J, V11, P659, DOI 10.1111/pbi.12056; Kuromori T, 2009, PLANT CELL PHYSIOL, V50, P1215, DOI 10.1093/pcp/pcp078; Lin R, 2007, PHYSIOL MOL PLANT P, V70, P60, DOI 10.1016/j.pmpp.2007.06.002; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Mao X, 2014, PLOS ONE, V10; Marcolino-Gomes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062294; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nakamura H, 2007, PLANT MOL BIOL, V65, P357, DOI 10.1007/s11103-007-9243-y; Peng H, 2005, PLANT SCI, V168, P1571, DOI 10.1016/j.plantsci.2005.02.011; Rong W, 2014, PLANT BIOTECHNOL J, V12, P468, DOI 10.1111/pbi.12153; Sakurai T, 2011, PLANT CELL PHYSIOL, V52, P265, DOI 10.1093/pcp/pcq190; Wan SY, 2009, PLANT MOL BIOL, V69, P69, DOI 10.1007/s11103-008-9406-5; Wang YH, 2009, PLANT MOL BIOL REP, V27, P454, DOI 10.1007/s11105-009-0111-6; Yang YZ, 2004, PLANT SCI, V167, P281, DOI 10.1016/j.plantsci.2004.03.026; Yi N, 2010, PLANTA, V232, P743, DOI 10.1007/s00425-010-1212-z; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhang LC, 2014, PLANT CELL PHYSIOL, V55, P1802, DOI 10.1093/pcp/pcu109; Zhang LN, 2015, PHYSIOL PLANTARUM, V153, P538, DOI 10.1111/ppl.12261	34	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132314	10.1371/journal.pone.0132314	http://dx.doi.org/10.1371/journal.pone.0132314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176782	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600099
J	Aviziotis, IG; Kavousanakis, ME; Boudouvis, AG				Aviziotis, Ioannis G.; Kavousanakis, Michail E.; Boudouvis, Andreas G.			Effect of Intrinsic Noise on the Phenotype of Cell Populations Featuring Solution Multiplicity: An Artificial lac Operon Network Paradigm	PLOS ONE			English	Article							MONTE-CARLO-SIMULATION; POSITIVE-FEEDBACK LOOP; BISTABLE BEHAVIOR; ESCHERICHIA-COLI; GENETIC NETWORK; HETEROGENEITY; MODEL; EXPRESSION; DYNAMICS; GROWTH	Heterogeneity in cell populations originates from two fundamentally different sources: the uneven distribution of intracellular content during cell division, and the stochastic fluctuations of regulatory molecules existing in small amounts. Discrete stochastic models can incorporate both sources of cell heterogeneity with sufficient accuracy in the description of an isogenic cell population; however, they lack efficiency when a systems level analysis is required, due to substantial computational requirements. In this work, we study the effect of cell heterogeneity in the behaviour of isogenic cell populations carrying the genetic network of lac operon, which exhibits solution multiplicity over a wide range of extracellular conditions. For such systems, the strategy of performing solely direct temporal solutions is a prohibitive task, since a large ensemble of initial states needs to be tested in order to drive the system-through long time simulations-to possible co-existing steady state solutions. We implement a multiscale computational framework, the so-called "equation-free" methodology, which enables the performance of numerical tasks, such as the computation of coarse steady state solutions and coarse bifurcation analysis. Dynamically stable and unstable solutions are computed and the effect of intrinsic noise on the range of bistability is efficiently investigated. The results are compared with the homogeneous model, which neglects all sources of heterogeneity, with the deterministic cell population balance model, as well as with a stochastic model neglecting the heterogeneity originating from intrinsic noise effects. We show that when the effect of intrinsic source of heterogeneity is intensified, the bistability range shifts towards higher extracellular inducer concentration values.	[Aviziotis, Ioannis G.; Kavousanakis, Michail E.; Boudouvis, Andreas G.] Natl Tech Univ Athens, Sch Chem Engn, Athens, Greece	National Technical University of Athens	Kavousanakis, ME (corresponding author), Natl Tech Univ Athens, Sch Chem Engn, Athens, Greece.	mihkavus@chemeng.ntua.gr	Boudouvis, Andreas G/B-2307-2010; Kavousanakis, Mihalis/V-3519-2019; Kavousanakis, Michail/AAO-1292-2020; Kavousanakis, Michail/AAS-6198-2020	Boudouvis, Andreas G/0000-0001-6651-7318; Kavousanakis, Michail/0000-0001-6621-9249				Alberts B., 1994, MOL BIOL CELL; Aviziotis IG, 2015, J MATH BIOL, V70, P1457, DOI 10.1007/s00285-014-0799-2; Baek K, 2003, J MOL BIOL, V334, P363, DOI 10.1016/j.jmb.2003.09.037; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Beckwith JR, 1970, THE LACTOSE OPERON; BLOCK DE, 1990, BIOTECHNOL PROGR, V6, P504, DOI 10.1021/bp00006a015; Bruggeman FJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000506; CHUNG JD, 1995, BIOTECHNOL BIOENG, V47, P234, DOI 10.1002/bit.260470215; COHN M, 1959, J BACTERIOL, V78, P613, DOI 10.1128/JB.78.5.613-623.1959; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; das Neves RP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000560; DELBRUCK M, 1945, J BACTERIOL, V50, P131; Dien BS, 1994, THESIS U MINNESOTA M; Elgart V, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041106; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gear CW, 2002, COMPUT CHEM ENG, V26, P941, DOI 10.1016/S0098-1354(02)00020-0; Gear CW., 2001, PROJECTIVE INTEGRATI, P2001; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOEDDEL DV, 1977, P NATL ACAD SCI USA, V74, P3292, DOI 10.1073/pnas.74.8.3292; Gorochowski TE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042790; Hallen M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002209; HATZIS C, 1995, BIOSYSTEMS, V36, P19, DOI 10.1016/0303-2647(95)01524-O; Hellweger FL, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-18; Higham DJ, 2001, SIAM REV, V43, P525, DOI 10.1137/S0036144500378302; Johnston IG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002416; Kavousanakis ME, 2009, CHEM ENG SCI, V64, P4247, DOI 10.1016/j.ces.2009.06.054; Keller H.B., 1977, APPL BIFURCATION THE; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kevrekidis IG, 2004, AICHE J, V50, P1346, DOI 10.1002/aic.10106; Kevrekidis IG, 2003, COMMUNICATIONS MATH, V1, P715, DOI DOI 10.4310/CMS.2003.V1.N4.A5; Maeda YT, 2006, J MOL BIOL, V359, P1107, DOI 10.1016/j.jmb.2006.03.064; Mantzaris NV, 2007, BIOPHYS J, V92, P4271, DOI 10.1529/biophysj.106.100271; Mantzaris NV, 2006, J THEOR BIOL, V241, P690, DOI 10.1016/j.jtbi.2006.01.005; Mantzaris NV, 2005, COMPUT CHEM ENG, V29, P897, DOI 10.1016/j.compchemeng.2004.09.012; Matsumoto Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/489265; Miller JH, 1978, THE OPERON; Murphy JT, 2011, P UND DYN BIOL SYST; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; PTASHNE M, 1987, GENETIC SWITCH GENE; Ramkrishna D., 2000, POPULATION BALANCES; Roma DM, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011902; Rubakhin SS, 2013, CURR OPIN BIOTECH, V24, P95, DOI 10.1016/j.copbio.2012.10.021; Santillan M, 2008, BIOPHYS J, V94, P2065, DOI 10.1529/biophysj.107.118026; Santillan M, 2004, BIOPHYS J, V86, P1282, DOI 10.1016/S0006-3495(04)74202-2; SHAH BH, 1976, MATH BIOSCI, V31, P1, DOI 10.1016/0025-5564(76)90037-7; Shu CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079196; Shu CC, 2012, CHEM ENG SCI, V70, P188, DOI 10.1016/j.ces.2011.07.062; Siettos CI, 2003, AICHE J, V49, P1922, DOI 10.1002/aic.690490727; Smith M, 1998, CHEM ENG SCI, V53, P1777, DOI 10.1016/S0009-2509(98)00045-1; Stamatakis M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-301; Stamatakis M, 2010, J THEOR BIOL, V266, P41, DOI 10.1016/j.jtbi.2010.06.002; Stamatakis M, 2009, BIOPHYS J, V96, P887, DOI 10.1016/j.bpj.2008.10.028; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Tischler J, 2013, CURR OPIN BIOTECH, V24, P69, DOI 10.1016/j.copbio.2012.09.013; Toni T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002960; VANKAMPEN NG, 1981, J STAT PHYS, V24, P175, DOI 10.1007/BF01007642; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2007, PLOS BIOL, V5, P67, DOI 10.1371/journal.pbio.0050009; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Zechner C, 2012, P NATL ACAD SCI USA, V109, P8340, DOI 10.1073/pnas.1200161109; Zhang L, 2009, MATH COMPUT MODEL, V49, P307, DOI 10.1016/j.mcm.2008.05.011; Zou Y, 2010, J COMPUT PHYS, V229, P5299, DOI 10.1016/j.jcp.2010.03.007	65	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132946	10.1371/journal.pone.0132946	http://dx.doi.org/10.1371/journal.pone.0132946			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185999	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700073
J	Greb-Markiewicz, B; Sadowska, D; Surgut, N; Godlewski, J; Zarebski, M; Ozyhar, A				Greb-Markiewicz, Beata; Sadowska, Daria; Surgut, Natalia; Godlewski, Jakub; Zarebski, Miroslaw; Ozyhar, Andrzej			Mapping of the Sequences Directing Localization of the Drosophila Germ Cell-Expressed Protein (GCE)	PLOS ONE			English	Article							METHOPRENE-TOLERANT MET; JUVENILE-HORMONE RECEPTOR; FTZ-F1 NUCLEAR RECEPTOR; BHLH-PAS; SUBCELLULAR-LOCALIZATION; INSECT METAMORPHOSIS; INTRINSIC DISORDER; TRANSCRIPTIONAL REGULATORS; PROGESTERONE-RECEPTOR; PHOSPHORYLATION SITES	Drosophila melanogaster germ cell-expressed protein (GCE) belongs to the family of bHLH-PAS transcription factors that are the regulators of gene expression networks that determine many physiological and developmental processes. GCE is a homolog of D. melanogaster methoprene tolerant protein (MET), a key mediator of anti-metamorphic signaling in insects and the putative juvenile hormone receptor. Recently, it has been shown that the functions of MET and GCE are only partially redundant and tissue specific. The ability of bHLH-PAS proteins to fulfill their function depends on proper intracellular trafficking, determined by specific sequences, i.e. the nuclear localization signal (NLS) and the nuclear export signal (NES). Nevertheless, until now no data has been published on the GCE intracellular shuttling and localization signals. We performed confocal microscopy analysis of the subcellular distribution of GCE fused with yellow fluorescent protein (YFP) and YFP-GCE derivatives which allowed us to characterize the details of the subcellular traffic of this protein. We demonstrate that GCE possess specific pattern of localization signals, only partially consistent with presented previously for MET. The presence of a strong NLS in the C-terminal part of GCE, seems to be unique and important feature of this protein. The intracellular localization of GCE appears to be determined by the NLSs localized in PAS-B domain and C-terminal fragment of GCE, and NESs localized in PAS-A, PAS-B domains and C-terminal fragment of GCE. NLSs activity can be modified by juvenile hormone (JH) and other partners, likely 14-3-3 proteins.	[Greb-Markiewicz, Beata; Sadowska, Daria; Surgut, Natalia; Ozyhar, Andrzej] Wroclaw Univ Technol, Fac Chem, Dept Biochem, PL-50370 Wroclaw, Poland; [Godlewski, Jakub] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg,Harvard Inst Med, Boston, MA 02115 USA; [Zarebski, Miroslaw] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biophys, Krakow, Poland	Wroclaw University of Science & Technology; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Jagiellonian University	Greb-Markiewicz, B (corresponding author), Wroclaw Univ Technol, Fac Chem, Dept Biochem, PL-50370 Wroclaw, Poland.	beata.greb-markiewicz@pwr.edu.pl	Greb-Markiewicz, Beata/AAB-5246-2020; Godlewski, Jakub/U-4700-2019	Greb-Markiewicz, Beata/0000-0002-2831-439X; Godlewski, Jakub/0000-0003-2122-9798; OZYHAR, Andrzej/0000-0002-5874-784X	Polish Ministry of Science and High Education for the Faculty of Chemistry of Wroclaw University of Technology; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	Polish Ministry of Science and High Education for the Faculty of Chemistry of Wroclaw University of Technology; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	This work has been supported by a statutory activity subsidy from The Polish Ministry of Science and High Education for the Faculty of Chemistry of Wroclaw University of Technology. Publication supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018.	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Baumann A, 2010, GENETICS, V185, P1327, DOI 10.1534/genetics.110.116962; Baumann A, 2010, J INSECT PHYSIOL, V56, P1445, DOI 10.1016/j.jinsphys.2010.05.001; Bernardo Travis J., 2012, Insects, V3, P324, DOI 10.3390/insects3010324; Bernardo TJ, 2012, J BIOL CHEM, V287, P7821, DOI 10.1074/jbc.M111.327254; Bitra K, 2009, ARCH INSECT BIOCHEM, V70, P90, DOI 10.1002/arch.20281; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boonyaratanakornkit V, 2008, STEROIDS, V73, P922, DOI 10.1016/j.steroids.2008.01.010; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Bustos DM, 2012, MOL BIOSYST, V8, P178, DOI 10.1039/c1mb05216k; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Dubrovsky EB, 2011, J BIOL CHEM, V286, P33689, DOI 10.1074/jbc.M111.273458; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Fu SC, 2013, NUCLEIC ACIDS RES, V41, pD338, DOI 10.1093/nar/gks936; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; Godlewski J, 2006, BIOCHEM BIOPH RES CO, V342, P1305, DOI 10.1016/j.bbrc.2006.02.097; Greb-Markiewicz B, 2011, MOL CELL ENDOCRINOL, V345, P16, DOI 10.1016/j.mce.2011.06.035; Guo EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053256; He QY, 2014, J BIOL CHEM, V289, P27874, DOI 10.1074/jbc.M114.582825; Henrich VC, 2003, INSECT BIOCHEM MOLEC, V33, P1239, DOI 10.1016/j.ibmb.2003.08.002; Homma K, 2012, MOL BIOSYST, V8, P247, DOI 10.1039/c1mb05208j; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jennings BH, 2011, MATER TODAY, V14, P190, DOI 10.1016/S1369-7021(11)70113-4; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee SH, 2003, ADV DRUG DELIVER REV, V55, P717, DOI 10.1016/S0169-409X(03)00052-8; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li H, 2005, MOL PHARMACEUT, V2, P509, DOI 10.1021/mp0500418; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Li XT, 2003, J BIOL CHEM, V278, P39261, DOI 10.1074/jbc.R300024200; Liu PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019776; Liu W, 2013, BBA-GEN SUBJECTS, V1830, P5184, DOI 10.1016/j.bbagen.2013.06.037; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Obsilova V, 2014, PHYSIOL RES, V63, pS155, DOI 10.33549/physiolres.932659; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Rajagopalan S, 2008, NUCLEIC ACIDS RES, V36, P5983, DOI 10.1093/nar/gkn598; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shin SW, 2012, P NATL ACAD SCI USA, V109, P16576, DOI 10.1073/pnas.1214209109; Sluchanko NN, 2012, FEBS LETT, V586, P4249, DOI 10.1016/j.febslet.2012.10.048; Sluchanko NN, 2012, BIOCHEMISTRY-US, V51, P6127, DOI 10.1021/bi300674e; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Wang SL, 2007, J INSECT PHYSIOL, V53, P246, DOI 10.1016/j.jinsphys.2006.07.011; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684	72	10	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133307	10.1371/journal.pone.0133307	http://dx.doi.org/10.1371/journal.pone.0133307			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186223	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700122
J	Hola, E; Kosnar, J; Kucera, J				Hola, Eva; Kosnar, Jiri; Kucera, Jan			Comparison of Genetic Structure of Epixylic Liverwort Crossocalyx hellerianus between Central European and Fennoscandian Populations	PLOS ONE			English	Article							HEPATIC ANASTROPHYLLUM-HELLERIANUM; OLD-GROWTH FOREST; COMPUTER-PROGRAM; LINKAGE DISEQUILIBRIUM; HABITAT FRAGMENTATION; ASEXUAL REPRODUCTION; BRYOPHYTE; MOSS; DISPERSAL; DIVERSITY	Patterns of genetic variation and spatial genetic structure (SGS) were investigated in Cross-ocalyx hellerianus, a strictly epixylic dioicous liverwort (Scapaniaceae s.l., Marchantiophyta). Studied populations were located in Fennoscandia and Central Europe, with localities differing in availability of substrate and the population connectivity, and their populations consequently different in size, density, and prevailing reproductive mode. A set of nine polymorphic microsatellites was successfully developed and used. Identical individuals were only found within populations. Especially in large populations, the majority of the individuals were genetically unique. Resampled number of genotypes, mean number of observed alleles per locus after rarefaction, and Nei's gene diversity in large populations reached high values and ranged between 4.41-4.97, 3.13-4.45, and 0.94-0.99, respectively. On the contrary, the values in small populations were lower and ranged between 1.00-4.42, 1.00-2.73, and 0.00-0.95, respectively. As expected, large populations were found to be more genetically diverse than small populations but relatively big diversity of genotypes was also found in small populations. This indicated that even small populations are important sources of genetic variation in bryophytes and processes causing loss of genetic variation might be compensated by other sources of variability, of which somatic mutations might play an important role. The presence of SGS was discovered in all populations. Large populations possessed less SGS, with individuals showing a pronounced decrease in kinship over 50 cm of distance. Apparent SGS of small populations even at distances up to 16 meters suggests the aggregation of similar genotypes, caused predominantly by the deposition of asexually formed gemmae. Although no strong kinship was detectable at the distances over 16 meters in both small and large populations, identical genotypes were occasionally detected at longer distances (20-80 m), suggesting effective dispersal of asexual propagules.	[Hola, Eva; Kosnar, Jiri; Kucera, Jan] Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice	Hola, E (corresponding author), Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic.	eva.neurazy@gmail.com	Kucera, Jan/B-3633-2009	Kucera, Jan/0000-0002-0230-5997; Kosnar, Jiri/0000-0001-5128-593X; Hola, Eva/0000-0002-5123-251X	Grant Agency of the University of South Bohemia in Ceske Budejovice [138/2010/P]	Grant Agency of the University of South Bohemia in Ceske Budejovice	The research was financially supported by the Grant Agency of the University of South Bohemia in Ceske Budejovice No. 138/2010/P.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Andersson Kjell, 2002, Lindbergia, V27, P90; [Anonymous], 2009, SUOMEN UHANALAISET S; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; BACZKIEWICZ A, 2012, BIODIV RES CONSERV, V27, P3; Bengtsson BO, 2003, J EVOLUTION BIOL, V16, P189, DOI 10.1046/j.1420-9101.2003.00523.x; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Bisang I, 2004, OIKOS, V104, P291, DOI 10.1111/j.0030-1299.2004.12853.x; BUSS LW, 1983, P NATL ACAD SCI-BIOL, V80, P1387, DOI 10.1073/pnas.80.5.1387; Crandall-Stotler B., 2009, Edinburgh Journal of Botany, V66, P155, DOI 10.1017/S0960428609005393; Dierssen K., 2001, BRYOPHYTORUM BIBLIOT, V56; Drag L, 2013, CONSERV GENET RESOUR, V5, P907, DOI 10.1007/s12686-013-9930-8; Eckert CG, 2001, EVOL ECOL, V15, P501, DOI 10.1023/A:1016005519651; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gunnarsson U, 2005, BRYOLOGIST, V108, P194, DOI 10.1639/0007-2745(2005)108[0194:GSOTEP]2.0.CO;2; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hassel K, 2005, AM J BOT, V92, P1684, DOI 10.3732/ajb.92.10.1684; Hogberg N, 1999, MOL ECOL, V8, P703, DOI 10.1046/j.1365-294X.1999.00561.x; Hutsemekers V, 2013, AQUAT BOT, V108, P1, DOI 10.1016/j.aquabot.2013.02.001; Jansova I, 2006, PRESLIA, V78, P67; Jonsson BG, 2005, SILVA FENN, V39, P289, DOI 10.14214/sf.390; Jonsson M, 2003, J INSECT CONSERV, V7, P111, DOI 10.1023/A:1025552623766; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Karlin EF, 2012, NEW PHYTOL, V193, P1088, DOI 10.1111/j.1469-8137.2011.03999.x; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Korpelainen H, 2013, PLANT BIOLOGY, V15, P514, DOI 10.1111/j.1438-8677.2012.00660.x; Korpelainen H, 2012, INT J PLANT SCI, V173, P1015, DOI 10.1086/667612; Korpelainen H, 2011, EVOL ECOL, V25, P45, DOI 10.1007/s10682-010-9378-1; Kucera J, 2012, PRESLIA, V84, P813; Laaka-Lindberg S, 2005, J BRYOL, V27, P119, DOI 10.1179/037366805X53031; Laaka-Lindberg S, 2006, J HATTORI BOT LAB, P311; Leonardia AAP, 2013, PLANT BIOLOGY, V15, P384, DOI 10.1111/j.1438-8677.2012.00640.x; Lienert Judit, 2004, Journal for Nature Conservation (Jena), V12, P53, DOI 10.1016/j.jnc.2003.07.002; Lockhart N., 2012, RARE THREATENED BRYO; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Newton A.E., 1994, J HATTORI BOT LAB, V76, P127, DOI DOI 10.18968/JHBL.76.0_127; Nunome T, 2006, PLANT MOL BIOL REP, V24, P305, DOI 10.1007/BF02913457; Patino J, 2010, J BRYOL, V32, P220, DOI 10.1179/037366810X12735734836133; Paton J. A., 1999, LIVERWORT FLORA BRIT; Pohjamo M, 2004, PLANT ECOL, V173, P73, DOI 10.1023/B:VEGE.0000026330.62021.0a; Pohjamo M, 2004, PERSPECT PLANT ECOL, V6, P159; Pohjamo M, 2008, BIOL CONSERV, V141, P1204, DOI 10.1016/j.biocon.2008.02.016; Pohjamo M, 2006, EVOL ECOL, V20, P415, DOI 10.1007/s10682-006-0011-2; Prusa E., 1985, BOHMISCHEN MAHRISCHE; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; Silvertown J, 2008, INT J PLANT SCI, V169, P157, DOI 10.1086/523357; Snall T, 2004, MOL ECOL, V13, P2109, DOI 10.1111/j.1365-294X.2004.02217.x; Soderstrom L, 1997, ADV BRYOLOG, V6, P205; SODERSTROM L, 1989, J BRYOL, V15, P793; Soderstrom L, 2010, PHYTOTAXA, V3, P47; Szovenyi P, 2009, HEREDITY, V103, P394, DOI 10.1038/hdy.2009.82; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Oppen Madeleine J.H., 2011, Diversity, V3, P405, DOI 10.3390/d3030405; van Zanten BO, 1981, ADV BRYOLOGY, V1, P479; van Zanten BO., 1978, J HATTORI BOT LAB, V44, P455, DOI DOI 10.1639/0007-2745(1997)100[380:OMDBIG]2.0.CO;2; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Weismann A., 1892, KEIMPLASMA THEORIE V; Werner O, 2002, J BRYOL, V24, P127, DOI 10.1179/037366802125000980; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; WYATT R, 1985, TAXON, V34, P420, DOI 10.2307/1221208; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zartman CE, 2006, MOL ECOL, V15, P2305, DOI 10.1111/j.1365-294X.2006.02929.x	65	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133134	10.1371/journal.pone.0133134	http://dx.doi.org/10.1371/journal.pone.0133134			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186214	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700098
J	Kim, TH; Zhou, HJ				Kim, Tae Hyun; Zhou, Huaijun			Functional Analysis of Chicken IRF7 in Response to dsRNA Analog Poly(I:C) by Integrating Overexpression and Knockdown	PLOS ONE			English	Article							INTERFERON-STIMULATED GENES; REGULATORY FACTOR IRF; PATTERN-RECOGNITION RECEPTORS; AVIAN INFLUENZA-VIRUSES; TOLL-LIKE RECEPTORS; NF-KAPPA-B; RNA-SEQ; RIG-I; EXPRESSION ANALYSIS; TRANSCRIPTION FACTORS	In order to develop novel strategies to protect against increasingly virulent bird-linked pathogens, a better understanding of the avian antiviral response mechanism is essential. Type I interferons (IFNs) are recognized as the first line of defense in a host's antiviral response; and it has been suggested that IRF7, a member of the IFN regulatory factor (IRF) family, plays an important role in modulating the immune response to avian influenza virus infection in chickens. The objective of this study was to identify candidate genes and pathways associated with IRF7 regulation at the transcriptome level as a first step towards elucidating the underlying cellular mechanisms of IRF7 modulation in the chicken antiviral response. IRF7 overexpression and knockdown DF-1 cell lines were established and stimulated by various pathogen-associated molecular patterns. Significant IRF7 and type I IFN expression changes were observed in both the IRF7 overexpression cell line and the IRF7-knockdown cell line upon exposure to the double stranded RNA (dsRNA) analog poly(I:C). Using RNA-seq based transcriptome analysis, we identified potential novel genes that IRF7 may help regulate as part of the host immune response to dsRNA; potential biomarkers and therapeutic targets revealed as a result of this study warrant further investigation. Based on our results, we suggest that IRF7 may have conserved functional activity in the avian antiviral response, and plays a crucial role in type I IFN regulation.	[Kim, Tae Hyun; Zhou, Huaijun] Univ Calif Davis, Dept Anim Sci, Integrat Genet & Genom Grad Grp, Davis, CA 95616 USA	University of California System; University of California Davis	Zhou, HJ (corresponding author), Univ Calif Davis, Dept Anim Sci, Integrat Genet & Genom Grad Grp, Davis, CA 95616 USA.	hzhou@ucdavis.edu		Kim, Tae Hyun/0000-0002-4272-1530	California Agricultural Experimental Station; United States Department of Agriculture, National Institute of Food and Agriculture [NC1170, NRSP8, NE1334]	California Agricultural Experimental Station; United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by the California Agricultural Experimental Station (HZ), United States Department of Agriculture, National Institute of Food and Agriculture, Multistate Research Project NC1170, NRSP8, and NE1334 (HZ).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baril M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003416; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; Castanier C, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-44; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen S, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-82; Ciraci C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-545; Cormican P, 2009, DEV COMP IMMUNOL, V33, P967, DOI 10.1016/j.dci.2009.04.001; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erickson AK, 2008, CELL RES, V18, P433, DOI 10.1038/cr.2008.46; Esnault E, 2011, VIRUS RES, V159, P32, DOI 10.1016/j.virusres.2011.04.022; Feng ZQ, 2015, GENE, V561, P138, DOI 10.1016/j.gene.2015.02.025; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Goossens KE, 2013, DEV COMP IMMUNOL, V41, P370, DOI 10.1016/j.dci.2013.05.020; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRANT CE, 1995, NUCLEIC ACIDS RES, V23, P2137, DOI 10.1093/nar/23.12.2137; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YC, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-40; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Karpala AJ, 2008, DEV COMP IMMUNOL, V32, P435, DOI 10.1016/j.dci.2007.08.004; Karpala AJ, 2011, J IMMUNOL, V186, P5397, DOI 10.4049/jimmunol.1003712; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Keestra AM, 2013, DEV COMP IMMUNOL, V41, P316, DOI 10.1016/j.dci.2013.04.009; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kong BW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-571; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Lee CW, 2008, J VIROL METHODS, V153, P22, DOI 10.1016/j.jviromet.2008.06.019; Lee MS, 2013, NAT IMMUNOL, V14, P346, DOI 10.1038/ni.2535; Lian L, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-23; Liniger M, 2012, J VIROL, V86, P705, DOI 10.1128/JVI.00742-11; Liu AL, 2015, VIRUS GENES, V50, P189, DOI 10.1007/s11262-014-1151-z; Liu HC, 2003, CYTOGENET GENOME RES, V102, P304, DOI 10.1159/000075767; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Magor KE, 2013, DEV COMP IMMUNOL, V41, P377, DOI 10.1016/j.dci.2013.04.010; Marcus PI, 2005, J VIROL, V79, P2880, DOI 10.1128/JVI.79.5.2880-2890.2005; Nehyba J, 2002, MOL CELL BIOL, V22, P3942, DOI 10.1128/MCB.22.11.3942-3957.2002; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Paladino P, 2006, J IMMUNOL, V177, P8008, DOI 10.4049/jimmunol.177.11.8008; Philbin VJ, 2005, IMMUNOLOGY, V114, P507, DOI 10.1111/j.1365-2567.2005.02125.x; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sanada T, 2008, J BIOL CHEM, V283, P33858, DOI 10.1074/jbc.M806923200; Sato M, 2001, CYTOKINE GROWTH F R, V12, P133, DOI 10.1016/S1359-6101(00)00032-0; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schmid S, 2010, J BIOL CHEM, V285, P42013, DOI 10.1074/jbc.M110.165936; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Staeheli P, 2001, J INTERF CYTOK RES, V21, P993, DOI 10.1089/107999001317205123; Stewart CR, 2013, DEV COMP IMMUNOL, V41, P463, DOI 10.1016/j.dci.2013.05.011; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tong YZ, 2012, CELL RES, V22, P822, DOI 10.1038/cr.2012.53; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang J, 2013, J IMMUNOL, V191, P3393, DOI 10.4049/jimmunol.1300740; Wang XA, 2013, AM J PHYSIOL-ENDOC M, V305, pE485, DOI 10.1152/ajpendo.00505.2012; Wang Y, 2014, POULTRY SCI, V93, P485, DOI 10.3382/ps.2013-03557; Wang Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-278; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Wise TG, 2007, ANIM BIOTECHNOL, V18, P153, DOI 10.1080/10495390600867515	68	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133450	10.1371/journal.pone.0133450	http://dx.doi.org/10.1371/journal.pone.0133450			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186542	gold, Green Published			2022-12-27	WOS:000358198700141
J	Liu, YQ; Wang, ZY; Su, JP; Liu, WW; Dhiloo, KH; Guo, YY				Liu, Yongqiang; Wang, Zhongyue; Su, Junping; Liu, Weiwei; Dhiloo, Khalid Hussain; Guo, Yuyuan			The Efficacy of Chinese Medicinal Herbs towards Grape Phylloxera (Daktulosphaira vitifoliae Fitch) (Hemiptera, Phylloxeridae)	PLOS ONE			English	Article							INSECT GROWTH-REGULATOR; HOMOPTERA; PESTICIDES; MANAGEMENT; MORTALITY; EXTRACTS; BIOTYPES; BIOLOGY; OIL	Bio-insecticidal effects of seven Chinese medicinal herbs on mortality, fecundity, developmental periods and life table parameters of the grape phylloxera were investigated. In an excised root bioassay experiment aqueous extracts from seven Chinese medicinal herbs increased grape phylloxera first instar mortality (26.00-38.50%) compared to other instars. The intrinsic rate of increase (r(m)), finite rate of increase (lambda), fecundity rate and net reproductive rate (R-0) were significantly reduced by A. bidentata, A. tataricus, O. basilicum, P. frutescensand N. cataria. In a glasshouse pot trial, eggs, nymphs, adults and total population were significantly reduced before population establishment compared to those after its population established, by A. bidentata, A. tataricus and O. basilicum. Overall, A. bidentata, A. tataricus and O. basilicum can be used to suppress all life-stages of grape phylloxera.	[Liu, Yongqiang; Wang, Zhongyue; Su, Junping; Liu, Weiwei; Dhiloo, Khalid Hussain; Guo, Yuyuan] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Guo, YY (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yyguo@ippcaas.cn			National Technology System project for Grape Industry [nycytx-30]	National Technology System project for Grape Industry	The work was supported by the National Technology System project for Grape Industry (nycytx-30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2012, CROP PROT, V38, P7, DOI 10.1016/j.cropro.2012.03.006; Athanassiou CG, 2005, J ECON ENTOMOL, V98, P1733, DOI 10.1603/0022-0493-98.5.1733; Benheim D, 2012, ANN APPL BIOL, V161, P91, DOI 10.1111/j.1744-7348.2012.00561.x; Bickerton MW, 2011, THESIS STATE U NEW J; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; CAHILL M, 1995, B ENTOMOL RES, V85, P181, DOI 10.1017/S0007485300034258; Charleston DS, 2004, THESIS, P1; Che PiLian, 2007, Journal of Shanghai Jiaotong University - Agricultural Science, V25, P587; Chokechaijaroenporn O, 1994, Phytomedicine, V1, P135, DOI 10.1016/S0944-7113(11)80031-0; DEBENEDICTIS JA, 1992, J ECON ENTOMOL, V85, P1527, DOI 10.1093/jee/85.4.1527; Dixon A.F.G., 1987, World Crop Pests, V2A, P269; Donald WL, 2000, THESIS; Dunstone RJ, 2003, AUST J GRAPE WINE R, V9, P107, DOI 10.1111/j.1755-0238.2003.tb00260.x; Forbes VE, 1999, ENVIRON TOXICOL CHEM, V18, P1544, DOI 10.1002/etc.5620180729; FUKAI S, 1993, FIELD CROP RES, V34, P247, DOI 10.1016/0378-4290(93)90117-6; GALET P, 1982, MALADIES PARASITES V, V2, P1059; GRANETT J, 1985, J ECON ENTOMOL, V78, P1463, DOI 10.1093/jee/78.6.1463; Granett J, 2001, ANNU REV ENTOMOL, V46, P387, DOI 10.1146/annurev.ento.46.1.387; Hao Hui-Ling, 2006, Acta Entomologica Sinica, V49, P533; Herbert KS, 2010, B ENTOMOL RES, V100, P671, DOI 10.1017/S0007485310000027; Herbert K, 2008, J ECON ENTOMOL, V101, P1934, DOI 10.1603/0022-0493-101.6.1934; Hummel JD, 2009, THESIS U ALBERTA CAN; Jeyabalan D, 2003, BIORESOURCE TECHNOL, V89, P185, DOI 10.1016/S0960-8524(03)00036-1; Kraiss H, 2008, PEST MANAG SCI, V64, P660, DOI 10.1002/ps.1541; Kumar P, 2011, IND CROP PROD, V34, P802, DOI 10.1016/j.indcrop.2011.02.019; Powell KS, 2013, ADV INSECT PHYSIOL, V45, P159, DOI 10.1016/B978-0-12-417165-7.00004-0; RANI PU, 1989, INSECT SCI APPL, V10, P327, DOI 10.1017/S1742758400003568; Ren Wei, 2007, Sichuan Journal of Zoology, V26, P635; Sisodia S., 2010, J AGR EXTENSION RURA, V2, P22, DOI DOI 10.5897/JAERD.9000005; Stark JD, 1997, ECOTOX ENVIRON SAFE, V37, P273, DOI 10.1006/eesa.1997.1552; STARK JD, 1995, J ECON ENTOMOL, V88, P1089, DOI 10.1093/jee/88.5.1089; Stark JD, 2007, J ECON ENTOMOL, V100, P1027, DOI 10.1603/0022-0493(2007)100[1027:IERMOP]2.0.CO;2; Tapondjou LA, 2002, J STORED PROD RES, V38, P395, DOI 10.1016/S0022-474X(01)00044-3; Walthall WK, 1997, ECOTOX ENVIRON SAFE, V37, P45, DOI 10.1006/eesa.1997.1521; Wang YX, 2009, THESIS NE NORMAL U J; WILLIAMS RN, 1988, ANN ENTOMOL SOC AM, V81, P1, DOI 10.1093/aesa/81.1.1; Worwood V. A., 1993, COMPLETE BOOK ESSENT; YANG RZ, 1988, ECON BOT, V42, P376, DOI 10.1007/BF02860162; ZHANG GZ, 2000, J QINGHAI U, V18, P3; Zhang HuaGe, 2009, Journal of Fruit Science, V26, P306; Zhong GH, 2001, J APPL ENTOMOL, V125, P563, DOI 10.1046/j.1439-0418.2001.00590.x; [No title captured]	42	1	1	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0128038	10.1371/journal.pone.0128038	http://dx.doi.org/10.1371/journal.pone.0128038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186216	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700002
J	Stern, S; Agudelo-Toro, A; Rotem, A; Moses, E; Neef, A				Stern, Shani; Agudelo-Toro, Andres; Rotem, Assaf; Moses, Elisha; Neef, Andreas			Chronaxie Measurements in Patterned Neuronal Cultures from Rat Hippocampus	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; CA1 PYRAMIDAL NEURONS; STRENGTH-DURATION RELATIONSHIP; ELECTRICAL-STIMULATION; DENDRITIC SPIKES; MAGNETIC STIMULATION; EXTRACELLULAR STIMULATION; PREFRONTAL CORTEX; ACTION-POTENTIALS; NERVOUS-SYSTEM	Excitation of neurons by an externally induced electric field is a long standing question that has recently attracted attention due to its relevance in novel clinical intervention systems for the brain. Here we use patterned quasi one-dimensional neuronal cultures from rat hippocampus, exploiting the alignment of axons along the linear patterned culture to separate the contribution of dendrites to the excitation of the neuron from that of axons. Network disconnection by channel blockers, along with rotation of the electric field direction, allows the derivation of strength-duration (SD) curves that characterize the statistical ensemble of a population of cells. SD curves with the electric field aligned either parallel or perpendicular to the axons yield the chronaxie and rheobase of axons and dendrites respectively, and these differ considerably. Dendritic chronaxie is measured to be about 1 ms, while that of axons is on the order of 0.1 ms. Axons are thus more excitable at short time scales, but at longer time scales dendrites are more easily excited. We complement these studies with experiments on fully connected cultures. An explanation for the chronaxie of dendrites is found in the numerical simulations of passive, realistically structured dendritic trees under external stimulation. The much shorter chronaxie of axons is not captured in the passive model and may be related to active processes. The lower rheobase of dendrites at longer durations can improve brain stimulation protocols, since in the brain dendrites are less specifically oriented than axonal bundles, and the requirement for precise directional stimulation may be circumvented by using longer duration fields.	[Stern, Shani; Moses, Elisha] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Agudelo-Toro, Andres; Neef, Andreas] Max Planck Inst Dynam & Self Org, Dept Nonlinear Dynam, Gottingen, Germany; [Agudelo-Toro, Andres; Neef, Andreas] Bernstein Grp Biophys Neural Computat, Gottingen, Germany; [Rotem, Assaf] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Rotem, Assaf] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Weizmann Institute of Science; Max Planck Society; Harvard University; Harvard University	Moses, E (corresponding author), Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel.	elisha.moses@weizmann.ac.il		Neef, Andreas/0000-0003-4445-7478; Stern, Shani/0000-0002-2644-7068	Minerva Foundation Israel; Ministry of Science and Technology Israel; Israel Science Foundation [1320/09]; Bi-National Science Foundation [2008331]; German Ministry for Education and Research through the Bernstein Focus Neurotechnology Gottingen [01GQ0811 01GQ0810]; Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (DFG) [226/1]	Minerva Foundation Israel; Ministry of Science and Technology Israel(Ministry of Science, Technology and Space (MOST), Israel); Israel Science Foundation(Israel Science Foundation); Bi-National Science Foundation(US-Israel Binational Science Foundation); German Ministry for Education and Research through the Bernstein Focus Neurotechnology Gottingen; Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (DFG)	This work was supported by the Minerva Foundation Israel to EM, the Ministry of Science and Technology Israel to SS, Israel Science Foundation to EM (1320/09), Bi-National Science Foundation to EM (2008331), German Ministry for Education and Research through the Bernstein Focus Neurotechnology Gottingen to AN (01GQ0811 01GQ0810), and by Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences to AN (DFG grant 226/1).	[Anonymous], 1901, ARCH ITAL BIOL; Boinagrov D, 2010, J NEUROPHYSIOL, V104, P2236, DOI 10.1152/jn.00343.2010; Bordey A, 1999, J NEUROPHYSIOL, V82, P3476, DOI 10.1152/jn.1999.82.6.3476; Braitenberg V, 1998, CORTEX STATISTICS AN; Breskin I, 2006, PHYSICAL REVIEW LETT, V97; Brunel N, 2007, BIOL CYBERN, V97, P341, DOI 10.1007/s00422-007-0189-6; CARTEE LA, 1992, IEEE T BIO-MED ENG, V39, P76, DOI 10.1109/10.108130; Downes JH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002522; Feinerman O, 2005, J NEUROPHYSIOL, V94, P3406, DOI 10.1152/jn.00264.2005; Feinerman O, 2008, NAT PHYS, V4, P967, DOI 10.1038/nphys1099; Floel A, 2008, J COGNITIVE NEUROSCI, V20, P1415, DOI 10.1162/jocn.2008.20098; Fox PT, 2004, HUM BRAIN MAPP, V22, P1, DOI 10.1002/hbm.20006; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; GUSTAFSSON B, 1976, J PHYSIOL-LONDON, V258, P33, DOI 10.1113/jphysiol.1976.sp011405; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; Higgs MH, 2011, J PHYSIOL-LONDON, V589, P5125, DOI 10.1113/jphysiol.2011.216721; Hill AV, 1936, PROC R SOC SER B-BIO, V119, P305, DOI 10.1098/rspb.1936.0012; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hoffman DA, 1997, NATURE, V390, P199, DOI 10.1038/36632; Hsu KH, 2000, IEEE T BIO-MED ENG, V47, P463, DOI 10.1109/10.828146; Iles JF, 2005, PROG BIOPHYS MOL BIO, V87, P17, DOI 10.1016/j.pbiomolbio.2004.06.002; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kim S, 2012, NAT NEUROSCI, V15, P600, DOI [10.1038/nn.3060, 10.1038/nn.3173]; Kincses TZ, 2004, NEUROPSYCHOLOGIA, V42, P113, DOI 10.1016/S0028-3932(03)00124-6; Lapicque L., 1907, J PHYSIOL PATH GEN, V9, P620, DOI DOI 10.1007/S00422-007-0189-6; MCNEAL DR, 1976, IEEE T BIO-MED ENG, V23, P329, DOI 10.1109/TBME.1976.324593; NAGARAJAN SS, 1993, IEEE T BIO-MED ENG, V40, P1175, DOI 10.1109/10.245636; Nowak LG, 1998, EXP BRAIN RES, V118, P477, DOI 10.1007/s002210050304; Nowak LG, 1998, EXP BRAIN RES, V118, P489, DOI 10.1007/s002210050305; Pashut T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002022; Peng YR, 2009, NEURON, V61, P71, DOI 10.1016/j.neuron.2008.11.015; Plonsey R, 2007, BIOELECTRICITY A QUA; Radman T, 2009, 31ST ANNUAL INTERNAT; Rahman A, 2013, J PHYSIOL-LONDON, V591, P2563, DOI 10.1113/jphysiol.2012.247171; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; Rattay F, 2012, NEUROSCIENCE, V214, P1, DOI 10.1016/j.neuroscience.2012.04.004; RATTAY F, 1986, IEEE T BIO-MED ENG, V33, P974, DOI 10.1109/TBME.1986.325670; REILLY JP, 1989, MED BIOL ENG COMPUT, V27, P101, DOI 10.1007/BF02446217; Rotem A, 2008, BIOPHYS J, V94, P5065, DOI 10.1529/biophysj.107.125708; ROTH BJ, 1990, IEEE T BIO-MED ENG, V37, P588, DOI 10.1109/10.55662; SHINODA Y, 1979, EXP BRAIN RES, V34, P59; Soriano J, 2008, P NATL ACAD SCI USA, V105, P13758, DOI 10.1073/pnas.0707492105; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Wagner T, 2009, CORTEX, V45, P1025, DOI 10.1016/j.cortex.2008.10.002; WARMAN EN, 1992, IEEE T BIO-MED ENG, V39, P1244, DOI 10.1109/10.184700; WEST DC, 1983, J PHYSIOL-LONDON, V337, P37, DOI 10.1113/jphysiol.1983.sp014610	52	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132577	10.1371/journal.pone.0132577	http://dx.doi.org/10.1371/journal.pone.0132577			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186201	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700050
J	Xu, C; Han, FF; Zeng, XT; Liu, TZ; Li, S; Gao, ZY				Xu, Chang; Han, Fang-Fang; Zeng, Xian-Tao; Liu, Tong-Zu; Li, Shen; Gao, Zheng-Yan			Fat Intake Is Not Linked to Prostate Cancer: A Systematic Review and Dose-Response Meta-Analysis	PLOS ONE			English	Review							BODY-MASS INDEX; DIETARY-FAT; RISK; COHORT; ASSOCIATION; GROWTH; ENERGY; CARCINOMA; CALCIUM; REDUCE	Background Since the late 1960s, the average global supply of fat has increased by 20 g per capita per day. While fat intake has been considered a potential risk factor for prostate cancer (Pca), the hypothesis from previous epidemiologic studies remained equivocal. Materials and Methods Relevant cohort studies were identified through a literature search in PubMed, ScienceDirect and Wiley Online Library up to March 1, 2015. A systematic review and dose-response meta-analysis were used to assess the relationship between fat intake and the risk for Pca. Results We identified 14 cohort studies, which included 37,349 cases and a total of 751,030 participants. We found no evidence of a non-linear association between fat intake and the risk for Pca. Overall, the summarized relative risks for every 28.35 g increment a day was 0.99 (95%CI: 0.98, 1.01; P=0.94; n=13) for total fat intake, 1.00 (95%CI: 1.00, 1.00; P=0.72; n=9) for saturated fat, 0.99 (95%CI: 0.95, 1.03; P=0.55; n=7) for polyunsaturated fat, and 1.00 (95%CI: 0.95, 1.04; P=0.85; n=8) for monounsaturated fat. Additionally, there was no link to the risk for advanced stage Pca regarding total fat intake (RR=1.02, 95%CI: 0.96, 1.08; P=0.63; n=5), saturated fat (RR=0.96, 95%CI: 0.84, 1.11; P=0.61; n=6), polyunsaturated fat (RR=0.96, 95%CI: 0.79, 1.17; P=0.68; n=6), or monounsaturated fat (RR=0.96, 95%CI: 0.86, 1.07; P=0.42; n=6). Subgroup and sensitively analyses showed consistent results. Conclusion Little evidence from published cohort studies supports the statement that total fat, saturated fat or unsaturated fat intake increases the risk for Pca or advanced stage Pca.	[Xu, Chang; Zeng, Xian-Tao; Liu, Tong-Zu; Li, Shen; Gao, Zheng-Yan] Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan 430072, Peoples R China; [Xu, Chang; Zeng, Xian-Tao; Liu, Tong-Zu; Li, Shen] Wuhan Univ, Zhongnan Hosp, Ctr Evidence Based Med & Translat Med, Wuhan 430072, Peoples R China; [Han, Fang-Fang] Wuhan Univ, Zhongnan Hosp, Dept Ophthalmol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Liu, TZ (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan 430072, Peoples R China.	Liutongzu@163.com		Zeng, Xian-Tao/0000-0003-1262-725X; Xu, Chang/0000-0002-2627-1250				Agalliu I, 2011, CANCER EPIDEMIOL, V35, P353, DOI 10.1016/j.canep.2010.11.002; Aronson AJ, 2001, UROLOGY, V58, P283, DOI 10.1016/S0090-4295(01)01116-5; Bekkering GE, 2008, AM J EPIDEMIOL, V167, P1017, DOI 10.1093/aje/kwn005; BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; BISHOP GA, 1988, IMMUNOGENETICS, V28, P184, DOI 10.1007/BF00375858; Bonn D, 1998, LANCET, V351, P961; Chan JM, 2000, CANCER CAUSE CONTROL, V11, P859, DOI 10.1023/A:1008947201132; Chavarro JE, 2007, CANCER EPIDEM BIOMAR, V16, P1364, DOI 10.1158/1055-9965.EPI-06-1033; Chua ME, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/826254; Crowe FL, 2008, AM J CLIN NUTR, V87, P1405, DOI 10.1093/ajcn/87.5.1405; Dagnelie PC, 2004, BJU INT, V93, P1139, DOI 10.1111/j.1464-410X.2004.04795.x; Dennis LK, 2004, AM J EPIDEMIOL, V160, P436, DOI 10.1093/aje/kwh243; Di Sebastiano KM, 2014, NUTRIENTS, V6, P6095, DOI 10.3390/nu6126095; Discacciati A, 2012, ANN ONCOL, V23, P1665, DOI 10.1093/annonc/mdr603; Gathirua-Mwangi WG, 2014, EUR J CANCER PREV, V23, P96, DOI 10.1097/CEJ.0b013e3283647394; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P1571, DOI 10.1093/jnci/85.19.1571; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Ho PJ, 1997, CLIN ENDOCRINOL, V46, P333; Hsieh LJ, 2003, UROLOGY, V61, P297, DOI 10.1016/S0090-4295(02)02120-9; Huang MG, 2012, PROSTATE, V72, P1779, DOI 10.1002/pros.22531; International Agency for Research on Cancer, GLOB 2012 EST CANC I; Khandrika L, 2009, CANCER LETT, V282, P125, DOI 10.1016/j.canlet.2008.12.011; Kristal AR, 2010, AM J EPIDEMIOL, V172, P566, DOI 10.1093/aje/kwq148; Larsson SC, 2011, AM J EPIDEMIOL, V174, P993, DOI 10.1093/aje/kwr226; Lee MM, 1998, CANCER CAUSE CONTROL, V9, P545, DOI 10.1023/A:1008840105531; Li HJ, 2007, PLOS MED, V4, P562, DOI 10.1371/journal.pmed.0040103; Liu YP, 2011, EUR UROL, V60, P1029, DOI 10.1016/j.eururo.2011.07.007; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MILLS PK, 1989, CANCER, V64, P598, DOI 10.1002/1097-0142(19890801)64:3&lt;598::AID-CNCR2820640306&gt;3.0.CO;2-6; Mitrou PN, 2007, INT J CANCER, V120, P2466, DOI 10.1002/ijc.22553; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Narita S, 2008, PROSTATE, V68, P321, DOI 10.1002/pros.20681; National Cancer Institute, 2005, MEAN INT POT MEAN IN; National Comprehensive Cancer Network (NCCN), 2011, NCCN CLIN PRACT GUID; Neuhouser ML, 2007, J NUTR, V137, P1821, DOI 10.1093/jn/137.7.1821; Ngo TH, 2003, ENDOCRINOLOGY, V144, P2319, DOI 10.1210/en.2003-221028; Orsini N, 2013, NORD BALT US GROUP M; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Park SY, 2007, INT J CANCER, V121, P1339, DOI 10.1002/ijc.22805; Pelser C, 2013, CANCER EPIDEM BIOMAR, V22, P697, DOI 10.1158/1055-9965.EPI-12-1196-T; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Satia-Abouta J, 2002, PREV MED, V34, P493, DOI 10.1006/pmed.2002.1018; Schuurman AG, 1999, CANCER, V86, P1019, DOI 10.1002/(SICI)1097-0142(19990915)86:6&lt;1019::AID-CNCR18&gt;3.0.CO;2-H; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3519; SEVERSON RK, 1989, CANCER RES, V49, P1857; Veierod MB, 1997, INT J CANCER, V73, P634, DOI 10.1002/(SICI)1097-0215(19971127)73:5&lt;634::AID-IJC4&gt;3.0.CO;2-Y; WALKER ARP, 1992, BRIT J CANCER, V65, P438, DOI 10.1038/bjc.1992.89; Wallstrom P, 2007, CANCER CAUSE CONTROL, V18, P1107, DOI 10.1007/s10552-007-9050-4; Wells GA, 2011, NEWCASTLE OTTAWA SCA; Wu JD, 2006, J CELL BIOCHEM, V99, P392, DOI 10.1002/jcb.20929; Xu C, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000759; Zeng XT, 2015, ORAL ONCOL, V51, P446, DOI 10.1016/j.oraloncology.2015.02.095; Zeng Xiantao, 2015, J Evid Based Med, V8, P2, DOI 10.1111/jebm.12141; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	55	27	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131747	10.1371/journal.pone.0131747	http://dx.doi.org/10.1371/journal.pone.0131747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186528	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700021
J	Borghans, L; Golsteyn, BHH; Zolitz, U				Borghans, Lex; Golsteyn, Bart H. H.; Zolitz, Ulf			School Quality and the Development of Cognitive Skills between Age Four and Six	PLOS ONE			English	Article							CHOICE; TECHNOLOGY	This paper studies the extent to which young children develop their cognitive ability in high and low quality schools. We use a representative panel data set containing cognitive test scores of 4-6 year olds in Dutch schools. School quality is measured by the school's average achievement test score at age 12. Our results indicate that children in high-quality schools develop their skills substantially faster than those in low-quality schools. The results remain robust to the inclusion of initial ability, parental background, and neighborhood controls. Moreover, using proximity to higher-achieving schools as an instrument for school choice corroborates the results. The robustness of the results points toward a causal interpretation, although it is not possible to erase all doubt about unobserved confounding factors.	[Borghans, Lex; Golsteyn, Bart H. H.; Zolitz, Ulf] Maastricht Univ, Dept Econ, Maastricht, Netherlands; [Borghans, Lex] Maastricht Univ, Res Ctr Educ & Lab Market ROA, Maastricht, Netherlands; [Golsteyn, Bart H. H.; Zolitz, Ulf] Maastricht Univ, Dept Econ, Maastricht, Netherlands; [Zolitz, Ulf] IZA, Bonn, Germany	Maastricht University; Maastricht University; Maastricht University; IZA Institute Labor Economics	Zolitz, U (corresponding author), IZA, Bonn, Germany.	zoelitz@iza.org		Golsteyn, Bart/0000-0002-2357-5857				Black SE, 1999, Q J ECON, V114, P577, DOI 10.1162/003355399556070; Blau David, 2006, HDB EC ED, V2, P1163, DOI [DOI 10.1016/S1574-0692(06)02020-4, DOI 10.3386/W10670]; Blomeyer D, 2009, J EUR ECON ASSOC, V7, P638, DOI 10.1162/JEEA.2009.7.2-3.638; Borghans L, 2015, BE J ECON ANAL POLI, V15, P85, DOI 10.1515/bejeap-2014-0032; Card D., 1995, MYTH MEASUREMENT NEW; CECI SJ, 1991, DEV PSYCHOL, V27, P703, DOI 10.1037/0012-1649.27.5.703; Chetty R, 2011, Q J ECON, V126, P1593, DOI 10.1093/qje/qjr041; Cullen JB, 2006, ECONOMETRICA, V74, P1191, DOI 10.1111/j.1468-0262.2006.00702.x; Cunha F, 2008, J HUM RESOUR, V43, P738; Cunha F, 2010, ECONOMETRICA, V78, P883, DOI 10.3982/ECTA6551; Downes TA, 2002, J URBAN ECON, V52, P1, DOI 10.1016/S0094-1190(02)00010-4; Hall J, 2009, OXFORD REV EDUC, V35, P331, DOI 10.1080/03054980902934613; Hastings JS, 2008, Q J ECON, V123, P1373, DOI 10.1162/qjec.2008.123.4.1373; Heckman J.J, 2000, RES ECON, V54, P3, DOI DOI 10.1006/REEC.1999.0225; Hoxby CM, 2002, J HUM RESOUR, V37, P846, DOI 10.2307/3069619; Knudsen EI, 2006, P NATL ACAD SCI USA, V103, P10155, DOI 10.1073/pnas.0600888103; Krueger AB, 1999, Q J ECON, V114, P497, DOI 10.1162/003355399556052; Peisner-Feinberg ES, 2001, CHILD DEV, V72, P1534, DOI 10.1111/1467-8624.00364; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD	19	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0129700	10.1371/journal.pone.0129700	http://dx.doi.org/10.1371/journal.pone.0129700			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RQ	26182123	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000358198200003
J	Jeon, J; Hong, S; Ohm, J; Yang, T				Jeon, Jieun; Hong, Suckchul; Ohm, Jay; Yang, Taeyong			Causal Relationships among Technology Acquisition, Absorptive Capacity, and Innovation Performance: Evidence from the Pharmaceutical Industry	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; MODELS; SPILLOVERS; ALLIANCES; BEHAVIOR; PATENTS; GROWTH; FIRMS	This paper discusses the importance of absorptive capacity in improving a firm's innovation performance. Specifically, we examine firm interaction with the knowledge and capabilities of outside organizations and the effect on the firm's bottom line. We use the impulse-response function of the vector auto-regressive model to gain insight into this relationship by estimating the time required for the effect of each activity level to reach outputs, the spillover effects. We apply this methodology to pharmaceutical firms, which we classify into two sub-groups - large firms and medium and small firms - based on sales. Our results show that the impact of an activity on any other activity is delayed by three years for large firms and by one to two years for small and medium firms.	[Jeon, Jieun; Ohm, Jay; Yang, Taeyong] Korea Adv Inst Sci & Technol, Grad Sch Innovat & Technol & Management, Taejon 305701, South Korea; [Hong, Suckchul] Korea Hlth Ind Dev Inst, Dept R&D Strategy, Cheongju, Chungcheongbuk, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Ohm, J (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Innovat & Technol & Management, Taejon 305701, South Korea.	wjswldms84@naver.com	Yang, Taeyong/C-1602-2011					ACS ZJ, 1989, KYKLOS, V42, P171; Ahuja G, 2001, STRATEGIC MANAGE J, V22, P197, DOI 10.1002/smj.157; ALBERT MB, 1991, RES POLICY, V20, P251, DOI 10.1016/0048-7333(91)90055-U; ANDERSON TW, 1982, J ECONOMETRICS, V18, P47, DOI 10.1016/0304-4076(82)90095-1; [Anonymous], 2005, BIOWORLD FIN WATCH; Arbussa A, 2007, RES POLICY, V36, P1545, DOI 10.1016/j.respol.2007.04.013; ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; ARELLANO M, 1995, J ECONOMETRICS, V68, P29, DOI 10.1016/0304-4076(94)01642-D; Bierly P, 1996, STRATEGIC MANAGE J, V17, P123, DOI 10.1002/smj.4250171111; Bottazzi L, 2007, ECON J, V117, P486, DOI 10.1111/j.1468-0297.2007.02027.x; Bresman H, 1999, J INT BUS STUD, V30, P439, DOI 10.1057/palgrave.jibs.8490078; Cantwell J, 1991, GLOBAL RES STRATEGY, P133; Chakrabarti AK., 1994, GLOBAL INFORMATION S, P361; Chesbrough H, 2003, OPEN INNOVATION NEW, P352; Chiu YC, 2004, INT J TECHNOL MANAGE, V27, P306, DOI 10.1504/IJTM.2004.003957; Cincera M, 1997, J APPL ECONOM, V12, P265, DOI 10.1002/(SICI)1099-1255(199705)12:3<265::AID-JAE439>3.0.CO;2-J; COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553; Darroch J., 2003, EUR J MARKETING, V37, P572, DOI [DOI 10.1108/03090560310459096, 10.1108/03090560310459096]; Desyllas P, 2010, RES POLICY, V39, P1105, DOI 10.1016/j.respol.2010.05.005; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Escribano A, 2009, RES POLICY, V38, P96, DOI 10.1016/j.respol.2008.10.022; Flatten TC, 2011, EUR MANAG REV, V8, P137, DOI 10.1111/j.1740-4762.2011.01015.x; Gassmann O, 2004, LEADING PHARM INNOVA, P178; George G., 2001, J HIGH TECHNOLOGY MA, V12, P205, DOI [DOI 10.1016/S1047-8310(01)00037-2, 10.1016/S1047-8310(01)00037-2]; GRANT RM, 1995, BEST PAP PROC, P17; Gruber M., 2004, SCHMALENBACH BUS REV, V56, P164, DOI DOI 10.1007/BF03396691; Hagedoorn J, 2002, TECHNOL ANAL STRATEG, V14, P67, DOI 10.1080/09537320220125892; Hamilton JD, 2004, J MONEY CREDIT BANK, V36, P265, DOI 10.1353/mcb.2004.0012; Harhoff D, 1999, REV ECON STAT, V81, P511, DOI 10.1162/003465399558265; Higgins MJ, 2006, J FINANC ECON, V80, P351, DOI 10.1016/j.jfineco.2005.04.004; HOLTZEAKIN D, 1988, ECONOMETRICA, V56, P1371, DOI 10.2307/1913103; JAFFE AB, 1993, Q J ECON, V108, P577, DOI 10.2307/2118401; Kilian L, 2001, J FORECASTING, V20, P161, DOI 10.1002/1099-131X(200104)20:3<161::AID-FOR770>3.0.CO;2-X; Kim L, 1998, ORGAN SCI, V9, P506, DOI 10.1287/orsc.9.4.506; Kim SK., 2004, INNOVATION PATTERNS, P221; Lane PJ, 2006, ACAD MANAGE REV, V31, P833, DOI [10.5465/AMR.2006.22527456, 10.2307/20159255]; Lian SH, 2007, J INF SCI, V33, P340; Liao JW, 2003, ENTREP THEORY PRACT, V28, P63, DOI 10.1111/1540-8520.00032; Love I, 2006, Q REV ECON FINANC, V46, P190, DOI 10.1016/j.qref.2005.11.007; MOWERY DC, 1995, CAMBRIDGE J ECON, V19, P67; NAPOLITANO G, 1990, TECHNOVATION, V10, P5, DOI 10.1016/0166-4972(90)90038-L; PATEL P, 1995, TECHNICAL CHANGE AND THE WORLD ECONOMY, P147; Prabhu JC, 2005, J MARKETING, V69, P114, DOI 10.1509/jmkg.69.1.114.55514; Ravenscraft DJ, 2000, NBER CONF R, P287; Rosenberg N., 1982, INSIDE BLACK BOX TEC, P304; Ruckman K, 2005, J INT BUS STUD, V36, P89, DOI 10.1057/palgrave.jibs.8400110; Sorensen JB, 2000, ADMIN SCI QUART, V45, P81, DOI 10.2307/2666980; Stock JH, 2003, INTRO ECONOMETRICS, P840; Stuart TE, 2000, STRATEGIC MANAGE J, V21, P791, DOI 10.1002/1097-0266(200008)21:8<791::AID-SMJ121>3.0.CO;2-K; Stuart TE, 1996, STRATEGIC MANAGE J, V17, P21; Teece DJ, 2007, STRATEGIC MANAGE J, V28, P1319, DOI 10.1002/smj.640; TRAJTENBERG M, 1990, RAND J ECON, V21, P172, DOI 10.2307/2555502; Van den Bosch FAJ, 1999, ORGAN SCI, V10, P551, DOI 10.1287/orsc.10.5.551; WHITTAKER E, 1994, R&D MANAGE, V24, P249, DOI 10.1111/j.1467-9310.1994.tb00877.x; Zahra S. A., 2000, pK1, DOI [DOI 10.5465/APBPP.2000.5438568, 10.5465/apbpp.2000.5438568]; Zahra SA, 2002, ACAD MANAGE REV, V27, P185, DOI 10.2307/4134351	56	7	8	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0131642	10.1371/journal.pone.0131642	http://dx.doi.org/10.1371/journal.pone.0131642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RQ	26181440	gold, Green Submitted, Green Published			2022-12-27	WOS:000358198200009
J	Moore, JH; Pinheiro, CCD; Zaenker, EI; Bolick, DT; Kolling, GL; van Opstal, E; Noronha, FJD; De Medeiros, PHQS; Rodriguez, RS; Lima, AA; Guerrant, RL; Warren, CA				Moore, John H.; Pinheiro, Caio C. D.; Zaenker, Edna I.; Bolick, David T.; Kolling, Glynis L.; van Opstal, Edward; Noronha, Francisco J. D.; De Medeiros, Pedro H. Q. S.; Rodriguez, Raphael S.; Lima, Aldo A.; Guerrant, Richard L.; Warren, Cirle A.			Defined Nutrient Diets Alter Susceptibility to Clostridium difficile Associated Disease in a Murine Model	PLOS ONE			English	Article							ANTIBIOTIC-ASSOCIATED DIARRHEA; COLONIZATION RESISTANCE; FECAL MICROBIOTA; TOXIN PRODUCTION; MOUSE MODEL; INFECTION; MALNUTRITION; MICE; EPIDEMIOLOGY; PATTERNS	Background Clostridium difficile is a major identifiable and treatable cause of antibiotic-associated diarrhea. Poor nutritional status contributes to mortality through weakened host defenses against various pathogens. The primary goal of this study was to assess the contribution of a reduced protein diet to the outcomes of C. difficile infection in a murine model. Methods C57BL/6 mice were fed a traditional house chow or a defined diet with either 20% protein or 2% protein and infected with C. difficile strain VPI10463. Animals were monitored for disease severity, clostridial shedding and fecal toxin levels. Select intestinal microbiota were measured in stool and C. difficilegrowth and toxin production were quantified ex vivoin intestinal contents from untreated or antibiotic-treated mice fed with the different diets. Results C. difficileinfected mice fed with defined diets, particularly (and unexpectedly) with protein deficient diet, had increased survival, decreased weight loss, and decreased overall disease severity. C. difficile shedding and toxin in the stool of the traditional diet group was increased compared with either defined diet 1 day post infection. Mice fed with traditional diet had an increased intestinal Firmicutes to Bacteroidetes ratio following antibiotic exposure compared with either a 2% or 20% protein defined nutrient diet. Ex vivo inoculation of cecal contents from antibiotic-treated mice showed decreased toxin production and C. difficile growth in both defined diets compared with a traditional diet. Conclusions Low protein diets, and defined nutrient diets in general, were found to be protective against CDI in mice. Associated diet-induced alterations in intestinal microbiota may influence colonization resistance and clostridial toxin production in a defined nutrient diet compared to a traditional diet, leading to increased survival. However, mechanisms which led to survival differences between 2% and 20% protein defined nutrient diets need to be further elucidated.	[Moore, John H.; Zaenker, Edna I.; Bolick, David T.; Kolling, Glynis L.; van Opstal, Edward; Guerrant, Richard L.; Warren, Cirle A.] Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA 22904 USA; [Pinheiro, Caio C. D.; Noronha, Francisco J. D.; De Medeiros, Pedro H. Q. S.; Rodriguez, Raphael S.; Lima, Aldo A.] Univ Fed Ceara, Inst Biomed, Fortaleza, Ceara, Brazil	University of Virginia; Universidade Federal do Ceara	Warren, CA (corresponding author), Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA 22904 USA.	ca6t@virginia.edu	Bolick, David/A-3467-2017; Lima, Aldo AM/D-8251-2018	Lima, Aldo AM/0000-0002-0299-1747; Pinheiro, Caio/0000-0003-1856-2442; van Opstal, Edward/0000-0002-2973-6308	NIH/NIAID [U01 AI075526]; Bill & Melinda Gates Foundation [APP16340]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075526] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by NIH/NIAID U01 AI075526 and the Bill & Melinda Gates Foundation APP16340. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Bartelt LA, 2013, J CLIN INVEST, V123, P2672, DOI 10.1172/JCI67294; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Baxter R, 2008, INFECT CONT HOSP EP, V29, P44, DOI 10.1086/524320; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bolick DT, 2014, GUT MICROBES, V5, P618, DOI 10.4161/19490976.2014.969642; Bolick DT, 2013, J MED MICROBIOL, V62, P896, DOI 10.1099/jmm.0.046300-0; Bosscher D, 2009, J PHYSIOL PHARMACOL, V60, P5; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Costa LB, 2011, J PARASITOL, V97, P1113, DOI 10.1645/GE-2848.1; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Gaskins HR, 2006, MICROBIAL ECOLOGY IN, V9; Gilca R, 2010, INFECT CONT HOSP EP, V31, P939, DOI 10.1086/655463; Gkouskou KK, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00028; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Hopkins MJ, 2003, APPL ENVIRON MICROB, V69, P1920, DOI 10.1128/AEM.69.4.1920-1927.2003; Houser BA, 2010, FOODBORNE PATHOG DIS, V7, P719, DOI 10.1089/fpd.2009.0483; Hurley BW, 2002, ARCH INTERN MED, V162, P2177, DOI 10.1001/archinte.162.19.2177; Hussein H S, 1998, J Nutr, V128, p2803S, DOI 10.1093/jn/128.12.2803S; Ikeda D, 1998, ZBL BAKT-INT J MED M, V287, P375; Karlstrom O, 1998, CLIN INFECT DIS, V26, P141, DOI 10.1086/516277; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Lamouse-Smith ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027662; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ling ZX, 2014, SCI REP-UK, V4, DOI 10.1038/srep07485; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; Panda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095476; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Pultz NJ, 2005, ANTIMICROB AGENTS CH, V49, P3529, DOI 10.1128/AAC.49.8.3529-3532.2005; Samore MH, 1996, AM J MED, V100, P32, DOI 10.1016/S0002-9343(96)90008-X; Solomon K, 2013, THER ADV INFECT DIS, V1, P19, DOI 10.1177/2049936112472173; TEODOSIO NR, 1990, ARCH LATINOAM NUTR, V40, P533; VOLLAARD EJ, 1994, ANTIMICROB AGENTS CH, V38, P409, DOI 10.1128/AAC.38.3.409; Warren CA, 2013, ANTIMICROB AGENTS CH, V57, P689, DOI 10.1128/AAC.00877-12; Warren CA, 2012, ANTIMICROB AGENTS CH, V56, P4103, DOI 10.1128/AAC.00360-12; WILSON KH, 1993, CLIN INFECT DIS, V16, pS214, DOI 10.1093/clinids/16.Supplement_4.S214; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004	42	19	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0131829	10.1371/journal.pone.0131829	http://dx.doi.org/10.1371/journal.pone.0131829			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181795	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198200012
J	Carthy, JM; Meredith, AJ; Boroomand, S; Abraham, T; Luo, ZS; Knight, D; McManus, BM				Carthy, Jon M.; Meredith, Anna J.; Boroomand, Seti; Abraham, Thomas; Luo, Zongshu; Knight, Darryl; McManus, Bruce M.			Versican V1 Overexpression Induces a Myofibroblast-Like Phenotype in Cultured Fibroblasts	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; RICH PERICELLULAR MATRIX; GROWTH-FACTOR-BETA; IN-VITRO; INDUCED APOPTOSIS; PROSTATE-CANCER; PG-M/VERSICAN; HYALURONAN; EXPRESSION; DECORIN	Background Versican, a chondroitin sulphate proteoglycan, is one of the key components of the provisional extracellular matrix expressed after injury. The current study evaluated the hypothesis that a versican-rich matrix alters the phenotype of cultured fibroblasts. Methods and Results The full-length cDNA for the V1 isoform of human versican was cloned and the recombinant proteoglycan was expressed in murine fibroblasts. Versican expression induced a marked change in fibroblast phenotype. Functionally, the versican-expressing fibroblasts proliferated faster and displayed enhanced cell adhesion, but migrated slower than control cells. These changes in cell function were associated with greater N-cadherin and integrin beta 1 expression, along with increased FAK phosphorylation. The versican-expressing fibroblasts also displayed expression of smooth muscle alpha-actin, a marker of myofibroblast differentiation. Consistent with this observation, the versican fibroblasts displayed increased synthetic activity, as measured by collagen III mRNA expression, as well as a greater capacity to contract a collagen lattice. These changes appear to be mediated, at least in part, by an increase in active TGF-beta signaling in the versican expressing fibroblasts, and this was measured by phosphorylation and nuclear accumulation of SMAD2. Conclusions Collectively, these data indicate versican expression induces a myofibroblast-like phenotype in cultured fibroblasts.	[Carthy, Jon M.; Meredith, Anna J.; Boroomand, Seti; Abraham, Thomas; Luo, Zongshu; Knight, Darryl; McManus, Bruce M.] Univ British Columbia, Dept Pathol & Lab Med, Providence Hlth Care, UBC James Hogg Res Ctr,Inst Heart Lung Hlth, Vancouver, BC, Canada	University of British Columbia	McManus, BM (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Providence Hlth Care, UBC James Hogg Res Ctr,Inst Heart Lung Hlth, Vancouver, BC, Canada.	bruce.mcmanus@hli.ubc.ca	Abraham, Thomas/AAJ-7950-2020; Abraham, Thomas/J-7080-2014	Abraham, Thomas/0000-0003-0750-8774	Heart and Stroke Foundation of British Columbia and Yukon [F08-00086]	Heart and Stroke Foundation of British Columbia and Yukon	This work was supported by a grant-in-aid from the Heart and Stroke Foundation of British Columbia and Yukon entitled "Regulation of mesenchymal cell behaviour by versican: Implications for arterial remodeling" F08-00086.(www.heartandstroke.ca) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baarsma HA, 2011, AM J PHYSIOL-LUNG C, V301, pL956, DOI 10.1152/ajplung.00123.2011; Bensadoun ES, 1997, EUR RESPIR J, V10, P2731, DOI 10.1183/09031936.97.10122731; Bensadoun ES, 1996, AM J RESP CRIT CARE, V154, P1819, DOI 10.1164/ajrccm.154.6.8970376; Cardoso LEM, 2010, J BIOL CHEM, V285, P6987, DOI 10.1074/jbc.M109.088674; Carthy JM, 2012, CARDIOVASC PATHOL, V21, P74, DOI 10.1016/j.carpath.2011.03.003; Carthy JM, 2012, LAB INVEST, V92, P246, DOI 10.1038/labinvest.2011.164; Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Choocheep K, 2010, J BIOL CHEM, V285, P21114, DOI 10.1074/jbc.M109.096479; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evanko SP, 1998, AM J PATHOL, V152, P533; Evanko SP, 2001, ARCH BIOCHEM BIOPHYS, V394, P29, DOI 10.1006/abbi.2001.2507; Farb A, 2004, CIRCULATION, V110, P940, DOI 10.1161/01.CIR.0000139337.56084.30; Geary RL, 1998, J VASC SURG, V27, P96, DOI 10.1016/S0741-5214(98)70296-4; Gupta V, 2009, CARDIOVASC PATHOL, V18, P191, DOI 10.1016/j.carpath.2008.05.001; Hattori N, 2011, J BIOL CHEM, V286, P34298, DOI 10.1074/jbc.M111.254938; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hirose J, 2001, J BIOL CHEM, V276, P5228, DOI 10.1074/jbc.M007542200; Huang R, 2006, CIRC RES, V98, P370, DOI 10.1161/01.RES.0000202051.28319.c8; KAHARI VM, 1991, J BIOL CHEM, V266, P10608; Keire PA, 2014, J BIOL CHEM, V289, P34089, DOI 10.1074/jbc.M114.607168; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin H, 1996, J HEART LUNG TRANSPL, V15, P1233; Merrilees MJ, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-41; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Nara Y, 1997, HISTOCHEM J, V29, P21, DOI 10.1023/A:1026460700592; Nikitovic D, 2006, IUBMB LIFE, V58, P47, DOI 10.1080/15216540500531713; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Rezai N, 2005, LAB INVEST, V85, P982, DOI 10.1038/labinvest.3700302; Ricciardelli C, 1998, CLIN CANCER RES, V4, P963; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Rudnicki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044891; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Toeda K, 2005, MOL CELL BIOCHEM, V280, P47, DOI 10.1007/s11010-005-8051-4; Van Bockstal Mieke, 2014, Oncoscience, V1, P634; Wang JF, CONNECT TISSUE RES, P195; Wang JF, 2008, LAB INVEST, V88, P1278, DOI 10.1038/labinvest.2008.101; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wu YJ, 2005, MATRIX BIOL, V24, P3, DOI 10.1016/j.matbio.2004.11.007; Wu YJ, 2002, J BIOL CHEM, V277, P12294, DOI 10.1074/jbc.M110748200; Xiang YY, 2006, J BIOL CHEM, V281, P19358, DOI 10.1074/jbc.M512980200; Yeung TL, 2013, CANCER RES, V73, P5016, DOI 10.1158/0008-5472.CAN-13-0023	43	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133056	10.1371/journal.pone.0133056	http://dx.doi.org/10.1371/journal.pone.0133056			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176948	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600206
J	Chang, WX; Asakawa, S; Toyoki, D; Nemoto, Y; Morimoto, C; Tamura, Y; Ota, T; Shibata, S; Fujigaki, Y; Shen, ZY; Uchida, S				Chang, Wen Xiu; Asakawa, Shinichiro; Toyoki, Daigo; Nemoto, Yoshikazu; Morimoto, Chikayuki; Tamura, Yoshifuru; Ota, Tatsuru; Shibata, Shigeru; Fujigaki, Yoshihide; Shen, Zhong Yang; Uchida, Shunya			Predictors and the Subsequent Risk of End-Stage Renal Disease - Usefulness of 30% Decline in Estimated GFR over 2 Years	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; DIABETIC-NEPHROPATHY; PROGRESSION; CKD; MORTALITY; FAILURE; POPULATION; THERAPY; HYPOXIA; INJURY	Background A goal of searching risk factors for chronic kidney disease (CKD) is to halt progressing to end-stage renal disease (ESRD) by potential intervention. To predict the future ESRD, 30% decline in estimated GFR over 2 years was examined in comparison with other time-dependent predictors. Methods CKD patients who had measurement of serum creatinine at baseline and 2 years were enrolled (n = 701) and followed up to 6 years. Time-dependent parameters were calculated as time-averaged values over 2 years by a trapezoidal rule. Risk factors affecting the incidence of ESRD were investigated by the extended Cox proportional hazard model with baseline dataset and 2-year time-averaged dataset. Predictive significance of 30% decline in estimated GFR over 2 years for ESRD was analyzed. Results For predicting ESRD, baseline estimated GFR and proteinuria were the most influential risk factors either with the baseline dataset or the 2-year time-averaged dataset. Using the 2-year time-averaged dataset, 30% decline in estimated GFR over 2 years by itself showed the highest HR of 31.6 for ESRD whereas addition of baseline estimated GFR, proteinuria, serum albumin and hemoglobin yielded a better model by a multivariate Cox regression model. This novel surrogate was mostly associated with time-averaged proteinuria over 2 years with the cut-off of similar to 1 g/g creatinine. Conclusion These results suggest that decline in estimated GFR and proteinuria are the risk factors while serum albumin and hemoglobin are the protective factors by the time-to-event analysis. Future incidence of ESRD is best predicted by 30% decline in eGFR over 2 years that can be modified by intervention to proteinuria, hemoglobin, uric acid, phosphorus, blood pressure and use of renin-angiotensin system inhibitors in the follow-up of 2 years.	[Chang, Wen Xiu; Asakawa, Shinichiro; Toyoki, Daigo; Nemoto, Yoshikazu; Morimoto, Chikayuki; Tamura, Yoshifuru; Ota, Tatsuru; Shibata, Shigeru; Fujigaki, Yoshihide; Uchida, Shunya] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan; [Chang, Wen Xiu] Tianjin First Cent Hosp, Dept Nephrol, Tianjin, Peoples R China; [Shen, Zhong Yang] Tianjin First Cent Hosp, Dept Organ Transplantat, Tianjin, Peoples R China	Teikyo University; Tianjin Medical University; Tianjin Medical University	Uchida, S (corresponding author), Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan.	s_uchida@netjoy.ne.jp		Shibata, Shigeru/0000-0002-6868-0626; , wen xiu/0000-0001-6269-5694	Ministry of Health, Labour and Welfare of Japan; Gout Research Foundation	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Gout Research Foundation	This study was supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, from the Ministry of Health, Labour and Welfare of Japan (to SU) and Gout Research Foundation (to SU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Bantis LE, 2014, BIOMETRICS, V70, P212, DOI 10.1111/biom.12107; Bouma-de Krijger A, 2014, NEPHROL DIAL TRANSPL, V29, P88, DOI 10.1093/ndt/gft456; Cancela AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036883; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Covic A, 2014, AM J NEPHROL, V40, P263, DOI 10.1159/000366025; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Erickson KF, 2013, CLIN J AM SOC NEPHRO, V8, P75, DOI 10.2215/CJN.03340412; George B, 2014, J NUCL CARDIOL, V21, P686, DOI 10.1007/s12350-014-9908-2; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hoefield RA, 2010, AM J KIDNEY DIS, V56, P1072, DOI 10.1053/j.ajkd.2010.06.010; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Inoue T, 2011, INTERNAL MED, V50, P1273, DOI 10.2169/internalmedicine.50.4059; Johnson ES, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-17; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nacak H, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-91; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Ni ZH, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-194; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Portoles J, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-2; Rahman M, 2014, CLIN J AM SOC NEPHRO, V9, P1190, DOI 10.2215/CJN.09320913; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Seiler S, 2013, CLIN J AM SOC NEPHRO, V8, P1764, DOI 10.2215/CJN.13021212; Shoji K, 2014, CURR OPIN NEPHROL HY, V23, P161, DOI 10.1097/01.mnh.0000441049.98664.6c; Sim JJ, 2013, AM J MED, V126, P311, DOI 10.1016/j.amjmed.2012.08.018; Steinman TI, 2000, SEMIN DIALYSIS, V13, P404, DOI 10.1046/j.1525-139x.2000.00110.x; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Torlen K, 2012, CLIN J AM SOC NEPHRO, V7, P1272, DOI 10.2215/CJN.00960112; Turin TC, 2012, NEPHROL DIAL TRANSPL, V27, P3835, DOI 10.1093/ndt/gfs263; Van Pottelbergh G, 2012, NEPHROL DIAL TRANSPL, V27, P2297, DOI 10.1093/ndt/gfr659; Varshney A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017230; Xie JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038904; Yang W, 2014, AM J KIDNEY DIS, V63, P236, DOI 10.1053/j.ajkd.2013.08.028; Zhuo L, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-4; Zoja C, 2015, NEPHROL DIAL TRANSPL, V30, P706, DOI 10.1093/ndt/gfu261	37	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132927	10.1371/journal.pone.0132927	http://dx.doi.org/10.1371/journal.pone.0132927			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177463	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600182
J	Lee, JW; Kang, JH; Yim, YR; Kim, JE; Wen, L; Lee, KE; Park, DJ; Kim, TJ; Park, YW; Lee, SS				Lee, Jeong-Won; Kang, Ji-Hyoun; Yim, Yi-Rang; Kim, Ji-Eun; Wen, Lihui; Lee, Kyung-Eun; Park, Dong-Jin; Kim, Tae-Jong; Park, Yong-Wook; Lee, Shin-Seok			Predictors of Switching Anti-Tumor Necrosis Factor Therapy in Patients with Ankylosing Spondylitis	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; ANTI-TNF AGENTS; EFFICACY; ARTHRITIS; SPONDYLOARTHRITIS; IMMUNOGENICITY; ANTAGONISTS; ADALIMUMAB; INHIBITORS; INFLIXIMAB	The aim of this study was to investigate the potential predictors of switching tumor necrosis factor (TNF)-alpha inhibitors in Korean patients with ankylosing spondylitis (AS). The patients who had been treated with TNF-alpha inhibitors were divided into two groups depending on whether they had switched TNF-alpha inhibitors. Demographic, clinical, laboratory, and treatment data at the time of initiation of TNF-alpha inhibitor treatment were compared between switchers and non-switchers, and within switchers according to the reasons for switching. Of the 269 patients, 70 (23%) had switched TNF-alpha inhibitors once; of these, 11 switched again. The median follow-up time was 52.7 months. Three-and five-year drug survival rates were 52%/48% for infliximab, 62%/42% for etanercept, and 71%/51% for adalimumab, respectively. Switchers were more likely to be prescribed disease-modifying anti-rheumatic drugs than non-switchers. A history of joint surgery and complete ankylosis of the sacroiliac joint was more frequent in switchers. Multivariate Cox's proportional hazard analysis showed that the use of adalimumab as the first TNF-alpha inhibitor was less likely to lead to switching and complete ankylosis of the sacroiliac joints was more likely to lead to switching. The principal reasons for switching were drug inefficacy and adverse events, but the differences in the clinical data of these two groups of switchers were not significant. In AS patients who are candidates for TNF-alpha inhibitor therapy, switching may improve the therapeutic outcome based on clinical information.	[Lee, Jeong-Won; Kang, Ji-Hyoun; Yim, Yi-Rang; Kim, Ji-Eun; Wen, Lihui; Lee, Kyung-Eun; Park, Dong-Jin; Kim, Tae-Jong; Park, Yong-Wook; Lee, Shin-Seok] Chonnam Natl Univ, Med Sch & Hosp, Dept Rheumatol, Gwangju, South Korea	Chonnam National University	Lee, SS (corresponding author), Chonnam Natl Univ, Med Sch & Hosp, Dept Rheumatol, Gwangju, South Korea.	shinseok@chonnam.ac.kr	Lee, Shin-Seok/AAC-6779-2021	Kim, Tae-Jong/0000-0002-2871-1635; Wen, Lihui/0000-0002-6385-0825	Chonnam National University Hospital Biomedical Research Institute [BCRI 14001-52]	Chonnam National University Hospital Biomedical Research Institute	This study was supported by a grant (BCRI 14001-52) from Chonnam National University Hospital Biomedical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PJ, 2005, SEMIN ARTHRITIS RHEU, V34, P19, DOI 10.1016/j.semarthrit.2005.01.005; Bartelds GM, 2011, JAMA-J AM MED ASSOC, V305, P1460, DOI 10.1001/jama.2011.406; Braun J, 2006, ANN RHEUM DIS, V65, P316, DOI 10.1136/ard.2005.040758; Busquets N, 2011, RHEUMATOLOGY, V50, P1999, DOI 10.1093/rheumatology/ker281; Dadoun S, 2011, CLIN EXP RHEUMATOL, V29, P1010; Davis JC, 2005, ANN RHEUM DIS, V64, P1557, DOI 10.1136/ard.2004.035105; Glintborg B, 2013, ANN RHEUM DIS, V72, P1149, DOI 10.1136/annrheumdis-2012-201933; Gomez-Reino JJ, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1881; Haberhauer G, 2010, WIEN MED WOCHENSCHR, V160, P220, DOI 10.1007/s10354-010-0795-0; Kristensen LE, 2010, ARTHRIT CARE RES, V62, P1362, DOI 10.1002/acr.20258; Lie E, 2011, ANN RHEUM DIS, V70, P157, DOI 10.1136/ard.2010.131797; Lukas C, 2007, J RHEUMATOL, V34, P862; Paccou J, 2011, RHEUMATOLOGY, V50, P714, DOI 10.1093/rheumatology/keq377; Plasencia C, 2012, ANN RHEUM DIS, V71, P1955, DOI 10.1136/annrheumdis-2011-200828; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; Soliman MM, 2011, ANN RHEUM DIS, V70, P583, DOI 10.1136/ard.2010.139774; van der Heijde D, 2005, ARTHRITIS RHEUM-US, V52, P582, DOI 10.1002/art.20852; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P2136, DOI 10.1002/art.21913; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361	19	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131864	10.1371/journal.pone.0131864	http://dx.doi.org/10.1371/journal.pone.0131864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176701	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600068
J	Meireles, AL; Xavier, CC; Andrade, ACD; Proietti, FA; Caiaffa, WT				Meireles, Adriana Lucia; Xavier, Cesar Coelho; de Souza Andrade, Amanda Cristina; Proietti, Fernando Augusto; Caiaffa, Waleska Teixeira			Self-Rated Health among Urban Adolescents: The Roles of Age, Gender, and Their Associated Factors	PLOS ONE			English	Article							SCHOOL; FAMILY; PREDICTORS; COMPLAINTS; MORTALITY; STRESS; ADULTS	Health status is often analyzed in population surveys. Self-rated health (SRH) is a single-item summary measure of the perception of one's health. In Brazil, studies on the SRH of adolescents remain scarce, especially those aiming to understand the domains that compose this construct. Therefore, the aim of this study is to determine the prevalence of poor SRH and its associated factors among 11- to 13-year-olds and 14- to 17-year-olds living in a large urban center in Brazil. This cross-sectional study was conducted using a household survey across Belo Horizonte that included 1,042 adolescents. Stratified logistic regression models were used for each age group to assess the associations between worse SRH and the following variables: socio-demographic, social and family support, lifestyles, psychological health, and anthropometry. Approximately 11% (95% CIs = 8.7-13.6) of the studied adolescents rated their health as poor, and SHR decreased with age among males and females. This trend was more pronounced among girls (from 6.9% among 11- to 13-year-old girls to 16.9% among 14- to 17-year-old girls) than boys (from 8.3% among 11- to 13-year-old boys to 11% among 14- to 17-year-old boys). Worse SRH was associated with family support (as assessed by the absence of parent-adolescent conversations; odds ratio [OR] = 3.5 among 11- to 13-year-olds), family structure (OR = 2.8 among 14- to 17-year-olds), and argument reporting (OR = 8.2 among 14- to 17-year-olds). Among older adolescents, the consumption of fruit fewer than five times per week (OR = 2.4), life dissatisfaction (OR = 2.8), underweight status (OR = 6.7), and overweight status (OR = 2.7) were associated with poor SRH. As adolescents age, their universe expands from their relationship with their parents to include more complex issues, such as their lifestyles and life satisfaction. Therefore, these results suggest the importance of evaluating SRH across adolescent age groups and demonstrate the influence of the family environment (in addition to other factors) on negative health assessments, particularly among 14- to 17-year-olds.	[Meireles, Adriana Lucia] Univ Fed Rio Grande do Norte, Nutr, Fac Ciencias Saude Trairi, BR-59072970 Natal, RN, Brazil; [Meireles, Adriana Lucia; Xavier, Cesar Coelho; de Souza Andrade, Amanda Cristina; Proietti, Fernando Augusto; Caiaffa, Waleska Teixeira] Univ Fed Minas Gerais, Observ Urban Hlth Belo Horizonte, Sch Med, Belo Horizonte, MG, Brazil; [Xavier, Cesar Coelho; Proietti, Fernando Augusto] Fac Saude & Ecol Humana, Med, Vespasiano, MG, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal de Minas Gerais	Meireles, AL (corresponding author), Univ Fed Rio Grande do Norte, Nutr, Fac Ciencias Saude Trairi, BR-59072970 Natal, RN, Brazil.	dri_meireles@yahoo.com.br		Cristina de Souza Andrade, Amanda/0000-0002-3366-4423	National Health Fund of the Ministry of Health [25000.102984/2006-97]; CNPq [475004/2006-0, 409688/2006-1, 479392/2008-0, 481113/2010-0]; FAPEMIG [APQ-00975-08]	National Health Fund of the Ministry of Health; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Funding sources are: 1. MOVE BH Project: funded by the National Health Fund of the Ministry of Health (Process 25000.102984/2006-97) and CNPq (Process 475004/2006-0); 2. Social Determinants of Health Project: funded by CNPq (Process 409688/2006-1); 3. Well-being of adolescents, funded by FAPEMIG (Process APQ-00975-08) and CNPq (Process 479392/2008-0 and Process 481113/2010-0).	[Anonymous], 2004, YOUNG PEOPLES HLTH C; da Silva RA, 2007, CAD SAUDE PUBLICA, V23, P1113, DOI 10.1590/S0102-311X2007000500013; Bailis DS, 2003, SOC SCI MED, V56, P203, DOI 10.1016/S0277-9536(02)00020-5; Baker AJL, 1999, FUTURE CHILD, V9, P116, DOI 10.2307/1602724; Boardman JD, 2006, J ADOLESCENT HEALTH, V38, P401, DOI 10.1016/j.jadohealth.2005.01.006; BRASIL. Ministerio da Saude. Secretaria de Atencao a Saude. Departamento de Atencao Basica. Programa Saude na Escola, 2014, OR GER AC PROM SEG A; Pavao ALB, 2013, CAD SAUDE PUBLICA, V29, P723, DOI 10.1590/S0102-311X2013000800010; Breidablik HJ, 2008, SCAND J PUBLIC HEALT, V36, P12, DOI 10.1177/1403494807085306; Centro de Pesquisas Epidemiologicas/Universidade Federal de Pelotas (CPE/UFPel), EST COORT NASCI 1993; Cheng JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117940; Currie C, 2012, HLTH BEHAV SCH AGED; Friche AAD, 2013, J URBAN HEALTH, V90, P246, DOI 10.1007/s11524-012-9737-z; Farias Junior JC, 2012, REV BRAS ATIV FIS SA, V17, P174; Finnell SME, 2014, APPL CLIN INFORM, V5, P651, DOI 10.4338/ACI-2014-02-RA-0012; Foti K, 2010, PUBLIC HEALTH REP, V125, P771, DOI 10.1177/003335491012500522; Franks P, 2003, SOC SCI MED, V56, P2505, DOI 10.1016/S0277-9536(02)00281-2; Galan I, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002644; Gerencia de Epidemiologia e Informacao Secretaria Municipal de Saude de Belo Horizonte, 2003, IND VULN SAUD; Hallal Pedro Curi, 2006, Cad. Saúde Pública, V22, P1277, DOI 10.1590/S0102-311X2006000600017; Haugland S, 2001, EUR J PUBLIC HEALTH, V11, P4, DOI 10.1093/eurpub/11.1.4; Heard HE, 2008, POPUL RES POLICY REV, V27, P773, DOI 10.1007/s11113-008-9090-9; Herrenkohl TI, 2009, J ADOLESCENT HEALTH, V44, P146, DOI 10.1016/j.jadohealth.2008.07.005; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Instituto Brasileiro de Geografia e Estatistica [Brazilian Institute of Geography and Statistics] (IBGE), 2011, SIN DO CENS DEM 2010; Jerden L, 2011, J ADOLESCENT HEALTH, V48, P143, DOI 10.1016/j.jadohealth.2010.06.005; Karademas EC, 2008, J HEALTH PSYCHOL, V13, P1012, DOI 10.1177/1359105308097965; Lima-Costa MF, 2012, AM J EPIDEMIOL, V175, P228, DOI 10.1093/aje/kwr290; Malta Deborah Carvalho, 2014, Rev. bras. epidemiol., V17, P77, DOI 10.1590/1809-4503201400050007; Manor O, 2000, INT J EPIDEMIOL, V29, P149, DOI 10.1093/ije/29.1.149; McDaid O, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002571; McDowell I., 1996, MEASURING HLTH GUIDE; MECHANIC D, 1987, J HEALTH SOC BEHAV, V28, P364, DOI 10.2307/2136790; Meireles AL, 2010, THESIS FEDERAL U MIN; Peres MA, 2010, REV SAUDE PUBL, V44, DOI 10.1590/S0034-89102010000500016; Pratta Elisângela Maria Machado, 2007, Psicol. Estud., V12, P247, DOI 10.1590/S1413-73722007000200005; Richter M, 2009, SOC SCI MED, V69, P396, DOI 10.1016/j.socscimed.2009.05.023; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Shooshtari S, 2007, RES AGING, V29, P512, DOI 10.1177/0164027507305729; Simões Anna Maria Azevedo, 2004, Cad. Saúde Pública, V20, P1169, DOI 10.1590/S0102-311X2004000500010; Sousa Thiago Ferreira de, 2010, Rev. paul. pediatr., V28, P333; Souza EM, 2006, COMUN CIENC SAUDE, V17, P9; VILHJALMSSON R, 1994, J YOUTH ADOLESCENCE, V23, P437, DOI 10.1007/BF01538038; Vingilis E, 1998, J ADOLESCENCE, V21, P83, DOI 10.1006/jado.1997.0131; Vingilis ER, 2002, CAN J PUBLIC HEALTH, V93, P193, DOI 10.1007/BF03404999; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wiklund M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-993; World Health Organization (WHO), 2007, GRWOTH REF DAT 5 19	47	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132254	10.1371/journal.pone.0132254	http://dx.doi.org/10.1371/journal.pone.0132254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177464	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600092
J	Sartori, L; Camperio-Ciani, A; Bulgheroni, M; Castiello, U				Sartori, Luisa; Camperio-Ciani, Andrea; Bulgheroni, Maria; Castiello, Umberto			Intersegmental Coordination in the Kinematics of Prehension Movements of Macaques	PLOS ONE			English	Article							MEDIAL PARIETOOCCIPITAL CORTEX; OBJECT SIZE; SELECTION; MONKEY	The most popular model to explain how prehensile movements are organized assumes that they comprise two "components", the reaching component encoding information regarding the object's spatial location and the grasping component encoding information on the object's intrinsic properties such as size and shape. Comparative kinematic studies on grasping behavior in the humans and in macaques have been carried out to investigate the similarities and differences existing across the two species. Although these studies seem to favor the hypothesis that macaques and humans share a number of kinematic features it remains unclear how the reaching and grasping components are coordinated during prehension movements in free-ranging macaque monkeys. Twelve hours of video footage was filmed of the monkeys as they snatched food items from one another (i.e., snatching) or collect them in the absence of competitors (i.e., unconstrained). The video samples were analyzed frame-by-frame using digitization techniques developed to perform two-dimensional post-hoc kinematic analyses of the two types of actions. The results indicate that only for the snatching condition when the reaching variability increased there was an increase in the amplitude of maximum grip aperture. Besides, the start of a break-point along the deceleration phase of the velocity profile correlated with the time at which maximum grip aperture occurred. These findings suggest that macaques can spatially and temporally couple the reaching and the grasping components when there is pressure to act quickly. They offer a substantial contribution to the debate about the nature of how prehensile actions are programmed.	[Sartori, Luisa; Castiello, Umberto] Univ Padua, Dipartimento Psicol Gen, Padua, Italy; [Sartori, Luisa; Castiello, Umberto] Univ Padua, Cognit Neurosci Ctr, Padua, Italy; [Camperio-Ciani, Andrea] Univ Padua, Dipartimento FISSPA, Padua, Italy; [Bulgheroni, Maria] Ab Acus, Milan, Italy; [Castiello, Umberto] Acad Lincei, Ctr Linceo Interdisciplinare Beniamino Segre, Rome, Italy	University of Padua; University of Padua; University of Padua	Castiello, U (corresponding author), Univ Padua, Dipartimento Psicol Gen, Padua, Italy.	umberto.castiello@unipd.it	Ciani, Andrea Camperio/A-8290-2013	Ciani, Andrea Camperio/0000-0002-4689-1799; Bulgheroni, Maria/0000-0001-8484-9834; Sartori, Luisa/0000-0002-3838-8958; Castiello, Umberto/0000-0003-0629-1286	MIUR [287713]; FP7: REWIRE project; Progetto Strategico, Universita di Padova [2010XPMFW4]; Ab.Acus	MIUR(Ministry of Education, Universities and Research (MIUR)); FP7: REWIRE project; Progetto Strategico, Universita di Padova; Ab.Acus	This work was supported by a grant from the MIUR (N. 287713), the FP7: REWIRE project and the Progetto Strategico, Universita di Padova (N. 2010XPMFW4) to Umberto Castiello. Ab.Acus provided support in the form of salaries for authors [MB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Castiello U, 1996, J EXP PSYCHOL HUMAN, V22, P582, DOI 10.1037/0096-1523.22.3.582; CHIEFFI S, 1993, EXP BRAIN RES, V94, P471; Christel MI, 2002, BEHAV BRAIN RES, V131, P169, DOI 10.1016/S0166-4328(01)00372-2; Ciani AC, 2005, BIOL CONSERV, V121, P635, DOI 10.1016/j.biocon.2004.06.009; DAMICO M, 1990, MED BIOL ENG COMPUT, V28, P407, DOI 10.1007/BF02441963; Fa J. E, 1984, BARBARY MACAQUE CASE; Fattori P, 2005, EUR J NEUROSCI, V22, P956, DOI 10.1111/j.1460-9568.2005.04288.x; Fattori P, 2010, J NEUROSCI, V30, P342, DOI 10.1523/JNEUROSCI.3800-09.2010; Filimon F, 2010, NEUROSCIENTIST, V16, P388, DOI 10.1177/1073858410375468; FOGASSI L, 1991, B SOC ITAL BIOL SPER, V7, P715; GENTILUCCI M, 1991, NEUROPSYCHOLOGIA, V29, P361, DOI 10.1016/0028-3932(91)90025-4; Hildebrand M., 1985, P38; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Jeannerod M., 1981, ATTENTION PERFORM, P153; Jindrich DL, 2011, EXP BRAIN RES, V209, P35, DOI 10.1007/s00221-010-2514-x; Mouna M, 1999, SEL P 1 INT C BIOD N, P91; Roy AC, 2006, EXP BRAIN RES, V169, P182, DOI 10.1007/s00221-005-0133-8; Roy AC, 2002, J NEUROPHYSIOL, V88, P1491, DOI 10.1152/jn.2002.88.3.1491; Roy AC, 2000, BEHAV BRAIN RES, V117, P75, DOI 10.1016/S0166-4328(00)00284-9; Sacrey LAR, 2009, BEHAV BRAIN RES, V204, P153, DOI 10.1016/j.bbr.2009.05.035; Sartori L, 2014, EXP BRAIN RES, V232, P919, DOI 10.1007/s00221-013-3804-x; Sartori L, 2014, SCI REP-UK, V4, DOI 10.1038/srep04019; Sartori L, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00114; Sartori L, 2013, EXP BRAIN RES, V224, P119, DOI 10.1007/s00221-012-3294-2; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Walker JA, 1998, J EXP BIOL, V201, P981; Wallace SA, JMB, V20, P81; WING AM, 1986, J MOTOR BEHAV, V18, P245	31	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132937	10.1371/journal.pone.0132937	http://dx.doi.org/10.1371/journal.pone.0132937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176232	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600185
J	Velasquez, J; Sanchez, JA				Velasquez, Johanna; Sanchez, Juan A.			Octocoral Species Assembly and Coexistence in Caribbean Coral Reefs	PLOS ONE			English	Article							PHYLOGENETIC COMMUNITY STRUCTURE; NEUTRAL THEORY; ECOLOGY; PATTERNS; LIGHT; BIODIVERSITY; ENVIRONMENT; ORGANISMS; SIGNAL; SIZE	Background What are the determinant factors of community assemblies in the most diverse ecosystem in the ocean? Coral reefs can be divided in continental (i.e., reefs that develop on the continental shelf, including siliciclastic reefs) and oceanic (i.e., far off the continental shelf, usually on volcanic substratum); whether or not these habitat differences impose community-wide ecological divergence or species exclusion/coexistence with evolutionary consequences, is unknown. Methods Studying Caribbean octocorals as model system, we determined the phylogenetic community structure in a coral reef community, making emphasis on species coexistence evidenced on trait evolution and environmental feedbacks. Forty-nine species represented in five families constituted the species pool from which a phylogenetic tree was reconstructed using mtDNA. We included data from 11 localities in the Western Caribbean (Colombia) including most reef types. To test diversity-environment and phenotype-environment relationships, phylogenetic community structure and trait evolution we carried out comparative analyses implementing ecological and evolutionary approaches. Results Phylogenetic inferences suggest clustering of oceanic reefs (e.g., atolls) contrasting with phylogenetic overdispersion of continental reefs (e.g., reefs banks). Additionally, atolls and barrier reefs had the highest species diversity (Shannon index) whereas phylogenetic diversity was higher in reef banks. The discriminant component analysis supported this differentiation between oceanic and continental reefs, where continental octocoral species tend to have greater calyx apertures, thicker branches, prominent calyces and azooxanthellate species. This analysis also indicated a clear separation between the slope and the remaining habitats, caused by the presence or absence of Symbiodinium. K statistic analysis showed that this trait is conserved as well as the branch shape. Discussion There was strong octocoral community structure with opposite diversity and composition patterns between oceanic and continental reefs. Even habitats with similar depths and overall environmental conditions did not share similar communities between oceanic and continental reefs. This indicates a strong regional influence over the local communities, probably due to water transparency differences between major reef types, i.e., oceanic vs. continental shelf-neritic. This was supported by contrasting patterns found in morphology, composition and evolutionary history of the species between atolls and reef banks.	[Velasquez, Johanna; Sanchez, Juan A.] Univ Los Andes, Fac Ciencias, Lab Biol Mol Marina BIOMMAR, Dept Ciencias Biol, Bogota 111711, Colombia	Universidad de los Andes (Colombia)	Sanchez, JA (corresponding author), Univ Los Andes, Fac Ciencias, Lab Biol Mol Marina BIOMMAR, Dept Ciencias Biol, Carrera 1E 18A-10, Bogota 111711, Colombia.	juansanc@uniandes.edu	sanchez, juan/GSD-8167-2022	Sanchez, Juan Armando/0000-0001-7149-8369	Facultad de Ciencias-Departamento de Ciencias Biologicas and Vicerrectoria de Investigaciones, Universidad de los Andes	Facultad de Ciencias-Departamento de Ciencias Biologicas and Vicerrectoria de Investigaciones, Universidad de los Andes	This study was funded by Facultad de Ciencias-Departamento de Ciencias Biologicas and Vicerrectoria de Investigaciones, Universidad de los Andes.	Ackerly DD, 2003, INT J PLANT SCI, V164, pS1, DOI 10.1086/374729; Andrefouet S, 2015, GLOBAL CHANGE BIOL, V21, P195, DOI 10.1111/gcb.12699; [Anonymous], 1961, SHALLOW WATER OCTOCO; Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; Beeravolu CR, 2009, ECOL MODEL, V220, P2603, DOI 10.1016/j.ecolmodel.2009.06.041; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Botero L., 1987, Anales del Instituto de Investigaciones Marinas de Punta de Betin, V17, P61; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; COFFROTH MA, 1992, MAR BIOL, V114, P317, DOI 10.1007/BF00349534; Connolly SR, 2005, SCIENCE, V309, P1363, DOI 10.1126/science.1113281; DAHLGREN EJ, 1989, B MAR SCI, V45, P678; Darwin C., 1842, STRUCTURE DISTRIBUTI; Darwin C, 1859, ORIGIN SPECIES MEANS, DOI [10.1007/s12064-009-0058-z, DOI 10.1007/S12064-009-0058-Z]; Diaz M, 2011, CORAL REEFS, V30, P73, DOI 10.1007/s00338-010-0668-4; Diaz-Pulido G, 2004, REV ACAD COLOMB CIEN, V28, P337; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; ELTON C, 1946, J ANIM ECOL, V15, P54, DOI 10.2307/1625; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Etnoyer Peter J, 2010, PLoS One, V5, pe10668, DOI 10.1371/journal.pone.0010668; Fabricius KE, 2008, ECOLOGY, V89, P3163, DOI 10.1890/08-0005.1; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gardner JPA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087971; Geister J, 1975, STUTTGARTER BEITRA B, V15, P1; Grajales A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-90; GRAUS RR, 1989, CORAL REEFS, V8, P9, DOI 10.1007/BF00304687; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Harrison P.L., 1990, P133; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hoogenboom MO, 2009, ECOLOGY, V90, P767, DOI 10.1890/07-2010.1; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hubbell Stephen P., 2001, V32, pi; HUGHES RN, 1983, BIOL J LINN SOC, V20, P39, DOI 10.1111/j.1095-8312.1983.tb01588.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Ives AR, 2010, AM NAT, V176, pE128, DOI 10.1086/656486; Kaandorp JA, 1999, MAR BIOL, V134, P295, DOI 10.1007/s002270050547; Lasker HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074587; LASKER HR, 1983, MAR ECOL PROG SER, V13, P21, DOI 10.3354/meps013021; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Marchinko KB, 2004, ECOL LETT, V7, P114, DOI 10.1046/j.1461-0248.2003.00557.x; Marshall DJ, 2010, ECOL LETT, V13, P128, DOI 10.1111/j.1461-0248.2009.01408.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Montaggioni LF, 2009, DEV MARINE GEOL; PORTER JW, 1976, AM NAT, V110, P731, DOI 10.1086/283100; Prada C, 2010, CORAL REEFS, V29, P41, DOI 10.1007/s00338-009-0547-z; Prada C, 2013, P NATL ACAD SCI USA, V110, P3961, DOI 10.1073/pnas.1208931110; Prada C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-47; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricklefs Robert E., 2005, P16; Ricklefs RE, 2008, AM NAT, V172, P741, DOI 10.1086/593002; Rosen B.R., 2002, P255; Ryan-Mishkin K, 2009, CARIBB J SCI, V45, P151; Sanchez JA, 2005, CARIBB J SCI, V41, P508; Sanchez JA, 2004, HYDROBIOLOGIA, V530, P283, DOI 10.1007/s10750-004-2684-2; Sanchez JA, 1999, B MAR SCI, V65, P215; Sanchez JA, 2003, MAR BIOL, V142, P975, DOI 10.1007/s00227-003-1018-7; Sanchez JA, 1997, B MAR SCI, V61, P453; Sanchez JA, 2005, EVALUATING CORAL REE; Sanchez JA, 2009, ZOOLOGICAL J LINNEAN; Sanchez Juan A., 1998, Caribbean Journal of Science, V34, P250; Sanchez JA, 2010, REV BIOL TROP, V58, P145; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Tilman D., 1982, Monographs in Population Biology, pi; Vamosi JC, 2007, DIVERS DISTRIB, V13, P1, DOI 10.1111/j.1472-4642.2006.00299.x; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Vernette G, 1986, THESIS MEM I GEOL BA, V20, P1; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011	71	15	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0129609	10.1371/journal.pone.0129609	http://dx.doi.org/10.1371/journal.pone.0129609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177191	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600014
J	Yang, Y; Jiang, M; Hu, J; Lv, X; Yu, LX; Qian, XP; Liu, BR				Yang, Yang; Jiang, Man; Hu, Jing; Lv, Xin; Yu, Lixia; Qian, Xiaoping; Liu, Baorui			Enhancement of Radiation Effects by Ursolic Acid in BGC-823 Human Adenocarcinoma Gastric Cancer Cell Line	PLOS ONE			English	Article							GAMBOGIC ACID; TUMORIGENESIS; RADIOTHERAPY; EXPRESSION; DOCETAXEL	Recent research has suggested that certain plant-derived polyphenols, i.e., ursolic acid (UA), which are reported to have antitumor activities, might be used to sensitize tumor cells to radiation therapy by inhibiting pathways leading to radiation therapy resistance. This experiment was designed to investigate the effects and possible mechanism of radiosensitization by UA in BGC-823 cell line from human adenocarcinoma gastric cancer in vitro. UA caused cytotoxicity in a dose-dependent manner, and we used a sub-cytotoxicity concentration of UA to test radioenhancement efficacy with UA in gastric cancer. Radiosensitivity was determined by clonogenic survival assay. Surviving fraction of the combined group with irradiation and sub-cytotoxicity UA significantly decreased compared with the irradiation group. The improved radiosensitization efficacy was associated with enhanced G2/M arrest, increased reactive oxygen species (ROS), down-regulated Ki-67 level and improved apoptosis. In conclusion, as UA demonstrated potent antiproliferation effect and synergistic effect, it could be used as a potential drug sensitizer for the application of radiotherapy.	[Qian, Xiaoping] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Comprehens Canc, Nanjing 210008, Jiangsu, Peoples R China; Nanjing Univ, Clin Canc Inst, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Qian, XP (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Comprehens Canc, Nanjing 210008, Jiangsu, Peoples R China.	qianxiaoping211@hotmail.com; baoruiliu@nju.edu.cn			National Natural Science Foundation of China [81172094]; Top Six Talents Project of Jiangsu Province [2011ws005]; Medical Science and Technology Development Projects of Nanjing [ZKX10011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Top Six Talents Project of Jiangsu Province; Medical Science and Technology Development Projects of Nanjing	Supported by grants from the National Natural Science Foundation of China (Grant No. 81172094), Top Six Talents Project of Jiangsu Province (Grant No. 2011ws005), and Medical Science and Technology Development Projects of Nanjing (Grant No. ZKX10011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai KK, 2011, BIOORGAN MED CHEM, V19, P4043, DOI 10.1016/j.bmc.2011.05.017; Barcellos-Hoff MH, 2005, NAT REV CANCER, V5, P867, DOI 10.1038/nrc1735; Cha HJ, 1996, CANCER RES, V56, P2281; Creane M, 1999, INT J RADIAT BIOL, V75, P731, DOI 10.1080/095530099140078; Garg AK, 2005, ANTIOXID REDOX SIGN, V7, P1630, DOI 10.1089/ars.2005.7.1630; Goishi H, 2000, ONCOL REP, V7, P713; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; HUANG MT, 1994, CANCER RES, V54, P701; LEE HY, 1994, J CANCER RES CLIN, V120, P513, DOI 10.1007/BF01221027; Liu YP, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep175; Mita T, 2001, J GASTROENTEROL, V36, P661, DOI 10.1007/s005350170028; Moran JM, 2005, LANCET ONCOL, V6, P51; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; SHON KH, 1995, CANCER LETT, V94, P213, DOI 10.1016/0304-3835(95)03856-R; TOKUDA H, 1986, CANCER LETT, V33, P279, DOI 10.1016/0304-3835(86)90067-4; Valentini V, 2007, EXPERT REV ANTICANC, V7, P1379, DOI 10.1586/14737140.7.10.1379; Valentini V, 2009, RADIOTHER ONCOL, V92, P176, DOI 10.1016/j.radonc.2009.06.014; Zhang W, 1996, CLIN CANCER RES, V2, P843; Zou ZY, 2012, CANCER BIOTHER RADIO, V27, P299, DOI 10.1089/cbr.2010.0943; Zou ZY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-58	20	15	16	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133169	10.1371/journal.pone.0133169	http://dx.doi.org/10.1371/journal.pone.0133169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177078	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600223
J	Christensen, J; Vonwil, D; Shastri, VP				Christensen, Jon; Vonwil, Daniel; Shastri, V. Prasad			Non-Invasive In Vivo Imaging and Quantification of Tumor Growth and Metastasis in Rats Using Cells Expressing Far-Red Fluorescence Protein	PLOS ONE			English	Article							HUMAN BREAST-CANCER; TUMORIGENICITY; PROGRESSION; COMPONENTS; MODELS; AGENTS	Non-invasive in vivo imaging is emerging as an important tool for basic and preclinical research. Near-infrared (NIR) fluorescence dyes and probes have been used for non-invasive optical imaging since in the NIR region absorption and auto fluorescence by body tissue is low, thus permitting for greater penetration depths and high signal to noise ratio. Currently, cell tracking systems rely on labeling cells prior to injection or administering probes targeting the cell population of choice right before imaging. These approaches do not enable imaging of tumor growth, as the cell label is diluted during cell division. In this study we have developed cell lines stably expressing the far-red fluorescence protein E2-Crimson, thus enabling continuous detection and quantification of tumor growth. In a xenograft rat model, we show that E2-Crimson expressing cells can be detected over a 5 week period using optical imaging. Fluorescence intensities correlated with tumor volume and weight and allowed for a reliable and robust quantification of the entire tumor compartment. Using a novel injection regime, the seeding of MDA-MB-231 breast cancer cells in the lungs in a rat model was established and verified.	[Christensen, Jon; Vonwil, Daniel; Shastri, V. Prasad] Univ Freiburg, Inst Macromol Chem, D-79104 Freiburg, Germany; [Christensen, Jon; Shastri, V. Prasad] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Shastri, VP (corresponding author), Univ Freiburg, Inst Macromol Chem, D-79104 Freiburg, Germany.	prasad.shastri@gmail.com			Excellence Initiative of the German Federal Government (Centre for Biological Signalling Studies, BIOSS) [EXC 294]; Excellence Initiative of the German State Government (Centre for Biological Signalling Studies, BIOSS) [EXC 294]; 5th INTERREG Upper Rhine Program (Project: Nano@MATRIX)	Excellence Initiative of the German Federal Government (Centre for Biological Signalling Studies, BIOSS); Excellence Initiative of the German State Government (Centre for Biological Signalling Studies, BIOSS); 5th INTERREG Upper Rhine Program (Project: Nano@MATRIX)	This work was supported by the Excellence Initiative of the German Federal and State Governments (Grant EXC 294; Centre for Biological Signalling Studies, BIOSS) and by the 5th INTERREG Upper Rhine Program (Project: Nano@MATRIX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050860; Blouin S, 2005, CLIN EXP METASTAS, V22, P605, DOI 10.1007/s10585-006-9002-5; Boyd NF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2942; Brekken RA, 2003, J CLIN INVEST, V111, P487, DOI 10.1172/JCI200316804; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Cui KM, 2008, LUMINESCENCE, V23, P292, DOI 10.1002/bio.1032; Direcks WGE, 2008, CANCER BIOL THER, V7, P532, DOI 10.4161/cbt.7.4.5481; Fournier LS, 2007, RADIOLOGY, V243, P105, DOI 10.1148/radiol.2431050658; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Histing T, 2011, BONE, V49, P591, DOI 10.1016/j.bone.2011.07.007; Iannaccone PM, 2009, DIS MODEL MECH, V2, P206, DOI 10.1242/dmm.002733; Kagadis GC, 2010, MED PHYS, V37, P6421, DOI 10.1118/1.3515456; Klerk CPW, 2007, BIOTECHNIQUES, V43, P7, DOI 10.2144/000112515; Leblond F, 2010, J PHOTOCH PHOTOBIO B, V98, P77, DOI 10.1016/j.jphotobiol.2009.11.007; Levin RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097415; Lim Yong Taik, 2003, Mol Imaging, V2, P50, DOI 10.1162/153535003765276282; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Mullen P, 1996, INT J CANCER, V67, P816, DOI 10.1002/(SICI)1097-0215(19960917)67:6<816::AID-IJC10>3.0.CO;2-#; Pierce MC, 2008, INT J CANCER, V123, P1979, DOI 10.1002/ijc.23858; PRICE JE, 1990, CANCER RES, V50, P717; Puissant A, 2014, CANCER CELL, V25, P226, DOI 10.1016/j.ccr.2014.01.022; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Sato A, 2004, COMPARATIVE MED, V54, P631; Sharma V, 2009, BRIT J PHARMACOL, V157, P907, DOI 10.1111/j.1476-5381.2009.00267.x; Sim H, 2011, CANCER RES, V71, P686, DOI 10.1158/0008-5472.CAN-10-2666; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Swirski FK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001075; TAKEUCHI J, 1976, CANCER RES, V36, P2133; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Vonwil D, 2014, MOL IMAGING BIOL, V16, P350, DOI 10.1007/s11307-013-0698-8; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Ying H, 2006, MOL CANCER THER, V5, P2158, DOI 10.1158/1535-7163.MCT-05-0440; Zhang YH, 2003, ONCOL REP, V10, P207	34	20	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132725	10.1371/journal.pone.0132725	http://dx.doi.org/10.1371/journal.pone.0132725			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186005	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700057
J	He, CH; Kang, L; Miao, L; Li, Q; Liang, J; Li, XH; Wang, YP; Zhu, J				He, Chunhua; Kang, Leni; Miao, Lei; Li, Qi; Liang, Juan; Li, Xiaohong; Wang, Yanping; Zhu, Jun			Pneumonia Mortality among Children under 5 in China from 1996 to 2013: An Analysis from National Surveillance System	PLOS ONE			English	Article							CHILDHOOD PNEUMONIA; DEATHS	Objectives We investigated the mortality rate of pneumonia (PMR) among children under 5 and its time trend from 1996 to 2013 to determine the priorities for ending preventable deaths from pneumonia in children under 5, and share China's successful experience in reducing PMR with other developing countries. Methods We used data from China's Under 5 Child Mortality Surveillance System (U5CMSS) to calculate the PMR and the proportion of pneumonia deaths to total deaths of children under 5. The data were grouped by urban and rural areas with Cochran-Mantel-Haensel (CMH) test and Chi-square test to examine the differences of PMR and proportion. The time trend was tested by Cochran-Armitage trend test. Results The overall PMR of children under 5 was reduced by 85.5%(from 1053.2 to 153.2 per 100,000 live births) from 1996 to 2013, with the urban and rural areas reduced by 69.1% (from 188.4 to 58.2 per 100,000 live births) and 84.7%(from 1252.8 to 191.9 per 100,000 live births), respectively. The overall proportion of pneumonia deaths to total deaths was also declined from 23.4% in 1996 to 12.8% in 2013, with the rural areas decreased from 24.4% to 13.2% and the urban areas decreased from 11.1% to 9.7%. The PMRs in neonates (0-27 days), post-neonates (1-11 months), and childhood (12-59 months) were reduced by 80.7%, 77.4%, and 80.1%, respectively in rural areas, and 71.7%, 69.6%, and 39.0%, respectively in urban areas. During 1996-2013, the PMR in children under 5 years was 4.9 fold higher in rural areas relative to that in urban areas, with relative risk (RR) of 3.6 and 6.4 in neonates and 1- to 59-month-old children, respectively. Conclusions PMR in children under 5 significantly declined in China from 1996 to 2013, especially in rural areas. However, huge disparities still existed between rural and urban areas. Infants had the highest PMR, which indicated that interventions aiming at prevention and control of infant pneumonia should be the priority for further reducing PMR in China.	[He, Chunhua; Kang, Leni; Miao, Lei; Li, Qi; Liang, Juan; Li, Xiaohong; Wang, Yanping; Zhu, Jun] Sichuan Univ, Natl Off Maternal & Child Hlth Surveillance China, West China Univ 2, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Wang, YP (corresponding author), Sichuan Univ, Natl Off Maternal & Child Hlth Surveillance China, West China Univ 2, Chengdu 610064, Sichuan, Peoples R China.	yanpingwang0618@163.com; zzhj3121@163.com		Li, Xiaohong/0000-0003-0336-7302	Chinese National Key Technology Support Program [2013BAI04B02]	Chinese National Key Technology Support Program	This study is funded by Chinese National Key Technology Support Program (Grant No. 2013BAI04B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; CEPSY China electricity council, 2013, CHIN EL POW STAT YB; DONG ZQ, 2000, CHIN J PEDIAT, V38, P597; Feng J, 2012, CHIN J EPIDEMIOL, V33, P558; Hajjeh R, 2012, EMERG INFECT DIS, V18, P1898, DOI 10.3201/eid1811.121217; Health EdoCJoR, 2008, CHIN J REPROD HLTH, V19, P280; Liang J, 2011, PAEDIATR PERINAT EP, V25, P593, DOI 10.1111/j.1365-3016.2011.01232.x; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Liu Y, 1996, CHIN J PEDIAT, V34, P365; Ministry of Foreign Affairs of the People's Republic of China, CHIN PROGR MILL DEV; *NAT I POP RES TRA, 2005, BANGL DEM HLTH SURV; National Bureau of statistics of the People's Republic of China, 2014, CHIN STAT YB 2014; National Bureau of Statistics of the People's Republic of China, 1997, CHIN STAT YB 1997; National health and family planning commission in China, 2008, CHIN HLTH STAT YB; National Health and Family Planning Commission of China, 2013, CHIN HLTH STAT YB 20; Pediatric The 7th Conference of Chinese Academy of, 1978, 7 C CHIN AC PED, V11; Research Group of Pneumonia in MCH Model County, 1990, CHIN J EPIDEMIOL, V11, P257; Ruan RS., 2004, EPIDEMIOLOGY PRINCIP; Rudan I, 2008, LANCET, V372, P781, DOI 10.1016/S0140-6736(08)61167-8; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; *UNICEF, 2008, COUNTD 2015 TRACK PR; UNICEF, 2015, COMMITTING CHILD SUR; UNICEF W. H. O, 2006, PNEUM FORG KILL CHIL; WANG H, 2003, CHIN J MATERNAL CHIL, V18, P395; Wang YP, 2011, PUBLIC HEALTH, V125, P301, DOI 10.1016/j.puhe.2011.01.003; Wang YP, 2012, ARCH DIS CHILD-FETAL, V97, pF285, DOI 10.1136/archdischild-2011-300412; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; World health organization, 2013, WORLD HLTH STAT 2013; World Health Organization and UNICEF, 2009, GLOB ACT PLAN PREV C; World Health Organization UNICEF, 2013, END PREV CHILD DEATH; World Health Organization [WHO], 1992, WORLD HLTH STAT ANN; ZHANG Y, 2003, CHINESE J CHILD HLTH, V11, P76; Zhang YF, 2007, CJCHC, V15, P519; Zhu FT, 1985, ZHU FT PRACTICE PEDI	38	23	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133620	10.1371/journal.pone.0133620	http://dx.doi.org/10.1371/journal.pone.0133620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186717	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700160
J	Inhestern, J; Oertel, K; Stemmann, V; Schmalenberg, H; Dietz, A; Rotter, N; Veit, J; Gorner, M; Sudhoff, H; Junghanss, C; Wittekindt, C; Pachmann, K; Guntinas-Lichius, O				Inhestern, Johanna; Oertel, Katrin; Stemmann, Viola; Schmalenberg, Harald; Dietz, Andreas; Rotter, Nicole; Veit, Johannes; Goerner, Martin; Sudhoff, Holger; Junghanss, Christian; Wittekindt, Claus; Pachmann, Katharina; Guntinas-Lichius, Orlando			Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer	PLOS ONE			English	Article							ADVANCED HEAD; NECK-CANCER; BONE-MARROW; PHASE-III; CARCINOMA; FLUOROURACIL; CISPLATIN; PROGRESSION; SURVIVAL; BLOOD	Background The prognostic role of circulating tumor cells (CTCs) after induction chemotherapy using docetaxel, cisplatin and fluorouracil (TPF) prior to surgery and adjuvant (chemo) radiation in locally advanced oral squamous cell cancer (OSCC) was evaluated. Methods In this prospective study, peripheral blood samples from 40 patients of the phase II study TISOC-1 (NCT01108042) with OSCC before, during, and after treatment were taken. CTCs were quantified using laser scanning cytometry of anti-epithelial cell adhesion molecule-stained epithelial cells. Their detection was correlated with clinical risk factors, recurrencefree (RFS) and overall survival (OS). Results Before starting the treatment CTCs were detected in 32 of 40 patients (80%). The median number at baseline was 3295 CTCs/ml. The median maximal number of CTCs during treatment was 5005 CTCs/ml. There was a significant increase of CTCs before postoperative radiotherapy compared to baseline before 1st cycle of IC (p = 0.011), 2nd cycle of IC (p = 0.001), 3rd cycle of IC (p = 0.004), and before surgery (p = 0.002), but not compared to end of therapy (p = 0.118). CTCs at baseline >median was also associated to risk of recurrence (p = 0.014). Maximal CTCs during therapy >median was more frequently observed in tumors of the oral cavity (p=0.022) and related to higher risk of death during follow-up (p = 0.028). Patients with CTCs at baseline >median value had significant lower RFS than patients with CTCs at baseline <median value (p = 0.025). Patients with maximal CTCs values >median during the complete course of therapy had a significantly lower OS than patients with values <median (p = 0.049). Finally, the multivariate analysis revealed that OS was significantly lower in patients with maximal CTCs during treatment higher than the median value (HR=6.151; CI: 1.244-30.420). Conclusions Baseline CTCs and maximal CTCs during therapy both seem to be good prognostic markers for OSCC when treated by TPF induction chemotherapy, surgery, and postoperative (chemo)radiation.	[Inhestern, Johanna; Oertel, Katrin; Stemmann, Viola; Guntinas-Lichius, Orlando] Jena Univ Hosp, Dept Otorhinolaryngol, Jena, Germany; [Schmalenberg, Harald] Jena Univ Hosp, Univ Tumor Ctr, Jena, Germany; [Dietz, Andreas] Univ Med Ctr Leipzig, Dept ENT Surg, Leipzig, Germany; [Rotter, Nicole; Veit, Johannes] Univ Ulm, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, D-89069 Ulm, Germany; [Goerner, Martin] Acad Teaching Hosp Bielefeld, Dept Hematol & Oncol, Bielefeld, Germany; [Sudhoff, Holger] Acad Teaching Hosp Bielefeld, Dept Otorhinolaryngol Head & Neck Surg, Bielefeld, Germany; [Junghanss, Christian] Univ Rostock, Dept Hematol Oncol & Palliat Med, Div Med, D-18055 Rostock, Germany; [Wittekindt, Claus] Univ Hosp Giessen & Marburg, Dept Otorhinolaryngol Head & Neck Surg, Giessen, Germany; [Pachmann, Katharina] Jena Univ Hosp, Div Hematol & Internal Oncol, Clin Internal Med 2, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Leipzig University; Ulm University; University of Rostock; University Hospital of Giessen & Marburg; Friedrich Schiller University of Jena	Guntinas-Lichius, O (corresponding author), Jena Univ Hosp, Dept Otorhinolaryngol, Jena, Germany.	orlando.guntinas@med.uni-jena.de	Sudhoff, Holger/AAV-9741-2020; Guntinas-Lichius, Orlando/L-1871-2016	Sudhoff, Holger/0000-0002-9274-5645; Guntinas-Lichius, Orlando/0000-0001-9671-0784; Rotter, Nicole/0000-0003-1537-8340	Sanofi-Aventis	Sanofi-Aventis(Sanofi-Aventis)	Funding was provided by Sanofi-Aventis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Balasubramanian P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042048; Buglione M, 2012, EUR J CANCER, V48, P3019, DOI 10.1016/j.ejca.2012.05.007; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Feng ZE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026399; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Glombitza F, 2010, PATHOL RES PRACT, V206, P229, DOI 10.1016/j.prp.2009.11.007; Grobe A, 2014, CLIN CANCER RES, V20, P425, DOI 10.1158/1078-0432.CCR-13-1101; Guntinas-Lichius O, 2014, ORAL ONCOL, V50, P1157, DOI 10.1016/j.oraloncology.2014.09.015; Hashimoto M, 2014, INTERACT CARDIOV TH, V18, P775, DOI 10.1093/icvts/ivu048; Hitt R, 2005, J CLIN ONCOL, V23, P8636, DOI 10.1200/JCO.2004.00.1990; Hristozova T, 2011, ANN ONCOL, V22, P1878, DOI 10.1093/annonc/mdr130; Hsieh JCH, 2015, HEAD NECK-J SCI SPEC, V37, P1448, DOI 10.1002/hed.23779; Jatana KR, 2010, ARCH OTOLARYNGOL, V136, P1274, DOI 10.1001/archoto.2010.223; Kusukawa J, 2000, J ORAL PATHOL MED, V29, P303, DOI 10.1034/j.1600-0714.2000.290703.x; Liu Z, 2007, CLIN CANCER RES, V13, P2992, DOI 10.1158/1078-0432.CCR-06-2072; Lorch JH, 2011, LANCET ONCOL, V12, P153, DOI 10.1016/S1470-2045(10)70279-5; Mirghani H, 2015, ORAL ONCOL, V51, P229, DOI 10.1016/j.oraloncology.2014.11.011; Mockelmann N, 2014, EUR ARCH OTO-RHINO-L, V271, P15, DOI 10.1007/s00405-013-2391-6; Nesteruk D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/712827; Nichols AC, 2012, HEAD NECK-J SCI SPEC, V34, P1440, DOI 10.1002/hed.21941; Oertel K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-483; Pachmann K, BREAST CANC RES, V7, pR975; Pachmann K, 2008, J CLIN ONCOL, V26, P1208, DOI 10.1200/JCO.2007.13.6523; Pachmann UA, 2011, WEBMEDCENTRAL CANC, V2; Perrone F, 2010, J CLIN ONCOL, V28, P761, DOI 10.1200/JCO.2009.22.4170; Posner M, 2008, SEMIN ONCOL, V35, P221, DOI 10.1053/j.seminoncol.2008.03.007; Scher HI, 2009, LANCET ONCOL, V10, P233, DOI 10.1016/S1470-2045(08)70340-1; SCHLIMOK G, 1987, P NATL ACAD SCI USA, V84, P8672, DOI 10.1073/pnas.84.23.8672; Tinhofer I, 2014, ANN ONCOL, V25, P2042, DOI 10.1093/annonc/mdu271; Weller P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113706; Wikner J, 2014, WORLD J CLIN ONCOL, V5, P114, DOI 10.5306/wjco.v5.i2.114; Zhong LP, 2013, J CLIN ONCOL, V31, P744, DOI 10.1200/JCO.2012.43.8820; Zhu DW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-301	36	47	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132901	10.1371/journal.pone.0132901	http://dx.doi.org/10.1371/journal.pone.0132901			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186556	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700069
J	Kawakami, T; Nakamura, Y; Karibe, H				Kawakami, Tomomi; Nakamura, Yuko; Karibe, Hiroyuki			Cyclophosphamide-Induced Morphological Changes in Dental Root Development of ICR Mice	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; LONG-TERM SURVIVORS; CHILDHOOD-CANCER SURVIVOR; HIGH-DOSE CHEMOTHERAPY; TOTAL-BODY IRRADIATION; ORAL-HEALTH; CHILDREN; ABNORMALITIES; RISK; DENTITION	Background Survivors of childhood cancer are at risk of late dental development. Cyclophosphamide is one of the most commonly used chemotherapeutic agents against cancer in children. The aim of this study was to investigate the effects of cyclophosphamide on root formation in the molars of growing mice and to assess the morphological changes in these roots using three-dimensional structural images. Methods We treated 16 12-day-old ICR mice with cyclophosphamide (100 mg/kg, i.p.) and 16 control mice with saline. At 16, 20, 24, and 27 days of age, the mandibular left first molars were scanned using soft micro-computed tomography. After scanning, the structural indices were calculated using a three-dimensional image analysis system, and the images were subjected to three-dimensional reconstruction. The length and apical foramen area of all distal roots were assessed. Histological changes in the apical region were then assessed via hematoxylin and eosin staining. Results The mandibular molars of all experimental mice showed evidence of cytotoxic injury, which appeared in the form of anomalous root shapes. Although all roots developed further after cyclophosphamide injection, the three-dimensional structural images showed that the roots in the experimental group tended to develop more slowly and were shorter than those in the control group. At 27 days of age, the mean root length was shorter in the experimental group than in the control group. Conversely, the apical foramen of the roots in the experimental group tended to close faster than that of roots in the control group. In addition, hematoxylin and eosin staining of the distal roots in the experimental group showed increased dentin thickness in the apical region. Conclusion Our results suggest that cyclophosphamide can result in short root lengths and early apical foramen closure, eventually leading to V-shaped or thin roots.	[Kawakami, Tomomi; Nakamura, Yuko; Karibe, Hiroyuki] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Pediat Dent, Tokyo, Japan	Nippon Dental University	Kawakami, T (corresponding author), Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Pediat Dent, Tokyo, Japan.	tomomi-k@tky.ndu.ac.jp	Karibe, Hiroyuki/AAV-4446-2020; Kawakami, Tomomi/AAV-9978-2020		Japan Society for the Promotion of Science, Tokyo, Japan [20592416, 23593048]	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grants-in-Aid for Scientific Research (C) 20592416 and (C) 23593048 from the Japan Society for the Promotion of Science, Tokyo, Japan.	Anton E, 1996, INT J EXP PATHOL, V77, P83, DOI 10.1046/j.1365-2613.1996.00967.x; Bagattoni S, 2014, EUR J PAEDIATR DENT, V15, P45; DAHLLOF G, 1994, ORAL SURG ORAL MED O, V77, P56, DOI 10.1016/S0030-4220(06)80107-6; Dahllof G, 1998, ACTA ODONTOL SCAND, V56, P378, DOI 10.1080/000163598428365; de Jonge ME, 2005, CLIN PHARMACOKINET, V44, P1135, DOI 10.2165/00003088-200544110-00003; Dickerman JD, 2007, PEDIATRICS, V119, P554, DOI 10.1542/peds.2006-2826; Duggal MS, 2003, ORAL ONCOL, V39, P178, DOI 10.1016/S1368-8375(02)00089-1; Effinger KE, 2014, SUPPORT CARE CANCER, V22, P2009, DOI 10.1007/s00520-014-2260-x; Gawade PL, 2014, PEDIATR BLOOD CANCER, V61, P407, DOI 10.1002/pbc.24842; Goho Curt, 1993, Pediatric Dentistry, V15, P6; Holtta P, 2002, BONE MARROW TRANSPL, V29, P121, DOI 10.1038/sj.bmt.1703330; Hsieh SGS, 2011, CANCER-AM CANCER SOC, V117, P2219, DOI 10.1002/cncr.25704; Hutton A, 2010, INT J PAEDIATR DENT, V20, P15, DOI 10.1111/j.1365-263X.2009.00999.x; Ide Y, 2015, ORAL DIS, V21, P232, DOI 10.1111/odi.12253; Ishida Y, 2014, BRIT J HAEMATOL, V164, P101, DOI 10.1111/bjh.12602; Ishida Y, 2010, INT J HEMATOL, V92, P95, DOI 10.1007/s12185-010-0611-z; Kaste SC, 1997, LEUKEMIA, V11, P792, DOI 10.1038/sj.leu.2400670; Kaste SC, 2009, CANCER-AM CANCER SOC, V115, P5817, DOI 10.1002/cncr.24670; Kawakami T, 2014, ODONTOLOGY; Lopes NNF, 2006, J DENT CHILD, V73, P140; Maeda Miho, 2008, Journal of Nippon Medical School, V75, P320; Mertens AC, 2015, CANCER-AM CANCER SOC, V121, P1108, DOI 10.1002/cncr.29170; Minicucci EM, 2003, LEUKEMIA RES, V27, P45, DOI 10.1016/S0145-2126(02)00080-2; Mitomi T, 2014, ARCH ORAL BIOL, V59, P47, DOI 10.1016/j.archoralbio.2013.09.009; Nasman M, 1997, ACTA ODONTOL SCAND, V55, P186, DOI 10.3109/00016359709115414; Nasman M, 1996, ACTA ODONTOL SCAND, V54, P287, DOI 10.3109/00016359609003540; Nemeth O, 2013, PEDIATR HEMAT ONCOL, V30, P208, DOI 10.3109/08880018.2013.763391; PAJARI U, 1995, MED PEDIATR ONCOL, V24, P310, DOI 10.1002/mpo.2950240508; Pedersen LB, 2012, INT J PAEDIATR DENT, V22, P239, DOI 10.1111/j.1365-263X.2011.01199.x; PURDELLLEWIS DJ, 1988, COMMUNITY DENT ORAL, V16, P68, DOI 10.1111/j.1600-0528.1988.tb01845.x; Remmers D, 2006, Orthod Craniofac Res, V9, P206; ROSENBERG SW, 1987, CANCER-AM CANCER SOC, V59, P1640, DOI 10.1002/1097-0142(19870501)59:9<1640::AID-CNCR2820590920>3.0.CO;2-V; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SONIS AL, 1990, CANCER, V66, P2645, DOI 10.1002/1097-0142(19901215)66:12<2645::AID-CNCR2820661230>3.0.CO;2-S; Ten Cate A R, 1996, Oral Dis, V2, P55; THOMAS HF, 1995, INT J DEV BIOL, V39, P231; Vasconcelos NPS, 2009, FORENSIC SCI INT, V184, P10, DOI 10.1016/j.forsciint.2008.11.009	37	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133256	10.1371/journal.pone.0133256	http://dx.doi.org/10.1371/journal.pone.0133256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186337	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700115
J	Kitagawa, H; Munekage, M; Matsumoto, T; Sadakane, C; Fukutake, M; Aoki, K; Watanabe, J; Maemura, K; Hattori, T; Kase, Y; Uezono, Y; Inui, A; Hanazaki, K				Kitagawa, Hiroyuki; Munekage, Masaya; Matsumoto, Takashi; Sadakane, Chiharu; Fukutake, Miwako; Aoki, Katsuyuki; Watanabe, Junko; Maemura, Kazuya; Hattori, Tomohisa; Kase, Yosio; Uezono, Yasuhito; Inui, Akio; Hanazaki, Kazuhiro			Pharmacokinetic Profiles of Active Ingredients and Its Metabolites Derived from Rikkunshito, a Ghrelin Enhancer, in Healthy Japanese Volunteers: A Cross-Over, Randomized Study	PLOS ONE			English	Article							CISPLATIN-INDUCED ANOREXIA; LICORICE-INDUCED PSEUDOALDOSTERONISM; 5-HT2C RECEPTOR; MEDICINE; DAIKENCHUTO; YOKUKANSAN; STOMACH; PEPTIDE; ACID; RATS	Background Rikkunshito, a traditional Japanese (Kampo) medicine, has been used to treat upper gastrointestinal disorders such as functional dyspepsia and gastroesophageal reflux. This study investigated the exposure and pharmacokinetics of the ingredients of rikkunshito in healthy volunteers. Methods and Results First, an exploratory nonrandomized, open-label, one-period, noncrossover study using four healthy Japanese volunteers to detect 32 typical ingredients of rikkunshito in plasma and urine. As a result, 18 or 21 of 32 ingredients was detected in plasma or urine samples after oral administration of rikkunshito (7.5 g/day). Furthermore, a randomized, open-label, three-arm, three-period, crossover study using 21 subjects was conducted to determine the amounts of exposure and pharmacokinetic parameters of nine ingredients derived from rikkunshito (atractylodin, atractylodin carboxylic acid, pachymic acid, 3,30,40,5,6,7,8-heptamethoxyflavone, naringenin, nobiletin, liquiritigenin, isoliquiritigenin, and 18 beta-glycyrrhetinic acid) after oral administration of rikkunshito at three different doses (2.5, 5.0, or 7.5 g/day) during each period. The pharmacokinetic profiles of the nine ingredients in plasma were characterized. The geometric means (95% confidence interval) for the Cmax of the ingredients at a dose of 7.5 g were 1570 (1210-2040), 14,300 (12,200-16,800), 91.0 (71.8-115), 105 (75.6-144), 1150 (802-1650), 35.9 (24.6-52.5), 800 (672-952), 42.8 (30.4-60.3), and 55,600 (39,600-78,100) pg/mL, respectively, and for the AUC(0-last) were 1760 (12902390), 12700 (11,100-14,600), 1210 (882-1650), 225 (157-322), 4630 (2930-7320), 35.7 (20.4-62.7), 4040 (3260-5010), 122 (88.2-168), and 832,000 (628,000-1,100,000) pg.h/mL respectively. Conclusions We identified the ingredients of rikkunshito that are absorbed in humans. Furthermore, we determined the pharmacokinetics of nine ingredients derived from rikkunshito. This information will be useful for elucidating the pharmacological effects of rikkunshito.	[Kitagawa, Hiroyuki; Munekage, Masaya; Hanazaki, Kazuhiro] Kochi Univ, Kochi Med Sch, Dept Surg, Kochi 780, Japan; [Matsumoto, Takashi; Sadakane, Chiharu; Fukutake, Miwako; Watanabe, Junko; Maemura, Kazuya; Hattori, Tomohisa; Kase, Yosio] Tsumura & Co, Kampo Sci Strategies Div, Tsumura Res Labs, Ibaraki, Japan; [Aoki, Katsuyuki] Tsumura & Co, Kampo Formulat Dev Ctr, Prod Div, Ibaraki, Japan; [Uezono, Yasuhito] Natl Canc Ctr, Res Inst, Div Canc Pathophysiol, Tokyo 104, Japan; [Inui, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima 890, Japan	Kochi University; Tsumura & Company; Tsumura & Company; National Cancer Center - Japan; Kagoshima University	Matsumoto, T (corresponding author), Tsumura & Co, Kampo Sci Strategies Div, Tsumura Res Labs, Ibaraki, Japan.	matsumoto_takashi@mail.tsumura.co.jp			Tsumura Co.	Tsumura Co.(Tsumura & Company)	Tsumura & Co., provided support in the form of salaries for authors TM, CS, MF, KA, JW, KM, TH and YK. The specific roles of these authors are articulated in the 'author contributions' section. This study was funded by Tsumura & Co. Tsumura & Co. was responsible for the study design, and the collection, analysis and interpretation of data.	[Anonymous], 1995, DRUG INFORM J; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; CONN JW, 1968, J AMER MED ASSOC, V205, P492, DOI 10.1001/jama.205.7.492; Fujitsuka N, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.25; Fujitsuka N, 2009, BIOL PSYCHIAT, V65, P748, DOI 10.1016/j.biopsych.2008.10.031; Gardana C, 2007, BRIT J NUTR, V98, P165, DOI 10.1017/S0007114507699358; Hisada T., 2014, DIAGNOSIS TREATMENT, V102, P1577; Kanaze FI, 2007, EUR J CLIN NUTR, V61, P472, DOI 10.1038/sj.ejcn.1602543; Kanno H, 2015, J ETHNOPHARMACOL, V159, P122, DOI 10.1016/j.jep.2014.10.058; Kawakami Z, 2010, EUR J PHARMACOL, V626, P154, DOI 10.1016/j.ejphar.2009.09.046; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; KRAHENBUHL S, 1994, J CLIN ENDOCR METAB, V78, P581, DOI 10.1210/jc.78.3.581; Kushida H, 2013, BIOMED CHROMATOGR, V27, P1647, DOI 10.1002/bmc.2974; Lee KK, 2013, J ETHNOPHARMACOL, V145, P286, DOI 10.1016/j.jep.2012.11.005; Makino T, 2014, BIOL PHARM BULL, V37, P898, DOI 10.1248/bpb.b13-00997; Mondal MS, 2005, REGUL PEPTIDES, V126, P55, DOI 10.1016/j.regpep.2004.08.038; Munekage M, 2011, DRUG METAB DISPOS, V39, P1784, DOI 10.1124/dmd.111.040097; Nahata M, 2013, PSYCHONEUROENDOCRINO, DOI S0306-4530(13)00109-1 PMID: 23583320; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nishi A, 2012, NEUROSCIENCE, V207, P124, DOI 10.1016/j.neuroscience.2012.01.037; Sadakane C, 2011, BIOCHEM BIOPH RES CO, V412, P506, DOI 10.1016/j.bbrc.2011.08.002; Sakata Y, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-116; Smith BP, 2000, PHARMACEUT RES, V17, P1278, DOI 10.1023/A:1026451721686; Suzuki H, 2014, NEUROGASTROENT MOTIL, V26, P950, DOI 10.1111/nmo.12348; Takeda H, 2008, GASTROENTEROLOGY, V134, P2004, DOI 10.1053/j.gastro.2008.02.078; Tokita Y., 2007, Inflammopharmacology, V15, P65, DOI 10.1007/s10787-006-1552-2; Tominaga K, 2014, J GASTROENTEROL, V49, P1392, DOI 10.1007/s00535-013-0896-9; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Yakabi K, 2010, REGUL PEPTIDES, V161, P97, DOI 10.1016/j.regpep.2010.02.003; Youdim KA, 2003, J NEUROCHEM, V85, P180, DOI 10.1046/j.1471-4159.2003.01652.x	30	31	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133159	10.1371/journal.pone.0133159	http://dx.doi.org/10.1371/journal.pone.0133159			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186592	Green Submitted, gold, Green Published			2022-12-27	WOS:000358198700102
J	Liao, HW; Hung, PH; Hsiao, CY; Liou, HH; Lin, HS; Huang, TH; Jou, IM; Tsai, KJ				Liao, Hung-Wei; Hung, Peir-Haur; Hsiao, Chih-Yen; Liou, Hung-Hsiang; Lin, Hsin-Shih; Huang, Tsang-Hai; Jou, I-Ming; Tsai, Kuen-Jer			Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy	PLOS ONE			English	Article							CIRCULATING LEVELS; GENE-EXPRESSION; ORAL PHOSPHATE; RENAL-FAILURE; MOUSE MODEL; IN-VIVO; HORMONE; FGF-23; FGF23; PHOSPHORUS	Background Phosphate burden in chronic kidney disease (CKD) leads to elevated serum fibroblast factor-23 (FGF-23) levels, secondary hyperparathyroidism and chronic kidney disease-mineral bone disorder (CKD-MBD). However dissociated hyperphosphatemia and low serum FGF-23 concentrations have been observed in experimentally parathyoridectomized rats. The relationships between serum mineral, hormone, and bone metabolism may be altered in the presence of CKD. The aim of our study was to investigate whether a consistent relationship existed between serum FGF-23 levels, specific serum biochemical markers, and histomorphometric parameters of bone metabolism in a parathyroidectomized CKD animal model. Results Sprague Dawley rats were divided into 3 groups: parathyroidectomy (PTX) and CKD (PTX+CKD, 9 rats), CKD without PTX (CKD, 9 rats), and neither PTX nor CKD (sham-operated control, 8 rats); CKD was induced by partial nephrectomy. At 8 weeks after partial nephrectomy, serum biomarkers were measured. Bone histomorphometries of the distal femoral metaphyseal bone were analyzed. The mean serum FGF-23 levels and mean bone formation rate were the highest in the CKD group and the lowest in the PTX+CKD group. Bone volume parameters increased significantly in the PTX+CKD group. Pearson's correlation revealed that serum FGF-23 levels associated with those of intact parathyroid hormone, phosphate, collagen type I C-telopeptide, and calcium. Univariate linear regression showed that serum FGF-23 values correlated with bone formation rate, bone volume, and osteoid parameters. Stepwise multivariate regression analysis revealed that circulating FGF-23 values were independently associated with bone volume and thickness (beta = -0.737; p < 0.001 and beta = -0.526; p = 0.006, respectively). Serum parathyroid hormone levels independently correlated with bone formation rate (beta = 0.714; p < 0.001) while collagen type I C-telopeptide levels correlated with osteoid parameter. Conclusion Serum FGF-23 levels independently correlated with bone volume parameters in rats with experimentally induced CKD.	[Liao, Hung-Wei] Jia Yi Clin, Taoyuan, Taiwan; [Hung, Peir-Haur; Hsiao, Chih-Yen] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Chiayi, Taiwan; [Hung, Peir-Haur] Chia Nan Univ Pharm & Sci, Dept Appl Life Sci & Hlth, Tainan, Taiwan; [Liou, Hung-Hsiang] Hsin Jen Hosp, Dept Med, Div Nephrol, New Taipei City, Taiwan; [Lin, Hsin-Shih; Huang, Tsang-Hai] Natl Cheng Kung Univ, Inst Phys Educ Hlth & Leisure Studies, Tainan 70101, Taiwan; [Jou, I-Ming] Natl Cheng Kung Univ, Coll Med, Dept Orthoped, Tainan 70101, Taiwan; [Tsai, Kuen-Jer] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan; [Tsai, Kuen-Jer] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Ctr Clin Med, Tainan 70101, Taiwan	Chia Nan University of Pharmacy & Science; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Tsai, KJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan.	kjtsai@mail.ncku.edu.tw	Tsai, Kuen-Jer/B-9393-2009; Tsai, Kuen-Jer/AAZ-2714-2021	Tsai, Kuen-Jer/0000-0002-2170-9735; Tsai, Kuen-Jer/0000-0002-2170-9735; Liao, Hung-Wei/0000-0003-3090-1937	National Cheng Kung University Hospital [NCKUH-10408012]; National Cheng Kung University	National Cheng Kung University Hospital; National Cheng Kung University	This study was supported by National Cheng Kung University Hospital (NCKUH-10408012) and National Cheng Kung University.	Abdelhadi M, 1998, J CLIN ENDOCR METAB, V83, P3845, DOI 10.1210/jc.83.11.3845; Asci G, 2011, NEPHROL DIAL TRANSPL, V26, P1010, DOI 10.1093/ndt/gfq491; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Danziger J, 2008, NEPHROL DIAL TRANSPL, V23, P2733, DOI 10.1093/ndt/gfn260; David V, 2013, ENDOCRINOLOGY, V154, P4469, DOI 10.1210/en.2013-1627; Desjardins L, 2012, OSTEOPOROSIS INT, V23, P2017, DOI 10.1007/s00198-011-1838-0; El-Abbadi MM, 2009, KIDNEY INT, V75, P1297, DOI 10.1038/ki.2009.83; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Evenepoel P, 2010, CLIN J AM SOC NEPHRO, V5, P1268, DOI 10.2215/CJN.08241109; Ferreira JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079721; Fukagawa M, 2003, NEPHROL DIAL TRA S10, V17, P2; Glorieux FH, 2000, BONE, V26, P103, DOI 10.1016/S8756-3282(99)00257-4; Graciolli FG, 2009, NEPHROL DIAL TRANSPL, V24, P1416, DOI 10.1093/ndt/gfn686; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; HRUSKA KA, 1995, NEW ENGL J MED, V333, P166, DOI 10.1056/NEJM199507203330307; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Kawata T, 2007, J AM SOC NEPHROL, V18, P2683, DOI 10.1681/ASN.2006070783; Lane NE, 2013, J BONE MINER RES, V28, P2325, DOI 10.1002/jbmr.1985; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Lopez I, 2011, KIDNEY INT, V80, P475, DOI 10.1038/ki.2011.107; Lu KC, 2012, CLIN ENDOCRINOL, V76, P634, DOI 10.1111/j.1365-2265.2011.04265.x; Mackenzie NCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032177; Manghat P, 2010, OSTEOPOROSIS INT, V21, P1853, DOI 10.1007/s00198-009-1142-4; Martin KJ, 2007, J AM SOC NEPHROL, V18, P875, DOI 10.1681/ASN.2006070771; Mazzaferro S, 2000, NEPHROL DIAL TRANSPL, V15, P877, DOI 10.1093/ndt/15.6.877; Mittalhenkle A, 2004, AM J KIDNEY DIS, V44, P672, DOI 10.1053/j.ajkd.2004.07.001; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Muras K, 2013, J CLIN ENDOCR METAB, V98, pE1901, DOI 10.1210/jc.2013-2418; Nishida Y, 2006, KIDNEY INT, V70, P2141, DOI 10.1038/sj.ki.5002000; Ott SM, 2008, CLIN J AM SOC NEPHRO, V3, pS151, DOI 10.2215/CJN.04301206; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pereira RC, 2009, BONE, V45, P1161, DOI 10.1016/j.bone.2009.08.008; PERETZ AM, 1992, J RHEUMATOL, V19, P411; Perwad F, 2007, AM J PHYSIOL-RENAL, V293, pF1577, DOI 10.1152/ajprenal.00463.2006; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; Reyes-Garcia R, 2014, DIABETES CARE, V37, pE89, DOI 10.2337/dc13-2235; Rhee Y, 2011, BONE, V49, P636, DOI 10.1016/j.bone.2011.06.025; RODRIGUEZ M, 1991, KIDNEY INT, V40, P1063, DOI 10.1038/ki.1991.315; Rodriguez-Ortiz ME, 2012, J AM SOC NEPHROL, V23, P1190, DOI 10.1681/ASN.2011101006; Samadfam R, 2009, ENDOCRINOLOGY, V150, P4835, DOI 10.1210/en.2009-0472; Sato T, 2004, AM J KIDNEY DIS, V44, P481, DOI 10.1053/j.ajkd.2004.05.026; Seiler S, 2009, KIDNEY INT, V76, pS34, DOI 10.1038/ki.2009.405; Shalhoub V, 2011, CALCIFIED TISSUE INT, V89, P140, DOI 10.1007/s00223-011-9501-5; SHERRARD DJ, 1993, KIDNEY INT, V43, P436, DOI 10.1038/ki.1993.64; Shimada T, 2004, BIOCHEM BIOPH RES CO, V314, P409, DOI 10.1016/j.bbrc.2003.12.102; Stubbs JR, 2012, J BONE MINER RES, V27, P38, DOI 10.1002/jbmr.516; Vervloet MG, 2011, CLIN J AM SOC NEPHRO, V6, P383, DOI 10.2215/CJN.04730510; Wesseling-Perry K, 2012, CLIN J AM SOC NEPHRO, V7, P146, DOI 10.2215/CJN.05940611; Wesseling-Perry K, 2009, J CLIN ENDOCR METAB, V94, P511, DOI 10.1210/jc.2008-0326; West SL, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-17; Wheater G, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-201; Yajima A, 2010, J BONE MINER RES, V25, P2374, DOI 10.1002/jbmr.126; Yoda K, 2012, J CLIN ENDOCR METAB, V97, pE2036, DOI 10.1210/jc.2012-2024; Yoshiko Y, 2007, BONE, V40, P1565, DOI 10.1016/j.bone.2007.01.017	55	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133278	10.1371/journal.pone.0133278	http://dx.doi.org/10.1371/journal.pone.0133278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186634	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700119
J	Rasamiravaka, T; Vandeputte, OM; Pottier, L; Huet, J; Rabemanantsoa, C; Kiendrebeogo, M; Andriantsimahavandy, A; Rasamindrakotroka, A; Stevigny, C; Duez, P; El Jaziri, M				Rasamiravaka, Tsiry; Vandeputte, Olivier M.; Pottier, Laurent; Huet, Joelle; Rabemanantsoa, Christian; Kiendrebeogo, Martin; Andriantsimahavandy, Abel; Rasamindrakotroka, Andry; Stevigny, Caroline; Duez, Pierre; El Jaziri, Mondher			Pseudomonas aeruginosa Biofilm Formation and Persistence, along with the Production of Quorum Sensing-Dependent Virulence Factors, Are Disrupted by a Triterpenoid Coumarate Ester Isolated from Dalbergia trichocarpa, a Tropical Legume	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; CAENORHABDITIS-ELEGANS; TWITCHING MOTILITY; SMALL RNAS; TRANSCRIPTIONAL REGULATION; ACYLHOMOSERINE LACTONES; BACTERIAL PATHOGENS; HOMOSERINE LACTONE; INFECTION MODEL; URSOLIC ACIDS	Recently, extracts of Dalbergia trichocarpabark have been shown to disrupt P. aeruginosa-PAO1 quorum sensing (QS) mechanisms, which are key regulators of virulence factor expression and implicated in biofilm formation. One of the active compounds has been isolated and identified as oleanolic aldehyde coumarate (OALC), a novel bioactive compound that inhibits the formation of P. aeruginosa PAO1 biofilm and its maintenance as well as the expression of the las and rhl QS systems. Consequently, the production of QS-controlled virulence factors including, rhamnolipids, pyocyanin, elastase and extracellular polysaccharides as well as twitching and swarming motilities is reduced. Native acylhomoserine lactones (AHLs) production is inhibited by OALC but exogenous supply of AHLs does not restore the production of virulence factors by OALC-treated cultures, indicating that OALC exerts its effect beyond AHLs synthesis in the QS pathways. Further experiments provided a significant inhibition of the global virulence factor activator gacA by OALC. OALC disorganizes established biofilm structure and improves the bactericidal activity of tobramycin against biofilm-encapsulated PAO1 cells. Finally, a significant reduction of Caenorhabditis elegans paralysis was recorded when the worms were infected with OALC-pre-treated P. aeruginosa. Taken together, these results show that triterpenoid coumarate esters are suitable chemical backbones to target P. aeruginosa virulence mechanisms.	[Rasamiravaka, Tsiry; Vandeputte, Olivier M.; Kiendrebeogo, Martin; El Jaziri, Mondher] Univ Libre Bruxelles, Lab Biotechnol Vegetale, Gosselies, Belgium; [Rasamiravaka, Tsiry; Andriantsimahavandy, Abel; Rasamindrakotroka, Andry] Univ Antananarivo, Fac Med, Lab Format & Rech Biol Med, Antananarivo, Madagascar; [Pottier, Laurent; Huet, Joelle; Stevigny, Caroline; Duez, Pierre] Univ Libre Bruxelles, Lab Pharmacognosie Bromatol & Nutr Humaine, Brussels, Belgium; [Rabemanantsoa, Christian] Inst Malgache Rech Appl, Lab Biodiversite & Biotechnol, Antananarivo, Madagascar; [Kiendrebeogo, Martin] Univ Ouagadougou, Lab Biochim & Chim Appl, Ouagadougou, Burkina Faso; [Duez, Pierre] Univ Mons, Serv Chim Therapeut & Pharmacognosie, B-7000 Mons, Belgium	Universite Libre de Bruxelles; University Antananarivo; Universite Libre de Bruxelles; University of Mons	El Jaziri, M (corresponding author), Univ Libre Bruxelles, Lab Biotechnol Vegetale, Gosselies, Belgium.	jaziri@ulb.ac.be	KIENDREBEOGO, Martin/F-5714-2011	Duez, Pierre/0000-0002-0484-1478	(Academie de Recherche et d'Enseignement Superieur-Commission de Cooperation au developpement) ARES-CCD; Universite Libre de Bruxelles Fonds Alice et David Van Buuren	(Academie de Recherche et d'Enseignement Superieur-Commission de Cooperation au developpement) ARES-CCD; Universite Libre de Bruxelles Fonds Alice et David Van Buuren	The study received funding from (Academie de Recherche et d'Enseignement Superieur-Commission de Cooperation au developpement) ARES-CCD "Projet PIC 2009-Madagascar" and from Universite Libre de Bruxelles Fonds Alice et David Van Buuren 2013-El Jaziri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adonizio A, 2008, J MED MICROBIOL, V57, P809, DOI 10.1099/jmm.0.47802-0; Albus AM, 1997, J BACTERIOL, V179, P3928, DOI 10.1128/jb.179.12.3928-3935.1997; An SW, 2010, APPL ENVIRON MICROB, V76, P8160, DOI 10.1128/AEM.01233-10; Azam A. T. M. Z., 2013, Research Journal of Phytochemistry, V7, P1; Billings N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003526; Blackledge MS, 2013, CURR OPIN PHARMACOL, V13, P699, DOI 10.1016/j.coph.2013.07.004; Bodini SF, 2009, LETT APPL MICROBIOL, V49, P551, DOI 10.1111/j.1472-765X.2009.02704.x; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Brink M., 2008, DALBERGIA TRICHOCARP; Busetti A, 2015, MAR DRUGS, V13, P1, DOI 10.3390/md13010001; Byrd MS, 2011, INFECT IMMUN, V79, P3087, DOI 10.1128/IAI.00057-11; Cady NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038492; Christensen LD, 2012, J ANTIMICROB CHEMOTH, V67, P1198, DOI 10.1093/jac/dks002; Chua SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5462; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; Darby C, 1999, P NATL ACAD SCI USA, V96, P15202, DOI 10.1073/pnas.96.26.15202; DARZINS A, 1993, J BACTERIOL, V175, P5934, DOI 10.1128/JB.175.18.5934-5944.1993; Das T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08398; Davey ME, 2003, J BACTERIOL, V185, P1027, DOI 10.1128/JB.185.3.1027-1036.2003; de Kievit TR, 2009, ENVIRON MICROBIOL, V11, P279, DOI 10.1111/j.1462-2920.2008.01792.x; Deep Antariksh, 2011, J Lab Physicians, V3, P4, DOI 10.4103/0974-2727.78553; Defoirdt T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000989; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Giannakaki Venetia, 2012, Recent Pat Antiinfect Drug Discov, V7, P182; Glessner A, 1999, J BACTERIOL, V181, P1623, DOI 10.1128/JB.181.5.1623-1629.1999; Gnoula C, 2007, TALANTA, V71, P1886, DOI 10.1016/j.talanta.2006.08.025; Gong AS, 2009, ENVIRON ENG SCI, V26, P1523, DOI 10.1089/ees.2008.0398; Gupta P, 2013, INDIAN J MED MICROBI, V31, P29, DOI 10.4103/0255-0857.108715; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; Hoge R., 2010, CURR RES TECHNOL ED, P383; Hope IA, 1999, C ELEGANS A PRACTICA; Hu JF, 2006, J NAT PROD, V69, P118, DOI 10.1021/np049600s; Imperi F, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00178; Irie Y, 2010, MOL MICROBIOL, V78, P158, DOI 10.1111/j.1365-2958.2010.07320.x; Ishida T, 2007, APPL ENVIRON MICROB, V73, P3183, DOI 10.1128/AEM.02233-06; Jackson KD, 2004, J BACTERIOL, V186, P4466, DOI 10.1128/JB.186.14.4466-4475.2004; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jakobsen TH, 2012, ANTIMICROB AGENTS CH, V56, P2314, DOI 10.1128/AAC.05919-11; Jermain JD, 2009, J FORENSIC SCI, V54, P612, DOI 10.1111/j.1556-4029.2009.00999.x; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Kalia VC, 2011, CRIT REV MICROBIOL, V37, P121, DOI 10.3109/1040841X.2010.532479; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Khalilzadeh P, 2010, CAN J MICROBIOL, V56, P317, DOI [10.1139/w10-013, 10.1139/W10-013]; Kim HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08656; Kiplimo JJ, 2011, AFR J PHARM PHARMACO, V5, P1150; Klausen M, 2003, MOL MICROBIOL, V50, P61, DOI 10.1046/j.1365-2958.2003.03677.x; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; KNUTSON CA, 1968, ANAL BIOCHEM, V24, P470, DOI 10.1016/0003-2697(68)90154-1; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Kretzschmar U, 2008, ARCH MICROBIOL, V190, P151, DOI 10.1007/s00203-008-0381-7; Kuo YH, 1997, PHYTOCHEMISTRY, V46, P1135, DOI 10.1016/S0031-9422(97)00227-6; Kuo YH, 2002, J CHIN CHEM SOC-TAIP, V49, P269, DOI 10.1002/jccs.200200042; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Li YH, 2012, SENSORS-BASEL, V12, P2519, DOI 10.3390/s120302519; Livermore DM, 2012, INT J ANTIMICROB AG, V39, P283, DOI 10.1016/j.ijantimicag.2011.12.012; Ma L, 2006, J BACTERIOL, V188, P8213, DOI 10.1128/JB.01202-06; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Maatta KR, 2003, J AGR FOOD CHEM, V51, P6736, DOI 10.1021/jf0347517; Makemson J, 2006, LUMINESCENCE, V21, P1, DOI 10.1002/bio.873; McKnight SL, 2000, J BACTERIOL, V182, P2702, DOI 10.1128/JB.182.10.2702-2708.2000; Medina G, 2003, MICROBIOL-SGM, V149, P3073, DOI 10.1099/mic.0.26282-0; Mogayzel PJ, 2013, AM J RESP CRIT CARE, V187, P680, DOI 10.1164/rccm.201207-1160OE; Moreau-Marquis S, 2015, J ANTIMICROB CHEMOTH, V70, P160, DOI 10.1093/jac/dku357; Muh U, 2006, ANTIMICROB AGENTS CH, V50, P3674, DOI 10.1128/AAC.00665-06; Narayanan MC, 2007, NAT PROD RES, V21, P903, DOI 10.1080/14786410601130091; Nickzad A, 2014, LETT APPL MICROBIOL, V58, P447, DOI 10.1111/lam.12211; O'Toole GA, 2003, J BACTERIOL, V185, P2687, DOI 10.1128/JB.185.9.2687-2689.2003; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Pamp SJ, 2007, J BACTERIOL, V189, P2531, DOI 10.1128/JB.01515-06; Papaioannou E, 2013, INT J MOL SCI, V14, P19309, DOI 10.3390/ijms140919309; Patriquin GM, 2008, J BACTERIOL, V190, P662, DOI 10.1128/JB.01473-07; Perez-Martinez I, 2011, ANTIMICROB AGENTS CH, V55, P3399, DOI 10.1128/AAC.01801-10; Pessi G, 2001, J BACTERIOL, V183, P6676, DOI 10.1128/JB.183.22.6676-6683.2001; Pinzon NM, 2009, APPL MICROBIOL BIOT, V82, P975, DOI 10.1007/s00253-009-1896-9; Rajaonson S, 2011, ENVIRON MICROBIOL, V13, P1236, DOI 10.1111/j.1462-2920.2011.02424.x; Rasamiravaka T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/759348; Rasamiravaka T, 2013, MICROBIOL-SGM, V159, P924, DOI 10.1099/mic.0.064378-0; Rasmussen TB, 2005, J BACTERIOL, V187, P1799, DOI 10.1128/JB.187.5.1799-1814.2005; Ravindranath N, 2004, CHEM PHARM BULL, V52, P608, DOI 10.1248/cpb.52.608; Reardon S., 2014, NATURE, DOI [10.1038/nature.2014.15135, DOI 10.1038/NATURE.2014.15135.N, DOI 10.1038/NATURE.2014.15135]; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; Reis RS, 2011, BIORESOURCE TECHNOL, V102, P6377, DOI 10.1016/j.biortech.2011.03.074; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07; Sauer K, 2004, J BACTERIOL, V186, P7312, DOI 10.1128/JB.186.21.7312-7326.2004; Shrout JD, 2006, MOL MICROBIOL, V62, P1264, DOI 10.1111/j.1365-2958.2006.05421.x; SMITH AW, 1989, NUCLEIC ACIDS RES, V17, P10509, DOI 10.1093/nar/17.24.10509; Songsiang U, 2009, FITOTERAPIA, V80, P427, DOI 10.1016/j.fitote.2009.06.002; Stalikas CD, 2007, J SEP SCI, V30, P3268, DOI 10.1002/jssc.200700261; Takahashi H, 1999, PHYTOCHEMISTRY, V51, P543, DOI 10.1016/S0031-9422(99)00070-9; Tanachatchairatana T, 2008, CHEM PHARM BULL, V56, P194, DOI 10.1248/cpb.56.194; Tay SB, 2013, INT J MOL SCI, V14, P16570, DOI 10.3390/ijms140816570; Tolker-Nielsen T, 2014, APMIS, V122, P1, DOI 10.1111/apm.12335; Torino MI, 2001, J APPL MICROBIOL, V91, P846, DOI 10.1046/j.1365-2672.2001.01450.x; Tseng BS, 2013, ENVIRON MICROBIOL, V15, P2865, DOI 10.1111/1462-2920.12155; Vandeputte OM, 2011, MICROBIOL-SGM, V157, P2120, DOI 10.1099/mic.0.049338-0; Vandeputte OM, 2010, APPL ENVIRON MICROB, V76, P243, DOI 10.1128/AEM.01059-09; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; von Rosenvinge EC, 2013, PATHOG DIS, V67, P25, DOI 10.1111/2049-632X.12020; Wade DS, 2005, J BACTERIOL, V187, P4372, DOI 10.1128/JB.187.13.4372-4380.2005; Wagner VE, 2008, CLIN REV ALLERG IMMU, V35, P124, DOI 10.1007/s12016-008-8079-9; Wei Q, 2013, INT J MOL SCI, V14, P20983, DOI 10.3390/ijms141020983; WHO-World Health Organization, 2014, ANTIMICROBIAL RESIST; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Wolska KI, 2010, CENT EUR J BIOL, V5, P543, DOI 10.2478/s11535-010-0045-x; Yang L, 2011, ENVIRON MICROBIOL, V13, P1705, DOI 10.1111/j.1462-2920.2011.02503.x; Yang ZG, 2007, CHEM PHARM BULL, V55, P15, DOI 10.1248/cpb.55.15; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181; Zhou LM, 2013, BIOTECHNOL LETT, V35, P631, DOI 10.1007/s10529-012-1126-x	114	61	65	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132791	10.1371/journal.pone.0132791	http://dx.doi.org/10.1371/journal.pone.0132791			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186595	Green Submitted, gold, Green Published			2022-12-27	WOS:000358198700062
J	Sandoval-Sierra, JV; Dieguez-Uribeondo, J				Sandoval-Sierra, Jose Vladimir; Dieguez-Uribeondo, Javier			A Comprehensive Protocol for Improving the Description of Saprolegniales (Oomycota): Two Practical Examples (Saprolegnia aenigmatica sp nov and Saprolegnia racemosa sp nov.)	PLOS ONE			English	Article							SPECIES DELIMITATION; DNA TAXONOMY; PARASITICA; IDENTIFICATION; STRAMINIPILA; DICLINA; AQUACULTURE; CHALLENGES; FUNGI; RIVER	The description, identification and classification of organisms are the pillar in biodiversity and evolutionary studies. The fungal-like organism Saprolegnia contains important animal pathogens. However, its taxonomy is weak, making it difficult to perform further studies. This problem mainly arises from the unavailability of suitable holotypes. We propose a standardized protocol for describing Saprolegnia spp. that includes good cultural practices and proper holotype preservation. In order to illustrate this new proposal, we describe two species, Saprolegnia aenigmatica sp. nov. and Saprolegnia racemosa sp. nov., based on the recently described molecular operational taxonomic units (MOTUs), phylogenetic relationships, and the analyses of morphological features. We show that they belong to two different MOTUs that are grouped into two sister clades. Morphologically, we find that S. racemosa exhibits a species-specific character, i.e., aggrupation of oogonia in racemes, while S. aenigmatica does not have any specific characters. Analyses of a combined set of characters, i.e., length and breadth of sporangia, length/breadth ratio (l/b) of oogonia, cyst and oospore diameter, and the number of oospores per oogomium, allow distinguishing these two species. To improve Saprolegnia taxonomy, we propose to incorporate into the protologue: (i) several isolates of the new species; (ii) the rDNA sequences to compare them to data-bases of Saprolegnia sequences of reference; (iii) a phylogenetic analysis to check relationships with other species; (iv) to preserve holotypes in absolute ethanol and to include lyophilized material from holotype; and (v) the ex-type as a pure culture from single-spore isolates stored in at least two different collections.	[Sandoval-Sierra, Jose Vladimir; Dieguez-Uribeondo, Javier] CSIC, Dept Micol, Real Jardin Bot, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Dieguez-Uribeondo, J (corresponding author), CSIC, Dept Micol, Real Jardin Bot, Madrid, Spain.	dieguez@rjb.csic.es	dieguez-uribeondo, javier/I-2178-2015; Sandoval, Vladimir/GYD-5018-2022; Diéguez-Uribeondo, Javier/ABF-1130-2021	dieguez-uribeondo, javier/0000-0002-4488-0658; Sandoval, Vladimir/0000-0003-2007-6582; Diéguez-Uribeondo, Javier/0000-0002-4488-0658	European Union [ITN-SAPRO-238550]; Ministerio de Economia y Competitividad [CGL2012-39357]; Foundation San Ignacio del Huinay, Endesa, Chile	European Union(European Commission); Ministerio de Economia y Competitividad(Spanish Government); Foundation San Ignacio del Huinay, Endesa, Chile	The funding or sources of support were grants of: (1) European Union (ITN-SAPRO-238550), (2) Ministerio de Economia y Competitividad (CGL2012-39357), which supported lab-bench expenses, experiments, and sampling, and (3) Foundation San Ignacio del Huinay, Endesa, Chile, which supported sampling expenses in the field station of San Ignacio del Huinay Chile. Moreover, Jose V. Sandoval-Sierra was supported by fellowships from ITN-SAPRO-238550 and Ministerio de Economia y Competitividad (CGL2012-39357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beakes GW, 1994, SALMON SAPROLEGNIASI, P33; Benson D.A., 2014, NUCL ACIDS RES, V42, P32, DOI [DOI 10.1017/S1462399401002204, DOI 10.1093/nar/gkx1094]; BURR AW, 1994, PROTOPLASMA, V181, P142, DOI 10.1007/BF01666393; Chakrabarty P, 2010, ZOOTAXA, P67, DOI 10.11646/zootaxa.2632.1.4; Coker WC., 1923, SAPROLEGNIACEAE NOTE; Crous PW, 2004, STUD MYCOL, P19; Crous PW, 2002, MYCOL RES, V106, P1378, DOI 10.1017/S0953756202227136; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Day JG, 2010, TAXON, V59, P3, DOI 10.1002/tax.591001; Dieguez-Uribeondo J, 2007, FUNGAL GENET BIOL, V44, P585, DOI 10.1016/j.fgb.2007.02.010; Eissa AE, 2013, INT J VET SCI MED, V1, P7, DOI 10.1016/j.ijvsm.2013.04.001; ELLIOTT RUTH F., 1968, N Z J BOT, V6, P94; Federhen S, 2015, NUCLEIC ACIDS RES, V43, pD1086, DOI 10.1093/nar/gku1127; Fernandez-Beneitez MJ, 2008, FEMS MICROBIOL LETT, V279, P23, DOI 10.1111/j.1574-6968.2007.01002.x; Fontaneto D, 2014, INT REV HYDROBIOL, V99, P178, DOI 10.1002/iroh.201301719; Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; Goker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006319; HATAI K, 1977, Fish Pathology, V12, P105; Inaba Shigeki, 2002, Mycoscience, V43, P73, DOI 10.1007/s102670200011; Johnson Jr TW, BIOL SYSTEMATICS SAP; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Leliaert F, 2014, EUR J PHYCOL, V49, P179, DOI 10.1080/09670262.2014.904524; Leliaert F, 2009, MOL PHYLOGENET EVOL, V53, P122, DOI 10.1016/j.ympev.2009.06.004; McNeill J, 2012, 18 INT BOT C MELB AU; MOLINA FI, 1995, ANTON LEEUW INT J G, V68, P65, DOI 10.1007/BF00873294; Mutanen M, 2015, MOL ECOL RESOUR, V15, P967, DOI 10.1111/1755-0998.12361; Paul B, 2004, FEMS MICROBIOL LETT, V237, P393, DOI 10.1016/j.femsle.2004.07.006; Perotti MG, 2013, AUSTRAL ECOL, V38, P672, DOI 10.1111/aec.12014; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Redecker D, 2013, MYCORRHIZA, V23, P515, DOI 10.1007/s00572-013-0486-y; Rezinciuc S, 2014, FUNGAL BIOL-UK, V118, P591, DOI 10.1016/j.funbio.2013.11.011; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEYMOUR R. L., 1970, Nova Hedwigia, V19, P1; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steciow MM, 2002, NEW ZEAL J BOT, V40, P679; Steciow MM, 2002, NEW ZEAL J BOT, V40, P473; Steciow MM, 2001, NEW ZEAL J BOT, V39, P483; Steciow M'OM, 2007, FEMS MICROBIOL LETT, V268, P225, DOI 10.1111/j.1574-6968.2006.00582.x; Steciow WM, 2003, FEMS MICROBIOL LETT, V219, P253, DOI 10.1016/S0378-1097(03)00024-7; van den Berg AH, 2013, FUNGAL BIOL REV, V27, P33, DOI 10.1016/j.fbr.2013.05.001; Van West Pieter, 2006, Mycologist, V20, P99, DOI 10.1016/j.mycol.2006.06.004; Venables WN., 2002, MODERN APPL STAT S 4; Sandoval-Sierra JV, 2014, AQUACULTURE, V434, P462, DOI 10.1016/j.aquaculture.2014.09.005; Sandoval-Sierra JV, 2014, FUNGAL BIOL-UK, V118, P559, DOI 10.1016/j.funbio.2013.10.005; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willoughby LG, 1998, NOVA HEDWIGIA, V66, P507	50	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132999	10.1371/journal.pone.0132999	http://dx.doi.org/10.1371/journal.pone.0132999			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186364	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700083
J	Tanito, M; Kaidzu, S; Takai, Y; Ohira, A				Tanito, Masaki; Kaidzu, Sachiko; Takai, Yasuyuki; Ohira, Akihiro			Correlation between Systemic Oxidative Stress and Intraocular Pressure Level	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; REACTIVE OXYGEN METABOLITES; TRABECULAR MESHWORK CELLS; TOTAL ANTIOXIDANT STATUS; NORMAL-TENSION GLAUCOMA; D-ROMS TEST; AQUEOUS-HUMOR; PSEUDOEXFOLIATION SYNDROME; EXFOLIATION SYNDROME; SULFHYDRYL-GROUPS	Background The involvement of local and systemic oxidative stress in intraocular pressure (IOP) elevation and optic nerve damage has been hypothesized in the pathogenesis of glaucoma. We reported previously that the level of systemic antioxidative capacity is lower in patients with open-angle glaucoma than controls without glaucoma. Here, we assessed the correlation between IOP and systemic levels of prooxidants and antioxidants by analyzing the blood biochemistry in patients with glaucoma. Methods Peripheral blood samples were collected from Japanese patients with primary open-angle glaucoma (n = 206), exfoliation syndrome (n = 199), and controls (n = 126). Serum levels of lipid peroxides, ferric-reducing activity, and thiol antioxidant activity were measured by diacron reactive oxygen metabolite (dROM), biological antioxidant potential (BAP), and sulfhydryl (SH) tests, respectively, using a free radical analyzer. To test the possible effect of oxidative stress on IOP levels, the patients were classified into one of four groups (Q1, Q2, Q3, and Q4, with Q1 having the lowest IOP) based on the quartile value of IOP. For this classification, the known highest IOP value in both the right and left eyes was regarded as each subject's IOP. For comparisons among the IOP groups, the differences were calculated using one-way analysis of variance followed by post-hoc unpaired t-tests. To adjust for differences in demographic characteristic distributions, the dROM, BAP, and SH test values were compared among the IOP groups using multiple logistic regression analysis; the odds ratio (OR) of each variable was calculated with the Q1 group as the reference. Results The dROM and the SH levels did not differ significantly (p = 0.6704 and p = 0.6376, respectively) among the four IOP groups. The BAP levels differed significantly (p = 0.0115) among the four IOP groups; the value was significantly lower in the Q4 group (1,932 mu mol/L) compared with the Q1 (2,023 mu mol/L, p = 0.0042) and Q2 (2,003 mu mol/L, p = 0.0302) groups and significantly lower in the Q3 group (1,948 mu mol/L) than the Q1 (p = 0.0174) group. After adjustment for differences in various demographic characteristics, lower BAP values were significantly associated with the classification into higher IOP groups (Q3 group, p = 0.0261 and OR = 0.06/range; Q4 group, p = 0.0018 and OR = 0.04/range). The dROM and SH values did not reach significance in any comparisons. Conclusions Lower systemic antioxidant capacity measured by ferric-reducing activity is involved in the pathogenesis of open-angle glaucoma via its roles in IOP elevation.	[Tanito, Masaki] Matsue Red Cross Hosp, Div Ophthalmol, Matsue, Shimane, Japan; [Tanito, Masaki; Kaidzu, Sachiko; Takai, Yasuyuki; Ohira, Akihiro] Shimane Univ, Dept Ophthalmol, Fac Med, Izumo, Shimane, Japan	Shimane University	Tanito, M (corresponding author), Matsue Red Cross Hosp, Div Ophthalmol, Matsue, Shimane, Japan.	tanito-oph@umin.ac.jp	; ohira, akihiro/G-8352-2017	TAKAI, YASUYUKI/0000-0003-3881-3624; Kaidzu, Sachiko/0000-0002-3324-6678; ohira, akihiro/0000-0002-1307-5592	Imai Memorial Glaucoma Research Foundation; Suda Memorial Glaucoma Research Foundation	Imai Memorial Glaucoma Research Foundation; Suda Memorial Glaucoma Research Foundation	Research grants from the Imai Memorial Glaucoma Research Foundation and the Suda Memorial Glaucoma Research Foundation (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVARADO JA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1769, DOI 10.1001/archopht.1992.01080240109042; Beyazyildiz E, 2014, JPN J OPHTHALMOL, V58, P353, DOI 10.1007/s10384-014-0325-5; Carratelli M, 2001, INT J CLIN PHARM RES, V21, P79; Cornelli U, 2001, J NUTR, V131, P3208, DOI 10.1093/jn/131.12.3208; Cumurcu T, 2010, OPHTHALMIC RES, V43, P169, DOI 10.1159/000272019; Demirdogen BC, 2014, CLIN LAB, V60, P79, DOI 10.7754/Clin.Lab.2013.121229; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Engin KN, 2010, MOL VIS, V16, P1260; Erdurmus M, 2011, CURR EYE RES, V36, P713, DOI 10.3109/02713683.2011.584370; Fatma N, 2009, FREE RADICAL RES, V43, P783, DOI 10.1080/10715760903062887; Foster A, 2005, EYE, V19, P1133, DOI 10.1038/sj.eye.6701973; Gherghel D, 2005, INVEST OPHTH VIS SCI, V46, P877, DOI 10.1167/iovs.04-0777; He Z, 2011, CLIN EXP OPTOM, V94, P133, DOI 10.1111/j.1444-0938.2010.00564.x; Himori N, 2013, J NEUROCHEM, V127, P669, DOI 10.1111/jnc.12325; Inomata Y, 2006, J NEUROCHEM, V98, P372, DOI 10.1111/j.1471-4159.2006.03871.x; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Izzotti A, 2003, AM J MED, V114, P638, DOI 10.1016/S0002-9343(03)00114-1; Izzotti A, 2011, PLOS ONE, V20, P14567, DOI DOI 10.1371/J0URNAL.P0NE.0014567; KAHN MG, 1983, INVEST OPHTH VIS SCI, V24, P1283; Kitaoka Y, 2011, ENDOCRINOLOGY, V152, P2775, DOI 10.1210/en.2011-0046; Koliakos GG, 2008, GRAEF ARCH CLIN EXP, V246, P1477, DOI 10.1007/s00417-008-0871-y; Kotani K, 2010, MED PRIN PRACT, V19, P496, DOI 10.1159/000320312; Lamoke F, 2012, FREE RADICAL BIO MED, V53, P577, DOI 10.1016/j.freeradbiomed.2012.04.010; Li L, 2009, EYE, V23, P1464, DOI 10.1038/eye.2008.281; Lopez-Riquelme N, 2015, INT OPHTHALMOL, V35, P527, DOI 10.1007/s10792-014-9979-8; Luna C, 2009, FOOD CHEM TOXICOL, V47, P198, DOI 10.1016/j.fct.2008.10.029; LUTJENDRECOLL E, 1986, EXP EYE RES, V42, P443, DOI 10.1016/0014-4835(86)90004-7; Majsterek I, 2011, EXP MOL PATHOL, V90, P231, DOI 10.1016/j.yexmp.2011.01.001; Martinovic J, 2009, INT J SPORTS MED, V30, P851, DOI 10.1055/s-0029-1238289; MICHELET F, 1995, CLIN CHEM, V41, P1509; Miyamoto N, 2011, INVEST OPHTH VIS SCI, V52, P1055, DOI 10.1167/iovs.10-5777; Munemasa Y, 2009, GENE THER, V16, P17, DOI 10.1038/gt.2008.126; Nakamura H, 2001, P NATL ACAD SCI USA, V98, P2688, DOI 10.1073/pnas.041624998; Nakayama Keisuke, 2007, Clin Exp Nephrol, V11, P218, DOI 10.1007/s10157-007-0486-3; Nucci C, 2013, MOL VIS, V19, P1841; Pasquini A, 2008, VET RES COMMUN, V32, P137, DOI 10.1007/s11259-007-9014-x; Sacca SC, 2005, ARCH OPHTHALMOL-CHIC, V123, P458, DOI 10.1001/archopht.123.4.458; Sacca SC, 2007, EXP EYE RES, V84, P389, DOI 10.1016/j.exer.2006.10.008; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Shimano M, 2009, HEART RHYTHM, V6, P935, DOI 10.1016/j.hrthm.2009.03.012; Sorkhabi R, 2011, MOL VIS, V17, P41; Takai Y, 2012, INVEST OPHTH VIS SCI, V53, P241, DOI 10.1167/iovs.11-8434; Tanito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049680; Tehrani S, 2015, CURR EYE RES, V40, P191, DOI 10.3109/02713683.2014.968935; Tezel G, 1998, INVEST OPHTH VIS SCI, V39, P2277; Vassalle C, 2008, CLIN BIOCHEM, V41, P1162, DOI 10.1016/j.clinbiochem.2008.07.005; Virgolici Bogdana, 2007, Rom J Intern Med, V45, P59; Wax MB, 1998, AM J OPHTHALMOL, V125, P145, DOI 10.1016/S0002-9394(99)80084-1; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yagci R, 2008, EYE, V22, P128, DOI 10.1038/sj.eye.6702751; Yang JJ, 2001, INVEST OPHTH VIS SCI, V42, P1273; Yildirim O, 2005, EYE, V19, P580, DOI 10.1038/sj.eye.6701565; Yokoyama Y, 2014, BIOCHEM BIOPH RES CO, V451, P510, DOI 10.1016/j.bbrc.2014.08.009; Yuki K, 2013, CURR EYE RES, V38, P983, DOI 10.3109/02713683.2013.800889; Yuki K, 2010, ACTA OPHTHALMOL, V88, pe259, DOI 10.1111/j.1755-3768.2010.01997.x; Zhou LL, 1999, J CELL PHYSIOL, V180, P182, DOI 10.1002/(SICI)1097-4652(199908)180:2<182::AID-JCP6>3.0.CO;2-X	57	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133582	10.1371/journal.pone.0133582	http://dx.doi.org/10.1371/journal.pone.0133582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186651	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700159
J	Albertsen, M; Karst, SM; Ziegler, AS; Kirkegaard, RH; Nielsen, PH				Albertsen, Mads; Karst, Soren M.; Ziegler, Anja S.; Kirkegaard, Rasmus H.; Nielsen, Per H.			Back to Basics - The Influence of DNA Extraction and Primer Choice on Phylogenetic Analysis of Activated Sludge Communities	PLOS ONE			English	Article							BIOLOGICAL PHOSPHORUS REMOVAL; MICROBIAL COMMUNITIES; ENVIRONMENTAL DNA; WASTE-WATER; RNA; PURIFICATION; SEQUENCES; MODEL; BIAS	DNA extraction and primer choice have a large effect on the observed community structure in all microbial amplicon sequencing analyses. Although the biases are well known, no comprehensive analysis has been conducted in activated sludge communities. In this study we systematically explored the impact of a number of parameters on the observed microbial community: bead beating intensity, primer choice, extracellular DNA removal, and various PCR settings. In total, 176 samples were subjected to 16S rRNA amplicon sequencing, and selected samples were investigated through metagenomics and metatranscriptomics. Quantitative fluorescence in situ hybridization was used as a DNA extraction-independent method for qualitative comparison. In general, an effect on the observed community was found on all parameters tested, although bead beating and primer choice had the largest effect. The effect of bead beating intensity correlated with cell-wall strength as seen by a large increase in DNA from Gram-positive bacteria (up to 400%). However, significant differences were present at lower phylogenetic levels within the same phylum, suggesting that additional factors are at play. The best primer set based on in silico analysis was found to underestimate a number of important bacterial groups. For 16S rRNA gene analysis in activated sludge we recommend using the FastDNA SPIN Kit for Soil with four times the normal bead beating and V1-3 primers.	[Albertsen, Mads; Karst, Soren M.; Ziegler, Anja S.; Kirkegaard, Rasmus H.; Nielsen, Per H.] Aalborg Univ, Ctr Microbial Communities, Dept Chem & Biosci, Aalborg, Denmark	Aalborg University	Nielsen, PH (corresponding author), Aalborg Univ, Ctr Microbial Communities, Dept Chem & Biosci, Aalborg, Denmark.	phn@bio.aau.dk	Nielsen, Per Halkjær/T-6796-2018; Albertsen, Mads/T-7358-2018	Nielsen, Per Halkjær/0000-0002-6402-1877; Albertsen, Mads/0000-0002-6151-190X; Karst, Soren Michael/0000-0002-0233-160X; Kirkegaard, Rasmus Hansen/0000-0003-3349-3617	Innovation Fond Denmark (EcoDesign-MBR)	Innovation Fond Denmark (EcoDesign-MBR)	This study was funded by the Innovation Fond Denmark (EcoDesign-MBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen M, 2012, ISME J, V6, P1094, DOI 10.1038/ismej.2011.176; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Allison DG, 2003, BIOFOULING, V19, P139, DOI [10.1080/0892701031000072190, 10.1038/nrmicro2415]; [Anonymous], 2014, IMPLEMENTING REPROD; Bourrain M, 1999, CURR MICROBIOL, V38, P315, DOI 10.1007/PL00006809; Cai L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053649; Cangelosi GA, 2014, APPL ENVIRON MICROB, V80, P5884, DOI 10.1128/AEM.01763-14; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; de Vries A., 2013, GGDENDRO TOOLS EXTRA; Dominiak DM, 2011, ENVIRON MICROBIOL, V13, P710, DOI 10.1111/j.1462-2920.2010.02375.x; Dowle M., 2014, DATA TABLE EXTENSION; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Gabor EM, 2003, FEMS MICROBIOL ECOL, V44, P153, DOI 10.1016/S0168-6496(02)00462-2; Guo F, 2013, APPL MICROBIOL BIOT, V97, P4607, DOI 10.1007/s00253-012-4244-4; Guo FD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071714, 10.1371/journal.pone.0076185]; Kennedy K, 2014, APPL ENVIRON MICROB, V80, P5717, DOI 10.1128/AEM.01451-14; Klindworth Anna, 2013, Nucleic Acids Res, V41, pe1, DOI 10.1093/nar/gks808; Kragelund C, 2011, FEMS MICROBIOL ECOL, V76, P451, DOI 10.1111/j.1574-6941.2011.01065.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McIlroy SJ, 2014, ISME J, V8, P613, DOI 10.1038/ismej.2013.162; McIlroy SJ, 2009, ANTON LEEUW INT J G, V96, P593, DOI 10.1007/s10482-009-9374-z; McIlroy SJ, 2015, MIDAS FIELD GUIDE MI; McLellan SL, 2010, ENVIRON MICROBIOL, V12, P378, DOI 10.1111/j.1462-2920.2009.02075.x; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morgan-Sagastume F, 2008, WATER RES, V42, P843, DOI 10.1016/j.watres.2007.08.026; Nielsen PH, 2012, CURR OPIN BIOTECH, V23, P452, DOI 10.1016/j.copbio.2011.11.027; Nielsen PH, 2010, WATER RES, V44, P5070, DOI 10.1016/j.watres.2010.07.036; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pages H, 2014, BIOSTRINGS STRING OB; Prinja S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043093, 10.1371/journal.pone.0030362]; Purohit HJ, 2003, J MICROBIOL METH, V52, P315, DOI 10.1016/S0167-7012(02)00185-9; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Roh C, 2006, APPL BIOCHEM BIOTECH, V134, P97, DOI 10.1385/ABAB:134:2:97; Shan GB, 2008, J ENVIRON SCI-CHINA, V20, P80, DOI 10.1016/S1001-0742(08)60012-1; Sheik AR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00047; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tchobanoglous G., 2014, WASTEWATER ENG TREAT, V5th; Vanysacker L, 2010, APPL MICROBIOL BIOT, V88, P299, DOI 10.1007/s00253-010-2770-5; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Wickham H., 2015, DPLYR GRAMMAR DATA M; Wickham H, 2012, MAKE IT EASIER WORK; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; Yu ZT, 1999, CAN J MICROBIOL, V45, P269, DOI 10.1139/cjm-45-3-269	50	297	302	6	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132783	10.1371/journal.pone.0132783	http://dx.doi.org/10.1371/journal.pone.0132783			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182345	gold, Green Submitted, Green Published			2022-12-27	WOS:000358198200035
J	Song, SS; Liu, XH; Bai, XL; Jiang, YB; Zhang, XZ; Yu, CQ; Shao, XM				Song, Shanshan; Liu, Xuehua; Bai, Xueliang; Jiang, Yanbin; Zhang, Xianzhou; Yu, Chengqun; Shao, Xiaoming			Impacts of Environmental Heterogeneity on Moss Diversity and Distribution of Didymodon (Pottiaceae) in Tibet, China	PLOS ONE			English	Article							PREDICTING SPECIES DISTRIBUTIONS; DISTRIBUTION MODELS; AIR HUMIDITY; NORTH-AFRICA; BRYOPHYTE; INDICATORS; RICHNESS; SOUTHWEST; ECOSYSTEM; ACCURACY	Tibet makes up the majority of the Qinghai-Tibet Plateau, often referred to as the roof of the world. Its complex landforms, physiognomy, and climate create a special heterogeneous environment for mosses. Each moss species inhabits its own habitat and ecological niche. This, in combination with its sensitivity to environmental change, makes moss species distribution a useful indicator of vegetation alteration and climate change. This study aimed to characterize the diversity and distribution of Didymodon (Pottiaceae) in Tibet, and model the potential distribution of its species. A total of 221 sample plots, each with a size of 10 x 10 m and located at different altitudes, were investigated across all vegetation types. Of these, the 181 plots in which Didymodon species were found were used to conduct analyses and modeling. Three noteworthy results were obtained. First, a total of 22 species of Didymodon were identified. Among these, Didymodon rigidulusvar. subulatus had not previously been recorded in China, and Didymodon constrictusvar. constrictus was the dominant species. Second, analysis of the relationships between species distributions and environmental factors using canonical correspondence analysis revealed that vegetation cover and altitude were the main factors affecting the distribution of Didymodon in Tibet. Third, based on the environmental factors of bioclimate, topography and vegetation, the distribution of Didymodon was predicted throughout Tibet at a spatial resolution of 1 km, using the presence-only MaxEnt model. Climatic variables were the key factors in the model. We conclude that the environment plays a significant role in moss diversity and distribution. Based on our research findings, we recommend that future studies should focus on the impacts of climate change on the distribution and conservation of Didymodon.	[Song, Shanshan] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Liu, Xuehua] Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China; [Bai, Xueliang] Inner Mongolia Univ, Coll Life Sci, Hohhot, Peoples R China; [Jiang, Yanbin] Huazhong Agr Univ, Coll Resources & Environm, Wuhan, Peoples R China; [Zhang, Xianzhou; Yu, Chengqun] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Shao, Xiaoming] China Agr Univ, Coll Resources & Environm Sci, Beijing Key Lab Biodivers & Organ Farming, Beijing 100094, Peoples R China	China Agricultural University; Tsinghua University; Inner Mongolia University; Huazhong Agricultural University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; China Agricultural University	Liu, XH (corresponding author), Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China.	xuehua-hjx@tsinghua.edu.cn; shaoxm@cau.edu.cn	zhang, xian/GYA-0290-2022		grant entitled "Research and demonstration on key techniques of safety growing and efficient use of forage grass in the One River, Two Streams area" from the Tibet Autonomous Region [Z2013C02N02]	grant entitled "Research and demonstration on key techniques of safety growing and efficient use of forage grass in the One River, Two Streams area" from the Tibet Autonomous Region	This work was supported by the grant entitled "Research and demonstration on key techniques of safety growing and efficient use of forage grass in the One River, Two Streams area" from the Tibet Autonomous Region (NO: Z2013C02N02, URL: http://tibetsti.gov.cn/xzkjtportal/index.aspx). XS received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Peng C, 2007, DIVERS DISTRIB, V13, P654, DOI 10.1111/j.1472-4642.2007.00393.x; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Baniya CB, 2010, MT RES DEV, V30, P275, DOI 10.1659/MRD-JOURNAL-D-09-00057.1; Belland RJ, 2005, CAN J BOT, V83, P243, DOI [10.1139/B04-172, 10.1139/b04-172]; Ceschin S, 2012, ECOL INDIC, V14, P74, DOI 10.1016/j.ecolind.2011.08.020; Cui XY, 2009, ECOL RES, V24, P645, DOI 10.1007/s11284-008-0535-8; del Hoyo LV, 2011, EUR J FOREST RES, V130, P983, DOI 10.1007/s10342-011-0488-2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ermakova EV, 2004, J RADIOANAL NUCL CH, V259, P51, DOI 10.1023/B:JRNC.0000015805.22707.a1; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Frahm JP, 2007, GEFAHRST REINHALT L, V67, P269; Frego KA, 2007, FOREST ECOL MANAG, V242, P65, DOI 10.1016/j.foreco.2007.01.030; Gao QZ, 2010, QUATERN INT, V226, P143, DOI 10.1016/j.quaint.2009.10.035; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchinson M.F., 2004, ANUSPLIN VERSION 4 3; Imada Y, 2011, P ROY SOC B-BIOL SCI, V278, P3026, DOI 10.1098/rspb.2011.0134; Immerzeel W, 2008, AGR SYST, V96, P52, DOI 10.1016/j.agsy.2007.05.005; Ingerpuu N, 2001, BIODIVERS CONSERV, V10, P2153, DOI 10.1023/A:1013141609742; Jia Y., 2013, SPECIES CATALOGUE CH, V1; Jiang YB, 2011, POL J ECOL, V59, P317; Jiang YB, 2014, ECOL INDIC, V38, P72, DOI 10.1016/j.ecolind.2013.10.024; Jimenez JA, 2005, ANN MO BOT GARD, V92, P225; Jimenez JA, 2006, J HATTORI BOT LAB, P211; Jimenez JA, 2009, J BRYOL, V31, P49, DOI 10.1179/037366808X389342; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Karger DN, 2012, ECOL INDIC, V20, P277, DOI 10.1016/j.ecolind.2012.02.026; Li Fen-Xia, 2006, Zhiwu Shengtai Xuebao, V30, P919; [李融 Li Rong], 2010, [干旱地区农业研究, Agricultural Research in the Arid Areas], V28, P228; Li XJ, 1985, MOSS FLORA OF TIBET; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; Ochyra R, 2002, J BRYOL, V24, P33, DOI 10.1179/037366802125000331; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pesch R, 2006, ECOL INDIC, V6, P137, DOI 10.1016/j.ecolind.2005.08.018; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Piao SL, 2006, CLIMATIC CHANGE, V74, P253, DOI 10.1007/s10584-005-6339-8; Prates-Clark CD, 2008, ECOL MODEL, V211, P309, DOI 10.1016/j.ecolmodel.2007.09.024; Rapalee G, 2001, J GEOPHYS RES-ATMOS, V106, P33551, DOI 10.1029/2001JD000509; Ren DM, 2012, THESIS INNER MONGOLI; Shao JJ, 2012, 28 CHIN CHEM SOC C; Tian WL, 2011, THESIS SICHUAN NORMA; Turetsky MR, 2012, NEW PHYTOL, V196, P49, DOI 10.1111/j.1469-8137.2012.04254.x; Vanderpoorten A, 2006, BIODIVERS CONSERV, V15, P829, DOI 10.1007/s10531-004-1873-7; Weibull H, 2005, BIOL CONSERV, V122, P71, DOI 10.1016/j.biocon.2004.07.001; Werner O, 2005, SYST BOT, V30, P461, DOI 10.1600/0363644054782198; Werner O, 2009, PLANT BIOSYST, V143, pS136, DOI 10.1080/11263500903226965; Wu PC, 1998, BRYOPHYTES BIOL; Zander R.H., 1993, B BUFFALO SOC NATURA, V32, P1; Zhang JT, 2011, QUANTITATIVE ECOLOGY, V2	49	20	23	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132346	10.1371/journal.pone.0132346	http://dx.doi.org/10.1371/journal.pone.0132346			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181326	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198200017
J	Khan, YA; Singh, BR; Ullah, R; Shoeb, M; Naqvi, AH; Abidi, SMA				Khan, Yasir Akhtar; Singh, Braj Raj; Ullah, Rizwan; Shoeb, Mohd; Naqvi, Alim H.; Abidi, Syed M. A.			Anthelmintic Effect of Biocompatible Zinc Oxide Nanoparticles (ZnO NPs) on Gigantocotyle explanatum, a Neglected Parasite of Indian Water Buffalo	PLOS ONE			English	Article							INDUCE OXIDATIVE STRESS; ANTIBACTERIAL ACTIVITY; ESCHERICHIA-COLI; CANCER-CELLS; SILVER NANOPARTICLES; SUPEROXIDE-DISMUTASE; TIO2 NANOPARTICLES; DNA-DAMAGE; MECHANISM; SIZE	Helminth parasites of veterinary importance cause huge revenue losses to agrarian economy worldwide. With the emergence of drug resistance against the current formulations, there is a need to focus on the alternative approaches in order to control this menace. In the present study, biocompatible zinc oxide nanoparticles (ZnO NPs) were used to see their in vitro effect on the biliary amphistomes, Gigantocotyle explanatum, infecting Bubalus bubalis because these nanoparticles are involved in generation of free radicals that induce oxidative stress, resulting in disruption of cellular machinery. The ZnO NPs were synthesized by using egg albumin as a biotemplate and subsequently characterized by Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM), X-ray Diffraction and Spectrophotometrical, which showed that ZnO NPs were highly purified wurtzite type polycrystals, with a mean size of 16.7 nm. When the parasites were treated with lower concentrations (0.004% and 0.008%) of the ZnO NPs, the worms mounted a protective response by stimulating the antioxidant system but the treatment of G. explanatum with 0.012% ZnO NPs produced significant inhibition of the antioxidant enzymes like superoxide dismutase (SOD) (p<0.05) and glutathione S-transferase (GST) (p<0.01), while the level of malondialdehyde (MDA), a lipid peroxidation marker, was significantly (p<0.01) elevated. SEM and histopathology revealed pronounced tegumental damage showing the disruption of surface papillae and the annulations, particularly in the posterior region near acetabulum. The under expression of a number of polypeptides, loss of worm motility in a time dependent manner, further reflect strong anthelmintic potential of ZnO NPs. It can be concluded that the anthelmintic effect might be due to the production of reactive oxygen species that target a variety of macromolecules such as nucleic acid, protein and lipids which are involved in different cellular processes.	[Khan, Yasir Akhtar; Ullah, Rizwan; Abidi, Syed M. A.] Aligarh Muslim Univ, Dept Zool, Sect Parasitol, Aligarh 202002, Uttar Pradesh, India; [Singh, Braj Raj; Shoeb, Mohd; Naqvi, Alim H.] Aligarh Muslim Univ, Dept Appl Phys, Ctr Excellence Mat Sci Nanomat, ZHCET, Aligarh 202002, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University; Zakir Husain College Of Engineering & Technology	Abidi, SMA (corresponding author), Aligarh Muslim Univ, Dept Zool, Sect Parasitol, Aligarh 202002, Uttar Pradesh, India.	abbasabidi92@hotmail.com	Shoeb, Mohd/B-4206-2014	Shoeb, Mohd/0000-0003-0582-7034; Khan, Yasir Akhtar/0000-0001-9277-7164	University Grant Commission, New Delhi, under Maulana Azad National Fellowship [F117.1/201112/MANFMUSUTT1151]	University Grant Commission, New Delhi, under Maulana Azad National Fellowship	The authors received no specific funding for this project; however, YAK received a fellowship grant (F117.1/201112/MANFMUSUTT1151) from the University Grant Commission, New Delhi, under the scheme of Maulana Azad National Fellowship.	Abidi SMA, 2000, J HELMINTHOL, V74, P283; Ali M, 2014, PARASITOL RES, V113, P681, DOI 10.1007/s00436-013-3696-5; Allahverdiyev AM, 2011, FUTURE MICROBIOL, V6, P933, DOI [10.2217/FMB.11.78, 10.2217/fmb.11.78]; [Anonymous], 2011, ANN REPORT DEP ANIMA, P1; Antoine TE, 2012, ANTIVIR RES, V96, P363, DOI 10.1016/j.antiviral.2012.09.020; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Buege J A, 1978, Methods Enzymol, V52, P302; Catherine EJ, 2007, TRENDS PARASITOL, V25, P28; Chitra K., 2013, International Food Research Journal, V20, P59; Chu XiuJuan, 2009, Modern Applied Science, V3, P177; Dwivedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111289; Emamifar A, 2010, INNOV FOOD SCI EMERG, V11, P742, DOI 10.1016/j.ifset.2010.06.003; Faisal M, 2011, J MATER SCI TECHNOL, V27, P594, DOI 10.1016/S1005-0302(11)60113-8; Giske CG, 2008, ANTIMICROB AGENTS CH, V52, P813, DOI 10.1128/AAC.01169-07; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hao LH, 2009, J ENVIRON SCI, V21, P1459, DOI 10.1016/S1001-0742(08)62440-7; Jin X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106991; Jin X, 2013, ADV MATER, V25, P1342, DOI 10.1002/adma.201203849; Jin X, 2012, ADV MATER, V24, P5676, DOI 10.1002/adma.201201780; Kirthi AV, 2011, PARASITOL RES, V109, P461, DOI 10.1007/s00436-011-2277-8; Kumar A, 2011, FREE RADICAL BIO MED, V51, P1872, DOI 10.1016/j.freeradbiomed.2011.08.025; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li XH, 2009, INT J FOOD SCI TECH, V44, P2161, DOI 10.1111/j.1365-2621.2009.02055.x; Li Y, 2012, ACS NANO, V6, P5164, DOI 10.1021/nn300934k; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mishra A, 2011, APPL MICROBIOL BIOT, V92, P617, DOI 10.1007/s00253-011-3556-0; Mishra YK, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752469; Mishra YK, 2011, ANTIVIR RES, V92, P305, DOI 10.1016/j.antiviral.2011.08.017; Morphew RM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000937; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Palanikumar L, 2013, APPL NANOSCI, V3, P441, DOI 10.1007/s13204-012-0141-5; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u; Ramyadevi J, 2011, PARASITOL RES, V109, P1403, DOI 10.1007/s00436-011-2387-3; Sawai J, 1996, J CHEM ENG JPN, V29, P627, DOI 10.1252/jcej.29.627; Shoeb M, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/035015; Singh BN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106937; Singh D., 2002, Journal of Veterinary Parasitology, V16, P115; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; SWARUP D, 1987, INDIAN J ANIM SCI, V57, P252; Tansatit T, 2012, EXP PARASITOL, V131, P8, DOI 10.1016/j.exppara.2012.02.018; Thangaraj P, 2011, VACUUM, V86, P140, DOI 10.1016/j.vacuum.2011.05.001; Unfried K, 2007, NANOTOXICOLOGY, V1, P52, DOI 10.1080/00222930701314932; van Bladeren PJ, 2000, CHEM-BIOL INTERACT, V129, P61, DOI 10.1016/S0009-2797(00)00214-3; von Samson-Himmelstjerna G, 2005, VET PARASITOL, V132, P223, DOI 10.1016/j.vetpar.2005.07.014; Wahab R, 2007, MATER RES BULL, V42, P1640, DOI 10.1016/j.materresbull.2006.11.035; Wahab R, 2014, COLLOID SURFACE B, V123, P664, DOI 10.1016/j.colsurfb.2014.10.012; Wahab R, 2014, COLLOID SURFACE B, V117, P267, DOI 10.1016/j.colsurfb.2014.02.038; Wahab R, 2013, J BIOMED NANOTECHNOL, V9, P1181, DOI 10.1166/jbn.2013.1652; Wahab R, 2013, J BIOMED NANOTECHNOL, V9, P441, DOI 10.1166/jbn.2013.1593; Wahab R, 2012, J BIOMED NANOTECHNOL, V8, P424, DOI 10.1166/jbn.2012.1448; Wahab R, 2011, CHEM ENG J, V175, P450, DOI 10.1016/j.cej.2011.09.055; Wahab R, 2011, J BIOL INORG CHEM, V16, P431, DOI 10.1007/s00775-010-0740-0; Wahab R, 2010, MET MATER INT, V16, P767, DOI 10.1007/s12540-010-1011-x; Wahab R, 2010, APPL MICROBIOL BIOT, V87, P1917, DOI 10.1007/s00253-010-2692-2; Wahab R, 2009, SYNTHETIC MET, V159, P2443, DOI 10.1016/j.synthmet.2009.08.006; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Yla-Herttuala S, 1999, ANN NY ACAD SCI, V874, P134, DOI 10.1111/j.1749-6632.1999.tb09231.x; Yu KN, 2013, TOXICOL IN VITRO, V27, P1187, DOI 10.1016/j.tiv.2013.02.010; Zak AK, 2011, INT J NANOMED, V6, P1399, DOI 10.2147/IJN.S19693; Zak AK, 2011, CERAM INT, V37, P393, DOI 10.1016/j.ceramint.2010.08.017	65	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133086	10.1371/journal.pone.0133086	http://dx.doi.org/10.1371/journal.pone.0133086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177503	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600213
J	Schmidt, T; Brodesser, A; Schnitzler, N; Gruger, T; Brandenburg, K; Zinserling, J; Zundorf, J				Schmidt, Thomas; Brodesser, Alva; Schnitzler, Norbert; Grueger, Thomas; Brandenburg, Kerstin; Zinserling, Joerg; Zuendorf, Josef			CD66b Overexpression and Loss of C5a Receptors as Surface Markers for Staphylococcus aureus-Induced Neutrophil Dysfunction	PLOS ONE			English	Article							PERIPHERAL-BLOOD NEUTROPHILS; LIPOTEICHOIC ACID; INNATE IMMUNITY; SEVERE SEPSIS; GENE FAMILY; ACTIVATION; EXPRESSION; PEPTIDOGLYCAN; GRANULOCYTE; INTEGRINS	Neutrophil granulocytes constitute the main component of innate immunity in the clearance of bacterial infections. However, during systemic inflammation, immunoparalysis may occur resulting in neutrophil dysfunction. This study presents a new in vitro model for analyzing the dysfunction of human peripheral blood neutrophils resulting from the interaction with Staphylococcus aureus components in whole blood. After induction of a massive complement activation by S. aureus supernatant, the neutrophils exhibit a reduced phagocytic capacity resulting in a dramatic reduction of the antibacterial activity similar to that of neutrophils isolated from septic patients. The number of phagocytozing neutrophils is drastically reduced as well as the phagocytic capacity designated by a significantly lower number of ingested microbes. This dysfunction correlates with the loss of complement component 5a receptor 1 from the neutrophil cell surface and can be further characterized by a C5a-induced CD66b overexpression. The presented in vitro model offers a new platform for preclinical testing of immunosuppressive drugs and delivers new information for the understanding of neutrophil dysfunctions under the conditions described.	[Schmidt, Thomas] Univ Marburg, Dept Dermatol, Marburg, Germany; [Brodesser, Alva; Grueger, Thomas; Brandenburg, Kerstin; Zuendorf, Josef] Fed Inst Drugs & Med Devices, Biosafety Lab L2, Bonn, Germany; [Schnitzler, Norbert] Gesundheitsamt Kreises Duren, Duren, Germany; [Zinserling, Joerg] Fed Inst Drugs & Med Devices, Biostat Unit, Bonn, Germany	Philipps University Marburg	Zundorf, J (corresponding author), Fed Inst Drugs & Med Devices, Biosafety Lab L2, Bonn, Germany.	josef.zuendorf@bfarm.de			BfArM, Bonn, Germany	BfArM, Bonn, Germany	This work was entirely funded by BfArM, Bonn, Germany.	Adib-Conquy M, 2007, FEBS LETT, V581, P3723, DOI 10.1016/j.febslet.2007.03.074; Alves JC, 2005, MEM I OSWALDO CRUZ, V100, P223, DOI 10.1590/S0074-02762005000900038; Alves JC, 2010, SHOCK, V34, P15, DOI 10.1097/SHK.0b013e3181e7e61b; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; DEKIMPE SJ, 1995, P NATL ACAD SCI USA, V92, P10359, DOI 10.1073/pnas.92.22.10359; DUCKER TP, 1992, J LEUKOCYTE BIOL, V52, P11, DOI 10.1002/jlb.52.1.11; ELSAKKA N, 2006, CRIT CARE SHOCK, V9, P9; FASANO MB, 1991, J CLIN INVEST, V88, P1452, DOI 10.1172/JCI115454; Fukuoka Y, 1998, BIOCHEM BIOPH RES CO, V242, P663, DOI 10.1006/bbrc.1997.8034; Furebring M, 2006, SCAND J IMMUNOL, V63, P208, DOI 10.1111/j.1365-3083.2006.01724.x; Furebring M, 2002, CRIT CARE, V6, P363, DOI 10.1186/cc1524; GRANOWITZ EV, 1994, J INFECT DIS, V169, P480, DOI 10.1093/infdis/169.2.480; Gruger T, 2012, CHEMOTHERAPY, V58, P206, DOI 10.1159/000338390; Guo RF, 2003, FASEB J, V17, P1889, DOI 10.1096/fj.03-0009fje; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hawkins PT, 2010, CURR TOP MICROBIOL, V346, P183, DOI 10.1007/82_2010_40; Hoarau C, 2007, J IMMUNOL, V179, P4754, DOI 10.4049/jimmunol.179.7.4754; Huber-Lang M, 2001, J IMMUNOL, V166, P1193, DOI 10.4049/jimmunol.166.2.1193; Huber-Lang MS, 2002, J IMMUNOL, V169, P3223, DOI 10.4049/jimmunol.169.6.3223; Kaufmann I, 2006, SHOCK, V26, P254, DOI 10.1097/01.shk.0000223131.64512.7a; Kobold ACM, 2000, INTENS CARE MED, V26, P883, DOI 10.1007/s001340051277; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marc MM, 2010, SCAND J IMMUNOL, V71, P386, DOI 10.1111/j.1365-3083.2010.02385.x; Martins PS, 2008, CRIT CARE, V12, DOI 10.1186/cc6801; Morris AC, 2011, BLOOD, V117, P5178, DOI 10.1182/blood-2010-08-304667; Morris AC, 2009, AM J RESP CRIT CARE, V180, P19, DOI 10.1164/rccm.200812-1928OC; NAKAE H, 1994, RES COMMUN CHEM PATH, V84, P189; Paulsen J, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0849-4; Presneill JJ, 2002, AM J RESP CRIT CARE, V166, P138, DOI 10.1164/rccm.2009005; Reddy RC, 2008, BLOOD, V112, P4250, DOI 10.1182/blood-2007-12-128967; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Schmidt T, 2013, CLIN MICROBIOL INFEC, V19, P279, DOI 10.1111/j.1469-0691.2012.03775.x; Schmidt T, 2012, J LEUKOCYTE BIOL, V91, P791, DOI 10.1189/jlb.0911483; Schnitzler N, 1999, NAT MED, V5, P231, DOI 10.1038/5597; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Scola AM, 2009, MOL IMMUNOL, V46, P1149, DOI 10.1016/j.molimm.2008.11.001; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; TELLADO JM, 1991, J LEUKOCYTE BIOL, V50, P547, DOI 10.1002/jlb.50.6.547; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; Torsteinsdottir I, 1999, SCAND J IMMUNOL, V50, P433, DOI 10.1046/j.1365-3083.1999.00602.x; van den Berg CW, 2014, J IMMUNOL, V192, P1787, DOI 10.4049/jimmunol.1301920; Ward PA, 2010, J INNATE IMMUN, V2, P439, DOI 10.1159/000317194; Zhou GQ, 2001, GENE, V264, P105, DOI 10.1016/S0378-1119(00)00595-3	44	15	16	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132703	10.1371/journal.pone.0132703	http://dx.doi.org/10.1371/journal.pone.0132703			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176669	Green Submitted, gold, Green Published			2022-12-27	WOS:000358197600143
J	Toefy, Y; Skinner, D; Thomsen, SC				Toefy, Yoesrie; Skinner, Donald; Thomsen, Sarah C.			"What do You Mean I've Got to Wait for Six Weeks?!" Understanding the Sexual Behaviour of Men and Their Female Partners after Voluntary Medical Male Circumcision in the Western Cape	PLOS ONE			English	Article							HIV PREVENTION; RISK; RESUMPTION; AFRICA; KISUMU; TOWN	Background Several studies have shown that voluntary male medical circumcision (VMMC) reduces the incidence of the Type-1 human immunodeficiency virus (HIV) in heterosexual men by up to 60%. However, there is an increased risk of transmission of STIs, including HIV, in the immediate post-operative period after receiving VMMC. This study is to understand sexual practices of couples in the post-operative period in a Coloured population in the Western Cape Province of South Africa. Methods Coloured Males who had undergone VMMC in the previous six months in the Cape Town area and their partners participated in eight single-gender focus group discussions. The groups explored why the men decided to undergo VMMC, what kind of counselling they received, and how they experienced the 6-week post-operative period, including sexually. Results The primary motivation to VMMC uptake included religious injunction and hygiene reasons and protection against sexually transmitted infections not necessarily HIV. There was some exploration of alternative sexual practices. During the period immediately post operation the respondents spoke of pain and fear of any sexual arousal, but towards the end of the six week period, sexual desire returned. Both men and women felt that sex was important to maintain the relationship. Gaps were identified in the pre- and post-MC procedure counselling. Conclusions There is a real risk that men in this population may begin sex before complete healing has occurred. VMMC counselling to encourage men to stay sexually safe in the wound-healing period, needs to take into account the real-life factors of the circumcised men. It is essential from a public health, and gender perspective that effective counselling strategies for the VMMC post-operative period, and the longer term, are developed and tested.	[Toefy, Yoesrie; Thomsen, Sarah C.] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Toefy, Yoesrie; Skinner, Donald] Univ Stellenbosch, Dept Interdisciplinary Hlth Sci, Cape Town, South Africa	Karolinska Institutet; Stellenbosch University	Toefy, Y (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	ytoefy@sun.ac.za			Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was made possible through funding from the Swedish Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NAT STRAT PLAN HIV S; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Delva W, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18034; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Green EdwardC., 2000, INDIGENOUS THEORIES; Grund JM, 2012, AIDS CARE, V24, P245, DOI 10.1080/09540121.2011.596516; Herman-Roloff A, 2012, AIDS BEHAV, V16, P1173, DOI 10.1007/s10461-011-0073-1; Hewett PC, 2012, AIDS, V26, P749, DOI 10.1097/QAD.0b013e32835097ff; LEIGH BC, 1993, AM PSYCHOL, V48, P1035, DOI 10.1037/0003-066X.48.10.1035; Mall S, 2013, AIDS CARE, V25, P194, DOI 10.1080/09540121.2012.689810; Maughan-Brown B, 2011, JAIDS-J ACQ IMM DEF, V58, P499, DOI 10.1097/QAI.0b013e31823584c1; Maughan-Brown B, 2010, SOC SCI MED, V70, P368, DOI 10.1016/j.socscimed.2009.09.041; Meade CS, 2012, DRUG ALCOHOL DEPEN, V126, P232, DOI 10.1016/j.drugalcdep.2012.05.024; National Department of Health, 2009, S AFR NAT IMPL GUID; Odoyo-June E, 2013, JAIDS-J ACQ IMM DEF, V62, P465, DOI [10.1097/QAI.0b013e3182800710, 10.1097/QAI.]; Peltzer K, 2011, GENDER BEHAV, V9, P3479; Peltzer K, 2010, SUBST USE MISUSE, V45, P2221, DOI 10.3109/10826084.2010.481594; STATSSA, 2011, S AFR NAT POP CENS 2; Terreblanche M., 2010, RES PRACTICE APPL ME, P271; UNAIDS, 2009, S AFR COUNTR SIT; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Weiss HA, 2010, AIDS, V24, pS61, DOI 10.1097/01.aids.0000390708.66136.f4; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; World Health Organization and UNAIDS, 2011, PROGR SCAL UP MAL CI	25	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133156	10.1371/journal.pone.0133156	http://dx.doi.org/10.1371/journal.pone.0133156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26176946	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600221
J	Alajmi, F; Zeng, CS; Jerry, DR				Alajmi, Fahad; Zeng, Chaoshu; Jerry, Dean R.			Domestication as a Novel Approach for Improving the Cultivation of Calanoid Copepods: A Case Study with Parvocalanus crassirostris	PLOS ONE			English	Article							EGG-PRODUCTION RATES; ACARTIA-TONSA DANA; MARINE FISH; STOCKING DENSITY; CULTURE; FOOD; ZOOPLANKTON; PARAMETERS; LARVAE; ADULT	Calanoid copepods are an important food source for most fish larvae. Their role as a natural prey item means that it is important to develop culture technology for copepods to meet the requirements of larvae culture in aquaculture hatcheries. Copepods have been cultured successfully for some time; however, the implications of long-term cultivation or domestication on copepod life history traits have not yet been assessed. Therefore, the aim of this study was to determine if the domesticated and wild populations of Parvocalanus crassirostris are phenotypically or physiologically different. Wild-caught P. crassirostris were compared to a long-held domesticated strain (>2 years) for size of developmental stage, fecundity and lifespan of adult females, culture density, ingestion rates, faecal pellet production and fatty acid profiles. The domesticated strain was significantly different from the wild strain in size (eggs, nauplii, copepodites and adults were larger in the domesticated strain), egg production (112.3 +/- 1.8 eggs female(-1) vs. 64.6 +/- 3.3 eggs female(-1)) and adult female lifespan (8.8 +/- 0.1 days vs., 7.5 +/- 0.1 days). At 1, 3 and 5 adults mL(-1), the domesticated strain performed significantly better than the wild strain in egg production (4189.8 +/- 61.2, 11224.0 +/- 71.7 and 21860.6 +/- 103.6 eggs vs. 1319.5 +/- 54.3, 2374.5 +/- 80.9 and 4933.8 +/- 269.5 eggs, respectively) and mean daily mortality rate (5.6% across all densities vs. 22.9 +/- 1.6, 29.8 +/- 1.2 and 31.3 +/- 1.3%, respectively). The domesticated strain had significantly higher ingestion rates than the wild stain (888.4 +/- 9.9 ng Cl-1 and 775.3 +/- 11.2 ng Cl-1, respectively), while faecal pellet production was not significantly different between strains. Fatty acid profiles indicated higher levels (as % of total fatty acid) of long-chain polyunsaturated fatty acids in the domesticated strain (36.2 +/- 0.4%) than the wild strain (16.1 +/- 0.1%). Overall, this study found that the reproductive capacity and tolerance to the culture environment of the calanoid P. crassirostris have improved significantly due to domestication.	[Zeng, Chaoshu] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; James Cook Univ, Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Zeng, CS (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia.	Chaoshu.Zeng@jcu.edu.au	Zeng, Chaoshu/A-9758-2012; Jerry, Dean R/B-3053-2012	Jerry, Dean/0000-0003-3735-1798; Zeng, Chaoshu/0000-0001-9022-6588; Alajmi, Fahad/0000-0002-0235-8482	James Cook University Graduate Research Scheme	James Cook University Graduate Research Scheme	James Cook University Graduate Research Scheme (2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alajmi F, 2013, AQUACULTURE RES; Alajmi F, 2014, AQUACULTURE, V434, P201, DOI 10.1016/j.aquaculture.2014.08.029; Alajmi F, 2014, AQUACULTURE, V420, P18, DOI 10.1016/j.aquaculture.2013.10.031; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Boxshall GA, 2004, INTRO COPEPOD DIVERS, P966; Bradley CJ, 2013, J PLANKTON RES, V35, P49, DOI 10.1093/plankt/fbs088; BUSKEY EJ, 1993, B MAR SCI, V53, P29; Campbell RW, 2000, CAN J FISH AQUAT SCI, V57, P518, DOI 10.1139/cjfas-57-3-518; Camus T, 2009, AQUACULTURE, V287, P145, DOI 10.1016/j.aquaculture.2008.10.005; Coman GJ, 2013, AQUACULTURE, V400, P125, DOI 10.1016/j.aquaculture.2013.03.015; Conceicao LEC, 2010, AQUAC RES, V41, P613, DOI 10.1111/j.1365-2109.2009.02242.x; Doi M, 1997, HYDROBIOLOGIA, V358, P259, DOI 10.1023/A:1003193121532; DOYLE RW, 1983, AQUACULTURE, V33, P167, DOI 10.1016/0044-8486(83)90398-8; Drillet G, 2011, AQUACULTURE, V315, P155, DOI 10.1016/j.aquaculture.2011.02.027; Evjemo JO, 1997, HYDROBIOLOGIA, V358, P159, DOI 10.1023/A:1003196829109; Hamre K, 2013, REV AQUACULT, V5, pS26, DOI 10.1111/j.1753-5131.2012.01086.x; HUMES AG, 1994, HYDROBIOLOGIA, V293, P1, DOI 10.1007/BF00229916; Huskin I, 2000, J EXP MAR BIOL ECOL, V248, P239, DOI 10.1016/S0022-0981(00)00167-2; Jepsen PM, 2007, AQUAC RES, V38, P764, DOI 10.1111/j.1365-2109.2007.01730.x; Kline MD, 2015, AQUACULTURE, V435, P128, DOI 10.1016/j.aquaculture.2014.09.022; Kreibich T, 2008, HELGOLAND MAR RES, V62, P241, DOI 10.1007/s10152-008-0112-0; Liao IC, 2000, RECENT ADV MEDITERRA; MARIN V, 1986, MAR BIOL, V93, P49, DOI 10.1007/BF00428654; Mauchline J., 1998, ADV MAR BIOL, V33, P1, DOI DOI 10.1163/156854008784513492; Mayzaud P, 1998, J MARINE SYST, V15, P483, DOI 10.1016/S0924-7963(97)00039-0; McKinnon A. D., 1997, Hydrobiologia, V362, P145, DOI 10.1023/A:1003138718716; McKinnon AD, 1998, HYDROBIOLOGIA, V362, P127; MORRISON WR, 1964, J LIPID RES, V5, P600; Niehoff B, 2007, PROG OCEANOGR, V74, P1, DOI 10.1016/j.pocean.2006.05.005; OHNO A, 1988, AQUACULTURE, V70, P39, DOI 10.1016/0044-8486(88)90005-1; Parrish CC, 2012, J PLANKTON RES, V34, P356, DOI 10.1093/plankt/fbs003; PARRISH KK, 1978, MAR BIOL, V46, P65, DOI 10.1007/BF00393822; Payne MF, 2001, AQUACULTURE, V201, P329, DOI 10.1016/S0044-8486(01)00608-1; Payne MF, 2001, AQUACULTURE, V194, P137, DOI 10.1016/S0044-8486(00)00513-5; RONG W, 2002, CHINESE J OCEANOLOGY, V20, P348; Sargent J, 1999, AQUACULTURE, V179, P217, DOI 10.1016/S0044-8486(99)00191-X; Schipp GR, 1999, AQUACULTURE, V174, P81, DOI 10.1016/S0044-8486(98)00508-0; SMITH SL, 1990, MAR BIOL, V106, P59, DOI 10.1007/BF02114675; Stottrup J.G., 2003, LIVE FEEDS MARINE AQ; STOTTRUP JG, 1986, AQUACULTURE, V52, P87, DOI 10.1016/0044-8486(86)90028-1; Stottrup JG, 1997, AQUACULTURE, V155, P231, DOI 10.1016/S0044-8486(97)00120-8; Stottrup JG, 2006, MEM OCT S INT NUTR A; TISELIUS P, 1995, ICES J MAR SCI, V52, P369, DOI 10.1016/1054-3139(95)80052-2; van der Meeren T, 2008, AQUACULTURE, V274, P375, DOI 10.1016/j.aquaculture.2007.11.041; VanderLugt K, 2008, AQUACULTURE, V276, P69, DOI 10.1016/j.aquaculture.2008.01.041; Zuberi A, 2011, AQUACULTURE, V321, P267, DOI 10.1016/j.aquaculture.2011.09.006	46	20	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133269	10.1371/journal.pone.0133269	http://dx.doi.org/10.1371/journal.pone.0133269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186526	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000358198700117
J	da Rocha, PA; Ferrari, SF; Feijo, A; Gouveia, SF				da Rocha, Patricio Adriano; Ferrari, Stephen Francis; Feijo, Anderson; Gouveia, Sidney Feitosa			Zoogeography of South American Forest-Dwelling Bats: Disjunct Distributions or Sampling Deficiencies?	PLOS ONE			English	Article							CLIMATE-CHANGE; SPECIES DISTRIBUTION; DISTRIBUTION MODELS; ATLANTIC; BRAZIL; PREDICTION; DIVERSITY; AMAZON; SITE	Many forest-dwelling bats are purported to be widespread in South America, although records are scant from the vast diagonal belt of dry ecosystems that straddles the continent, implying possible sampling deficiencies. Here, we investigate this possibility in the case of four species of bat (Centronycteris maximiliani, Lampronycteris brachyotis, Peropteryx kappleri and Trinycteris nicefori), evaluating whether their disjunct present-day distributions reflect their true zoogeographic characteristics or the subsampling of intermediate zones. We use environmental niche modelling (ENM) in an ensemble approach, combining four different modeling techniques, and using niche descriptors based on climatic and remote sensing data, to estimate the potential distribution of the four species. The models indicate that all four species have disjunct distributions in the Amazon and Atlantic forest biomes. The one possible exception is P. kappleri, which the models indicated might potentially occur in humid forest enclaves in western Brazil and eastern Bolivia. The present-day distribution of the species may date back to the Plio-Pleistocene, when the forested biomes of South America were more extensive and connected. Further studies of different chiropteran lineages may provide additional insights into the historic processes of faunal interchange between the Amazon and Atlantic forest biomes.	[da Rocha, Patricio Adriano; Ferrari, Stephen Francis; Gouveia, Sidney Feitosa] Univ Fed Sergipe, Dept Ecol, BR-49100000 Sao Cristovao, Sergipe, Brazil; [Ferrari, Stephen Francis; Feijo, Anderson] Univ Fed Paraiba, Dept Systemat & Ecol, Grad Program Zool, BR-58059900 Joao Pessoa, Paraiba, Brazil	Universidade Federal de Sergipe; Universidade Federal da Paraiba	da Rocha, PA (corresponding author), Univ Fed Sergipe, Dept Ecol, BR-49100000 Sao Cristovao, Sergipe, Brazil.	parocha2@yahoo.com.br	Gouveia, Sidney F/G-6438-2013; Rocha, Patrício/B-3875-2013; Feijó, Anderson/F-4287-2018	Gouveia, Sidney F/0000-0003-4941-7440; Rocha, Patrício/0000-0003-1661-3779; Ferrari, Stephen/0000-0003-0566-0000	CNPq [16448/2013-5, 476528/2013-5, 503122/2010-6, 303994/2011-8, 483220/2013-2]; CAPES; FAPITEC [7733.UNI314.18598.04032013]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPITEC(Fundacao de Amparo a Pesquisa do Estado do Sergipe (FAPITEC))	PAR was supported by a post-doctoral fellowship provided by CNPq (Process number 16448/2013-5) and AF by a graduate stipend provided by CAPES. SFG was supported by CNPq (476528/2013-5) and FAPITEC (7733.UNI314.18598.04032013) grants. SFF is supported by CNPq (503122/2010-6, 303994/2011-8 and 483220/2013-2).	Ab'Saber A.N, 1977, GEOMORFOLOGIA, V52, P1, DOI DOI 10.3897/ZOOKEYS.150.2109; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Auler AS, 2004, J QUATERNARY SCI, V19, P693, DOI 10.1002/jqs.876; Auler AS, 2001, QUATERNARY RES, V55, P159, DOI 10.1006/qres.2000.2213; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Batalha H, 2013, J ORNITHOL, V154, P41, DOI 10.1007/s10336-012-0866-7; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Davies BD, 2014, TRENDS ECOL IN PRESS; de Vivo M., 1997, AN 5 REUN ESP SBPC F, P60; Diniz JAF, 2010, INSECT CONSERV DIVER, V3, P213, DOI 10.1111/j.1752-4598.2010.00090.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gardner AL, 2008, MAMMALS S AM, V1; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Haberle SG, 1999, QUATERNARY RES, V51, P27, DOI 10.1006/qres.1998.2020; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Liang S., 2012, GLOBAL LAND SURFACE, DOI [10.6050/glass863.3004.db, DOI 10.6050/GLASS863.3004.DB]; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lomolino MV, 2004, FRONTIERS OF BIOGEOGRAPHY: NEW DIRECTIONS IN THE GEOGRAPHY OF NATURE, P1; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Martini AMZ, 2007, BIODIVERS CONSERV, V16, P3111, DOI 10.1007/s10531-007-9166-6; Nogueira MR, 2012, AM MUS NOVIT, P1; Peracchi Adriano, 1993, Revista Brasileira de Biologia, V53, P575; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Por FD, 1992, SOORETAMA ATLANTIC R; Porto, 2004, BREJOS ALTITUDE PERN, P285; RANGEL TFL, 2009, BIOENSEMBLES 1 0 SOF; REIS NR, 1983, REV ECOL, V38, P147; Ripley B. D., 1996, PATTERN RECOGNITION; Rocha PA, 2014, MASTOZOOL N IN PRESS; Santos AMM, 2007, J BIOGEOGR, V34, P437, DOI 10.1111/j.1365-2699.2006.01604.x; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tattoni C, 2012, ECOL MODEL, V245, P103, DOI 10.1016/j.ecolmodel.2012.03.020; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Van der Hammen T., 1974, J BIOGEOGR, V1, P3, DOI [10.2307/3038066, DOI 10.2307/3038066]; VUILLEUMIER SB, 1971, SCIENCE, V173, P771, DOI 10.1126/science.173.3999.771; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Xiao ZQ, 2014, IEEE T GEOSCI REMOTE, V52, P209, DOI 10.1109/TGRS.2013.2237780	50	7	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133276	10.1371/journal.pone.0133276	http://dx.doi.org/10.1371/journal.pone.0133276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186587	Green Published, gold			2022-12-27	WOS:000358198700118
J	Ma, ZX; Leng, YJ; Chen, GX; Zhou, PM; Ye, D; Chen, LQ				Ma, Zhao-Xia; Leng, Ya-Jun; Chen, Guang-Xia; Zhou, Peng-Min; Ye, De; Chen, Li-Qun			The THERMOSENSITIVE MALE STERILE 1 Interacts with the BiPs via DnaJ Domain and Stimulates Their ATPase Enzyme Activities in Arabidopsis	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; RETICULUM STRESS-RESPONSE; HEAT-SHOCK-PROTEIN; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; ER STRESS; MOLECULAR CHAPERONES; TEMPERATURE STRESS; QUALITY-CONTROL; POLLEN	The Arabidopsis TMS1 encodes a heat shock protein identical to the Hsp40 protein AtERdj3A and plays important roles in the thermotolerance of pollen tubes and other plant tissues. Despite its importance to plant growth and reproduction, little has been known about its mechanisms underlying thermotolerance of plants. In this study, the relationship between TMS1 and the Hsp70 proteins, Binding Immunoglobulin Proteins (BiPs) was explored to understand the molecular mechanisms of TMS1 in thermotolerance of plants. The expression of TMS1 was induced not only by heat shock, but also by dithiothreitol (DTT) and L-azetidine-2-carboxylic acid (AZC), similarly to the three BiP genes, indicating that TMS1 may be involved in unfolded protein response (UPR). The firefly luciferase complementary imaging (LCI), GST pull-down and ATPase enzyme activity assays demonstrated that the DnaJ domain of TMS1 could interact with BiP1 and BiP3, and could stimulate their ATPase enzyme activities. In addition, the expression level of TMS1 was reduced in the bzip28 bzip60 double mutant. These results suggest that TMS1 may function at the downstream of bZIP28 and bZIP60 and be involved in termotolerance of plants, possibly by participating in refolding or degradation of unfolded and misfolded proteins through interaction with the BiPs.	[Ma, Zhao-Xia; Leng, Ya-Jun; Chen, Guang-Xia; Zhou, Peng-Min; Ye, De; Chen, Li-Qun] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China; [Ye, De] Natl Ctr Plant Gene Res Beijing, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Sciences	Ye, D (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	yede@cau.edu.cn; chenliqun@cau.edu.cn			Natural Science Foundation of China (NSFC) [31470279, 31130007]; Ministry of Sciences and Technology [2013CB1945100]; Ministry of Education [B06003]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Sciences and Technology; Ministry of Education	This work was supported by the research grants from the Natural Science Foundation of China (NSFC, project numbers: 31470279 and 31130007), the Ministry of Sciences and Technology (project number: 2013CB1945100) and the Ministry of Education (111 project numbered B06003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilgin DD, 2003, DEV CELL, V4, P651, DOI 10.1016/S1534-5807(03)00125-4; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chen HM, 2008, PLANT PHYSIOL, V146, P368, DOI 10.1104/pp.107.111740; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; CYR DM, 1992, J BIOL CHEM, V267, P20927; Deng Y, 2013, INT J MOL SCI, V14, P8188, DOI 10.3390/ijms14048188; DUPUIS I, 1990, PLANT PHYSIOL, V94, P665, DOI 10.1104/pp.94.2.665; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Endo M, 2009, PLANT CELL PHYSIOL, V50, P1911, DOI 10.1093/pcp/pcp135; Gao HB, 2008, P NATL ACAD SCI USA, V105, P16398, DOI 10.1073/pnas.0808463105; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hosoda A, 2003, J BIOL CHEM, V278, P2669, DOI 10.1074/jbc.M208346200; Howell SH, 2013, ANNU REV PLANT BIOL, V64, P477, DOI 10.1146/annurev-arplant-050312-120053; Hua DP, 2012, PLANT CELL, V24, P2546, DOI 10.1105/tpc.112.100107; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Iwata Y, 2012, TRENDS PLANT SCI, V17, P720, DOI 10.1016/j.tplants.2012.06.014; Iwata Y, 2009, BIOSCI BIOTECH BIOCH, V73, P865, DOI 10.1271/bbb.80779; Iwata Y, 2008, PLANT CELL, V20, P3107, DOI 10.1105/tpc.108.061002; Kanapin A, 2003, GENOME RES, V13, P1335, DOI 10.1101/gr.978703; Koizumi N, 1996, PLANT CELL PHYSIOL, V37, P862, DOI 10.1093/oxfordjournals.pcp.a029023; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Maruyama D, 2014, PLANT CELL PHYSIOL, V55, P801, DOI 10.1093/pcp/pcu018; Maruyama D, 2010, P NATL ACAD SCI USA, V107, P1684, DOI 10.1073/pnas.0905795107; Mascarenhas JP, 1996, SEX PLANT REPROD, V9, P370, DOI 10.1007/BF02441959; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Noh SJ, 2003, GENE, V311, P81, DOI 10.1016/S0378-1119(03)00559-6; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SCHOPER JB, 1987, PLANT PHYSIOL, V83, P121, DOI 10.1104/pp.83.1.121; Sugio A, 2009, PLANT CELL, V21, P642, DOI 10.1105/tpc.108.062596; Sun L, 2013, MOL PLANT, V6, P1605, DOI 10.1093/mp/sst059; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; XIAO CM, 1985, PLANT PHYSIOL, V78, P887, DOI 10.1104/pp.78.4.887; Yamamoto M, 2008, PLANT CELL PHYSIOL, V49, P1547, DOI 10.1093/pcp/pcn119; Yang KZ, 2009, PLANT J, V57, P870, DOI 10.1111/j.1365-313X.2008.03732.x; Young LW, 2004, J EXP BOT, V55, P485, DOI 10.1093/jxb/erh038	39	14	19	1	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132500	10.1371/journal.pone.0132500	http://dx.doi.org/10.1371/journal.pone.0132500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186593	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700046
J	Arevalo-Gardini, E; Canto, M; Alegre, J; Loli, O; Julca, A; Baligar, V				Arevalo-Gardini, Enrique; Canto, Manuel; Alegre, Julio; Loli, Oscar; Julca, Alberto; Baligar, Virupax			Changes in Soil Physical and Chemical Properties in Long Lerm Improved Natural and Traditional Agroforestry Management Systems of Cacao Genotypes in Peruvian Amazon	PLOS ONE			English	Article							LAND-CLEARING METHOD; ORGANIC-MATTER; FOREST SOILS; SHORT-TERM; FIRE; FERTILITY; IMPACT; CARBON; WATER; TREE	Growing cacao (Theobroma cacao L.) in an agroforestry system generates a productive use of the land, preserves the best conditions for physical, chemical and biological properties of tropical soils, and plays an important role in improving cacao production and fertility of degraded tropical soils. The aim of this study was to evaluate the impact of two long term agroforestry systems of cacao management on soil physical and chemical properties in an area originally inhabited by 30 years old native secondary forest (SF). The two agroforestry systems adapted were: improved natural agroforestry system (INAS) where trees without economic value were selectively removed to provide 50% shade and improved traditional agroforestry system (ITAS) where all native trees were cut and burnt in the location. For evaluation of the changes of soil physical and chemical properties with time due to the imposed cacao management systems, plots of 10 cacao genotypes (ICS95, UF613, CCN51, ICT1112, ICT1026, ICT2162, ICT2171, ICT2142, H35, U30) and one plot with a spontaneous hybrid were selected. Soil samples were taken at 0-20, 20-40 and 40-60 cm depths before the installation of the management systems (2004), and then followed at two years intervals. Bulk density, porosity, field capacity and wilting point varied significantly during the years of assessment in the different soil depths and under the systems assessed. Soil pH, CEC, exchangeable Mg and sum of the bases were higher in the INAS than the ITAS. In both systems, SOM, Ext. P, K and Fe, exch. K, Mg and Al+H decreased with years of cultivation; these changes were more evident in the 0-20 cm soil depth. Overall improvement of SOM and soil nutrient status was much higher in the ITAS than INAS. The levels of physical and chemical properties of soil under cacao genotypes showed a marked difference in both systems.	[Arevalo-Gardini, Enrique] ICT, Tarapoto, Peru; [Canto, Manuel; Alegre, Julio; Loli, Oscar; Julca, Alberto] UNALM, Lima, Peru; [Baligar, Virupax] USDA ARS, Beltsville Agr Res Ctr, Beltsville, MD 20705 USA	University Nacional Agraria La Molina; United States Department of Agriculture (USDA)	Arevalo-Gardini, E (corresponding author), ICT, Tarapoto, Peru.	enriquearevaloga@gmail.com	AREVALO-GARDINI, ENRIQUE/AAQ-8931-2020; Alegre, Julio/ABE-5452-2021		Instituto de Cultivos Tropicales (ICT); United States-Department of Agriculture-Agricultural Research Service (USDA-ARS); United States Embassy (INL) in Lima-Peru; ARS [ARS-0426238] Funding Source: Federal RePORTER	Instituto de Cultivos Tropicales (ICT); United States-Department of Agriculture-Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)); United States Embassy (INL) in Lima-Peru; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported by Instituto de Cultivos Tropicales (ICT), United States-Department of Agriculture-Agricultural Research Service (USDA-ARS) and the United States Embassy (INL) in Lima-Peru.	Agoume V., 2009, Tropicultura, V27, P15; Alegre J, 2006, SISTEMAS AGROFLOREST, P27; ALEGRE JC, 1990, FIELD CROP RES, V24, P131, DOI 10.1016/0378-4290(90)90026-8; ALEGRE JC, 1988, SOIL SCI SOC AM J, V52, P1283, DOI 10.2136/sssaj1988.03615995005200050012x; ALEGRE JC, 1986, SOIL SCI SOC AM J, V50, P1379, DOI 10.2136/sssaj1986.03615995005000060002x; Alexis MA, 2007, BIOGEOCHEMISTRY, V82, P201, DOI 10.1007/s10533-006-9063-1; Alfaia SS, 2004, AGR ECOSYST ENVIRON, V102, P409, DOI 10.1016/j.agee.2003.08.011; Altieri M., 2011, EISA REV AGROECOLOGI, V27, P32; Altieri MA, 2004, MANEJO INTEGRADAO PL, V73, P8; Amusan A. A., 2006, Electronic Journal of Environmental, Agricultural and Food Chemistry, V5, P3; Anderson J. M., 1993, TROPICAL SOIL BIOL F; [Anonymous], 2012, REV CUBANA CIENCIA A; Are KS, 2009, SOIL TILL RES, V103, P4, DOI 10.1016/j.still.2008.08.011; Arevalo-Gardini E, 2004, CACAO MANEJO INTEGRA; Ayres E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005964; Azam M. G., 2008, Journal of Agronomy, V7, P56; Badia D, 2003, ARID LAND RES MANAG, V17, P23, DOI 10.1080/15324980301595; Barreto A. C., 2006, Caatinga, V19, P415; Bell MC, 2008, RENEW AGR FOOD SYST, V23, P70, DOI 10.1017/S1742170507001883; Boruvka L, 2005, J INORG BIOCHEM, V99, P1796, DOI 10.1016/j.jinorgbio.2005.06.028; Bot A., 2005, FAO SOILS B, V80, P71; Brye KR, 2006, ACTA OECOL, V30, P407, DOI 10.1016/j.actao.2006.06.001; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Chepstow-Lusty A, 2000, AMBIO, V29, P322, DOI 10.1639/0044-7447(2000)029[0322:IALFTP]2.0.CO;2; Clark MS, 1998, AGRON J, V90, P662, DOI 10.2134/agronj1998.00021962009000050016x; Close DC, 2011, PLANT SOIL, V349, P203, DOI 10.1007/s11104-011-0862-3; Couto-Vazquez A, 2006, SCI TOTAL ENVIRON, V371, P353, DOI 10.1016/j.scitotenv.2006.08.016; Czimczik CI, 2005, EUR J SOIL SCI, V56, P417, DOI 10.1111/j.1365-2389.2004.00665.x; Dai ZH, 1998, WATER AIR SOIL POLL, V108, P377, DOI 10.1023/A:1005015526022; Danoff LE, 2007, MINERAL NUTR PLANT D; De Schrijver A, 2006, SCI TOTAL ENVIRON, V361, P189, DOI 10.1016/j.scitotenv.2005.06.015; Di Rienzo J., 2013, INFOSTAT VERSION 201; Dinesh R, 2010, GEODERMA, V158, P252, DOI 10.1016/j.geoderma.2010.04.034; DRINKWATER LE, 1995, ECOL APPL, V5, P1098, DOI 10.2307/2269357; Ekinci H., 2006, INT J AGRIC BIOL, V1, P102; Fageria NK, 2002, ADV AGRON, V77, P185, DOI 10.1016/S0065-2113(02)77015-6; FASSBENDER HW, 1998, SOILS TROPICAL FORES; Flores PS, 1998, GEOECOLOGIA DESARROL; Garcia-Marco S, 2008, SCI TOTAL ENVIRON, V407, P297, DOI 10.1016/j.scitotenv.2008.08.021; GIL J, 2010, ACTUALIZACION METODO, P327; Gomez-Rey MX, 2013, GEODERMA, V195, P155, DOI 10.1016/j.geoderma.2012.12.005; Granged AJP, 2011, GEODERMA, V167-68, P125, DOI 10.1016/j.geoderma.2011.09.011; Granged AJP, 2011, GEODERMA, V164, P85, DOI 10.1016/j.geoderma.2011.05.017; Gregory P.J., 2006, PLANT ROOTS GROWTH A; Havlin JL., 2005, SOIL FERTILITY FERTI, V7th; He J, 2011, SOIL TILL RES, V113, P48, DOI 10.1016/j.still.2011.01.005; Holdridge L.R., 1971, FOREST ENV TROPICAL; Igwe C. A., 2005, Tropical and Subtropical Agroecosystems, V5, P57; Jacobi J, 2014, AGROFOREST SYST, V88, P1117, DOI 10.1007/s10457-013-9643-8; Jobbagy EG, 2004, ECOLOGY, V85, P2380, DOI 10.1890/03-0245; Johnson DW, 2001, FOREST ECOL MANAG, V140, P227, DOI 10.1016/S0378-1127(00)00282-6; Jose S, 2009, AGROFOREST SYST, V76, P1, DOI 10.1007/s10457-009-9229-7; Julio A., 2012, LINEAR MIXED MODELS; Juo ASR, 1996, AGR ECOSYST ENVIRON, V58, P49, DOI 10.1016/0167-8809(95)00656-7; Lal R., 1998, METHODS ASSESSMENT S, P17; Lambers H., 2008, PLANT PHYSL ECOLOGY; Magdoff F, 1999, AGROECOLOGIA BASES C; McGrath DA, 2001, AGR ECOSYST ENVIRON, V83, P271, DOI 10.1016/S0167-8809(00)00176-6; Mendonca-Santos ML, 2006, SOIL BIODIVERSITY IN AMAZONIAN AND OTHER BRAZILIAN ECOSYSTEMS, P13, DOI 10.1079/9781845930325.0013; Moussa-Machraoui SB, 2010, SOIL TILL RES, V106, P247, DOI 10.1016/j.still.2009.10.009; Nair PKR, 2009, ENVIRON SCI POLICY, V12, P1099, DOI 10.1016/j.envsci.2009.01.010; NAMBIAR EKS, 1992, TREE PHYSIOL, V10, P297, DOI 10.1093/treephys/10.3.297; OEEE-MINAG, SER HIST PROD AGR CO; Olanrewaju O. D., 2008, Journal of Applied Biological Sciences, V2, P9; Ololade I. A., 2010, Modern Applied Science, V4, P35; Pardini G, 2004, SCI TOTAL ENVIRON, V328, P237, DOI 10.1016/j.scitotenv.2004.01.026; Perrin AS, 2014, AGR ECOSYST ENVIRON, V184, P101, DOI 10.1016/j.agee.2013.11.009; Phillips RP, 2008, SOIL SCI SOC AM J, V72, P453, DOI 10.2136/sssaj2006.0389; Phillips RP, 2006, ECOLOGY, V87, P1302, DOI 10.1890/0012-9658(2006)87[1302:TSAMAI]2.0.CO;2; Pinheiro JC, 2004, MIXED EFFECTS MODELS; Porebska G, 2008, SCI TOTAL ENVIRON, V399, P105, DOI 10.1016/j.scitotenv.2008.03.029; Radersma S, 2004, PLANT SOIL, V259, P209, DOI 10.1023/B:PLSO.0000020970.40167.40; Portella CMR, 2012, REV BRAS CIENC SOLO, V36, P1868, DOI 10.1590/S0100-06832012000600021; Reganold J. P., 1988, American Journal of Alternative Agriculture, V3, P144, DOI 10.1017/S0889189300002423; Rice RA, 2008, AGR ECOSYST ENVIRON, V128, P212, DOI 10.1016/j.agee.2008.06.007; Roscoe R, 2000, GEODERMA, V95, P141, DOI 10.1016/S0016-7061(99)00089-0; Russell AE, 2007, SOIL SCI SOC AM J, V71, P1389, DOI 10.2136/sssaj2006.0069; Saxton KE, 2006, SOIL SCI SOC AM J, V70, P1569, DOI 10.2136/sssaj2005.0117; Schroth G, 2015, MITIG ADAPT STRAT GL, V20, P1175, DOI 10.1007/s11027-013-9530-7; Seguel O, 2013, J SOIL SCI PLANT NUT, V13, P690, DOI [10.4067/S0718-95162013005000046, 10.4067/S0718-95162013005000055]; Sharma KL, 2009, COMMUN SOIL SCI PLAN, V40, P1436, DOI 10.1080/00103620902818096; Soil Survey Staff, 1994, KEYS SOIL TAX; Somarriba E, 2013, AGR ECOSYST ENVIRON, V173, P46, DOI 10.1016/j.agee.2013.04.013; Sumpam Tangjang, 2009, Research Journal of Soil Biology, V1, P1, DOI 10.3923/rjsb.2009.1.7; Theodoro VCA, 2003, REV BRAS CIENC SOLO, V27, P1039, DOI 10.1590/S0100-06832003000600008; Thomaz EL, 2014, CATENA, V122, P209, DOI 10.1016/j.catena.2014.06.016; Tolk J.A., 2003, PLANT AVAILABLE SOIL, P669, DOI [DOI 10.1081/E-EWS120010265, 10.1081/E-EWS120010265]; Venables W., 2014, INTRO R NOTES R PROG; Villegas R, 2008, THESIS CATIE TURRIAL; Wang QL, 2008, GEODERMA, V144, P502, DOI 10.1016/j.geoderma.2008.01.003; Watson RT, 2000, LAND USE LAND USE CH; Werner S., 1999, Management of secondary and logged-over forests in Indonesia. Selected proceedings of an international workshop, 17-19 November 1997, Bogor, Indonesia., P33; Willer H, 2004, WORLD ORGANIC AGR ST, P96; WOOD G. A. R., 2001, COCOA	94	25	26	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132147	10.1371/journal.pone.0132147	http://dx.doi.org/10.1371/journal.pone.0132147			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181053	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198200016
J	Beksac, K; Beksac, M; Dalva, K; Karaagaoglu, E; Tirnaksiz, MB				Beksac, Kemal; Beksac, Meral; Dalva, Klara; Karaagaoglu, Ergun; Tirnaksiz, M. Bulent			Impact of "Killer Immunoglobulin-Like Receptor/Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival	PLOS ONE			English	Article							MHC CLASS-I; POLYMORPHISM; LIGANDS; GENES	Approximately 30% of patients with stage II/III colorectal cancer develop recurrence following surgery. How individual regulation of host mediated anti-tumor cytotoxicity is modified by the killer-cell immunoglobulin-like receptor (KIRs) genotype is essential for prediction of outcome. We analyzed the frequency of KIR and KIR ligand Human Leukocyte Antigen Class I genotypes, and their effects on recurrence and disease-free survival (DFS). Out of randomly selected 87 colorectal cancer patients who underwent R0 resection operations between 2005 and 2008, 29 patients whose cancers progressed within a median five-year follow-up period were compared with 58 patients with no recurrence within the same time period. Recurrent cases shared similar tumor stages with non-recurrent cases, but had different localizations. We used DNA isolated from pathological archival lymphoid and tumor tissues for KIR and KIR ligand (HLA-C, group C1, group C2, and HLA-A-Bw4) genotyping. Among cases with recurrence, KIR2DL1 (inhibitory KIR) and A-Bw4 (ligand for inhibitory KIR3DL1) were observed more frequently (p=0.017 and p=0.024); and KIR2DS2 and KIR2DS3 (both activating KIRs) were observed less frequently (p=0.005 and p=0.043). Similarly, in the non-recurrent group, inhibitory KIR-ligand combinations 2DL1-C2 and 2DL3-C1 were less frequent, while the activating combination 2DS2-C1 was more frequent. The lack of KIR2DL1, 2DL1-C2, and 2DL3-C1 improved disease-free survival (DFS) (100% vs. 62.3%, p=0.05; 93.8% vs. 60.0%, p=0.035; 73.6% vs. 55.9%, p=0.07). The presence of KIR2DS2, 2DS3, and 2DS2-C1 improved DFS (77.8% vs. 48.5%, p=0.01; 79.4% vs. 58.5%, p=0.003; 76.9% vs. 51.4%, p=0.023). KIR2DS3 reduced the risk of recurrence (HR=0.263, 95% CI =0.080-0.863, p=0.028). The number of activating KIRs are correlated strongly with DFS, none/one/two KIR : 54/77/98 months (p=0.004). In conclusion the inheritance of increasing numbers of activating KIRs and lack of inhibitory KIRs, independent of tumor localization or stage, is associated with long-term DFS.	[Beksac, Kemal; Tirnaksiz, M. Bulent] Hacettepe Univ, Dept Gen Surg, Ankara, Turkey; [Beksac, Meral; Dalva, Klara] Ankara Univ, Dept Hematol, TR-06100 Ankara, Turkey; [Karaagaoglu, Ergun] Hacettepe Univ, Dept Biostat, Ankara, Turkey	Hacettepe University; Ankara University; Hacettepe University	Beksac, K (corresponding author), Hacettepe Univ, Dept Gen Surg, Ankara, Turkey.	kemalbeksac@yahoo.com	Beksac, Kemal/AAI-6009-2020; dalva, klara/AAN-7704-2020	Beksac, Kemal/0000-0002-6339-505X; dalva, klara/0000-0001-6917-6870	Hacettepe University [GO 13/94]; Turkish Academy of Sciences	Hacettepe University(Hacettepe University); Turkish Academy of Sciences(Turkish Academy of Sciences)	This study was funded by research grants from Hacettepe University (GO 13/94) and Turkish Academy of Sciences (M. Beksac is a member of the Academy).	Al Omar S, 2010, HUM IMMUNOL, V71, P976, DOI 10.1016/j.humimm.2010.06.019; Babor F, 2014, BLOOD, V124, P2248, DOI 10.1182/blood-2014-05-572065; Beksac M, 2012, BONE MARROW RES, DOI 10.1155/2012/271695; Besson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000406; Bonagura VR, 2010, HUM IMMUNOL, V71, P212, DOI 10.1016/j.humimm.2009.10.009; Carrington M, 2005, J EXP MED, V201, P1069, DOI 10.1084/jem.20042158; De Re V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084940; Disis ML, 2010, J CLIN ONCOL, V28, P4531, DOI 10.1200/JCO.2009.27.2146; Dorak M Tevfik, 2007, Methods Mol Med, V134, P123; Faure M, 2002, J IMMUNOL, V168, P6208, DOI 10.4049/jimmunol.168.12.6208; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Inoue M, 2012, ONCOIMMUNOLOGY, V1, P1104, DOI 10.4161/onci.21056; Lopez-Vazquez A, 2005, J INFECT DIS, V192, P162, DOI 10.1086/430351; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Marsh SGE, 2003, HUM IMMUNOL, V64, P648, DOI 10.1016/S0198-8859(03)00067-3; Meguid RA, 2008, ANN SURG ONCOL, V15, P2388, DOI 10.1245/s10434-008-0015-y; Middleton D, 2007, TISSUE ANTIGENS, V69, P220, DOI 10.1111/j.1399-0039.2006.00792.x; Middleton D, 2010, IMMUNOLOGY, V129, P8, DOI 10.1111/j.1365-2567.2009.03208.x; Naumova E, 2005, CANCER IMMUNOL IMMUN, V54, P172, DOI 10.1007/s00262-004-0575-z; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Owen J. A., 2013, KUBY IMMUNOLOGY, P427; Pita-Fernandez S, 2014, ANN ONCOL; Salama P, 2008, ANZ J SURG, V78, P745, DOI 10.1111/j.1445-2197.2008.04642.x; Sandel MH, 2005, MOL IMMUNOL, V42, P541, DOI 10.1016/j.molimm.2004.07.039; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh K, 2013, NANOSCALE, V5, P2411, DOI 10.1039/c3nr33962a; Verheyden S, 2005, LEUKEMIA, V19, P1446, DOI 10.1038/sj.leu.2403839; Wisniewski A, 2012, HUM IMMUNOL, V73, P927, DOI 10.1016/j.humimm.2012.07.323; Yamazaki H, 2002, ONCOL REP, V9, P359	29	17	17	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132526	10.1371/journal.pone.0132526	http://dx.doi.org/10.1371/journal.pone.0132526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181663	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198200021
J	Geniole, SN; Denson, TF; Dixson, BJ; Carre, JM; McCormick, CM				Geniole, Shawn N.; Denson, Thomas F.; Dixson, Barnaby J.; Carre, Justin M.; McCormick, Cheryl M.			Evidence from Meta-Analyses of the Facial Width-to-Height Ratio as an Evolved Cue of Threat	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; FIGHTING ABILITY; SOCIAL-STATUS; FACE; PERSONALITY; AGGRESSION; DOMINANCE; ASSOCIATION; PERCEPTIONS; APPEARANCE	The facial width-to-height ratio (FWHR) is the width of the face divided by the height of the upper face. There is mixed evidence for the hypothesis that the FWHR is a cue of threat and dominance in the human face. We conducted a systematic review and meta-analyses of all peer-reviewed studies (and 2 unpublished studies) to estimate the magnitude of the sex difference in the FWHR, and the magnitude of the relationship between the FWHR and threatening and dominant behaviours and perceptions. Studies were eligible for inclusion if the authors reported an analysis involving the FWHR. Our analyses revealed that the FWHR was larger in men than in women ((d) over bar = .11, n = 10,853), cued judgements of masculinity in men ((r) over bar = .35, n of faces = 487; n of observers = 339), and was related to body mass index ((r) over bar = .31, n = 2,506). Further, the FWHR predicted both threat behaviour in men ((r) over bar = .16, n = 4,603) and dominance behaviour in both sexes ((r) over bar = .12, n = 948) across a variety of indices. Individuals with larger FWHRs were judged by observers as more threatening ((r) over bar = .46, n of faces = 1,691; n of observers = 2,076) and more dominant ((r) over bar = .20, n of faces = 603; n of observers = 236) than those with smaller FWHRs. Individuals with larger FWHRs were also judged as less attractive ((r) over bar = -.26, n of faces = 721; n of observers = 335), especially when women made the judgements. These findings provide some support for the hypothesis that the FWHR is part of an evolved cueing system of intra-sexual threat and dominance in men. A limitation of the meta-analyses on perceptions of threat and dominance were the low number of stimuli involving female and older adult faces.	[Geniole, Shawn N.; McCormick, Cheryl M.] Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada; [Denson, Thomas F.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Dixson, Barnaby J.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Dixson, Barnaby J.] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Carre, Justin M.] Nipissing Univ, Dept Psychol, North Bay, ON, Canada; [McCormick, Cheryl M.] Brock Univ, Ctr Neurosci, St Catharines, ON L2S 3A1, Canada	Brock University; University of New South Wales Sydney; University of Queensland; University of New South Wales Sydney; Nipissing University; Brock University	McCormick, CM (corresponding author), Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada.	cmccormick@brocku.ca	Denson, Thomas F./J-7840-2019; McCormick, Cheryl M/D-9678-2011	Denson, Thomas F./0000-0002-9620-4280; Dixson, Barnaby/0000-0003-0911-1244	Social Sciences and Humanities Research Council; Natural Sciences and Engineering Research Council [288348]; Australian Research Council [FT140100291, DE120101945]	Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Council(Australian Research Council)	The research was supported by a Canada Graduate Scholarship from the Social Sciences and Humanities Research Council to SNG, a Discovery Grant from the Natural Sciences and Engineering Research Council (288348) to CMM, a Discovery Early Career Researcher Award (DE120101945) and a Future Fellowship (FT140100291) from the Australian Research Council to TFD. The funders had no role in the design, conduct, or decision to publish the research.	Abel EL, 2013, J ANDROL GYNAECOL, V1, P1; Archer J, 2009, BEHAV BRAIN SCI, V32, P249, DOI 10.1017/S0140525X09990951; Arnott G, 2009, ANIM BEHAV, V77, P991, DOI 10.1016/j.anbehav.2009.02.010; Bashir NY, 2014, PSYCHOL MARKET, V31, P539, DOI 10.1002/mar.20715; BASSILI JN, 1979, J PERS SOC PSYCHOL, V37, P2049, DOI 10.1037/0022-3514.37.11.2049; BERRY DS, 1991, J PERS SOC PSYCHOL, V61, P298, DOI 10.1037/0022-3514.61.2.298; Blanchard DC, 2011, NEUROSCI BIOBEHAV R, V35, P991, DOI 10.1016/j.neubiorev.2010.10.016; Bonett DG, 2007, AM PSYCHOL, V62, P254, DOI 10.1037/0003-066X.62.3.254; Bruce V., 2013, FACE PERCEPTION; Bryan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045301; Carre JM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00567; Carre JM, 2010, PERCEPTION, V39, P356, DOI 10.1068/p6543; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Cheng JT, 2010, EVOL HUM BEHAV, V31, P334, DOI 10.1016/j.evolhumbehav.2010.02.004; Coetzee V, 2010, PERCEPTION, V39, P51, DOI 10.1068/p6560; CUNNINGHAM MR, 1990, J PERS SOC PSYCHOL, V59, P61, DOI 10.1037/0022-3514.59.1.61; Deaner RO, 2012, J RES PERS, V46, P235, DOI 10.1016/j.jrp.2012.01.005; Dixson BJ, 2012, BEHAV ECOL, V23, P481, DOI 10.1093/beheco/arr214; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Geniole SN, 2015, EVOL HUM BEHAV, V36, P279, DOI 10.1016/j.evolhumbehav.2014.12.005; Geniole SN, 2013, EVOL PSYCHOL-US, V11, P1027; Goetz SMM, 2013, PSYCHOL SCI, V24, P2329, DOI 10.1177/0956797613493294; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; Gomez-Valdes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052317; Grueter CC, 2015, EVOL HUM BEHAV, V36, P398, DOI 10.1016/j.evolhumbehav.2015.03.003; Haselhuhn MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122637; Haselhuhn MP, 2014, LEADERSHIP QUART, V25, P835, DOI 10.1016/j.leaqua.2013.12.003; Hedges L, 1985, STATISTICAL METHODS; Hehman E, 2014, PERS SOC PSYCHOL B, V40, P1624, DOI 10.1177/0146167214552791; Kleiman S, 2013, SOC PSYCHOL PERS SCI, V4, P453, DOI 10.1177/1948550612466115; Kramer RSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042705; Kramer RSS, 2012, EVOL PSYCHOL-US, V10, P320; Kramer RSS, 2011, EVOL HUM BEHAV, V32, P179, DOI 10.1016/j.evolhumbehav.2010.10.005; Lefevre CE, 2013, EVOL HUM BEHAV, V34, P273, DOI 10.1016/j.evolhumbehav.2013.03.005; Lefevre CE, 2012, EVOL HUM BEHAV, V33, P623, DOI 10.1016/j.evolhumbehav.2012.03.002; Lefevre CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093369; Levine SZ, 2011, PERS INDIV DIFFER, V50, P1233, DOI 10.1016/j.paid.2011.02.016; Lewis GJ, 2012, PERS INDIV DIFFER, V52, P855, DOI 10.1016/j.paid.2011.12.030; Lipsey M.W., 2001, PRACTICAL META ANAL, V49; Loehr J, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0049; Marsh AA, 2005, PERS SOC PSYCHOL B, V31, P73, DOI 10.1177/0146167204271306; Marsh AA, 2014, SOC PSYCHOL PERS SCI, V5, P684, DOI 10.1177/1948550613519684; Mayew WJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0538; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; McGugin R, 2013, THE OXFORD HANDBOOK, V2, P165; Mileva VR, 2014, PERS INDIV DIFFER, V69, P115, DOI 10.1016/j.paid.2014.05.019; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Orwin RG, 1983, J ED STAT, V8, P157, DOI [DOI 10.2307/1164923, 10.3102/10769986008002157]; Ozener B, 2012, EVOL HUM BEHAV, V33, P169, DOI 10.1016/j.evolhumbehav.2011.08.001; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Peterson RA, 2005, J APPL PSYCHOL, V90, P175, DOI 10.1037/0021-9010.90.1.175; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Said CP, 2009, EMOTION, V9, P260, DOI 10.1037/a0014681; Sanchez-Pages S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112157; Schulz MS, 2006, J CONSULT CLIN PSYCH, V74, P20, DOI 10.1037/0022-006X.74.1.20; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Stillman TF, 2010, EVOL HUM BEHAV, V31, P298, DOI 10.1016/j.evolhumbehav.2009.12.001; Stirrat M, 2012, EVOL HUM BEHAV, V33, P551, DOI 10.1016/j.evolhumbehav.2012.02.002; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Tibbetts EA, 2008, BIOL LETTERS, V4, P237, DOI 10.1098/rsbl.2008.0048; Todorov A, 2010, PERCEPTION, V39, P514, DOI 10.1068/p6501; Toscano H, 2014, EVOL PSYCHOL-US, V12, P1; Trebicky V, 2015, AGGRESSIVE BEHAV, V41, P331, DOI 10.1002/ab.21559; Wang YQ, 2013, INT CONF AFFECT, P479, DOI 10.1109/ACII.2013.85; Watkins CD, 2010, PERS INDIV DIFFER, V49, P967, DOI 10.1016/j.paid.2010.08.006; Welker KM, 2015, EVOL HUM BEHAV, V36, P423, DOI 10.1016/j.evolhumbehav.2015.03.006; Welker KM, 2015, ADAPT HUM BEHAV PHYS, V1, P17, DOI 10.1007/s40750-014-0003-3; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710; Wilson D. B., 2001, EFFECT SIZE DETERMIN; WILSON M, 1985, ETHOL SOCIOBIOL, V6, P59, DOI 10.1016/0162-3095(85)90041-X; Wilson V, 2014, PERS INDIV DIFFER, V58, P89, DOI 10.1016/j.paid.2013.10.008; Zilioli S, 2015, AGGRESSIVE BEHAV, V41, P322, DOI 10.1002/ab.21544	75	144	147	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132726	10.1371/journal.pone.0132726	http://dx.doi.org/10.1371/journal.pone.0132726			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RQ	26181579	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198200030
J	Meadows, SM; Cleaver, O				Meadows, Stryder M.; Cleaver, Ondine			Annexin A3 Regulates Early Blood Vessel Formation	PLOS ONE			English	Article							ENDOTHELIAL LINEAGE; EXPRESSION; XENOPUS; MORPHOGENESIS; CELLS; EXOCYTOSIS; CALPACTIN; RECEPTOR; FAMILY; MICE	Annexins are a large family of calcium binding proteins that associate with cell membrane phospholipids and are involved in various cellular processes including endocytosis, exocytosis and membrane-cytoskeletal organization. Despite studies on numerous Annexin proteins, the function of Annexin A3 (Anxa3) is largely unknown. Our studies identify Anxa3 as a unique marker of the endothelial and myeloid cell lineages of Xenopus laevis during development. Anxa3 transcripts are also detected in endothelial cells (ECs) of zebrafish and mouse embryos, suggesting an important evolutionary function during formation of blood vessels. Indeed, Anxa3 loss-of-function experiments in frog embryos reveal its critical role during the morphogenesis of early blood vessels, as angioblasts in MO injected embryos fail to form vascular cords. Furthermore, in vitro experiments in mammalian cells identify a role for Anxa3 in EC migration. Our results are the first to reveal an in vivo function for Anxa3 during vascular development and represent a previously unexplored aspect of annexin biology.	[Meadows, Stryder M.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Cleaver, Ondine] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	Tulane University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Meadows, SM (corresponding author), Tulane Univ, Dept Cell & Mol Biol, 2000 Percival Stern Hall,6400 Freret St, New Orleans, LA 70118 USA.	smeadows@tulane.edu		Cleaver, Ondine/0000-0003-2454-6641	American Heart Association [12POST11750032, 14BGIA18710018]; National Institutes of Health [NIH R01 HL113498, R01DK079862]; Cancer Prevention Research Institute of Texas [RP110405]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079862] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SMM was supported by the American Heart Association fellowship 12POST11750032 and currently by the American Heart Association award 14BGIA18710018 (www.heart.org). OC is supported by the National Institutes of Health grants: NIH R01 HL113498 and R01DK079862 (www.NIH.gov), and the Cancer Prevention Research Institute of Texas Award RP110405 (http://www.cprit.state.tx.us). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI SM, 1989, NATURE, V340, P313, DOI 10.1038/340313a0; Baltzinger M, 1999, DEV DYNAM, V216, P420, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<420::AID-DVDY10>3.0.CO;2-C; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Brachvogel B, 2001, MECH DEVELOP, V109, P389, DOI 10.1016/S0925-4773(01)00532-9; Costa RMB, 2008, BLOOD, V112, P2287, DOI 10.1182/blood-2008-04-150268; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; Devic E, 1996, MECH DEVELOP, V59, P129, DOI 10.1016/0925-4773(96)00585-0; Dreier R, 1998, HISTOCHEM CELL BIOL, V110, P137, DOI 10.1007/s004180050275; Farber SA, 2003, GENOME RES, V13, P1082, DOI 10.1101/gr.479603; FUTTER CE, 1993, J CELL BIOL, V120, P77, DOI 10.1083/jcb.120.1.77; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Huang BH, 2011, BLOOD, V118, P2918, DOI 10.1182/blood-2011-03-341214; Kamal A, 1998, J CELL BIOL, V142, P937, DOI 10.1083/jcb.142.4.937; Kluger MS, 2013, ARTERIOSCL THROM VAS, V33, P489, DOI 10.1161/ATVBAHA.112.300893; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; Lee C., 2008, CSH PROTOC; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Madureira PA, 2011, BLOOD, V118, P4789, DOI 10.1182/blood-2011-06-334672; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Nieuwkoop PD, 1994, NORMAL TABLE XENOPUI; Park JE, 2005, BIOCHEM BIOPH RES CO, V337, P1283, DOI 10.1016/j.bbrc.2005.10.004; Pin AL, 2012, J BIOL CHEM, V287, P30541, DOI 10.1074/jbc.M112.393561; Salanga MC, 2010, DEV DYNAM, V239, P1178, DOI 10.1002/dvdy.22277; SARAFIAN T, 1991, J CELL BIOL, V114, P1135, DOI 10.1083/jcb.114.6.1135; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Su SC, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M110.157271; Uittenbogaard A, 2002, J BIOL CHEM, V277, P4925, DOI 10.1074/jbc.M109278200	31	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132580	10.1371/journal.pone.0132580	http://dx.doi.org/10.1371/journal.pone.0132580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182056	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198200023
J	Zhao, B; Li, CH; Liu, DR; Li, YC				Zhao, Bo; Li, Chenghao; Liu, Derong; Li, Yuanchun			Decentralized Sliding Mode Observer Based Dual Closed-Loop Fault Tolerant Control for Reconfigurable Manipulator against Actuator Failure	PLOS ONE			English	Article							FLIGHT CONTROL-SYSTEM; LITHIUM-ION BATTERY; ELECTRIC VEHICLES; DESIGN; ROBOTS; IDENTIFICATION; DIAGNOSIS	This paper considers a decentralized fault tolerant control (DFTC) scheme for reconfigurable manipulators. With the appearance of norm-bounded failure, a dual closed-loop trajectory tracking control algorithm is proposed on the basis of the Lyapunov stability theory. Characterized by the modularization property, the actuator failure is estimated by the proposed decentralized sliding mode observer (DSMO). Moreover, the actuator failure can be treated in view of the local joint information, so its control performance degradation is independent of other normal joints. In addition, the presented DFTC scheme is significantly simplified in terms of the structure of the controller due to its dual closed-loop architecture, and its feasibility is highly reflected in the control of reconfigurable manipulators. Finally, the effectiveness of the proposed DFTC scheme is demonstrated using simulations.	[Zhao, Bo; Li, Yuanchun] Changchun Univ Technol, Dept Control Engn, Changchun, Peoples R China; [Zhao, Bo; Liu, Derong] Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China; [Li, Chenghao] FAW Car Co Ltd, Prod Dev Dept, Changchun, Peoples R China	Changchun University of Technology; Chinese Academy of Sciences; Institute of Automation, CAS	Li, YC (corresponding author), Changchun Univ Technol, Dept Control Engn, Changchun, Peoples R China.	liyc@ccut.edu.cn	Liu, Derong/A-5304-2010; Li, Yuan/GXV-1310-2022	Liu, Derong/0000-0003-3715-4778; 	National Natural Science Foundation of China [61374051, 60974010]; Scientific and Technological Development Plan Project in Jilin Province of China [20150520112JH]; FAW Car Co., Ltd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Development Plan Project in Jilin Province of China; FAW Car Co., Ltd	This work is supported by National Natural Science Foundation of China under grant nos. 61374051 and 60974010 and the Scientific and Technological Development Plan Project in Jilin Province of China under grant 20150520112JH. FAW Car Co., Ltd provided support in the form of salaries for author CL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Abdi H, 2012, ROBOTICA, V30, P635, DOI 10.1017/S0263574711000671; Abdul S, 2008, IEEE INT CONF ROBOT, P3520, DOI 10.1109/ROBOT.2008.4543749; Abdul S, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-5, P1236, DOI 10.1109/ROBIO.2007.4522341; Aghili F, 2007, IEEE INT CONF ROBOT, P4077, DOI 10.1109/ROBOT.2007.364105; Ahmad S, 2013, MECHATRONICS, V23, P607, DOI 10.1016/j.mechatronics.2013.05.008; Du M, 2012, INT J ROBUST NONLIN, V22, P105, DOI 10.1002/rnc.1797; Gao Z, 2007, OPTIM CONTR APPL MET, V28, P143, DOI 10.1002/oca.786; HABIBI SR, 1995, IEEE INT CONF ROBOT, P2206, DOI 10.1109/ROBOT.1995.525589; Hassan M, 2007, MECH MACH THEORY, V42, P1401, DOI 10.1016/j.mechmachtheory.2006.10.001; He X, 2013, IEEE T IND INFORM, V9, P1670, DOI 10.1109/TII.2013.2251891; Hu QL, 2011, NONLINEAR DYNAM, V64, P13, DOI 10.1007/s11071-010-9842-z; Hu XS, 2011, J CENT SOUTH UNIV T, V18, P1525, DOI 10.1007/s11771-011-0869-1; Hu XS, 2013, SIMUL MODEL PRACT TH, V34, P1, DOI 10.1016/j.simpat.2013.01.001; Izumikawa Y, 2005, IEEE-ASME T MECH, V10, P391, DOI 10.1109/TMECH.2005.852442; Li Q, 2012, IND ROBOT, V39, P69, DOI 10.1108/01439911211192510; Liu M, 2013, AUTOMATICA, V49, P1242, DOI 10.1016/j.automatica.2013.01.030; Lu KF, 2013, IET CONTROL THEORY A, V7, P1529, DOI 10.1049/iet-cta.2012.1031; Muenchhof M, 2009, ANNU REV CONTROL, V33, P136, DOI 10.1016/j.arcontrol.2009.08.002; Paradis CJJ, 1997, ROBOT AUTON SYST, V21, P289, DOI [10.1016/S0921-8890(97)00081-X, DOI 10.1016/S0921-8890(97)00081-X]; Park S, 2013, J FRANKLIN I, V350, P2535, DOI 10.1016/j.jfranklin.2013.01.014; Seron MM, 2010, INT J CONTROL, V83, P2328, DOI 10.1080/00207179.2010.520032; Shen H, 2013, IET CONTROL THEORY A, V7, P1233, DOI 10.1049/iet-cta.2012.0822; Shen QK, 2012, IEEE T FUZZY SYST, V20, P652, DOI 10.1109/TFUZZ.2011.2181181; Sprowitz A, 2010, IEEE COMPUT INTELL M, V5, P20, DOI 10.1109/MCI.2010.937320; Staroswiecki M, 2012, IEEE T AUTOMAT CONTR, V57, P3181, DOI 10.1109/TAC.2012.2199179; Sun FC, 2011, ENERGY, V36, P3531, DOI 10.1016/j.energy.2011.03.059; Wang YQ, 2008, INT J CONTROL AUTOM, V6, P339; Xu YY, 2013, NONLINEAR DYNAM, V73, P2013, DOI 10.1007/s11071-013-0919-3; Yu X, 2012, IEEE T CONTR SYST T, V20, P871, DOI 10.1109/TCST.2011.2159606; Yuan J, 2011, IEEE T IND ELECTRON, V58, P4880, DOI 10.1109/TIE.2011.2116753; Yuan SA, 2011, INT J SYST SCI, V42, P2125, DOI 10.1080/00207721003770726; Zhang L, 2014, ENERGIES, V7, P3204, DOI 10.3390/en7053204; Zhao B, 2014, NONLINEAR DYNAM, V77, P859, DOI 10.1007/s11071-014-1347-8; Zhao B, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/327916; Zhu MC, 2010, INT J ROBUST NONLIN, V20, P472, DOI 10.1002/rnc.1444	35	16	16	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0129315	10.1371/journal.pone.0129315	http://dx.doi.org/10.1371/journal.pone.0129315			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181826	Green Submitted, gold, Green Published			2022-12-27	WOS:000358198200002
J	Perez-Claros, JA; Jimenez-Arenas, JM; Palmqvist, P				Antonio Perez-Claros, Juan; Manuel Jimenez-Arenas, Juan; Palmqvist, Paul			Neurocranium versus Face: A Morphometric Approach with Classical Anthropometric Variables for Characterizing Patterns of Cranial Integration in Extant Hominoids and Extinct Hominins	PLOS ONE			English	Article							MORPHOLOGICAL INTEGRATION; EARLY HOMO; SAHELANTHROPUS-TCHADENSIS; MIDDLE AWASH; KOOBI FORA; EVOLUTION; AUSTRALOPITHECUS; SIZE; PLEISTOCENE; MODULARITY	The relative importance of the two main cranial complexes, the neurocranium and the splanchnocranium, has been examined in the five species of extant hominoids and in a huge sample of extinct hominins using six standard craniometric variables that measure the length, width and height of each cranial module. Factor analysis and two-block partial least squares were used for establishing the major patterns of developmental and evolutionary integration between both cranial modules. The results obtained show that all extant hominoids (including the anatomically modern humans) share a conserved pattern of developmental integration, a result that agrees with previous studies. The pattern of evolutionary integration between both cranial modules in australopiths runs in parallel to developmental integration. In contrast, the pattern of evolutionary and developmental integration of the species of the genus Homo is the opposite, which is probably the consequence of distinctive selective regimes for both hominin groups.	[Antonio Perez-Claros, Juan; Palmqvist, Paul] Univ Malaga, Fac Ciencias, Dept Ecol & Geol, E-29071 Malaga, Spain; [Manuel Jimenez-Arenas, Juan] Univ Granada, Fac Filosofia & Letras, Dept Prehist & Arqueol, Granada, Spain	Universidad de Malaga; University of Granada	Perez-Claros, JA (corresponding author), Univ Malaga, Fac Ciencias, Dept Ecol & Geol, E-29071 Malaga, Spain.	johnny@uma.es	Jimenez-Arenas, Juan Manuel/AFP-5493-2022; Palmqvist, Paul/B-5378-2013	Jimenez-Arenas, Juan Manuel/0000-0002-4165-0187; Palmqvist, Paul/0000-0002-6630-6956	Ministerio de Ciencia e Innovacion, Gobierno de Espana [CGL2011-30334]; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia, Espana [P11-HUM-7248]	Ministerio de Ciencia e Innovacion, Gobierno de Espana(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia, Espana(Junta de Andalucia)	JAPC, JMJA and PP received fundings from Ministerio de Ciencia e Innovacion, Gobierno de Espana (http://www.idi.mineco.gob.es), project CGL2011-30334, and Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia, Espana (http://www.juntadeandalucia.es/organismos/economiainnovacioncienciayempleo.html), project P11-HUM-7248 and Research Groups RNM-146 and HUM-607. Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2009, EVOL BIOL, V36, P149, DOI 10.1007/s11692-009-9050-2; Ackermann RR, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P302; Adam K.D., 1985, P272; AIELLO LC, 1993, CURR ANTHROPOL, V34, P184, DOI 10.1086/204160; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Alberch P., 1989, Geobios Memoire Special (Villeurbanne), P21; Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; Argue D, 2006, J HUM EVOL, V51, P360, DOI 10.1016/j.jhevol.2006.04.013; Arribas A, 1999, J ARCHAEOL SCI, V26, P571, DOI 10.1006/jasc.1998.0346; Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; Asfaw B, 2002, NATURE, V416, P317, DOI 10.1038/416317a; Baab KL, 2009, J HUM EVOL, V57, P608, DOI 10.1016/j.jhevol.2008.08.011; Bastir M, 2008, ANAT REC, V291, P130, DOI 10.1002/ar.20636; Benazzi S, 2014, AM J PHYS ANTHROPOL, V153, P154, DOI 10.1002/ajpa.22376; Benazzi S, 2011, J HUM EVOL, V61, P75, DOI 10.1016/j.jhevol.2011.02.005; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Bischoff JL, 2003, J ARCHAEOL SCI, V30, P275, DOI 10.1006/jasc.2002.0834; Brown FH, 2006, J GEOL SOC LONDON, V163, P185, DOI 10.1144/0016-764904-165; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Chaline J, 2003, J REPROD IMMUNOL, V59, P137, DOI 10.1016/S0165-0378(03)00043-3; CHEVERUD JM, 1982, EVOLUTION, V36, P499, DOI 10.1111/j.1558-5646.1982.tb05070.x; CLARKE MRB, 1980, BIOMETRIKA, V67, P441, DOI 10.1093/biomet/67.2.441; CORRUCCINI RS, 1975, HOMO, V26, P136; Delson E., 1988, P317; Ferring R, 2011, P NATL ACAD SCI USA, V108, P10432, DOI 10.1073/pnas.1106638108; Gathogo PN, 2006, J HUM EVOL, V51, P471, DOI 10.1016/j.jhevol.2006.05.005; Gonzalez-Jose R, 2008, NATURE, V453, P775, DOI 10.1038/nature06891; Gordon AD, 2008, P NATL ACAD SCI USA, V105, P4650, DOI 10.1073/pnas.0710041105; Goswami A, 2006, AM NAT, V168, P270, DOI 10.1086/505758; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; GOULD SJ, 1969, EVOLUTION, V23, P276, DOI 10.1111/j.1558-5646.1969.tb03512.x; Guy F, 2005, P NATL ACAD SCI USA, V102, P18836, DOI 10.1073/pnas.0509564102; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harvati K, 2011, J HUM EVOL, V60, P246, DOI 10.1016/j.jhevol.2010.09.008; Herries AIR, 2011, J HUM EVOL, V60, P523, DOI 10.1016/j.jhevol.2010.09.001; Howells W. W., 1973, PAPERS PEABODY MUSEU, V67; Howells W. W., 1995, PAP PEABODY MUS, V82, P1; Howells W. W., 1989, PAP PEABODY MUS, V79, P1; Hrdlicka A, 1943, AM J PHYS ANTHROP-NE, V1, P77, DOI 10.1002/ajpa.1330010116; Jacob T, 1967, SOME PROBLEMS PERTAI; Jimenez-Arenas JM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/406507; Joordens JCA, 2013, J HUM EVOL, V65, P731, DOI 10.1016/j.jhevol.2013.09.002; Keyser AW, 2000, S AFR J SCI, V96, P189; KIMBEL WH, 1994, NATURE, V368, P449, DOI 10.1038/368449a0; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; Lague MR, 2008, J ANAT, V213, P670, DOI 10.1111/j.1469-7580.2008.00989.x; LEAKEY MD, 1969, NATURE, V223, P756, DOI 10.1038/223756a0; Lebatard AE, 2008, P NATL ACAD SCI USA, V105, P3226, DOI 10.1073/pnas.0708015105; Leonard WR, 1996, CURR ANTHROPOL, V37, P125, DOI 10.1086/204476; Lieberman DE, 1996, J HUM EVOL, V30, P97, DOI 10.1006/jhev.1996.0008; Lieberman DE, 2002, P NATL ACAD SCI USA, V99, P1134, DOI 10.1073/pnas.022440799; Lieberman DE, 1998, NATURE, V393, P158, DOI 10.1038/30227; Lordkipanidze D, 2005, NATURE, V434, P717, DOI 10.1038/434717b; Lordkipanidze D, 2013, SCIENCE, V342, P326, DOI 10.1126/science.1238484; Jimenez-Arenas JM, 2011, QUATERN INT, V243, P219, DOI 10.1016/j.quaint.2011.02.024; Miller JMA, 2000, AM J PHYS ANTHROPOL, V112, P103, DOI 10.1002/(SICI)1096-8644(200005)112:1<103::AID-AJPA10>3.0.CO;2-6; Milton K, 2003, J NUTR, V133, p3886S, DOI 10.1093/jn/133.11.3886S; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; Mitteroecker P, 2008, EVOLUTION, V62, P943, DOI 10.1111/j.1558-5646.2008.00321.x; Mitteroecker P, 2007, SYST BIOL, V56, P818, DOI 10.1080/10635150701648029; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; MOSIMANN JE, 1979, EVOLUTION, V33, P444, DOI 10.1111/j.1558-5646.1979.tb04697.x; Olson E. C., 1958, MORPHOLOGICAL INTEGR; Espigares MP, 2013, QUATERN INT, V295, P113, DOI 10.1016/j.quaint.2012.09.032; Pickering R, 2010, J HUM EVOL, V59, P70, DOI 10.1016/j.jhevol.2010.03.014; PILBEAM D, 1974, SCIENCE, V186, P892, DOI 10.1126/science.186.4167.892; Poulianos AN, 1975, ANTHROPOS, V2, P40; Richmond BG, 2008, SCIENCE, V319, P1662, DOI 10.1126/science.1154197; Riquet R, 1970, LHOMME DE CRO MAGNON, P37; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; Rolian C, 2009, EVOL BIOL, V36, P1, DOI 10.1007/s11692-009-9052-0; Rose L, 1996, CURR ANTHROPOL, V37, P307, DOI 10.1086/204494; Ruff CB, 1997, NATURE, V387, P173, DOI 10.1038/387173a0; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Singh N, 2012, J HUM EVOL, V62, P155, DOI 10.1016/j.jhevol.2011.11.006; SOMERS KM, 1989, SYST ZOOL, V38, P169, DOI 10.2307/2992386; Vandermeersch B, 1981, HOMMES FOSSILES QUAF; VANVALEN L, 1971, EVOLUTION, V25, P420, DOI 10.1111/j.1558-5646.1971.tb01898.x; Weidenreich F., 1941, T AM PHILOS SOC, V31, P320, DOI DOI 10.2307/1005610; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Wood B., 1991, KOOBI FORA RES PROJE, V4; Wood B, 2007, YEARB PHYS ANTHROPOL, V50, P106, DOI 10.1002/ajpa.20732; ZELDITCH ML, 1987, SYST ZOOL, V36, P368, DOI 10.2307/2413401	87	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131055	10.1371/journal.pone.0131055	http://dx.doi.org/10.1371/journal.pone.0131055			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177535	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600034
J	Birken, CS; Lebovic, G; Anderson, LN; McCrindle, BW; Mamdani, M; Kandasamy, S; Khovratovich, M; Parkin, PC; Maguire, JL				Birken, Catherine S.; Lebovic, Gerald; Anderson, Laura N.; McCrindle, Brian W.; Mamdani, Muhammad; Kandasamy, Sharmilaa; Khovratovich, Marina; Parkin, Patricia C.; Maguire, Jonathon L.		TARGet Kids Collaboration	Association between Vitamin D and Circulating Lipids in Early Childhood	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; SERUM 25-HYDROXYVITAMIN D; METABOLIC SYNDROME; CARDIOMETABOLIC RISK; YOUNG-ADULTS; D DEFICIENCY; US CHILDREN; ADOLESCENTS; PREVALENCE; DISEASE	Vitamin D is associated with established cardiovascular risk factors such as low density lipoprotein (LDL) in adults. It is unknown whether these associations are present in early childhood. To determine whether serum 25-hydroxyvitamin D (25(OH) D) is associated with serum non-high density lipoprotein (non-HDL) cholesterol during early childhood we conducted a cross-sectional study of children aged 1 to 5 years. Healthy children were recruited through the TARGet Kids! practice based research network from 2008-2011 (n=1,961). The associations between 25(OH) D and non-fasting non-HDL cholesterol (the primary endpoint), total cholesterol, triglycerides, HDL, and low density lipoprotein (LDL) cholesterol, were evaluated using multiple linear regression adjusted for age, sex, skin pigmentation, milk intake, vitamin D supplementation, season, body mass index, outdoor play, and screen time. Each 10 nmol/L increase in 25(OH) D was associated with a decrease in non-HDL cholesterol concentration of -0.89 mg/dl (95% CI: -1.16,-0.50), total cholesterol of -1.08 mg/dl (95% CI: -1.49,-0.70), and triglycerides of -2.34 mg/dl (95% CI: -3.23,-1.45). The associations between 25(OH) D and LDL and HDL were not statistically significant. 25(OH) D concentrations were inversely associated with circulating lipids in early childhood, suggesting that vitamin D exposure in early life may be an early modifiable risk factor for cardiovascular disease.	[Birken, Catherine S.; Anderson, Laura N.; Khovratovich, Marina; Parkin, Patricia C.; Maguire, Jonathon L.] Hosp Sick Children, Dept Paediat, Div Paediat Med, Pediat Outcomes Res Team, Toronto, ON M5G 1X8, Canada; [Birken, Catherine S.; McCrindle, Brian W.; Parkin, Patricia C.; Maguire, Jonathon L.] Univ Toronto, Fac Med, Dept Pediat, Toronto, ON, Canada; [Birken, Catherine S.; Lebovic, Gerald; Parkin, Patricia C.; Maguire, Jonathon L.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Lebovic, Gerald; Anderson, Laura N.; Mamdani, Muhammad; Kandasamy, Sharmilaa; Maguire, Jonathon L.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr, Toronto, ON M5B 1W8, Canada; [McCrindle, Brian W.] Hosp Sick Children, Div Cardiol, Toronto, ON M5G 1X8, Canada; [Mamdani, Muhammad] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Maguire, Jonathon L.] St Michaels Hosp, Dept Pediat, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Birken, CS (corresponding author), Hosp Sick Children, Dept Paediat, Div Paediat Med, Pediat Outcomes Res Team, Toronto, ON M5G 1X8, Canada.	catherine.birken@sickkids.ca	Anderson, Laura/K-4707-2019	Anderson, Laura/0000-0002-6106-5073; Borkhoff, Cornelia/0000-0003-3420-1866; Lebovic, Gerald/0000-0003-3540-3339	Canadian Institutes of Health Research (CIHR); St. Michael's Hospital Foundation; Hospital for Sick Children Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); St. Michael's Hospital Foundation; Hospital for Sick Children Foundation	This work was supported by the Canadian Institutes of Health Research (CIHR), as well as the St. Michael's Hospital Foundation. The Pediatric Outcomes Research Team is supported by a grant from the Hospital for Sick Children Foundation. Funding agencies had no role in the design, collection, analyses or interpretation of data, the writing of the report, or the decision to submit the manuscript for publication.	American Heart Association, 2006, HEART DIS STROK STAT; [Anonymous], REGRESSION MODELING; [Anonymous], 2011, DIET REF INT CALC VI; Arnberg K, 2011, ACTA PAEDIATR, V100, P1244, DOI 10.1111/j.1651-2227.2011.02273.x; Ashraf AP, 2011, OBESITY, V19, P2214, DOI 10.1038/oby.2011.110; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Carsley S, 2015, INT J EPIDEMIOL, V44, P776, DOI 10.1093/ije/dyu123; de Onis Mercedes, 2003, Forum Nutr, V56, P238; Delvin EE, 2010, J NUTR, V140, P987, DOI 10.3945/jn.109.112250; Dietitians of Canada, 2010, Can J Diet Pract Res, V71, pe1; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Ford ES, 2005, DIABETES CARE, V28, P1228, DOI 10.2337/diacare.28.5.1228; Ganji V, 2011, AM J CLIN NUTR, V94, P225, DOI 10.3945/ajcn.111.013516; Johnson MD, 2010, J PEDIATR-US, V156, P444, DOI 10.1016/j.jpeds.2009.09.070; Jorde R, 2011, PROG LIPID RES, V50, P303, DOI 10.1016/j.plipres.2011.05.001; Khera AV, 2012, ARCH INTERN MED, V172, P1710, DOI 10.1001/2013.jamainternmed.263; Kumar J, 2009, PEDIATRICS, V124, pE362, DOI 10.1542/peds.2009-0051; LAUER RM, 1990, JAMA-J AM MED ASSOC, V264, P3034, DOI 10.1001/jama.264.23.3034; Maunsell Z, 2005, CLIN CHEM, V51, P1683, DOI 10.1373/clinchem.2005.052936; Norman PE, 2014, CIRC RES, V114, P379, DOI 10.1161/CIRCRESAHA.113.301241; Pacifico L, 2011, EUR J ENDOCRINOL, V165, P603, DOI 10.1530/EJE-11-0545; Pilz S, 2011, CLIN ENDOCRINOL, V75, P575, DOI 10.1111/j.1365-2265.2011.04147.x; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Rajakumar K, 2011, J CLIN ENDOCR METAB, V96, P1560, DOI 10.1210/jc.2010-2388; Sacheck J, 2011, J PEDIATR-US, V159, P945, DOI 10.1016/j.jpeds.2011.06.001; Schnatz PF, 2014, CLIN CHEM, V60, P600, DOI 10.1373/clinchem.2013.211037; Singh RJ, 2006, J CLIN ENDOCR METAB, V91, P3055, DOI 10.1210/jc.2006-0710; Skaaby T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057647; Steiner MJ, 2011, PEDIATRICS, V128, P463, DOI 10.1542/peds.2011-0844; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604; Warnick GR, 2008, CLIN CHEM, V54, P14, DOI 10.1373/clinchem.2007.098863; Williams DM, 2012, J CLIN ENDOCR METAB, V97, P1563, DOI 10.1210/jc.2011-2335; Williams DM, 2011, HEART, V97, P315, DOI 10.1136/hrt.2010.203224	37	18	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131938	10.1371/journal.pone.0131938	http://dx.doi.org/10.1371/journal.pone.0131938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176958	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600071
J	Kasumovic, MM; Kuznekoff, JH				Kasumovic, Michael M.; Kuznekoff, Jeffrey H.			Insights into Sexism: Male Status and Performance Moderates Female-Directed Hostile and Amicable Behaviour	PLOS ONE			English	Article							SEXUAL SELECTION; VIDEO GAMES; DOMINANCE; VIOLENT; PERCEPTIONS; PUNISHMENT; EVOLUTION; RESPONSES	Gender inequality and sexist behaviour is prevalent in almost all workplaces and rampant in online environments. Although there is much research dedicated to understanding sexist behaviour, we have almost no insight into what triggers this behaviour and the individuals that initiate it. Although social constructionist theory argues that sexism is a response towards women entering a male dominated arena, this perspective doesn't explain why only a subset of males behave in this way. We argue that a clearer understanding of sexist behaviour can be gained through an evolutionary perspective that considers evolved differences in intra-sexual competition. We hypothesised that female-initiated disruption of a male hierarchy incites hostile behaviour from poor performing males who stand to lose the most status. To test this hypothesis, we used an online first-person shooter video game that removes signals of dominance but provides information on gender, individual performance, and skill. We show that lower-skilled players were more hostile towards a female-voiced teammate, especially when performing poorly. In contrast, lower-skilled players behaved submissively towards a male-voiced player in the identical scenario. This difference in gender-directed behaviour became more extreme with poorer focal-player performance. We suggest that low-status males increase female-directed hostility to minimize the loss of status as a consequence of hierarchical reconfiguration resulting from the entrance of a woman into the competitive arena. Higher-skilled players, in contrast, were more positive towards a female relative to a male teammate. As higher-skilled players have less to fear from hierarchical reorganization, we argue that these males behave more positively in an attempt to support and garner a female player's attention. Our results provide the clearest picture of inter-sexual competition to date, highlighting the importance of considering an evolutionary perspective when exploring the factors that affect male hostility towards women.	[Kasumovic, Michael M.] Univ New S Wales, Ecol & Evolut Res Ctr, Sydney, NSW 2052, Australia; [Kuznekoff, Jeffrey H.] Miami Univ, Dept Integrat Studies, Middletown, OH 45042 USA	University of New South Wales Sydney; University System of Ohio; Miami University	Kasumovic, MM (corresponding author), Univ New S Wales, Ecol & Evolut Res Ctr, Sydney, NSW 2052, Australia.	m.kasumovic@unsw.edu.au		Kasumovic, Michael/0000-0003-0158-5517; Kuznekoff, Jeffrey/0000-0002-1740-1180	ARC DECRA Fellowship [DE120100214]	ARC DECRA Fellowship(Australian Research Council)	This research was supported by an ARC DECRA Fellowship (DE120100214) to MMK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejos AV, 2014, IEEE GLOB ENG EDUC C, P280, DOI 10.1109/EDUCON.2014.6826103; Amanatullah ET, 2013, ORGAN BEHAV HUM DEC, V120, P110, DOI 10.1016/j.obhdp.2012.03.006; Andersson Malte, 1994; [Anonymous], 2013, PHILOS T R SOC B, DOI [10.1098/rstb.2013.0079, DOI 10.1098/rstb.2013.0079]; Archer J, 2009, BEHAV BRAIN SCI, V32, P249, DOI 10.1017/S0140525X09990951; Conner AL, 2014, SCIENCE, V343, P1200, DOI 10.1126/science.343.6176.1200-a; Dill KE, 2007, SEX ROLES, V57, P851, DOI 10.1007/s11199-007-9278-1; Elwer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053246; ESA T, 2014, ESS FACTS COMP VID G; Ewoldsen DR, 2012, CYBERPSYCH BEH SOC N, V15, P277, DOI 10.1089/cyber.2011.0308; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fox J, 2009, J STAT SOFTW, V32, P1; Glick P, 1996, J PERS SOC PSYCHOL, V70, P491, DOI 10.1037/0022-3514.70.3.491; Greitemeyer T, 2014, PERS SOC PSYCHOL B, V40, P578, DOI 10.1177/0146167213520459; Gurven Michael, 2006, Soc Biol, V53, P81; Hawley PH, 1999, DEV REV, V19, P97, DOI 10.1006/drev.1998.0470; Hill AK, 2013, EVOL HUM BEHAV, V34, P334, DOI 10.1016/j.evolhumbehav.2013.05.004; Hosokawa T, 2012, J NEUROSCI, V32, P7662, DOI 10.1523/JNEUROSCI.6479-11.2012; Ivarsson M, 2013, PSYCHOSOM MED, V75, P390, DOI 10.1097/PSY.0b013e3182906a4c; Katsyri J, 2013, CEREB CORTEX, V23, P2829, DOI 10.1093/cercor/bhs259; Kuznekoff JH, 2013, NEW MEDIA SOC, V15, P541, DOI 10.1177/1461444812458271; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Ogletree SM, 2007, SEX ROLES, V56, P537, DOI 10.1007/s11199-007-9193-5; Mayer AP, 2014, ACAD MED, V89, P312, DOI 10.1097/ACM.0000000000000089; McDonald MM, 2012, PHILOS T R SOC B, V367, P670, DOI 10.1098/rstb.2011.0301; Meyer R, 2006, I C DEPEND SYS NETWO, P467, DOI 10.1109/DSN.2006.12; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Oei AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058546; Oxford J, 2010, EVOL HUM BEHAV, V31, P201, DOI 10.1016/j.evolhumbehav.2009.07.002; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Richerson PJ., 2005, NOT GENES ALONE CULT; Rudman LA, 1998, J PERS SOC PSYCHOL, V74, P629, DOI 10.1037/0022-3514.74.3.629; Stermer SP, 2012, SOC PERSONAL PSYCHOL, V6, P525, DOI 10.1111/j.1751-9004.2012.00442.x; Stockley P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0073; Vaillancourt T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0080; von Rueden C, 2011, P ROY SOC B-BIOL SCI, V278, P2223, DOI 10.1098/rspb.2010.2145; Winegard BM, 2014, REV GEN PSYCHOL, V18, P34, DOI 10.1037/a0036594; Yao MZ, 2010, SEX ROLES, V62, P77, DOI 10.1007/s11199-009-9695-4	40	28	28	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131613	10.1371/journal.pone.0131613	http://dx.doi.org/10.1371/journal.pone.0131613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26176699	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600053
J	Kojima, N; Kim, M; Saito, K; Yoshida, H; Yoshida, Y; Hirano, H; Obuchi, S; Shimada, H; Suzuki, T; Kim, H				Kojima, Narumi; Kim, Miji; Saito, Kyoko; Yoshida, Hideyo; Yoshida, Yuko; Hirano, Hirohiko; Obuchi, Shuichi; Shimada, Hiroyuki; Suzuki, Takao; Kim, Hunkyung			Lifestyle-Related Factors Contributing to Decline in Knee Extension Strength among Elderly Women: A Cross-Sectional and Longitudinal Cohort Study	PLOS ONE			English	Article							MUSCLE STRENGTH; PHYSICAL PERFORMANCE; SERUM-ALBUMIN; FUNCTIONAL-CAPACITY; PROTEIN-INTAKE; GRIP STRENGTH; OLDER WOMEN; COMMUNITY; VITAMIN; EXERCISE	This cross-sectional and 4-year longitudinal cohort study aimed to clarify how various lifestyle-related variables affect knee extension strength in elderly Japanese women. The participants were community-dwelling women (n = 575) living in the Itabashi Ward of Tokyo, Japan aged 75-85 years at baseline (in 2008) who returned for a follow-up examination 4 years later (in 2012). Maximum isometric knee extension strength in the dominant leg was measured during comprehensive medical check-ups at baseline and follow-up. Interviews with participants included questions on their history of 11 diseases and lifestyle-related factors such as physical activity as well as dietary, smoking, and drinking habits. Cross-sectional and longitudinal analyses yielded inconsistent results regarding the associations between lifestyle-related factors and knee extension strength. While going out more frequently and regular physical exercise positively affected baseline knee extension strength, they did not affect knee extension strength in the longitudinal analysis. The longitudinal analysis revealed that more frequent intake of soy products or green and yellow vegetables at baseline decreased age-related knee extension strength decline. The inconsistent results from the cross-sectional and longitudinal analyses indicate that conducting both types of analyses is crucial for researching this type of subject. The present study demonstrates that the age-related decline in muscle strength is lower in those who frequently eat soy products or green and yellow vegetables. Thus, recommending higher intake of soy products, and green and yellow vegetables for the elderly might help maintain their muscle health.	[Kojima, Narumi; Kim, Miji; Yoshida, Hideyo; Yoshida, Yuko; Hirano, Hirohiko; Obuchi, Shuichi; Kim, Hunkyung] Tokyo Metropolitan Inst Gerontol, Itabashi Ku, Tokyo, Japan; [Saito, Kyoko] Yokohama City Univ, Grad Sch Med, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Shimada, Hiroyuki; Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Res Inst, Obu, Aichi, Japan	Tokyo Metropolitan Institute of Gerontology; Yokohama City University; National Center for Geriatrics & Gerontology	Kojima, N (corresponding author), Tokyo Metropolitan Inst Gerontol, Itabashi Ku, Tokyo, Japan.	nkojima@tmig.or.jp		Kojima, Narumi/0000-0001-5742-0389				[Anonymous], 1997, JAMA-J AM MED ASSOC, V277, P925; Azegami M, 2007, NURS HEALTH SCI, V9, P168, DOI 10.1111/j.1442-2018.2007.00317.x; Bischoff HA, 1999, ARCH PHYS MED REHAB, V80, P54, DOI 10.1016/S0003-9993(99)90307-6; Cesari M, 2004, AM J CLIN NUTR, V79, P289; Cote MP, 2014, HUM FACTORS, V56, P228, DOI 10.1177/0018720813518220; Ekino S, 2007, J NEUROL SCI, V262, P131, DOI 10.1016/j.jns.2007.06.036; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Forrest KYZ, 2007, GERONTOLOGY, V53, P140, DOI 10.1159/000097979; Hughes VA, 2001, J GERONTOL A-BIOL, V56, pB209, DOI 10.1093/gerona/56.5.B209; Imai E, 2014, J AM GERIATR SOC, V62, P426, DOI 10.1111/jgs.12690; Kaneki M, 2001, NUTRITION, V17, P315, DOI 10.1016/S0899-9007(00)00554-2; Katsuyama H, 2004, J NUTR SCI VITAMINOL, V50, P114, DOI 10.3177/jnsv.50.114; Kim H, 2013, ARCH GERONTOL GERIAT, V57, P352, DOI 10.1016/j.archger.2013.06.008; Kim H, 2013, GERIATR GERONTOL INT, V13, P458, DOI 10.1111/j.1447-0594.2012.00923.x; Kimura M, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-8; Kitamura Kaori, 2012, Environmental Health and Preventive Medicine, V17, P164, DOI 10.1007/s12199-011-0233-y; Kojima N, 2014, GERIATR GERONTOL INT, V14, P674, DOI 10.1111/ggi.12158; Kumagai Shu, 2003, Nihon Koshu Eisei Zasshi, V50, P1117; Kwon J, 2006, EUR J CLIN NUTR, V60, P305, DOI 10.1038/sj.ejcn.1602314; Lands LC, 1999, J APPL PHYSIOL, V87, P1381, DOI 10.1152/jappl.1999.87.4.1381; Lauretani F, 2008, J GERONTOL A-BIOL, V63, P376, DOI 10.1093/gerona/63.4.376; Michelon E, 2006, J GERONTOL A-BIOL, V61, P600, DOI 10.1093/gerona/61.6.600; Mizushige T, 2010, BIOMED RES-TOKYO, V31, P347, DOI 10.2220/biomedres.31.347; Mori Mari, 2004, Clin Exp Pharmacol Physiol, V31 Suppl 2, pS44, DOI 10.1111/j.1440-1681.2004.04118.x; Mori Mari, 2004, Clin Exp Pharmacol Physiol, V31 Suppl 2, pS39, DOI 10.1111/j.1440-1681.2004.04117.x; Okamura T, 2008, J AM GERIATR SOC, V56, P529, DOI 10.1111/j.1532-5415.2007.01549.x; Rantanen T, 1998, J APPL PHYSIOL, V85, P2047, DOI 10.1152/jappl.1998.85.6.2047; Rantanen Taina, 2002, Aging Clin Exp Res, V14, P10; Renzoni A, 1998, ENVIRON RES, V77, P68, DOI 10.1006/enrs.1998.3832; Robinson SM, 2008, J AM GERIATR SOC, V56, P84, DOI 10.1111/j.1532-5415.2007.01478.x; Saito K, 2012, J GERONTOL A-BIOL, V67, P295, DOI 10.1093/gerona/glr174; Semba RD, 2003, AGING CLIN EXP RES, V15, P482, DOI 10.1007/BF03327377; Semba RD, 2007, ARCH BIOCHEM BIOPHYS, V458, P141, DOI 10.1016/j.abb.2006.11.025; Snyder CK, 2012, J AM GERIATR SOC, V60, P1663, DOI 10.1111/j.1532-5415.2012.04115.x; Stenholm S, 2012, J AM GERIATR SOC, V60, P77, DOI 10.1111/j.1532-5415.2011.03779.x	35	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132523	10.1371/journal.pone.0132523	http://dx.doi.org/10.1371/journal.pone.0132523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177292	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600120
J	Magrach, A; Ghazoul, J				Magrach, Ainhoa; Ghazoul, Jaboury			Climate and Pest-Driven Geographic Shifts in Global Coffee Production: Implications for Forest Cover, Biodiversity and Carbon Storage	PLOS ONE			English	Article							LAND; CONSERVATION; ADAPTATION	Coffee is highly sensitive to temperature and rainfall, making its cultivation vulnerable to geographic shifts in response to a changing climate. This could lead to the establishment of coffee plantations in new areas and potential conflicts with other land covers including natural forest, with consequent implications for biodiversity and ecosystem services. We project areas suitable for future coffee cultivation based on several climate scenarios and expected responses of the coffee berry borer, a principle pest of coffee crops. We show that the global climatically-suitable area will suffer marked shifts from some current major centres of cultivation. Most areas will be suited to Robusta coffee, demand for which could be met without incurring forest encroachment. The cultivation of Arabica, which represents 70% of consumed coffee, can also be accommodated in the future, but only by incurring some natural forest loss. This has corresponding implications for carbon storage, and is likely to affect areas currently designated as priority areas for biodiversity. Where Arabica coffee does encroach on natural forests, we project average local losses of 35% of threatened vertebrate species. The interaction of climate and coffee berry borer greatly influences projected outcomes.	[Magrach, Ainhoa; Ghazoul, Jaboury] ETH, Inst Terr Ecosyst, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Magrach, A (corresponding author), ETH, Inst Terr Ecosyst, CHN G 73-1 Univ Str 16, CH-8092 Zurich, Switzerland.	ainhoa.magrach@usys.ethz.chmailto	Ghazoul, Jaboury/B-2121-2018		Eidgenossische Technische Hochschule Zurich-Marie Curie CoFund [FEL-04 13-1]; ETH-Marie Curie postdoctoral fellowship	Eidgenossische Technische Hochschule Zurich-Marie Curie CoFund; ETH-Marie Curie postdoctoral fellowship	This study was funded by an Eidgenossische Technische Hochschule Zurich-Marie Curie CoFund (FEL-04 13-1). AM was funded by an ETH-Marie Curie postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ENV FACTORS SUITABLE; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Avelino J, 2015, FOOD SECUR, V7, P303, DOI 10.1007/s12571-015-0446-9; Baek HJ, 2013, ASIA-PAC J ATMOS SCI, V49, P603, DOI 10.1007/s13143-013-0053-7; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Bhagwat SA, 2005, CONSERV BIOL, V19, P1853, DOI 10.1111/j.1523-1739.2005.00248.x; Bryant D., 1997, LAST FRONTIER FOREST; Bunn C, 2015, CLIMATIC CHANGE, V129, P89, DOI 10.1007/s10584-014-1306-x; Butchart Stuart H M, 2012, PLoS One, V7, pe32529, DOI 10.1371/journal.pone.0032529; CABI, HYP HAMP; CIAT, 2012, FUT CLIM SCEN VIETN; DaMatta Fábio M., 2006, Braz. J. Plant Physiol., V18, P55, DOI 10.1590/S1677-04202006000100006; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Dossa EL, 2008, AGROFOREST SYST, V72, P103, DOI 10.1007/s10457-007-9075-4; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; FAO, 2006, DIG SOIL MAP WORLD D; FAO, 2014, FAOSTAT STAT DAT DAT; Fernandes FL, 2011, J ECON ENTOMOL, V104, P1909, DOI 10.1603/EC11032; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Haggar J., 2012, COFFEE CLIMATE CHANG; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; ICO. International Coffee Organization, 2014, HIST DAT; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jaramillo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051815; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jarvis A., 2008, HOLE FILLED SRTM GLO; Koh LP, 2010, P NATL ACAD SCI USA, V107, P11140, DOI 10.1073/pnas.1000530107; Laderach P, 2011, CLIM CHANG MANAG, P703, DOI 10.1007/978-3-642-14776-0_42; Lan C.C., 2004, COFFEE CROWING PROCE, P459; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Mayer A, 2013, BIOSCIENCE, V63, P781, DOI 10.1525/bio.2013.63.10.2; Meyfroidt P, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074012; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Mittermeier Russell A., 2004, P1; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NatureServe and BirdLife International, 2014, BIRD SPEC DISTR MAPS; O'Brien TG, 2003, SCIENCE, V300, P587, DOI 10.1126/science.1082328; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Parolo G, 2008, J APPL ECOL, V45, P1410, DOI 10.1111/j.1365-2664.2008.01516.x; Perfecto I, 2005, ECOL ECON, V54, P435, DOI 10.1016/j.ecolecon.2004.10.009; Peters VE, 2012, AGROFOREST SYST, V85, P95, DOI 10.1007/s10457-011-9476-2; Power S, 2013, NATURE, V502, P541, DOI 10.1038/nature12580; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Ramirez-Villegas J, 2012, CLIMATIC CHANGE, V115, P611, DOI 10.1007/s10584-012-0500-y; Ruesch A., 2008, NEW IPCC TIER 1 GLOB; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; USAID, 2013, UG CLIM CHANG VULN A; USDA, 2012, PROD SUPPL DISTR ONL; Vermeulen SJ, 2013, P NATL ACAD SCI USA, V110, P8357, DOI 10.1073/pnas.1219441110; Weyant J, 2009, REPORT OF 2 6 VERSUS; WorldClim, 2013, WORLDCLIM GLOB CLIM	61	62	63	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133071	10.1371/journal.pone.0133071	http://dx.doi.org/10.1371/journal.pone.0133071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177201	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600209
J	Miles, WTS; Mavor, R; Riddiford, NJ; Harvey, PV; Riddington, R; Shaw, DN; Parnaby, D; Reid, JM				Miles, Will T. S.; Mavor, Roddy; Riddiford, Nick J.; Harvey, Paul V.; Riddington, Roger; Shaw, Deryk N.; Parnaby, David; Reid, Jane M.			Decline in an Atlantic Puffin Population: Evaluation of Magnitude and Mechanisms	PLOS ONE			English	Article							SKUAS STERCORARIUS-SKUA; GREAT SKUAS; FRATERCULA-ARCTICA; CATHARACTA-SKUA; LONG-TERM; FOOD AVAILABILITY; ADULT SURVIVAL; ENVIRONMENTAL VARIABILITY; RELATIVE IMPORTANCE; AMMODYTES-MARINUS	Determining which demographic and ecological parameters contribute to variation in population growth rate is crucial to understanding the dynamics of declining populations. This study aimed to evaluate the magnitude and mechanisms of an apparent major decline in an Atlantic Puffin Fratercula arctica population. This was achieved using a 27-year dataset to estimate changes in population size and in two key demographic rates: adult survival and breeding success. Estimated demographic variation was then related to two ecological factors hypothesised to be key drivers of demographic change, namely the abundance of the main predator at the study site, the Great Skua Stercorarius skua, and Atlantic Puffin chick food supply, over the same 27-year period. Using a population model, we assessed whether estimated variation in adult survival and reproductive success was sufficient to explain the population change observed. Estimates of Atlantic Puffin population size decreased considerably during the study period, approximately halving, whereas Great Skua population estimates increased, approximately trebling. Estimated adult Atlantic Puffin survival remained high across all years and did not vary with Great Skua abundance; however, Atlantic Puffin breeding success and quantities of fish prey brought ashore by adults both decreased substantially through the period. A population model combining best possible demographic parameter estimates predicted rapid population growth, at odds with the long-term decrease observed. To simulate the observed decrease, population models had to incorporate low immature survival, high immature emigration, or increasingly high adult non-breeding rates. We concluded that reduced recruitment of immatures into the breeding population was the most likely cause of population decrease. This study showed that increase in the size of a predator population does not always impact on the survival of adult prey and that reduced recruitment can be a crucial determinant of seabird population size but can easily go undetected.	[Miles, Will T. S.; Reid, Jane M.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Aberdeen, Scotland; [Mavor, Roddy] Joint Nat Conservat Comm, Aberdeen, Aberdeen, Scotland; [Riddiford, Nick J.; Shaw, Deryk N.; Parnaby, David] Fair Isle Bird Observ, Fair Isle, Shetland, Scotland; [Harvey, Paul V.] Shetland Amen Trust, Shetland Biol Records Ctr, Lerwick, Shetland, Scotland; [Riddington, Roger] Spindrift, Virkie, Shetland, Scotland	University of Aberdeen	Miles, WTS (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Aberdeen, Scotland.	w.miles@abdn.ac.uk			Fair Isle Bird Observatory Trust; Fair Isle Bird Observatory	Fair Isle Bird Observatory Trust; Fair Isle Bird Observatory	This study was funded annually by Fair Isle Bird Observatory Trust (www.fairislebirdobs.co.uk) with contributions from the Joint Nature Conservation Committee (jncc.defra.gov.uk). Funding was received from these two sources by Fair Isle Bird Observatory from 1986 to 2013. The Joint Nature Conservation Committee and Fair Isle Bird Observatory Trust supplied guidance on study design, data collection, analyses, preparation of the manuscript and the decision to publish.	Bergallo HG, 1999, J MAMMAL, V80, P472, DOI 10.2307/1383294; Birkhead, 1993, GREAT AUK ISLANDS; Bogdanova MI, 2011, P ROY SOC B-BIOL SCI, V278, P2412, DOI 10.1098/rspb.2010.2601; Bradley JS, 2000, J ANIM ECOL, V69, P639, DOI 10.1046/j.1365-2656.2000.00422.x; BRAULT S, 1993, ECOLOGY, V74, P1444, DOI 10.2307/1940073; Bretagnolle V, 1998, BEHAVIOUR, V135, P1161, DOI 10.1163/156853998792913555; Breton AR, 2014, IBIS, V156, P35, DOI 10.1111/ibi.12100; Breton AR, 2006, ECOL MONOGR, V76, P133, DOI 10.1890/05-0704; Breton AR, 2005, AUK, V122, P773, DOI 10.1642/0004-8038(2005)122[0773:ASEFTA]2.0.CO;2; Brinkhof MWG, 1997, P ROY SOC B-BIOL SCI, V264, P291, DOI 10.1098/rspb.1997.0041; Brooke M, 1994, ALBATROSSES PETRELS; Buche BI, 2013, SEABIRD MONITO UNPUB; Burnham KP, 2002, J APPL STAT, V29, P245, DOI 10.1080/02664760120108755; Burnham KP, 1998, MODEL SELECTION INF; Caswell, 2000, MATRIX POPULATION MO; Chen LH, 2014, HYDROBIOLOGIA, V726, P179, DOI 10.1007/s10750-013-1763-7; Chu CJ, 2014, J ECOL, V102, P531, DOI 10.1111/1365-2745.12212; Clutton-Brock T. H., 1989, RED DEER HIGHLANDS; Cook ASCP, 2014, ECOL INDIC, V38, P1, DOI 10.1016/j.ecolind.2013.10.027; Coulson J.C., 2011, THE KITTIWAKE; COULSON JC, 1984, IBIS, V126, P525, DOI 10.1111/j.1474-919X.1984.tb02078.x; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Croxall J.P., 1991, Oxford Ornithology Series, P272; Croxall JP., 1987, SEABIRDS FEEDING ECO; Daunt F, 2006, BEHAV ECOL SOCIOBIOL, V59, P381, DOI 10.1007/s00265-005-0061-4; Daunt F, 2008, CAN J FISH AQUAT SCI, V65, P362, DOI 10.1139/F07-164; Dawson NM, 2011, IBIS, V153, P143, DOI 10.1111/j.1474-919X.2010.01065.x; Doxa A, 2013, ANIM CONSERV, V16, P684, DOI 10.1111/acv.12048; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Erikstad KE, 1998, ECOLOGY, V79, P1781; Espin S, 2012, MAR POLLUT BULL, V64, P2461, DOI 10.1016/j.marpolbul.2012.07.045; Finney SK, 2003, J APPL ECOL, V40, P545, DOI 10.1046/j.1365-2664.2003.00810.x; Foster S, 2012, BIODIVERSITY SEABIRD; Franklin AB, 2002, J APPL STAT, V29, P267, DOI 10.1080/02664760120108719; Frederiksen M, 2004, J APPL ECOL, V41, P1129, DOI 10.1111/j.0021-8901.2004.00966.x; Frederiksen M, 2006, J ANIM ECOL, V75, P1259, DOI 10.1111/j.1365-2656.2006.01148.x; Furness R. W., 1987, SKUAS; Furness RW, 2003, SCI MAR, V67, P33, DOI 10.3989/scimar.2003.67s233; FURNESS RW, 1981, J ZOOL, V195, P1, DOI 10.1111/j.1469-7998.1981.tb01890.x; Furness RW, 1997, ICES J MAR SCI, V54, P726, DOI 10.1006/jmsc.1997.0243; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaston A.J., 2004, SEABIRDS NATURAL HIS; HARRIS M P, 1982, Scottish Birds, V12, P11; Harris Michael P., 2012, Ringing & Migration, V27, P43; HARRIS MP, 1983, IBIS, V125, P109, DOI 10.1111/j.1474-919X.1983.tb03088.x; Harris MP, 2005, MAR ECOL PROG SER, V297, P283, DOI 10.3354/meps297283; Harris MP, 1997, J AVIAN BIOL, V28, P287, DOI 10.2307/3676941; Harris MP, 1989, 941 NCC CSD; Harris P, 2011, THE PUFFIN; Heath M, 2009, MARINE CLIMATE CHANG, P1; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Hooper T, 2014, MAR POLICY, V43, P295, DOI 10.1016/j.marpol.2013.06.011; Horswill C, 2014, J ANIM ECOL, V83, P1057, DOI 10.1111/1365-2656.12229; Hoyt E., 1981, ORCA WHALE CALLED KI, P175; Jenouvrier S, 2005, ECOLOGY, V86, P2889, DOI 10.1890/05-0514; Jenouvrier S, 2013, GLOBAL CHANGE BIOL, V19, P2036, DOI 10.1111/gcb.12195; Jones IL, 2013, IBIS, V155, P1, DOI 10.1111/ibi.12015; Jones IL, 2002, OECOLOGIA, V133, P38, DOI 10.1007/s00442-002-0991-8; Kappes PJ, 2014, BIODIVERS CONSERV, V23, P503, DOI 10.1007/s10531-013-0608-z; Le Corre M, 2008, NATURE, V451, P134, DOI 10.1038/451134a; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lescroel A, 2009, J ANIM ECOL, V78, P798, DOI 10.1111/j.1365-2656.2009.01542.x; Loison A, 2002, J APPL STAT, V29, P289, DOI 10.1080/02664760120108665; Louis M, 2014, MOL ECOL, V23, P857, DOI 10.1111/mec.12653; Maciejewski W, 2014, J THEOR BIOL, V340, P285, DOI 10.1016/j.jtbi.2013.09.032; McDonald David B., 1993, Current Ornithology, V10, P139; Mech D., 2003, WOLVES BEHAV ECOLOGY; Miles WTS, 2013, IBIS, V155, P16, DOI 10.1111/ibi.12007; Miles WTS, 2010, THESIS U GLASGOW GLA; Mitchell PI, 2004, SEABIRD POPULATIONS; MONAGHAN P, 1992, ARDEA, V80, P70; Mougeot F, 1998, J ZOOL, V244, P429, DOI 10.1017/S0952836998003136; Mougeot F, 2000, J AVIAN BIOL, V31, P376, DOI 10.1034/j.1600-048X.2000.310314.x; Mougeot F, 2000, ANIM BEHAV, V60, P647, DOI 10.1006/anbe.2000.1491; Mulder CPH, 2011, SEABIRD ISLANDS ECOL; Newson S.E., 2008, Seabird, V21, P77; Oro D, 2005, J ZOOL, V265, P421, DOI 10.1017/S0952836905006515; Oro D, 2002, ECOLOGY, V83, P2516; Oro D, 1999, OECOLOGIA, V118, P438, DOI 10.1007/s004420050746; Parsons M, 2008, ICES J MAR SCI, V65, P1520, DOI 10.1093/icesjms/fsn155; Perez-Ramirez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046418; Pfister CA, 1998, P NATL ACAD SCI USA, V95, P213, DOI 10.1073/pnas.95.1.213; Phillips RA, 1999, J APPL ECOL, V36, P218, DOI 10.1046/j.1365-2664.1999.00391.x; Phillips RA, 1999, BIRD STUDY, V46, P174, DOI 10.1080/00063659909461129; Planas M, 2012, J EXP MAR BIOL ECOL, V438, P154, DOI 10.1016/j.jembe.2012.10.003; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; R Development Core Team, 2012, R LANG ENV STAT COMP; Reid JM, 2004, J ANIM ECOL, V73, P777, DOI 10.1111/j.0021-8790.2004.00854.x; Reid JM, 2003, J ANIM ECOL, V72, P36, DOI 10.1046/j.1365-2656.2003.00673.x; Reid T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058230; Ricklefs R.E., 1973, P366; Rodway MS, 1996, BIOL CONSERV, V76, P311, DOI 10.1016/0006-3207(94)00118-9; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Sandvik H, 2005, J ANIM ECOL, V74, P817, DOI 10.1111/j.1365-2656.2005.00981.x; Sandvik H, 2008, AUK, V125, P723, DOI 10.1525/auk.2008.07059; Sandvik H, 2012, MAR ECOL PROG SER, V454, P273, DOI 10.3354/meps09558; Schwartz MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083809; Selig ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082898; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; SONERUD GA, 1992, OIKOS, V63, P223, DOI 10.2307/3545382; TAOKA M, 1989, AUK, V106, P471; van Deurs M, 2009, MAR ECOL PROG SER, V381, P249, DOI 10.3354/meps07960; Votier SC, 2004, J APPL ECOL, V41, P1117, DOI 10.1111/j.0021-8901.2004.00974.x; Votier SC, 2004, CONDOR, V106, P275, DOI 10.1650/7261; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Votier SC, 2003, POLAR BIOL, V26, P20, DOI 10.1007/s00300-002-0446-z; Votier SC, 2001, BIRD STUDY, V48, P373, DOI 10.1080/00063650109461237; Votier SC, 2007, J AVIAN BIOL, V38, P234, DOI 10.1111/j.0908-8857.2007.03893.x; Votier SC, 2006, J ORNITHOL, V147, P405, DOI 10.1007/s10336-005-0021-9; Votier SC, 2011, MAR BIOL, V158, P355, DOI 10.1007/s00227-010-1563-9; Walsh P.M., 1995, SEABIRD MONITORING H; Wanless S, 2004, MAR ECOL PROG SER, V279, P237, DOI 10.3354/meps279237; Wanless S, 2005, MAR ECOL PROG SER, V294, P1, DOI 10.3354/meps294001; Weimerskirch H, 2001, BEHAV ECOL, V12, P22, DOI 10.1093/oxfordjournals.beheco.a000374; White G. C., 2012, PROGRAM MARK VERSION; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilson JR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0053383, DOI 10.1371/JOURNAL.PONE.0053383]; Wright PJ, 1996, AQUATIC PREDATORS AND THEIR PREY, P154	120	8	11	7	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131527	10.1371/journal.pone.0131527	http://dx.doi.org/10.1371/journal.pone.0131527			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177461	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600047
J	Yang, C; Fei, YD; Qin, YL; Luo, D; Yang, SF; Kou, XY; Zi, YX; Deng, TT; Jin, M				Yang, Chao; Fei, Yuda; Qin, Yali; Luo, Dan; Yang, Shufei; Kou, Xinyun; Zi, Yingxin; Deng, Tingting; Jin, Ming			Bacterial Flora Changes in Conjunctiva of Rats with Streptozotocin-Induced Type I Diabetes	PLOS ONE			English	Article							KOCURIA-KRISTINAE; GUT MICROBIOTA	Background The microbiota of both humans and animals plays an important role in their health and the development of disease. Therefore, the bacterial flora of the conjunctiva may also be associated with some diseases. However, there are no reports on the alteration of bacterial flora in conjunctiva of diabetic rats in the literature. Therefore, we investigated the changes in bacterial flora in bulbar conjunctiva of rats with streptozotocin (STZ)-induced type I diabetes. Methods A high dose of STZ (60 mg/kg, i.p.) was injected into Sprague-Dawley (SD) rats to induce type I diabetes mellitus (T1DM). The diabetic rats were raised in the animal laboratory and at 8 months post-injection of STZ swab samples were taken from the bulbar conjunctiva for cultivation of aerobic bacteria. The bacterial isolates were identified by Gram staining and biochemical features. The identified bacteria from both diabetic and healthy rats were then compared. Results The diabetic and healthy rats had different bacterial flora present in their bulbar conjunctiva. In total, 10 and 8 bacterial species were found in the STZ and control groups, respectively, with only three species (Enterococcus faecium, Enterococcus gallinarum and Escherichia coli) shared between the two groups. Gram-positive bacteria were common in both groups and the most abundant was Enterococcus faecium. However, after the development of T1DM, the bacterial flora in the rat bulbar conjunctiva changed considerably, with a reduced complexity evident. Conclusions STZ-induced diabetes caused alterations of bacterial flora in the bulbar conjunctiva in rats, with some bacterial species disappearing and others emerging. Our results indicate that the conjunctival bacterial flora in diabetic humans should be surveyed for potential diagnostic markers or countermeasures to prevent eye infections in T1DM patients.	[Yang, Chao; Qin, Yali; Luo, Dan; Yang, Shufei; Kou, Xinyun; Zi, Yingxin; Deng, Tingting; Jin, Ming] Sino Japan Hosp, Beijing 100029, Peoples R China; [Yang, Chao] Beijing Hosp Tradit Chinese Med TCM, Beijing 100010, Peoples R China; [Fei, Yuda] China Acad Chinese Med Sci, Hosp Eye, Beijing 100040, Peoples R China	China Academy of Chinese Medical Sciences	Jin, M (corresponding author), Sino Japan Hosp, 1 Yinghua East St, Beijing 100029, Peoples R China.	jinming57@163.com		FEI, Yuda/0000-0002-9648-7911	Natural Science Foundation Committee of China [81373693]	Natural Science Foundation Committee of China(National Natural Science Foundation of China (NSFC))	This research was supported by Natural Science Foundation Committee of China (contract number 81373693). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayramoglu G, 2014, CYTOTECHNOLOGY, V66, P251, DOI 10.1007/s10616-013-9563-5; Bellenger J, 2011, DIABETES, V60, P1090, DOI 10.2337/db10-0901; Citro R, 2013, J MED MICROBIOL, V62, P932, DOI 10.1099/jmm.0.054536-0; de Goffau MC, 2014, DIABETOLOGIA, V57, P1569, DOI 10.1007/s00125-014-3274-0; Dong QF, 2011, INVEST OPHTH VIS SCI, V52, P5408, DOI 10.1167/iovs.10-6939; Ermis SS, 2004, EYE, V18, P249, DOI 10.1038/sj.eye.6700631; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Gomes AC, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-60; Jin YL, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/259368; Liu YC, 2014, J CELL MOL MED, V18, P1203, DOI 10.1111/jcmm.12267; Moore K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086570; Moreno-Indias I, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00190; Nara N, 2013, CLIN IMMUNOL, V146, P112, DOI 10.1016/j.clim.2012.12.001; Nejabat M, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.9678; NEMA HV, 1964, BRIT J OPHTHALMOL, V48, P690, DOI 10.1136/bjo.48.12.690; Okamoto T, 2008, EXP ANIM TOKYO, V57, P335, DOI 10.1538/expanim.57.335; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Reddy SC, 2013, INT J OPHTHALMOL-CHI, V6, P632, DOI 10.3980/j.issn.2222-3959.2013.05.14; Sambhav K, 2011, J MED MICROBIOL, V60, P670, DOI 10.1099/jmm.0.016675-0; Tewari R, 2013, J CLIN DIAGN RES, V7, P1692, DOI 10.7860/JCDR/2013/6077.3247; Vaarala Outi, 2012, Rev Diabet Stud, V9, P251, DOI 10.1900/RDS.2012.9.251; Verga Falzacappa C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019839; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Woo PCY, 2004, J CLIN MICROBIOL, V42, P919, DOI 10.1128/JCM.42.2.919-922.2004; Yang R, 2015, INFECT DIS T MED, V1, P16, DOI 10.11979/idtm.201501006; Zhang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05654; Zhou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061516	27	15	15	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133021	10.1371/journal.pone.0133021	http://dx.doi.org/10.1371/journal.pone.0133021			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176548	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600201
J	Hou, JX; An, XP; Song, YX; Gao, TN; Lei, Y; Cao, BY				Hou, Jinxing; An, Xiaopeng; Song, Yuxuan; Gao, Teyang; Lei, Yingnan; Cao, Binyun			Two Mutations in the Caprine MTHFR 3 ' UTR Regulated by MicroRNAs Are Associated with Milk Production Traits	PLOS ONE			English	Article							BOVINE MAMMARY-GLAND; METHYLENETETRAHYDROFOLATE REDUCTASE; EXPRESSION; GENE; IDENTIFICATION; POLYMORPHISMS; LACTATION	Background 5,10-Methylenetetrahydrofolate reductase (MTHFR) plays a central role in folate metabolism by irreversibly converting 5,10-methylenetetrahydrofolate to 5-methylenetetrahydrofolate, a predominant circulating form of folate. Folate is reportedly important for milk protein synthesis, and MTHFR may be a key regulatory point of folate metabolism for milk protein synthesis in mammary epithelial cells. Prior to this study, polymorphisms of the MTHFR gene were not associated with milk production traits from a breeding perspective. Single nucleotide polymorphisms (SNPs) at microRNA (miRNA) binding sites (miR-SNPs) can affect gene expression. This study aimed to identify the effects of miR-SNPs (g.2244A>G and g.2264A>G) in the caprine MTHFR 3'UTR on the milk production traits of dairy goats. Results Guanzhong dairy (GD, n = 325) goats were used to detect SNPs in the caprine MTHFR 3'UTR by DNA sequencing. Two novel SNPs (g.2244A>G and g.2264A>G) were identified in the said region. The homozygous haplotype A-G of the SNPs g.2244A>G and g.2264A>G was significantly associated with milk yield and milk protein levels in GD goats (P<0.05). Functional assays indicated that the MTHFR 2244 A -> G substitution could increase the binding activity of hsa-miR-1266 with the MTHFR 3'UTR. The MTHFR 2264 A -> G substitution could decrease the binding activity of hsa-miR-616 with the MTHFR 3'UTR. In addition, we observed a significant increase in the MTHFR mRNA levels of homozygous haplotype A-G carriers relative to those of homozygous haplotype G-A carriers. These results indicated that both SNPs altered the MTHFR mRNA levels. These altered levels of MTHFR mRNA may account for the association of SNPs with milk production traits. Conclusions This study is the first to report that the g.2244A>G and g.2264A>G polymorphisms were associated with milk production traits in GD goats. Further investigations should explore the underlying miRNA-mediated mechanisms that are modified by the g.2244A>G and g.2264A>G SNPs. The current study evaluated these SNPs as potential genetic markers in goats, with potential applications in breeding programs.	[Hou, Jinxing; An, Xiaopeng; Song, Yuxuan; Gao, Teyang; Lei, Yingnan; Cao, Binyun] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Cao, BY (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.	caobinyun@126.com			National Support Program of China [2011BAD28B05-3]; national sparking plan project [2013GA850003]; Science and Technology Innovation Project of Shaanxi Province [2011KTCL02-09]; Northwest AF University [2013BSJJ003]; China Postdoctoral Science Foundation [2014M560808, 2014M552498]	National Support Program of China; national sparking plan project; Science and Technology Innovation Project of Shaanxi Province; Northwest AF University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the National Support Program of China (2011BAD28B05-3), the national sparking plan project (2013GA850003), the Science and Technology Innovation Project of Shaanxi Province (2011KTCL02-09), the PhD Research Funding of Northwest A&F University (2013BSJJ003) and China Postdoctoral Science Foundation (2014M560808 and 2014M552498).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Bansal A, 2002, P NATL ACAD SCI USA, V99, P16871, DOI 10.1073/pnas.262671399; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Galio L, 2013, PHYSIOL GENOMICS, V45, P151, DOI 10.1152/physiolgenomics.00091.2012; Gao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084355; Gaysina D, 2008, AM J MED GENET B, V147B, P699, DOI 10.1002/ajmg.b.30665; Goyette P, 1998, MAMM GENOME, V9, P652, DOI 10.1007/s003359900838; Huang T, 2011, J NUTR, V141, P654, DOI 10.3945/jn.110.134353; Ji ZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049463; Lin XZ, 2013, GENE EXPRESSION, V16, P1, DOI 10.3727/105221613X13776146743262; Liu ME, 2013, ATHEROSCLEROSIS, V228, P161, DOI 10.1016/j.atherosclerosis.2013.01.036; Luo MF, 1989, ANIMAL HUSBANDRY VET, V1, P5; Menzies KK, 2009, FUNCT INTEGR GENOMIC, V9, P197, DOI 10.1007/s10142-008-0103-x; Nagaoka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065127; Senhaji N, 2013, GENE, V521, P45, DOI 10.1016/j.gene.2013.02.046; Sun XH, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-194; Trott JF, 2014, ANIM GENET, V45, P74, DOI 10.1111/age.12100; Verbraak EJC, 2011, THERIOGENOLOGY, V75, P362, DOI 10.1016/j.theriogenology.2010.09.008; Wu C, 2013, NUTR METAB CARDIOVAS, V23, P693, DOI 10.1016/j.numecd.2012.02.009; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998	26	21	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133015	10.1371/journal.pone.0133015	http://dx.doi.org/10.1371/journal.pone.0133015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186555	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700085
J	Song, ES; Ozbil, M; Zhang, TT; Sheetz, M; Lee, D; Tran, D; Li, S; Prabhakar, R; Hersh, LB; Rodgers, DW				Song, Eun Suk; Ozbil, Mehmet; Zhang, Tingting; Sheetz, Michael; Lee, David; Tran, Danny; Li, Sheng; Prabhakar, Rajeev; Hersh, Louis B.; Rodgers, David W.			An Extended Polyanion Activation Surface in Insulin Degrading Enzyme	PLOS ONE			English	Article							MASS-SPECTROMETRY; PROTEIN; EXCHANGE; RECOGNITION; SIMULATIONS; DEGRADATION; INSULYSIN; MODELS	Insulin degrading enzyme (IDE) is believed to be the major enzyme that metabolizes insulin and has been implicated in the degradation of a number of other bioactive peptides, including amyloid beta peptide (A beta), glucagon, amylin, and atrial natriuretic peptide. IDE is activated toward some substrates by both peptides and polyanions/anions, possibly representing an important control mechanism and a potential therapeutic target. A binding site for the polyanion ATP has previously been defined crystallographically, but mutagenesis studies suggest that other polyanion binding modes likely exist on the same extended surface that forms one wall of the substrate-binding chamber. Here we use a computational approach to define three potential ATP binding sites and mutagenesis and kinetic studies to confirm the relevance of these sites. Mutations were made at four positively charged residues (Arg 429, Arg 431, Arg 847, Lys 898) within the polyanion-binding region, converting them to polar or hydrophobic residues. We find that mutations in all three ATP binding sites strongly decrease the degree of activation by ATP and can lower basal activity and cooperativity. Computational analysis suggests conformational changes that result from polyanion binding as well as from mutating residues involved in polyanion binding. These findings indicate the presence of multiple polyanion binding modes and suggest the anion-binding surface plays an important conformational role in controlling IDE activity.	[Song, Eun Suk; Hersh, Louis B.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY USA; [Song, Eun Suk; Hersh, Louis B.; Rodgers, David W.] Univ Kentucky, Struct Biol Ctr, Lexington, KY USA; [Ozbil, Mehmet; Zhang, Tingting; Prabhakar, Rajeev] Univ Miami, Dept Chem, Miami, FL 33124 USA; [Sheetz, Michael] Univ Kentucky, Ctr Computat Sci, Lexington, KY USA; [Lee, David; Tran, Danny; Li, Sheng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Kentucky; University of Kentucky; University of Miami; University of Kentucky; University of California System; University of California San Diego	Prabhakar, R (corresponding author), Univ Miami, Dept Chem, Miami, FL 33124 USA.	rpr@miami.edu; lhersh@uky.edu; david.rodgers@uky.edu	Özbil, Mehmet/ABH-2905-2020; Ozbil, Mehmet/AAI-1882-2019	Özbil, Mehmet/0000-0002-1465-7674; Lee, David/0000-0001-7232-0968; Prabhakar, Rajeev/0000-0003-1137-1272	United States Department of Health and Human Services, National Institutes of Health [NS38041, DA02243, DA016176, GM110787, AI081982, GM020501, AI101436]; National Science Foundation [CHE1152846]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101436, R01AI081982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS038041, R01NS038041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002243, T32DA016176] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1152846] Funding Source: National Science Foundation	United States Department of Health and Human Services, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by United States Department of Health and Human Services, National Institutes of Health grants NS38041 (DWR); DA02243, DA016176, and GM110787 (LBH); and AI081982, GM020501, and AI101436 (SL). RP gratefully acknowledges support from the National Science Foundation (CHE1152846). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daura X, 1999, PROTEINS, V34, P269, DOI 10.1002/(SICI)1097-0134(19990215)34:3<269::AID-PROT1>3.0.CO;2-3; de Tullio MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059113; DUCKWORTH WC, 1994, J BIOL CHEM, V269, P24575; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guo Q, 2010, J MOL BIOL, V395, P430, DOI 10.1016/j.jmb.2009.10.072; HAMEL FG, 1991, DIABETES, V40, P436, DOI 10.2337/diabetes.40.4.436; Hamuro Y, 2002, J MOL BIOL, V323, P871, DOI 10.1016/S0022-2836(02)01003-3; Hersh LB, 2006, CELL MOL LIFE SCI, V63, P2432, DOI 10.1007/s00018-006-6238-9; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim YG, 2013, NAT PROTOC, V8, P1730, DOI 10.1038/nprot.2013.104; Krieger E, 2002, BIOINFORMATICS, V18, P315, DOI 10.1093/bioinformatics/18.2.315; KUO WL, 1994, J BIOL CHEM, V269, P22599; Kurochkin IV, 1998, FEBS LETT, V427, P153, DOI 10.1016/S0014-5793(98)00422-0; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; Marsh JJ, 2013, BIOCHEMISTRY-US, V52, P5491, DOI 10.1021/bi4007995; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Noinaj N, 2012, J BIOL CHEM, V287, P48, DOI 10.1074/jbc.M111.264614; Noinaj N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020864; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Rudovich N, 2009, J MOL MED, V87, P1145, DOI 10.1007/s00109-009-0540-6; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Song ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046790; Song ES, 2011, J BIOL CHEM, V286, P13852, DOI 10.1074/jbc.M110.191668; Song ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009719; Sowole MA, 2014, ANAL CHEM, V86, P6715, DOI 10.1021/ac501849n; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tundo GR, 2013, J BIOL CHEM, V288, P2281, DOI 10.1074/jbc.M112.393108; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	37	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133114	10.1371/journal.pone.0133114	http://dx.doi.org/10.1371/journal.pone.0133114			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186535	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700093
J	Song, HD; Zhu, FQ				Song, Hyun Deok; Zhu, Fangqiang			Conformational Changes in Two Inter-Helical Loops of Mhp1 Membrane Transporter	PLOS ONE			English	Article							ALTERNATING-ACCESS MECHANISM; FREE-ENERGY CALCULATIONS; MOLECULAR-MECHANISM; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; SODIUM SYMPORTER; OCCLUDED STATE; OUTWARD-OPEN; DYNAMICS; ION	Mhp1 is a bacterial secondary transporter with high-resolution crystal structures available for both the outward- and inward-facing conformations. Through molecular dynamics simulations of the ligand-free Mhp1 as well as analysis of its crystal structures, here we show that two inter-helical loops, respectively located at the extra-and intracellular ends of the "hash motif" in the protein, play important roles in the conformational transition. In the outward-and inward-facing states of the protein, the loops adopt different secondary structures, either wrapped to the end of an alpha-helix, or unwrapped to extended conformations. In equilibrium simulations of 100 ns with Mhp1 in explicit lipids and water, the loop conformations remain largely stable. In targeted molecular dynamics simulations with the protein structure driven from one state to the other, the loops exhibit resistance and only undergo abrupt changes when other parts of the protein already approach the target conformation. Free energy calculations on the isolated loops further confirm that the wrapping/unwrapping transitions are associated with substantial energetic barriers, and consist of multiple sequential steps involving the rotation of certain backbone torsion angles. Furthermore, in simulations with the loops driven from one state to the other, a large part of the protein follows the loops to the target conformation. Taken together, our simulations suggest that changes of the loop secondary structures would be among the slow degrees of freedom in the conformational transition of the entire protein. Incorporation of detailed loop structures into the reaction coordinate, therefore, should improve the convergence and relevance of the resulting conformational free energy.	[Song, Hyun Deok; Zhu, Fangqiang] Indiana Univ Purdue Univ, Dept Phys, Indianapolis, IN 46205 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Zhu, FQ (corresponding author), Indiana Univ Purdue Univ, Dept Phys, Indianapolis, IN 46205 USA.	fzhu0@iupui.edu			Grants to Enhance Interdisciplinary Research and Education, Institute for Mathematical Modeling and Computational Science, School of Science, IUPUI; Release Time for Research, IUPUI	Grants to Enhance Interdisciplinary Research and Education, Institute for Mathematical Modeling and Computational Science, School of Science, IUPUI; Release Time for Research, IUPUI	This work was supported by the following: Grants to Enhance Interdisciplinary Research and Education, Institute for Mathematical Modeling and Computational Science, School of Science, IUPUI; and Release Time for Research, IUPUI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Adelman JL, 2011, BIOPHYS J, V101, P2399, DOI 10.1016/j.bpj.2011.09.061; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Branduardi D, 2013, J CHEM THEORY COMPUT, V9, P4140, DOI 10.1021/ct400469w; Caplan DA, 2008, BIOPHYS J, V95, P4613, DOI 10.1529/biophysj.108.139741; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Forrest LR, 2013, SCIENCE, V339, P399, DOI 10.1126/science.1228465; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Fukunishi H, 2002, J CHEM PHYS, V116, P9058, DOI 10.1063/1.1472510; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karney CFF, 2007, J MOL GRAPH MODEL, V25, P595, DOI 10.1016/j.jmgm.2006.04.002; Kazmier K, 2014, P NATL ACAD SCI USA, V111, P14752, DOI 10.1073/pnas.1410431111; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Khavrutskii IV, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2363379; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Li J, 2013, P NATL ACAD SCI USA, V110, P7696, DOI 10.1073/pnas.1218986110; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maragliano L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212942; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moradi M, 2013, P NATL ACAD SCI USA, V110, P18916, DOI 10.1073/pnas.1313202110; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Noskov SY, 2008, PROTEINS, V73, P851, DOI 10.1002/prot.22108; Ovchinnikov V, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3544209; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Rosta E, 2009, J COMPUT CHEM, V30, P1634, DOI 10.1002/jcc.21312; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Simmons KJ, 2014, EMBO J, V33, P1831, DOI 10.15252/embj.201387557; Song HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068023; Suzuki S, 2006, J BACTERIOL, V188, P3329, DOI 10.1128/JB.188.9.3329-3336.2006; TANFORD C, 1983, P NATL ACAD SCI-BIOL, V80, P3701, DOI 10.1073/pnas.80.12.3701; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Weinan E, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.052301; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zdravkovic I, 2012, BBA-BIOMEMBRANES, V1818, P337, DOI 10.1016/j.bbamem.2011.10.031; Zhao CF, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003296; Zhao CF, 2012, BIOPHYS J, V103, P878, DOI 10.1016/j.bpj.2012.07.044; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhu FQ, 2012, J COMPUT CHEM, V33, P453, DOI 10.1002/jcc.21989; Zhu FQ, 2010, P NATL ACAD SCI USA, V107, P19814, DOI 10.1073/pnas.1009313107	59	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133388	10.1371/journal.pone.0133388	http://dx.doi.org/10.1371/journal.pone.0133388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186341	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700131
J	Stripp, ST; Lindenstrauss, U; Sawers, RG; Soboh, B				Stripp, Sven T.; Lindenstrauss, Ute; Sawers, R. Gary; Soboh, Basem			Identification of an Isothiocyanate on the HypEF Complex Suggests a Route for Efficient Cyanyl-Group Channeling during [NiFe]-Hydrogenase Cofactor Generation	PLOS ONE			English	Article							MATURATION PROTEINS HYPC; NIFE-HYDROGENASE; ACTIVE-SITE; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; INFRARED-SPECTRA; STRUCTURAL BASIS; ELECTRIC-FIELDS; MOLECULAR-BASIS; ISOMERIZATION	[NiFe]-hydrogenases catalyze uptake and evolution of H-2 in a wide range of microorganisms. The enzyme is characterized by an inorganic nickel/iron cofactor, the latter of which carries carbon monoxide and cyanide ligands. In vivo generation of these ligands requires a number of auxiliary proteins, the so-called Hyp family. Initially, HypF binds and activates the precursor metabolite carbamoyl phosphate. HypF catalyzes removal of phosphate and transfers the carbamate group to HypE. In an ATP-dependent condensation reaction, the C-terminal cysteinyl residue of HypE is modified to what has been interpreted as thiocyanate. This group is the direct precursor of the cyanide ligands of the [NiFe]-hydrogenase active site cofactor. We present a FT-IR analysis of HypE and HypF as isolated from E. coli. We follow the HypF-catalyzed cyanation of HypE in vitro and screen for the influence of carbamoyl phosphate and ATP. To elucidate on the differences between HypE and the HypEF complex, spectro-electrochemistry was used to map the vibrational Stark effect of naturally cyanated HypE. The IR signature of HypE could ultimately be assigned to isothiocyanate (-N=C=S) rather than thiocyanate (-S-C equivalent to N). This has important implications for cyanyl-group channeling during [NiFe]-hydrogenase cofactor generation.	[Stripp, Sven T.] Free Univ Berlin, Dept Phys, Berlin, Germany; [Lindenstrauss, Ute; Sawers, R. Gary; Soboh, Basem] Univ Halle Wittenberg, Inst Microbiol, D-06108 Halle, Germany	Free University of Berlin; Martin Luther University Halle Wittenberg	Stripp, ST (corresponding author), Free Univ Berlin, Dept Phys, Berlin, Germany.	sven.stripp@fu-berlin.de	Stripp, Sven Timo/O-9051-2019	Stripp, Sven Timo/0000-0002-8412-0258	Focus Area Nanoscale; EFRE; DFG [SA 494/3-2]	Focus Area Nanoscale; EFRE; DFG(German Research Foundation (DFG))	STS received funding from Focus Area Nanoscale (nanoscale.fu-berlin.de). RGS, BS, UL received funding from EFRE (foerderdatenbank.de) and DFG (Grant SA 494/3-2, dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataka K, 2013, BBA-BIOMEMBRANES, V1828, P2283, DOI 10.1016/j.bbamem.2013.04.026; Berggren G, 2013, NATURE, V499, P66, DOI 10.1038/nature12239; Blokesch M, 2004, EUR J BIOCHEM, V271, P3428, DOI 10.1111/j.1432-1033.2004.04280.x; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Bockris JOM, 2002, INT J HYDROGEN ENERG, V27, P731, DOI 10.1016/S0360-3199(01)00154-9; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Boxall CR, 1973, J PHOTOCHEM, V1, P363; Brewer SH, 2003, J CHEM PHYS, V119, P851, DOI 10.1063/1.1578471; Bron M, 1999, ELECTROCHIM ACTA, V45, P1121, DOI 10.1016/S0013-4686(99)00302-3; Buckingham DA, 1970, INORG CHEM, V9, P655, DOI 10.1021/ic50085a044; BUCKINGHAM DA, 1994, COORDIN CHEM REV, V135, P587, DOI 10.1016/0010-8545(94)80078-2; Burstel I, 2012, J BIOL CHEM, V287, P38845, DOI 10.1074/jbc.M112.376947; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; BURMEISTER JL, 1968, COORDIN CHEM REV, V3, P225, DOI 10.1016/S0010-8545(00)80114-9; CALDOW GL, 1958, SPECTROCHIM ACTA, V13, P212, DOI 10.1016/0371-1951(58)80079-X; CLARK GR, 1970, INORG CHEM, V9, P2754; Colthup N.B., 1990, INTRO INFRARED RAMAN; Czech I, 2011, FEBS LETT, V585, P225, DOI 10.1016/j.febslet.2010.11.052; De Lacey AL, 2000, J AM CHEM SOC, V122, P11232, DOI 10.1021/ja002441o; Esselborn J, 2013, NAT CHEM BIOL, V9, P607, DOI [10.1038/NCHEMBIO.1311, 10.1038/nchembio.1311]; FORNES V, 1978, J CHEM PHYS, V68, P4667, DOI 10.1063/1.435576; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; GUTKNECHT J, 1982, BIOCHIM BIOPHYS ACTA, V685, P233, DOI 10.1016/0005-2736(82)90062-1; HAM NS, 1960, SPECTROCHIM ACTA, V16, P279, DOI 10.1016/0371-1951(60)80091-4; Hampp N, 2000, CHEM REV, V100, P1755, DOI 10.1021/cr980072x; HIRSCHMANN RP, 1965, SPECTROCHIM ACTA, V21, P2125, DOI 10.1016/0371-1951(65)80228-4; JACKSON WG, 1987, INORG CHEM, V26, P1286, DOI 10.1021/ic00255a019; KOPUT J, 1988, J MOL SPECTROSC, V127, P51, DOI 10.1016/0022-2852(88)90007-0; LAMBERT DK, 1984, SOLID STATE COMMUN, V51, P297, DOI 10.1016/0038-1098(84)90691-4; Li CL, 1999, STRUCTURE, V7, P1155, DOI 10.1016/S0969-2126(99)80182-8; LIEBER E, 1959, SPECTROCHIM ACTA, V13, P296, DOI 10.1016/0371-1951(59)80030-8; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Ludwig M, 2009, J BIOL CHEM, V284, P2159, DOI 10.1074/jbc.M808488200; Maienschein-Cline MG, 2007, J PHYS CHEM A, V111, P10020, DOI 10.1021/jp0761158; Maroti G, 2010, INT J HYDROGEN ENERG, V35, P3358, DOI 10.1016/j.ijhydene.2009.10.059; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; MIRABELLA FM, 1985, APPL SPECTROSC REV, V21, P45, DOI 10.1080/05704928508060428; Oh K-I, 2008, J CHEM PHYS, V128; OSAWA M, 1993, APPL SPECTROSC, V47, P1497, DOI 10.1366/0003702934067478; PALMER DA, 1978, INORG CHIM ACTA, V30, P83, DOI 10.1016/S0020-1693(00)89019-2; Park ES, 1999, J PHYS CHEM B, V103, P9813, DOI 10.1021/jp992329g; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Petkun S, 2011, STRUCTURE, V19, P1773, DOI 10.1016/j.str.2011.09.023; Pierik AJ, 1998, FEBS LETT, V438, P231, DOI 10.1016/S0014-5793(98)01306-4; Rangarajan ES, 2008, J BACTERIOL, V190, P1447, DOI 10.1128/JB.01610-07; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; Rotzinger FP, 2000, INORG CHEM, V39, P944, DOI 10.1021/ic990948y; Rotzinger FP, 2005, CHEM REV, V105, P2003, DOI 10.1021/cr030715v; Shafaat HS, 2013, BBA-BIOENERGETICS, V1827, P986, DOI 10.1016/j.bbabio.2013.01.015; Shepard EM, 2011, CURR OPIN CHEM BIOL, V15, P319, DOI 10.1016/j.cbpa.2011.02.012; Shomura Y, 2007, J MOL BIOL, V372, P1045, DOI 10.1016/j.jmb.2007.07.023; Shomura Y, 2012, J BIOL CHEM, V287, P28409, DOI 10.1074/jbc.M112.387134; Shomura Y, 2011, NATURE, V479, P253, DOI 10.1038/nature10504; SMITH PAS, 1960, J AM CHEM SOC, V82, P3076, DOI 10.1021/ja01497a025; Soboh B, 2013, ENCY INORGANIC BIOIN, P1; Soboh B, 2014, BIOCHEM J, V464, P169, DOI 10.1042/BJ20140485; Soboh B, 2012, FEBS LETT, V586, P3882, DOI 10.1016/j.febslet.2012.09.019; Stripp ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107488; Stripp ST, 2013, BIOCHEMISTRY-US, V52, P3289, DOI 10.1021/bi400302v; Stripp ST, 2009, DALTON T, P9960, DOI 10.1039/b916246a; Supuran CT, 2003, MED RES REV, V23, P146, DOI 10.1002/med.10025; Suydam IT, 2006, SCIENCE, V313, P200, DOI 10.1126/science.1127159; Suydam IT, 2003, BIOCHEMISTRY-US, V42, P12050, DOI 10.1021/bi0352926; Tominaga T, 2013, P NATL ACAD SCI USA, V110, P20485, DOI 10.1073/pnas.1313620110; Tominaga T, 2012, ACTA CRYSTALLOGR F, V68, P1153, DOI 10.1107/S1744309112036421; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159; Volbeda A, 2013, STRUCTURE, V21, P184, DOI 10.1016/j.str.2012.11.010; Volbeda A, 2012, P NATL ACAD SCI USA, V109, P5305, DOI 10.1073/pnas.1119806109; Watanabe S, 2007, MOL CELL, V27, P29, DOI 10.1016/j.molcel.2007.05.039; Watanabe S, 2012, STRUCTURE, V20, P2124, DOI 10.1016/j.str.2012.09.018; Watanabe S, 2012, BIOL CHEM, V393, P1089, DOI 10.1515/hsz-2012-0197; Wierzejewska M, 2003, J PHYS CHEM A, V107, P11209, DOI 10.1021/jp030971b; Winkler M, 2013, BBA-BIOENERGETICS, V1827, P974, DOI 10.1016/j.bbabio.2013.03.004	74	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133118	10.1371/journal.pone.0133118	http://dx.doi.org/10.1371/journal.pone.0133118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186649	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700095
J	Lu, L; Ku, KM; Palma-Salgado, SP; Storm, AP; Feng, H; Juvik, JA; Nguyen, TH				Lu, Lu; Ku, Kang-Mo; Palma-Salgado, Sindy Paola; Storm, Andrew Page; Feng, Hao; Juvik, John A.; Nguyen, Thanh H.			Influence of Epicuticular Physicochemical Properties on Porcine Rotavirus Adsorption to 24 Leafy Green Vegetables and Tomatoes	PLOS ONE			English	Article							NOROVIRUS DISEASE BURDEN; HEPATITIS-A-VIRUS; INACTIVATION KINETICS; SURFACE-ROUGHNESS; ENTERIC VIRUSES; ROMAINE LETTUCE; ORGANIC-MATTER; WATER; ATTACHMENT; FOOD	Foodborne diseases are a persistent problem in the United States and worldwide. Fresh produce, especially those used as raw foods like salad vegetables, can be contaminated, causing illness. In this study, we determined the number of rotaviruses adsorbed on produce surfaces using group A porcine rotaviruses and 24 cultivars of leafy vegetables and tomato fruits. We also characterized the physicochemical properties of each produce's outermost surface layer, known as the epicuticle. The number of rotaviruses found on produce surfaces varied among cultivars. Three-dimensional crystalline wax structures on the epicuticular surfaces were found to significantly contribute to the inhibition of viral adsorption to the produce surfaces (p = 0.01). We found significant negative correlations between the number of rotaviruses adsorbed on the epicuticular surfaces and the concentrations of alkanes, fatty acids, and total waxes on the epicuticular surfaces. Partial least square model fitting results suggest that alkanes, ketones, fatty acids, alcohols, contact angle and surface roughness together can explain 60% of the variation in viral adsorption. The results suggest that various fresh produce surface properties need to be collectively considered for efficient sanitation treatments. Up to 10.8% of the originally applied rotaviruses were found on the produce surfaces after three washing treatments, suggesting a potential public health concern regarding rotavirus contamination.	[Lu, Lu; Nguyen, Thanh H.] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA; [Ku, Kang-Mo; Juvik, John A.] Univ Illinois, Dept Crop Sci, Urbana, IL USA; [Palma-Salgado, Sindy Paola; Feng, Hao] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL USA; [Storm, Andrew Page] Univ Illinois, Dept Mol & Cellular Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nguyen, TH (corresponding author), Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA.	thn@illinois.edu	nguyen, thanh/G-1792-2017	, Hao/0000-0002-1703-2194; Ku, Kang Mo/0000-0002-8588-1163; nguyen, thanh/0000-0002-5461-5233	USDA National Institute of Food and Agriculture [ILLU-000-615]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by the USDA National Institute of Food and Agriculture grant ILLU-000-615 to THN, JAJ and HF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Bargel H., 2004, EVOLUTION PLANT PHYS, P171, DOI DOI 10.1016/B978-012339552-8/50011-1; Barker SF, 2013, WATER RES, V47, P1421, DOI 10.1016/j.watres.2012.12.012; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; BOYCE RL, 1988, CAN J BOT, V66, P2599, DOI 10.1139/b88-353; Bozkurt H, 2015, INT J FOOD MICROBIOL, V193, P147, DOI 10.1016/j.ijfoodmicro.2014.10.015; Carter MJ, 2005, J APPL MICROBIOL, V98, P1354, DOI 10.1111/j.1365-2672.2005.02635.x; Cox I, 2013, DISCOVERING PARTIAL; D'Souza DH, 2006, INT J FOOD MICROBIOL, V108, P84, DOI 10.1016/j.ijfoodmicro.2005.10.024; Deboosere N, 2012, FOOD MICROBIOL, V32, P48, DOI 10.1016/j.fm.2012.04.007; Ensikat HJ, 2006, CHEM PHYS LIPIDS, V144, P45, DOI 10.1016/j.chemphyslip.2006.06.016; Eriksson L., 2006, MULTIMEGAVARIATE DAT; Esseili MA, 2012, APPL ENVIRON MICROB, V78, P6271, DOI 10.1128/AEM.01295-12; Esseili MA, 2012, APPL ENVIRON MICROB, V78, P786, DOI 10.1128/AEM.07081-11; Feikin DR, 2012, VACCINE, V30, pA52, DOI 10.1016/j.vaccine.2011.08.043; Fransisca L, 2012, J FOOD PROTECT, V75, P261, DOI 10.4315/0362-028X.JFP-11-279; Gniwotta F, 2005, PLANT PHYSIOL, V139, P519, DOI 10.1104/pp.104.053579; Gutierrez L, 2012, ENVIRON SCI TECHNOL, V46, P8705, DOI 10.1021/es301336u; Gutierrez L, 2010, ENVIRON SCI TECHNOL, V44, P4552, DOI 10.1021/es100120k; Gutierrez L, 2009, WATER RES, V43, P5198, DOI 10.1016/j.watres.2009.08.031; Hirneisen KA, 2013, PHYTOPATHOLOGY, V103, P389, DOI 10.1094/PHYTO-09-12-0231-FI; Jenks MA, 2010, HORTICULTURAL REV, P1; Jothikumar N, 2009, J VIROL METHODS, V155, P126, DOI 10.1016/j.jviromet.2008.09.025; Kiulia NM, 2010, J APPL MICROBIOL, V109, P818, DOI 10.1111/j.1365-2672.2010.04710.x; Koch K, 2008, SOFT MATTER, V4, P1943, DOI 10.1039/b804854a; Kosma DK, 2009, PLANT PHYSIOL, V151, P1918, DOI 10.1104/pp.109.141911; Kukavica-Ibrulj I, 2004, J APPL MICROBIOL, V97, P923, DOI 10.1111/j.1365-2672.2004.02366.x; Lou FF, 2011, APPL ENVIRON MICROB, V77, P8538, DOI 10.1128/AEM.06711-11; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Maffei M, 1996, BIOCHEM SYST ECOL, V24, P53, DOI 10.1016/0305-1978(95)00102-6; Maimon A, 2014, SCI TOTAL ENVIRON, V487, P20, DOI 10.1016/j.scitotenv.2014.03.133; Marshall GS, 2009, PEDIATR INFECT DIS J, V28, P355, DOI 10.1097/INF.0b013e318199494a; Mattioli MC, 2013, ENVIRON SCI TECHNOL, V47, P355, DOI 10.1021/es303878d; Mok HF, 2014, RISK ANAL, V34, P602, DOI 10.1111/risa.12178; Mok HF, 2014, WATER RES, V54, P347, DOI 10.1016/j.watres.2014.01.060; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Pathan AK, 2010, MATER TODAY, V12, P32, DOI 10.1016/S1369-7021(10)70143-7; Rhee Y, 1998, PLANT PHYSIOL, V116, P901, DOI 10.1104/pp.116.3.901; ROLSMA MD, 1994, J VIROL, V68, P258, DOI 10.1128/JVI.68.1.258-268.1994; Romero OC, 2011, ENVIRON SCI TECHNOL, V45, P10385, DOI 10.1021/es202067f; Romero-Maraccini OC, 2013, ENVIRON SCI TECHNOL, V47, P11004, DOI 10.1021/es402285u; Ruiz MC, 1996, J VIROL, V70, P4877, DOI 10.1128/JVI.70.8.4877-4883.1996; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; SCANION JT, 1985, J CHROMATOGR SCI, V23, P333, DOI 10.1093/chromsci/23.8.333; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; Symonds EM, 2014, WATER RES, V65, P257, DOI 10.1016/j.watres.2014.07.032; Trdan S., 2004, Acta Phytopathologica et Entomologica Hungarica, V39, P173, DOI 10.1556/APhyt.39.2004.1-3.17; U. S. Food and Drug Administration, 2004, PROD SAF PROD CONS 2; van Zyl WB, 2006, APPL ENVIRON MICROB, V72, P4554, DOI 10.1128/AEM.02119-05; Vega E, 2005, J FOOD PROTECT, V68, P2112, DOI 10.4315/0362-028X-68.10.2112; Vega E, 2008, J FOOD PROTECT, V71, P522, DOI 10.4315/0362-028X-71.3.522; Vogg G, 2004, J EXP BOT, V55, P1401, DOI 10.1093/jxb/erh149; Wang H, 2009, J FOOD SCI, V74, pE8, DOI 10.1111/j.1750-3841.2008.00998.x; Wei J, 2010, APPL ENVIRON MICROB, V76, P578, DOI 10.1128/AEM.02088-09; Wen M, 2009, J EXP BOT, V60, P1811, DOI 10.1093/jxb/erp061; Yuan Y., 2013, SURFACE SCI TECHNIQU, P3, DOI 10.1007/978-3-642-34243-1_1; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	57	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132841	10.1371/journal.pone.0132841	http://dx.doi.org/10.1371/journal.pone.0132841			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181904	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198200042
J	Roy, D; Kumar, V; James, J; Shihabudeen, MS; Kulshrestha, S; Goel, V; Thirumurugan, K				Roy, Debasish; Kumar, Vinod; James, Joel; Shihabudeen, Mohamed Sham; Kulshrestha, Shweta; Goel, Varun; Thirumurugan, Kavitha			Evidence that Chemical Chaperone 4-Phenylbutyric Acid Binds to Human Serum Albumin at Fatty Acid Binding Sites	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ER STRESS; HEMOGLOBIN; QUERCETIN	Endoplasmic reticulum stress elicits unfolded protein response to counteract the accumulating unfolded protein load inside a cell. The chemical chaperone, 4-Phenylbutyric acid (4-PBA) is a FDA approved drug that alleviates endoplasmic reticulum stress by assisting protein folding. It is found efficacious to augment pathological conditions like type 2 diabetes, obesity and neurodegeneration. This study explores the binding nature of 4-PBA with human serum albumin (HSA) through spectroscopic and molecular dynamics approaches, and the results show that 4-PBA has high binding specificity to Sudlow Site II (Fatty acid binding site 3, subdomain IIIA). Ligand displacement studies, RMSD stabilization profiles and MM-PBSA binding free energy calculation confirm the same. The binding constant as calculated from fluorescence spectroscopic studies was found to be k(PBA) = 2.69 x 10(5) M-1. Like long chain fatty acids, 4-PBA induces conformational changes on HSA as shown by circular dichroism, and it elicits stable binding at Sudlow Site II (fatty acid binding site 3) by forming strong hydrogen bonding and a salt bridge between domain II and III of HSA. This minimizes the fluctuation of HSA backbone as shown by limited conformational space occupancy in the principal component analysis. The overall hydrophobicity of W214 pocket (located at subdomain IIA), increases upon occupancy of 4-PBA at any FA site. Descriptors of this pocket formed by residues from other subdomains largely play a role in compensating the dynamic movement of W214.	[Roy, Debasish; Kumar, Vinod; James, Joel; Shihabudeen, Mohamed Sham; Kulshrestha, Shweta; Goel, Varun; Thirumurugan, Kavitha] VIT Univ, Ctr Biomed Res, Sch BioSci & Technol, Div Biomed Sci,Struct Biol Lab 206, Vellore 632014, Tamil Nadu, India	Vellore Institute of Technology	Thirumurugan, K (corresponding author), VIT Univ, Ctr Biomed Res, Sch BioSci & Technol, Div Biomed Sci,Struct Biol Lab 206, Vellore 632014, Tamil Nadu, India.	m.kavitha@vit.ac.in	Thirumurugan, Kavitha/B-3282-2010; James, Joel/X-8792-2019	Thirumurugan, Kavitha/0000-0002-4673-4099; Haider Ali, Mohamed Sham Shihabudeen/0000-0002-2847-8140; Kulshrestha, Shweta/0000-0001-6232-8771; Roy, Debasish/0000-0001-7516-8615	VIT University	VIT University	We thank VIT University for supporting this work. We thank Bioinformatics Resources and Applications Facility (BRAF) supercomputing facility at C-DAC (Pune and Bangalore) for providing grid facilities to carry out this work. We thank Dr. Bhaskar Mohan Murari and Prof. G. Jayaraman, VIT University for facilitating the fluorescence and CD studies.	Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; BHATTACHARYYA J, 1994, BIOCHEM PHARMACOL, V47, P2049, DOI 10.1016/0006-2952(94)90080-9; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Curry S, 1999, BBA-MOL CELL BIOL L, V1441, P131, DOI 10.1016/S1388-1981(99)00148-1; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Guizado TRC, 2012, EUR BIOPHYS J BIOPHY, V41, P1033, DOI 10.1007/s00249-012-0860-2; Domonkos C, 2013, MOL PHARMACEUT, V10, P4706, DOI 10.1021/mp400531n; DOVER GJ, 1994, BLOOD, V84, P339; Dufour C, 2005, BBA-GEN SUBJECTS, V1721, P164, DOI 10.1016/j.bbagen.2004.10.013; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; FEHSKE KJ, 1982, MOL PHARMACOL, V21, P387; Fujiwara SI, 2008, BIOPHYS J, V94, P95, DOI 10.1529/biophysj.107.111377; Fujiwara SI, 2006, PROTEINS, V64, P730, DOI 10.1002/prot.21053; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Graciani FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076849; He WY, 2006, J PHOTOCH PHOTOBIO A, V182, P158, DOI 10.1016/j.jphotochem.2006.02.004; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hess B, 2000, PHYS REV E, V62, P8438, DOI 10.1103/PhysRevE.62.8438; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Iranfar H, 2012, J PHYS CHEM B, V116, P1951, DOI 10.1021/jp210685q; KRAGHHANSEN U, 1990, DAN MED BULL, V37, P57; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Maestri NE, 1996, NEW ENGL J MED, V335, P855, DOI 10.1056/NEJM199609193351204; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pongprayoon P, 2014, J MOL GRAPH MODEL, V54, P164, DOI 10.1016/j.jmgm.2014.10.007; Sengupta B, 2003, BIOPOLYMERS, V72, P427, DOI 10.1002/bip.10489; Sengupta B, 2002, BIOCHEM BIOPH RES CO, V299, P400, DOI 10.1016/S0006-291X(02)02667-0; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Spitaleri, 2015, COMPUT PHYS COMMUN, V186, P105, DOI [10.1016/j.cpc.2014.09.010, DOI 10.1016/J.CPC.2014.09.010]; Subramanyam R, 2009, J PHOTOCH PHOTOBIO B, V94, P8, DOI 10.1016/j.jphotobiol.2008.09.002; Thumser AEA, 1998, J LIPID RES, V39, P1033; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zsila F, 2013, MOL PHARMACEUT, V10, P1668, DOI 10.1021/mp400027q	37	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133012	10.1371/journal.pone.0133012	http://dx.doi.org/10.1371/journal.pone.0133012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181488	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198200049
J	Chan, KKS; Mak, WWS				Chan, Kevin K. S.; Mak, Winnie W. S.			Attentional Bias Associated with Habitual Self-Stigma in People with Mental Illness	PLOS ONE			English	Article							INTERNALIZED STIGMA; EMOTIONAL STROOP; DEPRESSION; ANXIETY; IMPACT; INTERFERENCE; AUTOMATICITY; METAANALYSIS; SPECIFICITY; INHIBITION	As habitual self-stigma can have a tremendous negative impact on people with mental illness, it is of paramount importance to identify its risk factors. The present study aims to examine the potential contributory role of attentional bias in habitual self-stigma. People with mental illness having strong (n = 47) and weak (n = 47) habitual self-stigma completed a computerized emotional Stroop task which included stigma-related, positive, and non-affective words as stimuli. The strong habit group was found to exhibit faster color-naming of stigma-related words (compared to non-affective words), whereas the weak habit group showed no difference in the speed of response to different stimuli. These findings suggest that people with stronger habitual self-stigma may be more able to ignore the semantic meaning of stigma-related words and focus on the color-naming task. Moreover, people with stronger habitual self-stigma may have greater attentional avoidance of stigma-related material. The present study is the first to demonstrate a specific relationship between habitual self-stigma and biased processing of stigma-related information. In order to further determine the role and the nature of attentional bias in habitual self-stigma, future research should employ a broader range of experimental paradigms and measurement techniques to examine stigma-related attentional bias in people with mental illness.	[Chan, Kevin K. S.] Hong Kong Inst Educ, Dept Psychol Studies, Tai Po, Hong Kong, Peoples R China; [Chan, Kevin K. S.] Hong Kong Inst Educ, Ctr Psychosocial Hlth, Tai Po, Hong Kong, Peoples R China; [Mak, Winnie W. S.] Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China	Education University of Hong Kong (EdUHK); Education University of Hong Kong (EdUHK); Chinese University of Hong Kong	Chan, KKS (corresponding author), Hong Kong Inst Educ, Dept Psychol Studies, Tai Po, Hong Kong, Peoples R China.	kkschan@ied.edu.hk	Mak, Winnie/GNM-9841-2022	Mak, Winnie/0000-0002-9714-7847; CHAN, Ka Shing Kevin/0000-0002-9749-2755				Abramowitz JS, 2001, CLIN PSYCHOL REV, V21, P683, DOI 10.1016/S0272-7358(00)00057-X; Andersson Gerhard, 2006, Cognitive Behaviour Therapy, V35, P55, DOI 10.1080/16506070500372469; BECK AT, 1987, J ABNORM PSYCHOL, V96, P179, DOI 10.1037/0021-843X.96.3.179; Beck AT, 1997, BEHAV RES THER, V35, P49, DOI 10.1016/S0005-7967(96)00069-1; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; Chan KKS, 2014, SCHIZOPHR RES, V153, pS304, DOI 10.1016/S0920-9964(14)70860-6; Chan KKS, 2014, SCHIZOPHR RES, V153, pS282, DOI 10.1016/S0920-9964(14)70806-0; Chan KKS, 2014, QUAL LIFE RES, V23, P2559, DOI 10.1007/s11136-014-0695-7; Chan KKS, CONTENT PRO IN PRESS; Chan R. C. K., 2005, E ASIAN ARCH PSYCHIA, V15, P23; Constant EL, 2006, J CLIN EXP NEUROPSYC, V28, P790, DOI 10.1080/13803390591000990; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; Corrigan PW, 2011, PSYCHIAT RES, V189, P339, DOI 10.1016/j.psychres.2011.05.024; Corrigan PW, 2009, WORLD PSYCHIATRY, V8, P75; Corrigan PW, 2002, CLIN PSYCHOL-SCI PR, V9, P35, DOI 10.1093/clipsy/9.1.35; Dai Q, 2011, CLIN NEUROPHYSIOL, V122, P52, DOI 10.1016/j.clinph.2010.05.025; Eisen SV, 2004, MED CARE, V42, P1230, DOI 10.1097/00005650-200412000-00010; Fritzsche A, 2010, PSYCHOL MED, V40, P815, DOI 10.1017/S0033291709990948; Garner M, 2006, J ABNORM PSYCHOL, V115, P760, DOI 10.1037/0021-843X.115.4.760; Gebauer JE, 2012, J PERS SOC PSYCHOL, V103, P854, DOI 10.1037/a0029629; Hertel PT, 1997, COGNITION EMOTION, V11, P569, DOI 10.1080/026999397379890a; Kerr N, 2005, BRIT J CLIN PSYCHOL, V44, P343, DOI 10.1348/014466505X57755; Kinderman P, 2003, BRIT J CLIN PSYCHOL, V42, P1, DOI 10.1348/014466503762841977; Kyrios M, 1998, J ANXIETY DISORD, V12, P271, DOI 10.1016/S0887-6185(98)00015-2; LINK BG, 1989, AM SOCIOL REV, V54, P400, DOI 10.2307/2095613; Livingston JD, 2010, SOC SCI MED, V71, P2150, DOI 10.1016/j.socscimed.2010.09.030; Lysaker PH, 2007, SCHIZOPHRENIA BULL, V33, P192, DOI 10.1093/schbul/sbl016; Lysaker Paul H, 2010, Clin Schizophr Relat Psychoses, V4, P41, DOI 10.3371/CSRP.4.1.3; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mak WWS, 2007, SOC SCI MED, V65, P245, DOI 10.1016/j.socscimed.2007.03.015; Mak WWS, 2010, AM J ORTHOPSYCHIAT, V80, P267, DOI 10.1111/j.1939-0025.2010.01030.x; MARTIN M, 1991, BEHAV RES THER, V29, P147, DOI 10.1016/0005-7967(91)90043-3; McNeely HE, 2008, CLIN NEUROPHYSIOL, V119, P1578, DOI 10.1016/j.clinph.2008.03.031; Mogg K, 2004, COGNITION EMOTION, V18, P689, DOI 10.1080/02699930341000158; Moritz S, 2008, BEHAV RES THER, V46, P1101, DOI 10.1016/j.brat.2008.05.005; Phaf RH, 2007, J BEHAV THER EXP PSY, V38, P184, DOI 10.1016/j.jbtep.2006.10.008; Quinn DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096977; Quinn DM, 2011, SOC ISS POLICY REV, V5, P160, DOI 10.1111/j.1751-2409.2011.01029.x; Quinn DM, 2009, J PERS SOC PSYCHOL, V97, P634, DOI 10.1037/a0015815; Ritsher JB, 2004, PSYCHIAT RES, V129, P257, DOI 10.1016/j.psychres.2004.08.003; Rottenberg J, 2005, J ABNORM PSYCHOL, V114, P627, DOI 10.1037/0021-843X.114.4.627; Rusch N, 2010, J NERV MENT DIS, V198, P150, DOI 10.1097/NMD.0b013e3181cc43b5; Sigmon ST, 2007, COGNITIVE THER RES, V31, P619, DOI 10.1007/s10608-006-9029-6; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Teachman BA, 2012, CLIN PSYCHOL REV, V32, P575, DOI 10.1016/j.cpr.2012.06.004; Tsang HWH, 2010, PSYCHIAT RES, V180, P10, DOI 10.1016/j.psychres.2009.09.001; Vauth R, 2007, PSYCHIAT RES, V150, P71, DOI 10.1016/j.psychres.2006.07.005; Verplanken B, 2007, J PERS SOC PSYCHOL, V92, P526, DOI 10.1037/0022-3514.92.3.526; Verplanken B, 2014, MINDFULNESS, V5, P566, DOI 10.1007/s12671-013-0211-0; Verplanken B, 2011, PSYCHOL HEALTH, V26, P685, DOI 10.1080/08870441003763246; Watson AC, 2007, SCHIZOPHRENIA BULL, V33, P1312, DOI 10.1093/schbul/sbl076; Watson D., 1994, PANAS X MANUAL POSIT, DOI [10.17077/48vtm4t2, DOI 10.17077/48VTM4T2, DOI 10.13072/MIDSS.438]; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Yanos PT, 2008, PSYCHIAT SERV, V59, P1437, DOI 10.1176/appi.ps.59.12.1437	56	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0125545	10.1371/journal.pone.0125545	http://dx.doi.org/10.1371/journal.pone.0125545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177536	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600004
J	Larsson, H; Tegern, M; Monnier, A; Skoglund, J; Helander, C; Persson, E; Malm, C; Broman, L; Aasa, U				Larsson, Helena; Tegern, Matthias; Monnier, Andreas; Skoglund, Jorgen; Helander, Charlotte; Persson, Emelie; Malm, Christer; Broman, Lisbet; Aasa, Ulrika			Content Validity Index and Intra- and Inter-Rater Reliability of a New Muscle Strength/Endurance Test Battery for Swedish Soldiers	PLOS ONE			English	Article							PHYSICAL PERFORMANCE TESTS; BODY-MASS BIAS; LOAD-CARRIAGE; PREMATURE DISCHARGE; FITNESS; OUTCOMES; ARMY; STANDARDS; PROGRAM; GENDER	The objective of this study was to examine the content validity of commonly used muscle performance tests in military personnel and to investigate the reliability of a proposed test battery. For the content validity investigation, thirty selected tests were those described in the literature and/or commonly used in the Nordic and North Atlantic Treaty Organization (NATO) countries. Nine selected experts rated, on a four-point Likert scale, the relevance of these tests in relation to five different work tasks: lifting, carrying equipment on the body or in the hands, climbing, and digging. Thereafter, a content validity index (CVI) was calculated for each work task. The result showed excellent CVI (>= 0.78) for sixteen tests, which comprised of one or more of the military work tasks. Three of the tests; the functional lower-limb loading test (the Ranger test), dead-lift with kettlebells, and back extension, showed excellent content validity for four of the work tasks. For the development of a new muscle strength/endurance test battery, these three tests were further supplemented with two other tests, namely, the chins and side-bridge test. The inter-rater reliability was high (intraclass correlation coefficient, ICC2,1 0.99) for all five tests. The intra-rater reliability was good to high (ICC3,1 0.82-0.96) with an acceptable standard error of mean (SEM), except for the side-bridge test (SEM%>15). Thus, the final suggested test battery for a valid and reliable evaluation of soldiers' muscle performance comprised the following four tests; the Ranger test, dead-lift with kettlebells, chins, and back extension test. The criterion-related validity of the test battery should be further evaluated for soldiers exposed to varying physical workload.	[Larsson, Helena; Tegern, Matthias; Monnier, Andreas; Broman, Lisbet; Aasa, Ulrika] Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, SE-14183 Huddinge, Sweden; [Larsson, Helena; Monnier, Andreas] Swedish Armed Forces, SE-10785 Stockholm, Sweden; [Tegern, Matthias; Skoglund, Jorgen; Helander, Charlotte; Aasa, Ulrika] Umea Univ, Dept Community Med & Rehabil, SE-90187 Umea, Sweden; [Persson, Emelie; Malm, Christer] Umea Univ, Dept Surg & Perioperat Sci, SE-90887 Umea, Sweden	Karolinska Institutet; Umea University; Umea University	Larsson, H (corresponding author), Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, SE-14183 Huddinge, Sweden.	elena.larsson.2@ki.se	Malm, Christer B/O-3458-2014	Malm, Christer B/0000-0002-8436-2476; Aasa, Ulrika/0000-0002-3383-0540; Monnier, Andreas/0000-0001-8923-1670; Tegern, Matthias/0000-0001-6871-1341				ALTMAN DG, 1986, J EPIDEMIOL COMMUN H, V40, P274, DOI 10.1136/jech.40.3.274; BIERINGSORENSEN F, 1984, SPINE, V9, P106, DOI 10.1097/00007632-198403000-00002; Bilzon JLJ, 2001, OCCUP MED-OXFORD, V51, P357, DOI 10.1093/occmed/51.5.357; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown LE, 2007, STRENGTH TRAINING; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Currier D, 1990, ELEMENTS RES PHYS TH; Dean C, 2003, MODERN WARRIORS COMB; Evans K, 2007, J SCI MED SPORT, V10, P447, DOI 10.1016/j.jsams.2006.09.003; Feuerstein M, 1997, J OCCUP ENVIRON MED, V39, P68, DOI 10.1097/00043764-199701000-00013; Frohm A, 2012, SCAND J MED SCI SPOR, V22, P306, DOI 10.1111/j.1600-0838.2010.01267.x; Harman EA, 2008, MIL MED, V173, P36, DOI 10.7205/MILMED.173.1.36; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Jaenen S, 2009, 019 NATO RES TECHN G; KNAPIK J, 1989, MIL MED, V154, P326; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; Knapik JJ, 2006, MIL MED, V171, P45, DOI 10.7205/MILMED.171.1.45; Knapik JJ, 2004, INJURY PREV, V10, P37, DOI 10.1136/ip.2003.002808; Knapik JJ, 2007, MIL MED, V172, P115, DOI 10.7205/MILMED.172.2.115; Larsson H, 2009, THESIS KAROLINSKA I; Larsson H, 2006, MIL MED, V171, P1065, DOI 10.7205/MILMED.171.11.1065; Larsson H, 2012, WORK, V42, P241, DOI 10.3233/WOR-2012-1347; Larsson H, 2009, MIL MED, V174, P9, DOI 10.7205/MILMED-D-03-7407; Lexell JE, 2005, AM J PHYS MED REHAB, V84, P719, DOI 10.1097/01.phm.0000176452.17771.20; LYNN MR, 1986, NURS RES, V35, P382; Malmberg J, 2011, PHYS FITN TEST NORD; Milligan GS, 2013, EXTREME PHYSIOL MED, V2, DOI 10.1186/2046-7648-2-14; Optimizing Operational Physical Fitness, 2009, 019 NATO RES TECHN O; Pandorf Clay E, 2002, Work, V18, P179; Payne W, 2010, ERGONOMICS, V53, P858, DOI 10.1080/00140139.2010.489964; Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199; Portney L, 2000, FDN CLIN RES APPL PR, P223; Rayson M, 2000, ERGONOMICS, V43, P73, DOI 10.1080/001401300184675; Ropponen A, 2005, J ORTHOP SPORT PHYS, V35, P437, DOI 10.2519/jospt.2005.35.7.437; Sharp M, 2009, 019 NATO RES TECHN O; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Vanderburgh PM, 2008, MED SCI SPORT EXER, V40, P1538, DOI 10.1249/MSS.0b013e31817323ee; Vanderburgh PM, 2011, MIL MED, V176, P1032, DOI 10.7205/MILMED-D-11-00069; Williams AG, 2006, ERGONOMICS, V49, P661, DOI 10.1080/00140130500497447	39	37	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132185	10.1371/journal.pone.0132185	http://dx.doi.org/10.1371/journal.pone.0132185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177030	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600087
J	Panja, AS; Bandopadhyay, B; Maiti, S				Panja, Anindya Sundar; Bandopadhyay, Bidyut; Maiti, Smarajit			Protein Thermostability Is Owing to Their Preferences to Non-Polar Smaller Volume Amino Acids, Variations in Residual Physico-Chemical Properties and More Salt-Bridges	PLOS ONE			English	Article							STRUCTURAL DIFFERENCES; THERMAL-STABILITY; GENE-EXPRESSION; PEPTIDE-BONDS; PHOSPHORYLATION; DYNAMICS; PATTERNS; CIS; CONFORMATION; SUBSTITUTION	Introduction Protein thermostability is an important field for its evolutionary perspective of mesophilic versus thermophilic relationship and for its industrial/therapeutic applications. Methods Presently, a total 400 (200 thermophilic and 200 mesophilic homologue) proteins were studied utilizing several software/databases to evaluate their amino acid preferences. Randomly selected 50 homologous proteins with available PDB-structure of each group were explored for the understanding of the protein charges, isoelectric-points, hydrophilicity, hydrophobicity, tyrosine phosphorylation and salt-bridge occurrences. These 100 proteins were further probed to generate Ramachandran plot/data for the gross secondary structure prediction in and comparison between the thermophilic and mesophilic proteins. Results Present results strongly suggest that nonpolar smaller volume amino acids Ala (chi(2) = 238.54, p<0.001) and Gly (chi(2) = 73.35, p<0.001) are highly and Val moderately (chi(2) = 144.43, p<0.001) occurring in the 85% of thermophilic proteins. Phospho-regulated Tyr and redox-sensitive Cys are also moderately distributed (chi(2)similar to 20.0, p<0.01) in a larger number of thermophilic proteins. A consistent lower distribution of thermophilicity and discretely higher distribution of hydrophobicity is noticed in a large number of thermophilic versus their mesophilic protein homolog. The mean differences of isoelectric points and charges are found to be significantly less (7.11 vs. 6.39, p<0.05 and 1 vs. -0.6, p<0.01, respectively) in thermophilic proteins compared to their mesophilic counterpart. The possible sites for Tyr phosphorylation are noticed to be 25% higher (p<0.05) in thermophilic proteins. The 60% thermophiles are found with higher number of salt bridges in this study. The average percentage of salt-bridge of thermophiles is found to be higher by 20% than their mesophilic homologue. The GLU-HIS and GLU-LYS salt-bridge dyads are calculated to be significantly higher (p<0.05 and p<0.001, respectively) in thermophilic and GLU-ARG is higher in the mesophilic proteins. The Ramachandran plot/data suggest a higher abundance of the helix, left-handed helix, sheet, nonplanar peptide and lower occurrence of cis peptide, loop/turn and outlier in thermophiles. Pearson's correlation result suggests that the isoelectric points of mesophilic and thermophilic proteins are positively correlated (r = 0.93 and 0.84, respectively; p<0.001) to their corresponding charges. And their hydrophilicity is negatively associated with the corresponding hydrophobicity (r = -0.493, p<0.001 and r = -0.324, p<0.05) suggesting their reciprocal evolvement. Conclusions Present results for the first time with this large amount of datasets and multiple contributing factors suggest the greater occurrence of hydrophobicity, salt-bridges and smaller volume nonpolar residues (Gly, Ala and Val) and lesser occurrence of bulky polar residues in the thermophilic proteins. A more stoichiometric relationship amongst these factors minimized the hindrance due to side chain burial and increased compactness and secondary structural stability in thermophilic proteins.	[Panja, Anindya Sundar; Bandopadhyay, Bidyut] Vidyasagar Univ, Oriental Inst Sci & Technol, Post Grad Dept Biotechnol, Midnapore 721102, W Bengal, India; [Maiti, Smarajit] Vidyasagar Univ, Oriental Inst Sci & Technol, Post Grad Dept Biochem & Biotechnol, Cell & Mol Therapeut Lab, Midnapore 721102, W Bengal, India	Vidyasagar University; Vidyasagar University	Maiti, S (corresponding author), Vidyasagar Univ, Oriental Inst Sci & Technol, Post Grad Dept Biochem & Biotechnol, Cell & Mol Therapeut Lab, Midnapore 721102, W Bengal, India.	maitism@rediffmail.com	Panja, Anindya Sundar/AAB-2621-2020	Panja, Anindya Sundar/0000-0003-2823-9948				Arrigo AP, 1999, FREE RADICAL BIO MED, V27, P936, DOI 10.1016/S0891-5849(99)00175-6; Bakaysa DL, 1996, PROTEIN SCI, V5, P2521, DOI 10.1002/pro.5560051215; Balbach J., 2000, MECH PROTEIN FOLDING, P212; Banerjee R, 2012, J BIOL CHEM, V287, P4397, DOI 10.1074/jbc.R111.287995; Berkholz DS, 2012, P NATL ACAD SCI USA, V109, P449, DOI 10.1073/pnas.1107115108; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BROCK TD, 1969, J BACTERIOL, V98, P289, DOI 10.1128/JB.98.1.289-297.1969; Butterwick JA, 2006, PROTEIN SCI, V15, P2697, DOI 10.1110/ps.062398606; Chan CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030296; Chang CEA, 2008, P NATL ACAD SCI USA, V105, P7456, DOI 10.1073/pnas.0800452105; Das Rajdeep, 2000, Functional and Integrative Genomics, V1, P76, DOI 10.1007/s101420050009; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Edison AS, 2001, NAT STRUCT BIOL, V8, P201, DOI 10.1038/84921; Friedman R, 2004, GENETICS, V167, P1507, DOI 10.1534/genetics.104.026344; Fujiwara K, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-18; Han JDJ, 2008, CELL RES, V18, P224, DOI 10.1038/cr.2008.16; Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578; HASELMEIER R, 1995, J PHYS CHEM-US, V99, P2243, DOI 10.1021/j100008a001; HEADGORDON T, 1991, J AM CHEM SOC, V113, P5989, DOI 10.1021/ja00016a010; Ho PS, 1998, PRINCIPLES PHYS BIOC, P18; Ibrahim BS, 2004, BIOCHEM BIOPH RES CO, V325, P1082, DOI 10.1016/j.bbrc.2004.10.128; Joseph AP, 2012, AMINO ACIDS, V43, P1369, DOI 10.1007/s00726-011-1211-9; Karplus PA, 1996, PROTEIN SCI, V5, P1406, DOI 10.1002/pro.5560050719; Kawamura S, 1997, J BIOCHEM-TOKYO, V121, P448; Kaytor MD, 1999, J BIOL CHEM, V274, P37507, DOI 10.1074/jbc.274.53.37507; Kiraga J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-163; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kreil DP, 2001, NUCLEIC ACIDS RES, V29, P1608, DOI 10.1093/nar/29.7.1608; Kumar Vijay, 2014, J Amino Acids, V2014, P475839, DOI 10.1155/2014/475839; Lee NR, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-61; Liao SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-44; Lieph R, 2006, TRENDS MICROBIOL, V14, P423, DOI 10.1016/j.tim.2006.08.004; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MacArthur MW, 1996, J MOL BIOL, V264, P1180, DOI 10.1006/jmbi.1996.0705; Meruelo AD, 2012, PROTEIN SCI, V21, P1746, DOI 10.1002/pro.2157; Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406; Moreira IS, 2013, BBA-PROTEINS PROTEOM, V1834, P404, DOI 10.1016/j.bbapap.2012.07.005; Mrozek A, 2003, J MOL STRUCT, V655, P397, DOI 10.1016/S0022-2860(03)00282-5; Olson-Manning CF, 2012, NAT REV GENET, V13, P867, DOI 10.1038/nrg3322; Pack SP, 2013, APPL BIOCHEM BIOTECH, V171, P1212, DOI 10.1007/s12010-013-0195-1; Persidis A, 1998, NAT BIOTECHNOL, V16, P593, DOI 10.1038/nbt0698-593; RAMACHANDRAN GN, 1973, BIOCHIM BIOPHYS ACTA, V303, P8, DOI 10.1016/0005-2795(73)90142-6; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Sadeghi M, 2006, BIOPHYS CHEM, V119, P256, DOI 10.1016/j.bpc.2005.09.018; Sawle L, 2011, BIOPHYS J, V101, P217, DOI 10.1016/j.bpj.2011.05.059; Scandurra R, 1998, BIOCHIMIE, V80, P933, DOI 10.1016/S0300-9084(00)88890-2; Shaw KL, 2001, PROTEIN SCI, V10, P1206, DOI 10.1110/ps.440101; Shi ZS, 2006, CHEM REV, V106, P1877, DOI 10.1021/cr040433a; Singer GAC, 2003, GENE, V317, P39, DOI 10.1016/S0378-1119(03)00660-7; STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Tanner JJ, 1996, BIOCHEMISTRY-US, V35, P2597, DOI 10.1021/bi951988q; Taylor TJ, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-S1-S5; Tehei M, 2007, FEBS J, V274, P4034, DOI 10.1111/j.1742-4658.2007.05953.x; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Udgaonkar JB, 2013, ARCH BIOCHEM BIOPHYS, V531, P24, DOI 10.1016/j.abb.2012.10.003; van Bentem SD, 2008, J PROTEOME RES, V7, P2458, DOI 10.1021/pr8000173; van Bentem SD, 2009, TRENDS PLANT SCI, V14, P71, DOI 10.1016/j.tplants.2008.11.003; van den Burg B, 2003, CURR OPIN MICROBIOL, V6, P213, DOI 10.1016/S1369-5274(03)00060-2; Van den Burg B, 1998, P NATL ACAD SCI USA, V95, P2056, DOI 10.1073/pnas.95.5.2056; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Voigt CA, 2001, ADV PROTEIN CHEM, V55, P79; Warren GL, 1995, PROTEIN ENG, V8, P905, DOI 10.1093/protein/8.9.905; Yamakura F, 2006, NITRIC OXIDE-BIOL CH, V14, P152, DOI 10.1016/j.niox.2005.07.009; Yoda T, 2010, BIOPHYS J, V99, P1637, DOI 10.1016/j.bpj.2010.06.045; Yokota K, 2006, SCI TECHNOL ADV MAT, V7, P255, DOI 10.1016/j.stam.2006.03.003; Zeldovich KB, 2008, ANNU REV PHYS CHEM, V59, P105, DOI 10.1146/annurev.physchem.58.032806.104449; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104; Zhou XX, 2008, AMINO ACIDS, V34, P25, DOI 10.1007/s00726-007-0589-x; ZIMMERMAN SS, 1976, MACROMOLECULES, V9, P408, DOI 10.1021/ma60051a005	73	46	49	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131495	10.1371/journal.pone.0131495	http://dx.doi.org/10.1371/journal.pone.0131495			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177372	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600046
J	Plenge, E; Klein, SS; Niessen, WJ; Meijering, E				Plenge, Esben; Klein, Stefan S.; Niessen, Wiro J.; Meijering, Erik			Multiple Sparse Representations Classification	PLOS ONE			English	Article							IMAGE SUPERRESOLUTION; SEGMENTATION; HIPPOCAMPUS; ALGORITHM; LUMEN	Sparse representations classification (SRC) is a powerful technique for pixelwise classification of images and it is increasingly being used for a wide variety of image analysis tasks. The method uses sparse representation and learned redundant dictionaries to classify image pixels. In this empirical study we propose to further leverage the redundancy of the learned dictionaries to achieve a more accurate classifier. In conventional SRC, each image pixel is associated with a small patch surrounding it. Using these patches, a dictionary is trained for each class in a supervised fashion. Commonly, redundant/overcomplete dictionaries are trained and image patches are sparsely represented by a linear combination of only a few of the dictionary elements. Given a set of trained dictionaries, a new patch is sparse coded using each of them, and subsequently assigned to the class whose dictionary yields the minimum residual energy. We propose a generalization of this scheme. The method, which we call multiple sparse representations classification (mSRC), is based on the observation that an overcomplete, class specific dictionary is capable of generating multiple accurate and independent estimates of a patch belonging to the class. So instead of finding a single sparse representation of a patch for each dictionary, we find multiple, and the corresponding residual energies provides an enhanced statistic which is used to improve classification. We demonstrate the efficacy of mSRC for three example applications: pixelwise classification of texture images, lumen segmentation in carotid artery magnetic resonance imaging (MRI), and bifurcation point detection in carotid artery MRI. We compare our method with conventional SRC, K-nearest neighbor, and support vector machine classifiers. The results show that mSRC outperforms SRC and the other reference methods. In addition, we present an extensive evaluation of the effect of the main mSRC parameters: patch size, dictionary size, and sparsity level.	[Plenge, Esben; Klein, Stefan S.; Niessen, Wiro J.; Meijering, Erik] Erasmus Univ, Med Ctr, Biomed Imaging Grp Rotterdam, Dept Med Informat, Rotterdam, Netherlands; [Plenge, Esben; Klein, Stefan S.; Niessen, Wiro J.; Meijering, Erik] Erasmus Univ, Dept Radiol, Med Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Plenge, E (corresponding author), Technion Israel Inst Technol, Div Comp Sci, Haifa, Israel.	esben.plenge@gmail.com	Meijering, Erik/AAL-8143-2020	Klein, Stefan/0000-0003-4449-6784; Niessen, Wiro/0000-0002-5822-1995	Medical Delta (HST-Klein project); NWO, The Netherlands Organization of Scientific Research	Medical Delta (HST-Klein project); NWO, The Netherlands Organization of Scientific Research	This research was funded by Medical Delta (HST-Klein project) (EM), and by NWO, The Netherlands Organization of Scientific Research. In addition, the authors thank SURFsara (www.surfsara.nl) for the support in using the Lisa Compute Cluster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; Buades A, 2005, PROC CVPR IEEE, P60, DOI 10.1109/cvpr.2005.38; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheriyadat AM, 2014, IEEE T GEOSCI REMOTE, V52, P439, DOI 10.1109/TGRS.2013.2241444; Coupe P, 2012, NEUROIMAGE, V59, P3736, DOI 10.1016/j.neuroimage.2011.10.080; Coupe P, 2011, NEUROIMAGE, V54, P940, DOI 10.1016/j.neuroimage.2010.09.018; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; Elad M, 2010, SPARSE AND REDUNDANT REPRESENTATIONS, P3, DOI 10.1007/978-1-4419-7011-4_1; Elad M, 2009, IEEE T INFORM THEORY, V55, P4701, DOI 10.1109/TIT.2009.2027565; Gao YZ, 2012, MED PHYS, V39, P6372, DOI 10.1118/1.4754304; Guha T, 2012, IEEE T PATTERN ANAL, V34, P1576, DOI 10.1109/TPAMI.2011.253; Hameeteman K, 2013, PHYS MED BIOL, V58, P1605, DOI 10.1088/0031-9155/58/5/1605; Herredesvela J, 2005, WORKSH SIGN PROC AD, pTS1; Li ST, 2012, IEEE T BIO-MED ENG, V59, P417, DOI 10.1109/TBME.2011.2173935; Mairal J, 2008, PROC CVPR IEEE, P2415; Manjon JV, 2010, INT J BIOMED IMAGING, V2010, DOI 10.1155/2010/425891; Peyre G, 2009, J MATH IMAGING VIS, V34, P17, DOI 10.1007/s10851-008-0120-3; Plenge E, 2013, LECT NOTES COMPUT SC, V8151, P123, DOI 10.1007/978-3-642-40760-4_16; RAMIREZ I, 2010, PROC CVPR IEEE, P3501, DOI DOI 10.1109/CVPR.2010.5539964; Randen T, 1999, IEEE T PATTERN ANAL, V21, P291, DOI 10.1109/34.761261; Rousseau F, 2011, IEEE T MED IMAGING, V30, P1852, DOI 10.1109/TMI.2011.2156806; Rousseau F, 2010, MED IMAGE ANAL, V14, P594, DOI 10.1016/j.media.2010.04.005; Rubinstein R, 2010, P IEEE, V98, P1045, DOI 10.1109/JPROC.2010.2040551; Skretting K, 2006, EURASIP J APPL SIG P, DOI 10.1155/ASP/2006/52561; Tong T, 2013, NEUROIMAGE, V76, P11, DOI 10.1016/j.neuroimage.2013.02.069; Tropp JA, 2007, IEEE T INFORM THEORY, V53, P4655, DOI 10.1109/TIT.2007.909108; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; van 't Klooster R, 2012, J MAGN RESON IMAGING, V35, P156, DOI 10.1002/jmri.22809; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Yang JC, 2010, IEEE T IMAGE PROCESS, V19, P2861, DOI 10.1109/TIP.2010.2050625; Yang M, 2011, IEEE I CONF COMP VIS, P543, DOI 10.1109/ICCV.2011.6126286; Yuan C, 1999, MAGN RESON IMAGING, V17, P257, DOI 10.1016/S0730-725X(98)00162-3; ZONTAK M, 2011, PROC CVPR IEEE, P977, DOI DOI 10.1109/CVPR.2011.5995401; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	35	9	9	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131968	10.1371/journal.pone.0131968	http://dx.doi.org/10.1371/journal.pone.0131968			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177106	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600073
J	Rudqvist, N; Spetz, J; Schuler, E; Parris, TZ; Langen, B; Helou, K; Forssell-Aronsson, E				Rudqvist, Nils; Spetz, Johan; Schuler, Emil; Parris, Toshima Z.; Langen, Britta; Helou, Khalil; Forssell-Aronsson, Eva			Transcriptional Response in Mouse Thyroid Tissue after At-211 Administration: Effects of Absorbed Dose, Initial Dose-Rate and Time after Administration	PLOS ONE			English	Article							GENE-EXPRESSION; ASTATINE-211; DOSIMETRY; EXPOSURE; RADIOTHERAPY; IRRADIATION; I-125(-); ANTIBODY; I-131; MICE	Background At-211-labeled radiopharmaceuticals are potentially useful for tumor therapy. However, a limitation has been the preferential accumulation of released At-211 in the thyroid gland, which is a critical organ for such therapy. The aim of this study was to determine the effect of absorbed dose, dose-rate, and time after At-211 exposure on genome-wide transcriptional expression in mouse thyroid gland. Methods BALB/c mice were i.v. injected with 1.7, 7.5 or 100 kBq At-211. Animals injected with 1.7 kBq were killed after 1, 6, or 168 h with mean thyroid absorbed doses of 0.023, 0.32, and 1.8 Gy, respectively. Animals injected with 7.5 and 100 kBq were killed after 6 and 1 h, respectively; mean thyroid absorbed dose was 1.4 Gy. Total RNA was extracted from pooled thyroids and the Illumina RNA microarray platform was used to determine mRNA levels. Differentially expressed transcripts and enriched GO terms were determined with adjusted p-value <0.01 and fold change >1.5, and p-value <0.05, respectively. Results In total, 1232 differentially expressed transcripts were detected after At-211 administration, demonstrating a profound effect on gene regulation. The number of regulated transcripts increased with higher initial dose-rate/absorbed dose at 1 or 6 h. However, the number of regulated transcripts decreased with mean absorbed dose/time after 1.7 kBq At-211 administration. Furthermore, similar regulation profiles were seen for groups administered 1.7 kBq. Interestingly, few previously proposed radiation responsive genes were detected in the present study. Regulation of immunological processes were prevalent at 1, 6, and 168 h after 1.7 kBq administration (0.023, 0.32, 1.8 Gy).	[Rudqvist, Nils; Spetz, Johan; Schuler, Emil; Langen, Britta; Forssell-Aronsson, Eva] Univ Gothenburg, Inst Clin Sci, Dept Radiat Phys, Sahlgrenska Canc Ctr,Sahlgrenska Acad, Gothenburg, Sweden; [Parris, Toshima Z.; Helou, Khalil] Univ Gothenburg, Inst Clin Sci, Dept Oncol, Sahlgrenska Canc Ctr,Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Rudqvist, N (corresponding author), Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA.	nils.rudqvist@radfys.gu.se	Spetz, Johan/P-1662-2017; Parris, Toshima/Q-5427-2018	Spetz, Johan/0000-0002-5216-9786; Parris, Toshima/0000-0003-0834-5540; Forssell-Aronsson, Eva/0000-0002-7558-4368; Langen, Britta/0000-0002-3713-6169; Rudqvist, Nils/0000-0002-9720-3124	European Commission FP7 Collaborative Project TARCC [HEALTH-F2-2007-201962]; Swedish Research Council [21073]; Swedish Cancer Society [3427]; BioCARE - a National Strategic Research Program at the University of Gothenburg; Swedish Radiation Safety Authority; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital Research Funds; Wilhelm and Martina Lundgren foundation; Assar Gabrielsson Cancer Research Foundation	European Commission FP7 Collaborative Project TARCC; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); BioCARE - a National Strategic Research Program at the University of Gothenburg; Swedish Radiation Safety Authority; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital Research Funds; Wilhelm and Martina Lundgren foundation; Assar Gabrielsson Cancer Research Foundation	This study was supported by grants from the European Commission FP7 Collaborative Project TARCC HEALTH-F2-2007-201962, the Swedish Research Council (grant no. 21073), the Swedish Cancer Society (grant no. 3427), BioCARE - a National Strategic Research Program at the University of Gothenburg, the Swedish Radiation Safety Authority, the King Gustav V Jubilee Clinic Cancer Research Foundation, the Sahlgrenska University Hospital Research Funds, the Wilhelm and Martina Lundgren foundation, and the Assar Gabrielsson Cancer Research Foundation. EFA received all funding except from the Wilhelm and Martina Lundgren foundation and the Assar Gabrielsson Cancer Research Foundation of which NR was the receiver. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend M, 2013, BR J CANC; Amundson SA, 2001, RADIAT PROT DOSIM, V97, P11, DOI 10.1093/oxfordjournals.rpd.a006632; Amundson SA, 2008, RADIAT ENVIRON BIOPH, V47, P25, DOI 10.1007/s00411-007-0140-1; Andersson H, 2009, J NUCL MED, V50, P1153, DOI 10.2967/jnumed.109.062604; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Bolch WE, 2009, J NUCL MED, V50, P477, DOI 10.2967/jnumed.108.056036; BROWN I, 1986, APPL RADIAT ISOTOPES, V37, P789, DOI 10.1016/0883-2889(86)90273-X; Chaudhry MA, 2008, J BIOMED SCI, V15, P557, DOI 10.1007/s11373-008-9253-z; Filiano AN, 2011, RADIAT RES, V176, P49, DOI 10.1667/RR2419.1; GARG PK, 1990, CANCER RES, V50, P3514; Hauck ML, 1998, BRIT J CANCER, V77, P753, DOI 10.1038/bjc.1998.123; ICRU, 1984, ICRU REPORT 37; Jodal L, 2009, ACTA ONCOL, V48, P308, DOI 10.1080/02841860802245163; Josefsson A, 2014, THESIS; Josefsson A, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-29; LANCE GN, 1967, COMPUT J, V10, P271, DOI 10.1093/comjnl/10.3.271; Langen B, 2013, J NUCL MED, V54, P990, DOI 10.2967/jnumed.112.114462; Lindegren S, 2001, APPL RADIAT ISOTOPES, V55, P157, DOI 10.1016/S0969-8043(01)00044-6; Lindencrona U, 2001, NUCL MED BIOL, V28, P41, DOI 10.1016/S0969-8051(00)00179-7; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Rudqvist N, 2014, NUCLEAR MEDICINE AND; Rudqvist N., 2015, THESIS; Rudqvist N, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-32; Saal LH, 2002, GENOME BIOL, V3; Schuler E, 2014, NUCL MED BIOL, V41, P825, DOI 10.1016/j.nucmedbio.2014.07.010; Schuler E, 2014, NUCL MED BIOL, V41, P238, DOI 10.1016/j.nucmedbio.2013.12.001; Schuler E, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-29; Snyder AR, 2004, CANCER METAST REV, V23, P259, DOI 10.1023/B:CANC.0000031765.17886.fa; Spetz J, 2013, CANCER BIOTHER RADIO, V28, P657, DOI 10.1089/cbr.2013.1483; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Weber D. A., 1989, MIRD RADIONUCLIDE DA; Zalutsky MR, 2007, NUCL MED BIOL, V34, P779, DOI 10.1016/j.nucmedbio.2007.03.007	32	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131686	10.1371/journal.pone.0131686	http://dx.doi.org/10.1371/journal.pone.0131686			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177204	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600059
J	Ssengooba, W; Cobelens, FG; Nakiyingi, L; Mboowa, G; Armstrong, DT; Manabe, YC; Joloba, ML; de Jong, BC				Ssengooba, Willy; Cobelens, Frank G.; Nakiyingi, Lydia; Mboowa, Gerald; Armstrong, Derek T.; Manabe, Yukari C.; Joloba, Moses L.; de Jong, Bouke C.			High Genotypic Discordance of Concurrent Mycobacterium tuberculosis Isolates from Sputum and Blood of HIV-Infected Individuals	PLOS ONE			English	Article							EXTRAPULMONARY TUBERCULOSIS; PULMONARY TUBERCULOSIS; MULTIDRUG-RESISTANT; GENETIC DIVERSITY; MULTIPLE STRAINS; MIRU-VNTRPLUS; RABBIT MODEL; IDENTIFICATION; DISEASE; AFRICA	Background Among HIV-infected individuals with CD4 less than 200 cells/mm(3), tuberculosis often has an atypical presentation, is more likely to be disseminated and is diagnostically challenging. We sought to understand the genotypic discordance of concurrent sputum and blood M. tuberculosis (MTB) isolates from HIV-infected individuals. Methods From a prospective diagnostic accuracy study with 182 HIV-infected culture-positive TB adults, isolates were obtained from 51 of 66 participants who were MTB culture-positive by both sputum and blood. Isolates were subjected to susceptibility testing to 1st line drugs, spoligotyping and 24 locus-MIRU-VNTR. Results The median age of the participants was 31 (IQR; 27-38) years and 51% were male. The median CD4 count was 29 (IQR; 10-84) cells/mm(3) with 20% taking ART; 8.0% were previously treated for TB, and 63% were AFB smear-negative. The isolates belonged to two of the main global MTB-lineages; East-African-Indian (L3) 17 (16.7%) and Euro-American (L4) 85 (83.3%). We identified 26 (51.0%) participants with discordant MTB-genotypes between sputum and blood, including two patients with evidence of mixed infection in either compartment. Having discordant MTB-genotypes was not predicted by the MTB-lineage in either blood or sputum, CD4 cell count, or any other clinical characteristic. Conclusions There is a high genotypic discordance among M. tuberculosis concurrently isolated from sputum and blood of HIV-infected individuals. These findings suggest that infection with more than one strain of M. tuberculosis occurs in at least half of patients with advanced HIV infection.	[Ssengooba, Willy; Mboowa, Gerald; Joloba, Moses L.] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Ssengooba, Willy; Cobelens, Frank G.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Ssengooba, Willy; Cobelens, Frank G.] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Ssengooba, Willy; de Jong, Bouke C.] Inst Trop Med, Unit Mycobacteriol, B-2000 Antwerp, Belgium; [Cobelens, Frank G.] KNCV TB Fdn, The Hague, Netherlands; [Nakiyingi, Lydia; Manabe, Yukari C.; Joloba, Moses L.] Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda; [Armstrong, Derek T.; Manabe, Yukari C.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [de Jong, Bouke C.] NYU, Div Infect Dis, New York, NY USA	Makerere University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Institute of Tropical Medicine (ITM); KNCV Tuberculosis Foundation; Makerere University; Johns Hopkins University; New York University	de Jong, BC (corresponding author), Inst Trop Med, Unit Mycobacteriol, B-2000 Antwerp, Belgium.	bdejong@itg.be	Ssengooba, Willy/AAG-1202-2020; Ssengooba, Willy/ABE-2168-2020; de Jong, Bouke/A-3636-2013; Nakiyingi, Lydia/ABG-7669-2020; Mboowa, Gerald/K-9976-2018	Ssengooba, Willy/0000-0002-1643-110X; Ssengooba, Willy/0000-0002-1643-110X; de Jong, Bouke/0000-0002-1017-4675; Nakiyingi, Lydia/0000-0001-7263-3198; Mboowa, Gerald/0000-0001-8445-9414; Joloba, Moses/0000-0002-0334-9983; Cobelens, Frank/0000-0002-4367-1133	Erasmus Mundus Joint Doctorate Program of the European Union; European Research Council-INTERRUPTB starting grant [311725]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Erasmus Mundus Joint Doctorate Program of the European Union; European Research Council-INTERRUPTB starting grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported with financial support from the Erasmus Mundus Joint Doctorate Program of the European Union through a training grant to WS and the European Research Council-INTERRUPTB starting grant (nr. 311725) to BdJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LV, 2012, J CLIN MICROBIOL, V50, P2645, DOI 10.1128/JCM.00624-12; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Aminian M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/398484; Andrade MKN, 2009, BRAZ J MED BIOL RES, V42, P433, DOI 10.1590/S0100-879X2009000500006; Asiimwe BB, 2008, INT J TUBERC LUNG D, V12, P386; Barrios-Payan J, 2012, J INFECT DIS, V206, P1194, DOI 10.1093/infdis/jis381; Behr MA, 2004, AM J RESP CRIT CARE, V169, P554, DOI 10.1164/rccm.2401001; Behr MA, 2014, LANCET INFECT DIS, V14, P250, DOI 10.1016/S1473-3099(13)70253-6; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Crump JA, 2012, CLIN INFECT DIS, V55, P242, DOI 10.1093/cid/cis409; Das S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-404; Dickman KR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-349; Gomes T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074517; Harries AD, 2001, LANCET, V357, P1519, DOI 10.1016/S0140-6736(00)04639-0; Heysell SK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-344; Jacob ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070305; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lari N, 2009, CLIN MICROBIOL INFEC, V15, P538, DOI 10.1111/j.1469-0691.2009.02712.x; Leeds IL, 2012, CLIN INFECT DIS, V55, P75, DOI 10.1093/cid/cis303; Lukoye D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070763; Manabe YC, 2003, INFECT IMMUN, V71, P6004, DOI 10.1128/IAI.71.10.6004-6011.2003; Manabe YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101459; Martin A, 2010, TUBERCULOSIS, V90, P201, DOI 10.1016/j.tube.2010.03.012; Mudenda V, 2012, J INFECT DIS, V205, pS340, DOI 10.1093/infdis/jir859; Muhumuza J, 2006, INT J TUBERC LUNG D, V10, P1262; Nakiyingi L, 2014, JAIDS-J ACQ IMM DEF, V66, P270, DOI 10.1097/QAI.0000000000000151; Niemann S, 2000, EMERG INFECT DIS, V6, P548, DOI 10.3201/eid0605.000518; Pando RH, 2010, TUBERCULOSIS, V90, P268, DOI 10.1016/j.tube.2010.05.002; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; Scott LE, 2014, J CLIN MICROBIOL, V52, P1818, DOI 10.1128/JCM.03553-13; Shin SS, 2015, J INFECT DIS, V211, P347, DOI 10.1093/infdis/jiu421; Srilohasin P, 2014, J CLIN MICROBIOL, V52, P4267, DOI 10.1128/JCM.01467-14; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; Uchiya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071831; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; von Reyn CF, 2011, INT J TUBERC LUNG D, V15, P1087, DOI 10.5588/ijtld.10.0517; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organization, 2013, TUB DIAGN XP MTB RIF; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Zetola NM, 2014, J CLIN MICROBIOL, V52, P2422, DOI 10.1128/JCM.02489-13; Zetola NM, 2014, J INFECT DIS, V209, P1754, DOI 10.1093/infdis/jiu040	45	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132581	10.1371/journal.pone.0132581	http://dx.doi.org/10.1371/journal.pone.0132581			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176604	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600127
J	Valente, M; Denis, J; Grenier, N; Arvers, P; Foucher, B; Desangles, F; Martigne, P; Chaussard, H; Drouet, M; Abend, M; Herodin, F				Valente, Marco; Denis, Josiane; Grenier, Nancy; Arvers, Philippe; Foucher, Barbara; Desangles, Francois; Martigne, Patrick; Chaussard, Herve; Drouet, Michel; Abend, Michael; Herodin, Francis			Revisiting Biomarkers of Total-Body and Partial-Body Exposure in a Baboon Model of Irradiation	PLOS ONE			English	Article							RADIATION MODEL; DOSIMETRY; PLASMA; DAMAGE	In case of a mass casualty radiation event, there is a need to distinguish total-body irradiation (TBI) and partial-body irradiation (PBI) to concentrate overwhelmed medical resources to the individuals that would develop an acute radiation syndrome (ARS) and need hematologic support (i.e., mostly TBI victims). To improve the identification and medical care of TBI versus PBI individuals, reliable biomarkers of exposure could be very useful. To investigate this issue, pairs of baboons (n = 18) were exposed to different situations of TBI and PBI corresponding to an equivalent of either 5 Gy Co-60 gamma irradiation (5 Gy TBI; 7.5 Gy left hemibody/2.5 right hemibody TBI; 5.55 Gy 90% PBI; 6.25 Gy 80% PBI; 10 Gy 50% PBI, 15 Gy 30% PBI) or 2.5 Gy (2.5 Gy TBI; 5 Gy 50% PBI). More than fifty parameters were evaluated before and after irradiation at several time points up to 200 days. A partial least square discriminant analysis showed a good distinction of TBI from PBI situations that were equivalent to 5 Gy. Furthermore, all the animals were pooled in two groups, TBI (n = 6) and PBI (n = 12), for comparison using a logistic regression and a non parametric statistical test. Nine plasmatic biochemical markers and most of hematological parameters turned out to discriminate between TBI and PBI animals during the prodromal phase and the manifest illness phase. The most significant biomarkers were aspartate aminotransferase, creatine kinase, lactico dehydrogenase, urea, Flt3-ligand, iron, C-reactive protein, absolute neutrophil count and neutrophil-to-lymphocyte ratio for the early period, and Flt3-ligand, iron, platelet count, hemoglobin, monocyte count, absolute neutrophil count and neutrophil-tolymphocyte ratio for the ARS phase. These results suggest that heterogeneity could be distinguished within a range of 2.5 to 5 Gy TBI.	[Valente, Marco; Denis, Josiane; Grenier, Nancy; Arvers, Philippe; Desangles, Francois; Martigne, Patrick; Chaussard, Herve; Drouet, Michel; Herodin, Francis] IRBA, Dept Effets Biol Rayonnements EBR, Bretigny Sur Orge, France; [Foucher, Barbara] Hop Instruct Armees Desgenettes, Lab Serv, Lyon, France; [Abend, Michael] Bundeswehr Inst Radiobiol, Munich, Germany		Valente, M (corresponding author), IRBA, Dept Effets Biol Rayonnements EBR, Bretigny Sur Orge, France.	marco.valente@live.fr	Valente, Marco/A-8833-2018	FOUCHER, Barbara/0000-0002-2634-2098	French Ministry of Defense	French Ministry of Defense	Financial support was provided by the French Ministry of Defense.	Bertho JM, 2001, INT J RADIAT BIOL, V77, P703, DOI 10.1080/09553000110043711; Blakely WF, 2014, RADIAT PROT DOSIM, V159, P46, DOI 10.1093/rpd/ncu127; Blakely WF, 2010, HEALTH PHYS, V98, P153, DOI 10.1097/HP.0b013e3181b0306d; CHAUDHURI JP, 1979, ACTA RADIOL ONCOL, V18, P155, DOI 10.3109/02841867909128202; Deperas J, 2007, RADIAT PROT DOSIM, V124, P115, DOI 10.1093/rpd/ncm137; Dolphin G. W., 1969, BIOL DOSIMETRY PARTI, P215; Friesecke I, 2001, BRIT J RADIOL, V74, P121, DOI 10.1259/bjr.74.878.740121; Herodin F, 2005, EXP HEMATOL, V33, P1071, DOI 10.1016/j.exphem.2005.04.007; Herodin F, 2014, HEALTH PHYS, V106, P750, DOI 10.1097/HP.0000000000000059; Herodin F, 2012, HEALTH PHYS, V103, P143, DOI 10.1097/HP.0b013e3182475e54; Huchet A, 2003, INT J RADIAT ONCOL, V57, P508, DOI 10.1016/S0360-3016(03)00584-4; Norol F, 2000, BRIT J HAEMATOL, V109, P162, DOI 10.1046/j.1365-2141.2000.01995.x; Ossetrova NI, 2011, RADIAT MEAS, V46, P1019, DOI 10.1016/j.radmeas.2011.05.021; Ossetrova NI, 2009, INT J RADIAT BIOL, V85, P837, DOI 10.3109/09553000903154799; Palma Carlo-Rojas, 2009, TMT HDB TRIAGE MONIT; Prasanna Pataje G S, 2010, Radiat Res, V173, P245, DOI 10.1667/RR1993.1; Prasanna PGS, 2010, HEALTH PHYS, V98, P244, DOI 10.1097/01.HP.0000348020.14969.4; Trott KR, 2012, RADIOTHER ONCOL, V105, P79, DOI 10.1016/j.radonc.2012.05.008	18	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132194	10.1371/journal.pone.0132194	http://dx.doi.org/10.1371/journal.pone.0132194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177207	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600089
J	Alberti, L; Losi, L; Leyvraz, S; Benhattar, J				Alberti, Loredana; Losi, Lorena; Leyvraz, Serge; Benhattar, Jean			Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells	PLOS ONE			English	Article							TESTIS ANTIGEN BORIS; TUMOR-INITIATING CELLS; HEPATOCELLULAR-CARCINOMA; INDUCED APOPTOSIS; IMPRINTED SITES; SIDE POPULATION; IN-VITRO; TELOMERASE; IDENTIFICATION; CTCF	Cancer stem cells are cancer cells characterized by stem cell properties and represent a small population of tumor cells that drives tumor development, progression, metastasis and drug resistance. To date, the molecular mechanisms that generate and regulate cancer stem cells are not well defined. BORIS (Brother of Regulator of Imprinted Sites) or CTCFL (CTCF-like) is a DNA-binding protein that is expressed in normal tissues only in germ cells and is re-activated in tumors. Recent evidences have highlighted the correlation of BORIS/CTCFL expression with poor overall survival of different cancer patients. We have previously shown an association of BORIS-expressing cells with stemness gene expression in embryonic cancer cells. Here, we studied the role of BORIS in epithelial tumor cells. Using BORIS-molecular beacon that was already validated, we were able to show the presence of BORIS mRNA in cancer stem cell-enriched populations (side population and spheres) of cervical, colon and breast tumor cells. BORIS silencing studies showed a decrease of sphere formation capacity in breast and colon tumor cells. Importantly, BORIS-silencing led to down-regulation of hTERT, stem cell (NANOG, OCT4, SOX2 and BMI1) and cancer stem cell markers (ABCG2, CD44 and ALDH1) genes. Conversely, BORIS-induction led to up-regulation of the same genes. These phenotypes were observed in cervical, colon and invasive breast tumor cells. However, a completely different behavior was observed in the non-invasive breast tumor cells (MCF7). Indeed, these cells acquired an epithelial mesenchymal transition phenotype after BORIS silencing. Our results demonstrate that BORIS is associated with cancer stem cell-enriched populations of several epithelial tumor cells and the different phenotypes depend on the origin of tumor cells.	[Alberti, Loredana; Benhattar, Jean] Univ Lausanne Hosp, Inst Pathol, Lausanne, Switzerland; [Losi, Lorena] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Leyvraz, Serge] Univ Lausanne Hosp, Dept Oncol, Lausanne, Switzerland; [Benhattar, Jean] Biopath Lab, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universita di Modena e Reggio Emilia; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Benhattar, J (corresponding author), Univ Lausanne Hosp, Inst Pathol, Lausanne, Switzerland.	jean.benhattar@gmail.com	Losi, Lorena/B-2583-2012	Losi, Lorena/0000-0002-8483-3936	Swiss National Science Foundation [31003A-113505]; Emma Muschamp Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Emma Muschamp Foundation	Financial support was given by the Swiss National Science Foundation (31003A-113505) and Emma Muschamp Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors (JB) is employed by a molecular pathology laboratory (Biopath Lab). Biopath Lab provided support in the form of salaries, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alberti L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109921; Bollmann FM, 2008, BIOESSAYS, V30, P728, DOI 10.1002/bies.20793; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cheema Z, 2014, PROSTATE, V74, P164, DOI 10.1002/pros.22738; Chen KF, 2013, GENET TEST MOL BIOMA, V17, P160, DOI 10.1089/gtmb.2012.0242; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dougherty CJ, 2008, BIOCHEM BIOPH RES CO, V370, P109, DOI 10.1016/j.bbrc.2008.03.040; Dudognon C, 2004, ONCOGENE, V23, P7469, DOI 10.1038/sj.onc.1208029; Gaykalova D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040389; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kang HJ, 2004, J NEUROSCI, V24, P1280, DOI 10.1523/JNEUROSCI.4082-03.2004; Katayama R, 2009, CANCER SCI, V100, P2060, DOI 10.1111/j.1349-7006.2009.01288.x; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu Z, 2013, ONCOGENE, V32, P4203, DOI 10.1038/onc.2012.441; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Luiten RM, 2003, BLOOD, V101, P4512, DOI 10.1182/blood-2002-07-2018; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Muller T, 2002, EXP CELL RES, V280, P119, DOI 10.1006/excr.2002.5630; Okabayashi K, 2012, CANCER SCI, V103, P1617, DOI 10.1111/j.1349-7006.2012.02355.x; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; PUCK TT, 1956, J EXP MED, V103, P653, DOI 10.1084/jem.103.5.653; Pugacheva EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013872; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Renaud S, 2011, NUCLEIC ACIDS RES, V39, P862, DOI 10.1093/nar/gkq827; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rosa-Garrido M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039371; Sargent D, 2009, J CLIN ONCOL, V27, P872, DOI 10.1200/JCO.2008.19.5362; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Schatton T, 2009, BIOESSAYS, V31, P1038, DOI 10.1002/bies.200900058; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Tiffen JC, 2013, INT J CANCER, V133, P1603, DOI 10.1002/ijc.28184; Woloszynska-Read A, 2011, CLIN CANCER RES, V17, P2170, DOI 10.1158/1078-0432.CCR-10-2315; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	48	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132977	10.1371/journal.pone.0132977	http://dx.doi.org/10.1371/journal.pone.0132977			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185996	Green Submitted, gold, Green Published			2022-12-27	WOS:000358198700081
J	Li, JT; Zhong, BY; Xu, HH; Qiao, SY; Wang, G; Huang, J; Fan, HZ; Zhao, HC				Li, Jing-Tao; Zhong, Bao-Yuan; Xu, Hui-Hui; Qiao, Sheng-Yan; Wang, Gui; Huang, Jing; Fan, Hui-Zhen; Zhao, Hong-Chuan			Associations between NBS1 Polymorphisms and Colorectal Cancer in Chinese Population	PLOS ONE			English	Article							NIJMEGEN-BREAKAGE-SYNDROME; DOUBLE-STRAND BREAKS; SINGLE-NUCLEOTIDE POLYMORPHISMS; DNA-REPAIR GENES; LUNG-CANCER; RISK; SURVIVAL; DAMAGE; RADIOTHERAPY; RECURRENCE	As the central protein of the double strand breaks (DSB)-induced DNA repair pathway, NBS1 participates in detecting the DSBs and plays an essential role in maintaining genomic stability. Single nucleotide polymorphisms (SNPs) in NBS1 gene were commonly tested that associated with the susceptibility to multiple cancers, but the results remained controversial. Thus, we conducted two independent hospital-based case-control studies comprising 1,072 colorectal cancer patients and 1,263 controls to evaluate the association between four NBS1 SNPs and colorectal cancer risk. The result showed that rs2735383C/G polymorphism in the 3'-untranslated region (UTR) of NBS1 was significantly associated with risk of colorectal cancer using logistic regression (P<10(-4)). Furthermore, we observed that rs2735383CC genotype was associated with substantially increased risk of colorectal cancer (odds ratio=1.55, 95% confidence interval=1.27-1.94), compared with the rs2735383GC+GG genotypes. Further functional experiments demonstrated that the rs2735383C allele in the NBS1 disrupted the binding affinity of has-miR-509-5p to the NBS1 3'-UTR in colorectal cancer cells, affecting the NBS1 transcriptional activity and expression level. In conclusion, current evidence suggests that the rs2735383C/G polymorphism might contribute to the risk for colorectal cancer.	[Li, Jing-Tao; Zhao, Hong-Chuan] China Japan Friendship Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Zhong, Bao-Yuan] First Affiliated Hosp, Gannan Med Coll, Dept Gen Surg, Ganzhou, Peoples R China; [Xu, Hui-Hui; Qiao, Sheng-Yan; Wang, Gui; Huang, Jing] China Japan Friendship Hosp, Inst Clin Med, Beijing, Peoples R China; [Fan, Hui-Zhen] Peoples Hosp Yichun City, Dept Gastroenterol, Yichun, Peoples R China	China-Japan Friendship Hospital; Gannan Medical University; China-Japan Friendship Hospital	Fan, HZ (corresponding author), Peoples Hosp Yichun City, Dept Gastroenterol, Yichun, Peoples R China.	fhz9205@163.com; zhaohongchuan2000@163.com			National High Technology Research and Development Program of China (863 Program) [2014AA020801]; International Science & Technology Cooperation Program of China [2013DFA31510]; Research Fund of Beijing Municipal Science & Technology Commission [Z111107067311021]; National Natural Science Foundation of China [81360606]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); International Science & Technology Cooperation Program of China; Research Fund of Beijing Municipal Science & Technology Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Dr. Hong-Chuan Zhao received funds from the National High Technology Research and Development Program of China (863 Program) (No. 2014AA020801), International Science & Technology Cooperation Program of China (No. 2013DFA31510) and the Research Fund of Beijing Municipal Science & Technology Commission (No. Z111107067311021); Dr. Hui-Zhen Fan was supported by the National Natural Science Foundation of China (No. 81360606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Canbay E, 2011, CURR MED RES OPIN, V27, P1295, DOI 10.1185/03007995.2011.573544; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Choudhury A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-69; Du HN, 2014, SCI REP-UK, V4, DOI 10.1038/srep06700; Fan Li-hui, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P213; Forsti A, 2004, ONCOL REP, V11, P917; Gao P, 2013, MUTAGENESIS, V28, P683, DOI 10.1093/mutage/get048; Han JL, 2009, BREAST CANCER RES TR, V115, P613, DOI 10.1007/s10549-008-0089-z; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Iijima K, 2004, CHROMOSOMA, V113, P53, DOI 10.1007/s00412-004-0298-0; Jelonek K, 2010, J APPL GENET, V51, P343, DOI 10.1007/BF03208865; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kobayashi J, 2004, J RADIAT RES, V45, P473, DOI 10.1269/jrr.45.473; Lee JH, 2003, MOL CANCER RES, V1, P674; Li N, 2014, CARCINOGENESIS, V35, P2687, DOI 10.1093/carcin/bgu201; Li W, 2014, GASTROENTEROLOGY, V146, P1714, DOI 10.1053/j.gastro.2014.03.002; Lins S, 2009, GENE, V447, P12, DOI 10.1016/j.gene.2009.07.013; Lu JC, 2006, CARCINOGENESIS, V27, P2209, DOI 10.1093/carcin/bgl077; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Moghimi-Dehkordi B, 2012, WORLD J GASTRO ONCOL, V4, P71, DOI 10.4251/wjgo.v4.i4.71; Mohideen AMSH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113513; Rollinson S, 2006, LEUKEMIA LYMPHOMA, V47, P2567, DOI 10.1080/10428190600909743; Ryk C, 2006, LUNG CANCER, V54, P285, DOI 10.1016/j.lungcan.2006.08.004; Silva J, 2012, DNA CELL BIOL, V31, P1182, DOI 10.1089/dna.2011.1562; Smolinska K, 2010, ARCH MED SCI, V6, P605, DOI 10.5114/aoms.2010.14475; Stavridi ES, 2005, NAT CELL BIOL, V7, P648, DOI 10.1038/ncb0705-648; Teo MTW, 2012, CARCINOGENESIS, V33, P581, DOI 10.1093/carcin/bgr300; Tseng SF, 2005, J BIOL CHEM, V280, P39594, DOI 10.1074/jbc.M508425200; Vrieling A, 2010, AM J CLIN NUTR, V92, P471, DOI [10.3945/ajcn.2010.29005, 10.3945/ajcn.2009.29005]; Wang Y, 2000, GENE DEV, V14, P927; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Xing DY, 2003, ONCOL REP, V10, P1615; Yang L, 2012, CARCINOGENESIS, V33, P338, DOI 10.1093/carcin/bgr272; Yang TT, 2014, CANCER CAUSE CONTROL, V25, P11, DOI 10.1007/s10552-013-0303-0; Yao F, 2013, TUMOR BIOL, V34, P1255, DOI 10.1007/s13277-013-0668-4; Zhang GF, 2013, TUMOR BIOL, V34, P2753, DOI 10.1007/s13277-013-0830-z; Zhao S, 2002, NUCLEIC ACIDS RES, V30, P4815, DOI 10.1093/nar/gkf612; Zheng J, 2013, CANCER RES, V73, P5151, DOI 10.1158/0008-5472.CAN-13-0395; Zheng J, 2011, MOL CARCINOGEN, V50, P689, DOI 10.1002/mc.20803	42	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132332	10.1371/journal.pone.0132332	http://dx.doi.org/10.1371/journal.pone.0132332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186548	gold, Green Submitted, Green Published			2022-12-27	WOS:000358198700037
J	Liu, TB; Lu, QB; Yan, LL; Guo, J; Feng, FB; Qiu, JY; Wang, JY				Liu, Tiebing; Lu, Qing-Bin; Yan, Lailai; Guo, Jing; Feng, Fangbo; Qiu, Jinyun; Wang, Jingyu			Comparative Study on Serum Levels of 10 Trace Elements in Schizophrenia	PLOS ONE			English	Article							DNA FRAGMENTATION; HEAVY-METALS; COPPER; MANGANESE; SELENIUM; ZINC; IRON; RISK; PREVALENCE; MAGNESIUM	The etiology and pathophysiology of schizophrenia remain obscure. This study explored the associations between schizophrenia risk and serum levels of 10 trace elements. A 1: 1 matched case-control study was conducted and matched by age and sex. Blood samples were collected to determine the concentrations of nickel, molybdenum, arsenic, aluminum, chromium, manganese, selenium, copper, iron and zinc by an inductively coupled plasma-mass spectrometry. The conditional logistic regression model was used to analyze the associations between trace elements and schizophrenia risk. Totally 114 schizophrenia patients and 114 healthy controls were recruited in the study. The multivariate analysis demonstrated that copper <= 0.97 mu g/mL, selenium <= 72 ng/mL and manganese>3.95 ng/mL were associated with an increased risk of schizophrenia. The study showed that lower levels of selenium, copper and higher levels of manganese were found in schizophrenia patients compared with healthy controls.	[Liu, Tiebing; Lu, Qing-Bin; Yan, Lailai; Wang, Jingyu] Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China; [Liu, Tiebing] Civil Aviat Adm China, Civil Aviat Med Ctr, Beijing, Peoples R China; [Guo, Jing; Feng, Fangbo; Qiu, Jinyun] PLA 261 Hosp, Dept Clin Lab, Beijing, Peoples R China	Peking University	Wang, JY (corresponding author), Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China.	wjy@bjmu.edu.cn			Beijing Natural Science Foundation [2122051]	Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study is supported by the Beijing Natural Science Foundation (No. 2122051) (http://www.bjnsf.org/).	Alimonti A, 2007, NEUROTOXICOLOGY, V28, P450, DOI 10.1016/j.neuro.2006.12.001; Arinola G, 2010, J RES MED SCI, V15, P245; Benes FM, 2003, ARCH GEN PSYCHIAT, V60, P359, DOI 10.1001/archpsyc.60.4.359; Bowman AB, 2011, J TRACE ELEM MED BIO, V25, P191, DOI 10.1016/j.jtemb.2011.08.144; BROWN JS, 1994, SCHIZOPHRENIA BULL, V20, P387, DOI 10.1093/schbul/20.2.387; Chen Q, 1989, TRACE ELEMENTS AND H; Forte G, 2013, BIOL TRACE ELEM RES, V156, P79, DOI 10.1007/s12011-013-9858-6; Fraga Cesar G., 2005, Molecular Aspects of Medicine, V26, P235, DOI 10.1016/j.mam.2005.07.013; Fukushima T, 2010, NEUROEPIDEMIOLOGY, V34, P18, DOI 10.1159/000255462; Herran A, 2000, PSYCHIAT RES, V94, P51, DOI 10.1016/S0165-1781(00)00126-8; Insel BJ, 2008, ARCH GEN PSYCHIAT, V65, P1136, DOI 10.1001/archpsyc.65.10.1136; Kuloglu M, 2003, EUR NEUROPSYCHOPHARM, V13, P67, DOI 10.1016/S0924-977X(02)00073-1; Malecki EA, 2001, BRAIN RES BULL, V55, P225, DOI 10.1016/S0361-9230(01)00456-7; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Mukherjee S, 1996, COMPR PSYCHIAT, V37, P68, DOI 10.1016/S0010-440X(96)90054-1; Mustak MS, 2008, CLIN CHIM ACTA, V394, P47, DOI 10.1016/j.cca.2008.04.003; Nahar Z, 2010, BIOL TRACE ELEM RES, V133, P284, DOI 10.1007/s12011-009-8441-7; Nechifor M, 2004, J AM COLL NUTR, V23, p549S, DOI 10.1080/07315724.2004.10719401; Raffa M, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-124; Rahman MA, 2009, BIOL TRACE ELEM RES, V127, P102, DOI 10.1007/s12011-008-8230-8; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rethelyi JM, 2013, NEUROSCIENCE BIOBEHA; SALONEN JT, 1991, AM J EPIDEMIOL, V134, P268, DOI 10.1093/oxfordjournals.aje.a116080; Shohag H, 2012, BIOL TRACE ELEM RES, V148, P275, DOI 10.1007/s12011-012-9371-3; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; STIKA KM, 1981, FED PROC, V40, P2115; Tandon R, 2008, SCHIZOPHR RES, V102, P1, DOI 10.1016/j.schres.2008.04.011; Tyrer SP, 1979, AM J; Vidovic B, 2013, BIOL TRACE ELEM RES, V156, P22, DOI 10.1007/s12011-013-9842-1; Vural H, 2010, J TRACE ELEM MED BIO, V24, P169, DOI 10.1016/j.jtemb.2010.02.002; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Wolf TL, 2006, SCHIZOPHR RES, V86, P167, DOI 10.1016/j.schres.2006.05.027; Xiang YT, 2008, SCHIZOPHR RES, V102, P270, DOI 10.1016/j.schres.2008.04.009; Yang YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125925; Yanik M, 2004, BIOL TRACE ELEM RES, V98, P109, DOI 10.1385/BTER:98:2:109; Yin ZB, 2008, BRAIN RES, V1203, P1, DOI 10.1016/j.brainres.2008.01.079; Yuan PX, 2010, J AFFECT DISORDERS, V124, P164, DOI 10.1016/j.jad.2009.10.017	38	33	33	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133622	10.1371/journal.pone.0133622	http://dx.doi.org/10.1371/journal.pone.0133622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186003	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700161
J	Pidoux, G; Gerbaud, P; Guibourdenche, J; Therond, P; Ferreira, F; Simasotchi, C; Evain-Brion, D; Gil, S				Pidoux, Guillaume; Gerbaud, Pascale; Guibourdenche, Jean; Therond, Patrice; Ferreira, Fatima; Simasotchi, Christelle; Evain-Brion, Daniele; Gil, Sophie			Formaldehyde Crosses the Human Placenta and Affects Human Trophoblast Differentiation and Hormonal Functions	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; AMINO-ACID TRANSPORTERS; CELL-FUSION; ENVELOPE GLYCOPROTEIN; OXIDATIVE STRESS; PLASMA-MEMBRANE; GENE-EXPRESSION; HERV-W; RECEPTOR; MODULATION	The chorionic villus of the human placenta is the source of specific endocrine functions and nutrient exchanges. These activities are ensured by the syncytiotrophobast (ST), which bathes in maternal blood. The ST arises and regenerates throughout pregnancy by fusion of underlying cytotrophoblasts (CT). Any anomaly of ST formation or regeneration can affect pregnancy outcome and fetal growth. Because of its direct interaction with maternal blood, the ST is sensitive to drugs, pollutants and xenohormones. Ex vivo assays of perfused cotyledon show that formaldehyde, a common pollutant present in furniture, paint and plastics, can accumulate in the human placenta and cross to the fetal compartment. By means of RT-qPCR, immunoblot and immunocytochemistry experiments, we demonstrate in vitro that formaldehyde exerts endocrine toxicity on human trophoblasts, including a decrease in the production of protein hormones of pregnancy. In addition, formaldehyde exposure triggered human trophoblast fusion by upregulating syncitin-1 receptor expression (ASC-type amino-acid transporter 2: ASCT2). Moreover, we show that formaldehyde-exposed trophoblasts present an altered redox status associated with oxidative stress, and an increase in ASCT2 expression intended to compensate for this stress. Finally, we demonstrate that the adverse effects of formaldehyde on trophoblast differentiation and fusion are reversed by Nacetyl-L-cysteine (Nac), an antioxidant.	[Pidoux, Guillaume; Gerbaud, Pascale; Guibourdenche, Jean; Ferreira, Fatima; Evain-Brion, Daniele; Gil, Sophie] INSERM, U1139, Paris, France; [Pidoux, Guillaume; Gerbaud, Pascale; Guibourdenche, Jean; Ferreira, Fatima; Evain-Brion, Daniele; Gil, Sophie] Univ Paris 05, Paris, France; [Therond, Patrice] Univ Paris Sud, UFR Pharmacie, EA4529, Chatenay Malabry, France; [Therond, Patrice] Hop Bicetre, AP HP, Serv Biochim, F-94275 Le Kremlin Bicetre, France; [Guibourdenche, Jean; Simasotchi, Christelle; Evain-Brion, Daniele; Gil, Sophie] PremUp, Paris, France; [Pidoux, Guillaume; Simasotchi, Christelle; Gil, Sophie] Univ Paris Sud, Fac Pharm, Chatenay Malabry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay	Pidoux, G (corresponding author), INSERM, U1139, Paris, France.	guillaume.pidoux@inserm.fr	GIL, Sophie/ABB-1071-2020; Pidoux, Guillaume/O-1292-2018	Pidoux, Guillaume/0000-0002-5074-429X; Gerbaud, Pascale/0000-0001-5579-1979; /0000-0001-5197-7434	Inserm; program "Domaines d'Interet Majeur Sante, Environnement, Toxicologie" of Region Ile de France; Caisse d'Assurance Maladie des Professions Liberales Province	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); program "Domaines d'Interet Majeur Sante, Environnement, Toxicologie" of Region Ile de France(Region Ile-de-France); Caisse d'Assurance Maladie des Professions Liberales Province	This work was supported Inserm and by a fellowship from the program "Domaines d'Interet Majeur Sante, Environnement, Toxicologie" of Region Ile de France (to GP) and Caisse d'Assurance Maladie des Professions Liberales Province (tools).	Alsat E, 1996, J CELL PHYSIOL, V168, P346, DOI 10.1002/(SICI)1097-4652(199608)168:2<346::AID-JCP13>3.0.CO;2-1; ALSAT E, 1993, J CELL PHYSIOL, V154, P122, DOI 10.1002/jcp.1041540115; Alsat E, 1997, AM J OBSTET GYNECOL, V177, P1526, DOI 10.1016/S0002-9378(97)70103-0; APLIN JD, 1991, J CELL SCI, V99, P681; Attia D, 2016, TOXICOL IND HEALTH, V32, P1097, DOI 10.1177/0748233714547152; Benirschke KKP, 2000, PATHOLOGY OF THE HUM; Bjerregaard B, 2006, CELL MOL LIFE SCI, V63, P1906, DOI 10.1007/s00018-006-6201-9; Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Cariappa R, 2003, PLACENTA, V24, P713, DOI 10.1016/S0143-4004(03)00085-7; Challier J C, 1985, Contrib Gynecol Obstet, V13, P32; Chang C, 2004, BIOL REPROD, V71, P1956, DOI 10.1095/biolreprod.104.033340; Collins JJ, 2001, REGUL TOXICOL PHARM, V34, P17, DOI 10.1006/rtph.2001.1486; Cronier L, 2002, MOL HUM REPROD, V8, P1005, DOI 10.1093/molehr/8.11.1005; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Duong A, 2011, MUTAT RES-REV MUTAT, V728, P118, DOI 10.1016/j.mrrev.2011.07.003; EATON B, 1993, HUMAN PLACENTA, P471; Esnault C, 2008, P NATL ACAD SCI USA, V105, P17532, DOI 10.1073/pnas.0807413105; Fournier T, 2015, PLACENTA, V36, pS60, DOI 10.1016/j.placenta.2015.02.002; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Frendo JL, 2001, ENDOCRINOLOGY, V142, P3638, DOI 10.1210/en.142.8.3638; Frendo JL, 2000, PLACENTA, V21, P773, DOI 10.1053/plac.2000.0575; FURESZ TC, 1993, AM J PHYSIOL, V265, pC212, DOI 10.1152/ajpcell.1993.265.1.C212; Gerbaud P, 2015, PLACENTA, V36, pS35, DOI 10.1016/j.placenta.2014.12.015; Gerbaud P, 2011, ENDOCRINOLOGY, V152, P5017, DOI 10.1210/en.2011-1193; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Heazell AEP, 2009, REPROD BIOMED ONLINE, V18, P111, DOI 10.1016/S1472-6483(10)60432-4; HECK HD, 1985, AM IND HYG ASSOC J, V46, P1, DOI 10.1080/15298668591394275; HOELTZLI SD, 1989, AM J PHYSIOL, V256, pC630, DOI 10.1152/ajpcell.1989.256.3.C630; Honkisz E, 2012, REPROD TOXICOL, V34, P385, DOI 10.1016/j.reprotox.2012.05.094; Huang FM, 2005, J BIOMED MATER RES B, V74B, P768, DOI 10.1002/jbm.b.30283; Hutson JR, 2011, J POPUL THER CLIN PH, V18, pE533; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006, IARC Monogr Eval Carcinog Risks Hum, V88, P1; Inoue Y, 1999, J BIOL CHEM, V274, P27002, DOI 10.1074/jbc.274.38.27002; Jansson T, 2001, PEDIATR RES, V49, P141, DOI 10.1203/00006450-200102000-00003; JEAVONS CM, 1984, ALCOHOL CLIN EXP RES, V8, P352, DOI 10.1111/j.1530-0277.1984.tb05679.x; JOHN EM, 1994, EPIDEMIOLOGY, V5, P147, DOI 10.1097/00001648-199403000-00004; JOHNSON LW, 1988, AM J PHYSIOL, V254, pC773, DOI 10.1152/ajpcell.1988.254.6.C773; Katakura Y, 1990, Sangyo Igaku, V32, P42; Katakura Y, 1991, Sangyo Igaku, V33, P264; KATAKURA Y, 1993, BRIT J IND MED, V50, P176; Keryer G, 1998, J CELL SCI, V111, P995; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Lavillette D, 2002, J VIROL, V76, P6442, DOI 10.1128/JVI.76.13.6442-6452.2002; Levovich I, 2008, CANCER CHEMOTH PHARM, V62, P471, DOI 10.1007/s00280-007-0627-0; Lino-dos-Santos-Franco A, 2011, TOXICOL LETT, V207, P278, DOI 10.1016/j.toxlet.2011.09.026; Longtine MS, 2012, PLACENTA, V33, P971, DOI 10.1016/j.placenta.2012.09.013; Malassine A, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-6; Malassine A, 2011, ADV EXP MED BIOL, V714, P103, DOI 10.1007/978-94-007-0782-5_4; MARKS TA, 1980, TERATOLOGY, V22, P51, DOI 10.1002/tera.1420220108; Mohammadi S, 2014, ELECTRONIC PHYSICIAN, V6, P939, DOI 10.14661/2014.939-943; Monfared AL, 2014, TOXICOL IND HEALTH, V30, P174, DOI 10.1177/0748233712452603; Myatt L, 2002, ENDOCRINE, V19, P103, DOI 10.1385/ENDO:19:1:103; Neuberger A., 1981, COMP BIOCHEM, V19A, P257; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Ogren Linda, 1994, P875; Perot P, 2011, CELL FUSIONS: REGULATION AND CONTROL, P63, DOI 10.1007/978-90-481-9772-9_4; Pidoux G, 2004, PLACENTA, V25, pS79, DOI 10.1016/j.placenta.2004.01.007; Pidoux G, 2004, PLACENTA, V25, P469, DOI 10.1016/j.placenta.2003.10.016; Pidoux G, 2007, J CELL PHYSIOL, V212, P26, DOI 10.1002/jcp.20995; Pidoux G, 2014, J CELL SCI, V127, P4172, DOI 10.1242/jcs.149609; Pidoux G, 2010, AM J PHYSIOL-CELL PH, V298, pC1517, DOI 10.1152/ajpcell.00484.2008; Potgens AJG, 2004, HUM REPROD UPDATE, V10, P487, DOI 10.1093/humupd/dmh039; SCHMON B, 1991, J CLIN ENDOCR METAB, V73, P888, DOI 10.1210/jcem-73-4-888; SCHNEIDE.H, 1972, AM J OBSTET GYNECOL, V114, P822, DOI 10.1016/0002-9378(72)90909-X; Shi YQ, 2014, TOXICOL IND HEALTH, V30, P901, DOI 10.1177/0748233712466129; SOMMERFELT MA, 1990, VIROLOGY, V176, P58, DOI 10.1016/0042-6822(90)90230-O; SOMMERFELT MA, 1990, J VIROL, V64, P6214, DOI 10.1128/JVI.64.12.6214-6220.1990; Speit G, 2014, MUTAT RES-FUND MOL M, V760, P48, DOI 10.1016/j.mrfmmm.2013.11.007; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; Takamiya M, 2007, REPROD TOXICOL, V24, P265, DOI 10.1016/j.reprotox.2007.07.003; TASKINEN H, 1994, J OCCUP ENVIRON MED, V36, P311, DOI 10.1097/00043764-199403000-00008; Taskinen HK, 1999, AM J IND MED, V36, P206, DOI 10.1002/(SICI)1097-0274(199907)36:1&lt;206::AID-AJIM29&gt;3.0.CO;2-D; Teng S, 2001, CHEM-BIOL INTERACT, V130, P285, DOI 10.1016/S0009-2797(00)00272-6; Thrasher JD, 2001, ARCH ENVIRON HEALTH, V56, P300, DOI 10.1080/00039890109604460; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; WILBOURN J, 1995, SCAND J WORK ENV HEA, V21, P229, DOI 10.5271/sjweh.1368; Zeller J, 2012, ARCH TOXICOL, V86, P1465, DOI 10.1007/s00204-012-0830-6; Zhang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074974	80	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133506	10.1371/journal.pone.0133506	http://dx.doi.org/10.1371/journal.pone.0133506			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186596	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700150
J	Williams, J; Scarborough, P; Townsend, N; Matthews, A; Burgoine, T; Mumtaz, L; Rayner, M				Williams, Julianne; Scarborough, Peter; Townsend, Nick; Matthews, Anne; Burgoine, Thomas; Mumtaz, Lorraine; Rayner, Mike			Associations between Food Outlets around Schools and BMI among Primary Students in England: A Cross-Classified Multi-Level Analysis	PLOS ONE			English	Article							DIETARY BEHAVIORS; PHYSICAL-ACTIVITY; CHILDHOOD OVERWEIGHT; US CHILDREN; OBESITY; ENVIRONMENT; NEIGHBORHOOD; RESTAURANTS; ADOLESCENTS; WEIGHT	Introduction Researchers and policy-makers are interested in the influence that food retailing around schools may have on child obesity risk. Most previous research comes from North America, uses data aggregated at the school-level and focuses on associations between fast food outlets and school obesity rates. This study examines associations between food retailing and BMI among a large sample of primary school students in Berkshire, England. By controlling for individual, school and home characteristics and stratifying results across the primary school years, we aimed to identify if the food environment around schools had an effect on BMI, independent of socio-economic variables. Methods We measured the densities of fast food outlets and food stores found within schoolchildren's home and school environments using Geographic Information Systems (GIS) and data from local councils. We linked these data to measures from the 2010/11 National Child Measurement Programme and used a cross-classified multi-level approach to examine associations between food retailing and BMI z-scores. Analyses were stratified among Reception (aged 4-5) and Year 6 (aged 10-11) students to measure associations across the primary school years. Results Our multilevel model had three levels to account for individual (n = 16,956), home neighbourhood (n = 664) and school (n = 268) factors. After controlling for confounders, there were no significant associations between retailing near schools and student BMI, but significant positive associations between fast food outlets in home neighbourhood and BMI z-scores. Year 6 students living in areas with the highest density of fast food outlets had an average BMI z-score that was 0.12 (95% CI:0.04, 0.20) higher than those living in areas with none. Discussion We found little evidence to suggest that food retailing around schools influences student BMI. There is some evidence to suggest that fast food outlet densities in a child's home neighbourhood may have an effect on BMI, particularly among girls, but more research is needed to inform effective policies targeting the effects of the retail environment on child obesity.	[Williams, Julianne; Scarborough, Peter; Townsend, Nick; Matthews, Anne; Mumtaz, Lorraine; Rayner, Mike] Univ Oxford, British Heart Fdn, Ctr Populat Approaches Noncommunicable Dis Preven, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England; [Burgoine, Thomas] Univ Cambridge, Sch Clin Med, MRC, UKCRC Ctr Diet & Act Res CEDAR,Inst Metab Sci,Epi, Cambridge CB2 0QQ, England	University of Oxford; University of Cambridge	Williams, J (corresponding author), Univ Oxford, British Heart Fdn, Ctr Populat Approaches Noncommunicable Dis Preven, Nuffield Dept Populat Hlth, Old Rd Campus, Oxford OX3 7LF, England.	julianne.williams@dph.ox.ac.uk	Scarborough, Peter/ABD-6111-2021	Scarborough, Peter/0000-0002-2378-2944; Townsend, Nick/0000-0001-9890-0901	British Heart Foundation [006/P&C/CORE/2013/OXFSTATS, 021/P&C/Core/2010/HPRG]; National Health Services Berkshire project grant; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust under the UK Clinical Research Collaboration; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MR/K023187/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Health Services Berkshire project grant; Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust under the UK Clinical Research Collaboration(Wellcome Trust); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was undertaken in part by the British Heart Foundation Centre on Population Approaches for Non-Communicable Disease Prevention, a World Health Organization Collaborating Centre and by the Centre for Diet and Activity Research (CEDAR), a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence. Funding from the British Heart Foundation (006/P&C/CORE/2013/OXFSTATS, 021/P&C/Core/2010/HPRG), National Health Services Berkshire project grant, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academy of Royal Medical Colleges, 2013, MEAS MED PROF PRESCR; [Anonymous], 2013, CHILDREN YOUNG PEOPL; [Anonymous], BEG GUID UK GEOGR; Austin SB, 2005, AM J PUBLIC HEALTH, V95, P1575, DOI 10.2105/AJPH.2004.056341; Burgoine T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1464; Burgoine T, 2010, APPETITE, V55, P522, DOI 10.1016/j.appet.2010.08.020; Caspi CE, 2012, HEALTH PLACE, V18, P1172, DOI 10.1016/j.healthplace.2012.05.006; Cavill N, 2013, HLTH PEOPLE HLTH PLA; Cetateanu A, 2014, HEALTH PLACE, V27, P68, DOI 10.1016/j.healthplace.2014.01.007; Charreire H, 2014, HEALTH PLACE, V25, P1, DOI [10.1016/j.healthplace.2013.09.017, 10.1010/j.healthplace.2013.09.017]; Chiang PH, 2011, PUBLIC HEALTH NUTR, V14, P1601, DOI 10.1017/S1368980011001042; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Crawford PB, 2011, PREV CHRONIC DIS, V8; Cummins S, 2006, INT J EPIDEMIOL, V35, P100, DOI 10.1093/ije/dyi276; Cummins S, 2007, INT J EPIDEMIOL, V36, P355, DOI 10.1093/ije/dym033; Cummins S, 2009, PREV MED, V49, P527, DOI 10.1016/j.ypmed.2009.10.007; Currie J, 2010, AM ECON J-ECON POLIC, V2, P32, DOI 10.1257/pol.2.3.32; Day PL, 2011, AM J PREV MED, V40, P113, DOI 10.1016/j.amepre.2010.10.018; Department for Education, 2011, SCH CENS ENGL; Diller PA, 2011, J LAW MED ETHICS, V39, P89, DOI 10.1111/j.1748-720X.2011.00575.x; Drewnowski A, 2004, AM J PREV MED, V27, P154, DOI 10.1016/j.amepre.2004.06.011; Drewnowski A, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-59; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Ellaway A, 2012, HEALTH PLACE, V18, P1335, DOI 10.1016/j.healthplace.2012.06.001; Evans CEL, 2009, J HUM NUTR DIET, V22, P89, DOI 10.1111/j.1365-277X.2008.00941.x; Feng J, 2010, HEALTH PLACE, V16, P175, DOI 10.1016/j.healthplace.2009.09.008; Fleischhacker SE, 2011, OBES REV, V12, pe460, DOI 10.1111/j.1467-789X.2010.00715.x; Forsyth A, 2012, HEALTH PLACE, V18, P1261, DOI 10.1016/j.healthplace.2012.09.005; Gebremariam MK, 2012, SCAND J PUBLIC HEALT, V40, P491, DOI 10.1177/1403494812454948; Gilliland JA, 2012, CAN J PUBLIC HEALTH, V103, pS15, DOI 10.1007/BF03403830; Grier S, 2013, J PUBLIC POLICY MARK, V32, P116, DOI 10.1509/jppm.11.158; Harrison F, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-5; Harrison F, 2011, SOC SCI MED, V72, P1411, DOI 10.1016/j.socscimed.2011.02.023; Harrison F, 2011, HEALTH PLACE, V17, P710, DOI 10.1016/j.healthplace.2011.01.009; He MZ, 2012, INT J ENV RES PUB HE, V9, P1458, DOI 10.3390/ijerph9041458; Health and Social Care Information Centre, 2013, NAT CHILD MEAS PROGR; Holsten JE, 2009, PUBLIC HEALTH NUTR, V12, P397, DOI 10.1017/S1368980008002267; Jaime PC, 2009, PREV MED, V48, P45, DOI 10.1016/j.ypmed.2008.10.018; Katz DL, 2008, INT J OBESITY, V32, P1780, DOI 10.1038/ijo.2008.158; Kestens Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041418; Khambalia AZ, 2012, OBES REV, V13, P214, DOI 10.1111/j.1467-789X.2011.00947.x; Kubik MY, 2003, AM J PUBLIC HEALTH, V93, P1168, DOI 10.2105/AJPH.93.7.1168; Lake AA, 2010, HEALTH PLACE, V16, P666, DOI 10.1016/j.healthplace.2010.02.004; Larson N, 2009, ANN BEHAV MED, V38, pS56, DOI 10.1007/s12160-009-9120-9; Lytle LA, 2009, AM J PREV MED, V36, pS134, DOI 10.1016/j.amepre.2009.01.018; Maffeis C, 2001, HORM RES, V55, P42, DOI 10.1159/000063462; Matthews A, 2011, FOOD PURCHASES CONSU; Matthews SA, 2012, AM J PREV MED, V42, P516, DOI 10.1016/j.amepre.2012.02.004; McKinnon RA, 2009, AM J PREV MED, V36, pS124, DOI 10.1016/j.amepre.2009.01.012; Mhurchu CN, 2013, OBES REV, V14, P108, DOI 10.1111/obr.12080; Mitchell C, 2011, OBES REV, V12, P660, DOI 10.1111/j.1467-789X.2011.00872.x; Moudon AV, 2013, PUBLIC HEALTH NUTR, V16, P1238, DOI 10.1017/S1368980013000773; Neckerman KM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1817; Neckerman KM, 2010, AM J PREV MED, V39, P195, DOI 10.1016/j.amepre.2010.05.004; Nestle M, 2010, AM J PREV MED, V39, P280, DOI 10.1016/j.amepre.2010.06.001; Nixon H, 2011, J AGRIC FOOD SYST CO, V2, P181, DOI 10.5304/jafscd.2011.021.007; Oakes JM, 2009, AM J PREV MED, V36, pS177, DOI 10.1016/j.amepre.2009.01.015; Office for National Statistics, 2014, RUR URB CLASS; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, V3, P1, DOI DOI 10.1002/14651858.CD001872.PUB2; Park S, 2013, J ADOLESCENT HEALTH, V53, P655, DOI 10.1016/j.jadohealth.2013.06.002; Poti JM, 2014, J ACAD NUTR DIET, V114, P908, DOI 10.1016/j.jand.2013.08.012; Public Health England, 2013, NAT CHILD MEAS PROGR; Public Health England, 2013, OB ENV REG GROWTH FA; Rossen LM, 2013, J URBAN HEALTH, V90, P653, DOI 10.1007/s11524-012-9785-4; Rossen LM, 2012, HEALTH PLACE, V18, P956, DOI 10.1016/j.healthplace.2012.06.012; Rutter H, 2012, INT J PUBLIC HEALTH, P1; Sanchez BN, 2012, AM J EPIDEMIOL, V175, P1284, DOI 10.1093/aje/kwr454; Schabas L, 2014, NUTR BULL, V39, P99, DOI 10.1111/nbu.12074; Sinclair S, 2008, SCH FRINGE WHAT PUPI; Smith D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-70; Story M, 2006, FUTURE CHILD, V16, P109, DOI 10.1353/foc.2006.0007; Story M, 1999, INT J OBESITY, V23, pS43, DOI 10.1038/sj.ijo.0800859; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; The London Food Board Chartered Institute of Environmental Health, 2012, TAK TOOLK TOOLS INT; Timperio A, 2008, PREV MED, V46, P331, DOI 10.1016/j.ypmed.2007.11.011; Townsend N, 2012, INT J OBESITY, V36, P45, DOI 10.1038/ijo.2011.191; United Kingdom Government, 2014, TYP SCH; [United Kingdom Government Department for Communities and Local Government], 2010, CHILD WELLB IND; van der Horst K, 2008, AM J PREV MED, V35, P217, DOI 10.1016/j.amepre.2008.05.022; Waters E, 2011, COCHRANE COLLABORATI, V12, P1; Williams J, 2014, OBES REV, V15, P359, DOI 10.1111/obr.12142; Wooten H, 2012, ZONING LICENSING REG, P65; Zenk SN, 2011, HEALTH PLACE, V17, P1150, DOI 10.1016/j.healthplace.2011.05.001	84	19	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132930	10.1371/journal.pone.0132930	http://dx.doi.org/10.1371/journal.pone.0132930			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RV	26186610	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700070
J	Zhang, ML; Sun, T; Jian, CS; Lei, L; Han, PD; Lv, QL; Yang, R; Zhou, XH; Xu, JJ; Hu, YC; Men, YF; Huang, YU; Zhang, CM; Zhu, XJ; Wang, XH; Cheng, HP; Xiong, JW				Zhang, Meiling; Sun, Tao; Jian, Chongshu; Lei, Lei; Han, Peidong; Lv, Quanlong; Yang, Ran; Zhou, Xiaohai; Xu, Jiejia; Hu, Yingchun; Men, Yongfan; Huang, Yanyi; Zhang, Chuanmao; Zhu, Xiaojun; Wang, Xianhua; Cheng, Heping; Xiong, Jing-Wei			Remodeling of Mitochondrial Flashes in Muscular Development and Dystrophy in Zebrafish	PLOS ONE			English	Article							FISH ORYZIAS-LATIPES; SUPEROXIDE FLASHES; PERMEABILITY TRANSITION; MOUSE; PROLIFERATION; INHIBITION; APOPTOSIS; ELEMENT	Mitochondrial flash (mitoflash) is a highly-conserved, universal, and physiological mitochondrial activity in isolated mitochondria, intact cells, and live organisms. Here we investigated developmental and disease-related remodeling of mitoflash activity in zebrafish skeletal muscles. In transgenic zebrafish expressing the mitoflash reporter cpYFP, in vivo imaging revealed that mitoflash frequency and unitary properties underwent multiphasic and muscle type-specific changes, accompanying mitochondrial morphogenesis from 2 to 14 dpf. In particular, short (S)-type mitoflashes predominated in early muscle formation, then S-, transitory (T)- and regular (R)-type mitoflashes coexisted during muscle maturation, followed by a switch to R-type mitoflashes in mature skeletal muscles. In early development of muscular dystrophy, we found accelerated S-to R-type mitoflash transition and reduced mitochondrial NAD(P)H amidst a remarkable cell-to-cell heterogeneity. This study not only unravels a profound functional and morphological remodeling of mitochondria in developing and diseased skeletal muscles, but also underscores mitoflashes as a useful reporter of mitochondrial function in milieu of live animals under physiological and pathophysiological conditions.	[Zhang, Meiling; Sun, Tao; Jian, Chongshu; Lei, Lei; Han, Peidong; Yang, Ran; Zhou, Xiaohai; Xu, Jiejia; Zhu, Xiaojun; Wang, Xianhua; Cheng, Heping; Xiong, Jing-Wei] Peking Univ, Inst Mol Med, Beijing Key Lab Cardiometabol Mol Med, Beijing 100871, Peoples R China; [Sun, Tao; Jian, Chongshu; Han, Peidong; Lv, Quanlong; Xu, Jiejia; Zhang, Chuanmao; Wang, Xianhua; Cheng, Heping] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Cheng, Heping] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Hu, Yingchun; Men, Yongfan; Zhang, Chuanmao] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Men, Yongfan; Huang, Yanyi] Peking Univ, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Huang, Yanyi] Peking Univ, Coll Engn, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University; Peking University	Cheng, HP (corresponding author), Peking Univ, Inst Mol Med, Beijing Key Lab Cardiometabol Mol Med, Beijing 100871, Peoples R China.	chengp@pku.edu.cn; jingwei_xiong@pku.edu.cn	cheng, heping/A-7299-2011; Lu, Quanlong/M-4436-2015; Heping, Cheng/AAE-2680-2019; Hu, Ying/GQZ-8100-2022; Men, Yongfan/AAU-5701-2020	Lu, Quanlong/0000-0002-4261-5121; Heping, Cheng/0000-0002-9604-6702; Men, Yongfan/0000-0001-8265-1787; Xu, Jiejia/0000-0003-3885-3546	National Basic Research Program of China [2013CB531200, 2012CB944501, 2010CB529503]; National Natural Science Foundation of China [31430059, 81470399, 31221002, 31271549, 81270164]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2013CB531200, 2012CB944501, and 2010CB529503), and the National Natural Science Foundation of China (31430059, 81470399, 31221002, 31271549, and 81270164).	Bassett DI, 2003, DEVELOPMENT, V130, P5851, DOI 10.1242/dev.00799; Breckwoldt M, 2014, NAT MED, V20, P559, DOI 10.1038/nm.3520; De Palma C, 2010, CELL DEATH DIFFER, V17, P1684, DOI 10.1038/cdd.2010.48; Dickey AS, 2011, J NEUROSCI, V31, P15716, DOI 10.1523/JNEUROSCI.3159-11.2011; Douglas DS, 2009, NEUROCHEM RES, V34, P124, DOI 10.1007/s11064-008-9719-4; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Granato M, 1996, DEVELOPMENT, V123, P399; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Hou TT, 2014, J PHYSIOL-LONDON, V592, P3703, DOI 10.1113/jphysiol.2014.275735; Hou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076721; Hou Y, 2012, STEM CELLS, V30, P2535, DOI 10.1002/stem.1213; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Kawakami K, 2004, GENE, V338, P93, DOI 10.1016/j.gene.2004.05.013; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Kirchmaier BC, 2012, DEV BIOL, V363, P438, DOI 10.1016/j.ydbio.2012.01.015; Li KT, 2012, BIOPHYS J, V102, P1011, DOI 10.1016/j.bpj.2012.01.044; Lobbardi R, 2011, DEVELOPMENT, V138, P1783, DOI 10.1242/dev.059121; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Palma E, 2009, HUM MOL GENET, V18, P2024, DOI 10.1093/hmg/ddp126; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; Reutenauer J, 2008, BRIT J PHARMACOL, V155, P574, DOI 10.1038/bjp.2008.285; Schwarzlander M, 2012, TRENDS CELL BIOL, V22, P503, DOI 10.1016/j.tcb.2012.07.007; Schwarzlander M, 2011, BIOCHEM J, V437, P381, DOI 10.1042/BJ20110883; Shen EZ, 2014, NATURE, V508, P128, DOI 10.1038/nature13012; Stellabotte F, 2007, DEV DYNAM, V236, P2432, DOI 10.1002/dvdy.21253; Telfer WR, 2010, HUM MOL GENET, V19, P2433, DOI 10.1093/hmg/ddq126; Tidball JG, 2007, J APPL PHYSIOL, V102, P1677, DOI 10.1152/japplphysiol.01145.2006; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang XH, 2012, J MOL CELL CARDIOL, V52, P940, DOI 10.1016/j.yjmcc.2012.02.007; Wang X, 2013, J CELL SCI, V126, P1381, DOI 10.1242/jcs.116996; Wei L, 2012, J GEN PHYSIOL, V139, P425, DOI 10.1085/jgp.201210790; Wei L, 2011, FASEB J, V25, P3068, DOI 10.1096/fj.11-187252; Xu SH, 2014, DEV CELL, V31, P48, DOI 10.1016/j.devcel.2014.08.002; Zhang X, 2013, LIFE SCI, V93, P178, DOI 10.1016/j.lfs.2013.06.012	35	20	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132567	10.1371/journal.pone.0132567	http://dx.doi.org/10.1371/journal.pone.0132567			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186000	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700049
J	Aboalela, N; Lyon, D; Elswick, RK; Kelly, DL; Brumelle, J; Bear, HD; Jackson-Cook, C				Aboalela, Noran; Lyon, Debra; Elswick, R. K., Jr.; Kelly, Debra Lynch; Brumelle, Jenni; Bear, Harry D.; Jackson-Cook, Colleen			Perceived Stress Levels, Chemotherapy, Radiation Treatment and Tumor Characteristics Are Associated with a Persistent Increased Frequency of Somatic Chromosomal Instability in Women Diagnosed with Breast Cancer: A One Year Longitudinal Study	PLOS ONE			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; DNA-DAMAGE; IN-VIVO; MICRONUCLEUS FREQUENCIES; MOLECULAR PORTRAITS; IONIZING-RADIATION; AFRICAN-AMERICAN; TELOMERE LENGTH; TRISOMY 7; CELLS	While advances in therapeutic approaches have resulted in improved survival rates for women diagnosed with breast cancer, subsets of these survivors develop persistent psychoneurological symptoms (fatigue, depression/anxiety, cognitive dysfunction) that compromise their quality of life. The biological basis for these persistent symptoms is unclear, but could reflect the acquisition of soma-wide chromosomal instability following the multiple biological/psychological exposures associated with the diagnosis/treatment of breast cancer. An essential first step toward testing this hypothesis is to determine if these cancer-related exposures are indeed associated with somatic chromosomal instability frequencies. Towards this end, we longitudinally studied 71 women (ages 23-71) with early-stage breast cancer and quantified their somatic chromosomal instability levels using a cytokinesis-blocked micronuclear/cytome assay at 4 timepoints: before chemotherapy (baseline); four weeks after chemotherapy initiation; six months after chemotherapy (at which time some women received radiotherapy); and one year following chemotherapy initiation. Overall, a significant change in instability frequencies was observed over time, with this change differing based on whether the women received radiotherapy (p=0.0052). Also, significantly higher instability values were observed one year after treatment initiation compared to baseline for the women who received: sequential taxotere/doxorubicin/cyclophosphamide (p<0.001) or taxotere/cyclophosphamide (p=0.014). Significant predictive associations for acquired micronuclear/cytome abnormality frequencies were also observed for race (p=0.0052), tumor type [luminal B tumors] (p=0.0053), and perceived stress levels (p=0.0129). The impact of perceived stress on micronuclear/cytome frequencies was detected across all visits, with the highest levels of stress being reported at baseline (p=0.0024). These findings suggest that the cancer-related exposome has an impact on both healthy somatic cells and tumor cells, and may lead to persistent chromosomal instability. In addition, stress was a significant predictor of chromosomal instability; thus, interventions that aim to reduce stress may reduce acquired soma-wide chromosomal instability for cancer survivors.	[Aboalela, Noran; Jackson-Cook, Colleen] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA; [Lyon, Debra; Elswick, R. K., Jr.; Kelly, Debra Lynch] Virginia Commonwealth Univ, Sch Nursing, Family & Community Hlth Nursing, Richmond, VA USA; [Brumelle, Jenni; Jackson-Cook, Colleen] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA; [Bear, Harry D.] Virginia Commonwealth Univ, Div Surg Oncol, Richmond, VA USA; [Bear, Harry D.; Jackson-Cook, Colleen] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Jackson-Cook, C (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA.	ccook@mcvh-vcu.edu	Lyon, Deb/ABF-7547-2021		National Institute of Nursing Research, National Institutes of Health (multi-PIs) [R01NR012667]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012667] Funding Source: NIH RePORTER	National Institute of Nursing Research, National Institutes of Health (multi-PIs); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This research was supported by Award Number R01NR012667 from the National Institute of Nursing Research, National Institutes of Health (multi-PIs: DL CJC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Nursing Research or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abut YC, 2012, SAUDI J ANAESTH, V6, P46, DOI 10.4103/1658-354X.93059; Ahire V, 2014, J ENVIRON PATHOL TOX, V33, P69, DOI 10.1615/JEnvironPatholToxicolOncol.2014010743; Andreou E, 2011, INT J ENV RES PUB HE, V8, P3287, DOI 10.3390/ijerph8083287; [Anonymous], 2013, AM CANC SOC BREAST C; Aristei C, 2009, CANCER GENET CYTOGEN, V192, P24, DOI 10.1016/j.cancergencyto.2009.02.019; Badger T, 2007, NURS RES, V56, P44, DOI 10.1097/00006199-200701000-00006; Berger AM, 2010, SUPPORT CARE CANCER, V18, P105, DOI 10.1007/s00520-009-0636-0; Braybrooke JP, 2015, EUR J CANCER CARE, V24, P650, DOI 10.1111/ecc.12222; Broberg K, 1998, CYTOGENET CELL GENET, V83, P30, DOI 10.1159/000015160; Brown, 2006, APPL MIXED MODELS ME; Cardinale F, 2012, BRIT J CANCER, V106, P780, DOI 10.1038/bjc.2011.567; Carey LA, 2013, MOL INTRINSIC SUBTYP; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Castellanos MV, 2004, OSTEOARTHR CARTILAGE, V12, P982, DOI 10.1016/j.joca.2004.08.011; Ceppi M, 2011, MUTAGENESIS, V26, P247, DOI 10.1093/mutage/geq060; Clarke SJ, 1999, CLIN PHARMACOKINET, V36, P99, DOI 10.2165/00003088-199936020-00002; Cleeland CS, 2003, CANCER-AM CANCER SOC, V97, P2919, DOI 10.1002/cncr.11382; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dahlen A, 2001, CANCER GENET CYTOGEN, V131, P19, DOI 10.1016/S0165-4608(01)00488-5; Dantzer R, 2001, BRAIN BEHAV IMMUN, V15, P7, DOI 10.1006/brbi.2000.0613; Dhillon VS, 2011, MUTAGENESIS, V26, P33, DOI 10.1093/mutage/geq076; EASTMOND DA, 1989, ENVIRON MOL MUTAGEN, V13, P34, DOI 10.1002/em.2850130104; Elmore LW, 2002, J BIOL CHEM, V277, P35509, DOI 10.1074/jbc.M205477200; Elsendoorn TJ, 2001, MUTAT RES-GEN TOX EN, V498, P145, DOI 10.1016/S1383-5718(01)00278-9; Faggioli F, 2011, MECH AGEING DEV, V132, P429, DOI 10.1016/j.mad.2011.04.008; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Fenech M, 2003, MUTAT RES-GEN TOX EN, V534, P65, DOI 10.1016/S1383-5718(02)00249-8; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fenech M, 2011, MUTAGENESIS, V26, P43, DOI 10.1093/mutage/geq050; Fenech M, 2011, MUTAGENESIS, V26, P239, DOI 10.1093/mutage/geq051; Fumaz CR, 2012, BRAIN BEHAV IMMUN, V26, P568, DOI 10.1016/j.bbi.2012.01.001; Gamulin M, 2010, J ENVIRON SCI HEAL A, V45, P292, DOI 10.1080/10934520903467881; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Guerreiro PS, 2013, MUTAT RES-GEN TOX EN, V757, P140, DOI 10.1016/j.mrgentox.2013.08.003; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Huen K, 2006, ENVIRON MOL MUTAGEN, V47, P236, DOI 10.1002/em.20193; Ingle JN, 2013, J HUM GENET, V58, P306, DOI 10.1038/jhg.2013.35; Jagetia GC, 2001, MUTAT RES-GEN TOX EN, V491, P9, DOI 10.1016/S1383-5718(00)00132-7; Jones KH, 2011, MUTAGENESIS, V26, P745, DOI 10.1093/mutage/ger042; Khan F, 2009, J ENVIRON BIOL, V30, P409; Kinne RW, 2001, ARTHRITIS RES, V3, P319, DOI 10.1186/ar322; Kirsch-Volders M, 2011, ARCH TOXICOL, V85, P873, DOI 10.1007/s00204-011-0691-4; Knox RJ, 1986, CANC RES 2, V46, P1972; Koppelmans V, 2012, BREAST CANCER RES TR, V132, P1099, DOI 10.1007/s10549-011-1888-1; Leach NT, 2001, MUTAT RES-GEN TOX EN, V495, P11, DOI 10.1016/S1383-5718(01)00194-2; Lee BN, 2004, NEUROIMMUNOMODULAT, V11, P279, DOI 10.1159/000079408; Lee K, 2004, SLEEP MED REV, V8, P199, DOI 10.1016/j.smrv.2003.10.001; Lee SL, 2015, ENVIRON MOL MUTAGEN, V56, P32, DOI 10.1002/em.21890; Li P, 2012, INT J BIOCHEM CELL B, V44, P1531, DOI 10.1016/j.biocel.2012.06.020; Lien EA, 2013, BREAST CANCER RES TR, V141, P243, DOI 10.1007/s10549-013-2677-9; Lyon D, 2014, BIOL RES NURS, V16, P160, DOI 10.1177/1099800413483545; Machiela MJ, 2015, AM J HUM GENET, V96, P487, DOI 10.1016/j.ajhg.2015.01.011; McClelland SE, 2009, CELL CYCLE, V8, P3262, DOI 10.4161/cc.8.20.9690; Menzies V, 2013, NURS RES PRACT, V2013, DOI 10.1155/2013/795784; Mertens F, 1996, HUM GENET, V98, P651, DOI 10.1007/s004390050278; Milosevic-Djordjevic O, 2011, J BUON, V16, P437; Minicucci EM, 2008, CLIN EXP MED, V8, P79, DOI 10.1007/s10238-008-0161-3; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Morath J, 2014, PSYCHOTHER PSYCHOSOM, V83, P289, DOI 10.1159/000362739; Nagar S, 2010, ADV EXP MED BIOL, V678, P124; Park SB, 2013, CA-CANCER J CLIN, V63, P419, DOI 10.3322/caac.21204; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Phan VH, 2009, EXPERT OPIN DRUG MET, V5, P243, DOI [10.1517/17425250902800153, 10.1517/17425250902800153 ]; POWIS G, 1987, CANCER CHEMOTH PHARM, V20, P219, DOI 10.1007/BF00570489; Province MA, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt379; Quinlan J, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-40; Ramos DL, 2011, MUTAT RES-GEN TOX EN, V724, P28, DOI 10.1016/j.mrgentox.2011.04.013; Robinson TJW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078641; Rohena CC, 2014, NAT PROD REP, V31, P335, DOI 10.1039/c3np70092e; Sacharczuk M, 2003, MUTAT RES-GEN TOX EN, V535, P95, DOI 10.1016/S1383-5718(02)00290-5; Sanchenkov A, 2001, JNCI-J NATL CANCER I, V93, P347, DOI 10.1093/jnci/93.5.347; Santos RA, 2010, CLIN EXP MED, V10, P87, DOI 10.1007/s10238-009-0079-4; Selfe TK, 2012, EVID BASED COMPLEMEN; Shalev C, 2013, PSYCHONEUROENDOCRINO, V38, P1835, DOI 10.1016/j.psyneuen.2013.03.010; Starkweather AR, 2014, NURS RES, V63, P36, DOI 10.1097/NNR.0000000000000009; Surtees PG, 2011, J GERONTOL A-BIOL, V66, P1152, DOI 10.1093/gerona/glr112; Swain SM, 2013, J CLIN ONCOL, V31, P3197, DOI 10.1200/JCO.2012.48.1275; Vu T, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00062; Troester MA, 2004, CANCER RES, V64, P4218, DOI 10.1158/0008-5472.CAN-04-0107; Utne I, 2010, J PALLIAT MED, V13, P311, DOI 10.1089/jpm.2009.0294; Valeberg BT, 2008, EUR J PAIN, V12, P582, DOI 10.1016/j.ejpain.2007.09.004; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Vral A, 2011, MUTAGENESIS, V26, P11, DOI 10.1093/mutage/geq078; Watters JL, 2007, CANCER EPIDEM BIOMAR, V16, P1428, DOI 10.1158/1055-9965.EPI-06-1030; Wefel JS, 2011, LANCET ONCOL, V12, P703, DOI 10.1016/S1470-2045(10)70294-1; Westbrook K, 2013, PHARMACOL THERAPEUT, V139, P1, DOI 10.1016/j.pharmthera.2013.03.001; Wu SM, 2014, PSYCHOSOM MED, V76, P252, DOI 10.1097/PSY.0000000000000060; Yang F, 2014, BBA-REV CANCER, V1845, P84, DOI 10.1016/j.bbcan.2013.12.002; York TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055337	93	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133380	10.1371/journal.pone.0133380	http://dx.doi.org/10.1371/journal.pone.0133380			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177092	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600253
J	Cordero, OJ; Varela-Calvino, R; Lopez-Gonzalez, T; Calvino-Sampedro, C; Vinuela, JE; Mourino, C; Hernandez-Rodriguez, I; Rodriguez-Lopez, M; de la Iglesia, BA; Pego, JM				Cordero, Oscar J.; Varela-Calvino, Ruben; Lopez-Gonzalez, Tania; Calvino-Sampedro, Cristina; Vinuela, Juan E.; Mourino, Coral; Hernandez-Rodriguez, Inigo; Rodriguez-Lopez, Marina; Aspe de la Iglesia, Bruno; Maria Pego, Jose			CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-IV; SYNOVIAL-FLUID; SOLUBLE CD26; CELLS; INTERLEUKIN-12; TH17; AUTOANTIBODIES; ASSOCIATION; MEMORY	We studied dipeptidyl peptidase IV (DPP-IV, CD26) expression in different T helper cells and serum soluble DPP-IV/sCD26 levels in rheumatoid arthritis (RA) patients, correlated these with disease activity score (DAS), and examined how they were affected by different therapies, conventional or biological (anti-TNF, anti-CD20 and anti-IL6R or Ig-CTLA4). The percentage of CD4(+)CD45R0(+)CD26(-) cells was greatly reduced in patients (up to 50%) when compared with healthy subjects. Three other subsets of CD4 cells, including a CD26high Th1-associated population, changed variably with therapies. Data from these subsets (frequency and staining density) significantly correlated with DAS28 or DAS28 components but different in each group of patients undergoing the different therapies. Th17 and Th22 subsets were implicated in RA as independent CCR4(+) and CCR4(-) populations each, with distinct CD26 expression, and were targeted with varying efficiency by each therapy. Serum DPP-IV activity rather than sCD26 levels was lower in RA patients compared to healthy donors. DPP-IV and sCD26 serum levels were found related to specific T cell subsets but not to disease activity. We conclude that, according to their CD26 expression, different cell subsets could serve to monitor RA course, and an uncharacterized T helper CD26(-) subset, not targeted by therapies, should be monitored for early diagnosis.	[Cordero, Oscar J.; Varela-Calvino, Ruben; Lopez-Gonzalez, Tania; Calvino-Sampedro, Cristina] Univ Santiago de Compostela, Dept Biochem & Mol Biol, Santiago De Compostela, Spain; [Vinuela, Juan E.] Univ Hosp Complex Santiago de Compostela, Serv Immunol, Santiago De Compostela, Spain; [Mourino, Coral; Hernandez-Rodriguez, Inigo; Rodriguez-Lopez, Marina; Aspe de la Iglesia, Bruno; Maria Pego, Jose] Univ Hosp Complex Vigo, Serv Rheumatol, Vigo, Spain; [Mourino, Coral; Rodriguez-Lopez, Marina; Maria Pego, Jose] Xerencia Xest Integrada SERGAS, Inst Invest Biomed, IRIDIS Invest Rheumatol & Immunomediated Dis Grp, Vigo, Spain	Universidade de Santiago de Compostela	Cordero, OJ (corresponding author), Univ Santiago de Compostela, Dept Biochem & Mol Biol, Santiago De Compostela, Spain.	oscarj.cordero@usc.es	RODRIGUEZ, CORAL MOURIÑO/ABG-1819-2020; Varela-Calvino, Ruben/ABF-9910-2020; Sampedro Torres Quevedo, Cristina/GVW-1493-2022; Calviño Sampedro, Cristina/AAC-3301-2021; Cordero, Oscar J/K-5415-2015	Varela-Calvino, Ruben/0000-0002-4978-661X; Calviño Sampedro, Cristina/0000-0002-5121-0265; Cordero, Oscar J/0000-0003-1026-124X; Vinuela, Juan Evaristo/0000-0001-7778-901X	Pfizer Spain; European Union [316265]	Pfizer Spain(Pfizer); European Union(European Commission)	This work was supported by an unrestricted medical grant from Pfizer Spain to OJC and JMP. European Union Seventh Framework Programme [FP7/REGPOT-2012-2013.1] under grant agreement no 316265, BIOCAPS, supports to JMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Annunziato F, 2009, BLOOD, V114, P2213, DOI 10.1182/blood-2009-03-209189; Bayes HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090263; Bengsch B, 2012, J IMMUNOL, V188, P5438, DOI 10.4049/jimmunol.1103801; Biswas S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056246; Buljevic S, 2013, RHEUMATOL INT, V33, P2867, DOI 10.1007/s00296-013-2823-z; Busso N, 2005, AM J PATHOL, V166, P433, DOI 10.1016/S0002-9440(10)62266-3; Cordero OJ, 1997, IMMUNOBIOLOGY, V197, P522, DOI 10.1016/S0171-2985(97)80084-8; Cordero OJ, 2001, RHEUMATOL INT, V21, P69, DOI 10.1007/s002960100134; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; Cuchacovich M, 2001, CLIN EXP RHEUMATOL, V19, P673; De Chiara L, 2009, DIS MARKERS, V27, P311, DOI [10.3233/DMA-2009-0679, 10.1155/2009/986295]; Ellingsen T, 2007, SCAND J IMMUNOL, V66, P451, DOI 10.1111/j.1365-3083.2007.01966.x; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Gerlag DM, 2012, ANN RHEUM DIS, V71, P638, DOI 10.1136/annrheumdis-2011-200990; GOTOH H, 1989, CLIN CHEM, V35, P1016; HAGIHARA M, 1987, CLIN CHEM, V33, P1463; Hashimoto M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098202; Havre PA, 2009, BRIT J CANCER, V101, P983, DOI 10.1038/sj.bjc.6605236; Havre PA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-517; Ibegbu CC, 2009, IMMUNOLOGY, V126, P346, DOI 10.1111/j.1365-2567.2008.02899.x; Kobayashi H, 2002, J RHEUMATOL, V29, P1858; Krakauer M, 2006, J NEUROIMMUNOL, V181, P157, DOI 10.1016/j.jneuroim.2006.09.006; Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354; Mavropoulos JC, 2005, J RHEUMATOL, V32, P2116; MUSCAT C, 1994, CLIN EXP IMMUNOL, V98, P252; Narducci MG, 2006, BLOOD, V107, P1108, DOI 10.1182/blood-2005-04-1492; Proost P., 2003, METH MOL B, V239, P27; Salgado FJ, 2003, J BIOL CHEM, V278, P24849, DOI 10.1074/jbc.M212978200; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sanchez-Otero N, 2014, SCI REP-UK, V4, DOI 10.1038/srep03999; Sromova L, 2010, CLIN CHIM ACTA, V411, P1046, DOI 10.1016/j.cca.2010.03.034; STANCIKOVA M, 1992, CLIN EXP RHEUMATOL, V10, P381; Tejera-Alhambra M, 2014, CLIN IMMUNOL, V150, P170, DOI 10.1016/j.clim.2013.11.011; Truchetet ME, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3486; Uematsu T, 2004, ANTICANCER RES, V24, P619; van Eden W, 2002, ANN RHEUM DIS, V61, P25; Wan Q, 2011, J EXP MED, V208, P1875, DOI 10.1084/jem.20102516; WOLFE F, 1988, J RHEUMATOL, V15, P1480; Zhang L, 2012, J ENG FIBER FABR, V7, P7; Zhao F, 2012, J IMMUNOL, V188, P6055, DOI 10.4049/jimmunol.1102918	41	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131992	10.1371/journal.pone.0131992	http://dx.doi.org/10.1371/journal.pone.0131992			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177310	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600075
J	Kim, SY; Zhang, QY; Brunmeir, R; Han, WP; Xu, F				Kim, Sun-Yee; Zhang, Qiongyi; Brunmeir, Reinhard; Han, Weiping; Xu, Feng			SIRT1 Interacts with and Deacetylates ATP6V1B2 in Mature Adipocytes	PLOS ONE			English	Article							FATTY-ACID OXIDATION; LYSINE ACETYLATION; 2-DIMENSIONAL ELECTROPHORESIS; CELL-SURVIVAL; PGC-1-ALPHA; METABOLISM; SIRTUINS; ACETYLTRANSFERASE; INFLAMMATION; ACTIVATION	SIRT1 plays a key role in maintaining metabolic homeostasis in mammals by directly modulating the activities of various transcription factors and metabolic enzymes through lysine deacetylation. White adipose tissue plays a key role in lipid storage and metabolism. To identify novel molecular targets of SIRT1 in fat cells, we used a non-biased proteomic approach. We identified a number of proteins whose acetylation status was significantly affected by SIRT1 modulator treatment in 3T3-L1 adipocytes. Among them, ATP6V1B2, a subunit of the vacuolar (H+)-ATPase, was further shown to be associated with SIRT1 by co-immunoprecipitation assay. Moreover, SIRT1 deacetylates ATP6V1B2 in vitro and in vivo. Taken together, our study demonstrates that ATP6V1B2 is a molecular target of SIRT1 in fat cells and the role of SIRT1 and ATP6V1B2 acetylation in the vacuolar (H+)-ATPase function warrants further investigation.	[Kim, Sun-Yee; Zhang, Qiongyi; Brunmeir, Reinhard; Xu, Feng] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Han, Weiping] ASTAR, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore; [Han, Weiping; Xu, Feng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore	Xu, F (corresponding author), ASTAR, Singapore Inst Clin Sci, Singapore, Singapore.	xu_feng@sics.a-star.edu.sg		Xu, Feng/0000-0003-2016-7521; Brunmeir, Reinhard/0000-0001-7545-2819; KIM, Sun-Yee/0000-0002-8061-2271	Academic Center of Excellence Research Grant from GSK [100019545]; Industry Alignment Fund from the Agency for Science, Technology and Research (A*STAR) of Singapore [IAF111002]; A*STAR of Singapore	Academic Center of Excellence Research Grant from GSK; Industry Alignment Fund from the Agency for Science, Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); A*STAR of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Academic Center of Excellence Research Grant (No. 100019545) from GSK and the Industry Alignment Fund (IAF111002) from the Agency for Science, Technology and Research (A*STAR) of Singapore to F.X. Funding for the open-access charge was provided by A*STAR of Singapore. GSK provided the SIRT1 modulators for this study and performed the non-biased proteomic analysis to identify novel SIRT1 targets. Other than that, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; BURGESSCASSLER A, 1989, CLIN CHEM, V35, P2297; Canto C, 2009, TRENDS ENDOCRIN MET, V20, P325, DOI 10.1016/j.tem.2009.03.008; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Chen Y, 2012, MOL CELL PROTEOMICS, V11, P1048, DOI 10.1074/mcp.M112.019547; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dai H, 2010, J BIOL CHEM, V285, P32695, DOI 10.1074/jbc.M110.133892; Dobbin MM, 2013, NAT NEUROSCI, V16, P1008, DOI 10.1038/nn.3460; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Gertz M, 2013, P NATL ACAD SCI USA, V110, pE2772, DOI 10.1073/pnas.1303628110; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Yang HH, 2012, SCI WORLD J, P1, DOI 10.1100/2012/149132; Zhang QY, 2012, CELL CYCLE, V11, P4310, DOI 10.4161/cc.22224; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	36	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133448	10.1371/journal.pone.0133448	http://dx.doi.org/10.1371/journal.pone.0133448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177453	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600257
J	Madera, L; Greenshields, A; Coombs, MRP; Hoskin, DW				Madera, Laurence; Greenshields, Anna; Coombs, Melanie R. Power; Hoskin, David W.			4T1 Murine Mammary Carcinoma Cells Enhance Macrophage-Mediated Innate Inflammatory Responses	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; BREAST-CANCER; TNF-ALPHA; IMMUNE SUPPRESSION; METASTASIS; MICROENVIRONMENT; RECEPTOR; DISTINCT; MODEL; OLIGODEOXYNUCLEOTIDES	Tumor progression and the immune response are intricately linked. While it is known that cancers alter macrophage inflammatory responses to promote tumor progression, little is known regarding how cancers affect macrophage-dependent innate host defense. In this study, murine bone-marrow-derived macrophages (BMDM) were exposed to murine carcinoma-conditioned media prior to assessment of the macrophage inflammatory response. BMDMs exposed to 4T1 mammary carcinoma-conditioned medium demonstrated enhanced production of pro-inflammatory cytokines tumor necrosis factor alpha, interleukin-6, and CCL2 in response to lipopolysaccharide (LPS) while production of interleukin-10 remained unchanged. The increased LPS-induced production of pro-inflammatory cytokines was transient and correlated with enhanced cytokine production in response to other Toll-like receptor agonists, including peptidoglycan and flagellin. In addition, 4T1-conditioned BMDMs exhibited strengthened LPS-induced nitric oxide production and enhanced phagocytosis of Escherichia coli. 4T1-mediated augmentation of macrophage responses to LPS was partially dependent on the NF kappa B pathway, macrophage-colony stimulating factor, and actin polymerization, as well as the presence of 4T1-secreted extracellular vesicles. Furthermore, peritoneal macrophages obtained from 4T1 tumor-bearing mice displayed enhanced pro-inflammatory cytokine production in response to LPS. These results suggest that uptake of 4T1-secreted factors and actin-mediated ingestion of 4T1-secreted exosomes by macrophages cause a transient enhancement of innate inflammatory responses. Mammary carcinoma-mediated regulation of innate immunity may have significant implications for our understanding of host defense and cancer progression.	[Madera, Laurence; Hoskin, David W.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Greenshields, Anna; Coombs, Melanie R. Power; Hoskin, David W.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Hoskin, David W.] Dalhousie Univ, Dept Surg, Halifax, NS B3H 4H2, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Madera, L (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	Laurence.madera@dal.ca	Coombs, Melanie/GQH-9000-2022		Canadian Breast Cancer Foundation-Atlantic Region; Cancer Research Training Program as part of The Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR	Canadian Breast Cancer Foundation-Atlantic Region; Cancer Research Training Program as part of The Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR	This work was supported by funding from the Canadian Breast Cancer Foundation-Atlantic Region. D. Hoskin holds the Canadian Breast Cancer Foundation-Atlantic Region Endowed Chair in Breast Cancer Research. L. Madera is supported by a fellowship from the Canadian Breast Cancer Foundation-Atlantic Region, as well as a trainee award from the Cancer Research Training Program as part of The Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh D, 2010, CLIN CANCER RES, V16, P3399, DOI 10.1158/1078-0432.CCR-09-3087; Alokail MS, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0038-0; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Ben-Baruch A, 2003, BREAST CANCER RES, V5, P31, DOI 10.1186/bcr554; Bhatelia K, 2014, CELL SIGNAL, V26, P2350, DOI 10.1016/j.cellsig.2014.07.035; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Biswas SK, 2008, J IMMUNOL, V180, P2011, DOI 10.4049/jimmunol.180.4.2011; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Broomfield SA, 2009, J IMMUNOL, V182, P5217, DOI 10.4049/jimmunol.0803826; Brown KL, 2011, J IMMUNOL, V186, P5497, DOI 10.4049/jimmunol.1002508; Cho HJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3195; Chow A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05750; Davis MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00264-13; Ewens A, 2005, ANTICANCER RES, V25, P3905; Gajewski TF, 2006, J IMMUNOTHER, V29, P233, DOI 10.1097/01.cji.0000199193.29048.56; Holloway RW, 2012, J BIOL CHEM, V287, P39171, DOI 10.1074/jbc.M112.404293; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Kawarada Y, 2001, J IMMUNOL, V167, P5247, DOI 10.4049/jimmunol.167.9.5247; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Laoui D, 2011, INT J DEV BIOL, V55, P861, DOI 10.1387/ijdb.113371dl; Lin HH, 2005, J EXP MED, V201, P1615, DOI 10.1084/jem.20042307; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Pena OM, 2013, PLOS ONE, P8; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; REGO SL, 2014, BREAST TUMOR CELL TA, V17, P573, DOI DOI 10.1007/S10456-013-9405-2; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Sinha P, 2005, CANCER IMMUNOL IMMUN, V54, P1137, DOI 10.1007/s00262-005-0703-4; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Tang XQ, 2013, CANCER LETT, V332, P3, DOI 10.1016/j.canlet.2013.01.024; Tripsianis G, 2014, NEOPLASMA, V61, P205, DOI 10.4149/neo_2014_026; Vacchelli E, 2012, ONCOIMMUNOLOGY, V1, P894, DOI 10.4161/onci.20931; Weigel BJ, 2003, CLIN CANCER RES, V9, P3105; Yu L, 2013, BBA-REV CANCER, V1835, P144, DOI 10.1016/j.bbcan.2012.10.006; Yu MX, 2013, CANCER RES, V73, P4061, DOI 10.1158/0008-5472.CAN-12-3946; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	38	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133385	10.1371/journal.pone.0133385	http://dx.doi.org/10.1371/journal.pone.0133385			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177198	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600254
J	Tian, HQ; Chen, XY; Lu, Y; Lu, WM; Wang, ML; Zhao, HL; Lu, MP; Zhou, H; Chen, RX; Zhang, ZD; Shen, C; Cheng, L				Tian, Hui-Qin; Chen, Xin-Yuan; Lu, Ying; Lu, Wen-Min; Wang, Mei-Lin; Zhao, Hai-Long; Lu, Mei-Ping; Zhou, Han; Chen, Ruo-Xi; Zhang, Zheng-Dong; Shen, Chong; Cheng, Lei			Association of VDR and CYP2R1 Polymorphisms with Mite-Sensitized Persistent Allergic Rhinitis in a Chinese Population	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; GENE POLYMORPHISMS; IMMUNE-SYSTEM; D PATHWAY; ASTHMA; IMPACT; SUSCEPTIBILITY; ORGANIZATION; CHILDREN; DISEASE	As recent studies have described an association between vitamin D and allergic rhinitis, we hypothesized that vitamin D pathway-related genes may be candidate genes for susceptibility to allergic rhinitis. Thus, we sought to evaluate whether polymorphisms in the vitamin D receptor (VDR) and CYP2R1 genes are associated with mite-sensitized persistent allergic rhinitis (PER) in a Han Chinese population. A hospital-based case-control study consisting of 519 patients with mite-sensitized PER and 447 healthy controls was conducted. Five single nucleotide polymorphisms (SNPs) in VDR and CYP2R1 were selected for genotyping. The genotype and allele frequencies of rs9729, rs2228570, rs1544410, and rs731236 in VDR as well as rs2060793 in CYP2R1 were not significantly associated with susceptibility to mite-sensitized PER. After stratification analyses, however, both the CT and CT/TT genotypes of rs2228570 in VDR exhibited a significantly decreased risk (CT: adjusted odds ratio (OR)=0.58, 95% confidence intervals (CI)=0.37-0.91; CT/TT: adjusted OR=0.61, 95% CI=0.40-0.93) of mite-sensitized PER, while the AA genotype of rs2060793 in CYP2R1 exhibited a significantly increased risk (adjusted OR=1.85, 95% CI=1.03-3.34) of PER in the age subgroup of <16 years old. Both the AG and AG/GG genotypes of rs731236 in VDR exhibited a significantly decreased risk (AG: adjusted OR=0.43, 95% CI=0.21-0.89; AG/GG: adjusted OR=0.46, 95% CI=0.23-0.94) of PER in the female subgroup. Analysis of the locus-locus interactions of VDR and CYP2R1 revealed two models that involved combined SNPs of VDR and CYP2R1 were statistically significant (P<0.05). Our data suggest that age and gender may have an impact on the association of three SNPs (rs2228570, rs731236, and rs2060793) in genes of the vitamin D pathway with the risk of mite-sensitized PER in this Chinese population. The VDR and CYP2R1 variants may be involved in genetic interactions in the pathogenesis of PER.	[Tian, Hui-Qin; Chen, Xin-Yuan; Lu, Wen-Min; Lu, Mei-Ping; Zhou, Han; Chen, Ruo-Xi; Cheng, Lei] Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Jiangsu, Peoples R China; [Lu, Ying] Nanjing Med Univ, Affiliated Hosp 1, Dept Grp Healthcare, Nanjing, Jiangsu, Peoples R China; [Wang, Mei-Lin; Zhang, Zheng-Dong] Nanjing Med Univ, Sch Publ Hlth, Dept Mol & Genet Toxicol, Nanjing, Jiangsu, Peoples R China; [Zhao, Hai-Long; Shen, Chong] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Cheng, Lei] Nanjing Med Univ, Int Ctr Allergy Res, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Cheng, L (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Jiangsu, Peoples R China.	jspent@126.com	Lu, Wen-Min/K-9831-2019; zhang, zheng/HCH-9684-2022; Lu, Wen-Min/A-2837-2012; Cheng, Lei/AAT-2690-2021; LU, WEN-MIN/GRR-5111-2022	Lu, Wen-Min/0000-0003-2410-8502; Lu, Wen-Min/0000-0003-2410-8502; Cheng, Lei/0000-0001-6541-7702; 	National Natural Science Foundation of China [81300834, 81200747]; Health Promotion Project of Jiangsu Province, China [XK200719, RC2007065, RC2011071]; Priority Academic Program Development of Jiangsu Higher Education Institutions, China [JX10231801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Promotion Project of Jiangsu Province, China; Priority Academic Program Development of Jiangsu Higher Education Institutions, China	This work was supported by the National Natural Science Foundation of China (No. 81300834 to HQT and No. 81200747 to MPL). LC was supported by grants Nos. XK200719, RC2007065 and RC2011071 from the Health Promotion Project of Jiangsu Province, China, and grant No. JX10231801 from the Priority Academic Program Development of Jiangsu Higher Education Institutions, China, for Nanjing Medical University.	Bener A, 2014, J FAM COMMUNITY MED, V21, P154, DOI 10.4103/2230-8229.142967; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Bosse Y, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-98; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Chanock S, 2001, DIS MARKERS, V17, P89, DOI 10.1155/2001/858760; Chen RX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095033; Cheng JB, 2003, J BIOL CHEM, V278, P38084, DOI 10.1074/jbc.M307028200; Cheng L, 2004, CLIN EXP ALLERGY, V34, P1192, DOI 10.1111/j.1365-2222.2004.02008.x; Gross C, 1996, J BONE MINER RES, V11, P1850; Hitchon CA, 2012, J RHEUMATOL, V39, P1792, DOI 10.3899/jrheum.120387; Kamen DL, 2010, J MOL MED, V88, P441, DOI 10.1007/s00109-010-0590-9; Li F, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-103; Lu MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027363; Maalmi H, 2013, HUM IMMUNOL, V74, P234, DOI 10.1016/j.humimm.2012.11.005; Mai XM, 2014, ALLERGY, V69, P488, DOI 10.1111/all.12365; Miyake Y, 2012, HUM IMMUNOL, V73, P1046, DOI 10.1016/j.humimm.2012.07.339; Miyamoto K, 1997, MOL ENDOCRINOL, V11, P1165, DOI 10.1210/me.11.8.1165; Moran-Auth Y, 2013, J STEROID BIOCHEM, V136, P83, DOI 10.1016/j.jsbmb.2013.02.005; Mostowska A, 2013, MOL BIOL REP, V40, P803, DOI 10.1007/s11033-012-2118-6; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; Ramos-Lopez E, 2006, ANN NY ACAD SCI, V1079, P327, DOI 10.1196/annals.1375.050; Tizaoui K, 2014, LUNG, V192, P955, DOI 10.1007/s00408-014-9648-8; Toda M, 2002, IMMUNOLOGY, V106, P1, DOI 10.1046/j.1365-2567.2002.01407.x; van Etten E, 2007, EUR J IMMUNOL, V37, P395, DOI 10.1002/eji.200636043; Wang SS, 2014, ALLERGY, V69, P118, DOI 10.1111/all.12337; Wang YJ, 2012, ARCH BIOCHEM BIOPHYS, V523, P123, DOI 10.1016/j.abb.2012.04.001; Wei X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057981; Wjst M, 2007, ALLERGY, V62, P1085, DOI 10.1111/j.1398-9995.2007.01437.x	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133162	10.1371/journal.pone.0133162	http://dx.doi.org/10.1371/journal.pone.0133162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177022	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600222
J	Valsangkar, NP; Zimmers, TA; Kim, BJ; Blanton, C; Joshi, MM; Bell, TM; Nakeeb, A; Dunnington, GL; Koniaris, LG				Valsangkar, Nakul P.; Zimmers, Teresa A.; Kim, Bradford J.; Blanton, Casi; Joshi, Mugdha M.; Bell, Teresa M.; Nakeeb, Attila; Dunnington, Gary L.; Koniaris, Leonidas G.			Determining the Drivers of Academic Success in Surgery: An Analysis of 3,850 Faculty	PLOS ONE			English	Article							PUBLICATION PRODUCTIVITY; SURGICAL SPECIALTIES; CLINICIAN-EDUCATORS; PROMOTION CRITERIA; SCIENTIFIC IMPACT; SCHOLARLY IMPACT; UNITED-STATES; DEPARTMENTS; INDEX	Objective Determine drivers of academic productivity within U.S. departments of surgery. Methods Eighty academic metrics for 3,850 faculty at the top 50 NIH-funded university-and 5 outstanding hospital-based surgical departments were collected using websites, Scopus, and NIH RePORTER. Results Mean faculty size was 76. Overall, there were 35.3% assistant, 27.8% associate, and 36.9% full professors. Women comprised 21.8%; 4.9% were MD-PhDs and 6.1% PhDs. By faculty-rank, median publications/citations were: assistant, 14/175, associate, 39/649 and full-professor, 97/2250. General surgery divisions contributed the most publications and citations. Highest performing sub-specialties per faculty member were: research (58/1683), transplantation (51/1067), oncology (41/777), and cardiothoracic surgery (48/860). Overall, 23.5% of faculty were principal investigators for a current or former NIH grant, 9.5% for a current or former R01/U01/P01. The 10 most cited faculty (MCF) within each department contributed to 42% of all publications and 55% of all citations. MCF were most commonly general (25%), oncology (19%), or transplant surgeons (15%). Fifty-one-percent of MCF had current/former NIH funding, compared with 20% of the rest (p<0.05); funding rates for R01/U01/P01 grants was 25.1% vs. 6.8% (p<0.05). Rate of current-NIH MCF funding correlated with higher total departmental NIH rank (p < 0.05). Conclusions Departmental academic productivity as defined by citations and NIH funding is highly driven by sections or divisions of research, general and transplantation surgery. MCF, regardless of subspecialty, contribute disproportionally to major grants and publications. Approaches that attract, develop, and retain funded MCF may be associated with dramatic increases in total departmental citations and NIH-funding.	[Valsangkar, Nakul P.; Zimmers, Teresa A.; Kim, Bradford J.; Blanton, Casi; Joshi, Mugdha M.; Bell, Teresa M.; Nakeeb, Attila; Dunnington, Gary L.; Koniaris, Leonidas G.] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Koniaris, LG (corresponding author), Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA.	lkoniaris@me.com	Zimmers, Teresa/AAD-5461-2019; Bell, Teresa Maria/Q-9271-2019	Zimmers, Teresa/0000-0001-7872-0540; Kim, Bradford/0000-0002-1832-5298; Bell, Teresa/0000-0002-6519-4358				AMIN M, 2000, PERSPECTIVES PUBLISH, V1, P1; Atasoylu AA, 2003, J GEN INTERN MED, V18, P711, DOI 10.1046/j.1525-1497.2003.10425.x; Beasley BW, 1997, JAMA-J AM MED ASSOC, V278, P723, DOI 10.1001/jama.278.9.723; Bligh J, 2009, ACAD MED, V84, P1161, DOI 10.1097/ACM.0b013e3181ace633; Carpenter CR, 2014, ACAD EMERG MED, V21, P1160, DOI 10.1111/acem.12482; Colaco M, 2013, J UROLOGY, V190, P999, DOI 10.1016/j.juro.2013.02.3186; Eloy JA, 2013, OTOLARYNG HEAD NECK, V148, P215, DOI 10.1177/0194599812466055; Fuller Clifton D, 2009, J Am Coll Radiol, V6, P112, DOI 10.1016/j.jacr.2008.07.004; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Holliday EB, 2014, ACAD MED, V89, P767, DOI 10.1097/ACM.0000000000000229; Housri N, 2008, SURGERY, V144, P322, DOI 10.1016/j.surg.2008.03.011; Housri N, 2008, J SURG RES, V148, P13, DOI 10.1016/j.jss.2008.02.015; Hunt GE, 2010, HARVARD REV PSYCHIAT, V18, P207, DOI 10.3109/10673229.2010.493742; Jackson HH, 2004, J SURG RES, V116, P197, DOI 10.1016/j.jss.2003.10.012; Jacob BA, 2011, J PUBLIC ECON, V95, P1168, DOI 10.1016/j.jpubeco.2011.05.005; Khan NR, 2014, J NEUROSURG, V120, P746, DOI 10.3171/2013.11.JNS131708; Khan Nickalus R, 2013, World Neurosurg, V80, P766, DOI 10.1016/j.wneu.2013.07.011; Kurmis AP, 2003, J BONE JOINT SURG AM, V85A, P2449, DOI 10.2106/00004623-200312000-00028; Lee J, 2009, J NEUROSURG, V111, P387, DOI 10.3171/2008.10.JNS08978; Mann M, 2008, ANN SURG, V247, P217, DOI 10.1097/SLA.0b013e3181568e26; Ozomaro U, 2007, J SURG RES, V141, P16, DOI 10.1016/j.jss.2007.02.023; Pagel PS, 2011, ACTA ANAESTH SCAND, V55, P1085, DOI 10.1111/j.1399-6576.2011.02508.x; Petersen AM, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036114; Saha S, 2003, J MED LIBR ASSOC, V91, P42; Shah A, 2007, ANN SURG, V246, P1110, DOI 10.1097/SLA.0b013e3180f633f6; Svider PF, 2014, OPHTHALMOLOGY, V121, P423, DOI 10.1016/j.ophtha.2013.08.009; Svider PF, 2014, J NEUROSURG, V120, P191, DOI 10.3171/2013.8.JNS13938; Svider PF, 2013, LARYNGOSCOPE, V123, P884, DOI 10.1002/lary.23951	28	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131678	10.1371/journal.pone.0131678	http://dx.doi.org/10.1371/journal.pone.0131678			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177096	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600058
J	Wu, AP; Li, ZL; He, FF; Wang, YH; Dong, M				Wu, Ai-Ping; Li, Zi-Li; He, Fei-Fei; Wang, Yan-Hong; Dong, Ming			Screening Allelochemical-Resistant Species of the Alien Invasive Mikania micrantha for Restoration in South China	PLOS ONE			English	Article							MUSTARD BRASSICA-NIGRA; SEED-GERMINATION; BIOLOGICAL INVASIONS; LONICERA-MAACKII; ROOT EXTRACTS; GROWTH; PLANTS; RICE; LEAF; ESTABLISHMENT	To screen allelochemical-resistant species of the alien invasive weed Mikania micrantha, we studied the allelopathic inhibition effects of the leaf aqueous extract (LAE) of Mikania on seed germination and seedling growth of the 26 species native or naturalized in the invaded region in South China. Seed germination was more strongly negatively affected by LAE than seedling growth. Responses of seed germination and seed growth to LAE differed differently among the target species. LAE more strongly negatively affected seed germination, but less strongly negatively affected seedling growth, in non-legume species than in legume species. LAE more strongly negatively affected seed germination and seedling growth in native species than naturalized exotic species. Therefore, naturalized exotic non-legume seedlings are more suitable than seeds of native legume species for restoration of Mikania-invaded habitats.	[Wu, Ai-Ping; Li, Zi-Li] Hunan Agr Univ, Inst Ecol, Dept Ecol, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China; [He, Fei-Fei] Yunnan Univ, Sch Agr, Kunming 650091, Peoples R China; [Wang, Yan-Hong] Zhejiang Agr & Forestry Univ, Sch Forestry & Biotechnol, Hangzhou 311300, Zhejiang, Peoples R China; [Dong, Ming] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou 310036, Zhejiang, Peoples R China	Hunan Agricultural University; Yunnan University; Zhejiang A&F University; Hangzhou Normal University	Wu, AP (corresponding author), Hunan Agr Univ, Inst Ecol, Dept Ecol, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.	wuaip8101@126.com; dongming@hznu.edu.cn	wang, yan/GSE-6489-2022; wang, yi/GVT-8516-2022; Wang, Yanbo/HFZ-8018-2022; Wu, Aiping/AAU-8710-2020		National Natural Science Foundation of China [31301725]; Zhejiang Provincial Natural Science Foundation of China [LQ12C03002]; State Key Laboratory of Vegetation and Environmental Change [LVEC-2012kf05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); State Key Laboratory of Vegetation and Environmental Change	This research was financially supported by the National Natural Science Foundation of China (No. 31301725), Zhejiang Provincial Natural Science Foundation of China (No. LQ12C03002) and State Key Laboratory of Vegetation and Environmental Change (No. LVEC-2012kf05).	Ahn JK, 2000, AGRON J, V92, P1162, DOI 10.2134/agronj2000.9261162x; Alford ER, 2009, RESTOR ECOL, V17, P506, DOI 10.1111/j.1526-100X.2008.00405.x; Allaie RR, 2006, J AGRON CROP SCI, V192, P186, DOI 10.1111/j.1439-037X.2006.00205.x; Barnum Kimberly, 2013, International Journal of Plant Biology, V4, P8, DOI 10.4081/pb.2013.e2; Bauer JT, 2012, PLANT ECOL, V213, P1907, DOI 10.1007/s11258-012-0036-2; Bousquet-Melou A, 2005, CHEMOECOLOGY, V15, P193, DOI 10.1007/s00049-005-0311-y; Callaway RM, 2006, TRENDS ECOL EVOL, V21, P369, DOI 10.1016/j.tree.2006.04.008; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Catford JA, 2012, GLOBAL CHANGE BIOL, V18, P44, DOI 10.1111/j.1365-2486.2011.02549.x; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Djurdjevic L, 2004, BIOCHEM SYST ECOL, V32, P533, DOI 10.1016/j.bse.2003.10.001; Dorning M, 2006, PLANT ECOL, V184, P287, DOI 10.1007/s11258-005-9073-4; Ebana K, 2001, AGRON J, V93, P12, DOI 10.2134/agronj2001.93112x; El-Darier SM, 2000, ANN APPL BIOL, V136, P273, DOI 10.1111/j.1744-7348.2000.tb00035.x; Emeterio LS, 2004, GRASS FORAGE SCI, V59, P107; Escudero A, 1999, J ECOL, V87, P290, DOI 10.1046/j.1365-2745.1999.00356.x; Fitter A, 2003, SCIENCE, V301, P1337, DOI 10.1126/science.1089291; FOWLER N, 1986, ANNU REV ECOL SYST, V17, P89, DOI 10.1146/annurev.es.17.110186.000513; Harrod RJ, 2001, NORTHWEST SCI, V75, P85; Hickman JE, 2010, P NATL ACAD SCI USA, V107, P10115, DOI 10.1073/pnas.0912279107; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Hunter ME, 2002, AM J BOT, V89, P1113, DOI 10.3732/ajb.89.7.1113; Inderjit, 2003, PLANTA, V217, P529, DOI 10.1007/s00425-003-1054-z; Inderjit, 2001, AGRON J, V93, P79; Ismail B. S., 2002, Weed Biology and Management, V2, P31, DOI 10.1046/j.1445-6664.2002.00045.x; Jefferson LV, 2003, J ARID ENVIRON, V55, P275, DOI 10.1016/S0140-1963(03)00028-4; Kaur R, 2012, BIOL FERT SOILS, V48, P481, DOI 10.1007/s00374-011-0645-2; Li JM, 2009, BIOL INVASIONS, V11, P687, DOI 10.1007/s10530-008-9283-5; Li WH, 2006, PLANT SOIL, V281, P309, DOI 10.1007/s11104-005-9641-3; Limpens E, 2003, CURR OPIN PLANT BIOL, V6, P343, DOI 10.1016/S1369-5266(03)00068-2; Lind EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010429; Lorenzo P, 2013, SOIL BIOL BIOCHEM, V57, P156, DOI 10.1016/j.soilbio.2012.08.018; Mack MC, 1998, TRENDS ECOL EVOL, V13, P195, DOI 10.1016/S0169-5347(97)01286-X; Mao JA, 2006, SOIL BIOL BIOCHEM, V38, P201, DOI 10.1016/j.soilbio.2005.04.030; Myers JH, 2000, TRENDS ECOL EVOL, V15, P316, DOI 10.1016/S0169-5347(00)01914-5; Ni GY, 2007, ALLELOPATHY J, V19, P287; Ni GY, 2006, ALLELOPATHY J, V17, P247; Orr SP, 2005, PLANT ECOL, V181, P153, DOI 10.1007/s11258-005-5698-6; Parvez SS, 2004, PLANT GROWTH REGUL, V42, P245, DOI 10.1023/B:GROW.0000026493.95805.a5; Perry LG, 2005, RESTOR ECOL, V13, P725, DOI 10.1111/j.1526-100X.2005.00092.x; Saxena A, 1996, J ARID ENVIRON, V33, P255, DOI 10.1006/jare.1996.0061; Shao H, 2005, J CHEM ECOL, V31, P1657, DOI 10.1007/s10886-005-5805-0; Simons SB, 1999, SOUTHWEST NAT, V44, P256; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Tawaha AM, 2003, J AGRON CROP SCI, V189, P298, DOI 10.1046/j.1439-037X.2003.00047.x; Turk M. A., 2003, Weed Biology and Management, V3, P37, DOI 10.1046/j.1445-6664.2003.00079.x; Turk MA, 2003, CROP PROT, V22, P673, DOI 10.1016/S0261-2194(02)00241-7; Tyrer SJ, 2007, RANGELAND ECOL MANAG, V60, P604, DOI 10.2111/06-147R2.1; Uddin MN, 2014, AM J BOT, V101, P479, DOI 10.3732/ajb.1400021; Vidotto F, 2013, CROP PROT, V54, P161, DOI 10.1016/j.cropro.2013.08.009; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Vivanco JM, 2004, ECOL LETT, V7, P285, DOI 10.1111/j.1461-0248.2004.00576.x; Wang BS, 2004, INVASION ECOLOGY MAN, P80; Wardle DA, 1998, BIOL REV, V73, P305, DOI 10.1017/S0006323198005192; Weiner J, 1997, OIKOS, V79, P85, DOI 10.2307/3546093; Wetzel RG, 1999, AQUAT BOT, V64, P111, DOI 10.1016/S0304-3770(99)00013-3; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wu AP, 2009, TREES-STRUCT FUNCT, V23, P11, DOI 10.1007/s00468-008-0249-0; Wu AP, 2010, ALLELOPATHY J, V25, P503; Wu Z, 2013, BIOL INVASIONS, V15, P2755, DOI 10.1007/s10530-013-0490-3; Yu H, 2011, BIOL INVASIONS, V13, P747, DOI 10.1007/s10530-010-9865-x; Zalba SM, 2000, BIOL CONSERV, V93, P203, DOI 10.1016/S0006-3207(99)00146-9	64	8	9	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132967	10.1371/journal.pone.0132967	http://dx.doi.org/10.1371/journal.pone.0132967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177031	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600192
J	Chen, FY; Bo, J; Ma, XW; Dong, LX; Shan, ZG; Cui, Q; Chen, HY; Wang, KJ				Chen, Fangyi; Bo, Jun; Ma, Xiaowan; Dong, Lixia; Shan, Zhongguo; Cui, Qian; Chen, Huiyun; Wang, Kejian			A New Membrane Lipid Raft Gene SpFLT-1 Facilitating the Endocytosis of Vibrio alginolyticus in the Crab Scylla paramamosain	PLOS ONE			English	Article							MOLECULAR-CLONING; ANTIMICROBIAL ACTIVITY; BACTERIAL INVASION; ANCHORED PROTEINS; TETANUS TOXIN; CLATHRIN; FLOTILLIN-1; CELLS; MICRODOMAINS; EXPRESSION	Pathogens can enter their host cells by way of endocytosis in which the membrane lipid raft gene flotillins are probably involved in the invasion process and this is an important way to cause infection. In this study, a new gene SpFLT-1 was identified in Scylla paramamosain, which shared high identity with the flotillin-1 of other species. The SpFLT-1 gene was widely distributed in tissues and showed the highest level of mRNA transcripts in the hemocytes. This gene might be a maternal gene based on the evident results that it was highly expressed in maternal ovaries and in the early developmental stages of the zygote and early embryo stage whereas it gradually decreased in zoea 1. SpFLT-1 positively responded to the challenge of Vibrio alginolyticus with a significantly increased level of mRNA expression in the hemocytes and gills at 3 hours post infection (hpi). The SpFLT-1 protein was detected densely in the same fraction layer where the Vibrio protein was most present in the hemocytes and gills at 3 hpi. Furthermore, it was found that the expression of SpFLT-1 decreased to the base level following disappearance of the Vibrio protein at 6 hpi in the gills. Silencing SpFLT-1 inhibited the endocytosis rate of V. alginolyticus but overexpression of the gene could facilitate bacterial entry into the epithelioma papulosum cyprinid cells. Our study indicated that SpFLT-1 may act as a key protein involved in the process of bacterial infection and this sheds light on clarifying the pathogenesis of pathogens infecting S. paramamosain.	[Chen, Fangyi; Bo, Jun; Ma, Xiaowan; Dong, Lixia; Shan, Zhongguo; Cui, Qian; Chen, Huiyun; Wang, Kejian] Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; [Chen, Fangyi; Ma, Xiaowan; Dong, Lixia; Shan, Zhongguo; Cui, Qian; Chen, Huiyun; Wang, Kejian] Xiamen Univ, Fujian Collaborat Innovat Ctr Exploitat & Utiliza, Xiamen, Fujian, Peoples R China; [Chen, Fangyi; Ma, Xiaowan; Dong, Lixia; Shan, Zhongguo; Cui, Qian; Chen, Huiyun; Wang, Kejian] Xiamen Univ, Fujian Engn Lab Marine Bioprod & Technol, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Wang, KJ (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.	wkjian@xmu.edu.cn	Wang, KJ/G-4609-2010; Bo, Jun/ABG-7639-2020	Bo, Jun/0000-0002-8726-1654	National Natural Science Foundation of China (NSFC) [U1205123]; National Key Technology Support Program of China [2013BAD10B03-2]; 55th China Postdoctoral Science Foundation [2014M550354]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program of China(National Key Technology R&D Program); 55th China Postdoctoral Science Foundation	This study was supported by a grant (U1205123) from the National Natural Science Foundation of China (NSFC), a grant (2013BAD10B03-2) from National Key Technology Support Program of China and a grant (2014M550354) from the 55th China Postdoctoral Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Ait-Slimane T, 2009, MOL BIOL CELL, V20, P3792, DOI 10.1091/mbc.E09-04-0275; Amaddii M, 2012, J BIOL CHEM, V287, P7265, DOI 10.1074/jbc.M111.287599; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Campbell P A, 2001, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1406s12; Carcea I, 2010, J NEUROSCI, V30, P15317, DOI 10.1523/JNEUROSCI.1821-10.2010; Chen FY, 2010, FISH SHELLFISH IMMUN, V28, P167, DOI 10.1016/j.fsi.2009.10.017; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Ding J, 2013, AQUAC RES, P1; Ding J, 2013, GENOME, V56, P273, DOI 10.1139/gen-2013-0002; Duncan MJ, 2004, J BIOL CHEM, V279, P18944, DOI 10.1074/jbc.M400769200; Eto DS, 2008, CELL MICROBIOL, V10, P2553, DOI 10.1111/j.1462-5822.2008.01229.x; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Galbiati F, 1998, GENE, V210, P229, DOI 10.1016/S0378-1119(98)00064-X; Ge LA, 2011, P NATL ACAD SCI USA, V108, P551, DOI 10.1073/pnas.1014434108; Girardot N, 2003, NEUROPATH APPL NEURO, V29, P451, DOI 10.1046/j.1365-2990.2003.00479.x; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gomez V, 2010, J BIOL CHEM, V285, P20683, DOI 10.1074/jbc.M110.130591; Herreros J, 2001, MOL BIOL CELL, V12, P2947, DOI 10.1091/mbc.12.10.2947; Imjongjirak C, 2007, MOL IMMUNOL, V44, P3195, DOI 10.1016/j.molimm.2007.01.028; Imjongjirak C, 2009, MOL BIOL REP, V36, P841, DOI 10.1007/s11033-008-9253-0; Jacobowitz DM, 2004, NEUROTOX RES, V6, P245, DOI 10.1007/BF03033435; Kazlauskaite J, 2005, BIOCHEM SOC SYMP, V72, P211, DOI 10.1042/bss0720211; Korhonen JT, 2012, INFECT IMMUN, V80, P1072, DOI 10.1128/IAI.05528-11; Kumari S, 2010, CELL RES, V20, P256, DOI 10.1038/cr.2010.19; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Langui D, 2004, AM J PATHOL, V165, P1465, DOI 10.1016/S0002-9440(10)63405-0; Lee SY, 2002, FISH SHELLFISH IMMUN, V12, P421, DOI 10.1006/fsim.2002.0420; Liu HP, 2010, DEV COMP IMMUNOL, V34, P741, DOI 10.1016/j.dci.2010.02.005; Liu HP, 2010, FISH SHELLFISH IMMUN, V28, P862, DOI 10.1016/j.fsi.2010.02.008; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Ludwig A, 2010, J CELL BIOL, V191, P771, DOI 10.1083/jcb.201005140; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Moreno-Ruiz E, 2009, CELL MICROBIOL, V11, P1179, DOI 10.1111/j.1462-5822.2009.01319.x; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Moura T, 2011, MAR BIOL, V158, P401, DOI 10.1007/s00227-010-1568-4; Munderloh C, 2009, J NEUROSCI, V29, P6607, DOI 10.1523/JNEUROSCI.0870-09.2009; Nestorov P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056049; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Peng H, 2012, PROTEIN EXPRES PURIF, V82, P37, DOI 10.1016/j.pep.2011.11.008; Pust S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008844; Qu HD, 2013, BIOSCI BIOTECH BIOCH, V77, P103, DOI 10.1271/bbb.120600; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; Roy CR, 2003, NAT CELL BIOL, V5, P16, DOI 10.1038/ncb0103-16; Samuel BU, 2001, J BIOL CHEM, V276, P29319, DOI 10.1074/jbc.M101268200; Santamaria A, 2003, AM J PATHOL, V162, P897, DOI 10.1016/S0002-9440(10)63885-0; Saslowsky DE, 2010, J CLIN INVEST, V120, P4399, DOI 10.1172/JCI42958; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Swain P, 2009, FISH SHELLFISH IMMUN, V27, P89, DOI 10.1016/j.fsi.2009.04.008; Tomasovic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029739; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; von Philipsborn AC, 2005, J COMP NEUROL, V482, P257, DOI 10.1002/cne.20423; Xu WF, 2011, DEV COMP IMMUNOL, V35, P1076, DOI 10.1016/j.dci.2011.03.028	64	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133443	10.1371/journal.pone.0133443	http://dx.doi.org/10.1371/journal.pone.0133443			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186350	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700139
J	Cheng, CM; Nair, ADS; Jaworski, DC; Ganta, RR				Cheng, Chuanmin; Nair, Arathy D. S.; Jaworski, Deborah C.; Ganta, Roman R.			Mutations in Ehrlichia chaffeensis Causing Polar Effects in Gene Expression and Differential Host Specificities	PLOS ONE			English	Article							INFECTION; TRANSPOSON; TRANSMISSION; MUTAGENESIS; MUTANTS; BLOOD; LIVE	Ehrlichia chaffeensis, a tick-borne rickettsial, is responsible for human monocytic ehrlichiosis. In this study, we assessed E. chaffeensis insertion mutations impacting the transcription of genes near the insertion sites. We presented evidence that the mutations within the E. chaffeensis genome at four genomic locations cause polar effects in altering gene expressions. We also reported mutations causing attenuated growth in deer (the pathogen's reservoir host) and in dog (an incidental host), but not in its tick vector, Amblyomma americanum. This is the first study documenting insertion mutations in E. chaffeensis that cause polar effects in altering gene expression from the genes located upstream and downstream to insertion sites and the differential requirements of functionally active genes of the pathogen for its persistence in vertebrate and tick hosts. This study is important in furthering our knowledge on E. chaffeensis pathogenesis.	[Cheng, Chuanmin; Nair, Arathy D. S.; Jaworski, Deborah C.; Ganta, Roman R.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Ctr Excellence Vector Borne Dis, Manhattan, KS 66506 USA; [Jaworski, Deborah C.] Oklahoma State Univ, Noble Res Ctr, Dept Entomol & Plant Pathol, Stillwater, OK 74074 USA	Kansas State University; Oklahoma State University System; Oklahoma State University - Stillwater	Ganta, RR (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Ctr Excellence Vector Borne Dis, Manhattan, KS 66506 USA.	rganta@vet.ksu.edu			National Institutes of Health [AI070908]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070908, R01AI070908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AI070908 (http://projectreporter.nih.gov/project_info_description.cfm?aid=8704697&icde=23195389), National Institutes of Health, RRG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breitschwerdt EB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-298; Cartman ST, 2010, APPL ENVIRON MICROB, V76, P1103, DOI 10.1128/AEM.02525-09; Cheng CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003171; Cheng Chuanmin, 2008, Curr Protoc Microbiol, VChapter 3, DOI 10.1002/9780471729259.mc03a01s9; Conway T, 2014, MBIO, V5, DOI 10.1128/mBio.01442-14; Crosby FL, 2015, APPL ENVIRON MICROB, V81, P2206, DOI 10.1128/AEM.03241-14; Cuccui J, 2007, INFECT IMMUN, V75, P1186, DOI 10.1128/IAI.01240-06; Davidson WR, 2001, J WILDLIFE DIS, V37, P538, DOI 10.7589/0090-3558-37.3.538; DAWSON JE, 1991, J CLIN MICROBIOL, V29, P2741, DOI 10.1128/JCM.29.12.2741-2745.1991; Dugan VG, 2000, J CLIN MICROBIOL, V38, P448; DUMLER JS, 1993, CLIN INFECT DIS, V17, P903, DOI 10.1093/clinids/17.5.903; Felsheim RF, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-42; Hackett PB, 2010, MOL THER, V18, P674, DOI 10.1038/mt.2010.2; Hammac GK, 2013, VACCINE, V31, P3617, DOI 10.1016/j.vaccine.2013.04.069; Karim S, 2012, J MED ENTOMOL, V49, P547, DOI 10.1603/ME11214; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P6268, DOI 10.1093/nar/gki928; Kawula TH, 2004, APPL ENVIRON MICROB, V70, P6901, DOI 10.1128/AEM.70.11.6901-6904.2004; Kocan A, 2000, EMERG INFECT DIS, V6, P477, DOI 10.3201/eid0605.000505; McBride JW, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001730; McQuiston JH, 2000, TRANSFUSION, V40, P274, DOI 10.1046/j.1537-2995.2000.40030274.x; Nair ADS, 2015, INFECT IMMUN, V83, P2827, DOI 10.1128/IAI.00487-15; Nair ADS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109056; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Park KT, 2011, VACCINE, V29, P4709, DOI 10.1016/j.vaccine.2011.04.090; PATRICK CD, 1975, J MED ENTOMOL, V12, P389, DOI 10.1093/jmedent/12.3.389; Qin AP, 2004, APPL ENVIRON MICROB, V70, P2816, DOI 10.1128/AEM.70.5.2816-2822.2004; Sachdev SH, 2014, TRANSPL INFECT DIS, V16, P119, DOI 10.1111/tid.12172; SAMBROOK J, 2000, MOL CLONING LAB MANU; Sirigireddy KR, 2005, J MOL DIAGN, V7, P308, DOI 10.1016/S1525-1578(10)60559-4; Walker DH, 1996, EMERG INFECT DIS, V2, P18, DOI 10.3201/eid0201.960102; Yabsley MJ, 2010, VET PARASITOL, V167, P136, DOI 10.1016/j.vetpar.2009.09.015; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062454	32	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132657	10.1371/journal.pone.0132657	http://dx.doi.org/10.1371/journal.pone.0132657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186429	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700052
J	Nicolini, D; Mocchegiani, F; Palmonella, G; Coletta, M; Brugia, M; Montalti, R; Fava, G; Taccaliti, A; Risaliti, A; Vivarelli, M				Nicolini, Daniele; Mocchegiani, Federico; Palmonella, Gioia; Coletta, Martina; Brugia, Marina; Montalti, Roberto; Fava, Giammarco; Taccaliti, Augusto; Risaliti, Andrea; Vivarelli, Marco			Postoperative Insulin-Like Growth Factor 1 Levels Reflect the Graft's Function and Predict Survival after Liver Transplantation	PLOS ONE			English	Article							SINGLE-CENTER EXPERIENCE; I IGF-I; INDOCYANINE GREEN; BINDING-PROTEINS; CIRRHOSIS; SERUM; HORMONE; DYSFUNCTION; IGFBP-3; MORTALITY	Background The reduction of insulin-like growth factor 1 (IGF-1) plasma levels is associated with the degree of liver dysfunction and mortality in cirrhotic patients. However, little research is available on the recovery of the IGF-1 level and its prognostic role after liver transplantation (LT). Methods From April 2010 to May 2011, 31 patients were prospectively enrolled (25/6 M/F; mean age +/- SEM: 55.2 +/- 1.4 years), and IGF-1 serum levels were assessed preoperatively and at 15, 30, 90, 180 and 365 days after transplantation. The influence of the donor and recipient characteristics (age, use of extended criteria donor grafts, D-MELD and incidence of early allograft dysfunction) on hormonal concentration was analyzed. The prognostic role of IGF-1 level on patient survival and its correlation with routine liver function tests were also investigated. Results All patients showed low preoperative IGF-1 levels (mean +/- SEM: 29.5 +/- 2.1), and on postoperative day 15, a significant increase in the IGF-1 plasma level was observed (102.7 +/- 11.7 ng/ml; p<0.0001). During the first year after LT, the IGF-1 concentration remained significantly lower in recipients transplanted with older donors (>65 years) or extended criteria donor grafts. An inverse correlation between IGF-1 and bilirubin serum levels at day 15 (r = -0.3924, p = 0.0320) and 30 (r = -0.3894, p = 0.0368) was found. After multivariate analysis, early (within 15 days) IGF-1 normalization [Exp(b) = 3.913; p = 0.0484] was the only prognostic factor associated with an increased 3-year survival rate. Conclusion IGF-1 postoperative levels are correlated with the graft's quality and reflect liver function. Early IGF-1 recovery is associated with a higher 3-year survival rate after LT.	[Nicolini, Daniele; Mocchegiani, Federico; Coletta, Martina; Montalti, Roberto; Vivarelli, Marco] Polytech Univ Marche, Dept Gastroenterol & Transplantat, Div Hepatobiliary & Transplant Surg, Ancona, Italy; [Palmonella, Gioia; Taccaliti, Augusto] Polytech Univ Marche, Dept Clin & Mol Sci, Div Endocrinol, Ancona, Italy; [Brugia, Marina] AOU Osped Riuniti, Dept Serv, Div Lab Med, Ancona, Italy; [Fava, Giammarco] AOU Osped Riuniti, Dept Gastroenterol & Transplantat, Div Gastroenterol, Ancona, Italy; [Risaliti, Andrea] Univ Udine, Dept Med & Biol Sci, Div Liver & Kidney Transplant Surg, I-33100 Udine, Italy	Marche Polytechnic University; University of Udine	Mocchegiani, F (corresponding author), Polytech Univ Marche, Dept Gastroenterol & Transplantat, Div Hepatobiliary & Transplant Surg, Ancona, Italy.	federicomocchegiani@hotmail.com	Montalti, Roberto/AAF-5627-2019; NICOLINI, DANIELE/AAD-8241-2020; Palmonella, Gioia/K-3253-2018; Nicolini, Daniele/AAK-3717-2020	NICOLINI, DANIELE/0000-0002-5477-3346; Palmonella, Gioia/0000-0002-2983-8208; MOCCHEGIANI, FEDERICO/0000-0002-8833-5360; Fava, Giammarco/0000-0001-6757-1420; VIVARELLI, MARCO/0000-0003-0500-9461; Montalti, Roberto/0000-0002-3915-3851				Assy N, 2008, J HEPATOL, V49, P34, DOI 10.1016/j.jhep.2008.02.013; Barthel E, 2012, CLIN TRANSPLANT, V26, pE38, DOI 10.1111/j.1399-0012.2011.01516.x; Barshes NR, 2007, AM J TRANSPLANT, V7, P1265, DOI 10.1111/j.1600-6143.2007.01758.x; Baruch Y, 2000, J HEPATOL, V32, P505, DOI 10.1016/S0168-8278(00)80403-1; Bassanello M, 2004, LIVER TRANSPLANT, V10, P692, DOI 10.1002/lt.20111; Bonefeld K, 2011, LIVER INT, V31, P911, DOI 10.1111/j.1478-3231.2010.02428.x; Caregaro L, 1997, NUTRITION, V13, P185; Castro GRA, 2013, ANN TRANSPL, V18, P57, DOI 10.12659/AOT.883819; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; De Palo EF, 2001, CLIN CHIM ACTA, V310, P31, DOI 10.1016/S0009-8981(01)00511-3; Dehghani SM, 2012, EXP CLIN TRANSPLANT, V10, P252, DOI 10.6002/ect.2011.0095; Donaghy AJ, 2002, J HEPATOL, V36, P751, DOI 10.1016/S0168-8278(02)00049-1; Elmlinger MW, 2004, CLIN CHEM LAB MED, V42, P654, DOI 10.1515/CCLM.2004.112; Escorsell A, 2012, TRANSPL P, V44, P1539, DOI 10.1016/j.transproceed.2012.05.023; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Gruttadauria S, 2008, LIVER TRANSPLANT, V14, P220, DOI 10.1002/lt.21359; Halldorson JB, 2009, AM J TRANSPLANT, V9, P318, DOI 10.1111/j.1600-6143.2008.02491.x; Holt R I, 1998, Pediatr Transplant, V2, P76; Imber CJ, 2002, TRANSPLANTATION, V73, P701, DOI 10.1097/00007890-200203150-00008; Infante D, 1998, PEDIATR SURG INT, V13, P323, DOI 10.1007/s003830050330; Markmann JF, 2003, J AM COLL SURGEONS, V196, P566, DOI 10.1016/S1072-7515(02)01907-5; MOLLER S, 1995, J CLIN ENDOCR METAB, V80, P1148, DOI 10.1210/jc.80.4.1148; Monbaliu D, 2005, TRANSPLANT P, V37, P413, DOI 10.1016/j.transproceed.2004.12.103; Nikolic JA, 2000, CLIN CHIM ACTA, V294, P169, DOI 10.1016/S0009-8981(99)00254-5; O'Connor KG, 1998, J GERONTOL A-BIOL, V53, pM176, DOI 10.1093/gerona/53A.3.M176; Olthoff KM, 2010, LIVER TRANSPLANT, V16, P943, DOI 10.1002/lt.22091; RUSSELL WE, 1985, AM J PHYSIOL, V248, pE618, DOI 10.1152/ajpendo.1985.248.5.E618; Salso A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/240873; Schalch DS, 1998, METABOLISM, V47, P200, DOI 10.1016/S0026-0495(98)90221-9; Seehofer Daniel, 2002, Ann Transplant, V7, P32; Shaked A, 1997, CLIN CHEM, V43, P1539; Shen XY, 1998, J CLIN ENDOCR METAB, V83, P2532, DOI 10.1210/jc.83.7.2532; Siemens Healthcare Diagnostics Inc, 2013, IMM 2000 GROWTH HORM; Silva MA, 2008, TRANSPLANTATION, V85, P718, DOI 10.1097/TP.0b013e3181663366; Stockmann M, 2009, HEPATO-GASTROENTEROL, V56, P734; Sutton ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110642; Uemura T, 2007, LIVER TRANSPLANT, V13, P227, DOI 10.1002/lt.20992; Volzke H, 2009, EUR J ENDOCRINOL, V161, P705, DOI 10.1530/EJE-09-0374; Weber MM, 2002, HORM RES, V57, P105, DOI 10.1159/000057960; Wu YL, 2004, WORLD J GASTROENTERO, V10, P2740, DOI 10.3748/wjg.v10.i18.2740; Zietz B, 2003, EUR J GASTROEN HEPAT, V15, P495, DOI 10.1097/01.meg.0000059115.41030.e0	41	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133153	10.1371/journal.pone.0133153	http://dx.doi.org/10.1371/journal.pone.0133153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186540	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700101
J	Zhu, ZB; Zhu, JZ; Zhao, XR; Yang, K; Lu, L; Zhang, FR; Shen, WF; Zhang, RY				Zhu, Zhengbin; Zhu, Jinzhou; Zhao, Xiaoran; Yang, Ke; Lu, Lin; Zhang, Fengru; Shen, Weifeng; Zhang, Ruiyan			All-Trans Retinoic Acid Ameliorates Myocardial Ischemia/Reperfusion Injury by Reducing Cardiomyocyte Apoptosis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; REPERFUSION INJURY; EXPRESSION; MECHANISM; ISCHEMIA; INHIBITION; RECEPTORS; PATHWAYS; ADAM10; RAGE	Myocardial ischemia/reperfusion (I/R) injury interferes with the restoration of blood flow to ischemic myocardium. Oxidative stress-elicited apoptosis has been reported to contribute to I/R injury. All-trans retinoic acid (ATRA) has anti-apoptotic activity as previously reported. Here, we investigated the effects and the mechanism of action of ATRA on myocardial I/R injury both in vivo and in vitro. In vivo, ATRA reduced the size of the infarcted area (17.81 +/- 1.05% vs. 24.41 +/- 1.03%, P<0.05) and rescued cardiac function loss (ejection fraction 46.42 +/- 6.76% vs. 37.18 +/- 4.63%, P<0.05) after I/R injury. Flow-cytometric analysis and TUNEL assay demonstrated that the protective role of ATRA on myocardial I/R injury was related to its anti-apoptotic effects. The anti-apoptotic effects of ATRA were associated with partial inhibition of reactive oxygen species (ROS) production and significantly less phosphorylation of mitogen-activated protein kinases (MAPKs) including p38, JNK, and ERK. Western blot analysis also revealed that ATRA pre-treatment increased a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) expression (0.65 +/- 0.20 vs. 0.41 +/- 0.02 in vivo) and reduced the level of receptor for advanced glycation end-products (RAGE) (0.38 +/- 0.17 vs. 0.52 +/- 0.11 in vivo). Concomitantly, the protective role of ATRA on I/R injury was not observed in RAGE-KO mice. The current results indicated that ATRA could prevent myocardial injury and reduced cardiomyocyte apoptosis after I/R effectively. One possible mechanism underlying these effects is that ATRA could increase ADAM10 expression and thus cleave RAGE, which is the main receptor up-stream of MAPKs in myocardial I/R injury, resulting in the down-regulation of MAPK signaling and protective role on myocardial I/R injury.	[Zhu, Zhengbin; Zhu, Jinzhou; Zhao, Xiaoran; Lu, Lin; Zhang, Fengru; Shen, Weifeng; Zhang, Ruiyan] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Cardiol, Shanghai 200025, Peoples R China; [Zhu, Zhengbin; Zhu, Jinzhou; Zhao, Xiaoran; Yang, Ke; Lu, Lin; Shen, Weifeng; Zhang, Ruiyan] Shanghai Jiao Tong Univ, Sch Med, Inst Cardiovasc Dis, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, RY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Cardiol, Shanghai 200025, Peoples R China.	rjzhangruiyan@yahoo.cn	Zhang, Ruiyan/HHC-5329-2022	Yang, Ke/0000-0002-1870-1134	National Natural Science Foundation of China [81000050, 81300178, 81370401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grants 81000050, 81300178 and 81370401).	Amann PM, 2011, CURR MED CHEM, V18, P1405; Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Baines CP, 2011, J CARDIOVASC PHARM T, V16, P239, DOI 10.1177/1074248411407769; Bucciarelli LG, 2006, CIRCULATION, V113, P1226, DOI 10.1161/CIRCULATIONAHA.105.575993; Celay J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062771; Cicconi S, 2003, J CELL PHYSIOL, V195, P27, DOI 10.1002/jcp.10219; Clanachan AS, 2003, TRANSPLANTATION, V75, P173, DOI 10.1097/01.TP.0000040429.40245.3A; Gao F, 2002, CARDIOVASC RES, V53, P414, DOI 10.1016/S0008-6363(01)00488-6; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Komori R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061938; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Liu ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040943; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Rao JH, 2010, BIOL PHARM BULL, V33, P869, DOI 10.1248/bpb.33.869; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Reffelmann T, 2006, BASIC RES CARDIOL, V101, P359, DOI 10.1007/s00395-006-0615-2; Ren X, 2007, J NUTR BIOCHEM, V18, P832, DOI 10.1016/j.jnutbio.2006.12.023; Sanz Miguel A, 2006, Hematology Am Soc Hematol Educ Program, P147; Sanz-Rosa D, 2012, ANN NY ACAD SCI, V1254, P90, DOI 10.1111/j.1749-6632.2012.06501.x; Shang LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010092; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; Tsai FM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-15; Ueki S, 2008, J IMMUNOL, V181, P7689, DOI 10.4049/jimmunol.181.11.7689; Vanden Hoek TL, 2003, AM J PHYSIOL-HEART C, V284, pH141, DOI 10.1152/ajpheart.00132.2002; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; Woo AYH, 2005, CARDIOVASC RES, V65, P244, DOI 10.1016/j.cardiores.2004.09.027; Yan SF, 2010, CIRC RES, V106, P842, DOI 10.1161/CIRCRESAHA.109.212217; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhao ZQ, 2004, CURR OPIN PHARMACOL, V4, P159, DOI 10.1016/j.coph.2003.10.010; Zhu HL, 2011, EXP MOL MED, V43, P437, DOI 10.3858/emm.2011.43.8.049	31	26	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133414	10.1371/journal.pone.0133414	http://dx.doi.org/10.1371/journal.pone.0133414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186635	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700135
J	Pauletti, RB; Stynen, APR; Mol, JPD; Dorneles, EMS; Alves, TM; Souto, MDM; Minharro, S; Heinemann, MB; Lage, AP				Pauletti, Rebeca Barbosa; Reinato Stynen, Ana Paula; da Silva Mol, Juliana Pinto; Seles Dorneles, Elaine Maria; Alves, Telma Maria; Moura Souto, Monalisa de Sousa; Minharro, Silvia; Heinemann, Marcos Bryan; Lage, Andrey Pereira			Reduced Susceptibility to Rifampicin and Resistance to Multiple Antimicrobial Agents among Brucella abortus Isolates from Cattle in Brazil	PLOS ONE			English	Article							ANTIBIOTIC SUSCEPTIBILITY; MELITENSIS; QUINOLONES; ASSAY; PCR	This study aimed to determine the susceptibility profile of Brazilian Brucella abortus isolates from cattle to eight antimicrobial agents that are recommended for the treatment of human brucellosis and to correlate the susceptibility patterns with origin, biotype and MLVA16-genotype of the strains. Screening of 147 B. abortus strains showed 100% sensitivity to doxycycline and ofloxacin, one (0.68%) strain resistant to ciprofloxacin, two strains (1.36%) resistant to streptomycin, two strains (1.36%) resistant to trimethoprim-sulfamethoxazole and five strains (3.40%) resistant to gentamicin. For rifampicin, three strains (2.04%) were resistant and 54 strains (36.73%) showed reduced sensitivity. Two strains were considered multidrug resistant. In conclusion, the majority of B. abortus strains isolated from cattle in Brazil were sensitive to the antimicrobials commonly used for the treatment of human brucellosis; however, a considerable proportion of strains showed reduced susceptibility to rifampicin and two strains were considered multidrug resistant. Moreover, there was no correlation among the drug susceptibility pattern, origin, biotype and MLVA16-genotypes of these strains.	[Pauletti, Rebeca Barbosa; Reinato Stynen, Ana Paula; da Silva Mol, Juliana Pinto; Seles Dorneles, Elaine Maria; Alves, Telma Maria; Moura Souto, Monalisa de Sousa; Lage, Andrey Pereira] Univ Fed Minas Gerais, Escola Vet, Belo Horizonte, MG, Brazil; [Minharro, Silvia] Univ Fed Tocantins, Escola Med Vet & Zootecnia, Araguaina, Tocantins, Brazil; [Heinemann, Marcos Bryan] Univ Sao Paulo, Fac Med Vet & Zootecnia, Sao Paulo, Brazil	Universidade Federal de Minas Gerais; Universidade Federal do Tocantins (UFT); Universidade de Sao Paulo	Lage, AP (corresponding author), Univ Fed Minas Gerais, Escola Vet, Belo Horizonte, MG, Brazil.	alage@vet.ufmg.br	Minharro, Silvia SM/K-9933-2015; Dorneles, Elaine/V-2816-2019; Heinemann, Marcos Bryan/AAI-9390-2020; Dorneles, Elaine/J-1115-2016; Heinemann, Marcos B/G-2780-2015	Dorneles, Elaine/0000-0002-2753-1296; Heinemann, Marcos Bryan/0000-0001-6444-9788; Heinemann, Marcos B/0000-0001-6444-9788; Mol, Juliana/0000-0002-6946-8213; Minharro, Silvia/0000-0001-5844-5326	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-Fapemig; Fundacao de Estudo e Pesquisa em Medicina Veterinaria e Zootecnia-FEP-MVZ; Coordenacao de Aperfeicoamento do Pessoal de Ensino Superior-Capes	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-Fapemig(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Estudo e Pesquisa em Medicina Veterinaria e Zootecnia-FEP-MVZ; Coordenacao de Aperfeicoamento do Pessoal de Ensino Superior-Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-Fapemig and Fundacao de Estudo e Pesquisa em Medicina Veterinaria e Zootecnia-FEP-MVZ. RBP and MSMS are indebted with Coordenacao de Aperfeicoamento do Pessoal de Ensino Superior-Capes for their fellowships. APRS, JPSM, EMSD and APL had fellowships from CNPq.	Abdel-Maksoud M, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-24; Ariza J, 2007, PLOS MED, V4, P1872, DOI 10.1371/journal.pmed.0040317; BAILY GG, 1992, J TROP MED HYG, V95, P271; Bayram Y, 2011, INT J MED SCI, V8, P198, DOI 10.7150/ijms.8.198; Berkelman RL, 2003, CLIN INFECT DIS, V37, P407, DOI 10.1086/375595; Braibant M, 2002, ANTIMICROB AGENTS CH, V46, P3050, DOI 10.1128/AAC.46.9.3050-3053.2002; BRICKER BJ, 1994, J CLIN MICROBIOL, V32, P2660, DOI 10.1128/JCM.32.11.2660-2666.1994; CLSI, 2014, METH ANT DIL DISK SU; CLSI, 2007, M100S17 CLSI; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; GARCIARODRIGUEZ JA, 1991, ANTIMICROB AGENTS CH, V35, P756, DOI 10.1128/AAC.35.4.756; Jiang H, 2010, T ROY SOC TROP MED H, V104, P796, DOI 10.1016/j.trstmh.2010.08.002; Kocagoz S, 2002, CLIN MICROBIOL INFEC, V8, P240, DOI 10.1046/j.1469-0691.2002.00416.x; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Lopez-Goni I, 2008, J CLIN MICROBIOL, V46, P3484, DOI 10.1128/JCM.00837-08; Lopez-Merino A, 2004, SCAND J INFECT DIS, V36, P636, DOI 10.1080/00365540410020767; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Marianelli C, 2004, J CLIN MICROBIOL, V42, P5439, DOI 10.1128/JCM.42.12.5439-5443.2004; Marianelli C, 2007, J CLIN MICROBIOL, V45, P2923, DOI 10.1128/JCM.00822-07; Maves RC, 2011, ANTIMICROB AGENTS CH, V55, P1279, DOI 10.1128/AAC.00979-10; Memish Z, 2000, J INFECTION, V40, P59, DOI 10.1053/jinf.1999.0586; Minharro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081152; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Poester FP, 2002, VET MICROBIOL, V90, P55, DOI 10.1016/S0378-1135(02)00245-6; Radostits O., 2007, VET MED TXB DIS CATT, V10; Ramos TRR, 2008, BRAZ J INFECT DIS, V12, P133, DOI 10.1590/S1413-86702008000200007; Skalsky K, 2008, BMJ-BRIT MED J, V336, P701, DOI 10.1136/bmj.39497.500903.25; Souza A P, 1977, Rev Saude Publica, V11, P238; Turkmani Aun, 2006, Ann Clin Microbiol Antimicrob, V5, P24, DOI 10.1186/1476-0711-5-24; Van Bambeke F, 2003, J ANTIMICROB CHEMOTH, V51, P1055, DOI 10.1093/jac/dkg224; Verger JM, 1988, TECHNIQUES BRUCELLOS	31	14	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132532	10.1371/journal.pone.0132532	http://dx.doi.org/10.1371/journal.pone.0132532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181775	gold, Green Submitted, Green Published			2022-12-27	WOS:000358198200022
J	Takahara, B; Takahashi, KH				Takahara, Baku; Takahashi, Kazuo H.			Genome-Wide Association Study on Male Genital Shape and Size in Drosophila melanogaster	PLOS ONE			English	Article							MALE FERTILIZATION SUCCESS; GENETIC ARCHITECTURE; SEXUAL SELECTION; MATING-BEHAVIOR; MORPHOLOGY; SIMULANS; PHOSPHODIESTERASES; DIFFERENCE; EVOLUTION; TRAITS	Male genital morphology of animals with internal fertilization and promiscuous mating systems have been one of the most diverse and rapidly evolving morphological traits. The male genital morphology in general is known to have low phenotypic and genetic variations, but the genetic basis of the male genital variation remains unclear. Drosophila melanogaster and its closely related species are morphologically very similar, but the shapes of the posterior lobe, a cuticular projection on the male genital arch are distinct from each other, representing a model system for studying the genetic basis of male genital morphology. In this study, we used highly inbred whole genome sequenced strains of D. melanogaster to perform genome wide association analysis on posterior lobe morphology. We quantified the outline shape of posterior lobes with Fourier coefficients obtained from elliptic Fourier analysis and performed principal component analysis, and posterior lobe size. The first and second principal components (PC1 and PC2) explained approximately 88% of the total variation of the posterior lobe shape. We then examined the association between the principal component scores and posterior lobe size and 1902142 single nucleotide polymorphisms (SNPs). As a result, we obtained 15, 14 and 15 SNPs for PC1, PC2 and posterior lobe size with P-values smaller than 10-5. Based on the location of the SNPs, 13, 13 and six protein coding genes were identified as potential candidates for PC1, PC2 and posterior lobe size, respectively. In addition to the previous findings showing that the intraspecific posterior shape variation are regulated by multiple QTL with strong effects, the present study suggests that the intraspecific variation may be under polygenic regulation with a number of loci with small effects. Further studies are required for investigating whether these candidate genes are responsible for the intraspecific posterior lobe shape variation.	[Takahara, Baku] Okayama Univ, Fac Agr, Kita Ku, Okayama 7008530, Japan; [Takahashi, Kazuo H.] Okayama Univ, Grad Sch Environm Sci, Kita Ku, Okayama 7008530, Japan	Okayama University; Okayama University	Takahashi, KH (corresponding author), Okayama Univ, Grad Sch Environm Sci, Kita Ku, Tsushima Naka 1-1-1, Okayama 7008530, Japan.	kaz_tak@cc.okayama-u.ac.jp		Takahashi, Kazuo/0000-0002-1353-4971	 [25440212]		This study was supported by Grant-in-Aid for Scientific Research (C) (25440212).	Arnqvist G, 1998, ACTA ZOOL ACAD SCI H, V44, P73; Arnqvist G, 1999, EVOLUTION, V53, P147, DOI [10.2307/2640927, 10.1111/j.1558-5646.1999.tb05340.x]; Arnqvist G, 1998, GENET RES, V71, P193, DOI 10.1017/S0016672398003279; Ashburner M., 2004, DROSOPHILA LAB HDB; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonhomme V, 2014, J STAT SOFTW, V56, P1; Chatterjee SS, 2011, DEVELOPMENT, V138, P1099, DOI 10.1242/dev.055731; Danielsson I, 1999, BEHAV ECOL SOCIOBIOL, V46, P149, DOI 10.1007/s002650050604; Day JP, 2005, BIOCHEM J, V388, P333, DOI 10.1042/BJ20050057; Eberhard W.G., 1985, SEXUAL SELECTION ANI; Eberhard WG, 2001, EVOLUTION, V55, P93, DOI 10.1111/j.0014-3820.2001.tb01275.x; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; House CM, 2003, P ROY SOC B-BIOL SCI, V270, P447, DOI 10.1098/rspb.2002.2266; Inagaki S, 2005, GENES CELLS, V10, P1163, DOI 10.1111/j.1365-2443.2005.00910.x; Jagadeeshan S, 2006, J EVOLUTION BIOL, V19, P1058, DOI 10.1111/j.1420-9101.2006.01099.x; Kamimura Y, 2011, ENTOMOL SCI, V14, P399, DOI 10.1111/j.1479-8298.2011.00467.x; Khazaeli AA, 2010, EVOLUTION, V64, P3409, DOI 10.1111/j.1558-5646.2010.01139.x; Kleppisch Thomas, 2009, V191, P71, DOI 10.1007/978-3-540-68964-5_5; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; LeVasseur-Viens H, 2015, EVOLUTION; Liu J, 1996, GENETICS, V142, P1129; Macdonald SJ, 1999, GENETICS, V153, P1683; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Masly JP, 2014, EVOLUTION, V68, P2401, DOI 10.1111/evo.12436; Masly JP, 2011, GENETICS, V189, P357, DOI 10.1534/genetics.111.130815; McNeil CL, 2011, G3-GENES GENOM GENET, V1, P343, DOI 10.1534/g3.111.000661; Morton DB, 2010, GENETICS, V186, P159, DOI 10.1534/genetics.110.118018; Morton DB, 2002, ADV INSECT PHYSIOL, V29, P1, DOI 10.1016/S0065-2806(02)29001-3; Otronen M, 1998, BEHAV ECOL SOCIOBIOL, V42, P185, DOI 10.1007/s002650050430; Rasband W., 2006, IMAGEJ; Shingleton AW, 2009, P ROY SOC B-BIOL SCI, V276, P2625, DOI 10.1098/rspb.2008.1796; Tanaka KM, 2015, GENETICS, V200, P357, DOI 10.1534/genetics.114.174045; Turner MJ, 2005, PHYSIOL GENOMICS, V22, P76, DOI 10.1152/physiolgenomics.00243.2004; Zeng ZB, 2000, GENETICS, V154, P299	35	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132846	10.1371/journal.pone.0132846	http://dx.doi.org/10.1371/journal.pone.0132846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182199	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198200043
J	Chugh, D; Ali, I; Bakochi, A; Bahonjic, E; Etholm, L; Ekdahl, CT				Chugh, Deepti; Ali, Idrish; Bakochi, Anahita; Bahonjic, Elma; Etholm, Lars; Ekdahl, Christine T.			Alterations in Brain Inflammation, Synaptic Proteins, and Adult Hippocampal Neurogenesis during Epileptogenesis in Mice Lacking Synapsin2	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; CELL-ADHESION MOLECULE; I-DEFICIENT MICE; KNOCK-OUT MICE; INHIBITORY SYNAPSES; STATUS EPILEPTICUS; RECEPTOR SUBUNITS; DENTATE GYRUS; NEUROTRANSMITTER RELEASE; COTRANSPORTER KCC2	Synapsins are pre-synaptic vesicle-associated proteins linked to the pathogenesis of epilepsy through genetic association studies in humans. Deletion of synapsins causes an excitatory/inhibitory imbalance, exemplified by the epileptic phenotype of synapsin knock-out mice. These mice develop handling-induced tonic-clonic seizures starting at the age of about 3 months. Hence, they provide an opportunity to study epileptogenic alterations in a temporally controlled manner. Here, we evaluated brain inflammation, synaptic protein expression, and adult hippocampal neurogenesis in the epileptogenic (1 and 2 months of age) and tonic-clonic (3.5-4 months) phase of synapsin 2 knockout mice using immunohistochemical and biochemical assays. In the epileptogenic phase, region-specific microglial activation was evident, accompanied by an increase in the chemokine receptor CX3CR1, interleukin-6, and tumor necrosis factor-alpha, and a decrease in chemokine keratinocyte chemoattractant/ growth-related oncogene. Both post-synaptic density-95 and gephyrin, scaffolding proteins at excitatory and inhibitory synapses, respectively, showed a significant up-regulation primarily in the cortex. Furthermore, we observed an increase in the inhibitory adhesion molecules neuroligin-2 and neurofascin and potassium chloride co-transporter KCC2. Decreased expression of gamma-aminobutyric acid receptor-delta subunit and cholecystokinin was also evident. Surprisingly, hippocampal neurogenesis was reduced in the epileptogenic phase. Taken together, we report molecular alterations in brain inflammation and excitatory/inhibitory balance that could serve as potential targets for therapeutics and diagnostic biomarkers. In addition, the regional differences in brain inflammation and synaptic protein expression indicate an epileptogenic zone from where the generalized seizures in synapsin 2 knockout mice may be initiated or spread.	[Chugh, Deepti; Ali, Idrish; Bakochi, Anahita; Ekdahl, Christine T.] Lund Univ, Div Clin Neurophysiol, Inflammat & Stem Cell Therapy Grp, SE-22184 Lund, Sweden; [Chugh, Deepti; Ali, Idrish; Bakochi, Anahita; Ekdahl, Christine T.] Lund Univ, Lund Epilepsy Ctr, SE-22184 Lund, Sweden; [Bahonjic, Elma; Etholm, Lars] Univ Oslo, Inst Basic Med Sci, Dept Physiol, Oslo, Norway; [Etholm, Lars] Oslo Univ Hosp, Clin Neurophysiol Sect, Dept Neurol, Oslo, Norway	Lund University; Lund University; University of Oslo; University of Oslo	Ekdahl, CT (corresponding author), Lund Univ, Div Clin Neurophysiol, Inflammat & Stem Cell Therapy Grp, SE-22184 Lund, Sweden.	Christine.Ekdahl_Clementson@med.lu.se	Ali, Idrish/P-4989-2018; Ali, Idrish/K-1706-2015	Ali, Idrish/0000-0002-0971-4654; Ali, Idrish/0000-0002-0971-4654; Bakochi, Anahita/0000-0001-8144-8525	Swedish Research Council; ALF Grant; Zoega's Foundation; O. E. and Edla Johanssons Scientific Foundation; Tore Nilson's Foundation; Ahlen's Foundation; European Union's Seventh Framework Programme (FP7) [602102]	Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF Grant; Zoega's Foundation; O. E. and Edla Johanssons Scientific Foundation; Tore Nilson's Foundation; Ahlen's Foundation; European Union's Seventh Framework Programme (FP7)	This work was supported by the Swedish Research Council, ALF Grant for funding for medical training and research, Zoega's Foundation, O. E. and Edla Johanssons Scientific Foundation, Tore Nilson's Foundation, and Ahlen's Foundation. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no602102 (EPITARGET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali I, 2015, NEUROBIOL DIS, V74, P194, DOI 10.1016/j.nbd.2014.11.009; Avdic U, 2014, CELLULAR MOLECULAR I; Avoli M, 1996, J NEUROSCI, V16, P3912; Baldelli P, 2007, J NEUROSCI, V27, P13520, DOI 10.1523/JNEUROSCI.3151-07.2007; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Bonde S, 2006, EUR J NEUROSCI, V23, P965, DOI 10.1111/j.1460-9568.2006.04635.x; Chiappalone M, 2009, CEREB CORTEX, V19, P1422, DOI 10.1093/cercor/bhn182; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Chugh D, 2013, EXP NEUROL, V250, P176, DOI 10.1016/j.expneurol.2013.09.005; Corradi A, 2008, J CELL SCI, V121, P3042, DOI 10.1242/jcs.035063; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Delattre V, 2013, SCI REP-UK, V3, DOI 10.1038/srep02897; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Etholm L, 2013, EXP NEUROL, V247, P59, DOI 10.1016/j.expneurol.2013.03.025; Etholm L, 2012, EPILEPSY RES, V99, P252, DOI 10.1016/j.eplepsyres.2011.12.004; Etholm L, 2011, BRAIN RES, V1383, P270, DOI 10.1016/j.brainres.2011.01.070; Etholm L, 2009, EPILEPSY BEHAV, V14, P582, DOI 10.1016/j.yebeh.2009.02.021; Ferreira A, 1998, MOL MED, V4, P22, DOI 10.1007/BF03401726; Fritschy JM, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.005.2008; Garcia CC, 2004, J MED GENET, V41, P183, DOI 10.1136/jmg.2003.013680; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; GONZALEZ M, 2013, PUBMED CENTRAL, P85234, DOI DOI 10.3389/FNCEL.2013.00113; Gonzalez MI, 2013, EPILEPSIA, V54, P616, DOI 10.1111/epi.12063; Greco B, 2013, BEHAV BRAIN RES, V251, P65, DOI 10.1016/j.bbr.2012.12.015; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008; Jackson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035557; Jedlicka P, 2013, BRAIN STRUCTURE FUNC; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Kao HT, 2008, J COMP NEUROL, V507, P1860, DOI 10.1002/cne.21643; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Ketzef M, 2011, NEUROSCIENCE, V189, P108, DOI 10.1016/j.neuroscience.2011.05.030; Knuesel I, 2001, EUR J NEUROSCI, V13, P1113, DOI 10.1046/j.0953-816x.2001.01476.x; Kriebel M, 2011, J BIOL CHEM, V286, P24385, DOI 10.1074/jbc.M110.212191; Lakhan R, 2010, SYNAPSE, V64, P403, DOI 10.1002/syn.20740; Lehrmann E, 1997, J COMP NEUROL, V386, P461; Li H, 2007, NEURON, V56, P1019, DOI 10.1016/j.neuron.2007.10.039; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Limatola C, 2000, P NATL ACAD SCI USA, V97, P6197, DOI 10.1073/pnas.090105997; Medrihan L, 2014, CEREBRAL CORTEX; Medrihan L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2515; Mohapel P, 2004, NEUROBIOL DIS, V15, P196, DOI 10.1016/j.nbd.2003.11.010; Murashima YL, 2010, EPILEPSIA, V51, P131, DOI 10.1111/j.1528-1167.2010.02627.x; Noda M, 2011, J BIOL CHEM, V286, P2308, DOI 10.1074/jbc.M110.169839; Omari KM, 2009, AM J PATHOL, V174, P164, DOI 10.2353/ajpath.2009.080350; Parent JM, 1997, J NEUROSCI, V17, P3727; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P231, DOI 10.1007/s13311-014-0257-2; Poduri A, 2011, CURR OPIN GENET DEV, V21, P325, DOI 10.1016/j.gde.2011.01.005; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Roseti C, 2013, EPILEPSIA, V54, P1834, DOI 10.1111/epi.12354; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schuele SU, 2008, LANCET NEUROL, V7, P514, DOI 10.1016/S1474-4422(08)70108-X; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Sun CC, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-23; Tretter V, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00023; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Wood JC, 2011, EXP NEUROL, V229, P484, DOI 10.1016/j.expneurol.2011.03.019; Yeo SI, 2011, J NEUROIMMUNOL, V234, P93, DOI 10.1016/j.jneuroim.2011.03.005; Ying Z, 2004, EPILEPSIA, V45, P314, DOI 10.1111/j.0013-9580.2004.37703.x; Yu TS, 2014, NEUROSCIENTIST REV J	69	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132366	10.1371/journal.pone.0132366	http://dx.doi.org/10.1371/journal.pone.0132366			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177381	Green Published, gold			2022-12-27	WOS:000358197600106
J	Croes, M; Oner, FC; Kruyt, MC; Blokhuis, TJ; Bastian, O; Dhert, WJA; Alblas, J				Croes, Michiel; Oner, F. Cumhur; Kruyt, Moyo C.; Blokhuis, Taco J.; Bastian, Okan; Dhert, Wouter J. A.; Alblas, Jacqueline			Proinflammatory Mediators Enhance the Osteogenesis of Human Mesenchymal Stem Cells after Lineage Commitment	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTORS; ACTIVATED PROTEIN-KINASE; MARROW STROMAL CELLS; TNF-ALPHA; IN-VITRO; OSTEOBLAST DIFFERENTIATION; BONE REGENERATION; TISSUE REGENERATION; ENGINEERED BONE	Several inflammatory processes underlie excessive bone formation, including chronic inflammation of the spine, acute infections, or periarticular ossifications after trauma. This suggests that local factors in these conditions have osteogenic properties. Mesenchymal stem cells (MSCs) and their differentiated progeny contribute to bone healing by synthesizing extracellular matrix and inducing mineralization. Due to the variation in experimental designs used in vitro, there is controversy about the osteogenic potential of proinflammatory factors on MSCs. Our goal was to determine the specific conditions allowing the pro-osteogenic effects of distinct inflammatory stimuli. Human bone marrow MSCs were exposed to tumor necrosis factor alpha (TNF-alpha) and lipopolysaccharide (LPS). Cells were cultured in growth medium or osteogenic differentiation medium. Alternatively, bone morphogenetic protein 2 (BMP-2) was used as osteogenic supplement to simulate the conditions in vivo. Alkaline phosphatase activity and calcium deposition were indicators of osteogenicity. To elucidate lineage commitment-dependent effects, MSCs were pre-differentiated prior treatment. Our results show that TNF-a and LPS do not affect the expression of osteogenic markers by MSCs in the absence of an osteogenic supplement. In osteogenic differentiation medium or together with BMP-2 however, these mediators highly stimulated their alkaline phosphatase activity and subsequent matrix mineralization. In pre-osteoblasts, matrix mineralization was significantly increased by these mediators, but irrespective of the culture conditions. Our study shows that inflammatory factors potently enhance the osteogenic capacity of MSCs. These properties may be harnessed in bone regenerative strategies. Importantly, the commitment of MSCs to the osteogenic lineage greatly enhances their responsiveness to inflammatory signals.	[Croes, Michiel; Oner, F. Cumhur; Kruyt, Moyo C.; Dhert, Wouter J. A.; Alblas, Jacqueline] Univ Med Ctr Utrecht, Dept Orthoped, Utrecht, Netherlands; [Blokhuis, Taco J.; Bastian, Okan] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands; [Dhert, Wouter J. A.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University	Alblas, J (corresponding author), Univ Med Ctr Utrecht, Dept Orthoped, Utrecht, Netherlands.	j.alblas@umcutrecht.nl		Alblas, Jacqueline/0000-0002-2996-9697; Dhert, Wouter/0000-0001-9150-6143; Croes, Michiel/0000-0002-0270-8905				Arrington ED, 1996, CLIN ORTHOP RELAT R, P300, DOI 10.1097/00003086-199608000-00037; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Balboni TA, 2006, INT J RADIAT ONCOL, V65, P1289, DOI 10.1016/j.ijrobp.2006.03.053; Bandow K, 2010, BIOCHEM BIOPH RES CO, V402, P755, DOI 10.1016/j.bbrc.2010.10.103; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189; Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007; Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ding J, 2009, LIFE SCI, V84, P499, DOI 10.1016/j.lfs.2009.01.013; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eijken M, 2006, MOL CELL ENDOCRINOL, V248, P87, DOI 10.1016/j.mce.2005.11.034; Gawlitta D, 2012, TISSUE ENG PT A, V18, P208, DOI [10.1089/ten.tea.2010.0731, 10.1089/ten.TEA.2010.0731]; Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Geusens P, 2013, CURRENT OPINION RHEU; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Hess K, 2009, BONE, V45, P367, DOI 10.1016/j.bone.2009.04.252; Huang H, 2011, CELL PROLIFERAT, V44, P420, DOI 10.1111/j.1365-2184.2011.00769.x; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Lacey DC, 2009, OSTEOARTHR CARTILAGE, V17, P735, DOI 10.1016/j.joca.2008.11.011; Langenbach F, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt328; LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81; Li CH, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt456; Lories RJU, 2012, RHEUM DIS CLIN N AM, V38, P555, DOI 10.1016/j.rdc.2012.08.003; Lu ZF, 2012, STEM CELLS DEV, V21, P2420, DOI 10.1089/scd.2011.0589; Mo IFY, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-52; Mountziaris PM, 2008, TISSUE ENG PART B-RE, V14, P179, DOI 10.1089/ten.teb.2008.0038; Mountziaris PM, 2011, TISSUE ENG PART B-RE, V17, P393, DOI [10.1089/ten.teb.2011.0182, 10.1089/ten.TEB.2011.0182]; Osyczka AM, 2004, CELLS TISSUES ORGANS, V176, P109, DOI 10.1159/000075032; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Prins HJ, 2014, STEM CELL RES, V12, P428, DOI 10.1016/j.scr.2013.12.001; Rundle CH, 2006, BONE, V38, P521, DOI 10.1016/j.bone.2005.09.015; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Schmidt-Bleek K, 2014, EXPERT OPIN BIOL TH, V14, P247, DOI 10.1517/14712598.2014.857653; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563; Vincent C, 2009, J BONE MINER RES, V24, P1434, DOI [10.1359/jbmr.090305, 10.1359/JBMR.090305]; Yang X, 2007, BONE, V41, P928, DOI 10.1016/j.bone.2007.07.022	43	53	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132781	10.1371/journal.pone.0132781	http://dx.doi.org/10.1371/journal.pone.0132781			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176237	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600155
J	Crowley, TJ; Dalwani, MS; Mikulich-Gilbertson, SK; Young, SE; Sakai, JT; Raymond, KM; McWilliams, SK; Roark, MJ; Banich, MT				Crowley, Thomas J.; Dalwani, Manish S.; Mikulich-Gilbertson, Susan K.; Young, Susan E.; Sakai, Joseph T.; Raymond, Kristen M.; McWilliams, Shannon K.; Roark, Melissa J.; Banich, Marie T.			Adolescents' Neural Processing of Risky Decisions: Effects of Sex and Behavioral Disinhibition	PLOS ONE			English	Article							PURE CONDUCT DISORDER; PREFRONTAL CORTEX; EXTERNALIZING DISORDERS; RESPONSE-INHIBITION; BRAIN ABNORMALITIES; GENDER-DIFFERENCES; COGNITIVE CONTROL; MENTAL-DISORDER; FRONTAL-CORTEX; SUBSTANCE USE	Background Accidental injury and homicide, relatively common among adolescents, often follow risky behaviors; those are done more by boys and by adolescents with greater behavioral disinhibition (BD). Hypothesis Neural processing during adolescents' risky decision-making will differ in youths with greater BD severity, and in males vs. females, both before cautious behaviors and before risky behaviors. Methodology/Principal Findings 81 adolescents (Patients with substance and conduct problems, and comparison youths (Comparisons)), assessed in a 2 x 2 design (Patients: Comparisons x Male: Female) repeatedly decided between doing a cautious behavior that earned 1 cent, or a risky one that either won 5 or lost 10 cents. Odds of winning after risky responses gradually decreased. Functional magnetic resonance imaging captured brain activity during 4-sec deliberation periods preceding responses. Most neural activation appeared in known decision-making structures. Patients, who had more severe BD scores and clinical problems than Comparisons, also had extensive neural hypoactivity. Comparisons' greater activation before cautious responses included frontal pole, medial prefrontal cortex, striatum, and other regions; and before risky responses, insula, temporal, and parietal regions. Males made more risky and fewer cautious responses than females, but before cautious responses males activated numerous regions more than females. Before risky behaviors female-greater activation was more posterior, and male-greater more anterior. Conclusions/Significance Neural processing differences during risky-cautious decision-making may underlie group differences in adolescents' substance-related and antisocial risk-taking. Patients reported harmful real-life decisions and showed extensive neural hypoactivity during risky-or-cautious decision-making. Males made more risky responses than females; apparently biased toward risky decisions, males (compared with females) utilized many more neural resources to make and maintain cautious decisions, indicating an important risk-related brain sexual dimorphism. The results suggest new possibilities for prevention and management of excessive, dangerous adolescent risk-taking.	[Crowley, Thomas J.; Dalwani, Manish S.; Mikulich-Gilbertson, Susan K.; Young, Susan E.; Sakai, Joseph T.; Raymond, Kristen M.; McWilliams, Shannon K.; Roark, Melissa J.] Univ Colorado, Dept Psychiat, Div Subst Dependence, Denver, CO 80202 USA; [Banich, Marie T.] Univ Colorado, Inst Cognit Sci, Dept Psychol, Boulder, CO 80309 USA; [Banich, Marie T.] Univ Colorado, Inst Cognit Sci, Dept Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Crowley, TJ (corresponding author), Univ Colorado, Dept Psychiat, Div Subst Dependence, Denver, CO 80202 USA.	thomas.crowley@ucdenver.edu	Sakai, Joseph/AAH-5984-2020	BANICH, MARIE/0000-0001-9373-9194; Sakai, Joseph/0000-0003-1600-6100	National Institute on Drug Abuse [DA 009842, 011015, 034604, 031761]; Kane Family Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031761, R37DA009842, R01DA034604, R01DA009842, P60DA011015] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Kane Family Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by National Institute on Drug Abuse (www.nida.nih.gov) grants DA 009842, 011015, 034604, and 031761, and by the Kane Family Foundation (kanefamilyfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni E, 2013, P NATL ACAD SCI USA, V110, P6223, DOI 10.1073/pnas.1219302110; Aizer A, 2015, Q J ECON, V130, P759, DOI 10.1093/qje/qjv003; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; [Anonymous], 2002, MUNST T2T CONV ATL; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Bamford NS, 2008, NEURON, V58, P89, DOI 10.1016/j.neuron.2008.01.033; Baum K, 2005, JUVENILE VICTIMIZATI; Blair RJR, 2013, NAT REV NEUROSCI, V14, P786, DOI 10.1038/nrn3577; Buckholtz JW, 2010, NAT NEUROSCI, V13, P419, DOI 10.1038/nn.2510; Centers for Disease Control and Prevention FastStats, LEAD CAUS DEATHS LES; Chouinard PA, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00173; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Crowley TJ, 2010, ENCYCLOPEDIA OF BEHAVIORAL NEUROSCIENCE, VOL 1: A-G, P101; Crowley TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012835; Crowley TJ, 2006, J AM ACAD CHILD PSY, V45, P175, DOI 10.1097/01.chi.0000188893.60551.31; Cservenka A, 2013, NEUROIMAGE, V66, P184, DOI 10.1016/j.neuroimage.2012.11.003; Dalwani M, 2011, DRUG ALCOHOL DEPEN, V118, P295, DOI 10.1016/j.drugalcdep.2011.04.006; De Brito SA, 2009, BRAIN, V132, P843, DOI 10.1093/brain/awp011; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Du YPP, 2007, MAGN RESON MED, V57, P396, DOI 10.1002/mrm.21150; Eaton NR, 2012, J ABNORM PSYCHOL, V121, P282, DOI 10.1037/a0024780; Fairchild G, 2013, J CHILD PSYCHOL PSYC, V54, P86, DOI 10.1111/j.1469-7610.2012.02617.x; Fairchild G, 2011, AM J PSYCHIAT, V168, P624, DOI 10.1176/appi.ajp.2010.10081184; Finger EC, 2011, AM J PSYCHIAT, V168, P152, DOI 10.1176/appi.ajp.2010.10010129; Finger EC, 2012, PSYCHIAT RES-NEUROIM, V202, P239, DOI 10.1016/j.pscychresns.2011.11.002; Galvan A, 2007, DEVELOPMENTAL SCI, V10, pF8, DOI 10.1111/j.1467-7687.2006.00579.x; Gilman JM, 2014, J NEUROSCI, V34, P5529, DOI 10.1523/JNEUROSCI.4745-13.2014; Gorini A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00661; Gowin JL, 2013, DRUG ALCOHOL DEPEN, V132, P13, DOI 10.1016/j.drugalcdep.2013.03.019; Hamani C, 2011, BIOL PSYCHIAT, V69, P301, DOI 10.1016/j.biopsych.2010.09.034; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hansen HH, 2008, ANN NEUROL, V64, P42, DOI 10.1002/ana.21287; Harden KP, 2011, DEV PSYCHOL, V47, P739, DOI 10.1037/a0023279; Herting MM, 2011, NEUROIMAGE, V54, P2582, DOI 10.1016/j.neuroimage.2010.10.030; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Hicks BM, 2013, JAMA PSYCHIAT, V70, P1076, DOI 10.1001/jamapsychiatry.2013.258; Hikosaka O, 2010, TRENDS COGN SCI, V14, P154, DOI 10.1016/j.tics.2010.01.006; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; Iacono WG, 2008, ANNU REV CLIN PSYCHO, V4, P325, DOI 10.1146/annurev.clinpsy.4.022007.141157; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koziol LF, 2014, CEREBELLUM, V13, P151, DOI 10.1007/s12311-013-0511-x; Krueger RF, 2009, PSYCHOL MED, V39, P2061, DOI 10.1017/S0033291709990328; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; Lane SD, 2001, EXP CLIN PSYCHOPHARM, V9, P74, DOI 10.1037//1064-1297.9.1.74; Lee TMC, 2009, CEREB CORTEX, V19, P1303, DOI 10.1093/cercor/bhn172; Lenroot RK, 2010, BRAIN COGNITION, V72, P46, DOI 10.1016/j.bandc.2009.10.008; Li CSR, 2006, NEUROIMAGE, V32, P1918, DOI 10.1016/j.neuroimage.2006.05.017; Lindenfors P, 2011, ADV GENET, V75, P7, DOI 10.1016/B978-0-12-380858-5.00009-5; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; MacKay AP, 2007, PUBLICATION US DEP H; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; McNamee RL, 2008, ALCOHOL CLIN EXP RES, V32, P405, DOI 10.1111/j.1530-0277.2007.00604.x; Meynen G, 2013, INT J LAW PSYCHIAT, V36, P93, DOI 10.1016/j.ijlp.2013.01.001; MOFFITT TE, 1993, DEV PSYCHOPATHOL, V5, P135, DOI 10.1017/S0954579400004302; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Mohr PNC, 2010, J NEUROSCI, V30, P6613, DOI 10.1523/JNEUROSCI.0003-10.2010; NEWMAN JP, 1987, J ABNORM PSYCHOL, V96, P145, DOI 10.1037/0021-843X.96.2.145; Norman AL, 2011, DRUG ALCOHOL DEPEN, V119, P216, DOI 10.1016/j.drugalcdep.2011.06.019; O'Leary-Barrett M, 2013, J AM ACAD CHILD PSY, V52, P911, DOI 10.1016/j.jaac.2013.05.020; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P761, DOI 10.1001/archpsyc.62.7.761; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Pope K, 2012, J AM ACAD CHILD PSY, V51, P341, DOI 10.1016/j.jaac.2012.01.003; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Rawley JB, 2009, NEUROBIOL LEARN MEM, V91, P129, DOI 10.1016/j.nlm.2008.12.006; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rosenbloom MH, 2012, J NEUROPSYCH CLIN N, V24, P266, DOI 10.1176/appi.neuropsych.11060139; Rubia K, 2008, AM J PSYCHIAT, V165, P889, DOI 10.1176/appi.ajp.2008.07071084; Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Sacher J, 2013, MAGN RESON IMAGING, V31, P366, DOI 10.1016/j.mri.2012.06.007; Schneider S, 2012, AM J PSYCHIAT, V169, P39, DOI 10.1176/appi.ajp.2011.11030489; Somerville LH, 2011, J COGNITIVE NEUROSCI, V23, P2123, DOI 10.1162/jocn.2010.21572; Souza MJ, 2009, NEUROIMAGE, V46, P299, DOI 10.1016/j.neuroimage.2009.01.046; Steinberg L, 2010, DEV PSYCHOBIOL, V52, P216, DOI 10.1002/dev.20445; Sterzer P, 2007, NEUROIMAGE, V37, P335, DOI 10.1016/j.neuroimage.2007.04.043; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Tessner KD, 2010, NEUROPSYCHOL REV, V20, P1, DOI 10.1007/s11065-009-9111-4; Thirion B, 2007, NEUROIMAGE, V35, P105, DOI 10.1016/j.neuroimage.2006.11.054; Trent S, 2012, BIOL PSYCHOL, V89, P1, DOI 10.1016/j.biopsycho.2011.09.011; Wallace GL, 2014, J AM ACAD CHILD PSY, V53, P456, DOI 10.1016/j.jaac.2013.12.008; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Weintraub DB, 2013, REV NEUROSCIENCE, V24, P125, DOI 10.1515/revneuro-2012-0075; White SF, 2013, AM J PSYCHIAT, V170, P315, DOI 10.1176/appi.ajp.2012.12060840; Ye H, 2015, BEHAV BRAIN RES, V286, P17, DOI 10.1016/j.bbr.2015.02.037; Young SE, 2000, AM J MED GENET, V96, P684, DOI 10.1002/1096-8628(20001009)96:5<684::AID-AJMG16>3.3.CO;2-7; Young SE, 2009, J ABNORM PSYCHOL, V118, P117, DOI 10.1037/a0014657	88	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132322	10.1371/journal.pone.0132322	http://dx.doi.org/10.1371/journal.pone.0132322			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26176860	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600100
J	Papadakis, G; Skandalis, N; Dimopoulou, A; Glynos, P; Gizeli, E				Papadakis, George; Skandalis, Nicholas; Dimopoulou, Anastasia; Glynos, Paraskevas; Gizeli, Electra			Bacteria Murmur: Application of an Acoustic Biosensor for Plant Pathogen Detection	PLOS ONE			English	Article							SYRINGAE PV. TOMATO; XANTHOMONAS-CAMPESTRIS; MULTIPLEX PCR; DNA; MICROFLUIDICS; MICHIGANENSIS; VESICATORIA; ASSAY	A multi-targeting protocol for the detection of three of the most important bacterial phytopathogens, based on their scientific and economic importance, was developed using an acoustic biosensor (the Quartz Crystal Microbalance) for DNA detection. Acoustic detection was based on a novel approach where DNA amplicons were monitored and discriminated based on their length rather than mass. Experiments were performed during real time monitoring of analyte binding and in a direct manner, i.e. without the use of labels for enhancing signal transduction. The proposed protocol improves time processing by circumventing gel electrophoresis and can be incorporated as a routine detection method in a diagnostic lab or an automated lab-on-a-chip system for plant pathogen diagnostics.	[Papadakis, George; Gizeli, Electra] Inst Mol Biol & Biotechnol, Iraklion, Greece; [Skandalis, Nicholas; Dimopoulou, Anastasia; Glynos, Paraskevas] Benaki Phytopathol Inst, Athens, Greece; [Gizeli, Electra] Univ Crete, Dept Biol, Vassilika Vouton, Heraklion Crete, Greece	University of Crete	Gizeli, E (corresponding author), Inst Mol Biol & Biotechnol, Iraklion, Greece.	gizeli@imbb.forth.gr	Papadakis, George/V-9612-2019	Papadakis, George/0000-0001-5964-6568; Skandalis, Nicholas/0000-0002-4236-8909	European Regional Development Funds; Greek National Funds on "Competitiveness and Enterpreneurship"; European Commision [317742, 316223]	European Regional Development Funds(European Commission); Greek National Funds on "Competitiveness and Enterpreneurship"; European Commision	The European Regional Development Funds and Greek National Funds on "Competitiveness and Enterpreneurship" are acknowledged through SYNERGASIA 2011. This work was also supported by the European Commision through Framework Package 7-Information and Communication Technologies (FP7-ICT, Grant agreement No 317742) and Framework Package 7 Research Potential (REGPOT, Grant agreement No 316223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg T, 2006, LETT APPL MICROBIOL, V42, P624, DOI 10.1111/j.1472-765X.2006.01887.x; Campbell C. K., 1998, SURFACE ACOUSTIC WAV; Chen Y, 2010, J MICROBIOL BIOTECHN, V20, P193, DOI 10.4014/jmb.0906.06019; Cho YK, 2004, J COLLOID INTERF SCI, V278, P44, DOI 10.1016/j.jcis.2004.05.008; Cuppels DA, 2006, PLANT DIS, V90, P451, DOI 10.1094/PD-90-0451; EPPO, 2012, EUR MED PLANT PROT O; Gizeli E., 2002, BIOMOLECULAR SENSORS; Goto Mikihiro, 2010, 2010 International Ultrasonics Symposium, P736, DOI 10.1109/ULTSYM.2010.0189; Hauben L, 1997, INT J SYST BACTERIOL, V47, P328, DOI 10.1099/00207713-47-2-328; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; Jones JB., 1991, COMPENDIUM TOMATO DI; KING EO, 1954, J LAB CLIN MED, V44, P301; KLEMENT Z, 1964, PHYTOPATHOLOGY, V54, P474; Koo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082704; Landgraf A, 2006, MOL PLANT PATHOL, V7, P355, DOI 10.1111/j.1364-3703.2006.00343.x; Lapage SP, 1970, METHODS MICROBIOLOGY; Lee W, 2013, ANALYST, V138, P2558, DOI 10.1039/c3an00182b; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Marttila AT, 2000, FEBS LETT, V467, P31, DOI 10.1016/S0014-5793(00)01119-4; Matatagui D, 2013, SENSOR ACTUAT B-CHEM, V185, P218, DOI 10.1016/j.snb.2013.04.118; Mitsakakis K, 2008, J MICROELECTROMECH S, V17, P1010, DOI 10.1109/JMEMS.2008.927173; Mitsakakis K, 2011, BIOSENS BIOELECTRON, V26, P4579, DOI 10.1016/j.bios.2011.05.030; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Obradovic A, 2004, EUR J PLANT PATHOL, V110, P285, DOI 10.1023/B:EJPP.0000019797.27952.1d; Ozdemir Z, 2009, J PLANT PATHOL, V91, P495; Palacio-Bielsa A, 2009, J PLANT PATHOL, V91, P249; Papadakis G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02033; Papadakis G, 2014, ANAL METHODS-UK, V6, P363, DOI 10.1039/c3ay41143e; Pastrik KH, 2000, EUR J PLANT PATHOL, V106, P155, DOI 10.1023/A:1008736017029; Peterson AW, 2001, NUCLEIC ACIDS RES, V29, P5163, DOI 10.1093/nar/29.24.5163; Seal SE, 1999, PLANT PATHOL, V48, P115, DOI 10.1046/j.1365-3059.1999.00322.x; Skandalis N., 2012, Hellenic Plant Protection Journal, V5, P31; Tampakaki AP, 2010, ANNU REV PHYTOPATHOL, V48, P347, DOI 10.1146/annurev-phyto-073009-114407; Tsortos A, 2008, BIOPHYS J, V94, P2706, DOI 10.1529/biophysj.107.119271; Tsortos A, 2008, BIOSENS BIOELECTRON, V24, P836, DOI 10.1016/j.bios.2008.07.006; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Xu GL, 2015, CHEM COMMUN, V51, P2589, DOI 10.1039/c4cc08389j; Young J. M., 1996, Review of Plant Pathology, V75, P721	38	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132773	10.1371/journal.pone.0132773	http://dx.doi.org/10.1371/journal.pone.0132773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177507	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600153
J	Zhan, XY; Zhang, L; Zhou, BK; Zhu, P; Zhang, SX; Xu, MG				Zhan, Xiaoying; Zhang, Li; Zhou, Baoku; Zhu, Ping; Zhang, Shuxiang; Xu, Minggang			Changes in Olsen Phosphorus Concentration and Its Response to Phosphorus Balance in Black Soils under Different Long-Term Fertilization Patterns	PLOS ONE			English	Article							MAIZE CROPPING SYSTEMS; AVAILABLE PHOSPHORUS; DYNAMICS; ACCUMULATION; MANAGEMENT; RHIZOSPHERE; EFFICIENCY; DEPLETION; SORPTION; RELEASE	The Olsen phosphorus (P) concentration of a soil is a key index that can be used to evaluate the P supply capacity of the soil and to estimate the optimal P fertilization rate. A study of the relationship between the soil Olsen P concentration and the P balance (P input minus P output) and their variations among different fertilization patterns will help to provide useful information for proper management of P fertilization. In this paper, the two investigated long-term experiments were established on black soils in the northeast region of China. Six fertilization treatments were selected: (1) unfertilized (CK); (2) nitrogen only (N); (3) nitrogen and potassium (NK); (4) nitrogen and phosphorus (NP); (5) nitrogen, phosphorus, and potassium (NPK); and (6) nitrogen, phosphorus, potassium and manure (NPKM). The results showed that the average Olsen P concentrations in the black soils at Gongzhuling and Harbin (16-and 31-year study periods, respectively), decreased by 0.49 and 0.56 mg kg(-1) a(-1), respectively, without P addition and increased by 3.17 and 1.78 mg kg(-1) a(-1), respectively, with P fertilization. The changes in soil Olsen P concentrations were significantly (P<0.05) correlated with the P balances at both sites except for the NP and NPK treatments at Gongzhuling. Under an average deficit of 100 kg ha(-1) P, the soil Olsen P concentration at both sites decreased by 1.36 similar to 3.35 mg kg(-1) in the treatments without P addition and increased by 4.80 similar to 16.04 mg kg(-1) in the treatments with 100 kg ha-1 of P accumulation. In addition, the changes in Olsen P concentrations in the soil with 100 kg ha(-1)of P balance were significantly correlated with the P activation coefficient (PAC, percentage of Olsen P to total P, r=0.99, P<0.01) and soil organic matter content (r=0.91, P<0.01). A low pH was related to large changes of Olsen P by 1 kg ha(-1) of P balance. These results indicated that soil organic matter and pH have important effects on the change in soil Olsen P by 1 kg ha(-1)of P balance.	[Zhan, Xiaoying; Zhang, Li; Zhang, Shuxiang; Xu, Minggang] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing 100081, Peoples R China; [Zhou, Baoku] Heilongjiang Acad Agr Sci, Soil & Fertilizer Inst, Harbin 150086, Heilongjiang, Peoples R China; [Zhu, Ping] Jilin Acad Agr Sci, Ctr Agr Environm & Resources, Gongzhuling 136100, Jilin, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Heilongjiang Academy of Agricultural Sciences; Jilin Academy of Agricultural Sciences	Zhang, SX (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing 100081, Peoples R China.	zhangshuxiang@caas.cn			National Science Foundation of China [41471249]; Agro-scientific Research in the Public Interest of China [201203030]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agro-scientific Research in the Public Interest of China	This work is supported by the National Science Foundation of China http://www.nsfc.gov.cn/ (41471249) and by the Special Fund for Agro-scientific Research in the Public Interest of China http://www.moa.gov.cn/ (201203030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 2001, CHEMOSPHERE, V42, P161, DOI 10.1016/S0045-6535(00)00121-1; [Anonymous], 2005, NUTR CONT ORG FERT; [Anonymous], 1999, CHINA ORGANIC FERTIL, P5; Arai Y, 2007, ADV AGRON, V94, P135, DOI 10.1016/S0065-2113(06)94003-6; Aulakh MS, 2007, SOIL USE MANAGE, V23, P417, DOI 10.1111/j.1475-2743.2007.00124.x; Bai ZH, 2013, PLANT SOIL, V372, P27, DOI 10.1007/s11104-013-1696-y; Cao N, 2012, NUTR CYCL AGROECOSYS, V94, P161, DOI 10.1007/s10705-012-9530-0; Colomb B, 2007, EUR J AGRON, V26, P154, DOI 10.1016/j.eja.2006.09.004; Dobermann A, 2002, SOIL SCI SOC AM J, V66, P652, DOI 10.2136/sssaj2002.0652; *FAO, 2004, FAO FERT PLANT NUTR, V15; Fu XL, 2009, CATENA, V77, P200, DOI 10.1016/j.catena.2008.12.017; GAHOONIA TS, 1992, PLANT SOIL, V143, P185, DOI 10.1007/BF00007872; Garg S, 2008, BIORESOURCE TECHNOL, V99, P5773, DOI 10.1016/j.biortech.2007.10.063; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hinsinger P, 2003, PLANT SOIL, V248, P43, DOI 10.1023/A:1022371130939; HINSINGER P, 1995, AUST J SOIL RES, V33, P477, DOI 10.1071/SR9950477; Huang CY, 2000, SOIL SCI, P32; Johnston A E., 2000, SOIL PLANT PHOSPHATE, P27; Li XM, 1994, CHINESE J SOIL SCI, V25, P259; Liu Jianling, 2000, Yingyong Shengtai Xuebao, V11, P365; Lookman R, 1996, GEODERMA, V69, P265, DOI 10.1016/0016-7061(95)00068-2; Lu R. K., 1996, CHINESE J SOIL SCI, V27, P241; Lu R.K, 2000, ANAL METHOD SOIL AGR; Ma YB, 2009, FIELD CROP RES, V110, P207, DOI 10.1016/j.fcr.2008.08.007; Malik MA, 2012, SOIL BIOL BIOCHEM, V49, P106, DOI 10.1016/j.soilbio.2012.02.013; Meng HQ, 2013, J INTEGR AGR, V12, P2092, DOI 10.1016/S2095-3119(13)60398-6; Messiga AJ, 2010, SOIL USE MANAGE, V26, P354, DOI 10.1111/j.1475-2743.2010.00287.x; Pei RuiNa, 2010, Scientia Agricultura Sinica, V43, P4008; Qu JunFeng, 2008, Plant Nutrition and Fertilizer Science, V14, P90; [曲均峰 Qu Junfeng], 2008, [生态环境, Ecology and Environment], V17, P2068; Selles F, 2011, CAN J SOIL SCI, V91, P39, DOI 10.4141/CJSS10049; Shafqat MN, 2013, CHEMOSPHERE, V90, P691, DOI 10.1016/j.chemosphere.2012.09.050; Sheldrick WF, 2002, NUTR CYCL AGROECOSYS, V62, P61, DOI 10.1023/A:1015124930280; Shen JB, 2011, PLANT PHYSIOL, V156, P997, DOI 10.1104/pp.111.175232; Shen P, 2014, THESIS CHINESE ACAD; Shen P, 2014, CATENA, V118, P20, DOI 10.1016/j.catena.2014.01.020; Shen P, 2014, J INTEGR AGR, V13, P597, DOI 10.1016/S2095-3119(13)60717-0; Shepherd MA, 1999, NUTR CYCL AGROECOSYS, V54, P233, DOI 10.1023/A:1009744706679; Siddique MT, 2003, J ENVIRON QUAL, V32, P1114, DOI 10.2134/jeq2003.1114; Song C, 2007, BIOL FERT SOILS, V44, P37, DOI 10.1007/s00374-007-0176-z; Sugihara S, 2012, AGR ECOSYST ENVIRON, V162, P101, DOI 10.1016/j.agee.2012.07.019; Tang X, 2008, FIELD CROP RES, V108, P231, DOI 10.1016/j.fcr.2008.05.007; TATE KR, 1988, BIOGEOCHEMISTRY, V5, P99, DOI 10.1007/BF02180319; Tian K, 2015, AGR ECOSYST ENVIRON, V204, P40, DOI 10.1016/j.agee.2015.02.008; Xu YF, 2015, CHEM ENG J, V267, P260, DOI 10.1016/j.cej.2015.01.037; [张继光 Zhang Jiguang], 2010, [土壤, Soils], V42, P364; [周宝库 Zhou Baoku], 2005, [植物营养与肥料学报, Plant nutrition and fertitizer science], V11, P143	47	26	35	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131713	10.1371/journal.pone.0131713	http://dx.doi.org/10.1371/journal.pone.0131713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177293	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600060
J	Abrantes, P; Santos, MM; Sousa, I; Xavier, JM; Francisco, V; Krug, T; Sobral, J; Matos, M; Martins, M; Jacinto, A; Coiteiro, D; Oliveira, SA				Abrantes, Patricia; Santos, Maria M.; Sousa, Ines; Xavier, Joana M.; Francisco, Vania; Krug, Tiago; Sobral, Joao; Matos, Mafalda; Martins, Madalena; Jacinto, Antonio; Coiteiro, Domingos; Oliveira, Sofia A.			Genetic Variants Underlying Risk of Intracranial Aneurysms: Insights from a GWAS in Portugal	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ISOLATED BLOOD-VESSELS; POTENTIAL CANDIDATE; IDENTIFIES 3; COMPLEX; DISEASE; LOCI; AMERICANS; PACKAGE	Subarachnoid hemorrhage (SAH) is a life-threatening event that most frequently leads to severe disability and death. Its most frequent cause is the rupture of a saccular intracranial aneurysm (IA), which is a blood vessel dilation caused by disease or weakening of the vessel wall. Although the genetic contribution to IA is well established, to date no single gene has been unequivocally identified as responsible for IA formation or rupture. We aimed to identify IA susceptibility genes in the Portuguese population through a pool-based multi-stage genome-wide association study. Replicate pools were allelotyped in triplicate in a discovery dataset (100 IA cases and 92 gender-matched controls) using the Affymetrix Human SNP Array 6.0. Top SNPs (absolute value of the relative allele score difference between cases and controls vertical bar RAS(diff)vertical bar >= 13.0%) were selected for technical validation by individual genotyping in the discovery dataset. From the 101 SNPs successfully genotyped, 99 SNPs were nominally associated with IA. Replication of technically validated SNPs was conducted in an independent replication dataset (100 Portuguese IA cases and 407 controls). rs4667622 (between UBR3 and MYO3B), rs6599001 (between SCN11A and WDR48), rs3932338 (214 kilobases downstream of PRDM9), and rs10943471 (96 kilobases upstream of HTR1B) were associated with IA (unadjusted allelic chi-square tests) in the datasets tested (discovery: 6.84E-04 <= P <= 1.92E-02, replication: 2.66E-04 <= P <= 2.28E-02, and combined datasets: 6.05E-05 <= P <= 5.50E-04). Additionally, we confirmed the known association with IA of rs1333040 at the 9p21.3 genomic region, thus validating our dataset. These novel findings in the Portuguese population warrant further replication in additional independent studies, and provide additional candidates to more comprehensively understand IA etiopathogenesis.	[Abrantes, Patricia; Sousa, Ines; Xavier, Joana M.; Francisco, Vania; Krug, Tiago; Sobral, Joao; Matos, Mafalda; Martins, Madalena; Oliveira, Sofia A.] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; [Abrantes, Patricia; Sousa, Ines; Xavier, Joana M.; Francisco, Vania; Krug, Tiago; Sobral, Joao; Matos, Mafalda; Martins, Madalena; Oliveira, Sofia A.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Santos, Maria M.; Coiteiro, Domingos] Hosp Santa Maria, Serv Neurocirurgia, Lisbon, Portugal; [Jacinto, Antonio] Univ Nova Lisboa, Fac Ciencias Med, Ctr Estudos Doencas Cron CEDOC, P-1200 Lisbon, Portugal	Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Hospital Santa Maria; Universidade Nova de Lisboa	Oliveira, SA (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.	aaoliveira@medicina.ulisboa.pt	Sobral, João/M-5195-2015; Jacinto, Antonio/F-5729-2013; Abrantes, Patrícia/G-2649-2019; Xavier, Joana M./I-4676-2014	Sobral, João/0000-0002-7161-0661; Jacinto, Antonio/0000-0002-4193-6089; Xavier, Joana M./0000-0002-0702-6700; Abrantes, Patricia/0000-0002-7484-2441; Martins, Madalena/0000-0001-8360-6806	Fundacao para a Ciencia e Tecnologia (FCT-Portugal) [PTDC/SAU-GMG/101537/2008, PTDC/IIM-GES/5015/2012, CMUP-ERI/TPE/0028/2013, SFRH/BPD/35737/2007, SFRH/BPD/70008/2010, SFRH/BD/43895/2008]; Fundacao para a Ciencia e Tecnologia (FCT-Portugal) (Ciencia and Investigator-FCT); Fundação para a Ciência e a Tecnologia [PTDC/IIM-GES/5015/2012, PTDC/SAU-GMG/101537/2008, CMUP-ERI/TPE/0028/2013] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT-Portugal)(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia (FCT-Portugal) (Ciencia and Investigator-FCT); Fundação para a Ciência e a Tecnologia	This work was supported by the Fundacao para a Ciencia e Tecnologia (FCT-Portugal) through several grants (PTDC/SAU-GMG/101537/2008, PTDC/IIM-GES/5015/2012 and CMUP-ERI/TPE/0028/2013), fellowships and research contracts (SFRH/BPD/35737/2007 to PA, SFRH/BPD/70008/2010 to IS, SFRH/BD/43895/2008 to JMX, and Ciencia and Investigator-FCT contracts to SAO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-44; Akiyama K, 2010, J HUM GENET, V55, P656, DOI 10.1038/jhg.2010.82; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Belz MM, 2003, KIDNEY INT, V63, P1824, DOI 10.1046/j.1523-1755.2003.00918.x; Bermingham ML, 2014, HEREDITY, V112, P543, DOI 10.1038/hdy.2013.137; Bilguvar K, 2008, NAT GENET, V40, P1472, DOI 10.1038/ng.240; Bosse Y, 2009, HUM GENET, V125, P305, DOI 10.1007/s00439-009-0626-9; Bostrom MA, 2010, HUM GENET, V128, P195, DOI 10.1007/s00439-010-0842-3; Castro-Giner F, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-128; Comabella M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003490; Davis OSP, 2009, BIOINFORMATICS, V25, P281, DOI 10.1093/bioinformatics/btn587; Dose AC, 2002, GENOMICS, V79, P621, DOI 10.1006/geno.2002.6749; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Foroud T, 2014, STROKE, V45, P3194, DOI 10.1161/STROKEAHA.114.006096; Foroud T, 2012, STROKE, V43, P2846, DOI 10.1161/STROKEAHA.112.656397; Gangula NR, 2013, J BIOL CHEM, V288, P34545, DOI 10.1074/jbc.M113.503383; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Hashikata H, 2010, STROKE, V41, P1138, DOI 10.1161/STROKEAHA.109.576694; Hussin J, 2013, GENOME RES, V23, P419, DOI 10.1101/gr.144188.112; Inagawa T, 2001, STROKE, V32, P1499, DOI 10.1161/01.STR.32.7.1499; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Juvela S, 2003, STROKE, V34, P1852, DOI 10.1161/01.STR.0000080380.56799.DD; KAUMANN AJ, 1993, CARDIOVASC RES, V27, P2094, DOI 10.1093/cvr/27.12.2094; Kerns SL, 2013, J UROLOGY, V190, P102, DOI 10.1016/j.juro.2013.01.096; Kurki MI, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004134; Leung H. K., 2011, Hong Kong Medical Journal, V17, P151; Low SK, 2012, HUM MOL GENET, V21, P2102, DOI 10.1093/hmg/dds020; Macgregor S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1060; Macgregor S, 2007, EUR J HUM GENET, V15, P501, DOI 10.1038/sj.ejhg.5201768; Matarin M, 2007, LANCET NEUROL, V6, P414, DOI 10.1016/S1474-4422(07)70081-9; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Pearson JV, 2007, AM J HUM GENET, V80, P126, DOI 10.1086/510686; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Razzaque Z, 2002, BRIT J CLIN PHARMACO, V53, P266, DOI 10.1046/j.0306-5251.2001.01536.x; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Ruigrok YM, 2010, GENOME MED, V2, DOI 10.1186/gm182; Saunders EJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004129; Schwartz JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5370; Seshadri S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S15; Steer S, 2007, GENES IMMUN, V8, P57, DOI 10.1038/sj.gene.6364359; van den Broek RWM, 2002, CEPHALALGIA, V22, P83, DOI 10.1046/j.1468-2982.2002.00295.x; Verheggen R, 1996, BRIT J PHARMACOL, V117, P283, DOI 10.1111/j.1476-5381.1996.tb15188.x; Vlak MHM, 2012, J NEUROL, V259, P1298, DOI 10.1007/s00415-011-6341-1; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Woodward EL, 2014, BRIT J HAEMATOL, V166, P947, DOI 10.1111/bjh.12914; Xavier JM, 2015, ANN RHEUM DIS, V74, P618, DOI 10.1136/annrheumdis-2013-204475; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	49	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133422	10.1371/journal.pone.0133422	http://dx.doi.org/10.1371/journal.pone.0133422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186006	Green Submitted, gold, Green Published			2022-12-27	WOS:000358198700137
J	Perez-Jorge, S; Pereira, T; Corne, C; Wijtten, Z; Omar, M; Katello, J; Kinyua, M; Oro, D; Louzao, M				Perez-Jorge, Sergi; Pereira, Thalia; Corne, Chloe; Wijtten, Zeno; Omar, Mohamed; Katello, Jillo; Kinyua, Mark; Oro, Daniel; Louzao, Maite			Can Static Habitat Protection Encompass Critical Areas for Highly Mobile Marine Top Predators? Insights from Coastal East Africa	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; MANAGEMENT; CONSERVATION; PATTERNS; ENVIRONMENT; PREFERENCE; FISHERIES; MODELS; SHIFTS; CORAL	Along the East African coast, marine top predators are facing an increasing number of anthropogenic threats which requires the implementation of effective and urgent conservation measures to protect essential habitats. Understanding the role that habitat features play on the marine top predator' distribution and abundance is a crucial step to evaluate the suitability of an existing Marine Protected Area (MPA), originally designated for the protection of coral reefs. We developed species distribution models (SDM) on the IUCN data deficient Indo-Pacific bottlenose dolphin (Tursiops aduncus) in southern Kenya. We followed a comprehensive ecological modelling approach to study the environmental factors influencing the occurrence and abundance of dolphins while developing SDMs. Through the combination of ensemble prediction maps, we defined recurrent, occasional and unfavourable habitats for the species. Our results showed the influence of dynamic and static predictors on the dolphins' spatial ecology: dolphins may select shallow areas (5-30 m), close to the reefs (<500 m) and oceanic fronts (<10 km) and adjacent to the 100m isobath (<5 km). We also predicted a significantly higher occurrence and abundance of dolphins within the MPA. Recurrent and occasional habitats were identified on large percentages on the existing MPA (47% and 57% using presence-absence and abundance models respectively). However, the MPA does not adequately encompass all occasional and recurrent areas and within this context, we propose to extend the MPA to incorporate all of them which are likely key habitats for the highly mobile species. The results from this study provide two key conservation and management tools: (i) an integrative habitat modelling approach to predict key marine habitats, and (ii) the first study evaluating the effectiveness of an existing MPA for marine mammals in the Western Indian Ocean.	[Perez-Jorge, Sergi; Pereira, Thalia; Corne, Chloe; Wijtten, Zeno] Global Vision Int Kenya GVI, Shimoni 80409, Kenya; [Perez-Jorge, Sergi; Oro, Daniel] CSIC, UIB, IMEDEA, Populat Ecol Grp, Esporles 07190, Balearic Island, Spain; [Omar, Mohamed; Katello, Jillo; Kinyua, Mark] Kenya Wildlife Serv, Ukunda 80400, Kenya; [Louzao, Maite] AZTI Fdn, Pasaia, Spain; [Louzao, Maite] IEO, Ctr Oceanog Xixon, E-33212 Gijon Xixon, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; AZTI	Perez-Jorge, S (corresponding author), Global Vision Int Kenya GVI, POB 10, Shimoni 80409, Kenya.	sergiperezjorge@gmail.com	Jorge, Sergi Pérez/H-4865-2019; Louzao, Maite/N-5379-2014; Oro, Daniel/H-4208-2012	Jorge, Sergi Pérez/0000-0002-4843-0443; Oro, Daniel/0000-0003-4782-3007; Louzao, Maite/0000-0002-9997-5144	Spanish Ministry of Science and Innovation [JCI-2010-07639]; Ramon y Cajal postdoctoral contract [RYC-2012-09897]; Spanish Ministry of Economy [CGL2013-42203-R]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ramon y Cajal postdoctoral contract(Spanish Government); Spanish Ministry of Economy(Spanish Government)	ML was funded by a Juan de la Cierva postdoctoral contract (JCI-2010-07639, Spanish Ministry of Science and Innovation - http://www.idi.mineco.gob.es/) and a Ramon y Cajal postdoctoral contract (RYC-2012-09897). Funds were partially provided by a grant from the Spanish Ministry of Economy - http://www.idi.mineco.gob.es/(CGL2013-42203-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir OA, 2005, ESTUAR COAST SHELF S, V63, P429, DOI 10.1016/j.ecss.2004.12.006; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Barton K., 2013, MUMLN MULTIMODEL INF; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Bjornstad O. N., 2013, NCF SPATIAL NONPARAM; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Canadas A., 2006, Journal of Cetacean Research and Management, V8, P13; Canadas A, 2005, AQUAT CONSERV, V15, P495, DOI 10.1002/aqc.689; Castilla JC, 1998, ECOL APPL, V8, pS124, DOI 10.1890/1051-0761(1998)8[S124:SBFICO]2.0.CO;2; Cerchio S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086464; Christiansen Fredrik, 2010, Endangered Species Research, V11, P91, DOI 10.3354/esr00265; Cinner JE, 2015, GLOBAL ENVIRON CHANG, V30, P133, DOI 10.1016/j.gloenvcha.2014.10.003; Cockcroft V.G., 1990, P295; Crossman ND, 2008, DIVERS DISTRIB, V14, P213, DOI 10.1111/j.1472-4642.2007.00436.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; ESRI, 2011, ARCDESKTOP REL 10; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Ferguson MC, 2006, ECOL MODEL, V193, P645, DOI 10.1016/j.ecolmodel.2005.10.034; Francis J, 2002, AMBIO, V31, P503, DOI 10.1639/0044-7447(2002)031[0503:MPAITE]2.0.CO;2; Gallus Anja, 2012, Endangered Species Research, V18, P265, DOI 10.3354/esr00448; Game ET, 2008, CONSERV BIOL, V22, P1619, DOI 10.1111/j.1523-1739.2008.01037.x; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Gell F. R., 2002, FISHERY EFFECTS MARI, DOI 10.1016/s1386-5056(02)00038-2; Gormley AM, 2012, J APPL ECOL, V49, P474, DOI 10.1111/j.1365-2664.2012.02121.x; Halpern BS, 2003, ECOL APPL, V13, pS117; Hammond PS, 2012, TURSIOPS ADUNCUS IUC; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harwood J, 2001, J MAMMAL, V82, P630, DOI 10.1644/1545-1542(2001)082<0630:MMATEI>2.0.CO;2; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; IUCN, 2004, MAN MAR PROT AR TOOL; Kelleher G., 1999, GUIDELINES MARINE PR; Kenya Wildlife Service, 2011, KIS MPUNG MAR CONS A; Lennon JJ, 2000, ECOGRAPHY, V23, P101, DOI 10.1034/j.1600-0587.2000.230111.x; Louzao M, 2009, MAR ECOL PROG SER, V391, P183, DOI 10.3354/meps08124; Louzao M, 2013, ECOGRAPHY, V36, P57, DOI 10.1111/j.1600-0587.2012.07587.x; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; Mannocci L, 2014, ECOGRAPHY, V37, P261, DOI 10.1111/j.1600-0587.2013.00317.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; McClanahan TR, 2006, AQUAT CONSERV, V16, P147, DOI 10.1002/aqc.715; McClanahan TR, 2001, CORAL REEFS, V19, P380, DOI 10.1007/s003380000133; McClanahan TR, 1999, BIOL CONSERV, V89, P161, DOI 10.1016/S0006-3207(98)00123-2; Meyler S, 2012, W INDIAN OCEAN J MAR, V10, P201; Moore JE, 2013, MAR MAMMAL SCI, V29, P446, DOI 10.1111/j.1748-7692.2012.00586.x; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Pirotta E, 2011, MAR ECOL PROG SER, V436, P257, DOI 10.3354/meps09236; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ready J, 2010, ECOL MODEL, V221, P467, DOI 10.1016/j.ecolmodel.2009.10.025; Reeves RR., 2000, VALUE SANCTUARIES PA, P50; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rocliffe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103000; Silva MA, 2012, AQUAT CONSERV, V22, P122, DOI 10.1002/aqc.1243; Spyrakos E, 2011, HYDROBIOLOGIA, V670, P87, DOI 10.1007/s10750-011-0722-4; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; UN CBD, 2010, COP 10 DEC X 2 STRAT; Venables WN., 2002, MODERN APPL STAT S 4; VERON JEN, 1995, CORALS SPACE TIME BI; Wilson B, 1997, J APPL ECOL, V34, P1365, DOI 10.2307/2405254; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; [No title captured]	65	30	30	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133265	10.1371/journal.pone.0133265	http://dx.doi.org/10.1371/journal.pone.0133265			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186438	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700116
J	Tistad, M; von Koch, L				Tistad, Malin; von Koch, Lena			Usual Clinical Practice for Early Supported Discharge after Stroke with Continued Rehabilitation at Home: An Observational Comparative Study	PLOS ONE			English	Article							SERVICES; METAANALYSIS; CONSENSUS; LIFE; CARE	Introduction Based on randomised controlled trials, evidence exists that early supported discharge (ESD) from the hospital with continued rehabilitation at home has beneficial effects after stroke; however, the effects of ESD service in regular clinical practice have not been investigated. The purpose of the current study was to compare ESD service with conventional rehabilitation in terms of patient outcomes, caregiver burden at 3 and 12 months and the use and costs of healthcare during the first year after stroke. Material and Methods This study was a subgroup analysis of a longitudinal observational study of patients who received care in the stroke unit at Karolinska University Hospital in Sweden. Patients who met the inclusion criteria for ESD in previous experimental studies were included. The patients were referred to available rehabilitation services at discharge, and comparisons between those who received ESD service (the ESD group, n = 40) and those who received conventional rehabilitation (the NoESD group, n = 110) were performed with regard to independence in activities of daily living (ADL), the frequency of social activities, life satisfaction, and caregiver burden and the use and costs of healthcare during the first year after stroke. Results At 3 and 12 months, no differences were observed with regard to patient outcomes; however, ESD was associated with a lower caregiver burden (p = 0.01) at 12 months. The initial length of stay (LOS) at the hospital was 8 days for the ESD group and 15 days for the NoESD group (p = 0.02). The median number of outpatient rehabilitation contacts was 20.5 for the ESD group (81% constituting ESD service) and 3 for the NoESD group (p<0.001). There was no difference between the groups with regard to overall healthcare costs. Conclusions ESD service in usual clinical practice renders similar health benefits as conventional rehabilitation but a different pattern of resource use and with released capacity in acute stroke care.	[Tistad, Malin; von Koch, Lena] Care Sci & Soc Karolinska Inst, Dept Neurobiol, Div Occupat Therapy, Huddinge, Sweden; [Tistad, Malin] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden; [von Koch, Lena] Karolinska Univ Hosp, Karolinska Inst, Div Neurol, Dept Clin Neurosci, Huddinge, Sweden	Karolinska Institutet; Dalarna University; Karolinska Institutet; Karolinska University Hospital	Tistad, M (corresponding author), Care Sci & Soc Karolinska Inst, Dept Neurobiol, Div Occupat Therapy, Huddinge, Sweden.	malin.tistad@ki.se	von Koch, Lena/P-2310-2018	von Koch, Lena/0000-0002-8560-3016	Stockholm County Council [20060700]; Karolinska Institutet (ALF) [20060700]; Swedish Research Council (Vetenskapsradet) [2007-3087]; Swedish Brain Foundation (Hjarnfonden); Swedish Stroke Association (STROKE-Riksforbundet)	Stockholm County Council(Stockholm County Council); Karolinska Institutet (ALF)(Karolinska Institutet); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Brain Foundation (Hjarnfonden); Swedish Stroke Association (STROKE-Riksforbundet)	The study was funded by the regional agreement between the Stockholm County Council and Karolinska Institutet (ALF) (grant number 20060700), the Swedish Research Council (Vetenskapsradet) (grant number 2007-3087) http://www.vr.se/ the Swedish Brain Foundation (Hjarnfonden) http://www.hjarnfonden.se/startsida_1 the Swedish Stroke Association (STROKE-Riksforbundet) http://www.strokeforbundet.se/show.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASPLUND K, 1985, STROKE, V16, P885; Brusco NK, 2014, ARCH PHYS MED REHAB, V95, P94, DOI 10.1016/j.apmr.2013.03.017; Chouliara N, 2014, CLIN REHABIL, V28, P370, DOI 10.1177/0269215513502212; Cobley CS, 2013, CLIN REHABIL, V27, P750, DOI 10.1177/0269215512474030; Craig LE, 2014, INT J STROKE, V9, P88, DOI 10.1111/ijs.12041; Dow Briony, 2004, Aust Health Rev, V28, P260; Elmstahl S, 1996, ARCH PHYS MED REHAB, V77, P177, DOI 10.1016/S0003-9993(96)90164-1; Fearon P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000443.pub3; Fisher RJ, 2011, STROKE, V42, P1392, DOI 10.1161/STROKEAHA.110.606285; Fjaertoft H, 2004, CLIN REHABIL, V18, P580, DOI 10.1191/0269215504cr773oa; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Hackett ML, 2002, STROKE, V33, P643, DOI 10.1161/str.33.2.643; Haussen DC, 2011, NAT REV NEUROL, V7, P482, DOI 10.1038/nrneurol.2011.128; Intercollegiate Stroke Working Party, 2012, NAT CLIN GUID STROK, V4th ed; Langhorne P, 2005, LANCET, V365, P501; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; MAHONEY F I, 1965, Md State Med J, V14, P61; Mas MA, 2012, INT J STROKE, V11, P1747; Riksstroke, 2014, ARSR 2013 SWED STROK; Scottish Intercollegiate Guideline Network, 2010, MAN PAT STROK 591 RE; Seenan P, 2007, STROKE, V38, P1886, DOI 10.1161/STROKEAHA.106.480871; Socialstyrelsen, 2009, NAT RIKTL STROK 2009; SONN U, 1991, SCAND J REHABIL MED, V23, P193; Susanne P, 2012, J NEUROL SCI, V321, P29, DOI 10.1016/j.jns.2012.07.024; The Swedish Association of Local Authorities and Regions, 2018, PERS VARD SVER; Tistad M., 2012, THESIS KAROLINSKA I; Tistad M, 2012, J NEUROL SCI, V313, P160, DOI 10.1016/j.jns.2011.08.038; Tummers Johanneke F M M, 2012, Int J Integr Care, V12, pe193; VIITANEN M, 1988, SCAND J REHABIL MED, V20, P17; Von Koch L, 1998, DISABIL REHABIL, V20, P367, DOI 10.3109/09638289809166095; von Koch L, 2000, CLIN REHABIL, V14, P574, DOI 10.1191/0269215500cr364oa; Wade D T, 1985, Int Rehabil Med, V7, P176; Wottrich AW, 2007, PHYS THER, V87, P778, DOI 10.2522/ptj.20060152	34	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133536	10.1371/journal.pone.0133536	http://dx.doi.org/10.1371/journal.pone.0133536			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186211	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700154
J	Ursu, RG; Onofriescu, M; Luca, A; Prisecariu, LJ; Salceanu, SO; Nemescu, D; Iancu, LS				Ursu, Ramona Gabriela; Onofriescu, Mircea; Luca, Alexandru; Prisecariu, Liviu Jany; Salceanu, Silvia Olivia; Nemescu, Dragos; Iancu, Luminita Smaranda			The Need for Cervical Cancer Control in HIV-Positive and HIV-Negative Women from Romania by Primary Prevention and by Early Detection Using Clinically Validated HPV/DNA Tests	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; HPV INFECTION; VIRUS	Background In Romania, a country with no organized national surveillance program regarding cervical cancer, the early diagnosis of HPV (Human Papilloma Virus) infections is a major requirement, especially in HIV-infected women. The objective of this study was to determine the HPV prevalence and type distribution in young HIV-positive women and to assess the difference in the risk factors for developing cervical cancer compared to those of HIV-negative women. Method We conducted one cross-sectional cohort study from June 2013-September 2014, including 1,032 women: 992 HIV-women who were 36.5 years old (limits: 17 ->divided by 84) and 40 HIV + women who were 22.9 years old (limits: 17 divided by 30) with iatrogenic HIV infected. We detected HPV types with the Linear Array HPV Genotyping test (Roche, Romania). Results DNA/HPV was detected in 18/40 (45%) of the HIV+ patients and in 350/992 (35.2%) of the HIV-patients (OR = 1.5, 95%CI 0.76 divided by 2.96). After age adjustment, the overall HPV prevalence was 51.6% in HIV+ versus 63.2% in HIV-women aged under 25, and 22.2% in HPV+ versus 47.2% in HIV-women aged 25-34. We detect HIV being a risk factor for acquiring multiple HPV type infections (OR = 2.30, 95% CI 0.88 divided by 5.97). The eight most common HPV types (high-risk, and low-risk) for women below age 30, HIV+/-were: HPV 16, 18, 31, 51, 58, 68, and 6 and 82 respectively. To assess the risk factors of HIV-positive women for acquiring HPV infection, we analyzed the CD4/mu L, ARN/HIV copies/mu L, the age group, the number of sexual partners, smoking, and the type of HPV infection (single versus multiple infections). We found that the number of sexual partners and smoking are statistically significant risk factors. Conclusion Even though there are no significant differences regarding the prevalence of HPV infection in HIV + versus HIV - patients, multiple infections were more frequent in the first group. In our study group young HIV-infected patients under HAART therapy, high number of sexual partners (more than 3) and smoking were detected to be risk factors. Future organized screening for HPV infection using sensitive and specific methods are necessary at the national level in Romania.	[Ursu, Ramona Gabriela; Iancu, Luminita Smaranda] Univ Med & Pharm Gr T Popa, Dept Microbiol, Iasi, Romania; [Onofriescu, Mircea; Nemescu, Dragos] Univ Med & Pharm Gr T Popa, Dept Obstet & Gynecol, Iasi, Romania; [Onofriescu, Mircea; Luca, Alexandru; Nemescu, Dragos] Cuza Voda Obstet & Gynecol Hosp, Iasi, Romania; [Prisecariu, Liviu Jany] Infect Dis St Parascheva Clin Univ Hosp Iasi, Iasi, Romania; [Salceanu, Silvia Olivia] Clin Hosp Cai Ferate Iasi, Iasi, Romania	Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy	Ursu, RG (corresponding author), Univ Med & Pharm Gr T Popa, Dept Microbiol, Iasi, Romania.	ramonagabrielaursu@yahoo.com	Ursu, Ramona Gabriela/U-6053-2017; Iancu, Luminita-Smaranda/U-4331-2017; Iancu, Luminita Smaranda C./C-8864-2015; Onofriescu, Mircea/Y-5702-2018; Nemescu, Dragos/AAC-7813-2019	Iancu, Luminita-Smaranda/0000-0002-2592-3982; Iancu, Luminita Smaranda C./0000-0002-2592-3982; Nemescu, Dragos/0000-0003-2345-1077; Ursu, Ramona Gabriela/0000-0002-1811-7923	European Social Fund, Human Resources Development Operational Programme [POSDRU/159/1.5/136893]	European Social Fund, Human Resources Development Operational Programme	This paper was published under the frame of European Social Fund, Human Resources Development Operational Programme 2007-2013, project no. POSDRU/159/1.5/136893.	[Anonymous], 2013, ANN EPIDEMIOLOGICAL; Castellsague X, 2008, GYNECOL ONCOL, V110, pS4, DOI 10.1016/j.ygyno.2008.07.045; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Dames DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085429; De Vuyst H, 2012, BRIT J CANCER, V107, P1624, DOI 10.1038/bjc.2012.441; Denny LA, 2012, VACCINE, V30, pF168, DOI 10.1016/j.vaccine.2012.06.045; Desruisseau Andrew J, 2009, Infect Dis Obstet Gynecol, V2009, P810596, DOI 10.1155/2009/810596; Ezechi OC, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-5; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Firnhaber C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053494; Heard I, 2013, BJOG-INT J OBSTET GY, V120, P41, DOI 10.1111/1471-0528.12015; Kojic EM, 2014, CLIN INFECT DIS, V59, P127, DOI 10.1093/cid/ciu238; Stuardo V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047755; Ursu RG, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-558; Vaccarella S, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-50; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; World Health Organization, 2013, KEY FACTS HIV EP ROM	17	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132271	10.1371/journal.pone.0132271	http://dx.doi.org/10.1371/journal.pone.0132271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186361	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700035
J	Xia, J; Jiang, SC; Peng, HJ				Xia, Jing; Jiang, Shi-chen; Peng, Hong-Juan			Association between Liver Fluke Infection and Hepatobiliary Pathological Changes: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							OPISTHORCHIS-VIVERRINI INFECTION; CLONORCHIS-SINENSIS INFECTION; RISK-FACTORS; FASCIOLA-HEPATICA; CHOLANGIOCARCINOMA; DISEASE; GALLSTONES; ANTIBODIES; INTENSITY; FIBROSIS	Objective To provide information about the role of liver fluke infection as a risk factor for hepatobiliary pathological changes and promote awareness among the people living in endemic areas, a systematic review and meta-analysis based on published studies was conducted to examine the association between liver fluke infection and hepatobiliary pathological changes. Methods Relevant original literature was searched in multiple literature databases, including PubMed, Cochrane, Clinical Evidence, Trip Database, Clinical Trials, Current Controlled Trials, Web of Science, the China National Knowledge Infrastructure (CNKI) database, and the Wanfang academic journal full-text database. Studies were selected based on strict screening with inclusion and exclusion criteria. Tests of heterogeneity, sensitivity and publication bias were performed with the Review Manager software, version 5.3, and meta-regression analyses were performed with the Stata software, version 11.0 (Stata Corporation, College Station, TX, USA). Pooled risk ratios (RRs) and odds ratios (ORs) with their 95% confidence intervals (95% CIs) were calculated and used to evaluate the risk of hepatobiliary pathological changes resulting from liver fluke infection. Linear trend analyses were conducted to determine the dose-response relationship using IBM SPSS Statistics 20.0. Result A total of 36 studies were included in the meta-analysis. Significant associations were found between liver fluke infection and cholangitis or cholecystitis (RR: 7.80, P<0.001; OR: 15.98, P<0.001), cholelithiasis (RR: 2.42, P = 0.03; OR: 4.96, P = 0.03), hepatocellular carcinoma (OR: 4.69, P<0.001) and cholangiocarcinoma (RR: 10.43, P<0.001; OR: 4.37, P<0.001). In addition, heavier infection was significantly associated with higher incidence of hepatobiliary pathological changes (P<0.05). However, cirrhosis was not significantly associated with liver fluke infection (RR: 3.50, P = 0.06; OR: 5.79, P = 0.08). The statistical heterogeneity was significant, no significant difference was observed in the sensitivity analysis, and no publication bias was found. Conclusion The meta-analysis found that liver fluke infection was significantly associated with cholangitis, cholecystitis, cholelithiasis, hepatocellular carcinoma and cholangiocarcinoma and that more severe infection was associated with higher incidence. However, the association between liver fluke infection and cirrhosis was not significant.	[Xia, Jing; Jiang, Shi-chen; Peng, Hong-Juan] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Prov Key Lab Trop Dis Res, Dept Pathogen Biol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Peng, HJ (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Prov Key Lab Trop Dis Res, Dept Pathogen Biol, Guangzhou, Guangdong, Peoples R China.	hongjuan@smu.edu.cn	Peng, Hongjuan/GYV-5462-2022	Xia, Jing/0000-0002-7590-4544	National Natural Science Foundation of China [81271866]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme	This research was supported by the funding of National Natural Science Foundation of China (no. 81271866), and Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2014) to HJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Rojas CA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0715-7; Cai WK, 2011, WORLD J GASTROENTERO, V17, P249, DOI 10.3748/wjg.v17.i2.249; Chen HN, 1994, CHIN J CANCER, P128; Chen MF, 2001, GUANGDONG J HLTH EPI, V27, P67, DOI [10.3969/j.issn.1671-5039.2001.01.029, DOI 10.3969/J.ISSN.1671-5039.2001.01.029]; Chen XQ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002606; Chen ZZ., 1997, J PATHOGEN BIOL, P33; Choi D, 2006, J HEPATOL, V44, P1066, DOI 10.1016/j.jhep.2005.11.040; Choi D, 2008, J GASTROEN HEPATOL, V23, pE399, DOI 10.1111/j.1440-1746.2007.05242.x; Choi MS, 2005, AM J TROP MED HYG, V73, P1139, DOI 10.4269/ajtmh.2005.73.1139; Chung C. S., 1976, Korean Journal of Pathology, V10, P33; ELKINS DB, 1990, T ROY SOC TROP MED H, V84, P715, DOI 10.1016/0035-9203(90)90159-C; Furst T, 2012, LANCET INFECT DIS, V12, P210, DOI 10.1016/S1473-3099(11)70294-8; Gao LB, 2013, HEBEI MED, V19, P93, DOI [10.3969/j.issn.1006-6233.2013.01.036, DOI 10.3969/J.ISSN.1006-6233.2013.01.036]; Gibson RB, 1971, IARC SCI PUBLICATION, V1; HARINASUTA T, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1167; HASWELLELKINS MR, 1994, INT J CANCER, V59, P505, DOI 10.1002/ijc.2910590412; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian, 2002, J Health Serv Res Policy, V7, P51, DOI 10.1258/1355819021927674; Honjo S, 2005, INT J CANCER, V117, P854, DOI 10.1002/ijc.21146; HOU MF, 1989, J TROP MED HYG, V92, P108; HOU PC, 1956, J PATHOL BACTERIOL, V72, P95; Huang JiaYin, 2010, Journal of Tropical Medicine (Guangzhou), V10, P226; Huang MH, 2005, J GASTROEN HEPATOL, V20, P141, DOI 10.1111/j.1440-1746.2004.03523.x; ITOH M, 1994, AM J TROP MED HYG, V51, P424, DOI 10.4269/ajtmh.1994.51.424; Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614; Kim HG, 2009, WORLD J GASTROENTERO, V15, P86, DOI 10.3748/wjg.15.86; KIM YI, 1974, SEOUL J MED, V15, P247; Kujawa M., 1995, WHO TECHNICAL REPORT, V849, P166, DOI [10.1002/food.19960400342, DOI 10.1002/FOOD.19960400342]; KURATHONG S, 1985, GASTROENTEROLOGY, V89, P151, DOI 10.1016/0016-5085(85)90755-3; Lee TY, 2008, AM J GASTROENTEROL, V103, P1716, DOI 10.1111/j.1572-0241.2008.01796.x; Li T, 2010, TRENDS PARASITOL, V26, P264, DOI 10.1016/j.pt.2010.02.007; Lim JH, 2011, KOREAN J RADIOL, V12, P269, DOI 10.3348/kjr.2011.12.3.269; LIM JH, 1991, AM J ROENTGENOL, V157, P1; LIN AC, 1987, SOUTHERN MED J, V80, P919, DOI 10.1097/00007611-198707000-00030; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Luo XiaoBing, 2013, Chinese Journal of Zoonoses, V29, P1084; MAIRIANG E, 1992, J GASTROEN HEPATOL, V7, P17, DOI 10.1111/j.1440-1746.1992.tb00928.x; Mairiang E, 2012, PARASITOL INT, V61, P208, DOI 10.1016/j.parint.2011.07.009; Manwong M, 2013, ASIAN PAC J CANCER P, V14, P5953, DOI 10.7314/APJCP.2013.14.10.5953; Marcos LA, 2009, J HELMINTHOL, V83, P23, DOI 10.1017/S0022149X08067205; Marcos LA, 2011, J PARASITOL, V97, P82, DOI 10.1645/GE-2420.1; Mas-Coma S., 2004, SE ASIAN J TROP MED, V35, P1; Min DY., REMARKS DIAGNOSIS CL, P1153; Moher D, 2009, PREFERRED REPORTING, V10, P49; PARKIN DM, 1991, INT J CANCER, V48, P323, DOI 10.1002/ijc.2910480302; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peng NF, 2011, ANN SURG ONCOL, V18, P1258, DOI 10.1245/s10434-010-1458-5; Poomphakwaen K, 2009, ASIAN PAC J CANCER P, V10, P251; Saijuntha W, 2014, ADV EXP MED BIOL, V766, P153, DOI 10.1007/978-1-4939-0915-5_6; Shin HR, 1996, INT J EPIDEMIOL, V25, P933, DOI 10.1093/ije/25.5.933; Smout MJ, 2011, MOL BIOSYST, V7, P1367, DOI 10.1039/c0mb00295j; Sripa B, 2000, INT J PARASITOL, V30, P735, DOI 10.1016/S0020-7519(00)00054-0; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Sripa B, 2012, TRENDS PARASITOL, V28, P395, DOI 10.1016/j.pt.2012.07.006; Sripa B, 2009, HEPATOLOGY, V50, P1273, DOI 10.1002/hep.23134; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Tan S. G., 2007, THESIS; Tan Sheng-Kui, 2008, Zhonghua Gan Zang Bing Za Zhi, V16, P114; Utzinger J, CONTROL NEGLECTED TR, pe112; Villegas F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001720; Wang XP, 2012, CHINA MODERN DOCTOR, V50, P75, DOI [10.3969/j.issn.1673-9701.2012.16.034, DOI 10.3969/J.ISSN.1673-9701.2012.16.034]; WONGRATANACHEEWIN S, 1988, AM J TROP MED HYG, V38, P356, DOI 10.4269/ajtmh.1988.38.356; Zeng SQ, 2005, J TROPICAL MED, P350; Zhang X, 2010, PRATICAL J CARDIAC C, P1585; Zheng ZX, 1997, GUANGDONG J HLTH EPI, P35; Zhu SH., 1982, GUANGDONG MED J, P1	67	44	44	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132673	10.1371/journal.pone.0132673	http://dx.doi.org/10.1371/journal.pone.0132673			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186510	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700053
J	Glynn, JR; Guerra-Assuncao, JA; Houben, RMGJ; Sichali, L; Mzembe, T; Mwaungulu, LK; Mwaungulu, JN; McNerney, R; Khan, P; Parkhill, J; Crampin, AC; Clark, TG				Glynn, Judith R.; Guerra-Assuncao, Jose Afonso; Houben, Rein M. G. J.; Sichali, Lifted; Mzembe, Themba; Mwaungulu, Lorrain K.; Mwaungulu, J. Nimrod; McNerney, Ruth; Khan, Palwasha; Parkhill, Julian; Crampin, Amelia C.; Clark, Taane G.			Whole Genome Sequencing Shows a Low Proportion of Tuberculosis Disease Is Attributable to Known Close Contacts in Rural Malawi	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TRANSMISSION; HOUSEHOLDS; COMMUNITY; UK	Background The proportion of tuberculosis attributable to transmission from close contacts is not well known. Comparison of the genome of strains from index patients and prior contacts allows transmission to be confirmed or excluded. Methods In Karonga District, Malawi, all tuberculosis patients are asked about prior contact with others with tuberculosis. All available strains from culture-positive patients were sequenced. Up to 10 single nucleotide polymorphisms between index patients and their prior contacts were allowed for confirmation, and >= 100 for exclusion. The population attributable fraction was estimated from the proportion of confirmed transmissions and the proportion of patients with contacts. Results From 1997-2010 there were 1907 new culture-confirmed tuberculosis patients, of whom 32% reported at least one family contact and an additional 11% had at least one other contact; 60% of contacts had smear-positive disease. Among case-contact pairs with sequences available, transmission was confirmed from 38% (62/163) smear-positive prior contacts and 0/17 smear-negative prior contacts. Confirmed transmission was more common in those related to the prior contact (42.4%, 56/132) than in non-relatives (19.4%, 6/31, p = 0.02), and in those with more intense contact, to younger index cases, and in more recent years. The proportion of tuberculosis attributable to known contacts was estimated to be 9.4% overall. Conclusions In this population known contacts only explained a small proportion of tuberculosis cases. Even those with a prior family contact with smear positive tuberculosis were more likely to have acquired their infection elsewhere.	[Glynn, Judith R.; Guerra-Assuncao, Jose Afonso; Houben, Rein M. G. J.; Khan, Palwasha; Crampin, Amelia C.; Clark, Taane G.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Sichali, Lifted; Mzembe, Themba; Mwaungulu, Lorrain K.; Mwaungulu, J. Nimrod; Crampin, Amelia C.] Karonga Prevent Study, Chilumba, Malawi; [McNerney, Ruth; Clark, Taane G.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Parkhill, Julian] Wellcome Trust Sanger Inst, Hinxton, England	University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit; University of London; London School of Hygiene & Tropical Medicine; Wellcome Trust Sanger Institute	Glynn, JR (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	Judith.glynn@lshtm.ac.uk	Clark, Taane G./AAM-2570-2020; khan, Palwasha/GRS-4835-2022; Parkhill, Julian/G-4703-2011; Guerra-Assuncao, Jose Afonso/F-3887-2011	Clark, Taane G./0000-0001-8985-9265; Parkhill, Julian/0000-0002-7069-5958; Crampin, Amelia/0000-0002-1513-4330; Khan, Palwasha Yousafzai/0000-0002-0873-8355; Guerra-Assuncao, Jose Afonso/0000-0001-6593-403X	Wellcome Trust [096249/Z/11/B]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by The Wellcome Trust grant number 096249/Z/11/B (PI JG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LF, 2014, LANCET INFECT DIS, V14, P406, DOI 10.1016/S1473-3099(14)70022-2; Behr MA, 1998, AM J RESP CRIT CARE, V158, P465, DOI 10.1164/ajrccm.158.2.9801062; Bennett DE, 2002, EMERG INFECT DIS, V8, P1224; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0; Coll F, 2012, BIOINFORMATICS, V28, P2991, DOI 10.1093/bioinformatics/bts544; Crampin AC, 2006, EMERG INFECT DIS, V12, P729; Crampin AC, 2004, INT J TUBERC LUNG D, V8, P194; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Guerra-Assuncao JA, 2015, ELIFE, V4, DOI 10.7554/eLife.05166; Guerra-Assuncao JA, 2014, J INFECT DIS JIU, P574; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Mallard K, 2010, J CLIN MICROBIOL, V48, P4512, DOI 10.1128/JCM.01683-10; Marais BJ, 2009, J CLIN MICROBIOL, V47, P1338, DOI 10.1128/JCM.02490-08; Mboma SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058192; NARAIN R, 1966, B WORLD HEALTH ORGAN, V34, P639; Schaaf HS, 2003, INT J TUBERC LUNG D, V7, P426; Sloot R, 2014, AM J RESP CRIT CARE, V190, P1044, DOI 10.1164/rccm.201406-1159OC; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; Walker TM, 2014, LANCET RESP MED, V2, P285, DOI 10.1016/S2213-2600(14)70027-X; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; World Health Organization, 2013, SYST SCREEN ACT TUB; Zachariah R, 2011, INT J TUBERC LUNG D, V15, P933, DOI 10.5588/ijtld.10.0666	24	70	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132840	10.1371/journal.pone.0132840	http://dx.doi.org/10.1371/journal.pone.0132840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181760	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000358198200041
J	Brosseau, N; Andreev, E; Ramotar, D				Brosseau, Nicolas; Andreev, Emil; Ramotar, Dindial			Complementation of the Yeast Model System Reveals that Caenorhabditis elegans OCT-1 Is a Functional Transporter of Anthracyclines	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTER; ACUTE MYELOID-LEUKEMIA; CALCIUM SIGNALING PATHWAY; GENOME-WIDE SCREEN; SACCHAROMYCES-CEREVISIAE; CARNITINE TRANSPORTER; POLYAMINE UPTAKE; DRUG-RESISTANCE; GROUP-B; DOXORUBICIN	The yeast plasma membrane protein Agp2 belongs to the family of amino acid transporters. It acts as a regulator that controls the expression of several uptake transporter genes such as DUR3 and SAM3 encoding two high-affinity polyamine permeases. agp2 Delta mutants display extreme resistance to several cationic compounds including polyamines, the anticancer agent bleomycin, and cationic antifungal peptides. We propose that Agp2 might be involved in regulating the uptake of other cationic anticancer drugs. To date, an uptake transporter has not been reported for anthracyclines, a family of chemotherapeutic agents that are used for treating adult patients with acute myeloid leukemia. Herein, we develop assay conditions to monitor the uptake of the anthracycline doxorubicin into yeast cells and demonstrate for the first time that Agp2 is required for the drug uptake. Deletion of both the DUR3 and SAM3 genes reduced doxorubicin uptake, but not the deletion of either gene alone, while theagp2 Delta mutant was severely compromised, suggesting that Agp2 controls the drug uptake via Dur3 and Sam3 and at least one additional transporter. Overexpression of DUR3 or SAM3 from the endogenous promoter rescued doxorubicin uptake into the sam3 Delta dur3 Delta double mutant, consistent with a role for these transporters in the uptake of anthracyclines. We further show by cross-species complementation analysis that expression of the Caenorhabditis elegans oct-1 gene encoding an organic cation transporter restored full doxorubicin uptake in the agp2D mutant. Four separate variants of CeOCT-1 derived by substituting the amino acid residues Gln15, Cys31, Gln109 and Lys300 with alanine were stably expressed, but did not mediate doxorubicin uptake into the agp2D mutant. Moreover, we show that overexpression of CeOCT-1 sensitized parent yeast cells to doxorubicin, suggesting that CeOCT-1 related members might be key transporters to facilitate entry of anthracyclines into human cells.	[Brosseau, Nicolas; Andreev, Emil; Ramotar, Dindial] Univ Montreal, Res Ctr, Maisonneuve Rosemont Hosp, Dept Med, Montreal, PQ, Canada	Universite de Montreal	Ramotar, D (corresponding author), Univ Montreal, Res Ctr, Maisonneuve Rosemont Hosp, Dept Med, 5415 Boul Assompt, Montreal, PQ, Canada.	dindial.ramotar@umontreal.ca			Canadian Institute of Health Research [MOP-93573, RGPIN/202432-2012]; Natural Science and Engineering Research Council of Canada	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by research grants (MOP-93573 and RGPIN/202432-2012) to D. R. from the Canadian Institute of Health Research and the Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouida M, 2005, J BIOL CHEM, V280, P24267, DOI 10.1074/jbc.M503071200; Aouida M, 2004, CANCER RES, V64, P1102, DOI 10.1158/0008-5472.CAN-03-2729; Aouida M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065717; Becker ML, 2009, PHARMACOGENOMICS J, V9, P242, DOI 10.1038/tpj.2009.15; Bleackley MR, 2014, ANTIMICROB AGENTS CH, V58, P2688, DOI 10.1128/AAC.02087-13; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Chauncey TR, 2001, CURR OPIN ONCOL, V13, P21, DOI 10.1097/00001622-200101000-00005; Cheah IK, 2013, FREE RADICAL RES, V47, P1036, DOI 10.3109/10715762.2013.848354; CHEN G, 1994, CANCER RES, V54, P4980; Cunningham KW, 2011, CELL CALCIUM, V50, P129, DOI 10.1016/j.ceca.2011.01.010; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Dean M, 2001, J LIPID RES, V42, P1007; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gottesman MM, 1995, ANNU REV GENET, V29, P607, DOI 10.1146/annurev.ge.29.120195.003135; Hillgren KM, 2013, CLIN PHARMACOL THER, V94, P52, DOI 10.1038/clpt.2013.74; Koepsell H, 2013, MOL ASPECTS MED, V34, P413, DOI 10.1016/j.mam.2012.10.010; Kolitz JE, 2010, BLOOD, V116, P1413, DOI 10.1182/blood-2009-07-229492; Lavina WA, 2013, J BIOSCI BIOENG, V115, P138, DOI 10.1016/j.jbiosc.2012.08.022; Marie JP, 2001, CURR OPIN ONCOL, V13, P463, DOI 10.1097/00001622-200111000-00008; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Nikitovic D, 2014, CHEST, V146, P1123, DOI 10.1378/chest.14-0460; Okabe M, 2005, BIOCHEM BIOPH RES CO, V333, P754, DOI 10.1016/j.bbrc.2005.05.174; Sinclair CJ, 2000, J LIPID RES, V41, P1841; Stefan CP, 2013, EUKARYOT CELL, V12, P204, DOI 10.1128/EC.00299-12; Swietach P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035949; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; van Roermund CWT, 1999, EMBO J, V18, P5843, DOI 10.1093/emboj/18.21.5843; Westmoreland TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005830; White DL, 2010, LEUKEMIA, V24, P1962, DOI 10.1038/leu.2010.188; Wu X, 1999, BBA-BIOMEMBRANES, V1418, P239, DOI 10.1016/S0005-2736(99)00020-6; Xia L, 2007, CANCER RES, V67, P11411, DOI 10.1158/0008-5472.CAN-07-2399; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200	34	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133182	10.1371/journal.pone.0133182	http://dx.doi.org/10.1371/journal.pone.0133182			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177450	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600227
J	Cao, LQ; Xie, BH; Yang, XW; Liang, HH; Jiang, XF; Zhang, DW; Xue, P; Chen, D; Shao, ZL				Cao, Liangqi; Xie, Binhui; Yang, Xuewei; Liang, Huihong; Jiang, Xiaofeng; Zhang, Dawei; Xue, Ping; Chen, De; Shao, Zili			MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; PROSTATE-CANCER; BREAST-CANCER; MATRIX METALLOPROTEINASE-2; VASCULAR INVASION; EXPRESSION; MMP-9; MICRORNAS; PROMOTES; METASTASIS	Hepatocellular carcinoma (HCC) is one of the common malignancies, which is highly metastatic and the third common cause of cancer deaths in the world. The invasion and metastasis of cancer cells is a multistep and complex process which is mainly initiated by extracellular matrix (ECM) degradation. Aberrant expression of microRNA has been investigated in HCC and shown to play essential roles during HCC progression. In the present study, we found that microRNA-324-5p (miR-324-5p) was downregulated in both HCC cell lines and tissues. Ectopic miR-324-5p led to the reduction of HCC cells invasive and metastatic capacity, whereas inhibition of miR-324-5p promoted the invasion of HCC cells. Matrix metalloproteinase 2 (MMP2) and MMP9, the major regulators of ECM degradation, were found to be downregulated by ectopic miR-324-5p, while upregulated by miR-324-5p inhibitor. E26 transformation-specific 1 (ETS1) and Specificity protein 1 (SP1), both of which could modulate MMP2 and MMP9 expression and activity, were presented as the direct targets of and downregulated by miR-324-5p. Downregulation of ETS1 and SP1 mediated the inhibitory function of miR-324-5p on HCC migration and invasion. Our study demonstrates that miR-324-5p suppresses hepatocellular carcinoma cell invasion and might provide new clues to invasive HCC therapy.	[Cao, Liangqi; Yang, Xuewei; Liang, Huihong; Jiang, Xiaofeng; Zhang, Dawei; Xue, Ping; Chen, De; Shao, Zili] Guangzhou Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China; [Xie, Binhui] Gannan Med Univ, Affiliated Hosp 1, Dept Gen Surg, Ganzhou, Peoples R China	Guangzhou Medical University; Gannan Medical University	Shao, ZL (corresponding author), Guangzhou Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China.	43478443@qq.com			Science & Technology Project in Guangzhou City-Zhujiang Science & Technology New Star [2012J2200039]; Natural Science Foundation of Jiangxi Province [2012ZBAB205001]; Science and Technology Projects Foundation of Jiangxi Province [20112BBG70037]	Science & Technology Project in Guangzhou City-Zhujiang Science & Technology New Star; Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); Science and Technology Projects Foundation of Jiangxi Province	This work was financially supported by the Science & Technology Project in Guangzhou City-Zhujiang Science & Technology New Star (2012J2200039), Natural Science Foundation of Jiangxi Province (2012ZBAB205001), and Science and Technology Projects Foundation of Jiangxi Province (20112BBG70037).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behrens P, 2001, J PATHOL, V194, P43, DOI 10.1002/path.844; Behrens P, 2001, INT J MOL MED, V8, P149; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calli AO, 2011, PATHOL RES PRACT, V207, P628, DOI 10.1016/j.prp.2011.07.010; Chang WC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-94; Chen D, 2012, INT J MOL SCI, V13, P10594, DOI 10.3390/ijms130810594; Chen KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072927; Chen RX, 2012, ANN SURG ONCOL, V19, pS375, DOI 10.1245/s10434-011-1836-7; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Fan HX, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-90; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; Fromigue O, 2008, J BIOL CHEM, V283, P30549, DOI 10.1074/jbc.M801436200; Fujimoto J, 2002, ANN ONCOL, V13, P1598, DOI 10.1093/annonc/mdf248; Guan HY, 2012, INT J CANCER, V130, P593, DOI 10.1002/ijc.26049; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahne JC, 2005, ONCOGENE, V24, P5384, DOI 10.1038/sj.onc.1208761; Hsu TI, 2012, ONCOGENE, V31, P3973, DOI 10.1038/onc.2011.568; Ito Y, 2000, AM J CLIN PATHOL, V114, P719, DOI 10.1309/RAVV-8NM1-CJB7-GJFR; Jacob A, 2013, J CELL SCI, V126, P4647, DOI 10.1242/jcs.126573; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang LL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-406; Jiang NY, 2008, CANCER EPIDEM BIOMAR, V17, P1648, DOI 10.1158/1055-9965.EPI-07-2791; Jonas S, 2001, HEPATOLOGY, V33, P1080, DOI 10.1053/jhep.2001.23561; Kondo S, 2007, J CELL SCI, V120, P849, DOI 10.1242/jcs.03388; Kousidou OC, 2004, ANTICANCER RES, V24, P4025; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Moroz A, 2013, BIOCHEM BIOPH RES CO, V430, P1319, DOI 10.1016/j.bbrc.2012.12.031; Murthy S, 2012, BIOCHEM J, V445, P229, DOI 10.1042/BJ20120053; Naito S, 2000, PATHOL RES PRACT, V196, P103, DOI 10.1016/S0344-0338(00)80041-2; Okuducu AF, 2006, HISTOPATHOLOGY, V48, P836, DOI 10.1111/j.1365-2559.2006.02432.x; Pande P, 1999, J PATHOL, V189, P40, DOI 10.1002/(SICI)1096-9896(199909)189:1<40::AID-PATH405>3.0.CO;2-#; Park KS, 2011, J GASTROEN HEPATOL, V26, P391, DOI 10.1111/j.1440-1746.2010.06504.x; Pavelic SK, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-22; Pazzaglia L, 2004, ANTICANCER RES, V24, P967; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sankpal UT, 2011, MED CHEM, V7, P518; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Shaikhibrahim Z, 2012, INT J ONCOL, V40, P1748, DOI 10.3892/ijo.2012.1380; Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83; Somiari SB, 2006, INT J CANCER, V119, P1403, DOI 10.1002/ijc.21989; Span PN, 2002, ONCOGENE, V21, P8506, DOI 10.1038/sj.onc.1206040; Takai N, 2002, INT J MOL MED, V9, P287; Teo EK, 2001, DIGEST DIS, V19, P263, DOI 10.1159/000050692; Thuluvath PJ, 2009, J CLIN GASTROENTEROL, V43, P101, DOI 10.1097/MCG.0b013e318191e64f; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Xia L, 2001, GENE, V268, P77, DOI 10.1016/S0378-1119(01)00429-2; Zhang J, 2013, EUR REV MED PHARMACO, V17, P2372; Zhao WN, 2013, INT J MOL SCI, V14, P13577, DOI 10.3390/ijms140713577; Zhou CF, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-102; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697	60	58	61	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133074	10.1371/journal.pone.0133074	http://dx.doi.org/10.1371/journal.pone.0133074			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177288	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600210
J	Chen, XP; Kong, YF; Dang, LX; Hou, YN; Ye, XY				Chen, Xiaopan; Kong, Yunfeng; Dang, Lanxue; Hou, Yane; Ye, Xinyue			Exact and Metaheuristic Approaches for a Bi-Objective School Bus Scheduling Problem	PLOS ONE			English	Article							VEHICLE-ROUTING PROBLEM; LOCAL SEARCH; OPTIMIZATION; ALGORITHM	As a class of hard combinatorial optimization problems, the school bus routing problem has received considerable attention in the last decades. For a multi-school system, given the bus trips for each school, the school bus scheduling problem aims at optimizing bus schedules to serve all the trips within the school time windows. In this paper, we propose two approaches for solving the bi-objective school bus scheduling problem: an exact method of mixed integer programming (MIP) and a metaheuristic method which combines simulated annealing with local search. We develop MIP formulations for homogenous and heterogeneous fleet problems respectively and solve the models by MIP solver CPLEX. The bus type-based formulation for heterogeneous fleet problem reduces the model complexity in terms of the number of decision variables and constraints. The metaheuristic method is a two-stage framework for minimizing the number of buses to be used as well as the total travel distance of buses. We evaluate the proposed MIP and the metaheuristic method on two benchmark datasets, showing that on both instances, our metaheuristic method significantly outperforms the respective state-of-the-art methods.	[Chen, Xiaopan; Kong, Yunfeng; Dang, Lanxue; Hou, Yane] Henan Univ, Key Lab Geospatial Technol Middle & Lower Yellow, Minist Educ, Kaifeng 475004, Henan, Peoples R China; [Chen, Xiaopan; Dang, Lanxue; Hou, Yane] Henan Univ, Coll Comp & Informat Engn, Kaifeng 475004, Henan, Peoples R China; [Ye, Xinyue] Kent State Univ, Dept Geog, Kent, OH 44242 USA	Henan University; Henan University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Kong, YF (corresponding author), Henan Univ, Key Lab Geospatial Technol Middle & Lower Yellow, Minist Educ, Kaifeng 475004, Henan, Peoples R China.	yfkong@henu.edu.cn	Ye, Xinyue/A-7677-2011	Ye, Xinyue/0000-0001-8838-9476; Kong, Yunfeng/0000-0002-0777-3116	National Natural Science Foundation of China [41401461]; Key Project of Education Department of Henan Province [Y1317005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Education Department of Henan Province	This paper is supported by National Natural Science Foundation of China (Grant No. 41401461) and by the Key Project of Education Department of Henan Province (Grant No. Y1317005).	Addas M, 2009, THESIS DALHOUSI U; Arias-Rojas Juan S, 2012, Rev.EIA.Esc.Ing.Antioq, P193; Baldacci R, 2008, OPER RES COMPUT SCI, V43, P3, DOI 10.1007/978-0-387-77778-8_1; Bektas T, 2007, J OPER RES SOC, V58, P1599, DOI 10.1057/palgrave.jors.2602305; Ben Sghaier S, 2013, 2013 INTERNATIONAL CONFERENCE ON ADVANCED LOGISTICS AND TRANSPORT (ICALT), P7; Bent R, 2004, TRANSPORT SCI, V38, P515, DOI 10.1287/trsc.1030.0049; Bogl M, 2015, NETWORKS, V65, P180, DOI 10.1002/net.21589; BOWERMAN R, 1995, TRANSPORT RES A-POL, V29, P107, DOI 10.1016/0965-8564(94)E0006-U; Braca J, 1997, IIE TRANS, V29, P693, DOI 10.1023/A:1018526202990; Braysy I, 2005, TRANSPORT SCI, V39, P104, DOI 10.1287/trsc.1030.0056; Campbell J. F., 2015, QUANTITATIVE APPROAC, P3; CLARKE G, 1964, OPER RES, V12, P568, DOI 10.1287/opre.12.4.568; Corberan A, 2002, J OPER RES SOC, V53, P427, DOI 10.1057/palgrave.jors.2601324; Crama Y., 1995, Artificial Neural Networks. An Introduction to ANN Theory and Practice, P157, DOI 10.1007/BFb0027029; [党兰学 Dang Lanxue], 2013, [计算机科学, Computer Science], V40, P248; Fugenschuh A, 2009, EUR J OPER RES, V193, P867, DOI 10.1016/j.ejor.2007.10.055; Fugenschuh A, 2006, ANN OPER RES, V147, P199, DOI 10.1007/s10479-006-0066-Z; Groer C, 2010, MATH PROGRAM COMPUT, V2, P79, DOI 10.1007/s12532-010-0013-5; Huo L., 2014, 2014 IEEE C EXP TRAN, P1; Kim BI, 2012, EUR J OPER RES, V218, P577, DOI 10.1016/j.ejor.2011.11.035; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Laporte G, 2009, TRANSPORT SCI, V43, P408, DOI 10.1287/trsc.1090.0301; Martinez LM., 2011, PROCEDIA SOCIAL BEHA, V20, P120; Minocha B, 2014, ADV INTELL SYST, V236, P93, DOI 10.1007/978-81-322-1602-5_11; Pacheco J, 2013, TRANSPORT SCI, V47, P397, DOI 10.1287/trsc.1120.0437; Park J, 2012, EUR J OPER RES, V217, P204, DOI 10.1016/j.ejor.2011.08.022; Park J, 2010, EUR J OPER RES, V202, P311, DOI 10.1016/j.ejor.2009.05.017; Repoussis PP, 2010, TRANSPORT RES C-EMER, V18, P695, DOI 10.1016/j.trc.2009.08.004; Riera-Ledesma J, 2013, COMPUT OPER RES, V40, P566, DOI 10.1016/j.cor.2012.08.011; Riera-Ledesma J, 2012, COMPUT OPER RES, V39, P391, DOI 10.1016/j.cor.2011.04.015; Ripplinger D, 2005, TRANSPORT RES REC, P105; Ruiz PA, 2015, LECT NOTES MANAGEMEN, P105; Schittekat P, 2006, 2006 INTERNATIONAL CONFERENCE ON SERVICE SYSTEMS AND SERVICE MANAGEMENT, VOLS 1 AND 2, PROCEEDINGS, P1552, DOI 10.1109/ICSSSM.2006.320767; Spasovic L, 2001, TRANSPORTATION RES B, P7; Subramanian A, 2012, EUR J OPER RES, V221, P285, DOI 10.1016/j.ejor.2012.03.016; Toth P, 2002, SIAM MONOG DISCR MAT, P1; Zhang M., 2008, RES MULTIOBJECTIVE S	37	21	24	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132600	10.1371/journal.pone.0132600	http://dx.doi.org/10.1371/journal.pone.0132600			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176764	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600129
J	Cipriani, S; Renga, B; D'Amore, C; Simonetti, M; De Tursi, AA; Carino, A; Monti, MC; Sepe, V; Zampella, A; Fiorucci, S				Cipriani, Sabrina; Renga, Barbara; D'Amore, Claudio; Simonetti, Michele; De Tursi, Antonio Angelo; Carino, Adriana; Monti, Maria Chiara; Sepe, Valentina; Zampella, Angela; Fiorucci, Stefano			Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling	PLOS ONE			English	Article							FARNESOID-X RECEPTOR; BILE-ACID RECEPTOR; PRIMARY SCLEROSING CHOLANGITIS; LIVER-DISEASES; TGR5; EXPRESSION; PRURITUS; AGONIST; FXR; DETOXIFICATION	Background & Aims In cholestatic syndromes, body accumulation of bile acids is thought to cause itching. However, the mechanisms supporting this effect remain elusive. Recently, GPBAR1 (TGR5) a G-protein coupled receptor has been shown to mediate itching caused by intradermal administration of DCA and LCA. 6 alpha-ethyl-3 alpha, 7 alpha-dihydroxy-24-nor-5 beta-cholan-23-ol (BAR502) is a non-bile acid dual ligand for FXR and GPBAR1. Methods Cholestasis was induced in wild type and GPBAR1(-/-) mice by administration of alpha-naphthylisothiocyanate (ANIT) or 17 alpha-ethynylestradiol. Results. In naive mice skin application of DCA, TLCA, 6-ECDCA, oleanolic and betulinic acid induces a GPBAR1 dependent pruritogenic response that could be desensitized by re-challenging the mice with the same GPBAR1 agonist. In wild type and GPBAR1(-/-) mice cholestasis induced by ANIT fails to induce spontaneous itching and abrogates scratching behavior caused by intradermal administration of DCA. In this model, co-treatment with BAR502 increases survival, attenuates serum alkaline phosphatase levels and robustly modulates the liver expression of canonical FXR target genes including OSTa, BSEP, SHP and MDR1, without inducing pruritus. Betulinic acid, a selective GPBAR1 ligand, failed to rescue wild type and GPBAR1(-/-) mice from ANIT cholestasis but did not induced itching. In the 17 alpha-ethynylestradiol model BAR502 attenuates cholestasis and reshapes bile acid pool without inducing itching. Conclusions The itching response to intradermal injection of GPBAR1 agonists desensitizes rapidly and is deactivated in models of cholestasis, explain the lack of correlation between bile acids levels and itching severity in cholestatic syndromes. In models of non-obstructive cholestasis, BAR502 attenuates liver injury without causing itching.	[Cipriani, Sabrina] Univ Perugia, Dept Med, I-06100 Perugia, Italy; [Renga, Barbara; D'Amore, Claudio; Simonetti, Michele; De Tursi, Antonio Angelo; Carino, Adriana; Fiorucci, Stefano] Univ Perugia, Dept Surg & Biomed Sci, I-06100 Perugia, Italy; [Monti, Maria Chiara] Univ Salerno, Dept Pharm, I-84100 Salerno, Italy; [Sepe, Valentina; Zampella, Angela] Univ Naples Federico II, Dept Pharm, Naples, Italy	University of Perugia; University of Perugia; University of Salerno; University of Naples Federico II	Fiorucci, S (corresponding author), Univ Perugia, Dept Surg & Biomed Sci, I-06100 Perugia, Italy.	Stefano.Fiorucci@unipg.it	Sepe, Valentina/F-5994-2010	Carino, Adriana/0000-0003-2341-9528; Sepe, Valentina/0000-0002-0169-4441; D'Amore, Claudio/0000-0001-9217-9404	BAR Pharmaceuticals; PSC seeking a cure	BAR Pharmaceuticals; PSC seeking a cure	This study was partially supported by a grant form BAR Pharmaceuticals and by a grant from "PSC seeking a cure". BAR502 was provided by BAR Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Alemi F, 2013, J CLIN INVEST, V123, P1513, DOI 10.1172/JCI64551; Braz J, 2014, NEURON, V82, P522, DOI 10.1016/j.neuron.2014.01.018; D'Amore C, 2014, J MED CHEM, V57, P937, DOI 10.1021/jm401873d; Eaton JE, 2013, GASTROENTEROLOGY, V145, P521, DOI 10.1053/j.gastro.2013.06.052; Fagan E A, 1999, Clin Liver Dis, V3, P603, DOI 10.1016/S1089-3261(05)70087-8; Festa C, 2014, J MED CHEM, V57, P8477, DOI 10.1021/jm501273r; Fiorucci S, 2005, J PHARMACOL EXP THER, V313, P604, DOI 10.1124/jpet.104.079665; Fiorucci S, 2011, MINI-REV MED CHEM, V11, P753, DOI 10.2174/138955711796355258; Fiorucci S, 2004, GASTROENTEROLOGY, V127, P1497, DOI 10.1053/j.gastro.2004.08.001; Fiorucci S, 2014, EXPERT OPIN THER TAR, V18, P1449, DOI 10.1517/14728222.2014.956087; Fiorucci S, 2010, PROG LIPID RES, V49, P171, DOI 10.1016/j.plipres.2009.11.001; Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001; Fiorucci S, 2009, CURR OPIN GASTROEN, V25, P252, DOI 10.1097/MOG.0b013e328324f87e; Hirschfield GM, 2013, GASTROENTEROLOGY, V144, P1357, DOI 10.1053/j.gastro.2013.03.053; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Jonker JW, 2012, J STEROID BIOCHEM, V130, P147, DOI 10.1016/j.jsbmb.2011.06.012; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Keitel V, 2009, HEPATOLOGY, V50, P861, DOI 10.1002/hep.23032; KIRBY J, 1974, BMJ-BRIT MED J, V4, P693, DOI 10.1136/bmj.4.5946.693; Kowdley KV, 2011, J HEPATOL, V54, pS13, DOI 10.1016/S0168-8278(11)60030-5; Kremer AE, 2010, GASTROENTEROLOGY, V139, P1008, DOI 10.1053/j.gastro.2010.05.009; LaMotte RH, 2014, NAT REV NEUROSCI, V15, P19, DOI 10.1038/nrn3641; Leva FS, 2013, J MED CHEM, V56, P4701, DOI [10.1021/jm400419e, DOI 10.1021/JM400419E]; Li TT, 2011, MOL ENDOCRINOL, V25, P1066, DOI 10.1210/me.2010-0460; Lieu T, 2014, GASTROENTEROLOGY, V147, P1417, DOI 10.1053/j.gastro.2014.08.042; Marschall HU, 2006, J LIPID RES, V47, P582, DOI 10.1194/jlr.M500427-JLR200; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Mela M, 2003, ALIMENT PHARM THER, V17, P857, DOI 10.1046/j.1365-2036.2003.01458.x; Mencarelli A, 2013, DIABETES, V62, P3384, DOI 10.2337/db13-0299; Pellicciari R, 2002, J MED CHEM, V45, P3569, DOI 10.1021/jm025529g; Poupon R, 2012, CLIN RES HEPATOL GAS, V36, pS3, DOI 10.1016/S2210-7401(12)70015-3; Renga B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030443; Renga B, 2011, BBA-GENE REGUL MECH, V1809, P157, DOI 10.1016/j.bbagrm.2011.01.008; Ruparel NB, 2011, MOL PHARMACOL, V80, P117, DOI 10.1124/mol.110.068940; SCHOENFI.LJ, 1967, NATURE, V213, P93, DOI 10.1038/213093b0; Sinakos E, 2013, INFLAMM BOWEL DIS, V19, P1004, DOI 10.1097/MIB.0b013e3182802893; Stedman C, 2006, P NATL ACAD SCI USA, V103, P11323, DOI 10.1073/pnas.0604772103; Tabibian JH, 2013, EXPERT REV GASTROENT, V7, P103, DOI [10.1586/egh.12.80, 10.1586/EGH.12.80]; VARADI DP, 1974, ARCH DERMATOL, V109, P678, DOI 10.1001/archderm.109.5.678; Wagner M, 2003, GASTROENTEROLOGY, V125, P825, DOI 10.1016/S0016-5085(03)01068-0; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Zollner G, 2007, LIVER INT, V27, P920, DOI 10.1111/j.1478-3231.2007.01506.x	43	33	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0129866	10.1371/journal.pone.0129866	http://dx.doi.org/10.1371/journal.pone.0129866			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177448	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600017
J	Cleuren, ACA; Blankevoort, VT; van Diepen, JA; Verhoef, D; Voshol, PJ; Reitsma, PH; van Vlijmen, BJM				Cleuren, Audrey C. A.; Blankevoort, Vicky T.; van Diepen, Janna A.; Verhoef, Daniel; Voshol, Peter J.; Reitsma, Pieter H.; van Vlijmen, Bart J. M.			Changes in Dietary Fat Content Rapidly Alters the Mouse Plasma Coagulation Profile without Affecting Relative Transcript Levels of Coagulation Factors	PLOS ONE			English	Article							ORAL-CONTRACEPTIVE USE; WEIGHT-LOSS; OBESE MICE; THROMBIN GENERATION; VENOUS THROMBOSIS; ENDOTHELIAL-CELLS; GENE-EXPRESSION; FACTOR-VIII; RISK; ADAPTATION	Background Obesity is associated with a hypercoagulable state and increased risk for thrombotic cardiovascular events. Objective Establish the onset and reversibility of the hypercoagulable state during the development and regression of nutritionally-induced obesity in mice, and its relation to transcriptional changes and clearance rates of coagulation factors as well as its relation to changes in metabolic and inflammatory parameters. Methods Male C57BL/6J mice were fed a low fat (10% kcal as fat; LFD) or high fat diet (45% kcal as fat; HFD) for 2, 4, 8 or 16 weeks. To study the effects of weight loss, mice were fed the HFD for 16 weeks and switched to the LFD for 1, 2 or 4 weeks. For each time point analyses of plasma and hepatic mRNA levels of coagulation factors were performed after overnight fasting, as well as measurements of circulating metabolic and inflammatory parameters. Furthermore, in vivo clearance rates of human factor (F) VII, FVIII and FIX proteins were determined after 2 weeks of HFD-feeding. Results HFD feeding gradually increased the body and liver weight, which was accompanied by a significant increase in plasma glucose levels from 8 weeks onwards, while insulin levels were affected after 16 weeks. Besides a transient rise in cytokine levels at 2 weeks after starting the HFD, no significant effect on inflammation markers was present. Increased plasma levels of fibrinogen, FII, FVII, FVIII, FIX, FXI and FXII were observed in mice on a HFD for 2 weeks, which in general persisted throughout the 16 weeks of HFD-feeding. Interestingly, with the exception of FXI the effects on plasma coagulation levels were not paralleled by changes in relative transcript levels in the liver, nor by decreased clearance rates. Switching from HFD to LFD reversed the HFD-induced procoagulant shift in plasma, again not coinciding with transcriptional modulation. Conclusions Changes in dietary fat content rapidly alter the mouse plasma coagulation profile, thereby preceding plasma metabolic changes, which cannot be explained by changes in relative expression of coagulation factors or decreased clearance rates.	[Cleuren, Audrey C. A.; Blankevoort, Vicky T.; Verhoef, Daniel; Reitsma, Pieter H.; van Vlijmen, Bart J. M.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Dept Thrombosis & Hemostasis, Leiden, Netherlands; [van Diepen, Janna A.; Voshol, Peter J.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Dept Endocrinol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Vlijmen, BJM (corresponding author), Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Dept Thrombosis & Hemostasis, Leiden, Netherlands.	b.j.m.van_vlijmen@lumc.nl	van Diepen, Janna/E-9485-2010; Cleuren, Audrey/AAV-3684-2021	van Diepen, Janna/0000-0001-9091-1075; Cleuren, Audrey/0000-0003-1384-4651	Leducq Foundation (Paris, France); Netherlands Heart Foundation [2006B045]	Leducq Foundation (Paris, France)(Leducq Foundation); Netherlands Heart Foundation(Netherlands Heart Foundation)	This study was supported by the Leducq Foundation (Paris, France; LINAT project) and grant 2006B045 from the Netherlands Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi M, 2003, THROMB HAEMOSTASIS, V89, P493, DOI 10.1055/s-0037-1613379; Ay L, 2010, J THROMB HAEMOST, V8, P759, DOI 10.1111/j.1538-7836.2010.03766.x; Cleuren ACA, 2010, J THROMB HAEMOST, V8, P1838, DOI 10.1111/j.1538-7836.2010.03930.x; Cleuren ACA, 2009, THROMB HAEMOSTASIS, V102, P993, DOI 10.1160/TH09-03-0169; Do GM, 2011, MOL NUTR FOOD RES, V55, pS173, DOI 10.1002/mnfr.201100064; Everett LA, 2014, BLOOD, V123, P3697, DOI 10.1182/blood-2014-02-554501; Fahs SA, 2014, BLOOD, V123, P3706, DOI 10.1182/blood-2014-02-555151; FOLSOM AR, 1993, ARTERIOSCLER THROMB, V13, P162, DOI 10.1161/01.ATV.13.2.162; Godsland IF, 2005, J CLIN ENDOCR METAB, V90, P190, DOI 10.1210/jc.2004-1292; HAUS E, 1990, CHRONOBIOL INT, V7, P203, DOI 10.3109/07420529009056976; Kaji N, 2013, J VET MED SCI, V75, P1245, DOI 10.1292/jvms.13-0029; Mertens I, 2002, Obes Rev, V3, P85, DOI 10.1046/j.1467-789X.2002.00056.x; Muller M, 2003, NAT REV GENET, V4, P315, DOI 10.1038/nrg1047; Nagai N, 2008, THROMB RES, V122, P549, DOI 10.1016/j.thromres.2007.12.017; Oishi K, 2006, J THROMB HAEMOST, V4, P1774, DOI 10.1111/j.1538-7836.2006.02032.x; Pomp ER, 2007, BRIT J HAEMATOL, V139, P289, DOI 10.1111/j.1365-2141.2007.06780.x; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Rosito GA, 2004, THROMB HAEMOSTASIS, V91, P683, DOI 10.1160/TH03-01-0014; Samad F, 1999, THROMB HAEMOSTASIS, V82, P742, DOI 10.1055/s-0037-1615906; Sanchez C, 2012, ARTERIOSCL THROM VAS, V32, P2394, DOI 10.1161/ATVBAHA.112.250332; Sola E, 2009, THROMB RES, V123, P697, DOI 10.1016/j.thromres.2008.07.017	21	11	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131859	10.1371/journal.pone.0131859	http://dx.doi.org/10.1371/journal.pone.0131859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176620	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600067
J	Kao, HW; Lee, KW; Kuo, CL; Huang, CS; Tseng, WM; Liu, CS; Lin, CP				Kao, Hung-Wen; Lee, Kwo-Whei; Kuo, Chen-Ling; Huang, Ching-Shan; Tseng, Wan-Min; Liu, Chin-San; Lin, Ching-Po			Interleukin-6 as a Prognostic Biomarker in Ruptured Intracranial Aneurysms	PLOS ONE			English	Article							ENDOTHELIN RECEPTOR ANTAGONIST; SUBARACHNOID HEMORRHAGE; CEREBRAL VASOSPASM; DOUBLE-BLIND; CLAZOSENTAN; CYTOKINES; ISCHEMIA; IL-6; ASSOCIATION; INCREASE	Background Interleukin-6 (IL-6), a proinflammatory cytokine, was found to surge in the cerebral spinal fluid after aneurysmal subarachnoid hemorrhage (SAH). We hypothesized that the plasma level of IL-6 could be an independent biomarker in predicting clinical outcome of patients with ruptured intracranial aneurysm. Methods We prospectively included 53 consecutive patients treated with platinum coil embolization of the ruptured intracranial aneurysm. Plasma IL-6 levels were measured in the blood samples at the orifices of the aneurysms and from peripheral veins. The outcome measure was the modified Rankin Scale one month after SAH. Multiple logistic regression analyses were used to evaluate the associations between the plasma IL-6 levels and the neurological outcome. Results Significant risk factors for the poor outcome were old age, low Glasgow Coma Scale (GCS) on day 0, high Fisher grades, and high aneurysmal and venous IL-6 levels in univariate analyses. Aneurysmal IL-6 levels showed modest to moderate correlations with GCS on day 0, vasospasm grade and Fisher grade. A strong correlation was found between the aneurysmal and the corresponding venous IL-6 levels (rho = 0.721; P<0.001). In the multiple logistic regression models, the poor 30-day mRS was significantly associated with high aneurysmal IL-6 level (OR, 17.97; 95% CI, 1.51-214.33; P = 0.022) and marginally associated with high venous IL-6 level (OR, 12.71; 95% CI, 0.90-180.35; P = 0.022) after adjusting for dichotomized age, GCS on day 0, and vasospasm and Fisher grades. Conclusions The plasma level of IL-6 is an independent prognostic biomarker that could be used to aid in the identification of patients at high-risk of poor neurological outcome after rupture of the intracranial aneurysm.	[Kao, Hung-Wen] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Radiol, Taipei, Taiwan; [Kao, Hung-Wen; Lin, Ching-Po] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Lee, Kwo-Whei] Changhua Christian Hosp, Dept Med Imaging, Changhua, Taiwan; [Lee, Kwo-Whei; Kuo, Chen-Ling; Huang, Ching-Shan; Tseng, Wan-Min; Liu, Chin-San] Changhua Christian Hosp, Vasc & Genom Ctr, Changhua, Taiwan; [Liu, Chin-San] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Liu, Chin-San] China Med Univ, Grad Inst Integrat Med, Taichung, Taiwan; [Lin, Ching-Po] Natl Yang Ming Univ, Sch Life Sci, Inst Neurosci, Taipei 112, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; China Medical University Taiwan; National Yang Ming Chiao Tung University	Lee, KW (corresponding author), Changhua Christian Hosp, Dept Med Imaging, Changhua, Taiwan.	94692@cch.org.tw; liu48111@gmail.com			Changhua Christian Hospital, Changhua, Taiwan [98-CCH-IRP-34, 101-CCH-IRP-84]	Changhua Christian Hospital, Changhua, Taiwan	This work was supported by Changhua Christian Hospital, Changhua, Taiwan under grants 98-CCH-IRP-34 and 101-CCH-IRP-84.	BROWN JM, 1989, SURG GYNECOL OBSTET, V169, P568; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Chalouhi N, 2013, STROKE, V44, P2594, DOI 10.1161/STROKEAHA.113.002361; Dhar R, 2008, NEUROCRIT CARE, V8, P253, DOI 10.1007/s12028-007-9020-4; Dorhout SM, 2012, STROKE, V43, P2126, DOI 10.1161/STROKEAHA.111.639690; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Fassbender K, 2001, J NEUROL NEUROSUR PS, V70, P534, DOI 10.1136/jnnp.70.4.534; FASSBENDER K, 1994, J NEUROL SCI, V122, P135, DOI 10.1016/0022-510X(94)90289-5; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Heikkila K, 2008, EUR J CANCER, V44, P937, DOI 10.1016/j.ejca.2008.02.047; Hendryk S, 2004, NEUROENDOCRINOL LETT, V25, P141; Jones KG, 2001, CIRCULATION, V103, P2260; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; LE JM, 1989, LAB INVEST, V61, P588; LJUNGGREN B, 1985, J NEUROSURG, V62, P547, DOI 10.3171/jns.1985.62.4.0547; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; Macdonald RL, 2013, ACTA NEUROCHIR SUPPL, V115, P27, DOI 10.1007/978-3-7091-1192-5_7; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; Macdonald RL, 2010, NEUROCRIT CARE, V13, P416, DOI 10.1007/s12028-010-9433-3; McMahon CJ, 2013, J NEUROINTERV SURG, V5, P512, DOI 10.1136/neurintsurg-2012-010386; Meyers PM, 2011, NAT REV NEUROL, V7, P660, DOI 10.1038/nrneurol.2011.168; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; PAKARINEN S, 1967, ACTA NEUROL SCAND, VS 43, P9; Rose MJ, 2011, CURR OPIN ANESTHESIO, V24, P500, DOI 10.1097/ACO.0b013e32834ad45b; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Sarrafzadeh A, 2010, NEUROCRIT CARE, V13, P339, DOI 10.1007/s12028-010-9432-4; Schoch B, 2007, NEUROSURGERY, V60, P828, DOI 10.1227/01.NEU.0000255440.21495.80; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wermer MJH, 2007, STROKE, V38, P1404, DOI 10.1161/01.STR.0000260955.51401.cd; Yalamanchili K, 1998, AM J NEURORADIOL, V19, P553	31	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132115	10.1371/journal.pone.0132115	http://dx.doi.org/10.1371/journal.pone.0132115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176774	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600084
J	Kimura, M; Cutler, S; Isobe, S				Kimura, Mitsuhiro; Cutler, Sean; Isobe, Sachiko			A Novel Phenolic Compound, Chloroxynil, Improves Agrobacterium-Mediated Transient Transformation in Lotus japonicus	PLOS ONE			English	Article							MODEL LEGUME; FLORAL-DIP; GENETIC-TRANSFORMATION; PLANT TRANSFORMATION; TRANSGENIC PLANTS; MIYAKOJIMA MG-20; TUMEFACIENS; EFFICIENCY; EXPRESSION; TISSUE	Agrobacterium-mediated transformation is a commonly used method for plant genetic engineering. However, the limitations of Agrobacterium host-plant interactions and the complexity of plant tissue culture often make the production of transgenic plants difficult. Transformation efficiency in many legume species, including soybean and the common bean, has been reported to be quite low. To improve the transformation procedure in legumes, we screened for chemicals that increase the transformation efficiency of Lotus japonicus, a model legume species. A Chemical library was screened and chemicals that increase in transient transformation efficiency of L. japonicus accession, Miyakojima MG-20 were identified. The transient transformation efficiency was quantified by reporter activity in which an intron-containing reporter gene produces the GUS protein only when the T-DNA is expressed in the plant nuclei. We identified a phenolic compound, chloroxynil, which increased the genetic transformation of L. japonicus by Agrobacterium tumefaciens strain EHA105. Characterization of the mode of chloroxynil action indicated that it enhanced Agrobacterium-mediated transformation through the activation of the Agrobacterium vir gene expression, similar to acetosyringone, a phenolic compound known to improve Agrobacterium-mediated transformation efficiency. Transient transformation efficiency of L. japonicus with 5 mu M chloroxynil was 60- and 6-fold higher than that of the control and acetosyringone treatment, respectively. In addition, transgenic L. japonicus lines were successfully generated by 5 mu M chloroxynil treatment. Furthermore, we show that chloroxynil improves L. japonicus transformation by Agrobacterium strain GV3101 and rice transformation. Our results demonstrate that chloroxynil significantly improves Agrobacterium tumefaciens-mediated transformation efficiency of various agriculturally important crops.	[Kimura, Mitsuhiro; Isobe, Sachiko] Kazusa DNA Res Inst, Dept Frontier Res, Chiba, Japan; [Cutler, Sean] Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Cutler, Sean] Univ Calif Riverside, Dept Bot & Plant Sci, Inst Integrat Genome Biol, Riverside, CA 92521 USA	Kazusa DNA Research Institute; University of California System; University of California Riverside; University of California System; University of California Riverside	Kimura, M (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	mitsukimu@okayama-u.ac.jp			Kazusa DNA Research Institute Foundation	Kazusa DNA Research Institute Foundation	The research was supported by the Kazusa DNA Research Institute Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2002, PLANT CELL REP, V21, P238, DOI 10.1007/s00299-002-0494-4; Brookes Graham, 2013, GM CROPS GLOBAL SOCI; Buzas DM, 2005, PLANT CELL PHYSIOL, V46, P1202, DOI 10.1093/pcp/pci129; CANADAY CH, 1986, PLANT DIS, V70, P863, DOI 10.1094/PD-70-863; Cheng M, 1997, PLANT PHYSIOL, V115, P971, DOI 10.1104/pp.115.3.971; Cheng M, 1996, PLANT CELL REP, V15, P653, DOI 10.1007/BF00231918; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colebatch G, 2004, PLANT J, V39, P487, DOI 10.1111/j.1365-313X.2004.02150.x; Curtis IS, 2001, TRANSGENIC RES, V10, P363, DOI 10.1023/A:1016600517293; Cutler SR, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-4; Dam S, 2009, PLANT PHYSIOL, V149, P1325, DOI 10.1104/pp.108.133405; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Desbrosses GG, 2005, PLANT PHYSIOL, V137, P1302, DOI 10.1104/pp.104.054957; Fukai E, 2012, PLANT J, V69, P720, DOI 10.1111/j.1365-313X.2011.04826.x; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; HANDBERG K, 1992, PLANT J, V2, P487, DOI 10.1111/j.1365-313X.1992.00487.x; Hiei Y, 1997, PLANT MOL BIOL, V35, P205, DOI 10.1023/A:1005847615493; Imaizumi R, 2005, J PLANT RES, V118, P391, DOI 10.1007/s10265-005-0231-5; Ishida Y, 1996, NAT BIOTECHNOL, V14, P745, DOI 10.1038/nbt0696-745; JEFFERSON RA, 1987, EMBO J, V6, P3901; Johal GS, 2009, EUR J AGRON, V31, P144, DOI 10.1016/j.eja.2009.04.004; Kato T, 2005, J BIOSCI BIOENG, V99, P165, DOI 10.1263/jbb.99.165; Kawaguchi M, 2000, J PLANT RES, V113, P507, DOI 10.1007/PL00013961; Kouchi H, 2004, DNA RES, V11, P263, DOI 10.1093/dnares/11.4.263; KRAMER MG, 1994, EUPHYTICA, V79, P293, DOI 10.1007/BF00022530; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; MANSUR EA, 1993, PLANT SCI, V89, P93, DOI 10.1016/0168-9452(93)90174-X; McCullen CA, 2006, ANNU REV CELL DEV BI, V22, P101, DOI 10.1146/annurev.cellbio.22.011105.102022; Nadolska-Orczyk A, 2000, MOL BREEDING, V6, P185, DOI 10.1023/A:1009679908948; Peters NK, MOL PLANT MICROBE IN, V3, P4; Piers KL, 1996, P NATL ACAD SCI USA, V93, P1613, DOI 10.1073/pnas.93.4.1613; Pitzschke A, 2010, EMBO J, V29, P1021, DOI 10.1038/emboj.2010.8; Polowick PL, 2000, PLANT SCI, V153, P161, DOI 10.1016/S0168-9452(99)00267-8; Rashid H, 1996, PLANT CELL REP, V15, P727, DOI 10.1007/BF00232216; Rohini VK, 2000, PLANT SCI, V150, P41, DOI 10.1016/S0168-9452(99)00160-0; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Shimmen T, 2012, J PLANT RES, V125, P749, DOI 10.1007/s10265-012-0487-5; Shimmen T, 2010, J PLANT RES, V123, P715, DOI 10.1007/s10265-009-0297-6; STACHEL SE, 1985, NATURE, V318, P624, DOI 10.1038/318624a0; Stiller J, 1997, J EXP BOT, V48, P1357, DOI 10.1093/jxb/48.7.1357; Takanashi K, 2012, MOL PLANT MICROBE IN, V25, P869, DOI 10.1094/MPMI-01-12-0011-R; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Urbanski DF, 2012, PLANT J, V69, P731, DOI 10.1111/j.1365-313X.2011.04827.x; Wenck AR, 1999, PLANT MOL BIOL, V39, P407, DOI 10.1023/A:1006126609534; Yoshioka M, 2006, J BIOL CHEM, V281, P21660, DOI 10.1074/jbc.M602896200; Zale JM, 2009, PLANT CELL REP, V28, P903, DOI 10.1007/s00299-009-0696-0	47	6	7	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131626	10.1371/journal.pone.0131626	http://dx.doi.org/10.1371/journal.pone.0131626			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176780	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600054
J	Lee, JA; Shinn, P; Jaken, S; Oliver, S; Willard, FS; Heidler, S; Peery, RB; Oler, J; Chu, SY; Southall, N; Dexheimer, TS; Smallwood, J; Huang, R; Guha, R; Jadhav, A; Cox, K; Austin, CP; Simeonov, A; Sittampalam, GS; Husain, S; Franklin, N; Wild, DJ; Yang, JJ; Sutherland, JJ; Thomas, CJ				Lee, Jonathan A.; Shinn, Paul; Jaken, Susan; Oliver, Sarah; Willard, Francis S.; Heidler, Steven; Peery, Robert B.; Oler, Jennifer; Chu, Shaoyou; Southall, Noel; Dexheimer, Thomas S.; Smallwood, Jeffrey; Huang, Ruili; Guha, Rajarshi; Jadhav, Ajit; Cox, Karen; Austin, Christopher P.; Simeonov, Anton; Sittampalam, G. Sitta; Husain, Saba; Franklin, Natalie; Wild, David J.; Yang, Jeremy J.; Sutherland, Jeffrey J.; Thomas, Craig J.			Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; ANTI-ATHEROSCLEROTIC AGENTS; FUNCTIONAL-CHARACTERIZATION; DIHYDROFOLATE-REDUCTASE; COLORECTAL-CANCER; OXIDATIVE STRESS; CETABEN SODIUM; BETA-CATENIN; MECHANISMS; FOLATE	Phenotypic assays have a proven track record for generating leads that become first-in-class therapies. Whole cell assays that inform on a phenotype or mechanism also possess great potential in drug repositioning studies by illuminating new activities for the existing pharmacopeia. The National Center for Advancing Translational Sciences (NCATS) pharmaceutical collection (NPC) is the largest reported collection of approved small molecule therapeutics that is available for screening in a high-throughput setting. Via a wide-ranging collaborative effort, this library was analyzed in the Open Innovation Drug Discovery (OIDD) phenotypic assay modules publicly offered by Lilly. The results of these tests are publically available online at www.ncats.nih.gov/expertise/preclinical/pd2 and via the PubChem Database (https://pubchem.ncbi.nlm.nih.gov/) (AID 1117321). Phenotypic outcomes for numerous drugs were confirmed, including sulfonylureas as insulin secretagogues and the anti-angiogenesis actions of multikinase inhibitors sorafenib, axitinib and pazopanib. Several novel outcomes were also noted including the Wnt potentiating activities of rotenone and the antifolate class of drugs, and the anti-angiogenic activity of cetaben.	[Lee, Jonathan A.; Jaken, Susan; Oliver, Sarah; Willard, Francis S.; Heidler, Steven; Peery, Robert B.; Oler, Jennifer; Chu, Shaoyou; Smallwood, Jeffrey; Cox, Karen; Husain, Saba; Franklin, Natalie; Sutherland, Jeffrey J.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Shinn, Paul; Southall, Noel; Dexheimer, Thomas S.; Huang, Ruili; Guha, Rajarshi; Jadhav, Ajit; Austin, Christopher P.; Simeonov, Anton; Sittampalam, G. Sitta; Thomas, Craig J.] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Wild, David J.; Yang, Jeremy J.] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA	Eli Lilly; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Indiana University System; Indiana University Bloomington	Sutherland, JJ (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.	sutherland_jeffrey_james@lilly.com; craigt@mail.nih.gov	Southall, Noel T/H-8991-2012	Southall, Noel T/0000-0003-4500-880X; Thomas, Craig/0000-0001-9386-9001; Jadhav, Ajit/0000-0001-7955-1451	Intramural Program of NCATS; Lilly Research Laboratories; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZICTR000242] Funding Source: NIH RePORTER	Intramural Program of NCATS; Lilly Research Laboratories(Eli Lilly); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the Intramural Program of NCATS and the Lilly Research Laboratories. The funders of this study provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALBRIGHT JD, 1979, J PHARM SCI, V68, P936, DOI 10.1002/jps.2600680749; ALBRIGHT JD, 1983, J MED CHEM, V26, P1393, DOI 10.1021/jm00364a010; ALBRIGHT JD, 1983, J MED CHEM, V26, P1378, DOI 10.1021/jm00364a009; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Almeida M, 2011, J BIOL CHEM, V286, P44326, DOI 10.1074/jbc.M111.283481; Alvim-Gaston M, 2014, CURR TOP MED CHEM, V14, P294, DOI 10.2174/1568026613666131127125858; [Anonymous], 1982, 184 M AM CHEM SOC; Arlt A, 2009, ONCOGENE, V28, P3983, DOI 10.1038/onc.2009.264; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bostrom J, INVENTORSBISAMLDE DE; Browne CD, 2006, FASEB J, V20, P2027, DOI 10.1096/fj.05-5404com; Butlin R, INVENTORSPIPERIDINE; Butlin RJ, INVENTORSSULFONAMIDE; Chadwick W, 2007, J PHARM PHARMACOL, V59, P95, DOI 10.1211/jpp.59.1.0013; Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992; Crott JW, 2008, J NUTR BIOCHEM, V19, P328, DOI 10.1016/j.jnutbio.2007.05.003; Dandapani S, 2009, CURRENT PROTOCOLS CH; Dunn EF, 2011, ONCOGENE, V30, P561, DOI 10.1038/onc.2010.430; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Ganesan L, 2011, BIOCHEM PHARMACOL, V81, P810, DOI 10.1016/j.bcp.2010.12.020; Garcia-Gomez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034914; Giuliano S, 2013, BIOCHIMIE, V95, P1110, DOI 10.1016/j.biochi.2013.03.002; Gray JD, 2010, HUM MOL GENET, V19, P4560, DOI 10.1093/hmg/ddq384; Griner LAM, 2014, P NATL ACAD SCI USA, V111, P2349, DOI 10.1073/pnas.1311846111; Han MD, 2009, DIS MODEL MECH, V2, P467, DOI 10.1242/dmm.001438; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herbst M, 2002, CELL CALCIUM, V31, P115, DOI 10.1054/ceca.2001.0266; HOLLANDER W, 1978, ATHEROSCLEROSIS, V31, P307, DOI 10.1016/0021-9150(78)90066-7; Hoogeboom D, 2009, BBA-REV CANCER, V1796, P63, DOI 10.1016/j.bbcan.2009.02.002; Horst D, 2012, CANCER RES, V72, P1547, DOI 10.1158/0008-5472.CAN-11-3222; Hu SL, 2000, J PHARMACOL EXP THER, V293, P444; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Iismaa TP, 2000, DIABETES, V49, P392, DOI 10.2337/diabetes.49.3.392; KATOCS AS, 1982, ARTERY, V11, P192; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim KC, 2009, J NUTR BIOCHEM, V20, P917, DOI 10.1016/j.jnutbio.2009.06.008; Kim SY, 2012, J BONE MINER RES, V27, P789, DOI 10.1002/jbmr.1489; Klinghoffer RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006892; Kovacs WJ, 2004, HISTOCHEM CELL BIOL, V122, P95, DOI 10.1007/s00418-004-0689-6; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; L'Episcopo F, 2011, NEUROBIOL DIS, V41, P508, DOI 10.1016/j.nbd.2010.10.023; Lee J, 2011, JNCI-J NATL CANCER I, V103, P674, DOI 10.1093/jnci/djr070; Lee JA, 2012, J MED CHEM, V55, P4527, DOI 10.1021/jm201649s; Lee JA, 2011, J BIOMOL SCREEN, V16, P588, DOI 10.1177/1087057111405379; Lee T, 2008, MOL PHARMACOL, V74, P1599, DOI 10.1124/mol.108.049536; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Loges Sonja, 2010, Genes Cancer, V1, P12, DOI 10.1177/1947601909356574; LOOKENE A, 1994, EUR J BIOCHEM, V222, P395, DOI 10.1111/j.1432-1033.1994.tb18878.x; Lowes DJ, 2011, J MED CHEM, V54, P7477, DOI 10.1021/jm2005546; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Mayer-Kuckuk P, 2002, P NATL ACAD SCI USA, V99, P3400, DOI 10.1073/pnas.062036899; Murillo G, 2009, CANCER PREV RES, V2, P942, DOI 10.1158/1940-6207.CAPR-08-0232; RINDI G, 1990, AM J PATHOL, V136, P1349; Schulz MMP, 2012, P NATL ACAD SCI USA, V109, pE2665, DOI 10.1073/pnas.1206036109; Seguin F, 2012, BRIT J CANCER, V107, P977, DOI 10.1038/bjc.2012.355; Shen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075252; Sounni NE, 2014, CELL METAB, V20, P280, DOI 10.1016/j.cmet.2014.05.022; Sutherland JJ, 2013, BBA-PROTEINS PROTEOM, V1834, P1425, DOI 10.1016/j.bbapap.2012.12.023; Swinney DC, 2013, J BIOMOL SCREEN, V18, P1186, DOI 10.1177/1087057113501199; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Urano W, 2009, J BONE MINER METAB, V27, P574, DOI 10.1007/s00774-009-0073-7; Volvert Marie-Laure, 2008, BMC Pharmacology, V8, P10, DOI 10.1186/1471-2210-8-10; Weber-Hamann B, 2006, J CLIN PSYCHIAT, V67, P1856, DOI 10.4088/JCP.v67n1204; Wu WZ, 2008, J BIOMOL SCREEN, V13, P128, DOI 10.1177/1087057107313763; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Yuan J, 2011, SCIENCE, V333, P724, DOI 10.1126/science.1205216; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006548	75	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130796	10.1371/journal.pone.0130796	http://dx.doi.org/10.1371/journal.pone.0130796			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177200	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600029
J	Naundrup, PJ; Svenning, JC				Naundrup, Pernille Johansen; Svenning, Jens-Christian			A Geographic Assessment of the Global Scope for Rewilding with Wild-Living Horses (Equus ferus)	PLOS ONE			English	Article							BUTTERFLY DISTRIBUTION MAPS; ANCIENT FEEDING ECOLOGY; LAND-COVER DATA; FERAL HORSES; SPECIES DISTRIBUTIONS; PLEISTOCENE EXTINCTIONS; HABITAT SELECTION; CLIMATE-CHANGE; SAMPLING BIAS; EVOLUTIONARY HISTORY	Megafaunas worldwide have been decimated during the late Quaternary. Many extirpated species were keystone species, and their loss likely has had large effects on ecosystems. Therefore, it is increasingly considered how megafaunas can be restored. The horse (Equus ferus) is highly relevant in this context as it was once extremely widespread and, despite severe range contraction, survives in the form of domestic, feral, and originally wild horses. Further, it is a functionally important species, notably due to its ability to graze coarse, abrasive grasses. Here, we used species distribution modelling to link locations of wild-living E. ferus populations to climate to estimate climatically suitable areas for wild-living E. ferus. These models were combined with habitat information and past and present distributions of equid species to identify areas suitable for rewilding with E. ferus. Mean temperature in the coldest quarter, precipitation in the coldest quarter, and precipitation in the driest quarter emerged as the best climatic predictors. The distribution models estimated the climate to be suitable in large parts of the Americas, Eurasia, Africa, and Australia and, combined with habitat mapping, revealed large areas to be suitable for rewilding with horses within its former range, including up to 1.5 million ha within five major rewilding areas in Europe. The widespread occurrence of suitable climates and habitats within E. ferus' former range together with its important functions cause it to be a key candidate for rewilding in large parts of the world. Successful re-establishment of wild-living horse populations will require handling the complexity of human-horse relations, for example, potential conflicts with ranchers and other agriculturalists or with other conservation aims, perception as a non-native invasive species in some regions, and coverage by legislation for domestic animals.	[Naundrup, Pernille Johansen; Svenning, Jens-Christian] Aarhus Univ, Sect Ecoinformat & Biodivers, Dept Biosci, Aarhus C, Denmark	Aarhus University	Naundrup, PJ (corresponding author), Aarhus Univ, Sect Ecoinformat & Biodivers, Dept Biosci, Aarhus C, Denmark.	Samic1988@gmail.com; svenning@bios.au.dk	Svenning, Jens-Christian/C-8977-2012	Svenning, Jens-Christian/0000-0002-3415-0862	Aarhus University; Aarhus University Research Foundation under the AU IDEAS program	Aarhus University; Aarhus University Research Foundation under the AU IDEAS program	We would like to thank Peder Klith Bocher for his assistance in ArcGIS and Jonas Nuchel for help with MAXENT. JCS considers this study a contribution to Center for Informatics Research on Complexity in Ecology, CIRCE (funded by Aarhus University and Aarhus University Research Foundation under the AU IDEAS program) and the Danish National Research Foundation Niels Bohr professorship project, Aarhus University Research on the Anthropocene (AURA).	Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Agerskov U, 2012, STAT YB 2012; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Arino O, 2008, ESA BULL-EUR SPACE, P24; AZZAROLI A, 1991, ANN ZOOL FENN, V28, P151; Ballesteros-Mejia L, 2013, GLOBAL ECOL BIOGEOGR, V22, P586, DOI 10.1111/geb.12039; Bennett D, 1992, WORLD ANIMAL SCI S C; Bennett D., 1999, MAMMAL SPECIES, V628, P1; Berger J., 1986, WILD HORSES GREAT BA; Bhattacharyya J, 2011, HUM ECOL, V39, P613, DOI 10.1007/s10745-011-9416-9; Bignon O, 2005, J ARCHAEOL SCI, V32, P375, DOI 10.1016/j.jas.2004.02.016; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Bocherens H, 1999, J ARCHAEOL SCI, V26, P599, DOI 10.1006/jasc.1998.0377; Bonde AM, 2013, PALEOECOLOGY LATE PA; Buckley AW, 1983, PUB LAND L REV, V4, P29; Burke A, 2003, QUATERNARY RES, V59, P459, DOI 10.1016/S0033-5894(03)00059-0; Buttenschon RM, 2007, GREASNING OG HOSLET; Cameron EZ, 2001, POPULATIONS DYNAMICS; Caro T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4535; Caro T, 2009, NATURE, V462, P985, DOI 10.1038/462985b; Carpenter D, 2012, BIODIVERS CONSERV, V21, P3385, DOI 10.1007/s10531-012-0369-0; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Churcher CS, 1999, PALAEOGEOGR PALAEOCL, V154, P301, DOI 10.1016/S0031-0182(99)00104-2; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Colbert E. H., 1940, American Museum Novitates, Vno. 1099; Cothran EG, 2001, J S AFR VET ASSOC, V72, P18; Cran KK, 1997, J RANGE MANAGE, V50, P374, DOI 10.2307/4003303; Cromsigt JPGM, 2012, DIVERS DISTRIB, V18, P1253, DOI 10.1111/j.1472-4642.2012.00927.x; Csurhes S., 2009, PEST ANIMAL RISK ASS; Davies KW, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00171.1; Dawson M, 2006, P NATL FER HORS MAN; Dennis RLH, 2000, J INSECT CONSERV, V4, P73, DOI 10.1023/A:1009690919835; Dennis RLH, 1999, J INSECT CONSERV, V3, P33, DOI 10.1023/A:1009678422145; Diedrich Cajus G., 2006, Bulletin of Geosciences, V81, P237; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Dobbie W. R., 1993, MANAGING VERTEBRATE; Domingo L, 2012, QUATERNARY SCI REV, V55, P103, DOI 10.1016/j.quascirev.2012.08.017; DUNCAN P, 1983, J ANIM ECOL, V52, P93, DOI 10.2307/4590; Edwards WE, 1967, P 7 C INT ASS QUART; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Feranec R, 2010, PALAEOGEOGR PALAEOCL, V297, P263, DOI 10.1016/j.palaeo.2010.08.006; Ferrusquia-Villafranca I, 2010, QUATERN INT, V217, P53, DOI 10.1016/j.quaint.2009.11.036; Forsten A, 1998, GEOBIOS-LYON, V31, P545, DOI 10.1016/S0016-6995(98)80125-3; FORSTEN A, 1986, J MAMMAL, V67, P422, DOI 10.2307/1380904; FORSTEN A, 1988, PALAEOGEOGR PALAEOCL, V65, P23, DOI 10.1016/0031-0182(88)90109-5; Fox-Dobbs K, 2008, PALAEOGEOGR PALAEOCL, V261, P30, DOI 10.1016/j.palaeo.2007.12.011; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; GANSKOPP D, 1987, NORTHWEST SCI, V61, P74; GARROTT RA, 1991, J WILDLIFE MANAGE, V55, P641, DOI 10.2307/3809513; Girard TL, 2013, RANGELAND ECOL MANAG, V66, P428, DOI 10.2111/REM-D-12-00081.1; Girard TL, 2013, ENVIRON MANAGE, V51, P435, DOI [10.1007/s00267-012-9987-2, 10.1007/s00267-012-9987-]; GOODLOE RB, 1991, J WILDLIFE MANAGE, V55, P412, DOI 10.2307/3808969; Greyling T, 2007, S AFR J BOT, V73, P328, DOI 10.1016/j.sajb.2007.02.161; Greyling T, 2005, FACTORS AFFECTING PO; Griffiths CJ, 2010, CONSERV BIOL, V24, P645, DOI 10.1111/j.1523-1739.2010.01511.x; Groves CP, 1974, HORSES ASSESS ZEBRAS; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106; Hampson BA, 2010, EQUINE VET J, V42, P582, DOI 10.1111/j.2042-3306.2010.00203.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hu J, 2010, J ZOOL, V282, P54, DOI 10.1111/j.1469-7998.2010.00715.x; Hughes FMR, 2011, J NAT CONSERV, V19, P245, DOI 10.1016/j.jnc.2011.02.003; IUCN, 2013, IUCN RED LIST THREAT; Jelinek A, 1967, 7 C INT ASS QUART RE; Kerley GIH, 2012, ECOGRAPHY, V35, P519, DOI 10.1111/j.1600-0587.2011.07146.x; Klein RG, 1984, QUARTERNARY EXTINCTI; Klimov V, 1985, MUSTANGS MANYCH LAKE; Kuemmerle T, 2011, ECOL APPL, V21, P830, DOI 10.1890/10-0073.1; Kurten B., 1980, PLEISTOCENE MAMMALS; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Latif QS, 2013, ECOL EVOL, V3, P4348, DOI 10.1002/ece3.790; Leitao PJ, 2011, INT J GEOGR INF SCI, V25, P439, DOI 10.1080/13658816.2010.531020; Levin PS, 2002, CONSERV BIOL, V16, P1364, DOI 10.1046/j.1523-1739.2002.01167.x; Linklater WL, 2000, NEW ZEAL J ECOL, V24, P139; Linnartz L., 2014, REWILDING HORSES EUR; Lippold S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-328; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lomolino MV., 2010, BIOGEOGRAPHY, P137; Long JL, 2003, INTRO MAMMALS WORLD; Loydi A, 2010, NAT AREA J, V30, P148, DOI 10.3375/043.030.0203; MacFadden BJ, 1999, SCIENCE, V283, P824, DOI 10.1126/science.283.5403.824; MacFadden BJ, 1997, PALEOBIOLOGY, V23, P77, DOI 10.1017/S0094837300016651; MacFadden BJ, 1999, GLOBAL ECOL BIOGEOGR, V8, P137, DOI 10.1046/j.1466-822X.1999.00127.x; MacFadden BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059277; Martin PS, 1967, P 7 C INT ASS QUAT R; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Menard C, 2002, J APPL ECOL, V39, P120, DOI 10.1046/j.1365-2664.2002.00693.x; Mihlbachler MC, 2011, SCIENCE, V331, P1178, DOI 10.1126/science.1196166; MILLER R, 1983, J RANGE MANAGE, V36, P195, DOI 10.2307/3898161; Moehlman P.D., 2002, EQUIDS ZEBRAS ASSES; Morueta-Holme N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010360; National Research Counsil, 1980, WILD FREE ROAM HORS; Nimmo DG, 2007, WILDLIFE RES, V34, P408, DOI 10.1071/WR06102; Oliveira-Santos LGR, 2010, CONSERV BIOL, V24, P4, DOI 10.1111/j.1523-1739.2009.01379.x; Orlando L, 2008, J MOL EVOL, V66, P533, DOI 10.1007/s00239-008-9100-x; Orlando L, 2009, P NATL ACAD SCI USA, V106, P21754, DOI 10.1073/pnas.0903672106; Ostermann-Kelm Stacey D., 2009, BMC Ecology, V9, P22, DOI 10.1186/1472-6785-9-22; Ottaviani D, 2009, ECOL MODEL, V220, P111, DOI 10.1016/j.ecolmodel.2008.09.014; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; OWENSMITH N, 1987, PALEOBIOLOGY, V13, P351; Palmqvist P, 2003, PALEOBIOLOGY, V29, P205, DOI 10.1666/0094-8373(2003)029<0205:PROALP>2.0.CO;2; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Politis GG, 1998, LAT AM ANTIQ, V9, P111, DOI 10.2307/971990; Prado Jose L., 2011, BMC Ecology, V11, P15, DOI 10.1186/1472-6785-11-15; PRATT RM, 1986, J APPL ECOL, V23, P539, DOI 10.2307/2404035; Pratt-Phillips SE, 2011, J EQUINE VET SCI, V31, P640, DOI 10.1016/j.jevs.2011.05.012; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Rheinhardt RD, 2004, J RANGE MANAGE, V57, P253, DOI 10.2307/4003793; Richmond OMW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012899; Rivals F, 2012, PALEOGEOGR PALEOCLIM; ROGERS GM, 1991, NEW ZEAL J ECOL, V15, P49; ROGERS PM, 1980, J APPL ECOL, V17, P545, DOI 10.2307/2402636; Rubenstein D.I., 1986, P282; Rubenstein DR, 2006, BIOL CONSERV, V132, P232, DOI 10.1016/j.biocon.2006.04.003; Saastamoinen MT, 2012, FORAGES GRAZING HORS, V132, DOI [10.3920/978-90-8686-755-4, DOI 10.3920/978-90-8686-755-4]; SALTER RE, 1979, J RANGE MANAGE, V32, P221, DOI 10.2307/3897127; Sanchez B, 2006, AMEGHINIANA, V43, P427; Sandom C., 2013, KEY TOPICS CONSERVAT, V2, P430, DOI DOI 10.1002/9781118520178.ch23; Sandom CJ, 2014, P NATL ACAD SCI USA, V111, P4162, DOI 10.1073/pnas.1311014111; Scorolli Alberto L., 2006, Mastozool. neotrop., V13, P255; Seddon PJ, 2014, SCIENCE, V345, P406, DOI 10.1126/science.1251818; Smith CI, 2005, NATURE, V437, P318, DOI 10.1038/437318a; Solomonov N G, 2009, Dokl Biol Sci, V427, P358; Solow AR, 2006, P NATL ACAD SCI USA, V103, P7351, DOI 10.1073/pnas.0509480103; Sommer RS, 2011, J QUATERNARY SCI, V26, P805, DOI 10.1002/jqs.1509; Soule M, 1998, WILD EARTH, V8; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; The Department of Conservation, KAIM WILD HORS PLAN; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Turner JW, 2001, SOUTHWEST NAT, V46, P183, DOI 10.2307/3672527; van Asperen EN, 2010, PALAEOGEOGR PALAEOCL, V297, P584, DOI 10.1016/j.palaeo.2010.09.007; van Beest FM, 2014, J ANIM ECOL, V83, P147, DOI 10.1111/1365-2656.12115; van de Vlasakker JWG., 2006, EVALUATION NATURAL G; van Klink R, 2015, BIOL REV, V90, P347, DOI 10.1111/brv.12113; VanDierendonck MC, 1996, CONSERV BIOL, V10, P728, DOI 10.1046/j.1523-1739.1996.10030728.x; vanDierendonck MC, 1996, APPL ANIM BEHAV SCI, V50, P95, DOI 10.1016/0168-1591(96)01089-1; Vera Frans W.M., 2009, British Wildlife, V20, P28; Verbruggen H., 2012, OCCURRENCETHINNER VE; Waring G.H., 1983, BEHAV TRAITS ADAPTAT; Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109; Warmuth V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018194; Weinstock J, 2005, PLOS BIOL, V3, P1373, DOI 10.1371/journal.pbio.0030241; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Yang WJ, 2013, J BIOGEOGR, V40, P1415, DOI 10.1111/jbi.12108; Zalba SM, 2004, ANIM CONSERV, V7, P35, DOI 10.1017/S1367943003001094; Zeigenfuss LC, 2014, WEST N AM NATURALIST, V74, P286, DOI 10.3398/064.074.0304	154	33	33	1	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132359	10.1371/journal.pone.0132359	http://dx.doi.org/10.1371/journal.pone.0132359			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177104	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600103
J	Rashed, L; Hay, RA; Hay, RA; Hasan, N; Zahra, A; Fayez, S				Rashed, Laila; Hay, Rania Abdel; Hay, Rania Abdel; Hasan, Nermeen; Zahra, Amr; Fayez, Salwa			Association of Angiotensin-Converting Enzyme (ACE) Gene Polymorphism with Inflammation and Cellular Cytotoxicity in Vitiligo Patients	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE ACTIVITIES; GENERALIZED VITILIGO; AUTOIMMUNE-DISEASES; HUMAN MELANOCYTES; I/D POLYMORPHISM; GRAVES-DISEASE; NITRIC-OXIDE; CELLS; SERUM; INSERTION/DELETION	Background Vitiligo is a disorder with profound heterogeneity in its aetio-pathophysiology. Angiotensin converting enzyme (ACE) plays an important role in the physiology of the vasculature, blood pressure and inflammation. An insertion/deletion (I/D) polymorphism of the ACE gene was reported be associated with the development of vitiligo. Objective Our aim was to evaluate the ACE I/D polymorphism in vitiligo patients and controls. Our second aim was to find a possible association between ACE gene polymorphism and inflammatory mediators (as interleukin (IL)-6) and/or cellular cytotoxicity induced by serum nitrite (as a breakdown product of the cytotoxic nitric oxide) in vitiligo patients. Methods This case-control study included 74 vitiligo patients and 75 apparently healthy controls. The distribution of ACE gene I/D genotype was investigated using PCR. Serum ACE, IL-6 and nitrite were measured by colorimetric method, ELISA and Griess assay respectively. Results The ACE allele frequency was significantly different between vitiligo patients and healthy controls (P = 0.026). However there was no significant difference between the ACE genotyping frequency in both groups (P = 0.115). There were statistically significant higher VIDA score (P = 0.007), and serum IL-6 (P < 0.001) in patients with the DD genotype when compared to other genotypes. Serum nitrite in patients with the DD genotype was significantly higher (P = 0.007) when compared to patients with II genotype. Serum levels of ACE, IL-6 and nitrite in vitiligo patients were statistically significantly higher than those in controls. Conclusion As a conclusion, ACE gene polymorphism might grant susceptibility to develop vitiligo. Serum IL-6 and nitrite levels might have an important role in the pathogenesis of vitiligo. Targeting these two factors might have an implication in the treatment of some resistant cases.	[Rashed, Laila; Hasan, Nermeen; Fayez, Salwa] Cairo Univ, Fac Med, Dept Biochem, Cairo, Egypt; [Hay, Rania Abdel] Cairo Univ, Dept Dermatol, Fac Med, Cairo, Egypt; [Hay, Rania Abdel; Zahra, Amr] Fayoum Univ, Dept Biochem, Al Fayyum, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Fayoum University	Hay, RA (corresponding author), Fayoum Univ, Dept Biochem, Al Fayyum, Egypt.	raniahosnibiochemistry@gmail.com	Hay, Rania Abdel/E-7472-2010	Hay, Rania Abdel/0000-0002-3280-0796; Zahra, Amr/0000-0001-5983-3507				Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Beazley WD, 1999, BRIT J DERMATOL, V141, P301; Behl P N, 1999, Indian J Dermatol Venereol Leprol, V65, P161; CZERNOBILSKY H, 1985, KLIN WOCHENSCHR, V63, P518, DOI 10.1007/BF01747982; Deeba F, 2009, INT J MED MED SCI, V1; Hazneci E, 2005, INT J DERMATOL, V44, P636, DOI 10.1111/j.1365-4632.2004.02027.x; Jagannath C, 1998, NITRIC OXIDE-BIOL CH, V2, P174, DOI 10.1006/niox.1998.9999; Jin SY, 2004, PIGM CELL RES, V17, P84, DOI 10.1046/j.1600-0749.2003.00105.x; KASAHARA Y, 1981, CLIN CHEM, V27, P1922; Kemp EH, 1997, J INVEST DERMATOL, V109, P69, DOI 10.1111/1523-1747.ep12276556; KIRNBAUER R, 1992, J INVEST DERMATOL, V98, P320, DOI 10.1111/1523-1747.ep12499793; Lv YJ, 2013, ARCH DERMATOL RES, V305, P365, DOI 10.1007/s00403-013-1315-z; Marz P, 1998, P NATL ACAD SCI USA, V95, P3251, DOI 10.1073/pnas.95.6.3251; Miranda KM, 2000, NITRIC OXIDE BIOL PA, P49; Moretti S, 2002, PIGM CELL RES, V15, P87, DOI 10.1034/j.1600-0749.2002.1o049.x; Nickoloff BJ, 2004, J CLIN INVEST, V113, P1664, DOI 10.1172/JCI200422147; NORRIS DA, 1988, J INVEST DERMATOL, V90, P783, DOI 10.1111/1523-1747.ep12461505; OCHI Y, 1969, ANN INTERN MED, V71, P935, DOI 10.7326/0003-4819-71-5-935; Onay H, 2007, EUR J DERMATOL, V17, P146, DOI 10.1684/ejd.2007.0128; Papadopoulos KI, 2000, J INTERN MED, V247, P71, DOI 10.1046/j.1365-2796.2000.00575.x; Patwardhan M, 2013, BRIT J DERMATOL, V168, P1195, DOI 10.1111/bjd.12177; Pehlivan S, 2009, EUR J DERMATOL, V19, P126, DOI 10.1684/ejd.2008.0578; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; Rocha IM, 2001, ARCH DERMATOL RES, V293, P245; SCHALLREUTER KU, 1994, SCIENCE, V263, P1444, DOI 10.1126/science.8128228; Singh Suman, 2012, Indian J Dermatol, V57, P12, DOI 10.4103/0019-5154.92668; Song GG, 2015, J RENIN-ANGIO-ALDO S, V16, P195, DOI 10.1177/1470320313478285; Spritz RA, 2007, PIGM CELL RES, V20, P271, DOI 10.1111/j.1600-0749.2007.00384.x; Takahashi T, 2000, ANN NY ACAD SCI, V902, P283; Tippisetty S, 2011, EUR J DERMATOL, V21, P173, DOI 10.1684/ejd.2011.1279; Vrijman C, 2013, BRIT J DERMATOL, V168, P1003, DOI 10.1111/bjd.12162; Weger W, 2007, EXP DERMATOL, V16, P993, DOI 10.1111/j.1600-0625.2007.00620.x; Yildirim M, 2004, J EUR ACAD DERMATOL, V18, P683, DOI 10.1111/j.1468-3083.2004.01080.x; Yildirim M, 2003, J DERMATOL, V30, P104, DOI 10.1111/j.1346-8138.2003.tb00356.x; Yu HS, 1997, J INVEST DERMATOL, V108, P527, DOI 10.1111/1523-1747.ep12289743	35	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132915	10.1371/journal.pone.0132915	http://dx.doi.org/10.1371/journal.pone.0132915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177100	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600178
J	Yang, XX; Wang, J; Sun, J; Liu, R				Yang, Xiaoxia; Wang, Jia; Sun, Jun; Liu, Rong			SNBRFinder: A Sequence-Based Hybrid Algorithm for Enhanced Prediction of Nucleic Acid-Binding Residues	PLOS ONE			English	Article							PROTEIN-STRUCTURE ALIGNMENT; STRUCTURAL INFORMATION; RNA INTERFACE; DNA; SITES; SERVER; FEATURES; CONSERVATION; EVOLUTIONARY; ACCURATE	Protein-nucleic acid interactions are central to various fundamental biological processes. Automated methods capable of reliably identifying DNA-and RNA-binding residues in protein sequence are assuming ever-increasing importance. The majority of current algorithms rely on feature-based prediction, but their accuracy remains to be further improved. Here we propose a sequence-based hybrid algorithm SNBRFinder (Sequence-based Nucleic acid-Binding Residue Finder) by merging a feature predictor SNBRFinder(F) and a template predictor SNBRFinder(T). SNBRFinder(F) was established using the support vector machine whose inputs include sequence profile and other complementary sequence descriptors, while SNBRFinder(T) was implemented with the sequence alignment algorithm based on profile hidden Markov models to capture the weakly homologous template of query sequence. Experimental results show that SNBRFinder(F) was clearly superior to the commonly used sequence profile-based predictor and SNBRFinder(T) can achieve comparable performance to the structure-based template methods. Leveraging the complementary relationship between these two predictors, SNBRFinder reasonably improved the performance of both DNA-and RNA-binding residue predictions. More importantly, the sequence-based hybrid prediction reached competitive performance relative to our previous structure-based counterpart. Our extensive and stringent comparisons show that SNBRFinder has obvious advantages over the existing sequence-based prediction algorithms. The value of our algorithm is highlighted by establishing an easy-to-use web server that is freely accessible at http://ibi.hzau.edu.cn/SNBRFinder.	[Yang, Xiaoxia; Wang, Jia; Sun, Jun; Liu, Rong] Huazhong Agr Univ, Coll Informat, Agr Bioinformat Key Lab Hubei Prov, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Liu, R (corresponding author), Huazhong Agr Univ, Coll Informat, Agr Bioinformat Key Lab Hubei Prov, Wuhan, Hubei, Peoples R China.	liurong116@mail.hzau.edu.cn		Yang, Catherine/0000-0001-6040-6393; Sun, Jun/0000-0003-1190-3937	National Natural Science Foundation of China [31301091]; Fundamental Research Funds for the Central Universities [2014JC003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31301091) and the Fundamental Research Funds for the Central Universities (2014JC003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Carson MB, 2010, NUCLEIC ACIDS RES, V38, pW431, DOI 10.1093/nar/gkq361; Chen K, 2012, BIOINFORMATICS, V28, P331, DOI 10.1093/bioinformatics/btr657; Chen Y, 2005, FEBS J, V272, P2088, DOI 10.1111/j.1742-4658.2005.04650.x; Chen YC, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1299; Chen YC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn008; Dey S, 2012, NUCLEIC ACIDS RES, V40, P7150, DOI 10.1093/nar/gks405; Dror I, 2012, PROTEINS, V80, P482, DOI 10.1002/prot.23214; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Gao M, 2008, NUCLEIC ACIDS RES, V36, P3978, DOI 10.1093/nar/gkn332; Hwang S, 2007, BIOINFORMATICS, V23, P634, DOI 10.1093/bioinformatics/btl672; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kim OTP, 2006, NUCLEIC ACIDS RES, V34, P6450, DOI 10.1093/nar/gkl819; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Kuznetsov IB, 2006, PROTEINS, V64, P19, DOI 10.1002/prot.20977; Li SL, 2014, NUCLEIC ACIDS RES, V42, P10086, DOI 10.1093/nar/gku681; Liu R, 2013, PROTEINS, V81, P1885, DOI 10.1002/prot.24330; Liu ZP, 2010, BIOINFORMATICS, V26, P1616, DOI 10.1093/bioinformatics/btq253; Ma X, 2011, PROTEINS, V79, P1230, DOI 10.1002/prot.22958; Maetschke SR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-341; Murakami Y, 2010, NUCLEIC ACIDS RES, V38, pW412, DOI 10.1093/nar/gkq474; Nagarajan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091140; Nagarajan R, 2013, NUCLEIC ACIDS RES, V41, P7606, DOI 10.1093/nar/gkt544; Perez-Cano L, 2010, PROTEINS, V78, P25, DOI 10.1002/prot.22527; Puton T, 2012, J STRUCT BIOL, V179, P261, DOI 10.1016/j.jsb.2011.10.001; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; SHENKIN PS, 1991, PROTEINS, V11, P297, DOI 10.1002/prot.340110408; Si JN, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S7; Stawiski EW, 2003, J MOL BIOL, V326, P1065, DOI 10.1016/S0022-2836(03)00031-7; Terribilini M, 2007, NUCLEIC ACIDS RES, V35, pW578, DOI 10.1093/nar/gkm294; Tjong H, 2007, NUCLEIC ACIDS RES, V35, P1465, DOI 10.1093/nar/gkm008; Towfic F, 2010, INT J DATA MIN BIOIN, V4, P21, DOI 10.1504/IJDMB.2010.030965; Tsuchiya Y, 2004, PROTEINS, V55, P885, DOI 10.1002/prot.20111; Walia RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097725; Walia RR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-89; Wang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-385; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang LJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S3; Wang LJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S1; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wu JS, 2009, BIOINFORMATICS, V25, P30, DOI 10.1093/bioinformatics/btn583; Xiong Y, 2011, PROTEINS, V79, P509, DOI 10.1002/prot.22898; Yan CH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-262; Yang XX, 2014, PROTEINS, V82, P2455, DOI 10.1002/prot.24610; Yang YD, 2012, PROTEINS, V80, P2080, DOI 10.1002/prot.24100; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096694; Zhao HY, 2011, RNA BIOL, V8, P988, DOI 10.4161/rna.8.6.17813; Zhao HY, 2011, NUCLEIC ACIDS RES, V39, P3017, DOI 10.1093/nar/gkq1266; Zhao HY, 2010, BIOINFORMATICS, V26, P1857, DOI 10.1093/bioinformatics/btq295; Zhu XL, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt617	59	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133260	10.1371/journal.pone.0133260	http://dx.doi.org/10.1371/journal.pone.0133260			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176857	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600235
J	Geier, CB; Piller, A; Linder, A; Sauerwein, KMT; Eibl, MM; Wolf, HM				Geier, Christoph B.; Piller, Alexander; Linder, Angela; Sauerwein, Kai M. T.; Eibl, Martha M.; Wolf, Hermann M.			Leaky RAG Deficiency in Adult Patients with Impaired Antibody Production against Bacterial Polysaccharide Antigens	PLOS ONE			English	Article							COMBINED IMMUNE-DEFICIENCY; B-CELLS; GENE-EXPRESSION; IMMUNODEFICIENCY; MUTATIONS; AGAMMAGLOBULINEMIA; AUTOIMMUNITY; LYMPHOPENIA; PHENOTYPES; DELETION	Loss of function mutations in the recombination activating genes RAG1 and RAG2 have been reported to cause a T-B-NK+ type of severe combined immunodeficiency. In addition identification of hypomorphic mutations in RAG1 and RAG2 has led to an expansion of the spectrum of disease to include Omenn syndrome, early onset autoimmunity, granuloma, chronic cytomegalovirus-or EBV-infection with expansion of gamma/delta T-cells, idiophatic CD4 lymphopenia and a phenotype resembling common variable immunodeficiency. Herein we describe a novel presentation of leaky RAG1 and RAG2 deficiency in two unrelated adult patients with impaired antibody production against bacterial polysaccharide antigens. Clinical manifestation included recurrent pneumonia, sinusitis, otitis media and in one patient recurrent cutaneous vasculitis. Both patients harbored a combination of a null mutation on one allele with a novel hypomorphic RAG1/2 mutation on the other allele. One of these novel mutations affected the start codon of RAG1 and resulted in an aberrant gene and protein expression. The second novel RAG2 mutation leads to a truncated RAG2 protein, lacking the C-terminus with intact core RAG2 and reduced VDJ recombination capacity as previously described in a mouse model. Both patients presented with severely decreased numbers of naive CD4(+) T cells and defective T independent IgG responses to bacterial polysaccharide antigens, while T cell-dependent IgG antibody formation e.g. after tetanus or TBEV vaccination was intact. In conclusion, hypomorphic mutations in genes responsible for SCID should be considered in adults with predominantly antibody deficiency.	[Geier, Christoph B.; Piller, Alexander; Linder, Angela; Sauerwein, Kai M. T.; Eibl, Martha M.; Wolf, Hermann M.] Immunol Outpatient Clin, Vienna, Austria; [Eibl, Martha M.] Biomed Forsch GmbH, Vienna, Austria		Wolf, HM (corresponding author), Immunol Outpatient Clin, Vienna, Austria.	hermann.wolf@meduniwien.ac.at						Abolhassani H, 2014, J ALLERGY CLIN IMMUN, V134, P1375, DOI 10.1016/j.jaci.2014.04.042; Abraham RS, 2013, J ALLERGY CLIN IMMUN, V131, P1421, DOI 10.1016/j.jaci.2012.09.016; Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P1209, DOI 10.1073/pnas.0237043100; Al-Herz W, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00054; AMBROSINO DM, 1987, NEW ENGL J MED, V316, P790, DOI 10.1056/NEJM198703263161306; Aspalter RM, 2007, J ALLERGY CLIN IMMUN, V120, P1193, DOI 10.1016/j.jaci.2007.07.004; Avila EM, 2010, PEDIATRICS, V126, pE1248, DOI 10.1542/peds.2009-3171; Ban SA, 2014, J CLIN IMMUNOL, V34, P941, DOI 10.1007/s10875-014-0088-2; Browning MJ, 2010, J INVEST ALLERG CLIN, V20, P263; Buchbinder D, 2015, J CLIN IMMUNOL, V35, P119, DOI 10.1007/s10875-014-0121-5; Charles ED, 2011, BLOOD, V117, P5425, DOI 10.1182/blood-2010-10-312942; Corneo B, 2001, BLOOD, V97, P2772, DOI 10.1182/blood.V97.9.2772; De Ravin SS, 2010, BLOOD, V116, P1263, DOI 10.1182/blood-2010-02-267583; de Villartay JP, 2005, J CLIN INVEST, V115, P3291, DOI 10.1172/JCI25178; Desiderio S, 1996, CURR TOP MICROBIOL, V217, P45; DREYER WJ, 1965, P NATL ACAD SCI USA, V54, P864, DOI 10.1073/pnas.54.3.864; Eibl N, 2002, CLIN IMMUNOL, V103, P249, DOI 10.1006/clim.2002.5220; Foerster C, 2010, J IMMUNOL, V184, P7305, DOI 10.4049/jimmunol.1000434; Ghosh S, 2014, CLIN IMMUNOL, V152, P65, DOI 10.1016/j.clim.2014.02.009; Gomez CA, 2000, MOL CELL BIOL, V20, P5653, DOI 10.1128/MCB.20.15.5653-5664.2000; GORSKI J, 1994, J IMMUNOL, V152, P5109; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Hassaballa AE, 2011, IMMUNOLOGY, V134, P469, DOI 10.1111/j.1365-2567.2011.03509.x; Hedayat M, 2014, J ALLERGY CLIN IMMUN, V134, P983, DOI 10.1016/j.jaci.2014.04.037; Henderson LA, 2013, J ALLERGY CLIN IMMUN, V132, P969, DOI 10.1016/j.jaci.2013.06.032; Isnardi I, 2010, BLOOD, V115, P5026, DOI 10.1182/blood-2009-09-243071; Karamchandani-Patel G, 2011, ANN ALLERG ASTHMA IM, V107, P50, DOI 10.1016/j.anai.2011.03.009; Kato T, 2015, J CLIN IMMUNOL, V35, P280, DOI 10.1007/s10875-015-0146-4; Kuijpers TW, 2011, BLOOD, V117, P5892, DOI 10.1182/blood-2011-01-329052; Kuijpers TW, 2010, J CLIN INVEST, V120, P214, DOI 10.1172/JCI40231; Lansford R, 1998, INT IMMUNOL, V10, P325, DOI 10.1093/intimm/10.3.325; Murray JM, 2003, IMMUNOL CELL BIOL, V81, P487, DOI 10.1046/j.1440-1711.2003.01191.x; Pasic S, 2009, ACTA PAEDIATR, V98, P1062, DOI 10.1111/j.1651-2227.2009.01250.x; Rakhmanov M, 2009, P NATL ACAD SCI USA, V106, P13451, DOI 10.1073/pnas.0901984106; Reiff A, 2013, J CLIN IMMUNOL, V33, P1289, DOI 10.1007/s10875-013-9953-7; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Schuetz C, 2008, NEW ENGL J MED, V358, P2030, DOI 10.1056/NEJMoa073966; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; Sharapova SO, 2013, HUM IMMUNOL, V74, P18, DOI 10.1016/j.humimm.2012.10.010; SMITH CIE, 1994, IMMUNOL REV, V138, P159, DOI 10.1111/j.1600-065X.1994.tb00851.x; Stich N, 2014, TOXINS, V6, P1724, DOI 10.3390/toxins6061724; Thiel J, 2012, J ALLERGY CLIN IMMUN, V129, P801, DOI 10.1016/j.jaci.2011.09.027; UMETSU DT, 1985, NEW ENGL J MED, V313, P1247, DOI 10.1056/NEJM198511143132002; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; Wood PMD, 2001, J PEDIATR-US, V139, P148, DOI 10.1067/mpd.2001.115970	46	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133220	10.1371/journal.pone.0133220	http://dx.doi.org/10.1371/journal.pone.0133220			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186701	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700111
J	Han, J; Bao, GS; Zhang, DQ; Gao, PC; Wu, TJ; Craig, P; Giraudoux, P; Chen, X; Xin, Q; He, LL; Chen, G; Jing, T				Han, Jian; Bao, Genshu; Zhang, Duoqiang; Gao, Pengcheng; Wu, Tinjun; Craig, Philip; Giraudoux, Patrick; Chen, Xiao; Xin, Qi; He, Lili; Chen, Gen; Jing, Tao			A Newly Discovered Epidemic Area of Echinococcus multilocularis in West Gansu Province in China	PLOS ONE			English	Article							HUMAN ALVEOLAR ECHINOCOCCOSIS; AUTONOMOUS REGION; TRANSMISSION; IDENTIFICATION; COMMUNITIES; NORTHWEST; LANDSCAPE; HOST	Alveolar echinococcosis (AE) is a lethal parasitic disease. In Gansu Province of China, all AE cases reported in literature were from Zhang and Min Counties, the southern part of the province. Here, we report the discovery of nine AE cases and one cystic echinococcosis (CE) case from Nanfeng Town of Minle County, in the middle of Hexi Corridor in west Gansu Province. The diagnosis of these cases were confirmed by serology, histopathology, computed tomography, B-ultrasound, immunohistochemistry method, DNA polymerase chain reaction and sequencing analysis. Because eight of nine AE cases came from First Zhanglianzhuang (FZLZ) village, we conducted preliminary epidemiological analyses of 730 persons on domestic water, community and ecology such as 356 dogs' faeces of FZLZ, in comparison with those of other five villages surrounding FZLZ. Our studies indicate that Nanfeng Town of Minle County is a newly discovered focus of AE in China as a CE and AE co-epidemic area. Further research of Echinococcus multilocularis transmission pattern in the area should be carried for prevention of this parasitic disease.	[Han, Jian; Bao, Genshu; Xin, Qi; He, Lili; Chen, Gen; Jing, Tao] Lanzhou Univ, Dept Pathogen Biol, Sch Basic Med Sci, Lanzhou 730000, Peoples R China; [Han, Jian; Jing, Tao] Lanzhou Univ, Res Inst Biomed Nanotechnol, Sch Basic Med Sci, Lanzhou 730000, Peoples R China; [Zhang, Duoqiang] Ningxia Peoples Hosp, Dept Hepatobiliary Surg, Yinchuan, Peoples R China; [Gao, Pengcheng] Zhangye Peoples Hosp, Dept Gen Surg, Zhangye, Peoples R China; [Wu, Tinjun] Ctr Dis Control Minle Cty, Minle, Peoples R China; [Craig, Philip] Univ Salford, Sch Environm & Life Sci, Cestode Zoonoses Res Grp, Manchester, Lancs, England; [Giraudoux, Patrick] Univ Franche Comte, Chrono Environm Lab, F-25030 Besancon, France; [Chen, Xiao] Lanzhou Univ, Hosp 2, Dept Gen Surg, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University; University of Manchester; University of Salford; Universite de Franche-Comte; Lanzhou University	Jing, T (corresponding author), Lanzhou Univ, Dept Pathogen Biol, Sch Basic Med Sci, Lanzhou 730000, Peoples R China.	jtao@lzu.edu.cn	EHEDE, Ecosystem health GDRI/G-1677-2016; Giraudoux, Patrick/B-9274-2011	Giraudoux, Patrick/0000-0003-2376-0136; Chen, Gen/0000-0002-5780-0901	Fundamental Research Funds for the Central Universities [lzujbky-2014-m02]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the Fundamental Research Funds for the Central Universities, Grant number: lzujbky-2014-m02, JH.	Beiromvand M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002313; Craig P, 2003, CURR OPIN INFECT DIS, V16, P437, DOI 10.1097/00001432-200310000-00010; Craig PS, 2006, PARASITOL INT, V55, pS221, DOI 10.1016/j.parint.2005.11.034; CRAIG PS, 1992, LANCET, V340, P826, DOI 10.1016/0140-6736(92)92693-A; Craig PS, 2000, ACTA TROP, V77, P167, DOI 10.1016/S0001-706X(00)00134-0; Eckert J, 2000, INT J PARASITOL, V30, P1283, DOI 10.1016/S0020-7519(00)00130-2; Giraudoux P, 2003, PARASITOLOGY, V127, pS121, DOI 10.1017/S0031182003003512; Ito A, 1996, J HELMINTHOL, V70, P355, DOI 10.1017/S0022149X00015662; Jiang CP, 2002, CHINESE MED J-PEKING, V115, P1244; JIANG CP, 1981, CHINESE MED J-PEKING, V94, P771; Kern P, 2010, CURR OPIN INFECT DIS, V23, P505, DOI 10.1097/QCO.0b013e32833d7516; Li TY, 2008, T ROY SOC TROP MED H, V102, P585, DOI 10.1016/j.trstmh.2008.02.019; Li TY, 2010, ACTA TROP, V113, P248, DOI 10.1016/j.actatropica.2009.11.006; Li TY, 2005, EMERG INFECT DIS, V11, P1866, DOI 10.3201/eid1112.050079; Liccioli S, 2013, PARASITOL INT, V62, P355, DOI 10.1016/j.parint.2013.03.007; McManus DP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-196; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Moro P, 2009, INT J INFECT DIS, V13, P125, DOI 10.1016/j.ijid.2008.03.037; Moss JE, 2013, PARASITOLOGY, V140, P1685, DOI 10.1017/S0031182013001200; Schneider R, 2008, INT J PARASITOL, V38, P1065, DOI 10.1016/j.ijpara.2007.11.008; Tanner F, 2006, SCHWEIZ ARCH TIERH, V148, P501, DOI 10.1024/0036-7281.148.9.501; Tappe D, 2010, ACTA TROP, V115, P167, DOI 10.1016/j.actatropica.2010.03.001; Vuitton DA, 2003, PARASITOLOGY, V127, pS87, DOI 10.1017/S0031182003004153; Wang CM, 2009, J WILDLIFE DIS, V45, P288, DOI 10.7589/0090-3558-45.2.288; Wang ZH, 2008, ECOHEALTH, V5, P115, DOI 10.1007/s10393-008-0174-0; World Health Organization, 1991, BAS LAB METH MED PAR; Yang YR, 2008, T ROY SOC TROP MED H, V102, P319, DOI 10.1016/j.trstmh.2008.01.007; Zhang WB, 2015, ACTA TROP, V141, P235, DOI 10.1016/j.actatropica.2014.03.014; Zhao Z-Y., 2010, ENDEMIC DIS B, V25, P27; Zhou HX, 2000, ANN TROP MED PARASIT, V94, P715, DOI 10.1080/00034983.2000.11813595	30	16	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132731	10.1371/journal.pone.0132731	http://dx.doi.org/10.1371/journal.pone.0132731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186219	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700058
J	Capraro, V; Barcelo, H				Capraro, Valerio; Barcelo, Helene			Group Size Effect on Cooperation in One-Shot Social Dilemmas II: Curvilinear Effect	PLOS ONE			English	Article							COLLECTIVE ACTION; PUBLIC-GOODS; CONDITIONAL COOPERATION; RESEARCH QUALITY; CRITICAL MASS; EVOLUTION; PROVISION; BEHAVIOR; COMMONS; HETEROGENEITY	In a world in which many pressing global issues require large scale cooperation, understanding the group size effect on cooperative behavior is a topic of central importance. Yet, the nature of this effect remains largely unknown, with lab experiments insisting that it is either positive or negative or null, and field experiments suggesting that it is instead curvilinear. Here we shed light on this apparent contradiction by considering a novel class of public goods games inspired to the realistic scenario in which the natural output limits of the public good imply that the benefit of cooperation increases fast for early contributions and then decelerates. We report on a large lab experiment providing evidence that, in this case, group size has a curvilinear effect on cooperation, according to which intermediate-size groups cooperate more than smaller groups and more than larger groups. In doing so, our findings help fill the gap between lab experiments and field experiments and suggest concrete ways to promote large scale cooperation among people.	[Capraro, Valerio] Ctr Math & Comp Sci CWI, NL-1098 XG Amsterdam, Netherlands; [Barcelo, Helene] Math Sci Res Inst, Berkeley, CA 94720 USA		Capraro, V (corresponding author), Ctr Math & Comp Sci CWI, NL-1098 XG Amsterdam, Netherlands.	V.Capraro@cwi.nl			Dutch Research Organization (NWO) [612.001.352]; National Science Foundation [0932078000]	Dutch Research Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); National Science Foundation(National Science Foundation (NSF))	V.C. is supported by the Dutch Research Organization (NWO) grant no. 612.001.352. This material is based upon work supported by the National Science Foundation under grant no. 0932078000 while the first author was in residence at the Mathematical Science Research Institute in Berkeley, California, during the spring 2015 semester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2006, WORLD DEV, V34, P149, DOI 10.1016/j.worlddev.2005.07.013; Agrawal A, 2001, COMP POLIT STUD, V34, P63, DOI 10.1177/0010414001034001003; Agrawal A, 2000, PEOPLE FORESTS COMMU, P57; ANDREONI J, 1988, J PUBLIC ECON, V37, P291, DOI 10.1016/0047-2727(88)90043-6; [Anonymous], 1965, LOGIC COLLECTIVE ACT; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Baland JM, 1999, WORLD DEV, V27, P773, DOI 10.1016/S0305-750X(99)00026-1; Barcelo H, 2015, SCI REP-UK, V5, DOI 10.1038/srep07937; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Capraro V, 2014, PREPRINT; Capraro V, 2014, SCI REP-UK, V4, DOI 10.1038/srep07470; Capraro V, 2014, SCI REP-UK, V4, DOI 10.1038/srep06790; Capraro V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102881; Capraro V, 2013, LECT NOTES COMPUT SC, V8146, P146, DOI 10.1007/978-3-642-41392-6_13; Capraro V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072427; CHAMBERLIN J, 1974, AM POLIT SCI REV, V68, P707, DOI 10.2307/1959515; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; Cinner JE, 2013, GLOBAL ENVIRON CHANG, V23, P1359, DOI 10.1016/j.gloenvcha.2013.11.001; DAWES RM, 1977, J PERS SOC PSYCHOL, V35, P1, DOI 10.1037/0022-3514.35.1.1; DIEKMANN A, 1985, J CONFLICT RESOLUT, V29, P605, DOI 10.1177/0022002785029004003; Esteban J, 2001, AM POLIT SCI REV, V95, P663, DOI 10.1017/S0003055401003124; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2010, AM ECON REV, V100, P541, DOI 10.1257/aer.100.1.541; Frey BS, 2004, AM ECON REV, V94, P1717, DOI 10.1257/0002828043052187; Gallo E, 2015, P NATL ACAD SCI USA, V112, P3647, DOI 10.1073/pnas.1415883112; Gautam AP, 2007, INT J SUST DEV WORLD, V14, P574, DOI 10.1080/13504500709469756; Gomez-Gardenes J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00620; Grujic J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00638; Haan M, 2002, J PUBLIC ECON, V83, P277, DOI 10.1016/S0047-2727(00)00157-2; Hauser OP, 2014, NATURE, V511, P220, DOI 10.1038/nature13530; Heckathorn DD, 1996, AM SOCIOL REV, V61, P250, DOI 10.2307/2096334; Hilbe C, 2013, P NATL ACAD SCI USA, V110, P6913, DOI 10.1073/pnas.1214834110; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; ISAAC RM, 1994, J PUBLIC ECON, V54, P1, DOI 10.1016/0047-2727(94)90068-X; Jiang LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02483; Kaplan H.S., 2005, MORAL SENTIMENTS MAT, P75; Kenna R, 2012, IMA J MANAG MATH, V23, P195, DOI 10.1093/imaman/dpr021; Kenna R, 2011, SCIENTOMETRICS, V86, P527, DOI 10.1007/s11192-010-0282-9; Kenna R, 2011, HIGH ED MANAG POL, V23, P9, DOI DOI 10.1787/HEMP-23-5KG0VSWCM27G; KOMORITA SS, 1982, J PERS SOC PSYCHOL, V42, P487, DOI 10.1037/0022-3514.42.3.487; Marwell G., 1993, CRITICAL MASS COLLEC; Masel J, 2007, J ECON BEHAV ORGAN, V64, P216, DOI 10.1016/j.jebo.2005.07.003; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; McGuire M., 1974, PUBLIC CHOICE, V18, P107, DOI [10.1007/bf01718500, DOI 10.1007/BF01718500]; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Nosenzo D, 2015, EXP ECON, V18, P4, DOI 10.1007/s10683-013-9382-8; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; OLIVER PE, 1988, AM SOCIOL REV, V53, P1, DOI 10.2307/2095728; Ostrom E, 2005, UNDERSTANDING INSTITUTIONAL DIVERSITY, P1; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Pecorino P, 2008, J PUBLIC ECON THEORY, V10, P785, DOI 10.1111/j.1467-9779.2008.00386.x; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Poteete AR, 2004, DEV CHANGE, V35, P435, DOI 10.1111/j.1467-7660.2004.00360.x; Press WH, 2012, P NATL ACAD SCI USA, V109, P10409, DOI 10.1073/pnas.1206569109; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Rustagi D, 2010, SCIENCE, V330, P961, DOI 10.1126/science.1193649; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Szolnoki A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.047102; Szolnoki A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057101; Todd S, 1992, COLLECTIVE ACTION TH; Tomasello Michael, 2014, NATURAL HIST HUMAN T; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vilone D, 2014, PARTNER SELECTION SU; Yang W, 2013, P NATL ACAD SCI USA, V110, P10916, DOI 10.1073/pnas.1301733110; Zhang XQ, 2011, AM ECON REV, V101, P1601, DOI 10.1257/aer.101.4.1601	72	31	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0131419	10.1371/journal.pone.0131419	http://dx.doi.org/10.1371/journal.pone.0131419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RQ	26182247	Green Submitted, gold, Green Published			2022-12-27	WOS:000358198200004
J	Ivarsson, M; Peckmann, J; Tehler, A; Broman, C; Bach, W; Behrens, K; Reitner, J; Bottcher, ME; Ivarsson, LN				Ivarsson, Magnus; Peckmann, Joern; Tehler, Anders; Broman, Curt; Bach, Wolfgang; Behrens, Katharina; Reitner, Joachim; Boettcher, Michael E.; Ivarsson, Lena Norback			Zygomycetes in Vesicular Basanites from Vesteris Seamount, Greenland Basin - A New Type of Cryptoendolithic Fungi	PLOS ONE			English	Article							LIFE; DIVERSITY; OXIDATION; METALS; BASALT; ROCKS; GLASS	Fungi have been recognized as a frequent colonizer of subseafloor basalt but a substantial understanding of their abundance, diversity and ecological role in this environment is still lacking. Here we report fossilized cryptoendolithic fungal communities represented by mainly Zygomycetes and minor Ascomycetes in vesicles of dredged volcanic rocks (basanites) from the Vesteris Seamount in the Greenland Basin. Zygomycetes had not been reported from subseafloor basalt previously. Different stages in zygospore formation are documented in the studied samples, representing a reproduction cycle. Spore structures of both Zygomycetes and Ascomycetes are mineralized by romanechite-like Mn oxide phases, indicating an involvement in Mn(II) oxidation to form Mn(III, VI) oxides. Zygospores still exhibit a core of carbonaceous matter due to their resistance to degradation. The fungi are closely associated with fossiliferous marine sediments that have been introduced into the vesicles. At the contact to sediment infillings, fungi produced haustoria that penetrated and scavenged on the remains of fragmented marine organisms. It is most likely that such marine debris is the main carbon source for fungi in shallow volcanic rocks, which favored the establishment of vital colonies.	[Ivarsson, Magnus] Swedish Museum Nat Hist, Dept Palaeobiol, S-10405 Stockholm, Sweden; [Ivarsson, Magnus] Swedish Museum Nat Hist, Ctr Earth Evolut NordCEE, S-10405 Stockholm, Sweden; [Peckmann, Joern] Univ Vienna, Ctr Earth Sci, Dept Geodynam & Sedimentol, Vienna, Austria; [Tehler, Anders] Swedish Museum Nat Hist, Dept Bot, S-10405 Stockholm, Sweden; [Broman, Curt] Stockholm Univ, Dept Geol Sci, S-10691 Stockholm, Sweden; [Bach, Wolfgang; Behrens, Katharina] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Reitner, Joachim] Univ Gottingen, Geosci Ctr, Geobiol Grp, D-37073 Gottingen, Germany; [Boettcher, Michael E.] Leibniz Inst Balt Sea Res IOW, Dept Marine Geol, Geochem & Isotope Biogeochem Grp, Warnemunde, Germany; [Ivarsson, Lena Norback] Sodertorn Univ, Sch Nat Sci, Technol & Environm Studies, Stockholm, Sweden	Swedish Museum of Natural History; Swedish Museum of Natural History; University of Vienna; Swedish Museum of Natural History; Stockholm University; University of Bremen; University of Gottingen; Leibniz Institut fur Ostseeforschung Warnemunde; Sodertorn University	Ivarsson, M (corresponding author), Swedish Museum Nat Hist, Dept Palaeobiol, S-10405 Stockholm, Sweden.	Magnus.ivarsson@nrm.se	Bach, Wolfgang/D-3713-2017	Bach, Wolfgang/0000-0002-3099-7142; Bottcher, Michael Ernst/0000-0002-8877-0303; Peckmann, Jorn/0000-0002-8572-0060	Swedish Research Council [2012-4364]; Deutsche Forschungsgemeinschaft [BO 1583/3, PE 847/3, RE 665/25, 1144]; Danish National Research Foundation [DNRF53]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was funded by the Swedish Research Council (Contract No. 2012-4364), the Deutsche Forschungsgemeinschaft through project BO 1583/3, PE 847/3, RE 665/25 within priority program 1144 'From Mantle to Ocean: Energy-, Material-and Lifecycles at Spreading Axes', and the Danish National Research Foundation (DNRF53).	Bengtson S, 2014, GEOBIOLOGY, V12, P489, DOI 10.1111/gbi.12100; BENNY GL, 1992, MYCOLOGIA, V84, P615, DOI 10.2307/3760372; CANFIELD DE, 1989, GEOCHIM COSMOCHIM AC, V53, P619, DOI 10.1016/0016-7037(89)90005-7; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Dellwig O, 2002, CHEM GEOL, V182, P423, DOI 10.1016/S0009-2541(01)00335-7; Downs R. T., 2006, 19 GEN M INT MIN ASS, pO03; Edwards KJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00008; Eickmann B, 2009, PALAEOGEOGR PALAEOCL, V283, P120, DOI 10.1016/j.palaeo.2009.09.006; Fisk M, 2013, GEOSPHERE, V9, P317, DOI 10.1130/GES00827.1; FOSSING H, 1989, BIOGEOCHEMISTRY, V8, P205; Francis CA, 2002, APPL ENVIRON MICROB, V68, P874, DOI 10.1128/AEM.68.2.874-880.2002; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Glass NL, 2006, MYCOTA 1 GROWTH DIFF; HAASE KM, 1994, J PETROL, V35, P295, DOI 10.1093/petrology/35.2.295; Hansel CM, 2012, P NATL ACAD SCI USA, V109, P12621, DOI 10.1073/pnas.1203885109; Henrich R., 1992, Facies, V27, P71, DOI 10.1007/BF02536805; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Ivarsson M, 2012, BIOGEOSCIENCES, V9, P3625, DOI 10.5194/bg-9-3625-2012; Ivarsson M, 2013, GEO-MAR LETT, V33, P233, DOI 10.1007/s00367-013-0321-7; Ivarsson M, 2012, GEOLOGY, V40, P163, DOI 10.1130/G32590.1; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; LAMPILA LE, 1985, MYCOPATHOLOGIA, V90, P65, DOI 10.1007/BF00436853; Le Maitre R. W., 1989, CLASSIFICATION IGNEO; Leipe T, 2013, CHEM ERDE-GEOCHEM, V73, P249, DOI 10.1016/j.chemer.2013.06.005; Lever MA, 2013, SCIENCE, V339, P1305, DOI 10.1126/science.1229240; Lysnes K, 2004, FEMS MICROBIOL ECOL, V50, P213, DOI 10.1016/j.femsec.2004.06.014; Mason OU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015399; Mertz D. F., 1995, Journal of Geodynamics, V19, P79, DOI 10.1016/0264-3707(94)E0001-B; Orcutt BN, 2011, ISME J, V5, P692, DOI 10.1038/ismej.2010.157; Peckmann J, 2008, GEOBIOLOGY, V6, P125, DOI 10.1111/j.1472-4669.2007.00131.x; Reitner J., 2006, FUNGI BIOGEOCHEMICAL, P377, DOI DOI 10.1017/CBO9780511550522.017; Santelli CM, 2008, NATURE, V453, P653, DOI 10.1038/nature06899; Schulz HN, 2001, ANNU REV MICROBIOL, V55, P105, DOI 10.1146/annurev.micro.55.1.105; Schumann G, 2004, GEOMICROBIOL J, V21, P241, DOI 10.1080/01490450490438748; Staudigel H, 2008, EARTH-SCI REV, V89, P156, DOI 10.1016/j.earscirev.2008.04.005; Thiede J., 1991, Berichte zur Polarforschung, V80, P1; Thorseth IH, 2001, EARTH PLANET SC LETT, V194, P31, DOI 10.1016/S0012-821X(01)00537-4; Webster J., 2007, INTRO FUNGI, V3rd; ZAMARRENO I, 1989, AM MINERAL, V74, P1054	39	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133368	10.1371/journal.pone.0133368	http://dx.doi.org/10.1371/journal.pone.0133368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181773	gold, Green Published			2022-12-27	WOS:000358198200062
J	Volkers, RJM; Snoek, LB; Ruijssenaars, HJ; de Winde, JH				Volkers, Rita J. M.; Snoek, L. Basten; Ruijssenaars, Harald J.; de Winde, Johannes H.			Dynamic Response of Pseudomonas putida S12 to Sudden Addition of Toluene and the Potential Role of the Solvent Tolerance Gene trgI	PLOS ONE			English	Article							ORGANIC-SOLVENTS; MOLECULAR CHARACTERIZATION; TRANSCRIPTIONAL REGULATOR; ESCHERICHIA-COLI; FATTY-ACID; BACTERIA; STRESS; METABOLISM; AERUGINOSA; EFFLUX	Pseudomonas putida S12 is exceptionally tolerant to various organic solvents. To obtain further insight into this bacterium's primary defence mechanisms towards these potentially harmful substances, we studied its genome wide transcriptional response to sudden addition of toluene. Global gene expression profiles were monitored for 30 minutes after toluene addition. During toluene exposure, high oxygen-affinity cytochrome c oxidase is specifically expressed to provide for an adequate proton gradient supporting solvent efflux mechanisms. Concomitantly, the glyoxylate bypass route was up-regulated, to repair an apparent toluene stress-induced redox imbalance. A knock-out mutant of trgI, a recently identified toluene-repressed gene, was investigated in order to identify TrgI function. Remarkably, upon addition of toluene the number of differentially expressed genes initially was much lower in the trgI-mutant than in the wild-type strain. This suggested that after deletion of trgI cells were better prepared for sudden organic solvent stress. Before, as well as after, addition of toluene many genes of highly diverse functions were differentially expressed in trgI-mutant cells as compared to wild-type cells. This led to the hypothesis that TrgI may not only be involved in the modulation of solvent-elicited responses but in addition may affect basal expression levels of large groups of genes.	[Volkers, Rita J. M.; Snoek, L. Basten] Wageningen Univ, Lab Nematol Plant Sci, NL-6700 AP Wageningen, Netherlands; [Ruijssenaars, Harald J.] Corbion, Gorinchem, Netherlands; [de Winde, Johannes H.] Delft Univ Technol, Fac Sci Appl, Dept Biotechnol, Delft, Netherlands; [Volkers, Rita J. M.; Ruijssenaars, Harald J.; de Winde, Johannes H.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands	Wageningen University & Research; Delft University of Technology	de Winde, JH (corresponding author), Leiden Univ, Fac Sci, Inst Biol, Leiden, Netherlands.	j.h.de.winde@science.leidenuniv.nl	de Winde, J.H./AAC-5520-2021; Snoek, Basten L/E-4713-2014	de Winde, J.H./0000-0002-7999-9317; Snoek, Basten L/0000-0001-5321-2996	Kluyver Centre for Genomics of Industrial Fermentation; Netherlands Genomics Initiative (NGI); Corbion	Kluyver Centre for Genomics of Industrial Fermentation; Netherlands Genomics Initiative (NGI); Corbion	This research was funded by the Kluyver Centre for Genomics of Industrial Fermentation (www.kluyvercentre.nl), which is supported by the Netherlands Genomics Initiative (NGI) (www.genomics.nl). Corbion provided support in the form of a salary for author HJR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 1982, MOL CLONING LAB MANU; Arai H, 2014, J BACTERIOL, V196, P4206, DOI 10.1128/JB.02176-14; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bernal P, 2007, ENVIRON MICROBIOL, V9, P1658, DOI 10.1111/j.1462-2920.2007.01283.x; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Cray JA, 2015, CURR OPIN BIOTECH, V33, P228, DOI 10.1016/j.copbio.2015.02.010; Cray JA, 2013, ENVIRON MICROBIOL, V15, P287, DOI 10.1111/1462-2920.12018; del Castillo T, 2007, J BACTERIOL, V189, P5142, DOI 10.1128/JB.00203-07; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; Fonseca P, 2014, INT J BIOL MACROMOL, V71, P14, DOI 10.1016/j.ijbiomac.2014.04.014; Frunzke J, 2008, MOL MICROBIOL, V67, P305, DOI 10.1111/j.1365-2958.2007.06020.x; Hall DR, 1999, EMBO J, V18, P1435, DOI 10.1093/emboj/18.6.1435; Hallsworth JE, 2003, APPL ENVIRON MICROB, V69, P7032, DOI 10.1128/AEM.69.12.7032-7034.2003; HARTMANS S, 1989, APPL ENVIRON MICROB, V55, P2850, DOI 10.1128/AEM.55.11.2850-2855.1989; He MX, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-75; Heipieper HJ, 2007, APPL MICROBIOL BIOT, V74, P961, DOI 10.1007/s00253-006-0833-4; INOUE A, 1989, NATURE, V338, P264, DOI 10.1038/338264a0; Isken S, 1999, APPL ENVIRON MICROB, V65, P2631; Isken S, 1998, EXTREMOPHILES, V2, P229, DOI 10.1007/s007920050065; Kazakov AE, 2009, J BACTERIOL, V191, P52, DOI 10.1128/JB.01175-08; Kieboom J, 1998, J BACTERIOL, V180, P6769, DOI 10.1128/JB.180.24.6769-6772.1998; Kieboom J, 1998, J BIOL CHEM, V273, P85, DOI 10.1074/jbc.273.1.85; Kieboom J, 2001, MICROBIOL-SGM, V147, P43, DOI 10.1099/00221287-147-1-43; Kuepper J, 2015, J BIOTECHNOL, V200, P17, DOI 10.1016/j.jbiotec.2015.02.027; Lauchnor EG, 2011, BIOTECHNOL BIOENG, V108, P750, DOI 10.1002/bit.22999; MERCENIER A, 1980, J BACTERIOL, V144, P159, DOI 10.1128/JB.144.1.159-163.1980; Muller EEL, 2011, ENVIRON MICROBIOL, V13, P2518, DOI 10.1111/j.1462-2920.2011.02524.x; Ramos JL, 2002, ANNU REV MICROBIOL, V56, P743, DOI 10.1146/annurev.micro.56.012302.161038; Ramos JL, 2015, FEMS MICROBIOL REV; Rhee HJ, 2007, J CELL MOL MED, V11, P685, DOI 10.1111/j.1582-4934.2007.00077.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SUNNARBORG A, 1990, J BACTERIOL, V172, P2642, DOI 10.1128/jb.172.5.2642-2649.1990; Swanson BL, 2000, MOL MICROBIOL, V37, P561, DOI 10.1046/j.1365-2958.2000.02012.x; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Trautwein K, 2008, APPL ENVIRON MICROB, V74, P2267, DOI 10.1128/AEM.02381-07; Volkers RJM, 2006, ENVIRON MICROBIOL, V8, P1674, DOI 10.1111/j.1462-2920.2006.01056.x; Volkers RJM, 2010, ENV MICROBIOL REP, V2, P456, DOI 10.1111/j.1758-2229.2010.00172.x; Volkers RJM, 2009, EXTREMOPHILES, V13, P283, DOI 10.1007/s00792-008-0216-0; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	40	11	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132416	10.1371/journal.pone.0132416	http://dx.doi.org/10.1371/journal.pone.0132416			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181384	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198200018
J	Adamczyk, B; Chydzinski, A				Adamczyk, Blazej; Chydzinski, Andrzej			Achieving High Resolution Timer Events in Virtualized Environment	PLOS ONE			English	Article								Virtual Machine Monitors (VMM) have become popular in different application areas. Some applications may require to generate the timer events with high resolution and precision. This however may be challenging due to the complexity of VMMs. In this paper we focus on the timer functionality provided by five different VMMs-Xen, KVM, Qemu, VirtualBox and VMWare. Firstly, we evaluate resolutions and precisions of their timer events. Apparently, provided resolutions and precisions are far too low for some applications (e.g. networking applications with the quality of service). Then, using Xen virtualization we demonstrate the improved timer design that greatly enhances both the resolution and precision of achieved timer events.	[Adamczyk, Blazej; Chydzinski, Andrzej] Silesian Tech Univ, Inst Informat, Gliwice, Poland	Silesian University of Technology	Adamczyk, B (corresponding author), Silesian Tech Univ, Inst Informat, Gliwice, Poland.	blazej.adamczyk@polsl.pl		Chydzinski, Andrzej/0000-0002-0168-6919	GeCONiI-Upper Silesian Center for Computational Science and Engineering [POIG.02.03.01-24-099/13]	GeCONiI-Upper Silesian Center for Computational Science and Engineering	The infrastructure was supported by POIG.02.03.01-24-099/13 grant: "GeCONiI-Upper Silesian Center for Computational Science and Engineering."	[Anonymous], 2004, IA PC HPET HIGH PREC; Barham P., 2003, ACM SIGOPS OPER SYST, V37, P164, DOI DOI 10.1145/1165389.945462; Burakowski W., 2012, Proceedings of the 2012 13th ACIS International Conference on Software Engineering, Artificial Intelligence, Networking and Parallel & Distributed Computing (SNPD 2012), P679, DOI 10.1109/SNPD.2012.67; Chisnall D., 2007, DEFINITIVE GUIDE XEN; Davis R., 2014, ACM SIGBED REV, V11, P8, DOI [10.1145/2597457.2597458, DOI 10.1145/2597457.2597458]; Gleixner Thomas, 2006, P LINUX S, V1, P333; Hamayun MM., 2014, P 10 ANN WORKSH OP S, P39; Hewlett-Packard Corp. Intel Corp. Microsoft Corp. Phoenix Technologies Ltd. Toshiba Corp., 2011, ADV CONF POW INT SPE; Intel Corporation, 2012, INT 64 IA 32 ARCH SO, V2; Intel Corporation, 1997, MULTIPROCESSOR SPEC; Intel Corporation, 2004, 8254 82C54 INTR PROG; Kiszka J, 2009, 11 REAL TIM LIN WORK; Maxim Integrated Products, 2011, REAL TIM CLOCKS PROD; Oberle V, 2001, IBM LINUX CHALLENGE; Oracle Corporation, OR VM VIRTUALBOX; POPEK GJ, 1974, COMMUN ACM, V17, P412, DOI 10.1145/361011.361073; Siddha S., 2007, P LIN S, V2, P201; Vattikonda BC, 2011, PROCEEDINGS OF THE 3RD ACM WORKSHOP CLOUD COMPUTING SECURITY WORKSHOP (CCSW'11), P41; VMware Inc, 2008, TIM VMWARE VIRT MACH; VMware Inc., 2007, UND FULL VIRT PAR HA; VMware Inc, VMWARE PLAYER; Wei G, 2009, ON GOING EVOLUTIONS	22	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130887	10.1371/journal.pone.0130887	http://dx.doi.org/10.1371/journal.pone.0130887			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177366	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600031
J	Chagas, BS; Comar, M; Gurgel, APAD; Paiva, S; Seraceni, S; de Freitas, AC; Crovella, S				Chagas, Barbara Simas; Comar, Manola; Almeida Diniz Gurgel, Ana Pavla; Paiva, Sergio; Seraceni, Silva; de Freitas, Antonio Carlos; Crovella, Sergio			Association Study between Cervical Lesions and Single or Multiple Vaccine-Target and Non-Vaccine Target Human Papillomavirus (HPV) Types in Women from Northeastern Brazil	PLOS ONE			English	Article							HPV-16/18 AS04-ADJUVANTED VACCINE; CROSS-PROTECTIVE EFFICACY; OF-STUDY ANALYSIS; HIGH-RISK; CONCURRENT INFECTIONS; VARIANT LINEAGES; E7 ONCOGENES; E6 VARIANTS; CANCER; PREVALENCE	We performed an association between high-grade squamous intraepithelial lesions (HSIL), low-grade squamous intraepithelial lesions (LSIL) and single or multiple vaccine-target as well as non-vaccine target Human papillomavirus (HPV) types. Using bead-based HPV genotyping, 594 gynecological samples were genotyped. An association between squamous intraepithelial lesion (SIL) and presence of HPV16, 18, 31, 58 and 56 types were calculated. The risk was estimated by using odds ratio (OR) and 95% of confidence intervals (CI). A total of 370 (62.3%) women were HPV positive. Among these, 157 (42.7%) presented a single HPV infection, and 212 (57.3%) were infected by more than one HPV type. HPV31 was the most prevalent genotype, regardless single and multiple HPV infections. Single infection with HPV31 was associated with LSIL (OR=2.32; 95% CI: 1.01 to 5.32; p=0.04); HPV31 was also associated with LSIL (OR=3.28; 95% CI: 1.74 to 6.19; p=0.0002) and HSIL (OR=3.82; 95% CI: 2.10 to 6.97; p<0.001) in multiple HPV infections. Risk to harbor cervical lesions was observed in multiple HPV infections with regard to the HPV56 (OR=5.39; 95% CI: 2.44 to 11.90; p<0.001 for LSIL; OR=5.37; 95% CI: 2.71 to 10.69; p<0.001) and HPV58 (OR=3.29; 95% CI: 1.34 to 8.09; p=0.0091 for LSIL; OR=3.55; 95% CI: 1.56 to 8.11; p=0.0026) genotypes. In addition, women coinfected with HPV16/31/56 types had 6 and 5-fold increased risk of HSIL (OR=6.46; 95% CI: 1.89 to 22.09; p=0.002) and LSIL (OR=5.22; 95% CI: 1.10 to 24.70; p=0.03), respectively. Multiple HPV infections without HPV16/18 has 2-fold increased risk of HSIL (OR=2.57; 95% CI: 1.41 to 4.70; p=0.002) and LSIL OR=2.03; 95% CI: 1.08 to 3.79; p=0.02). The results of this study suggest that single and multiple vaccine target as well as non-vaccine target HPV types are associated with LSIL and HSIL. These finding should be taken into consideration in the design of HPV vaccination strategies.	[Chagas, Barbara Simas; Almeida Diniz Gurgel, Ana Pavla; Paiva, Sergio; de Freitas, Antonio Carlos] Univ Fed Pernambuco, Dept Genet, Lab Mol Studies & Expt Therapy, Caruaru, PE, Brazil; [Comar, Manola; Seraceni, Silva; Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Seraceni, Silva; Crovella, Sergio] Univ Trieste, Trieste, Italy	Universidade Federal de Pernambuco; IRCCS Burlo Garofolo; University of Trieste	de Freitas, AC (corresponding author), Univ Fed Pernambuco, Dept Genet, Lab Mol Studies & Expt Therapy, Caruaru, PE, Brazil.	acf_ufpe@yahoo.com.br	Comar, Manola/K-4613-2016; Chagas, Bárbara/M-9327-2019; Freitas, Antonio/G-1843-2012; Crovella, Sergio/K-5050-2016; COMAR, Manola/K-4613-2016	Comar, Manola/0000-0001-6310-3320; Freitas, Antonio/0000-0002-4957-9549; Crovella, Sergio/0000-0001-8493-1168; Simas Chagas, Barbara/0000-0003-3917-9055; COMAR, Manola/0000-0002-9487-861X; Gurgel, Ana Pavla A.D./0000-0001-5848-6419	Brazilian Institute CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Brazilian Institute FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco); Brazilian Institute PPSUS (Programa Pesquisa para o Sistema Unico de Saude); Brazilian Institute CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	Brazilian Institute CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Institute FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco); Brazilian Institute PPSUS (Programa Pesquisa para o Sistema Unico de Saude); Brazilian Institute CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	This work was supported by Brazilian Institutes CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), - FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco), PPSUS (Programa Pesquisa para o Sistema Unico de Saude), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior).	Ah Lee S, 2003, CANC LETT, V198, P187, DOI 10.1016/S0304-3835(03)00312-4; Alencar TR, 2007, VIRUS GENES, V35, P1, DOI 10.1007/s11262-006-0040-5; Gurgel APAD, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/546354; Gurgel APAD, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/130828; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Baldez da Silva M F P T, 2009, Genet Mol Res, V8, P1437, DOI 10.4238/vol8-4gmr677; da Silva MFPTB, 2012, GENET MOL RES, V11, P462, DOI 10.4238/2012.March.1.3; Beca F, 2014, DIAGN CYTOPATHOL, V42, P919, DOI 10.1002/dc.23143; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Burk RD, 2003, CANCER RES, V63, P7215; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Burroni E, 2013, J MED VIROL, V85, P83, DOI 10.1002/jmv.23417; Carozzi F, 2012, EUR J CANCER, V48, P1633, DOI 10.1016/j.ejca.2011.10.010; Castro MM, 2011, GENET MOL RES, V10, P186, DOI 10.4238/vol10-1gmr992; Chagas BS, 2011, GYNECOL ONCOL, V123, P284, DOI 10.1016/j.ygyno.2011.07.008; Chagas BS, 2013, INFECT GENET EVOL, V16, P13, DOI 10.1016/j.meegid.2013.02.001; Chang YJ, 2011, INT J CANCER, V129, P965, DOI 10.1002/ijc.25724; Chansaenroj J, 2012, ASIAN PAC J CANCER P, V13, P599, DOI 10.7314/APJCP.2012.13.2.599; Chaturvedi AK, 2011, J INFECT DIS, V203, P910, DOI 10.1093/infdis/jiq139; Comar M, 2012, J CLIN MICROBIOL, V50, P4041, DOI 10.1128/JCM.02105-12; Combita A, 2013, REV COLOMB CANCEROL, V17, P103, DOI 10.1016/S0123-9015(13)70012-X; Cornet I, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-4; Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12; Cruz MR, 2004, MEM I OSWALDO CRUZ, V99, P281, DOI 10.1590/S0074-02762004000300007; Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68; Resende LSDA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-214; de Freitas AC, 2012, GYNECOL ONCOL, V126, P304, DOI 10.1016/j.ygyno.2012.03.047; Fernandes TAADM, 2008, BRAZ J MICROBIOL, V39, P573, DOI [10.1590/S1517-83822008000300031, 10.1590/S1517-838220080003000031]; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; De Vincenzo R, 2013, GYNECOL ONCOL, V130, P642, DOI 10.1016/j.ygyno.2013.05.033; Dickson EL, 2014, GYNECOL ONCOL, V133, P405, DOI 10.1016/j.ygyno.2014.03.552; Dickson EL, 2013, INT J GYNECOL CANCER, V23, P1295, DOI 10.1097/IGC.0b013e31829e9fb4; Fernandes Jose V, 2010, BMC Res Notes, V3, P96, DOI 10.1186/1756-0500-3-96; Fernandes JV, 2011, MOL MED REP, V4, P1321, DOI 10.3892/mmr.2011.579; Freitas LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100746; Gheit T, 2006, J CLIN MICROBIOL, V44, P2025, DOI 10.1128/JCM.02305-05; Gheit T, 2011, CANCER EPIDEM BIOMAR, V20, P1315, DOI 10.1158/1055-9965.EPI-10-1187; Goldstone SE, 2013, VACCINE, V31, P3849, DOI 10.1016/j.vaccine.2013.06.057; Hildesheim A, 2014, VACCINE, V32, P5087, DOI 10.1016/j.vaccine.2014.06.038; Kahn JA, 2012, PEDIATRICS, V130, pE249, DOI 10.1542/peds.2011-3587; Kavanagh K, 2014, BRIT J CANCER, V110, P2804, DOI 10.1038/bjc.2014.198; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Londesborough P, 1996, INT J CANCER, V69, P364; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Mejlhede N, 2009, APMIS, V117, P108, DOI 10.1111/j.1600-0463.2008.00019.x; Munagala R, 2009, INT J ONCOL, V34, P263, DOI 10.3892/ijo_00000148; Nielsen A, 2008, SEX TRANSM DIS, V35, P276, DOI 10.1097/OLQ.0b013e31815ac5c7; Orlando PA, 2012, J INFECT DIS, V205, P272, DOI 10.1093/infdis/jir717; Pista A, 2011, CLIN MICROBIOL INFEC, V17, P941, DOI 10.1111/j.1469-0691.2010.03387.x; Quint KD, 2010, GYNECOL ONCOL, V117, P297, DOI 10.1016/j.ygyno.2010.02.003; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Tabrizi SN, 2014, LANCET INFECT DIS, V14, P958, DOI 10.1016/S1473-3099(14)70841-2; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Trottier H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; XI LF, 1995, J INFECT DIS, V172, P747, DOI 10.1093/infdis/172.3.747; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; Zehbe I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-77; Zuna RE, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-19; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	67	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132570	10.1371/journal.pone.0132570	http://dx.doi.org/10.1371/journal.pone.0132570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176537	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600126
J	Crowe, S; Prost, A; Hossen, M; Azad, K; Kuddus, A; Roy, S; Nair, N; Tripathy, P; Saville, N; Sen, A; Sikorski, C; Manandhar, D; Costello, A; Pagel, C				Crowe, Sonya; Prost, Audrey; Hossen, Munir; Azad, Kishwar; Kuddus, Abdul; Roy, Swati; Nair, Nirmala; Tripathy, Prasanta; Saville, Naomi; Sen, Aman; Sikorski, Catherine; Manandhar, Dharma; Costello, Anthony; Pagel, Christina			Generating Insights from Trends in Newborn Care Practices from Prospective Population-Based Studies: Examples from India, Bangladesh and Nepal	PLOS ONE			English	Article							INTRAPARTUM-RELATED STILLBIRTHS; RANDOMIZED CONTROLLED-TRIAL; NEONATAL DEATHS; FUTURE IMPLICATIONS; CHILD-MORTALITY; SURVIVAL; DECADE; INTERVENTIONS; COUNTRIES	Background Delivery of essential newborn care is key to reducing neonatal mortality rates, yet coverage of protective birth practices remains incomplete and variable, with or without skilled attendance. Evidence of changes over time in newborn care provision, disaggregated by care practice and delivery type, can be used by policymakers to review efforts to reduce mortality. We examine such trends in four areas using control arm trial data. Methods and Findings We analysed data from the control arms of cluster randomised controlled trials in Bangladesh (27 553 births), eastern India (8 939), Dhanusha, Nepal (15 344) and Makwanpur, Nepal (6 765) over the period 2001-2011. For each trial, we calculated the observed proportion of attended births and the coverage of WHO essential newborn care practices by year, adjusted for clustering and stratification. To explore factors contributing to the observed trends, we then analysed expected trends due only to observed shifts in birth attendance, accounted for stratification, delivery type and statistically significant interaction terms, and examined disaggregated trends in care practice coverage by delivery type. Attended births increased over the study periods in all areas from very low rates, reaching a maximum of only 30% of deliveries. Newborn care practice trends showed marked heterogeneity within and between areas. Adjustment for stratification, birth attendance and interaction revealed that care practices could change in opposite directions over time and/or between delivery types - e.g. in Bangladesh hygienic cord-cutting and skin-to-skin contact fell in attended deliveries but not home deliveries, whereas in India birth attendant hand-washing rose for institutional deliveries but fell for home deliveries. Conclusions Coverage of many essential newborn care practices is improving, albeit slowly and unevenly across sites and delivery type. Time trend analyses of birth patterns and essential newborn care practices can inform policy-makers about effective intervention strategies.	[Crowe, Sonya; Pagel, Christina] UCL, Clin Operat Res Unit, London WC1H 0BT, England; [Prost, Audrey; Saville, Naomi; Sikorski, Catherine; Costello, Anthony] UCL, Inst Global Hlth, London WC1N 1EH, England; [Hossen, Munir; Azad, Kishwar; Kuddus, Abdul] Diabet Assoc Bangladesh, Perinatal Care Project, Dhaka 1000, Bangladesh; [Roy, Swati; Nair, Nirmala; Tripathy, Prasanta] Ekjut, West Singhbhum, Jharkhand, India; [Saville, Naomi; Sen, Aman; Sikorski, Catherine; Manandhar, Dharma] Mother Infant Res Act, Kathmandu, Nepal	University of London; University College London; University of London; University College London	Crowe, S (corresponding author), UCL, Clin Operat Res Unit, 4 Taviton St, London WC1H 0BT, England.	sonya.crowe@ucl.ac.uk	; Saville, Naomi/J-7244-2015	Crowe, Sonya/0000-0003-1882-5476; Pagel, Christina/0000-0002-2857-1628; Saville, Naomi/0000-0002-1735-3684	Wellcome Trust Strategic Award [085417MA/Z/08/Z]; Big Lottery Fund; Wellcome Trust; Health Foundation; UK Department for International Development; UBS Optimus Foundation; USAID; DFID Towards 4 + 5 Research Programme Consortium; "Population Science of Maternal and Child Survival" Wellcome Trust Strategic Award	Wellcome Trust Strategic Award(Wellcome Trust); Big Lottery Fund; Wellcome Trust(Wellcome TrustEuropean Commission); Health Foundation; UK Department for International Development; UBS Optimus Foundation; USAID(United States Agency for International Development (USAID)); DFID Towards 4 + 5 Research Programme Consortium; "Population Science of Maternal and Child Survival" Wellcome Trust Strategic Award	The contributions of CP and SC to this project were funded by a Wellcome Trust Strategic Award (085417MA/Z/08/Z). In Bangladesh, the Perinatal Care Project (covering MH, KA, AK) has received funding from the Big Lottery Fund and the Wellcome Trust. It is registered with trial number ISRCTN54792066. In Eastern India, the Ekjut trial was funded by the Health Foundation (covering SR, NN, PT) and is registered with trial number ISRCTN21817853. The Makwanpur (Nepal) trial (covering AS, DM) was funded by the UK Department for International Development and is registered with trial number ISRCTN31137309. The Dhanusha (Nepal) study team (covering NS, CS) acknowledge funding from: UBS Optimus Foundation for covering most of the costs involved since 2004; USAID for assistance 2005-8; DFID Towards 4 + 5 Research Programme Consortium for contributing to the costs of capacity building and staffing of the sepsis management intervention during 2008-10; "Population Science of Maternal and Child Survival" Wellcome Trust Strategic Award for covering technical advisor and some principal investigator staff costs since November 2009. The Dhanusha trial is registered with trial number ISRCTN87820538. The funders played no part in the development of the article or the decision to submit it for publication.	Acuin CS, 2011, LANCET, V377, P516, DOI 10.1016/S0140-6736(10)62049-1; Ameh C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049938; Azad K, 2010, LANCET, V375, P1193, DOI 10.1016/S0140-6736(10)60142-0; Bloom T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001607; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Ellis M, 2011, PEDIATRICS, V127, pE1182, DOI 10.1542/peds.2010-0842; Grady K, 2011, J OBSTET GYNAECOL, V31, P18, DOI 10.3109/01443615.2010.533218; Hayes RJ, 2009, INTERD STAT, P3; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Kumar V, 2009, J PERINATOL, V29, P401, DOI 10.1038/jp.2008.233; Lawn JE, 2012, HEALTH POLICY PLANN, V27, P6, DOI 10.1093/heapol/czs053; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Minnery M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-779; Nahar T, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-5; Nguyen KH, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-45; Pagel C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-99; Pradhan YV, 2012, HEALTH POLICY PLANN, V27, P57, DOI 10.1093/heapol/czs052; Rubayet S, 2012, HEALTH POLICY PLANN, V27, P40, DOI 10.1093/heapol/czs044; Seward N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001180; Shrestha BP, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-136; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; UNICEF WHO, 2013, EV NEWB ACT PLAN END; Wall SN, 2010, SEMIN PERINATOL, V34, P395, DOI 10.1053/j.semperi.2010.09.009; Winani S, 2007, J MIDWIFERY WOM HEAL, V52, P37, DOI 10.1016/j.jmwh.2006.09.004; World Health Organization, 2006, PREGN CHILDB POSTP N; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R	30	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0127893	10.1371/journal.pone.0127893	http://dx.doi.org/10.1371/journal.pone.0127893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176535	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600006
J	Eisermann, K; Dar, JA; Dong, J; Wang, D; Masoodi, KZ; Wang, Z				Eisermann, Kurtis; Dar, Javid A.; Dong, Jun; Wang, Dan; Masoodi, Khalid Z.; Wang, Zhou			Poly (A) Binding Protein Cytoplasmic 1 Is a Novel Co-Regulator of the Androgen Receptor	PLOS ONE			English	Article							ADVANCED PROSTATE-CANCER; N-TERMINAL DOMAIN; GENE-EXPRESSION; POLY(A)-BINDING PROTEIN-1; INCREASED SURVIVAL; PAXILLIN; BICALUTAMIDE; ACTIVATION; VARIANTS; GENOMICS	The androgen receptor (AR) is a member of the steroid receptor superfamily that regulates gene expression in a ligand-dependent manner. The NTD of the AR plays a key role in AR transactivation including androgen-independent activation of the AR in castration-resistant prostate cancer (CRPC) cells. We recently reported that amino acids (a. a.) 50-250 of the NTD are capable of modulating AR nucleocytoplasmic trafficking. To further explore the mechanism associated with a. a. 50-250, GFP pull-down assays were performed in C4-2 CRPC cells transfected with GFP tagged a. a. 50-250 of the AR. Mass spectrometry analysis of the pulled down proteins identified poly (A) binding protein cytoplasmic 1 (PABPC1) interaction with this region of the AR. In silicoanalysis of gene expression data revealed PABPC1 up-regulation in prostate cancer tissue specimens and this up-regulation correlates to increased disease recurrence. Co-immunoprecipitation assays confirmed the association of PABPC1 with a. a. 50-250 of the NTD of the AR. Knockdown of PABPC1 decreased nuclear AR protein levels and inhibited androgen activation of the AR target PSA in LNCaP and C4-2 cells. Additionally, knockdown of PABPC1 inhibited transactivation of the PSA promoter by NAR (AR lacking the LBD) and attenuated proliferation of AR-positive prostate cancer cells. These findings suggest that PABPC1 is a novel co-regulator of the AR and may be a potential target for blocking activation of the AR in CRPC.	[Eisermann, Kurtis; Dar, Javid A.; Dong, Jun; Wang, Dan; Masoodi, Khalid Z.; Wang, Zhou] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15260 USA; [Wang, Zhou] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Wang, Zhou] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA USA; [Dar, Javid A.] King Saud Univ, Coll Sci, Cent Lab, Riyadh 11451, Saudi Arabia; [Masoodi, Khalid Z.] Sher e Kashmir Univ Agr Sci & Technol, Div Biotechnol, Srinagar, Jammu & Kashmir, India	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; King Saud University; Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir (SKUAST Kashmir)	Wang, Z (corresponding author), Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15260 USA.	wangz2@upmc.edu	Masoodi, KhalidZ./ABG-5492-2021; Masoodi, Khalid Z/F-1787-2015; Dar, Javid/D-6276-2015	Masoodi, KhalidZ./0000-0002-4889-5558; Masoodi, Khalid Z/0000-0002-4889-5558; Dar, Javid/0000-0002-4102-6202	National Institutes of Health [R01 CA186780, R01 DK088793, T32 DK007774, P30 CA047904]; NATIONAL CANCER INSTITUTE [R01CA186780, P30CA047904] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088793, T32DK007774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by National Institutes of Health grants R01 CA186780, R01 DK088793, T32 DK007774, and P30 CA047904 (ZW). KE is a postdoctoral scholar supported by T32 DK007774. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Claessens Frank, 2008, Nucl Recept Signal, V6, pe008, DOI 10.1621/nrs.06008; Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P148, DOI 10.1210/me.11.2.148; Dar JA, 2014, J STEROID BIOCHEM, V139, P16, DOI 10.1016/j.jsbmb.2013.09.013; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dehm SM, 2011, ENDOCR-RELAT CANCER, V18, pR183, DOI 10.1530/ERC-11-0141; Eisermann K, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-7; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Klotz Laurence, 2005, Clin Prostate Cancer, V3, P215, DOI 10.3816/CGC.2005.n.002; LABRIE F, 1993, CLIN INVEST MED, V16, P499; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; McEwan Iain J, 2007, Nucl Recept Signal, V5, pe001; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schellhammer Paul F, 2002, Expert Opin Pharmacother, V3, P1313, DOI 10.1517/14656566.3.9.1313; Scher HI, 1997, J CLIN ONCOL, V15, P2928, DOI 10.1200/JCO.1997.15.8.2928; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; See WA, 2002, J UROLOGY, V168, P429, DOI 10.1016/S0022-5347(05)64652-6; Sen A, 2012, J CLIN INVEST, V122, P2469, DOI 10.1172/JCI62044; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thomas MA, 2010, BIOCHEM J, V425, P575, DOI 10.1042/BJ20091109; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; Vanaja DK, 2003, CANCER RES, V63, P3877; Woods AJ, 2002, J BIOL CHEM, V277, P6428, DOI 10.1074/jbc.M109446200; Woods AJ, 2005, MOL CELL BIOL, V25, P3763, DOI 10.1128/MCB.25.9.3763-3773.2005; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	33	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0128495	10.1371/journal.pone.0128495	http://dx.doi.org/10.1371/journal.pone.0128495			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176602	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000358197600007
J	Gu, RP; Fu, LL; Jiang, CH; Xu, YF; Wang, X; Yu, J				Gu, R. P.; Fu, L. L.; Jiang, C. H.; Xu, Y. F.; Wang, X.; Yu, J.			Retina Is Protected by Neuroserpin from Ischemic/Reperfusion-Induced Injury Independent of Tissue-Type Plasminogen Activator	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; ISCHEMIA-REPERFUSION INJURY; BLOOD-BRAIN-BARRIER; NERVOUS-SYSTEM; RAT RETINA; INHIBITOR NEUROSERPIN; CELL-DEATH; STROKE; TPA; MODEL	The purpose of the present study was to investigate the potential neuroprotective effect of neuroserpin (NSP) on acute retinal ischemic/reperfusion-induced (IR) injury. An IR injury model was established by elevating intraocular pressure (IOP) for 60 minutes in wild type and tPA-deficient (tPA-/-) mice. Prior to IR injury, 1 mu L of 20 mu mol/L NSP or an equal volume of bovine serum albumin (BSA) was intravitreally administered. Retinal function was evaluated by electroretinograph (ERG) and the number of apoptotic neurons was determined via TUNEL labeling. Caspase-3, -8, -9, poly (ADP-ribose) polymerase (PARP) and their cleaved forms were subsequently analyzed. It was found that IR injury significantly damaged retinal function, inducing apoptosis in the retina, while NSP attenuated the loss of retinal function and significantly reduced the number of apoptotic neurons in both wild type and tPA-/-mice. The levels of cleaved caspase-3, cleaved PARP (the substrate of caspase-3) and caspase-9 (the modulator of the caspase-3), which had increased following IR injury, were significantly inhibited by NSP in both wild type and tPA(-/-)mice. NSP increased ischemic tolerance in the retina at least partially by inhibiting the intrinsic cell death signaling pathway of caspase-3. It was therefore concluded that the protective effect of neuroserpin maybe independent from its canonical interaction with a tissue-type plasminogen activator.	[Gu, R. P.; Jiang, C. H.; Xu, Y. F.; Wang, X.; Yu, J.] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Vis Sci,State Hlth Minist, Shanghai 200031, Peoples R China; [Gu, R. P.; Jiang, C. H.; Xu, Y. F.; Wang, X.; Yu, J.] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Key Lab Myopia,State Hlth Minist, Shanghai 200031, Peoples R China; [Fu, L. L.] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Ophthalmol, Wuhan 430074, Peoples R China; [Jiang, C. H.] 5 Peoples Hosp Shanghai, Dept Ophthalmol, Shanghai 200240, Peoples R China	Fudan University; Fudan University; Huazhong University of Science & Technology	Jiang, CH (corresponding author), Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Vis Sci,State Hlth Minist, Shanghai 200031, Peoples R China.	chhjiang70@163.com			Science and Technology Ministry of China [2012YQ12008003]; National Major Scientific Equipment program [2012YQ120080]; Shanghai Key Laboratory of Visual Impairment and Restoration; Shanghai Science and Technology Committee program [13430710500]	Science and Technology Ministry of China(Ministry of Science and Technology, China); National Major Scientific Equipment program; Shanghai Key Laboratory of Visual Impairment and Restoration; Shanghai Science and Technology Committee program	The present study was supported by a project of the Science and Technology Ministry of China (2012YQ12008003), the National Major Scientific Equipment program (2012YQ120080), Shanghai Key Laboratory of Visual Impairment and Restoration, and Shanghai Science and Technology Committee program (13430710500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Benchenane K, 2007, J CELL SCI, V120, P578, DOI 10.1242/jcs.03354; BU GJ, 1993, J BIOL CHEM, V268, P13002; Chen FT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064262; Chen SN, 2003, OPHTHALMOLOGY, V110, P704, DOI 10.1016/S0161-6420(02)01979-6; Cinelli P, 2001, MOL CELL NEUROSCI, V18, P443, DOI 10.1006/mcne.2001.1028; D'Onofrio PM, 2013, ACTA PHARMACOL SIN, V34, P91, DOI 10.1038/aps.2012.165; DENT MAR, 1993, EUR J NEUROSCI, V5, P633, DOI 10.1111/j.1460-9568.1993.tb00529.x; Gelderblom M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063118; Gonzalez RG, 2013, STROKE, V44, P3109, DOI 10.1161/STROKEAHA.113.001938; Hanninen VA, 2002, CURR EYE RES, V25, P389; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; Hattenbach LO, 1999, RETINA-J RET VIT DIS, V19, P383, DOI 10.1097/00006982-199909000-00003; Hill RM, 2001, PROTEIN EXPRES PURIF, V22, P406, DOI 10.1006/prep.2001.1463; Hsiao Y, 2008, J GASTROEN HEPATOL, V23, pE258, DOI 10.1111/j.1440-1746.2007.05100.x; Huang P, 2013, EXP EYE RES, V115, P131, DOI 10.1016/j.exer.2013.06.015; HUGHES WF, 1991, EXP EYE RES, V53, P573, DOI 10.1016/0014-4835(91)90215-Z; Husain S, 2011, INVEST OPHTH VIS SCI, V52, P2577, DOI 10.1167/iovs.10-5629; JOHNSON RN, 1989, ARCH OPHTHALMOL-CHIC, V107, P891, DOI 10.1001/archopht.1989.01070010913040; Kermer P, 2000, MOL BRAIN RES, V85, P144, DOI 10.1016/S0169-328X(00)00256-4; Kim YR, 2013, INT J MOL MED, V32, P1303, DOI 10.3892/ijmm.2013.1511; Krueger SR, 1997, J NEUROSCI, V17, P8984; Lee TW, 2008, J NEUROSCI RES, V86, P1243, DOI 10.1002/jnr.21592; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; Ma J, 2012, BIOL RES, V45, P357, DOI 10.4067/S0716-97602012000400005; Makarova A, 2003, J BIOL CHEM, V278, P50250, DOI 10.1074/jbc.M309150200; Millard WB, 2013, ANN EMERG MED, V62, p13A, DOI 10.1016/j.annemergmed.2013.05.010; Mitka M, 2013, JAMA-J AM MED ASSOC, V310, P1111, DOI 10.1001/jama.2013.278292; Mohr S, 2002, DIABETES, V51, P1172, DOI 10.2337/diabetes.51.4.1172; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Osterwalder T, 1996, EMBO J, V15, P2944, DOI 10.1002/j.1460-2075.1996.tb00657.x; Parathath SR, 2006, J CELL SCI, V119, P339, DOI 10.1242/jcs.02734; Rodriguez-Gonzalez R, 2011, THROMB HAEMOSTASIS, V105, P421, DOI 10.1160/TH10-09-0621; Rodriguez-Gonzalez R, 2011, NEUROCHEM INT, V58, P337, DOI 10.1016/j.neuint.2010.12.006; Shima C, 2012, OPHTHALMIC RES, V48, P199, DOI 10.1159/000340059; Shu Q, 2014, J MOL NEUROSCI; SUMI Y, 1992, DEVELOPMENT, V116, P625; Sun D, 2007, J COMP NEUROL, V505, P114, DOI 10.1002/cne.21481; Tian Y, 2014, INT J MOL SCI, V15, P3172, DOI 10.3390/ijms15023172; Vote BJ, 2004, RETINA-J RET VIT DIS, V24, P808, DOI 10.1097/00006982-200410000-00024; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Wu B, 2004, AM J PHYSIOL-GASTR L, V286, pG580, DOI 10.1152/ajpgi.00335.2003; Wu JL, 2010, AM J PATHOL, V177, P2576, DOI 10.2353/ajpath.2010.100466; Yamamoto T, 2008, GRAEF ARCH CLIN EXP, V246, P509, DOI 10.1007/s00417-007-0670-x; Yang Y, 2011, INT J OPHTHALMOL-CHI, V4, P259, DOI 10.3980/j.issn.2222-3959.2011.03.09; Yepes M, 2004, EXP BIOL MED, V229, P1097, DOI 10.1177/153537020422901103; Yepes M, 2004, TRENDS CARDIOVAS MED, V14, P173, DOI 10.1016/j.tcm.2004.03.004; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Yepes M, 2002, J CLIN INVEST, V109, P1571, DOI 10.1172/JCI200214308; Yepes M, 2000, BLOOD, V96, P569; Zhang ZG, 2002, CIRCULATION, V106, P740, DOI 10.1161/01.CIR.0000023942.10849.41	51	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130440	10.1371/journal.pone.0130440	http://dx.doi.org/10.1371/journal.pone.0130440			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176694	Green Submitted, gold, Green Published			2022-12-27	WOS:000358197600023
J	Oh, YJ; An, JN; Kim, CT; Yang, SH; Lee, H; Kim, DK; Joo, KW; Paik, JH; Kang, SW; Park, JT; Lim, CS; Kim, YS; Lee, JP				Oh, Yun Jung; An, Jung Nam; Kim, Clara Tammy; Yang, Seung Hee; Lee, Hajeong; Kim, Dong Ki; Joo, Kwon Wook; Paik, Jin Ho; Kang, Shin-Wook; Park, Jung Tak; Lim, Chun Soo; Kim, Yon Su; Lee, Jung Pyo			Circulating Tumor Necrosis Factor a Receptors Predict the Outcomes of Human IgA Nephropathy: A Prospective Cohort Study	PLOS ONE			English	Article							EXPERIMENTAL CRESCENTIC GLOMERULONEPHRITIS; CHRONIC-RENAL-FAILURE; TNF-ALPHA; KIDNEY-FUNCTION; GLOMERULAR-DISEASES; EPITHELIAL-CELLS; INFLAMMATION; PROGRESSION; DYSFUNCTION; EXPRESSION	The circulating tumor necrosis factor receptors (TNFRs) could predict the long-term renal outcome in diabetes, but the role of circulating TNFRs in other chronic kidney disease has not been reported. Here, we investigated the correlation between circulating TNFRs and renal histologic findings on kidney biopsy in IgA nephropathy (IgAN) and assessed the notion that the circulating TNFRs could predict the clinical outcome. 347 consecutive biopsy-proven IgAN patients between 2006 and 2012 were prospectively enrolled. Concentrations of circulating TNFRs were measured using serum samples stored at the time of biopsy. The primary clinical endpoint was the decline of estimated glomerular filtration rate (eGFR; >= 30% decline compared to baseline). Mean eGFR decreased and proteinuria worsened proportionally as circulating TNFR1 and TNFR2 increased (P < 0.001). Tubuloin-terstitial lesions such as interstitial fibrosis and tubular atrophy were significantly more severe as concentrations of circulating TNFRs increased, regardless of eGFR levels. The risks of reaching the primary endpoint were significantly higher in the highest quartile of TNFRs compared with other quartiles by the Cox proportional hazards model (TNFR1; hazard ratio 7.48, P < 0.001, TNFR2; hazard ratio 2.51, P = 0.021). In stratified analysis according to initial renal function classified by the eGFR levels of 60 mL/min/1.73 m(2), TNFR1 and TNFR2 were significant predictors of renal progression in both subgroups. In conclusion, circulating TNFRs reflect the histology and clinical severity of IgAN. Moreover, elevated concentrations of circulating TNFRs at baseline are early biomarkers for subsequent renal progression in IgAN patients.	[Oh, Yun Jung] Cheju Halla Gen Hosp, Dept Internal Med, Jeju, South Korea; [An, Jung Nam; Lim, Chun Soo; Lee, Jung Pyo] Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea; [An, Jung Nam; Lee, Hajeong; Kim, Dong Ki; Joo, Kwon Wook; Lim, Chun Soo; Kim, Yon Su; Lee, Jung Pyo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Clara Tammy] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Yang, Seung Hee] Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea; [Paik, Jin Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Kang, Shin-Wook; Park, Jung Tak] Yonsei Univ, Coll Med, Dept Internal Med, Severance Biomed Sci Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System	Lee, JP (corresponding author), Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea.	nephrolee@gmail.com	Kim, Dong Ki/J-5389-2012	Kim, Dong Ki/0000-0002-5195-7852; Kim, Clara Tammy/0000-0001-7381-7044; Park, Jung Tak/0000-0002-2325-8982	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A070001]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea	This study was funded by the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A070001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lamki RS, 2005, FASEB J, V19, P1637, DOI 10.1096/fj.05-3841com; Al-Lamki RS, 2001, LAB INVEST, V81, P1503, DOI 10.1038/labinvest.3780364; ALAMARTINE E, 1991, AM J KIDNEY DIS, V18, P12, DOI 10.1016/S0272-6386(12)80284-8; Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; BERTANI T, 1989, AM J PATHOL, V134, P419; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; BEUKHOF JR, 1986, KIDNEY INT, V29, P549, DOI 10.1038/ki.1986.33; Bolton CH, 2001, NEPHROL DIAL TRANSPL, V16, P1189, DOI 10.1093/ndt/16.6.1189; Carlsson AC, 2014, J AM SOC NEPHROL, V25, P1313, DOI 10.1681/ASN.2013080860; Chan LYY, 2005, KIDNEY INT, V67, P602, DOI 10.1111/j.1523-1755.2005.67116.x; Chang JH, 2009, NEPHROL DIAL TRANSPL, V24, P2406, DOI 10.1093/ndt/gfp091; DAMICO G, 1995, AM J KIDNEY DIS, V26, P124, DOI 10.1016/0272-6386(95)90165-5; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Ernandez T, 2009, KIDNEY INT, V76, P262, DOI 10.1038/ki.2009.142; Feldmann M, 2006, J AM SOC NEPHROL, V17, P1243, DOI 10.1681/ASN.2005121359; Frimat L, 1997, NEPHROL DIAL TRANSPL, V12, P2569; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Grell M, 1998, EUR J IMMUNOL, V28, P257, DOI 10.1002/(SICI)1521-4141(199801)28:01<257::AID-IMMU257>3.0.CO;2-G; Guo GJ, 1999, AM J PHYSIOL-RENAL, V277, pF766, DOI 10.1152/ajprenal.1999.277.5.F766; Hasegawa M, 2009, NEPHRON CLIN PRACT, V113, pC222, DOI 10.1159/000235242; Idasiak-Piechocka I, 2010, NEPHROL DIAL TRANSPL, V25, P3948, DOI 10.1093/ndt/gfq310; ISHA N, 1989, J IMMUNOL, V142, P3083; Julian B A, 1999, Adv Nephrol Necker Hosp, V29, P53; Karkar AM, 2001, NEPHROL DIAL TRANSPL, V16, P518, DOI 10.1093/ndt/16.3.518; Keller C, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-9; Khan SB, 2005, KIDNEY INT, V67, P1812, DOI 10.1111/j.1523-1755.2005.00279.x; Knight EL, 2004, J AM SOC NEPHROL, V15, P1897, DOI 10.1097/01.asn.0000128966.55133.69; Kollias G, 2002, CYTOKINE GROWTH F R, V13, P315, DOI 10.1016/S1359-6101(02)00019-9; Krolewski AS, 2014, DIABETES CARE, V37, P226, DOI 10.2337/dc13-0985; Lai KN, 2008, AM J PHYSIOL-RENAL, V294, pF945, DOI 10.1152/ajprenal.00423.2007; Lee H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051225; Lee HS, 2005, NEPHROL DIAL TRANSPL, V20, P342, DOI 10.1093/ndt/gfh633; Lee JP, 2011, AM J PHYSIOL-RENAL, V300, pF1283, DOI 10.1152/ajprenal.00733.2010; Lee SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104354; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lopes-Virella MF, 2013, DIABETES CARE, V36, P2317, DOI 10.2337/dc12-2521; Miyazawa I, 2011, DIABETES RES CLIN PR, V92, P174, DOI 10.1016/j.diabres.2011.01.008; NEALE TJ, 1995, AM J PATHOL, V146, P1444; NICHOLLS KM, 1984, Q J MED, V53, P227; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Niewczas MA, 2009, CLIN J AM SOC NEPHRO, V4, P62, DOI 10.2215/CJN.03010608; PEREIRA BJG, 1994, KIDNEY INT, V45, P890, DOI 10.1038/ki.1994.117; Pfeffer K, 2003, CYTOKINE GROWTH F R, V14, P185, DOI 10.1016/S1359-6101(03)00022-4; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Richter C, 2012, MOL CELL BIOL, V32, P2515, DOI 10.1128/MCB.06458-11; Sonoda Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122212; Speeckaert MM, 2012, AM J NEPHROL, V36, P261, DOI 10.1159/000342333; Upadhyay A, 2011, NEPHROL DIAL TRANSPL, V26, P920, DOI 10.1093/ndt/gfq471; Vielhauer V, 2005, J CLIN INVEST, V115, P1199, DOI 10.1172/JCI200523348; Wu TF, 2007, J IMMUNOL, V179, P7166, DOI 10.4049/jimmunol.179.10.7166; Wu TF, 2007, ARTHRITIS RHEUM-US, V56, P949, DOI 10.1002/art.22556; Xie JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038904; Zhu L, 2009, LUPUS, V18, P116, DOI 10.1177/0961203308094764	53	19	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132826	10.1371/journal.pone.0132826	http://dx.doi.org/10.1371/journal.pone.0132826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177311	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600165
J	Pan, LY; Weng, HB; Li, H; Liu, ZZ; Xu, YY; Zhou, CJ; Lu, XX; Su, XY; Zhang, YY; Chen, DF				Pan, Lingyu; Weng, Hongbo; Li, Hong; Liu, Zhenzhen; Xu, Yanyan; Zhou, Chunjiao; Lu, Xiaoxiao; Su, Xiaoyu; Zhang, Yunyi; Chen, Daofeng			Therapeutic Effects of Bupleurum Polysaccharides in Streptozotocin Induced Diabetic Mice	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; OXIDATIVE STRESS; CATATHELASMA-VENTRICOSUM; HYPERGLYCEMIA; INFLAMMATION; SELENIUM; INSULIN; ROOTS	Diabetes mellitus is related to low-grade chronic inflammation and oxidative stress. Bupleurum Polysaccharides (BPs), isolated from Bupleurum smithii var. parvifolium has anti-inflammatory and anti-oxidative properties. However, little is known about its therapeutic effects on diabetes. In this experiment, the effects of BPs on alleviation of diabetes and the underlying mechanisms were investigated. Diabetic mice model was established via successive intraperitoneal injections of streptozotocin (100 mg/kg body weight) for two days. Mice with blood glucose levels higher than 16.8mmol/L were selected for experiments. The diabetic mice were orally administered with BPs (30 and 60 mg/kg) once a day for 35 days. BPs not only significantly decreased levels of blood glucose, but also increased those of serum insulin and liver glycogen in diabetic mice compared to model mice. Additionally, BPs adminstration improved the insulin expression and suppressed the apoptosis in pancreas of the diabetic mice. Histopathological observations further demonstrated that BPs protected the pancreas and liver from oxidative and inflammatory damages. These results suggest that BPs protect pancreatic beta cells and liver hepatocytes and ameliorate diabetes, which is associated with its anti-oxidative and anti-inflammatory properties.	[Pan, Lingyu; Weng, Hongbo; Li, Hong; Liu, Zhenzhen; Xu, Yanyan; Zhou, Chunjiao; Lu, Xiaoxiao; Su, Xiaoyu; Zhang, Yunyi] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China; [Chen, Daofeng] Fudan Univ, Sch Pharm, Dept Pharmacognosy, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Li, H (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China.	lxzhang@shmu.edu.cn; dfchen@shmu.edu.cn	hong, li/T-6392-2019		National Natural Science Foundation of China [30925042, 81330089, 81274165]; State Key Program for New Drugs from the Ministry of Science and Technology, China [2012ZX09301001-003]; Science and Technology Commission of Shanghai Municipality [10XD1405900, 12JC1400800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program for New Drugs from the Ministry of Science and Technology, China; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China (Grant No. 30925042, 81330089, 81274165), the State Key Program for New Drugs from the Ministry of Science and Technology, China (Grant No. 2012ZX09301001-003), and the Science and Technology Commission of Shanghai Municipality (Grant No. 10XD1405900, 12JC1400800). The authors are fully responsible for the content of this report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronoff S.L, 2004, DIABETES SPECTR, V17, P183, DOI [DOI 10.2337/DIASPECT.17.3.183, 10.2337/diaspect.17.3.183]; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN V, 1982, CAN J PHYSIOL PHARM, V60, P1251, DOI 10.1139/y82-183; Cheng XQ, 2010, J ETHNOPHARMACOL, V130, P363, DOI 10.1016/j.jep.2010.05.019; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Formigare A, 2007, COMP BIOCHEM PHYS C, V146, P443, DOI 10.1016/j.cbpc.2007.07.010; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; Goodman L, 1941, ANESTHESIOLOGY, V2, P341; He K, 2011, J ETHNOPHARMACOL, V137, P1135, DOI 10.1016/j.jep.2011.07.033; Hu FD, 2010, CAN J PHYSIOL PHARM, V88, P64, DOI 10.1139/Y09-098; Jia W, 2003, PHYTOTHER RES, V17, P1127, DOI 10.1002/ptr.1398; Jiang YW, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/842928; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; KATZ J, 1979, BIOCHEM J, V180, P389, DOI 10.1042/bj1800389; Kawahito S, 2009, WORLD J GASTROENTERO, V15, P4137, DOI 10.3748/wjg.15.4137; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603; Leckstrom A, 1996, PANCREAS, V13, P259, DOI 10.1097/00006676-199610000-00008; Li WL, 2004, J ETHNOPHARMACOL, V92, P1, DOI 10.1016/j.jep.2003.12.031; Li YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065892; Lin B, 2010, CHINESE JOURNEY CLIN, P6; Liu M, 2010, J ETHNOPHARMACOL, V127, P32, DOI 10.1016/j.jep.2009.09.055; Liu YT, 2013, FOOD CHEM TOXICOL, V62, P285, DOI 10.1016/j.fct.2013.08.082; Liu YT, 2013, FOOD CHEM TOXICOL, V57, P39, DOI 10.1016/j.fct.2013.03.001; Lontchi-Yimagou E, 2013, CURR DIABETES REP, V13, P435, DOI 10.1007/s11892-013-0375-y; Ma SW, 2008, DIABETES OBES METAB, V10, P1125, DOI 10.1111/j.1463-1326.2008.00858.x; Okada S, 2003, DIABETES, V52, P2586, DOI 10.2337/diabetes.52.10.2586; Pitocco D, 2013, INT J MOL SCI, V14, P21525, DOI 10.3390/ijms141121525; PRESTON AM, 1985, NUTR RES, V5, P435, DOI 10.1016/S0271-5317(85)80228-1; Rotondo F, IMMUNOHISTOCHEMICAL, P303; Ryu M, 2008, J ETHNOPHARMACOL, V115, P184, DOI 10.1016/j.jep.2007.09.027; Serrano-Martin X, 2006, ANTIMICROB AGENTS CH, V50, P4214, DOI 10.1128/AAC.00617-06; Wang Z, 2009, J ETHNOPHARMACOL, V124, P481, DOI 10.1016/j.jep.2009.05.013; Wu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078051; Xie W, 2011, DIABETES OBES METAB, V13, P289, DOI 10.1111/j.1463-1326.2010.01336.x; Xu H, 2007, INT IMMUNOPHARMACOL, V7, P175, DOI 10.1016/j.intimp.2006.09.006; Yang SJ, 2014, EUR J PHARMACOL, V736, P26, DOI 10.1016/j.ejphar.2014.04.031; Zeng JH, 2009, J NUTR BIOCHEM, V20, P530, DOI 10.1016/j.jnutbio.2008.05.012; Zhang TT, 2012, EXPERT OPIN INV DRUG, V21, P1625, DOI 10.1517/13543784.2012.713937; Zhang T, 2014, INT J BIOL MACROMOL, V65, P436, DOI 10.1016/j.ijbiomac.2014.01.063; Zhang ZG, 2008, MOL ENDOCRINOL, V22, P186, DOI 10.1210/me.2007-0119; Zhao LY, 2011, PHYTOMEDICINE, V18, P661, DOI 10.1016/j.phymed.2011.01.001; Zhen Z, 2011, AM J CHINESE MED, V39, P53, DOI 10.1142/S0192415X11008646	44	10	10	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133212	10.1371/journal.pone.0133212	http://dx.doi.org/10.1371/journal.pone.0133212			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176625	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600232
J	Tashima, R; Nishimura, R; Osako, T; Nishiyama, Y; Okumura, Y; Nakano, M; Fujisue, M; Toyozumi, Y; Arima, N				Tashima, Rumiko; Nishimura, Reiki; Osako, Tomofumi; Nishiyama, Yasuyuki; Okumura, Yasuhiro; Nakano, Masahiro; Fujisue, Mamiko; Toyozumi, Yasuo; Arima, Nobuyuki			Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study	PLOS ONE			English	Article							CHEMOTHERAPY; PREDICTOR; WOMEN; KI67; RECURRENCE; EXPRESSION; FEATURES; MARKERS; HER2; P53	The Ki-67 index is an important biomarker for indicating the proliferation of cancer cells and is considered to be an effective prognostic factor for breast cancer. However, a standard cut-off point for the Ki-67 index has not yet been established. Therefore, the aim of this retrospective study was to determine an optimal cut-off point in order to establish it as a more accurate prognostic factor. Immunohistochemical analysis of the Ki-67 index was performed on 4329 patients with primary breast cancer from August 1987 to March 2012. Out of this sample, there were 3186 consecutive cases from September 1997 with simultaneous evaluations of ER, PgR and HER2 status. Cox's proportional hazard model was used to perform univariate and multivariate analyses of the factors related to OS. The hazard ratios (HR) and the p values were then compared to determine the optimal cut-off point for the Ki-67 index. The median Ki-67 index value was 20.5% (mean value 26.2%). The univariate analysis revealed that there was a statistically significant negative correlation with DFS and OS and the multivariate analysis revealed that the Ki-67 index value was a significant factor for DFS and OS. The top seven cut-off points were then carefully chosen based on the results of the univariate analysis using the lowest p-values and the highest HR as the main selection criteria. The multivariate analysis of the factors for OS showed that the cut-off point of 20% had the highest HR in all of the cases. However, the cutoff point of 20% was only a significant factor for OS in the Luminal/HER2-subtype. There was no correlation between the Ki-67 index value and OS in any of the other subtypes. These data indicate that the optimal cut-off point of 20% is the most effective prognostic factor for Luminal/HER2-breast cancer.	[Tashima, Rumiko] Kumamoto City Hosp, Surg, Kumamoto, Japan; [Nishimura, Reiki; Osako, Tomofumi; Nishiyama, Yasuyuki; Nakano, Masahiro; Fujisue, Mamiko] Kumamoto City Hosp, Breast & Endocrine Surg, Kumamoto, Japan; [Okumura, Yasuhiro; Toyozumi, Yasuo; Arima, Nobuyuki] Kumamoto City Hosp, Pathol, Kumamoto, Japan		Nishimura, R (corresponding author), Kumamoto City Hosp, Breast & Endocrine Surg, Kumamoto, Japan.	j_nishimura2002@yahoo.co.jp						Aleskandarany MA, 2010, INT J CANCER, V126, P1761, DOI 10.1002/ijc.24860; Arima N, 2013, CANC RES S, V15, P24; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Denkert C, 2013, ANN ONCOL, P1; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1; Fasching PA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-486; Finek J, 2007, ANTICANCER RES, V27, P1893; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2011, ANN ONCOL, V23, P2997; Gong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054912; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Honma N, 2013, BREAST CANC, V12; Kai Kazuharu, 2006, Int J Clin Oncol, V11, P426, DOI 10.1007/s10147-006-0601-6; Kikuchi S, 2013, ANTICANCER RES, V33, P3891; Nishimura R, 2013, ONCOLOGY-BASEL, V85, P100, DOI 10.1159/000353099; Nishimura R, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-131; Nishimura R, 2010, EXP THER MED, V1, P747, DOI 10.3892/etm.2010.133; Nishimura R, 2010, BREAST CANCER-TOKYO, V17, P269, DOI 10.1007/s12282-009-0161-5; Penault-Llorca F, 2009, J CLIN ONCOL, V27, P2809, DOI 10.1200/JCO.2008.18.2808; Reyal F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055901; Ruiz C, 2006, INT J CANCER, V118, P2190, DOI 10.1002/ijc.21581; Senkus E, 2013, ANN ONCOL, V24, P7, DOI 10.1093/annonc/mdt284; Taktak AFG, 2008, COMPUT BIOL MED, V38, P785, DOI 10.1016/j.compbiomed.2008.04.005; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124	28	44	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0119565	10.1371/journal.pone.0119565	http://dx.doi.org/10.1371/journal.pone.0119565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177501	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600003
J	Vickers, TW; Sanchez, JN; Johnson, CK; Morrison, SA; Botta, R; Smith, T; Cohen, BS; Huber, PR; Ernest, HB; Boyce, WM				Vickers, T. Winston; Sanchez, Jessica N.; Johnson, Christine K.; Morrison, Scott A.; Botta, Randy; Smith, Trish; Cohen, Brian S.; Huber, Patrick R.; Ernest, Holly B.; Boyce, Walter M.			Survival and Mortality of Pumas (Puma concolor) in a Fragmented, Urbanizing Landscape	PLOS ONE			English	Article							MOUNTAIN LION POPULATION; GENETIC RESTORATION; CONSERVATION; COUGARS; CONNECTIVITY; CARNIVORES; DYNAMICS; GROWTH; MODEL	Wide-ranging large carnivores pose myriad challenges for conservation, especially in highly fragmented landscapes. Over a 13-year period, we combined monitoring of radio collared pumas (Puma concolor) with complementary multi-generational genetic analyses to inform puma conservation in southern California, USA. Our goals were to generate survivorship estimates, determine causes of mortality, identify barriers to movement, and determine the genetic and demographic challenges to puma persistence among >20,000,000 people and extensive urban, suburban, and exurban development. Despite protection from hunting, annual survival for radio collared pumas was surprisingly low (55.8%), and humans caused the majority of puma deaths. The most common sources of mortality were vehicle collisions (28% of deaths), and mortalities resulting from depredation permits issued after pumas killed domestic animals (17% of deaths). Other human-caused mortalities included illegal shootings, public safety removals, and human-caused wildfire. An interstate highway (I-15) bisecting this study area, and associated development, have created a nearly impermeable barrier to puma movements, resulting in severe genetic restriction and demographic isolation of the small puma population (n similar to 17-27 adults) in the Santa Ana Mountains west of I-15. Highways that bisect habitat or divide remaining "conserved" habitat, and associated ongoing development, threaten to further subdivide this already fragmented puma population and increase threats to survival. This study highlights the importance of combining demographic and genetic analyses, and illustrates that in the absence of effective measures to reduce mortality and enhance safe movement across highways, translocation of pumas, such as was done with the endangered Florida panther (P. c. coryi), may ultimately be necessary to prevent further genetic decline and ensure persistence of the Santa Ana Mountains population.	[Vickers, T. Winston; Sanchez, Jessica N.; Johnson, Christine K.; Ernest, Holly B.; Boyce, Walter M.] Univ Calif Davis, Sch Vet Med, Karen C Drayer Wildlife Hlth Ctr, Davis, CA 95616 USA; [Morrison, Scott A.; Smith, Trish; Cohen, Brian S.] Nature Conservancy, San Francisco, CA USA; [Botta, Randy] Calif Dept Fish & Wildlife, Valley Ctr, CA USA; [Huber, Patrick R.] Univ Calif Davis, Environm Informat Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; Nature Conservancy; University of California System; University of California Davis	Vickers, TW (corresponding author), Univ Calif Davis, Sch Vet Med, Karen C Drayer Wildlife Hlth Ctr, Davis, CA 95616 USA.	twvickers@ucdavis.edu; wmboyce@ucdavis.edu	; Ernest, Holly/D-5731-2012	Sanchez, Jessica/0000-0002-7689-0324; Ernest, Holly/0000-0002-0205-8818	California State Department of Parks and Recreation; California Department of Fish and Wildlife; Nature Conservancy; McBeth Foundation; Anza Borrego Foundation; Nature Reserve of Orange County; National Science Foundation; Foothill/Eastern Transportation Corridor Agency; San Diego County Association of Governments Environmental Mitigation Program; San Diego Foundation; Felidae Conservation Fund; Mountain Lion Foundation; Santa Rosa Plateau Foundation; Institute for Wildlife Studies; private donors	California State Department of Parks and Recreation; California Department of Fish and Wildlife; Nature Conservancy; McBeth Foundation; Anza Borrego Foundation; Nature Reserve of Orange County; National Science Foundation(National Science Foundation (NSF)); Foothill/Eastern Transportation Corridor Agency; San Diego County Association of Governments Environmental Mitigation Program; San Diego Foundation; Felidae Conservation Fund; Mountain Lion Foundation; Santa Rosa Plateau Foundation; Institute for Wildlife Studies; private donors	The work was supported by the following: California State Department of Parks and Recreation (WMB; http://www.parks.ca.gov/), California Department of Fish and Wildlife (WMB; https://www.dfg.ca.gov/), The Nature Conservancy (WMB, TWV, SAM, HBE; http://www.nature.org/), The McBeth Foundation (WMB, TWV; http://mcbethfoundation.com/), The Anza Borrego Foundation (WMB; http://theabf.org/), The Nature Reserve of Orange County (TWV, HBE, WMB; http://www.naturereserveoc.org/), The National Science Foundation (WMB; http://www.nsf.gov/), The Foothill/Eastern Transportation Corridor Agency (TWV, WMB, PRH; https://www.thetollroads.com/), San Diego County Association of Governments Environmental Mitigation Program (TWV, WMB; http://www.sandag.org/index.asp?classid=17&projectid=263&fuseaction=projects.detail), The San Diego Foundation (TWV; http://www.sdfoundation.org/), Felidae Conservation Fund (WMB, TWV; http://www.felidaefund.org/), The Mountain Lion Foundation (TWV; Http://www.mountainlion.org/), the Santa Rosa Plateau Foundation (TWV; http://www.srpf.org/), the Institute for Wildlife Studies (TWV; http://www.iws.org), and private donors. The Nature Conservancy (SAM, TS) helped with study design, as well as sample collection, analysis, and preparation of the manuscript (SAM, TS, BSC). California Department of Fish and Wildlife (RB), helped with sample and data collection. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambient Communities, 2014, VILL W; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Ashman D, 1983, W4815 NEV FISH GAM D; Bauer JW, 2005, SOUTHWEST NAT, V50, P466, DOI 10.1894/0038-4909(2005)050[0466:SBIP]2.0.CO;2; Beier P, 2006, J WILDLIFE MANAGE, V70, P236, DOI 10.2193/0022-541X(2006)70[236:ESIATF]2.0.CO;2; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; Beier P, 1993, COUGAR SANTA ANA MOU; Boucly C, 2013, ORANGE COUNTY REGIST; BRESLOW N, 1974, BIOMETRICS, V30, P89, DOI 10.2307/2529620; Burdett CL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00005.1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; California Department of Fish and Wildlife, 2014, NAT COMM CONS PLANN; California Department of Fish and Wildlife, 2014, MOUNT LION DEPR STAT; California Department of Fish and Wildlife, 2014, KEEP ME WILD; Clark Tim W., 2005, P211; Clevenger AP, 2006, ANAL WILDLIFE UNPUB; Conservation Biology Institute, 2004, CAL BIN CONS I UNPUB; Corlatti L, 2009, CONSERV BIOL, V23, P548, DOI 10.1111/j.1523-1739.2008.01162.x; Cougar Management Guidelines Working Group, 2005, COUG MAN GUID; Crooks K. R., 2006, CONNECTIVITY CONSERV; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Ernest HB, 2003, CONSERV GENET, V4, P353, DOI 10.1023/A:1024069014911; Ernest HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107985; Galetti M, 2013, BIOL CONSERV, V163, P1, DOI 10.1016/j.biocon.2013.04.020; Grinnell J., 1937, FUR BEARING MAMMALS; HEISEY DM, 1985, J WILDLIFE MANAGE, V49, P668, DOI 10.2307/3801692; Hostetler JA, 2013, J ANIM ECOL, V82, P608, DOI 10.1111/1365-2656.12033; Johnson CJ, 2004, J WILDLIFE MANAGE, V68, P966, DOI 10.2193/0022-541X(2004)068[0966:MSAOTA]2.0.CO;2; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Kertson BN, 2013, J MAMMAL, V94, P269, DOI 10.1644/12-MAMM-A-051.1; Kunkel KE, 2013, ANIM CONSERV, V16, P32, DOI 10.1111/j.1469-1795.2012.00568.x; LaPoint S, 2013, LANDSCAPE ECOL, V28, P1615, DOI 10.1007/s10980-013-9910-0; Laundre JW, 2002, J WILDLIFE MANAGE, V66, P849, DOI 10.2307/3803149; Laundre JW, 2000, WILDLIFE SOC B, V28, P963; Logan K.A., 2001, DESERT PUMA EVOLUTIO; Logan KA, 1999, WILDLIFE SOC B, V27, P201; LOGAN KA, 1986, J WILDLIFE MANAGE, V50, P648, DOI 10.2307/3800975; Luke C, 2004, LINKAGE DESIGN UNPUB; McRae BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052604; Miotto RA, 2012, BIOTROPICA, V44, P98, DOI 10.1111/j.1744-7429.2011.00772.x; Mondol S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0496; Morrison SA, 2009, CONSERV BIOL, V23, P275, DOI 10.1111/j.1523-1739.2008.01079.x; Mountain Lion Foundation, 2014, DEF MOUNT DEPR CAL; Noss R, 2006, EVALUATION COAL CANY; Nowell K, 1996, STATUS SURVEY CONSER; Orange County Transportation Corridor Agency, 2013, FOOTH E TRANSP CORR; Ordenana MA, 2010, J MAMMAL, V91, P1322, DOI 10.1644/09-MAMM-A-312.1; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Peters M, 2014, NOTICE PREPARATION D; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Riley SPD, 2014, CURR BIOL, V24, P1989, DOI 10.1016/j.cub.2014.07.029; Riley Seth P.D., 2010, P121; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; Schwab AC, 2011, APPL GEOGR, V31, P859, DOI 10.1016/j.apgeog.2010.10.015; Spencer WD, 2001, GLOBAL REGIONAL ECOL; Storer T. I, 1996, CALIFORNIA GRIZZLY; Teel TL, 2005, 58 CO COL STAT U HUM, P58; Theobald DM, 2005, ECOL SOC, V10; United States Department of Transportation, 2014, MOST TRAV URB HIGHW; US Census Bureau, 2010, 2010 CENS POP HOUS S; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Winterbach HEK, 2013, MAMMAL REV, V43, P89, DOI 10.1111/j.1365-2907.2011.00209.x; Wolfe ML, 2015, BIOL CONSERV, V182, P187, DOI 10.1016/j.biocon.2014.12.008	66	57	57	1	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131490	10.1371/journal.pone.0131490	http://dx.doi.org/10.1371/journal.pone.0131490			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177290	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600045
J	Zhang, CL; Chen, XH; Li, L; Zhou, Y; Wang, C; Hou, SX				Zhang, Chunli; Chen, Xiaohua; Li, Lu; Zhou, Ying; Wang, Chao; Hou, Shuxun			The Association between Telomere Length and Cancer Prognosis: Evidence from a Meta-Analysis	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMA; PREDICTS POOR-PROGNOSIS; COLORECTAL-CANCER; BREAST-CANCER; BLADDER-CANCER; SUSCEPTIBILITY LOCI; TERT-CLPTM1L LOCUS; LUNG-CANCER	Background Telomeres are essential for chromosomal integrity and stability. Shortened telomere length (TL) has been associated with risk of cancers and aging-related diseases. Several studies have explored associations between TL and cancer prognosis, but the results are conflicting. Methods Prospective studies on the relationship between TL and cancer survival were identified by a search of PubMed up to May 25, 2015. There were no restrictions on the cancer type or DNA source. The quality of the included studies was assessed using the Newcastle-Ottawa Scale. Meta-analysis approaches were conducted to determine pooled relative risks and 95% confidence intervals. Results Thirty-three articles containing forty-five independent studies were ultimately involved in our meta-analysis, of which twenty-seven were about overall cancer survival and eighteen were about cancer progression. Short TL was associated with increased cancer mortality risk (RR = 1.30, 95% CI: 1.06-1.59) and poor cancer progression (RR = 1.44, 95% CI: 1.10-1.88), both with high levels of heterogeneity (I-2 = 83.5%, P = 0.012 for overall survival and I-2 = 75.4%, P = 0.008 for progression). TL was an independent predictor of overall cancer survival and progression in chronic lymphocytic leukemia. Besides, short telomeres were also associated with increased colorectal cancer mortality and decreased overall survival of esophageal cancer, but not in other cancers. Cancer progression was associated with TL in Asian and America populations and short TL predicted poor cancer survival in older populations. Compared with tumor tissue cells, TL in blood lymphocyte cells was better for prediction. In addition, the associations remained significant when restricted to studies with adjustments for age, with larger sample sizes, measuring TL using southern blotting or estimating risk effects by hazard ratios. Conclusion Short TL demonstrated a significant association with poor cancer survival, suggesting the potential prognostic significance of TL. Additional large well-designed studies are needed to confirm our findings.	[Zhang, Chunli; Zhou, Ying; Hou, Shuxun] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Inst Orthoped, Beijing, Peoples R China; [Zhang, Chunli; Hou, Shuxun] Chinese Peoples Liberat Army, Sch Med, Beijing, Peoples R China; [Chen, Xiaohua] Peoples Liberat Army, Hosp 161, Dept Lab Med, Wuhan, Peoples R China; [Li, Lu] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Li, Lu] Huazhong Univ Sci & Technol, Minist Environm Protect, Wuhan 430074, Peoples R China; [Li, Lu] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth Incubating, Wuhan 430074, Peoples R China; [Wang, Chao] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Gen Surg, Wuhan 430074, Peoples R China	Chinese People's Liberation Army General Hospital; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhou, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Inst Orthoped, Beijing, Peoples R China.	kendyzhouying@163.com; wangchao75@163.com; ortho304@163.com			Chinese National Natural Science Foundation [81472095]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese National Natural Science Foundation Project. The grant number is 81472095, and for detail information can search on http://npd.nsfc.gov.cn/fundingProjectSearchAction!search.action. YZ received the funding. She had a role in the study design of the manuscript.	Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Augustine TA, 2015, BRIT J CANCER, V112, P313, DOI 10.1038/bjc.2014.561; Bechter OE, 1998, CANCER RES, V58, P4918; Bertorelle R, 2013, BRIT J CANCER, V108, P278, DOI 10.1038/bjc.2012.602; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Borssen M, 2011, EXP HEMATOL, V39, P1144, DOI 10.1016/j.exphem.2011.08.014; Boscolo-Rizzo P, 2015, ORAL ONCOL, V51, P500, DOI 10.1016/j.oraloncology.2015.02.100; Burke LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071121; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chen Y, 2014, ANN ONCOL, V25, P869, DOI 10.1093/annonc/mdu016; Chen Y, 2015, J CANC RES IN PRESS; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; D'Mello MJJ, 2015, CIRC-CARDIOVASC GENE, V8, P82, DOI 10.1161/CIRCGENETICS.113.000485; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Duggan C, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju035; Engelhardt M, 1997, CLIN CANCER RES, V3, P1931; Garcia-Aranda C, 2006, CANCER-AM CANCER SOC, V106, P541, DOI 10.1002/cncr.21625; Gertler R, 2004, J CLIN ONCOL, V22, P1807, DOI 10.1200/JCO.2004.09.160; Gertler R, 2008, CANCER-AM CANCER SOC, V112, P2173, DOI 10.1002/cncr.23419; Gunes C, 2013, CELL, V152, P390, DOI 10.1016/j.cell.2013.01.010; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227; Heaphy CM, 2013, CANCER DISCOV, V3, P1130, DOI 10.1158/2159-8290.CD-13-0135; Huffman KE, 2000, J BIOL CHEM, V275, P19719, DOI 10.1074/jbc.M002843200; Hultdin M, 2003, BRIT J CANCER, V88, P593, DOI 10.1038/sj.bjc.6600763; Jeon HS, 2014, MOL CARCINOGEN, V53, P272, DOI 10.1002/mc.21972; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kinnersley B, 2012, BRIT J CANCER, V107, P1001, DOI 10.1038/bjc.2012.329; Kotsopoulos J, 2014, CANCER EPIDEM BIOMAR, V23, P2603, DOI 10.1158/1055-9965.EPI-14-0885; Li JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093437; Lin J, 2015, CANCER EPIDEM BIOMAR, V24, P336, DOI 10.1158/1055-9965.EPI-14-0992; Liu HQ, 2012, CARCINOGENESIS, V33, P1040, DOI 10.1093/carcin/bgs098; Lotsch D, 2013, NEURO-ONCOLOGY, V15, P423, DOI 10.1093/neuonc/nos329; Lu LG, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2893; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Mansouri L, 2013, AM J HEMATOL, V88, P647, DOI 10.1002/ajh.23466; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Nan HM, 2011, CANCER RES, V71, P6758, DOI 10.1158/0008-5472.CAN-11-1988; Nelson HD, 2012, ANN INTERN MED, V156, P635, DOI 10.7326/0003-4819-156-9-201205010-00006; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pezzolo A, 2015, ONCOTARGET, V6, P7493, DOI 10.18632/oncotarget.2115; Qu FL, 2015, MOL ONCOL, V9, P727, DOI 10.1016/j.molonc.2014.11.008; Rachakonda PS, 2013, P NATL ACAD SCI USA, V110, P17426, DOI 10.1073/pnas.1310522110; Rampazzo E, 2010, BRIT J CANCER, V102, P1300, DOI 10.1038/sj.bjc.6605644; Rampazzo E, 2012, HAEMATOL-HEMATOL J, V97, P56, DOI 10.3324/haematol.2011.049874; Roos G, 2008, BLOOD, V111, P2246, DOI 10.1182/blood-2007-05-092759; Rossi D, 2009, LEUKEMIA, V23, P1062, DOI 10.1038/leu.2008.399; Russo A, 2014, CANCER EPIDEM BIOMAR, V23, P2439, DOI 10.1158/1055-9965.EPI-14-0228; Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008; Shen J, 2012, BREAST CANCER RES TR, V134, P393, DOI 10.1007/s10549-012-2058-9; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Spanoudakis E, 2011, LEUKEMIA RES, V35, P459, DOI 10.1016/j.leukres.2010.07.042; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; Svenson U, 2009, CANCER RES, V69, P2896, DOI 10.1158/0008-5472.CAN-08-3513; Tahara H, 1995, CLIN CANCER RES, V1, P1245; Valls-Bautista C, 2015, J SURG ONCOL, V111, P899, DOI 10.1002/jso.23894; Weischer M, 2013, JNCI-J NATL CANCER I, V105, P459, DOI 10.1093/jnci/djt016; Wells G.A., NEWCASTLE OTTAWA SCA; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Willeit P, 2011, JAMA-J AM MED ASSOC, V306, P42, DOI 10.1001/jama.2011.901; Xie H, 2013, CANCER-AM CANCER SOC, V119, P1885, DOI 10.1002/cncr.27984; Yan SY, 2013, LEUKEMIA LYMPHOMA, V54, P1437, DOI 10.3109/10428194.2012.729834; Zhang DH, 2014, CANCER-AM CANCER SOC, V120, P2673, DOI 10.1002/cncr.28797; Zhong R, 2013, MOL CARCINOGEN, V52, P118, DOI 10.1002/mc.22043; Zhu BB, 2015, MOL CARCINOGEN, V54, P761, DOI 10.1002/mc.22140; Zhu BB, 2014, CLIN GASTROENTEROL H, V12, P1991, DOI 10.1016/j.cgh.2014.03.019	72	52	52	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133174	10.1371/journal.pone.0133174	http://dx.doi.org/10.1371/journal.pone.0133174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177192	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600224
J	Kumar, G; Ho, CC; Co, CC				Kumar, Girish; Ho, Chia-Chi; Co, Carlos C.			Cell-Substrate Interactions Feedback to Direct Cell Migration along or against Morphological Polarization	PLOS ONE			English	Article							RHO-FAMILY GTPASES; MOUSE EMBRYONIC FIBROBLASTS; HEPARIN-BINDING DOMAIN; ACTIN STRESS FIBERS; SIGNALING MOLECULES; FOCAL ADHESIONS; PROTEIN RHO; CDC42; MOTILITY; POLARITY	In response to external stimuli, cells polarize morphologically into teardrop shapes prior to moving in the direction of their blunt leading edge through lamellipodia extension and retraction of the rear tip. This textbook description of cell migration implies that the initial polarization sets the direction of cell migration. Using microfabrication techniques to control cell morphologies and the direction of migration without gradients, we demonstrate that after polarization, lamelipodia extension and attachment can feedback to change and even reverse the initial morphological polarization. Cells do indeed migrate faster in the direction of their morphologically polarization. However, feedback from subsequent lamellipodia extension and attachment can be so powerful as to induce cells to reverse and migrate against their initial polarization, albeit at a slower speed. Constitutively active mutants of RhoA show that RhoA stimulates cell motility when cells are guided either along or against their initial polarization. Cdc42 activation and inhibition, which results in loss of directional motility during chemotaxis, only reduces the speed of migration without altering the directionality of migration on the micropatterns. These results reveal significant differences between substrate directed cell migration and that induced by chemotactic gradients.	[Kumar, Girish; Ho, Chia-Chi; Co, Carlos C.] Univ Cincinnati, Biomed Chem & Environm Engn, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Co, CC (corresponding author), Univ Cincinnati, Biomed Chem & Environm Engn, Cincinnati, OH 45221 USA.	cocc@ucmail.uc.edu			National Institutes of Health [R01EB010043, R01GM112017]; National Science Foundation [CBET0928219]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health (R01EB010043 and R01GM112017) and the National Science Foundation (CBET0928219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Anand-Apte B, 1997, J BIOL CHEM, V272, P30688, DOI 10.1074/jbc.272.49.30688; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; BERGMANN JE, 1983, P NATL ACAD SCI-BIOL, V80, P1367, DOI 10.1073/pnas.80.5.1367; Bershadsky AD, 2011, P NATL ACAD SCI USA, V108, P20275, DOI 10.1073/pnas.1116814108; Bourne HR, 2002, NATURE, V419, P21, DOI 10.1038/419021a; Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chen B, 2013, SCI REP-UK, V3, DOI 10.1038/srep02827; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Cory GOC, 2002, NATURE, V418, P732, DOI 10.1038/418732a; Degani S, 2002, J CELL BIOL, V156, P377, DOI 10.1083/jcb.200108030; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FRENZ DA, 1989, DEV BIOL, V136, P87, DOI 10.1016/0012-1606(89)90132-2; FRENZ DA, 1989, DEV BIOL, V136, P97, DOI 10.1016/0012-1606(89)90133-4; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fujimoto K, 1997, J CELL SCI, V110, P311; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gilbert S.F., 2003, DEV BIOL, V7th Edn; Guo FK, 2004, ONCOGENE, V23, P5577, DOI 10.1038/sj.onc.1207752; Guo FK, 2004, MOL CELL BIOL, V24, P1426, DOI 10.1128/MCB.24.3.1426-1438.2004; Guo FK, 2003, J BIOL CHEM, V278, P14414, DOI 10.1074/jbc.M300341200; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hall BK, 1995, INT J DEV BIOL, V39, P881; Harland B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015011; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; ILLC D, 1995, NATURE, V377, P539; Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021; Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Katoh K, 2001, J CELL BIOL, V153, P569, DOI 10.1083/jcb.153.3.569; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KRAWCZYK WS, 1971, J CELL BIOL, V49, P247, DOI 10.1083/jcb.49.2.247; Kumar G, 2003, LANGMUIR, V19, P10550, DOI 10.1021/la035309l; Kumar G, 2007, ADV MATER, V19, P1084, DOI 10.1002/adma.200601629; Kumar G, 2011, LANGMUIR, V27, P3803, DOI 10.1021/la2000206; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lehmann R, 2001, CURR OPIN GENET DEV, V11, P457, DOI 10.1016/S0959-437X(00)00217-3; Leopoldt D, 1998, J BIOL CHEM, V273, P7024, DOI 10.1074/jbc.273.12.7024; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Li R, 1999, J BIOL CHEM, V274, P29648, DOI 10.1074/jbc.274.42.29648; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818; Mandeville JTH, 1997, J LEUKOCYTE BIOL, V61, P188, DOI 10.1002/jlb.61.2.188; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Nakamura T, 2006, METHOD ENZYMOL, V406, P315, DOI 10.1016/S0076-6879(06)06023-X; Ngalim SH, 2010, J ONCOL, V2010, DOI 10.1155/2010/363106; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ofera N, 2011, P NATL ACAD SCI USA, V108, P20394, DOI 10.1073/pnas.1105333108; PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; Rhoads DS, 2007, EXP CELL RES, V313, P3859, DOI 10.1016/j.yexcr.2007.06.005; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; SMALL JV, 1995, J CELL BIOL, V129, P1275, DOI 10.1083/jcb.129.5.1275; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Tsutsumi S, 2002, CANCER RES, V62, P4484; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	79	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133117	10.1371/journal.pone.0133117	http://dx.doi.org/10.1371/journal.pone.0133117			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186588	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700094
J	Listowski, MA; Leluk, J; Kraszewski, S; Sikorski, AF				Listowski, Marcin A.; Leluk, Jacek; Kraszewski, Sebastian; Sikorski, Aleksander F.			Cholesterol Interaction with the MAGUK Protein Family Member, MPP1, via CRAC and CRAC-Like Motifs: An In Silico Docking Analysis	PLOS ONE			English	Article							H-RAS; PLASMA-MEMBRANE; IDENTIFICATION; BINDING; PALMITOYLATION; RECEPTOR; ORGANIZATION; RECOGNITION; ALGORITHM; SEQUENCE	Cholesterol is essential for the proper organization of the biological membrane. Therefore, predicting which proteins can bind cholesterol is important in understanding how proteins participate in lateral membrane organization. In this study, a simple bioinformatics approach was used to establish whether MPP1, a member of the MAGUK protein family, is capable of binding cholesterol. Modelled and experimentally-validated fragment structures were mined from online resources and searched for CRAC and CRAC-like motifs. Several of these motifs were found in the primary structure of MPP1, and these were structurally visualized to see whether they localized to the protein surface. Since all of the CRAC and CRAC-like motifs were found at the surface of MPP1 domains, in silico docking experiments were performed to assess the possibility of interaction between CRAC motifs and cholesterol. The results obtained show that MPP1 can bind cholesterol via CRAC and CRAC-like motifs with moderate to high affinity (K-I in the nano-to micro-molar range). It was also found that palmitoylation-mimicking mutations (C/F or C/M) did not affect the affinity of MPP1 towards cholesterol. Data presented here may help to understand at least one of the molecular mechanisms via which MPP1 affects lateral organization of the membrane.	[Listowski, Marcin A.; Sikorski, Aleksander F.] Univ Wroclaw, Fac Biotechnol, Dept Cytobiochem, PL-50138 Wroclaw, Poland; [Leluk, Jacek; Sikorski, Aleksander F.] Univ Zielona Gora, Dept Mol Biol, Zielona Gora, Poland; [Kraszewski, Sebastian] Wroclaw Univ Technol, Dept Biomed Engn, PL-50370 Wroclaw, Poland	University of Wroclaw; University of Zielona Gora; Wroclaw University of Science & Technology	Sikorski, AF (corresponding author), Univ Wroclaw, Fac Biotechnol, Dept Cytobiochem, PL-50138 Wroclaw, Poland.	afsbc@ibmb.uni.wroc.pl	Sikorski, Aleksander F/C-3361-2009; Kraszewski, Sebastian/ABA-9541-2021; Sikorski, Aleksander/HGD-5159-2022	Kraszewski, Sebastian/0000-0003-3244-7694; Sikorski, Aleksander F./0000-0003-3779-8266	NCN (NCN = Narodowe Centrum Nauki (National Centre for Research)); Department of Biotechnology, University of Wroclaw, Poland [DEC-2012/05/B/NZ/01638]; Wroclaw Center of Biotechnology Program, The Leading National Research Center (KNOW)	NCN (NCN = Narodowe Centrum Nauki (National Centre for Research)); Department of Biotechnology, University of Wroclaw, Poland; Wroclaw Center of Biotechnology Program, The Leading National Research Center (KNOW)	This work was supported by NCN (NCN = Narodowe Centrum Nauki (National Centre for Research)); and Grant DEC-2012/05/B/NZ/01638 and faculty grant of Department of Biotechnology, University of Wroclaw, Poland. Publication cost was supported by Wroclaw Center of Biotechnology Program, The Leading National Research Center (KNOW) for years 2014-2018.	Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; Baier CJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00069; Barylko B, 2009, J BIOL CHEM, V284, P9994, DOI 10.1074/jbc.M900724200; Biernatowska A, 2013, BBA-MOL CELL RES, V1833, P1876, DOI 10.1016/j.bbamcr.2013.03.009; Boesze-Battaglia K, 2009, J BIOL CHEM, V284, P10650, DOI 10.1074/jbc.M809094200; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; EISENBERG D, 1982, FARADAY SYMP CHEM S, P109, DOI 10.1039/fs9821700109; Epand RF, 2006, BIOCHEMISTRY-US, V45, P6105, DOI 10.1021/bi060245+; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P976, DOI 10.1021/bi051978h; HEMMING NJ, 1995, J BIOL CHEM, V270, P5360, DOI 10.1074/jbc.270.10.5360; Jayasinghe S, 2001, J MOL BIOL, V312, P927, DOI 10.1006/jmbi.2001.5008; Kusunoki H, 2007, BIOCHEM BIOPH RES CO, V359, P972, DOI 10.1016/j.bbrc.2007.05.215; Kusunoki H, 2006, PROTEINS, V64, P804, DOI 10.1002/prot.21028; Lach A, 2012, J BIOL CHEM, V287, P18974, DOI 10.1074/jbc.M111.332981; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Munoz-Barroso I, 1999, J VIROL, V73, P6089; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; Oddi S, 2011, J NEUROCHEM, V116, P858, DOI 10.1111/j.1471-4159.2010.07041.x; Palmer M, 2004, FEMS MICROBIOL LETT, V238, P281, DOI 10.1016/j.femsle.2004.07.059; Picazo-Juarez G, 2011, J BIOL CHEM, V286, P24966, DOI 10.1074/jbc.M111.237537; Rosnizeck IC, 2010, ANGEW CHEM INT EDIT, V49, P3830, DOI 10.1002/anie.200907002; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; RUFF P, 1991, P NATL ACAD SCI USA, V88, P6595, DOI 10.1073/pnas.88.15.6595; Seo PS, 2009, EXP BIOL MED, V234, P255, DOI 10.3181/0809-RM-275; Sheng R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2221; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Vishwanathan SA, 2008, BIOCHEMISTRY-US, V47, P11869, DOI 10.1021/bi8014828; Wilkins MR, 1999, METH MOL B, V112, P531; Wimley WC, 1996, P NATL ACAD SCI USA, V93, P2985, DOI 10.1073/pnas.93.7.2985; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yang GH, 2014, BBA-BIOMEMBRANES, V1838, P2588, DOI 10.1016/j.bbamem.2014.06.018; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou QJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4552	45	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133141	10.1371/journal.pone.0133141	http://dx.doi.org/10.1371/journal.pone.0133141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186446	Green Published, gold			2022-12-27	WOS:000358198700100
J	Qiao, M; Sun, JW; Liu, N; Sun, TJ; Liu, G; Han, SF; Hou, CY; Wang, DM				Qiao, Mei; Sun, Jiawei; Liu, Na; Sun, Tianjie; Liu, Gang; Han, Shengfang; Hou, Chunyan; Wang, Dongmei			Changes of Nitric Oxide and Its Relationship with H2O2 and Ca2+ in Defense Interactions between Wheat and Puccinia Triticina	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; CELL-DEATH; PATHOGEN DEFENSE; PROTEIN-KINASES; CALCIUM; ARABIDOPSIS; CHANNELS; INCREASE; NO; INVOLVEMENT	In this research, the wheat cultivar 'Lovrin 10' and Puccinia triticina races 165 and 260 were used to constitute compatible and incompatible combinations to investigate the relationship between NO and H2O2 and between NO and calcium (Ca2+) signaling in the cell defense process by pharmacological means. The specific fluorescent probe DAF-FM DA was coupled with confocal laser scanning microscopy and used to label intracellular nitric oxide (NO) and monitoring the real-time NO dynamics during the processes of wheat defense response triggered by P. triticina infection. The results showed that at 4 h after inoculation, weak green fluorescence was observed in the stomatal guard cells at the P. triticina infection site in the incompatible combination, which indicates a small amount of NO production. Twelve hours after inoculation, the fluorescence of NO in-cell adjacent to the stomata gradually intensified, and the NO fluorescent area also expanded continuously; the green fluorescence primarily occurred in the cells undergoing a hypersensitive response (HR) at 24-72 h after inoculation. For the compatible combination, however, a small amount of green fluorescence was observed in stomata where the pathogenic contact occurred at 4 h after inoculation, and fluorescence was not observed thereafter. Injections of the NO scavenger c-PTIO prior to inoculation postponed the onset of NO production to 48 h after inoculation and suppressed HR advancement. The injection of imidazole, a NADPH oxidase inhibitor, or EGTA, an extracellular calcium chelator, in the leaves prior to inoculation, delayed the onset of NO production in the incompatible combination and suppressed HR advancement. Combined with our previous results, it could be concluded that, Ca2+ and hydrogen peroxide (H2O2) are involved in upstream of NO production to induce the HR cell death during P. triticina infection, and Ca2+, NO and H2O2 are jointly involved in the signal transduction process of HR in the interaction system.	[Qiao, Mei; Sun, Jiawei; Liu, Na; Sun, Tianjie; Liu, Gang; Han, Shengfang; Hou, Chunyan; Wang, Dongmei] Agr Univ Hebei, Coll Life Sci, Baoding, Hebei Province, Peoples R China	Hebei Agricultural University	Wang, DM (corresponding author), Agr Univ Hebei, Coll Life Sci, Baoding, Hebei Province, Peoples R China.	dongmeiwang63@126.com	Sun, Tianjie/AAC-8087-2020		National Natural Science Foundation of China [31171472]; Doctoral Program of Higher Education Research Fund [20111302130001]; Key Basic Research Program of Hebei on Basic Research for Application [12967149D]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Higher Education Research Fund; Key Basic Research Program of Hebei on Basic Research for Application	This work was supported by the National Natural Science Foundation of China (no. 31171472), the Doctoral Program of Higher Education Research Fund (no. 20111302130001) and the Key Basic Research Program of Hebei on Basic Research for Application (no. 12967149D).	Ali R, 2007, PLANT CELL, V19, P1081, DOI 10.1105/tpc.106.045096; Bei Z, 2010, ACTA AGRON SIN, V36, P833; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; [陈晓波 Chen Xiaobo], 2002, [植物生理与分子生物学学报, Journal of Plant Physiology and Molecular Biology], V28, P344; Chen YH, 2011, SCI AGR SIN, V44, P2061; Cheval C, 2013, BBA-MOL CELL RES, V1833, P1766, DOI 10.1016/j.bbamcr.2013.01.031; de Pinto MC, 2006, PLANT J, V48, P784, DOI 10.1111/j.1365-313X.2006.02919.x; DEAN JV, 1986, PLANT PHYSIOL, V82, P718, DOI 10.1104/pp.82.3.718; Delledonne M, 2005, CURR OPIN PLANT BIOL, V8, P390, DOI 10.1016/j.pbi.2005.05.002; Delledonne M, 2001, P NATL ACAD SCI USA, V98, P13454, DOI 10.1073/pnas.231178298; DENG EX, 1992, PLANT PHYSL COMM, V28, P296; Dong XN, 2001, CURR OPIN PLANT BIOL, V4, P309, DOI 10.1016/S1369-5266(00)00178-3; Feilner T, 2005, MOL CELL PROTEOMICS, V4, P1558, DOI 10.1074/mcp.M500007-MCP200; Furch ACU, 2009, PLANT CELL, V21, P2118, DOI 10.1105/tpc.108.063107; Garcia-Mata C, 2003, P NATL ACAD SCI USA, V100, P11116, DOI 10.1073/pnas.1434381100; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; [关春蕾 Guan Chunlei], 2006, [河北农业大学学报, Journal of Agricultural University of Hebei], V29, P4; Hai-bo W, 2010, NO HORTICULTURE, V22, P189; Heo WD, 1999, P NATL ACAD SCI USA, V96, P766, DOI 10.1073/pnas.96.2.766; Hong JK, 2008, J EXP BOT, V59, P147, DOI 10.1093/jxb/erm244; [侯春燕 HOU Chunyan], 2007, [华北农学报, Acta Agriculturae Boreali-Sinica], V22, P145; Imbaby IA, 2014, SCI WORLD J, DOI 10.1155/2014/574285; Jasid S, 2006, PLANT PHYSIOL, V142, P1246, DOI 10.1104/pp.106.086918; Jeandroz S, 2013, PLANT PHYSIOL, V163, P459, DOI 10.1104/pp.113.220624; KLEPPER L, 1979, ATMOS ENVIRON, V13, P537, DOI 10.1016/0004-6981(79)90148-3; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Kuta D. D., 2004, African Journal of Biotechnology, V3, P76; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lamattina L, 2003, ANNU REV PLANT BIOL, V54, P109, DOI 10.1146/annurev.arplant.54.031902.134752; Lamotte O, 2006, FREE RADICAL BIO MED, V40, P1369, DOI 10.1016/j.freeradbiomed.2005.12.006; Lecourieux D, 2002, PLANT CELL, V14, P2627, DOI 10.1105/tpc.005579; Li AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028810; Lin AH, 2012, PLANT PHYSIOL, V158, P451, DOI 10.1104/pp.111.184531; Liu Gang, 2005, Shi Yan Sheng Wu Xue Bao, V38, P331; Liu G, 2010, PHYSIOL MOL PLANT P, V74, P267, DOI 10.1016/j.pmpp.2010.04.002; Liu Gang, 2007, Fen Zi Xi Bao Sheng Wu Xue Bao, V40, P205; Lu Dong, 2005, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V31, P62; Lum HK, 2002, NITRIC OXIDE-BIOL CH, V6, P205, DOI 10.1006/niox.2001.0395; Ma W, 2007, CELL MICROBIOL, V9, P2571, DOI 10.1111/j.1462-5822.2007.01031.x; Ma W, 2011, NEW PHYTOL, V190, P566, DOI 10.1111/j.1469-8137.2010.03577.x; Ma Y, 2013, PLANT PHYSIOL, V163, P1459, DOI 10.1104/pp.113.226068; Neill SJ, 2003, NEW PHYTOL, V159, P11, DOI 10.1046/j.1469-8137.2003.00804.x; Neill SJ, 2002, J EXP BOT, V53, P1237, DOI 10.1093/jexbot/53.372.1237; Ninnemann H, 1996, PHOTOCHEM PHOTOBIOL, V64, P393, DOI 10.1111/j.1751-1097.1996.tb02477.x; Qi Yan, 2008, Fen Zi Xi Bao Sheng Wu Xue Bao, V41, P245; [乔妹 Qiao Mei], 2015, [植物学报, Chinese Bulletin of Botany], V50, P1; Ren LiMei, 2010, Scientia Agricultura Sinica, V43, P1577; Ribeiro EA, 1999, FEBS LETT, V445, P283, DOI 10.1016/S0014-5793(99)00138-6; ROHRINGER R, 1977, PHYTOPATHOLOGY, V67, P808, DOI 10.1094/Phyto-67-808; She XP, 2004, ACTA BOT SIN, V46, P1292; Shi FM, 2008, BMB REP, V41, P79, DOI 10.5483/BMBRep.2008.41.1.079; Sridharamurthy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113643; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Vandelle E, 2006, MOL PLANT MICROBE IN, V19, P429, DOI 10.1094/MPMI-19-0429; Wendehenne D, 2001, TRENDS PLANT SCI, V6, P177, DOI 10.1016/S1360-1385(01)01893-3; Yamasaki H, 1999, TRENDS PLANT SCI, V4, P128, DOI 10.1016/S1360-1385(99)01393-X; Zago E, 2006, PLANT PHYSIOL, V141, P404, DOI 10.1104/pp.106.078444; [赵晓刚 Zhao Xiaogang], 2004, [植物学通报, Chinese Bulletin of Botany], V21, P44; 刘新, 2003, [自然科学进展, Progress in Natural Science], V13, P355; 刘国华, 2009, [自然科学进展, Progress in Natural Science], V19, P841	60	16	21	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132265	10.1371/journal.pone.0132265	http://dx.doi.org/10.1371/journal.pone.0132265			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185989	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700033
J	Liu, W; Sigdel, KR; Wang, Y; Su, Q; Huang, Y; Zhang, YL; Chen, J; Duan, LH; Shi, GX				Liu, Wen; Sigdel, Keshav Raj; Wang, Ying; Su, Qun; Huang, Yan; Zhang, Yan Lin; Chen, Jie; Duan, Lihua; Shi, Guixiu			High Level Serum Procalcitonin Associated Gouty Arthritis Susceptibility: From a Southern Chinese Han Population	PLOS ONE			English	Article							BACTERIAL-INFECTION; RHEUMATOID-ARTHRITIS; SEPTIC ARTHRITIS; ACTIVITY SCORE; INFLAMMATORY MARKERS; DIAGNOSTIC-VALUE; DISEASE; DIFFERENTIATION; METAANALYSIS; PREVALENCE	Objectives To study the serum Procalcitonin (PCT) level in inflammatory arthritis including gouty arthritis (GA), Rheumatoid arthritis (RA), and ankylosing spondylitis (AS) without any evidence of infection were evaluated the possible discriminative role of PCT in gouty arthritis susceptibility in southern Chinese Han Population. Material and Methods From Feb, 2012 to Feb, 2015, 51 patients with GA, 37 patients with RA, 41 patients with AS and 33 healthy control were enrolled in this study with no evidence of infections. The serum level of PCT (normal range < 0.05 ng/ml) was measured by electrochemiluminescence immunoassay (ECLIA). Disease activity was determined by scores of VAS (4.07 +/- 1.15), DAS28 (4.97 +/- 1.12), and ASDAS (2.97 +/- 0.81) in GA, RA and AS groups respectively. Other laboratory parameters such as, serum creatinine (CRE), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), uric acid (UA) and white blood cells (WBC) were extracted from medical record system. Results Serum PCT level was predominantly higher in gouty arthritis than in RA and AS patients, especially in the GA patients with tophi. PCT was significantly positively correlated with VAS, CRP and ESR in gouty arthritis and CRP in AS. PCT also had positive correlationship with ESR, DAS28 and ASDAS in RA and AS patients respectively, but significant differences were not observed. Conclusions These data suggested that PCT is not solely a biomarker for infection, but also an indicator in inflammatory arthritis, especially in gouty arthritis.	[Liu, Wen; Wang, Ying; Su, Qun; Huang, Yan; Duan, Lihua; Shi, Guixiu] Xiamen Univ, Affiliated Hosp 1, Dept Rheumatol & Clin Immunol, Xiamen, Fujian, Peoples R China; [Sigdel, Keshav Raj; Zhang, Yan Lin] Xiamen Univ, Affiliated Hosp 1, Dept Nephrol, Xiamen, Fujian, Peoples R China; [Chen, Jie] Xiamen Univ, Coll Med, Dept Immunol, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Duan, LH (corresponding author), Xiamen Univ, Affiliated Hosp 1, Dept Rheumatol & Clin Immunol, Xiamen, Fujian, Peoples R China.	lh-duan@163.com; gshi@xmu.edu.cn		shi, guixiu/0000-0003-4044-3394	National Natural Science Foundation of China [81302564, 81471534, 81301786]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (81302564 to Lihua Duan, 81471534 to Guixiu Shi, 81301786 to Jie Chen).	Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; Badulescu M, 2014, MED-SURG J, V118, P942; Becker KL, 2004, J CLIN ENDOCR METAB, V89, P1512, DOI 10.1210/jc.2002-021444; Chen DY, 2009, ANN RHEUM DIS, V68, P1074, DOI 10.1136/ard.2008.098335; Dalbeth N, 2014, J RHEUMATOL, V41, P558, DOI 10.3899/jrheum.131244; Delevaux I, 2003, ANN RHEUM DIS, V62, P337, DOI 10.1136/ard.62.4.337; Eberhard OK, 1997, ARTHRITIS RHEUM, V40, P1250, DOI 10.1002/1529-0131(199707)40:7<1250::AID-ART9>3.0.CO;2-A; Fernandez-Espartero C, 2014, ANN RHEUM DIS, V73, P1350, DOI 10.1136/annrheumdis-2012-202976; Heegaard C, 2013, CLIN RHEUMATOL, V32, P1493, DOI 10.1007/s10067-013-2300-9; Hugle T, 2008, CLIN EXP RHEUMATOL, V26, P453; Kettelhack C, 2000, CRIT CARE MED, V28, P1040, DOI 10.1097/00003246-200004000-00021; Khanna D, 2012, ARTHRIT CARE RES, V64, P1447, DOI 10.1002/acr.21773; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Limper M, 2012, J RHEUMATOL, V39, P1914, DOI 10.3899/jrheum.120586; Liote F, 2006, RHEUM DIS CLIN N AM, V32, P295, DOI 10.1016/j.rdc.2006.03.001; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinot M, 2005, CLIN EXP RHEUMATOL, V23, P303; Maruna P, 2000, PHYSIOL RES, V49, pS57; Meisner M, 2001, EUR J ANAESTH, V18, P79, DOI 10.1046/j.0265-0215.2000.00783.x; Okada Y, 2004, J INFECTION, V48, P199, DOI 10.1016/j.jinf.2003.08.002; Ottaviani S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4303; Ozmen M, 2014, INT J RHEUMATIC DIS; Petrilli V, 2007, JOINT BONE SPINE, V74, P571, DOI 10.1016/j.jbspin.2007.04.004; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Saeed K, 2014, EXPERT REV MOL DIAGN, V14, P47, DOI 10.1586/14737159.2014.864238; Sato H, 2012, J RHEUMATOL, V39, P1517, DOI 10.3899/jrheum.111601; Schneider HG, 2007, PATHOLOGY, V39, P383, DOI 10.1080/00313020701444564; Schuetz P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-107; Shah K, 2007, J EMERG MED, V32, P23, DOI 10.1016/j.jemermed.2006.07.019; Shaikh MM, 2014, RHEUMATOLOGY OXFORD; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Soderquist B, 1998, SCAND J INFECT DIS, V30, P591, DOI 10.1080/00365549850161151; Talebi-Taher M, 2013, RHEUMATOL INT, V33, P319, DOI 10.1007/s00296-012-2363-y; V N Panicker, 2014, Open Orthop J, V8, P482, DOI 10.2174/1874325001408010482; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Wang CG, 2014, EXP THER MED, V8, P1075, DOI 10.3892/etm.2014.1870; Weng CT, 2009, CLIN EXP RHEUMATOL, V27, P902; Zeng QY, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2368; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	39	12	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132855	10.1371/journal.pone.0132855	http://dx.doi.org/10.1371/journal.pone.0132855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182343	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198200044
J	Morgado-Santos, M; Pereira, HM; Vicente, L; Collares-Pereira, MJ				Morgado-Santos, Miguel; Pereira, Henrique Miguel; Vicente, Lus; Collares-Pereira, Maria Joao			Mate Choice Drives Evolutionary Stability in a Hybrid Complex	PLOS ONE			English	Article							REPRODUCTIVE STRATEGIES; SEXUAL SELECTION; PLOIDY LEVEL; GENOME SIZE; SPECIATION; HYBRIDIZATION; POPULATIONS; MALES; FROGS; REINFORCEMENT	Previous studies have shown that assortative mating acts as a driver of speciation by countering hybridization between two populations of the same species (pre-zygotic isolation) or through mate choice among the hybrids (hybrid speciation). In both speciation types, assortative mating promotes speciation over a transient hybridization stage. We studied mate choice in a hybrid vertebrate complex, the allopolyploid fish Squalius alburnoides. This complex is composed by several genomotypes connected by an intricate reproductive dynamics. We developed a model that predicts the hybrid complex can persist when females exhibit particular mate choice patterns. Our model is able to reproduce the diversity of population dynamic outcomes found in nature, namely the dominance of the triploids and the dominance of the tetraploids, depending on female mate choice patterns and frequency of the parental species. Experimental mate choice trials showed that females exhibit the preferences predicted by the model. Thus, despite the known role of assortative mating in driving speciation, our findings suggest that certain mate choice patterns can instead hinder speciation and support the persistence of hybrids over time without speciation or extinction.	[Morgado-Santos, Miguel; Pereira, Henrique Miguel; Collares-Pereira, Maria Joao] Univ Lisbon, Fac Ciencias, CE3C Ctr Ecol Evolut & Environm Changes, P-1749016 Lisbon, Portugal; [Morgado-Santos, Miguel; Vicente, Lus] Univ Lisbon, Fac Ciencias, Ctr Estudos Ambiente & Mar, Dept Biol Anim, P-1749016 Lisbon, Portugal; [Pereira, Henrique Miguel] IDiv German Ctr Integrat Biodivers Res, Leipzig, Germany; [Vicente, Lus] Univ Lisbon, CFCUL Ctr Filosofia Ciencias, Fac Ciencias, P-1749016 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa	Morgado-Santos, M (corresponding author), Univ Lisbon, Fac Ciencias, CE3C Ctr Ecol Evolut & Environm Changes, P-1749016 Lisbon, Portugal.	mfsantos@fc.ul.pt	Pereira, Henrique/B-3975-2009; VICENTE, LIERN/B-6112-2008; Vicente, Luis/A-7443-2013; Collares-Pereira, Maria/M-6246-2013	Pereira, Henrique/0000-0003-1043-1675; VICENTE, LIERN/0000-0001-5883-9640; Vicente, Luis/0000-0002-3383-5480; Collares-Pereira, Maria/0000-0002-8081-9539	Centro de Biologia Ambiental [PEstOE/BIA/UI0329/2014]; Portuguese Fundacao para a Ciencia e Tecnologia [SFRH/BD/65154/2009]	Centro de Biologia Ambiental; Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Centro de Biologia Ambiental (www.cba.pt, PEstOE/BIA/UI0329/2014) and the Portuguese Fundacao para a Ciencia e Tecnologia (www.fct.pt, PhD grant SFRH/BD/65154/2009 awarded to M.M.-S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABT G, 1993, BEHAV ECOL SOCIOBIOL, V32, P221; Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; [Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; Bank C, 2012, EVOLUTION, V66, P229, DOI 10.1111/j.1558-5646.2011.01423.x; Brown JL, 1997, BEHAV ECOL, V8, P60, DOI 10.1093/beheco/8.1.60; BUTLIN R, 1987, TRENDS ECOL EVOL, V2, P8, DOI 10.1016/0169-5347(87)90193-5; Cabral M.J., 2005, LIVRO VERMELHO VERTE; Christiansen DG, 2005, EVOLUTION, V59, P1348; Christiansen DG, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-135; Christiansen DG, 2009, EVOLUTION, V63, P1754, DOI 10.1111/j.1558-5646.2009.00673.x; Collares-Pereira MJ, 2013, CYTOGENET GENOME RES, V140, P97, DOI 10.1159/000351729; Coyne J.A., 2004, SPECIATION; Cunha C, 2009, J EVOLUTION BIOL, V22, P718, DOI 10.1111/j.1420-9101.2009.01695.x; Cunha C, 2008, PHILOS T R SOC B, V363, P2921, DOI 10.1098/rstb.2008.0048; Darwin C., 1871, P423; Dawley R. M, 1989, EVOLUTION ECOLOGY UN; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; GROSS MR, 1991, PHILOS T R SOC B, V332, P59, DOI 10.1098/rstb.1991.0033; Janko K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045384; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jiang YX, 2013, AM NAT, V181, pE125, DOI 10.1086/670160; Kirkpatrick M, 2001, P ROY SOC B-BIOL SCI, V268, P1259, DOI 10.1098/rspb.2000.1427; KNOPPIEN P, 1985, BIOL REV, V60, P81, DOI 10.1111/j.1469-185X.1985.tb00418.x; Kokko H, 2005, EVOL ECOL, V19, P123, DOI 10.1007/s10682-004-7919-1; Lamatsch DK, 2000, CYTOMETRY, V39, P91, DOI 10.1002/(SICI)1097-0320(20000201)39:2<91::AID-CYTO1>3.0.CO;2-4; Lamatsch DK, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P399, DOI 10.1007/978-90-481-2770-2_19; Maan ME, 2011, ECOL LETT, V14, P591, DOI 10.1111/j.1461-0248.2011.01606.x; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mavarez J, 2006, NATURE, V441, P868, DOI 10.1038/nature04738; Melo MC, 2009, EVOLUTION, V63, P1660, DOI 10.1111/j.1558-5646.2009.00633.x; Meyer A, 2006, MOL ECOL, V15, P721, DOI 10.1111/j.1365-294X.2006.02810.x; Morgado-Santos M, 2010, J FISH BIOL, V76, P1228, DOI 10.1111/j.1095-8649.2010.02591.x; Neaves WB, 2011, TRENDS GENET, V27, P81, DOI 10.1016/j.tig.2010.12.002; Nolte AW, 2007, TIG, V26, P54; Petrie M, 1998, P NATL ACAD SCI USA, V95, P9390, DOI 10.1073/pnas.95.16.9390; Pruvost NBM, 2015, J EVOLUTION BIOL, V28, P189, DOI 10.1111/jeb.12556; R Core Team, 2012, R LANG ENV STAT COMP; Saitoh K, 2010, MOL PHYLOGENET EVOL, V56, P1001, DOI 10.1016/j.ympev.2010.04.021; SCHLUPP I, 1994, SCIENCE, V263, P373, DOI 10.1126/science.8278809; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Sousa-Santos C, 2005, DNA SEQUENCE, V16, P462, DOI 10.1080/10425170500356065; Sousa-Santos C., 2007, THESIS LISBON U; StatSoft Inc, 2013, EL STAT TXB; van Doorn GS, 2009, SCIENCE, V326, P1704, DOI 10.1126/science.1181661; Willis PM, 2011, BEHAV ECOL, V22, P1234, DOI 10.1093/beheco/arr119	46	7	7	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132760	10.1371/journal.pone.0132760	http://dx.doi.org/10.1371/journal.pone.0132760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181664	Green Published, gold			2022-12-27	WOS:000358198200031
J	Aberg, KA; Xie, LY; Chan, RF; Zhao, M; Pandey, AK; Kumar, G; Clark, SL; van den Oord, EJCG				Aberg, Karolina A.; Xie, Linying; Chan, Robin F.; Zhao, Min; Pandey, Ashutosh K.; Kumar, Gaurav; Clark, Shaunna L.; van den Oord, Edwin J. C. G.			Evaluation of Methyl-Binding Domain Based Enrichment Approaches Revisited	PLOS ONE			English	Article							DNA METHYLATION; WIDE ASSOCIATION; HIGH-THROUGHPUT; GENOME; BLOOD; COVERAGE; PROTOCOL; SITES	Methyl-binding domain (MBD) enrichment followed by deep sequencing (MBD-seq), is a robust and cost efficient approach for methylome-wide association studies (MWAS). MBD-seq has been demonstrated to be capable of identifying differentially methylated regions, detecting previously reported robust associations and producing findings that replicate with other technologies such as targeted pyrosequencing of bisulfite converted DNA. There are several kits commercially available that can be used for MBD enrichment. Our previous work has involved MethylMiner (Life Technologies, Foster City, CA, USA) that we chose after careful investigation of its properties. However, in a recent evaluation of five commercially available MBD-enrichment kits the performance of the MethylMiner was deemed poor. Given our positive experience with MethylMiner, we were surprised by this report. In an attempt to reproduce these findings we here have performed a direct comparison of MethylMiner with MethylCap (Diagenode Inc, Denville, NJ, USA), the best performing kit in that study. We find that both MethylMiner and MethylCap are two well performing MBD-enrichment kits. However, MethylMiner shows somewhat better enrichment efficiency and lower levels of background "noise". In addition, for the purpose of MWAS where we want to investigate the majority of CpGs, we find MethylMiner to be superior as it allows tailoring the enrichment to the regions where most CpGs are located. Using targeted bisulfite sequencing we confirmed that sites where methylation was detected by either MethylMiner or by MethylCap indeed were methylated.	[Aberg, Karolina A.; Xie, Linying; Chan, Robin F.; Zhao, Min; Kumar, Gaurav; Clark, Shaunna L.; van den Oord, Edwin J. C. G.] Virginia Commonwealth Univ, Ctr Biomarker Res & Precis Med, Richmond, VA 23284 USA; [Pandey, Ashutosh K.] Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Memphis, TN USA; [Pandey, Ashutosh K.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA	Virginia Commonwealth University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Aberg, KA (corresponding author), Virginia Commonwealth Univ, Ctr Biomarker Res & Precis Med, Richmond, VA 23284 USA.	kaaberg@vcu.edu	Aberg, Karolina/A-6772-2010	Aberg, Karolina/0000-0001-6103-5168; Chan, Robin/0000-0002-1774-4087	National Institute of Mental Health [1R01MH099110]; National Institute for Alcohol Abuse and Alcoholism [5K01AA021266]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA021266] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute for Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by the National Institute of Mental Health (grant 1R01MH099110; PI: van den Oord). The tissue collection was supported by the National Institute for Alcohol Abuse and Alcoholism (grant 5K01AA021266; PI: Clark). The MethylCap kit was provided by Diagenode free of charge. The funders had no role in study data collection, analysis, decision to publish, or preparation of the manuscript.	Aberg KA, 2014, JAMA PSYCHIAT, V71, P255, DOI 10.1001/jamapsychiatry.2013.3730; Aberg KA, 2013, EPIGENETICS-US, V8, P542, DOI 10.4161/epi.24508; Aberg KA, 2012, EPIGENOMICS-UK, V4, P605, DOI [10.2217/EPI.12.59, 10.2217/epi.12.59]; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; De Meyer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059068; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Fraga MF, 2003, NUCLEIC ACIDS RES, V31, P1765, DOI 10.1093/nar/gkg249; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hogart A, 2012, GENOME RES, V22, P1407, DOI 10.1101/gr.132878.111; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; Invitrogen, ENR DIFF METH REG ME; Khrapunov S, 2014, BIOCHEMISTRY-US, V53, P3379, DOI 10.1021/bi500424z; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Lan X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022226; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; McClay JL, 2014, HUM MOL GENET, V23, P1175, DOI 10.1093/hmg/ddt511; Nair SS, 2011, EPIGENETICS-US, V6, P34, DOI 10.4161/epi.6.1.13313; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Royo JL, 2007, NAT PROTOC, V2, P1734, DOI 10.1038/nprot.2007.244; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; van den Oord EJCG, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-50; Wang XS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-O7	24	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132205	10.1371/journal.pone.0132205	http://dx.doi.org/10.1371/journal.pone.0132205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177298	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600090
J	Auzmendi, JA; Smoler, M; Moffatt, L				Auzmendi, Jeronimo A.; Smoler, Mariano; Moffatt, Luciano			Dynamics of T-Junction Solution Switching Aimed at Patch Clamp Experiments	PLOS ONE			English	Article							AUTOMATED ELECTROPHYSIOLOGY; MEMBRANE PATCHES; P2X RECEPTORS; ATP BINDING; PHARMACOLOGY; CHANNELS; CELLS; TEMPERATURE; IONFLUX; SYSTEM	Solutions exchange systems are responsible for the timing of drug application on patch clamp experiments. There are two basic strategies for generating a solution exchange. When slow exchanges are bearable, it is easier to perform the exchange inside the tubing system upstream of the exit port. On the other hand, fast, reproducible, exchanges are usually performed downstream of the exit port. As both strategies are combinable, increasing the performance of upstream exchanges is desirable. We designed a simple method for manufacturing T-junctions (300 mu m I.D.) and we measured the time profile of exchange of two saline solutions using a patch pipette with an open tip. Three factors were found to determine the timing of the solution switching: pressure, travelled distance and off-center distance. A linear relationship between the time delay and the travelled distance was found for each tested pressure, showing its dependence to the fluid velocity, which increased with pressure. The exchange time was found to increase quadratically with the delay, although a sizeable variability remains unexplained by this relationship. The delay and exchange times increased as the recording pipette moved away from the center of the stream. Those increases became dramatic as the pipette was moved close to the stream borders. Mass transport along the travelled distance between the slow fluid at the border and the fast fluid at the center seems to contribute to the time course of the solution exchange. This effect would be present in all tubing based devices. Present results might be of fundamental importance for the adequate design of serial compound exchangers which would be instrumental in the discovery of drugs that modulate the action of the physiological agonists of ion channels with the purpose of fine tuning their physiology.	[Auzmendi, Jeronimo A.; Smoler, Mariano; Moffatt, Luciano] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Quim Fis Mat Medio Ambiente & Energia, Buenos Aires, DF, Argentina	University of Buenos Aires	Moffatt, L (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Quim Fis Mat Medio Ambiente & Energia, Buenos Aires, DF, Argentina.	lmoffatt@qi.fcen.uba.ar	Moffatt, Luciano/E-9805-2012	Smoler, Mariano/0000-0001-6248-3851; Moffatt, Luciano/0000-0003-4994-4304; Auzmendi, Jeronimo/0000-0002-4819-2713	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 06-1902 LM]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This investigation received financial support from the Agencia Nacional de Promocion Cientifica y Tecnologica www.agencia.mincyt.gob.ar (PICT 06-1902 LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accolla R, 2007, J NEUROSCI, V27, P1396, DOI 10.1523/JNEUROSCI.5188-06.2007; Auzmendi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042275; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; Bowie D, 2002, J PHYSIOL-LONDON, V539, P725, DOI 10.1113/jphysiol.2001.013407; BRETT RS, 1986, BIOPHYS J, V50, P987, DOI 10.1016/S0006-3495(86)83539-1; Bridle H, 2008, LAB CHIP, V8, P480, DOI 10.1039/b718368b; Dunlop J, 2008, COMB CHEM HIGH T SCR, V11, P514, DOI 10.2174/138620708785204117; Dunlop J, 2008, NAT REV DRUG DISCOV, V7, P358, DOI 10.1038/nrd2552; Farre C, 2014, EXPERT OPIN DRUG DIS, V9, P1103, DOI 10.1517/17460441.2014.942217; Farre C, 2009, COMB CHEM HIGH T SCR, V12, P24, DOI 10.2174/138620709787047966; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; Feldman DH, 2008, GLIA, V56, P1238, DOI 10.1002/glia.20693; Golden AP, 2011, ASSAY DRUG DEV TECHN, V9, P608, DOI 10.1089/adt.2010.0362; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hille Bertil, 2001, pi; Ionescu-Zanetti C, 2009, J BIOMOL SCREEN, V14, P884; Jiang RT, 2013, TRENDS BIOCHEM SCI, V38, P20, DOI 10.1016/j.tibs.2012.10.006; Jones KS, 2002, J NEUROSCI, V22, P2044, DOI 10.1523/JNEUROSCI.22-06-02044.2002; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lundius EG, 2010, J NEUROSCI, V30, P4369, DOI 10.1523/JNEUROSCI.0378-10.2010; MACONOCHIE DJ, 1989, PFLUG ARCH EUR J PHY, V414, P589, DOI 10.1007/BF00580996; Matthews B, 2003, I IEEE EMBS C NEUR E, P648, DOI 10.1109/CNE.2003.1196912; Milligan Carol J, 2013, Methods Mol Biol, V998, P171, DOI 10.1007/978-1-62703-351-0_13; Moller C, 2010, DRUG DISCOV TODAY, V15, P384, DOI 10.1016/j.drudis.2010.02.010; Moffatt L, 2007, J GEN PHYSIOL, V130, P183, DOI 10.1085/jgp.200709779; Newell JG, 2002, MUTATION GABAA RECEP; Polonchuk L, 2014, METHODS MOL BIOL, V1183, P81, DOI 10.1007/978-1-4939-1096-0_5; Priest BT, 2007, CURR PHARM DESIGN, V13, P2325; SAKMANN B, 1984, ANNU REV PHYSIOL, V46, P455, DOI 10.1146/annurev.ph.46.030184.002323; Sinclair J, 2002, ANAL CHEM, V74, P6133, DOI 10.1021/ac026133f; Soto D, 2014, J NEUROSCI, V34, P11673, DOI 10.1523/JNEUROSCI.0383-14.2014; Spencer CI, 2010, BIOPHYS J, V98, p194A, DOI 10.1016/j.bpj.2009.12.1029; Spencer CI, 2012, ASSAY DRUG DEV TECHN, V10, P313, DOI 10.1089/adt.2011.414; Stoelzle S, 2009, J PHYSIOL SCI, V59, P402; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Xiao YC, 2014, MOL PHARMACOL, V86, P159, DOI 10.1124/mol.114.092338	40	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133187	10.1371/journal.pone.0133187	http://dx.doi.org/10.1371/journal.pone.0133187			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177538	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600229
J	Chen, CM; Tsai, MJ; Wei, PJ; Su, YC; Yang, CJ; Wu, MN; Hsu, CY; Hwang, SJ; Chong, IW; Huang, MS				Chen, Chia-Min; Tsai, Ming-Ju; Wei, Po-Ju; Su, Yu-Chung; Yang, Chih-Jen; Wu, Meng-Ni; Hsu, Chung-Yao; Hwang, Shang-Jyh; Chong, Inn-Wen; Huang, Ming-Shyan			Erectile Dysfunction in Patients with Sleep Apnea - A Nationwide Population-Based Study	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; QUALITY-OF-LIFE; SEXUAL FUNCTION; MEN; ASSOCIATION; SILDENAFIL; THERAPY; DISEASE; RISK; METAANALYSIS	Increased incidence of erectile dysfunction (ED) has been reported among patients with sleep apnea (SA). However, this association has not been confirmed in a large-scale study. We therefore performed a population-based cohort study using Taiwan National Health Insurance (NHI) database to investigate the association of SA and ED. From the database of one million representative subjects randomly sampled from individuals enrolled in the NHI system in 2010, we identified adult patients having SA and excluded those having a diagnosis of ED prior to SA. From these suspected SA patients, those having SA diagnosis after polysomnography were defined as probable SA patients. The dates of their first SA diagnosis were defined as their index dates. Each SA patient was matched to 30 randomly-selected, age-matched control subjects without any SA diagnosis. The control subjects were assigned index dates as their corresponding SA patients, and were ensured having no ED diagnosis prior to their index dates. Totally, 4,835 male patients with suspected SA (including 1,946 probable SA patients) were matched to 145,050 control subjects (including 58,380 subjects matched to probable SA patients). The incidence rate of ED was significantly higher in probable SA patients as compared with the corresponding control subjects (5.7 vs. 2.3 per 1000 patient-year; adjusted incidence rate ratio = 2.0 [95% CI: 1.8-2.2], p<0.0001). The cumulative incidence was also significantly higher in the probable SA patients (p<0.0001). In multivariable Cox regression analysis, probable SA remained a significant risk factor for the development of ED after adjusting for age, residency, income level and comorbidities (hazard ratio = 2.0 [95% CI: 1.5-2.7], p<0.0001). In line with previous studies, this population-based large-scale study confirmed an increased ED incidence in SA patients in Chinese population. Physicians need to pay attention to the possible underlying SA while treating ED patients.	[Chen, Chia-Min; Tsai, Ming-Ju; Wei, Po-Ju; Yang, Chih-Jen; Chong, Inn-Wen; Huang, Ming-Shyan] Kaohsiung Med Univ, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Tsai, Ming-Ju; Yang, Chih-Jen; Huang, Ming-Shyan] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Tsai, Ming-Ju; Wu, Meng-Ni; Hsu, Chung-Yao] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Sleep Disorders Ctr, Kaohsiung, Taiwan; [Su, Yu-Chung; Yang, Chih-Jen] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Su, Yu-Chung; Yang, Chih-Jen; Hsu, Chung-Yao; Huang, Ming-Shyan] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung, Taiwan; [Wu, Meng-Ni; Hsu, Chung-Yao] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Hwang, Shang-Jyh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan; [Hwang, Shang-Jyh] Kaohsiung Med Univ, Dept Renal Care, Coll Med, Kaohsiung, Taiwan; [Chong, Inn-Wen] Kaohsiung Med Univ, Dept Resp Care, Coll Med, Kaohsiung, Taiwan; [Huang, Ming-Shyan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Geriatr & Gerontol, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Huang, MS (corresponding author), Kaohsiung Med Univ, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan.	shyan310@gmail.com	Tsai, Ming-Ju/D-5566-2011; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Chen, Chia Min/0000-0001-7045-1251; Hsu, Chung-Yao/0000-0002-9880-5944				Andersen ML, 2010, SLEEP MED, V11, P1019, DOI 10.1016/j.sleep.2009.08.016; Arzt M, 2005, AM J RESP CRIT CARE, V172, P1447, DOI 10.1164/rccm.200505-702OC; Aytac IA, 1999, BJU INT, V84, P50; Bouloukaki I, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/568951; Budweiser S, 2013, J SEX MED, V10, P524, DOI 10.1111/j.1743-6109.2012.02968.x; Budweiser S, 2009, J SEX MED, V6, P3147, DOI 10.1111/j.1743-6109.2009.01372.x; Chou KT, 2012, AM J MED, V125, P374, DOI 10.1016/j.amjmed.2011.07.003; Chou PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093081; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fanfulla F, 2000, SLEEP, V23, P775; Gandaglia G, 2014, EUR UROL, V65, P968, DOI 10.1016/j.eururo.2013.08.023; Goncalves MA, 2005, SLEEP MED, V6, P333, DOI 10.1016/j.sleep.2005.03.001; Heruti R, 2005, J SEX MED, V2, P543, DOI 10.1111/j.1743-6109.2005.00072.x; HIRSHKOWITZ M, 1990, UROLOGY, V36, P232, DOI 10.1016/0090-4295(90)80262-L; Hoekema A, 2007, J SEX MED, V4, P1153, DOI 10.1111/j.1743-6109.2006.00341.x; Hoyos CM, 2015, SLEEP MED REV, V20, P5, DOI 10.1016/j.smrv.2014.03.004; Huang CC, 2013, ANDROLOGY-US, V1, P240, DOI 10.1111/j.2047-2927.2012.00037.x; Huyghe E, 2009, J SEX MED, V6, P1395, DOI 10.1111/j.1743-6109.2008.01169.x; JONLER M, 1995, BRIT J UROL, V75, P651, DOI 10.1111/j.1464-410X.1995.tb07426.x; Kang JH, 2012, UROLOGY, V79, P340, DOI 10.1016/j.urology.2011.08.040; Khafagy AH, 2012, INT J CLIN PRACT, V66, P1204, DOI 10.1111/j.1742-1241.2012.02990.x; Knapp A, 2014, CLIN ENDOCRINOL, V81, P254, DOI 10.1111/cen.12401; Kohler M, 2011, AM J RESP CRIT CARE, V184, P1192, DOI 10.1164/rccm.201106-0964OC; Li XM, 2010, AGING MALE, V13, P82, DOI 10.3109/13685530903406789; Liu K, 2012, J ANDROL, V33, P1186, DOI 10.2164/jandrol.112.016642; Maiorino MI, 2014, DIABET METAB SYND OB, V7, P95, DOI 10.2147/DMSO.S36455; Margel D, 2004, UROLOGY, V63, P545, DOI 10.1016/j.urology.2003.10.016; Meller SM, 2013, J INVASIVE CARDIOL, V25, P313; Myers KA, 2013, JAMA-J AM MED ASSOC, V310, P731, DOI 10.1001/jama.2013.276185; Pastore AL, 2014, INT J CLIN PRACT, V68, P995, DOI 10.1111/ijcp.12463; Perimenis P, 2007, INT UROL NEPHROL, V39, P547, DOI 10.1007/s11255-006-9079-4; Perimenis P, 2007, ASIAN J ANDROL, V9, P259, DOI 10.1111/j.1745-7262.2007.00085.x; Reichmuth KJ, 2005, AM J RESP CRIT CARE, V172, P1590, DOI 10.1164/rccm.200504-637OC; Roizenblatt S, 2006, ARCH INTERN MED, V166, P1763, DOI 10.1001/archinte.166.16.1763; Shin HW, 2008, INT J IMPOT RES, V20, P549, DOI 10.1038/ijir.2008.39; Shin HW, 2013, J SEX MED, V10, P2053, DOI 10.1111/jsm.12128; Soukhova-O'Hare GK, 2008, AM J RESP CRIT CARE, V178, P644, DOI 10.1164/rccm.200801-190OC; Su VYF, 2013, ALLERGY, V68, P440, DOI 10.1111/all.12100; Teloken PE, 2006, UROLOGY, V67, P1033, DOI 10.1016/j.urology.2005.11.040; Vlachopoulos CV, 2013, CIRC-CARDIOVASC QUAL, V6, P99, DOI 10.1161/CIRCOUTCOMES.112.966903; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zias N, 2009, SLEEP BREATH, V13, P3, DOI 10.1007/s11325-008-0212-8	43	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132510	10.1371/journal.pone.0132510	http://dx.doi.org/10.1371/journal.pone.0132510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177206	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600119
J	Cho, KS; Lee, JH; Park, MK; Park, HK; Yu, HS; Roh, HJ				Cho, Kyu-Sup; Lee, Jung-Hoon; Park, Mi-Kyung; Park, Hye-Kyung; Yu, Hak-Sun; Roh, Hwan-Jung			Prostaglandin E2 and Transforming Growth Factor-beta Play a Critical Role in Suppression of Allergic Airway Inflammation by Adipose-Derived Stem Cells	PLOS ONE			English	Article							T-CELLS; TGF-BETA; ASTHMA; LYMPHOCYTE; SECRETION; RHINITIS; MODEL; GAMMA; E-2	Background The role of soluble factors in the suppression of allergic airway inflammation by adipose-derived stem cells (ASCs) remains to be elucidated. Moreover, the major soluble factors responsible for the immunomodulatory effects of ASCs in allergic airway diseases have not been well documented. We evaluated the effects of ASCs on allergic inflammation in asthmatic mice treated with a prostaglandin E2 (PGE2) inhibitor or transforming growth factor-beta (TGF-beta) neutralizing antibodies. Methods and Findings Asthmatic mice were injected intraperitoneally with a PGE2 inhibitor or TGF-beta neutralizing antibodies at approximately the same time as ASCs injection and were compared with nontreated controls. In asthmatic mice, ASCs significantly reduced airway hyperresponsiveness, the number of total inflammatory cells and eosinophils in the bronchoalveolar lavage fluid (BALF), eosinophilic inflammation, goblet cell hyperplasia, and serum total and allergen-specific IgE and IgG1. ASCs significantly inhibited Th2 cytokines, such as interleukin (IL)-4, IL-5, and IL-1 beta, and enhanced the Th1 cytokine (Interferon-gamma) and regulatory cytokines (IL-10 and TGF-beta) in the BALF and lung draining lymph nodes (LLNs). ASCs engraftment caused significant increases in the regulatory T cell (Treg) and IL-10(+)T cell populations in LLNs. However, blocking PGE2 or TGF-beta eliminated the immunosuppressive effect of ASCs in allergic airway inflammation. Conclusions ASCs are capable of secreting PGE2 and TGF-beta, which may play a role in inducing Treg expansion. Furthermore, treatment with a PGE2 inhibitor or TGF-beta neutralizing antibodies eliminated the beneficial effect of ASCs treatment in asthmatic mice, suggesting that PGE2 and TGF-beta are the major soluble factors responsible for suppressing allergic airway inflammation.	[Cho, Kyu-Sup; Lee, Jung-Hoon] Pusan Natl Univ Hosp, Dept Otorhinolaryngol, Busan, South Korea; [Cho, Kyu-Sup; Lee, Jung-Hoon] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Park, Mi-Kyung; Yu, Hak-Sun] Pusan Natl Univ, Sch Med, Dept Parasitol, Yangsan, South Korea; [Park, Hye-Kyung] Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea; [Roh, Hwan-Jung] Pusan Natl Univ, Yangsan Hosp, Dept Otorhinolaryngol, Yangsan, South Korea; [Roh, Hwan-Jung] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Roh, HJ (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Otorhinolaryngol, Yangsan, South Korea.	rohhj@pusan.ac.kr			Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0315]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Bonfield TL, 2010, AM J PHYSIOL-LUNG C, V299, pL760, DOI 10.1152/ajplung.00182.2009; Bonfield TL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-51; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245; Cho KS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/436476; Cho KS, 2010, CURR STEM CELL RES T, V5, P111, DOI 10.2174/157488810791268681; Cho KS, 2009, STEM CELLS, V27, P259, DOI 10.1634/stemcells.2008-0283; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Cui L, 2007, TISSUE ENG, V13, P1185, DOI 10.1089/ten.2006.0315; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; English K, 2008, IMMUNOL LETT, V115, P50, DOI 10.1016/j.imlet.2007.10.002; Fu QL, 2012, ALLERGY, V67, P1215, DOI [10.1111/j.1398-9995.2012.02875.x, 10.1111/j.1398-9995.2012.02875.x.]; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Ge XH, 2013, CELL BIOL INT, V37, P675, DOI 10.1002/cbin.10084; Goodwin M, 2011, STEM CELLS, V29, P1137, DOI 10.1002/stem.656; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Jaffar Z, 2004, J IMMUNOL, V172, P3842, DOI 10.4049/jimmunol.172.6.3842; Kang JH, 2009, AM J RESP CRIT CARE, V179, P875, DOI 10.1164/rccm.200806-893OC; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Mathias LJ, 2013, J IMMUNOL, V191, P5914, DOI 10.4049/jimmunol.1300667; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Park HK, 2010, STEM CELLS DEV, V19, P1811, DOI 10.1089/scd.2009.0513; Pellaton-Longaretti C, 2011, INT IMMUNOL, V23, P17, DOI 10.1093/intimm/dxq453; Peters-Golden M, 2004, AM J RESP CELL MOL, V31, P3, DOI 10.1165/rcmb.f279; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Shi HZ, 2005, ALLERGY, V60, P986, DOI 10.1111/j.1398-9995.2005.00844.x; Shi M, 2011, CLIN EXP IMMUNOL, V164, P1, DOI 10.1111/j.1365-2249.2011.04327.x; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Sun YQ, 2012, STEM CELLS, V30, P2692, DOI 10.1002/stem.1241; Tournoy KG, 2000, CLIN EXP ALLERGY, V30, P79; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572	36	28	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131813	10.1371/journal.pone.0131813	http://dx.doi.org/10.1371/journal.pone.0131813			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176545	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600066
J	Garavito, NT; Newton, AC; Golicher, D; Oldfield, S				Garavito, Natalia Tejedor; Newton, Adrian C.; Golicher, Duncan; Oldfield, Sara			The Relative Impact of Climate Change on the Extinction Risk of Tree Species in the Montane Tropical Andes	PLOS ONE			English	Article							IUCN RED LIST; DISTRIBUTION MODELS; PLANT DIVERSITY; LAND-USE; BIODIVERSITY; CONSERVATION; HABITAT; DISTRIBUTIONS; FUTURE; FOREST	There are widespread concerns that anthropogenic climate change will become a major cause of global biodiversity loss. However, the potential impact of climate change on the extinction risk of species remains poorly understood, particularly in comparison to other current threats. The objective of this research was to examine the relative impact of climate change on extinction risk of upper montane tree species in the tropical Andes, an area of high biodiversity value that is particularly vulnerable to climate change impacts. The extinction risk of 129 tree species endemic to the region was evaluated according to the IUCN Red List criteria, both with and without the potential impacts of climate change. Evaluations were supported by development of species distribution models, using three methods (generalized additive models, recursive partitioning, and support vector machines), all of which produced similarly high AUC values when averaged across all species evaluated (0.82, 0.86, and 0.88, respectively). Inclusion of climate change increased the risk of extinction of 18-20% of the tree species evaluated, depending on the climate scenario. The relative impact of climate change was further illustrated by calculating the Red List Index, an indicator that shows changes in the overall extinction risk of sets of species over time. A 15% decline in the Red List Index was obtained when climate change was included in this evaluation. While these results suggest that climate change represents a significant threat to tree species in the tropical Andes, they contradict previous suggestions that climate change will become the most important cause of biodiversity loss in coming decades. Conservation strategies should therefore focus on addressing the multiple threatening processes currently affecting biodiversity, rather than focusing primarily on potential climate change impacts.	[Garavito, Natalia Tejedor; Newton, Adrian C.; Golicher, Duncan] Bournemouth Univ, Fac Sci & Technol, Poole BH12 5BB, Dorset, England; [Oldfield, Sara] Bot Garden Conservat Int, Richmond, Surrey, England	Bournemouth University	Newton, AC (corresponding author), Bournemouth Univ, Fac Sci & Technol, Poole BH12 5BB, Dorset, England.	anewton@bournemouth.ac.uk	Golicher, Duncan/B-4240-2009; Tejedor, Natalia/A-5601-2012	Tejedor, Natalia/0000-0002-1140-6263	Bournemouth University studentship; Franklinia Foundation	Bournemouth University studentship; Franklinia Foundation	This research was supported by a Bournemouth University studentship to the senior author, and support from the Franklinia Foundation to BGCI.	Akcakaya HR, 2006, GLOBAL CHANGE BIOL, V12, P2037, DOI 10.1111/j.1365-2486.2006.01253.x; Allen MR, 2000, NATURE, V407, P617, DOI 10.1038/35036559; Anderson EP., 2011, CLIMATE CHANGE BIODI, P1, DOI DOI 10.13140/2.1.3718.4969; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bomhard B, 2005, GLOBAL CHANGE BIOL, V11, P1452, DOI 10.1111/j.1365-2486.2005.00997.x; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Busch J, 2012, CONSERV BIOL, V26, P408, DOI 10.1111/j.1523-1739.2012.01838.x; Bush M.B., 2007, TROPICAL RAINFOREST, P59, DOI DOI 10.1007/978-3-540-48842-2; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Campbell A., 2009, TECHNICAL SERIES, V42, P124; Cayuela L, 2009, TROP CONSERV SCI, V2, P319, DOI 10.1177/194008290900200304; Cubasch U, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P525; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; FAO, 2020, GLOBAL FOREST RESOUR; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Franklin J, 2009, MAPPING SPECIES DIST; Garavito N. T., 2014, REGIONAL RED LIST MO; Garavito N.T., 2012, ECOSISTEMAS, P1; Golicher DJ, 2012, BIOTROPICA, V44, P284, DOI 10.1111/j.1744-7429.2011.00815.x; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; HASTIE T, 2008, GAM GEN ADDITIVE MOD; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hilbert DW, 2004, BIOL CONSERV, V116, P367, DOI 10.1016/S0006-3207(03)00230-1; Ibanez I, 2006, ECOLOGY, V87, P1896, DOI 10.1890/0012-9658(2006)87[1896:PBCOTC]2.0.CO;2; IPCC, 2000, IPCC SPEC REP EM SCE, P20; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; IUCN, 2022, GUID US IUCN RED LIS; IUCN U.-W., 2012, WORLD DAT PROT AR WD; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Karatzoglou A, 2013, SUPPORT VECTOR MACHI; Ladle RJ, 2005, INTERDISCIPL SCI REV, V30, P231, DOI 10.1179/030801805X42036; Lamoreux J, 2003, TRENDS ECOL EVOL, V18, P214, DOI 10.1016/S0169-5347(03)00090-9; Laurance WF, 2011, BIOL CONSERV, V144, P548, DOI 10.1016/j.biocon.2010.10.010; Leadley P., 2010, TECHNICAL SERIES SEC, V50, P1; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; Lomolino MV, 2004, CONSERVATION BIOGEOG, P293; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson D.M., 1997, GLOBAL 200 CONSERVIN; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Ponce-Reyes R, 2013, DIVERS DISTRIB, V19, P518, DOI 10.1111/ddi.12064; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; R Core Team, 2016, R FDN STAT COMP; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Ramirez J, 2012, HIGH RESOLUTION STAT; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Secretariat of the Convention on Biological Diversity (SCDB), 2010, GLOB BIOD OUTL, V3; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Staudt A, 2013, FRONT ECOL ENVIRON, V11, P494, DOI 10.1890/120275; Stein BA, 2013, FRONT ECOL ENVIRON, V11, P502, DOI 10.1890/120277; Swab RM, 2012, J BIOGEOGR, V39, P1266, DOI 10.1111/j.1365-2699.2012.02690.x; Therneau T., 2013, RPART RECURSIVE PART; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Tovar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063634; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Urrutia R, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011021; Van Bogaert E., 2012, GLOBAL LAND COVER MA; van Vuuren DP, 2006, ECOL SOC, V11; Vuille M, 2000, GEOPHYS RES LETT, V27, P3885, DOI 10.1029/2000GL011871; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x; Young KR, 2007, PHYS GEOGRAPHY S AM, P200	80	10	11	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131388	10.1371/journal.pone.0131388	http://dx.doi.org/10.1371/journal.pone.0131388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177097	Green Published, gold, Green Accepted			2022-12-27	WOS:000358197600043
J	Li, SW; Shi, RF; Leng, Y				Li, Shi-Weng; Shi, Rui-Fang; Leng, Yan			De Novo Characterization of the Mung Bean Transcriptome and Transcriptomic Analysis of Adventitious Rooting in Seedlings Using RNA-Seq	PLOS ONE			English	Article							GENE-EXPRESSION; GENOME ANNOTATION; HYDROGEN-PEROXIDE; IN-VITRO; AUXIN; PLANT; ARABIDOPSIS; LIGNIN; ACID; IDENTIFICATION	Adventitious rooting is the most important mechanism underlying vegetative propagation and an important strategy for plant propagation under environmental stress. The present study was conducted to obtain transcriptomic data and examine gene expression using RNA-Seq and bioinformatics analysis, thereby providing a foundation for understanding the molecular mechanisms controlling adventitious rooting. Three cDNA libraries constructed from mRNA samples from mung bean hypocotyls during adventitious rooting were sequenced. These three samples generated a total of 73 million, 60 million, and 59 million 100-bp reads, respectively. These reads were assembled into 78,697 unigenes with an average length of 832 bp, totaling 65 Mb. The unigenes were aligned against six public protein databases, and 29,029 unigenes (36.77%) were annotated using BLASTx. Among them, 28,225 (35.75%) and 28,119 (35.62%) unigenes had homologs in the TrEMBL and NCBI non-redundant (Nr) databases, respectively. Of these unigenes, 21,140 were assigned to gene ontology classes, and a total of 11,990 unigenes were classified into 25 KOG functional categories. A total of 7,357 unigenes were annotated to 4,524 KOs, and 4,651 unigenes were mapped onto 342 KEGG pathways using BLAST comparison against the KEGG database. A total of 11,717 unigenes were differentially expressed (fold change>2) during the root induction stage, with 8,772 unigenes down-regulated and 2,945 unigenes up-regulated. A total of 12,737 unigenes were differentially expressed during the root initiation stage, with 9,303 unigenes down-regulated and 3,434 unigenes up-regulated. A total of 5,334 unigenes were differentially expressed between the root induction and initiation stage, with 2,167 unigenes down-regulated and 3,167 unigenes up-regulated. qRT-PCR validation of the 39 genes with known functions indicated a strong correlation (92.3%) with the RNA-Seq data. The GO enrichment, pathway mapping, and gene expression profiles reveal molecular traits for root induction and initiation. This study provides a platform for functional genomic research with this species.	[Li, Shi-Weng; Shi, Rui-Fang; Leng, Yan] Lanzhou Jiaotong Univ, Sch Chem & Biol Engn, Key Lab Extreme Environm Microbial Resources & En, Lanzhou 730070, Peoples R China	Lanzhou Jiaotong University	Li, SW (corresponding author), Lanzhou Jiaotong Univ, Sch Chem & Biol Engn, Key Lab Extreme Environm Microbial Resources & En, 88 West Anning Rd, Lanzhou 730070, Peoples R China.	lishweng@mail.lzjtu.cn	Li, Shi-Weng/J-6005-2019	Li, Shi Weng/0000-0002-2584-0562	National Natural Science Foundation of China [31260090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31260090).	Alvarez S, 2008, PLANT CELL ENVIRON, V31, P325, DOI 10.1111/j.1365-3040.2007.01770.x; Annadurai RS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-663; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai XG, 2012, PLANT PHYSIOL, V158, P725, DOI 10.1104/pp.111.185769; Barrero RA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-600; Batish DR, 2008, J PLANT PHYSIOL, V165, P297, DOI 10.1016/j.jplph.2007.05.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOUDET AM, 1995, NEW PHYTOL, V129, P203, DOI 10.1111/j.1469-8137.1995.tb04292.x; Braun N, 2008, PLANT CELL, V20, P2746, DOI 10.1105/tpc.108.059048; Brinker M, 2004, PLANT PHYSIOL, V135, P1526, DOI 10.1104/pp.103.032235; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Cho M, 2007, PLANT CELL, V19, P3930, DOI 10.1105/tpc.107.054288; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Davin LB, 2008, NAT PROD REP, V25, P1015, DOI 10.1039/b510386j; De Klerk GJ, 1999, IN VITRO CELL DEV-PL, V35, P189, DOI 10.1007/s11627-999-0076-z; DEKLERK GJ, 1995, J EXP BOT, V46, P965, DOI 10.1093/jxb/46.8.965; DeKlerk GJ, 1997, BIOL PLANTARUM, V39, P53, DOI 10.1023/A:1000304922507; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hatzilazarou SP, 2006, J PLANT PHYSIOL, V163, P827, DOI 10.1016/j.jplph.2005.06.018; Holmes P, 2010, FUNCT PLANT BIOL, V37, P1117, DOI 10.1071/FP10159; Holmes P, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-21; Huang HH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-648; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li SW, 2014, ENVIRON SCI POLLUT R, V21, P525, DOI 10.1007/s11356-013-1942-0; Li SW, 2009, ENVIRON EXP BOT, V66, P442, DOI 10.1016/j.envexpbot.2009.03.005; Li SW, 2009, BOT REV, V75, P230, DOI 10.1007/s12229-009-9029-9; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Metaxas DJ, 2004, PLANT GROWTH REGUL, V44, P257, DOI 10.1007/s10725-004-5931-7; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MYLONA P, 1994, PLANT MOL BIOL, V26, P39, DOI 10.1007/BF00039518; Negi S, 2010, PLANT J, V61, P3, DOI 10.1111/j.1365-313X.2009.04027.x; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Ramirez-Carvajal GA, 2010, PLANT SIGNAL BEHAV, V5, P281, DOI 10.4161/psb.5.3.10705; Ramirez-Carvajal GA, 2009, PLANT PHYSIOL, V150, P759, DOI 10.1104/pp.109.137505; Rigal A, 2012, PLANT PHYSIOL, V160, P1996, DOI 10.1104/pp.112.204453; Rorat T, 2006, CELL MOL BIOL LETT, V11, P536, DOI 10.2478/s11658-006-0044-0; Macedo ES, 2012, PLANT CELL REP, V31, P1581, DOI 10.1007/s00299-012-1272-6; Schafleitner R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1556-7; Shin R, 2007, PLANT CELL, V19, P2440, DOI 10.1105/tpc.107.050963; Sorin C, 2006, PLANT PHYSIOL, V140, P349, DOI 10.1104/pp.105.067868; Sweetman C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-691; Tamagnone L, 1998, PLANT CELL, V10, P1801, DOI 10.1105/tpc.10.11.1801; Tromas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006648; Turktas M, 2015, TURK J AGRIC FOR, V39, P361, DOI 10.3906/tar-1409-93; Vidoz ML, 2010, PLANT J, V63, P551, DOI 10.1111/j.1365-313X.2010.04262.x; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wei K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107201; WIESMAN Z, 1988, PHYSIOL PLANTARUM, V74, P556, DOI 10.1111/j.1399-3054.1988.tb02018.x; Wong MML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-342; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Yang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084580; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zazimalova E, 2007, CELL MOL LIFE SCI, V64, P1621, DOI 10.1007/s00018-007-6566-4	66	32	36	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132969	10.1371/journal.pone.0132969	http://dx.doi.org/10.1371/journal.pone.0132969			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177103	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600193
J	Pont-Sunyer, C; Iranzo, A; Gaig, C; Fernandez-Arcos, A; Vilas, D; Valldeoriola, F; Compta, Y; Fernandez-Santiago, R; Fernandez, M; Bayes, A; Calopa, M; Casquero, P; de Fabregues, O; Jauma, S; Puente, V; Salamero, M; Marti, MJ; Santamaria, J; Tolosa, E				Pont-Sunyer, Claustre; Iranzo, Alex; Gaig, Carles; Fernandez-Arcos, Ana; Vilas, Dolores; Valldeoriola, Francesc; Compta, Yaroslau; Fernandez-Santiago, Ruben; Fernandez, Manel; Bayes, Angels; Calopa, Matilde; Casquero, Pilar; de Fabregues, Oriol; Jauma, Serge; Puente, Victor; Salamero, Manel; Marti, Maria Jose; Santamaria, Joan; Tolosa, Eduard			Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; RESTLESS LEGS SYNDROME; QUALITY-OF-LIFE; BEHAVIOR DISORDER; REM-SLEEP; G2019S MUTATION; DIAGNOSTIC-CRITERIA; DISEASE PATIENTS; RATING-SCALE; PENETRANCE	Objective In idiopathic Parkinson disease (IPD) sleep disorders are common and may antedate the onset of parkinsonism. Based on the clinical similarities between IPD and Parkinson disease associated with LRRK2 gene mutations (LRRK2-PD), we aimed to characterize sleep in parkinsonian and nonmanifesting LRRK2 mutation carriers (NMC). Methods A comprehensive interview conducted by sleep specialists, validated sleep scales and questionnaires, and video-polysomnography followed by multiple sleep latency test (MSLT) assessed sleep in 18 LRRK2-PD (17 carrying G2019S and one R1441G mutations), 17 NMC (11 G2019S, three R1441G, three R1441C), 14 non-manifesting non-carriers (NMNC) and 19 unrelated IPD. Results Sleep complaints were frequent in LRRK2-PD patients; 78% reported poor sleep quality, 33% sleep onset insomnia, 56% sleep fragmentation and 39% early awakening. Sleep onset insomnia correlated with depressive symptoms and poor sleep quality. In LRRK2-PD, excessive daytime sleepiness (EDS) was a complaint in 33% patients and short sleep latencies on the MSLT, which are indicative of objective EDS, were found in 71%. Sleep attacks occurred in three LRRK2-PD patients and a narcoleptic phenotype was not observed. REM sleep behavior disorder (RBD) was diagnosed in three LRRK2-PD. EDS and RBD were always reported to start after the onset of parkinsonism in LRRK2-PD. In NMC, EDS was rarely reported and RBD was absent. When compared to IPD, sleep onset insomnia was more significantly frequent, EDS was similar, and RBD was less significantly frequent and less severe in LRRK2-PD. In NMC, RBD was not detected and sleep complaints were much less frequent than in LRRK2-PD. No differences were observed in sleep between NMC and NMNC. Conclusions Sleep complaints are frequent in LRRK2-PDand show a pattern that when compared to IPD is characterized by more frequent sleep onset insomnia, similar EDS and less prominent RBD. Unlike in IPD, RBD and EDS seem to be not markers of the prodromal stage of LRRK2-PD.	[Pont-Sunyer, Claustre; Vilas, Dolores; Valldeoriola, Francesc; Compta, Yaroslau; Marti, Maria Jose; Tolosa, Eduard] Univ Barcelona, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Hosp Clin Barcelona,Neurol Serv,Parkinsons Dis &, Barcelona, Spain; [Iranzo, Alex; Gaig, Carles; Fernandez-Arcos, Ana; Santamaria, Joan] Univ Barcelona, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Hosp Clin Barcelona,Neurol Serv,Multidisciplinary, Barcelona, Spain; [Fernandez-Santiago, Ruben; Fernandez, Manel] Univ Barcelona, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Dept Clin & Expt Neurol,Hosp Clin Barcelona,Lab N, Barcelona, Spain; [Bayes, Angels] Unidad Parkinson Teknon, Barcelona, Spain; [Calopa, Matilde; Jauma, Serge] Hosp Univ Bellvitge, Neurol Serv, Barcelona, Spain; [Casquero, Pilar] Hosp Mateu Orfila, Mao, Menorca, Spain; [de Fabregues, Oriol] Hosp Univ Vall DHebron, Neurol Serv, Barcelona, Spain; [Puente, Victor] Hosp Del Mar, Neurol Serv, Barcelona, Spain; [Salamero, Manel] Hosp Clin Barcelona, Psychol Serv, Barcelona, Spain	CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Mateu Orfila; Hospital Universitari Vall d'Hebron; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; Hospital Clinic de Barcelona	Iranzo, A (corresponding author), Univ Barcelona, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Hosp Clin Barcelona,Neurol Serv,Multidisciplinary, Barcelona, Spain.	airanzo@clinic.ub.es	Vilas, Dolores/AAB-7244-2019; Fernández-Santiago, Rubén/K-3808-2014; De Fabregues, Oriol/AAG-7420-2020; Compta, Yaroslau/U-8298-2017; Bayés, Àngels/AAB-3873-2019; Fernandez, Manel/AAC-2447-2020	Fernández-Santiago, Rubén/0000-0002-4582-0702; De Fabregues, Oriol/0000-0002-3518-5338; Compta, Yaroslau/0000-0001-6443-0104; Fernandez, Manel/0000-0002-8558-9920; Calopa, Matilde/0000-0002-6943-3707; Pont-Sunyer, Claustre/0000-0003-1102-7746	"La Fundacio la Marato de TV3" [061130/31]	"La Fundacio la Marato de TV3"	This manuscript received support through the grant number 061130/31 from "La Fundacio la Marato de TV3" to Eduard Tolosa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 2005, NEUROLOGY, V65, P1442, DOI 10.1212/01.wnl.0000183056.89590.0d; Alcalay RN, 2013, MOVEMENT DISORD, V28, P1966, DOI 10.1002/mds.25647; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; [Anonymous], 2014, INT CLASSIFICATION S, V3rd; Arnulf I, 2002, NEUROLOGY, V58, P1019, DOI 10.1212/WNL.58.7.1019; Ataide Marcelo, 2014, Sleep Disord, V2014, P767181, DOI 10.1155/2014/767181; Belarbi S, 2010, PARKINSONISM RELAT D, V16, P676, DOI 10.1016/j.parkreldis.2010.09.003; Berg D, 2005, BRAIN, V128, P3000, DOI 10.1093/brain/awh666; Brockmann K, 2011, MOVEMENT DISORD, V26, P2335, DOI 10.1002/mds.23991; Buskova J, 2011, J NEUROL, V258, P2254, DOI 10.1007/s00415-011-6109-7; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Chahine LM, 2013, MOVEMENT DISORD, V28, P1146, DOI 10.1002/mds.25438; De Cock VC, 2008, NAT CLIN PRACT NEURO, V4, P254, DOI 10.1038/ncpneuro0775; De Cock VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107278; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Frauscher B, 2012, SLEEP, V35, P835, DOI 10.5665/sleep.1886; Gaig C, 2006, ARCH NEUROL-CHICAGO, V63, P377, DOI 10.1001/archneur.63.3.377; Gaig C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108982; Gaig CI A, 2013, J NEUROL S1, pS32; Gallego ML., 2009, ALZHEIMER REAL INVES, V43, P4; Gao JJ, 2011, AM J EPIDEMIOL, V173, P1032, DOI 10.1093/aje/kwq478; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Goldwurm S, 2006, PARKINSONISM RELAT D, V12, P410, DOI 10.1016/j.parkreldis.2006.04.001; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hobson DE, 2002, JAMA-J AM MED ASSOC, V287, P455, DOI 10.1001/jama.287.4.455; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Iber C., 2007, AASM MANUAL SCORING; Iranzo A, 2005, NEUROLOGY, V65, P247, DOI 10.1212/01.wnl.0000168864.97813.e0; Iranzo A, 2005, SLEEP, V28, P203, DOI 10.1093/sleep/28.2.203; Iranzo A, 2013, LANCET NEUROL, V12, P443, DOI 10.1016/S1474-4422(13)70056-5; Iranzo A, 2011, J NEUROL SCI, V310, P283, DOI 10.1016/j.jns.2011.07.049; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Johansen KK, 2011, PARKINSONISM RELAT D, V17, P528, DOI 10.1016/j.parkreldis.2011.04.014; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kalia LV, 2015, JAMA NEUROL, V72, P100, DOI 10.1001/jamaneurol.2014.2704; Marras C, 2011, NEUROLOGY, V77, P325, DOI 10.1212/WNL.0b013e318227042d; Martinez-Martin P, 1998, J NEUROL, V245, pS34, DOI 10.1007/PL00007737; Martinez-Martin P, 2011, J NEUROL SCI, V310, P12, DOI 10.1016/j.jns.2011.05.006; Merino-Andreu M, 2003, NEUROLOGY, V60, P1553, DOI 10.1212/01.WNL.0000058905.71369.97; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Peever J, 2014, TRENDS NEUROSCI, V37, P279, DOI 10.1016/j.tins.2014.02.009; Plomhause L, 2013, SLEEP MED, V14, P1035, DOI 10.1016/j.sleep.2013.04.018; Prudon B, 2014, MOVEMENT DISORD, V29, P259, DOI 10.1002/mds.25730; Ruiz-Martinez J, 2011, MOVEMENT DISORD, V26, P2026, DOI 10.1002/mds.23773; Santamaria J, 2004, NEUROLOGY, V63, pS21, DOI 10.1212/WNL.63.8_suppl_3.S21; Schwab R.S., 1969, 3 S PARK DIS, P152; Sierra M, 2013, NEUROLOGY, V80, P621, DOI 10.1212/WNL.0b013e31828250d6; Sierra M, 2011, MOVEMENT DISORD, V26, P2343, DOI 10.1002/mds.23965; Stiasny-Kolster K, 2007, MOVEMENT DISORD, V22, P2386, DOI 10.1002/mds.21740; Suzuki K, 2015, ACTA NEUROL SCAND, V131, P426, DOI 10.1111/ane.12347; Tolosa E, 2011, J NEUROL SCI, V310, P4, DOI 10.1016/j.jns.2011.05.027; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Trenkwalder C, 2011, MOVEMENT DISORD, V26, P644, DOI 10.1002/mds.23476; Valldeoriola F, 2011, J NEUROL, V258, P1126, DOI 10.1007/s00415-010-5896-6; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	60	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132368	10.1371/journal.pone.0132368	http://dx.doi.org/10.1371/journal.pone.0132368			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177462	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600107
J	Rueda-Cediel, P; Anderson, KE; Regan, TJ; Franklin, J; Regan, HM				Rueda-Cediel, Pamela; Anderson, Kurt E.; Regan, Tracey J.; Franklin, Janet; Regan, Helen M.			Combined Influences of Model Choice, Data Quality, and Data Quantity When Estimating Population Trends	PLOS ONE			English	Article							ENDANGERED SPECIES ACT; VIABILITY ANALYSIS; OBSERVATION ERROR; EXTINCTION MODELS; RISK; DYNAMICS; RECOVERY; GROWTH; VARIABILITY; ASSESSMENTS	Estimating and projecting population trends using population viability analysis (PVA) are central to identifying species at risk of extinction and for informing conservation management strategies. Models for PVA generally fall within two categories, scalar (count-based) or matrix (demographic). Model structure, process error, measurement error, and time series length all have known impacts in population risk assessments, but their combined impact has not been thoroughly investigated. We tested the ability of scalar and matrix PVA models to predict percent decline over a ten-year interval, selected to coincide with the IUCN Red List criterion A. 3, using data simulated for a hypothetical, short-lived organism with a simple life-history and for a threatened snail, Tasmaphena lamproides. PVA performance was assessed across different time series lengths, population growth rates, and levels of process and measurement error. We found that the magnitude of effects of measurement error, process error, and time series length, and interactions between these, depended on context. We found that high process and measurement error reduced the reliability of both models in predicted percent decline. Both sources of error contributed strongly to biased predictions, with process error tending to contribute to the spread of predictions more than measurement error. Increasing time series length improved precision and reduced bias of predicted population trends, but gains substantially diminished for time series lengths greater than 10-15 years. The simple parameterization scheme we employed contributed strongly to bias in matrix model predictions when both process and measurement error were high, causing scalar models to exhibit similar or greater precision and lower bias than matrix models. Our study provides evidence that, for short-lived species with structured but simple life histories, short time series and simple models can be sufficient for reasonably reliable conservation decision-making, and may be preferable for population projections when unbiased estimates of vital rates cannot be obtained.	[Rueda-Cediel, Pamela; Anderson, Kurt E.; Regan, Helen M.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Regan, Tracey J.] Arthur Rylah Inst Environm Res, Heidelberg, Vic, Australia; [Regan, Tracey J.] Univ Melbourne, Sch Biosci, Parkville, Vic 3052, Australia; [Franklin, Janet] Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ 85287 USA	University of California System; University of California Riverside; Arthur Rylah Institute for Environmental Research (ARI); University of Melbourne; Arizona State University; Arizona State University-Tempe	Anderson, KE (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	kurt.anderson@ucr.edu	Anderson, Kurt E/A-1339-2013		National Science Foundation [DEB-0824708, EF-1065753]; California Landscape Conservation Cooperative [5288768]	National Science Foundation(National Science Foundation (NSF)); California Landscape Conservation Cooperative	This research was supported by the National Science Foundation (www.nsf.gov; DEB-0824708, and EF-1065753) and the California Landscape Conservation Cooperative (californialcc.org; 5288768) through grants to HMR, JF and KEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, 1999, APPL POPULAR ECOLOGY; Andelman SJ, 2004, ACTA OECOL, V26, P75, DOI 10.1016/j.actao.2004.04.005; Baxter PWJ, 2005, ECOL APPL, V15, P1331, DOI 10.1890/02-5382; Beissinger SR, 2002, POPULATION VIABILITY ANALYSIS, P5; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Boor GKH, 2014, CONSERV BIOL, V28, P33, DOI 10.1111/cobi.12155; BURGMAN MA, 1988, BIOL CONSERV, V43, P9, DOI 10.1016/0006-3207(88)90075-4; BURGMAN MA, 1993, RISK ASSESMENT CONSE; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; De Valpine P, 2002, ECOL MONOGR, V72, P57, DOI 10.1890/0012-9615(2002)072[0057:FPMIPN]2.0.CO;2; Dennis B, 2010, ECOLOGY, V91, P610, DOI 10.1890/08-1095.1; DOAK D, 1994, ECOL APPL, V4, P446, DOI 10.2307/1941949; Drake JM, 2004, ECOL LETT, V7, P26, DOI 10.1046/j.1461-0248.2003.00546.x; Dunham AE, 2006, CONSERV BIOL, V20, P1499, DOI 10.1111/j.1523-1739.2006.00474.x; Fieberg J, 2000, ECOLOGY, V81, P2040; Holmes EE, 2001, P NATL ACAD SCI USA, V98, P5072, DOI 10.1073/pnas.081055898; Holmes EE, 2007, ECOL LETT, V10, P1182, DOI 10.1111/j.1461-0248.2007.01105.x; Hovestadt T, 2008, BIODIVERS CONSERV, V17, P3417, DOI 10.1007/s10531-008-9426-0; Humbert JY, 2009, OIKOS, V118, P1940, DOI 10.1111/j.1600-0706.2009.17839.x; IUCN Standards and Petitions Subcommittee, 2014, GUID IUCN RED LIST C; Lande R., 2003, OXFORD SERIES ECOLOG; LEWONTIN RC, 1969, P NATL ACAD SCI USA, V62, P1056, DOI 10.1073/pnas.62.4.1056; Linden A, 2009, OIKOS, V118, P675, DOI 10.1111/j.1600-0706.2008.17250.x; MARTIN TE, 1992, ECOLOGY, V73, P579, DOI 10.2307/1940764; McCarthy MA, 2003, CONSERV BIOL, V17, P982, DOI 10.1046/j.1523-1739.2003.01570.x; Meir E, 2000, CONSERV BIOL, V14, P148, DOI 10.1046/j.1523-1739.2000.98502.x; Morris W. F., 2002, QUANTITATIVE CONSERV; Morris WF, 2002, ECOL APPL, V12, P708, DOI 10.2307/3060981; Oli MK, 2003, AM NAT, V161, P422, DOI 10.1086/367591; Regan HM, 2010, ECOLOGY, V91, P1114, DOI 10.1890/09-0287.1; Regan HM, 2003, HUM ECOL RISK ASSESS, V9, P889, DOI 10.1080/713610015; Regan TJ, 2001, ECOL MODEL, V139, P253, DOI 10.1016/S0304-3800(01)00240-X; Regan TJ, 2013, CONSERV BIOL, V27, P821, DOI 10.1111/cobi.12055; Shaffer M, 2002, POPULATION VIABILITY ANALYSIS, P123; SHAFFER ML, 1990, CONSERV BIOL, V4, P39, DOI 10.1111/j.1523-1739.1990.tb00265.x; Stover JP, 2012, THEOR ECOL-NETH, V5, P297, DOI 10.1007/s12080-011-0129-x; The Mathworks Inc, 2007, MATLAB VER 7 14 0; TULJAPURKAR SD, 1980, THEOR POPUL BIOL, V18, P314, DOI 10.1016/0040-5809(80)90057-X; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilson HB, 2011, CONSERV BIOL, V25, P747, DOI 10.1111/j.1523-1739.2011.01671.x; Zeigler SL, 2013, CONSERV BIOL, V27, P1265, DOI 10.1111/cobi.12130	41	16	16	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132255	10.1371/journal.pone.0132255	http://dx.doi.org/10.1371/journal.pone.0132255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177511	Green Published, gold			2022-12-27	WOS:000358197600093
J	Sun, Y; Zhu, DM; Wang, GH; Wang, D; Zhou, HS; Liu, XT; Jiang, ML; Liao, LJ; Zhou, ZG; Hu, JY				Sun, Yi; Zhu, Demao; Wang, Guihua; Wang, Di; Zhou, Huashan; Liu, Xueting; Jiang, Manli; Liao, Lingjuan; Zhou, Zhiguang; Hu, Jinyue			Pro-Inflammatory Cytokine IL-1 beta Up-Regulates CXC Chemokine Receptor 4 via Notch and ERK Signaling Pathways in Tongue Squamous Cell Carcinoma	PLOS ONE			English	Article							LYMPHOID-TISSUE LYMPHOMA; GROWTH IN-VITRO; BREAST-CANCER; HUMAN-PAPILLOMAVIRUS; HELICOBACTER-PYLORI; TUMOR-SUPPRESSOR; GASTRIC-CANCER; BONE-MARROW; EXPRESSION; INTERLEUKIN-1	Chronic inflammation contributes to tumor development through the induction of oncogenic mutations, genomic instability, early tumor promotion, and enhanced angiogenesis. Here, we report that IL-1 receptor 1 (IL-1R1) was expressed in 40 of 41 human tongue squamous cell carcinomas (TSCC). IL-1 beta up-regulated the expression of CXCR4, a CXC chemokine receptor that mediates cancer growth and metastasis, at both mRNA and protein levels in Tca8113 TSCC cells. IL-1 beta treatment of Tca8113 cells promoted migration in response to CXCR4 ligand stromal-derived factor a (SDF-1 alpha). The inhibition of IL-1R1 by its antagonist IL-1Ra or RNA interference significantly reversed the up-regulation of CXCR4 induced by IL-1 beta. IL-1R1 activation also up-regulated the expression of IL-1 beta itself, suggesting a positive feedback regulation of CXCR4 expression. Furthermore, IL-1 beta induced the activation of Notch, which was originally considered a stem cell regulator. Pharmacological inhibition of Notch signaling reversed the up-regulation of CXCR4 induced by IL-1 beta, suggesting that Notch signaling may be involved in the growth and metastasis of cancers via up-regulation of CXCR4. In addition, IL-1 beta induced the activation of extracellular signal regulated kinase (ERK) and ERK inhibition decreased the up-regulation of CXCR4 induced by IL-1 beta, suggesting the involvement of ERK signaling in cancer metastasis. Taken together these data suggest that IL-1 beta and IL-1R1 promote cancer growth and metastasis by up-regulating CXCR4 expression and that CXCR4 may be a link between inflammation and cancer.	[Sun, Yi] Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China; [Sun, Yi; Liu, Xueting; Jiang, Manli; Liao, Lingjuan; Hu, Jinyue] Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China; [Zhu, Demao; Zhou, Huashan] Changsha Cent Hosp, Dept Pathol, Changsha, Hunan, Peoples R China; [Wang, Guihua; Wang, Di] Changsha Cent Hosp, Dept Oncol, Changsha, Hunan, Peoples R China; [Zhou, Zhiguang] Cent S Univ, Xiangya Hosp 2, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Zhou, ZG (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China.	zhouzg@hotmail.com; jinyueh@yahoo.com		Zhou, Zhiguang/0000-0002-0374-1838	National Natural Science Foundation of China [81172042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (JH, 81172042, www.nsfc.gov.cn).	Asnaghi L, 2012, CLIN CANCER RES, V18, P654, DOI 10.1158/1078-0432.CCR-11-1406; Barber MD, 2000, BRIT J CANCER, V83, P1443, DOI 10.1054/bjoc.2000.1479; Brozovic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076397; Choi C, 2014, ONCOGENE, V33, P3668, DOI 10.1038/onc.2013.341; Clifford G, 2007, LANCET, V370, P6, DOI 10.1016/S0140-6736(07)61023-X; Gonzalez-Losa MD, 2009, ORAL ONCOL, V45, pE72, DOI 10.1016/j.oraloncology.2009.02.002; Didigu CA, 2014, BLOOD, V123, P61, DOI 10.1182/blood-2013-08-521229; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Elango KJ, 2011, ASIAN PAC J CANCER P, V12, P889; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; Fang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062823; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gromminger S, 2012, BRIT J HAEMATOL, V156, P719, DOI 10.1111/j.1365-2141.2011.09007.x; Guo MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090518; Hasegawa M, 2012, J IMMUNOL, V189, P3085, DOI 10.4049/jimmunol.1200821; Hefler LA, 2005, CLIN CANCER RES, V11, P5718, DOI 10.1158/1078-0432.CCR-05-0001; Hu JY, 2005, CLIN CANCER RES, V11, P4658, DOI 10.1158/1078-0432.CCR-04-1798; Hu ZB, 2006, CANCER LETT, V236, P269, DOI 10.1016/j.canlet.2005.05.015; Ito M, 2014, BLOOD, V123, P1499, DOI 10.1182/blood-2013-09-527739; Kauppila JH, 2013, BRIT J CANCER, V108, P638, DOI 10.1038/bjc.2012.589; Kew MC, 2013, J VIRAL HEPATITIS, V20, P149, DOI 10.1111/jvh.12043; Kikuchi Y, 2014, AM J PATHOL, V184, P859, DOI 10.1016/j.ajpath.2013.11.012; Kochetkova M, 2009, CELL DEATH DIFFER, V16, P664, DOI 10.1038/cdd.2008.190; Lee JH, 2010, CANCER LETT, V290, P68, DOI 10.1016/j.canlet.2009.08.027; Lewis AM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-48; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091509; Lindmark F, 2005, BRIT J CANCER, V93, P493, DOI 10.1038/sj.bjc.6602729; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Marignol L, 2013, NAT REV UROL, V10, P405, DOI 10.1038/nrurol.2013.110; Mirandola L, 2013, LEUKEMIA, V27, P1558, DOI 10.1038/leu.2013.27; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakamura S, 2013, WORLD J GASTROENTERO, V19, P8181, DOI 10.3748/wjg.v19.i45.8181; Neufert C, 2013, J CLIN INVEST, V123, P1428, DOI 10.1172/JCI63748; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nordfors C, 2013, EUR J CANCER, V49, P2522, DOI 10.1016/j.ejca.2013.03.019; Oh JW, 2001, J IMMUNOL, V166, P2695, DOI 10.4049/jimmunol.166.4.2695; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Renshaw J, 2013, CLIN CANCER RES, V19, P5940, DOI 10.1158/1078-0432.CCR-13-0850; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; South AP, 2012, SEMIN CELL DEV BIOL, V23, P458, DOI 10.1016/j.semcdb.2012.01.017; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Suman S, 2013, BRIT J CANCER, V109, P2587, DOI 10.1038/bjc.2013.642; Sun RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.178798; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x; Tsimplaki E, 2014, ANTICANCER RES, V34, P1021; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007572; Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089991; Wang YC, 2009, J BIOL CHEM, V284, P15993, DOI 10.1074/jbc.M901144200; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Williams CK, 2008, CANCER RES, V68, P1889, DOI 10.1158/0008-5472.CAN-07-2181; Wu S, 2013, CANCER LETT, V337, P293, DOI 10.1016/j.canlet.2013.04.003; Wundisch T, 2012, GASTROENTEROLOGY, V143, P936, DOI 10.1053/j.gastro.2012.06.035; Xie J, 2013, CELL IMMUNOL, V281, P68, DOI 10.1016/j.cellimm.2013.02.001; Yang YN, 2011, J CLIN INVEST, V121, P1373, DOI 10.1172/JCI42579; Yu T, 2014, ONCOGENE, V33, P5017, DOI 10.1038/onc.2013.448; Zaghloul Mohamed S, 2008, J Egypt Natl Canc Inst, V20, P168; Zhang DP, 2014, CANCER LETT, V348, P100, DOI 10.1016/j.canlet.2014.03.006; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049	65	20	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132677	10.1371/journal.pone.0132677	http://dx.doi.org/10.1371/journal.pone.0132677			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176534	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600141
J	Depiereux, S; De Meulder, B; Bareke, E; Berger, F; Le Gac, F; Depiereux, E; Kestemont, P				Depiereux, Sophie; De Meulder, Bertrand; Bareke, Eric; Berger, Fabrice; Le Gac, Florence; Depiereux, Eric; Kestemont, Patrick			Adaptation of a Bioinformatics Microarray Analysis Workflow for a Toxicogenomic Study in Rainbow Trout	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; FALSE DISCOVERY RATE; MOLECULAR RESPONSES; SEX-DIFFERENTIATION; ONCORHYNCHUS-MYKISS; POWERFUL APPROACH; T-TEST; FISH; IDENTIFICATION; ONTOLOGY	Sex steroids play a key role in triggering sex differentiation in fish, the use of exogenous hormone treatment leading to partial or complete sex reversal. This phenomenon has attracted attention since the discovery that even low environmental doses of exogenous steroids can adversely affect gonad morphology (ovotestis development) and induce reproductive failure. Modern genomic-based technologies have enhanced opportunities to find out mechanisms of actions (MOA) and identify biomarkers related to the toxic action of a compound. However, high throughput data interpretation relies on statistical analysis, species genomic resources, and bioinformatics tools. The goals of this study are to improve the knowledge of feminisation in fish, by the analysis of molecular responses in the gonads of rainbow trout fry after chronic exposure to several doses (0.01, 0.1, 1 and 10 mu g/L) of ethynylestradiol (EE2) and to offer target genes as potential biomarkers of ovotestis development. We successfully adapted a bioinformatics microarray analysis workflow elaborated on human data to a toxicogenomic study using rainbow trout, a fish species lacking accurate functional annotation and genomic resources. The workflow allowed to obtain lists of genes supposed to be enriched in true positive differentially expressed genes (DEGs), which were subjected to over-representation analysis methods (ORA). Several pathways and ontologies, mostly related to cell division and metabolism, sexual reproduction and steroid production, were found significantly enriched in our analyses. Moreover, two sets of potential ovotestis biomarkers were selected using several criteria. The first group displayed specific potential biomarkers belonging to pathways/ontologies highlighted in the experiment. Among them, the early ovarian differentiation gene foxl2a was overexpressed. The second group, which was highly sensitive but not specific, included the DEGs presenting the highest fold change and lowest p-value of the statistical workflow output. The methodology can be generalized to other (non-model) species and various types of microarray platforms.	[Depiereux, Sophie; Kestemont, Patrick] Univ Namur, Lab Ecophysiol & Ecotoxicol, Unit Res Environm & Evolutionary Biol URBE NARILI, Namur, Belgium; [De Meulder, Bertrand; Bareke, Eric; Berger, Fabrice; Depiereux, Eric] Univ Namur, Unit Res Mol Biol URBM NARILIS, Namur, Belgium; [Le Gac, Florence] INRA, LPGP, UPR1037, F-35042 Rennes, France; [Bareke, Eric] Univ Montreal, St Justine UHC Res Ctr, Montreal, PQ H3T 1C5, Canada	University of Namur; University of Namur; INRAE; Universite de Montreal	Depiereux, S (corresponding author), Univ Namur, Lab Ecophysiol & Ecotoxicol, Unit Res Environm & Evolutionary Biol URBE NARILI, Namur, Belgium.	sophie.depiereux@unamur.be		Bareke, Eric/0000-0003-3928-7160	'Fond de la recherche scientifique' (FNRS)	'Fond de la recherche scientifique' (FNRS)(Fonds de la Recherche Scientifique - FNRS)	SD was funded by a grant from the 'Fond de la recherche scientifique' (FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agilent Technologies, ON COL MICR BAS GEN, P92; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Baron D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-357; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger F, 2008, CENT EUR J BIOL, V3, P327, DOI 10.2478/s11535-008-0030-9; Berger F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-510; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cope LM, 2004, BIOINFORMATICS, V20, P323, DOI 10.1093/bioinformatics/btg410; Currie RA, 2005, REPROD TOXICOL, V20, P433, DOI 10.1016/j.reprotox.2005.03.014; Dagnelie P., 2013, STAT THEORIQUE APPL, V3e; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; De Hertogh B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-17; De Meulder B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086699; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Denslow ND, 2007, MOL BIOSYST, V3, P172, DOI 10.1039/b612802p; Depiereux S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098531; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Dietrich DR, 2009, HISTOLOGICAL ANAL EN; Dudoit S, 2002, STAT SINICA, V12, P111; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fertuck KC, 2003, PHYSIOL GENOMICS, V15, P127, DOI 10.1152/physiolgenomics.00058.2003; Filby AL, 2007, AQUAT TOXICOL, V81, P219, DOI 10.1016/j.aquatox.2006.12.003; Flicek P, 2012, NUCLEIC ACIDS RES, V2012, P40; Foster D L., 1994, PHYSL REPROD, V2; Handley-Goldstone HM, 2005, TOXICOL SCI, V85, P683, DOI 10.1093/toxsci/kfi116; Harris CA, 2011, ENVIRON HEALTH PERSP, V119, P306, DOI 10.1289/ehp.1002555; Helaers Raphael, 2011, BMC Res Notes, V4, P452, DOI 10.1186/1756-0500-4-452; Hirakawa I, 2012, CHEMOSPHERE, V87, P668, DOI 10.1016/j.chemosphere.2011.12.047; Hoffmann JL, 2006, AQUAT TOXICOL, V79, P233, DOI 10.1016/j.aquatox.2006.06.009; Hook SE, 2006, AQUAT TOXICOL, V77, P372, DOI 10.1016/j.aquatox.2006.01.007; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jobling S, 1996, ENVIRON TOXICOL CHEM, V15, P194, DOI [10.1002/etc.5620150218, 10.1897/1551-5028(1996)015&lt;0194:IOTGIR&gt;2.3.CO;2]; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Konishi T, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S6; Koskinen H, 2004, BIOCHEM BIOPH RES CO, V320, P745, DOI 10.1016/j.bbrc.2004.06.024; Larkin P, 2003, ECOTOXICOLOGY, V12, P463, DOI 10.1023/B:ECTX.0000003031.05390.b5; Larkin P, 2002, ENV HLTH PERSPECT, V111, P839; Legler J, 2002, SCI TOTAL ENVIRON, V293, P69, DOI 10.1016/S0048-9697(01)01146-9; Martyniuk CJ, 2007, AQUAT TOXICOL, V84, P38, DOI 10.1016/j.aquatox.2007.05.012; Moens LN, 2006, TOXICOL SCI, V93, P298, DOI 10.1093/toxsci/kfl057; Moggs JG, 2005, TOXICOLOGY, V213, P177, DOI 10.1016/j.tox.2005.05.020; Nadzialek S, 2011, ARCH ENVIRON CON TOX, V60, P471, DOI 10.1007/s00244-010-9548-8; Nguyen C., 2010, NANOSCIENCE NANOBIOT, P911; Opgen-Rhein R, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1252; Owens JW, 2002, CRIT REV TOXICOL, V32, P445, DOI 10.1080/20024091064291; Pierre M, 2011, J PROTEOM BIOINFORM, V04, P36; Pierre M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-176; Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554; Rao YL, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1287; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rolland AD, 2010, TRANSCRIPTOME WIDE P; Routledge EJ, 1998, ENVIRON SCI TECHNOL, V32, P1559, DOI 10.1021/es970796a; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tilton SC, 2006, TOXICOL SCI, V90, P61, DOI 10.1093/toxsci/kfi341; van Aerle R, 2001, ENVIRON TOXICOL CHEM, V20, P2841, DOI 10.1002/etc.5620201225; Vizziano D, 2007, DEV DYNAM, V236, P2198, DOI 10.1002/dvdy.21212; Vizziano-Cantonnet D, 2008, J MOL ENDOCRINOL, V41, P277, DOI 10.1677/JME-08-0039; Wang RL, 2008, ENVIRON TOXICOL CHEM, V27, P664, DOI 10.1897/07-192.1; Wang RL, 2010, AQUAT TOXICOL, V98, P230, DOI 10.1016/j.aquatox.2010.02.021; Yano A, 2012, CURR BIOL; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	73	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0128598	10.1371/journal.pone.0128598	http://dx.doi.org/10.1371/journal.pone.0128598			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186543	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700005
J	Eom, BW; Joo, J; Kim, S; Shin, A; Yang, HR; Park, J; Choi, IJ; Kim, YW; Kim, J; Nam, BH				Eom, Bang Wool; Joo, Jungnam; Kim, Sohee; Shin, Aesun; Yang, Hye-Ryung; Park, Junghyun; Choi, Il Ju; Kim, Young-Woo; Kim, Jeongseon; Nam, Byung-Ho			Prediction Model for Gastric Cancer Incidence in Korean Population	PLOS ONE			English	Article							BODY-MASS INDEX; AMERICAN JOINT COMMITTEE; PHYSICAL-ACTIVITY; SOCIOECONOMIC-STATUS; RISK; ADENOCARCINOMA; COHORT; ALCOHOL; STOMACH; VALIDATION	Background Predicting high risk groups for gastric cancer and motivating these groups to receive regular checkups is required for the early detection of gastric cancer. The aim of this study is was to develop a prediction model for gastric cancer incidence based on a large population-based cohort in Korea. Method Based on the National Health Insurance Corporation data, we analyzed 10 major risk factors for gastric cancer. The Cox proportional hazards model was used to develop gender specific prediction models for gastric cancer development, and the performance of the developed model in terms of discrimination and calibration was also validated using an independent cohort. Discrimination ability was evaluated using Harrell's C-statistics, and the calibration was evaluated using a calibration plot and slope. Results During a median of 11.4 years of follow-up, 19,465 (1.4%) and 5,579 (0.7%) newly developed gastric cancer cases were observed among 1,372,424 men and 804,077 women, respectively. The prediction models included age, BMI, family history, meal regularity, salt preference, alcohol consumption, smoking and physical activity for men, and age, BMI, family history, salt preference, alcohol consumption, and smoking for women. This prediction model showed good accuracy and predictability in both the developing and validation cohorts (C-statistics: 0.764 for men, 0.706 for women). Conclusions In this study, a prediction model for gastric cancer incidence was developed that displayed a good performance.	[Eom, Bang Wool; Choi, Il Ju; Kim, Young-Woo] Natl Canc Ctr, Res Inst & Hosp, Gastr Canc Branch, Goyang Si, South Korea; [Joo, Jungnam; Kim, Sohee; Yang, Hye-Ryung; Park, Junghyun; Nam, Byung-Ho] Natl Canc Ctr, Res Inst & Hosp, Div Canc Epidemiol & Prevent, Biometr Res Branch, Goyang Si, South Korea; [Shin, Aesun; Kim, Jeongseon] Natl Canc Ctr, Res Inst & Hosp, Div Canc Epidemiol & Prevent, Mol Epidemiol Branch, Goyang Si, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Nam, BH (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Div Canc Epidemiol & Prevent, Biometr Res Branch, Goyang Si, South Korea.	byunghonam@ncc.re.kr	Eom, Bang Wool/K-4412-2016; KIM, JEONGSEON/AAA-4643-2022; Shin, Aesun/E-9145-2014	Eom, Bang Wool/0000-0002-0332-2051; Shin, Aesun/0000-0002-6426-1969; Kim, Sohee/0000-0003-4660-6043; Kim, Young-Woo/0000-0002-1559-9672	National Cancer Center of Korea [NCC-1110310]	National Cancer Center of Korea	This work was supported by a grant from the National Cancer Center of Korea (No. NCC-1110310).	Ahn HS, 2010, CANCER-AM CANCER SOC, V116, P5592, DOI 10.1002/cncr.25550; Bae JM, 2008, GASTRIC CANCER, V11, P23, DOI 10.1007/s10120-007-0447-2; Bang YJ, 2010, LANCET, V376, P1302; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; BROWN LM, 1994, CANCER CAUSE CONTROL, V5, P333, DOI 10.1007/BF01804984; Carolyn JA, 2008, BEST PRACTICES QUANT; D'Agostino RB, 2004, HANDB STAT, V23, P1; Fernandez E, 1999, AM J CLIN NUTR, V70, P85; Gammon MD, 1997, J NATL CANCER I, V89, P1277, DOI 10.1093/jnci/89.17.1277; Gonzalez CA, 2006, JNCI-J NATL CANCER I, V98, P345, DOI 10.1093/jnci/djj071; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; International Agency for Research on Cancer, 2004, IARC MONOGR EVAL CAR, V83, P1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung H, 2011, CANCER-AM CANCER SOC, V117, P2371, DOI 10.1002/cncr.25778; Jung KW, 2012, CANCER RES TREAT, V44, P11, DOI 10.4143/crt.2012.44.1.11; Kim J, 2010, AM J CLIN NUTR, V91, P1289, DOI 10.3945/ajcn.2009.28732; Kim Y, 2011, ASIAN PAC J CANCER P, V12, P725; Larsson SC, 2006, J NATL CANCER I, V98, P1078, DOI 10.1093/jnci/djj301; Lee DS, 2009, CANCER NURS, V32, P135, DOI 10.1097/NCC.0b013e3181982c2e; Lee Hyuk-Joon, 2002, Gastric Cancer, V5, P177, DOI 10.1007/s101200200031; Lee K, 2010, PUBLIC HEALTH, V124, P698, DOI 10.1016/j.puhe.2010.07.004; Lee KJ, 2006, INT J CANCER, V118, P2315, DOI 10.1002/ijc.21664; Levi Z, 2013, CANCER-AM CANCER SOC, V119, P4086, DOI 10.1002/cncr.28241; Lin XJ, 2014, JPN J CLIN ONCOL, V44, P783, DOI 10.1093/jjco/hyu082; Lindblad M, 2005, CANCER CAUSE CONTROL, V16, P285, DOI 10.1007/s10552-004-3485-7; Lindblad M, 2004, CANCER EPIDEM BIOMAR, V13, P2203; Mayne ST, 2001, CANCER EPIDEM BIOMAR, V10, P1055; McMichael AJ, 2008, PUBLIC HEALTH NUTR, V11, P762, DOI 10.1017/S1368980008002358; Merry AHH, 2007, GUT, V56, P1503, DOI 10.1136/gut.2006.116665; Miyamoto A, 2007, PREV MED, V44, P12, DOI 10.1016/j.ypmed.2006.07.016; Mouw T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003639; Nam SY, 2009, EUR J GASTROEN HEPAT, V21, P855, DOI 10.1097/MEG.0b013e328318ed42; Ngoan LT, 2002, BRIT J CANCER, V87, P37, DOI 10.1038/sj.bjc.6600415; Park S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054823; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Shin CM., 2010, J CLIN GASTROENTEROL, V44, pe34, DOI [DOI 10.1097/MCG.0B013E3181A159C4, 10.1097/MCG.0b013e3181a159c4]; Sjodahl K, 2008, CANCER EPIDEM BIOMAR, V17, P135, DOI 10.1158/1055-9965.EPI-07-0704; Tramacere I, 2012, ANN ONCOL, V23, P28, DOI 10.1093/annonc/mdr135; Tsubono Y, 2001, NEW ENGL J MED, V344, P632, DOI 10.1056/NEJM200103013440903; Vainio H, 2002, EUR J CANCER PREV, V11, pS94; van Houwelingen HC, 2000, STAT MED, V19, P3401, DOI 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2; Yaghoobi M, 2010, BRIT J CANCER, V102, P237, DOI 10.1038/sj.bjc.6605380	45	20	21	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132613	10.1371/journal.pone.0132613	http://dx.doi.org/10.1371/journal.pone.0132613			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186332	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700051
J	Hu, GP; Zhou, YM; Wu, YK; Yu, Y; Liang, WQ; Ran, PX				Hu, Guoping; Zhou, Yumin; Wu, Yankui; Yu, Yan; Liang, Weiqiang; Ran, Pixin			The Pneumonia Severity Index as a Predictor of In-Hospital Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							COPD EXACERBATION; RISK; DYSPNEA; SCORE; COMORBIDITIES; VALIDATION; ADMISSION; SURVIVAL; AUDIT	Objective To determine whether the pneumonia severity index (PSI) can predict in-hospital mortality for AECOPD patients and compare its usefulness with the CURB65 and BAP65 indexes to predict mortality. Methods Demographics, clinical signs and symptoms, comorbidities, and laboratory and radiographic findings of hospitalized AECOPD patients were obtained. Univariate and multiple logistic regression analyses were used to identify the risk factors for in-hospital mortality. The PSI, CURB65 and BAP65 scores were calculated. Receiver operating characteristic (ROC) curve analysis was used to identify the PSI, CURB65 and BAP65 scores that could discriminate between non-survivors and survivors. To control for the confounding factor of invasive mechanical ventilation (IMV) regarding the mortality of AECOPD, subgroup analysis was performed when excluded patients who had met the criteria of IMV but who had not received the cure of IMV according to their wishes. Results During the in-hospital period, 73 patients died and 679 patients recovered. Age, PaO2<60 mmHg, pH < 7.35, PaCO2 >= 50 mmHg, nursing home residency, congestive heart failure, liver disease, sodium<130 mmol/L, lower FEV1% and altered mental status were risk factors for in-hospital mortality. The areas under the ROC curves (AUCs) of the PSI for death were 0.847 (95% CI: 0.799-0.895). The cut-off value was 116.5 with a sensitivity of 82.2% and a specificity of 77.6%. However, the AUCs of the CURB65 and BAP65 for death were only 0.744 (95% CI: 0.680-0.809) and 0.665 (95% CI: 0.594-0.736), respectively. Subgroup analysis also showed that the PSI score could predict the mortality of AECOPD patients with an AUC = 0.857 (95% CI: 0.802-0.913), with exclusion of the patients who met the criteria of IMV but who did not receive the cure of IMV. Conclusion The PSI score may be used to predict in-hospital mortality for hospitalized AECOPD patients, with a prognostic capacity superior to CURB65 and BAP65.	[Hu, Guoping; Yu, Yan; Liang, Weiqiang] Guangzhou Med Univ, Affiliated Hosp 3, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Zhou, Yumin; Ran, Pixin] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Wu, Yankui] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Resp Dis, Nanning, Guangxi Zhuang, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Ran, PX (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	pxran@gzhmc.edu.cn			Guangzhou municipal health bureau scientific research fund [201102A213176]	Guangzhou municipal health bureau scientific research fund	This work was funded by the Guangzhou municipal health bureau scientific research fund (201102A213176) (URL: http://kjgl.gzmed.gov.cn/stmsres/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro P, 2014, CHEST, V145, P972, DOI 10.1378/chest.13-1328; Almagro P, 2012, CHEST, V142, P1126, DOI 10.1378/chest.11-2413; Asiimwe AC, 2011, LUNG, V189, P225, DOI 10.1007/s00408-011-9298-z; Bartziokas K, 2014, EUR RESPIR J, V43, P43, DOI 10.1183/09031936.00209212; Celli BR, 2008, RESP MED, V102, pS27, DOI 10.1016/S0954-6111(08)70005-2; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chalmers JD, 2010, THORAX, V65, P878, DOI 10.1136/thx.2009.133280; Chang CL, 2007, INTERN MED J, V37, P236, DOI 10.1111/j.1445-5994.2006.01283.x; Chang CL, 2011, RESPIROLOGY, V16, P146, DOI 10.1111/j.1440-1843.2010.01866.x; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Edwards L, 2011, RESPIROLOGY, V16, P625, DOI 10.1111/j.1440-1843.2011.01926.x; Esteban C, 2011, RESP MED, V105, P1662, DOI 10.1016/j.rmed.2011.05.005; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Francis RFMT, 1998, INTRO MED STAT; Fruchter O, 2015, AM J MED SCI, V349, P29, DOI 10.1097/MAJ.0000000000000332; FUSO L, 1995, AM J MED, V98, P272, DOI 10.1016/S0002-9343(99)80374-X; Garcia-Rio F, 2012, CHEST, V142, P338, DOI 10.1378/chest.11-2014; Groenewegen KH, 2003, CHEST, V124, P459, DOI 10.1378/chest.124.2.459; Gunen H, 2005, EUR RESPIR J, V26, P234, DOI 10.1183/09031936.05.00024804; Hoiseth AD, 2011, THORAX, V66, P775, DOI 10.1136/thx.2010.153122; Soler-Cataluna JJ, 2009, RESP MED, V103, P692, DOI 10.1016/j.rmed.2008.12.005; Ko FWS, 2011, RESP MED, V105, P266, DOI 10.1016/j.rmed.2010.06.022; Loke YK, 2010, THORAX, V65, P884, DOI 10.1136/thx.2009.134072; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Madkour AM, 2013, EGYPT J CHEST DIS TU, V62, P393, DOI 10.1016/j.ejcdt.2013.07.003; Miravitlles M, 2011, RESP MED, V105, P740, DOI 10.1016/j.rmed.2010.12.020; Murphy SA, 2010, RESP MED, V104, P1668, DOI 10.1016/j.rmed.2010.04.025; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Puhan MA, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-002152; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Roberts CM, 2002, THORAX, V57, P137, DOI 10.1136/thorax.57.2.137; Roche N, 2008, EUR RESPIR J, V32, P953, DOI 10.1183/09031936.00129507; Ruiz-Gonzalez A, 2008, RESPIROLOGY, V13, P1028, DOI 10.1111/j.1440-1843.2008.01403.x; Shorr AF, 2011, CHEST, V140, P1177, DOI 10.1378/chest.10-3035; Singanayagam Aran, 2013, Ann Am Thorac Soc, V10, P81, DOI 10.1513/AnnalsATS.201208-043OC; Slenter RHJ, 2013, RESPIRATION, V85, P15, DOI 10.1159/000342036; Steer J, 2012, THORAX, V67, P117, DOI 10.1136/thoraxjnl-2011-200332; Steer J, 2012, THORAX, V67, P970, DOI 10.1136/thoraxjnl-2012-202103; Sundh J, 2012, PRIM CARE RESP J, V21, P295, DOI 10.4104/pcrj.2012.00054; Tabak YP, 2009, ARCH INTERN MED, V169, P1595, DOI 10.1001/archinternmed.2009.270; Tofan Fatmeh, 2012, Pneumologia, V61, P160	42	14	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133160	10.1371/journal.pone.0133160	http://dx.doi.org/10.1371/journal.pone.0133160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186637	gold, Green Submitted, Green Published			2022-12-27	WOS:000358198700103
J	Lee, S; Eguchi, A; Tsuzuki, S; Matsumura, S; Inoue, K; Iwanaga, T; Masuda, D; Yamashita, S; Fushiki, T				Lee, Shinhye; Eguchi, Ai; Tsuzuki, Satoshi; Matsumura, Shigenobu; Inoue, Kazuo; Iwanaga, Toshihiko; Masuda, Daisaku; Yamashita, Shizuya; Fushiki, Tohru			Expression of CD36 by Olfactory Receptor Cells and Its Abundance on the Epithelial Surface in Mice	PLOS ONE			English	Article							FATTY-ACID; PROTEINS; FAMILY; PREFERENCE; OXIDATION; NEURONS; MUSCLE; SNMP-1	CD36 is a transmembrane protein that is involved in the recognition of certain amphiphilic molecules such as polar lipids in various tissues and body fluids. So far, CD36 homologues in insects have been demonstrated to be present on the surface of olfactory dendrites and to participate in the perception of exogenous compounds. However, little is known about the relationship between CD36 and mammalian olfaction. Indeed, the detection of only CD36 mRNA in the mouse olfactory epithelium has been reported to date. In the present study, to provide potential pieces of evidence for the involvement of CD36 in mammalian olfactory perception, we extensively investigated the localisation of this protein in the mouse olfactory mucosa. In situ hybridisation analysis using antisense oligonucleotides to CD36 mRNA detected aggregated signals within the deeper epithelial layer of olfactory mucosa. The mRNA signals were also detected consistently in the superficial layer of the olfactory epithelium, which is occupied by supporting cells. Immunostaining with an anti-CD36 polyclonal antibody revealed that CD36 localises in the somata and dendrites of distinct olfactory receptor cells and that it occurs abundantly on the olfactory epithelial surface. However, immunoreactive CD36 was rarely detectable in the nerve bundles running in the lamina propria of olfactory mucosa, the axons forming the olfactory nerve layer in the outermost layer of the bulb and axon terminals in the glomeruli. We also obtained electron microscopic evidence for the association of CD36 protein with olfactory cilia. Altogether, we suggest that CD36 plays a role in the mammalian olfaction. In addition, signals for CD36 protein were also detected on or around the microvilli of olfactory supporting cells and the cilia of nasal respiratory epithelium, suggesting a role for this protein other than olfaction in the nasal cavity.	[Lee, Shinhye; Eguchi, Ai; Tsuzuki, Satoshi; Matsumura, Shigenobu; Inoue, Kazuo; Fushiki, Tohru] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Nutr Chem Lab, Kyoto, Japan; [Iwanaga, Toshihiko] Hokkaido Univ, Grad Sch Med, Lab Histol & Cytol, Sapporo, Hokkaido, Japan; [Masuda, Daisaku] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Yamashita, Shizuya] Osaka Univ, Grad Sch Med, Dept Community Med, Suita, Osaka, Japan	Kyoto University; Hokkaido University; Osaka University; Osaka University	Tsuzuki, S (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Nutr Chem Lab, Kyoto, Japan.	tkmone@kais.kyoto-u.ac.jp	Matsumura, Shigenobu/Z-2088-2019	Tsuzuki, Satoshi/0000-0003-4385-0075; Masuda, Daisaku/0000-0002-0954-4042	JSPS KAKENHI [25292071]; Science and technology research promotion program for agriculture, forestry, fisheries and food industry	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Science and technology research promotion program for agriculture, forestry, fisheries and food industry	This work was supported by a JSPS KAKENHI Grant (B), Grant number 25292071, http://www.jsps.go.jp/english/e-grants/; and The Science and technology research promotion program for agriculture, forestry, fisheries and food industry, grant number not assigned, http://www.s.affrc.go.jp/docs/research_fund/2014/sinki_koubo_2014.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoul-Azize S, 2014, BIOCHIMIE, V96, P8, DOI 10.1016/j.biochi.2013.06.005; Alkhatatbeh MJ, 2011, J THROMB HAEMOST, V9, P844, DOI 10.1111/j.1538-7836.2011.04220.x; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Forstner M, 2008, CHEM SENSES, V33, P291, DOI 10.1093/chemse/bjm087; Fujitani M, 2014, BIOSCI BIOTECH BIOCH, V78, P1871, DOI 10.1080/09168451.2014.940835; Fukuwatari T, 1997, FEBS LETT, V414, P461, DOI 10.1016/S0014-5793(97)01055-7; Glezer I, 2009, J COMP NEUROL, V517, P906, DOI 10.1002/cne.22185; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Martin C, 2011, PHYSIOL BEHAV, V105, P36, DOI 10.1016/j.physbeh.2011.02.029; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Mochida S, 2010, J BIOCHEM, V148, P721, DOI 10.1093/jb/mvq108; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Pepino MY, 2014, ANNU REV NUTR, V34, P281, DOI 10.1146/annurev-nutr-071812-161220; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Strotmann J, 2004, J NEUROSCI, V24, P7754, DOI 10.1523/JNEUROSCI.2588-04.2004; Strotmann J, 2011, HISTOCHEM CELL BIOL, V136, P357, DOI 10.1007/s00418-011-0850-y; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039	26	19	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133412	10.1371/journal.pone.0133412	http://dx.doi.org/10.1371/journal.pone.0133412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186589	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700134
J	Rajapakse, NW; Karim, F; Evans, RG; Kaye, DM; Head, GA				Rajapakse, Niwanthi W.; Karim, Florian; Evans, Roger G.; Kaye, David M.; Head, Geoffrey A.			Augmented Endothelial-Specific L-Arginine Transport Blunts the Contribution of the Sympathetic Nervous System to Obesity Induced Hypertension in Mice	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; HIGH BLOOD-PRESSURE; MENTAL STRESS; ZUCKER RATS; RESPONSES; ANGIOTENSIN; DYSFUNCTION; INHIBITION; ACTIVATION; SYNTHASE	Augmenting endothelial specific transport of the nitric oxide precursor L-arginine via cationic amino acid transporter-1 (CAT1) can prevent obesity related hypertension. We tested the hypotheses that CAT1 overexpression prevents obesity-induced hypertension by buffering the influence of the sympathetic nervous system (SNS) on the maintenance of arterial pressure and by buffering pressor responses to stress. Wild type (WT; n=13) and CAT1 overexpressing mice (CAT+; n=13) were fed a normal or a high fat diet for 20 weeks. Mice fed a high fat diet were returned to the control diet before experiments commenced. Baseline mean arterial pressure (MAP) and effects of restraint-, shaker-and almond feeding-stress and ganglionic blockade (pentolinium; 5 mg/kg; i.p.) on MAP were determined in conscious mice. Fat feeding increased body weight to a similar extent in WT and CAT+ but MAP was greater only in WT compared to appropriate controls (by 29%). The depressor response to pentolinium was 65% greater in obese WT than lean WT (P < 0.001), but was similar in obese and lean CAT+ (P = 0.65). In lean WT and CAT+, pressor responses to shaker and feeding stress, but not restraint stress, were less in the latter genotype compared to the former (P <= 0.001). Pressor responses to shaker and feeding stress were less in obese WT than lean WT (P <= 0.001), but similar in obese and lean CAT+. The increase in MAP in response to restraint stress was less in obese WT (22 +/- 2%), but greater in obese CAT+ (37 +/- 2%), when compared to respective lean WT (31 +/- 3%) and lean CAT+ controls (27 +/- 2%; P <= 0.02). We conclude that CAT1 overexpression prevents obesity-induced hypertension by reducing the influence of the SNS on the maintenance of arterial pressure but not by buffering pressor responses to stress.	[Rajapakse, Niwanthi W.; Karim, Florian; Kaye, David M.; Head, Geoffrey A.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Rajapakse, Niwanthi W.; Evans, Roger G.] Monash Univ, Dept Physiol, Melbourne, Vic 3168, Australia	Baker Heart and Diabetes Institute; Monash University	Rajapakse, NW (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	niwanthi.rajapakse@bakeridi.edu.au	Head, Geoffrey A./B-2177-2010; Kaye, David/AAF-1202-2021; Evans, Roger/N-8580-2019	Head, Geoffrey A./0000-0002-7623-137X; Evans, Roger/0000-0002-9241-0757; Kaye, David/0000-0003-4058-0372; Rajapakse, Niwanthi/0000-0001-9777-1087	National Heart Foundation [PF09M4668]; National Health and Medical Research Council; Victorian Government's Operational Infrastructure Support Program	National Heart Foundation(National Heart Foundation of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	NR was a recipient of a National Heart Foundation post-doctoral fellowship (PF09M4668) for part of this study. The present study was supported by a National Health and Medical Research Council Program Grant to DK, and also in part by the Victorian Government's Operational Infrastructure Support Program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JA, 2012, HYPERTENSION, V60, P163, DOI 10.1161/HYPERTENSIONAHA.111.190413; Bayraktar H. Ozyurt, 2013, Autonomic & Autacoid Pharmacology, V33, P7, DOI 10.1111/aap.12004; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; Cardillo C, 1998, J AM COLL CARDIOL, V32, P1207, DOI 10.1016/S0735-1097(98)00391-X; Chin-Dusting JPF, 2007, PHARMACOL THERAPEUT, V116, P428, DOI 10.1016/j.pharmthera.2007.08.001; D'Angelo G, 2006, HYPERTENSION, V48, P1109, DOI 10.1161/01.HYP.0000247306.53547.d4; da Silva AA, 2009, CURR HYPERTENS REP, V11, P206, DOI 10.1007/s11906-009-0036-3; Davern PJ, 2014, J HYPERTENS, V32, P352, DOI 10.1097/HJH.0000000000000015; Davern PJ, 2010, AM J HYPERTENS, V23, P838, DOI 10.1038/ajh.2010.69; Durand S, 2005, J PHYSIOL-LONDON, V562, P629, DOI 10.1113/jphysiol.2004.075747; Hall JE, 2010, J BIOL CHEM, V285, P17271, DOI 10.1074/jbc.R110.113175; Head GA, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0466-4; Jackson K, 2007, AM J HYPERTENS, V20, P893, DOI 10.1016/j.amjhyper.2007.02.010; KASSAB S, 1995, HYPERTENSION, V25, P893, DOI 10.1161/01.HYP.25.4.893; Kuniyoshi FHS, 2003, OBES RES, V11, P1411, DOI 10.1038/oby.2003.190; Mayorov DN, 2007, NEUROSCI LETT, V424, P89, DOI 10.1016/j.neulet.2007.07.007; PACAK K, 1995, ENDOCRINOLOGY, V136, P4360, DOI 10.1210/en.136.10.4360; Palma-Rigo K, 2011, J HYPERTENS, V29, P2156, DOI 10.1097/HJH.0b013e32834bbb6b; Rajapakse NW, 2014, ACTA PHYSIOL, V212, P39, DOI 10.1111/apha.12344; Rajapakse NW, 2014, CLIN EXP PHARMACOL P, V41, P1031, DOI 10.1111/1440-1681.12279; Rajapakse NW, 2013, CURR OPIN NEPHROL HY, V22, P45, DOI 10.1097/MNH.0b013e32835a6ff7; Rajapakse NW, 2009, CLIN EXP PHARMACOL P, V36, P249, DOI 10.1111/j.1440-1681.2008.05123.x; Rajapakse NW, 2005, AM J PHYSIOL-REG I, V289, pR745, DOI 10.1152/ajpregu.00477.2004; Ramchandra R, 2014, AM J PHYSIOL-REG I, V307, pR271, DOI 10.1152/ajpregu.00057.2014; Sadler CJ, 2004, BRAIN RES, V1016, P222, DOI 10.1016/j.brainres.2004.05.007; Schmidt FP, 2013, EUR HEART J, V34, P3508, DOI 10.1093/eurheartj/eht269; Skarphedinsson JO, 1997, J PHYSIOL-LONDON, V501, P671, DOI 10.1111/j.1469-7793.1997.671bm.x; Tabara Y, 2008, HYPERTENS RES, V31, P1219, DOI 10.1291/hypres.31.1219; Wofford MR, 2001, AM J HYPERTENS, V14, P694, DOI 10.1016/S0895-7061(01)01293-6; Yang ZY, 2007, CIRCULATION, V115, P1269, DOI 10.1161/CIRCULATIONAHA.106.665836	31	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131424	10.1371/journal.pone.0131424	http://dx.doi.org/10.1371/journal.pone.0131424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186712	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700016
J	Vinay, M; Franche, N; Gregori, G; Fantino, JR; Pouillot, F; Ansaldi, M				Vinay, Manon; Franche, Nathalie; Gregori, Gerald; Fantino, Jean-Raphael; Pouillot, Flavie; Ansaldi, Mireille			Phage-Based Fluorescent Biosensor Prototypes to Specifically Detect Enteric Bacteria Such as E. coli and Salmonella enterica Typhimurium	PLOS ONE			English	Article							ESCHERICHIA-COLI; CHROMOSOMAL GENES; MYCOBACTERIUM-TUBERCULOSIS; REPORTER PHAGE; FLOW-CYTOMETRY; WATER; SUSCEPTIBILITY; GFP; BACTERIOPHAGES; CONSTRUCTION	Water safety is a major concern for public health and for natural environment preservation. We propose to use bacteriophages to develop biosensor tools able to detect human and animal pathogens present in water. For this purpose, we take advantage of the highly discriminating properties of the bacteriophages, which specifically infect their bacterial hosts. The challenge is to use a fluorescent reporter protein that will be synthesized, and thus detected, only once the specific recognition step between a genetically modified temperate bacteriophage and its bacterial host has occurred. To ensure the accuracy and the execution speed of our system, we developed a test that does not require bacterial growth, since a simple 1-hour infection step is required. To ensure a high sensitivity of our tool and in order to detect up to a single bacterium, fluorescence is measured using a portable flow cytometer, also allowing on-site detection. In this study, we have constructed and characterized several "phagosensor" prototypes using the HK620 bacteriophage and its host Escherichia coli TD2158 and we successfully adapted this method to Salmonella detection. We show that the method is fast, robust and sensitive, allowing the detection of as few as 10 bacteria per ml with no concentration nor enrichment step. Moreover, the test is functional in sea water and allows the detection of alive bacteria. Further development will aim to develop phagosensors adapted on demand to the detection of any human or animal pathogen that may be present in water.	[Vinay, Manon; Franche, Nathalie; Fantino, Jean-Raphael; Ansaldi, Mireille] Aix Marseille Univ, CNRS, Chim Bacterienne Lab, UMR7283, Marseille, France; [Gregori, Gerald] Aix Marseille Univ, Univ Sud Toulon Var, CNRS, IRD,Mediterranean Inst Oceanol,UM110, Marseille, France; [Pouillot, Flavie] Pherecydes Pharma, Romainville, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Ansaldi, M (corresponding author), Aix Marseille Univ, CNRS, Chim Bacterienne Lab, UMR7283, Marseille, France.	mireille.ansaldi@imm.cnrs.fr	Grégori, Gérald J/D-8657-2013	Grégori, Gérald J/0000-0003-1645-9468; ANSALDI, Mireille/0000-0002-2878-0702	Centre National pour la Recherche Scientifique (CNRS); Agence Nationale pour la Recherche (ANR) [ECOTECH 11ECOT00902]; joint Pherecydes Pharma - Provence Alpes Cote d'Azur (PACA) region fellowship; Pherecydes-Pharma	Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); joint Pherecydes Pharma - Provence Alpes Cote d'Azur (PACA) region fellowship(Region Provence-Alpes-Cote d'Azur); Pherecydes-Pharma	This work was supported by the Centre National pour la Recherche Scientifique (CNRS), Agence Nationale pour la Recherche (ANR) grant ECOTECH 11ECOT00902 and a joint Pherecydes Pharma - Provence Alpes Cote d'Azur (PACA) region fellowship to MV. The funder Pherecydes-Pharma provided support in the form of a salary for author FP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	ALDEA M, 1989, EMBO J, V8, P3923, DOI 10.1002/j.1460-2075.1989.tb08573.x; [Anonymous], 2006, OFFICIAL J EUROPEA L, V64, P37; Barbesti S, 2005, CYTOM PART B-CLIN CY, V68B, P43, DOI 10.1002/cyto.b.20068; Battaglioli EJ, 2011, APPL ENVIRON MICROB, V77, P6630, DOI 10.1128/AEM.05307-11; Clark AJ, 2001, J MOL BIOL, V311, P657, DOI 10.1006/jmbi.2001.4868; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; D'Herelle F, 2007, RES MICROBIOL, V158, P553, DOI 10.1016/j.resmic.2007.07.005; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Denes T, 2014, CURR OPIN BIOTECH, V26, P45, DOI 10.1016/j.copbio.2013.09.001; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Derda R, 2013, ANAL CHEM, V85, P7213, DOI 10.1021/ac400961b; Dhillon TS, 1998, FEMS MICROBIOL LETT, V161, P129, DOI 10.1111/j.1574-6968.1998.tb12938.x; Edgar R, 2006, P NATL ACAD SCI USA, V103, P4841, DOI 10.1073/pnas.0601211103; Efstratiou MA, 2009, MAR POLLUT BULL, V58, P1039, DOI 10.1016/j.marpolbul.2009.02.007; Foladori P, 2010, WATER RES, V44, P3807, DOI 10.1016/j.watres.2010.04.027; Funatsu T, 2002, MICROBIOL IMMUNOL, V46, P365, DOI 10.1111/j.1348-0421.2002.tb02708.x; Goodridge L, 1999, APPL ENVIRON MICROB, V65, P1397; Goodridge L., 2003, SIM NEWS, V53, P254; Haq IU, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-9; Husseiny MI, 2005, INFECT IMMUN, V73, P1598, DOI 10.1128/IAI.73.3.1598-1605.2005; Jain P, 2012, J CLIN MICROBIOL, V50, P1362, DOI 10.1128/JCM.06192-11; Jia B, 2010, BIOTECHNOL LETT, V32, P521, DOI 10.1007/s10529-009-0189-9; Katashkina JI, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-34; Lee JW, 2013, INT J NANOMED, V8, P3917, DOI 10.2147/IJN.S51894; Lesic B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-20; Loessner MJ, 1997, APPL ENVIRON MICROB, V63, P2961, DOI 10.1128/AEM.63.8.2961-2965.1997; Mansilha CR, 2010, MAR POLLUT BULL, V60, P819, DOI 10.1016/j.marpolbul.2010.01.013; Mosier-Boss PA, 2003, APPL SPECTROSC, V57, P1138, DOI 10.1366/00037020360696008; Namura M, 2008, BIOTECHNOL PROGR, V24, P481, DOI 10.1021/bp070326c; Panis G, 2010, VIROLOGY, V404, P41, DOI 10.1016/j.virol.2010.04.027; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Piuri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004870; POND K, 2005, WATER RECREATION DIS; Schmelcher Mathias, 2014, Bacteriophage, V4, pe28137; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schofield DA, 2012, APPL ENVIRON MICROB, V78, P3592, DOI 10.1128/AEM.00252-12; Singh A, 2013, SENSORS-BASEL, V13, P1763, DOI 10.3390/s130201763; Steen HB, 2004, CYTOM PART A, V57A, P94, DOI 10.1002/cyto.a.10115; Tanji Y, 2004, J BIOTECHNOL, V114, P11, DOI 10.1016/j.jbiotec.2004.05.011; Twort FW, 1915, LANCET, V2, P1241, DOI 10.1016/s0140-6736(01)20383-3; Ul Haq I, 2012, MICROB ECOL, V63, P954, DOI 10.1007/s00248-011-9944-2; Waddell TE, 2000, FEMS MICROBIOL LETT, V182, P285, DOI 10.1016/S0378-1097(99)00603-5; Willford John D, 2011, Bacteriophage, V1, P101; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Yamamoto S, 2009, GENE, V438, P57, DOI 10.1016/j.gene.2009.02.015; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	46	42	42	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131466	10.1371/journal.pone.0131466	http://dx.doi.org/10.1371/journal.pone.0131466			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186207	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700018
J	Zheng, ZQ; Yan, DS; Chen, XY; Huang, H; Chen, K; Li, GJ; Zhou, LL; Zheng, DD; Tu, LL; Dong, XD				Zheng, Zhiqiang; Yan, Dongsheng; Chen, Xiaoyan; Huang, He; Chen, Ke; Li, Guangjing; Zhou, Linglin; Zheng, Dandan; Tu, Lili; Dong, Xiang Da			MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway	PLOS ONE			English	Article							DOWN-REGULATION; OVEREXPRESSION; PROLIFERATION; METASTASIS; CARCINOMA	MicroRNAs are endogenous short chain nucleotide RNAs that regulate gene function by direct binding of target mRNAs. In this study, we investigated the effects of microRNA-206 (miR-206) on the development of gastric cancer. miR-206 was first confirmed to be downregulated in gastric cancer specimens. Conversely, upregulation of c-Met was confirmed in tissue samples of human gastric cancer, with its level inversely correlated with miR-206 expression. Introduction of miR-206 inhibited cellular proliferation by inducing G1 cell cycle arrest, as well as migration and invasion. Moreover, important proliferation and/or migration related molecules such as c-Met, CDK4, p-Rb, p-Akt and p-ERK were confirmed to be downregulated by Western blot analysis. Targeting of c-Met also directly affected AGS cell proliferation, migration and invasion. In vivo, miR-206 expressing tumor cells also displayed growth delay in comparison to unaffected tumor cells. Our results demonstrated that miR-206 suppressed c-Met expression in gastric cancer and could function as a potent tumor suppressor in c-Met overexpressing tumors. Inhibition of miR-206 function could contribute to aberrant cell proliferation and migration, leading to gastric cancer development.	[Zheng, Zhiqiang; Yan, Dongsheng; Chen, Xiaoyan; Huang, He; Chen, Ke; Li, Guangjing; Zhou, Linglin; Zheng, Dandan; Tu, Lili] Wenzhou Med Univ, Wenzhou, Zhejiang, Peoples R China; [Zheng, Zhiqiang; Huang, He; Chen, Ke] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China; [Yan, Dongsheng; Chen, Xiaoyan; Li, Guangjing; Zhou, Linglin; Zheng, Dandan; Tu, Lili] Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Yan, Dongsheng; Chen, Xiaoyan; Li, Guangjing; Zhou, Linglin; Zheng, Dandan; Tu, Lili] Minist Hlth, State Key Lab Cultivat Base, Wenzhou, Zhejiang, Peoples R China; [Yan, Dongsheng; Chen, Xiaoyan; Li, Guangjing; Zhou, Linglin; Zheng, Dandan; Tu, Lili] Minist Hlth, Key Lab Vis Sci, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Dong, Xiang Da] Columbia Univ, Stamford Hosp Affiliate, Dept Surg, Stamford, CT USA	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Columbia University; Stamford Hospital	Tu, LL (corresponding author), Wenzhou Med Univ, Wenzhou, Zhejiang, Peoples R China.	tulili@mail.eye.ac.cn; xddong@hotmail.com	chen, xia/GXM-5435-2022; Yan, Dongsheng/B-1861-2018; chen, xi/GXH-3653-2022; chen, xia/GYR-3948-2022	Yan, Dongsheng/0000-0003-0551-2219; 	National Natural Science Foundation of China Grant [81100671]; Zhejiang Provincial Natural Science Foundation of China Grant [Y2110609]; Wenzhou Science & Technology Bureau Grant [Y20080096]	National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China Grant; Wenzhou Science & Technology Bureau Grant	This work was supported, in part, by the National Natural Science Foundation of China Grant 81100671 (DY), Zhejiang Provincial Natural Science Foundation of China Grant Y2110609 (DY), and Wenzhou Science & Technology Bureau Grant Y20080096 (DY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Gommans Willemijn M, 2012, Methods Mol Biol, V822, P1, DOI 10.1007/978-1-61779-427-8_1; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He XP, 2012, FEBS J, V279, P4201, DOI 10.1111/febs.12013; Huang TJ, 2001, ACTA ONCOL, V40, P638; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; NAITO S, 1986, CANCER RES, V46, P4109; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Parasramka MA, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-16; Peng Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092924, 10.1371/journal.pone.0084502, 10.1371/journal.pone.0085663]; Ren J, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-26; Shrestha S, 2014, CANCER MED-US, V3, P878, DOI 10.1002/cam4.246; Sotoudeh K, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-57; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Xu XH, 2013, ONCOL LETT, V6, P631, DOI 10.3892/ol.2013.1428; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Yan DS, 2009, INVEST OPHTH VIS SCI, V50, P1559, DOI 10.1167/iovs.08-2681; Zeng ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073278; Zhang L, 2013, CANCER LETT, V332, P94, DOI 10.1016/j.canlet.2013.01.023	21	24	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0128751	10.1371/journal.pone.0128751	http://dx.doi.org/10.1371/journal.pone.0128751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186594	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700006
J	Goh, J; Ali, NHM				Goh, Joan; Ali, Norhashidah Hj. M.			High Accuracy Spline Explicit Group (SEG) Approximation for Two Dimensional Elliptic Boundary Value Problems	PLOS ONE			English	Article							CUBIC-SPLINES	Over the last few decades, cubic splines have been widely used to approximate differential equations due to their ability to produce highly accurate solutions. In this paper, the numerical solution of a two-dimensional elliptic partial differential equation is treated by a specific cubic spline approximation in the x-direction and finite difference in the y-direction. A four point explicit group (EG) iterative scheme with an acceleration tool is then applied to the obtained system. The formulation and implementation of the method for solving physical problems are presented in detail. The complexity of computational is also discussed and the comparative results are tabulated to illustrate the efficiency of the proposed method.	[Goh, Joan; Ali, Norhashidah Hj. M.] Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia	Universiti Sains Malaysia	Goh, J (corresponding author), Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia.	joangoh.usm@gmail.com	Ali, Norhashidah/R-6351-2019	Ali, Norhashidah/0000-0002-2060-611X	Universiti Sains Malaysia Research University [1001/JPEND/AUPE002]; FRGS Grant from the School of Mathematical Sciences, Universiti Sains Malaysia, USM Penang, Malaysia [203/PMATHS/6711321]	Universiti Sains Malaysia Research University(Universiti Sains Malaysia); FRGS Grant from the School of Mathematical Sciences, Universiti Sains Malaysia, USM Penang, Malaysia	This study was fully supported by Universiti Sains Malaysia Research University Grant No. 1001/JPEND/AUPE002 and FRGS Grant No. 203/PMATHS/6711321 from the School of Mathematical Sciences, Universiti Sains Malaysia, 11800 USM Penang, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarao J, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/18/185202; ABDULLAH AR, 1991, INT J COMPUT MATH, V38, P61, DOI 10.1080/00207169108803958; Ahlberg JH, 1967, THEORY SPLINES THEIR; Al-Said EA, 2006, APPL MATH COMPUT, V174, P180, DOI 10.1016/j.amc.2005.03.022; ALBASINY EL, 1969, COMPUT J, V12, P151, DOI 10.1093/comjnl/12.2.151; Ali N. H. M., 2012, APPL MATH SCI, V6, P2465; Ali NHM, 2007, APPLIED MATHEMATICS FOR SCIENCE AND ENGINEERING, P162; Bialecki B, 2005, SIAM J SCI COMPUT, V27, P575, DOI 10.1137/040609793; BICKLEY WG, 1968, COMPUT J, V11, P206, DOI 10.1093/comjnl/11.2.206; Ding HF, 2012, APPL MATH COMPUT, V218, P4671, DOI 10.1016/j.amc.2011.10.078; EVANS DJ, 1984, COMPUTING, V32, P239, DOI 10.1007/BF02243575; FYFE DJ, 1969, COMPUT J, V12, P188, DOI 10.1093/comjnl/12.2.188; Goh J, 2012, COMPUT MATH APPL, V64, P115, DOI 10.1016/j.camwa.2012.01.022; Goh J, 2012, J APPL MATH, DOI 10.1155/2012/458701; Goh J, 2011, COMPUT MATH APPL, V62, P4492, DOI 10.1016/j.camwa.2011.10.028; Mohanty RK, 2011, APPL MATH COMPUT, V218, P4234, DOI 10.1016/j.amc.2011.09.054; Mohanty RK, 2012, ISRN MATH PHYS, V2012, DOI [10.5402/2012/234516, DOI 10.5402/2012/234516]; Molavi-Arabshahi SM, 2007, APPL MATH COMPUT, V188, P1371, DOI 10.1016/j.amc.2006.11.028; Othman M, 2000, INT J COMPUT MATH, V76, P203, DOI 10.1080/00207160008805020; Saeed A. M., 2010, APPL MATH SCI, V4, P1165; Wang YM, 2008, J COMPUT APPL MATH, V221, P76, DOI 10.1016/j.cam.2007.10.007; Young DM., 1971, ITERATIVE SOLUTION L; YOUSIF WS, 1986, MATH COMPUT SIMULAT, V28, P453, DOI 10.1016/0378-4754(86)90040-6	23	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132782	10.1371/journal.pone.0132782	http://dx.doi.org/10.1371/journal.pone.0132782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182211	gold, Green Submitted, Green Published			2022-12-27	WOS:000358198200034
J	Politikos, I; Kim, HT; Nikiforow, S; Li, LQ; Brown, J; Antin, JH; Cutler, C; Ballen, K; Ritz, J; Boussiotis, VA				Politikos, Ioannis; Kim, Haesook T.; Nikiforow, Sarah; Li, Lequn; Brown, Julia; Antin, Joseph H.; Cutler, Corey; Ballen, Karen; Ritz, Jerome; Boussiotis, Vassiliki A.			IL-7 and SCF Levels Inversely Correlate with T Cell Reconstitution and Clinical Outcomes after Cord Blood Transplantation in Adults	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; RECENT THYMIC EMIGRANTS; IMMUNE RECONSTITUTION; IN-VIVO; PLASMA-LEVELS; STEM-CELLS; ACUTE GVHD; INTERLEUKIN-7; RECOVERY	Recovery of thymopoiesis is critical for immune reconstitution after HSCT. IL-7 and SCF are two major thymotropic cytokines. We investigated whether the kinetics of circulating levels of these cytokines might provide insight into the prolonged immunodeficiency after double umbilical cord blood transplantation (dUCBT) in adults. We examined plasma levels of IL-7 and SCF, T-cell receptor rearrangement excision circle (TREC) levels and T cell subsets in 60 adult patients undergoing dUCBT. Median levels of IL-7 increased by more than 3-fold at 4 weeks and remained elevated through 100 days after dUCBT. SCF showed a less than 2-fold increase and more protracted elevation than IL-7. IL-7 levels inversely correlated with the reconstitution of various T cell subsets but not with TRECs. SCF levels inversely correlated with reconstitution of CD4(+)T cells, especially the naive CD4(+)CD45RA(+) subset, and with TRECs suggesting that SCF but not IL-7 had an effect on thymic regeneration. In Cox models, elevated levels of IL-7 and SCF were associated with higher non-relapse mortality (p = 0.03 and p = 0.01) and worse overall survival (p = 0.002 and p = 0.001). Elevated IL-7 but not SCF was also associated with development of GvHD (p = 0.03). Thus, IL-7 and SCF are elevated for a prolonged period after dUCBT and persistently high levels of these cytokines may correlate with worse clinical outcomes.	[Politikos, Ioannis; Li, Lequn; Brown, Julia; Boussiotis, Vassiliki A.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Politikos, Ioannis; Li, Lequn; Brown, Julia; Boussiotis, Vassiliki A.] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA; [Kim, Haesook T.] Dana Farber Canc Inst, Dept Computat Biol, Boston, MA 02115 USA; [Nikiforow, Sarah; Antin, Joseph H.; Cutler, Corey; Ritz, Jerome] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ballen, Karen] Massachusetts Gen Hosp, Bone Marrow Transplantat Unit, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital	Boussiotis, VA (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.	vboussio@bidmc.harvard.edu	Ritz, Jerome/C-7929-2009	Ritz, Jerome/0000-0001-5526-4669	National Institutes of Health [A1098129, CA183605, CA142106, CA183559, CA183560]; Leukemia and Lymphoma grant [TRP 6222-11]; HHV6 Foundation Pilot Grant; NATIONAL CANCER INSTITUTE [P01CA142106, R01CA183605, R01CA183559, R01CA183560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma grant; HHV6 Foundation Pilot Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health Grants A1098129 (V.A.B.), CA183605 (V.A.B.), CA142106 (J.R.), CA183559 (J.R.) and CA183560 (J.R.); the Leukemia and Lymphoma grant TRP 6222-11 (V.A.B.); and the HHV6 Foundation Pilot Grant (V.A.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpdogan O, 2001, BLOOD, V98, P2256, DOI 10.1182/blood.V98.7.2256; Arora M, 2007, BIOL BLOOD MARROW TR, V13, P1145, DOI 10.1016/j.bbmt.2007.06.004; Ballen K, 2012, BIOL BLOOD MARROW TR, V18, P1851, DOI 10.1016/j.bbmt.2012.06.016; Ballen KK, 2007, BIOL BLOOD MARROW TR, V13, P82, DOI 10.1016/j.bbmt.2006.08.041; Barker JN, 2005, BLOOD, V105, P1343, DOI 10.1182/blood-2004-07-2717; Bolotin E, 1996, BLOOD, V88, P1887; Bolotin E, 1999, BONE MARROW TRANSPL, V23, P783, DOI 10.1038/sj.bmt.1701655; Broers AEC, 2003, BLOOD, V102, P1534, DOI 10.1182/blood-2002-11-3349; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Brown JA, 2010, BLOOD, V115, P4111, DOI 10.1182/blood-2009-09-244145; Chung B, 2008, BIOL BLOOD MARROW TR, V14, P16, DOI 10.1016/j.bbmt.2007.07.015; Chung B, 2007, BLOOD, V110, P2803, DOI 10.1182/blood-2006-11-055673; Chung B, 2011, BIOL BLOOD MARROW TR, V17, P48, DOI 10.1016/j.bbmt.2010.07.027; Clave E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00054; Cutler C, 2011, BONE MARROW TRANSPL, V46, P659, DOI 10.1038/bmt.2010.192; Cutler C, 2013, BLOOD, V122, P3074, DOI 10.1182/blood-2013-05-503177; De Bock M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055876; Dean RM, 2008, J CLIN ONCOL, V26, P5735, DOI 10.1200/JCO.2008.17.1314; DECASTRO CM, 1994, EXP HEMATOL, V22, P1025; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Fry TJ, 2001, BLOOD, V97, P1525, DOI 10.1182/blood.V97.6.1525; Fry TJ, 2001, TRENDS IMMUNOL, V22, P564, DOI 10.1016/S1471-4906(01)02028-2; GODFREY DI, 1992, J IMMUNOL, V149, P2281; Gray R, 1988, ANN STAT, V16, P1140; Jacobson CA, 2012, BIOL BLOOD MARROW TR, V18, P565, DOI 10.1016/j.bbmt.2011.08.018; Kanda J, 2012, BIOL BLOOD MARROW TR, V18, P1664, DOI 10.1016/j.bbmt.2012.06.005; Kielsen K, 2015, SCAND J IMMUNOL, V81, P72, DOI 10.1111/sji.12244; Kim HT, 2015, BIOL BLOOD MARROW TR; Komanduri KV, 2007, BLOOD, V110, P4543, DOI 10.1182/blood-2007-05-092130; Krenger W, 2011, BLOOD, V117, P6768, DOI 10.1182/blood-2011-02-334623; Krenger W, 2008, SEMIN IMMUNOPATHOL, V30, P439, DOI 10.1007/s00281-008-0131-6; LEVY RB, 1995, J IMMUNOL, V154, P106; Mackall CL, 2001, BLOOD, V97, P1491, DOI 10.1182/blood.V97.5.1491; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Massa S, 2006, EUR J IMMUNOL, V36, P526, DOI 10.1002/eji.200535760; Milano F, 2013, BIOL BLOOD MARROW TR, V19, P847, DOI 10.1016/j.bbmt.2013.04.006; MORRISSEY PJ, 1994, CELL IMMUNOL, V157, P118, DOI 10.1006/cimm.1994.1210; Murray R, 1989, Int Immunol, V1, P526, DOI 10.1093/intimm/1.5.526; Narimatsu H, 2008, BLOOD, V112, P2579, DOI 10.1182/blood-2007-11-118893; Newell LF, 2013, BONE MARROW TRANSPL, V48, P1285, DOI 10.1038/bmt.2013.48; Okamoto Y, 2002, BLOOD, V99, P2851, DOI 10.1182/blood.V99.8.2851; Perales MA, 2012, BLOOD, V120, P4882, DOI 10.1182/blood-2012-06-437236; Plum J, 1996, BLOOD, V88, P4239; Politikos I, 2014, BLOOD, V124, P3201, DOI 10.1182/blood-2014-07-589176; Ponce DM, 2013, BIOL BLOOD MARROW TR, V19, P904, DOI 10.1016/j.bbmt.2013.02.008; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; Sairafi D, 2012, CLIN IMMUNOL, V142, P343, DOI 10.1016/j.clim.2011.12.001; Sinha ML, 2002, BLOOD, V100, P2642, DOI 10.1182/blood-2002-04-1082; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; TESTA U, 1994, BLOOD, V84, P3532; Thiant S, 2011, BONE MARROW TRANSPL, V46, P1374, DOI 10.1038/bmt.2010.300; Thiant S, 2010, BONE MARROW TRANSPL, V45, P1546, DOI 10.1038/bmt.2010.13; Uhlin M, 2012, STEM CELLS DEV, V21, P1409, DOI 10.1089/scd.2011.0310; Williams KA, 2007, SEMIN IMMUNOL, V19, P318, DOI 10.1016/j.smim.2007.10.004; Wils EJ, 2011, HAEMATOL-HEMATOL J, V96, P1846, DOI 10.3324/haematol.2011.047696; Wils EJ, 2011, J IMMUNOL, V187, P2974, DOI 10.4049/jimmunol.1004209; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725	60	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132564	10.1371/journal.pone.0132564	http://dx.doi.org/10.1371/journal.pone.0132564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177551	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600124
J	Samanta, AK; Jayaram, C; Jayapal, N; Sondhi, N; Kolte, AP; Senani, S; Sridhar, M; Dhali, A				Samanta, Ashis Kumar; Jayaram, C.; Jayapal, N.; Sondhi, N.; Kolte, A. P.; Senani, S.; Sridhar, M.; Dhali, A.			Assessment of Fecal Microflora Changes in Pigs Supplemented with Herbal Residue and Prebiotic	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; INTESTINAL MICROFLORA; MICROBIAL DIVERSITY; T-RFLP; 16S; BACTERIUM; ACID; IDENTIFICATION; COMMUNITIES; PERFORMANCE	Antibiotic usage in animals as a growth promoter is considered as public health issue due to its negative impact on consumer health and environment. The present study aimed to evaluate effectiveness of herbal residue (ginger, Zingiber officinale, dried rhizome powder) and prebiotic (inulin) as an alternative to antibiotics by comparing fecal microflora composition using terminal restriction fragment length polymorphism. The grower pigs were offered feed containing antibiotic (tetracycline), ginger and inulin separately and un-supplemented group served as control. The study revealed significant changes in the microbial abundance based on operational taxonomic units (OTUs) among the groups. Presumptive identification of organisms was established based on the fragment length of OTUs generated with three restriction enzymes (MspI, Sau3AI and BsuRI). The abundance of OTUs representing Bacteroides intestinalis, Eubacterium oxidoreducens, Selonomonas sp., Methylobacterium sp. and Denitrobacter sp. was found significantly greater in inulin supplemented pigs. Similarly, the abundance of OTUs representing Bacteroides intestinalis, Selonomonas sp., and Phascolarcobacterium faecium was found significantly greater in ginger supplemented pigs. In contrast, the abundance of OTUs representing pathogenic microorganisms Atopostipes suicloacalis and Bartonella quintana str. Toulouse was significantly reduced in ginger and inulin supplemented pigs. The OTUs were found to be clustered under two major phylotypes; ginger-inulin and control-tetracycline. Additionally, the abundance of OTUs was similar in ginger and inulin supplemented pigs. The results suggest the potential of ginger and prebioticsto replace antibiotics in the diet of grower pig.	[Samanta, Ashis Kumar; Jayaram, C.; Jayapal, N.; Sondhi, N.; Senani, S.] Natl Inst Anim Nutr & Physiol, Feed Addit & Nutraceut Lab, Bangalore 560030, Karnataka, India; [Kolte, A. P.; Dhali, A.] Natl Inst Anim Nutr & Physiol, Omics Lab, Bangalore 560030, Karnataka, India; [Sridhar, M.] Natl Inst Anim Nutr & Physiol, Fermentat Technol Lab, Bangalore 560030, Karnataka, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Animal Nutrition & Physiology; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Animal Nutrition & Physiology; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Animal Nutrition & Physiology	Samanta, AK (corresponding author), Natl Inst Anim Nutr & Physiol, Feed Addit & Nutraceut Lab, Hosur Rd, Bangalore 560030, Karnataka, India.	drashiskumarsamanta@gmail.com	Samanta, Ashis Kumar/AAE-6920-2019; Senani, Swaraj/ABD-8567-2020; Chikkerur, Jayaram/ABI-5147-2020	Samanta, Ashis Kumar/0000-0003-1646-294X; Chikkerur, Jayaram/0000-0001-8575-7632	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR13932/AAQ/01/435/2010]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	The grant was received by AKS from the Department of Biotechnology, Ministry of Science and Technology, Government of India (www.dbtindia.nic.in) Grant No. BT/PR13932/AAQ/01/435/2010.	Al Jassim RAM, 2003, LETT APPL MICROBIOL, V37, P213, DOI 10.1046/j.1472-765X.2003.01380.x; Apajalahti J, 2005, J APPL POULTRY RES, V14, P444, DOI 10.1093/japr/14.2.444; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Casewell M, 2003, J ANTIMICROB CHEMOTH, V52, P159, DOI 10.1093/jac/dkg313; Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Costa E, 2009, J MICROBIOL METH, V78, P175, DOI 10.1016/j.mimet.2009.05.011; Costa LB, 2013, S AFR J ANIM SCI, V43, P181, DOI 10.4314/sajas.v43i2.9; de Lange CFM, 2010, LIVEST SCI, V134, P124, DOI 10.1016/j.livsci.2010.06.117; Dicksved J, 2007, APPL ENVIRON MICROB, V73, P2284, DOI 10.1128/AEM.02223-06; Duncan SH, 1998, FEMS MICROBIOL LETT, V164, P283, DOI 10.1111/j.1574-6968.1998.tb13099.x; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Economic and Social Committee of the European Union, 1998, OP RES ANT THREAT PU; Engebretson JJ, 2003, APPL ENVIRON MICROB, V69, P4823, DOI 10.1128/AEM.69.8.4823-4829.2003; Fukuda S, 2006, J APPL MICROBIOL, V100, P787, DOI 10.1111/j.1365-2672.2006.02864.x; Gaggia F, 2010, INT J FOOD MICROBIOL, V141, pS15, DOI 10.1016/j.ijfoodmicro.2010.02.031; Genersch E, 2005, APPL ENVIRON MICROB, V71, P7551, DOI 10.1128/AEM.71.11.7551-7555.2005; Hong PY, 2014, APPL ENVIRON MICROB, V80, P2084, DOI 10.1128/AEM.03176-13; Konstantinov SR, 2004, APPL ENVIRON MICROB, V70, P3821, DOI 10.1128/AEM.70.7.3821-3830.2004; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Li JR, 2003, APPL ENVIRON MICROB, V69, P901, DOI 10.1128/AEM.69.2.901-908.2003; Li PF, 2012, ASIAN AUSTRAL J ANIM, V25, P1617, DOI 10.5713/ajas.2012.12292; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Loh G, 2006, J NUTR, V136, P1198, DOI 10.1093/jn/136.5.1198; Lynch MB, 2007, ANIMAL, V1, P1112, DOI 10.1017/S1751731107000407; Marsh TL, 1999, CURR OPIN MICROBIOL, V2, P323, DOI 10.1016/S1369-5274(99)80056-3; MOORE LVH, 1987, INT J SYST BACTERIOL, V37, P271, DOI 10.1099/00207713-37-3-271; MUDARRIS M, 1994, INT J SYST BACTERIOL, V44, P447, DOI 10.1099/00207713-44-3-447; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; O'Mahony R, 2005, WORLD J GASTROENTERO, V11, P7499, DOI 10.3748/wjg.v11.i47.7499; Ohl ME, 2000, CLIN INFECT DIS, V31, P131, DOI 10.1086/313890; Oli MW, 1998, DIGEST DIS SCI, V43, P138, DOI 10.1023/A:1018892524790; Patterson JK, 2010, J NUTR, V140, P2158, DOI 10.3945/jn.110.130302; Pedersen R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-30; Prive F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069076; Samanta AK, 2011, CURR SCI INDIA, V101, P43; Samanta AK, 2012, J MICROBIOL, V50, P218, DOI 10.1007/s12275-012-1362-8; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P125, DOI 10.1007/BF02289630; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Spear GT, 2010, AIDS RES HUM RETROV, V26, P193, DOI 10.1089/aid.2009.0166; Sun YZ, 2011, J APPL MICROBIOL, V110, P1093, DOI 10.1111/j.1365-2672.2011.04967.x; Suryanarayana M.V.A.N., 2013, J AGR SUSTAIN, V3, P183; Thies JE, 2007, SOIL SCI SOC AM J, V71, P579, DOI 10.2136/sssaj2006.0318; Torok VA, 2008, APPL ENVIRON MICROB, V74, P783, DOI 10.1128/AEM.01384-07; Ueno N, 2011, INFLAMM BOWEL DIS, V17, P2235, DOI 10.1002/ibd.21597; Van Loo J, 2007, J NUTR, V137, p2594S, DOI 10.1093/jn/137.11.2594S; Varley PF, 2010, J SCI FOOD AGR, V90, P2447, DOI 10.1002/jsfa.4105; Watanabe Y, 2012, APPL ENVIRON MICROB, V78, P511, DOI 10.1128/AEM.06035-11; WINTER J, 1989, APPL ENVIRON MICROB, V55, P1203, DOI 10.1128/AEM.55.5.1203-1208.1989; World Health Organization, 1997, MED IMP US ANT FOOD; Yan L, 2012, LIVEST SCI, V145, P189, DOI 10.1016/j.livsci.2012.02.001	55	11	14	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132961	10.1371/journal.pone.0132961	http://dx.doi.org/10.1371/journal.pone.0132961			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176779	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600189
J	Uno, K; Yoshizaki, K; Iwahashi, M; Yamana, J; Yamana, S; Tanigawa, M; Yagi, K				Uno, Kazuko; Yoshizaki, Kazuyuki; Iwahashi, Mitsuhiro; Yamana, Jiro; Yamana, Seizo; Tanigawa, Miki; Yagi, Katsumi			Pretreatment Prediction of Individual Rheumatoid Arthritis Patients' Response to Anti-Cytokine Therapy Using Serum Cytokine/Chemokine/Soluble Receptor Biomarkers	PLOS ONE			English	Article							ANTITUMOR NECROSIS FACTOR; DISEASE-ACTIVITY; DOUBLE-BLIND; CONCOMITANT METHOTREXATE; MONOCLONAL-ANTIBODY; GENE-EXPRESSION; SOLUBLE IL-6; TOCILIZUMAB; TRIAL; REMISSION	The inability to match rheumatoid arthritis (RA) patients with the anti-cytokine agent most efficacious for them is a major hindrance to patients' speedy recovery and to the clinical use of anti-cytokine therapy. Identifying predictive biomarkers that can assist in matching RA patients with more suitable anti-cytokine treatment was our aim in this report. The sample consisted of 138 RA patients (naive and non-naive) who were administered tocilizumab or etanercept for a minimum of 16 weeks as a prescribed RA treatment. Pretreatment serum samples were obtained from patients and clinical measures of their disease activity were evaluated at baseline and 16 weeks after treatment commenced. Using patients' pretreatment serum, we measured 31 cytokines/chemokines/soluble receptors and used multiple linear regression analysis to identify biomarkers that correlated with patients' symptom levels (DAS28-CRP score) at week 16 and multiple logistic analyses for biomarkers that correlated with patients' final outcome. The results revealed that sgp130, logIL-6, logIL-8, logEotaxin, logIP-10, logVEGF, logsTNFR-I and logsTNFR-II pretreatment serum levels were predictive of the week 16 DAS28-CRP score in naive tocilizumab patients while sgp130, logGM-CSF and logIP-10 were predictive in non-naive patients. Additionally, we found logIL-9, logVEGF and logTNF-alpha to be less reliable at predicting the week 16 DAS28-CRP score in naive etanercept patients. Multiple linear regression and multiple logistic regression analyses identified biomarkers that were predictive of remission/non-remission in tocilizumab and etanercept therapy. Although less reliable than those for tocilizumab, we identified a few possible biomarkers for etanercept therapy. The biomarkers for these two therapies differ suggesting that their efficacy will vary for individual patients. We discovered biomarkers in RA pretreatment serum that predicted their week 16 DAS28-CRP score and clinical outcome to tocilizumab therapy. Most of these biomarkers, especially sgp130, are involved in RA pathogenesis and IL-6 signal transduction, which further suggests that they are highly reliable.	[Uno, Kazuko; Yoshizaki, Kazuyuki; Tanigawa, Miki] Osaka Univ, Inst Sci & Ind Res, Dept Organ Fine Chem, Div Biol & Mol Sci, Suita, Osaka, Japan; [Uno, Kazuko; Yagi, Katsumi] Louis Pasteur Ctr Med Res, Kyoto, Kyoto, Japan; [Iwahashi, Mitsuhiro; Yamana, Jiro; Yamana, Seizo] Higashi Hiroshima Mem Hosp, Higashihiroshima, Hiroshima, Japan; [Yoshizaki, Kazuyuki] Tokushukai Med Corp, Tokyo, Japan	Osaka University	Yoshizaki, K (corresponding author), Osaka Univ, Inst Sci & Ind Res, Dept Organ Fine Chem, Div Biol & Mol Sci, Suita, Osaka, Japan.	kyoshi@sanken.osaka-u.ac.jp			Japan Health Foundation [25460784]	Japan Health Foundation(Japan Health Foundation)	Support was provided by Grants-in-Aid for Scientific Research, the Japan Health Foundation, (No. 25460784).	Aga AB, 2013, ANN RHEUM DIS; Arend WP, 2002, J RHEUMATOL, V29, P16; Bienkowska JR, 2009, GENOMICS, V94, P423, DOI 10.1016/j.ygeno.2009.08.008; Boettger MK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3079; Burmester GR, 2011, ANN RHEUM DIS, V70, P755, DOI 10.1136/ard.2010.139725; Conaghan PG, 2011, CLIN RHEUMATOL, V30, pS41, DOI 10.1007/s10067-010-1639-4; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Hagihara K, 2004, BIOCHEM BIOPH RES CO, V314, P363, DOI 10.1016/j.bbrc.2003.12.096; Hambardzumyan K, 2014, ANN RHEUM DIS; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Lindstrom TM, 2010, SCAND J CLIN LAB INV, V70, P79, DOI 10.3109/00365513.2010.493406; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Marotte H, 2010, JOINT BONE SPINE, V77, P297, DOI 10.1016/j.jbspin.2010.02.026; Nakahara H, 2003, ARTHRITIS RHEUM-US, V48, P1521, DOI 10.1002/art.11143; Navarro-Millan I, 2013, CURR OPIN RHEUMATOL, V25, P384, DOI 10.1097/BOR.0b013e32835fc62e; Nishikawa T, 2008, J IMMUNOL, V180, P3492, DOI 10.4049/jimmunol.180.5.3492; Nishimoto N, 2004, ARTHRITIS RHEUM-US, V50, P1761, DOI 10.1002/art.20303; Nishimoto N, 2003, J RHEUMATOL, V30, P1426; Nishimoto N, 2010, MOD RHEUMATOL, V20, P539, DOI 10.1007/s10165-010-0328-0; Nishina N, 2014, ANN RHEUM DIS, V73, P945, DOI 10.1136/annrheumdis-2013-204137; Nowell MA, 2003, J IMMUNOL, V171, P3202, DOI 10.4049/jimmunol.171.6.3202; Ortea I, 2012, J PROTEOMICS, V77, P372, DOI 10.1016/j.jprot.2012.09.011; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Sanayama Y, 2014, ARTHRITIS RHEUMATOL, V66, P1421, DOI 10.1002/art.38400; Serada S, 2014, METHODS MOL BIOL, V1142, P99, DOI 10.1007/978-1-4939-0404-4_12; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Smolen JS, 2013, ANN RHEUM DIS; Solomon DH, 2014, ARTHRITIS RHEUMATOL, V66, P775, DOI 10.1002/art.38323; Song SNJ, 2015, EXPERT OPIN DRUG MET, V11, P307, DOI 10.1517/17425255.2015.992779; Song SNJ, 2010, BLOOD, V116, P3627, DOI 10.1182/blood-2010-03-271791; Tanaka T, 2010, EXPERT REV CLIN IMMU, V6, P843, DOI [10.1586/eci.10.70, 10.1586/ECI.10.70]; van den Broek M, 2013, CURR OPIN PHARMACOL, V13, P463, DOI 10.1016/j.coph.2013.03.006; van der Heijde D, 2005, ANN RHEUM DIS, V64, P1582, DOI 10.1136/ard.2004.034371; van der Heijde D, 2010, J RHEUMATOL, V37, P2237, DOI 10.3899/jrheum.100208; van der Kooij SM, 2009, ANN RHEUM DIS, V68, P914, DOI 10.1136/ard.2008.092254; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697	36	23	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132055	10.1371/journal.pone.0132055	http://dx.doi.org/10.1371/journal.pone.0132055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176225	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600080
J	Wang, Z; Li, XF; Jiang, Y; Shao, QZ; Liu, Q; Chen, BY; Huang, DS				Wang, Zhen; Li, Xianfeng; Jiang, Yi; Shao, Qianzhi; Liu, Qi; Chen, BingYu; Huang, Dongsheng			swDMR: A Sliding Window Approach to Identify Differentially Methylated Regions Based on Whole Genome Bisulfite Sequencing	PLOS ONE			English	Article							DNA METHYLATION; METHYLOME; PATTERNS; IDENTIFICATION; MODEL	DNA methylation is a widespread epigenetic modification that plays an essential role in gene expression through transcriptional regulation and chromatin remodeling. The emergence of whole genome bisulfite sequencing (WGBS) represents an important milestone in the detection of DNA methylation. Characterization of differential methylated regions (DMRs) is fundamental as well for further functional analysis. In this study, we present swDMR (http://sourceforge.net/projects/swdmr/) for the comprehensive analysis of DMRs from whole genome methylation profiles by a sliding window approach. It is an integrated tool designed for WGBS data, which not only implements accessible statistical methods to perform hypothesis test adapted to two or more samples without replicates, but false discovery rate was also controlled by multiple test correction. Downstream analysis tools were also provided, including cluster, annotation and visualization modules. In summary, based on WGBS data, swDMR can produce abundant information of differential methylated regions. As a convenient and flexible tool, we believe swDMR will bring us closer to unveil the potential functional regions involved in epigenetic regulation.	[Wang, Zhen; Chen, BingYu; Huang, Dongsheng] Wenzhou Med Univ, Minist Educ, Zhejiang Prov Peoples Hosp, Res Ctr Blood Transfus Med,Key Lab Lab Med, Hangzhou, Zhejiang, Peoples R China; [Li, Xianfeng] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Jiang, Yi; Shao, Qianzhi; Liu, Qi] Wenzhou Med Univ, Inst Genom Med, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Zhejiang Provincial People's Hospital; Central South University; Wenzhou Medical University	Chen, BY (corresponding author), Wenzhou Med Univ, Minist Educ, Zhejiang Prov Peoples Hosp, Res Ctr Blood Transfus Med,Key Lab Lab Med, Hangzhou, Zhejiang, Peoples R China.	mmizjpph66@163.com; mmizjpph668@163.com	li, xianfeng/GYD-5825-2022		Traditional Chinese Medicine of Scientific Research [2014ZB007]; outstanding young talent foundation of Zhejiang Province [2014ZQ005]; Natural Science Foundation of Zhejiang Province [LY15C090004]	Traditional Chinese Medicine of Scientific Research; outstanding young talent foundation of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the Traditional Chinese Medicine of Scientific Research (2014ZB007, BC), outstanding young talent foundation of Zhejiang Province (2014ZQ005, ZW) and the Natural Science Foundation of Zhejiang Province (LY15C090004, ZW).	Aryee MJ, 2011, BIOSTATISTICS, V12, P197, DOI 10.1093/biostatistics/kxq055; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Fang F, 2012, P NATL ACAD SCI USA, V109, P7332, DOI 10.1073/pnas.1201310109; Feng H, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku154; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Hebestreit K, 2013, BIOINFORMATICS, V29, P1647, DOI 10.1093/bioinformatics/btt263; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim JH, 2011, GENOME RES, V21, P1028, DOI 10.1101/gr.119347.110; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li S, 2013, BMC BIOINFORMATICS, P14; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Park Y, 2014, BIOINFORMATICS; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Saito Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1373; Su JZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks829; Sun DQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r38; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Yagi S, 2008, GENOME RES, V18, P1969, DOI 10.1101/gr.074070.107; Yan Zhou B Z, 2013, METHYLMNM DETECT DIF; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr053	35	36	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132866	10.1371/journal.pone.0132866	http://dx.doi.org/10.1371/journal.pone.0132866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176536	Green Submitted, gold, Green Published			2022-12-27	WOS:000358197600171
J	Wu, W; Qu, Y; Hu, N; Zeng, YX; Yang, J; Xu, HW; Yin, ZQ				Wu, Wei; Qu, Ya; Hu, Ning; Zeng, Yuxiao; Yang, Jun; Xu, Haiwei; Yin, Zheng Qin			A Cell Electrofusion Chip for Somatic Cells Reprogramming	PLOS ONE			English	Article							EMBRYONIC STEM-CELL; DNA DEMETHYLATION; MICROFLUIDIC DEVICE; TET PROTEINS; IN-VITRO; ES CELLS; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; PLURIPOTENCY; FUSION	Cell fusion is a potent approach to explore the mechanisms of somatic cells reprogramming. However, previous fusion methods, such as polyethylene glycol (PEG) mediated cell fusion, are often limited by poor fusion yields. In this study, we developed a simplified cell electrofusion chip, which was based on a micro-cavity/discrete microelectrode structure to improve the fusion efficiency and to reduce multi-cell electrofusion. Using this chip, we could efficiently fuse NIH3T3 cells and mouse embryonic stem cells (mESCs) to induce somatic cells reprogramming. We also found that fused cells demethylated gradually and 5-hydroxy-methylcytosine (5hmC) was involved in the demethylation during the reprogramming. Thus, the cell electrofusion chip would facilitate reprogramming mechanisms research by improving efficiency of cell fusion and reducing workloads.	[Wu, Wei; Qu, Ya; Zeng, Yuxiao; Xu, Haiwei; Yin, Zheng Qin] Third Mil Med Univ, Southwest Hosp, Southwest Eye Hosp, Chongqing, Peoples R China; [Wu, Wei; Qu, Ya; Hu, Ning; Zeng, Yuxiao; Yang, Jun; Xu, Haiwei; Yin, Zheng Qin] Key Lab Visual Damage & Regenerat & Restorat Chon, Chongqing, Peoples R China; [Hu, Ning; Yang, Jun] Chongqing Univ, Bioengn Coll, Chongqing 630044, Peoples R China	Army Medical University; Chongqing University	Xu, HW (corresponding author), Third Mil Med Univ, Southwest Hosp, Southwest Eye Hosp, Chongqing, Peoples R China.	haiweixu2001@163.com; qinzyin@aliyun.com		Wu, Wei/0000-0002-7097-2150	National Basic Research Program of China [2013CB967002]	National Basic Research Program of China(National Basic Research Program of China)	This study was supported by National Basic Research Program of China (No. 2013CB967002) (http://www.973.gov.cn/Default_3.aspx).	Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Clow AL, 2010, BIOMED MICRODEVICES, V12, P777, DOI 10.1007/s10544-010-9432-3; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Gel M, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3422544; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hamdi FS, 2014, BIOELECTROCHEMISTRY, V100, P27, DOI 10.1016/j.bioelechem.2014.05.004; Hu N, 2013, SENSOR ACTUAT B-CHEM, V178, P63, DOI 10.1016/j.snb.2012.12.034; Hu N, 2012, ELECTROPHORESIS, V33, P1980, DOI 10.1002/elps.201100579; Hu N, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3630125; Hu N, 2011, ELECTROPHORESIS, V32, P2488, DOI 10.1002/elps.201100082; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kemna EWM, 2011, ELECTROPHORESIS, V32, P3138, DOI 10.1002/elps.201100227; Kirschbaum M, 2012, LAB CHIP, V12, P443, DOI 10.1039/c1lc20818g; Liang GY, 2013, CELL RES, V23, P49, DOI 10.1038/cr.2012.175; Morganti E, 2011, MICROFLUID NANOFLUID, V10, P1211, DOI 10.1007/s10404-010-0751-8; Piccolo FM, 2013, MOL CELL, V49, P1023, DOI 10.1016/j.molcel.2013.01.032; Pucihar G, 2001, BIOELECTROCHEMISTRY, V54, P107, DOI 10.1016/S1567-5394(01)00117-7; Qu Y, 2011, MICROFLUID NANOFLUID, V11, P633, DOI 10.1007/s10404-011-0829-y; Rajasingh J, 2008, CIRC RES, V102, pE107, DOI 10.1161/CIRCRESAHA.108.176115; Rems L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03382; Sancho M, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3454129; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Skelley AM, 2009, NAT METHODS, V6, P147, DOI [10.1038/NMETH.1290, 10.1038/nmeth.1290]; Tada M, 2003, DEV DYNAM, V227, P504, DOI 10.1002/dvdy.10337; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Tada M, 2006, METH MOL B, V325, P67; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Tang J, 2008, NEUROSCI RES, V62, P86, DOI 10.1016/j.neures.2008.06.005; Techaumnat B, 2008, IET NANOBIOTECHNOL, V2, P93, DOI 10.1049/iet-nbt:20080008; Tresset G, 2004, BIOMED MICRODEVICES, V6, P213, DOI 10.1023/B:BMMD.0000042050.95246.af; Usaj M, 2012, J MEMBRANE BIOL, V245, P583, DOI 10.1007/s00232-012-9470-2; Wang J, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2402122; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yamazaki Y, 2006, MOL REPROD DEV, V73, P180, DOI 10.1002/mrd.20411; Yang H, 2010, CELL RES, V20, P1034, DOI 10.1038/cr.2010.97	43	10	10	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131966	10.1371/journal.pone.0131966	http://dx.doi.org/10.1371/journal.pone.0131966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177036	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600072
J	Ayllon, N; Naranjo, V; Hajdusek, O; Villar, M; Galindo, RC; Kocan, KM; Alberdi, P; Sima, R; Cabezas-Cruz, A; Ruckert, C; Bell-Sakyi, L; Kazimirova, M; Havlikova, S; Klempa, B; Kopacek, P; de la Fuente, J				Ayllon, Nieves; Naranjo, Victoria; Hajdusek, Ondrej; Villar, Margarita; Galindo, Ruth C.; Kocan, Katherine M.; Alberdi, Pilar; Sima, Radek; Cabezas-Cruz, Alejandro; Rueckert, Claudia; Bell-Sakyi, Lesley; Kazimirova, Myria; Havlikova, Sabna; Klempa, Boris; Kopacek, Petr; de la Fuente, Jose			Nuclease Tudor-SN Is Involved in Tick dsRNA-Mediated RNA Interference and Feeding but Not in Defense against Flaviviral or Anaplasma phagocytophilum Rickettsial Infection	PLOS ONE			English	Article							QUANTITATIVE PROTEOMICS; GENE-EXPRESSION; CELL-LINES; MACHINERY; INSIGHTS; ACCURATE; DISEASE; BINDING; GROWTH	Tudor staphylococcal nuclease (Tudor-SN) and Argonaute (Ago) are conserved components of the basic RNA interference (RNAi) machinery with a variety of functions including immune response and gene regulation. The RNAi machinery has been characterized in tick vectors of human and animal diseases but information is not available on the role of Tudor-SN in tick RNAi and other cellular processes. Our hypothesis is that tick Tudor-SN is part of the RNAi machinery and may be involved in innate immune response and other cellular processes. To address this hypothesis, Ixodes scapularis and I. ricinus ticks and/or cell lines were used to annotate and characterize the role of Tudor-SN in dsRNA-mediated RNAi, immune response to infection with the rickettsia Anaplasma phagocytophilum and the flaviviruses TBEV or LGTV and tick feeding. The results showed that Tudor-SN is conserved in ticks and involved in dsRNA-mediated RNAi and tick feeding but not in defense against infection with the examined viral and rickettsial pathogens. The effect of Tudor-SN gene knockdown on tick feeding could be due to down-regulation of genes that are required for protein processing and blood digestion through a mechanism that may involve selective degradation of dsRNAs enriched in G:U pairs that form as a result of adenosine-to-inosine RNA editing. These results demonstrated that Tudor-SN plays a role in tick RNAi pathway and feeding but no strong evidence for a role in innate immune responses to pathogen infection was found.	[Ayllon, Nieves; Naranjo, Victoria; Villar, Margarita; Galindo, Ruth C.; Alberdi, Pilar; Cabezas-Cruz, Alejandro; de la Fuente, Jose] CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, SaBio, Ciudad Real 13005, Spain; [Naranjo, Victoria; Galindo, Ruth C.; Kocan, Katherine M.; de la Fuente, Jose] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [Hajdusek, Ondrej; Sima, Radek; Kopacek, Petr] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Cabezas-Cruz, Alejandro] Univ Lille Nord France, CNRS, Inst Pasteur Lille, CIIL,INSERM U1019,UMR 8204, Lille, France; [Rueckert, Claudia; Bell-Sakyi, Lesley] Pirbright Inst, Woking GU24 0NF, Surrey, England; [Kazimirova, Myria] Slovak Acad Sci, Inst Zool, Bratislava 84506, Slovakia; [Havlikova, Sabna; Klempa, Boris] Slovak Acad Sci, Inst Virol, Bratislava 84505, Slovakia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Oklahoma State University System; Oklahoma State University - Stillwater; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Slovak Academy of Sciences; Slovak Academy of Sciences	de la Fuente, J (corresponding author), CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, SaBio, Ronda Toledo S-N, Ciudad Real 13005, Spain.	jose_delafuente@yahoo.com	Hajdusek, Ondrej/G-7911-2014; Alberdi, Pilar/K-7788-2014; Klempa, Boris/N-3096-2019; Villar-Rayo, Marga M/J-4155-2012; Šíma, Radek/E-6658-2012; Kopacek, Petr/G-8414-2014; Cabezas-Cruz, Alejandro/P-2755-2017; Kazimirova, Maria/U-8222-2017; Klempa, Boris/J-8876-2012	Alberdi, Pilar/0000-0002-6999-9735; Klempa, Boris/0000-0002-6931-1224; Villar-Rayo, Marga M/0000-0003-4172-9079; Kopacek, Petr/0000-0003-2412-5724; Cabezas-Cruz, Alejandro/0000-0002-8660-730X; Kazimirova, Maria/0000-0001-6904-8342; Klempa, Boris/0000-0002-6931-1224; Ruckert, Claudia/0000-0003-3732-6752	European Union [278976, 316304]; Ministerio de Educacion y Ciencia, Spain; European Social Fund; Junta de Comunidades de Castilla-La Mancha (Program FSE), Spain; project Postdok_BIOGLOBE [CZ.1.07/2.3.00/30.0032]; GA CR [13-12816P]; Grant Agency of the Czech Republic [3-27630P]; United Kingdom Biotechnology and Biological Sciences Research Council's National Capability Grant;  [BFU2011-23896]; BBSRC [BBS/E/I/00001741] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001741] Funding Source: researchfish	European Union(European Commission); Ministerio de Educacion y Ciencia, Spain(Spanish Government); European Social Fund(European Social Fund (ESF)); Junta de Comunidades de Castilla-La Mancha (Program FSE), Spain(Junta de Comunidades de Castilla-La Mancha); project Postdok_BIOGLOBE; GA CR(Grant Agency of the Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); United Kingdom Biotechnology and Biological Sciences Research Council's National Capability Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by grants BFU2011-23896 and the European Union FP7 ANTIGONE project number 278976 (JdlF). NA was funded by Ministerio de Educacion y Ciencia, Spain. VN was funded by the European Social Fund and the Junta de Comunidades de Castilla-La Mancha (Program FSE 2007-2013), Spain. RS was supported by the project Postdok_BIOGLOBE (CZ.1.07/2.3.00/30.0032) and by the Grant 13-12816P (GA CR). OH was supported by the Grant Agency of the Czech Republic grant no. 13-27630P and European Union FP7 MODBIOLIN project number 316304. CR and LBS were supported by the United Kingdom Biotechnology and Biological Sciences Research Council's National Capability Grant to the Pirbright Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achazi K, 2012, ANTIVIR RES, V93, P94, DOI 10.1016/j.antiviral.2011.10.023; Aljamali MN, 2002, EXP APPL ACAROL, V28, P89, DOI 10.1023/A:1025346131903; Alsford S, 2010, MOL BIOCHEM PARASIT, V174, P70, DOI 10.1016/j.molbiopara.2010.06.006; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Aung KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028407; Ayllon N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005120; Ayllon N, 2013, INFECT IMMUN, V81, P2415, DOI 10.1128/IAI.00194-13; Barnard AC, 2012, GENES-BASEL, V3, P702, DOI 10.3390/genes3040702; Barry G, 2013, EXP APPL ACAROL, V59, P319, DOI 10.1007/s10493-012-9598-x; Bell-Sakyi L, 2004, J COMP PATHOL, V130, P285, DOI 10.1016/j.jcpa.2003.12.002; Bell-Sakyi L, 2007, TRENDS PARASITOL, V23, P450, DOI 10.1016/j.pt.2007.07.009; Beugnet F, 2009, VET PARASITOL, V163, P298, DOI 10.1016/j.vetpar.2009.03.028; Bonzon-Kulichenko E, 2011, J PROTEOMICS, V75, P561, DOI 10.1016/j.jprot.2011.08.022; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Contreras M, 2014, MOL ECOL RESOUR, V14, P1095, DOI 10.1111/1755-0998.12298; de la Fuente J, 2005, CELL MICROBIOL, V7, P549, DOI 10.1111/j.1462-5822.2004.00485.x; de la Fuente J, 2008, FRONT BIOSCI-LANDMRK, V13, P6938, DOI 10.2741/3200; de la Fuente J, 2007, TRENDS PARASITOL, V23, P427, DOI 10.1016/j.pt.2007.07.002; Donald Claire L, 2012, Insects, V3, P511, DOI 10.3390/insects3020511; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frey NFD, 2010, PLANT CELL, V22, P1575, DOI 10.1105/tpc.109.070680; Friberg A, 2009, J MOL BIOL, V387, P921, DOI 10.1016/j.jmb.2009.02.018; Garcia S, 2005, J VIROL, V79, P8942, DOI 10.1128/JVI.79.14.8942-8947.2005; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Havlikova S, 2013, VACCINE, V31, P1582, DOI 10.1016/j.vaccine.2013.01.017; Jorge I, 2009, MOL CELL PROTEOMICS, V8, P1130, DOI 10.1074/mcp.M800260-MCP200; Joshua-Tor L, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003772; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kocan KM, 2011, JOVE-J VIS EXP, DOI 10.3791/2474; Kocan KM, 2012, TICKS TICK-BORNE DIS, V3, P147, DOI 10.1016/j.ttbdis.2012.01.004; Kurscheid S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-26; Li CL, 2008, NUCLEIC ACIDS RES, V36, P3579, DOI 10.1093/nar/gkn236; Li X, 2014, WIRES RNA, V5, P111, DOI 10.1002/wrna.1201; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Martinez-Bartolome S, 2008, MOL CELL PROTEOMICS, V7, P1135, DOI 10.1074/mcp.M700239-MCP200; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Navarro P, 2014, J PROTEOME RES, V13, P1234, DOI 10.1021/pr4006958; Navarro P, 2009, J PROTEOME RES, V8, P1792, DOI 10.1021/pr800362h; Nicolas FE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003089; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Phetrungnapha A, 2011, FISH SHELLFISH IMMUN, V31, P373, DOI 10.1016/j.fsi.2011.05.026; Popara M, 2013, VACCINE, V31, P4728, DOI 10.1016/j.vaccine.2013.08.031; Scadden ADJ, 2008, BIOCHEM SOC T, V36, P534, DOI 10.1042/BST0360534; Schnettler E, 2014, NUCLEIC ACIDS RES, V42, P9436, DOI 10.1093/nar/gku657; Sojka D, 2013, TRENDS PARASITOL, V29, P276, DOI 10.1016/j.pt.2013.04.002; Sprong H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-77; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuckow AP, 2015, INSECT MOL BIOL, V24, P454, DOI 10.1111/imb.12172; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Weissbach R, 2012, RNA, V18, P462, DOI 10.1261/rna.027656.111; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]	51	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133038	10.1371/journal.pone.0133038	http://dx.doi.org/10.1371/journal.pone.0133038			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186700	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700087
J	Chung, J; Ou, XZ; Kulkarni, RP; Yang, CH				Chung, Jaebum; Ou, Xiaoze; Kulkarni, Rajan P.; Yang, Changhuei			Counting White Blood Cells from a Blood Smear Using Fourier Ptychographic Microscopy	PLOS ONE			English	Article							HEART-DISEASE; MORTALITY; CORONARY; FLOW	White blood cell (WBC) count is a valuable metric for assisting with diagnosis or prognosis of various diseases such as coronary heart disease, type 2 diabetes, or infection. Counting WBCs can be done either manually or automatically. Automatic methods are capable of counting a large number of cells to give a statistically more accurate reading of the WBC count of a sample, but the specialized equipment tends to be expensive. Manual methods are inexpensive since they only involve a conventional light microscope setup. However, it is more laborious and error-prone because the small field-of-view (FOV) of the microscope necessitates mechanical scanning of a specimen for counting an adequate number of WBCs. Here, we investigate the use of Fourier ptychographic microscopy (FPM) to bypass these issues of the manual methods. With a 2x objective, FPM can provide a FOV of 120 mm(2) with enhanced resolution comparable to that of a 20x objective, which is adequate for non-differentially counting WBCs in just one FOV. A specialist was able to count the WBCs in FPM images with 100% accuracy compared to the count as determined from conventional microscope images. An automatic counting algorithm was also developed to identify WBCs from FPM's captured images with 95% accuracy, paving the way for a cost-effective WBC counting setup with the advantages of both the automatic and manual counting methods.	[Chung, Jaebum; Ou, Xiaoze; Yang, Changhuei] CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA; [Kulkarni, Rajan P.] Univ Calif Los Angeles, Div Dermatol, Los Angeles, CA 90024 USA; [Yang, Changhuei] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA	California Institute of Technology; University of California System; University of California Los Angeles; California Institute of Technology	Chung, J (corresponding author), CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA.	jchung@caltech.edu		Chung, Jaebum/0000-0003-3932-8428	NIH [1DP2OD007307]; Caltech Innovation Initiative (CI2) Program; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007307] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech Innovation Initiative (CI2) Program; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant 1DP2OD007307; 2014 Caltech Innovation Initiative (CI2) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron HV, 2000, CIRCULATION, V102, P2329, DOI 10.1161/01.CIR.102.19.2329; Bellwood B, 2013, VET TECHNICIANS HDB; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Brown DW, 2001, J CLIN EPIDEMIOL, V54, P316, DOI 10.1016/S0895-4356(00)00296-1; Fritsma GA, 2008, HEMATOLOGY CLIN PRIN; Ghaznavi F, 2013, ANNU REV PATHOL-MECH, V8, P331, DOI 10.1146/annurev-pathol-011811-120902; GRIMM RH, 1985, JAMA-J AM MED ASSOC, V254, P1932, DOI 10.1001/jama.254.14.1932; Horstmeyer R, 2014, OPT EXPRESS, V22, P338, DOI 10.1364/OE.22.000338; Huh D, 2005, PHYSIOL MEAS, V26, pR73, DOI 10.1088/0967-3334/26/3/R02; JAFFE DM, 1991, PEDIATRICS, V87, P670; KANNEL WB, 1992, JAMA-J AM MED ASSOC, V267, P1253, DOI 10.1001/jama.267.9.1253; Kessel R. G., 1998, BASIC MED HISTOLOGY; Mandel L., 1995, OPTICAL COHERENCE QU; Ou XZ, 2015, OPT EXPRESS, V23, P3472, DOI 10.1364/OE.23.003472; Ou XZ, 2014, OPT EXPRESS, V22, P4960, DOI 10.1364/OE.22.004960; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Tong PC, 2004, DIABETES CARE, V27, P216, DOI 10.2337/diacare.27.1.216; Turgeon M.L., 2005, CLIN HEMATOLOGY THEO; Twig G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047183; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; YARNELL JWG, 1991, CIRCULATION, V83, P836, DOI 10.1161/01.CIR.83.3.836; Zheng GA, 2013, NAT PHOTONICS, V7, P739, DOI [10.1038/NPHOTON.2013.187, 10.1038/nphoton.2013.187]; Zuba-Surma EK, 2007, FOLIA HISTOCHEM CYTO, V45, P279	23	48	64	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133489	10.1371/journal.pone.0133489	http://dx.doi.org/10.1371/journal.pone.0133489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186353	Green Published, gold, Green Accepted			2022-12-27	WOS:000358198700147
J	Lewis, KL; Han, PKJ; Hooker, GW; Klein, WMP; Biesecker, LG; Biesecker, BB				Lewis, Katie L.; Han, Paul K. J.; Hooker, Gillian W.; Klein, William M. P.; Biesecker, Leslie G.; Biesecker, Barbara B.			Characterizing Participants in the ClinSeq Genome Sequencing Cohort as Early Adopters of a New Health Technology	PLOS ONE			English	Article							PERSONAL GENOMICS; RISK; INTENTIONS; PSYCHOLOGY; AMBIGUITY; OPTIMISM	Genome sequencing is a novel clinical tool that has the potential to identify genetic origins of disease. However, the complexities of this new technology are significant and little is known about its integration into clinical care, and its potential adoption by patients. Expectations of its promise for personalized medicine are high and it is important to properly match expectations to the realities of the test. The NIH ClinSeq cohort study pilots the integration of genome sequencing into clinical research and care to assess the technical, medical and socio-behavioral aspects of implementing this technology. Over 950 adults ages 45-65 have been enrolled and clinically phenotyped. As an initial study, we describe the personality traits of ClinSeq participants, and explore how these traits compare to those that characterize early adopters of other new technologies. Our analysis was conducted on responses from 630 members of the cohort who completed a baseline survey on health cognitions, affect, health-related behaviors and personality traits, prior to receipt of any genome sequencing results. The majority of participants were white (90.5%), had at least a college degree (86.5%), and had at least one biological child (74.6%). Members of this ClinSeq sample were found to be high in dispositional optimism and resilience. Their high SES paralleled that of other early adopters of new technology. These attributes may contribute to participants' expectations for favorable outcomes and willingness to take higher risks when compared to the general population. These characteristics may distinguish those who are most likely to pursue genome sequencing and be indicative of their psychological resources to manage returned results.	[Lewis, Katie L.; Biesecker, Leslie G.; Biesecker, Barbara B.] NHGRI, Med Genom & Metab Genet Branch, Bethesda, MD 20892 USA; [Han, Paul K. J.] Ctr Outcomes Res & Evaluat, Maine Med Ctr Res Inst, Scarborough, ME USA; [Hooker, Gillian W.; Biesecker, Barbara B.] NHGRI, Social & Behav Res Branch, Bethesda, MD 20892 USA; [Hooker, Gillian W.] NextGxDx, Franklin, TN USA; [Klein, William M. P.] NCI, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Maine Medical Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lewis, KL (corresponding author), NHGRI, Med Genom & Metab Genet Branch, Bethesda, MD 20892 USA.	lewiskatie@mail.nih.gov	Biesecker, Leslie/AAG-2526-2021	Han, Paul/0000-0003-0165-1940; Biesecker, Barbara/0000-0001-9665-8963	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200317, ZIAHG200387] Funding Source: NIH RePORTER	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was funded by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. NextGxDx provided support in the form of salary for one author (GWH) during the time that this manuscript was prepared, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of that author are articulated in the 'author contributions' section.	Achat H, 2000, ANN BEHAV MED, V22, P127, DOI 10.1007/BF02895776; Armstrong K, 2005, JAMA-J AM MED ASSOC, V293, P1729, DOI 10.1001/jama.293.14.1729; Aspinwall LG, 2008, CANCER EPIDEM BIOMAR, V17, P1510, DOI 10.1158/1055-9965.EPI-08-0010; Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI 10.1056/NEJMra1312543; Biesecker LG, 2013, GENOME RES, V23, P1051, DOI 10.1101/gr.157826.113; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Bloss CS, 2011, NEW ENGL J MED, V364, P524, DOI 10.1056/NEJMoa1011893; Bloss CS, 2010, GENET MED, V12, P556, DOI 10.1097/GIM.0b013e3181eb51c6; Bollinger JM, 2012, GENET MED, V14, P451, DOI 10.1038/gim.2011.66; Carere DA, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0096-0; Chapman BP, 2010, AM J EPIDEMIOL, V171, P83, DOI 10.1093/aje/kwp323; Costa PT, NEO PERSONALITY INVE; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Facio FM, 2013, EUR J HUM GENET, V21, P261, DOI 10.1038/ejhg.2012.179; Facio FM, 2011, EUR J HUM GENET, V19, P1213, DOI 10.1038/ejhg.2011.123; Feero WG, 2013, JAMA-J AM MED ASSOC, V309, P1235, DOI 10.1001/jama.2013.113; Ferrer RA, COGN EMOT IN PRESS; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Furnham A., 2013, PSYCHOLOGY, V4, P717, DOI [10.4236/psych.2013.49102, DOI 10.4236/PSYCH.2013.49102]; Gelade GA, 2002, GENET SOC GEN PSYCH, V128, P213; GELLER G, 1993, MED CARE, V31, P989, DOI 10.1097/00005650-199311000-00002; Georgsdottir A. S., 2004, CREATIVITY INNOVATIO, V13, P166, DOI DOI 10.1111/J.0963-1690.2004.00306.X; Gollust SE, 2012, PUBLIC HEALTH GENOM, V15, P22, DOI 10.1159/000327296; Gray SW, 2014, GENET MED, V16, P727, DOI 10.1038/gim.2014.26; Han PKJ, 2011, MED DECIS MAKING, V31, P828, DOI 10.1177/0272989X11393976; Heshka JT, 2008, GENET MED, V10, P19, DOI 10.1097/GIM.0b013e31815f524f; Hopwood CJ, 2007, J STUD ALCOHOL DRUGS, V68, P455, DOI 10.15288/jsad.2007.68.455; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Kaphingst KA, 2012, CLIN GENET, V82, P408, DOI 10.1111/j.1399-0004.2012.01909.x; Kirkpatrick B, 2013, J GENET COUNS, V22, P407, DOI 10.1007/s10897-013-9572-8; Klein WMP, 2015, PERS SOC PSYCHOL REV, V19, P77, DOI 10.1177/1088868314539852; Marcati A, 2008, RES POLICY, V37, P1579, DOI 10.1016/j.respol.2008.06.004; McBride CM, 2010, ANNU REV PUBL HEALTH, V31, P89, DOI 10.1146/annurev.publhealth.012809.103532; McGowan ML, 2010, NEW GENET SOC, V29, P261, DOI 10.1080/14636778.2010.507485; Michie S, 2001, J MED GENET, V38, P519, DOI 10.1136/jmg.38.8.519; Munafo MR, 2007, NICOTINE TOB RES, V9, P405, DOI 10.1080/14622200701188851; Presidential Commission for the Study of Bioethical Issues, ANT COMM ETH MAN INC; Rogers EM, 1962, DIFFUSION INNOVATION; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; SCHEIER MF, 1987, J PERS, V55, P169, DOI 10.1111/j.1467-6494.1987.tb00434.x; Srivastava S, 2008, J PERS SOC PSCYHOL, V84, P1041; Taber JM, HLTH PSYCHO IN PRESS; Taber JM, ANN BEHAV M IN PRESS; Wagnild GM., THE RESILIENCE SCALE; Wright MF, 2014, GENET MED, V16, P442, DOI 10.1038/gim.2013.170; Zhao H, 2006, J APPL PSYCHOL, V91, P259, DOI 10.1037/0021-9010.91.2.259	46	36	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132690	10.1371/journal.pone.0132690	http://dx.doi.org/10.1371/journal.pone.0132690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186621	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700055
J	Liu, QY; Tang, Y; Huang, CJ; Xie, C				Liu, Qingyou; Tang, Yang; Huang, Chongjun; Xie, Chong			Study on a Mechanical Semi-Active Heave Compensation System of Drill String for Use on Floating Drilling Platform	PLOS ONE			English	Article							BUS	There are some disadvantages for existing heave compensation systems of drill string used for the Floating Drilling Platform (FDP), including high energy consumption, large and complex structure, and expensive manufacturing and maintenance costs. In view of the above, we present a streamlined mechanical semi-active heave compensation system (MSAHC) in this study. This system consists of active compensation part with the pinion and rack and passive compensation part. In order to evaluate system performance of the MSAHC, we establish its simulation model with AMEsim software. In the process of simulation, displacement of rotary hook and energy consumption is regarded as performance parameters of the system. And the change rule of two performance parameters are analyzed by changing these design parameters including gear radius of the pinion and rack, scale coefficient of PID, rotary hook load, heave height and heave period of the FDP, and accumulator volume. Then, based on the simulation results of the MSAHC system performance, we have selected out a best set of design parameters from them. Moreover, the feasibility of the design scheme of the MSAHC is effectively verified by comparison with the existing three heave compensation system. The result shows that the energy consumption of the MSAHC is lower than the active heave compensation system (AHC) and the semi-active heave compensation system (SAHC) when achieving a same compensation effect as well as the accumulator volume of MSAHC is half of the passive heave compensation system (PHC). Therefore, the new designed MSAHC not only ensure compensation effect but also lower energy consumption, and its structure is simplified by adopting the simple mechanical structure to decrease manufacturing cost, maintenance cost and floor space.	[Liu, Qingyou; Tang, Yang; Xie, Chong] Southwest Petr Univ, Sch Mechatron Engn, Chengdu, Peoples R China; [Liu, Qingyou; Tang, Yang] Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China; [Liu, Qingyou] Xi Hua Univ, Chengdu, Peoples R China; [Huang, Chongjun] Chuanqing Drilling Engn Co Ltd, CNPC, Drilling & Prod Engn Technol Res Inst, Guanghan, Peoples R China	Southwest Petroleum University; Southwest Petroleum University; China National Petroleum Corporation	Tang, Y (corresponding author), Southwest Petr Univ, Sch Mechatron Engn, Chengdu, Peoples R China.	tangyanggreat@126.com	Yang, Tang/D-2003-2017	Yang, Tang/0000-0001-7919-1409	Natural Science Foundation of China [51274171]; Graduate Student Innovation Fund of School of Mechatronic Engineering. Southwest Petroleum University [CX2014BZ04]; Graduate Innovation Foundation of Southwest Petroleum University, SGIFSWPU	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Student Innovation Fund of School of Mechatronic Engineering. Southwest Petroleum University; Graduate Innovation Foundation of Southwest Petroleum University, SGIFSWPU	The work was supported by the Natural Science Foundation of China (grant no. 51274171), the Graduate Student Innovation Fund of School of Mechatronic Engineering. Southwest Petroleum University (CX2014BZ04), and the Graduate Innovation Foundation of Southwest Petroleum University, SGIFSWPU.	[Anonymous], 1997, SPE IADC DRILL C; Driscoll FR, 2000, OCEANS 2000 MTS/IEEE - WHERE MARINE SCIENCE AND TECHNOLOGY MEET, VOLS 1-3, CONFERENCE PROCEEDINGS, P1121, DOI 10.1109/OCEANS.2000.881753; Egbert GL., 1991, Drill string compensator with improved transloaders, Patent No. [US5066059, 5066059]; Gu P, 2013, INT J MACH LEARN CYB, V4, P85, DOI 10.1007/s13042-012-0076-x; Hatleskog J.T., 1993, U.S. Patent, Patent No. [5,209,302, 5209302]; Hu XS, 2014, IEEE T INTELL TRANSP, V15, P1193, DOI 10.1109/TITS.2013.2294675; Hu XS, 2013, APPL ENERG, V111, P1001, DOI 10.1016/j.apenergy.2013.06.056; Huang LM, 2013, PETROL EXPLOR DEV+, V40, P665, DOI 10.1016/S1876-3804(13)60089-0; [姜浩 Jiang Hao], 2012, [石油学报, Acta Petrolei Sinica], V33, P483; Jiang Hao, 2011, 2011 International Conference on Fluid Power and Mechatronics, P791, DOI 10.1109/FPM.2011.6045869; Kim H J, 2006, U.S. Patent, Patent No. [7,004,694, 7004694]; Korde UA, 1998, OCEAN ENG, V25, P541, DOI 10.1016/S0029-8018(97)00028-0; Liu Q, 2014, J SICHUAN U, P153; Mao L J, 2014, PLOS ONE; Moe MM, 2007, U.S. Patent, Patent No. [7,231,981, 7231981]; [倪佳 Ni Jia], 2010, [计算机仿真, Computer Simulation], V27, P247; Ni J, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, VOLS 1-7, CONFERENCE PROCEEDINGS, P5111; Tang Y, 2015, ENG FAIL ANAL, V50, P39, DOI 10.1016/j.engfailanal.2014.12.018; Totten GE, 2011, HDB HYDRAULIC FLUID, Vsecond; Wu Baihai, 2003, Chinese Journal of Mechanical Engineering, V39, P128, DOI 10.3901/JME.2003.07.128; Xu Xiao-jun, 2007, Journal of National University of Defense Technology, V29, P118; Yu J, 2012, PROCEEDINGS OF THE 10TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION (WCICA 2012), P30, DOI 10.1109/WCICA.2012.6357834; Zhang WZ, 2009, IND ROBOT, V36, P255, DOI 10.1108/01439910910950522; ZHANG X, 2010, INT SYST DES ENG APP, V2, P378	24	5	6	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133026	10.1371/journal.pone.0133026	http://dx.doi.org/10.1371/journal.pone.0133026			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186620	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700086
J	Meiyazhagan, G; Raju, R; Winfred, SB; Mannivanan, B; Bhoopalan, H; Shankar, V; Sekar, S; Venkatachalam, DP; Pitani, R; Nagendrababu, V; Thaiman, M; Devivanayagam, K; Jayaraman, J; Ragavachary, R; Venkatraman, G				Meiyazhagan, Gowri; Raju, Rajesh; Winfred, Sofi Beaula; Mannivanan, Bhavani; Bhoopalan, Hemadev; Shankar, Venkatesh; Sekar, Sathiya; Venkatachalam, Deepa Parvathi; Pitani, Ravishankar; Nagendrababu, Venkateshbabu; Thaiman, Malini; Devivanayagam, Kandaswamy; Jayaraman, Jeyakanthan; Ragavachary, Raghunathan; Venkatraman, Ganesh			Bioactivity Studies of beta-Lactam Derived Polycyclic Fused Pyrroli-Dine/Pyrrolizidine Derivatives in Dentistry: In Vitro, In Vivo and In Silico Studies	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS; ENDODONTIC TREATMENT; CALCIUM HYDROXIDE; INHIBITORS; MECHANISM; ANTIBIOTICS; PENICILLINS; POTENT	The antibacterial activity of beta-lactam derived polycyclic fused pyrrolidine/pyrrolizidine derivatives synthesized by 1, 3-dipolar cycloaddition reaction was evaluated against microbes involved in dental infection. Fifteen compounds were screened; among them compound 3 showed efficient antibacterial activity in an ex vivo dentinal tubule model and in vivo mice infectious model. In silico docking studies showed greater affinity to penicillin binding protein. Cell damage was observed under Scanning Electron Microscopy (SEM) which was further proved by Confocal Laser Scanning Microscope (CLSM) and quantified using Flow Cytometry by PI up-take. Compound 3 treated E. faecalis showed ROS generation and loss of membrane integrity was quantified by flow cytometry. Compound 3 was also found to be active against resistant E. faecalis strains isolated from failed root canal treatment cases. Further, compound 3 was found to be hemocompatible, not cytotoxic to normal mammalian NIH 3T3 cells and non mutagenic. It was concluded that beta-lactam compound 3 exhibited promising antibacterial activity against E. faecalis involved in root canal infections and the mechanism of action was deciphered. The results of this research can be further implicated in the development of potent antibacterial medicaments with applications in dentistry.	[Meiyazhagan, Gowri; Winfred, Sofi Beaula; Mannivanan, Bhavani; Bhoopalan, Hemadev; Venkatachalam, Deepa Parvathi; Venkatraman, Ganesh] Sri Ramachandra Univ, Dept Human Genet, Madras, Tamil Nadu, India; [Raju, Rajesh; Ragavachary, Raghunathan] Univ Madras, Dept Organ Chem, Madras, Tamil Nadu, India; [Shankar, Venkatesh; Jayaraman, Jeyakanthan] Alagappa Univ, Dept Bioinformat, Karaikkudi, Tamil Nadu, India; [Sekar, Sathiya] Sri Ramachandra Univ, Ctr Toxicol & Dev Res, Madras, Tamil Nadu, India; [Pitani, Ravishankar] Sri Ramachandra Univ, Dept Community Med, Madras, Tamil Nadu, India; [Nagendrababu, Venkateshbabu; Devivanayagam, Kandaswamy] Sri Ramachandra Univ, Dept Conservat Dent & Endodont, Madras, Tamil Nadu, India; [Thaiman, Malini] Sri Ramachandra Univ, Cent Res Facil, Madras, Tamil Nadu, India	Sri Ramachandra Institute of Higher Education & Research; University of Madras; Alagappa University; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research	Ragavachary, R (corresponding author), Univ Madras, Dept Organ Chem, Guindy Campus, Madras, Tamil Nadu, India.	ragharaghunathan@yahoo.com; ganeshv@sriramachandra.edu.in	Venkatraman, Ganesh/AAB-1467-2020; Parvathi, Venkatachalam Deepa/AAX-7300-2020; Sekar, Sathiya/AAN-7175-2020	Venkatraman, Ganesh/0000-0003-0179-9785; Parvathi, Venkatachalam Deepa/0000-0002-5177-8862; Raju, Rajesh/0000-0003-3724-3148	Department of Biotechnology, Ministry of Science & Technology, Government of India [BT/PR13246/27/GBD/230/2009]	Department of Biotechnology, Ministry of Science & Technology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Ministry of Science & Technology, Government of India (BT/PR13246/27/GBD/230/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinlaja OA, 1998, NIG Q J HOSP MED, V8, P148; ALCAIDE B, 1992, J ORG CHEM, V57, P5921, DOI 10.1021/jo00048a027; Alcaide B, 2000, J ORG CHEM, V65, P3453, DOI 10.1021/jo991984h; Alder J, 2003, ANTIMICROB AGENTS CH, V47, P3561, DOI 10.1128/AAC.47.11.3561-3566.2003; Andiappan M, 2013, PROG BIOMATER, V2, DOI 10.1186/2194-0517-2-6; [Anonymous], 2014, LIGPREP VERS 3 0; Arumugam N, 2011, EUR J MED CHEM, V46, P600, DOI 10.1016/j.ejmech.2010.11.039; Arumugam N, 2010, BIOORG MED CHEM LETT, V20, P3698, DOI 10.1016/j.bmcl.2010.04.084; Ballal V, 2007, AUST DENT J, V52, P257; Borthwick AD, 1998, BIOORG MED CHEM LETT, V8, P365, DOI 10.1016/S0960-894X(98)00032-8; CIMARUSTI CM, 1984, MED RES REV, V4, P1, DOI 10.1002/med.2610040103; Curson I, 1966, Br Dent J, V121, P381; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Estrela C, 1999, J ENDODONT, V25, P416, DOI 10.1016/S0099-2399(99)80269-6; Evans M, 2002, INT ENDOD J, V35, P221, DOI 10.1046/j.1365-2591.2002.00504.x; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Flavia A, 2012, BMC COMPLEM ALTERN M, V12, P203, DOI [10.1186/1472-6882-12-203, DOI 10.1186/1472-6882-12-203]; Gentry-Weeks C, 2003, INFECT IMMUN, V71, P1434, DOI 10.1128/IAI.71.3.1434-1441.2003; GRIEVE AR, 1973, BRIT DENT J, V134, P188, DOI 10.1038/sj.bdj.4802977; Halve AK, 2007, BIOORG MED CHEM LETT, V17, P341, DOI 10.1016/j.bmcl.2006.10.064; HAN WT, 1995, BIOORGAN MED CHEM, V3, P1123, DOI 10.1016/0968-0896(95)00101-L; Kavindra VS, 2012, ANTIMICROB AGENTS CH, V56, P3457, DOI [10.1128/AAC.06102-11, DOI 10.1128/AAC.06102-11]; Kishen A, 2008, J ENDODONT, V34, P1515, DOI 10.1016/j.joen.2008.08.035; LLC S, 2014, PRIME VERSION 35; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Maurya IK, 2011, PEPTIDES, V32, P1732, DOI 10.1016/j.peptides.2011.06.003; Mims C, 2001, MIMS PATHOGENESIS IN, P474; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; Muthumanickkam A, 2013, IRAN POLYM J, V22, P143, DOI 10.1007/s13726-012-0113-3; Nagarajan S, 2012, TETRAHEDRON, V68, P3037, DOI 10.1016/j.tet.2012.02.017; Nair PNR, 2005, ORAL SURG ORAL MED O, V99, P231, DOI 10.1016/j.tripleo.2004.10.005; Prasanna MS, 2011, ACTA CRYSTALLOGR E, VE 67; Rajesh R, 2014, TETRAHEDRON LETT, V55, P699, DOI 10.1016/j.tetlet.2013.11.117; Rajesh R, 2013, EUR J ORG CHEM, V2013, P2597, DOI 10.1002/ejoc.201201471; Rosenblum SB, 1998, J MED CHEM, V41, P973, DOI 10.1021/jm970701f; Sarah S, 2011, J MOL BIOL, V405, P173, DOI [10.1016/j.jmb.2010.10.024, DOI 10.1016/J.JMB.2010.10.024]; SARIKA P, 2011, ANTIMICROB AGENTS CH, V55, P2178; SHAYMAA EE, 2012, J BIOMED RES, V26, P193, DOI DOI 10.7555/JBR.26.20110136; Singh GS, 2004, MINI-REV MED CHEM, V4, P69, DOI 10.2174/1389557043487501; Sundqvist G, 1998, ORAL SURG ORAL MED O, V85, P86, DOI 10.1016/S1079-2104(98)90404-8; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133; TOMASZ A, 1979, ANNU REV MICROBIOL, V33, P113, DOI 10.1146/annurev.mi.33.100179.000553; Vales G, 2013, NANOTOXICOLOGY, V7, P462, DOI 10.3109/17435390.2012.689882; Vivek R, 2009, J SCI RES, V2, P45; Warshaviak DT, 2014, J CHEM INF MODEL, V54, P1941, DOI 10.1021/ci500175r; Wojnicz D, 2012, UROL RES, V40, P683, DOI 10.1007/s00240-012-0499-6; Yamada M, 2007, ANTIMICROB AGENTS CH, V51, P3902, DOI 10.1128/AAC.00743-07; Zapata RO, 2008, J ENDODONT, V34, P1198, DOI 10.1016/j.joen.2008.07.001; Zehnder M, 2006, J ENDODONT, V32, P389, DOI 10.1016/j.joen.2005.09.014; Zhu K, 2014, J CHEM INF MODEL, V54, P1932, DOI 10.1021/ci500118s	51	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131433	10.1371/journal.pone.0131433	http://dx.doi.org/10.1371/journal.pone.0131433			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185985	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700017
J	Ye, S; Yang, JX; You, Y; Cao, DY; Huang, HF; Wu, M; Chen, J; Lang, JH; Shen, K				Ye, Shuang; Yang, Jiaxin; You, Yan; Cao, Dongyan; Huang, Huifang; Wu, Ming; Chen, Jie; Lang, Jinghe; Shen, Keng			Comparison of Clinical Characteristic and Prognosis between Ovarian Clear Cell Carcinoma and Serous Carcinoma: A 10-Year Cohort Study of Chinese Patients	PLOS ONE			English	Article							HISTOLOGICAL SUBTYPES; TUMOR TYPE; STAGE-I; CANCER; CHEMOTHERAPY; CA-125; ADENOCARCINOMA	Objectives To compare the clinicopathologic features and prognosis of Chinese patients with ovarian clear cell carcinoma (CCC) and serous carcinoma (SC). Methods A retrospective cohort study was designed to investigate the clinicopathologic characteristic and prognosis of patients with CCC and SC who were diagnosed and treated in in a tertiary referral center (Peking Union Medical College Hospital) between 1999 and 2009. The Kaplan-Meier method and Cox regression were employed in the survival analysis. Results A total of 504 cases were included in the study, comprising 197 cases of CCC and 307 cases of SC. The mean age of the patients with SC was greater than of CCC patients (3.6 +/- 0.94, P<0.001). Patients with CCC were more likely to be early-stage and optimally debulked (P<0.001). Regarding cancer-antigen 125, 22% of the patients with CCC had normal values, and the level was significantly lower than in patients with SC (P<0.001). More CCC patients had platinum-resistant tumors compared with platinum-sensitive disease (45.7% in CCC vs. 61.0% in SC [P=0.008]). The 5-year survival rate was 51.2% in the CCC group vs. 49.8% in the SC group (P=0.428). Patients with advanced CCC had a statistically significant poorer overall survival (OS) compared with their SC counterparts (38.0 vs. 52.0 months; hazard ratio 1.584, 95% confidence interval [CI] 1.167-2.150, P=0.003). However, the advantage of improved progression-free survival (PFS) existed across all stages. Conclusions Women with ovarian CCC presented at a younger age and early stage. Patients with ovarian CCC also had improved PFS, but they had similar OS compared to patients with SC. However, patients with advanced CCC had decreased survival.	[Ye, Shuang; Yang, Jiaxin; Cao, Dongyan; Huang, Huifang; Wu, Ming; Lang, Jinghe; Shen, Keng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing 100730, Peoples R China; [Ye, Shuang; Yang, Jiaxin; You, Yan; Cao, Dongyan; Huang, Huifang; Wu, Ming; Chen, Jie; Lang, Jinghe; Shen, Keng] Peking Union Med Coll, Beijing 100021, Peoples R China; [You, Yan; Chen, Jie] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Shen, K (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing 100730, Peoples R China.	shenkeng@vip.sina.com		Ye, Shuang/0000-0001-5624-7908	National High Technology Research Development Program of China (863 program) [2012AA02A507]; National Natural Science Foundation of China [81172482, 81372780]	National High Technology Research Development Program of China (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by National High Technology Research Development Program of China (863 program) grant number:2012AA02A507 [URL: http://www.863.gov.cn/]; and the National Natural Science Foundation of China grant number: 81172482 and 81372780 [URL: http://www.nsfc.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan JK, 2008, GYNECOL ONCOL, V109, P370, DOI 10.1016/j.ygyno.2008.02.006; Cooper BC, 2002, OBSTET GYNECOL, V100, P59, DOI 10.1016/S0029-7844(02)02057-4; del Carmen MG, 2012, GYNECOL ONCOL, V126, P481, DOI 10.1016/j.ygyno.2012.04.021; Erceg-Hurn DM, 2008, AM PSYCHOL, V63, P591, DOI 10.1037/0003-066X.63.7.591; Goff BA, 1996, GYNECOL ONCOL, V60, P412, DOI 10.1006/gyno.1996.0065; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Kobel M, 2010, GYNECOL ONCOL, V116, P50, DOI 10.1016/j.ygyno.2009.09.029; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Lee YY, 2011, GYNECOL ONCOL, V122, P541, DOI 10.1016/j.ygyno.2011.05.009; Mackay HJ, 2010, INT J GYNECOL CANCER, V20, P945, DOI 10.1111/IGC.0b013e3181dd0110; Mizuno M, 2006, J SURG ONCOL, V94, P138, DOI 10.1002/jso.20251; Okamoto A, 2014, INT J GYNECOL CANCER, V24, pS20, DOI 10.1097/IGC.0000000000000289; Pectasides D, 2006, GYNECOL ONCOL, V102, P285, DOI 10.1016/j.ygyno.2005.12.038; Rustin GJS, 2001, J CLIN ONCOL, V19, P4054, DOI 10.1200/JCO.2001.19.20.4054; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sung PL, 2014, GYNECOL ONCOL, V133, P147, DOI 10.1016/j.ygyno.2014.02.016; Tan DSP, 2007, J CLIN PATHOL, V60, P355, DOI 10.1136/jcp.2006.040030; Tavassoli FA, 2003, WHO CLASSIFICATION T; Tian CQ, 2009, CANCER-AM CANCER SOC, V115, P1395, DOI 10.1002/cncr.24152; Timmers PJ, 2009, INT J GYNECOL CANCER, V19, P88, DOI 10.1111/IGC.0b013e3181991546; Trimbos JB, 2003, JNCI-J NATL CANCER I, V95, P105; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Vergote I, 2001, LANCET, V357, P176, DOI 10.1016/S0140-6736(00)03590-X; Ye S, 2014, INT J GYNECOL CANCER, V24, P1590, DOI 10.1097/IGC.0000000000000275	24	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133498	10.1371/journal.pone.0133498	http://dx.doi.org/10.1371/journal.pone.0133498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186453	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700148
J	Herzeel, C; Costanza, P; Decap, D; Fostier, J; Reumers, J				Herzeel, Charlotte; Costanza, Pascal; Decap, Dries; Fostier, Jan; Reumers, Joke			elPrep: High-Performance Preparation of Sequence Alignment/Map Files for Variant Calling	PLOS ONE			English	Article							SECONDARY ANALYSIS; WHOLE-GENOME	elPrep is a high-performance tool for preparing sequence alignment/map files for variant calling in sequencing pipelines. It can be used as a replacement for SAMtools and Picard for preparation steps such as filtering, sorting, marking duplicates, reordering contigs, and so on, while producing identical results. What sets elPrep apart is its software architecture that allows executing preparation pipelines by making only a single pass through the data, no matter how many preparation steps are used in the pipeline. elPrep is designed as a multithreaded application that runs entirely in memory, avoids repeated file I/O, and merges the computation of several preparation steps to significantly speed up the execution time. For example, for a preparation pipeline of five steps on a whole-exome BAM file (NA12878), we reduce the execution time from about 1: 40 hours, when using a combination of SAMtools and Picard, to about 15 minutes when using elPrep, while utilising the same server resources, here 48 threads and 23GB of RAM. For the same pipeline on whole-genome data (NA12878), elPrep reduces the runtime from 24 hours to less than 5 hours. As a typical clinical study may contain sequencing data for hundreds of patients, elPrep can remove several hundreds of hours of computing time, and thus substantially reduce analysis time and cost.	[Herzeel, Charlotte] IMEC, Leuven, Belgium; [Costanza, Pascal] Intel Corp, Leuven, Belgium; [Decap, Dries; Fostier, Jan] Univ Ghent, Dept Informat Technol, iMinds, B-9000 Ghent, Belgium; [Reumers, Joke] Janssen Pharmaceut NV, Janssen Res & Dev, Div, Beerse, Belgium; [Herzeel, Charlotte; Costanza, Pascal; Decap, Dries; Fostier, Jan; Reumers, Joke] ExaSci Life Lab, Leuven, Belgium	IMEC; Intel Corporation; Ghent University; IMEC; Johnson & Johnson; Janssen Pharmaceuticals	Herzeel, C (corresponding author), IMEC, Leuven, Belgium.	Charlotte.Herzeel@imec.be	Fostier, Jan/A-8275-2012	Fostier, Jan/0000-0002-9994-8269; Herzeel, Charlotte/0000-0002-9319-9885; Reumers, Joke/0000-0001-5434-6515	Intel; Janssen Pharmaceutica; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT) [130406]	Intel(Intel Corporation); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work is funded by Intel, Janssen Pharmaceutica, and by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT): IWT O&O Project 130406. Charlotte Herzeel is an employee of IMEC vzw, Belgium; Pascal Costanza is an employee of Intel Corporation NV/SA, Belgium; Dries Decap and Jan Fostier are employees of iMinds vzw, Ghent, Belgium; Joke Reumers is an employee of Janssen Pharmaceutica NV/SA, Belgium. All authors are also affiliated with ExaScience Life Lab which is a consortium of companies and universities. These companies provided support in the form of salaries for these authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of each author is articulated in the "author contributions" section.	[Anonymous], 2012, EMBNET J, DOI DOI 10.14806/EJ.17.B.286; Blumofe RD, 1999, J ACM, V46, P720, DOI 10.1145/324133.324234; Cochrane G, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-2; Decap D, 2015, BIOINFORMATICS, V31, P2482, DOI 10.1093/bioinformatics/btv179; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Faust GG, 2014, BIOINFORMATICS, V30, P2503, DOI 10.1093/bioinformatics/btu314; Fritz MHY, 2011, GENOME RES, V21, P734, DOI 10.1101/gr.114819.110; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo RB, 2014, PEERJ, V2, DOI 10.7717/peerj.421; Raczy C, 2013, BIOINFORMATICS, V29, P2041, DOI 10.1093/bioinformatics/btt314; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tarasov A, 2012, SAMBAMBA; The SAM/BAM Format Specification Working Group, 2015, SEQ AL MAP FORM SPEC; Tischler G, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-13; Van der Auwera G, 2013, COLLECTED FAQS BAM F; Wing MK, 2010, BAMUTIL OVERVIEW	16	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132868	10.1371/journal.pone.0132868	http://dx.doi.org/10.1371/journal.pone.0132868			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182406	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198200045
J	Cho, MC; Cho, SY; Yoon, CY; Lee, SB; Kwak, C; Kim, HH; Jeong, H				Cho, Min Chul; Cho, Sung Yong; Yoon, Cheol Yong; Lee, Seung Bae; Kwak, Cheol; Kim, Hyeon Hoe; Jeong, Hyeon			EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells	PLOS ONE			English	Article							FOCAL ADHESION KINASE; RECEPTOR TYROSINE KINASE; PROSTATE-CANCER; OVEREXPRESSION; ADENOCARCINOMA; EXPRESSION; SURVIVAL; INVASION; DISEASE; TARGET	Objectives To investigate the role of EphA2 in malignant cellular behavior in renal cell carcinoma (RCC) cells and whether FAK/RhoA signaling can act as downstream effectors of EphA2 on RCC cells. Methods Expression of EphA2 protein in non-metastatic RCC (Caki-2 and A498), metastatic RCC cells (Caki-1 and ACHN), HEK-293 cells and prostate cancer cells (PC-3 and DU-145; positive controls of EphA2 expression) was evaluated by Western blot. Changes in mRNA or protein expression of EphA2, FAK or membrane-bound RhoA following EphA2, FAK or RhoA small interfering RNA (siRNA) transfection were determined by reverse transcription polymerase chain reaction or Western blot. The effect of siRNA treatment on cellular viability, apoptosis and invasion was analyzed by cell counting kit-8, Annexin-V and modified Matrigel-Boyden assays, respectively. Results In all RCC cell lines, the expression of EphA2 protein was detectable at variable levels; however, in HEK-293 cells, EphA2 expression was very low. Treatment with EphA2 siRNA significantly reduced the expression of EphA2 mRNA and protein in all RCC cell lines. For non-metastatic RCC cells (Caki-2 and A498) but not metastatic RCC cells (Caki-1 and ACHN), cellular viability, invasiveness, resistance to apoptosis, expression of membrane-bound RhoA protein and FAK phosphorylation were significantly decreased in EphA2 siRNA-treated cells compared to the control. In non-metastatic RCC cells, FAK siRNA significantly attenuated the invasiveness, resistance to apoptosis, as well as expression of membrane-bound RhoA protein without changing protein expression of EphA2. RhoA siRNA significantly decreased the malignant cellular behavior and expression of membrane-bound RhoA protein without changing EphA2 protein expression or FAK phosphorylation. Conclusions Our data provide the first functional evidence that the EphA2/FAK/RhoA signaling pathway plays a critical role in the malignant cellular behavior of RCC and appears to be functional particularly in the early stage of malignant progression of non-metastatic RCC.	[Cho, Min Chul] Dongguk Univ, Coll Med, Dept Urol, Seoul, South Korea; [Cho, Sung Yong; Lee, Seung Bae; Jeong, Hyeon] SMG SNU Boramae Med Ctr, Dept Urol, Seoul, South Korea; [Yoon, Cheol Yong] Korea Univ, Dept Urol, Guro Hosp, Seoul, South Korea; [Kwak, Cheol; Kim, Hyeon Hoe] Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea	Dongguk University; Seoul National University (SNU); Seoul National University Hospital; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Jeong, H (corresponding author), SMG SNU Boramae Med Ctr, Dept Urol, Seoul, South Korea.	drjh@brm.co.kr	CHO, MIN CHUL/R-7835-2019		Seoul National University Hospital (SNUH) Research Fund [04-2009-042-0]	Seoul National University Hospital (SNUH) Research Fund	This study was supported by grant no. 04-2009-042-0 from the Seoul National University Hospital (SNUH) Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of our manuscript.	Brantley-Sieders D, 2004, CURR PHARM DESIGN, V10, P3431, DOI 10.2174/1381612043383160; Brantley-Sieders DM, 2008, J CLIN INVEST, V118, P64, DOI 10.1172/JCI33154; Carles-Kinch K, 2002, CANCER RES, V62, P2840; Castano J, 2008, HISTOL HISTOPATHOL, V23, P1011, DOI 10.14670/HH-23.1011; Chan PC, 2002, J BIOL CHEM, V277, P50373, DOI 10.1074/jbc.M204691200; Cindolo L, 2005, CANCER-AM CANCER SOC, V104, P1362, DOI 10.1002/cncr.21331; Coppin C, 2011, BJU INT, V108, P1556, DOI 10.1111/j.1464-410X.2011.10629.x; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Herrem CJ, 2005, CLIN CANCER RES, V11, P226; Ireton RC, 2005, CURR CANCER DRUG TAR, V5, P149, DOI 10.2174/1568009053765780; Jenq WM, 1996, CONNECT TISSUE RES, V34, P161, DOI 10.3109/03008209609000696; Jones J, 2007, J CELL MOL MED, V11, P826, DOI 10.1111/j.1582-4934.2007.00071.x; Parri M, 2007, J BIOL CHEM, V282, P19619, DOI 10.1074/jbc.M701319200; Parri M, 2009, CANCER RES, V69, P2072, DOI 10.1158/0008-5472.CAN-08-1845; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Schwock J, 2010, EXPERT OPIN THER TAR, V14, P77, DOI 10.1517/14728220903460340; Taddei ML, 2009, AM J PATHOL, V174, P1492, DOI 10.2353/ajpath.2009.080473; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Walker-Daniels J, 1999, PROSTATE, V41, P275, DOI 10.1002/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhou ZM, 2008, SURG NEUROL, V70, P562, DOI 10.1016/j.surneu.2008.04.031	23	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130975	10.1371/journal.pone.0130975	http://dx.doi.org/10.1371/journal.pone.0130975			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177500	gold, Green Published			2022-12-27	WOS:000358197600033
J	Goto, R; Nakamura, Y; Takami, T; Sanke, T; Tozuka, Z				Goto, Rieko; Nakamura, Yasushi; Takami, Tomonori; Sanke, Tokio; Tozuka, Zenzaburo			Quantitative LC-MS/MS Analysis of Proteins Involved in Metastasis of Breast Cancer	PLOS ONE			English	Article							TANDEM MASS-SPECTRA; PEPTIDE-IDENTIFICATION; MATRIX PROTEINS; XIV COLLAGEN; SPECTROMETRY; UNDULIN; SEQUEST; VALIDATION; STRATEGIES; BINDING	The purpose of this study was to develop quantitative liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods for the analysis of proteins involved in metastasis of breast cancer for diagnosis and determining disease prognosis, as well as to further our understand of metastatic mechanisms. We have previously demonstrated that the protein type XIV collagen may be specifically expressed in metastatic tissues by two dimensional LC-MS/MS. In this study, we developed quantitative LC-MS/MS methods for type XIV collagen. Type XIV collagen was quantified by analyzing 2 peptides generated by digesting type XIV collagen using stable isotope-labeled peptides. The individual concentrations were equivalent between 2 different peptides of type XIV collagen by evaluation of imprecise transitions and using the best transition for the peptide concentration. The results indicated that type XIV collagen is highly expressed in metastatic tissues of patients with massive lymph node involvement compared to non-metastatic tissues. These findings were validated by quantitative real-time RT-PCR. Further studies on type XIV collagen are desired to verify its role as a prognostic factor and diagnosis marker for metastasis.	[Goto, Rieko; Nakamura, Yasushi; Sanke, Tokio] Wakayama Med Univ, Dept Clin Lab Med, Wakayama, Japan; [Goto, Rieko; Takami, Tomonori] JCL Bioassay Corp, Nishiwaki, Hyogo, Japan; [Tozuka, Zenzaburo] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan	Wakayama Medical University; Osaka University	Goto, R (corresponding author), Wakayama Med Univ, Dept Clin Lab Med, Wakayama, Japan.	r.goto@jclbio.com			JCL Bioassay Corporation, Nishiwaki, Hyogo, Japan	JCL Bioassay Corporation, Nishiwaki, Hyogo, Japan	JCL Bioassay Corporation, Nishiwaki, Hyogo, Japan provided support in the form of salaries for authors RG & TT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbatiello SE, 2010, CLIN CHEM, V56, P291, DOI 10.1373/clinchem.2009.138420; Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Amelinckx A, 2009, J PROTEOME RES, V8, P3727, DOI 10.1021/pr900294g; Anderson DC, 2003, J PROTEOME RES, V2, P137, DOI 10.1021/pr0255654; Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200; Dings PJM, 2013, ANN SURG ONCOL, V20, P2607, DOI 10.1245/s10434-013-2932-7; Ehnis T, 1996, EXP CELL RES, V229, P388, DOI 10.1006/excr.1996.0384; Elias JE, 2004, NAT BIOTECHNOL, V22, P214, DOI 10.1038/nbt930; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; GERECKE DR, 1993, J BIOL CHEM, V268, P12177; Goto R, 2014, J WAKAYAMA MED SOC, V65, P84; Goto R, 2006, PCT application, Patent No. [PCT/JP2006/325008, 2006325008]; Kamiie J, 2008, PHARM RES-DORDR, V25, P1469, DOI 10.1007/s11095-008-9532-4; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; Kiyonami R, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002931; LOHR M, 1994, BRIT J CANCER, V69, P144, DOI 10.1038/bjc.1994.24; Lopez-Ferrer D, 2004, ANAL CHEM, V76, P6853, DOI 10.1021/ac049305c; Mathupala SP, 2010, BBA-BIOENERGETICS, V1797, P1225, DOI 10.1016/j.bbabio.2010.03.025; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; Nakamura Y, 2003, CLIN CANCER RES, V9, P5313; Nakamura Y, US patent publication, Patent No. [8030014 (B2), 8030014]; Nakamura Y, EP patent publication, Patent No. [1962094 (A1), 1962094]; NEMOTO T, 1980, CANCER, V45, P2917, DOI 10.1002/1097-0142(19800615)45:12<2917::AID-CNCR2820451203>3.0.CO;2-M; Prakash C, 2007, MASS SPECTROM REV, V26, P340, DOI 10.1002/mas.20128; Razumovskaya J, 2004, PROTEOMICS, V4, P961, DOI 10.1002/pmic.200300656; Reiter L, 2011, NAT METHODS, V8, P430, DOI [10.1038/NMETH.1584, 10.1038/nmeth.1584]; Remane D, 2010, RAPID COMMUN MASS SP, V24, P3103, DOI 10.1002/rcm.4736; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Rosano C, 1999, STRUCT FOLD DES, V7, P1427, DOI 10.1016/S0969-2126(00)80032-5; Savitski MM, 2005, MOL CELL PROTEOMICS, V4, P1180, DOI 10.1074/mcp.T500009-MCP200; SCHUPPAN D, 1990, J BIOL CHEM, V265, P8823; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; TRUEB J, 1992, EUR J BIOCHEM, V207, P549, DOI 10.1111/j.1432-1033.1992.tb17081.x; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045	35	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130760	10.1371/journal.pone.0130760	http://dx.doi.org/10.1371/journal.pone.0130760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176947	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600026
J	Gworek, B; Dmuchowski, W; Gozdowski, D; Koda, E; Osiecka, R; Borzyszkowski, J				Gworek, Barbara; Dmuchowski, Wojciech; Gozdowski, Dariusz; Koda, Eugeniusz; Osiecka, Renata; Borzyszkowski, Jan			Influence of a Municipal Waste Landfill on the Spatial Distribution of Mercury in the Environment	PLOS ONE			English	Article							CONTAMINATION; SOIL; ACCUMULATION; ATMOSPHERE; LEACHATES; TRANSPORT; EMPHASIS; EXCHANGE; SURFACE; WATER	The study investigations were focused on assessing the influence of a 35-year-old municipal waste landfill on environmental mercury pollution. The total Hg content was determined in the soil profile, groundwater, and the plants (Solidago virgaurea and Poaceae sp.) in the landfill area. Environmental pollution near the landfill was relatively low. The topsoil layer, groundwater and the leaves of Solidago virgaurea and Poaceae sp. contained 19-271 mu g kg(-1), 0.36-3.01 mu g l(-1), 19-66 mu g kg(-1) and 8-29 mu g kg(-1) of Hg, respectively. The total Hg content in the soil decreased with the depth. The results are presented as pollution maps of the landfill area based on the total Hg content in the soil, groundwater and plants. Statistical analysis revealed the lack of correlation between the total Hg content in the soil and plants, but a relationship between the total concentration of Hg in groundwater and soil was shown. The landfill is not a direct source of pollution in the area. The type of land morphology did not influence the pollution level. Construction of bentonite cut-off wall bypassing MSW landfill reduces the risk of mercury release into ground-water environment.	[Gworek, Barbara; Osiecka, Renata; Borzyszkowski, Jan] Natl Res Inst, Inst Environm Protection, Warsaw, Poland; [Gworek, Barbara; Dmuchowski, Wojciech; Gozdowski, Dariusz; Koda, Eugeniusz] Warsaw Univ Life Sci SGGW, Warsaw, Poland; [Dmuchowski, Wojciech] Polish Acad Sci, Bot Garden Ctr Biol Div Conservat, Warsaw, Poland	Institute of Environmental Protection - National Research Institute; Warsaw University of Life Sciences; Polish Academy of Sciences	Dmuchowski, W (corresponding author), Warsaw Univ Life Sci SGGW, Warsaw, Poland.	w.dmuchowski@obpan.pl		Gozdowski, Dariusz/0000-0002-7365-7607; Gworek, Barbara/0000-0002-2368-5888; Koda, Eugeniusz/0000-0002-3895-960X				AMAP/UNEP, 2008, GLOBAL MERCURY ASSES; Barringer JL, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1475-7; Barzi F, 1996, CONTAMINANTS AND THE SOIL ENVIRONMENT IN THE AUSTRALASIA-PACIFIC REGION, P451; Birke M., 2011, MAPPING CHEM ENV URB, P245, DOI DOI 10.1002/9780470670071.CH17; Boszke L, 2008, ENVIRON GEOL, V55, P1075, DOI 10.1007/s00254-007-1056-4; CARPI A, 1994, J AIR WASTE MANAGE, V44, P669; Cheng HF, 2012, ENVIRON SCI TECHNOL, V46, P593, DOI 10.1021/es2026517; Christensen TH, 2001, APPL GEOCHEM, V16, P659, DOI 10.1016/S0883-2927(00)00082-2; De Temmerman L, 2007, ENVIRON POLLUT, V146, P458, DOI 10.1016/j.envpol.2006.07.002; Ding ZH, 2007, J ENVIRON SCI, V19, P200, DOI 10.1016/S1001-0742(07)60032-1; Dryzalowska A, 2014, ECOTOX ENVIRON SAFE, V107, P97, DOI 10.1016/j.ecoenv.2014.05.020; Earle CDA, 1999, WASTE MANAGE RES, V17, P305, DOI 10.1034/j.1399-3070.1999.00047.x; Ericksen JA, 2006, SCI TOTAL ENVIRON, V366, P851, DOI 10.1016/j.scitotenv.2005.08.019; Falkowska L, 2013, OCEANOL HYDROBIOL ST, V42, P99, DOI 10.2478/s13545-013-0064-0; Fay L, 2007, WATER AIR SOIL POLL, V181, P373, DOI 10.1007/s11270-006-9308-6; Feng XB, 2009, MERCURY FATE AND TRANSPORT IN THE GLOBAL ATMOSPHERE, P67, DOI 10.1007/978-0-387-93958-2_3; Fitzgerald WF, 2005, TREATISE ON GEOCHEMISTRY, VOL 9: ENVIRONMENTAL GEOCHEMISTRY, P107; Golimowski J, 2001, ANN WARSAW AGR U LAN, V32, P17; Gray JE, 2015, ENVIRON GEOCHEM HLTH, V37, P35, DOI 10.1007/s10653-014-9628-1; Ilgen G, 2008, WASTE MANAGE, V28, P1518, DOI 10.1016/j.wasman.2007.06.020; Kabata-Pendias A, 2010, TRACE ELEMENTS SOILS, Vfourth, DOI [DOI 10.1201/B10158, 10.1201/9781420039900]; Khatiwada NR, 2002, WATER SCI TECHNOL, V46, P147, DOI 10.2166/wst.2002.0226; Koda E, 2012, POL J ENVIRON STUD, V21, P929; Kowalski A, 2007, POL J ENVIRON STUD, V16, P67; KRABBENHOFT DP, 1992, WATER RESOUR RES, V28, P3119, DOI 10.1029/92WR01766; Kulikowska D, 2008, BIORESOURCE TECHNOL, V99, P5981, DOI 10.1016/j.biortech.2007.10.015; Li P, 2009, J HAZARD MATER, V168, P591, DOI 10.1016/j.jhazmat.2009.03.031; LIS J, 2005, POL GEOL I SPEC PAPE, V17, P42; Lodenius Martin, 1994, P343; Loska K, 2004, ENVIRON INT, V30, P159, DOI 10.1016/S0160-4120(03)00157-0; Matejczyk M, 2011, CHEMOSPHERE, V82, P1017, DOI 10.1016/j.chemosphere.2010.10.066; Mukherjee AB, 2004, RESOUR CONSERV RECY, V42, P155, DOI 10.1016/j.resconrec.2004.02.009; Mukherjee AB, 2009, MERCURY FATE AND TRANSPORT IN THE GLOBAL ATMOSPHERE, P81, DOI 10.1007/978-0-387-93958-2_4; MURPHY EA, 1994, WATER AIR SOIL POLL, V78, P61, DOI 10.1007/BF00475668; Niu ZC, 2013, ENVIRON SCI POLLUT R, V20, P6337, DOI 10.1007/s11356-013-1691-0; Olivero-Verbel J, 2008, ECOTOX ENVIRON SAFE, V70, P294, DOI 10.1016/j.ecoenv.2007.05.016; Ottesen RT, 2013, APPL GEOCHEM, V33, P1, DOI 10.1016/j.apgeochem.2012.12.013; Oygard JK, 2004, WATER RES, V38, P2851, DOI 10.1016/j.watres.2004.03.036; Pirrone N, 2010, ATMOS CHEM PHYS, V10, P5951, DOI 10.5194/acp-10-5951-2010; Salminen R., 2005, GEOCHEMICAL ATLAS EU; SCHUSTER E, 1991, WATER AIR SOIL POLL, V56, P667, DOI 10.1007/BF00342308; SUSZCYNSKY EM, 1995, ENVIRON TOXICOL CHEM, V14, P61, DOI 10.1002/etc.5620140108; [汤庆合 Tang Qinghe], 2003, [城市环境与城市生态, Urban Environment and Urban Ecology], V16, P15; Tomiyasu T, 2004, ENV SCI, V12, P231; Tsarpali V, 2012, J HAZARD MATER, V233, P163, DOI 10.1016/j.jhazmat.2012.07.007; US EPA, 2005, NAT EM INV NEI; Zhang L, 2007, ENVIRON INT, V33, P108, DOI 10.1016/j.envint.2006.06.022; Zhang XM, 2006, SCI TOTAL ENVIRON, V368, P713, DOI 10.1016/j.scitotenv.2006.01.037; Zhu W, 2013, ATMOS ENVIRON, V79, P188, DOI 10.1016/j.atmosenv.2013.05.083	49	24	25	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133130	10.1371/journal.pone.0133130	http://dx.doi.org/10.1371/journal.pone.0133130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176607	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600217
J	Juel, HB; Faber, C; Munthe-Fog, L; Bastrup-Birk, S; Reese-Petersen, AL; Falk, MK; Singh, A; Sorensen, TL; Garred, P; Nissen, MH				Juel, Helene Baek; Faber, Carsten; Munthe-Fog, Lea; Bastrup-Birk, Simone; Reese-Petersen, Alexander Lynge; Falk, Mads Krueger; Singh, Amardeep; Sorensen, Torben Lykke; Garred, Peter; Nissen, Mogens Holst			Systemic and Ocular Long Pentraxin 3 in Patients with Age-Related Macular Degeneration	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; C-REACTIVE PROTEIN; VISUAL IMPAIRMENT; PLASMA-LEVELS; DRUSEN; ACTIVATION; EXPRESSION; BIOMARKERS; BINDING; CELLS	Age-related macular degeneration (AMD) has been associated with both systemic and ocular alterations of the immune system. In particular dysfunction of complement factor H (CFH), a soluble regulator of the alternative pathway of the complement system, has been implicated in AMD pathogenesis. One of the ligands for CFH is long pentraxin 3 (PTX3), which is produced locally in the retinal pigment epithelium (RPE). To test the hypothesis that PTX3 is relevant to retinal immunohomeostasis and may be associated with AMD pathogenesis, we measured plasma PTX3 protein concentration and analyzed the RPE/choroid PTX3 gene expression in patients with AMD. To measure the ability of RPE cells to secrete PTX3 in vitro, polarized ARPE-19 cells were treated with activated T cells or cytokines (interferon (IFN)-gamma and/or tumor necrosis factor (TNF)-alpha) from the basolateral side; then PTX3 protein concentration in supernatants and PTX3 gene expression in tissue lysates were quantified. Plasma levels of PTX3 were generally low and did not significantly differ between patients and controls (P=0.307). No statistically significant difference was observed between dry and exudative AMD nor was there any correlation with hsCRP or CFH genotype. The gene expression of PTX3 increased in RPE/choroid with age (P=0.0098 macular; P=0.003 extramacular), but did not differ between aged controls and AMD patients. In vitro, ARPE-19 cells increased expression of the PTX3 gene as well PTX3 apical secretions after stimulation with TNF-alpha or activated T cells (P<0.01). These findings indicate that PTX3 expressed in the eye cannot be detected systemically and systemic PTX3 may have little or no impact on disease progression, but our findings do not exclude that locally produced PTX3 produced in the posterior segment of the eye may be part of the AMD immunopathogenesis.	[Juel, Helene Baek; Faber, Carsten; Reese-Petersen, Alexander Lynge; Nissen, Mogens Holst] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Eye Res Unit, Copenhagen, Denmark; [Faber, Carsten] Glostrup Cty Hosp, Dept Ophthalmol, Glostrup, Denmark; [Munthe-Fog, Lea; Bastrup-Birk, Simone; Garred, Peter] Copenhagen Univ Hosp, Dept Clin Immunol, Mol Med Lab, Rigshosp, Copenhagen, Denmark; [Falk, Mads Krueger; Singh, Amardeep; Sorensen, Torben Lykke] Copenhagen Univ Hosp, Dept Ophthalmol, Roskilde, Denmark; [Sorensen, Torben Lykke] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Faber, C (corresponding author), Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Eye Res Unit, Copenhagen, Denmark.	carstenfaber@gmail.com	Singh, Amardeep/ABI-4544-2020; Faber, Carsten/N-3210-2019; Juel, Helene/AAD-2843-2020; Faber, Carsten/I-4150-2013; Nissen, Mogens/B-4825-2008; Bastrup-Birk, Annemarie/K-1937-2016	Faber, Carsten/0000-0002-2517-7270; Faber, Carsten/0000-0002-2517-7270; Nissen, Mogens/0000-0001-7729-8667; Munthe-Fog, Lea/0000-0003-1345-176X; Juel, Helene B/0000-0002-5763-8545; Bastrup Israelsen, Simone/0000-0002-0653-1289; Garred, Peter/0000-0002-2876-8586; Bastrup-Birk, Annemarie/0000-0002-8405-8538	Lundbeck Foundation; Danish Eye Research Foundation; Fight for Sight Denmark; Rigshospitalet; Medical Research Council; Novo Nordisk Research Foundation	Lundbeck Foundation(Lundbeckfonden); Danish Eye Research Foundation; Fight for Sight Denmark; Rigshospitalet; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Research Foundation(Novo Nordisk Foundation)	This work was funded by The Lundbeck Foundation, The Danish Eye Research Foundation, Fight for Sight Denmark, Rigshospitalet, The Medical Research Council, and The Novo Nordisk Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari M, 2013, HUM MOL GENET, V22, P4857, DOI 10.1093/hmg/ddt336; Bastrup-Birk S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073119; Brantley MA, 2012, AM J OPHTHALMOL, V153, P460, DOI 10.1016/j.ajo.2011.08.033; Buch H, 2004, OPHTHALMOLOGY, V111, P53, DOI 10.1016/j.ophtha.2003.05.010; Clark SJ, 2013, J IMMUNOL, V190, P2049, DOI 10.4049/jimmunol.1201751; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; Doni A, 2012, IMMUNOBIOLOGY, V217, P1122, DOI 10.1016/j.imbio.2012.07.004; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Faber C, 2013, OPHTHALMOLOGY, V120, P2310, DOI 10.1016/j.ophtha.2013.04.014; Faber C, 2012, INVEST OPHTH VIS SCI, V53, P6324, DOI 10.1167/iovs.12-10385; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472; Hong T, 2011, SURV OPHTHALMOL, V56, P184, DOI 10.1016/j.survophthal.2010.08.007; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Juel HB, 2012, INVEST OPHTH VIS SCI, V53, P8472, DOI 10.1167/iovs.12-9963; Juel HB, 2011, EXP EYE RES, V92, P180, DOI 10.1016/j.exer.2011.01.003; Katta S, 2009, J GENET, V88, P425, DOI 10.1007/s12041-009-0064-4; Khandhadia S, 2012, IMMUNOBIOLOGY, V217, P127, DOI 10.1016/j.imbio.2011.07.019; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Le Fur I, 2010, NEUROBIOL AGING, V31, P165, DOI 10.1016/j.neurobiolaging.2008.03.003; Lee HW, 2011, MOVEMENT DISORD, V26, P2364, DOI 10.1002/mds.23871; Lindekleiv H, 2013, ACTA OPHTHALMOL, V91, P307, DOI 10.1111/j.1755-3768.2012.02399.x; Mihlan M, 2009, CELL DEATH DIFFER, V16, P1630, DOI 10.1038/cdd.2009.103; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Newman AM, 2012, GENOME MED, V4, DOI [10.1186/PREACCEPT-1418491035586234, 10.1186/gm315]; Noma H, 2014, RETINA-J RET VIT DIS, V34, P352, DOI 10.1097/IAE.0b013e3182993d74; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Robman L, 2010, OPHTHALMOLOGY, V117, P1982, DOI 10.1016/j.ophtha.2010.02.003; Rodrigues EB, 2007, OPHTHALMOLOGICA, V221, P143, DOI 10.1159/000099293; Russell SR, 2000, AM J OPHTHALMOL, V129, P205, DOI 10.1016/S0002-9394(99)00345-1; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Shimada Y, 2014, MOD RHEUMATOL, V24, P78, DOI 10.3109/14397595.2013.852837; Singh A, 2012, AM J OPHTHALMOL, V154, P193, DOI 10.1016/j.ajo.2012.01.036; Smailhodzic D, 2012, OPHTHALMOLOGY, V119, P339, DOI 10.1016/j.ophtha.2011.07.056; Sofat R, 2010, ATHEROSCLEROSIS, V213, P184, DOI 10.1016/j.atherosclerosis.2010.07.021; Trouw LA, 2011, CLIN EXP IMMUNOL, V166, P333, DOI 10.1111/j.1365-2249.2011.04482.x; Uusitalo-Seppala R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053661; Wang HH, 2013, MULT SCLER J, V19, P926, DOI 10.1177/1352458512457845; Wang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010329; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Woo JM, 2013, MOL VIS, V19, P303; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001	48	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132800	10.1371/journal.pone.0132800	http://dx.doi.org/10.1371/journal.pone.0132800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176960	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600161
J	Neiva, J; Assis, J; Coelho, NC; Fernandes, F; Pearson, GA; Serrao, EA				Neiva, Joao; Assis, Jorge; Coelho, Nelson C.; Fernandes, Francisco; Pearson, Gareth A.; Serrao, Ester A.			Genes Left Behind: Climate Change Threatens Cryptic Genetic Diversity in the Canopy-Forming Seaweed Bifurcaria bifurcata	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; RANGE SHIFTS; PSEUDO-ABSENCES; REAR EDGE; SEA-ICE; MARINE; RESPONSES; BIODIVERSITY; SOFTWARE; REFUGIA	The global redistribution of biodiversity will intensify in the coming decades of climate change, making projections of species range shifts and of associated genetic losses important components of conservation planning. Highly-structured marine species, notably brown seaweeds, often harbor unique genetic variation at warmer low-latitude rear edges and thus are of particular concern. Here, a combination of Ecological Niche Models (ENMs) and molecular data is used to forecast the potential near-future impacts of climate change for a warm-temperate, canopy forming seaweed, Bifurcaria bifurcata. ENMs for B. bifurcata were developed using marine and terrestrial climatic variables, and its range projected for 2040-50 and 2090-2100 under two greenhouse emission scenarios. Geographical patterns of genetic diversity were assessed by screening 18 populations spawning the entire distribution for two organelle genes and 6 microsatellite markers. The southern limit of B. bifurcata was predicted to shift northwards to central Morocco by the mid-century. By 2090-2100, depending on the emission scenario, it could either retreat further north to western Iberia or be relocated back to Western Sahara. At the opposing margin, B. bifurcata was predicted to expand its range to Scotland or even Norway. Microsatellite diversity and endemism were highest in Morocco, where a unique and very restricted lineage was also identified. Our results imply that B. bifurcata will maintain a relatively broad latitudinal distribution. Although its persistence is not threatened, the predicted extirpation of a unique southern lineage or even the entire Moroccan diversity hotspot will erase a rich evolutionary legacy and shrink global diversity to current (low) European levels. NW Africa and similarly understudied southern regions should receive added attention if expected range changes and diversity loss of warm-temperate species is not to occur unnoticed.	[Neiva, Joao; Assis, Jorge; Coelho, Nelson C.; Fernandes, Francisco; Pearson, Gareth A.; Serrao, Ester A.] Univ Algarve, Ctr Ciencias Mar, Faro, Portugal	Universidade do Algarve	Neiva, J (corresponding author), Univ Algarve, Ctr Ciencias Mar, Faro, Portugal.	jmneiva@ualg.pt	Serrao, Ester A/C-6686-2012; Assis, Jorge/AAC-6524-2019; Assis, Jorge/G-9688-2012; Neiva, Joao/AAP-6267-2020; Neiva, João/M-3818-2013; Pearson, Gareth/J-3911-2013	Serrao, Ester A/0000-0003-1316-658X; Assis, Jorge/0000-0002-6624-4820; Assis, Jorge/0000-0002-6624-4820; Neiva, Joao/0000-0002-5927-4570; Neiva, João/0000-0002-5927-4570; Pearson, Gareth/0000-0002-0768-464X; Coelho, Nelson/0000-0002-8331-5889	Portuguese FCT (Fundacao para a Ciencia e a Tecnologia) [PTDC/AAC-CLI/109108/2008, EXPL/BIA-BIC/1471/2012, EXCL/AAG-GLO/0661/2012];  [SFRH/BPD/88935/2012]; Fundação para a Ciência e a Tecnologia [PTDC/AAC-CLI/109108/2008, EXPL/BIA-BIC/1471/2012] Funding Source: FCT	Portuguese FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); ; Fundação para a Ciência e a Tecnologia	This work was funded by Portuguese FCT (Fundacao para a Ciencia e a Tecnologia) through projects EDGES (PTDC/AAC-CLI/109108/2008), ReUp (EXPL/BIA-BIC/1471/2012) and EXTANT (EXCL/AAG-GLO/0661/2012) and a postdoctoral fellowship to JN (SFRH/BPD/88935/2012).	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Alsos IG, 2012, P ROY SOC B-BIOL SCI, V279, P2042, DOI 10.1098/rspb.2011.2363; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Assis J, 2014, MOL ECOL, V23, P2797, DOI 10.1111/mec.12772; Assis J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068646; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barton ED, 2013, PROG OCEANOGR, V116, P167, DOI 10.1016/j.pocean.2013.07.007; Bartsch I, 2012, SEAWEED BIOL, P383, DOI DOI 10.1007/978-3-642-28451-9_18; Bates AE, 2014, GLOBAL ENVIRON CHANG, V26, P27, DOI 10.1016/j.gloenvcha.2014.03.009; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Benhissoune S, 2002, BOT MAR, V45, P217, DOI 10.1515/BOT.2002.021; Bennett KD, 2008, QUATERNARY SCI REV, V27, P2449, DOI 10.1016/j.quascirev.2008.08.019; Berge J, 2005, MAR ECOL PROG SER, V303, P167, DOI 10.3354/meps303167; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Calenge C, 2008, ECOLOGY, V89, P555, DOI 10.1890/06-1750.1; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; D'Amen M, 2013, GLOBAL ECOL BIOGEOGR, V22, P93, DOI 10.1111/j.1466-8238.2012.00774.x; Dalen L, 2007, P NATL ACAD SCI USA, V104, P6726, DOI 10.1073/pnas.0701341104; de Valera M., 1962, P R IR ACAD B, V62B, P77; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Donlon CJ, 2012, REMOTE SENS ENVIRON, V116, P140, DOI 10.1016/j.rse.2010.10.017; Duarte L, 2013, ACTA OECOL, V51, P1, DOI 10.1016/j.actao.2013.05.002; Dudgeon S, 2001, FUNCT ECOL, V15, P595, DOI 10.1046/j.0269-8463.2001.00559.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Fraser CI, 2009, P NATL ACAD SCI USA, V106, P3249, DOI 10.1073/pnas.0810635106; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gallardo GT, 2000, FLORA PHYCOLOGICA IB, V1, P91; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hardy F.D., 2003, CHECK LIST ATLAS SEA; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Helmuth B, 2006, ECOL MONOGR, V76, P461, DOI 10.1890/0012-9615(2006)076[0461:MPOTSI]2.0.CO;2; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jueterbock A, 2013, ECOL EVOL, V3, P1356, DOI 10.1002/ece3.541; Jump AS, 2009, TRENDS PLANT SCI, V14, P51, DOI 10.1016/j.tplants.2008.10.002; Le Corguille G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-253; Lee YK, 1999, EUR J PHYCOL, V34, P205, DOI 10.1080/09670269910001736262; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lima FP, 2007, GLOBAL CHANGE BIOL, V13, P2592, DOI 10.1111/j.1365-2486.2007.01451.x; Lima FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1713; Luning K, 1990, SEAWEEDS THEIR ENV B; McGregor HV, 2007, SCIENCE, V315, P637, DOI 10.1126/science.1134839; Mieszkowska N, 2006, HYDROBIOLOGIA, V555, P241, DOI 10.1007/s10750-005-1120-6; Mieszkowska N, 2005, MARINE BIOL ASS OCCA, V20; Mieszkowska N., 2010, 9212010 CCW; Montecinos A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-97; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Mota CF, 2015, FUNCT ECOL, V29, P640, DOI 10.1111/1365-2435.12373; Motomura T, 2010, J PLANT RES, V123, P185, DOI 10.1007/s10265-010-0313-x; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Neiva J, 2014, J BIOGEOGR, V41, P1137, DOI 10.1111/jbi.12278; Neiva J, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-78; Neiva J, 2012, J BIOGEOGR, V39, P1167, DOI 10.1111/j.1365-2699.2011.02670.x; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Nicastro KR, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-6; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pfenninger M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-224; Phillips NE, 2005, PHYCOL RES, V53, P1; Pitt NR, 2010, MAR FRESHWATER RES, V61, P963, DOI 10.1071/MF09225; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Provan J., 2013, FRONT BIOGEOGR, V5, P60, DOI [10.21425/F5FBG14732, DOI 10.21425/F55114732]; Provan J, 2012, P ROY SOC B-BIOL SCI, V279, P39, DOI 10.1098/rspb.2011.0536; Ramstein G, 2007, CLIMATE DISCUSSIONS, V3, P197, DOI DOI 10.5194/CPD-3-197-2007; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Rubidge EM, 2012, NAT CLIM CHANGE, V2, P285, DOI 10.1038/NCLIMATE1415; SERRAO EA, 1997, PHYCOLOGIA S, V36, P101; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; Wethey DS, 2008, HYDROBIOLOGIA, V606, P139, DOI 10.1007/s10750-008-9338-8; Wethey DS, 2011, J EXP MAR BIOL ECOL, V400, P132, DOI 10.1016/j.jembe.2011.02.008; Willis KJ, 2010, SYST BIODIVERS, V8, P3, DOI 10.1080/14772000903495833	95	47	47	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131530	10.1371/journal.pone.0131530	http://dx.doi.org/10.1371/journal.pone.0131530			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177545	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600049
J	Tan, SY; Jiang, QY; Zhuo, F; Liu, H; Wang, YT; Li, SS; Ye, ZH; Jing, YX				Tan, Shi-Yun; Jiang, Qiu-Yun; Zhuo, Feng; Liu, Hui; Wang, Yu-Tao; Li, Shao-Shan; Ye, Zhi-Hong; Jing, Yuan-Xiao			Effect of Inoculation with Glomus versiforme on Cadmium Accumulation, Antioxidant Activities and Phytochelatins of Solanum photeinocarpum	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; HEAVY-METAL TOLERANCE; CD-HYPERACCUMULATOR; CONTAMINATED SOILS; HYDROGEN-PEROXIDE; POLLUTED SOILS; L.; GLUTATHIONE; GROWTH; PLANTS	The plant growth, phosphate acquisition, Cd translocation, phytochelatins (PCs) production and antioxidant parameters [superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POD), ascorbate peroxidase (APX), glutathione reductase (GR), glutathione (GSH), ascorbate (ASA) and malonaldehyde (MDA)] were investigated in Cd-hyperaccumulator Solanum photeinocarpum inoculated with Glomus versiforme BGC GD01C (Gv) in Cd-added soils (0, 5, 10, 20, 40 mg Cd kg(-1) soil). Mycorrhizal colonization rates were generally high (from 77% to 94%), and hardly affected by Cd. Gv colonization significantly enhanced P acquisition, growth and total Cd uptakes in both shoots and roots of S. photeinocarpum at all Cd levels. Meanwhile, Gv symbiosis significantly increased Cd concentration in the roots, and decreased Cd concentration in the shoots at all Cd levels, which indicates that Gv could promote phytostabilization by enhancing Cd accumulation in the roots to inhibit its translocation to shoots and the "dilution effects" linked to an increase in plant dry matter yield and a reduced Cd partitioning to shoots. Moreover, the improvement of CAT, POD and APX activities in the leaves of mycorrhizal plants infers that Gv symbiosis helped S. photeinocarpum to relieve oxidative damage to biomolecules in Cd-contaminated soil. The evident decline of MDA content in the leaves of mycorrhizal plants indicates that Gv symbiosis evidently improved antioxidant activities, and the enhancement of PCs production in the leaves of mycorrhizal plants suggests that Gv-inoculated plant may be more efficient to relieve Cd phytotoxicity. Therefore, the possible mechanisms of Cd phytotoxicity alleviation by Gv can be concluded as the decline of Cd concentration in the shoots and the improvement of P acquisition, PCs production and activities of CAT, POD, APX in mycorrhizal plants.	[Tan, Shi-Yun; Jiang, Qiu-Yun; Zhuo, Feng; Liu, Hui; Wang, Yu-Tao; Li, Shao-Shan; Jing, Yuan-Xiao] S China Normal Univ, Coll Life Sci, Key Lab Ecol & Environm Sci Guangdong Higher Educ, Guangzhou, Guangdong, Peoples R China; [Ye, Zhi-Hong] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Ye, Zhi-Hong] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	South China Normal University; Sun Yat Sen University; Sun Yat Sen University	Jing, YX (corresponding author), S China Normal Univ, Coll Life Sci, Key Lab Ecol & Environm Sci Guangdong Higher Educ, Guangzhou, Guangdong, Peoples R China.	jingyx@scnu.edu.cn			Guangzhou Science and Technology Program [201510010056, 2014J4100053]; Guangdong Natural Science Foundation of China [S2013010012969]	Guangzhou Science and Technology Program; Guangdong Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province)	The work was supported by the Guangzhou Science and Technology Program (201510010056; 2014J4100053) (http://www.gzsi.gov.cn/) and the Guangdong Natural Science Foundation of China (S2013010012969) (http://pro.gdstc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adediran GA, 2015, J HAZARD MATER, V283, P490, DOI 10.1016/j.jhazmat.2014.09.064; Aebi H, 1984, METHOD ENZYMOL, V6, P105, DOI DOI 10.1016/S0076-6879(84)05016-3; Amir H, 2013, MYCORRHIZA, V23, P585, DOI 10.1007/s00572-013-0499-6; Andrade SAL, 2010, ENVIRON EXP BOT, V68, P198, DOI 10.1016/j.envexpbot.2009.11.009; Azcon R, 2009, APPL SOIL ECOL, V41, P168, DOI 10.1016/j.apsoil.2008.10.008; Arias MSB, 2015, INT J PHYTOREMEDIAT, V17, P405, DOI 10.1080/15226514.2014.898023; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; Bhargava P, 2005, J PLANT PHYSIOL, V162, P1220, DOI 10.1016/j.jplph.2004.12.006; Bissonnette L, 2010, PLANT SOIL, V332, P55, DOI 10.1007/s11104-009-0273-x; Bolan N, 2014, J HAZARD MATER, V266, P141, DOI 10.1016/j.jhazmat.2013.12.018; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Carvalho LM, 2006, PLANT SOIL, V285, P161, DOI 10.1007/s11104-006-9001-y; Chan WF, 2013, J HAZARD MATER, V262, P1116, DOI 10.1016/j.jhazmat.2012.08.020; Chen BD, 2005, ENVIRON SCI POLLUT R, V12, P325, DOI 10.1065/espr2005.06.267; Chen LH, 2015, ECOTOX ENVIRON SAFE, V113, P460, DOI 10.1016/j.ecoenv.2014.12.033; Degola F, 2014, PLANT CELL PHYSIOL, V55, P1884, DOI 10.1093/pcp/pcu117; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Garg N, 2013, J AGRON CROP SCI, V199, P118, DOI 10.1111/j.1439-037X.2012.00533.x; Garg N, 2012, J PLANT GROWTH REGUL, V31, P292, DOI 10.1007/s00344-011-9239-3; Garg N, 2012, PLANT GROWTH REGUL, V66, P9, DOI 10.1007/s10725-011-9624-8; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gupta M, 1998, CHEMOSPHERE, V37, P785, DOI 10.1016/S0045-6535(98)00073-3; HANSON WC, 1950, J SCI FOOD AGR, V1, P172, DOI 10.1002/jsfa.2740010604; He HD, 2013, CHEMOSPHERE, V90, P1960, DOI 10.1016/j.chemosphere.2012.10.057; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hildebrandt U, 2007, PHYTOCHEMISTRY, V68, P139, DOI 10.1016/j.phytochem.2006.09.023; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hu JL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04671; Hu JL, 2013, CHEMOSPHERE, V93, P1359, DOI 10.1016/j.chemosphere.2013.07.089; Jarrah M, 2014, BIOREMEDIAT J, V18, P71, DOI 10.1080/10889868.2013.847401; Jemo M, 2014, SOIL BIOL BIOCHEM, V79, P117, DOI 10.1016/j.soilbio.2014.09.014; Jia L, 2013, ECOTOXICOLOGY, V22, P476, DOI 10.1007/s10646-013-1041-5; Jimenez A, 1997, PLANT PHYSIOL, V114, P275, DOI 10.1104/pp.114.1.275; Kaldorf M, 1999, J PLANT PHYSIOL, V154, P718, DOI 10.1016/S0176-1617(99)80250-8; Latef AAHA, 2011, MYCORRHIZA, V21, P495, DOI 10.1007/s00572-010-0360-0; LAW MY, 1983, BIOCHEM J, V210, P899, DOI 10.1042/bj2100899; Leyval C, 1997, MYCORRHIZA, V7, P139, DOI 10.1007/s005720050174; Liu H, 2015, APPL SOIL ECOL, V89, P44, DOI 10.1016/j.apsoil.2015.01.006; MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357; Mani D, 2014, INT J ENVIRON SCI TE, V11, P843, DOI 10.1007/s13762-013-0299-8; Meharg AA, 2000, ADV ECOL RES, V30, P69, DOI 10.1016/S0065-2504(08)60017-3; Meier S, 2015, J PLANT NUTR SOIL SC, V178, P126, DOI 10.1002/jpln.201400092; Meier S, 2012, CRIT REV ENV SCI TEC, V42, P741, DOI 10.1080/10643389.2010.528518; Muhling KH, 2003, PLANT SOIL, V253, P219, DOI 10.1023/A:1024517919764; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; NIELSEN JD, 1983, PLANT SOIL, V70, P165, DOI 10.1007/BF02374777; Orlowska E, 2011, ENVIRON POLLUT, V159, P3730, DOI 10.1016/j.envpol.2011.07.008; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Rozpadek P, 2014, CHEMOSPHERE, V112, P217, DOI 10.1016/j.chemosphere.2014.04.023; Singh P, 2014, PLANT PHYSIOL BIOCH, V83, P180, DOI 10.1016/j.plaphy.2014.07.018; Southam CM, 1943, PHYTOPATHOLOGY, V33, P517; Sun RL, 2007, ENVIRON EXP BOT, V60, P468, DOI 10.1016/j.envexpbot.2007.01.004; Trotta A, 2006, CHEMOSPHERE, V65, P74, DOI 10.1016/j.chemosphere.2006.02.048; Vazquez S, 2009, PLANT PHYSIOL BIOCH, V47, P63, DOI 10.1016/j.plaphy.2008.09.010; Vodnik D, 2008, SCI TOTAL ENVIRON, V392, P130, DOI 10.1016/j.scitotenv.2007.11.016; Wei Y, 2014, APPL SOIL ECOL, V82, P11, DOI 10.1016/j.apsoil.2014.05.005; Wu Y, 2014, AQUAT TOXICOL, V148, P122, DOI 10.1016/j.aquatox.2014.01.005; Yuan M, 2014, CHEMOSPHERE, V103, P99, DOI 10.1016/j.chemosphere.2013.11.040; Zan NR, 2013, ENVIRON MONIT ASSESS, V185, P10015, DOI 10.1007/s10661-013-3309-x; Zenk MH, 1996, GENE, V179, P21, DOI 10.1016/S0378-1119(96)00422-2; Zhang XF, 2011, J HAZARD MATER, V189, P414, DOI 10.1016/j.jhazmat.2011.02.053; Zhong WL, 2012, J ENVIRON MONITOR, V14, P2497, DOI 10.1039/c2em30333g	63	33	36	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132347	10.1371/journal.pone.0132347	http://dx.doi.org/10.1371/journal.pone.0132347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176959	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600101
J	Andersson, DP; Ekstrom, U; Lehtihet, M				Andersson, Daniel Peter; Ekstrom, Urban; Lehtihet, Mikael			Rigiscan Evaluation of Men with Diabetes Mellitus and Erectile Dysfunction and Correlation with Diabetes Duration, Age, BMI, Lipids and HbA1c	PLOS ONE			English	Article							COMPLICATIONS; PREVALENCE; SYMPTOMS	Objective This study aimed to investigate differences between patients with type 1 and type 2 diabetes mellitus with erectile dysfunction (ED) evaluated with Rigiscan and if there were a correlation to age, duration of diabetes, BMI, sex hormones, lipids and HbA1c. Research design and methods: A retrospective study on patients with type 1 diabetes (n=15), type 2 diabetes (n=17) and a control group (n=31) that underwent Rigiscan examination for ED. Age, BMI, blood pressure, sex hormones, lipids and HbA1c were recorded and analyzed between groups. Results Diabetes duration and HbA1C did not correlate with Rigiscan outcome. Rigiscan measures did not differ between patients with type 1 diabetes and control subjects besides from fewer erectile episodes (p<0.01) and lower tumescence activity units in base (p<0.05). By contrast, patients with type 2 diabetes differed significantly with respect to RigiScan parameters both in comparison with the type 1 diabetic patients and the control group. BMI had a strong correlation to number of erectile episodes, duration of erection, duration of erection >60 % and rigidity activated unit (RAU) in tip and base. Age and HDL-cholesterol had a significant correlation with number of erectile episodes during night (p<0.05). Conclusion Our results indicate that erectile dysfunction in men with diabetes differ between type 1 and type 2 diabetes patients. Neither diabetes duration nor HbA1C correlated to grade of erectile dysfunction among patients with diabetes. Increased BMI might be an explanation to the increased rate of erectile dysfunction seen in patients with type 2 diabetes.	[Andersson, Daniel Peter; Lehtihet, Mikael] Karolinska Univ Hosp, Dept Med, Huddinge, Sweden; [Andersson, Daniel Peter; Ekstrom, Urban; Lehtihet, Mikael] Karolinska Inst, Huddinge, Sweden; [Ekstrom, Urban; Lehtihet, Mikael] Karolinska Univ Hosp, Dept Med, Huddinge, Sweden; [Ekstrom, Urban; Lehtihet, Mikael] Karolinska Univ Hosp, Ctr Androl & Sexual Med, Huddinge, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Andersson, DP (corresponding author), Karolinska Univ Hosp, Dept Med, Huddinge, Sweden.	daniel.p.andersson@ki.se	Andersson, Daniel/AAY-6362-2021; Andersson, Daniel Peter/AAN-8648-2020	Andersson, Daniel Peter/0000-0003-4655-4837	Stockholm County Council	Stockholm County Council(Stockholm County Council)	DPA was supported by the Stockholm County Council (combined clinical residency and PhD training program). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancroft J, 1996, DIABETIC MED, V13, P84, DOI 10.1002/(SICI)1096-9136(199601)13:1<84::AID-DIA16>3.3.CO;2-1; Dale AC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.39582.447998.BE; Elhanbly S, 2004, J ANDROL, V25, P991; Gokkaya SC, 2008, SCAND J UROL NEPHROL, V42, P437, DOI 10.1080/00365590801950279; Jacobson AM, 2013, DIABETES CARE, V36, P3131, DOI 10.2337/dc12-2109; Jannini EA, 2009, J SEX MED, V6, P1820, DOI 10.1111/j.1743-6109.2009.01343.x; Jerums G, 2015, J HUM HYPERTENS, V29, P473, DOI 10.1038/jhh.2014.117; Knopfholz J, 2014, CHOLESTEROL, DOI 10.1155/2014/261878; MCCULLOCH DK, 1980, DIABETOLOGIA, V18, P279; Orchard TJ, 2015, JAMA-J AM MED ASSOC, V313, P45, DOI 10.1001/jama.2014.16107; Rowland DL, 2012, J SEX MARITAL THER, V38, P115, DOI 10.1080/0092623X.2011.569640; SCHIAVI RC, 1993, DIABETOLOGIA, V36, P745, DOI 10.1007/BF00401146; Schouten BWV, 2010, J SEX MED, V7, P2547, DOI 10.1111/j.1743-6109.2010.01849.x; Shabsigh R, 1998, UROLOGY, V52, P848, DOI 10.1016/S0090-4295(98)00292-1; Sohn M H, 1993, Int J Impot Res, V5, P59; Van Den Eeden SK, 2009, DIABETES CARE, V32, P664, DOI 10.2337/dc07-2375; Zimmern P, 1999, PROG UROL, V9, P37	17	15	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133121	10.1371/journal.pone.0133121	http://dx.doi.org/10.1371/journal.pone.0133121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186716	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700096
J	Cunha, CW; Taylor, KE; Pritchard, SM; Delboy, MG; Sari, TK; Aguilar, HC; Mossman, KL; Nicola, AV				Cunha, Cristina W.; Taylor, Kathryne E.; Pritchard, Suzanne M.; Delboy, Mark G.; Sari, Tri Komala; Aguilar, Hector C.; Mossman, Karen L.; Nicola, Anthony V.			Widely Used Herpes Simplex Virus 1 ICP0 Deletion Mutant Strain dl1403 and Its Derivative Viruses Do Not Express Glycoprotein C Due to a Secondary Mutation in the gC Gene	PLOS ONE			English	Article							REGULATORY PROTEIN ICP0; IMMEDIATE EARLY GENE-1; HEPARAN-SULFATE; INFECTED-CELLS; IN-VIVO; COMPLEMENT COMPONENT; CLINICAL ISOLATE; GENOME SEQUENCE; TYPE-1 VIRIONS; TEGUMENT ICP0	Herpes simplex virus 1 (HSV-1) ICP0 is a multi-functional phosphoprotein expressed with immediate early kinetics. An ICP0 deletion mutant, HSV-1 dl1403, has been widely used to study the roles of ICP0 in the HSV-1 replication cycle including gene expression, latency, entry and assembly. We show that HSV-1 dl1403 virions lack detectable levels of envelope protein gC, and that gC is not synthesized in infected cells. Sequencing of the gC gene from HSV-1 dl1403 revealed a single amino acid deletion that results in a frameshift mutation. The HSV-1 dl1403 gC gene is predicted to encode a polypeptide consisting of the original 62 N-terminal amino acids of the gC protein followed by 112 irrelevant, non-gC residues. The mutation was also present in a rescuant virus and in two dl1403-derived viruses, D8 and FXE, but absent from the parental 17+, suggesting that the mutation was introduced during the construction of the dl1403 virus, and not as a result of passage in culture.	[Cunha, Cristina W.; Pritchard, Suzanne M.; Sari, Tri Komala; Aguilar, Hector C.; Nicola, Anthony V.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Taylor, Kathryne E.; Mossman, Karen L.] McMaster Univ, McMaster Immunol Res Ctr, Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Delboy, Mark G.] Virginia Commonwealth Univ, Sch Med, Dept Microbiol & Immunol, Richmond, VA USA; [Aguilar, Hector C.; Nicola, Anthony V.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	Washington State University; McMaster University; Virginia Commonwealth University; Washington State University	Mossman, KL (corresponding author), McMaster Univ, McMaster Immunol Res Ctr, Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON, Canada.	mossk@mcmaster.ca; nicola@vetmed.wsu.edu	Cunha, Cristina/AAC-6120-2021; Aguilar, Hector/AAD-6663-2022; Taylor, Kathryne/AAD-4025-2019; Cunha, Cristina/V-7622-2019	Cunha, Cristina/0000-0002-8168-5448; Komala Sari, Tri/0000-0002-7801-474X	National Institutes of Health [AI113619]; Marvel Shields Autzen Foundation; Canadian Institutes for Health Research [MOP-57669]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI113619, R01AI109022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marvel Shields Autzen Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health AI113619 to AVN and a grant from the Marvel Shields Autzen Foundation to AVN. This work was also supported by Canadian Institutes for Health Research MOP-57669 to KLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrow E, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-177; BROWN SM, 1973, J GEN VIROL, V18, P329, DOI 10.1099/0022-1317-18-3-329; CAI WH, 1993, J VIROL, V67, P7501, DOI 10.1128/JVI.67.12.7501-7512.1993; CAI WZ, 1992, J VIROL, V66, P2904, DOI 10.1128/JVI.66.5.2904-2915.1992; CAI WZ, 1991, J VIROL, V65, P4078, DOI 10.1128/JVI.65.8.4078-4090.1991; CLEMENTS GB, 1989, J GEN VIROL, V70, P2501, DOI 10.1099/0022-1317-70-9-2501; Delboy MG, 2008, J VIROL, V82, P3381, DOI 10.1128/JVI.02296-07; Delboy MG, 2011, J VIROL, V85, P5910, DOI 10.1128/JVI.00267-11; Delboy MG, 2010, J VIROL, V84, P1637, DOI 10.1128/JVI.02041-09; DELUCA N, 1982, VIROLOGY, V122, P411, DOI 10.1016/0042-6822(82)90240-9; Dollery SJ, 2011, J VIROL, V85, P9964, DOI 10.1128/JVI.05291-11; Dollery SJ, 2010, J VIROL, V84, P3759, DOI 10.1128/JVI.02573-09; Drolet BS, 2004, CURR EYE RES, V29, P181, DOI 10.1080/02713680490504542; EISENBERG RJ, 1987, MICROB PATHOGENESIS, V3, P423, DOI 10.1016/0882-4010(87)90012-X; EISENBERG RJ, 1985, J VIROL, V53, P634, DOI 10.1128/JVI.53.2.634-644.1985; Everett RD, 2004, J VIROL, V78, P9599, DOI 10.1128/JVI.78.18.9599-9604.2004; EVERETT RD, 1989, J GEN VIROL, V70, P1185, DOI 10.1099/0022-1317-70-5-1185; Everett RD, 2000, BIOESSAYS, V22, P761, DOI 10.1002/1521-1878(200008)22:8<761::AID-BIES10>3.0.CO;2-A; FENG Y, 1992, J VIROL, V66, P2709, DOI 10.1128/JVI.66.5.2709-2716.1992; Friedman Harvey M, 2003, Trans Am Clin Climatol Assoc, V114, P103; FRIEDMAN HM, 1984, NATURE, V309, P633, DOI 10.1038/309633a0; Grant K, 2012, J VIROL, V86, P4029, DOI 10.1128/JVI.06962-11; Gu HD, 2009, J VIROL, V83, P181, DOI 10.1128/JVI.01940-08; Gu HD, 2005, P NATL ACAD SCI USA, V102, P7571, DOI 10.1073/pnas.0502658102; Hagglund R, 2004, J VIROL, V78, P2169, DOI 10.1128/JVI.78.5.2169-2178.2004; Halford WP, 2001, J VIROL, V75, P3240, DOI 10.1128/JVI.75.7.3240-3249.2001; HARRIS RA, 1989, J VIROL, V63, P3513, DOI 10.1128/JVI.63.8.3513-3515.1989; Haugo AC, 2011, J VIROL, V85, P7203, DOI 10.1128/JVI.00262-11; HEINE JW, 1974, J VIROL, V14, P640, DOI 10.1128/JVI.14.3.640-651.1974; HEROLD BC, 1994, J GEN VIROL, V75, P1211, DOI 10.1099/0022-1317-75-6-1211; Herold BC, 1996, J VIROL, V70, P3461, DOI 10.1128/JVI.70.6.3461-3469.1996; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Kawaguchi Y, 1997, J VIROL, V71, P1019, DOI 10.1128/JVI.71.2.1019-1024.1997; Kawaguchi Y, 1997, J VIROL, V71, P7328, DOI 10.1128/JVI.71.10.7328-7336.1997; Kawaguchi Y, 2001, P NATL ACAD SCI USA, V98, P1877, DOI 10.1073/pnas.041592598; Kyratsous CA, 2009, J VIROL, V83, P10637, DOI 10.1128/JVI.01144-09; LEIB DA, 1989, J VIROL, V63, P759, DOI 10.1128/JVI.63.2.759-768.1989; Liang Y, 2006, J VIROL, V80, P3349, DOI 10.1128/JVI.80.7.3349-3359.2006; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5838, DOI 10.1073/pnas.0501253102; Lilley CE, 2010, EMBO J, V29, P943, DOI 10.1038/emboj.2009.400; Liu MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010975; LIU Y, 1993, ARCH VIROL, V129, P105, DOI 10.1007/BF01316888; Lomonte P, 2004, J VIROL, V78, P6744, DOI 10.1128/JVI.78.13.6744-6757.2004; Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08; Loret S, 2012, J GEN VIROL, V93, P624, DOI 10.1099/vir.0.039776-0; Lubinski JM, 2002, J VIROL, V76, P9232, DOI 10.1128/JVI.76.18.9232-9241.2002; Lubinski JM, 1998, J VIROL, V72, P8257, DOI 10.1128/JVI.72.10.8257-8263.1998; Macdonald SJ, 2012, J VIROL, V86, P9540, DOI 10.1128/JVI.01469-12; Macdonald SJ, 2012, J VIROL, V86, P6371, DOI 10.1128/JVI.00646-12; Maringer K, 2010, J VIROL, V84, P4682, DOI 10.1128/JVI.00126-10; Minagawa H, 1997, MICROBIOL IMMUNOL, V41, P545, DOI 10.1111/j.1348-0421.1997.tb01890.x; Morency E, 2007, J CELL BIOL, V177, P757, DOI 10.1083/jcb.200612107; Mossman KL, 2000, J VIROL, V74, P2052, DOI 10.1128/JVI.74.4.2052-2056.2000; Nagel CH, 2011, J VIROL, V85, P7644, DOI 10.1128/JVI.02207-10; Negatsch A, 2011, J GEN VIROL, V92, P167, DOI 10.1099/vir.0.026484-0; Nicola AV, 2004, J VIROL, V78, P7508, DOI 10.1128/JVI.78.14.7508-7517.2004; Paladino P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010428; Pritchard SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070889; Radtke K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000991; Reston CAP, 2007, J VIROL, V81, P11781, DOI 10.1128/JVI.01234-07; Roller DG, 2008, VIROLOGY, V382, P207, DOI 10.1016/j.virol.2008.09.015; RUSSELL J, 1987, J GEN VIROL, V68, P3009, DOI 10.1099/0022-1317-68-12-3009; RUYECHAN WT, 1979, J VIROL, V29, P677, DOI 10.1128/JVI.29.2.677-697.1979; SACKS WR, 1987, J VIROL, V61, P829, DOI 10.1128/JVI.61.3.829-839.1987; SAKAI Y, 1994, OPHTHALMOLOGICA, V208, P157, DOI 10.1159/000310474; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; STOW ND, 1986, J GEN VIROL, V67, P2571, DOI 10.1099/0022-1317-67-12-2571; SUNSTRUM JC, 1988, VIRUS RES, V11, P17, DOI 10.1016/0168-1702(88)90064-0; Szpara ML, 2014, GENOME ANNOUNCEMENTS, V2; Taylor KE, 2014, J VIROL, V88, P8091, DOI 10.1128/JVI.00944-14; Thompson RL, 2006, J VIROL, V80, P10919, DOI 10.1128/JVI.01253-06; Van Sant C, 1999, P NATL ACAD SCI USA, V96, P8184, DOI 10.1073/pnas.96.14.8184; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Yu XA, 2010, BIOCHIMIE, V92, P1024, DOI 10.1016/j.biochi.2010.04.025; ZEZULAK KM, 1984, J VIROL, V49, P741, DOI 10.1128/JVI.49.3.741-747.1984	77	5	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131129	10.1371/journal.pone.0131129	http://dx.doi.org/10.1371/journal.pone.0131129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186447	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700012
J	de Brito, LC; Rezende, RA; da Silva, ND; Tinucci, T; Casarini, DE; Cipolla-Neto, J; Forjaz, CLM				de Brito, Leandro C.; Rezende, Rafael A.; da Silva Junior, Natan D.; Tinucci, Tais; Casarini, Dulce E.; Cipolla-Neto, Jose; Forjaz, Claudia L. M.			Post-Exercise Hypotension and Its Mechanisms Differ after Morning and Evening Exercise: A Randomized Crossover Study	PLOS ONE			English	Article							STRAIN-GAUGE PLETHYSMOGRAPHY; BLOOD-PRESSURE REDUCTION; FLOW-MEDIATED DILATION; HEART-RATE-VARIABILITY; CIRCADIAN VARIATION; DIURNAL-VARIATION; HEMODYNAMICS; RESPONSES; INTERMITTENT; HUMANS	Post-exercise hypotension (PEH), calculated by the difference between post and pre-exercise values, it is greater after exercise performed in the evening than the morning. However, the hypotensive effect of morning exercise may be masked by the morning circadian increase in blood pressure. This study investigated PEH and its hemodynamic and autonomic mechanisms after sessions of aerobic exercise performed in the morning and evening, controlling for responses observed after control sessions performed at the same times of day. Sixteen pre-hypertensive men underwent four sessions (random order): two conducted in the morning (7:30am) and two in the evening (5pm). At each time of day, subjects underwent an exercise (cycling, 45 min, 50%VO(2)peak) and a control (sitting rest) session. Measurements were taken pre- and post-interventions in all the sessions. The net effects of exercise were calculated for each time of day by [(post-pre exercise)-(post-pre control)] and were compared by paired t-test (P<0.05). Exercise hypotensive net effects (e.g., decreasing systolic, diastolic and mean blood pressure) occurred at both times of day, but systolic blood pressure reductions were greater after morning exercise (-7 +/- 3 vs. -3 +/- 4 mmHg, P<0.05). Exercise decreased cardiac output only in the morning (-460 +/- 771 ml/min, P<0.05), while it decreased stroke volume similarly at both times of day and increased heart rate less in the morning than in the evening (+7 +/- 5 vs. +10 +/- 5 bpm, P<0.05). Only evening exercise increased sympathovagal balance (+1.5 +/- 1.6, P<0.05) and calf blood flow responses to reactive hyperemia (+120 +/- 179 vs. -70 +/- 188 U, P<0.05). In conclusion, PEH occurs after exercise conducted at both times of day, but the systolic hypotensive effect is greater after morning exercise when circadian variations are considered. This greater effect is accompanied by a reduction of cardiac output due to a smaller increase in heart rate and cardiac sympathovagal balance.	[de Brito, Leandro C.; da Silva Junior, Natan D.; Tinucci, Tais; Forjaz, Claudia L. M.] Univ Sao Paulo, Sch Phys Educ & Sport, Exercise Hemodynam Lab, Sao Paulo, Brazil; [Cipolla-Neto, Jose] Univ Sao Paulo, Inst Biomed Sci, Neurobiol Lab, Sao Paulo, Brazil; [Casarini, Dulce E.] Univ Fed Sao Paulo, Sch Paulista Med, Dept Med, Div Nephrol, Sao Paulo, Brazil; [Rezende, Rafael A.] Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, Brazil; [Tinucci, Tais] Univ 9 July, Postgrad Program Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Forjaz, CLM (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil.	cforjaz@usp.br	Forjaz, Claudia L M/I-6339-2012; Casarini, Dulce E/D-4091-2012; Cipolla-Neto, Jose/B-1619-2009; Brito, Leandro/AHA-0497-2022; da Silva, Natan Daniel/O-8625-2018; Brito, Leandro/C-1068-2018; Junior, Natan Daniel Silva/I-5979-2012	Forjaz, Claudia L M/0000-0001-7584-4265; Cipolla-Neto, Jose/0000-0003-3748-3731; da Silva, Natan Daniel/0000-0001-5689-9535; Brito, Leandro/0000-0001-9902-7390; Casarini, Dulce/0000-0003-1912-4292	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/03584-8]; Centro Nacional de Desenvolvimento Cientifico (CNPq) [305365-2011-8, 472288/2011-3]; Coordenacao de Aperfeicoamento Pessoal (CAPES-PROEX): CLMF	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Centro Nacional de Desenvolvimento Cientifico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Coordenacao de Aperfeicoamento Pessoal (CAPES-PROEX): CLMF	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2011/03584-8), Centro Nacional de Desenvolvimento Cientifico (CNPq 305365-2011-8 and 472288/2011-3) and Coordenacao de Aperfeicoamento Pessoal (CAPES-PROEX): CLMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson G, 2010, EUR J APPL PHYSIOL, V108, P15, DOI 10.1007/s00421-009-1243-y; Bisquolo VAF, 2005, J APPL PHYSIOL, V98, P866, DOI 10.1152/japplphysiol.00251.2004; Brito LC, 2014, BRAZ J MED BIOL RES, V47, P626, DOI 10.1590/1414-431X20143832; Buysse D J, 1989, Psychiatry Res, V28, P193; Camm AJ, 1996, CIRCULATION, V93, P1043; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; COLLIER CR, 1956, J APPL PHYSIOL, V9, P25, DOI 10.1152/jappl.1956.9.1.25; Cornelissen VA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004473; Cugini P, 2004, Clin Ter, V155, P287; de Berrazueta JR, 2010, EUR J HEART FAIL, V12, P477, DOI 10.1093/eurjhf/hfq036; Dujic Z, 2006, MED SCI SPORT EXER, V38, P318, DOI 10.1249/01.mss.0000187460.73235.3b; Endo MY, 2012, EUR J CLIN NUTR, V66, P1208, DOI 10.1038/ejcn.2012.139; Forjaz C L, 1998, Arq Bras Cardiol, V70, P99, DOI 10.1590/S0066-782X1998000200006; Forjaz CLM, 2004, J SPORT MED PHYS FIT, V44, P54; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Grassi G, 2010, HYPERTENS RES, V33, P381, DOI 10.1038/hr.2010.26; Halliwill JR, 2013, EXP PHYSIOL, V98, P7, DOI 10.1113/expphysiol.2011.058065; Halliwill JR, 1996, J PHYSIOL-LONDON, V495, P279, DOI 10.1113/jphysiol.1996.sp021592; Hamer M, 2006, J HUM HYPERTENS, V20, P612, DOI 10.1038/sj.jhh.1002035; Hecksteden A, 2013, CLIN J SPORT MED, V23, P58, DOI 10.1097/JSM.0b013e31825b6974; Hermida RC, 2007, ADV DRUG DELIVER REV, V59, P904, DOI 10.1016/j.addr.2006.08.003; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Jones H, 2008, EUR J APPL PHYSIOL, V104, P481, DOI 10.1007/s00421-008-0797-4; Jones H, 2010, AM J PHYSIOL-REG I, V298, pR427, DOI 10.1152/ajpregu.00442.2009; Jones H, 2009, CHRONOBIOL INT, V26, P293, DOI 10.1080/07420520902739717; Jones H, 2008, CHRONOBIOL INT, V25, P987, DOI 10.1080/07420520802548044; JONES NL, 1967, CLIN SCI, V32, P311; KENNEY MJ, 1993, HYPERTENSION, V22, P653, DOI 10.1161/01.HYP.22.5.653; Legramante JM, 2002, AM J PHYSIOL-REG I, V282, pR1037, DOI 10.1152/ajpregu.00603.2001; Liu S, 2012, MED SCI SPORT EXER, V44, P1644, DOI 10.1249/MSS.0b013e31825408fb; LOMBARDI F, 1992, AM HEART J, V123, P1521, DOI 10.1016/0002-8703(92)90804-5; Lynn BM, 2009, J PHYSIOL-LONDON, V587, P3605, DOI 10.1113/jphysiol.2009.171199; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mark A L, 1996, HDB PHYSL, P795; MONTANO N, 1994, CIRCULATION, V90, P1826, DOI 10.1161/01.CIR.90.4.1826; Morais PK, 2011, DIABETES METAB, V37, P112, DOI 10.1016/j.diabet.2010.08.008; New KJ, 2013, AM J HYPERTENS, V26, P126, DOI 10.1093/ajh/hps025; North American Association for the Study of Obesity NHL Blood Institute NIoHNOEI, 2000, PRACTICAL GUIDE IDEN; Otto ME, 2004, CIRCULATION, V109, P2507, DOI 10.1161/01.CIR.0000128207.26863.C4; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Rondon MUP, 2002, J AM COLL CARDIOL, V39, P676, DOI 10.1016/S0735-1097(01)01789-2; Santaella DF, 2006, CLIN J SPORT MED, V16, P341, DOI 10.1097/00042752-200607000-00010; Santana HAP, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-71; Taylor CE, 2011, HYPERTENSION, V58, P51, DOI 10.1161/HYPERTENSIONAHA.111.171512; Teixeira L, 2011, EUR J APPL PHYSIOL, V111, P2069, DOI 10.1007/s00421-010-1811-1; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Voogel AJ, 2001, KIDNEY INT, V59, P1873, DOI 10.1046/j.1523-1755.2001.0590051873.x; Walker HA, 2001, BRIT J CLIN PHARMACO, V51, P225, DOI 10.1046/j.1365-2125.2001.00330.x; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; Wilkinson IB, 2001, BRIT J CLIN PHARMACO, V52, P631, DOI 10.1046/j.0306-5251.2001.01495.x	51	44	44	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132458	10.1371/journal.pone.0132458	http://dx.doi.org/10.1371/journal.pone.0132458			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186444	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700044
J	Hanschen, FS; Yim, B; Winkelmann, T; Smalla, K; Schreiner, M				Hanschen, Franziska S.; Yim, Bunlong; Winkelmann, Traud; Smalla, Kornelia; Schreiner, Monika			Degradation of Biofumigant Isothiocyanates and Allyl Glucosinolate in Soil and Their Effects on the Microbial Community Composition	PLOS ONE			English	Article							ENHANCED BIODEGRADATION; BENZYL ISOTHIOCYANATE; RHIZOSPHERE; PRODUCTS; DECOMPOSITION; NITRILES; SINIGRIN; KINETICS; SPROUTS; RADISH	Brassicales species rich in glucosinolates are used for biofumigation, a process based on releasing enzymatically toxic isothiocyanates into the soil. These hydrolysis products are volatile and often reactive compounds. Moreover, glucosinolates can be degraded also without the presence of the hydrolytic enzyme myrosinase which might contribute to bioactive effects. Thus, in the present study the stability of Brassicaceae plant-derived and pure glucosinolates hydrolysis products was studied using three different soils ( model biofumigation). In addition, the degradation of pure 2-propenyl glucosinolate was investigated with special regard to the formation of volatile breakdown products. Finally, the influence of pure glucosinolate degradation on the bacterial community composition was evaluated using denaturing gradient gel electrophoresis of 16S rRNA gene amplified from total community DNA. The model biofumigation study revealed that the structure of the hydrolysis products had a significant impact on their stability in the soil but not the soil type. Following the degradation of pure 2-propenyl glucosinolate in the soils, the nitrile as well as the isothiocyanate can be the main degradation products, depending on the soil type. Furthermore, the degradation was shown to be both chemically as well as biologically mediated as autoclaving reduced degradation. The nitrile was the major product of the chemical degradation and its formation increased with iron content of the soil. Additionally, the bacterial community composition was significantly affected by adding pure 2-propenyl glucosinolate, the effect being more pronounced than in treatments with myrosinase added to the glucosinolate. Therefore, glucosinolates can have a greater effect on soil bacterial community composition than their hydrolysis products.	[Hanschen, Franziska S.; Schreiner, Monika] Leibniz Inst Vegetable & Ornamental Crops Grossbe, Dept Qual, D-14979 Grossbeeren, Germany; [Yim, Bunlong; Winkelmann, Traud] Leibniz Univ Hannover, Inst Hort Prod Syst, Sect Woody Plant & Propagat Physiol, D-30419 Hannover, Germany; [Yim, Bunlong; Smalla, Kornelia] Fed Res Ctr Cultivated Plants JKI, Inst Epidemiol & Pathogen Diagnost, Julius Kuhn Inst, D-38104 Braunschweig, Germany	Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ); Leibniz University Hannover; Julius Kuhn-Institut	Hanschen, FS (corresponding author), Leibniz Inst Vegetable & Ornamental Crops Grossbe, Dept Qual, Theodor Echtermeyer Weg 1, D-14979 Grossbeeren, Germany.	hanschen@igzev.de	Hanschen, Franziska/AAO-2855-2020; Smalla, Kornelia/H-4002-2011	Winkelmann, Traud/0000-0002-2509-1418; Hanschen, Franziska/0000-0003-0949-6228; Schreiner, Monika/0000-0002-5629-4429	Bundesanstalt fur Landwirtschaft und Ernahrung Geschaftsstelle Bundesprogramm Okologischer Landbau und andere Formen nachhaltiger Landwirtschaft (BOLN) [2811NA065]	Bundesanstalt fur Landwirtschaft und Ernahrung Geschaftsstelle Bundesprogramm Okologischer Landbau und andere Formen nachhaltiger Landwirtschaft (BOLN)	The work was part of a project funded by the Bundesanstalt fur Landwirtschaft und Ernahrung Geschaftsstelle Bundesprogramm Okologischer Landbau und andere Formen nachhaltiger Landwirtschaft (BOLN), grant number FKZ: 2811NA065 (http://www.bundesprogramm-oekolandbau.de/).	Agerbirk N, 2012, PHYTOCHEMISTRY, V77, P16, DOI 10.1016/j.phytochem.2012.02.005; Aissani N, 2013, J AGR FOOD CHEM, V61, P4723, DOI 10.1021/jf4008949; [Anonymous], 1991, VDLUFA METHODENBUCH, VI, P1; Araujo JF, 2012, MICROB ECOL, V64, P760, DOI 10.1007/s00248-012-0057-3; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Bangarwa SK, 2011, WEED SCI, V59, P247, DOI 10.1614/WS-D-10-00137.1; Bellostas N, 2007, J SCI FOOD AGR, V87, P1586, DOI 10.1002/jsfa.2896; Bending GD, 2000, SOIL BIOL BIOCHEM, V32, P1261, DOI 10.1016/S0038-0717(00)00043-2; BOREK V, 1995, J AGR FOOD CHEM, V43, P1935, DOI 10.1021/jf00055a033; BOREK V, 1994, J AGR FOOD CHEM, V42, P1030, DOI 10.1021/jf00040a037; Bressan M, 2009, ISME J, V3, P1243, DOI 10.1038/ismej.2009.68; Ding GC, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00290; Dungan RS, 2003, WATER AIR SOIL POLL, V142, P299, DOI 10.1023/A:1022092907878; Fahey JW, 2002, P NATL ACAD SCI USA, V99, P7610, DOI 10.1073/pnas.112203099; Gabler FM, 2006, PLANT DIS, V90, P1019, DOI 10.1094/PD-90-1019; Gimsing AL, 2006, SOIL BIOL BIOCHEM, V38, P2255, DOI 10.1016/j.soilbio.2006.01.024; Gimsing AL, 2009, ENVIRON TOXICOL CHEM, V28, P1178, DOI 10.1897/08-516.1; Gimsing AL, 2007, ENVIRON SCI TECHNOL, V41, P4271, DOI 10.1021/es061987t; Gimsing AL, 2007, APPL CLAY SCI, V35, P212, DOI 10.1016/j.clay.2006.08.008; Gimsing AL, 2006, ENVIRON TOXICOL CHEM, V25, P2038, DOI 10.1897/05-610R.1; Gimsing AL, 2009, PHYTOCHEM REV, V8, P299, DOI 10.1007/s11101-008-9105-5; Grosch R, 2010, BERICHTE J KUHN I, V155, P36; Hallmann J, 2009, CHANCEN GRENZEN BIOF; Hanschen FS, 2014, ANGEW CHEM INT EDIT, V53, P11430, DOI 10.1002/anie.201402639; Hanschen FS, 2012, J AGR FOOD CHEM, V60, P7735, DOI 10.1021/jf301718g; Hanschen FS, 2012, J AGR FOOD CHEM, V60, P2231, DOI 10.1021/jf204830p; Heuer H, 2001, ENVIRONMENTAL MOLECULAR MICROBIOLOGY : PROTOCOLS AND APPLICATIONS, P177; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Hu P, 2015, FRONT MICROBIOL, V5; Ignatieff V, 1941, SOIL SCI, V51, P249, DOI 10.1097/00010694-194104000-00001; KJAER A, 1963, ACTA CHEM SCAND, V17, P2143; KOSEMURA S, 1993, TETRAHEDRON LETT, V34, P481, DOI 10.1016/0040-4039(93)85107-8; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; Matsuoka H, 1997, BIOSCI BIOTECH BIOCH, V61, P2109, DOI 10.1271/bbb.61.2109; Matthiessen JN, 2006, CRIT REV PLANT SCI, V25, P235, DOI 10.1080/07352680600611543; Montaut S, 2010, PHYTOCHEMISTRY, V71, P6, DOI 10.1016/j.phytochem.2009.09.021; Morra MJ, 2002, SOIL BIOL BIOCHEM, V34, P1683, DOI 10.1016/S0038-0717(02)00153-0; Mullaney JA, 2013, J AGR FOOD CHEM, V61, P3039, DOI 10.1021/jf305442j; Omirou M, 2013, EUR J SOIL BIOL, V56, P49, DOI 10.1016/j.ejsobi.2013.01.005; Omirou M, 2011, MICROB ECOL, V61, P201, DOI 10.1007/s00248-010-9740-4; Rumberger A, 2003, SOIL BIOL BIOCHEM, V35, P445, DOI 10.1016/S0038-0717(02)00296-1; Sarwar M, 1998, PLANT SOIL, V201, P103, DOI 10.1023/A:1004381129991; Schreiter S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00144; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Smetanska I, 2006, THESIS TU BERLIN BER; Song D, 2013, J AGR FOOD CHEM, V61, P5097, DOI 10.1021/jf400355d; SPENCER GF, 1980, J SCI FOOD AGR, V31, P359, DOI 10.1002/jsfa.2740310406; van Loon LC, 2007, EUR J PLANT PATHOL, V119, P243, DOI 10.1007/s10658-007-9165-1; Warton B, 2003, SOIL BIOL BIOCHEM, V35, P1123, DOI 10.1016/S0038-0717(03)00164-0; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Wiesner M, 2013, INT J MOL SCI, V14, P14996, DOI 10.3390/ijms140714996; Wittstock U., 2010, Arabidopsis Book, V8, pe0134, DOI 10.1199/tab.0134; Witzel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071877; Wu H, 2011, CROP PROT, V30, P33, DOI 10.1016/j.cropro.2010.09.004; Yim B, 2013, PLANT SOIL, V366, P617, DOI 10.1007/s11104-012-1454-6; YOUNGS CG, 1967, CAN J CHEMISTRY, V45, P1801, DOI 10.1139/v67-289	56	40	42	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132931	10.1371/journal.pone.0132931	http://dx.doi.org/10.1371/journal.pone.0132931			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186695	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700071
J	Huang, CC; Kuo, KK; Cheng, TC; Chuang, CH; Kao, CH; Hsieh, YC; Cheng, KH; Wang, JY; Cheng, CM; Chen, CS; Cheng, TL				Huang, Chien-Chiao; Kuo, Kung-Kai; Cheng, Ta-Chun; Chuang, Chih-Hung; Kao, Chien-Han; Hsieh, Yuan-Chin; Cheng, Kuang-Hung; Wang, Jaw-Yuan; Cheng, Chiu-Min; Chen, Chien-Shu; Cheng, Tian-Lu			Development of Membrane-Bound GM-CSF and IL-18 as an Effective Tumor Vaccine	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; GAMMA-INDUCING FACTOR; ANTITUMOR IMMUNITY; CANCER-IMMUNOTHERAPY; CELL VACCINES; ACTIVATION; INTERLEUKIN-12; MICROENVIRONMENT; PROLIFERATION; INFLAMMATION	The development of effective adjuvant is the key factor to boost the immunogenicity of tumor cells as a tumor vaccine. In this study, we expressed membrane-bound granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-18 (IL-18) as adjuvants in tumor cells to stimulate immune response. B7 transmembrane domain fused GM-CSF and IL-18 was successfully expressed in the cell membrane and stimulated mouse splenocyte proliferation. Co-expression of GM-CSF and IL-18 reduced tumorigenesis (P<0.05) and enhanced tumor protective efficacy (P<0.05) significantly in comparison with GM-CSF alone. These results indicated that the combination of GM-CSF andIL-18 will enhance the immunogenicity of a cell-based anti-tumor vaccine. This membrane-bound approach can be applied to other cytokines for the development of novel vaccine strategies.	[Huang, Chien-Chiao; Cheng, Ta-Chun; Chuang, Chih-Hung; Kao, Chien-Han; Cheng, Tian-Lu] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Kuo, Kung-Kai] Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan; [Huang, Chien-Chiao; Hsieh, Yuan-Chin; Wang, Jaw-Yuan; Cheng, Tian-Lu] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Cheng, Ta-Chun] Taipei Med Univ, Grad Inst Pharmacognosy, Taipei, Taiwan; [Chuang, Chih-Hung; Cheng, Tian-Lu] Kaohsiung Med Univ, Ctr Biomarkers & Biotech Drugs, Kaohsiung, Taiwan; [Cheng, Kuang-Hung; Cheng, Tian-Lu] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Surg, Kaohsiung, Taiwan; [Cheng, Chiu-Min] Natl Kaohsiung Marine Univ, Dept Aquaculture, Kaohsiung, Taiwan; [Chen, Chien-Shu] China Med Univ, Sch Pharm, Taichung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Taipei Medical University; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; National Kaohsiung University of Science & Technology; China Medical University Taiwan	Chen, CS (corresponding author), China Med Univ, Sch Pharm, Taichung, Taiwan.	cschen7@mail.cmu.edu.tw; tlcheng@kmu.edu.tw	Jaw-Yuan, Wang/AFS-8845-2022	Jaw-Yuan, Wang/0000-0002-7705-2621; Hsieh, Yuan Chin/0000-0003-4005-5340; Cheng, Tian-Lu/0000-0002-7263-2766	Ministry of Science and Technology, Taipei, Taiwan [MOST 104-2325-B-037-007, MOST 104-2325-B-037-005, MOST 104-2325-B-041-001]; Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan; Kaohsiung Medical University [KMU-TP103C00, KMU-TP103H00, KMU-DT103005]	Ministry of Science and Technology, Taipei, Taiwan; Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan; Kaohsiung Medical University	This work was supported by grants from the National Research Program for Biopharmaceuticals, Ministry of Science and Technology, Taipei, Taiwan (MOST 104-2325-B-037-007, MOST 104-2325-B-037-005, MOST 104-2325-B-041-001), the Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan. This study is also supported partially by Kaohsiung Medical University "Aim for the Top 500 Universities grant, grant No. KMU-TP103C00, KMU-TP103H00, and KMU-DT103005."	Aldrich JF, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/697158; Bozeman EN, 2013, VACCINE, V31, P2449, DOI 10.1016/j.vaccine.2013.03.028; BURGESS AW, 1977, J BIOL CHEM, V252, P1998; Campbell IK, 1997, ANN RHEUM DIS, V56, P364, DOI 10.1136/ard.56.6.364; Cook AD, 2004, J IMMUNOL, V173, P4643, DOI 10.4049/jimmunol.173.7.4643; Copier J, 2006, INT REV IMMUNOL, V25, P297, DOI 10.1080/08830180600992472; Dao T, 1996, CELL IMMUNOL, V173, P230, DOI 10.1006/cimm.1996.0272; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Dunussi-Joannopoulos K, 1998, BLOOD, V91, P222, DOI 10.1182/blood.V91.1.222.222_222_230; Faries MB, 2009, CLIN CANCER RES, V15, P7029, DOI 10.1158/1078-0432.CCR-09-1540; Gajewski TF, 2012, MOL ONCOL, V6, P242, DOI 10.1016/j.molonc.2012.01.002; Gerritsen WR, 2009, GEN CANC S P AM SOC; Gupta R, 2010, DISCOV MED, V10, P52; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; HAZENBERG BPC, 1989, BLOOD, V74, P2769, DOI 10.1182/blood.V74.8.2769.2769; He H, 2012, INT J MOL MED, V30, P599, DOI 10.3892/ijmm.2012.1027; Higano CSF, 2009, GEN CANC S P AM SOC; Iwai Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002404; Jaffee EM, 2001, J CLIN ONCOL, V19, P145, DOI 10.1200/JCO.2001.19.1.145; Keenan BP, 2012, SEMIN ONCOL, V39, P276, DOI 10.1053/j.seminoncol.2012.02.007; Kim Young Sang, 2009, Immune Netw, V9, P158, DOI 10.4110/in.2009.9.5.158; Kohno K, 1997, J IMMUNOL, V158, P1541; Le DT, 2010, CANCER J, V16, P304, DOI 10.1097/PPO.0b013e3181eb33d7; Liao KW, 2001, BIOTECHNOL BIOENG, V73, P313, DOI 10.1002/bit.1064; Lutz E, 2011, ANN SURG, V253, P328, DOI 10.1097/SLA.0b013e3181fd271c; Marshall DJ, 2006, VACCINE, V24, P244, DOI 10.1016/j.vaccine.2005.07.087; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Pan WY, 2012, MOL THER, V20, P927, DOI 10.1038/mt.2012.10; Sankar S, 2013, ASIAN PAC J CANCER P, V14, P4041, DOI 10.7314/APJCP.2013.14.7.4041; Srivatsan S, 2013, HUMAN VACCINES IMMUN, V10; TAHARA H, 1994, CANCER RES, V54, P182; Tian HW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-48; Tomura M, 1998, J IMMUNOL, V160, P4738; Tse BWC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024241; Tsutsui H, 1996, J IMMUNOL, V157, P3967; van den Boorn JG, 2013, IMMUNITY, V39, P27, DOI 10.1016/j.immuni.2013.07.011; van Nieuwenhuijze A, 2013, MOL IMMUNOL, V56, P675, DOI 10.1016/j.molimm.2013.05.002; Zhang XJ, 2012, J UROLOGY, V187, P1071, DOI 10.1016/j.juro.2011.10.126	38	2	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133470	10.1371/journal.pone.0133470	http://dx.doi.org/10.1371/journal.pone.0133470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186692	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198700143
J	Irfan, N; Brooks, A; Mithoowani, S; Celetti, SJ; Main, C; Mertz, D				Irfan, Neal; Brooks, Annie; Mithoowani, Siraj; Celetti, Steve J.; Main, Cheryl; Mertz, Dominik			A Controlled Quasi-Experimental Study of an Educational Intervention to Reduce the Unnecessary Use of Antimicrobials For Asymptomatic Bacteriuria	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; DISEASES-SOCIETY; INAPPROPRIATE TREATMENT; HOSPITALIZED-PATIENTS; AMERICA GUIDELINES; PREVENTION; WOMEN; OVERTREATMENT; ANTIBIOTICS; DIAGNOSIS	Background Asymptomatic bacteriuria (ABU) should only be treated in cases of pregnancy or in-patients undergoing urologic procedures; however, unnecessary treatment of ABU is common in clinical practice. Objective To identify risk factors for unnecessary treatment and to assess the impact of an educational intervention focused on these risk factors on treatment of ABU. Design Quasi-experimental study with a control group. Setting Two tertiary teaching adult care hospitals. Participants Consecutive patients with positive urine cultures between January 30th and April 17th, 2012 (baseline) and January 30th and April 30th, 2013 (intervention). Intervention In January 2013, a multifaceted educational intervention based on risk factors identified during the baseline period was provided to medical residents (monthly) on one clinical teaching unit (CTU) at one hospital site, with the CTU of the other hospital serving as the control. Results During the baseline period, 160/341 (46.9%) positive urine cultures were obtained from asymptomatic patients at the two hospitals, and 94/160 (58.8%) were inappropriately treated with antibiotics. Risk factors for inappropriate use included: female gender (OR 2.1, 95% CI 1.1-4.3), absence of a catheter (OR 2.5, 1.2-5), bacteriuria versus candiduria (OR 10.6, 3.8-29.4), pyuria (OR 2.0, 1.1-3.8), and positive nitrites (OR 2.2, 1.1-4.5). In 2013, only 2/24 (8%) of ABU patients were inappropriately treated on the intervention CTU as compared to 14/29 (52%) on the control CTU (OR 0.10; 95% CI 0.02-0.49). A reduction was also observed as compared to baseline on the intervention CTU (OR 0.1, 0.02-0.7) with no significant change noted on the control CTU (OR 0.47, 0.13-1.7). Conclusions A multifaceted educational intervention geared towards medical residents with a focus on identified risk factors for inappropriate management of ABU was effective in reducing unnecessary antibiotic use.	[Irfan, Neal; Brooks, Annie; Main, Cheryl; Mertz, Dominik] Hamilton Hlth Sci, Hamilton, ON, Canada; [Brooks, Annie; Mithoowani, Siraj; Mertz, Dominik] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Celetti, Steve J.] Univ Waterloo, Fac Pharm, Kitchener, ON, Canada; [Main, Cheryl; Mertz, Dominik] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Mertz, Dominik] McMaster Univ, Hlth Sci Ctr, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Mertz, Dominik] Michael G DeGroote Inst Infect Dis Res IIDR, Hamilton, ON, Canada	McMaster University; McMaster University; University of Waterloo; McMaster University; McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba	Mertz, D (corresponding author), Hamilton Hlth Sci, Hamilton, ON, Canada.	mertzd@mcmaster.ca						Cai T, 2012, CLIN INFECT DIS, V55, P771, DOI 10.1093/cid/cis534; Chowdhury F, 2012, J COMMUNITY HOSP INT, V2, DOI 10.3402/jchimp.v2i2.17814; CLASSEN DC, 1991, AM J INFECT CONTROL, V19, P136, DOI 10.1016/0196-6553(91)90019-9; Cope M, 2009, CLIN INFECT DIS, V48, P1182, DOI 10.1086/597403; Dalen Dawn M, 2005, Can J Infect Dis Med Microbiol, V16, P166; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Gandhi T, 2009, INFECT CONT HOSP EP, V30, P193, DOI 10.1086/593951; GARIBALDI RA, 1974, NEW ENGL J MED, V291, P215, DOI 10.1056/NEJM197408012910501; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Hartley S, 2013, INFECT CONT HOSP EP, V34, P1204, DOI 10.1086/673449; HARTSTEIN AI, 1981, INFECT CONT HOSP EP, V2, P380, DOI 10.1017/S0195941700055533; Hecker MT, 2003, ARCH INTERN MED, V163, P972, DOI 10.1001/archinte.163.8.972; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Kelley D, 2014, INFECT CONT HOSP EP, V35, P193, DOI 10.1086/674848; Khawcharoenporn T, 2011, AM J EMERG MED, V29, P828, DOI 10.1016/j.ajem.2011.04.007; KUNIN CM, 1966, NEW ENGL J MED, V274, P1155, DOI 10.1056/NEJM196605262742101; Leis JA, 2014, CLIN INFECT DIS, V58, P980, DOI 10.1093/cid/ciu010; Leis JA, 2013, INFECT CONT HOSP EP, V34, P1113, DOI 10.1086/673151; Lin E, 2012, ARCH INTERN MED, V172, P33, DOI 10.1001/archinternmed.2011.565; Mody L, 2014, JAMA-J AM MED ASSOC, V311, P844, DOI 10.1001/jama.2014.303; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; RUBIN RH, 1992, CLIN INFECT DIS, V15, pS216, DOI 10.1093/clind/15.Supplement_1.S216; Silver SA, 2009, CAN J INFECT DIS MED, V20, P107, DOI 10.1155/2009/702545; Srigley JA, 2013, AM J INFECT CONTROL, V41, P1116, DOI 10.1016/j.ajic.2013.04.017; Trautner BW, 2014, AM J INFECT CONTROL, V42, P653, DOI 10.1016/j.ajic.2014.02.003; Tsan L, 2010, AM J INFECT CONTROL, V38, P461, DOI 10.1016/j.ajic.2009.12.009; WARREN JW, 1987, J INFECT DIS, V155, P1151, DOI 10.1093/infdis/155.6.1151; WARREN JW, 1982, J INFECT DIS, V146, P719, DOI 10.1093/infdis/146.6.719; Zabarsky TF, 2008, AM J INFECT CONTROL, V36, P476, DOI 10.1016/j.ajic.2007.11.007	29	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132071	10.1371/journal.pone.0132071	http://dx.doi.org/10.1371/journal.pone.0132071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182348	gold, Green Submitted, Green Published			2022-12-27	WOS:000358198200015
J	Kang, JH; Park, HJ; Jung, YW; Shim, SH; Sung, SR; Park, JE; Cha, DH; Ahn, EH				Kang, J. H.; Park, H. J.; Jung, Y. W.; Shim, S. H.; Sung, S. R.; Park, J. E.; Cha, D. H.; Ahn, E. H.			Comparative Transcriptome Analysis of Cell-Free Fetal RNA from Amniotic Fluid and RNA from Amniocytes in Uncomplicated Pregnancies	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; MESSENGER; DNA	Objectives We aimed to compare tissue-specific expression profiles and biological pathways of RNA from amniocytes and amniotic fluid supernatant (AFS) from second-trimester pregnancies by using transcriptome analysis. Additionally, we wanted to explore whether cell-free RNA from AFS exhibits a unique gene expression signature that more adequately reflects the fetal developmental process than amniocyte RNA. Methods Amniotic fluid samples were prospectively collected in the second trimester of pregnancy from euploid fetuses. Total RNA was extracted from amniocytes and AFS and hybridized to Affymetrix GeneChip Human Arrays. Significantly differentially expressed transcripts between amniocytes and AFS were obtained by using Welch's t-test. Unsupervised hierarchical clustering was used to visualize overall expression characteristics and differences in transcripts between AFS and amniocytes. The biological functions of selected genes were analyzed using various online Gene Ontology databases. Results A total of 3,072 and 15,633 transcripts were detected in the second-trimester AFS and amniocytes, respectively. Hierarchical clustering revealed differential transcript expression between AFS and amniocytes. We found 353 genes that were specifically enriched in the AFS only, and tissue expression analysis showed enrichment of brain-specific genes in the AFS. Biological pathway analysis revealed that AFS-specific transcripts were mainly involved in embryonic development, cardiovascular development, and cellular morphology pathways. Conclusion This study demonstrated differential tissue-specific gene expression profiles and biological pathways between AFS and amniocytes. The results suggested that AFS is the preferred RNA source to investigate potential biomarkers of fetal neurodevelopment.	[Kang, J. H.] CHA Univ, CHA Grad Sch Med, Dept Obstet & Gynecol, Seoul, South Korea; [Park, H. J.; Jung, Y. W.; Cha, D. H.] CHA Univ, CHA Gangnam Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Shim, S. H.; Sung, S. R.; Park, J. E.] CHA Univ, CHA Gangnam Med Ctr, Fertil Ctr, Genet Lab, Seoul, South Korea; [Ahn, E. H.] CHA Univ, CHA Bundang Med Ctr, Dept Obstet & Gynecol, Songnam, South Korea; [Kang, J. H.] Zion Womens Hosp, Dept Obstet & Gynecol, Suwon, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University; Pochon Cha University	Cha, DH (corresponding author), CHA Univ, CHA Gangnam Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea.	chadh001@hanmail.net; vital-a@hanmail.net		jung, yong wook/0000-0003-2098-8143				Bianchi DW, 2001, CLIN CHEM, V47, P1867; Edlow AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088661; Gahan PB, 2010, CELL BIOCHEM FUNCT, V28, P529, DOI 10.1002/cbf.1690; Hui L, 2011, HUM REPROD UPDATE, V17, P362, DOI 10.1093/humupd/dmq049; Hui LS, 2013, PRENATAL DIAG, V33, P873, DOI 10.1002/pd.4150; Hui L, 2013, OBSTET GYNECOL, V121, P1248, DOI 10.1097/AOG.0b013e318293d70b; Hui LS, 2012, HUM GENET, V131, P1751, DOI 10.1007/s00439-012-1195-x; Hui L, 2012, OBSTET GYNECOL, V119, P111, DOI 10.1097/AOG.0b013e31823d4150; Koide K, 2011, HUM GENET, V129, P295, DOI 10.1007/s00439-010-0923-3; Larrabee PB, 2005, CLIN CHEM, V51, P1024, DOI 10.1373/clinchem.2004.047670; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YM, 1997, LANCET, V350, P485, DOI DOI 10.1016/S0140-6736(97)02174-0; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Massingham LJ, 2014, HUM GENET, V133, P1075, DOI 10.1007/s00439-014-1448-y; Slonim DK, 2009, P NATL ACAD SCI USA, V106, P9425, DOI 10.1073/pnas.0903909106; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; Zwemer LM, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023101	17	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0132955	10.1371/journal.pone.0132955	http://dx.doi.org/10.1371/journal.pone.0132955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181329	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198200047
J	Cattaneo, L; Cicconi, R; Mignogna, G; Giorgi, A; Mattei, M; Graziani, G; Ferracane, R; Grosso, A; Aducci, P; Schinina, ME; Marra, M				Cattaneo, Lucia; Cicconi, Rosella; Mignogna, Giuseppina; Giorgi, Alessandra; Mattei, Maurizio; Graziani, Giulia; Ferracane, Rosalia; Grosso, Alessandro; Aducci, Patrizia; Schinina, M. Eugenia; Marra, Mauro			Anti-Proliferative Effect of Rosmarinus officinalis L. Extract on Human Melanoma A375 Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PROTEIN DISULFIDE-ISOMERASE; TANDEM MASS-SPECTROMETRY; SALVIA-OFFICINALIS; ROSEMARY EXTRACT; CARNOSIC ACID; CYCLE ARREST; ANTIOXIDANT PROPERTIES; MYELOID-LEUKEMIA; BRONCHIAL CELLS	Rosemary (Rosmarinus officinalis L.) has been used since ancient times in traditional medicine, while nowadays various rosemary formulations are increasingly exploited by alternative medicine to cure or prevent a wide range of health disorders. Rosemary's bioproperties have prompted scientific investigation, which allowed us to ascertain antioxidant, anti-inflammatory, cytostatic, and cytotoxic activities of crude extracts or of pure components. Although there is a growing body of experimental work, information about rosemary's anticancer properties, such as chemoprotective or anti-proliferative effects on cancer cells, is very poor, especially concerning the mechanism of action. Melanoma is a skin tumor whose diffusion is rapidly increasing in the world and whose malignancy is reinforced by its high resistance to cytotoxic agents; hence the availability of new cytotoxic drugs would be very helpful to improve melanoma prognosis. Here we report on the effect of a rosemary hydroalcoholic extract on the viability of the human melanoma A375 cell line. Main components of rosemary extract were identified by liquid chromatography coupled to tandem mass spectrometry (LC/ESI-MS/MS) and the effect of the crude extract or of pure components on the proliferation of cancer cells was tested by MTT and Trypan blue assays. The effect on cell cycle was investigated by using flow cytometry, and the alteration of the cellular redox state was evaluated by intracellular ROS levels and protein carbonylation analysis. Furthermore, in order to get information about the molecular mechanisms of cytotoxicity, a comparative proteomic investigation was performed.	[Cattaneo, Lucia; Grosso, Alessandro; Aducci, Patrizia; Marra, Mauro] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Cicconi, Rosella; Mattei, Maurizio] Univ Roma Tor Vergata, Ctr Serv Interdipartimentale, Staz Tecnol Anim, Rome, Italy; [Mignogna, Giuseppina; Giorgi, Alessandra; Schinina, M. Eugenia] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Graziani, Giulia; Ferracane, Rosalia] Univ Naples Federico II, Dept Agr & Food Sci, Naples, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; Sapienza University Rome; University of Naples Federico II	Marra, M (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	marra@uniroma2.it	Graziani, Giulia/AAN-4828-2020; Mattei, Maurizio/AAC-1303-2019	Graziani, Giulia/0000-0003-3070-5389; Mattei, Maurizio/0000-0002-0814-8873; Mignogna, Giuseppina/0000-0001-9238-132X; Ferracane, Rosalia/0000-0002-1323-7715	Italian grant from MIUR [PRIN 2010HEBBB8_002]; Sapienza University grant [C26A124WCR]	Italian grant from MIUR; Sapienza University grant	This work has been partly supported by an Italian grant from MIUR (to MES; grant number PRIN 2010HEBBB8_002) and by a Sapienza University grant (to MES; grant number C26A124WCR).	Al-Sereiti M. R., 1999, Indian Journal of Experimental Biology, V37, P124; Atallah Ehab, 2005, Curr Treat Options Oncol, V6, P185; Bai HH, 2014, SCANNING, V36, P622, DOI 10.1002/sca.21170; Bai NS, 2010, J AGR FOOD CHEM, V58, P5363, DOI 10.1021/jf100332w; Bakirel T, 2008, J ETHNOPHARMACOL, V116, P64, DOI 10.1016/j.jep.2007.10.039; Benham AM, 2012, ANTIOXID REDOX SIGN, V16, P781, DOI 10.1089/ars.2011.4439; Bozin B, 2007, J AGR FOOD CHEM, V55, P7879, DOI 10.1021/jf0715323; Chang IS, 2007, BLOOD, V110, P994, DOI 10.1182/blood-2007-03-078303; Cheung S, 2007, ONCOL REP, V17, P1525; Chiu CC, 2011, CLIN CANCER RES, V17, P4629, DOI 10.1158/1078-0432.CCR-10-2107; Cho NH, 2006, J PROTEOME RES, V5, P643, DOI 10.1021/pr050460x; Choi EJ, 2013, ONCOL LETT, V6, P1784, DOI 10.3892/ol.2013.1601; D'Alessio C, 1999, J BIOL CHEM, V274, P25899, DOI 10.1074/jbc.274.36.25899; Das S, 2012, EXP BIOL MED, V237, P1433, DOI 10.1258/ebm.2012.012148; Dias PC, 2000, J ETHNOPHARMACOL, V69, P57, DOI 10.1016/S0378-8741(99)00133-6; Ding HY, 2010, FOOD CHEM, V123, P254, DOI 10.1016/j.foodchem.2010.04.025; Drenth JPH, 2005, TRENDS MOL MED, V11, P37, DOI 10.1016/j.molmed.2004.11.004; George VC, 2013, ASIAN PAC J CANCER P, V14, P631, DOI 10.7314/APJCP.2013.14.2.631; Gonzalez-Trujano ME, 2007, J ETHNOPHARMACOL, V111, P476, DOI 10.1016/j.jep.2006.12.011; Gutierrez R, 2010, PHYTOTHER RES, V24, P595, DOI 10.1002/ptr.2997; Han W, 2013, J CLIN INVEST, V123, P2103, DOI 10.1172/JCI61820; Herrero M, 2010, J CHROMATOGR A, V1217, P2512, DOI 10.1016/j.chroma.2009.11.032; Higa A, 2014, MOL CELL BIOL, V34, P1839, DOI 10.1128/MCB.01484-13; Hu CE, 2014, BIOCHEM BIOPH RES CO, V448, P437, DOI 10.1016/j.bbrc.2014.04.124; HUANG MT, 1994, CANCER RES, V54, P701; Huang SC, 2005, BIOCHEM PHARMACOL, V69, P221, DOI 10.1016/j.bcp.2004.09.019; Johnson JJ, 2011, CANCER LETT, V305, P1, DOI 10.1016/j.canlet.2011.02.005; Johnson JJ, 2008, PHARM RES-DORDR, V25, P2125, DOI 10.1007/s11095-008-9552-0; Kontogianni VG, 2013, FOOD CHEM, V136, P120, DOI 10.1016/j.foodchem.2012.07.091; Liao Y, 2014, PLOS ONE, V19; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Lovat PE, 2008, CANCER RES, V68, P5363, DOI 10.1158/0008-5472.CAN-08-0035; Marugame T, 2010, JPN J CLIN ONCOL, V40, P710, DOI 10.1093/jjco/hyq107; Menoret A, 2014, MOL CARCINOGEN, V53, pE11, DOI 10.1002/mc.21986; Molinaro RJ, 2006, NUCLEIC ACIDS RES, V34, P6684, DOI 10.1093/nar/gkl968; Moran AE, 2005, CANCER RES, V65, P1097; OFFORD EA, 1995, CARCINOGENESIS, V16, P2057, DOI 10.1093/carcin/16.9.2057; Offord EA, 1997, CANCER LETT, V114, P275, DOI 10.1016/S0304-3835(97)04680-6; Pappin Darryl J C, 2003, Methods Mol Biol, V211, P211; Park SJ, 2009, BONE, V45, P994, DOI 10.1016/j.bone.2009.07.018; Qu J, 2001, J CHROMATOGR A, V919, P437, DOI 10.1016/S0021-9673(01)00849-4; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Russo A, 2009, NAT PROD COMMUN, V4, P1707; Senorans FJ, 2000, J CHROMATOGR A, V870, P491, DOI 10.1016/S0021-9673(99)00941-3; Shabtay A, 2008, ONCOLOGY-BASEL, V75, P203, DOI 10.1159/000163849; Sharabani H, 2006, INT J CANCER, V118, P3012, DOI 10.1002/ijc.21736; Singletary K, 1996, CANCER LETT, V104, P43, DOI 10.1016/0304-3835(96)04227-9; Singletary KW, 1997, PLANT FOOD HUM NUTR, V50, P47, DOI 10.1007/BF02436042; Sotelo-Felix JI, 2002, J ETHNOPHARMACOL, V81, P145, DOI 10.1016/S0378-8741(02)00090-9; Steiner M, 2001, NUTR CANCER, V41, P135, DOI 10.1207/S15327914NC41-1&amp;2_19; Sun W, 2001, Curr Treat Options Oncol, V2, P193, DOI 10.1007/s11864-001-0033-5; Tawbi Hussein A, 2010, Clin Adv Hematol Oncol, V8, P259; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Ullah MF, 2013, CELL BIOCHEM BIOPHYS, V67, P431, DOI 10.1007/s12013-011-9303-4; Urich-Merzenich G, 2009, PHYTOMEDICINE, V16, P495, DOI 10.1016/j.phymed.2009.04.001; Visanji JM, 2006, CANCER LETT, V237, P130, DOI 10.1016/j.canlet.2005.05.045; Wang F, 2014, DRUG RES; Wei Feng-Xiang, 2008, Zhong Yao Cai, V31, P877; Xavier CPR, 2009, NUTR CANCER, V61, P564, DOI 10.1080/01635580802710733; Xu SL, 2014, DRUG DISCOV TODAY, V19, P222, DOI 10.1016/j.drudis.2013.10.017; Yamamoto J, 2005, NUTRITION, V21, P580, DOI 10.1016/j.nut.2004.09.016; Yang B, 2013, CARBOHYD POLYM, V92, P1308, DOI 10.1016/j.carbpol.2012.10.012; Yesil-Celiktas O, 2010, PLANT FOOD HUM NUTR, V65, P158, DOI 10.1007/s11130-010-0166-4; YU SG, 1995, J NUTR, V125, P2763; Zhang JY, 2014, INT IMMUNOPHARMACOL, V21, P94, DOI 10.1016/j.intimp.2014.04.011; Zhavoronkov A, 2012, J MOL MED, V90, P1361, DOI 10.1007/s00109-012-0962-4	66	51	56	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132439	10.1371/journal.pone.0132439	http://dx.doi.org/10.1371/journal.pone.0132439			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176704	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600113
J	Earl, SC; Rogers, MT; Keen, J; Bland, DM; Houppert, AS; Miller, C; Temple, I; Anderson, DM; Marketon, MM				Earl, Shaun C.; Rogers, Miles T.; Keen, Jennifer; Bland, David M.; Houppert, Andrew S.; Miller, Caitlynn; Temple, Ian; Anderson, Deborah M.; Marketon, Melanie M.			Resistance to Innate Immunity Contributes to Colonization of the Insect Gut by Yersinia pestis	PLOS ONE			English	Article							EARLY-PHASE TRANSMISSION; XENOPSYLLA-CHEOPIS SIPHONAPTERA; PSEUDOMONAS-AERUGINOSA INFECTION; OROPSYLLA-MONTANA SIPHONAPTERA; DROSOPHILA-MELANOGASTER; MODEL HOST; ANTIMICROBIAL PEPTIDES; BIOFILM FORMATION; MURINE TOXIN; STAPHYLOCOCCUS-AUREUS	Yersinia pestis, the causative agent of bubonic and pneumonic plague, is typically a zoonotic vector-borne disease of wild rodents. Bacterial biofilm formation in the proventriculus of the flea contributes to chronic infection of fleas and facilitates efficient disease transmission. However prior to biofilm formation, ingested bacteria must survive within the flea midgut, and yet little is known about vector-pathogen interactions that are required for flea gut colonization. Here we establish a Drosophila melanogaster model system to gain insight into Y. pestis colonization of the insect vector. We show that Y. pestis establishes a stable infection in the anterior midgut of fly larvae, and we used this model system to study the roles of genes involved in biofilm production and/or resistance to gut immunity stressors. We find that PhoP and GmhA both contribute to colonization and resistance to antimicrobial peptides in flies, and furthermore, the data suggest biofilm formation may afford protection against antimicrobial peptides. Production of reactive oxygen species in the fly gut, as in fleas, also serves to limit bacterial infection, and OxyR mediates Y. pestis survival in both insect models. Overall, our data establish the fruit fly as an informative model to elucidate the relationship between Y. pestis and its flea vector.	[Earl, Shaun C.; Rogers, Miles T.; Keen, Jennifer; Houppert, Andrew S.; Miller, Caitlynn; Temple, Ian; Marketon, Melanie M.] Indiana Univ, Dept Biol, Bloomington, IN 47401 USA; [Bland, David M.; Anderson, Deborah M.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Indiana University System; Indiana University Bloomington; University of Missouri System; University of Missouri Columbia	Marketon, MM (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47401 USA.	mmarketo@indiana.edu		Rogers, Miles/0000-0003-2804-880X; Keen, Jennifer/0000-0002-4271-4349; Bland, David/0000-0002-5052-5599	University of Missouri Research Board; Office of the Vice Provost of Research at Indiana University-Bloomington through the Faculty Research Support Program; United States Public Health Service (NIAID) [R21AI101242, P40OD018537]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101242] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	University of Missouri Research Board; Office of the Vice Provost of Research at Indiana University-Bloomington through the Faculty Research Support Program; United States Public Health Service (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	DMA acknowledges the University of Missouri Research Board for partial funding of this work. MMM acknowledges funding for this work by the Office of the Vice Provost of Research at Indiana University-Bloomington through the Faculty Research Support Program and by the grant R21AI101242 from the United States Public Health Service (NIAID; www.niaid.nih.gov). Fly stocks used in this study were obtained from the Bloomington Drosophila Stock Center, which is supported through grant P40OD018537 from the United States Public Health Service (NIAID; www.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi KL, 2015, MICROBIOL-SGM, V161, P628, DOI 10.1099/mic.0.000018; Apidianakis Y, 2009, NAT PROTOC, V4, P1285, DOI 10.1038/nprot.2009.124; Asare R, 2010, ENVIRON MICROBIOL, V12, P2587, DOI 10.1111/j.1462-2920.2010.02230.x; Bacot A W, 1914, J Hyg (Lond), V13, P423; Barnes A.M., 1982, Symposia of the Zoological Society of London, V50, P237; BIBIKOVA VA, 1977, ANNU REV ENTOMOL, V22, P23, DOI 10.1146/annurev.en.22.010177.000323; Brooke JS, 1996, J BIOL CHEM, V271, P3608; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; BURROUGHS AL, 1947, J HYG-CAMBRIDGE, V45, P371, DOI 10.1017/S0022172400014042; Butler T, 2013, AM J TROP MED HYG, V89, P788, DOI 10.4269/ajtmh.13-0191; Chan C, 2004, J BIOL CHEM, V279, P38749, DOI 10.1074/jbc.M406044200; Charroux B, 2010, FLY, V4, P40, DOI 10.4161/fly.4.1.10810; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; D'Argenio DA, 2001, J BACTERIOL, V183, P1466, DOI 10.1128/JB.183.4.1466-1471.2001; Darby C, 2005, INFECT IMMUN, V73, P7236, DOI 10.1128/IAI.73.11.7236-7242.2005; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dentovskaya SV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P808, DOI 10.1134/S0006297911070121; Dewoody R, 2011, MOL MICROBIOL, V79, P1445, DOI 10.1111/j.1365-2958.2011.07534.x; Dionne MS, 2003, INFECT IMMUN, V71, P3540, DOI 10.1128/IAI.71.6.3540-3550.2003; Drancourt M, 2006, LANCET INFECT DIS, V6, P234, DOI 10.1016/S1473-3099(06)70438-8; Eisen RJ, 2008, J MED ENTOMOL, V45, P1160, DOI 10.1603/0022-2585(2008)45[1160:DOETOY]2.0.CO;2; Eisen RJ, 2008, AM J TROP MED HYG, V78, P949, DOI 10.4269/ajtmh.2008.78.949; Eisen RJ, 2007, J MED ENTOMOL, V44, P678, DOI 10.1603/0022-2585(2007)44[678:ETOYPB]2.0.CO;2; Eisen RJ, 2007, J MED ENTOMOL, V44, P672, DOI 10.1603/0022-2585(2007)44[672:TDOETO]2.0.CO;2; Eisen RJ, 2006, P NATL ACAD SCI USA, V103, P15380, DOI 10.1073/pnas.0606831103; Eisen RJ, 2009, J MED ENTOMOL, V46, P737, DOI 10.1603/033.046.0403; Erickson DL, 2011, MICROB PATHOGENESIS, V51, P389, DOI 10.1016/j.micpath.2011.08.008; Eskey C. R., 1940, PLAGUE W PART US; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; Gabitzsch ES, 2008, AM J TROP MED HYG, V79, P99, DOI 10.4269/ajtmh.2008.79.99; GAGE KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI DOI 10.1146/annurev.ento.50.071803.130337; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Han YP, 2008, DNA CELL BIOL, V27, P453, DOI 10.1089/dna.2007.0657; Hao ZG, 2003, INSECT BIOCHEM MOLEC, V33, P1155, DOI 10.1016/j.ibmb.2003.07.001; Hinnebusch BJ, 2005, CURR ISSUES MOL BIOL, V7, P197, DOI 10.21775/cimb.007.197; Hinnebusch BJ, 1996, SCIENCE, V273, P367, DOI 10.1126/science.273.5273.367; Hinnebusch BJ, 2002, SCIENCE, V296, P733, DOI 10.1126/science.1069972; Hitchen PG, 2002, MOL MICROBIOL, V44, P1637, DOI 10.1046/j.1365-2958.2002.02990.x; Houppert AS, 2013, INFECT IMMUN, V81, P1186, DOI 10.1128/IAI.01417-12; Houppert AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034039; Hubbart JA, 2011, J VECTOR ECOL, V36, P117, DOI 10.1111/j.1948-7134.2011.00148.x; Jarrett CO, 2004, J INFECT DIS, V190, P783, DOI 10.1086/422695; Johnson TL, 2014, MICROBIOL-SGM, V160, P2517, DOI 10.1099/mic.0.082123-0; Joo H. S., 2015, BIOCH BIOPHYS ACTA; Kim JK, 2014, DEV COMP IMMUNOL, V43, P10, DOI 10.1016/j.dci.2013.10.010; Kim SH, 2008, INFECT IMMUN, V76, P4152, DOI 10.1128/IAI.01637-07; Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006; Knirel YA, 2007, ADV EXP MED BIOL, V603, P88; Kounatidis I, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120075; Kurata S, 2010, ADV EXP MED BIOL, V708, P205; Kurata S, 2010, INT IMMUNOL, V22, P143, DOI 10.1093/intimm/dxp128; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Nayduch D, 2013, J MED ENTOMOL, V50, P171, DOI 10.1603/ME12189; Needham AJ, 2004, MICROBIOL-SGM, V150, P2347, DOI 10.1099/mic.0.27116-0; Nuri R, 2015, BIOCH BIOPHYS ACTA; Olcott MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012504; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Rebeil R, 2013, J BACTERIOL, V195, P1920, DOI 10.1128/JB.02000-12; Royet J, 2011, CELL MOL LIFE SCI, V68, P3651, DOI 10.1007/s00018-011-0828-x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rudolph AE, 1999, J BIOL CHEM, V274, P11824, DOI 10.1074/jbc.274.17.11824; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; Shanbhag S, 2005, J MEMBRANE BIOL, V206, P61, DOI 10.1007/s00232-005-0774-1; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaw AE, 2012, J VIROL, V86, P9015, DOI 10.1128/JVI.00131-12; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Tan L, 2006, MOL MICROBIOL, V61, P861, DOI 10.1111/j.1365-2958.2006.05265.x; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Uliczka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020425; Uvell H, 2007, TRENDS GENET, V23, P342, DOI 10.1016/j.tig.2007.05.003; Vadyvaloo V, 2015, MICROBIOLOGY; Vadyvaloo V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000783; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Vetter SM, 2010, MICROBIOL-SGM, V156, P2216, DOI 10.1099/mic.0.037952-0; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Whitfield GB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00471; Wigglesworth VB, 1972, PRINCIPLES INSECT PH; Wilder AP, 2008, VECTOR-BORNE ZOONOT, V8, P359, DOI 10.1089/vbz.2007.0181; Wood JW, 2003, HUM BIOL, V75, P427, DOI 10.1353/hub.2003.0067; Zhou W, 2012, J MED ENTOMOL, V49, P364, DOI 10.1603/ME11172	87	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133318	10.1371/journal.pone.0133318	http://dx.doi.org/10.1371/journal.pone.0133318			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177454	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600242
J	Gaitas, A; Kim, G				Gaitas, Angelo; Kim, Gwangseong			Chemically Modified Plastic Tube for High Volume Removal and Collection of Circulating Tumor Cells	PLOS ONE			English	Article							INTRAOPERATIVE BLOOD SALVAGE; CANCER-PATIENTS; DIALYSIS MEMBRANE; DEPLETION; CAPTURE; TRAIL	In this preliminary effort, we use a commercially available and chemically modified tube to selectively capture circulating tumor cells (CTCs) from the blood stream by immobilizing human anti-EpCAM antibodies on the tube's interior surface. We describe the requisite and critical steps required to modify a tube into a cancer cell-capturing device. Using these simple modifications, we were able to capture or entrap about 85% of cancer cells from suspension and 44% of cancer cells from spiked whole blood. We also found that the percentage of cells captured was dependent on the tube's length and also the number of cancer cells present. It is our strong belief that with the utilization of appropriate tube lengths and procedures, we can ensure capture and removal of nearly the entire CTC population in whole blood. Importantly after a patient's entire blood volume has circulated through the tube, the tube can then be trypsinized to release the captured live CTCs for further analysis and testing.	[Gaitas, Angelo; Kim, Gwangseong] Kytaro Inc, Miami, FL 33199 USA; [Gaitas, Angelo; Kim, Gwangseong] Florida Int Univ, Miami, FL 33199 USA	State University System of Florida; Florida International University	Gaitas, A (corresponding author), Kytaro Inc, Miami, FL 33199 USA.	agaitas@fiu.edu		Gaitas, Angelo/0000-0003-4428-3949	NIH [GM084520]; Kytaro, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM084520, R44GM084520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kytaro, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by NIH grant #GM084520 (PI: Gaitas) Kytaro, Inc. which provided support in the form of salaries for authors AG and GK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Adams D, CANC DET DIAGN TECHN, V301, P983; Adams D, 2011, P 102 AACR M; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Edelman MJ, 1996, UROLOGY, V47, P179, DOI 10.1016/S0090-4295(99)80411-7; Fruhauf NR, 2001, PERFUSION-UK, V16, P51, DOI 10.1177/026765910101600i107; Gertler R, 2003, RECENT RES CANCER, V162, P149; Hu YJ, 2010, CYTOM PART A, V77A, P213, DOI 10.1002/cyto.a.20838; Kemmner W., 2011, J CLIN EXP PATHOL, V40, P1125; Kim G, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2771530; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kim WS, 2007, LANGMUIR, V23, P4732, DOI 10.1021/la070074p; King MR, 2009, J BIONIC ENG, V6, P311, DOI 10.1016/S1672-6529(08)60129-8; King MR, THERAPEUTIC TARGETIN; Lopez-Riquelme N, 2013, APMIS, V121, P1139, DOI 10.1111/apm.12061; Lu J, 2010, INT J CANCER, V126, P669, DOI 10.1002/ijc.24814; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Mitchell MJ, 2014, P NATL ACAD SCI USA, V111, P930, DOI 10.1073/pnas.1316312111; Munz M, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-44; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Perseghin P, 1997, VOX SANG, V72, P221, DOI 10.1046/j.1423-0410.1997.7240221.x; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; Rana K, 2009, BIOTECHNOL BIOENG, V102, P1692, DOI 10.1002/bit.22204; Ricci SB, 2007, CLIN NEPHROL, V68, P354; Ricci SB, 2012, MED HYPOTHESES, V78, P1, DOI 10.1016/j.mehy.2011.09.026; Ricci SB, 2009, MED HYPOTHESES, V73, P328, DOI 10.1016/j.mehy.2009.03.043; Saucedo-Zeni N, 2012, INT J ONCOL, V41, P1241, DOI 10.3892/ijo.2012.1557; Sieben S, 2001, J MAGN MAGN MATER, V225, P175, DOI 10.1016/S0304-8853(00)01248-8; Sui GD, 2006, ANAL CHEM, V78, P5543, DOI 10.1021/ac060605z; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Yoon HJ, 2013, NAT NANOTECHNOL, V8, P735, DOI 10.1038/nnano.2013.194	31	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133194	10.1371/journal.pone.0133194	http://dx.doi.org/10.1371/journal.pone.0133194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176235	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600230
J	Karmacharya, D; Manandhar, S; Sharma, A; Bhatta, T; Adhikari, P; Sherchan, AM; Shrestha, B; Bista, M; Rajbhandari, R; Oberoi, M; Bisht, K; Hero, JM; Dissanayake, R; Dhakal, M; Hughes, J; Debnath, N				Karmacharya, Dibesh; Manandhar, Sulochana; Sharma, Ajay; Bhatta, Tarka; Adhikari, Pratikshya; Sherchan, Adarsh Man; Shrestha, Bishwo; Bista, Manisha; Rajbhandari, Rajesh; Oberoi, Mohinder; Bisht, Khadak; Hero, Jean-Marc; Dissanayake, Ravi; Dhakal, Maheshwar; Hughes, Jane; Debnath, Nitish			Surveillance of Influenza A Virus and Its Subtypes in Migratory Wild Birds of Nepal	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; INFECTION; H5N1; PREVALENCE; PATTERNS; A(H7N9); DUCKS	Nepal boarders India and China and all three countries lie within the Central Asian Flyway for migratory birds. Novel influenza A H7N9 caused human fatalities in China in 2013. Sub-clinical infections of influenza A H7N9 in birds and the potential for virus dispersal by migratory birds prompted this study to assess avian H7N9 viral intrusion into Nepal. Surveillance of influenza A virus in migratory birds was implemented in early 2014 with assistance from the Food and Agricultural Organization (FAO). Of 1811 environmental fecal samples collected from seven wetland migratory bird roosting areas, influenza A H9N2 was found in one sample from a ruddy shelduck in Koshi Tappu Wildlife Reserve located in southern Nepal. Avian H7N9 and other highly pathogenic avian influenza viruses were not detected. This study provides baseline data on the status of avian influenza virus in migratory bird populations in Nepal.	[Karmacharya, Dibesh; Manandhar, Sulochana; Sharma, Ajay; Bhatta, Tarka; Adhikari, Pratikshya; Sherchan, Adarsh Man; Shrestha, Bishwo; Bista, Manisha; Rajbhandari, Rajesh] Ctr Mol Dynam Nepal, Kathmandu, Nepal; [Oberoi, Mohinder; Bisht, Khadak; Dissanayake, Ravi; Debnath, Nitish] Food & Agr Org, Kathmandu, Nepal; [Hero, Jean-Marc; Hughes, Jane] Griffith Univ, Sch Environm, Nathan, Qld 4111, Australia; [Dhakal, Maheshwar] Dept Natl Pk & Wildlife Conservat, Kathmandu, Nepal	Food & Agriculture Organization of the United Nations (FAO); Griffith University	Karmacharya, D (corresponding author), Ctr Mol Dynam Nepal, Thapathali 11, Kathmandu, Nepal.	dibesh@cmdn.org	hughes, jane m/C-5321-2008; Karmacharya, Dibesh/GVU-4782-2022	Karmacharya, Dibesh/0000-0001-5093-6737; Dissanayake, Ravi Bandara/0000-0001-8059-9436	USAID through FAO under H7N9 AIV surveillance program	USAID through FAO under H7N9 AIV surveillance program(United States Agency for International Development (USAID))	This study was funded by USAID through FAO under H7N9 AIV surveillance program.	AAHL (Australian Animal Health Laboratory), 2004, MAN NUCL AC DET DIS; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; [Anonymous], 2013, MOL DIAGN CSIRO AN F; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Cui LB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4142; DeLiberto TJ, 2009, INTEGR ZOOL, V4, P426, DOI 10.1111/j.1749-4877.2009.00180.x; Fereidouni SR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-43; Gaidet N, 2007, EMERG INFECT DIS, V13, P626, DOI 10.3201/eid1304.061011; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Huang YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081842; Inskipp C, 1991, GUIDE BIRDS NEPAL; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; Karki S, 2014, ZOONOSES PUBLIC HLTH, V61, P442, DOI 10.1111/zph.12097; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Leung YHC, 2007, EMERG INFECT DIS, V13, P1380, DOI 10.3201/eid1309.070517; Liu D, 2014, LANCET, V383, P869, DOI 10.1016/S0140-6736(14)60386-X; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Marinova-Petkova A, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.11; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Newman SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030636; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Olson SH, 2013, EMERG INFECT DIS, V19, P2031, DOI 10.3201/eid1912.130649; Parry J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2568; Sergeant ESG, 2015, EPITOOLS SURVEY TOOL; Spackman E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-190; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; Takekawa JY, 2013, VIRUSES-BASEL, V5, P2129, DOI 10.3390/v5092129; Tsukamoto K, 2008, J CLIN MICROBIOL, V46, P3048, DOI 10.1128/JCM.02386-07; Vijaykrishna D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000161; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Wang GH, 2008, J GEN VIROL, V89, P697, DOI 10.1099/vir.0.83419-0; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1976, J GEN VIROL, V32, P217, DOI 10.1099/0022-1317-32-2-217; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Whitworth D., 2007, WILD BIRDS AVIAN INF; World Health Organization, CUM NUMB CONF HUM CA; World Health Organization, 2006, GUIDE FOR FIELD OPER; World Organization for Animal Health, UPD HIGHL PATH AV IN; Wu AP, 2013, CELL HOST MICROBE, V14, P446, DOI 10.1016/j.chom.2013.09.001; Zhao BH, 2014, EMERG INFECT DIS, V20, P850, DOI 10.3201/eid2005.131707	43	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133035	10.1371/journal.pone.0133035	http://dx.doi.org/10.1371/journal.pone.0133035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176773	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600204
J	Khandkar, C; Harrington, Z; Jelfs, PJ; Sintchenko, V; Dobler, CC				Khandkar, Chinmay; Harrington, Zinta; Jelfs, Peter J.; Sintchenko, Vitali; Dobler, Claudia C.			Epidemiology of Peripheral Lymph Node Tuberculosis and Genotyping of M. tuberculosis Strains: A Case-Control Study	PLOS ONE			English	Article							EXTRA-PULMONARY TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; SEX-DIFFERENCES; MIRU-VNTRPLUS; DISEASE; LYMPHADENITIS; DIAGNOSIS; LINEAGES; RISK	Background This study examined potential risk factors of lymph node tuberculosis (LNTB), including phylogenetic lineages of Mycobacterium tuberculosis (MTB), in comparison to pulmonary tuberculosis (PTB) in a setting with an ethnically diverse population. Methods We conducted a case-control study at a major tuberculosis clinic in Sydney, Australia, which included all patients with peripheral LNTB seen at the clinic between 2000 and 2012. Controls were randomly selected patients with PTB seen at the same clinic during the study period. Epidemiological data were extracted from the hospital electronic database and medical records. Associations between LNTB and age, sex, ethnicity, comorbidities and phylogenetic lineages of MTB in comparison to PTB were examined using logistic regression in univariate and multivariate analyses. Results There were 212 cases with LNTB and 424 randomly selected controls with PTB. Among patients with LNTB, 74% were female and the mean age (standard deviation, SD) was 42 (16) years. Among patients with PTB, 43% were female and the mean age was 44 (22) years. Females, 45 to 64-year-olds and Southern Asians had an increased risk for LNTB (OR 3.13, 95% CI 2.10-4.67; OR 2.50, 95% CI 1.29-4.84; OR 3.95, 95% CI 1.54-10.12 respectively). Patients with diabetes were at a higher risk of PTB (OR 0.40, 95% CI 0.19-0.83 for LNTB). A subset analysis showed that patients infected with the East African Indian strain of MTB were more likely to develop LNTB (OR 10.07, 95% CI 2.37-42.77). Conclusions An increased risk for LNTB (but still lower rates than for PTB) was found among females, people aged 45 to 64 years and people born in Southern Asia. An increased risk for PTB was found among patients with diabetes. The East African Indian strain of MTB was significantly associated with a higher likelihood of LNTB compared to other MTB strains.	[Khandkar, Chinmay; Harrington, Zinta; Dobler, Claudia C.] Univ New S Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia; [Jelfs, Peter J.; Sintchenko, Vitali] Westmead Hosp, NSW Mycobacterium Reference Lab, Ctr Infect Dis & Microbiol Lab Serv, Inst Clin Pathol & Med Res, Sydney, NSW, Australia; [Sintchenko, Vitali] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney	Khandkar, C (corresponding author), Univ New S Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia.	chinmay.khandkar@gmail.com		Dobler, Claudia/0000-0002-5460-0189; Sintchenko, Vitali/0000-0002-9261-3650				Al-Otaibi F, 2010, INDIAN J PATHOL MICR, V53, P227, DOI 10.4103/0377-4929.64327; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; [Anonymous], 2003, KEKKAKU TUBERCULOSIS, V78, P717; BAREJA C, 2011, COMMUNICABLE DIS INT, V38, P356; Chan-Yeung M, 2002, INT J TUBERC LUNG D, V6, P11; CHEN YM, 1992, TUBERCLE LUNG DIS, V73, P368, DOI 10.1016/0962-8479(92)90042-I; Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788; Dale JW, 2005, J MED MICROBIOL, V54, P575, DOI 10.1099/jmm.0.45959-0; Fader T, 2010, INT J INFECT DIS, V14, pE102, DOI 10.1016/j.ijid.2009.03.023; Fanning A, 1999, CAN MED ASSOC J, V160, P1597; FARER LS, 1979, AM J EPIDEMIOL, V109, P205, DOI 10.1093/oxfordjournals.aje.a112675; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Geldmacher H, 2002, CHEST, V121, P1177, DOI 10.1378/chest.121.4.1177; Golden MP, 2005, AM FAM PHYSICIAN, V72, P1751; HOPEWELL P C, 1991, Kekkaku, V66, P433; Khan AH, 2010, PHARM PRACTICE, V1, P7; Lari N, 2009, CLIN MICROBIOL INFEC, V15, P538, DOI 10.1111/j.1469-0691.2009.02712.x; Leeds IL, 2012, CLIN INFECT DIS, V55, P75, DOI 10.1093/cid/cis303; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Lin JN, 2009, INT J TUBERC LUNG D, V13, P620; Lowbridge Chris, 2013, N S W Public Health Bull, V24, P3, DOI 10.1071/NB12115; MOUDGIL H, 1994, RESP MED, V88, P507, DOI 10.1016/S0954-6111(05)80332-4; NSW Ministry of Health, 2012, COMMUNICABLE DIS INT, V36, P286; Ong A, 2004, CLIN INFECT DIS, V38, P25, DOI 10.1086/380448; PANG SC, 1992, TUBERCLE LUNG DIS, V73, P362, DOI 10.1016/0962-8479(92)90041-H; Pareek M, 2013, THORAX, V68, P221, DOI 10.1136/thoraxjnl-2012-201824; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Polesky A, 2005, MEDICINE, V84, P350, DOI 10.1097/01.md.0000189090.52626.7a; Sankar MM, 2013, TUBERCULOSIS, V93, P75, DOI 10.1016/j.tube.2012.10.005; Sharma SK, 2004, INDIAN J MED RES, V120, P316; Sreeramareddy CT, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-8; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Temple SEL, 2008, CELL IMMUNOL, V251, P69, DOI 10.1016/j.cellimm.2008.04.013; Torgersen J, 2006, CLIN INFECT DIS, V42, P1375, DOI 10.1086/503421; United Nations Statisical Division, 2003, COMP MACR GEOGR CONT; Watkins RE, 2006, EPIDEMIOL INFECT, V134, P333, DOI 10.1017/S0950268805005042; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Young F, 2012, J EPIDEMIOL COMMUN H, V66, P519, DOI 10.1136/jech.2010.114595; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	40	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132400	10.1371/journal.pone.0132400	http://dx.doi.org/10.1371/journal.pone.0132400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177546	Green Submitted, gold, Green Published			2022-12-27	WOS:000358197600109
J	Nerandzic, MM; Sunkesula, VCK; Sankar, CT; Setlow, P; Donskey, CJ				Nerandzic, Michelle M.; Sunkesula, Venkata C. K.; Sankar, Thriveen C.; Setlow, Peter; Donskey, Curtis J.			Unlocking the Sporicidal Potential of Ethanol: Induced Sporicidal Activity of Ethanol against Clostridium difficile and Bacillus Spores under Altered Physical and Chemical Conditions	PLOS ONE			English	Article							HAND HYGIENE; ASYMPTOMATIC CARRIERS; AGENTS; DISINFECTANTS; RESISTANCE; INFECTION; OUTBREAK; EFFICACY; REMOVAL; SOAP	Background Due to their efficacy and convenience, alcohol-based hand sanitizers have been widely adopted as the primary method of hand hygiene in healthcare settings. However, alcohols lack activity against bacterial spores produced by pathogens such as Clostridium difficile and Bacillus anthracis. We hypothesized that sporicidal activity could be induced in alcohols through alteration of physical or chemical conditions that have been shown to degrade or allow penetration of spore coats. Principal Findings Acidification, alkalinization, and heating of ethanol induced rapid sporicidal activity against C. difficile, and to a lesser extent Bacillus thuringiensis and Bacillus subtilis. The sporicidal activity of acidified ethanol was enhanced by increasing ionic strength and mild elevations in temperature. On skin, sporicidal ethanol formulations were as effective as soap and water hand washing in reducing levels of C. difficile spores. Conclusions These findings demonstrate that novel ethanol-based sporicidal hand hygiene formulations can be developed through alteration of physical and chemical conditions.	[Nerandzic, Michelle M.; Sunkesula, Venkata C. K.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA; [Sunkesula, Venkata C. K.; Sankar, Thriveen C.; Donskey, Curtis J.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Setlow, Peter] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT USA; [Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH USA	Case Western Reserve University; University of Connecticut; Geriatric Research Education & Clinical Center	Nerandzic, MM (corresponding author), Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA.	michellenerandzi@aim.com			Merit Review Grant from the Department of Veterans Affairs; Veterans Affairs [I01BX002944] Funding Source: NIH RePORTER	Merit Review Grant from the Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This study was funded by a Merit Review Grant from the Department of Veterans Affairs awarded to Curtis Donskey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Testing and Materials, 2012, E289712 AM SOC TEST; American Society for Testing and Materials, 2010, E227610 AM SOC TEST; Blaak J, 2011, J COSMETICS DERMATOL, V1, P50, DOI [10.4236/jcdsa.2011.13009, DOI 10.4236/JCDSA.2011.13009]; Boyce JM, 2002, INFECT CONT HOSP EP, V23, pS3, DOI 10.1086/503164; Cubin HK, 1929, BIOCHEM J, V23, P25, DOI 10.1042/bj0230025; Curry SR, 2013, CLIN INFECT DIS, V57, P1094, DOI 10.1093/cid/cit475; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; Edmonds SL, 2013, INFECT CONT HOSP EP, V34, P302, DOI 10.1086/669521; Girou E, 2002, BRIT MED J, V325, P362, DOI 10.1136/bmj.325.7360.362; GORMAN SP, 1987, J APPL BACTERIOL, V63, P183, DOI 10.1111/j.1365-2672.1987.tb02701.x; GOULD GW, 1963, J GEN MICROBIOL, V33, P413, DOI 10.1099/00221287-33-3-413; Hilburn J, 2003, AM J INFECT CONTROL, V31, P109, DOI 10.1067/mic.2003.15; ISSAHARY G, 1970, J BACTERIOL, V101, P418, DOI 10.1128/JB.101.2.418-422.1970; JONES DS, 1995, INT J PHARM, V119, P247, DOI 10.1016/0378-5173(94)00409-X; Kampf G, 2004, CLIN MICROBIOL REV, V17, P863, DOI 10.1128/CMR.17.4.863-893.2004; Kundrapu S, 2014, INFECT CONT HOSP EP, V35, P204, DOI 10.1086/674859; Lambers H., 2006, International Journal of Cosmetic Science, V28, P359, DOI 10.1111/j.1467-2494.2006.00344.x; Leggett MJ, 2012, J APPL MICROBIOL, V113, P485, DOI 10.1111/j.1365-2672.2012.05336.x; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; MACHEBOEUF M, 1953, B SOC CHIM BIOL, V35, P399; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Muto CA, 2007, CLIN INFECT DIS, V45, P1266, DOI 10.1086/522654; Nerandzic MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123809; Nerandzic MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068706; Nerandzic MM, 2009, J CLIN MICROBIOL, V47, P397, DOI 10.1128/JCM.01591-08; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Oughton MT, 2009, INFECT CONT HOSP EP, V30, P939, DOI 10.1086/605322; Paredes-Sabja D, 2014, TRENDS MICROBIOL, V22, P406, DOI 10.1016/j.tim.2014.04.003; Permpoonpattana P, 2013, J BACTERIOL, V195, P1492, DOI 10.1128/JB.02104-12; Poxton IR, 2001, CLIN MICROBIOL INFEC, V7, P421, DOI 10.1046/j.1198-743x.2001.00287.x; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Roberts D, 2014, MOL PHARMACEUT, V11, P2475, DOI 10.1021/mp5002334; Rodriguez-Palacios A, 2011, APPL ENVIRON MICROB, V77, P3085, DOI 10.1128/AEM.01589-10; Russell AD, 1999, J HOSP INFECT, V43, pS57, DOI 10.1016/S0195-6701(99)90066-X; Schmidt FC, 1955, BACTERIOL P, V40; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; STEERE AC, 1975, ANN INTERN MED, V83, P683, DOI 10.7326/0003-4819-83-5-683; Voss A, 1997, INFECT CONT HOSP EP, V18, P205; Weber DJ, 2003, JAMA-J AM MED ASSOC, V289, P1274, DOI 10.1001/jama.289.10.1274	40	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132805	10.1371/journal.pone.0132805	http://dx.doi.org/10.1371/journal.pone.0132805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177038	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600162
J	Pagano, S; Gaertner, H; Cerini, F; Mannic, T; Satta, N; Teixeira, PC; Cutler, P; Mach, F; Vuilleumier, N; Hartley, O				Pagano, Sabrina; Gaertner, Hubert; Cerini, Fabrice; Mannic, Tiphaine; Satta, Nathalie; Teixeira, Priscila Camillo; Cutler, Paul; Mach, Francois; Vuilleumier, Nicolas; Hartley, Oliver			The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?	PLOS ONE			English	Article							SOLID-PHASE SYNTHESIS; A-1 AUTOANTIBODIES; RHEUMATOID-ARTHRITIS; IGG; ANTIBODIES; RISK; CHOLESTEROL; EVENTS	Background Cardiovascular disease (CVD) is the leading cause of death worldwide and new approaches for both diagnosis and treatment are required. Autoantibodies directed against apolipoprotein A-I (ApoA-I) represent promising biomarkers for use in risk stratification of CVD and may also play a direct role in pathogenesis. Methodology To characterize the anti-ApoA-I autoantibody response, we measured the immunoreactivity to engineered peptides corresponding to the different alpha-helical regions of ApoA-I, using plasma from acute chest pain cohort patients known to be positive for anti-ApoA-I autoantibodies. Principal Findings Our results indicate that the anti-ApoA-I autoantibody response is strongly biased towards the C-terminal alpha-helix of the protein, with an optimized mimetic peptide corresponding to this part of the protein recapitulating the diagnostic accuracy for an acute ischemic coronary etiology (non-ST segment elevation myocardial infarction and unstable angina) obtainable using intact endogenous ApoA-I in immunoassay. Furthermore, the optimized mimetic peptide strongly inhibits the pathology-associated capacity of anti-ApoA-I antibodies to elicit proinflammatory cytokine release from cultured human macrophages. Conclusions In addition to providing a rationale for the development of new approaches for the diagnosis and therapy of CVD, our observations may contribute to the elucidation of how anti-ApoA-I autoantibodies are elicited in individuals without autoimmune disease.	[Pagano, Sabrina; Mannic, Tiphaine; Satta, Nathalie; Vuilleumier, Nicolas] Univ Geneva, Dept Human Prot Sci, Fac Med, Geneva, Switzerland; [Pagano, Sabrina; Mannic, Tiphaine; Satta, Nathalie; Vuilleumier, Nicolas] Univ Hosp Geneva, Dept Genet & Lab Med, Div Lab Med, Geneva, Switzerland; [Gaertner, Hubert; Cerini, Fabrice; Hartley, Oliver] Univ Geneva, Dept Pathol & Immunol, Fac Med, Geneva, Switzerland; [Teixeira, Priscila Camillo; Cutler, Paul] F Hoffmann La Roche, Pharmaceut Sci Pharma Res & Early Dev, Basel, Switzerland; [Mach, Francois] Univ Geneva, Div Cardiol, Fdn Med Res, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; Roche Holding; University of Geneva	Vuilleumier, N (corresponding author), Univ Geneva, Dept Human Prot Sci, Fac Med, Geneva, Switzerland.	Nicolas.Vuilleumier@hcuge.ch; Oliver.Hartley@unige.ch		, Nicolas/0000-0002-1122-438X; Camillo Teixeira, Priscila/0000-0002-9698-4563	Swiss National Science Foundation [310030_140736]; Leenaards Foundation [3698]; deReuters foundation [566]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leenaards Foundation; deReuters foundation	This work was supported by Swiss National Science Foundation Grants #310030_140736 to NV, by grants from the Leenaards Foundation no. 3698 to NV and OH, and from the deReuters foundation no. 566 to NV. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. F. Hoffmann-La Roche played an indirect role in the form of salaries for authors PC and PT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103; Ames PRJ, 2010, LUPUS, V19, P711, DOI 10.1177/0961203309357765; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Batuca JR, 2007, ANN NY ACAD SCI, V1108, P137, DOI 10.1196/annals.1422.016; Bloedon LT, 2008, J LIPID RES, V49, P1344, DOI 10.1194/jlr.P800003-JLR200; Cunningham MW, 2012, CURR OPIN RHEUMATOL, V24, P408, DOI 10.1097/BOR.0b013e32835461d3; Davidson WS, 2007, J BIOL CHEM, V282, P22249, DOI 10.1074/jbc.R700014200; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dinu AR, 1998, LUPUS, V7, P355, DOI 10.1191/096120398678920262; Eyre H, 2004, CIRCULATION, V109, P3244, DOI 10.1161/01.CIR.0000133321.00456.00; Finckh A, 2012, ARTHRIT CARE RES, V64, P817, DOI 10.1002/acr.21631; Hafiane A, 2014, CURR OPIN ENDOCRINOL, V21, P134, DOI 10.1097/MED.0000000000000049; Henchey LK, 2008, CURR OPIN CHEM BIOL, V12, P692, DOI 10.1016/j.cbpa.2008.08.019; KATES SA, 1993, TETRAHEDRON LETT, V34, P1549, DOI 10.1016/0040-4039(93)85003-F; Keller PF, 2012, J INTERN MED, V271, P451, DOI 10.1111/j.1365-2796.2011.02479.x; Krauel K, 2011, BLOOD, V117, P1370, DOI 10.1182/blood-2010-08-301424; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; McManus DD, 2011, AM J MED, V124, P40, DOI 10.1016/j.amjmed.2010.07.023; Montecucco F, 2011, EUR HEART J, V32, P412, DOI 10.1093/eurheartj/ehq521; Naghavi M, 2006, AM J CARDIOL, V98, p2H, DOI 10.1016/j.amjcard.2006.03.002; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Pagano S, 2012, J INTERN MED, V272, P344, DOI 10.1111/j.1365-2796.2012.02530.x; Patgiri A, 2010, NAT PROTOC, V5, P1857, DOI 10.1038/nprot.2010.146; Rossier MF, 2012, ENDOCRINOLOGY, V153, P1269, DOI 10.1210/en.2011-1835; Roux-Lombard P, 2013, CLIN REV ALLERG IMMU, V44, P84, DOI 10.1007/s12016-010-8233-z; Srivastava R, 2011, ARTHRITIS RHEUM-US, V63, P201, DOI 10.1002/art.27764; Taylor JW, 2002, BIOPOLYMERS, V66, P49, DOI 10.1002/bip.10203; Teixeira PC, 2014, J BIOL CHEM, V289, P28249, DOI 10.1074/jbc.M114.589002; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Vuilleumier N, 2010, SCAND J RHEUMATOL, V39, P447, DOI 10.3109/03009741003742755; Vuilleumier N, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13781; Vuilleumier N, 2013, THROMB HAEMOSTASIS, V109, P706, DOI 10.1160/TH12-10-0714; Vuilleumier N, 2010, ARTHRITIS RHEUM-US, V62, P2640, DOI 10.1002/art.27546; Vuilleumier N, 2010, EUR HEART J, V31, P815, DOI 10.1093/eurheartj/ehq055; Watson CE, 2011, J LIPID RES, V52, P361, DOI 10.1194/jlr.M011098; Wick PA, 2013, J PERIODONTAL RES, V48, P350, DOI 10.1111/jre.12014; Yuki N, 2001, Lancet Infect Dis, V1, P29	37	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132780	10.1371/journal.pone.0132780	http://dx.doi.org/10.1371/journal.pone.0132780			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177543	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600154
J	Thijs, T; Broos, K; Soenen, SJ; Vandenbulcke, A; Vanhoorelbeke, K; Deckmyn, H; Salles-Crawley, II				Thijs, Tim; Broos, Katleen; Soenen, Stefaan J.; Vandenbulcke, Aline; Vanhoorelbeke, Karen; Deckmyn, Hans; Salles-Crawley, Isabelle I.			Artificial MiRNA Knockdown of Platelet Glycoprotein Ib alpha: A Tool for Platelet Gene Silencing	PLOS ONE			English	Article							BERNARD-SOULIER-SYNDROME; SHORT HAIRPIN RNA; MAMMALIAN-CELLS; IN-VIVO; GPIB-ALPHA; EXPRESSION; MICRORNA; MODEL; INTERFERENCE; SHRNA	In recent years, candidate genes and proteins implicated in platelet function have been identified by various genomic approaches. To elucidate their exact role, we aimed to develop a method to apply miRNA interference in platelet progenitor cells by using GPIb alpha as a proof-of-concept target protein. After in silico and in vitro screening of siRNAs targeting GPIba (siGPIBAs), we developed artificial miRNAs (miGPIBAs), which were tested in CHO cells stably expressing GPIb-IX complex and megakaryoblastic DAMI cells. Introduction of siGPIBAs in CHO GPIb-IX cells resulted in 44 to 75% and up to 80% knockdown of GPIba expression using single or combined siRNAs, respectively. Conversion of siGPIBAs to miGPIBAs resulted in reduced silencing efficiency, which could however be circumvented by tandem integration of two hairpins targeting different regions of GPIBA mRNA where 72% GPIba knockdown was achieved. CHO GPIb-IX cells transfected with the miG-PIBA construct displayed a significant decrease in their ability to aggregate characterized by lower aggregate numbers and size compared to control CHO GPIb-IX cells. More importantly, we successfully silenced GPIba in differentiating megakaryoblastic DAMI cells that exhibited morphological changes associated with actin organization. In conclusion, we here report the successful use of miRNA technology to silence a platelet protein in megakaryoblastic cells and demonstrate its usefulness in functional assays. Hence, we believe that artificial miRNAs are suitable tools to unravel the role of a protein of interest in stem cells, megakaryocytes and platelets, thereby expanding their application to novel fields of basic and translational research.	[Thijs, Tim; Broos, Katleen; Vandenbulcke, Aline; Vanhoorelbeke, Karen; Deckmyn, Hans; Salles-Crawley, Isabelle I.] KU Leuven Kulak, Lab Thrombosis Res, Interdisciplinary Res Facil Life Sci, Kortrijk, Belgium; [Soenen, Stefaan J.] Katholieke Univ Leuven, Dept Imaging & Technol, Biomed MRI, Leuven, Belgium; [Salles-Crawley, Isabelle I.] Univ London Imperial Coll Sci Technol & Med, Ctr Haematol, London, England	KU Leuven; KU Leuven; Imperial College London	Salles-Crawley, II (corresponding author), KU Leuven Kulak, Lab Thrombosis Res, Interdisciplinary Res Facil Life Sci, Kortrijk, Belgium.	i.salles@imperial.ac.uk	Deckmyn, Hans/N-8932-2019; Soenen, Stefaan J/D-7370-2014; Salles, Isabelle/O-1375-2019; Soenen, Stefaan/GLR-3797-2022; Deckmyn, Hans/L-9434-2015	Deckmyn, Hans/0000-0003-3952-5501; Soenen, Stefaan J/0000-0003-2390-3133; Salles, Isabelle/0000-0001-7394-0587; Deckmyn, Hans/0000-0003-3952-5501	Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie; Katholieke Universiteit Leuven [GOA09/829, CIF-2]; Fonds voorWetenschappelijk Onderzoek [G.0564.08]; European Union 6th Framework Programme [LSHM-CT-2004-503485]; British Heart Foundation [FS/10/004/28165]; British Heart Foundation [PG/14/90/31219] Funding Source: researchfish	Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie; Katholieke Universiteit Leuven(KU Leuven); Fonds voorWetenschappelijk Onderzoek(FWO); European Union 6th Framework Programme(European Commission); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by the Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie (http://www.iwt.be/) to TT, Katholieke Universiteit Leuven (www.kuleuven.be/), GOA09/829 and CIF-2 to HD, Fonds voorWetenschappelijk Onderzoek (http://www.fwo.be/), G. 0564.08 to HD, European Union 6th Framework Programme, LSHM-CT-2004-503485 to HD, and British Heart Foundation (https://www.bhf.org.uk/), FS/10/004/28165 to IS-C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola M, 2009, MOL THER, V17, P1039, DOI 10.1038/mt.2009.48; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Boden D, 2004, NUCLEIC ACIDS RES, V32, P1154, DOI 10.1093/nar/gkh278; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Burkhart JM, 2014, CIRC RES, V114, P1204, DOI 10.1161/CIRCRESAHA.114.301598; Cauwenberghs N, 2001, BLOOD, V98, P652, DOI 10.1182/blood.V98.3.652; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; DONG JF, 1995, BLOOD, V86, P4175, DOI 10.1182/blood.V86.11.4175.bloodjournal86114175; Falet H, 2010, J EXP MED, V207, P1967, DOI 10.1084/jem.20100222; Gras C, 2013, HUM GENE THER, V24, P1018, DOI 10.1089/hum.2013.074; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hong W, 2011, CTS-CLIN TRANSL SCI, V4, P180, DOI 10.1111/j.1752-8062.2011.00279.x; Kanaji T, 2012, BLOOD, V119, P2906, DOI 10.1182/blood-2011-08-376566; Kauskot A, 2013, BLOOD, V121, P5208, DOI 10.1182/blood-2012-10-462887; LOPEZ JA, 1994, BLOOD COAGUL FIBRIN, V5, P479; Lopez JA, 1998, BLOOD, V91, P4397, DOI 10.1182/blood.V91.12.4397.412k42_4397_4418; Lordier L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1704; Ma HM, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.27; Maczuga P, 2013, MOL THER, V21, P217, DOI 10.1038/mt.2012.160; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Mittal V, 2004, NAT REV GENET, V5, P355, DOI 10.1038/nrg1323; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; Ohmori T, 2007, ARTERIOSCL THROM VAS, V27, P2266, DOI 10.1161/ATVBAHA.107.149872; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Perrault C, 1999, BLOOD, V94, P4186, DOI 10.1182/blood.V94.12.4186.424k24_4186_4194; Poujol CR, 2002, EXP HEMATOL, V30, P352, DOI 10.1016/S0301-472X(02)00774-9; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Saito H, 1997, BAILLIERE CLIN HAEM, V10, P47, DOI 10.1016/S0950-3536(97)80050-9; Sakata A, 2014, THROMB J, V12, DOI 10.1186/1477-9560-12-1; Scherr Michaela, 2009, V506, P207, DOI 10.1007/978-1-59745-409-4_15; Shan ZX, 2010, MOL BIOL REP, V37, P1831, DOI 10.1007/s11033-009-9618-z; Snyder LL, 2008, ANTIVIR RES, V80, P36, DOI 10.1016/j.antiviral.2008.04.001; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Sun DQ, 2006, BIOTECHNIQUES, V41, P59, DOI 10.2144/000112203; Thijs T, 2012, BLOOD, V119, P1634, DOI 10.1182/blood-2011-10-381715; Ware J, 2000, P NATL ACAD SCI USA, V97, P2803, DOI 10.1073/pnas.050582097; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Wu Junzhu, 2009, V487, P205, DOI 10.1007/978-1-60327-547-7_10; Zufferey A, 2011, THROMB HAEMOSTASIS, V106, P466, DOI 10.1160/TH11-04-0226	42	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132899	10.1371/journal.pone.0132899	http://dx.doi.org/10.1371/journal.pone.0132899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176854	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000358197600175
J	Tsukamoto, K; Ozeki, C; Kohda, T; Tsuji, T				Tsukamoto, Kentaro; Ozeki, Chikako; Kohda, Tomoko; Tsuji, Takao			CRISPR/Cas9-Mediated Genomic Deletion of the Beta-1, 4 N-acetylgalactosaminyltransferase 1 Gene in Murine P19 Embryonal Carcinoma Cells Results in Low Sensitivity to Botulinum Neurotoxin Type C	PLOS ONE			English	Article							BIOLOGICAL-ACTIVITY; PROTEIN-RECEPTOR; GANGLIOSIDE; ENTRY; BINDING; SV2	Botulinum neurotoxins produced by Clostridium botulinum cause flaccid paralysis by inhibiting neurotransmitter release at peripheral nerve terminals. Previously, we found that neurons derived from the murine P19 embryonal carcinoma cell line exhibited high sensitivity to botulinum neurotoxin type C. In order to prove the utility of P19 cells for the study of the intracellular mechanism of botulinum neurotoxins, ganglioside-knockout neurons were generated by deletion of the gene encoding beta-1,4 N-acetylgalactosaminyltransferase 1 in P19 cells using the clustered regularly interspaced short palindromic repeats combined with Cas9 (CRISPR/Cas9) system. By using this system, knockout cells could be generated more easily than with previous methods. The sensitivity of the generated beta-1,4 N-acetylgalactosaminyltransferase 1-depleted P19 neurons to botulinum neurotoxin type C was decreased considerably, and the exogenous addition of the gangliosides GD1a, GD1b, and GT1b restored the susceptibility of P19 cells to botulinum neurotoxin type C. In particular, addition of a mixture of these three ganglioside more effectively recovered the sensitivity of knockout cells compared to independent addition of GD1a, GD1b, or GT1b. Consequently, the genome-edited P19 cells generated by the CRISPR/Cas9 system were useful for identifying and defining the intracellular molecules involved in the toxic action of botulinum neurotoxins.	[Tsukamoto, Kentaro; Ozeki, Chikako; Tsuji, Takao] Fujita Hlth Univ, Sch Med, Dept Microbiol, Toyoake, Aichi 47011, Japan; [Kohda, Tomoko] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Vet Sci, Osaka, Japan	Fujita Health University; Osaka Metropolitan University	Tsukamoto, K (corresponding author), Fujita Hlth Univ, Sch Med, Dept Microbiol, Toyoake, Aichi 47011, Japan.	tsuka-k@fujita-hu.ac.jp	Tsukamoto, Kentaro/AFQ-2771-2022	Tsukamoto, Kentaro/0000-0002-9254-4632	Japan Society for the Promotion of Science (JSPS) KAKENHI [15K08476]; grant of Strategic Research Foundation Grant-aided Project for Private Universities from Ministry of Education, Culture, Sport, Science, and Technology, Japan [S1001035]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); grant of Strategic Research Foundation Grant-aided Project for Private Universities from Ministry of Education, Culture, Sport, Science, and Technology, Japan	This study was supported by by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS) KAKENHI (15K08476 for KT), and a grant of Strategic Research Foundation Grant-aided Project for Private Universities from Ministry of Education, Culture, Sport, Science, and Technology, Japan (S1001035 for TT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binz T, 2009, J NEUROCHEM, V109, P1584, DOI 10.1111/j.1471-4159.2009.06093.x; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2007, J CELL BIOL, V179, P1511, DOI 10.1083/jcb.200707184; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Foran P, 1986, BIOCHEMISTRY-US, V35, P2630; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karalewitz APA, 2012, J BIOL CHEM, V287, P40806, DOI 10.1074/jbc.M112.404244; Kozaki S, 1998, MICROB PATHOGENESIS, V25, P91, DOI 10.1006/mpat.1998.0214; KURAZONO H, 1985, FEMS MICROBIOL LETT, V30, P47; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; Nakamura K, 2012, INFECT IMMUN, V80, P2886, DOI 10.1128/IAI.00302-12; Nakamura K, 2010, VET MICROBIOL, V140, P147, DOI 10.1016/j.vetmic.2009.07.023; NISHIKI T, 1994, J BIOL CHEM, V269, P10498; Peng LS, 2012, J CELL SCI, V125, P3233, DOI 10.1242/jcs.103564; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; SIMPSON LL, 1986, ANNU REV PHARMACOL, V26, P427, DOI 10.1146/annurev.pa.26.040186.002235; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Strotmeier J, 2011, MOL MICROBIOL, V81, P143, DOI 10.1111/j.1365-2958.2011.07682.x; Tsukamoto K, 2005, J BIOL CHEM, V280, P35164, DOI 10.1074/jbc.M507596200; Tsukamoto K, 2012, MICROBIOL IMMUNOL, V56, P664, DOI 10.1111/j.1348-0421.2012.00490.x	25	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132363	10.1371/journal.pone.0132363	http://dx.doi.org/10.1371/journal.pone.0132363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177297	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600105
J	Vesk, PA; Robinson, D; van der Ree, R; Wilson, CM; Saywell, S; McCarthy, MA				Vesk, Peter A.; Robinson, Doug; van der Ree, Rodney; Wilson, Caroline M.; Saywell, Shirley; McCarthy, Michael A.			Demographic Effects of Habitat Restoration for the Grey-Crowned Babbler Pomatostomus temporalis, in Victoria, Australia	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEME; WOODLAND BIRDS; POPULATION-STRUCTURE; FARMLAND BIRDS; REVEGETATION; BIODIVERSITY; VEGETATION; LANDSCAPE; ATTRIBUTES; MANAGEMENT	Background Considerable resources are spent on habitat restoration across the globe to counter the impacts of habitat loss and degradation on wildlife populations. But, because of time and resourcing constraints on many conservation programs, the effectiveness of these habitat restoration programs in achieving their long-termgoals of improving the population viability of particular wildlife species is rarely assessed and many restoration programs cannot demonstrate their effectiveness. Without such demonstration, and in particular demonstrating the causal relationships between habitat restoration actions and demographic responses of the target species, investments in restoration to achieve population outcomes are of uncertain value. Approach Here, we describe an approach that builds on population data collected for a threatened Australian bird - the Grey-crowned Babbler Pomatostomus temporalis - to evaluate how effectively targeted habitat restoration work improves its viability. We built upon an extensive historical survey by conducting surveys 13 years later at 117 sites stratified by presence/absence of restoration works and by detection or not of birds in the first survey. Our performance metric was the number of individuals in a social group, which is both a measure of local abundance and directly related to breeding success. We employed an occupancy model to estimate the response of Grey-crowned Babbler social group size to the effects of time, restoration works, local habitat as measured by the density of large trees, and distance to the nearest other known group of babblers. Results and implications Babbler group size decreased over the survey period at sites without restoration works, but restoration works were effective in stemming declines where they were done. Restoration was responsible for a difference of about one bird per group of 3-5 individuals; this is an important effect on the reproductive success of the social group. Effectiveness of restoration works targeted at the Grey-crowned Babbler was only demonstrable by sampling through time and including control sites without restoration works. This work demonstrates that while calls for better monitoring of restoration are valid, scope exists to recover a signal of effectiveness from opportunistic retrospective analyses.	[Vesk, Peter A.; McCarthy, Michael A.] Univ Melbourne, Sch Biosci, Australian Res Council Ctr Excellence Environm De, Parkville, Vic 3052, Australia; [Robinson, Doug] Trust Nat, Melbourne, Vic, Australia; [van der Ree, Rodney; Wilson, Caroline M.] Univ Melbourne, Sch Biosci, Australian Res Ctr Urban Ecol, Parkville, Vic 3052, Australia; [Saywell, Shirley] Friends Grey Crowned Babbler, Euroa, Vic, Australia	University of Melbourne; University of Melbourne	Vesk, PA (corresponding author), Univ Melbourne, Sch Biosci, Australian Res Council Ctr Excellence Environm De, Parkville, Vic 3052, Australia.	pvesk@unimelb.edu.au	Vesk, Peter/AAG-9970-2020; McCarthy, Michael/O-5655-2014	Vesk, Peter/0000-0003-2008-7062; McCarthy, Michael/0000-0003-1039-7980	Norman Wettenhall Foundation; Goulburn Broken Catchment Management Authority; Baker Foundation; Australian Centre of Excellence in Environmental Decisions from the Australian Research Council; Australian Research Council	Norman Wettenhall Foundation; Goulburn Broken Catchment Management Authority; Baker Foundation; Australian Centre of Excellence in Environmental Decisions from the Australian Research Council(Australian Research Council); Australian Research Council(Australian Research Council)	The authors acknowledge funding from The Norman Wettenhall Foundation (http://nwf.org.au/), the Goulburn Broken Catchment Management Authority (http://www.gbcma.vic.gov.au/), The Baker Foundation and the Australian Centre of Excellence in Environmental Decisions (http://ceed.edu.au/) from the Australian Research Council (http://www.arc.gov.au/). MAM was supported by an Australian Research Council Future Fellowship (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ANAO, 1997, 36199697 ANAO; Ausden M, 2002, BIOL CONSERV, V106, P279, DOI 10.1016/S0006-3207(01)00254-3; Australian National Audit Office (ANAO), 2008, 21200708 ANAO; Barrett GW, 2008, WILDLIFE RES, V35, P19, DOI 10.1071/WR07100; Barrett G.W., 2003, NEW ATLAS AUSTR BIRD; Bennett A. F, 2003, LINKAGES LANDSCAPE R, DOI DOI 10.2305/IUCN.CH.2004.FR.1.EN; Bennett AF, 2011, EMU, V111, pI, DOI 10.1071/MUv111n1_ED; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Blackmore CJ, 2007, J ZOOL, V273, P326, DOI 10.1111/j.1469-7998.2007.00332.x; Blakers M., 1984, ATLAS AUSTR BIRDS; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Brown J.L., 1981, P244; BROWN JL, 1978, BEHAV ECOL SOCIOBIOL, V4, P43, DOI 10.1007/BF00302560; BROWN JL, 1983, BEHAV ECOL SOCIOBIOL, V13, P115, DOI 10.1007/BF00293801; BROWN JL, 1977, CONDOR, V79, P312, DOI 10.2307/1368008; Cale P., 1999, THESIS U NEW ENGLAND; Cale PG, 2003, BIOL CONSERV, V109, P237, DOI 10.1016/S0006-3207(02)00152-0; Chandler RB, 2011, ECOLOGY, V92, P1429, DOI 10.1890/10-2433.1; Cristofoli S, 2010, ECOL INDIC, V10, P773, DOI 10.1016/j.ecolind.2009.11.013; Cunningham RB, 2008, CONSERV BIOL, V22, P742, DOI 10.1111/j.1523-1739.2008.00924.x; Davidson I, 1992, COMMUNICATION; DOW DD, 1984, EMU, V84, P193, DOI 10.1071/MU9840193; Duncan DH, 2013, ECOL APPL, V23, P1277, DOI 10.1890/12-1670.1; Emison W., 1987, ATLAS VICTORIAN BIRD; Ford HA, 2011, EMU, V111, P1, DOI 10.1071/MU09115; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Grice P, 2004, IBIS, V146, P239, DOI 10.1111/j.1474-919X.2004.00359.x; Hajkowicz S, 2009, LAND USE POLICY, V26, P471, DOI 10.1016/j.landusepol.2008.06.004; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Higgins P.J., 2002, HDB AUSTR NZ ANTARCT; Hobbs Richard J., 2003, Ecological Management & Restoration, V4, pS2, DOI 10.1046/j.1442-8903.4.s.10.x; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; KING BR, 1980, EMU, V80, P59, DOI 10.1071/MU9800059; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Lindenmayer DB, 2010, BIOL CONSERV, V143, P289, DOI 10.1016/j.biocon.2009.10.010; Lindenmayer D, 2012, BIOL CONSERV, V152, P62, DOI 10.1016/j.biocon.2012.02.026; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P285, DOI 10.1111/j.1442-9993.2011.02314.x; Munro Nicola T., 2007, Ecological Management & Restoration, V8, P199, DOI 10.1111/j.1442-8903.2007.00368.x; Patten MA, 1997, RESTOR ECOL, V5, P156, DOI 10.1046/j.1526-100X.1997.09718.x; Peach WJ, 2001, BIOL CONSERV, V101, P361, DOI 10.1016/S0006-3207(01)00083-0; Plummer M., 2003, P 3 INT WORKSH DISTR; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Robinson D, 2008, STATE AUSTR BIRDS 20, P37; Robinson D, 1996, WINGSPAN S, V10, P16; ROBINSON D, 1994, RES PLAN THREATENED; Robinson Doug, 2006, Ecological Management & Restoration, V7, P93, DOI 10.1111/j.1442-8903.2006.00263.x; Robinson D, 2012, BIODIVERSITY MONITORING IN AUSTRALIA, P141; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2006, J AGR BIOL ENVIR ST, V11, P249, DOI 10.1198/108571106X129153; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Saunders DA, 1995, CONSERVING BIODIVERSITY: THREATS AND SOLUTIONS, P104; Selwood K, 2009, OECOLOGIA, V159, P435, DOI 10.1007/s00442-008-1221-9; Su Y.-S., 2009, R PACKAGE R2JAGS PAC; van der Ree R, 2003, J ZOOL, V259, P327, DOI 10.1017/S0952836902003229; van der Ree R, 2008, EFFECTS TRAFFIC OCCU; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Vesk PA, 2006, AGR ECOSYST ENVIRON, V112, P356, DOI 10.1016/j.agee.2005.08.038; Vesk PA, 2008, BIOL CONSERV, V141, P174, DOI 10.1016/j.biocon.2007.09.010; Walker KJ, 2004, BIOL CONSERV, V119, P1, DOI 10.1016/j.biocon.2003.10.020; Yen JDL, 2011, ECOGRAPHY, V34, P946, DOI 10.1111/j.1600-0587.2011.06651.x	60	7	7	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130153	10.1371/journal.pone.0130153	http://dx.doi.org/10.1371/journal.pone.0130153			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177497	Green Published, gold			2022-12-27	WOS:000358197600018
J	Warrier, V; Chakrabarti, B; Murphy, L; Chan, A; Craig, I; Mallya, U; Lakatosova, S; Rehnstrom, K; Peltonen, L; Wheelwright, S; Allison, C; Fisher, SE; Baron-Cohen, S				Warrier, Varun; Chakrabarti, Bhismadev; Murphy, Laura; Chan, Allen; Craig, Ian; Mallya, Uma; Lakatosova, Silvia; Rehnstrom, Karola; Peltonen, Leena; Wheelwright, Sally; Allison, Carrie; Fisher, Simon E.; Baron-Cohen, Simon			A Pooled Genome-Wide Association Study of Asperger Syndrome	PLOS ONE			English	Article							AUTISM; DNA; MICROARRAYS; RISK; LOCI; IDENTIFICATION; IMPAIRMENT; OVERLAP; SAMPLES; SNPS	Asperger Syndrome (AS) is a neurodevelopmental condition characterized by impairments in social interaction and communication, alongside the presence of unusually repetitive, restricted interests and stereotyped behaviour. Individuals with AS have no delay in cognitive and language development. It is a subset of Autism Spectrum Conditions (ASC), which are highly heritable and has a population prevalence of approximately 1%. Few studies have investigated the genetic basis of AS. To address this gap in the literature, we performed a genome-wide pooled DNA association study to identify candidate loci in 612 individuals (294 cases and 318 controls) of Caucasian ancestry, using the Affymetrix GeneChip Human Mapping version 6.0 array. We identified 11 SNPs that had a p-value below 1x10(-5). These SNPs were independently genotyped in the same sample. Three of the SNPs (rs1268055, rs7785891 and rs2782448) were nominally significant, though none remained significant after Bonferroni correction. Two of our top three SNPs (rs7785891 and rs2782448) lie in loci previously implicated in ASC. However, investigation of the three SNPs in the ASC genome-wide association dataset from the Psychiatric Genomics Consortium indicated that these three SNPs were not significantly associated with ASC. The effect sizes of the variants were modest, indicating that our study was not sufficiently powered to identify causal variants with precision.	[Warrier, Varun; Chakrabarti, Bhismadev; Murphy, Laura; Chan, Allen; Mallya, Uma; Lakatosova, Silvia; Wheelwright, Sally; Allison, Carrie; Baron-Cohen, Simon] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Chakrabarti, Bhismadev] Univ Reading, Ctr Integrat Neurosci & Neurodynam, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Craig, Ian] Kings Coll London, Inst Psychiat, MRC Ctr Social Genet & Dev Psychiat, London WC2R 2LS, England; [Rehnstrom, Karola; Peltonen, Leena] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Fisher, Simon E.] Max Planck Inst Psycholinguist, NL-6500 AH Nijmegen, Netherlands; [Fisher, Simon E.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Baron-Cohen, Simon] Cambridgeshire & Peterborough NHS Fdn Trust CPFT, CLASS Clin, Cambridge, England	University of Cambridge; University of Reading; University of London; King's College London; Wellcome Trust Sanger Institute; Max Planck Society; Radboud University Nijmegen	Warrier, V (corresponding author), Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England.	vw260@medschl.cam.ac.uk; sb205@cam.ac.uk	Fisher, Simon E./E-9130-2012; Craig, Ian/AAF-9167-2019	Fisher, Simon E./0000-0002-3132-1996; Chakrabarti, Bhismadev/0000-0002-6649-7895; Murphy, Laura/0000-0003-0029-0434; Warrier, Varun/0000-0003-4532-8571; Wheelwright, Sally/0000-0003-0657-2483; Baron-Cohen, Simon/0000-0001-9217-2544	Nancy Lurie Marks Family Foundation; Medical Research Council (MRC) UK; Target Autism Genome; Autism Research Trust (ART); Max Planck Society; St. John's College, Cambridge; Cambridge Commonwealth Trust	Nancy Lurie Marks Family Foundation; Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Target Autism Genome; Autism Research Trust (ART); Max Planck Society(Max Planck SocietyFoundation CELLEX); St. John's College, Cambridge; Cambridge Commonwealth Trust	This work was funded by grants to SB-C from the Nancy Lurie Marks Family Foundation, the Medical Research Council (MRC) UK, Target Autism Genome, and the Autism Research Trust (ART). LM and SEF were supported by the Max Planck Society. VW is funded by St. John's College, Cambridge and the Cambridge Commonwealth Trust.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], CEREB CORTEX; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Barratt BJ, 2002, ANN HUM GENET, V66, P393, DOI [10.1046/j.1469-1809.2002.00125.x, 10.1017/S0003480002001252]; Bartlett CW, 2004, HUM HERED, V57, P10, DOI 10.1159/000077385; Bartlett CW, 2002, AM J HUM GENET, V71, P45, DOI 10.1086/341095; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Butcher LM, 2004, BEHAV GENET, V34, P549, DOI 10.1023/B:BEGE.0000038493.26202.d3; Butcher LM, 2005, HUM MOL GENET, V14, P1315, DOI 10.1093/hmg/ddi142; Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80; Chelala C, 2009, BIOINFORMATICS, V25, P655, DOI 10.1093/bioinformatics/btn653; Davis OSP, 2009, BIOINFORMATICS, V25, P281, DOI 10.1093/bioinformatics/btn587; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Lai M-C, 2013, LANCET, V13, P61539; Maestrini E, 2010, MOL PSYCHIATR, V15, P954, DOI 10.1038/mp.2009.34; Mbadiwe Tafari, 2013, Autism Res Treat, V2013, P826156, DOI 10.1155/2013/826156; Meaburn EL, 2008, MOL PSYCHIATR, V13, P729, DOI 10.1038/sj.mp.4002063; Pagnamenta AT, 2010, BIOL PSYCHIAT, V68, P320, DOI 10.1016/j.biopsych.2010.02.002; Persico AM, 2013, BEHAV BRAIN RES, V251, P95, DOI 10.1016/j.bbr.2013.06.012; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Samaco RC, 2005, HUM MOL GENET, V14, P483, DOI 10.1093/hmg/ddi045; Schosser Alexandra, 2010, BMC Res Notes, V3, P274, DOI 10.1186/1756-0500-3-274; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Szelinger S, 2011, METHODS MOL BIOL, V700, P49, DOI 10.1007/978-1-61737-954-3_4; Talebizadeh Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067569; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917	30	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131202	10.1371/journal.pone.0131202	http://dx.doi.org/10.1371/journal.pone.0131202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176695	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000358197600038
J	Bargagna-Mohan, P; Lei, L; Thompson, A; Shaw, C; Kasahara, K; Inagaki, M; Mohan, R				Bargagna-Mohan, Paola; Lei, Ling; Thompson, Alexis; Shaw, Camille; Kasahara, Kousuke; Inagaki, Masaki; Mohan, Royce			Vimentin Phosphorylation Underlies Myofibroblast Sensitivity to Withaferin A In Vitro and during Corneal Fibrosis	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEIN; UBIQUITIN-PROTEASOME PATHWAY; LIVING CELLS; KINASE; ADHESION; FIBROBLASTS; ACTIVATION; BHK-21-CELLS; MECHANISMS; DEFICIENT	Vimentin is a newly recognized target for corneal fibrosis. Using primary rabbit corneal fibroblasts and myofibroblasts we show that myofibroblasts, unlike fibroblasts, display impaired cell spreading and cell polarization, which is associated with increased levels of soluble serine-38 phosphorylated vimentin (pSer38Vim). This pSer38Vim isoform is inefficiently incorporated into growing vimentin intermediate filaments (IFs) of myofibroblasts during cell spreading, and as a result, myofibroblasts maintain higher soluble pSer38Vim levels compared to fibroblasts. Moreover, the soluble vimentin-targeting small molecule and fibrotic inhibitor withaferin A (WFA) causes a potent blockade of cell spreading selectively in myofibroblasts by targeting soluble pSer38Vim for hyperphosphorylation. WFA treatment does not induce vimentin hyperphosphorylation in fibroblasts. This hyperphosphorylated pSer38Vim species in WFA-treated myofibroblasts becomes complexed with adaptor protein filamin A (FlnA), and these complexes appear as short squiggles when displaced from focal adhesions. The extracellular-signal regulated kinase (ERK) is also phosphorylated (pERK) in response to WFA, but surprisingly, pERK does not enter the nucleus but remains bound to pSer38Vim in cytoplasmic complexes. Using a model of corneal alkali injury, we show that fibrotic corneas of wild type mice possess high levels of pERK, whereas injured corneas of vimentin-deficient (Vim KO) mice that heal with reduced fibrosis have highly reduced pERK expression. Finally, WFA treatment causes a decrease in pERK and pSer38Vim expression in healing corneas of wild type mice. Taken together, these findings identify a hereto-unappreciated role for pSer38Vim as an important determinant of myofibroblast sensitivity to WFA.	[Bargagna-Mohan, Paola; Lei, Ling; Thompson, Alexis; Shaw, Camille; Mohan, Royce] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA; [Kasahara, Kousuke; Inagaki, Masaki] Aichi Canc Ctr, Res Inst, Div Biochem, Nagoya, Aichi 464, Japan	University of Connecticut; Aichi Cancer Center	Mohan, R (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA.	mohan@uchc.edu	Inagaki, Masaki/B-9920-2016		National Eye Institute [EY016782]; National Institutes of Health [EY016782]; University of Connecticut Foundation, John A. and Linda Florence Solomon Endowed Chair funds; NATIONAL EYE INSTITUTE [R01EY016782] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25460089] Funding Source: KAKEN	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Connecticut Foundation, John A. and Linda Florence Solomon Endowed Chair funds; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Eye Institute, National Institutes of Health grant EY016782 (https://www.nei.nih.gov/), and the University of Connecticut Foundation (www.foundation.uconn.edu/), John A. and Linda Florence Solomon Endowed Chair funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bargagna-Mohan P, 2006, INVEST OPHTH VIS SCI, V47, P4138, DOI 10.1167/iovs.05-1452; Bargagna-Mohan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063881; Bargagna-Mohan P, 2012, J BIOL CHEM, V287, P989, DOI 10.1074/jbc.M111.297150; Baum M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5494; Bhattacharya R, 2009, J CELL SCI, V122, P1390, DOI 10.1242/jcs.043042; Chou YH, 1996, J CELL SCI, V109, P817; Chou YH, 2007, EXP CELL RES, V313, P2236, DOI 10.1016/j.yexcr.2007.04.008; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Gladilin E, 2014, J BIOMECH, V47, P2598, DOI 10.1016/j.jbiomech.2014.05.020; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Gregor M, 2014, FASEB J, V28, P715, DOI 10.1096/fj.13-231829; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Havel LS, 2014, ONCOGENE; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Helfand BT, 2004, J CELL SCI, V117, P133, DOI 10.1242/jcs.00936; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hyder C, 2014, THESIS ABO AKAD U; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; Jester JV, 2002, EXP EYE RES, V75, P645, DOI 10.1006/exer.2002.2066; Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kim H, 2010, AM J PHYSIOL-CELL PH, V298, pC221, DOI 10.1152/ajpcell.00323.2009; Kim KB, 2013, NAT PROD REP, V30, P600, DOI 10.1039/c3np20126k; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Lynch CD, 2013, MOL BIOL CELL, V24, P21, DOI 10.1091/mbc.E12-05-0377; Mahammad S, 2013, J CLIN INVEST, V123, P1964, DOI 10.1172/JCI66387; Masur SK, 1999, INVEST OPHTH VIS SCI, V40, P904; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Menko AS, 2014, MOL BIOL CELL, V25, P776, DOI 10.1091/mbc.E12-12-0900; Middeldorp J, 2009, FASEB J, V23, P2710, DOI 10.1096/fj.08-127696; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perlson E, 2006, J MOL BIOL, V364, P938, DOI 10.1016/j.jmb.2006.09.056; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; RonnovJessen L, 1996, J CELL BIOL, V134, P67, DOI 10.1083/jcb.134.1.67; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929; Stramer BM, 2001, INVEST OPHTH VIS SCI, V42, P1698; Takai Y, 1996, J CELL BIOL, V133, P141, DOI 10.1083/jcb.133.1.141; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Toda M, 2012, J BIOL CHEM, V287, P24516, DOI 10.1074/jbc.M111.319624; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; VIKSTROM KL, 1989, P NATL ACAD SCI USA, V86, P549, DOI 10.1073/pnas.86.2.549; WESTMAYS JA, 1995, P NATL ACAD SCI USA, V92, P6768, DOI 10.1073/pnas.92.15.6768; Wong VW, 2012, NAT MED, V18, P148, DOI 10.1038/nm.2574	56	18	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133399	10.1371/journal.pone.0133399	http://dx.doi.org/10.1371/journal.pone.0133399			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186445	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700132
J	Hitier, M; Hamon, M; Denise, P; Lacoudre, J; Thenint, MA; Mallet, JF; Moreau, S; Quarck, G				Hitier, Martin; Hamon, Michele; Denise, Pierre; Lacoudre, Julien; Thenint, Marie-Aude; Mallet, Jean-Francois; Moreau, Sylvain; Quarck, Gaelle			Lateral Semicircular Canal Asymmetry in Idiopathic Scoliosis: An Early Link between Biomechanical, Hormonal and Neurosensory Theories?	PLOS ONE			English	Article							REFERENT BONE TURNOVER; OTIC CAPSULE; VESTIBULAR NUCLEI; CRITICAL PERIOD; HORSERADISH-PEROXIDASE; AFFERENT-PROJECTIONS; VERTEBRAL ROTATION; ADOLESCENT GIRLS; EARLY EXPERIENCE; NEURON ACTIVITY	Introduction Despite its high incidence and severe morbidity, the physiopathogenesis of adolescent idiopathic scoliosis (AIS) is still unknown. Here, we looked for early anomalies in AIS which are likely to be the cause of spinal deformity and could also be targeted by early treatments. We focused on the vestibular system, which is suspected of acting in AIS pathogenesis and which exhibits an end organ with size and shape fixed before birth. We hypothesize that, in adolescents with idiopathic scoliosis, vestibular morphological anomalies were already present at birth and could possibly have caused other abnormalities. Materials and Methods The vestibular organ of 18 adolescents with AIS and 9 controls were evaluated with MRI in a prospective case controlled study. We studied lateral semicircular canal orientation and the three semicircular canal positions relative to the midline. Lateral semicircular canal function was also evaluated by vestibulonystagmography after bithermal caloric stimulation. Results The left lateral semicircular canal was more vertical and further from the midline in AIS (p = 0.01) and these two parameters were highly correlated (r = -0.6; p = 0.02). These morphological anomalies were associated with functional anomalies in AIS (lower excitability, higher canal paresis), but were not significantly different from controls (p>0.05). Conclusion Adolescents with idiopathic scoliosis exhibit morphological vestibular asymmetry, probably determined well before birth. Since the vestibular system influences the vestibulospinal pathway, the hypothalamus, and the cerebellum, this indicates that the vestibular system is a possible cause of later morphological, hormonal and neurosensory anomalies observed in AIS. Moreover, the simple lateral SCC MRI measurement demonstrated here could be used for early detection of AIS, selection of children for close follow-up, and initiation of preventive treatment before spinal deformity occurs.	[Hitier, Martin; Lacoudre, Julien; Moreau, Sylvain] CHU Caen, Dept Otolaryngol Head & Neck Surg, F-14000 Caen, France; [Hitier, Martin; Moreau, Sylvain] UNICAEN, Dept Anat, F-14032 Caen, France; [Hitier, Martin] Univ Otago, Sch Med Sci, Dept Pharmacol & Toxicol, Dunedin, New Zealand; [Hitier, Martin] Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand; [Hitier, Martin; Denise, Pierre; Quarck, Gaelle] INSERM, U COMETE 1075, F-14032 Caen, France; [Hamon, Michele; Thenint, Marie-Aude] CHU Caen, Dept Neuroradiol, F-14000 Caen, France; [Mallet, Jean-Francois] CHU Caen, Dept Paediat Surg, F-14000 Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; University of Otago; University of Otago; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Hitier, M (corresponding author), CHU Caen, Dept Otolaryngol Head & Neck Surg, F-14000 Caen, France.	mart1_hit@yahoo.fr	Denise, Pierre/E-2174-2011; Quarck, Gaelle/O-1247-2015	Denise, Pierre/0000-0002-9049-7692; Hitier, Martin/0000-0002-1323-133X	Marie Curie International Research Staff Exchange Scheme Fellowship within the 7th European Community Framework Program [918980]; Emergence Program Basse-Normandie Region [11P03919/11P03921]	Marie Curie International Research Staff Exchange Scheme Fellowship within the 7th European Community Framework Program; Emergence Program Basse-Normandie Region(Region Normandie)	This research was supported by a Marie Curie International Research Staff Exchange Scheme Fellowship within the 7th European Community Framework Program #918980, and Emergence Program (No 11P03919/11P03921) Basse-Normandie Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaf F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2508; Angelaki DE, 2010, CEREBELLUM, V9, P174, DOI 10.1007/s12311-009-0147-z; Asher MA, 2006, SCOLIOSIS SPINAL DIS, V1, DOI 10.1186/1748-7161-1-2; Assaiante C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040646; Bast TH, 1930, OSSIFICATION OF THE; Bast TH, 1949, THE TEMPORAL BONE AN; Best C, 2014, BRAIN STRUCT FUNCT, V219, P2141, DOI 10.1007/s00429-013-0628-1; BLANKS RHI, 1983, EXP BRAIN RES, V52, P293; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; British Society of Audiology, 2010, RECOMMENDED PROCEDUR; BRODAL A, 1985, EXP BRAIN RES, V58, P62; Burwell RG, 2006, STUD HEALTH TECHNOL, V123, P72; Burwell RG, 2006, ST HEAL T, V123, P57; Burwell RG, 2006, ST HEAL T, V123, P66; Burwell RG, 2009, STUD HEALTH TECHNOL, V135, P3; Burwell RG, 2009, SCOLIOSIS SPINAL DIS, V4, DOI 10.1186/1748-7161-4-24; BYL NN, 1993, J ORTHOP RES, V11, P215, DOI 10.1002/jor.1100110209; CARLETON SC, 1984, BRAIN RES, V294, P281, DOI 10.1016/0006-8993(84)91040-0; Cheng JC, 2001, SPINE, V26, pC1; Cheng JCY, 1999, SPINE, V24, P1218, DOI 10.1097/00007632-199906150-00008; Cheng JCY, 2000, J BONE MINER RES, V15, P1587, DOI 10.1359/jbmr.2000.15.8.1587; Cheng JCY, 1997, SPINE, V22, P1716, DOI 10.1097/00007632-199708010-00006; Chettier R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117708; Cook JS, 2010, J APPL PHYSIOL, V109, P1697, DOI 10.1152/japplphysiol.00698.2010; Cox PG, 2007, J MORPHOL, V268, P878, DOI 10.1002/jmor.10559; Curthoys IS, 2012, LARYNGOSCOPE, V122, P1342, DOI 10.1002/lary.23258; Curthoys IS, 2000, CURR OPIN NEUROL, V13, P27, DOI 10.1097/00019052-200002000-00006; Dahm MC, 2009, ACTA OTO-LARYNGOL, V113, P4; Dalleau G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036755; DE GEORGE FRANCES V., 1967, J MED GENET, V4, P251, DOI 10.1136/jmg.4.4.251; Denise P, 2009, Aviakosm Ekolog Med, V43, P36; DEWAELE C, 1989, EXP BRAIN RES, V77, P166, DOI 10.1007/BF00250579; Dieterich M, 2003, CEREB CORTEX, V13, P994, DOI 10.1093/cercor/13.9.994; Eugene D, 2009, ANN NY ACAD SCI, V1164, P180, DOI 10.1111/j.1749-6632.2008.03727.x; Fraschini F, 1999, BIOL SIGNAL RECEPT, V8, P111; Frisch T, 1998, BONE, V22, P677, DOI 10.1016/S8756-3282(98)00050-7; Frisch T, 2000, ANN OTO RHINOL LARYN, V109, P33, DOI 10.1177/000348940010900106; Frisch T, 2015, ACTA OTO-LARYNGOL, V135, P771, DOI 10.3109/00016489.2015.1035400; GEISSELE AE, 1991, SPINE, V16, P761; Girardo M, 2011, EUR SPINE J, V20, P68, DOI 10.1007/s00586-011-1750-5; Goldberg C J, 1993, Eur Spine J, V2, P29, DOI 10.1007/BF00301052; HALLPIKE C S, 1956, J Laryngol Otol, V70, P15, DOI 10.1017/S0022215100052610; Hensch TK, 2005, CURR TOP DEV BIOL, V69, P215, DOI 10.1016/S0070-2153(05)69008-4; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Hublin JJ, 1996, NATURE, V381, P224, DOI 10.1038/381224a0; Jansen M, 1912, BRIT MED J, V1912, P1372; Janssen MMA, 2011, SPINE, V36, pE486, DOI 10.1097/BRS.0b013e3181f468cc; Jeffery N, 2004, J ANAT, V204, P71, DOI 10.1111/j.1469-7580.2004.00250.x; JONGKEES L B, 1962, Pract Otorhinolaryngol (Basel), V24, P65; KANE WJ, 1977, CLIN ORTHOP RELAT R, P43; KATAFUCHI T, 1987, BRAIN RES, V400, P62, DOI 10.1016/0006-8993(87)90653-6; Keuroghlian AS, 2007, PROG NEUROBIOL, V82, P109, DOI 10.1016/j.pneurobio.2007.03.005; KORTE GE, 1979, J COMP NEUROL, V184, P265, DOI 10.1002/cne.901840204; KOTCHABHAKDI N, 1978, EXP BRAIN RES, V31, P591; Kou I, 2013, NAT GENET, V45, P676, DOI 10.1038/ng.2639; Kouwenhoven JWM, 2007, SPINE, V32, P2545, DOI 10.1097/BRS.0b013e318158cd86; Kouwenhoven JWM, 2006, SPINE, V31, P1467, DOI 10.1097/01.brs.0000219938.14686.b3; Kouwenhoven JWM, 2008, SPINE, V33, P2898, DOI 10.1097/BRS.0b013e3181891751; Lambert FM, 2009, J NEUROSCI, V29, P12477, DOI 10.1523/JNEUROSCI.2583-09.2009; Liu TM, 2008, J MAGN RESON IMAGING, V27, P732, DOI 10.1002/jmri.21321; Londono D, 2014, J MED GENET, V51, P401, DOI 10.1136/jmedgenet-2013-102067; Lowe TG, 2000, J BONE JOINT SURG AM, V82A, P1157, DOI 10.2106/00004623-200008000-00014; Mazzucchelli C, 1996, MOL BRAIN RES, V39, P117, DOI 10.1016/0169-328X(96)00017-4; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Miyake A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072802; Moorman SJ, 2002, DEV DYNAM, V223, P285, DOI 10.1002/dvdy.10052; Moreau A, 2004, SPINE, V29, P1772, DOI 10.1097/01.BRS.0000134567.52303.1A; Naganuma H, 2003, ANN OTO RHINOL LARYN, V112, P419, DOI 10.1177/000348940311200506; Nemzek WR, 1996, AM J NEURORADIOL, V17, P1467; NORMELLI H, 1985, SPINE, V10, P590, DOI 10.1097/00007632-198507000-00015; Pietkiewicz P, 2012, INT J OCCUP MED ENV, V25, P59, DOI [10.2478/s13382-012-0002-1, 10.2478/S13382-012-0002-1]; Podda MV, 2003, NEUROSCI LETT, V341, P209, DOI 10.1016/S0304-3940(03)00209-X; Qiu Y, 2007, SPINE, V32, P2703, DOI 10.1097/BRS.0b013e31815a59e5; Reamy BV, 2001, AM FAM PHYSICIAN, V64, P111; Richards BS, 2003, SPINE, V28, P1148, DOI 10.1097/00007632-200306010-00012; Risold PY, 1997, BRAIN RES REV, V24, P197, DOI 10.1016/S0165-0173(97)00007-6; Sato T, 1902, VERGLEICHENDE UNTERS; Schlosser TPC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097461; Sharma S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7452; Shi L, 2009, AM J NEURORADIOL, V30, P1302, DOI 10.3174/ajnr.A1577; Shi L, 2006, LECT NOTES COMPUT SC, V4190, P175; Shi L, 2013, SPINE J, V13, P1904, DOI 10.1016/j.spinee.2013.06.045; Shi L, 2011, NEUROIMAGE, V54, pS180, DOI 10.1016/j.neuroimage.2010.04.002; Simoneau M, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-68; Simoneau M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-102; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; SMITH PF, 1989, BRAIN RES REV, V14, P155, DOI 10.1016/0165-0173(89)90013-1; Sorensen M S, 1992, Acta Otolaryngol Suppl, V496, P1; SORENSEN MS, 1990, ACTA OTO-LARYNGOL, V110, P217, DOI 10.3109/00016489009122540; Spoor F, 2002, PORTRAIT ARTIST CHIL, V22, P287; Spoor F, 2002, THE BONY LABYRINTH O, P215; Stankovic KM, 2010, HEARING RES, V265, P83, DOI 10.1016/j.heares.2010.02.006; Takahashi Y, 2011, NAT GENET, V43, P1237, DOI 10.1038/ng.974; Vignaux G, 2013, J BONE MINER RES, V28, P2136, DOI 10.1002/jbmr.1940; WALBERG F, 1988, BRAIN RES, V449, P47, DOI 10.1016/0006-8993(88)91022-0; Wallace MT, 2007, J NEUROPHYSIOL, V97, P921, DOI 10.1152/jn.00497.2006; Wang DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083767; Wang DF, 2012, NEUROIMAGE, V59, P935, DOI 10.1016/j.neuroimage.2011.07.097; Wang WJ, 2011, J PEDIATR ORTHOPED, V31, pS14, DOI 10.1097/BPO.0b013e3181f73c12; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3; Wiener-Vacher SR, 1998, J PEDIATR-US, V132, P1028, DOI 10.1016/S0022-3476(98)70403-2; WORTHINGTON V, 1993, J MANIP PHYSIOL THER, V16, P169; Yates BJ, 2005, J VESTIBUL RES-EQUIL, V15, P119; YATES BJ, 1992, BRAIN RES REV, V17, P51, DOI 10.1016/0165-0173(92)90006-8; Yates BJ, 1996, ANN NY ACAD SCI, V781, P458, DOI 10.1111/j.1749-6632.1996.tb15720.x; Zhou SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059929	107	17	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0131120	10.1371/journal.pone.0131120	http://dx.doi.org/10.1371/journal.pone.0131120			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186348	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700011
J	Zhao, Y; Kong, CC; Wang, YF				Zhao, Yan; Kong, Congcong; Wang, Yunfeng			Multiple Comparison Analysis of Two New Genomic Sequences of ILTV Strains from China with Other Strains from Different Geographic Regions	PLOS ONE			English	Article							INFECTIOUS LARYNGOTRACHEITIS VIRUS; HERPES-SIMPLEX-VIRUS; FRAGMENT-LENGTH-POLYMORPHISM; POLYMERASE-CHAIN-REACTION; HERPESVIRUS-1 SA-2 STRAIN; LIVE ATTENUATED VACCINES; GLYCOPROTEIN-GB GENE; NUCLEOTIDE-SEQUENCE; UNITED-STATES; MOLECULAR-BIOLOGY	To date, twenty complete genome sequences of ILTV strains have been published in GenBank, including one strain from China, and nineteen strains from Australian and the United States. To investigate the genomic information on ILTVs from different geographic regions, two additional individual complete genome sequences of WG and K317 strains from China were determined. The genomes of WG and K317 strains were 153,505 and 153,639 bp in length, respectively. Alignments performed on the amino acid sequences of the twelve glycoproteins showed that 13 out of 116 mutational sites were present only among the Chinese strain WG and the Australian strains SA2 and A20. The phylogenetic tree analysis suggested that the WG strain established close relationships with the Australian strain SA2. The recombination events were detected and confirmed in different subregions of the WG strain with the sequences of SA2 and K317 strains as parental. In this study, two new complete genome sequences of Chinese ILTV strains were used in comparative analysis with other complete genome sequences of ILTV strains from China, the United States, and Australia. The analysis of genome comparison, phylogenetic trees, and recombination events showed close relationships among the Chinese strain WG and the Australian strains SA2. The information of the two new complete genome sequences from China will help to facilitate the analysis of phylogenetic relationships and the molecular differences among ILTV strains from different geographic regions.	[Zhao, Yan; Kong, Congcong; Wang, Yunfeng] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Avian Resp Dis Grp, Harbin, Peoples R China; [Wang, Yunfeng] Natl Engn Res Ctr Vet Biol, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Wang, YF (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Avian Resp Dis Grp, 427 Maduan St, Harbin, Peoples R China.	yfwang@hvri.ac.cn			Basic Scientific Research Operation Cost of State-leveled Public Welfare Scientific Research Courtyard [0302012009]	Basic Scientific Research Operation Cost of State-leveled Public Welfare Scientific Research Courtyard	This work was supported by the Basic Scientific Research Operation Cost of State-leveled Public Welfare Scientific Research Courtyard (0302012009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamiak B, 2010, VIROLOGY, V400, P197, DOI 10.1016/j.virol.2010.01.032; Antal Z, 2004, CURR GENET, V46, P240, DOI 10.1007/s00294-004-0524-6; Bagust TJ, 2000, REV SCI TECH OIE, V19, P483, DOI 10.20506/rst.19.2.1229; Bender FC, 2005, J VIROL, V79, P11588, DOI 10.1128/JVI.79.18.11588-11597.2005; Blacker HP, 2011, AUST VET J, V89, P89, DOI 10.1111/j.1751-0813.2010.00665.x; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Chandra YG, 2012, VIRUS GENES, V44, P470, DOI 10.1007/s11262-012-0728-7; Chang PC, 1997, J VIROL METHODS, V66, P179, DOI 10.1016/S0166-0934(97)00050-5; Chen J, 2013, J VIROL, V87, P3620, DOI 10.1128/JVI.03245-12; Fuchs W, 2005, VIRUS RES, V112, P108, DOI 10.1016/j.virusres.2005.03.002; Fuchs W, 1996, J GEN VIROL, V77, P2221, DOI 10.1099/0022-1317-77-9-2221; Fuchs W, 2000, J GEN VIROL, V81, P627, DOI 10.1099/0022-1317-81-3-627; Fuchs W, 1999, J GEN VIROL, V80, P2173, DOI 10.1099/0022-1317-80-8-2173; Fuchs W, 2007, VET RES, V38, P261, DOI 10.1051/vetres:200657; Garcia M, 2001, AVIAN DIS, V45, P558, DOI 10.2307/1592895; Graham DA, 2000, AVIAN PATHOL, V29, P57, DOI 10.1080/03079450094298; GRIFFIN AM, 1990, NUCLEIC ACIDS RES, V18, P3664, DOI 10.1093/nar/18.12.3664; GRIFFIN AM, 1989, J GEN VIROL, V70, P3085, DOI 10.1099/0022-1317-70-11-3085; GRIFFIN AM, 1990, J GEN VIROL, V71, P841, DOI 10.1099/0022-1317-71-4-841; GRIFFIN AM, 1991, J GEN VIROL, V72, P393, DOI 10.1099/0022-1317-72-2-393; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; IGARASHI K, 1993, J VIROL, V67, P2123, DOI 10.1128/JVI.67.4.2123-2132.1993; JOHNSON MA, 1991, ARCH VIROL, V119, P181, DOI 10.1007/BF01310669; JOHNSON MA, 1995, VIRUS RES, V35, P193, DOI 10.1016/0168-1702(94)00096-U; Johnson MA, 1997, ARCH VIROL, V142, P1903, DOI 10.1007/s007050050209; JOHNSON MA, 1995, DNA SEQUENCE, V5, P191, DOI 10.3109/10425179509029362; JOHNSON MA, 1995, ARCH VIROL, V140, P623, DOI 10.1007/BF01309954; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KEELER CL, 1993, AVIAN DIS, V37, P418, DOI 10.2307/1591668; King AMQ, 2012, 9 INT COMM TAX VIR, V1344; KINGSLEY DH, 1994, VIROLOGY, V203, P336, DOI 10.1006/viro.1994.1492; Kong CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070154; KONGSUWAN K, 1993, VIRUS RES, V29, P125, DOI 10.1016/0168-1702(93)90054-Q; KONGSUWAN K, 1995, ARCH VIROL, V140, P27, DOI 10.1007/BF01309721; KONGSUWAN K, 1993, VIRUS GENES, V7, P297, DOI 10.1007/BF01702590; KONGSUWAN K, 1991, VIROLOGY, V184, P404, DOI 10.1016/0042-6822(91)90859-A; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lee SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055121; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Lee SW, 2011, VACCINE, V29, P9583, DOI 10.1016/j.vaccine.2011.10.055; Lee SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-197; LEIB DA, 1987, ARCH VIROL, V93, P287, DOI 10.1007/BF01310982; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mardberg K, 2004, GLYCOBIOLOGY, V14, P571, DOI 10.1093/glycob/cwh075; Neff C, 2008, AVIAN DIS, V52, P278, DOI 10.1637/8168-110107-Reg.1; Oldoni I, 2008, AVIAN DIS, V52, P59, DOI 10.1637/8054-070607-Reg; Oldoni I, 2007, AVIAN PATHOL, V36, P167, DOI 10.1080/03079450701216654; POLVINOBODNAR M, 1987, J VIROL, V61, P3528, DOI 10.1128/JVI.61.11.3528-3535.1987; POULSEN DJ, 1991, VIRUS GENES, V5, P335, DOI 10.1007/BF00271532; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Spatz SJ, 2012, VIRUS GENES, V44, P273, DOI 10.1007/s11262-011-0696-3; Thureen DR, 2006, J VIROL, V80, P7863, DOI 10.1128/JVI.00134-06; Tittsler RP, 1925, J AM VET MED ASS, V67, P229; Uchida H, 2013, J VIROL, V87, P1430, DOI 10.1128/JVI.02804-12; Wild MA, 1996, VIRUS GENES, V12, P107, DOI 10.1007/BF00572949; Ziemann K, 1998, J VIROL, V72, P847, DOI 10.1128/JVI.72.1.847-852.1998; Ziemann K, 1998, J VIROL, V72, P6867, DOI 10.1128/JVI.72.8.6867-6874.1998	57	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132747	10.1371/journal.pone.0132747	http://dx.doi.org/10.1371/journal.pone.0132747			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186451	gold, Green Submitted, Green Published			2022-12-27	WOS:000358198700060
J	Li, WH; Qiu, Y; Zhang, HQ; Tian, XX; Fang, WG				Li, Wei-Hua; Qiu, Ying; Zhang, Hong-Quan; Tian, Xin-Xia; Fang, Wei-Gang			P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 Pathway	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EXTRACELLULAR ATP; INTERLEUKIN-8; METASTASIS; EXPRESSION; P2Y(2); PHOSPHORYLATION; IDENTIFICATION; SITES	As one member of G protein-coupled P2Y receptors, P2Y2 receptor can be equally activated by extracellular ATP and UTP. Our previous studies have proved that activation of P2Y2 receptor by extracellular ATP could promote prostate cancer cell invasion and metastasis in vitro and in vivo via regulating the expressions of some epithelial-mesenchymal transition/invasion-related genes (including IL-8, E-cadherin, Snail and Claudin-1), and the most significant change in expression of IL-8 was observed after P2Y2 receptor activation. However, the signaling pathway downstream of P2Y2 receptor and the role of IL-8 in P2Y2-mediated prostate cancer cell invasion remain unclear. Here, we found that extracellular ATP/UTP induced activation of EGFR and ERK1/2. After knockdown of P2Y2 receptor, the ATP -stimulated phosphorylation of EGFR and ERK1/2 was significantly suppressed. Further experiments showed that inactivation of EGFR and ERK1/2 attenuated ATP-induced invasion and migration, and suppressed ATP-mediated IL-8 production. In addition, knockdown of IL-8 inhibited ATP-mediated invasion and migration of prostate cancer cells. These findings suggest that P2Y2 receptor and EGFR cooperate to upregulate IL-8 production via ERK1/2 pathway, thereby promoting prostate cancer cell invasion and migration. Thus blocking of the P2Y2-EGFR-ERK1/2 pathway may provide effective therapeutic interventions for prostate cancer.	[Li, Wei-Hua; Qiu, Ying; Zhang, Hong-Quan; Tian, Xin-Xia; Fang, Wei-Gang] Peking Univ, Hlth Sci Ctr, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing 100191, Peoples R China; [Li, Wei-Hua; Qiu, Ying; Tian, Xin-Xia; Fang, Wei-Gang] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100191, Peoples R China; [Zhang, Hong-Quan] Peking Univ, Hlth Sci Ctr, Dept Anat Histol & Embryol, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University	Tian, XX (corresponding author), Peking Univ, Hlth Sci Ctr, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing 100191, Peoples R China.	tianxinxia@163.com; wgfang@bjmu.edu.cn			National Natural Science Foundation of China [81321003]; Ministry of Science and Technology of China [2010CB529402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants to WGF from National Natural Science Foundation of China (81321003) and 973 Program (2010CB529402) from the Ministry of Science and Technology of China.	ALBINI A, 1987, CANCER RES, V47, P3239; Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Bagchi S, 2005, J BIOL CHEM, V280, P39050, DOI 10.1074/jbc.M504819200; Bertagnolo V, 2007, CARCINOGENESIS, V28, P1638, DOI 10.1093/carcin/bgm078; Burnstock G, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.11; Burnstock G, 2011, BJU INT, V107, P192, DOI 10.1111/j.1464-410X.2010.09926.x; Buzzi N, 2009, BBA-GEN SUBJECTS, V1790, P1651, DOI 10.1016/j.bbagen.2009.10.005; Cathomas R, 2012, CLIN CANCER RES, V18, P6049, DOI 10.1158/1078-0432.CCR-12-2219; Chen L, 2004, CANCER LETT, V215, P239, DOI 10.1016/j.canlet.2004.05.023; De Luca A, 2008, J CELL PHYSIOL, V214, P559, DOI 10.1002/jcp.21260; FANG WG, 1992, J CLIN INVEST, V89, P191, DOI 10.1172/JCI115562; Green AR, 1997, INT J CANCER, V72, P937; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Inoue K, 2000, CLIN CANCER RES, V6, P2104; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Lehrer S, 2004, TECHNOL CANCER RES T, V3, P411, DOI 10.1177/153303460400300501; Li WH, 2013, BRIT J CANCER, V109, P1666, DOI 10.1038/bjc.2013.484; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Liu YX, 2001, CHINESE MED J-PEKING, V114, P35; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATSUSHIMA K, 1992, CHEM IMMUNOL, V51, P236; Molliver DC, 2002, EUR J NEUROSCI, V16, P1850, DOI 10.1046/j.1460-9568.2002.02253.x; Norambuena A, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.081166; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Ratchford AM, 2010, J BIOL CHEM, V285, P7545, DOI 10.1074/jbc.M109.078170; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schlomm T, 2007, CLIN CANCER RES, V13, P6579, DOI 10.1158/1078-0432.CCR-07-1257; Bilbao PS, 2010, ARCH BIOCHEM BIOPHYS, V494, P7, DOI 10.1016/j.abb.2009.11.002; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Turner T, 1996, CLIN EXP METASTAS, V14, P409, DOI 10.1007/BF00123400; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; Yokdang N, 2011, BRIT J CANCER, V104, P1628, DOI 10.1038/bjc.2011.134; Zhang Y, 2010, CANCER LETT, V293, P189, DOI 10.1016/j.canlet.2010.01.010	35	27	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133165	10.1371/journal.pone.0133165	http://dx.doi.org/10.1371/journal.pone.0133165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182292	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198200054
J	Buj, I; Caleta, M; Marcic, Z; Sanda, R; Vukic, J; Mrakovcic, M				Buj, Ivana; Caleta, Marko; Marcic, Zoran; Sanda, Radek; Vukic, Jasna; Mrakovcic, Milorad			Different Histories, Different Destinies-Impact of Evolutionary History and Population Genetic Structure on Extinction Risk of the Adriatic Spined Loaches (Genus Cobitis; Cypriniformes, Actinopterygii)	PLOS ONE			English	Article							DINARIDE LAKE SYSTEM; RED LIST CRITERIA; MIDDLE MIOCENE; CONSERVATION; SIZES; DIVERSITY; INFERENCE	The region of Balkans is often considered as an ichthyologic "hot spot", with a great number of species and high portion of endemics living in fresh waters in a relatively small area. The Adriatic watershed in Croatia and Herzegovina is inhabited by six spined loach species (genus Cobitis) whose extinction risk estimations were based solely on their extent of occurrence (and/or area of occupancy) and its fragmentation, and conservation proposals do not consider diversity below species level. In this investigation we employed molecular genetic methods to describe present genetic structure of the Adriatic spined loaches and reveal their demographic history. The divergence of the Adriatic lineages inside the genus Cobitis started in Miocene and lasted until Pleistocene epoch. Geological events responsible for shaping recent diversity of spined loaches in the Adriatic basin are: the Dinarid Mountains upwelling, the evolution of Dinaric Lake system, local tectonic activity, river connections during glaciations and differences in sea level. Even though all the investigated species inhabit karstic rivers located in the same geographic area and that were subject of similar geological events, the results obtained reveal great differences in their genetic diversity and structure and point out the necessity of different conservation measures to ensure their future viability. High level of genetic polymorphism is characteristic for species located more to the south. Two species comprised of more than one population have completely different intraspecific structure; populations of C. illyrica are genetically distinct and represent separate evolutionary significant units, whereas intraspecific structure of C. narentana corresponds to metapopulational pattern. Without population genetic data, evolutionary significant units could be easily misidentified. Furthermore, the obtained results affirm that population genetic measurements are able to detect differences among closely located and related species and estimate extinction risk even more accurately than currently applied IUCN criteria.	[Buj, Ivana; Marcic, Zoran; Mrakovcic, Milorad] Univ Zagreb, Fac Sci, Dept Zool, Zagreb 41000, Croatia; [Caleta, Marko] Univ Zagreb, Fac Teacher Educ, Zagreb 41000, Croatia; [Sanda, Radek] Natl Museum, Prague, Czech Republic; [Vukic, Jasna] Charles Univ Prague, Dept Ecol, Prague, Czech Republic	University of Zagreb; University of Zagreb; National Museum; Charles University Prague	Buj, I (corresponding author), Univ Zagreb, Fac Sci, Dept Zool, Zagreb 41000, Croatia.	ivaradic@biol.pmf.hr	Ćaleta, Marko/AGT-7655-2022; Vukic, Jasna/D-2811-2015	Ćaleta, Marko/0000-0002-4675-556X; Vukic, Jasna/0000-0003-2243-0303	Croatian Ministry of Science, Education and Sport [119-0000000-3184]; Czech Ministry of Culture [DKRVO 2014/14]; Czech Ministry of Culture (National Museum) [00023272]; SYNTHESYS programme project (Museo Nacional de Ciencias Naturales) - European Community [ES-TAF-2061]	Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); Czech Ministry of Culture; Czech Ministry of Culture (National Museum); SYNTHESYS programme project (Museo Nacional de Ciencias Naturales) - European Community	This investigation was supported by the Croatian Ministry of Science, Education and Sport (project no. 119-0000000-3184), the Czech Ministry of Culture (DKRVO 2014/14, National Museum, 00023272) and the SYNTHESYS programme project (ES-TAF-2061 at the Museo Nacional de Ciencias Naturales) financed by European Community Research Infrastructure Action under the FP7 "Capacities" Programme.	Akcakaya HR, 2006, GLOBAL CHANGE BIOL, V12, P2037, DOI 10.1111/j.1365-2486.2006.01253.x; Alfirevic S, 1965, GEOLOGIJA JADRANA; Allendorf F., 2007, CONSERVATION GENETIC; Allendorf F, 2013, CONSERV GENET, V2nd; Baucic I, 1967, CETINA RAZVOJ RELJEF, V6; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 1998, NATO ADV SCI I A-LIF, V306, P39; Beerli Peter, 2009, V17, P42; Bender M. G., 2012, Endangered Species Research, V18, P247, DOI 10.3354/esr00449; Brito D, 2010, BIOL CONSERV, V143, P1154, DOI 10.1016/j.biocon.2010.02.015; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Buj I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099833; Coric S, 2009, GEOL CROAT, V62, P31; Doadrio I, 2005, MOL PHYLOGENET EVOL, V37, P484, DOI 10.1016/j.ympev.2005.07.009; Dov Por Francis, 2009, BioRisk, V3, P5; Feulner PGD, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004966; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Franklin I.R., 1980, CONSERVATION BIOL EV; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Gardenfors U, 2001, CONSERV BIOL, V16, P511; Gilpin M.E., 1986, P19; Harzhauser M, 2008, PALAEOGEOGR PALAEOCL, V260, P417, DOI 10.1016/j.palaeo.2007.12.013; Harzhauser M, 2012, HYDROBIOLOGIA, V682, P27, DOI 10.1007/s10750-011-0618-3; Hidasi-Neto J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073431; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jimenez-Moreno G, 2008, REV PALAEOBOT PALYNO, V152, P237, DOI 10.1016/j.revpalbo.2008.05.005; Li WLS, 2012, MOL BIOL EVOL, V29, P751, DOI 10.1093/molbev/msr232; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Marjanac Lj, 2004, QUATERNARY GLACIATIO; McNeely J. A., 1990, CONSERVING WORLDS BI; Moran P, 2002, ECOL FRESHW FISH, V11, P30, DOI 10.1034/j.1600-0633.2002.110105.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Neubauer TA, 2011, ARCH MOLLUSKENKD, V140, P201, DOI 10.1127/arch.moll/1869-0963/140/201-237; Perdices A, 2001, MOL PHYLOGENET EVOL, V19, P468, DOI 10.1006/mpev.2000.0900; Perdices A, 2008, MOL PHYLOGENET EVOL, V46, P382, DOI 10.1016/j.ympev.2007.05.007; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suric M, 2010, GEOL CROAT, V63, P155, DOI 10.4154/gc.2010.13; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Waples R.S., 1991, MAR FISH REV, V53, P11; Waples RS, 1995, AM FISH S S, V17, P8; Zou JB, 2013, ANN BOT-LONDON, V112, P1829, DOI 10.1093/aob/mct241	51	17	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131580	10.1371/journal.pone.0131580	http://dx.doi.org/10.1371/journal.pone.0131580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176227	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600050
J	Cappelli, J; Garcia, A; Ceacero, F; Gomez, S; Luna, S; Gallego, L; Gambin, P; Landete-Castillejos, T				Cappelli, Jamil; Garcia, Andres; Ceacero, Francisco; Gomez, Santiago; Luna, Salvador; Gallego, Laureano; Gambin, Pablo; Landete-Castillejos, Tomas			Manganese Supplementation in Deer under Balanced Diet Increases Impact Energy and Contents in Minerals of Antler Bone Tissue	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; CHEMICAL-COMPOSITION; PHYSIOLOGICAL EFFORT; GLYCOSAMINOGLYCAN; SILICON; GROWTH; WEIGHT; PLANTS	Bone ash, collagen, Ca and P composition, are considered the main factors affecting mechanical properties in bones. However, a series of studies in bone and antler have shown that some trace minerals, such as manganese, may play a role whose importance exceeds what may be expected considering their low content. A previous study showed that a reduction in manganese in antlers during a year of late winter frosts led to generalized antler breakage in Spain, which included a reduction of 30% of cortical thickness, 27% reduction in impact energy, and 10% reduction in work to peak force. Starting for this observation, we experimentally studied the effects of manganese supplementation in adults and yearling (yearlings) red deer under a balanced diet. Subjects were 29 deer of different age classes (adult n = 19, yearlings n = 10) that were divided in a manganese injected group (n = 14) and a control group (n = 15). Antler content in ashes and minerals, intrinsic mechanical properties and cross section structure were examined at 4 points along the antler beam. A one way ANOVA (mean per antler) showed that in yearlings, manganese supplementation only increased its content and that of Fe. However, in adults, Mn supplementation increased the mean content per antler of Ca, Na, P, B, Co, Cu, K, Mn, Ni, Se (while Si content was reduced), and impact work but not Young's modulus of elasticity, bending strength or work to peak force. A GLM series on characteristics in the uppermost part examined in the antler, often showing physiological exhaustion and depletion of body stores, showed also a 16% increase in work to peak force in the antlers of the treated group. Thus, manganese supplementation altered mineral composition of antler and improved structure and some mechanical properties despite animals having a balanced diet.	[Cappelli, Jamil; Garcia, Andres; Gallego, Laureano; Gambin, Pablo; Landete-Castillejos, Tomas] CSIC UCLM JCCM, IREC Sect Albacete, Anim Sci Tech Appl Wildlife Management Res Grp, Albacete, Spain; [Cappelli, Jamil; Garcia, Andres; Gallego, Laureano; Gambin, Pablo; Landete-Castillejos, Tomas] Univ Castilla La Mancha, IDR, Secc Recursos Cineget & Ganaderos, Albacete, Spain; [Cappelli, Jamil; Garcia, Andres; Gallego, Laureano; Gambin, Pablo; Landete-Castillejos, Tomas] Univ Castilla La Mancha, ETSIAM, Dept Ciencia & Tecnol Agroforestal & Genet, Albacete, Spain; [Ceacero, Francisco] Czech Univ Life Sci, Fac Trop AgriSci, Dept Anim Sci & Food Proc, Prague 6, Suchdol, Czech Republic; [Gomez, Santiago] Univ Cadiz, Dept Anat Patol, Cadiz, Spain; [Luna, Salvador] Univ Cadiz, Dept Enfermeria & Fisioterapia, Cadiz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Czech University of Life Sciences Prague; Universidad de Cadiz; Universidad de Cadiz	Landete-Castillejos, T (corresponding author), CSIC UCLM JCCM, IREC Sect Albacete, Anim Sci Tech Appl Wildlife Management Res Grp, Campus UCLM, Albacete, Spain.	Tomas.Landete@uclm.es	Ceacero, Francisco/C-1088-2009; Gallego, Laureano/G-9715-2015; Cappelli, Jamil/L-8326-2018; Garcia Diaz, Andres Jose/A-9162-2012	Ceacero, Francisco/0000-0001-9014-147X; Luna Galvez, Salvador/0000-0002-4668-1732; Gallego, Laureano/0000-0001-8219-087X; Landete Castillejos, Tomas/0000-0001-9753-5295; Cappelli, Jamil/0000-0001-5746-5835; Garcia Diaz, Andres Jose/0000-0002-4662-2185	Ministerio de Economia y Competitividad, Government of Spain (MINECO) [AGL2012-38898]; Consejeria de Educacion y Deportes de Castilla-La Mancha [PEII-2014-004-P]	Ministerio de Economia y Competitividad, Government of Spain (MINECO); Consejeria de Educacion y Deportes de Castilla-La Mancha	Funding was provided by Ministerio de Economia y Competitividad, Government of Spain (MINECO): Project AGL2012-38898 to TLC, AG, LG, FC, JC; Consejeria de Educacion y Deportes de Castilla-La Mancha: Project PEII-2014-004-P to LG TLC AG.	Bertassoni LE, 2014, J MECH BEHAV BIOMED, V38, P91, DOI 10.1016/j.jmbbm.2014.06.008; BOLZE MS, 1985, J NUTR, V115, P352, DOI 10.1093/jn/115.3.352; Burr DB, 2014, BASIC AND APPLIED BONE BIOLOGY, P3, DOI 10.1016/B978-0-12-416015-6.00001-0; Ceacero F, 2014, J ANIM SCI, V92, P4130, DOI 10.2527/jas.2014-7716; Ceacero F, 2010, PHYSIOL BEHAV, V100, P122, DOI 10.1016/j.physbeh.2010.02.008; Currey JD, 2009, J EXP BIOL, V212, P3985, DOI 10.1242/jeb.032292; Currey J.D., 2002, BONES STRUCTURE MECH; Currey JD, 2004, P ROY SOC B-BIOL SCI, V271, P517, DOI 10.1098/rspb.2003.2634; CURREY JD, 1979, J BIOMECH, V12, P313, DOI 10.1016/0021-9290(79)90073-3; Davison KS, 2006, SEMIN ARTHRITIS RHEU, V36, P22, DOI 10.1016/j.semarthrit.2006.04.002; Estevez JA, 2009, ACTA THERIOL, V54, P235, DOI 10.4098/j.at.0001-7051.070.2008; FORE H, 1952, BIOCHEM J, V51, P598, DOI 10.1042/bj0510598; Gaspar-Lopez E, 2008, EUR J WILDLIFE RES, V54, P1, DOI 10.1007/s10344-007-0096-0; Gomez Notario R, 2002, 50 ANOS HOMOLOGACION; Gomez S, 2013, BONE, V52, P506, DOI 10.1016/j.bone.2012.09.015; HYVARINEN H, 1977, BRIT J NUTR, V38, P301, DOI 10.1079/BJN19770094; Kierdorf H, 1995, ANN ANAT, V177, P525, DOI 10.1016/S0940-9602(11)80085-3; Klimlis-Zacas D, 2008, CELL BIOL TOXICOL, V24, P341; Krauss S, 2011, J STRUCT BIOL, V175, P457, DOI 10.1016/j.jsb.2011.06.005; Krauss S, 2009, BONE, V44, P1105, DOI 10.1016/j.bone.2009.02.009; Landete-Castilleijos T, 2007, BONE, V41, P794, DOI 10.1016/j.bone.2007.07.013; Landete-Castillejos T, 2007, BONE, V40, P1095, DOI 10.1016/j.bone.2006.11.022; Landete-Castillejos T, 2007, BONE, V40, P230, DOI 10.1016/j.bone.2006.07.009; Landete-Castillejos T, 2012, BONE, V50, P245, DOI 10.1016/j.bone.2011.10.026; Landete-Castillejos T, 2010, BONE, V47, P815, DOI 10.1016/j.bone.2010.07.021; Launey ME, 2010, ACTA BIOMATER, V6, P1505, DOI 10.1016/j.actbio.2009.11.026; LEACH RM, 1969, ARCH BIOCHEM BIOPHYS, V133, P22, DOI 10.1016/0003-9861(69)90483-4; Liang YC, 2007, ENVIRON POLLUT, V147, P422, DOI 10.1016/j.envpol.2006.06.008; Ma JF, 2004, SOIL SCI PLANT NUTR, V50, P11, DOI 10.1080/00380768.2004.10408447; Ma JF, 2006, TRENDS PLANT SCI, V11, P392, DOI 10.1016/j.tplants.2006.06.007; Mobasheri A, 1998, PHYSIOL RES, V47, P47; Olguin CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065461; STRAUSE LG, 1986, J NUTR, V116, P135, DOI 10.1093/jn/116.1.135; SVENSSON O, 1987, CLIN ORTHOP RELAT R, P302; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Wopenka B, 2005, MAT SCI ENG C-BIO S, V25, P131, DOI 10.1016/j.msec.2005.01.008; Xiao JF, 2014, POULTRY SCI, V93, P380, DOI 10.3382/ps.2013-03354; Yang PY, 1998, BIOL TRACE ELEM RES, V64, P275, DOI 10.1007/BF02783343	38	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132738	10.1371/journal.pone.0132738	http://dx.doi.org/10.1371/journal.pone.0132738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177083	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600148
J	Caudrillier, A; Mallavia, B; Rouse, L; Marschner, S; Looney, MR				Caudrillier, Axelle; Mallavia, Benat; Rouse, Lindsay; Marschner, Susanne; Looney, Mark R.			Transfusion of Human Platelets Treated with Mirasol Pathogen Reduction Technology Does Not Induce Acute Lung Injury in Mice	PLOS ONE			English	Article							MOUSE MODEL; LIGHT; INACTIVATION	Pathogen reduction technology (PRT) has been developed in an effort to make the blood supply safer, but there is controversy as to whether it may induce structural or functional changes to platelets that could lead to acute lung injury after transfusion. In this study, we used a commercial PRT system to treat human platelets that were then transfused into immunodeficient mice, and the development of acute lung injury was determined. P-selectin expression was higher in the Mirasol PRT-treated platelets compared to control platelets on storage day 5, but not storage day 1. Transfusion of control vs. Mirasol PRT-treated platelets (day 5 of storage, 109 platelets per mouse) into NOD/SCID mice did not result in lung injury, however transfusion of storage day 5 platelets treated with thrombin receptor-activating peptide increased both extravascular lung water and lung vascular permeability. Transfusion of day 1 platelets did not produce lung injury in any group, and LPS priming 24 hours before transfusion had no effect on lung injury. In a model of transfusion-related acute lung injury, NOD/SCID mice were susceptible to acute lung injury when challenged with H-2Kd monoclonal antibody vs. isotype control antibody. Using lung intravital microscopy, we did not detect a difference in the dynamic retention of platelets in the lung circulation in control vs. Mirasol PRT-treated groups. In conclusion, Mirasol PRT produced an increase in P-selectin expression that is storage-dependent, but transfusion of human platelets treated with Mirasol PRT into immunodeficient mice did not result in greater platelet retention in the lungs or the development of acute lung injury.	[Caudrillier, Axelle; Mallavia, Benat; Looney, Mark R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Rouse, Lindsay; Marschner, Susanne] Terumo BCT Inc, Lakewood, CO USA; [Looney, Mark R.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Looney, MR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	mark.looney@ucsf.edu		Hartson, Lindsay/0000-0002-3131-3507	Terumo BCT, Inc.	Terumo BCT, Inc.	This study was funded by Terumo BCT, Inc. Lindsay Rouse and Susanne Marschner are employees of Terumo BCT, Inc. Terumo BCT, Inc. provided support in the form of salaries for authors LR and SM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Chi X, 2014, TRANSFUSION, V54, P74, DOI 10.1111/trf.12242; Chi X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044829; Cookson P, 2012, TRANSFUSION, V52, P983, DOI 10.1111/j.1537-2995.2011.03388.x; Dwyre DM, 2011, VOX SANG, V100, P92, DOI 10.1111/j.1423-0410.2010.01426.x; Fung YL, 2010, BLOOD, V116, P3073, DOI 10.1182/blood-2010-05-284570; Gelderman MP, 2011, TRANSFUSION, V51, P2343, DOI 10.1111/j.1537-2995.2011.03135.x; Goodrich RP, 2006, TRANSFUS APHER SCI, V35, P5, DOI 10.1016/j.transci.2006.01.007; Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238; Looney MR, 2011, NAT METHODS, V8, P91, DOI 10.1038/NMETH.1543; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; Ortiz-Munoz G, 2014, BLOOD, V124, P2625, DOI 10.1182/blood-2014-03-562876; Schlenke P, 2014, TRANSFUS MED HEMOTH, V41, P309, DOI 10.1159/000365646; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Snyder E, 2005, TRANSFUSION, V45, P1864, DOI 10.1111/j.1537-2995.2005.00639.x; Spinella PC, 2008, CRIT CARE MED, V36, pS340, DOI 10.1097/CCM.0b013e31817e2ef9; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499	17	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133022	10.1371/journal.pone.0133022	http://dx.doi.org/10.1371/journal.pone.0133022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176623	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600202
J	Fendler, WP; Wenter, V; Thornton, HI; Ilhan, H; von Schweinitz, D; Coppenrath, E; Schmid, I; Bartenstein, P; Pfluger, T				Fendler, Wolfgang Peter; Wenter, Vera; Thornton, Henriette Ingrid; Ilhan, Harun; von Schweinitz, Dietrich; Coppenrath, Eva; Schmid, Irene; Bartenstein, Peter; Pfluger, Thomas			Combined Scintigraphy and Tumor Marker Analysis Predicts Unfavorable Histopathology of Neuroblastic Tumors with High Accuracy	PLOS ONE			English	Article							NEURON-SPECIFIC ENOLASE; CHILDREN; URINARY; CLASSIFICATION; CRITERIA; ACID	Objectives Our aim was to improve the prediction of unfavorable histopathology (UH) in neuroblastic tumors through combined imaging and biochemical parameters. Methods I-123-MIBG SPECT and MRI was performed before surgical resection or biopsy in 47 consecutive pediatric patients with neuroblastic tumor. Semi-quantitative tumor-to-liver count-rate ratio (TLCRR), MRI tumor size and margins, urine catecholamine and NSE blood levels of neuron specific enolase (NSE) were recorded. Accuracy of single and combined variables for prediction of UH was tested by ROC analysis with Bonferroni correction. Results 34 of 47 patients had UH based on the International Neuroblastoma Pathology Classification (INPC). TLCRR and serum NSE both predicted UH with moderate accuracy. Optimal cut-off for TLCRR was 2.0, resulting in 68% sensitivity and 100% specificity (AUC-ROC 0.86, p < 0.001). Optimal cut-off for NSE was 25.8 ng/ml, resulting in 74% sensitivity and 85% specificity (AUC-ROC 0.81, p = 0.001). Combination of TLCRR/NSE criteria reduced false negative findings from 11/9 to only five, with improved sensitivity and specificity of 85% (AUC-ROC 0.85, p < 0.001). Conclusion Strong I-123-MIBG uptake and high serum level of NSE were each predictive of UH. Combined analysis of both parameters improved the prediction of UH in patients with neuroblastic tumor. MRI parameters and urine catecholamine levels did not predict UH.	[Fendler, Wolfgang Peter; Wenter, Vera; Thornton, Henriette Ingrid; Ilhan, Harun; Bartenstein, Peter; Pfluger, Thomas] Univ Munich, Dept Nucl Med, Munich, Germany; [von Schweinitz, Dietrich] Univ Munich, Dept Pediat Surg, Munich, Germany; [Coppenrath, Eva] Univ Munich, Inst Clin Radiol, Munich, Germany; [Schmid, Irene] Univ Munich, Dept Pediat Haematol & Oncol, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Fendler, WP (corresponding author), Univ Munich, Dept Nucl Med, Munich, Germany.	wolfgang.fendler@med.uni-muenchen.de	Fendler, Wolfgang/AAH-1611-2021	Fendler, Wolfgang/0000-0002-5106-3584				Aydin GB, 2010, PEDIATR HEMAT ONCOL, V27, P435, DOI 10.3109/08880018.2010.489932; Brans B, 1998, EUR J NUCL MED, V25, P144, DOI 10.1007/s002590050207; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Cangemi G, 2012, ONCOTARGETS THER, V5, P417, DOI 10.2147/OTT.S36366; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; EVERITT BS, 1975, BRIT J PSYCHIAT, V126, P237, DOI 10.1192/bjp.126.3.237; Fendler WP, 2013, EUR J NUCL MED MOL I, V40, P1701, DOI 10.1007/s00259-013-2491-y; IZBICKI T, 1991, J PEDIATR SURG, V26, P1230, DOI 10.1016/0022-3468(91)90340-Y; Lau L, 2002, PEDIATR HEMAT ONCOL, V19, P79, DOI 10.1080/08880010252825669; LAUG WE, 1978, PEDIATRICS, V62, P77; Maris JM, 2005, CURR OPIN PEDIATR, V17, P7, DOI 10.1097/01.mop.0000150631.60571.89; Matthay KK, 1998, J CLIN ONCOL, V16, P1256, DOI 10.1200/JCO.1998.16.4.1256; Mueller WP, 2013, PEDIATR RADIOL, V43, P418, DOI 10.1007/s00247-012-2512-1; Nour-Eldin NEA, 2012, MAGN RESON IMAGING, V30, P893, DOI 10.1016/j.mri.2012.02.028; Okuyama C, 1999, Kaku Igaku, V36, P827; Olivier P, 2003, EUR J NUCL MED MOL I, V30, pBP45, DOI 10.1007/s00259-003-1138-9; Shimada H, 1999, CANCER, V86, P349, DOI 10.1002/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.3.CO;2-P; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; Simon T, 2003, EUR J CANCER, V39, P1899, DOI 10.1016/S0959-8049(03)00376-9; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; ZELTZER PM, 1983, LANCET, V2, P361	22	11	12	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132809	10.1371/journal.pone.0132809	http://dx.doi.org/10.1371/journal.pone.0132809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177109	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600163
J	Lopez-Larraz, E; Montesano, L; Gil-Agudo, A; Minguez, J; Oliviero, A				Lopez-Larraz, Eduardo; Montesano, Luis; Gil-Agudo, Angel; Minguez, Javier; Oliviero, Antonio			Evolution of EEG Motor Rhythms after Spinal Cord Injury: A Longitudinal Study	PLOS ONE			English	Article							SYSTEM FUNCTION; IMAGERY; STROKE; CORTEX; REORGANIZATION; RECOVERY; DESYNCHRONIZATION; MOVEMENTS; FNIRS; TIME	Spinal cord injury (SCI) does not only produce a lack of sensory and motor function caudal to the level of injury, but it also leads to a progressive brain reorganization. Chronic SCI patients attempting to move their affected limbs present a significant reduction of brain activation in the motor cortex, which has been linked to the deafferentation. The aim of this work is to study the evolution of the motor-related brain activity during the first months after SCI. Eighteen subacute SCI patients were recruited to participate in bi-weekly experimental sessions during at least two months. Their EEG was recorded to analyze the temporal evolution of the event-related desynchronization (ERD) over the motor cortex, both during motor attempt and motor imagery of their paralyzed hands. The results show that the a and beta ERD evolution after SCI is negatively correlated with the clinical progression of the patients during the first months after the injury. This work provides the first longitudinal study of the event-related desynchronization during the subacute phase of spinal cord injury. Furthermore, our findings reveal a strong association between the ERD changes and the clinical evolution of the patients. These results help to better understand the brain transformation after SCI, which is important to characterize the neuroplasticity mechanisms involved after this lesion and may lead to new strategies for rehabilitation and motor restoration of these patients.	[Lopez-Larraz, Eduardo; Montesano, Luis; Minguez, Javier] Univ Zaragoza, Dpto Informat & Ingn Sistemas, Zaragoza, Spain; [Lopez-Larraz, Eduardo; Montesano, Luis; Minguez, Javier] Inst Invest Ingn Aragon I3A, Zaragoza, Spain; [Gil-Agudo, Angel] Hosp Nacl Paraplejicos, Biomech & Tech Aids Unit, Toledo, Spain; [Minguez, Javier] Bit&Brain Technol SL, Zaragoza, Spain; [Oliviero, Antonio] Hosp Nacl Paraplejicos, FENNSI Grp, Toledo, Spain	University of Zaragoza; Hospital Nacional de Paraplejicos; Hospital Nacional de Paraplejicos	Lopez-Larraz, E (corresponding author), Univ Zaragoza, Dpto Informat & Ingn Sistemas, Zaragoza, Spain.	edulop@unizar.es	Oliviero, Antonio/ABH-4485-2020; Gil-Agudo, Ángel/ABD-3065-2021; López-Larraz, Eduardo/AAB-9689-2019	Oliviero, Antonio/0000-0001-7723-0478; Gil-Agudo, Ángel/0000-0001-5082-4225; López-Larraz, Eduardo/0000-0001-5482-1347; Minguez Zafra, Javier/0000-0002-2957-0133	Ministerio de Ciencia e Innovacion (Spanish Government) [HYPER-CSD2009-00067]; Diputacion General de Aragon (Spain), DGA-FSE (grupo T04); BitAMP;Brain Technologies SL; Ministerio de Economia y competitividad (Spanish Government) [DPI2011-25892]	Ministerio de Ciencia e Innovacion (Spanish Government)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Diputacion General de Aragon (Spain), DGA-FSE (grupo T04); BitAMP;Brain Technologies SL; Ministerio de Economia y competitividad (Spanish Government)(Spanish Government)	This work was supported by Ministerio de Ciencia e Innovacion (Spanish Government), Project HYPER-CSD2009-00067: ELL, LM, AGA; Ministerio de Economia y competitividad (Spanish Government), Project DPI2011-25892: ELL, LM; and Diputacion General de Aragon (Spain), DGA-FSE (grupo T04): ELL, LM. Bit&Brain Technologies SL, provided support in the form of salaries for author JM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Alkadhi H, 2005, CEREB CORTEX, V15, P131, DOI 10.1093/cercor/bhh116; Blokland Y, 2014, IEEE T NEUR SYS REH, V22, P222, DOI 10.1109/TNSRE.2013.2292995; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Castro A, 2013, INT J PSYCHOPHYSIOL, V87, P205, DOI 10.1016/j.ijpsycho.2013.01.012; Catz A, 2007, J REHABIL RES DEV, V44, P65, DOI 10.1682/JRRD.2005.07.0123; Cramer SC, 2005, BRAIN, V128, P2941, DOI 10.1093/brain/awh648; Cramer SC, 2007, EXP BRAIN RES, V177, P233, DOI 10.1007/s00221-006-0662-9; Curt A, 2002, J NEUROTRAUM, V19, P43, DOI 10.1089/089771502753460222; Enzinger C, 2008, EXP BRAIN RES, V190, P215, DOI 10.1007/s00221-008-1465-y; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; Graimann B, 2006, PROG BRAIN RES, V159, P79, DOI 10.1016/S0079-6123(06)59006-5; Green JB, 1999, NEUROLOGY, V53, P736, DOI 10.1212/WNL.53.4.736; Hotz-Boenden-Naker S, 2008, NEUROIMAGE, V39, P383, DOI 10.1016/j.neuroimage.2007.07.065; Jurkiewicz MT, 2010, NEUROREHAB NEURAL RE, V24, P136, DOI 10.1177/1545968309347680; Jurkiewicz MT, 2006, NEUROLOGY, V66, P762, DOI 10.1212/01.wnl.0000201276.28141.40; Kaiser V, 2014, NEUROIMAGE, V85, P432, DOI 10.1016/j.neuroimage.2013.04.097; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Lopez-Larraz E, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-153; Lopez-Larraz E, 2012, IEEE ENG MED BIO, P1798, DOI 10.1109/EMBC.2012.6346299; Lotze M, 2006, NEUROREHAB NEURAL RE, V20, P14, DOI 10.1177/1545968305282919; Moxon KA, 2014, NEUROSCIENCE, V283, P78, DOI 10.1016/j.neuroscience.2014.06.056; Muller-Putz GR, 2007, BRAIN RES, V1137, P84, DOI 10.1016/j.brainres.2006.12.052; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Roiha K, 2011, CLIN NEUROPHYSIOL, V122, P339, DOI 10.1016/j.clinph.2010.06.032; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tangwiriyasakul C, 2014, CLIN NEUROPHYSIOL, V125, P1112, DOI 10.1016/j.clinph.2013.10.047; Turner JA, 2003, NEUROREHAB NEURAL RE, V17, P37, DOI 10.1177/0888439002250443; Turner JA, 2001, IEEE T NEUR SYS REH, V9, P154, DOI 10.1109/7333.928575; Ward NS, 2004, ANN NEUROL, V55, P829, DOI 10.1002/ana.20099; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	38	36	37	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131759	10.1371/journal.pone.0131759	http://dx.doi.org/10.1371/journal.pone.0131759			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177457	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600062
J	Reddig, A; Fatahi, M; Friebe, B; Guttek, K; Hartig, R; Godenschweger, F; Roggenbuck, D; Ricke, J; Reinhold, D; Speck, O				Reddig, Annika; Fatahi, Mahsa; Friebe, Bjoern; Guttek, Karina; Hartig, Roland; Godenschweger, Frank; Roggenbuck, Dirk; Ricke, Jens; Reinhold, Dirk; Speck, Oliver			Analysis of DNA Double-Strand Breaks and Cytotoxicity after 7 Tesla Magnetic Resonance Imaging of Isolated Human Lymphocytes	PLOS ONE			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; COMET ASSAY; IONIZING-RADIATION; GAMMA-H2AX FOCI; MICRONUCLEUS; DAMAGE; MECHANISMS; BIOMARKER; IMPACT; REPAIR	The global use of magnetic resonance imaging (MRI) is constantly growing and the field strengths increasing. Yet, only little data about harmful biological effects caused by MRI exposure are available and published research analyzing the impact of MRI on DNA integrity reported controversial results. This in vitro study aimed to investigate the genotoxic and cytotoxic potential of 7 T ultra-high-field MRI on isolated human peripheral blood mononuclear cells. Hence, unstimulated mononuclear blood cells were exposed to 7 T static magnetic field alone or in combination with maximum permissible imaging gradients and radiofrequency pulses as well as to ionizing radiation during computed tomography and gamma-ray exposure. DNA double-strand breaks were quantified by flow cytometry and automated microscopy analysis of immunofluorescence stained gamma H2AX. Cytotoxicity was studied by CellTiter-Blue viability assay and [H-3]-thymidine proliferation assay. Exposure of unstimulated mononuclear blood cells to 7 T static magnetic field alone or combined with varying gradient magnetic fields and pulsed radiofrequency fields did not induce DNA double-strand breaks, whereas irradiation with X-and gamma-rays led to a dose-dependent induction of gamma H2AX foci. The viability assay revealed a time-and dose-dependent decrease in metabolic activity only among samples exposed to gamma-radiation. Further, there was no evidence for altered proliferation response after cells were exposed to 7 T MRI or low doses of ionizing radiation (<= 0.2 Gy). These findings confirm the acceptance of MRI as a safe non-invasive diagnostic imaging tool, but whether MRI can induce other types of DNA lesions or DNA double-strand breaks during altered conditions still needs to be investigated.	[Reddig, Annika; Guttek, Karina; Hartig, Roland; Reinhold, Dirk] Otto Von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany; [Fatahi, Mahsa; Godenschweger, Frank; Speck, Oliver] Otto Von Guericke Univ, Dept Biomed Magnet Resonance, Magdeburg, Germany; [Friebe, Bjoern; Ricke, Jens] Otto Von Guericke Univ, Dept Radiol & Nucl Med, Magdeburg, Germany; [Roggenbuck, Dirk] Medipan GmbH, Dahlewitz Berlin, Germany; [Roggenbuck, Dirk] Brandenburg Univ Technol Cottbus Senftenberg, Fac Nat Sci, Senftenberg, Germany; [Speck, Oliver] Leibniz Inst Neurobiol, Magdeburg, Germany; [Speck, Oliver] Ctr Behav Brain Sci, Magdeburg, Germany; [Speck, Oliver] German Ctr Neurodegenerat Dis, Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; Brandenburg University of Technology Cottbus; Leibniz Institut fur Neurobiologie (LIN); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Reddig, A (corresponding author), Otto Von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany.	annika.reddig@med.ovgu.de	Speck, Oliver/F-1406-2013	Speck, Oliver/0000-0002-6019-5597; Roggenbuck, Dirk/0000-0002-6861-6827; Reddig, Annika/0000-0001-6587-206X; Hartig, Roland/0000-0002-3706-7458	GA Generic Assays GmbH; Medipan GmbH; HiMR (High Field Magnetic Resonance), an initial training network - FP7 Marie Curie Actions of the European Commission [FP7-PEOPLE-2012-ITN-316716]	GA Generic Assays GmbH; Medipan GmbH; HiMR (High Field Magnetic Resonance), an initial training network - FP7 Marie Curie Actions of the European Commission	Mahsa Fatahi was supported by the HiMR (High Field Magnetic Resonance), an initial training network, funded by the FP7 Marie Curie Actions of the European Commission (FP7-PEOPLE-2012-ITN-316716). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GA Generic Assays GmbH and Medipan GmbH provided support in the form of salaries for author DR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Caldecott KW, 2007, DNA REPAIR, V6, P443, DOI 10.1016/j.dnarep.2006.10.006; Carpenter D.O., 2012, PATTYS TOXICOLOGY, P109, DOI DOI 10.1002/0471435139.TOX100.PUB2; Cho S, 2014, DRUG CHEM TOXICOL, V37, P440, DOI 10.3109/01480545.2013.879662; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; Collins CM, 2006, ULTRAHIGH FIELD MAGN, P231, DOI [10.1007/978-0-387-49648-1, DOI 10.1007/978-0-387-49648-1]; European Commission-Research Directorate General, 2005, HLTH EL FIELDS EU FU; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fiechter M, 2013, EUR HEART J, V34, P2340, DOI 10.1093/eurheartj/eht184; Friedrich KM, 2009, SEMIN MUSCULOSKEL R, V13, P74, DOI 10.1055/s-0029-1202942; Ghodbane S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/602987; Hartmann A, 2001, FOOD CHEM TOXICOL, V39, P843, DOI 10.1016/S0278-6915(01)00031-X; Hartwig V, 2009, INT J ENV RES PUB HE, V6, P1778, DOI 10.3390/ijerph6061778; Hiemann R, 2009, AUTOIMMUN REV, V9, P17, DOI 10.1016/j.autrev.2009.02.033; Ivashkevich A, 2012, CANCER LETT, V327, P123, DOI 10.1016/j.canlet.2011.12.025; Ivashkevich AN, 2011, MUTAT RES-FUND MOL M, V711, P49, DOI 10.1016/j.mrfmmm.2010.12.015; Kimura A, 2013, MUTAGENESIS, V28, P583, DOI 10.1093/mutage/get036; Kuefner MA, 2010, EUR RADIOL, V20, P2917, DOI 10.1007/s00330-010-1873-9; Lee J, 2011, BIOELECTROMAGNETICS, V32, P535, DOI 10.1002/bem.20664; Norimura Toshiyuki, 1993, Journal of UOEH, V15, P103; Onodera H, 2003, RADIAT RES, V159, P775, DOI 10.1667/0033-7587(2003)159[0775:EOTSMF]2.0.CO;2; Phillips J L, 2009, Pathophysiology, V16, P79, DOI 10.1016/j.pathophys.2008.11.005; Redon CE, 2011, AGING-US, V3, P168, DOI 10.18632/aging.100284; Redon CE, 2011, METHODS MOL BIOL, V682, P249, DOI 10.1007/978-1-60327-409-8_18; Redon CE, 2009, ADV SPACE RES, V43, P1171, DOI 10.1016/j.asr.2008.10.011; Rothkamm K, 2002, INT J ONCOL, V21, P433; Rothkamm K, 2007, RADIOLOGY, V242, P244, DOI 10.1148/radiol.2421060171; Runge R, 2012, INT J RADIAT BIOL, V88, P439, DOI 10.3109/09553002.2012.658468; Schwab SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070660; Schwenzer NF, 2007, J MAGN RESON IMAGING, V26, P1308, DOI 10.1002/jmri.21138; Simi S, 2008, MUTAT RES-FUND MOL M, V645, P39, DOI 10.1016/j.mrfmmm.2008.08.011; Speck O, 2012, HIGH FIELD MR IMAGIN, P84, DOI [10.1007/978-3-540-85090-8, DOI 10.1007/978-3-540-85090-8]; Szerencsi A, 2013, INT J RADIAT BIOL, V89, P870, DOI 10.3109/09553002.2013.804962; van Deventer TE, 2005, PROG BIOPHYS MOL BIO, V87, P355, DOI 10.1016/j.pbiomolbio.2004.08.017; van Osch MJP., 2014, CURR RADIOL REP, V2, P61, DOI DOI 10.1007/S40134-014-0061-0; Vijayalaxmi, 2015, MUTAT RES-REV MUTAT, V764, P51, DOI 10.1016/j.mrrev.2015.02.002; Watters GP, 2009, MUTAT RES-GEN TOX EN, V679, P50, DOI 10.1016/j.mrgentox.2009.07.007; WHO, 2006, ENV HLTH CRIT 232 ST; Willitzki A, 2013, CYTOM PART A, V83, P1017, DOI 10.1002/cyto.a.22350; Willitzki A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/284740; Yildiz S, 2011, CLIN BIOCHEM, V44, P975, DOI 10.1016/j.clinbiochem.2011.05.005; Yu YK, 2006, TOXICOL IN VITRO, V20, P959, DOI 10.1016/j.tiv.2006.01.004	42	25	26	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132702	10.1371/journal.pone.0132702	http://dx.doi.org/10.1371/journal.pone.0132702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176601	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600142
J	Reynolds, TH; Banerjee, S; Sharma, VM; Donohue, J; Couldwell, S; Sosinsky, A; Frulla, A; Robinson, A; Puri, V				Reynolds, Thomas H.; Banerjee, Sayani; Sharma, Vishva Mitra; Donohue, Jacob; Couldwell, Sandrine; Sosinsky, Alexandra; Frulla, Ashton; Robinson, Allegra; Puri, Vishwajeet			Effects of a High Fat Diet and Voluntary Wheel Running Exercise on Cidea and Cidec Expression in Liver and Adipose Tissue of Mice	PLOS ONE			English	Article							DEFICIENT MICE; TRANSCRIPTIONAL ACTIVATION; HEPATIC GLUCONEOGENESIS; INSULIN SENSITIVITY; ADIPOCYTE LIPOLYSIS; SKELETAL-MUSCLE; PGC-1-ALPHA; FSP27; COACTIVATOR; RESISTANCE	Cidea and Cidec play an important role in regulating triglyceride storage in liver and adipose tissue. It is not known if the Cidea and Cidec genes respond to a high fat diet (HFD) or exercise training, two interventions that alter lipid storage. The purpose of the present study was to determine the effect of a HFD and voluntary wheel running (WR) on Cidea and Cidec mRNA and protein expression in adipose tissue and liver of mice. A HFD promoted a significant increase in Cidea and Cidec mRNA levels in adipose tissue and liver. The increase in Cidea and Cidec mRNAs in adipose tissue and liver in response to a HFD was prevented by WR. Similar to the changes in Cidea mRNA, Cidea protein levels in adipose tissue significantly increased in response to a HFD, a process that was, again, prevented by WR. However, in adipose tissue the changes in Cidec mRNA did not correspond to the changes in Cidec protein levels, as a HFD decreased Cidec protein abundance. Interestingly, in adipose tissue Cidea protein expression was significantly related to body weight (R=.725), epididymal adipose tissue (EWAT) mass (R=.475) and insulin resistance (R=.706), whereas Cidec protein expression was inversely related to body weight (R=-.787), EWAT mass (R=.706), and insulin resistance (R=-.679). Similar to adipose tissue, Cidea protein expression in liver was significantly related to body weight (R=.660), EWAT mass (R=.468), and insulin resistance (R=.599); however, unlike adipose tissue, Cidec protein levels in liver were not related to body weight or EWAT mass and only moderately associated with insulin resistance (R=-.422, P=0.051). Overall, our findings indicate that Cidea is highly associated with adiposity and insulin resistance, whereas Cidec is related to insulin sensitivity. The present study suggests that Cide proteins might play an important functional role in the development of obesity, hepatic steatosis, as well as the pathogenesis of type 2 diabetes.	[Reynolds, Thomas H.; Donohue, Jacob; Couldwell, Sandrine; Sosinsky, Alexandra; Frulla, Ashton; Robinson, Allegra] Skidmore Coll, Dept Hlth & Exercise Sci, Saratoga Springs, NY 12866 USA; [Banerjee, Sayani; Sharma, Vishva Mitra; Puri, Vishwajeet] Boston Univ, Dept Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA	Skidmore College; Boston University	Reynolds, TH (corresponding author), Skidmore Coll, Dept Hlth & Exercise Sci, Saratoga Springs, NY 12866 USA.	treynold@skidmore.edu	Sosinsky, Alexandra Z/N-9092-2019; Couldwell, Sandrine/GNH-4078-2022	Sosinsky, Alexandra Z/0000-0003-2051-7333; Reynolds, Thomas/0000-0002-0290-528X	Smith Family Grant; National Institutes of Health [1 R15 DK090722-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK090722] Funding Source: NIH RePORTER	Smith Family Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Smith Family Grant, (THR)and by the National Institutes of Health (grand no. 1 R15 DK090722-01 to THR).	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; [Anonymous], 2009, NCHS DATA BRIEF; Baar K, 2004, P NUTR SOC, V63, P269, DOI 10.1079/PNS2004334; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Christianson JL, 2010, J LIPID RES, V51, P3455, DOI 10.1194/jlr.M009498; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; Hallberg M, 2008, MOL CELL BIOL, V28, P6785, DOI 10.1128/MCB.00504-08; Hammarstedt A, 2003, BIOCHEM BIOPH RES CO, V301, P578, DOI 10.1016/S0006-291X(03)00014-7; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Jeppesen J, 2012, J PHYSIOL-LONDON, V590, P1059, DOI 10.1113/jphysiol.2011.225011; Kim YJ, 2008, BIOCHEM BIOPH RES CO, V377, P297, DOI 10.1016/j.bbrc.2008.09.129; Larigauderie G, 2006, FEBS J, V273, P3498, DOI 10.1111/j.1742-4658.2006.05357.x; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Liu K, 2009, AM J PHYSIOL-ENDOC M, V297, pE1395, DOI 10.1152/ajpendo.00188.2009; Matiello R, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-36; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Nian ZQ, 2010, J BIOL CHEM, V285, P9604, DOI 10.1074/jbc.M109.043786; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Ranjit S, 2011, J LIPID RES, V52, P221, DOI 10.1194/jlr.M008771; Reynolds TH, 2012, AM J PHYSIOL-REG I, V303, pR1186, DOI 10.1152/ajpregu.00358.2012; Reynolds TH, 2009, J APPL PHYSIOL, V107, P1479, DOI 10.1152/japplphysiol.00574.2009; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Sahlin K, 2008, ACTA PHYSIOL, V194, P283, DOI 10.1111/j.1748-1716.2008.01879.x; Sato W, 2006, HEPATOL RES, V34, P256, DOI 10.1016/j.hepres.2006.01.003; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Semple RK, 2004, INT J OBESITY, V28, P176, DOI 10.1038/sj.ijo.0802482; Singh M, 2014, J BIOL CHEM, V289, P14481, DOI 10.1074/jbc.C114.563080; Pauli LSS, 2014, J PHYSIOL-LONDON, V592, P1325, DOI 10.1113/jphysiol.2013.264002; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Viswakarma N, 2007, J BIOL CHEM, V282, P18613, DOI 10.1074/jbc.M701983200; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yonezawa T, 2009, BIOCHEM BIOPH RES CO, V384, P535, DOI 10.1016/j.bbrc.2009.05.012; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang XD, 2014, AM J PHYSIOL-ENDOC M, V307, pE1047, DOI 10.1152/ajpendo.00125.2014; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	46	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130259	10.1371/journal.pone.0130259	http://dx.doi.org/10.1371/journal.pone.0130259			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176546	gold, Green Submitted, Green Published			2022-12-27	WOS:000358197600021
J	Romero-Lorca, A; Novillo, A; Gaibar, M; Bandres, F; Fernandez-Santander, A				Romero-Lorca, Alicia; Novillo, Apolonia; Gaibar, Maria; Bandres, Fernando; Fernandez-Santander, Ana			Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients	PLOS ONE			English	Article							UDP-GLUCURONOSYLTRANSFERASE; HUMAN LIVER; GENETIC POLYMORPHISMS; ESTROGEN-RECEPTOR; N-GLUCURONIDATION; POTENTIAL ROLE; PHASE-I; CYP2D6; RECURRENCE; PHARMACOGENETICS	Tamoxifen is used to prevent and treat estrogen-dependent breast cancer. It is described as a prodrug since most of its antiestrogen effects are exerted through its hydroxylated metabolites 4-OH-tamoxifen and endoxifen. In prior work, we correlated optimal plasma levels of these metabolites with certain genotypes of CYP2D6 and SULT1A2. This descriptive study examines correlations between concentrations of tamoxifen's glucuronide metabolites and genotypes UGT1A4 Pro24Thr, UGT1A4 Leu48Val, UGT2B7 His268Tyr, UGT2B15 Asp85YTyr UGT2B15 Lys523Thrand UGT2B17delin 132 patients with estrogen receptor-positive breast cancer under treatment with tamoxifen. Patients were genotyped by real-time and conventional PCR-RFLP. The glucuronides 4-OH-tamoxifen-N-glucuronide, 4-OH-tamoxifen-O-glucuronide and endoxifen-O-glucuronide were isolated from blood plasma and quantified using a high-pressure liquid chromatography-tandem mass spectrometry system. Individuals who were homozygous for UGT1A4(48VAL) showed significantly lower mean concentrations of both glucuronide metabolites compared to subjects genotyped as wt/wt plus wt/48Val (p=0.037 and p=0.031, respectively). Women homozygous for UGT2B7(268Tyr) also showed mean substrate/product ratios of 4-OH-tamoxifen/4-OH-tamoxifen-O-glucuronide and 4-OH-tamoxifen/4-OH-tamoxifen-N-glucuronide indicative of reduced glucuronidase activity compared to wt homozygotes or to heterozygotes for the polymorphism (p=0.005 and p=0.003, respectively). In contrast, UGT2B15 Lys523Thrand UGT2B17del were associated with possibly increased enzyme activity. Patients with at least one variant allele UGT2B15(523Thr) showed significantly higher 4-OH-tamoxifen-O-glucuronide and endoxifen-glucuronide levels (p=0.023 and p=0.025, respectively) indicating a variant gene-dose effect. Higher 4-OH-tamoxifen-N-glucuronide levels observed in UGT2B17del genotypes (p=0.042) could be attributed to a mechanism that compensates for the greater expression of other genes in UGT2B17 del/del individuals. Our observations suggest that patients carrying mutations UGT1A4(48Val), UGT2B7(268Tyr) or with wt genotypes for UGT2B17(nodel) and UGT2B15(523Lys) could be the best candidates for a good response to tamoxifen therapy in terms of eliciting effective plasma active tamoxifen metabolite levels. However, additional studies examining the effects of UGT genotype on overall patient response to TAM are needed to further examine the role of UGT polymorphisms in the therapeutic efficacy of TAM.	[Romero-Lorca, Alicia; Novillo, Apolonia; Gaibar, Maria; Fernandez-Santander, Ana] Univ Europea Madrid, Dept Basic Biomed Sci, Fac Biomed Sci, Madrid, Spain; [Bandres, Fernando] Fdn Tejerina, Sch Adv Studies, Madrid, Spain	European University of Madrid	Fernandez-Santander, A (corresponding author), Univ Europea Madrid, Dept Basic Biomed Sci, Fac Biomed Sci, Madrid, Spain.	ana.fernandez@uem.es	Novillo, Apolonia/M-7389-2017; Lorca, Alicia Romero/O-4074-2016; Gaibar, Maria/AHA-5931-2022; FERNÁNDEZ SANTANDER, ANA/ABT-4005-2022; Fernandez-Santander, Ana/L-5707-2014	Novillo, Apolonia/0000-0003-0902-0991; Lorca, Alicia Romero/0000-0002-1920-034X; Fernandez-Santander, Ana/0000-0001-7545-1170; , GAIBAR/0000-0003-3881-8345; BANDRES MOYA, FERNANDO/0000-0002-4675-8226	National Natural Science Foundation of China [51404260]; Basic Research Program of Jiangsu Province [BK20140206]; China Postdoctoral Science Foundation [2015M572112]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Fundamental Research Funds for the Central Universities [2013QNB01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Program of Jiangsu Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Priority Academic Program Development of Jiangsu Higher Education Institutions; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 51404260) (http://www.nsfc.gov.cn), the Basic Research Program of Jiangsu Province (No. BK20140206) (http://www.jskjjh.gov.cn), the China Postdoctoral Science Foundation (No. 2015M572112) (http://res.chinapostdoctor.org.cn/BshWeb/index.shtml), "A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions" (http://www.cumt.edu.cn), and the Fundamental Research Funds for the Central Universities (No. 2013QNB01) (http://www.cumt.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit-Biancamano MO, 2009, PHARMACOGENET GENOM, V19, P945, DOI 10.1097/FPC.0b013e3283331637; Blevins-Primeau AS, 2009, CANCER RES, V69, P1892, DOI 10.1158/0008-5472.CAN-08-3708; Breyer-Pfaff U, 2000, DRUG METAB DISPOS, V28, P869; CHEN F, 1993, BIOCHEMISTRY-US, V32, P10648, DOI 10.1021/bi00091a015; Chen G, 2010, CANCER RES, V70, P7543, DOI 10.1158/0008-5472.CAN-09-4582; Chung JY, 2005, CLIN PHARMACOL THER, V77, P486, DOI 10.1016/j.clpt.2005.02.006; Court MH, 2004, J PHARMACOL EXP THER, V310, P656, DOI 10.1124/jpet.104.067660; Damodaran SE, 2012, CANCER CHEMOTH PHARM, V70, P75, DOI 10.1007/s00280-012-1891-1; Ehmer U, 2004, HEPATOLOGY, V39, P970, DOI 10.1002/hep.20131; Fernandez-Santander A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070183; Fisher B, 1996, JNCI-J NATL CANCER I, V88, P1529, DOI 10.1093/jnci/88.21.1529; Gjerde J, 2008, ANN ONCOL, V19, P56, DOI 10.1093/annonc/mdm434; GJERDE J, 2010, BMC CANCER, V21, P10; Green MD, 1998, DRUG METAB DISPOS, V26, P860; GREEN MD, 1994, DRUG METAB DISPOS, V22, P799; Greer AK, 2014, DRUG METAB DISPOS, V42, P1392, DOI 10.1124/dmd.114.058016; He X, 2009, BRIT J CLIN PHARMACO, V68, P721, DOI 10.1111/j.1365-2125.2009.03519.x; Jin Y, 2005, JNCI-J NATL CANCER I, V97, P30, DOI 10.1093/jnci/dji005; Johnson MD, 2004, BREAST CANCER RES TR, V85, P151, DOI 10.1023/B:BREA.0000025406.31193.e8; Kaku T, 2004, BIOCHEM PHARMACOL, V67, P2093, DOI 10.1016/j.bcp.2004.02.014; Kiyotani K, 2010, J CLIN ONCOL, V28, P1287, DOI 10.1200/JCO.2009.25.7246; Lampe JW, 2000, CANCER EPIDEM BIOMAR, V9, P329; Lazarus P, 2009, ANN NY ACAD SCI, V1155, P99, DOI 10.1111/j.1749-6632.2009.04114.x; LIEN EA, 1989, CANCER RES, V49, P2175; LIEN EA, 1988, CANCER RES, V48, P2304; Lim HS, 2007, J CLIN ONCOL, V25, P3837, DOI 10.1200/JCO.2007.11.4850; Murdter TE, 2011, CLIN PHARMACOL THER, V89, P708, DOI 10.1038/clpt.2011.27; Nadeau G, 2011, J CLIN ENDOCR METAB, V96, pE1550, DOI 10.1210/jc.2011-1049; Nishiyama T, 2002, BIOCHEM PHARMACOL, V63, P1817, DOI 10.1016/S0006-2952(02)00994-2; Nowell SA, 2005, BREAST CANCER RES TR, V91, P249, DOI 10.1007/s10549-004-7751-x; POON GK, 1993, DRUG METAB DISPOS, V21, P1119; Rae JM, 2012, JNCI-J NATL CANCER I, V104, P452, DOI 10.1093/jnci/djs126; Saeki Mayumi, 2005, Drug Metab Pharmacokinet, V20, P144, DOI 10.2133/dmpk.20.144; Schulze JJ, 2011, J CLIN ENDOCR METAB, V96, P3440, DOI 10.1210/jc.2011-0521; Schulze JJ, 2008, PHARMACOGENET GENOM, V18, P477, DOI 10.1097/FPC.0b013e3282fad38a; Strahm Emmanuel, 2013, Front Endocrinol (Lausanne), V4, P75, DOI 10.3389/fendo.2013.00075; Sun D, 2007, DRUG METAB DISPOS, V35, P2006, DOI 10.1124/dmd.107.017145; Sun DX, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1539; Turgeon D, 2000, J MOL BIOL, V295, P489, DOI 10.1006/jmbi.1999.3374; Wiener D, 2004, DRUG METAB DISPOS, V32, P72, DOI 10.1124/dmd.32.1.72; Wiener D, 2004, CANCER RES, V64, P1190, DOI 10.1158/0008-5472.CAN-03-3219; Wilson W, 2004, GENOMICS, V84, P707, DOI 10.1016/j.ygeno.2004.06.011; Zhou J, 2011, PHARMACOGENOMICS, V12, P1671, DOI [10.2217/PGS.11.105, 10.2217/pgs.11.105]	43	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132269	10.1371/journal.pone.0132269	http://dx.doi.org/10.1371/journal.pone.0132269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176234	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600095
J	Zhang, KDD; Stoller, ML; Fekete, DM				Zhang, Kaidi D.; Stoller, Michelle L.; Fekete, Donna M.			Expression and Misexpression of the miR-183 Family in the Developing Hearing Organ of the Chicken	PLOS ONE			English	Article							DEVELOPING INNER-EAR; HAIR-CELL-DEVELOPMENT; IN-SITU DETECTION; BASILAR PAPILLA; ACTIN-FILAMENTS; GENE-EXPRESSION; OTIC PLACODE; COCHLEA; MICRORNAS; DIFFERENTIATION	The miR-183 family consists of 3 related microRNAs (miR-183, miR-96, miR-182) that are required to complete maturation of primary sensory cells in the mammalian inner ear. Because the level of these microRNAs is not uniform across hair cell subtypes in the murine cochlea, the question arises as to whether hair cell phenotypes are influenced by microRNA expression levels. To address this, we used the chicken embryo to study expression and misexpression of this gene family. By in situ hybridization, expression of all 3 microRNAs is robust in immature hair cells of both auditory and vestibular organs and is present in the statoacoustic ganglion. The auditory organ, called the basilar papilla, shows a weak radial gradient (highest on the neural side) in prosensory cells near the base on embryonic day 7. About nine days later, the basilar papilla also displays a longitudinal gradient (highest in apical hair cells) for the 3 microRNAs. Tol2-mediated gene delivery was used to ask whether cell phenotypes are malleable when the prosensory epithelium was forced to over-express the miR-183 family. The expression plasmid included EGFP as a reporter located upstream of an intron carrying the microRNA genes. The vectors were electroporated into the otic cup/vesicle, resulting in strong co-expression of EGFP and the miR-183 family that persisted for at least 2 weeks. This manipulation did not generate ectopic hair cells in non-sensory territories of the cochlear duct, although within the basilar papilla, hair cells were over-represented relative to supporting cells. There was no evidence for a change in hair cell phenotypes, such as short-to-tall, or basal-to-apical hair cell features. Therefore, while increasing expression of the miR-183 family was sufficient to influence cell lineage decisions, it did not redirect the differentiation of hair cells towards alternative radial or longitudinal phenotypes.	[Zhang, Kaidi D.; Stoller, Michelle L.; Fekete, Donna M.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Fekete, Donna M.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Fekete, DM (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	dfekete@purdue.edu	Fekete, Donna M/B-9170-2009	Fekete, Donna M/0000-0003-0662-0246	National Institutes of Health [R01DC002756, F31DC011687, P300CA023168]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002756, F31DC011687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by the National Institutes of Health (http://www.nih.gov/; R01DC002756 to D.M.F.; F31DC011687 to M.L.S.; P300CA023168).	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BARTOLAMI S, 1991, J COMP NEUROL, V314, P777, DOI 10.1002/cne.903140410; Battisti AC, 2014, HEARING RES, V310, P1, DOI 10.1016/j.heares.2014.01.003; Bell D, 2008, DEV BIOL, V322, P109, DOI 10.1016/j.ydbio.2008.07.011; Beurg M, 2013, NEURON, V79, P69, DOI 10.1016/j.neuron.2013.05.018; BROWNELL WE, 1990, EAR HEARING, V11, P82, DOI 10.1097/00003446-199004000-00003; Bulankina AV, 2012, PHYSIOLOGY, V27, P100, DOI 10.1152/physiol.00036.2011; Busskamp V, 2014, NEURON, V83, P586, DOI 10.1016/j.neuron.2014.06.020; Chen J, 2014, EUR J NEUROSCI, V39, P744, DOI 10.1111/ejn.12484; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Chrysostomou E, 2012, DEVELOPMENT, V139, P3764, DOI 10.1242/dev.074476; COTANCHE DA, 1983, ARCH OTO-RHINO-LARYN, V237, P191, DOI 10.1007/BF00453723; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; FISCHER FP, 1992, HEARING RES, V61, P167, DOI 10.1016/0378-5955(92)90048-R; Frucht CS, 2011, JARO-J ASSOC RES OTO, V12, P423, DOI 10.1007/s10162-011-0259-2; FUCHS PA, 1988, J NEUROSCI, V8, P2460; GOODYEAR R, 1995, J COMP NEUROL, V351, P81, DOI 10.1002/cne.903510108; Goodyear R, 1997, J NEUROSCI, V17, P6289; Goodyear RJ, 2010, JARO-J ASSOC RES OTO, V11, P573, DOI 10.1007/s10162-010-0231-6; Groves AK, 2013, ANNU REV NEUROSCI, V36, P361, DOI 10.1146/annurev-neuro-062012-170309; Groves AK, 2012, DEVELOPMENT, V139, P245, DOI 10.1242/dev.067074; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; KATAYAMA A, 1989, J COMP NEUROL, V281, P129, DOI 10.1002/cne.902810110; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Knowlton VY, 1967, J MORPHOLOGY, V121, P179; Kowalik L, 2011, DEV BIOL, V354, P221, DOI 10.1016/j.ydbio.2011.03.031; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Kuhn S, 2011, P NATL ACAD SCI USA, V108, P2355, DOI 10.1073/pnas.1016646108; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Li H, 2010, ROLES MICRORNAS ZEBR; Li HQ, 2010, J NEUROSCI, V30, P3254, DOI 10.1523/JNEUROSCI.4948-09.2010; LIM DJ, 1986, HEARING RES, V22, P117, DOI 10.1016/0378-5955(86)90089-4; LIM DJ, 1980, J ACOUST SOC AM, V67, P1686, DOI 10.1121/1.384295; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lumayag S, 2013, P NATL ACAD SCI USA, V110, pE507, DOI 10.1073/pnas.1212655110; Mann ZF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4839; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Molea D, 1999, J COMP NEUROL, V406, P183; Neves J, 2007, J COMP NEUROL, V503, P487, DOI 10.1002/cne.21299; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Sanchez-Guardado LO, 2014, DEVELOPMENT, V141, P2302, DOI 10.1242/dev.101667; Powder KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035111; Sacheli R, 2009, GENE EXPR PATTERNS, V9, P364, DOI 10.1016/j.gep.2009.01.003; Sato Y, 2007, DEV BIOL, V305, P616, DOI 10.1016/j.ydbio.2007.01.043; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sienknecht UJ, 2008, J COMP NEUROL, V510, P378, DOI 10.1002/cne.21791; Stoller ML, 2013, INT J MOL SCI, V14, P18239, DOI 10.3390/ijms140918239; TANAKA K, 1978, AM J ANAT, V153, P251, DOI 10.1002/aja.1001530206; Thiede BR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4840; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; TILNEY LG, 1983, J CELL BIOL, V96, P807, DOI 10.1083/jcb.96.3.807; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Weston MD, 2011, DEV DYNAM, V240, P808, DOI 10.1002/dvdy.22591; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Zhu QB, 2011, J BIOL CHEM, V286, P31749, DOI 10.1074/jbc.M111.259028	59	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132796	10.1371/journal.pone.0132796	http://dx.doi.org/10.1371/journal.pone.0132796			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176784	Green Submitted, Green Published, gold			2022-12-27	WOS:000358197600159
J	Zhao, WW; Chen, F; Wu, MH; Jiang, S; Wu, BB; Luo, HL; Wen, JY; Hu, CH; Yu, SH				Zhao, Weiwei; Chen, Fan; Wu, Menghua; Jiang, Shuai; Wu, Binbin; Luo, Huali; Wen, Jingyi; Hu, Chaohui; Yu, Shihui			Postnatal Identification of Trisomy 21: An Overview of 7,133 Postnatal Trisomy 21 Cases Identified in a Diagnostic Reference Laboratory in China	PLOS ONE			English	Article							DOWN-SYNDROME; MATERNAL AGE; EPIDEMIOLOGIC FINDINGS; AUTOSOMAL ANEUPLOIDY; PRENATAL-DIAGNOSIS; TERMINATION RATES; BIRTH-DEFECTS; UNITED-STATES; SEX-RATIO; PREVALENCE	This study describes the cytogenetic characteristics of 7,133 trisomy 21 (Tri21) identified from 247,818 consecutive postnatal cases karyotyped in a single reference laboratory in China for a period of 4 years. The average detection rate of Tri21 is 2.88% ranging from 3.39% in 2011 to 2.52% in 2014. The decreased detection rates over the years might reflect a possible impact of noninvasive prenatal testing applied rapidly in China and elective termination of affected pregnancies. 95.32% of the Tri21 karyotypes are standard Tri21, 4.53% are Robertsonian Tri21, and less than 1% are other Tri21 forms. There are more mosaic Tri21 in older children and adults, consistent with previous observations that clinical features in individuals with mosaic Tri21 are generally milder and easily missed during perinatal period. The male/female (M/F ratio) for the total 7,133 Tri21 cases and for the 6,671 cases with non-mosaic standard Tri21 are 1.50 and 1.53 respectively, significantly higher than the 0.93 for all the 247,818 cases we karyotyped, the 1.30 for the Down syndrome (DS) identified during perinatal period in China, and the 1.20 for the livebirth in Chinese population. In contrast, the mosaic standard Tri21 case has a significantly lower proportion of males when compared with the non-mosaic standard Tri21, indicating different underlying mechanisms leading to their formations. Opposite M/F ratios in different subtypes of ROB Tri21 were observed. A long list of rare or private karyotypes where Tri21 are concurrently present was identified. The large collection of Tri21 cases with a diversity of clinical findings and a wide age range allowed us to determine the frequency of the different karyotypes of Down syndrome in China, given the fact that this kind of national epidemiological data is lacking currently.	[Zhao, Weiwei; Chen, Fan; Wu, Menghua; Jiang, Shuai; Wu, Binbin; Luo, Huali; Wen, Jingyi; Hu, Chaohui; Yu, Shihui] KingMed Genome Diagnost Lab, Guangzhou, Guangdong, Peoples R China; [Yu, Shihui] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [Yu, Shihui] Seattle Childrens Hosp, Seattle, WA USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital	Yu, SH (corresponding author), KingMed Genome Diagnost Lab, Guangzhou, Guangdong, Peoples R China.	shihui.yu@seattlechildrens.org			KingMed Genome Diagnostic Laboratory	KingMed Genome Diagnostic Laboratory	KingMed Genome Diagnostic Laboratory provided support in the form of salaries for authors WWZ, FC, MHW, SJ, BBW, HLL, JYW, and CHH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alfarawati S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003025; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Bandyopadhyay R, 2001, CHROMOSOME RES, V9, P235, DOI 10.1023/A:1016652621226; Bornstein E, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.017; Carothers AD, 1999, J MED GENET, V36, P386; Chen SP, 2013, PRENATAL DIAG, V33, P584, DOI 10.1002/pd.4110; Deng C, 2014, PRENAT DIAGN; Devlin L, 2004, Ulster Med J, V73, P4; Freeman SB, 2008, GENET MED, V10, P173, DOI 10.1097/GIM.0b013e3181634867; Gardner R, 2012, CHROMOSOME ABNORMALI, V4th; Griffin DK, 1996, AM J HUM GENET, V59, P1108; Hecht CA, 1996, AM J MED GENET, V62, P376, DOI 10.1002/(SICI)1096-8628(19960424)62:4<376::AID-AJMG10>3.0.CO;2-L; Hindley D, 2002, ARCH DIS CHILD-FETAL, V87, P220, DOI 10.1136/fn.87.3.F220; Hook EB, 1999, AM J MED GENET, V84, P316, DOI 10.1002/(SICI)1096-8628(19990604)84:4<316::AID-AJMG2>3.3.CO;2-T; Hoshi N, 1999, AM J MED GENET, V84, P340, DOI 10.1002/(SICI)1096-8628(19990604)84:4<340::AID-AJMG6>3.0.CO;2-N; Huether CA, 1996, AM J MED GENET, V63, P492, DOI 10.1002/(SICI)1096-8628(19960614)63:3<492::AID-AJMG15>3.0.CO;2-H; Hulten MA, 2010, CURR GENOMICS, V11, P409, DOI 10.2174/138920210793176056; Hulten MA, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-4; Hulten MA, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-21; Jackson-Cook C, 2011, CLIN LAB MED, V31, P481, DOI 10.1016/j.cll.2011.08.002; Jon HJ, 2005, PRENATAL DIAG, V25, P665, DOI 10.1002/pd.1220; Lai FM, 2002, SINGAP MED J, V43; Loane M, 2013, EUR J HUM GENET, V21, P27, DOI 10.1038/ejhg.2012.94; Mai CT, 2013, BIRTH DEFECTS RES A, V97, P709, DOI 10.1002/bdra.23198; Mandava S, 2010, GENET TEST MOL BIOMA, V14, P499, DOI 10.1089/gtmb.2009.0167; Mansfield C, 1999, PRENATAL DIAG, V19, P808, DOI 10.1002/(SICI)1097-0223(199909)19:9<808::AID-PD637>3.0.CO;2-B; Morris JK, 2012, AM J MED GENET A, V158A, P1151, DOI 10.1002/ajmg.a.35248; Murthy SK, 2007, MED PRIN PRACT, V16, P25, DOI 10.1159/000096136; Mutton D, 1996, J MED GENET, V33, P387, DOI 10.1136/jmg.33.5.387; Natoli JL, 2012, PRENATAL DIAG, V32, P142, DOI 10.1002/pd.2910; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; O'Nuallain S, 2007, Ir Med J, V100, P329; Papavassiliou P, 2015, AM J MED GENET A, V167, P26, DOI 10.1002/ajmg.a.36861; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Pennington BF, 2003, CHILD DEV, V74, P75, DOI 10.1111/1467-8624.00522; Shin M, 2010, AM J MED GENET A, V152A, P800, DOI 10.1002/ajmg.a.33295; Skotko BG, 2009, PEDIATRICS, V124, pE751, DOI 10.1542/peds.2009-0480; Stoll C, 1998, ANN GENET-PARIS, V41, P44; Zhang H, 2015, ULTRASOUND OBSTET GY; Zhu JL, 2013, GENET MED, V15, P64, DOI 10.1038/gim.2012.93	40	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133151	10.1371/journal.pone.0133151	http://dx.doi.org/10.1371/journal.pone.0133151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176847	Green Submitted, gold, Green Published			2022-12-27	WOS:000358197600220
J	Chung, HJ; Pellegrini, KL; Chung, J; Wanigasuriya, K; Jayawardene, I; Lee, K; Lee, H; Vaidya, VS; Weissleder, R				Chung, Hyun Jung; Pellegrini, Kathryn L.; Chung, Jaehoon; Wanigasuriya, Kamani; Jayawardene, Innocent; Lee, Kyungheon; Lee, Hakho; Vaidya, Vishal S.; Weissleder, Ralph			Nanoparticle Detection of Urinary Markers for Point-of-Care Diagnosis of Kidney Injury	PLOS ONE			English	Article							BIOMARKERS; CELLS	The high incidence of acute and chronic kidney injury due to various environmental factors such as heavy metals or chemicals has been a major problem in developing countries. However, the diagnosis of kidney injury in these areas can be more challenging due to the lack of highly sensitive and specific techniques that can be applied in point-of-care settings. To address this, we have developed a technique called 'micro-urine nanoparticle detection (mu UNPD)', that allows the detection of trace amounts of molecular markers in urine. Specifically, this technique utilizes an automated on-chip assay followed by detection with a hand-held device for the read-out. Using the mu UNPD technology, the kidney injury markers KIM-1 and Cystatin C were detected down to concentrations of 0.1 ng/ml and 20 ng/ml respectively, which meets the cut-off range required to identify patients with acute or chronic kidney injury. Thus, we show that the mu UNPD technology enables point of care and non-invasive detection of kidney injury, and has potential for applications in diagnosing kidney injury with high sensitivity in resource-limited settings.	[Chung, Hyun Jung; Chung, Jaehoon; Lee, Kyungheon; Lee, Hakho; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Pellegrini, Kathryn L.; Vaidya, Vishal S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Renal Div,Dept Med, Boston, MA 02115 USA; [Wanigasuriya, Kamani] Univ Sri Jayewardenepura, Fac Med Sci, Dept Med, Nugegoda, Sri Lanka; [Jayawardene, Innocent] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab,Dept Med, Boston, MA 02115 USA; [Jayawardene, Innocent] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Vaidya, Vishal S.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University Sri Jayewardenepura; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Weissleder, R (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, 185 Cambridge St,CPZN 5206, Boston, MA 02114 USA.	rweissleder@mgh.harvard.edu	Chung, Hyun Jung/J-3205-2014	/0000-0003-0828-4143; Pellegrini, Kathryn/0000-0002-5089-5477	National Institute of Health [HHSN268201000044C, U54 CA151884]; National Institute of Environmental Health Sciences [ES017543]; NATIONAL CANCER INSTITUTE [U54CA151884] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES017543, R01ES017543] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work in the Weissleder laboratory was funded in parts by National Institute of Health grants HHSN268201000044C and U54 CA151884. The research in Vaidya laboratory was supported by Outstanding New Environmental Scientist Award (ES017543) from the National Institute of Environmental Health Sciences.	Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436; Bonventre JV, 2009, NEPHROL DIAL TRANSPL, V24, P3265, DOI 10.1093/ndt/gfp010; Chung HJ, 2013, NAT NANOTECHNOL, V8, P369, DOI [10.1038/nnano.2013.70, 10.1038/NNANO.2013.70]; Chung HJ, 2011, ACS NANO, V5, P8834, DOI 10.1021/nn2029692; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Devaraj NK, 2009, ANGEW CHEM INT EDIT, V48, P7013, DOI 10.1002/anie.200903233; Ferguson MA, 2012, CLIN CHEM, V58, P680, DOI 10.1373/clinchem.2011.167494; Ghazani AA, 2014, NANOMED-NANOTECHNOL, V10, P661, DOI 10.1016/j.nano.2013.10.008; Gupta BK, 2012, SMALL, V8, P3028, DOI 10.1002/smll.201200909; Haun JB, 2010, NAT NANOTECHNOL, V5, P660, DOI [10.1038/NNANO.2010.148, 10.1038/nnano.2010.148]; Iqbal MCM, 2014, SCIENCE, V344, P981, DOI 10.1126/science.344.6187.981-b; Koyner JL, 2008, KIDNEY INT, V74, P1059, DOI 10.1038/ki.2008.341; Lee H, 2008, NAT MED, V14, P869, DOI 10.1038/nm.1711; Li Z, 2011, SMALL, V7, P3193, DOI 10.1002/smll.201100959; Shao HL, 2012, NAT MED, V18, P1835, DOI 10.1038/nm.2994; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Vaidya VS, 2009, KIDNEY INT, V76, P108, DOI 10.1038/ki.2009.96; Vaidya VS, 2008, CTS-CLIN TRANSL SCI, V1, P200, DOI 10.1111/j.1752-8062.2008.00053.x; Vanmassenhove J, 2013, NEPHROL DIAL TRANSPL, V28, P254, DOI 10.1093/ndt/gfs380; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Yaqub F, 2014, LANCET, V383, P1794, DOI 10.1016/S0140-6736(14)60867-9	23	25	25	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133417	10.1371/journal.pone.0133417	http://dx.doi.org/10.1371/journal.pone.0133417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186708	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700136
J	Colombo, MC; Giverso, C; Faggiano, E; Boffano, C; Acerbi, F; Ciarletta, P				Colombo, Maria Cristina; Giverso, Chiara; Faggiano, Elena; Boffano, Carlo; Acerbi, Francesco; Ciarletta, Pasquale			Towards the Personalized Treatment of Glioblastoma: Integrating Patient-Specific Clinical Data in a Continuous Mechanical Model	PLOS ONE			English	Article							SOLID TUMOR-GROWTH; MATHEMATICAL-MODEL; BRAIN-TUMORS; GLIOMA GROWTH; GUIDED SURGERY; PHASE-III; DIFFUSION; RESECTION; EXTENT; MRI	Glioblastoma multiforme (GBM) is the most aggressive and malignant among brain tumors. In addition to uncontrolled proliferation and genetic instability, GBM is characterized by a diffuse infiltration, developing long protrusions that penetrate deeply along the fibers of the white matter. These features, combined with the underestimation of the invading GBM area by available imaging techniques, make a definitive treatment of GBM particularly difficult. A multidisciplinary approach combining mathematical, clinical and radiological data has the potential to foster our understanding of GBM evolution in every single patient throughout his/her oncological history, in order to target therapeutic weapons in a patient-specific manner. In this work, we propose a continuous mechanical model and we perform numerical simulations of GBM invasion combining the main mechano-biological characteristics of GBM with the micro-structural information extracted from radiological images, i.e. by elaborating patient-specific Diffusion Tensor Imaging (DTI) data. The numerical simulations highlight the influence of the different biological parameters on tumor progression and they demonstrate the fundamental importance of including anisotropic and heterogeneous patient-specific DTI data in order to obtain a more accurate prediction of GBM evolution. The results of the proposed mathematical model have the potential to provide a relevant benefit for clinicians involved in the treatment of this particularly aggressive disease and, more importantly, they might drive progress towards improving tumor control and patient's prognosis.	[Colombo, Maria Cristina; Giverso, Chiara; Faggiano, Elena] Politecn Milan, MOX Dept Math, I-20133 Milan, Italy; [Colombo, Maria Cristina; Giverso, Chiara] Fdn CEN, I-20133 Milan, Italy; [Faggiano, Elena] Politecn Milan, Labs Dept Chem Mat & Chem Engn, I-20133 Milan, Italy; [Boffano, Carlo] Fdn IRCCS Ist Neurol Carlo Besta, Neuroradiol, I-20133 Milan, Italy; [Acerbi, Francesco] Fdn IRCCS Ist Neurol Carlo Besta, Dept Neurosurg, I-20133 Milan, Italy; [Ciarletta, Pasquale] Univ Paris 06, Sorbonne Univ, CNRS, Inst Jean Rond Alembert,UMR 7190, F-75005 Paris, France	Polytechnic University of Milan; Polytechnic University of Milan; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Sorbonne Universite	Ciarletta, P (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS, Inst Jean Rond Alembert,UMR 7190, F-75005 Paris, France.	pasquale.ciarletta@upmc.fr	Ciarletta, Pasquale/L-2052-2015; Acerbi, Francesco/K-6810-2016	Ciarletta, Pasquale/0000-0002-1011-5587; Acerbi, Francesco/0000-0002-4063-3924; Faggiano, Elena/0000-0001-5027-3910	"Start-up Packages and PhD Program" project - Regione Lombardia through the "Fondo per lo sviluppo e la coesione"; Progetto Giovani GNFM - National Group of Mathematical Physics (GNFM-INdAM)	"Start-up Packages and PhD Program" project - Regione Lombardia through the "Fondo per lo sviluppo e la coesione"; Progetto Giovani GNFM - National Group of Mathematical Physics (GNFM-INdAM)	This work was partially supported by the "Start-up Packages and PhD Program" project, co-funded by Regione Lombardia through the "Fondo per lo sviluppo e la coesione 2007-2013 -formerly FAS", and by the "Progetto Giovani GNFM 2014," funded by the National Group of Mathematical Physics (GNFM-INdAM).	Acerbi F, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2013.11.FOCUS13487; Acerbi F, 2013, ACTA NEUROCHIR, V155, P1277, DOI 10.1007/s00701-013-1734-9; Ambrosi D, 2002, MATH MOD METH APPL S, V12, P737, DOI 10.1142/S0218202502001878; Ambrosi D, 2002, INT J ENG SCI, V40, P1297, DOI 10.1016/S0020-7225(02)00014-9; Antiga L, 2008, MED BIOL ENG COMPUT, V46, P1097, DOI 10.1007/s11517-008-0420-1; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; Arbit E, 1994, INTRACRANIAL PRESSUR, P609; Artzi M, 2015, J NEURO-ONCOL, V121, P349, DOI 10.1007/s11060-014-1639-3; Barazzuol L, 2010, J THEOR BIOL, V262, P553, DOI 10.1016/j.jtbi.2009.10.021; Bondiau PY, 2008, PHYS MED BIOL, V53, P879, DOI 10.1088/0031-9155/53/4/004; Boucher Y, 1997, BRIT J CANCER, V75, P829, DOI 10.1038/bjc.1997.148; Bowen RM., 1976, CONTINUUM PHYS, V3; Bruehlmeier M, 2003, J NUCL MED, V44, P1210; Burgess PK, 1997, J NEUROPATH EXP NEUR, V56, P704; Byrne H, 2003, MATH MED BIOL, V20, P341; Byrne HM, 2006, PHILOS T R SOC A, V364, P1563, DOI 10.1098/rsta.2006.1786; Byrne HM, 2003, APPL MATH LETT, V16, P567, DOI 10.1016/S0893-9659(03)00038-7; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chatelain C, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/11/115013; Chen LL, 2010, PHYS MED BIOL, V55, P329, DOI 10.1088/0031-9155/55/2/001; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Clatz O, 2005, IEEE T MED IMAGING, V24, P1334, DOI 10.1109/TMI.2005.857217; Corwin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079115; CRANK J, 1947, P CAMB PHILOS SOC, V43, P50, DOI 10.1007/BF02127704; Cristini V, 2009, J MATH BIOL, V58, P723, DOI 10.1007/s00285-008-0215-x; Deisboeck TS, 2001, CELL PROLIFERAT, V34, P115, DOI 10.1046/j.1365-2184.2001.00202.x; DOI M, 1992, J PHYS II, V2, P1631, DOI 10.1051/jp2:1992225; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Engwer C, 2014, J MATH BIOL, P09; FORD RM, 1991, B MATH BIOL, V53, P721; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Harpold HLP, 2007, J NEUROPATH EXP NEUR, V66, P1, DOI 10.1097/nen.0b013e31802d9000; Hatzikirou H, 2005, MATH MOD METH APPL S, V15, P1779, DOI 10.1142/S0218202505000960; Hillen T, 2009, J MATH BIOL, V58, P183, DOI 10.1007/s00285-008-0201-3; Hogea C, 2008, J MATH BIOL, V56, P793, DOI 10.1007/s00285-007-0139-x; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jain RK, 2014, ANNU REV BIOMED ENG, V16, P321, DOI 10.1146/annurev-bioeng-071813-105259; Jbabdi S, 2005, MAGN RESON MED, V54, P616, DOI 10.1002/mrm.20625; JELLINGER K, 1978, ACTA NEUROCHIR, V42, P5, DOI 10.1007/BF01406628; Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640; Jung SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069323; Kansal AR, 2000, J THEOR BIOL, V203, P367, DOI 10.1006/jtbi.2000.2000; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Kiran KL, 2009, CAN J CHEM ENG, V87, P732, DOI 10.1002/cjce.20204; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Logg A, 2012, AUTOMATED SOLUTION D, V84, P141; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Martinez-Gonzalez A, 2012, B MATH BIOL, V74, P2875, DOI 10.1007/s11538-012-9786-1; McAuliffe MJ, 2001, COMP MED SY, P381; McGirt MJ, 2009, J NEUROSURG, V110, P156, DOI 10.3171/2008.4.17536; Moreira J, 2002, ADV COMPLEX SYST, V5, P247, DOI [10.1142/s0219525902000572, DOI 10.1142/S0219525902000572]; Neal ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051951; Okegawa T, 2004, ACTA BIOCHIM POL, V51, P445; Painter KJ, 2013, J THEOR BIOL, V323, P25, DOI 10.1016/j.jtbi.2013.01.014; Painter KJ, 2009, B MATH BIOL, V71, P1117, DOI 10.1007/s11538-009-9396-8; Pieper S, 2004, IEEE INT S BIOMED IM, V26, P632, DOI DOI 10.1109/ISBI.2004.1398617; PIERPAOLI C, 2010, ISMRM P, V18, P1597; POHL KM, 2004, BIOM IM NAN MACR 200, P81; Porter KR, 2010, NEURO-ONCOLOGY, V12, P520, DOI 10.1093/neuonc/nop066; Provenzale JM, 2006, RADIOLOGY, V239, P632, DOI 10.1148/radiol.2393042031; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Roose T, 2007, SIAM REV, V49, P179, DOI 10.1137/S0036144504446291; Sander LM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051901; Schuetz TA, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/437094; Senft C, 2011, LANCET ONCOL, V12, P997, DOI 10.1016/S1470-2045(11)70196-6; Shieh AC, 2011, ANN BIOMED ENG, V39, P1379, DOI 10.1007/s10439-011-0252-2; Si H, 2006, WEIERSTRASS INSTITUT; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Suarez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039616; SWABB EA, 1974, CANCER RES, V34, P2814; Swanson KR, 2008, BRIT J CANCER, V98, P113, DOI 10.1038/sj.bjc.6604125; Swanson KR, 2000, CELL PROLIFERAT, V33, P317, DOI 10.1046/j.1365-2184.2000.00177.x; Swanson KR, 2003, J NEUROL SCI, V216, P1, DOI 10.1016/j.jns.2003.06.001; Swanson KR, 2003, MATH COMPUT MODEL, V37, P1177, DOI 10.1016/S0895-7177(03)00129-8; Swanson KR, 2002, ACTA BIOTHEOR, V50, P223, DOI 10.1023/A:1022644031905; Tanaka ML, 2009, CELL PROLIFERAT, V42, P637, DOI 10.1111/j.1365-2184.2009.00631.x; Toma A, 2013, CURR MED IMAGING, V9, P145, DOI 10.2174/1573405611309020010; Tonn Jorg-Christian, 2008, Clin Neurosurg, V55, P20; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; TRACQUI P, 1995, CELL PROLIFERAT, V28, P17, DOI 10.1111/j.1365-2184.1995.tb00036.x; Tracqui P, 1995, ACTA BIOTHEOR, V43, P443, DOI 10.1007/BF00713564; Walker L, 2011, NEUROIMAGE, V54, P1168, DOI 10.1016/j.neuroimage.2010.08.048; Wise SM, 2008, J THEOR BIOL, V253, P524, DOI 10.1016/j.jtbi.2008.03.027; Woodward DE, 1996, CELL PROLIFERAT, V29, P269, DOI 10.1111/j.1365-2184.1996.tb01580.x; Wu M, 2008, LECT NOTES COMPUT SC, V5242, P321, DOI 10.1007/978-3-540-85990-1_39; Yankeelov TE, 2010, INTEGR BIOL-UK, V2, P338, DOI 10.1039/b921497f; Zhang JY, 2007, MAGN RESON MED, V58, P454, DOI 10.1002/mrm.21371	91	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132887	10.1371/journal.pone.0132887	http://dx.doi.org/10.1371/journal.pone.0132887			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186462	Green Published, gold			2022-12-27	WOS:000358198700068
J	Cooksey, R; Husain, MJ; Brophy, S; Davies, H; Rahman, MA; Atkinson, MD; Phillips, CJ; Siebert, S				Cooksey, Roxanne; Husain, Muhammad J.; Brophy, Sinead; Davies, Helen; Rahman, Muhammad A.; Atkinson, Mark D.; Phillips, Ceri J.; Siebert, Stefan			The Cost of Ankylosing Spondylitis in the UK Using Linked Routine and Patient-Reported Survey Data	PLOS ONE			English	Article							3 EUROPEAN COUNTRIES; HEALTH-CARE COSTS; QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; WORK PRODUCTIVITY; QUESTIONNAIRE; PERSPECTIVE; VALIDITY; ILLNESS	Background Ankylosing spondylitis (AS) is a chronic inflammatory arthritis which typically begins in early adulthood and impacts on healthcare resource utilisation and the ability to work. Previous studies examining the cost of AS have relied on patient-reported questionnaires based on recall. This study uses a combination of patient-reported and linked-routine data to examine the cost of AS in Wales, UK. Methods Participants in an existing AS cohort study (n = 570) completed questionnaires regarding work status, out-of-pocket expenses, visits to health professionals and disease severity. Participants gave consent for their data to be linked to routine primary and secondary care clinical datasets. Health resource costs were calculated using a bottom-up micro-costing approach. Human capital costs methods were used to estimate work productivity loss costs, particularly relating to work and early retirement. Regression analyses were used to account for age, gender, disease activity. Results The total cost of AS in the UK is estimated at 19016 pound per patient per year, calculated to include GP attendance, administration costs and hospital costs derived from routine data records, plus patient-reported non-NHS costs, out-of-pocket AS-related expenses, early retirement, absenteeism, presenteeism and unpaid assistance costs. The majority of the cost (>80%) was as a result of work-related costs. Conclusion The major cost of AS is as a result of loss of working hours, early retirement and unpaid carer's time. Therefore, much of AS costs are hidden and not easy to quantify. Functional impairment is the main factor associated with increased cost of AS. Interventions which keep people in work to retirement age and reduce functional impairment would have the greatest impact on reducing costs of AS. The combination of patient-reported and linked routine data significantly enhanced the health economic analysis and this methodology that can be applied to other chronic conditions.	[Cooksey, Roxanne; Brophy, Sinead; Davies, Helen; Rahman, Muhammad A.; Atkinson, Mark D.] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Husain, Muhammad J.] Keele Univ, Keele Management Sch, Newcastle Upon Tyne, Tyne & Wear, England; [Phillips, Ceri J.] Swansea Univ, Coll Human & Hlth Sci, Swansea, W Glam, Wales; [Siebert, Stefan] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	Swansea University; Keele University; Swansea University; University of Glasgow	Cooksey, R (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	r.cooksey@swansea.ac.uk	Atkinson, Mark D/K-1813-2013; Rahman, Muhammad Azizur/GLR-8606-2022	Atkinson, Mark D/0000-0003-4237-3588; Rahman, Muhammad Azizur/0000-0002-0805-7461; Phillips, Ceri/0000-0003-1076-9289; Cooksey, Roxanne/0000-0002-6763-9373; Siebert, Stefan/0000-0002-1802-7311; Brophy, Sinead/0000-0001-7417-2858; Husain, Muhammad Jami/0000-0001-6049-0505	Medical Research Council; National Institute for Social care and Health Research (NISCHR) as part of their Patient Research Cohort Initiative [G0800583]; I-CRP award from Pfizer; Medical Research Council [G0800583, MR/K006525/1] Funding Source: researchfish; MRC [MR/K006525/1, G0800583] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Social care and Health Research (NISCHR) as part of their Patient Research Cohort Initiative; I-CRP award from Pfizer; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The PAS cohort was funded by the Medical Research Council and the National Institute for Social care and Health Research (NISCHR) as part of their Patient Research Cohort Initiative (grant number: G0800583) (SB & SS). The health economics component was funded by an I-CRP award from Pfizer (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara RM, 2008, RHEUMATOLOGY, V47, P68, DOI 10.1093/rheumatology/kem296; Atkinson MD, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-197; Bakland G, 2011, J RHEUMATOL, V38, P479, DOI 10.3899/jrheum.100686; Boonen A, 2003, ANN RHEUM DIS, V62, P741, DOI 10.1136/ard.62.8.741; Boonen A, 2003, ANN RHEUM DIS, V62, P732, DOI 10.1136/ard.62.8.732; Boonen A, 2002, ANN RHEUM DIS, V61, P429, DOI 10.1136/ard.61.5.429; Boonen A, 2010, ANN RHEUM DIS, V69, P1123, DOI 10.1136/ard.2009.116764; CALIN A, 1994, J RHEUMATOL, V21, P2281; Coons SJ, 2009, VALUE HEALTH, V12, P419, DOI 10.1111/j.1524-4733.2008.00470.x; Curtis L., 2010, UNIT COSTS HLTH SOCI; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Hamilton L, 2011, RHEUMATOLOGY, V50, P1991, DOI 10.1093/rheumatology/ker013; Healey EL, 2011, SCAND J RHEUMATOL, V40, P34, DOI 10.3109/03009742.2010.487838; Hodgson TA, 1982, MILBANK MEM FUND Q, V6, P429; Hulsemann JL, 2005, ANN RHEUM DIS, V64, P1456, DOI 10.1136/ard.2004.031880; Husain MJ, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-24; Huscher D, 2006, ANN RHEUM DIS, V65, P1175, DOI 10.1136/ard.2005.046367; Kobelt G, 2006, J RHEUMATOL, V33, P289; Kobelt G, 2008, VALUE HEALTH, V11, P408, DOI 10.1111/j.1524-4733.2007.00252.x; Lerner D, 2002, J CLIN EPIDEMIOL, V55, P197, DOI 10.1016/S0895-4356(01)00424-3; Lerner D, 2001, MED CARE, V39, P72, DOI 10.1097/00005650-200101000-00009; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Merkesdal S, 2005, ARTHRIT RHEUM-ARTHR, V53, P234, DOI 10.1002/art.21080; NWIS, 2010, PRESCR COST AN WAL 2; Pincus T, 2001, BRIT J CLIN PSYCHOL, V40, P143, DOI 10.1348/014466501163599; Poole CD, 2010, RHEUMATOLOGY, V49, P1949, DOI 10.1093/rheumatology/keq182; Rafia R, 2012, CLIN EXP RHEUMATOL, V30, P246; Reilly MC, 2010, RHEUMATOLOGY, V49, P812, DOI 10.1093/rheumatology/kep457; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; RICE DP, 1967, AM J PUBLIC HEALTH N, V57, P424, DOI 10.2105/AJPH.57.3.424; Singh JA, 2009, RHEUMATOLOGY, V48, P272, DOI 10.1093/rheumatology/ken472; Strombeck B, 2010, J RHEUMATOL, V37, P2348, DOI 10.3899/jrheum.100099; Verstappen SMM, 2007, ANN RHEUM DIS, V66, P727, DOI 10.1136/ard.2006.061283; Verstappen SMM, 2005, ANN RHEUM DIS, V64, P1754, DOI 10.1136/ard.2004.033977; Zhu TY, 2008, RHEUMATOLOGY, V47, P1422, DOI 10.1093/rheumatology/ken287; 1990, HLTH POLICY, V16, P199	37	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0126105	10.1371/journal.pone.0126105	http://dx.doi.org/10.1371/journal.pone.0126105			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26185984	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000358198700001
J	Howie, RN; Borke, JL; Kurago, Z; Daoudi, A; Cray, J; Zakhary, IE; Brown, TL; Raley, JN; Tran, LT; Messer, R; Medani, F; Elsalanty, ME				Howie, R. Nicole; Borke, James L.; Kurago, Zoya; Daoudi, Asma; Cray, James; Zakhary, Ibrahim E.; Brown, Tara L.; Raley, J. Nathan; Tran, Loan T.; Messer, Regina; Medani, Fardous; Elsalanty, Mohammed E.			A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma	PLOS ONE			English	Article							BISPHOSPHONATE-RELATED OSTEONECROSIS; INDUCE OSTEONECROSIS; RAT MODEL; PERIAPICAL DISEASE; ANIMAL-MODEL; BONE; ACID; CANCER; MICE; HISTOMORPHOMETRY	This study aims to develop a reproducible rat model for post-traumatic bisphosphonate-related osteonecrosis of the jaw (BRONJ). In our previous studies using dental extraction as an inducing factor, only 30% - 60% of zoledronate-treated animals fulfilled the definition of clinical BRONJ. We modified the zoledronate regimen and introduced repeated surgical extraction to illicit quantifiable BRONJ in all animals. Eighty retired-breeder female Sprague-Dawley rats were divided between the treatment (IV zoledronate; 80 mu g/kg/week for 13 weeks) and control (saline) groups. On week 13, the left mandibular first molar was surgically extracted, followed by the second molar a week later. Animals were euthanized at 1-week, 2-weeks, and 8-weeks following extraction. The occurrence and severity of BRONJ were scored in each animal based on gross and MicroCT analysis. Parameters of bone formation and osteoclast functions at the extraction site were compared between groups. All zoledronate-treated animals developed a severe case of BRONJ that fulfilled the clinical definition of the condition in humans. Osteoclast attachment continued to be defective eight weeks after stopping the treatment. There were no signs of kidney or liver toxicity. Our data confirmed that repeated surgical extraction (major trauma) by itself consistently precipitated massive bone necrosis in ZA-treated animals, eliminating the need to induce pre-existing infection or comorbidity. These results will be the basis for further studies examining the in-vivo pathogenesis and prevention of BRONJ.	[Howie, R. Nicole; Kurago, Zoya; Brown, Tara L.; Raley, J. Nathan; Tran, Loan T.; Messer, Regina; Medani, Fardous; Elsalanty, Mohammed E.] Georgia Regents Univ, Coll Dent Med, Augusta, GA 30912 USA; [Borke, James L.] Western Univ Hlth Sci, Coll Dent Med, Pomona, CA USA; [Daoudi, Asma] Georgia Regents Univ, Coll Sci & Math, Augusta, GA USA; [Cray, James] Med Univ S Carolina, Coll Dent Med, Charleston, SC 29425 USA; [Zakhary, Ibrahim E.] Univ Detroit Mercy, Sch Dent, Detroit, MI 48221 USA	University System of Georgia; Augusta University; Western University of Health Sciences; University System of Georgia; Augusta University; Medical University of South Carolina; University of Detroit Mercy	Elsalanty, ME (corresponding author), Georgia Regents Univ, Coll Dent Med, Augusta, GA 30912 USA.	melsalanty@gru.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [1P01AG036675]; National Institute of Dental and Craniofacial Research (NIDCR) [1R15DE025134-01]; Georgia Regents University Extramural Success Award (ESA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R15DE025134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036675] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Georgia Regents University Extramural Success Award (ESA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 1P01AG036675, The National Institute of Dental and Craniofacial Research (NIDCR) 1R15DE025134-01, and a Georgia Regents University Extramural Success Award (ESA).	Abtahi J, 2013, INT J ORAL MAX SURG, V42, P632, DOI 10.1016/j.ijom.2013.02.007; Abtahi J, 2013, J DENT RES, V92, P279, DOI 10.1177/0022034512472335; Abtahi J, 2012, J ORAL PATHOL MED, V41, P494, DOI 10.1111/j.1600-0714.2011.01125.x; Aghaloo TL, 2014, J BONE MINER RES, V29, P843, DOI 10.1002/jbmr.2097; Aghaloo TL, 2014, J ORAL MAXIL SURG, V72, P702, DOI 10.1016/j.joms.2013.09.008; Aghaloo TL, 2011, J BONE MINER RES, V26, P1871, DOI 10.1002/jbmr.379; Aguirre JI, 2012, J BONE MINER RES, V27, P2130, DOI 10.1002/jbmr.1669; Ali-Erdem M, 2011, MED ORAL PATOL ORAL, V16, pC879, DOI 10.4317/medoral.17150; Allen MR, 2011, OSTEOPOROSIS INT, V22, P693, DOI 10.1007/s00198-010-1268-4; Allen MR, 2011, ODONTOLOGY, V99, P8, DOI 10.1007/s10266-010-0153-0; Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670; Biasotto M, 2010, J ORAL PATHOL MED, V39, P390, DOI 10.1111/j.1600-0714.2009.00878.x; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Boabaid F, 2004, J PERIODONTOL, V75, P1247, DOI 10.1902/jop.2004.75.9.1247; Cankaya AB, 2011, INT J MED SCI, V8, P667, DOI 10.7150/ijms.8.667; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Doggrell SA, 2009, EXPERT REV ANTICANC, V9, P1211, DOI [10.1586/era.09.95, 10.1586/ERA.09.95]; ENGBAEK K, 1979, J CLIN PATHOL, V32, P187, DOI 10.1136/jcp.32.2.187; Ersan N, 2014, DENTOMAXILLOFAC RAD, V43, DOI 10.1259/dmfr.20130144; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gabriel P, 2008, AM SOC HEM 50 ANN M; Guevarra CS, 2013, J ORAL IMPLANTOL; Herberg S, 2013, TISSUE ENG A; Jabbour Z, 2014, ORAL ONCOL, V50, P485, DOI 10.1016/j.oraloncology.2014.02.013; Kang B, 2013, J BONE MINER RES, V28, P1631, DOI 10.1002/jbmr.1894; Khan AA, 2015, J BONE MINER RES, V30, P3, DOI 10.1002/jbmr.2405; Kikuiri T, 2010, J BONE MINER RES, V25, P1668, DOI 10.1002/jbmr.37; Kozloff KM, 2010, J BONE MINER RES, V25, P1748, DOI 10.1002/jbmr.66; Landesberg R, 2011, ANN NY ACAD SCI, V1218, P62, DOI 10.1111/j.1749-6632.2010.05835.x; Leu CT, 2006, BONE, V38, P628, DOI 10.1016/j.bone.2005.07.023; Marino KL, 2012, J ORAL IMPLANTOL, V38, P511, DOI 10.1563/AAID-JOI-D-11-00057; Neto NC, 2013, INT J EXP PATHOL, V94, P65, DOI 10.1111/iep.12007; Palaska PK, 2009, ONCOLOGIST; Pautke C, 2012, BONE, V51, P592, DOI 10.1016/j.bone.2012.04.020; Reid IR, 2012, NAT REV RHEUMATOL, V8, P90, DOI 10.1038/nrrheum.2011.181; Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807; Ruggiero S, 2014, MED RELATED OSTEONEC; Ruggiero SL, 2009, AUST ENDOD J, V35, P119, DOI 10.1111/j.1747-4477.2009.00213.x; Sonis ST, 2009, ORAL ONCOL, V45, P164, DOI 10.1016/j.oraloncology.2008.04.013; VIGNERY A, 1980, ANAT REC, V196, P191, DOI 10.1002/ar.1091960210; Weiss HM, 2008, DRUG METAB DISPOS, V36, P2043, DOI 10.1124/dmd.108.021071; Xue DT, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-45	42	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132520	10.1371/journal.pone.0132520	http://dx.doi.org/10.1371/journal.pone.0132520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186665	gold, Green Published, Green Submitted			2022-12-27	WOS:000358198700047
J	Mazaheri, M; Moosavi-Movahedi, AA; Saboury, AA; Khodagholi, F; Shaerzadeh, F; Sheibani, N				Mazaheri, Mansooreh; Moosavi-Movahedi, Ali Akbar; Saboury, Ali Akbar; Khodagholi, Fariba; Shaerzadeh, Fatemeh; Sheibani, Nader			Curcumin Protects beta-Lactoglobulin Fibril Formation and Fibril-Induced Neurotoxicity in PC12Cells	PLOS ONE			English	Article							DISULFIDE BOND FORMATION; AFLATOXIN M-1; CHEESE PRODUCTION; TOXICITY; BINDING; CYTOTOXICITY; AGGREGATION; STABILITY; STORAGE; DAMAGE	In this study the beta-lactoglobulin fibrillation, in the presence or absence of lead ions, aflatoxin M1 and curcumin, was evaluated using ThT fluorescence, Circular dichroism spectroscopy and atomic force microscopy. To investigate the toxicity of the different form of beta-Lg fibrils, in the presence or absence of above toxins and curcumin, we monitored changes in the level of reactive oxygen species and morphology of the differentiated neuron-like PC12 cells. The cell viability, cell body area, average neurite length, neurite width, number of primary neurites, percent of bipolar cells and node/primary neurite ratios were used to assess the growth and complexity of PC12 cells exposed to different form of beta-Lg fibrils. Incubation of beta-Lg with curcumin resulted in a significant decrease in ROS levels even in the presence of lead ions and aflatoxin M1. The beta-Lg fibrils formed in the presence of lead ions and aflatoxin M1 attenuated the growth and complexity of PC12 cells compared with other form of beta-Lg fibrils. However, the adverse effects of these toxins and protein fibrils were negated in the presence of curcumin. Furthermore, the antioxidant and inhibitory effects of curcumin protected PC12 cells against fibril neurotoxicity and enhanced their survival. Thus, curcumin may provide a protective effect toward beta-Lg, and perhaps other protein, fibrils mediated neurotoxicity.	[Mazaheri, Mansooreh; Moosavi-Movahedi, Ali Akbar; Saboury, Ali Akbar] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran; [Mazaheri, Mansooreh] Standard Res Inst, Food Dept, Karaj, Iran; [Moosavi-Movahedi, Ali Akbar; Saboury, Ali Akbar] Univ Tehran, Ctr Excellence Biothermodynam, Tehran, Iran; [Khodagholi, Fariba; Shaerzadeh, Fatemeh] Shahid Beheshti Univ Med Sci, Neuro Biol Res Ctr, Tehran, Iran; [Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol, Madison, WI USA; [Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Visual Sci, Madison, WI USA	University of Tehran; University of Tehran; Shahid Beheshti University Medical Sciences; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Moosavi-Movahedi, AA (corresponding author), Univ Tehran, Inst Biochem & Biophys, Tehran, Iran.	moosavi@ut.ac.ir	Saboury, Ali Akbar/L-6136-2019; Mazaheri, Mansooreh/H-1464-2011; Sheibani, Nader/AAG-2379-2020; Mazaheri, Mansooreh/ABB-3490-2020; Khodagholi, Fariba/AAZ-4436-2020; Shaerzadeh, Fatemeh/L-4425-2017	Sheibani, Nader/0000-0003-2723-9217; Saboury, Ali Akbar/0000-0003-0604-9465; Khodagholi, Fariba/0000-0002-4911-4530; Moosavi-Movahedi, Ali Akbar/0000-0002-1707-8432; Shaerzadeh, Fatemeh/0000-0002-3342-4139; Mazaheri, Mansooreh/0000-0001-8568-6694	NATIONAL EYE INSTITUTE [R24EY022883] Funding Source: NIH RePORTER; NEI NIH HHS [R24 EY022883] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akkermans C, 2008, BIOMACROMOLECULES, V9, P1474, DOI 10.1021/bm7014224; Barzegar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026012; Brownlow S, 1997, STRUCTURE, V5, P481, DOI 10.1016/S0969-2126(97)00205-0; Bryant CM, 1998, TRENDS FOOD SCI TECH, V9, P143, DOI 10.1016/S0924-2244(98)00031-4; Cattaneo TMP, 2013, FOOD CONTROL, V32, P77, DOI 10.1016/j.foodcont.2012.11.007; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cornelis R, 2005, HDB ELEMENTAL SPECIA; Daniel S, 2004, J INORG BIOCHEM, V98, P266, DOI 10.1016/j.jinorgbio.2003.10.014; Deveci O, 2007, FOOD CONTROL, V18, P1103, DOI 10.1016/j.foodcont.2006.07.012; Divsalar A, 2005, FEBS J, V272, P340; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; DUFOUR E, 1992, J PROTEIN CHEM, V11, P645, DOI 10.1007/BF01024965; Fox PF, 2003, ADV DAIRY CHEM 1 PRO, P9; Gotz J, 2006, MED J AUSTRALIA, V185, P381, DOI 10.5694/j.1326-5377.2006.tb00615.x; Govaris A, 2001, FOOD ADDIT CONTAM A, V18, P437, DOI 10.1080/02652030010022700; Gupta SC, 2011, NAT PROD REP, V28, P1937, DOI 10.1039/c1np00051a; Huang WH, 2014, RSC ADV, V4, P52088, DOI 10.1039/c4ra09193k; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Iyer HV, 1996, J COLLOID INTERF SCI, V177, P391, DOI 10.1006/jcis.1996.0049; Jiang T, 2012, RSC ADV, V2, P9106, DOI 10.1039/c2ra21453a; Kachooei E, 2014, J BIOCHEM, V155, P361, DOI 10.1093/jb/mvu012; Kachooei E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041344; Kamkar A, 2008, FOOD CHEM TOXICOL, V46, P2236, DOI 10.1016/j.fct.2008.02.028; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Klafki HW, 2006, BRAIN, V129, P2840, DOI 10.1093/brain/awl280; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Kontopidis G, 2004, J DAIRY SCI, V87, P785, DOI 10.3168/jds.S0022-0302(04)73222-1; Kroes-Nijboer A, 2012, FOOD FUNCT, V3, P221, DOI 10.1039/c1fo10163c; Kroes-Nijboer A, 2011, LANGMUIR, V27, P5753, DOI 10.1021/la104797u; Kroes-Nijboer A, 2009, FOOD BIOPHYS, V4, P59, DOI 10.1007/s11483-009-9101-3; Kunwar A, 2006, BBA-GEN SUBJECTS, V1760, P1513, DOI 10.1016/j.bbagen.2006.06.012; Liu XY, 2010, NEUROCHEM INT, V57, P588, DOI 10.1016/j.neuint.2010.07.007; Manetta AC, 2009, FOOD CHEM, V113, P595, DOI 10.1016/j.foodchem.2008.07.091; Oruc HH, 2006, FOOD ADDIT CONTAM A, V23, P190, DOI 10.1080/02652030500389048; Patrick L, 2006, ALTERN MED REV, V11, P114; Picciano AL, 2013, BIOPHYS CHEM, V184, P62, DOI 10.1016/j.bpc.2013.09.004; PIKE CJ, 1991, EUR J PHARM-MOLEC PH, V207, P367, DOI 10.1016/0922-4106(91)90014-9; POLLACK SJ, 1995, NEUROSCI LETT, V184, P113, DOI 10.1016/0304-3940(94)11182-I; Rader AJ, 2002, P NATL ACAD SCI USA, V99, P3540, DOI 10.1073/pnas.062492699; Rehder DS, 2010, BIOCHEMISTRY-US, V49, P7748, DOI 10.1021/bi1008694; Relkin P, 1998, INT J BIOL MACROMOL, V22, P59, DOI 10.1016/S0141-8130(97)00089-5; Remondetto GE, 2003, BIOPOLYMERS, V69, P461, DOI 10.1002/bip.10423; Sardar S, 2014, INT J BIOL MACROMOL, V69, P137, DOI 10.1016/j.ijbiomac.2014.05.006; Schleeger M, 2013, POLYMER, V54, P2473, DOI 10.1016/j.polymer.2013.02.029; Scrocchi LA, 2003, DIABETOLOGIA, V46, pA49; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Shoval H, 2008, BBA-PROTEINS PROTEOM, V1784, P1570, DOI 10.1016/j.bbapap.2008.08.007; Sneharani AH, 2010, J AGR FOOD CHEM, V58, P11130, DOI 10.1021/jf102826q; Visschers RW, 2005, BIOTECHNOL ADV, V23, P75, DOI 10.1016/j.biotechadv.2004.09.005; Zako T, 2009, BIOPHYS J, V96, P3331, DOI 10.1016/j.bpj.2008.12.3957; Zhang C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012529	52	13	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0133206	10.1371/journal.pone.0133206	http://dx.doi.org/10.1371/journal.pone.0133206			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186474	Green Submitted, Green Published, gold			2022-12-27	WOS:000358198700108
J	Yu, Q; Vegh, V; Liu, FW; Turner, I				Yu, Qiang; Vegh, Viktor; Liu, Fawang; Turner, Ian			A Variable Order Fractional Differential-Based Texture Enhancement Algorithm with Application in Medical Imaging	PLOS ONE			English	Article							DIFFUSION EQUATION; NUMERICAL-METHODS; DIGITAL IMAGE; SPACE; APPROXIMATION; ENTROPY	Texture enhancement is one of the most important techniques in digital image processing and plays an essential role in medical imaging since textures discriminate information. Most image texture enhancement techniques use classical integral order differential mask operators or fractional differential mask operators using fixed fractional order. These masks can produce excessive enhancement of low spatial frequency content, insufficient enhancement of large spatial frequency content, and retention of high spatial frequency noise. To improve upon existing approaches of texture enhancement, we derive an improved Variable Order Fractional Centered Difference (VOFCD) scheme which dynamically adjusts the fractional differential order instead of fixing it. The new VOFCD technique is based on the second order Riesz fractional differential operator using a Lagrange 3-point interpolation formula, for both grey scale and colour image enhancement. We then use this method to enhance photographs and a set of medical images related to patients with stroke and Parkinson's disease. The experiments show that our improved fractional differential mask has a higher signal to noise ratio value than the other fractional differential mask operators. Based on the corresponding quantitative analysis we conclude that the new method offers a superior texture enhancement over existing methods.	[Yu, Qiang; Liu, Fawang; Turner, Ian] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Vegh, Viktor] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia	Queensland University of Technology (QUT); University of Queensland	Yu, Q (corresponding author), Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia.	qiang.yu@cai.uq.edu.au	Yu, Qiang/A-2275-2014; Liu, Fawang/G-3456-2010	Yu, Qiang/0000-0002-2664-8310; Liu, Fawang/0000-0003-1034-2349; Turner, Ian/0000-0003-2794-3968; Vegh, Viktor/0000-0002-4310-1421	Queensland University of Technology Write Up Scholarship	Queensland University of Technology Write Up Scholarship	This work was supported by Queensland University of Technology Write Up Scholarship (QY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chappard D, 2003, BIOMATERIALS, V24, P1399, DOI 10.1016/S0142-9612(02)00524-0; Chen DL, 2012, SIGNAL IMAGE VIDEO P, V6, P503, DOI 10.1007/s11760-012-0334-0; Chen DL, 2011, IEEE T CIRCUITS-II, V58, P758, DOI 10.1109/TCSII.2011.2168022; Do MN, 2005, IEEE T IMAGE PROCESS, V14, P2091, DOI 10.1109/TIP.2005.859376; Fazel S. A. A., 2011, Proceedings of the 2011 International Conference on Digital Image Computing: Techniques and Applications (DICTA 2011), P308, DOI 10.1109/DICTA.2011.58; Gao C, 2011, J COMPUT INF SYST, V7, P257; Gao CB, 2011, IET IMAGE PROCESS, V5, P261, DOI 10.1049/iet-ipr.2009.0409; Gao CB, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/325785; Garg V, 2012, INT J ADV COMPUT SC, V3, P130; Gilboa G, 2002, IEEE T IMAGE PROCESS, V11, P689, DOI 10.1109/TIP.2002.800883; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Gorenflo R., 1998, FRACT CALC APPL ANAL, V1, P167; GROENEWALD AM, 1993, PATTERN RECOGN LETT, V14, P567, DOI 10.1016/0167-8655(93)90107-O; Huang Guo, 2012, Journal of Shenyang University of Technology, V34, P446; Kumar R, 2005, INT J MACH TOOL MANU, V45, P228, DOI 10.1016/j.ijmachtools.2004.07.001; LeBihan D, 1995, NMR BIOMED, V8, P375, DOI 10.1002/nbm.1940080711; Liu F, 2007, APPL MATH COMPUT, V191, P12, DOI 10.1016/j.amc.2006.08.162; Liu F, 2004, J COMPUT APPL MATH, V166, P209, DOI 10.1016/j.cam.2003.09.028; Mathieu B, 2003, SIGNAL PROCESS, V83, P2421, DOI 10.1016/S0165-1684(03)00194-4; Ortigueira M. D., 2006, INT J MATH MATH SCI, V2006, DOI [DOI 10.1155/IJMMS/2006/48391, 10.1155/IJMMS/2006/48391]; Pal SK, 2005, PATTERN RECOGN LETT, V26, P2509, DOI 10.1016/j.patrec.2005.05.007; Panda CS, 2009, INT J IMAGE PROCESS, V3, P105; Pesquet-Popescu B, 2002, IEEE SIGNAL PROC MAG, V19, P48, DOI 10.1109/MSP.2002.1028352; Podlubny I., 1999, FRACTIONAL DIFFERENT; Pu YF, 2010, IEEE T IMAGE PROCESS, V19, P491, DOI 10.1109/TIP.2009.2035980; Pu YF, 2008, SCI CHINA SER F, V51, P1319, DOI 10.1007/s11432-008-0098-x; Roop JP, 2006, J COMPUT APPL MATH, V193, P243, DOI 10.1016/j.cam.2005.06.005; Sejdic E, 2011, SIGNAL PROCESS, V91, P1351, DOI 10.1016/j.sigpro.2010.10.008; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shuja SZ, 2001, COMPUT METHOD APPL M, V190, P3623, DOI 10.1016/S0045-7825(00)00291-7; Trampel R, 2002, MAGNET RESON MED, V48, P543, DOI 10.1002/mrm.10228; WESZKA JS, 1979, IEEE T SYST MAN CYB, V9, P38; Yang QQ, 2011, SIAM J SCI COMPUT, V33, P1159, DOI 10.1137/100800634; Yu Q, 2014, J COMPUT APPL MATH, V255, P635, DOI 10.1016/j.cam.2013.06.027; Yu Q, 2012, APPL MATH COMPUT, V219, P4082, DOI 10.1016/j.amc.2012.10.056; Yu Q, 2013, ANZIAM J, V54, pC590; Yu Q., 2013, THESIS QUEENSLAND U; Yu Q, 2011, ANZIAM J, V52, pC18; Yu Q, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0150; Zhang H, 2010, APPL MATH COMPUT, V217, P2534, DOI 10.1016/j.amc.2010.07.066; Zhang Y., 2010, J COMPUT INFORM SYST, V6, P3191; Zhuang P, 2009, SIAM J NUMER ANAL, V47, P1760, DOI 10.1137/080730597; Zhuang P, 2008, SIAM J NUMER ANAL, V46, P1079, DOI 10.1137/060673114	43	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2015	10	7							e0132952	10.1371/journal.pone.0132952	http://dx.doi.org/10.1371/journal.pone.0132952			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RV	26186221	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198700074
J	Korkola, JE; Collisson, EA; Heiser, L; Oates, C; Bayani, N; Itani, S; Esch, A; Thompson, W; Griffith, OL; Wang, NJ; Kuo, WL; Cooper, B; Billig, J; Ziyad, S; Hung, JL; Jakkula, L; Feiler, H; Lu, YL; Mills, GB; Spellman, PT; Tomlin, C; Mukherjee, S; Gray, JW				Korkola, James E.; Collisson, Eric A.; Heiser, Laura; Oates, Chris; Bayani, Nora; Itani, Sleiman; Esch, Amanda; Thompson, Wallace; Griffith, Obi L.; Wang, Nicholas J.; Kuo, Wen-Lin; Cooper, Brian; Billig, Jessica; Ziyad, Safiyyah; Hung, Jenny L.; Jakkula, Lakshmi; Feiler, Heidi; Lu, Yiling; Mills, Gordon B.; Spellman, Paul T.; Tomlin, Claire; Mukherjee, Sach; Gray, Joe W.			Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+Breast Cancer	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; KINASE INHIBITOR; CELL-LINES; TRASTUZUMAB; LAPATINIB; THERAPY; CHEMOTHERAPY; ACTIVATION; RESISTANCE; PIK3CA	We report here on experimental and theoretical efforts to determine how best to combine drugs that inhibit HER2 and AKT in HER2+ breast cancers. We accomplished this by measuring cellular and molecular responses to lapatinib and the AKT inhibitors (AKT(i)) GSK690693 and GSK2141795 in a panel of 22 HER2+ breast cancer cell lines carrying wild type or mutant PIK3CA. We observed that combinations of lapatinib plus AKTi were synergistic in HER2(+)/PIK3CA(mut) cell lines but not in HER2(+)/PIK3CA(wt)cell lines. We measured changes in phospho-protein levels in 15 cell lines after treatment with lapatinib, AKT(i) or lapatinib + AKT(i) to shed light on the underlying signaling dynamics. This revealed that pS6RP levels were less well attenuated by lapatinib in HER2(+)/PIK3CA(mut)cells compared to HER2(+)/PIK3CA(wt)cells and that lapatinib + AKT(i) reduced p-S6RP levels to those achieved in HER2(+)/PIK3CA(wt) cells with lapatinib alone. We also found that that compensatory upregulation of p-HER3 and p-HER2 is blunted in PIK3CA(mut) cells following lapatinib + AKT(i)-treatment. Responses of HER2(+) SKBR3 cells transfected with lentiviruses carrying control or PIK3CAmut sequences were similar to those observed in HER2(+)/PIK3CA(mut) cell lines but not in HER2(+)/PIK3CA(wt)cell lines. We used a nonlinear ordinary differential equation model to support the idea that PIK3CA mutations act as downstream activators of AKT that blunt lapatinib inhibition of downstream AKT signaling and that the effects of PIK3CA mutations can be countered by combining lapatinib with an AKT(i). This combination does not confer substantial benefit beyond lapatinib in HER2(+)/PIK3CA(wt) cells.	[Korkola, James E.; Heiser, Laura; Esch, Amanda; Thompson, Wallace; Wang, Nicholas J.; Feiler, Heidi; Spellman, Paul T.; Gray, Joe W.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97239 USA; [Bayani, Nora; Griffith, Obi L.; Kuo, Wen-Lin; Cooper, Brian; Billig, Jessica; Ziyad, Safiyyah; Hung, Jenny L.; Jakkula, Lakshmi; Feiler, Heidi] Lawrence Berkeley Natl Labs, Div Life Sci, Berkeley, CA USA; [Collisson, Eric A.] Univ Calif San Francisco, Div Heme Onc, San Francisco, CA 94143 USA; [Oates, Chris; Mukherjee, Sach] Netherlands Canc Inst, Div Biochem, Amsterdam, Netherlands; [Oates, Chris] Univ Warwick, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England; [Itani, Sleiman; Tomlin, Claire] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Lu, Yiling; Mills, Gordon B.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Oregon Health & Science University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Francisco; Netherlands Cancer Institute; University of Warwick; University of California System; University of California Berkeley; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Gray, JW (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97239 USA.	grayjo@ohsu.edu	Gray, Joe/AAX-9549-2020; Griffith, Obi/P-1286-2014	, James/0000-0002-0030-6216; Griffith, Obi/0000-0002-0843-4271	National Institutes of Health, National Cancer Institute [U54 CA 112970, U24 CA 126477, U01 CA164720]; OHSU Knight Cancer Institute [5P30CA069533-16]; Susan G. Komen Foundation [SAC110012]; Prospect Creek Foundation; NATIONAL CANCER INSTITUTE [U01CA195469, P30CA069533, U01CA164720, U54CA112970, P30CA016672, U24CA126477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OHSU Knight Cancer Institute; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Prospect Creek Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, National Cancer Institute grants U54 CA 112970, the U24 CA 126477, the U01 CA164720, by the OHSU Knight Cancer Institute 5P30CA069533-16, by the Susan G. Komen Foundation SAC110012 and by the Prospect Creek Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Amin DN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000389; BAND V, 1990, CANCER RES, V50, P7351; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Chakrabarty A, 2010, ONCOGENE, V29, P5193, DOI 10.1038/onc.2010.257; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Dave B, 2011, J CLIN ONCOL, V29, P166, DOI 10.1200/JCO.2009.27.7814; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esteva FJ, 2010, AM J PATHOL, V177, P1647, DOI 10.2353/ajpath.2010.090885; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gould CM, 2011, J BIOL CHEM, V286, P28922, DOI 10.1074/jbc.M111.272526; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Heiser LM, 2011, P NATL ACAD SCI US; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Johnston S, 2009, J CLIN ONCOL, V27, P5538, DOI 10.1200/JCO.2009.23.3734; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuo WL, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-77; Lee JJ, 2007, J BIOPHARM STAT, V17, P461, DOI 10.1080/10543400701199593; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Park JW, 2008, CLIN BREAST CANCER, V8, P392, DOI 10.3816/CBC.2008.n.047; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pritchard JR, 2012, DRUG RESIST UPDATE, V15, P249, DOI 10.1016/j.drup.2012.10.003; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Rhodes N, 2008, CANCER RES, V68, P2366, DOI 10.1158/0008-5472.CAN-07-5783; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; She QB, 2003, CLIN CANCER RES, V9, P4340; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Wang LP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-248; Winter GE, 2012, NAT CHEM BIOL, V8, P905, DOI [10.1038/nchembio.1085, 10.1038/NCHEMBIO.1085]	36	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133219	10.1371/journal.pone.0133219	http://dx.doi.org/10.1371/journal.pone.0133219			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26181325	Green Published, Green Submitted, gold			2022-12-27	WOS:000358198200057
J	Zhao, MZ; Lei, CN; Yang, YD; Bu, XL; Ma, HL; Gong, H; Liu, J; Fang, XD; Hu, ZY; Fang, QJ				Zhao, Minzhi; Lei, Chunni; Yang, Yadong; Bu, Xiangli; Ma, Huailei; Gong, He; Liu, Juan; Fang, Xiangdong; Hu, Zhiyuan; Fang, Qiaojun			Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp	PLOS ONE			English	Article							ALBUMIN-BOUND PACLITAXEL; MULTIDRUG-RESISTANCE; CANCER-CELLS; RNA-SEQ; CREMOPHOR-FREE; GENE; GLYCOPROTEIN; ADHESION; ABI-007; PHARMACOKINETICS	P-glycoprotein (P-gp) can actively pump paclitaxel (PTX) out of cells and induces drug resistance. Abraxane, a nanoparticle (NP) formulation of PTX, has multiple clinical advantages over the single molecule form. However, it is still unclear whether Abraxane overcomes the common small molecule drug resistance problem mediated by P-gp. Here we were able to establish an Abraxane-resistant cell line from the lung adenocarcinoma cell line A549. We compared the transcriptome of A549/Abr resistant cell line to that of its parental cell line using RNA-Seq technology. Several pathways were found to be up or down regulated. Specifically, the most significantly up-regulated gene was ABCB1, which translates into P-glycoprotein. We verified the overexpression of P-glycoprotein and confirmed its function by reversing the drug resistance with P-gp inhibitor Verapamil. The results suggest that efflux pathway plays an important role in the Abraxane-resistant cell line we established. However, the relevance of this P-gp mediated Abraxane resistance in tumors of lung cancer patients remains unknown.	[Zhao, Minzhi; Lei, Chunni; Bu, Xiangli; Ma, Huailei; Gong, He; Liu, Juan; Hu, Zhiyuan; Fang, Qiaojun] Chinese Acad Sci, Natl Ctr Nanosci & Technol, CAS Key Lab Biol Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China; [Yang, Yadong; Fang, Xiangdong] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing 100101, Peoples R China; [Hu, Zhiyuan] Beijing Proteome Res Ctr, Beijing Inst Radiat Med, Beijing 102206, Peoples R China	Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Fang, XD (corresponding author), Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing 100101, Peoples R China.	fangxd@big.ac.cn; huzy@nanoctr.cn; fangqj@nanoctr.cn		Liu, Juan/0000-0003-1399-6719; Leggas, Markos/0000-0003-4314-4533	National Natural Science Foundation of China [31270875, 31470049]; Chinese Academy of Science [YZ201217, Y4362911ZX]; International S&T Cooperation Program of China [2010DFB33880]; State Key Development Program for Basic Research of China [2011CB915502]; "Strategic Priority Research Program" of Chinese Academy of Sciences; Stem Cell and Regenerative Medicine Research [XDA01040405]; National Programs for High Technology Research and Development (863 Project) [2012AA022502]; National "Twelfth Five-Year" Plan for Science & Technology Support [2013BAI01B09]; Shanghai Leading Academic Discipline Project [B502]; Shanghai Key Laboratory Project [08DZ2230500]; Science and Technology Commission of Shanghai Municipality Project [11nm0507000]; Scientific Research Foundation for Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); International S&T Cooperation Program of China; State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); "Strategic Priority Research Program" of Chinese Academy of Sciences(Chinese Academy of Sciences); Stem Cell and Regenerative Medicine Research; National Programs for High Technology Research and Development (863 Project); National "Twelfth Five-Year" Plan for Science & Technology Support; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Key Laboratory Project; Science and Technology Commission of Shanghai Municipality Project(Science & Technology Commission of Shanghai Municipality (STCSM)); Scientific Research Foundation for Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	The authors acknowledge funding from the National Natural Science Foundation of China (31270875, 31470049), Chinese Academy of Science (YZ201217, Y4362911ZX), the International S&T Cooperation Program of China (2010DFB33880), the State Key Development Program for Basic Research of China grant (2011CB915502), the "Strategic Priority Research Program" of the Chinese Academy of Sciences, Stem Cell and Regenerative Medicine Research (XDA01040405 to X.F.), National Programs for High Technology Research and Development (863 Projects, 2012AA022502 to X.F.), National "Twelfth Five-Year" Plan for Science & Technology Support (2013BAI01B09 to X.F.), Shanghai Leading Academic Discipline Project (B502), Shanghai Key Laboratory Project (08DZ2230500), Science and Technology Commission of Shanghai Municipality Project (11nm0507000), and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Armstrong SR, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-40; Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/NNANO.2012.45, 10.1038/nnano.2012.45]; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Chen X, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-598; Cukierman E, 2010, BIOCHEM PHARMACOL, V80, P762, DOI 10.1016/j.bcp.2010.04.020; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Desai N, 2006, CLIN CANCER RES, V12, P1317, DOI 10.1158/1078-0432.CCR-05-1634; Desai N, 2007, NAB TECHNOLOGY DRUG, V2008, P37; Dong XW, 2009, CANCER RES, V69, P3918, DOI 10.1158/0008-5472.CAN-08-2747; Dumontet C, 1996, CANCER RES, V56, P1091; Fan JT, 2010, BIOORGAN MED CHEM, V18, P8226, DOI 10.1016/j.bmc.2010.10.019; Gardner ER, 2008, J CHROMATOGR B, V862, P213, DOI 10.1016/j.jchromb.2007.12.013; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Grantab R, 2006, CANCER RES, V66, P1033, DOI 10.1158/0008-5472.CAN-05-3077; Hung TH, 2014, ONCOTARGET, V5, P12273, DOI 10.18632/oncotarget.2631; Hutter G, 2001, PROTEOMICS, V1, P1233; Johnstone RW, 2000, TRENDS BIOCHEM SCI, V25, P1, DOI 10.1016/S0968-0004(99)01493-0; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Ke WF, 2011, MED ONCOL, V28, pS135, DOI 10.1007/s12032-010-9747-1; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Liu JH, 2012, BIOMATERIALS, V33, P6155, DOI 10.1016/j.biomaterials.2012.05.035; Liu Y, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/38/385302; Ma Ping, 2013, J Nanomed Nanotechnol, V4, P1000164; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Matsumura Y, 2009, CANCER SCI, V100, P572, DOI 10.1111/j.1349-7006.2009.01103.x; McGrail DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09529; Metzinger DS, 2006, CANCER LETT, V236, P302, DOI 10.1016/j.canlet.2005.05.016; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Nyman DW, 2005, J CLIN ONCOL, V23, P7785, DOI 10.1200/JCO.2004.00.6148; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pahor M, 1996, LANCET, V348, P493, DOI 10.1016/S0140-6736(96)04277-8; Pahor M, 1996, AM J HYPERTENS, V9, P695, DOI 10.1016/0895-7061(96)00186-0; PANDA D, 1994, P NATL ACAD SCI USA, V91, P11358, DOI 10.1073/pnas.91.24.11358; Riganti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060975; Sahay G, 2010, J CONTROL RELEASE, V145, P182, DOI 10.1016/j.jconrel.2010.01.036; Shain KH, 2001, MOL CANCER THER, V1, P69; Sparreboom A, 2005, CLIN CANCER RES, V11, P4136, DOI 10.1158/1078-0432.CCR-04-2291; Stordal B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040717; TANG C, 1994, LEUKEMIA, V8, P1960; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; van Vlerken Lilian E, 2006, Expert Opin Drug Deliv, V3, P205, DOI 10.1517/17425247.3.2.205; Vara D, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.141; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei CM, 2007, NANOMED-NANOTECHNOL, V3, P322, DOI 10.1016/j.nano.2007.10.005; Yang YD, 2013, GENOMICS, V102, P431, DOI 10.1016/j.ygeno.2013.09.005; Zhang F, 2009, J PROTEOME RES, V8, P5041, DOI 10.1021/pr900461c; Zhang LB, 2013, CLIN CANCER RES, V19, P5972, DOI 10.1158/1078-0432.CCR-13-1485; Zhao XF, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-3	54	66	77	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0131429	10.1371/journal.pone.0131429	http://dx.doi.org/10.1371/journal.pone.0131429			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	26182353	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198200005
J	Chen, LW; Simonsen, N; Liu, L				Chen, Liwei; Simonsen, Neal; Liu, Li			Racial Differences of Pediatric Hypertension in Relation to Birth Weight and Body Size in the United States	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; BLOOD-PRESSURE DIFFERENCES; NATIONAL-HEALTH; CHILDREN; PREVALENCE; PREHYPERTENSION	Background The prevalence of hypertension is known to differ by racial group in adults in the United States (US), but findings in children are scarce and inconsistent. The objective of this study was to assess the racial differences in pediatric hypertension and to explore whether these differences, if any, can be explained by low birth weight (LBW) and obesity. Methods Analyses were performed for participants aged 8-17 years (N = 9,250) included in the 1999-2010 National Health and Nutrition Examination Survey. Multivariate logistic regressions and weighted analysis were carried out considering the complex survey design. Results Compared to non-Hispanic White youth, the crude prevalence of hypertension was significantly higher in non-Hispanic Blacks (7.1% vs. 5.6%; P = 0.04), but not in Mexican Americans (5.4% vs. 5.6%; P = 0.77). Blacks also had higher rates of LBW (14.6% vs. 5.9%; P < 0.001) and obesity (22.9% vs. 15.8%; P < 0.001) than Whites. In stratified analysis by age-sex groups, the Black-White difference in hypertension prevalence was only significant in boys aged 13-17 (9.6% vs. 6.6%). After controlling for age, Black boys had a 51% higher odds of having hypertension (Odds ratio = 1.51; 95% confidence interval: 1.03, 3.43; P = 0.04) compared to White youth at ages 13-17. This racial difference persisted with additional adjustment for birth weight (odds ratio (OR) = 2.00; P = 0.02) and for current body mass index (OR = 1.50; P = 0.04). Mexican American youth had no difference in hypertension prevalence as compared to White youth after adjusting for age, sex, birth weight and obesity (Odds ratio = 0.82; P = 0.16) and in age-sex stratified subgroups. Conclusions Non-Hispanic Black adolescent boys have a significantly higher hypertension rate than their non-Hispanic White counterparts in the US. This racial difference cannot be explained by LBW and current obesity status within the Black population.	[Chen, Liwei] Clemson Univ, Dept Publ Hlth Sci, Clemson, SC USA; [Simonsen, Neal] Louisiana State Univ, Sch Publ Hlth, Hlth Sci Ctr, New Orleans, LA USA; [Liu, Li] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA; [Liu, Li] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Clemson University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Liu, L (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.	lliu26@jhu.edu	liu, li/HGC-0900-2022		School of Public Health, Louisiana State University Health Sciences Center	School of Public Health, Louisiana State University Health Sciences Center	This research was partly supported by School of Public Health, Louisiana State University Health Sciences Center. The authors received no other specific funding for this work.	Bowers K, 2011, PEDIATRICS, V127, pE1272, DOI 10.1542/peds.2010-2213; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; CASEY R, 1992, CLIN PEDIATR, V31, P200, DOI 10.1177/000992289203100402; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; Fattal-Valevski A, 2011, ISR MED ASSOC J, V13, P480; Gidding SS, 2008, CIRCULATION, V117, P3163, DOI 10.1161/CIRCULATIONAHA.108.787168; Lo JC, 2013, PEDIATRICS, V131, pE415, DOI 10.1542/peds.2012-1292; McNiece KL, 2007, J PEDIATR-US, V150, P640, DOI 10.1016/j.jpeds.2007.01.052; Mu M, 2012, ARCH CARDIOVASC DIS, V105, P99, DOI 10.1016/j.acvd.2011.10.006; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ostchega Y, 2009, AM J HYPERTENS, V22, P59, DOI 10.1038/ajh.2008.312; Rosner B, 2000, AM J EPIDEMIOL, V151, P1007, DOI 10.1093/oxfordjournals.aje.a010129; Rosner B, 2013, HYPERTENSION, V62, pE45, DOI 10.1161/HYPERTENSIONAHA.113.02128; Rosner B, 2009, HYPERTENSION, V54, P502, DOI 10.1161/HYPERTENSIONAHA.109.134049; Shay CM, 2013, CIRCULATION, V127, P1369, DOI 10.1161/CIRCULATIONAHA.113.001559; Sorof JM, 2004, PEDIATRICS, V113, P475, DOI 10.1542/peds.113.3.475; Tourangeau R, 2000, SCIENCE OF SELF-REPORT, P29; Wodskou PM, 2010, ACTA OBSTET GYN SCAN, V89, P1134, DOI 10.3109/00016349.2010.500370	19	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132606	10.1371/journal.pone.0132606	http://dx.doi.org/10.1371/journal.pone.0132606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176843	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600130
J	Jemielita, T; Gerton, GL; Neidell, M; Chillrud, S; Yan, BZ; Stute, M; Howarth, M; Saberi, P; Fausti, N; Penning, TM; Roy, J; Propert, KJ; Panettieri, RA				Jemielita, Thomas; Gerton, George L.; Neidell, Matthew; Chillrud, Steven; Yan, Beizhan; Stute, Martin; Howarth, Marilyn; Saberi, Pounw; Fausti, Nicholas; Penning, Trevor M.; Roy, Jason; Propert, Kathleen J.; Panettieri, Reynold A., Jr.			Unconventional Gas and Oil Drilling Is Associated with Increased Hospital Utilization Rates	PLOS ONE			English	Article							SHALE GAS; OPERATIONS; EXTRACTION	Over the past ten years, unconventional gas and oil drilling (UGOD) has markedly expanded in the United States. Despite substantial increases in well drilling, the health consequences of UGOD toxicant exposure remain unclear. This study examines an association between wells and healthcare use by zip code from 2007 to 2011 in Pennsylvania. Inpatient discharge databases from the Pennsylvania Healthcare Cost Containment Council were correlated with active wells by zip code in three counties in Pennsylvania. For overall inpatient prevalence rates and 25 specific medical categories, the association of inpatient prevalence rates with number of wells per zip code and, separately, with wells per km(2) (separated into quantiles and defined as well density) were estimated using fixed-effects Poisson models. To account for multiple comparisons, a Bonferroni correction with associations of p<0.00096 was considered statistically significant. Cardiology inpatient prevalence rates were significantly associated with number of wells per zip code (p<0.00096) and wells per km(2) (p<0.00096) while neurology inpatient prevalence rates were significantly associated with wells per km(2) (p<0.00096). Furthermore, evidence also supported an association between well density and inpatient prevalence rates for the medical categories of dermatology, neurology, oncology, and urology. These data suggest that UGOD wells, which dramatically increased in the past decade, were associated with increased inpatient prevalence rates within specific medical categories in Pennsylvania. Further studies are necessary to address healthcare costs of UGOD and determine whether specific toxicants or combinations are associated with organ-specific responses.	[Jemielita, Thomas; Roy, Jason; Propert, Kathleen J.] Univ Penn, Perelman Sch Med, Dept Biostat, Philadelphia, PA 19104 USA; [Gerton, George L.; Howarth, Marilyn; Saberi, Pounw; Fausti, Nicholas; Penning, Trevor M.; Panettieri, Reynold A., Jr.] Univ Penn, Ctr Excellence Environm Toxicol, Airways Biol Initiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Neidell, Matthew] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY USA; [Chillrud, Steven; Yan, Beizhan] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Columbia University; Columbia University	Panettieri, RA (corresponding author), Univ Penn, Ctr Excellence Environm Toxicol, Airways Biol Initiat, Perelman Sch Med, Philadelphia, PA 19104 USA.	rap@mail.med.upenn.edu	panettieri, reynold/AAG-9485-2019	Penning, Trevor/0000-0002-3937-1066	National Institute of Environmental Health Sciences [P30-ES013508, P30-ES009089]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508, P30ES009089] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by grants from the National Institute of Environmental Health Sciences (www.niehs.nih.gov): P30-ES013508 (GLG MH PS NF TMP JR KJP RAP) and P30-ES009089 (GLG MN SC BY MS MH PS NF TMP JR KJP RAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adgate JL, 2014, ENVIRON SCI TECHNOL, V48, P8307, DOI 10.1021/es404621d; Bernstein AB, 2003, DHHS PUBLICATION, V2004-1031; Colborn T, 2011, HUM ECOL RISK ASSESS, V17, P1039, DOI 10.1080/10807039.2011.605662; Earthworks, EARTHW HYDR FRACT 10, V101; EIA, 2014, ANN EN OUTL 2014; EPA, 2014, PROC HYDR FRACT; Gross SA, 2013, J AIR WASTE MANAGE, V63, P424, DOI 10.1080/10962247.2012.759166; IER, 2012, US LEADS WORLD NAT G; Jackson RB, 2013, P NATL ACAD SCI USA, V110, P11250, DOI 10.1073/pnas.1221635110; Lampe DJ, 2015, J ENVIRON SCI HEAL A, V50, P434, DOI 10.1080/10934529.2015.992653; Lanki T., 2015, ENV HLTH PERSPECT; Macy PG, 2014, ENV HLTH, V13, P82, DOI [10.1186/1476-069X-13-82, DOI 10.1186/1476-069X-13-82]; McKenzie LM, 2014, ENVIRON HEALTH PERSP, V122, P412, DOI 10.1289/ehp.1306722; McKenzie LM, 2012, SCI TOTAL ENVIRON, V424, P79, DOI 10.1016/j.scitotenv.2012.02.018; PA Department of Environmental Protection, 2013, 2013 OIL GAS ANN REP; PA Department of Environmental Protection, 2013, MARC SHAK DEV; Penning TM, 2014, ENVIRON HEALTH PERSP, V122, P1155, DOI 10.1289/ehp.1408207; Rabinowitz PM, 2014, ENV HLTH PERSPECT; Schnoor JL, 2012, ENVIRON SCI TECHNOL, V46, P4686, DOI 10.1021/es3011767; US Government, 2010, 2010 CENS DAT; Warner NR, 2013, ENVIRON SCI TECHNOL, V47, P11849, DOI 10.1021/es402165b; Wooldridge JM, 1999, J ECONOMETRICS, V90, P77, DOI 10.1016/S0304-4076(98)00033-5	22	61	63	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131093	10.1371/journal.pone.0131093	http://dx.doi.org/10.1371/journal.pone.0131093			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176544	Green Published, Green Submitted, gold			2022-12-27	WOS:000358197600036
J	Johnson, V; Xiang, MQ; Chen, Z; Junge, HJ				Johnson, Verity; Xiang, Mengqing; Chen, Zhe; Junge, Harald J.			Neurite Mistargeting and Inverse Order of Intraretinal Vascular Plexus Formation Precede Subretinal Vascularization in Vldlr Mutant Mice	PLOS ONE			English	Article							RETINAL ANGIOMATOUS PROLIFERATION; DENSITY LIPOPROTEIN RECEPTOR; HORIZONTAL CELLS; MOUSE RETINA; MACULAR DEGENERATION; OUTER RETINA; SYNAPSE FORMATION; KNOCKOUT MICE; NEOVASCULARIZATION; AGE	In the retina blood vessels are required to support a high metabolic rate, however, uncontrolled vascular growth can lead to impaired vision and blindness. Subretinal vascularization (SRV), one type of pathological vessel growth, occurs in retinal angiomatous proliferation and proliferative macular telangiectasia. In these diseases SRV originates from blood vessels within the retina. We use mice with a targeted disruption in the Vldl-receptor (Vldlr) gene as a model to study SRV with retinal origin. We find that Vldlr mRNA is strongly expressed in the neuroretina, and we observe both vascular and neuronal phenotypes in Vldlr(-/-)mice. Unexpectedly, horizontal cell (HC) neurites are mistargeted prior to SRV in this model, and the majority of vascular lesions are associated with mistargeted neurites. In Foxn4(-/-)mice, which lack HCs and display reduced amacrine cell (AC) numbers, we find severe defects in intraretinal capillary development. However, SRV is not suppressed in Foxn4(-/-); Vldlr(-/-)mice, which reveals that mistargeted HC neurites are not required for vascular lesion formation. In the absence of VLDLR, the intraretinal capillary plexuses form in an inverse order compared to normal development, and subsequent to this early defect, vascular proliferation is increased. We conclude that SRV in the Vldlr(-/-)model is associated with mistargeted neurites and that SRV is preceded by altered retinal vascular development.	[Johnson, Verity; Chen, Zhe; Junge, Harald J.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Xiang, Mengqing] Rutgers State Univ, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08901 USA; [Xiang, Mengqing] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pediat, Piscataway, NJ 08901 USA; [Xiang, Mengqing] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China	University of Colorado System; University of Colorado Boulder; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Sun Yat Sen University	Junge, HJ (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	harald.junge@colorado.edu	Chen, Zhe/AAI-3485-2020	JUNGE, HARALD/0000-0003-2458-6010; CHEN, ZHE/0000-0003-0683-9491	National Eye Institute [1R01EY024261-01, R01EY020849]; Boettcher Foundation Webb-Waring Biomedical Research Award; Gordon Stone Fellowship; Linda Crnik Institute sponsored Dean's research grant; NATIONAL EYE INSTITUTE [R01EY024261, R01EY020849] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Boettcher Foundation Webb-Waring Biomedical Research Award; Gordon Stone Fellowship; Linda Crnik Institute sponsored Dean's research grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute, 1R01EY024261-01 to HJ, Boettcher Foundation Webb-Waring Biomedical Research Award to HJ, Linda Crnik Institute sponsored Dean's research grant to VJ, Gordon Stone Fellowship to VJ, and National Eye Institute R01EY020849 to MX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Alves CH, 2013, HUM MOL GENET, V22, P35, DOI 10.1093/hmg/dds398; Bayley PR, 2007, J COMP NEUROL, V500, P286, DOI 10.1002/cne.21188; Cai X, 2014, BIOMATERIALS, V35, P249, DOI 10.1016/j.biomaterials.2013.10.022; Chen Y, 2007, J BIOL CHEM, V282, P34420, DOI 10.1074/jbc.M611289200; Chen Y, 2009, MICROVASC RES, V78, P119, DOI 10.1016/j.mvr.2009.02.005; Claes E, 2004, INVEST OPHTH VIS SCI, V45, P2039, DOI 10.1167/iovs.03-0741; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Donovan SL, 2004, VISION RES, V44, P3323, DOI 10.1016/j.visres.2004.08.007; Dorrell MI, 2006, PROG RETIN EYE RES, V25, P277, DOI 10.1016/j.preteyeres.2006.01.001; Dorrell MI, 2009, J CLIN INVEST, V119, P611, DOI 10.1172/JCI35977; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haines JL, 2006, INVEST OPHTH VIS SCI, V47, P329, DOI 10.1167/iovs.05-0116; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Hippenmeyer S, 2014, ADV EXP MED BIOL, V800, P1, DOI 10.1007/978-94-007-7687-6_1; Hu WZ, 2008, INVEST OPHTH VIS SCI, V49, P407, DOI 10.1167/iovs.07-0870; Hua J, 2011, INVEST OPHTH VIS SCI, V52, P2809, DOI 10.1167/iovs.10-6496; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; Ivanova E, 2014, INVEST OPHTH VIS SCI, V55, P78, DOI 10.1167/iovs.13-13196; Jiang AH, 2009, INVEST OPHTH VIS SCI, V50, P844, DOI 10.1167/iovs.08-2447; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kunzevitzky NJ, 2011, MOL CELL NEUROSCI, V46, P731, DOI 10.1016/j.mcn.2011.02.004; Kyosseva SV, 2013, EXP EYE RES, V116, P63, DOI 10.1016/j.exer.2013.08.003; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Li C, 2007, ARCH OPHTHALMOL-CHIC, V125, P795, DOI 10.1001/archopht.125.6.795; Li SG, 2004, NEURON, V43, P795, DOI 10.1016/j.neuron.2004.08.041; Luo L, 2013, ELIFE, V2, DOI 10.7554/eLife.00324; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Marticorena J, 2011, CURR DRUG TARGETS, V12, P199, DOI 10.2174/138945011794182683; Matsuoka RL, 2012, J NEUROSCI, V32, P6859, DOI 10.1523/JNEUROSCI.0267-12.2012; Michalakis S, 2013, CELL MOL LIFE SCI, V70, P1831, DOI 10.1007/s00018-012-1230-z; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Paes KT, 2011, INVEST OPHTH VIS SCI, V52, P6452, DOI 10.1167/iovs.10-7146; Park B, 2011, J NEUROSCI, V31, P17230, DOI 10.1523/JNEUROSCI.4430-11.2011; Poche RA, 2009, DEVELOPMENT, V136, P2141, DOI 10.1242/dev.033175; Rice DS, 2001, NEURON, V31, P929, DOI 10.1016/S0896-6273(01)00436-6; Richard M, 2006, HUM MOL GENET, V15, pR235, DOI 10.1093/hmg/ddl195; Samuel MA, 2014, NAT NEUROSCI, V17, P1190, DOI 10.1038/nn.3772; Samuel MA, 2011, J NEUROSCI, V31, P16033, DOI 10.1523/JNEUROSCI.3580-11.2011; Sapieha P, 2012, BLOOD, V120, P2182, DOI 10.1182/blood-2012-04-396846; Schafer NF, 2009, INVEST OPHTH VIS SCI, V50, P906, DOI 10.1167/iovs.08-1731; Sonntag S, 2012, J NEUROSCI, V32, P10713, DOI 10.1523/JNEUROSCI.0442-12.2012; Takahashi Sadao, 2004, J Atheroscler Thromb, V11, P200; Terzibasi E, 2009, NEUROBIOL AGING, V30, P819, DOI 10.1016/j.neurobiolaging.2007.08.017; Thoreson WB, 2012, PROG RETIN EYE RES, V31, P407, DOI 10.1016/j.preteyeres.2012.04.003; Trotter JH, 2011, J NEUROSCI, V31, P14413, DOI 10.1523/JNEUROSCI.3135-11.2011; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Westenskow PD, 2013, J CLIN INVEST, V123, P4900, DOI 10.1172/JCI70230; Xia CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075186; Xia CH, 2011, INVEST OPHTH VIS SCI, V52, P6572, DOI 10.1167/iovs.10-7082; Xiang MQ, 2013, SCI CHINA LIFE SCI, V56, P985, DOI 10.1007/s11427-013-4543-8; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Zhang J, 2013, SYNAPSE, V67, P515, DOI 10.1002/syn.21674; Zhou XH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016733, 10.1371/journal.pone.0017812]; Zhou YD, 2011, EXP EYE RES, V93, P636, DOI 10.1016/j.exer.2011.07.017	57	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132013	10.1371/journal.pone.0132013	http://dx.doi.org/10.1371/journal.pone.0132013			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177550	gold, Green Published, Green Submitted			2022-12-27	WOS:000358197600079
J	Megas, Z; Martinez, C; Manzano, S; Garcia, A; Rebolloso-Fuentes, MD; Garrido, D; Valenzuela, JL; Jamilena, M				Megas, Zoraida; Martinez, Cecilia; Manzano, Susana; Garcia, Alicia; del Mar Rebolloso-Fuentes, Maria; Garrido, Dolores; Luis Valenzuela, Juan; Jamilena, Manuel			Individual Shrink Wrapping of Zucchini Fruit Improves Postharvest Chilling Tolerance Associated with a Reduction in Ethylene Production and Oxidative Stress Metabolites	PLOS ONE			English	Article							COLD-STORAGE; SHELF-LIFE; QUALITY; INJURY; MAINTENANCE; TEMPERATURE; SQUASH; FILMS; POLYAMINES; RESPIRATION	We have studied the effect of individual shrink wrapping (ISW) on the postharvest performance of refrigerated fruit from two zucchini cultivars that differ in their sensitivity to cold storage: Sinatra (more sensitive) and Natura (more tolerant). The fruit was individually shrink wrapped before storing at 4 degrees C for 0, 7 and 14 days. Quality parameters, ethylene and CO2 productions, ethylene gene expression, and oxidative stress metabolites were assessed in shrink wrapped and non- wrapped fruit after conditioning the fruit for 6 hours at 20 degrees C. ISW decreased significantly the postharvest deterioration of chilled zucchini in both cultivars. Weight loss was reduced to less than 1%, pitting symptoms were completely absent in ISW fruit at 7 days, and were less than 25% those of control fruits at 14 days of cold storage, and firmness loss was significantly reduced in the cultivar Sinatra. These enhancements in quality of ISW fruit were associated with a significant reduction in cold-induced ethylene production, in the respiration rate, and in the level of oxidative stress metabolites such as hydrogen peroxide and malonyldialdehyde (MDA). A detailed expression analysis of ethylene biosynthesis, perception and signaling genes demonstrated a downregulation of CpACS1 and CpACO1 genes in response to ISW, two genes that are upregulated by cold storage. However, the expression patterns of six other ethylene biosynthesis genes (CpACS2 to CpACS7) and five ethylene signal transduction pathway genes (CpCTR1, CpETR1, CpERS1, CpEIN3.1 and CpEN3.2), suggest that they do not play a major role in response to cold storage and ISW packaging. In conclusion, ISW zucchini packaging resulted in improved tolerance to chilling concomitantly with a reduction in oxidative stress, respiration rate and ethylene production, as well as in the expression of ethylene biosynthesis genes, but not of those involved in ethylene perception and sensitivity.	[Megas, Zoraida; Martinez, Cecilia; Manzano, Susana; Garcia, Alicia; Luis Valenzuela, Juan; Jamilena, Manuel] Univ Almeria, Campus Int Excellence ceiA3, Dept Biol & Geol, Agrifood, Almeria 04120, Spain; [del Mar Rebolloso-Fuentes, Maria] Univ Almeria, Campus Int Excellence ceiA3, Dept Agron, Agrifood, Almeria 04120, Spain; [Garrido, Dolores] Univ Granada, Fac Ciencias, Dept Fisiol Vegetal, E-18071 Granada, Spain	Universidad de Almeria; Universidad de Almeria; University of Granada	Jamilena, M (corresponding author), Univ Almeria, Campus Int Excellence ceiA3, Dept Biol & Geol, Agrifood, La Canada de San Urbano S-N, Almeria 04120, Spain.	mjamille@ual.es	Jamilena, Manuel/ABE-9137-2020; Jamilena, Manuel/K-3331-2014; Valenzuela, Juan Luis/L-6974-2014; Manzano, Susana/M-1372-2015; Martínez, Cecilia/AAA-5090-2020; Garrido, Dolores/K-7475-2017	Jamilena, Manuel/0000-0001-7072-0458; Jamilena, Manuel/0000-0001-7072-0458; Valenzuela, Juan Luis/0000-0002-5726-3464; Garrido, Dolores/0000-0002-0426-7146; Martinez, Cecilia/0000-0003-0464-1828	Spanish Ministry of Science and Innovation [AGL2011-30568-C02/ALI, PTA2011-479-I]; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, Spain [AGR1423]; MEC, Spain	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, Spain(Junta de Andalucia); MEC, Spain(Spanish Government)	This work was supported by grants AGL2011-30568-C02/ALI from the Spanish Ministry of Science and Innovation, and AGR1423 from the Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, Spain. Z.M. acknowledges FPU program scholarships from MEC, Spain. S.M. is funded by grant PTA2011-479-I from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; Amoros A, 2008, FOOD SCI TECHNOL INT, V14, P95, DOI 10.1177/1082013208089985; Balandran-Quintana RR, 2003, BIOCHEM BIOPH RES CO, V307, P553, DOI 10.1016/S0006-291X(03)01212-9; Begheldo M, 2008, POSTHARVEST BIOL TEC, V48, P84, DOI 10.1016/j.postharvbio.2007.09.023; BENYEHOSHUA S, 1983, PLANT PHYSIOL, V73, P87, DOI 10.1104/pp.73.1.87; BHOWMIK SR, 1989, LEBENSM WISS TECHNOL, V22, P119; Blanca J, 2011, BMC GENOMICS, P12; Cai C, 2006, POSTHARVEST BIOL TEC, V41, P252, DOI 10.1016/j.postharvbio.2006.04.015; Cantwell M.I., 2011, POSTHARVEST TECHNOLO, P407; Carvajal F, 2015, ANN APPL BIOL, V166, P340, DOI 10.1111/aab.12189; Carvajal F, 2011, SCI HORTIC-AMSTERDAM, V130, P90, DOI 10.1016/j.scienta.2011.06.016; Chiriboga MA, 2013, POSTHARVEST BIOL TEC, V86, P212, DOI 10.1016/j.postharvbio.2013.07.003; Choudhury SR, 2008, J PLANT PHYSIOL, V165, P1865, DOI 10.1016/j.jplph.2008.04.012; COLLINS JK, 1990, HORTSCIENCE, V25, P1409, DOI 10.21273/HORTSCI.25.11.1409; Dhall RK, 2012, J FOOD SCI TECH MYS, V49, P495, DOI 10.1007/s13197-011-0284-5; Diaz-Mula HM, 2011, POSTHARVEST BIOL TEC, V61, P103, DOI 10.1016/j.postharvbio.2011.02.010; El-Sharkawy I, 2003, J EXP BOT, V54, P1615, DOI 10.1093/jxb/erg158; Fahmy Khandra, 2014, Environmental Control in Biology, V52, P233, DOI 10.2525/ecb.52.233; Fante CA, 2014, FOOD SCI TECH-BRAZIL, V34, P309, DOI 10.1590/fst.2014.0044; Floros JD, 2005, INNOVATIONS IN FOOD PACKAGING, P159, DOI 10.1016/B978-012311632-1/50042-5; Goulas V, 2014, FOOD CHEM, V155, P227, DOI 10.1016/j.foodchem.2014.01.054; Guillen F, 2013, POSTHARVEST BIOL TEC, V83, P54, DOI 10.1016/j.postharvbio.2013.03.011; Hariyadi P., 1991, Postharvest Biology and Technology, V1, P33, DOI 10.1016/0925-5214(91)90017-6; Hertog MLATM, 1998, POSTHARVEST BIOL TEC, V14, P335, DOI 10.1016/S0925-5214(98)00058-1; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Ilic ZS, 2012, INT J FOOD SCI TECH, V47, P83, DOI 10.1111/j.1365-2621.2011.02810.x; Lado J, 2015, POSTHARVEST BIOL TEC, V100, P176, DOI 10.1016/j.postharvbio.2014.10.002; LEE DS, 1991, J FOOD SCI, V56, P1580, DOI 10.1111/j.1365-2621.1991.tb08645.x; Lin ZF, 2008, PLANT J, V54, P1083, DOI 10.1111/j.1365-313X.2008.03481.x; Manzano S, 2013, J PLANT GROWTH REGUL, V32, P789, DOI 10.1007/s00344-013-9344-6; Martinez C, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-139; Martinez-Romero D, 2013, POSTHARVEST BIOL TEC, V86, P107, DOI 10.1016/j.postharvbio.2013.06.022; Martinez-Tellez MA, 2002, BIOCHEM BIOPH RES CO, V295, P98, DOI 10.1016/S0006-291X(02)00631-9; Megias Z, 2014, LWT-FOOD SCI TECHNOL, V57, P194, DOI 10.1016/j.lwt.2013.12.044; MENCARELLI F, 1983, J AM SOC HORTIC SCI, V108, P884; Nanda S, 2001, POSTHARVEST BIOL TEC, V22, P61, DOI 10.1016/S0925-5214(00)00181-2; Palma F, 2015, POSTHARVEST BIOL TEC, V99, P131, DOI 10.1016/j.postharvbio.2014.08.010; Palma F, 2014, PLANT PHYSIOL BIOCH, V82, P161, DOI 10.1016/j.plaphy.2014.06.001; Pesis E, 2002, POSTHARVEST BIOL TEC, V26, P157, DOI 10.1016/S0925-5214(02)00024-8; PRETEL MT, 1993, FOOD SCI TECHNOL-LEB, V26, P8, DOI 10.1006/fstl.1993.1002; Rao SDV, 2000, INDIAN FOOD PACK, V54, P65; Rugkong A, 2011, POSTHARVEST BIOL TEC, V61, P1, DOI 10.1016/j.postharvbio.2011.02.009; Serrano M, 2006, POSTHARVEST BIOL TEC, V39, P61, DOI 10.1016/j.postharvbio.2005.08.004; Serrano M, 2005, INNOV FOOD SCI EMERG, V6, P115, DOI 10.1016/j.ifset.2004.09.001; Serrano M, 1998, J AGR FOOD CHEM, V46, P2465, DOI 10.1021/jf970864c; Sevillano L, 2009, J SCI FOOD AGR, V89, P555, DOI 10.1002/jsfa.3468; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Sharma RR, 2013, J FOOD SCI TECH MYS, V50, P590, DOI 10.1007/s13197-011-0332-1; Singh SP, 2005, J FOOD SCI TECH MYS, V42, P523; Sonkar RK, 1999, J FOOD SCI TECH MYS, V36, P273; Tano K, 2007, POSTHARVEST BIOL TEC, V46, P212, DOI 10.1016/j.postharvbio.2007.05.008; WANG CY, 1995, POSTHARVEST BIOL TEC, V5, P67, DOI 10.1016/0925-5214(94)00020-S; Wang CY, 1997, POSTHARVEST BIOL TEC, V10, P195, DOI 10.1016/S0925-5214(97)01405-1; WANG CY, 1989, SCI HORTIC-AMSTERDAM, V39, P1, DOI 10.1016/0304-4238(89)90031-9; Wang P, 2010, J EXP BOT, V61, P179, DOI 10.1093/jxb/erp302; Wong WS, 2001, PLANT SCI, V161, P969, DOI 10.1016/S0168-9452(01)00505-2; Xie XB, 2014, POSTHARVEST BIOL TEC, V97, P1, DOI 10.1016/j.postharvbio.2014.06.002; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Yin XR, 2009, POSTHARVEST BIOL TEC, V52, P9, DOI 10.1016/j.postharvbio.2008.09.016; Zou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116002	60	14	14	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133058	10.1371/journal.pone.0133058	http://dx.doi.org/10.1371/journal.pone.0133058			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177024	Green Published, gold			2022-12-27	WOS:000358197600207
J	Monden, R; Wardenaar, KJ; Stegeman, A; Conradi, HJ; de Jonge, P				Monden, Rei; Wardenaar, Klaas J.; Stegeman, Alwin; Conradi, Henk Jan; de Jonge, Peter			Simultaneous Decomposition of Depression Heterogeneity on the Person-, Symptom- and Time-Level: The Use of Three-Mode Principal Component Analysis	PLOS ONE			English	Article							MAJOR DEPRESSION; PSYCHOMETRIC PROPERTIES; PRIMARY-CARE; INVENTORY; REMISSION; DISORDER; RECOVERY; PSYCHOPATHOLOGY; CLASSIFICATION; DIMENSIONS	Although heterogeneity of depression hinders research and clinical practice, attempts to reduce it with latent variable models have yielded inconsistent results, probably because these techniques cannot account for all interacting sources of heterogeneity at the same time. Therefore, to simultaneously decompose depression heterogeneity on the person-, symptom and time-level, three-mode Principal Component Analysis (3MPCA) was applied to data of 219 Major Depression patients, who provided Beck Depression Inventory assessments every three months for two years. The resulting person-level components were correlated with external baseline clinical and demographic variables. The 3MPCA extracted two symptom-level components ('cognitive', 'somatic-affective'), two time-level components ('improving', 'persisting') and three person-level components, characterized by different interaction-patterns between the symptom-and time-components ('severe non-persisting', 'somatic depression' and 'cognitive depression'). This model explained 28% of the total variance and 65% when also incorporating the general trend in the data). Correlations with external variables illustrated the content differentiation between the person-components. Severe non-persisting depression was positively correlated with psychopathology (r=0.60) and negatively with quality of life (r=-0.50). Somatic depression was negatively correlated with physical functioning (r=-0.45). Cognitive depression was positively correlated with neuroticism (r=0.38) and negatively with self-esteem (r=-0.47). In conclusion, 3MPCA decomposes depression into homogeneous entities, while accounting for the interactions between different sources of heterogeneity, which shows the utility of the technique to investigate the underlying structure of complex psychopathology data and could help future development of better empirical depression subtypes.	[Monden, Rei; Wardenaar, Klaas J.; de Jonge, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Stegeman, Alwin] Univ Groningen, Heijmans Inst Psychol Res, Dept Psychometr & Stat, Groningen, Netherlands; [Conradi, Henk Jan] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands	University of Groningen; University of Groningen; University of Amsterdam	Monden, R (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	r.tendeiro-monden@umcg.nl	Wardenaar, Klaas J./E-2985-2013; de Jonge, Peter/L-6395-2013	Monden, Rei/0000-0003-1744-5447; de Jonge, Peter/0000-0002-0866-6929	VICI grant from Netherlands Organization for Scientific Research (NWO-ZonMW) [91812607]; NWO; Medical Sciences Program; Chronic Diseases Program; Research Foundations of Health Insurance Company 'Het Groene Land'; Regional Health Insurance Company (RZG); National Fund Mental Health (NFGV); University Medical Center Groningen; Dutch Organisation for Scientific Research (NWO), VIDI grant [452-08-001]	VICI grant from Netherlands Organization for Scientific Research (NWO-ZonMW)(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO)); Medical Sciences Program; Chronic Diseases Program; Research Foundations of Health Insurance Company 'Het Groene Land'; Regional Health Insurance Company (RZG); National Fund Mental Health (NFGV); University Medical Center Groningen; Dutch Organisation for Scientific Research (NWO), VIDI grant(Netherlands Organization for Scientific Research (NWO))	The current study was supported by a VICI grant (no: 91812607) received by Peter de Jonge from the Netherlands Organization for Scientific Research (NWO-ZonMW). The trial from which the data were sourced was supported by grants from NWO, Medical Sciences Program and Chronic Diseases Program, Research Foundations of Health Insurance Company 'Het Groene Land', Regional Health Insurance Company (RZG), National Fund Mental Health (NFGV), and the University Medical Center Groningen. The research of Alwin Stegeman is supported by the Dutch Organisation for Scientific Research (NWO), VIDI grant 452-08-001.	Abbott A, 2008, NATURE, V454, P154, DOI 10.1038/454154a; [Anonymous], 1963, PROBLEMS MEASURING C; [Anonymous], 1997, COMP INT DIAGN INT C; Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; BECK AT, 1988, COGNITIVE THER RES, V12, P459, DOI 10.1007/BF01173413; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Catteil R.B., 1966, HDB MULTIVARIATE EXP, P67; CLARK LA, 1995, ANNU REV PSYCHOL, V46, P121, DOI 10.1146/annurev.ps.46.020195.001005; COLLINS LM, 1992, MULTIVAR BEHAV RES, V27, P131, DOI 10.1207/s15327906mbr2701_8; Conradi HJ, 2007, PSYCHOL MED, V37, P849, DOI 10.1017/S0033291706009809; Conradi HJ, 2012, DEPRESS ANXIETY, V29, P638, DOI 10.1002/da.21960; Corruble E, 1999, J AFFECT DISORDERS, V56, P95, DOI 10.1016/S0165-0327(99)00055-5; Costa Jr PT, 1978, NEO PI FFI MANUAL SU; de Jonge P, 2006, AM J PSYCHIAT, V163, P138, DOI 10.1176/appi.ajp.163.1.138; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; FLECK MPA, 1995, ACTA PSYCHIAT SCAND, V92, P168, DOI 10.1111/j.1600-0447.1995.tb09562.x; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; Greenberg DL, 2008, PSYCHIAT RES-NEUROIM, V163, P126, DOI 10.1016/j.pscychresns.2007.12.009; HASLAM N, 1993, J NERV MENT DIS, V181, P725, DOI 10.1097/00005053-199312000-00003; Honaker J., 2012, AMELIA 2 PROGRAM MIS; Hybels CF, 2009, AM J GERIAT PSYCHIAT, V17, P387, DOI 10.1097/JGP.0b013e31819431ff; KELLER MB, 1992, ARCH GEN PSYCHIAT, V49, P809; Kiers HAL, 1998, J CLASSIF, V15, P245, DOI 10.1007/s003579900033; Kiers HAL, 2000, J CHEMOMETR, V14, P151, DOI 10.1002/1099-128X(200005/06)14:3<151::AID-CEM585>3.0.CO;2-G; Kiers HAL, 2003, BRIT J MATH STAT PSY, V56, P119, DOI 10.1348/000711003321645386; Kiers HAL, 2001, PSYCHOL METHODS, V6, P84, DOI 10.1037/1082-989X.6.1.84; Kraemer HC, 2007, INT J METH PSYCH RES, V16, pS8, DOI 10.1002/mpr.211; Kroonenberg PM, 2012, CURR ANAL CHEM, V8, P224; KROONENBERG PM, 1980, PSYCHOMETRIKA, V45, P69, DOI 10.1007/BF02293599; Kroonenberg PM, 2002, STAT METHODS MED RES, V11, P275, DOI 10.1191/0962280202sm287ra; Kroonenberg PM, 2008, WILEY SERIES PROBAB; Lamers F, 2010, J CLIN PSYCHIAT, V71, P1582, DOI 10.4088/JCP.09m05398blu; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; Lubke GH, 2005, PSYCHOL METHODS, V10, P21, DOI 10.1037/1082-989X.10.1.21; Lux V, 2010, PSYCHOL MED, V40, P1691, DOI 10.1017/S0033291709992066; Magidson J, 2004, HDB QUANTITATIVE MET, P175, DOI DOI 10.4135/9781412986311.N19; Nagin DS, 2001, PSYCHOL METHODS, V6, P18, DOI 10.1037/1082-989X.6.1.18; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Romera I, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-4; Rosenberg M, 1965, SOC ADOLESCENT CHILD; Rush AJ, 2007, J CLIN PSYCHIAT, V68, P4; Shafer AB, 2006, J CLIN PSYCHOL, V62, P123, DOI 10.1002/jclp.20213; STEER RA, 1987, J PSYCHOPATHOL BEHAV, V9, P327, DOI 10.1007/BF00964561; Sullivan PF, 1998, AM J PSYCHIAT, V155, P1398, DOI 10.1176/ajp.155.10.1398; Ten Berge JMF, 1977, PSYCHOMETRIKA, V42, P267, DOI 10.1007/BF02294053; Ter Smitten MH, 1988, COMPOSITE INT DIAGNO; Timmerman ME, 2000, BRIT J MATH STAT PSY, V53, P1, DOI 10.1348/000711000159132; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464; van Loo HM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-156; Van Mechelen I, 1999, EUR J PERSONALITY, V13, P409, DOI 10.1002/(SICI)1099-0984(199909/10)13:5<409::AID-PER360>3.0.CO;2-I; Wardenaar KJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-201; Wardenaar KJ, 2010, J AFFECT DISORDERS, V125, P146, DOI 10.1016/j.jad.2009.12.020; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Widiger TA, 2000, PSYCHOL BULL, V126, P946, DOI 10.1037//0033-2909.126.6.946; Zimmerman M, 2006, AM J PSYCHIAT, V163, P148, DOI 10.1176/appi.ajp.163.1.148	57	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132765	10.1371/journal.pone.0132765	http://dx.doi.org/10.1371/journal.pone.0132765			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177365	Green Published, gold			2022-12-27	WOS:000358197600151
J	Wu, X; Fu, XW; Guo, JL; Zhao, XC; Wu, KM				Wu, Xiao; Fu, Xiaowei; Guo, Jianglong; Zhao, Xincheng; Wu, Kongming			Annual Migration of Cabbage Moth, Mamestra brassicae L. (Lepidoptera: Noctuidae), over the Sea in Northern China	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; BOHAI SEA; AUTUMN MIGRATION; CNAPHALOCROCIS-MEDINALIS; SEASONAL MIGRATION; JUVENILE-HORMONE; INSECT MIGRATION; RADAR; FLIGHT; PYRALIDAE	The cabbage moth, Mamestra brassicae L. (Lepidoptera: Noctuidae), is a serious pest of vegetable crops throughout the world. In order to determine whether or not M. brassicae is a migrant, and if yes, what is the pattern of M. brassicae seasonal migration, a long-term study on M. brassicae from April to October in 2003-2014 was carried out by means of a searchlight trap on a small island located in the center of the Bohai Strait. The results show that a large number of M. brassicae were trapped every year on the island, which indicates that M. brassicae is a migrant and migrated at least 40-60 km across the Bohai Strait. The mean migration period of M. brassicae over the sea within one year is 151 +/- 8 d in 2003-2014, with the shortest time span 78 d in 2003 and the longest 189 d in 2014, respectively. The number of M. brassicae captured, however, varies considerably between months or years. The majority of captures were female, with different levels of ovarian development and mating status. Most of the females trapped in May-July during 2010-2014 had a high mating rate and advanced level of ovarian development, suggesting that the migration of this species does not conform to the hypothesis of 'oogenesis-flight syndrome'. The findings of the present study are beneficial to the development of forecasting systems and management strategies of M. brassicae.	[Wu, Xiao; Fu, Xiaowei; Guo, Jianglong; Wu, Kongming] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Wu, Xiao; Guo, Jianglong; Zhao, Xincheng] Henan Agr Univ, Coll Plant Protect, Dept Entomol, Zhengzhou 450002, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Henan Agricultural University	Wu, KM (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn			National Natural Science Foundation of China [31321004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National Natural Science Foundation of China (grant number 31321004) to KMW (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmospheric science dictionary editorial committee, 1994, ATMOSPHERIC SCI DICT, P1; BUHLER A, 1983, J INSECT PHYSIOL, V29, P885, DOI 10.1016/0022-1910(83)90051-3; Carde RT, 2008, CURR BIOL, V18, pR1007, DOI 10.1016/j.cub.2008.09.013; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; CUSSON M, 1990, J INSECT PHYSIOL, V36, P139, DOI 10.1016/0022-1910(90)90185-I; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; DRAKE VA, 1988, ANNU REV ENTOMOL, V33, P183, DOI 10.1146/annurev.en.33.010188.001151; Feng H.Q., 2010, China Patent, Patent No. [CN201020229775.3, 2010202297753, 201020229775.3]; Feng HQ, 2008, ENVIRON ENTOMOL, V37, P774, DOI 10.1603/0046-225X(2008)37[774:AMOMSL]2.0.CO;2; Feng HQ, 2006, ECOL ENTOMOL, V31, P511, DOI 10.1111/j.1365-2311.2006.00813.x; Feng HQ, 2009, J ECON ENTOMOL, V102, P95, DOI 10.1603/029.102.0114; Feng HQ, 2005, J INSECT BEHAV, V18, P335, DOI 10.1007/s10905-005-3694-2; Feng HQ, 2004, J ECON ENTOMOL, V97, P1874, DOI 10.1603/0022-0493-97.6.1874; Feng HQ, 2004, ENVIRON ENTOMOL, V33, P1253, DOI 10.1603/0046-225X-33.5.1253; Feng HQ, 2003, B ENTOMOL RES, V93, P115, DOI 10.1079/BER2002221; Finch S., 1992, P87; Fu XW, 2014, CROP PROT, V64, P143, DOI 10.1016/j.cropro.2014.06.021; Fu XW, 2014, J ECON ENTOMOL, V107, P1399, DOI 10.1603/EC13380; Gan GF, 1997, SUGAR CROPS CHINA, V1, P20; Heinrich B., 1993, HOT BLOODED INSECTS; HUANG L, 2007, ENCY KNOWLEDGE, V7, P4; IBM Corp, 2011, IBM SPSS STAT 20 BRI; JOHNSON CG, 1963, NATURE, V198, P423, DOI 10.1038/198423a0; Johnson CG, 1969, MIGRATION DISPERSAL, P1; KOERWITZ F. L., 1964, J KANS ENTOMOL SOC, V37, P234; Li R.D, 1987, OVARIAN DISSECTION I; Luo Lizhi, 1995, Acta Entomologica Sinica, V38, P284; OGAARD L, 1983, Entomologiske Meddelelser, V50, P36; Ou YF, 2013, CHINESE J APPL ENTOM, V50, P305; Qi G.J., 2011, CHINA PLANT PROT, V31, P18; Rankin M.A., 1986, P27; RILEY JR, 1995, B ENTOMOL RES, V85, P397, DOI 10.1017/S0007485300036130; Rojas JC, 2000, J INSECT BEHAV, V13, P247, DOI 10.1023/A:1007792332046; SAS Institute, 1990, SAS STAT US GUID; SHI BC, 2005, CHINA VEGET, V9, P56; Showers WB, 1997, ANNU REV ENTOMOL, V42, P393, DOI 10.1146/annurev.ento.42.1.393; TURNOCK WJ, 1995, BIOCONTROL SCI TECHN, V5, P55, DOI 10.1080/09583159550040015; van Geffen KG, 2014, ECOL EVOL, V4, P2082, DOI 10.1002/ece3.1090; WADA T, 1988, ENTOMOL EXP APPL, V46, P141, DOI 10.1007/BF00190844; Wu Kong-ming, 2006, Acta Phytophylacica Sinica, V33, P163; Wu Kongming, 1998, Acta Phytophylacica Sinica, V25, P337; WU KQ, 2013, J AGR, V3, P25; ZHANG XX, 2008, J SHANXI AGR U NAT S, V28, P442	43	15	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132904	10.1371/journal.pone.0132904	http://dx.doi.org/10.1371/journal.pone.0132904			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176951	Green Published, gold, Green Submitted			2022-12-27	WOS:000358197600176
J	Duan, JL; Hu, HH; Wang, G; Arao, T				Duan, Jiali; Hu, Huanhuan; Wang, Guan; Arao, Takashi			Study on Current Levels of Physical Activity and Sedentary Behavior among Middle School Students in Beijing, China	PLOS ONE			English	Article							BLOOD-PRESSURE; METABOLIC SYNDROME; SCREEN-TIME; ADOLESCENTS; CHILDREN; INACTIVITY; OBESITY; NUTRITION; OVERWEIGHT; HEALTH	Introduction This study aimed to determine current levels of physical activity and sedentary behavior in middle school students on the basis of grade, sex, student attitudes toward physical education, and residence location. Methods In 2013, a cross-sectional study of 1793 students aged 12 to 15 years was conducted across eight middle schools in Beijing, China. Four schools were selected from an urban district and another four schools were from a suburban district. Physical activity and sedentary behavior data were collected using the commonly used school-based Chinese version of the China Health and Nutrition Survey. Results The mean age of sampled students was 13.3 +/- 1.0 years; 51.5% were boys. Approximately 76.6% of students reported having three 45-minute physical education classes every week. A total of 35.6% students spent >= 1 h/day performing moderate to vigorous physical activity (MVPA) during school, and 34.9% spent >= 1 h/day in MVPA outside school time. Approximately half (49.7%) of the students engaged in reading, writing, or drawing for >= 2 h/day, and 42.9% reported screen time for >= 2 h/day. Although boys spent more time engaged in physical activity than girls did, they also spent more time exhibiting sedentary behavior. Each 10-unit increase in attitudes toward physical education was associated with an increased odds of 1.15 (95% CI: 1.09-1.20) for spending more than 1 h/day on MVPA. Students in suburban schools reported engaging in physical activity less when compared with those in urban schools. Conclusion The majority of our students did not meet the current physical activity recommendations, and about half of the students spent excessive time engaging in sedentary behaviors. Findings from this study highlight a positive association between student attitudes toward physical education and physical activity. Studies are needed to further explore the role of student attitudes toward physical education in promoting physical activity among Chinese students.	[Duan, Jiali; Wang, Guan] Beijing Ctr Dis Control & Prevent, Inst Sch Hlth, Beijing, Peoples R China; [Hu, Huanhuan] Waseda Univ, Sch Sport Sci, Lab Exercise Epidemiol, Saitama, Japan; [Arao, Takashi] Waseda Univ, Fac Sport Sci, Lab Exercise Epidemiol, Saitama, Japan	Waseda University; Waseda University	Hu, HH (corresponding author), Waseda Univ, Sch Sport Sci, Lab Exercise Epidemiol, Saitama, Japan.	hu.huanhuan@yahoo.com	Duan, Jiaobo/AAA-8651-2019		GCOE in Waseda University	GCOE in Waseda University	This research was supported by grant of GCOE in Waseda University (http://www.sport-sciences-gcoe-waseda.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Albarwani S, 2009, METAB SYNDR RELAT D, V7, P369, DOI 10.1089/met.2008.0052; Bucksch J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-351; Cao H, 2011, PREV MED, V53, P316, DOI 10.1016/j.ypmed.2011.09.002; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Chen Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-744; Cothran DJ, 1998, J TEACH PHYS EDUC, V17, P307, DOI 10.1123/jtpe.17.3.307; Cui ZH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-93; Ding HY, 2014, QUEST, V66, P117, DOI 10.1080/00336297.2013.821415; Ennis, 2003, STUDENT LEARNING PHY, P207; Gordon-Larsen P, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e83; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hobbs M, 2015, BRIT J SPORT MED, V49, P1179, DOI 10.1136/bjsports-2014-093754; Hu HH, 2014, ADV PHYS ED, V4, P181, DOI DOI 10.4236/APE.2014.44022; Jiang XX, 2014, J EPIDEMIOL, V24, P397, DOI 10.2188/jea.JE20140006; Kristjansdottir G, 2001, ACTA PAEDIATR, V90, P429, DOI 10.1111/j.1651-2227.2001.tb00445.x; Lam JWK, 2010, PREV MED, V51, P96, DOI 10.1016/j.ypmed.2010.04.017; Leary SD, 2008, HYPERTENSION, V51, P92, DOI 10.1161/HYPERTENSIONAHA.107.099051; Leatherdale ST, 2008, INT J PEDIATR OBES, V3, P93, DOI 10.1080/17477160701830879; LeBlanc AGW, 2010, PEDIATR EXERC SCI, V22, P523, DOI 10.1123/pes.22.4.523; Lees C, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.130010; Li M, 2007, J ADOLESCENT HEALTH, V41, P99, DOI 10.1016/j.jadohealth.2007.02.005; Liang YJ, 2011, BLOOD PRESSURE, V20, P45, DOI 10.3109/08037051.2010.524085; Liu JH, 2008, J RURAL HEALTH, V24, P407, DOI 10.1111/j.1748-0361.2008.00188.x; Liu WJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-780; Lutfiyya MN, 2007, OBESITY, V15, P2348, DOI 10.1038/oby.2007.278; Martinez-Gomez D, 2011, ARCH DIS CHILD, V96, P240, DOI 10.1136/adc.2010.187161; PORTMAN PA, 1995, J TEACH PHYS EDUC, V14, P445, DOI 10.1123/jtpe.14.4.445; Rey-Lopez JP, 2008, NUTR METAB CARDIOVAS, V18, P242, DOI 10.1016/j.numecd.2007.07.008; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Schmitz KH, 2002, PREV MED, V34, P266, DOI 10.1006/pmed.2001.0982; Shi ZM, 2006, PREV MED, V43, P218, DOI 10.1016/j.ypmed.2006.04.017; Sigmundova D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-731; Silva K, 2014, INT J PUBLIC HEALTH, V59, P77, DOI 10.1007/s00038-013-0464-3; Springer AE, 2009, PREV CHRONIC DIS, V6; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Tandon PS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-88; Tian BenChun, 2007, International Electronic Journal of Health Education, V10, P35; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P65, DOI 10.1139/H11-013; Tudor-Locke C, 2003, INT J OBESITY, V27, P1093, DOI 10.1038/sj.ijo.0802377; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Wang CKJ, 2010, INT J SPORT EXERC PS, V8, P284, DOI 10.1080/1612197X.2010.9671954; Welk GJ, 1999, QUEST, V51, P5, DOI 10.1080/00336297.1999.10484297; Wu Tsu-Yin, 2006, J Sch Nurs, V22, P25, DOI 10.1177/10598405060220010501; Zhang YX, 2013, ANN HUM BIOL, V40, P88, DOI 10.3109/03014460.2012.740073	45	34	38	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2015	10	7							e0133544	10.1371/journal.pone.0133544	http://dx.doi.org/10.1371/journal.pone.0133544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RQ	25664813	Green Published, gold, Green Submitted			2022-12-27	WOS:000358198200066
J	Duan, JB; Fu, JF; Gao, HJ; Chen, CS; Fu, JF; Shi, X; Liu, XF				Duan, Jiaobo; Fu, Jufang; Gao, Hongjie; Chen, Changsheng; Fu, Jianfang; Shi, Xin; Liu, Xufeng			Factor Analysis of the Caregiver Quality of Life Index-Cancer (CQOLC) Scale for Chinese Cancer Caregivers: A Preliminary Reliability and Validity Study of the CQOLC-Chinese Version	PLOS ONE			English	Article							FAMILY CAREGIVER; SURVIVORS; HOME	The English version of the Caregiver Quality of Life Index-Cancer (CQOLC) was translated into simplified Chinese (CQOLC-C), following cultural translation, back-translation and pretest steps. Three hundred and sixty one cancer caregivers participated in this study. Cronbach's alpha was used to assess CQOLC-C reliability. Exploratory factor analyses (EFA) was used to generate two models of the measure's factor structure, and confirmatory factor analyses (CFA) were used to test each model, such that the best model to explain the latent structure of the CQOLC-C was identified. EFA using different factor extraction methods yielded two models including four and eight factors. According to the CFA results, model 2 was better fit for the original study data, based on the RMSEA criterion [ 0.058(90% CI = 0.051-0.065)],X-2 (531) = 853.92, p < 0.0001; CFI (0.96), NNFI (0.96), IFI (0.97), and NFI (0.92). We also examined the effect of removing three items on the CQOLC-C factor structure and discuss the resulting differences from other versions. These results indicate that the CQOLC-C's factor structure does not fully fit the original theorized model. This study provides preliminary support for further use of the CQOLC-C. However, the present work provides only partial support for the relevance and construct validity of the scale for Chinese caregivers.	[Duan, Jiaobo; Liu, Xufeng] Fourth Mil Med Univ, Sch Psychol, Xian 710032, Shaanxi, Peoples R China; [Fu, Jufang] Fourth Mil Med Univ, Infect Control Ctr, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Gao, Hongjie] Fourth Mil Med Univ, Sch Prevent Med, Dept Hlth Serv, Xian 710032, Shaanxi, Peoples R China; [Chen, Changsheng] Fourth Mil Med Univ, Sch Prevent Med, Dept Stat, Xian 710032, Shaanxi, Peoples R China; [Fu, Jianfang] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol, Xian 710032, Shaanxi, Peoples R China; [Shi, Xin] Fourth Mil Med Univ, Sch Pharm, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Liu, XF (corresponding author), Fourth Mil Med Univ, Sch Psychol, Xian 710032, Shaanxi, Peoples R China.	lllfmmu@fmmu.edu.cn	Duan, Jiaobo/AAA-8651-2019		Fourth Military Medical University Scientific Research Projects	Fourth Military Medical University Scientific Research Projects	This study received external funding from the Fourth Military Medical University Scientific Research Projects. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACWF (All Chinese Women's Federation), 2008, NAT RUR LEFT BEH CHI; Bektas HA, 2009, J CLIN NURS, V18, P3003, DOI 10.1111/j.1365-2702.2009.02915.x; Bergelt C, 2008, QUAL LIFE RES, V17, P653, DOI 10.1007/s11136-008-9349-y; Cella D F, 1996, Oncology (Williston Park), V10, P233; Chen WQ, 2011, CANC FAR US CHINESE; Cong HW, 2007, MEASUREMENTS APPL QU, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Ferrell B, 1991, Hosp J, V7, P9; Ferrell B R, 1995, Oncol Nurs Forum, V22, P1211; Ferrell BR, 1995, QUAL LIFE RES, V4, P523, DOI 10.1007/BF00634747; Fu YD, 2012, XUE SHU YUE KAN, V5, P9; Given BA, 2001, CA-CANCER J CLIN, V51, P213, DOI 10.3322/canjclin.51.4.213; Haley William E, 2003, J Palliat Med, V6, P215; HINDS C, 1985, J ADV NURS, V10, P575, DOI 10.1111/j.1365-2648.1985.tb00550.x; Hodges LJ, 2005, SOC SCI MED, V60, P1, DOI 10.1016/j.socscimed.2004.04.018; Huang LL, 2012, EC RES GUIDE, V21, P238; John F, 2003, J PAIN SYMPTOM MANAG, V26, P922; Kim Y, 2008, CANCER-AM CANCER SOC, V112, P2556, DOI 10.1002/cncr.23449; Lafaye A, 2013, QUAL LIFE RES, V22, P119, DOI 10.1007/s11136-012-0113-y; Li DH, 2012, LIAONING DA XUE XUE, P22; Lu QQ, 2010, SIXIANG ZHENG ZHI GO, P10; McMillan S C, 1994, Oncol Nurs Forum, V21, P1189; National Office of Aging Beijing, 2010, URB RUR AG PEOPL STA; Otis WB, 2010, 16 INT C CANC NURS U, P1; Ozer ZC, 2009, QUAL LIFE RES, V18, P913, DOI 10.1007/s11136-009-9503-1; Panke JT, 2004, OXFORD TXB PALLIATIV; Pitceathly C, 2003, EUR J CANCER, V39, P1517, DOI 10.1016/S0959-8049(03)00309-5; Rhee YS, 2005, QUAL LIFE RES, V14, P899, DOI 10.1007/s11136-004-1264-2; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Shultz K. S., 2004, MEASUREMENT THEORY A; Su CT, 2002, AM J OCCUP THER, V56, P581, DOI 10.5014/ajot.56.5.581; Tang WR, 2009, CANCER NURS, V32, P220, DOI 10.1097/NCC.0b013e31819b5ae8; Weitzner M A, 1997, Cancer Pract, V5, P25; Weitzner MA, 1999, QUAL LIFE RES, V8, P55, DOI 10.1023/A:1026407010614; Weitzner MA, 1999, J PAIN SYMPTOM MANAG, V17, P418, DOI 10.1016/S0885-3924(99)00014-7; Weitzner MA, 1999, J PALLIAT CARE, V15, P13, DOI 10.1177/082585979901500203; Xia Q, 2012, ZHONGGUO JIA TING JI, V2, P13	36	34	38	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0116438	10.1371/journal.pone.0116438	http://dx.doi.org/10.1371/journal.pone.0116438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UO	25664813	gold, Green Published, Green Submitted			2022-12-27	WOS:000349123100009
